PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhou, JZ; Riquelme, MA; Gu, S; Kar, R; Gao, X; Sun, L; Jiang, JX				Zhou, J. Z.; Riquelme, M. A.; Gu, S.; Kar, R.; Gao, X.; Sun, L.; Jiang, J. X.			Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasis	ONCOGENE			English	Article							GAP-JUNCTION HEMICHANNELS; HUMAN-TUMOR-CELLS; PARATHYROID-HORMONE; IN-VIVO; INTERCELLULAR COMMUNICATION; PHYSICAL-ACTIVITY; ATP RELEASE; FLUID-FLOW; SURVIVAL; MICE	Although the skeleton is one of the predominant sites for breast cancer metastasis, why breast cancer cells often become dormant after homing to bone is not well understood. Here, we reported an intrinsic self-defense mechanism of bone cells against breast cancer cells: a critical role of connexin (Cx) 43 hemichannels in osteocytes in the suppression of breast cancer bone metastasis. Cx43 hemichannels allow passage of small molecules between the intracellular and extracellular environments. The treatment of bisphosphonate drugs, either alendronate (ALN) or zoledronic acid (ZOL), opened Cx43 hemichannels in osteocytes. Conditioned media (CM) collected from MLO-Y4 osteocyte cells treated with bisphosphonates inhibited the anchorage-independent growth, migration and invasion of MDA-MB-231 human breast cancer cells and Py8119 mouse mammary carcinoma cells, and this inhibitory effect was attenuated with Cx43(E2), a specific hemichannel-blocking antibody. The opening of osteocytic Cx43 hemichannels by mechanical stimulation had similar inhibitory effects on breast cancer cells and this inhibition was attenuated by Cx43(E2) antibody as well. These inhibitory effects on cancer cells were mediated by ATP released from osteocyte Cx43 hemichannels. Furthermore, both Cx43 osteocyte-specific knockout mice and osteocyte-specific.130-136 transgenic mice with impaired Cx43 gap junctions and hemichannels showed significantly increased tumor growth and attenuated the inhibitory effect of ZOL. However, R76W transgenic mice with functional hemichannels but not gap junctions in osteocytes did not display a significant difference. Together, our studies establish the specific inhibitory role of osteocytic Cx43 hemichannels, and exploiting the activity of this channel could serve as a de novo therapeutic strategy.	[Zhou, J. Z.; Riquelme, M. A.; Gu, S.; Kar, R.; Gao, X.; Jiang, J. X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Sun, L.] Dept Cellular & Struct Biol, San Antonio, TX USA; [Sun, L.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Riquelme, Manuel/B-1082-2015	Riquelme, Manuel/0000-0002-1915-0434; Jiang, Jean/0000-0002-2185-5716	Welch Foundation [AQ-1507]; NIH [EY012085, ES022057]; NCI Cancer Center grant [2 P30 CA054174-17]; NATIONAL CANCER INSTITUTE [R01CA196214, P30CA054174] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012085, R29EY012085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022057] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Hongyun Cheng for technical assistance, Dr Lesley Ellies at the University of California at San Diego for providing Py8119 cells, Dr Lynda Bonewald at the University of Missouri at Kansas City for MLO-Y4 osteocytic cells, Dr Stephen Harris at UTHSCSA for 10-kb dentin matrix protein 1 (DMP1)-Cre mice and Dr Klaus Willecke at the University of Bonn and Dr Roberto Civitelli for mice with floxed Cx43 gene. The work was supported by Welch Foundation grant AQ-1507 and NIH grant EY012085 to JXJ, ES022057 to LZS and the NCI Cancer Center grant 2 P30 CA054174-17 to Cancer Therapy and Research Center.	AARDEN EM, 1994, J CELL BIOCHEM, V55, P287, DOI 10.1002/jcb.240550304; Avanzo JL, 2004, CARCINOGENESIS, V25, P1973, DOI 10.1093/carcin/bgh193; Bennett MVL, 2012, BRAIN RES, V1487, P3, DOI 10.1016/j.brainres.2012.08.042; Bivi N, 2013, J ORTHOP RES, V31, P1075, DOI 10.1002/jor.22341; Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Brown Sue A, 2007, Curr Osteoporos Rep, V5, P120; Calder BW, 2015, TISSUE ENG PT A, V21, P1752, DOI [10.1089/ten.tea.2014.0651, 10.1089/ten.TEA.2014.0651]; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Cherian PP, 2008, CELL COMMUN ADHES, V15, P43, DOI 10.1080/15419060802310208; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; Cronier L, 2009, ANTIOXID REDOX SIGN, V11, P323, DOI 10.1089/ars.2008.2153; D'hondt C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00348; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Holick CN, 2008, CANCER EPIDEM BIOMAR, V17, P379, DOI 10.1158/1055-9965.EPI-07-0771; Irwin ML, 2011, CANCER PREV RES, V4, P522, DOI 10.1158/1940-6207.CAPR-10-0295; Jiang JX, 2007, FRONT BIOSCI-LANDMRK, V12, P1450, DOI 10.2741/2159; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kato Y, 2001, J BONE MINER RES, V16, P1622, DOI 10.1359/jbmr.2001.16.9.1622; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kohno N, 2008, INT J CLIN ONCOL, V13, P18, DOI 10.1007/s10147-007-0726-2; Kretschmann KL, 2012, CANCER METAST REV, V31, P579, DOI 10.1007/s10555-012-9378-4; Laird DW, 1999, CANCER RES, V59, P4104; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Loiselle AE, 2013, J ORTHOP RES, V31, P147, DOI 10.1002/jor.22178; Lynch ME, 2013, J BONE MINER RES, V28, P2357, DOI 10.1002/jbmr.1966; Matsuo K, 2009, CURR OPIN NEPHROL HY, V18, P292, DOI 10.1097/MNH.0b013e32832b75f1; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; Mesnil M, 2002, BIOL CELL, V94, P493, DOI 10.1016/S0248-4900(02)00025-4; Milne HM, 2008, BREAST CANCER RES TR, V108, P279, DOI 10.1007/s10549-007-9602-z; Orellana JA, 2012, GLIA, V60, P53, DOI 10.1002/glia.21246; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Plante I, 2011, ONCOGENE, V30, P1681, DOI 10.1038/onc.2010.551; Plotkin LI, 2001, CELL COMMUN ADHES, V8, P377, DOI 10.3109/15419060109080757; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Plotkin LI, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00131; RAPAPORT E, 1983, CANCER RES, V43, P4402; Riquelme MA, 2013, NEUROPHARMACOLOGY, V75, P525, DOI 10.1016/j.neuropharm.2013.02.021; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Saez JC, 2003, ACTA PHYSIOL SCAND, V179, P9, DOI 10.1046/j.1365-201X.2003.01196.x; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Savariar EN, 2013, CANCER RES, V73, P855, DOI 10.1158/0008-5472.CAN-12-2969; Schwartz AL, 2007, ONCOL NURS FORUM, V34, P627, DOI 10.1188/07.ONF.627-633; Shabbir M, 2009, INT J UROL, V16, P143, DOI 10.1111/j.1442-2042.2008.02207.x; Siller-Jackson AJ, 2008, J BIOL CHEM, V283, P26374, DOI 10.1074/jbc.M803136200; Stains JP, 2005, BBA-BIOMEMBRANES, V1719, P69, DOI 10.1016/j.bbamem.2005.10.012; Sterling Julie A, 2011, Curr Osteoporos Rep, V9, P89, DOI 10.1007/s11914-011-0052-5; Stoletov K, 2013, J CELL SCI, V126, P904, DOI 10.1242/jcs.112748; Theis M, 2001, GENESIS, V29, P1, DOI 10.1002/1526-968X(200101)29:1<1::AID-GENE1000>3.0.CO;2-0; Theriault RL, 2012, CANCER CONTROL, V19, P92, DOI 10.1177/107327481201900203; Van der Pluijm G, 2001, J BONE MINER RES, V16, P1077, DOI 10.1359/jbmr.2001.16.6.1077; Welch D. R., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P30; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Xu HY, 2014, J BONE MINER RES, V29, pS430; Xu HY, 2015, J BONE MINER RES, V30, P550, DOI 10.1002/jbmr.2374; Yang WC, 2005, J BIOL CHEM, V280, P20680, DOI 10.1074/jbc.M500104200; Zhang W, 2011, BIOCHEM PHARMACOL, V82, P411, DOI 10.1016/j.bcp.2011.05.009; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023516; Zhou JZ, 2015, ONCOGENE, V34, P1831, DOI 10.1038/onc.2014.113; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001	74	57	61	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 27	2016	35	43					5597	5607		10.1038/onc.2016.101	http://dx.doi.org/10.1038/onc.2016.101			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XP	27041582	Green Accepted			2022-12-26	WOS:000386998300003
J	Bomhof, MR; Paul, HA; Geuking, MB; Eller, LK; Reimer, RA				Bomhof, Marc R.; Paul, Heather A.; Geuking, Markus B.; Eller, Lindsay K.; Reimer, Raylene A.			Improvement in adiposity with oligofructose is modified by antibiotics in obese rats	FASEB JOURNAL			English	Article						Bifidobacterium; gut microbiota; Lactobacillus; prebiotics	DIET-INDUCED OBESITY; GLUCAGON-LIKE PEPTIDE-1; INULIN-TYPE FRUCTANS; GUT MICROBIOTA; INSULIN-RESISTANCE; SATIETY HORMONES; LIPID-METABOLISM; PPAR-GAMMA; INFLAMMATION; PREBIOTICS	Given the intimate link between gut microbiota and host physiology, there is growing interest in understanding the mechanisms by which diet influences gut microbiota and affects human metabolic health. Using antibiotics and the prebiotic oligofructose, which has been shown to counteract excess fat mass, we explored the gut microbiota-dependent effects of oligofructose on body composition and host metabolism. Diet-induced obese male Sprague Dawley rats, fed a background high-fat/sucrose diet, were randomized to one of the following diets for 6 wk:1) high-energy control; 2) 10% oligofructose; 3) ampicillin; 4) ampicillin + 10% oligofructose; 5) ampicillin/neomycin; or 6) ampicillin/neomycin + 10% oligofructose. Combining oligofructose with ampicillin treatment blunted the decrease in adiposity seen with oligofructose. Although ampicillin did not affect total bacteria, ampicillin impeded oligofructose-induced increases in Bifidobacterium and Lactobacillus. In contrast, the combination of ampicillin and neomycin reduced total bacteria but did not abrogate the oligofructose-induced decrease in adiposity. Oligofructose-mediated effects on host adiposity and metabolic health appear to be in part dependent on the presence of specific microbial species within the gut.	[Bomhof, Marc R.; Eller, Lindsay K.; Reimer, Raylene A.] Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Paul, Heather A.; Reimer, Raylene A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Geuking, Markus B.] Univ Bern, Div Gastroenterol, Dept Clin Res, Univ Clin Visceral Surg & Med, Bern, Switzerland	University of Calgary; University of Calgary; University of Bern; University Hospital of Bern	Reimer, RA (corresponding author), Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	reimer@ucalgary.ca		Reimer, Raylene/0000-0001-5088-7947	Canadian Institutes of Health Research (CIHR) [MOP 115076]; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Health Solutions (AIHS); Izaak Walton Killam Doctoral Scholarship; AIHS; CIHR; Beneo-Orafti, Inc.	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Health Solutions (AIHS); Izaak Walton Killam Doctoral Scholarship; AIHS; CIHR(Canadian Institutes of Health Research (CIHR)); Beneo-Orafti, Inc.	The authors thank K. Lee (Faculty of Kinesiology, University of Calgary) for technical assistance, and S. Wegener, R. Pon, and P. Gordon (University Core DNA Services and Alberta Children's Hospital Research Institute, University of Calgary) for technical assistance and support with the 16S rRNA gene sequencing and analysis. The authors also thank Chieh Jason Chou (Nestle Institute of Health Sciences, Lausanne, Switzerland) for valuable discussion regarding antibiotics. This work was supported by a research grant from the Canadian Institutes of Health Research (CIHR) (MOP 115076). M.R.B. is supported by the Natural Sciences and Engineering Research Council of Canada, Alberta Innovates Health Solutions (AIHS), and an Izaak Walton Killam Doctoral Scholarship. H.A.P. is supported by AIHS and CIHR. R. A. R. previously held a research grant from Beneo-Orafti, Inc., manufacturer of Orafti P95, for a project unrelated to the current work.	Alligier M, 2014, OBESITY, V22, P1653, DOI 10.1002/oby.20733; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Bermudez-Brito M, 2015, MOL NUTR FOOD RES, V59, P698, DOI 10.1002/mnfr.201400811; Bomhof MR, 2014, OBESITY, V22, P763, DOI 10.1002/oby.20632; Brockman DA, 2014, J NUTR, V144, P1415, DOI 10.3945/jn.114.191577; Brownawell AM, 2012, J NUTR, V142, P962, DOI 10.3945/jn.112.158147; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, BRIT J NUTR, V98, P32, DOI 10.1017/S0007114507691648; Cani PD, 2004, BRIT J NUTR, V92, P521, DOI 10.1079/BJN20041225; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chou CJ, 2008, NESTLE NUTR WORKS SE, V62, P127, DOI 10.1159/000146256; Collins KH, 2015, OSTEOARTHR CARTILAGE, V23, P1989, DOI 10.1016/j.joca.2015.03.014; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Delzenne NM, 2005, BRIT J NUTR, V93, pS157, DOI 10.1079/BJN20041342; Dewulf EM, 2011, J NUTR BIOCHEM, V22, P712, DOI 10.1016/j.jnutbio.2010.05.009; Di Luccia B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134893; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dubourg G, 2013, INT J ANTIMICROB AG, V41, P149, DOI 10.1016/j.ijantimicag.2012.10.012; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Geuking MB, 2014, GUT MICROBES, V5, P411, DOI 10.4161/gmic.29330; Gibson G. R., 2010, Food Science and Technology Bulletin: Functional Foods, V7, P1; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Hepple RT, 2005, FASEB J, V19, P1320, DOI 10.1096/fj.04-3535fje; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Johnson LP, 2015, NUTRIENTS, V7, P4480, DOI 10.3390/nu7064480; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Louie TJ, 2012, CLIN INFECT DIS, V55, pS132, DOI 10.1093/cid/cis338; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Maurer AD, 2009, J PHYSIOL-LONDON, V587, P679, DOI 10.1113/jphysiol.2008.161844; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Miyauchi S, 2010, J PHARMACOL SCI, V112, P19, DOI 10.1254/jphs.09R09FM; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Parnell JA, 2010, BRIT J NUTR, V103, P1577, DOI 10.1017/S0007114509993539; Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465; Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001; Rampelli S, 2015, CURR BIOL, V25, P1682, DOI 10.1016/j.cub.2015.04.055; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Rune I, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/319321; Schroeder N, 2013, NUTRIENTS, V5, P2093, DOI 10.3390/nu5062093; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vogt L, 2015, CRIT REV FOOD SCI, V55, P414, DOI 10.1080/10408398.2012.656772; Woting A, 2015, MOL NUTR FOOD RES, V59, P2267, DOI 10.1002/mnfr.201500249; Zenhom M, 2011, J NUTR, V141, P971, DOI 10.3945/jn.110.136176; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	57	28	28	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2720	2732		10.1096/fj.201600151R	http://dx.doi.org/10.1096/fj.201600151R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27059718				2022-12-26	WOS:000380994000009
J	Popa, IL; Milac, AL; Sima, LE; Alexandru, PR; Pastrama, F; Munteanu, CVA; Negroiu, G				Popa, Ioana L.; Milac, Adina L.; Sima, Livia E.; Alexandru, Petruta R.; Pastrama, Florin; Munteanu, Cristian V. A.; Negroiu, Gabriela			Cross-talk between Dopachrome Tautomerase and Caveolin-1 Is Melanoma Cell Phenotype-specific and Potentially Involved in Tumor Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINASE-RELATED PROTEIN-2; SCAFFOLDING DOMAIN; RADIATION-RESISTANCE; E-CADHERIN; CHOLESTEROL; EXPRESSION; BINDING; RAFTS; TRP-2; DIFFERENTIATION	L-Dopachrome tautomerase (L-DCT), also called tyrosinase-related protein-2 (TRP-2), is a melanoma antigen overexpressed in most chemo-/radiotherapeutic stress-resistant tumor clones, and caveolin-1 (CAV1) is a main regulator of numerous signaling processes. A structural and functional relationship between DCT and CAV1 is first presented here in two human amelanotic melanoma cell lines, derived from vertical growth phase (MelJuSo) and metastatic (SKMel28) melanomas. DCTco-localizes at the plasma membrane with CAV1 and Cavin-1, another molecular marker for caveolae in both cell phenotypes. Our novel structural model proposed for the DCT-CAV1 complex, in addition to co-immunoprecipitation and mass spectrometry data, indicates a possible direct interaction between DCT and CAV1. The CAV1 control on DCT gene expression, DCT post-translational processing, and subcellular distribution is cell phenotype-dependent. DCT is a modulator of CAV1 stability and supramolecular assembly in both cell phenotypes. During autocrine stimulation, the expressions of DCT and CAV1 are oppositely regulated; DCT increases while CAV1 decreases. Sub-confluent MelJuSo clones DCThigh/CAV1(low) are proliferating and acquire fibroblast-like morphology, forming massive, confluent clusters as demonstrated by immunofluorescent staining and TissueFAXS quantitative image cytometry analysis. CAV1 down-regulation directly contributes to the expansion of MelJuSo DCThigh subtype. CAV1 involved in the perpetuation of cell phenotype-overexpressing anti-stress DCT molecule supports the concept that CAV1 functions as a tumor suppressor in early stages of melanoma. DCT is a regulator of the CAV1-associated structures and is possibly a new molecular player in CAV1-mediated processes in melanoma.	[Popa, Ioana L.] Romanian Acad, Inst Biochem, Dept Prot Folding, Bucharest 060031, Romania; [Milac, Adina L.; Pastrama, Florin] Romanian Acad, Inst Biochem, Dept Bioinformat & Struct Biochem, Bucharest 060031, Romania; [Sima, Livia E.; Alexandru, Petruta R.; Munteanu, Cristian V. A.; Negroiu, Gabriela] Romanian Acad, Inst Biochem, Dept Mol Cell Biol, Splaiul Independentei 296, Bucharest 060031, Romania	Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Nicolae Simionescu Institute of Cellular Biology & Pathology	Negroiu, G (corresponding author), Romanian Acad, Inst Biochem, Dept Mol Cell Biol, Splaiul Independentei 296, Bucharest 060031, Romania.	gnegroiu@biochim.ro	Munteanu, Cristian V.A./I-9290-2016; Negroiu, Gabriela/AAO-3980-2020; Milac, Adina/C-1070-2011; Sima, Livia E/C-2882-2011; Sima, Livia/M-4389-2019	Munteanu, Cristian V.A./0000-0002-2998-0458; Milac, Adina/0000-0003-1845-4281; Sima, Livia E/0000-0002-3404-4162; Sima, Livia/0000-0002-3404-4162; Negroiu, Gabriela/0000-0003-3712-7681	Grant Application [156]; Exploratory Research Projects [PN-II-ID-PCE-2011-3-0492-1]; Ministerul Educatiei si Cercetarii Stiintifice; Academia Romana Project of the Institute of Biochemistry [1/2011]	Grant Application; Exploratory Research Projects; Ministerul Educatiei si Cercetarii Stiintifice(Ministry of Education and Research - Romania); Academia Romana Project of the Institute of Biochemistry	This work was supported by Grant Application 156, Exploratory Research Projects PN-II-ID-PCE-2011-3-0492-1, funded by Ministerul Educatiei si Cercetarii Stiintifice and in part by Academia Romana Project 1/2011 of the Institute of Biochemistry.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; [Anonymous], 2002, NCBI HDB; Aoki S, 2012, BBA-BIOMEMBRANES, V1818, P12, DOI 10.1016/j.bbamem.2011.09.009; Baruthio F, 2008, PROTEOMICS, V8, P4733, DOI 10.1002/pmic.200800169; Bastian BC, 2014, ANNU REV PATHOL-MECH, V9, P239, DOI 10.1146/annurev-pathol-012513-104658; BransburgZabary S, 1996, BBA-BIOMEMBRANES, V1285, P146, DOI 10.1016/S0005-2736(96)00148-4; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chen ST, 2004, INT J MOL MED, V14, P577; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Chu W, 2000, ONCOGENE, V19, P395, DOI 10.1038/sj.onc.1203315; Dalton LE, 2013, J INVEST DERMATOL, V133, P1572, DOI 10.1038/jid.2013.23; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Felicetti F, 2009, INT J CANCER, V125, P1514, DOI 10.1002/ijc.24451; Fielding PE, 2004, BIOCHEMISTRY-US, V43, P2578, DOI 10.1021/bi035442c; Filimon A, 2014, MELANOMA RES, V24, P219, DOI 10.1097/CMR.0000000000000066; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; Hoop CL, 2012, BIOCHEMISTRY-US, V51, P90, DOI 10.1021/bi201356v; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang S, 2010, FREE RADICAL BIO MED, V48, P1144, DOI 10.1016/j.freeradbiomed.2010.01.033; Jiao ZX, 2006, DEV BIOL, V296, P396, DOI 10.1016/j.ydbio.2006.06.006; JIMENEZ M, 1991, J BIOL CHEM, V266, P1147; Jung AC, 2015, ONCOTARGET, V6, P41884, DOI 10.18632/oncotarget.6099; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Le Lan C, 2006, FEBS LETT, V580, P5301, DOI 10.1016/j.febslet.2006.08.075; Le Lan C, 2010, EUR BIOPHYS J BIOPHY, V39, P307, DOI 10.1007/s00249-009-0548-4; Lee JW, 2012, BBA-BIOMEMBRANES, V1818, P1158, DOI 10.1016/j.bbamem.2011.12.033; Levin AM, 2006, PROTEIN SCI, V15, P478, DOI 10.1110/ps.051911706; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Liu GT, 2003, J IMMUNOTHER, V26, P301, DOI 10.1097/00002371-200307000-00002; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Lobos-Gonzales L., 2011, ADV MALIGNANT MELANO, P200, DOI [10.5772/21829, DOI 10.5772/21829]; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Makwana KM, 2015, PROTEIN SCI, V24, P1920, DOI 10.1002/pro.2814; Michard Q, 2008, FREE RADICAL BIO MED, V44, P1023, DOI 10.1016/j.freeradbiomed.2007.11.021; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Nakashima H, 2007, CANCER SCI, V98, P512, DOI 10.1111/j.1349-7006.2007.00419.x; Negroiu G, 2005, BIOCHEM BIOPH RES CO, V328, P914, DOI 10.1016/j.bbrc.2005.01.040; Negroiu G, 2003, J BIOL CHEM, V278, P27035, DOI 10.1074/jbc.M303167200; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Orlow SJ, 1998, CANCER RES, V58, P1521; Pak BJ, 2000, MELANOMA RES, V10, P499, DOI 10.1097/00008390-200010000-00013; Pak BJ, 2004, ONCOGENE, V23, P30, DOI 10.1038/sj.onc.1207007; Pak BJ, 2001, CANCER METAST REV, V20, P27, DOI 10.1023/A:1013175516793; Popa I, 2014, BIOCHEM CELL BIOL, V92, P127, DOI 10.1139/bcb-2013-0064; Recamier KS, 2010, J MEMBRANE BIOL, V237, P31, DOI 10.1007/s00232-010-9304-z; RODECK U, 1991, J INVEST DERMATOL, V97, P20, DOI 10.1111/1523-1747.ep12477822; Salem AF, 2011, CELL CYCLE, V10, P3692, DOI 10.4161/cc.10.21.17895; Sanna E, 2007, EXP CELL RES, V313, P1307, DOI 10.1016/j.yexcr.2007.02.005; Savage K, 2007, CLIN CANCER RES, V13, P90, DOI 10.1158/1078-0432.CCR-06-1371; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; Sendoel A, 2010, NATURE, V465, P577, DOI 10.1038/nature09141; Setaluri V, 2000, PIGM CELL RES, V13, P128, DOI 10.1034/j.1600-0749.2000.130302.x; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Shan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097239; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Slominski A., 2004, PHYSIOL REV, V84, P1164; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Smedley RC, 2011, VET PATHOL, V48, P32, DOI 10.1177/0300985810387447; Sprong H, 2001, J CELL BIOL, V155, P369, DOI 10.1083/jcb.200106104; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Torres VA, 2007, MOL CELL BIOL, V27, P7703, DOI 10.1128/MCB.01991-06; Trane AE, 2015, EUR J PHARMACOL, V766, P46, DOI 10.1016/j.ejphar.2015.09.033; Trimmer C, 2010, CANCER RES, V70, P7489, DOI 10.1158/0008-5472.CAN-10-0900; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Watabe H, 2004, J BIOL CHEM, V279, P7971, DOI 10.1074/jbc.M309714200; Watanabe R, 2004, CURR OPIN CELL BIOL, V16, P350, DOI 10.1016/j.ceb.2004.06.010; Zhuang GL, 2012, EMBO J, V31, P3513, DOI 10.1038/emboj.2012.183; ZIEGLERHEITBROCK HWL, 1985, CANCER RES, V45, P1344	76	7	8	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12481	12500		10.1074/jbc.M116.714733	http://dx.doi.org/10.1074/jbc.M116.714733			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27053106	Green Published, hybrid			2022-12-26	WOS:000378119900004
J	Mastantuono, T; Starita, N; Sapio, D; D'Avanzo, SA; Di Maro, M; Muscariello, E; Paterni, M; Colantuoni, A; Lapi, D				Mastantuono, Teresa; Starita, Noemy; Sapio, Daniela; D'Avanzo, Sabato Andrea; Di Maro, Martina; Muscariello, Espedita; Paterni, Marco; Colantuoni, Antonio; Lapi, Dominga			The Effects of Vaccinium myrtillus Extract on Hamster Pial Microcirculation during Hypoperfusion-Reperfusion Injury	PLOS ONE			English	Article							CHEEK-POUCH MICROCIRCULATION; IN-VITRO; BEHAVIORAL DEFICITS; OXIDANT STRESS; BRAIN-DAMAGE; RATS; FENTANYL; ANTHOCYANINS; BLUEBERRY; ARTERY	Introduction The present study was aimed to assess the in vivo hamster pial microvessel alterations due to 30 min transient bilateral common carotid artery occlusion (BCCAO) and reperfusion (60 min); moreover, the neuroprotective effects of Vaccinium myrtillus extract, containing 34.7% of anthocyanins, were investigated. Materials and Methods Two groups of male hamsters were used: the first fed with control diet and the other with Vaccinium myrtillus supplemented diet. Hamster pial microcirculation was visualized by fluorescence microscopy through an open cranial window. Pial arterioles were classified according to Strahler's method. Results In age-matched control diet-fed hamsters, BCCAO caused a decrease in diameter of all arterioles. At the end of reperfusion, the reduction of diameter in order 3 arterioles was by 8.4 +/- 3.1%, 10.8 +/- 2.3% and 12.1 +/- 1.1% of baseline in the 2, 4 and 6 month control diet-fed hamsters, respectively. Microvascular permeability and leukocyte adhesion were markedly enhanced, while perfused capillary length (PCL) decreased. The response to acetylcholine and papaverine topical application was impaired; 2'-7'-dichlorofluoresceine-diacetate assay demonstrated a significant ROS production. At the end of BCCAO, in age-matched Vaccinium myrtillussupplemented diet-fed hamsters, the arteriolar diameter did not significantly change compared to baseline. After 60 min reperfusion, order 3 arterioles dilated by 9.3 +/- 2.4%, 10.6 +/- 3.1% and 11.8 +/- 2.7% of baseline in the 2, 4 and 6 month Vaccinium myrtillus supplemented diet-fed hamsters, respectively. Microvascular leakage and leukocyte adhesion were significantly reduced in all groups according to the time-dependent treatment, when compared with the age-matched control diet-fed hamsters. Similarly, the reduction in PCL was progressively prevented. Finally, the response to acetylcholine and papaverine topical application was preserved and there was no significant increase in ROS production in all groups. Conclusions In conclusion, Vaccinium myrtillusextract protected pial microcirculation during hypoperfusion-reperfusion, preventing vasoconstriction, microvascular permeability, leukocyte adhesion, reduction in PCL and preserving the endothelium function.	[Mastantuono, Teresa; Starita, Noemy; Sapio, Daniela; D'Avanzo, Sabato Andrea; Di Maro, Martina; Muscariello, Espedita; Colantuoni, Antonio; Lapi, Dominga] Univ Naples Federico II, Sch Med, Dept Clin Med & Surg, Naples, Italy; [Paterni, Marco] CNR, Inst Clin Physiol, Via Savi 8, I-56100 Pisa, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Lapi, D (corresponding author), Univ Naples Federico II, Sch Med, Dept Clin Med & Surg, Naples, Italy.	d.lapi@dfb.unipi.it	Starita, Noemy/AHC-7586-2022; Paterni, Marco/AAX-9367-2020	Starita, Noemy/0000-0002-5169-7640; Muscariello, Espedita/0000-0002-4678-562X; Colantuoni, Antonio/0000-0003-1152-5630; Mastantuono, Teresa/0000-0002-5626-553X; Paterni, Marco/0000-0002-9799-7059				[Anonymous], [No title captured], DOI DOI 10.1201/B10787-5; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BERTUGLIA S, 1995, PHARMACOL RES, V31, P183, DOI 10.1016/1043-6618(95)80016-6; Bornsek SM, 2012, FOOD CHEM, V134, P1878, DOI 10.1016/j.foodchem.2012.03.092; Brookes ZLS, 2003, ANESTH ANALG, V96, P456, DOI 10.1097/00000539-200302000-00030; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Colantuoni A, 2005, J VASC RES, V42, P55, DOI 10.1159/000083092; COLANTUONI A, 1984, INT J MICROCIRC, V3, P13; FISCHER S, 1995, ANESTHESIOLOGY, V82, P451, DOI 10.1097/00000542-199502000-00015; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Gursoy S, 2006, EUR J ANAESTH, V23, P496, DOI 10.1017/S0265021506000172; HELFAER MA, 1990, STROKE, V21, P795, DOI 10.1161/01.STR.21.5.795; Heo JH, 2005, FREE RADICAL BIO MED, V39, P51, DOI 10.1016/j.freeradbiomed.2005.03.035; HUDETZ AG, 1995, AM J PHYSIOL-HEART C, V268, pH2202, DOI 10.1152/ajpheart.1995.268.6.H2202; KASSAB GS, 1993, AM J PHYSIOL, V265, pH350, DOI 10.1152/ajpheart.1993.265.1.H350; Kaye Alan D, 2006, Am J Ther, V13, P478, DOI 10.1097/01.mjt.0000178338.43545.3a; Lapi D, 2008, J VASC RES, V45, P69, DOI 10.1159/000109078; Lapi D, 2015, MICROCIRCULATION, V22, P79, DOI 10.1111/micc.12175; Lee SG, 2014, J NUTR BIOCHEM, V25, P404, DOI 10.1016/j.jnutbio.2013.12.001; Leinonen JS, 2000, STROKE, V31, P33, DOI 10.1161/01.STR.31.1.33; Malin DH, 2011, NUTRITION, V27, P338, DOI 10.1016/j.nut.2010.05.001; MORII S, 1986, J CEREBR BLOOD F MET, V6, P34, DOI 10.1038/jcbfm.1986.5; NGAI AC, 1988, AM J PHYSIOL, V254, pH133, DOI 10.1152/ajpheart.1988.254.1.H133; Phillips SA, 2005, AM J PHYSIOL-REG I, V288, pR522, DOI 10.1152/ajpregu.00655.2004; Prior RL, 2000, J AOAC INT, V83, P950; Sahin AE, 2005, J CARDIOTHOR VASC AN, V19, P197, DOI 10.1053/j.jvca.2005.01.031; Sweeney MI, 2002, NUTR NEUROSCI, V5, P427, DOI 10.1080/1028415021000055970; Vepsalainen S, 2013, J NUTR BIOCHEM, V24, P360, DOI 10.1016/j.jnutbio.2012.07.006; Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020; Watanabe Shigeru, 1998, Keio Journal of Medicine, V47, P92; Youdim KA, 2000, BBA-GEN SUBJECTS, V1523, P117, DOI 10.1016/S0304-4165(00)00109-4; Ziche M, 2001, METH MOLEC MED, V46, P131, DOI 10.1385/1-59259-143-4:131	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0150659	10.1371/journal.pone.0150659	http://dx.doi.org/10.1371/journal.pone.0150659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070318	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700004
J	Nespeca, M; Giorgetti, C; Nobile, S; Ferrini, I; Simonato, M; Verlato, G; Cogo, P; Carnielli, VP				Nespeca, Matteo; Giorgetti, Chiara; Nobile, Stefano; Ferrini, Ilaria; Simonato, Manuela; Verlato, Giovanna; Cogo, Paola; Carnielli, Virgilio Paolo			Does Whole-Body Hypothermia in Neonates with Hypoxic-Ischemic Encephalopathy Affect Surfactant Disaturated-Phosphatidylcholine Kinetics?	PLOS ONE			English	Article							PERINATAL ASPHYXIAL ENCEPHALOPATHY; RESPIRATORY-DISTRESS-SYNDROME; CRITICALLY-ILL INFANTS; STABLE-ISOTOPES; SYSTEMIC HYPOTHERMIA; NEWBORN-INFANTS; TRIAL	Background It is unknown whether Whole-Body Hypothermia (WBH) affects pulmonary function. In vitro studies, at relatively low temperatures, suggest that hypothermia may induce significant changes to the surfactant composition. The effect of WBH on surfactant kinetics in newborn infants is unknown. We studied in vivo kinetics of disaturated-phosphatidylcholine (DSPC) in asphyxiated newborns during WBH and in normothermic controls (NTC) with no or mild asphyxia. Both groups presented no clinically apparent lung disease. Methods Twenty-seven term or near term newborns requiring mechanical ventilation were studied (GA 38.6 +/- 2.2 wks). Fifteen during WBH and twelve NTC. All infants received an intra-tracheal dose of C-13 labelled DSPC and tracheal aspirate were performed. DSPC amount, DSPC half-life (HL) and pool size (PS) were calculated. Results DSPC amount in tracheal aspirates was 0.42 [0.22-0.54] and 0.36 [0.10-0.58] mg/ml in WBH and NTC respectively (p = 0.578). DSPC HL was 24.9 [15.7-52.5] and 25.3 [15.8-59.3] h (p = 0.733) and DSPC PS was 53.2 [29.4-91.6] and 40.2 [29.8-64.6] mg/kg (p = 0.598) in WBH and NTC respectively. Conclusions WBH does not alter DSPC HL and PS in newborn infants with no clinical apparent lung disease.	[Nespeca, Matteo; Giorgetti, Chiara; Nobile, Stefano; Carnielli, Virgilio Paolo] Polytech Univ Marche, Dept Clin Sci, Div Neonatol, Ancona, Italy; [Nespeca, Matteo; Giorgetti, Chiara; Nobile, Stefano; Carnielli, Virgilio Paolo] Azienda Osped Univ Ospedali Riuniti, Ancona, Italy; [Ferrini, Ilaria; Verlato, Giovanna] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Simonato, Manuela] Pediat Res Inst Citta della Speranza, Padua, Italy; [Cogo, Paola] Univ Udine, Dept Expt & Clin Med, I-33100 Udine, Italy	Marche Polytechnic University; University of Padua; Fondazione Citta della Speranza; University of Udine	Carnielli, VP (corresponding author), Polytech Univ Marche, Dept Clin Sci, Div Neonatol, Ancona, Italy.; Carnielli, VP (corresponding author), Azienda Osped Univ Ospedali Riuniti, Ancona, Italy.	v.carnielli@univpm.it	Cogo, Paola P/J-6918-2018; nobile, stefano/G-9775-2017; Simonato, Manuela/AAX-5656-2020	Cogo, Paola P/0000-0002-6235-140X; nobile, stefano/0000-0002-5304-1485; Simonato, Manuela/0000-0002-2745-7305				Azzopardi D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-17; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Ball MK, 2010, RESUSCITATION, V81, P749, DOI 10.1016/j.resuscitation.2009.12.007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cogo PE, 2008, PEDIATR RES, V63, P433, DOI 10.1203/PDR.0b013e3181659759; Cogo PE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-13; Cogo PE, 1999, PEDIATR RES, V45, P242, DOI 10.1203/00006450-199902000-00015; Cogo PE, 2003, PEDIATR RES, V54, P653, DOI 10.1203/01.PDR.0000084344.42409.C6; Cogo PE, 1997, PEDIATR RES, V41, P178, DOI 10.1203/00006450-199702000-00004; Dassios T, 2014, ACTA PAEDIATR, V103, P157, DOI 10.1111/apa.12476; De Luca D, 2014, EUR RESPIR J, V44, P1708, DOI 10.1183/09031936.00117714; Duan M, 2011, RESP CARE, V56, P1956, DOI 10.4187/respcare.01211; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Howard FB, 2010, INT J MOL SCI, V11, P754, DOI 10.3390/ijms11020754; JONES PJH, 1991, CLIN SCI, V80, P277, DOI 10.1042/cs0800277; Lapointe Anie, 2011, J Pediatr, V158, pe19, DOI 10.1016/j.jpeds.2010.11.008; Lista G, 2011, J MATERN-FETAL NEO M, V24, P67, DOI 10.3109/14767058.2011.607615; MARTINANCEL A, 1995, J PEDIATR-US, V127, P786, DOI 10.1016/S0022-3476(95)70174-5; Nagle JF, 2000, CURR OPIN STRUC BIOL, V10, P474, DOI 10.1016/S0959-440X(00)00117-2; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Pietrini D, 2012, EUR J PEDIATR, V171, P1855, DOI 10.1007/s00431-012-1769-6; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Suri LNM, 2012, BBA-BIOMEMBRANES, V1818, P1581, DOI 10.1016/j.bbamem.2012.02.021; SUWABE A, 1992, J BIOL CHEM, V267, P19884; Torresin M, 2000, AM J RESP CRIT CARE, V161, P1584, DOI 10.1164/ajrccm.161.5.9905088	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153328	10.1371/journal.pone.0153328	http://dx.doi.org/10.1371/journal.pone.0153328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070307	gold, Green Published, Green Submitted			2022-12-26	WOS:000373900700052
J	Noroozi, M; Zakaria, A; Radiman, S; Wahab, ZA				Noroozi, Monir; Zakaria, Azmi; Radiman, Shahidan; Wahab, Zaidan Abdul			Environmental Synthesis of Few Layers Graphene Sheets Using Ultrasonic Exfoliation with Enhanced Electrical and Thermal Properties	PLOS ONE			English	Article							LIQUID-PHASE EXFOLIATION; HIGH-YIELD PRODUCTION; SHEAR EXFOLIATION; GRAPHITE; CONDUCTIVITY; DISPERSIONS; REDUCTION; NANOSHEETS; NANOTUBES; FILMS	In this paper, we report how few layers graphene that can be produced in large quantity with low defect ratio from exfoliation of graphite by using a high intensity probe sonication in water containing liquid hand soap and PVP. It was founded that the graphene powder obtained by this simple exfoliation method after the heat treatment had an excellent exfoliation into a single or layered graphene sheets. The UV-visible spectroscopy, FESEM, TEM, X-ray powder diffraction and Raman spectroscopy was used to analyse the graphene product. The thermal diffusivity of the samples was analysed using a highly accurate thermal-wave cavity photothermal technique. The data obtained showed excellent enhancement in the thermal diffusivity of the graphene dispersion. This well-dispersed graphene was then used to fabricate an electrically conductive polymer-graphene film composite. The results demonstrated that this low cost and environmental friendly technique allowed to the production of high quality layered graphene sheets, improved the thermal and electrical properties. This may find use in the wide range of applications based on graphene.	[Noroozi, Monir; Zakaria, Azmi; Wahab, Zaidan Abdul] Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang 43400, Selangor, Malaysia; [Radiman, Shahidan] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Appl Phys, Bangi 43600, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Kebangsaan Malaysia	Noroozi, M; Zakaria, A (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang 43400, Selangor, Malaysia.	monir.noroozi@gmail.com; azmizak@gmail.com			Ministry of Education [01-02-13-134FR]	Ministry of Education	This work was supported by the Ministry of Education under Fundamental Research Grant Scheme of No. 01-02-13-134FR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolhosseinzadeh S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10160; Akhavan O, 2010, CARBON, V48, P509, DOI 10.1016/j.carbon.2009.09.069; Alofi A, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115421; American Cleaning Institute, 2015, SOAPS DET CHEM; Assael MJ, 2005, INT J THERMOPHYS, V26, P647, DOI 10.1007/s10765-005-5569-3; Baby TT, 2010, J APPL PHYS, V108, DOI 10.1063/1.3516289; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/NNANO.2010.132, 10.1038/nnano.2010.132]; Balderas-Lopez JA, 2000, REV SCI INSTRUM, V71, P2933, DOI 10.1063/1.1150713; Becerril HA, 2008, ACS NANO, V2, P463, DOI 10.1021/nn700375n; Bonaccorso F, 2012, MATER TODAY, V15, P564, DOI 10.1016/S1369-7021(13)70014-2; Calizo I, 2007, NANO LETT, V7, P2645, DOI 10.1021/nl071033g; Cao BY, 2016, CARBON, V96, P711, DOI 10.1016/j.carbon.2015.09.097; Chabot V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01378; Chaturvedi S, 2012, J SAUDI CHEM SOC, V16, P307, DOI 10.1016/j.jscs.2011.01.015; Chen IWP, 2013, J MATER CHEM C, V1, P5970, DOI 10.1039/c3tc31014k; Ciesielski A, 2014, CHEM SOC REV, V43, P381, DOI 10.1039/c3cs60217f; Davidsohn AS, 2013, SOAP DETERGENT CHEM; Dorgan VE, 2013, NANO LETT, V13, P4581, DOI 10.1021/nl400197w; Fugallo G, 2014, NANO LETT, V14, P6109, DOI 10.1021/nl502059f; Haar S, 2015, SMALL, V11, P1691, DOI 10.1002/smll.201402745; Hamilton CE, 2009, NANO LETT, V9, P3460, DOI 10.1021/nl9016623; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; Jobst J, 2010, MATER SCI FORUM, V645-648, P637, DOI 10.4028/www.scientific.net/MSF.645-648.637; Kashyap S, 2014, J NANOPARTICLES, V2014, P1, DOI [10.1155/2014/640281, DOI 10.1155/2014/640281]; Khan U, 2010, SMALL, V6, P864, DOI 10.1002/smll.200902066; Krishnamoorthy K, 2013, ULTRASON SONOCHEM, V20, P644, DOI 10.1016/j.ultsonch.2012.09.007; Kuang YD, 2015, NANO LETT, V15, P6121, DOI 10.1021/acs.nanolett.5b02403; Lee GJ, 2014, J MATER SCI, V49, P1506, DOI 10.1007/s10853-013-7831-6; Lee J, 2014, NAT NANOTECHNOL, V9, P101, DOI 10.1038/nnano.2013.297; Li C, 2008, COMPOS SCI TECHNOL, V68, P1227, DOI 10.1016/j.compscitech.2008.01.006; Li J, 2012, J MATER CHEM, V22, P8426, DOI 10.1039/c2jm16386a; Lin H, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/41/415706; Lotya M, 2010, ACS NANO, V4, P3155, DOI 10.1021/nn1005304; Lotya M, 2009, J AM CHEM SOC, V131, P3611, DOI 10.1021/ja807449u; Mattevi C, 2011, J MATER CHEM, V21, P3324, DOI 10.1039/c0jm02126a; Mehrali M, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-15; Nicolosi V, 2013, SCIENCE, V340, P1420, DOI 10.1126/science.1226419; Noroozi M, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-645; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ou EC, 2013, RSC ADV, V3, P9490, DOI 10.1039/c3ra40602d; Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]; Parviz D, 2012, ACS NANO, V6, P8857, DOI 10.1021/nn302784m; Paton KR, 2014, NAT MATER, V13, P624, DOI [10.1038/nmat3944, 10.1038/NMAT3944]; Ruecha N, 2014, BIOSENS BIOELECTRON, V52, P13, DOI 10.1016/j.bios.2013.08.018; Sen Gupta S, 2011, J APPL PHYS, V110, DOI 10.1063/1.3650456; SHEN J, 1995, REV SCI INSTRUM, V66, P4999, DOI 10.1063/1.1146123; Shin HJ, 2009, ADV FUNCT MATER, V19, P1987, DOI 10.1002/adfm.200900167; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Sur UK, 2012, INT J ELECTROCHEM, V2012, DOI 10.1155/2012/237689; Vandana S, 2015, INT J ENG TRENDS TEC, V26, P1; Varrla E, 2014, NANOSCALE, V6, P11810, DOI 10.1039/c4nr03560g; Wajid AS, 2012, CARBON, V50, P526, DOI 10.1016/j.carbon.2011.09.008; Ye ZQ, 2015, CARBON, V93, P915, DOI 10.1016/j.carbon.2015.06.008; Yigen S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.241411; Yoon D, 2009, J KOREAN PHYS SOC, V55, P1299, DOI 10.3938/jkps.55.1299; Yu AP, 2007, J PHYS CHEM C, V111, P7565, DOI 10.1021/jp071761s; Yu W, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/5/055705; Zhu HT, 2010, SCI CHINA TECHNOL SC, V53, P360, DOI 10.1007/s11431-010-0032-5	58	31	31	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152699	10.1371/journal.pone.0152699	http://dx.doi.org/10.1371/journal.pone.0152699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064575	Green Submitted, Green Published, gold			2022-12-26	WOS:000373891000016
J	Souza, CE; Camargo, LB; Pinter, A; Donalisio, MR				Souza, Celso Eduardo; Camargo, Luciana Bonato; Pinter, Adriano; Donalisio, Maria Rita			High Seroprevalence for Rickettsia rickettsii in Equines Suggests Risk of Human Infection in Silent Areas for the Brazilian Spotted Fever	PLOS ONE			English	Article							TICKS AMBLYOMMA-CAJENNENSE; CAPYBARAS HYDROCHOERUS-HYDROCHAERIS; SAO-PAULO; SOUTHERN BRAZIL; NONENDEMIC AREA; ENDEMIC AREA; STATE; HORSES; TRANSMISSION; ANTIBODIES	Equines play a role in the epidemiology of Brazilian spotted fever (BSF) since they are a primary host for the tick Amblyomma sculptum. We studied the seroprevalence for three species of Rickettsia in equines in four endemic (with human cases) and in four non-endemic areas (no human cases) in the Piracicaba River Basin, Sao Paulo, Brazil. A serological survey of 504 equines was performed: around 63 animals were sampled in each area and tested through indirect immunofluorescence assay for R. rickettsii, R. parkeri, and R. bellii in 2012-2013. Blood samples were seropositive for 183 equines (36.3%) in which 73 (39.9%) were from non-endemic areas. In the studied sites equines were highly exposed to Rickettsia infection ranging from 6.1% to 54.7%, with Geometric Mean Titers greater in endemic area (p = 0.012). Results suggest that Rickettsia may be more widespread than the surveillance of BSF has detected. These results highlight the need to include data on the seroprevalence of sentinel animals to improve human diagnoses and surveillance in areas with no reported human cases.	[Souza, Celso Eduardo; Pinter, Adriano] Superintendence Control Endem Dis, Reference Rickettsial Dis Lab, Sao Paulo, Brazil; [Camargo, Luciana Bonato; Donalisio, Maria Rita] Univ Estadual Campinas, Dept Publ Hlth, Sao Paulo, Brazil	Universidade Estadual de Campinas	Donalisio, MR (corresponding author), Univ Estadual Campinas, Dept Publ Hlth, Sao Paulo, Brazil.	rita.donalisio@gmail.com	Donalisio, Maria Rita/C-5263-2012; Donalisio, Maria Rita/Z-3934-2019; Pinter, Adriano/B-9827-2012; Pinter, Adriano/AAG-6459-2019	Donalisio, Maria Rita/0000-0003-4457-9897; Donalisio, Maria Rita/0000-0003-4457-9897; Pinter, Adriano/0000-0003-4596-3268; Pinter, Adriano/0000-0003-4596-3268	National Counsel of Technological and Scientific Development (CNPq) [472573/2011-0]; Sao Paulo Research Foundation (FAPESP) [2012/02447-0]	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the National Counsel of Technological and Scientific Development (CNPq), Grant: 472573/2011-0 and Sao Paulo Research Foundation (FAPESP), Grant: 2012/02447-0.	Batista FG, 2010, REV BRAS PARASITOL V, V19, P205, DOI 10.1590/S1984-29612010000400003; Cardoso Luciane Daniele, 2006, Cad. Saúde Pública, V22, P495, DOI 10.1590/S0102-311X2006000300004; de Souza CE, 2008, CIENC RURAL, V38, P1694, DOI 10.1590/S0103-84782008000600031; Freitas MCDD, 2010, REV BRAS PARASITOL V, V19, P130, DOI 10.4322/rbpv.01902012; Fortes FS, 2011, PESQUI VET BRASIL, V31, P1014, DOI 10.1590/S0100-736X2011001100013; Horta MC, 2009, VECTOR-BORNE ZOONOT, V9, P109, DOI 10.1089/vbz.2008.0114; Horta MC, 2004, AM J TROP MED HYG, V71, P93, DOI 10.4269/ajtmh.2004.71.93; Krawczak FS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-7; Labruna MB, 2009, ANN NY ACAD SCI, V1166, P156, DOI 10.1111/j.1749-6632.2009.04516.x; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Labruna MB, 2002, VET PARASITOL, V105, P65, DOI 10.1016/S0304-4017(01)00649-5; Moraes Filho J., 2009, Brazilian Journal of Veterinary Research and Animal Science, V46, P85; Moreira J.A., 1935, BRAS MED, V44, P465; Pacheco RC, 2009, REV SOC BRAS MED TRO, V42, P351, DOI 10.1590/S0037-86822009000300023; Pinter A, 2006, ANN NY ACAD SCI, V1078, P523, DOI 10.1196/annals.1374.103; Sangioni LA, 2005, EMERG INFECT DIS, V11, P265, DOI 10.3201/eid1102.040656; Silveira I, 2007, EMERG INFECT DIS, V13, P1111, DOI 10.3201/eid1307.061397; Souza CE, 2009, VET PARASITOL, V161, P116, DOI 10.1016/j.vetpar.2008.12.010; WALKER DH, 1989, CLIN MICROBIOL REV, V2, P227, DOI 10.1128/CMR.2.3.227-240.1989	19	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153303	10.1371/journal.pone.0153303	http://dx.doi.org/10.1371/journal.pone.0153303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064788	Green Published, gold, Green Submitted			2022-12-26	WOS:000373891000042
J	Valverde, A; De Maayer, P; Oberholster, T; Henschel, J; Louw, MK; Cowan, D				Valverde, Angel; De Maayer, Pieter; Oberholster, Tanzelle; Henschel, Joh; Louw, Michele K.; Cowan, Don			Specific Microbial Communities Associate with the Rhizosphere of Welwitschia mirabilis, a Living Fossil	PLOS ONE			English	Article							PYROSEQUENCING REVEALS; BACTERIAL COMMUNITY; PLANT DIVERSITY; SOIL MICROBES; PATTERNS; ROOTS	Welwitschia mirabilis is an ancient and rare plant distributed along the western coast of Namibia and Angola. Several aspects of Welwitschia biology and ecology have been investigated, but very little is known about the microbial communities associated with this plant. This study reports on the bacterial and fungal communities inhabiting the rhizosphere of W. mirabilis and the surrounding bulk soil. Rhizosphere communities were dominated by sequences of Alphaproteobacteria and Euromycetes, while Actinobacteria, Alphaproteobacteria, and fungi of the class Dothideomycetes jointly dominated bulk soil communities. Although microbial communities within the rhizosphere and soil samples were highly variable, very few "species" (OTUs defined at a 97% identity cut-off) were shared between these two environments. There was a small 'core' rhizosphere bacterial community (formed by Nitratireductor, Steroidobacter, Pseudonocardia and three Phylobacteriaceae) that together with Rhizophagus, an arbuscular mycorrhizal fungus, and other putative plant growth-promoting microbes may interact synergistically to promote Welwitschia growth.	[Valverde, Angel; De Maayer, Pieter; Oberholster, Tanzelle; Cowan, Don] Univ Pretoria, Dept Genet, Ctr Microbial Ecol & Genom, ZA-0002 Pretoria, South Africa; [Henschel, Joh] Gobabeb Res & Training Ctr, Namib Ecol Restorat & Monitoring Unit, Walvis Bay, Namibia; [Henschel, Joh] SAEON Arid Lands Node, Hadison Pk, Kimberley, South Africa; [Louw, Michele K.] Swakop Uranium, Swakopmund, Namibia	University of Pretoria; National Research Foundation - South Africa; South African Environmental Observation Network (SAEON)	Valverde, A (corresponding author), Univ Pretoria, Dept Genet, Ctr Microbial Ecol & Genom, ZA-0002 Pretoria, South Africa.	angel.valverde@up.ac.za	De Maayer, Pieter/AAC-2732-2020; Henschel, Joh R/ABE-5970-2021; Valverde, Angel/C-1308-2009; Oberholster, Tanzelle/C-5214-2015; Cowan, Don/E-3991-2012	Valverde, Angel/0000-0003-0439-9605; Oberholster, Tanzelle/0000-0002-6433-9404; Henschel, Joh/0000-0001-7122-2768; Cowan, Don/0000-0001-8059-861X; De Maayer, Pieter/0000-0001-8550-642X	National Research Foundation, South Africa	National Research Foundation, South Africa(National Research Foundation - South Africa)	This work was supported by funding from the National Research Foundation, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Swakop Uranium provided support in the form of salaries for MKL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; BORNMAN C H, 1972, Madoqua, V1, P53; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Coats VC, 2014, MOL ECOL, V23, P1318, DOI 10.1111/mec.12544; Cooper-Driver GA, 2000, J ARID ENVIRON, V46, P181, DOI 10.1006/jare.2000.0660; Dilcher DL, 2005, AM J BOT, V92, P1294, DOI 10.3732/ajb.92.8.1294; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Hartmann M, 2012, ISME J, V6, P2199, DOI 10.1038/ismej.2012.84; Henschel JR, 2000, PLANT ECOL, V150, P7, DOI 10.1023/A:1026512608982; JACOBSON KM, 1993, MYCORRHIZA, V3, P13, DOI 10.1007/BF00213462; Jorquera MA, 2012, MICROB ECOL, V64, P1008, DOI 10.1007/s00248-012-0071-5; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mendes LW, 2014, ISME J, V8, P1577, DOI 10.1038/ismej.2014.17; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Ogut M, 2010, BIOL FERT SOILS, V46, P707, DOI 10.1007/s00374-010-0475-7; Panhwar QA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097241; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Prober SM, 2015, ECOL LETT, V18, P85, DOI 10.1111/ele.12381; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Stafford WHL, 2005, ENVIRON MICROBIOL, V7, P1755, DOI 10.1111/j.1462-2920.2005.00929.x; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Valverde A, 2015, MOL ECOL, V24, P812, DOI 10.1111/mec.13068; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14	37	24	24	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153353	10.1371/journal.pone.0153353	http://dx.doi.org/10.1371/journal.pone.0153353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064484	Green Published, gold, Green Submitted			2022-12-26	WOS:000373891000051
J	Soliman, MK; Sadiq, MA; Agarwal, A; Sarwar, S; Hassan, M; Hanout, M; Graf, F; High, R; Do, DV; Nguyen, QD; Sepah, YJ				Soliman, Mohamed Kamel; Sadiq, Mohammad Ali; Agarwal, Aniruddha; Sarwar, Salman; Hassan, Muhammad; Hanout, Mostafa; Graf, Frank; High, Robin; Do, Diana V.; Quan Dong Nguyen; Sepah, Yasir J.			High-Resolution Imaging of Parafoveal Cones in Different Stages of Diabetic Retinopathy Using Adaptive Optics Fundus Camera	PLOS ONE			English	Article							PHOTORECEPTOR PACKING DENSITY; ECCENTRICITY; VARIABILITY; VISION; IDENTIFICATION	Purpose To assess cone density as a marker of early signs of retinopathy in patients with type II diabetes mellitus. Methods An adaptive optics (AO) retinal camera (rtx1 (TM); Imagine Eyes, Orsay, France) was used to acquire images of parafoveal cones from patients with type II diabetes mellitus with or without retinopathy and from healthy controls with no known systemic or ocular disease. Cone mosaic was captured at 0 degrees and 2 degrees eccentricities along the horizontal and vertical meridians. The density of the parafoveal cones was calculated within 100x100-mu m squares located at 500-mu m from the foveal center along the orthogonal meridians. Manual corrections of the automated counting were then performed by 2 masked graders. Cone density measurements were evaluated with ANOVA that consisted of one between-subjects factor, stage of retinopathy and the within-subject factors. The ANOVA model included a complex covariance structure to account for correlations between the levels of the within-subject factors. Results Ten healthy participants (20 eyes) and 25 patients (29 eyes) with type II diabetes mellitus were recruited in the study. The mean (+/- standard deviation [SD]) age of the healthy participants (Control group), patients with diabetes without retinopathy (No DR group), and patients with diabetic retinopathy (DR group) was 55 +/- 8, 53 +/- 8, and 52 +/- 9 years, respectively. The cone density was significantly lower in the moderate nonproliferative diabetic retinopathy (NPDR) and severe NPDR/proliferative DR groups compared to the Control, No DR, and mild NPDR groups (P < 0.05). No correlation was found between cone density and the level of hemoglobin A(1c) (HbA(1c)) or the duration of diabetes. Conclusions The extent of photoreceptor loss on AO imaging may correlate positively with severity of DR in patients with type II diabetes mellitus. Photoreceptor loss may be more pronounced among patients with advanced stages of DR due to higher risk of macular edema and its sequelae.	[Soliman, Mohamed Kamel; Sadiq, Mohammad Ali; Agarwal, Aniruddha; Sarwar, Salman; Hassan, Muhammad; Hanout, Mostafa; Graf, Frank; Do, Diana V.; Quan Dong Nguyen; Sepah, Yasir J.] Univ Nebraska Med Ctr, Stanley M Truhlsen Eye Inst, Ocular Imaging Reading & Res Ctr, Omaha, NE USA; [Soliman, Mohamed Kamel] Assiut Univ, Dept Ophthalmol, Assiut, Egypt; [High, Robin] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; Egyptian Knowledge Bank (EKB); Assiut University; University of Nebraska System; University of Nebraska Medical Center	Sepah, YJ (corresponding author), Univ Nebraska Med Ctr, Stanley M Truhlsen Eye Inst, Ocular Imaging Reading & Res Ctr, Omaha, NE USA.	yasir.sepah@unmc.edu	Hanout, Mostafa/Q-6840-2017; Soliman, Mohamed/M-4243-2019	Hanout, Mostafa/0000-0001-7829-9776; Soliman, Mohamed/0000-0003-1671-8925	Stanley M. Truhlsen Eye Institute at the University of Nebraska Medical Center from Research to Prevent Blindness (RPB); Otis Glebe Foundation, Omaha, Nebraska, USA	Stanley M. Truhlsen Eye Institute at the University of Nebraska Medical Center from Research to Prevent Blindness (RPB); Otis Glebe Foundation, Omaha, Nebraska, USA	This work was supported by The Stanley M. Truhlsen Eye Institute at the University of Nebraska Medical Center has received an unrestricted grant from Research to Prevent Blindness (RPB). The rtx1 (TM) adaptive optics imaging device employed in this study has been acquired by the Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, with generous support from Otis Glebe Foundation, Omaha, Nebraska, USA.	AHNELT PK, 1987, J COMP NEUROL, V255, P18, DOI 10.1002/cne.902550103; Alvarez Y, 2010, DIS MODEL MECH, V3, P236, DOI 10.1242/dmm.003772; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; Bearse MA, 2004, INVEST OPHTH VIS SCI, V45, P296, DOI 10.1167/iovs.03-0424; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Carroll J, 2009, P NATL ACAD SCI USA, V106, P20948, DOI 10.1073/pnas.0910128106; Chui TYP, 2008, INVEST OPHTH VIS SCI, V49, P4679, DOI 10.1167/iovs.08-2135; Chui TYP, 2008, J OPT SOC AM A, V25, P3021, DOI 10.1364/JOSAA.25.003021; CURCIO CA, 1992, VISUAL NEUROSCI, V9, P169, DOI 10.1017/S0952523800009639; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dabir S, 2014, EYE, V28, P1488, DOI 10.1038/eye.2014.229; DALEY ML, 1987, DIABETES CARE, V10, P777, DOI 10.2337/diacare.10.6.777; Dees EW, 2011, BIOMED OPT EXPRESS, V2, P1351, DOI 10.1364/BOE.2.001351; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Fletcher Erica L, 2005, Clin Exp Optom, V88, P132; Garnier MB, 2014, CLIN EXP OPHTHALMOL, V42, P833, DOI 10.1111/ceo.12356; KLEIN R, 1995, OPHTHALMOLOGY, V102, P7; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Lieth E, 2000, CLIN EXP OPHTHALMOL, V28, P3, DOI 10.1046/j.1442-9071.2000.00222.x; Lombardo M, 2014, RETINA-J RET VIT DIS, V34, P546, DOI 10.1097/IAE.0b013e3182a10850; Mrejen S, 2014, OSLI RETINA, V45, P562, DOI 10.3928/23258160-20141118-12; Murakami T, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/920713; Osterberg G., 1935, TOPOGRAPHY OF THE LA; Park SP, 2013, EXP EYE RES, V108, P1, DOI 10.1016/j.exer.2012.12.011; Pinhas A, 2014, INVEST OPHTH VIS SCI, V55, P8056, DOI 10.1167/iovs.14-15136; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; SOKOL S, 1985, ARCH OPHTHALMOL-CHIC, V103, P51; Song HX, 2011, INVEST OPHTH VIS SCI, V52, P7376, DOI 10.1167/iovs.11-7199; Tan W, 2015, INVEST OPHTH VIS SCI, V56, P6339, DOI 10.1167/iovs.15-16817; Tarr Joanna M, 2013, ISRN Ophthalmol, V2013, P343560, DOI 10.1155/2013/343560; van Dijk HW, 2009, INVEST OPHTH VIS SCI, V50, P3404, DOI 10.1167/iovs.08-3143; Verma A, 2009, EYE, V23, P1824, DOI 10.1038/eye.2009.184; Wagner-Schuman M, 2010, VISION RES, V50, P2396, DOI 10.1016/j.visres.2010.09.015; YUODELIS C, 1986, VISION RES, V26, P847, DOI 10.1016/0042-6989(86)90143-4	38	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152788	10.1371/journal.pone.0152788	http://dx.doi.org/10.1371/journal.pone.0152788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27057752	gold, Green Published, Green Submitted			2022-12-26	WOS:000373604800011
J	Bertoluci, G; Masset, G; Gomy, C; Mottet, J; Darmon, N				Bertoluci, Gwenola; Masset, Gabriel; Gomy, Catherine; Mottet, Julien; Darmon, Nicole			How to Build a Standardized Country-Specific Environmental Food Database for Nutritional Epidemiology Studies	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; SELF-SELECTED DIETS; LIFE-CYCLE; LAND-USE; ENERGY; QUALITY; HEALTH; MEAT; SUSTAINABILITY; FOOTPRINT	There is a lack of standardized country-specific environmental data to combine with nutritional and dietary data for assessing the environmental impact of individual diets in epidemiology surveys, which are consequently reliant on environmental food datasets based on values retrieved from a heterogeneous literature. The aim of this study was to compare and assess the relative strengths and limits of a database of food greenhouse gas emissions (GHGE) values estimated with a hybrid method combining input/output and LCA approaches, with a dataset of GHGE values retrieved from the literature. France is the geographical perimeter considered in this study, but the methodology could be applied to other countries. The GHGE of 402 foodstuffs, representative of French diet, were estimated using the hybrid method. In parallel, the GHGE of individual foods were collected from existing literature. Median per-food-category GHGE values from the hybrid method and the reviewed literature were found to correlate strongly (Spearman correlation was 0.83), showing similar rankings of food categories. Median values were significantly different for only 5 (out of 29) food categories, including the ruminant meats category for which the hybrid method gave lower estimates than those from existing literature. Analysis also revealed that literature values came from heterogeneous studies that were not always sourced and that were conducted under different LCA modeling hypotheses. In contrast, the hybrid method helps build reliably-sourced, representative national standards for product-based datasets. We anticipate this hybrid method to be a starting point for better environmental impact assessments of diets.	[Bertoluci, Gwenola] Cent Supelec, Lab Genie Ind, Grande Voie Vignes, F-92290 Chatenay Malabry, France; [Bertoluci, Gwenola] SESG UFR MIDEAL, AgroParisTech, Massy, France; [Masset, Gabriel; Darmon, Nicole] Aix Marseille Univ, Unite Mixte Rech UMR Nutr Obes & Risk Thrombosis, Inst Natl Rech Agron 1260, Inst Natl Sante & Rech Med 1062, F-13385 Marseille, France; [Gomy, Catherine] BIO Deloitte, F-92200 Neuilly Sur Seine, France; [Mottet, Julien] AgroParisTech, UMR GENIAL, INRA1145, Cnam, Massy, France; [Bertoluci, Gwenola] AgroParisTech, UFR MIDEAL, 1 Ave Olympiades, F-91744 Massy, France	UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Deloitte Touche Tohmatsu Limited; AgroParisTech; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; AgroParisTech	Bertoluci, G (corresponding author), Cent Supelec, Lab Genie Ind, Grande Voie Vignes, F-92290 Chatenay Malabry, France.; Bertoluci, G (corresponding author), SESG UFR MIDEAL, AgroParisTech, Massy, France.; Bertoluci, G (corresponding author), AgroParisTech, UFR MIDEAL, 1 Ave Olympiades, F-91744 Massy, France.	gwenola.bertoluci@agroparistech.fr	Bris, Gwenola Yannou-Le/L-4119-2015; Masset, Gabriel/I-4636-2019	Bris, Gwenola Yannou-Le/0000-0002-3279-9473; Masset, Gabriel/0000-0001-6977-0247	French National Research Agency under the OCAD project [558, ANR-11-ALID-0002]; Daniel and Nina Carasso Foundation under AVASUN project	French National Research Agency under the OCAD project(French National Research Agency (ANR)); Daniel and Nina Carasso Foundation under AVASUN project	This work was supported by the French National Research Agency under the OCAD project (grant 558 number ANR-11-ALID-0002). GM was supported by a grant from the Daniel and Nina Carasso Foundation, under the AVASUN project. The funders had no role in the design analysis or writing of this article. One of the authors was employed by a commercial company: "Bio by Deloitte" but the society was a partner and any salary or funding has been received from that company. Its participation is related to the work conducted at different steps of the study by C. Gomy, who Conceived and designed the experiments, Analyzed the data, and Contributed to the writing of the manuscript.	AFNOR, 2015, GEN PRINC ENV COMM M; Andersson K., 1998, CLEANER PRODUCTION, V6, P277, DOI DOI 10.1016/S0959-6526(98)00027-4; Andriankaja H, 2013, J ENG DESIGN, V24, P1, DOI 10.1080/09544828.2012.665226; [Anonymous], 2006, 14044 ISO; Aston LM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001072; Audsley E., 2009, LOW CAN WE GO ASSESS; Biesbroek S, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-27; Boeing H, 2013, EUR J CLIN NUTR, V67, P424, DOI 10.1038/ejcn.2013.47; Briggs ADM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003543; Carlsson-Kanyama A, 2003, ECOL ECON, V44, P293, DOI 10.1016/S0921-8009(02)00261-6; Carlsson-Kanyama A, 2009, AM J CLIN NUTR, V89, pS1704, DOI 10.3945/ajcn.2009.26736AA; Coley D, 2009, FOOD POLICY, V34, P150, DOI 10.1016/j.foodpol.2008.11.001; Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027; Dolle J, 2011, COMP GAZ EFFET SERRE; Elmadfa I, 2010, EUR J CLIN NUTR, V64, pS4, DOI 10.1038/ejcn.2010.202; European Commission, 2010, ILCD HDB GEN GUID LI; European Food SCP Round Table, 2012, CONT ENV IMPR FIN RE; European Food SCP Round Table, 2012, ENV ASS FOOD DRINK P; Fanzo J, 2015, TECHNICAL BRIEF METR; Food and Agriculture Organization, 2012, ANN 1 INT SCI S BIOD; Hoolohan C, 2013, ENERG POLICY, V63, P1065, DOI 10.1016/j.enpol.2013.09.046; Hou DY, 2014, J CLEAN PROD, V83, P87, DOI 10.1016/j.jclepro.2014.07.062; Huppes G, 2008, ENV IMPACTS DIET CHA; Joyanes M, 2006, CRIT REV FOOD SCI, V46, P329, DOI 10.1080/10408390600688156; Le Pochat S, 2007, J CLEAN PROD, V15, P671, DOI 10.1016/j.jclepro.2006.01.004; Lee A, 2013, OBES REV, V14, P82, DOI 10.1111/obr.12078; Lenzen M., 2000, J IND ECOL, V4, P127, DOI DOI 10.1162/10881980052541981; Leontief W., 1966, INPUT OUTPUT EC; Macdiarmid JI, 2012, AM J CLIN NUTR, V96, P632, DOI 10.3945/ajcn.112.038729; Masset G, 2014, AM J CLIN NUTR, V99, P1460, DOI 10.3945/ajcn.113.077958; Masset G, 2014, J ACAD NUTR DIET, V114, P862, DOI 10.1016/j.jand.2014.02.002; Monsivais P, 2015, AM J CLIN NUTR; Nelson M, 1997, DESIGN CONCEPTS NUTR; Ogino A, 2007, ANIM SCI J, V78, P424, DOI 10.1111/j.1740-0929.2007.00457.x; Pairotti MB, 2015, J CLEAN PROD, V103, P507, DOI 10.1016/j.jclepro.2013.12.082; Paloviita A, 2002, 14 INT C INP OUTP TE; Payen S, 2015, J CLEAN PROD, V87, P139, DOI 10.1016/j.jclepro.2014.10.007; Pradhan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062228; Roy P, 2012, J ENVIRON MANAGE, V93, P218, DOI 10.1016/j.jenvman.2011.09.017; Salomone R, 2012, J CLEAN PROD, V28, P88, DOI 10.1016/j.jclepro.2011.10.004; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Schrodera H, 2016, BRIT J NUTR S1  0113, V2016, P1; Soret S, 2014, AM J CLIN NUTR, V100, p490S, DOI 10.3945/ajcn.113.071589; Temme EHM, 2013, PUBLIC HEALTH NUTR, V16, P1900, DOI 10.1017/S1368980013000232; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Vazquez-Rowe I, 2013, J CLEAN PROD, V44, P200, DOI 10.1016/j.jclepro.2012.11.049; Vieux F, 2012, ECOL ECON, V75, P91, DOI 10.1016/j.ecolecon.2012.01.003; Vieux F, 2013, AM J CLIN NUTR, V97, P569, DOI 10.3945/ajcn.112.035105; Wiedmann T, 2009, ECOL ECON, V69, P211, DOI 10.1016/j.ecolecon.2009.08.026; Wiedmann TO, 2011, ENVIRON SCI TECHNOL, V45, P5900, DOI 10.1021/es2007287; Williams AG, 2006, DETERMINING ENV BURD	51	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0150617	10.1371/journal.pone.0150617	http://dx.doi.org/10.1371/journal.pone.0150617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054565	Green Published, gold			2022-12-26	WOS:000373608000004
J	Cunningham, D; Shearer, DA; Drawer, S; Eager, R; Taylor, N; Cook, C; Kilduff, LP				Cunningham, Daniel; Shearer, David A.; Drawer, Scott; Eager, Robin; Taylor, Neil; Cook, Christian; Kilduff, Liam P.			Movement Demands of Elite U20 International Rugby Union Players	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; TIME-MOTION ANALYSIS; PROFESSIONAL RUGBY; MATCH-PLAY; PHYSIOLOGICAL DEMANDS; PHYSICAL DEMANDS; SOCCER PLAYERS; GAME DEMANDS; SPEED; REHABILITATION	The purpose of this study was to quantify movement demands of elite international age grade (U20) rugby union players during competitive tournament match play. Forty elite professional players from an U20 international performance squad were monitored using 10Hz global positioning systems (GPS) during 15 international tournament matches during the 2014/15 and 2015/16 seasons. Data on distances, velocities, accelerations, decelerations, high metabolic load (HML) distance and efforts, and number of sprints were derived. Data files from players who played over 60 min (n = 161) were separated firstly into Forwards and Backs, and more specifically into six positional groups; FR-Front Row (prop & hooker), SR-Second Row, BR-Back Row (Flankers & No. 8), HB-Half Backs (scrum half & outside half), MF-Midfield (centres), B3-Back Three (wings & full back) for match analysis. Analysis revealed significant differences between forwards and backs positions. Backs scored higher on all variables measured with the exception of number of moderate accelerations, decelerations (no difference). The centres covered the greatest total distance with the front row covering the least (6.51 +/- 0.71 vs 4.97 +/- 0.75 km, p < 0.001). The front row also covered the least high speed running (HSR) distance compared to the back three (211.6 +/- 112.7 vs 728.4 +/- 150.2 m, p < 0.001) who covered the most HSR distance, affirming that backs cover greater distances but forwards have greater contact loads. These findings highlight for the first time differences in the movement characteristics of elite age grade rugby union players specific to positional roles.	[Cunningham, Daniel; Cook, Christian; Kilduff, Liam P.] Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales; [Shearer, David A.] Univ South Wales, Dept Psychol, Pontypridd, Wales; [Drawer, Scott; Eager, Robin; Taylor, Neil] Rugby Football Union, Greater London, England	Swansea University; University of South Wales	Kilduff, LP (corresponding author), Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales.	l.kilduff@swansea.ac.uk	Shearer, David/K-8025-2019	Shearer, David/0000-0002-5877-8160; Cunningham, Dan/0000-0002-5249-0609; Cook, Christian/0000-0001-9677-0306	Rugby Football Union	Rugby Football Union	The authors received no specific funding for this work and no authors have any financial or other interest in the products or distributor of the products named in the study. The Rugby Football Union provided support in the form of salaries for authors SD, RE, and NT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abt G, 2009, J SPORT SCI, V27, P893, DOI 10.1080/02640410902998239; Argus CK, 2012, J STRENGTH COND RES, V26, P2698, DOI 10.1519/JSC.0b013e318241382a; Austin D, 2011, J SCI MED SPORT, V14, P259, DOI 10.1016/j.jsams.2011.01.003; Austin DJ, 2013, J STRENGTH COND RES, V27, P14, DOI 10.1519/JSC.0b013e31824e108c; Barr MJ, 2014, J STRENGTH COND RES, V28, P2724, DOI 10.1519/JSC.0000000000000364; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Cahill N, 2013, J SPORT SCI, V31, P229, DOI 10.1080/02640414.2012.727456; Castellano J, 2011, J SPORT SCI MED, V10, P233; Coughlan GF, 2011, J ORTHOP SPORT PHYS, V41, P600, DOI 10.2519/jospt.2011.3508; Cunniffe B, 2009, J STRENGTH COND RES, V23, P1195, DOI 10.1519/JSC.0b013e3181a3928b; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; DOCHERTY D, 1988, J HUM MOVEMENT STUD, V14, P269; Duthie G, 2005, J SPORT SCI, V23, P523, DOI 10.1080/02640410410001730188; Eaton C, 2006, PHYS THER SPORT, V7, P22, DOI 10.1016/j.ptsp.2005.08.006; Gabbett TJ, 2012, J SCI MED SPORT, V15, P80, DOI 10.1016/j.jsams.2011.07.004; Gabbett TJ, 2011, J SCI MED SPORT, V14, P204, DOI 10.1016/j.jsams.2010.12.002; Gabbett TJ., 2015, J STRENGTH COND RES; Hansen KT, 2011, J STRENGTH COND RES, V25, P2382, DOI 10.1519/JSC.0b013e318201bf48; Harley JA, 2010, J SPORT SCI, V28, P1391, DOI 10.1080/02640414.2010.510142; Hartwig TB, 2011, J STRENGTH COND RES, V25, P966, DOI 10.1519/JSC.0b013e3181d09e24; Higham DG, 2012, J SCI MED SPORT, V15, P277, DOI 10.1016/j.jsams.2011.11.256; Jones MR, 2015, EUR J SPORT SCI, V15, P488, DOI 10.1080/17461391.2015.1010106; Jones MR, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-38; Lindsay A, 2015, EUR J SPORT SCI, V15, P480, DOI 10.1080/17461391.2015.1025858; Lloyd RS, 2015, J STRENGTH COND RES, V29, P1439, DOI 10.1519/JSC.0000000000000756; McLellan CP, 2011, J STRENGTH COND RES, V25, P1703, DOI 10.1519/JSC.0b013e3181ddf678; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; Quarrie KL, 2000, J SPORT SCI, V18, P237; Randers MB, 2010, J SPORT SCI, V28, P171, DOI 10.1080/02640410903428525; Reardon C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133410; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; West DJ, 2014, J STRENGTH COND RES, V28, P194, DOI 10.1519/JSC.0b013e318291b726	34	29	30	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153275	10.1371/journal.pone.0153275	http://dx.doi.org/10.1371/journal.pone.0153275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055230	Green Published, Green Submitted, gold			2022-12-26	WOS:000373608000113
J	Treat, AC; Wheeler, DS; Stolz, DB; Tsang, M; Friedman, PA; Romero, G				Treat, Anny Caceres; Wheeler, David S.; Stolz, Donna B.; Tsang, Michael; Friedman, Peter A.; Romero, Guillermo			The PDZ Protein Na+/H+ Exchanger Regulatory Factor-1 (NHERF1) Regulates Planar Cell Polarity and Motile Cilia Organization	PLOS ONE			English	Article							PARATHYROID-HORMONE; ASYMMETRIC LOCALIZATION; APICAL MEMBRANE; RECEPTOR; BETA; PHOSPHORYLATION; CILIOGENESIS; ASSOCIATION; DYNAMICS; SIGNALS	Directional flow of the cerebrospinal fluid requires coordinated movement of the motile cilia of the ependymal epithelium that lines the cerebral ventricles. Here we report that mice lacking the Na+/H+ Exchanger Regulatory Factor 1 (NHERF1/Slc9a3r1, also known as EBP50) develop profound communicating hydrocephalus associated with fewer and disorganized ependymal cilia. Knockdown of NHERF1/slc9a3r1 in zebrafish embryos also causes severe hydrocephalus of the hindbrain and impaired ciliogenesis in the otic vesicle. Ultrastructural analysis did not reveal defects in the shape or organization of individual cilia. Similar phenotypes have been described in animals with deficiencies in Wnt signaling and the Planar Cell Polarity (PCP) pathway. We show that NHERF1 binds the PCP core genes Frizzled (Fzd) and Vangl. We further show that NHERF1 assembles a ternary complex with Fzd4 and Vangl2 and promotes translocation of Vangl2 to the plasma membrane, in particular to the apical surface of ependymal cells. Taken together, these results strongly support an important role for NHERF1 in the regulation of PCP signaling and the development of functional motile cilia.	[Treat, Anny Caceres; Wheeler, David S.; Friedman, Peter A.; Romero, Guillermo] Univ Pittsburgh, Pittsburgh Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA USA; [Wheeler, David S.] Univ Pittsburgh, Sch Med, Med Scientist Training Program, Pittsburgh, PA USA; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA; [Tsang, Michael] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Romero, G (corresponding author), Univ Pittsburgh, Pittsburgh Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA USA.	ggr@pitt.edu	Tsang, Michael W/I-9305-2014; Tsang, Michael/AAG-9338-2020; Tsang, Michael/ABV-0504-2022	Tsang, Michael W/0000-0001-7123-0063; Tsang, Michael/0000-0001-7123-0063	National Institute of Diabetes and Digestive and Kidney Diseases [DK079864, DK069998, DK083211]; National Institute of General Medical Sciences [T32GM008424]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK079864, F30DK083211, R01DK069998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008424] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases (www.niddk.nih.gov) grants DK079864 (GR), DK069998 (PAF) and DK083211 (DSW), and National Institute of General Medical Sciences (www.nigms.nih.gov) T32GM008424 (ACT and DSW).	[Anonymous], 1989, POSTGRAD MED; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Boutin C, 2014, P NATL ACAD SCI USA, V111, pE3129, DOI 10.1073/pnas.1404988111; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Clark MA, 2007, FEBS LETT, V581, P764, DOI 10.1016/j.febslet.2007.01.045; Ferkol TW, 2012, J PEDIATR-US, V160, P366, DOI 10.1016/j.jpeds.2011.11.024; Flynt AS, 2010, CELL CYCLE, V9, P235, DOI 10.4161/cc.9.2.10434; Francis SS, 2011, J CELL BIOL, V193, P219, DOI 10.1083/jcb.201009001; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; Guerra L, 2005, J BIOL CHEM, V280, P40925, DOI 10.1074/jbc.M505103200; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Hoque MT, 2009, BIOCHEM BIOPH RES CO, V379, P60, DOI 10.1016/j.bbrc.2008.12.014; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ibanez-Tallon I, 2002, HUM MOL GENET, V11, P715, DOI 10.1093/hmg/11.6.715; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Kinlough CL, 2011, J BIOL CHEM, V286, P39072, DOI 10.1074/jbc.M111.289504; Kreimann EL, 2007, ONCOGENE, V26, P5290, DOI 10.1038/sj.onc.1210336; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Morales FC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.131; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Sun LC, 2016, FASEB J, V30, P578, DOI 10.1096/fj.15-275586; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Wheeler DS, 2011, ONCOGENE, V30, P32, DOI 10.1038/onc.2010.389; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Yao R, 2004, ONCOGENE, V23, P6023, DOI 10.1038/sj.onc.1207817; Yin HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031988; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011	45	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153144	10.1371/journal.pone.0153144	http://dx.doi.org/10.1371/journal.pone.0153144			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055101	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000373608000087
J	du Plessis, WJ; Kleynhans, L; du Plessis, N; Stanley, K; Malherbe, ST; Maasdorp, E; Ronacher, K; Chegou, NN; Walzl, G; Loxton, AG				du Plessis, Willem J.; Kleynhans, Leanie; du Plessis, Nelita; Stanley, Kim; Malherbe, Stephanus T.; Maasdorp, Elizna; Ronacher, Katharina; Chegou, Novel N.; Walzl, Gerhard; Loxton, Andre G.			The Functional Response of B Cells to Antigenic Stimulation: A Preliminary Report of Latent Tuberculosis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; FLOW-CYTOMETRY; INNATE; AUTOIMMUNE; EXPRESSION; INFECTION; SUSCEPTIBILITY	Mycobacterium tuberculosis (M.tb) remains a successful pathogen, causing tuberculosis disease numbers to constantly increase. Although great progress has been made in delineating the disease, the host-pathogen interaction is incompletely described. B cells have shown to function as both effectors and regulators of immunity via non-humoral methods in both innate and adaptive immune settings. Here we assessed specific B cell functional interaction following stimulation with a broad range of antigens within the LTBI milieu. Our results indicate that B cells readily produce pro-and anti-inflammatory cytokines (including IL-1 beta, IL-10, IL-17, IL-21 and TNF-alpha) in response to stimulation. TLR4 and TLR9 based stimulations achieved the greatest secreted cytokine-production response and BCG stimulation displayed a clear preference for inducing IL-1 beta production. We also show that the cytokines produced by B cells are implicated strongly in cell-mediated communication and that plasma (memory) B cells (CD19(+)CD27(+)CD138(+)) is the subset with the greatest contribution to cytokine production. Collectively our data provides insight into B cell responses, where they are implicated in and quantifies responses from specific B cell phenotypes. These findings warrant further functional B cell research with a focus on specific B cell phenotypes under conditions of active TB disease to further our knowledge about the contribution of various cell subsets which could have implications for future vaccine development or refined B cell orientated treatment in the health setting.	[du Plessis, Willem J.; Kleynhans, Leanie; du Plessis, Nelita; Stanley, Kim; Malherbe, Stephanus T.; Maasdorp, Elizna; Ronacher, Katharina; Chegou, Novel N.; Walzl, Gerhard; Loxton, Andre G.] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, SA MRC Ctr TB Res,DST NRF Ctr Excellence Biomed T, Cape Town, South Africa	Stellenbosch University	Loxton, AG (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, SA MRC Ctr TB Res,DST NRF Ctr Excellence Biomed T, Cape Town, South Africa.	GL2@sun.ac.za	Ronacher, Katharina/N-9603-2016; Walzl, Gerhard/N-6371-2016	Ronacher, Katharina/0000-0002-6371-1462; Maasdorp, Elizna/0000-0002-3402-169X; du Plessis, Jacques/0000-0002-8887-4938; Kleynhans, Leanie/0000-0003-1635-253X; Chegou, Novel N/0000-0002-8690-1699; Loxton, Andre/0000-0003-0659-9803; du Plessis, Nelita/0000-0001-7881-925X; Walzl, Gerhard/0000-0003-2487-125X	NRF	NRF	WJ du Plessis holds an NRF scholarship. GW holds the DST/NRF SA Research Chair Initiative (SARChI) for TB Biomarkers. The authors received no specific funding for this work.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; Achkar JM, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a018432; Achkar JM, 2015, IMMUNOL REV, V264, P167, DOI 10.1111/imr.12276; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Algood HMS, 2004, J IMMUNOL, V172, P6846, DOI 10.4049/jimmunol.172.11.6846; [Anonymous], 2015, GLOBAL TUBERCULOSIS; Bao Y, 2014, CELL RES, V24, P161, DOI 10.1038/cr.2013.155; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Bean AGD, 1999, J IMMUNOL, V162, P3504; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Brighenti S, 2012, J INFECT DIS, V205, pS316, DOI 10.1093/infdis/jis043; Briken V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00062; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Chan J, 2014, SEMIN IMMUNOL, V26, P588, DOI 10.1016/j.smim.2014.10.005; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; de Wit J, 2015, J ALLERGY CLIN IMMUN, V135, P1053, DOI 10.1016/j.jaci.2014.08.012; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Fernando TR, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-7; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gharibi T, 2016, IMMUNOBIOLOGY, V221, P357, DOI 10.1016/j.imbio.2015.09.021; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Gopalakrishnan A, 2016, CELL IMMUNOL, V302, P11, DOI 10.1016/j.cellimm.2015.12.009; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hoehlig K, 2008, ADV IMMUNOL, V98, P1, DOI 10.1016/S0065-2776(08)00401-X; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Kaufmann SHE, 2013, CURR OPIN IMMUNOL, V25, P441, DOI 10.1016/j.coi.2013.05.005; Kaufmann SHE, 2012, TRENDS IMMUNOL, V33, P373, DOI 10.1016/j.it.2012.03.004; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Killick KE, 2013, CELL MICROBIOL, V15, P1484, DOI 10.1111/cmi.12161; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Lebeis SL, 2009, CELL HOST MICROBE, V5, P114, DOI 10.1016/j.chom.2009.01.008; Lenaerts A, 2015, IMMUNOL REV, V264, P288, DOI 10.1111/imr.12252; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; McShane H, 2012, TUBERCULOSIS, V92, P283, DOI 10.1016/j.tube.2011.12.003; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Rangaka MX, 2015, LANCET, P6736; Rao M, 2015, CLIN INFECT DIS, V61, pS225, DOI 10.1093/cid/civ614; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Saiga H, 2015, J INFECT DIS, V211, P1831, DOI 10.1093/infdis/jiu675; Salie M, 2015, INFECT GENET EVOL, V34, P221, DOI 10.1016/j.meegid.2015.07.004; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schurz H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139711; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; WILLIAMSON BD, 1983, P NATL ACAD SCI-BIOL, V80, P5397, DOI 10.1073/pnas.80.17.5397; Wu LL, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0166-1; Zhao LL, 2015, MED SCI MONITOR, V21, P1097, DOI 10.12659/MSM.893755; Zhou Y, 2015, ANTON LEEUW INT J G, V108, P163, DOI 10.1007/s10482-015-0475-6	62	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152710	10.1371/journal.pone.0152710	http://dx.doi.org/10.1371/journal.pone.0152710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050308	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500049
J	Fischer, AW; Heinze, S; Putnam, DK; Li, B; Pino, JC; Xia, Y; Lopez, CF; Meiler, J				Fischer, Axel W.; Heinze, Sten; Putnam, Daniel K.; Li, Bian; Pino, James C.; Xia, Yan; Lopez, Carlos F.; Meiler, Jens			CASP11-An Evaluation of a Modular BCL:: Fold-Based Protein Structure Prediction Pipeline	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; SECONDARY STRUCTURE; CONTACT ORDER; SOFTWARE; BINDING; SYSTEM; RATES; AMBER	In silico prediction of a protein's tertiary structure remains an unsolved problem. The community-wide Critical Assessment of Protein Structure Prediction (CASP) experiment provides a double-blind study to evaluate improvements in protein structure prediction algorithms. We developed a protein structure prediction pipeline employing a three-stage approach, consisting of low-resolution topology search, high-resolution refinement, and molecular dynamics simulation to predict the tertiary structure of proteins from the primary structure alone or including distance restraints either from predicted residue-residue contacts, nuclear magnetic resonance (NMR) nuclear overhauser effect (NOE) experiments, or mass spectroscopy (MS) cross-linking (XL) data. The protein structure prediction pipeline was evaluated in the CASP11 experiment on twenty regular protein targets as well as thirtythree 'assisted' protein targets, which also had distance restraints available. Although the low-resolution topology search module was able to sample models with a global distance test total score (GDT_TS) value greater than 30% for twelve out of twenty proteins, frequently it was not possible to select the most accurate models for refinement, resulting in a general decay of model quality over the course of the prediction pipeline. In this study, we provide a detailed overall analysis, study one target protein in more detail as it travels through the protein structure prediction pipeline, and evaluate the impact of limited experimental data.	[Fischer, Axel W.; Heinze, Sten; Li, Bian; Xia, Yan; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Fischer, Axel W.; Heinze, Sten; Li, Bian; Xia, Yan; Lopez, Carlos F.; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Putnam, Daniel K.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37232 USA; [Pino, James C.] Vanderbilt Univ, Chem & Phys Biol Grad Program, Nashville, TN 37232 USA; [Lopez, Carlos F.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Lopez, Carlos F.] Vanderbilt Univ, Ctr Quantitat Sci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA.; Meiler, J (corresponding author), Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA.	jens@meilerlab.org	Putnam, Daniel/X-9760-2019; Li, Bian/AAM-4001-2020; Lopez, Carlos/P-7257-2019; Li, Bian/AAV-3933-2021	Putnam, Daniel/0000-0001-8080-775X; Li, Bian/0000-0002-8280-5018; Lopez, Carlos/0000-0003-3668-7468; Li, Bian/0000-0002-8280-5018; Fischer, Axel Walter/0000-0003-0237-7365	National Institutes of Health [R01 GM080403, R01 GM099842, R01 DK097376]; National Science Foundation [CHE 1305874, BIO 1411482]; U.S. National Library of Medicine [5T15LM007450-09]; Initiative for Maximizing Student Development [R25 GM 062459]; U.S. Department of Energy [DE-AC05-00OR22725]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099842, R25GM062459, R01GM080403] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Initiative for Maximizing Student Development; U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funded by National Institutes of Health, http://www.nih.gov R01 GM080403, R01 GM099842, R01 DK097376 (JM), National Science Foundation http://www.nsf.gov CHE 1305874, BIO 1411482 (JM CFL), U.S. National Library of Medicine-5T15LM007450-09 (DKP), Initiative for Maximizing Student Development-https://www.nigms.nih.gov/Training/IMSD/Pages/default.aspx-R25 GM 062459 (JCP), and U.S. Department of Energy-http://energy.gov/-DE-AC05-00OR22725 (JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonneau R, 2002, PROTEIN SCI, V11, P1937, DOI 10.1110/ps.3790102; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; BRYNGELSON JD, 1989, J PHYS CHEM-US, V93, P6902, DOI 10.1021/j100356a007; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; Case D.A., 2022, AMBER; Dastvan R, 2016, P NATL ACAD SCI USA, V113, P1220, DOI 10.1073/pnas.1520431113; Durham E, 2009, J MOL MODEL, V15, P1093, DOI 10.1007/s00894-009-0454-9; Feig M, 2016, PROTEINS, V84, P282, DOI 10.1002/prot.24871; Fischer AW, 2014, BCL MP FOLD MEMBRANC, DOI 10.13140/2.1.4128.8004; Hanukoglu I, 2015, BIOCHEM MOL BIOL EDU, V43, P206, DOI 10.1002/bmb.20849; Hardin C, 2003, P NATL ACAD SCI USA, V100, P1679, DOI 10.1073/pnas.252753899; Hardin C, 2002, J COMPUT CHEM, V23, P138, DOI 10.1002/jcc.1162; Heinze S, 2015, PROTEINS, V83, P547, DOI 10.1002/prot.24733; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Hofmann T, 2015, METHODS, V89, P79, DOI 10.1016/j.ymeth.2015.05.014; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karakas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049240; Kim H, 2016, PROTEINS, V84, P105, DOI 10.1002/prot.24920; Ko J, 2012, NUCLEIC ACIDS RES, V40, pW294, DOI 10.1093/nar/gks493; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Leman JK, 2013, PROTEINS, V81, P1127, DOI 10.1002/prot.24258; Lindert S, 2015, J CHEM THEORY COMPUT, V11, P1337, DOI 10.1021/ct500995d; Lindert S, 2012, BIOPOLYMERS, V97, P669, DOI 10.1002/bip.22027; Lindert S, 2012, STRUCTURE, V20, P464, DOI 10.1016/j.str.2012.01.023; Lindert S, 2009, STRUCTURE, V17, P990, DOI 10.1016/j.str.2009.06.001; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Mendenhall J, 2014, SERMACS, DOI 10.13140/RG.2.1.2545.8724; MIYAMOTO S, 1992, J AM CHEM SOC, V114, P3668, DOI 10.1021/ja00036a015; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Ovchinnikov S, 2016, PROTEINS, V84, P67, DOI 10.1002/prot.24974; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Putnam DK, 2015, PROTEINS, V83, P1500, DOI 10.1002/prot.24838; Ramanathan A, 2009, J PHYS CHEM B, V113, P16669, DOI 10.1021/jp9077213; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Weiner BE, 2014, PROTEINS, V82, P587, DOI 10.1002/prot.24427; Weiner BE, 2013, STRUCTURE, V21, P1107, DOI 10.1016/j.str.2013.04.022; Woetzel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049242; Yang JY, 2016, PROTEINS, V84, P233, DOI 10.1002/prot.24918; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang WX, 2016, PROTEINS, V84, P76, DOI 10.1002/prot.24930	52	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152517	10.1371/journal.pone.0152517	http://dx.doi.org/10.1371/journal.pone.0152517			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046050	gold, Green Published, Green Submitted			2022-12-26	WOS:000373599600022
J	Buenzli, PR				Buenzli, Pascal R.			Governing Equations of Tissue Modelling and Remodelling: A Unified Generalised Description of Surface and Bulk Balance	PLOS ONE			English	Article							HUMAN CORTICAL BONE; MATHEMATICAL-MODEL; OSTEOCYTE NETWORK; DYNAMICS; GROWTH; MINERALIZATION; TRANSPORT; FRAMEWORK; THEOREMS; POROSITY	Several biological tissues undergo changes in their geometry and in their bulk material properties by modelling and remodelling processes. Modelling synthesises tissue in some regions and removes tissue in others. Remodelling overwrites old tissue material properties with newly formed, immature tissue properties. As a result, tissues are made up of different "patches", i.e., adjacent tissue regions of different ages and different material properties, within evolving boundaries. In this paper, generalised equations governing the spatio-temporal evolution of such tissues are developed within the continuum model. These equations take into account nonconservative, discontinuous surface mass balance due to creation and destruction of material at moving interfaces, and bulk balance due to tissue maturation. These equations make it possible to model patchy tissue states and their evolution without explicitly maintaining a record of when/where resorption and formation processes occurred. The time evolution of spatially averaged tissue properties is derived systematically by integration. These spatially-averaged equations cannot be written in closed form as they retain traces that tissue destruction is localised at tissue boundaries. The formalism developed in this paper is applied to bone tissues, which exhibit strong material heterogeneities due to their slow mineralisation and remodelling processes. Evolution equations are proposed in particular for osteocyte density and bone mineral density. Effective average equations for bone mineral density (BMD) and tissue mineral density (TMD) are derived using a mean-field approximation. The error made by this approximation when remodelling patchy tissue is investigated. The specific signatures of the time evolution of BMD or TMD during remodelling events are exhibited. These signatures may provide a way to detect remodelling events at lower, unseen spatial resolutions from microCT scans.	[Buenzli, Pascal R.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia	Monash University	Buenzli, PR (corresponding author), Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia.	pascal.buenzli@monash.edu		Buenzli, Pascal/0000-0003-3962-5393	Australian Research Council; Discovery Early Career Researcher Award [DE130101191]	Australian Research Council(Australian Research Council); Discovery Early Career Researcher Award(Australian Research Council)	This work was supported by Australian Research Council (www.arc.gov.au), Discovery Early Career Researcher Award, project number DE130101191. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANO AM, 1979, PHYSICA A, V99, P293, DOI 10.1016/0378-4371(79)90136-5; Arhatari BD, 2011, PHYS MED BIOL, V56, P5265, DOI 10.1088/0031-9155/56/16/012; Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336; Bidan CM, 2012, ADV HEALTHCARE MAT; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Briggs AM, 2010, J CLIN DENSITOM, V13, P161, DOI 10.1016/j.jocd.2010.01.120; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Buenzli PR, 2011, BONE, V48, P918, DOI 10.1016/j.bone.2010.12.009; Buenzli PR, 2015, BONE, V75, P144, DOI 10.1016/j.bone.2015.02.016; Buenzli PR, 2015, J THEOR BIOL, V364, P418, DOI 10.1016/j.jtbi.2014.09.028; Buenzli PR, 2014, BIOMECH MODEL MECHAN, V13, P185, DOI 10.1007/s10237-013-0495-y; Buenzli PR, 2013, INT J NUMER METH BIO, V29, P1307, DOI 10.1002/cnm.2567; Cantrell C. D., 2000, MODERN MATH METHODS; COHEN J, 1958, J BONE JOINT SURG AM, V40, P419, DOI 10.2106/00004623-195840020-00015; Cowin SC, 2012, MECH MATER, V44, P47, DOI 10.1016/j.mechmat.2011.07.005; Cumming BD, 2010, J R SOC INTERFACE, V7, P19, DOI 10.1098/rsif.2008.0536; Cushman JH, 1982, ADV WATER RESOUR, V5, P248, DOI 10.1016/0309-1708(82)90009-4; DEEMER AR, 1978, INT J MULTIPHAS FLOW, V4, P171, DOI 10.1016/0301-9322(78)90043-5; Evans DJ, 2008, STAT MECH NONEQUILIB; Giga Y., 2006, SURFACE EVOLUTION EQ; GOLLNICK PD, 1973, J APPL PHYSIOL, V34, P107, DOI 10.1152/jappl.1973.34.1.107; Gray W. G., 1977, International Journal of Multiphase Flow, V2, P333, DOI 10.1016/0301-9322(77)90013-1; GRAY WG, 1983, INT J MULTIPHAS FLOW, V9, P755, DOI 10.1016/0301-9322(83)90120-9; Guyot Y, 2015, BIOTECHNOL BIOENG, V112, P2591, DOI 10.1002/bit.25672; HUET C, 1990, J MECH PHYS SOLIDS, V38, P813, DOI 10.1016/0022-5096(90)90041-2; Irschik H, 2003, ACTA MECH, V162, P195, DOI 10.1007/s00707-002-0995-9; Jones D.S, 1982, THEORY GEN FUNCTIONS; Kerschnitzki M, 2013, J BONE MINER RES, V28, P1837, DOI 10.1002/jbmr.1927; Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062; Landau L.D., 1959, FLUID MECH-SOV RES, DOI DOI 10.1016/C2013-0-03799-1; Lange RJ, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2012)032; Lasseux D, 2004, CHEM ENG SCI, V59, P1949, DOI 10.1016/j.ces.2004.02.003; Leigh SR, 2001, EVOL ANTHROPOL, V10, P223, DOI 10.1002/evan.20002; Lerebours C, 2015, BONE, V72, P109, DOI 10.1016/j.bone.2014.11.016; Lerebours C, 2015, BIOMECH MOD IN PRESS; Li Z., 2006, FRONT APP M; Lighthill M.J., 1958, INTRO FOURIER ANAL G; Liu D, 2013, BIOMECH MODEL MECHAN, V12, P19, DOI 10.1007/s10237-012-0378-7; Lowengrub JS, 2010, NONLINEARITY, V23, pR1, DOI 10.1088/0951-7715/23/1/R01; Lukas C, 2011, J STAT PHYS, V144, P316, DOI 10.1007/s10955-011-0209-8; Makarov B., 2013, REAL ANAL MEASURES I; MARTIN RB, 1972, J BIOMECH, V5, P447, DOI 10.1016/0021-9290(72)90003-6; MARTIN RB, 1984, CRIT REV BIOMED ENG, V10, P179; Martin RB, 1998, SKELETAL TISSUE MECH; Osher S, 2006, LEVEL SET METHODS DY; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Parfitt AM., 1983, BONE HISTOMORPHOMETR, V1983, P143; Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025; Robling AG, 1999, CELLS TISSUES ORGANS, V164, P192, DOI 10.1159/000016659; RONIS D, 1978, PHYSICA A, V90, P487, DOI 10.1016/0378-4371(78)90005-5; Ryser MD, 2010, SIAM J APPL MATH, V70, P1899, DOI 10.1137/090746094; Ryser MD, 2009, J BONE MINER RES, V24, P860, DOI 10.1359/JBMR.081229; Sansalone V, 2012, BONE, V50, P876, DOI 10.1016/j.bone.2011.12.020; Sethian JA, 1999, CAMBRIDGE MONOGRAPHS; Slattery J.C., 2007, INTERFACIAL TRANSPOR, V2nd ed.; Smith DW, 2013, WIRES SYST BIOL MED, V5, P523, DOI 10.1002/wsbm.1229; Stueckelberg ECG, 1974, THERMOCINETIQUE PHEN; TAO LN, 1986, SIAM J APPL MATH, V46, P254, DOI 10.1137/0146018; TAPPEN NC, 1977, AM J ANAT, V149, P301, DOI 10.1002/aja.1001490302; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; van Oers RFM, 2008, BONE, V42, P250, DOI 10.1016/j.bone.2007.10.009; WHITAKER S, 1973, CHEM ENG SCI, V28, P139, DOI 10.1016/0009-2509(73)85094-8; WHITAKER S, 1992, CHEM ENG SCI, V47, P1677, DOI 10.1016/0009-2509(92)85015-4	65	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152582	10.1371/journal.pone.0152582	http://dx.doi.org/10.1371/journal.pone.0152582			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043309	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100017
J	Pezier, AP; Jezzini, SH; Bacon, JP; Blagburn, JM				Pezier, Adeline P.; Jezzini, Sami H.; Bacon, Jonathan P.; Blagburn, Jonathan M.			Shaking B Mediates Synaptic Coupling between Auditory Sensory Neurons and the Giant Fiber of Drosophila melanogaster	PLOS ONE			English	Article							GAP-JUNCTION PROTEINS; TRANSGENIC RNAI; ELECTRICAL SYNAPSES; DISTINCT ROLES; EXPRESSION; SYSTEM; GENE; INNEXINS; REPRESENTATIONS; ACETYLCHOLINE	The Johnston's Organ neurons (JONs) form chemical and electrical synapses onto the giant fiber neuron (GF), as part of the neuronal circuit that mediates the GF escape response in Drosophila melanogaster. The purpose of this study was to identify which of the 8 Drosophila innexins (invertebrate gap junction proteins) mediates the electrical connection at this synapse. The GF is known to express Shaking B (ShakB), specifically the ShakB (N+16) isoform only, at its output synapses in the thorax. The shakB(2) mutation disrupts these GF outputs and also abolishes JON-GF synaptic transmission. However, the identity of the innexin that forms the presynaptic hemichannels in the JONs remains unknown. We used electrophysiology, immunocytochemistry and dye injection, along with presynaptically- driven RNA interference, to investigate this question. The amplitude of the compound action potential recorded in response to sound from the base of the antenna (sound-evoked potential, or SEP) was reduced by RNAi of the innexins Ogre, Inx3, Inx6 and, to a lesser extent Inx2, suggesting that they could be required in JONs for proper development, excitability, or synchronization of action potentials. The strength of the JON-GF connection itself was reduced to background levels only by RNAi of shakB, not of the other seven innexins. ShakB knockdown prevented Neurobiotin coupling between GF and JONs and removed the plaques of ShakB protein immunoreactivity that are present at the region of contact. Specific shakB RNAi lines that are predicted to target the ShakB(L) or ShakB(N) isoforms alone did not reduce the synaptic strength, implying that it is ShakB(N+ 16) that is required in the presynaptic neurons. Overexpression of ShakB(N+ 16) in JONs caused the formation of ectopic dye coupling, whereas ShakB(N) prevented it altogether, supporting this conclusion and also suggesting that gap junction proteins may have an instructive role in synaptic target choice.	[Pezier, Adeline P.; Jezzini, Sami H.; Blagburn, Jonathan M.] Univ Puerto Rico Med Sci Campus, Inst Neurobiol, San Juan, PR USA; [Bacon, Jonathan P.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Sussex	Blagburn, JM (corresponding author), Univ Puerto Rico Med Sci Campus, Inst Neurobiol, San Juan, PR USA.	jonathan.blagburn@upr.edu		Blagburn, Jonathan/0000-0002-7681-2764	NINDS [SC1NS081726]; NSF [DBI 0115825, DBI 1337284]; DoD [52680-RT-ISP]; NIMHD [G12 MD007600]; BBSRC [85/S15289]; Bloomington Drosophila Stock Center [NIH P40OD018537]; TRiP at Harvard Medical School (NIH/NIGMS) [R01-GM084947]; NIH [R01-GM09815101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098151, R01GM084947, P20GM103642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC1NS081726] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF(National Science Foundation (NSF)); DoD(United States Department of Defense); NIMHD; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bloomington Drosophila Stock Center; TRiP at Harvard Medical School (NIH/NIGMS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors declare no competing financial interests. This work was supported by an NINDS grant SC1NS081726 to JMB. The Institute Pascal confocal microscope was funded by NSF DBI 0115825, DoD 52680-RT-ISP and NIMHD G12 MD007600 (RCMI). The Nikon confocal microscope was funded by NSF DBI 1337284. The Institute Drosophila resource center was supported by NIMHD G12 MD007600 (RCMI). Some of the antibodies and transgenic fly lines used in this study were made with the support of a grant from the BBSRC (85/S15289) to JPB. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. The authors thank the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing transgenic RNAi fly stocks used in this study. The authors also acknowledge the Vienna Drosophila RNAi Center for the supply of fly lines. This work was made possible in part by software funded by the NIH: Fluorender: An Imaging Tool for Visualization and Analysis of Confocal Data as Applied to Zebrafish Research, R01-GM09815101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare no competing financial interests. This work was supported by an NINDS grant SC1NS081726 to JMB. The Institute Pascal confocal microscope was funded by NSF DBI 0115825, DoD 52680-RT-ISP and NIMHD G12 MD007600 (RCMI). The Nikon confocal microscope was funded by NSF DBI 1337284. The Institute Drosophila resource center was supported by NIMHD G12 MD007600 (RCMI). Some of the antibodies and transgenic fly lines used in this study were made with the support of a grant from the BBSRC (85/S15289) to JPB. We thank Pauline Phelan, Andrea Brand and Michael Hoch for donating antibodies. We thank Pauline Phelan, Tanja Godenschwege, Liqun Luo and Bruno Marie for donating fly stocks. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. We thank the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing transgenic RNAi fly stocks used in this study. We also acknowledge the Vienna Drosophila RNAi Center for the supply of fly lines. This work was made possible in part by software funded by the NIH: Fluorender: An Imaging Tool for Visualization and	Allen M.J., 2010, COLD SPRING HARB PRO, V2010; Allen MJ, 2007, EUR J NEUROSCI, V26, P439, DOI 10.1111/j.1460-9568.2007.05686.x; BACON JP, 1986, J COMP PHYSIOL A, V158, P529, DOI 10.1007/BF00603798; Baker MW, 2014, FEBS LETT, V588, P1470, DOI 10.1016/j.febslet.2014.02.010; Baker MW, 2013, J NEUROSCI, V33, P16673, DOI 10.1523/JNEUROSCI.2387-13.2013; Bauer R, 2004, MOL BIOL CELL, V15, P2992, DOI 10.1091/mbc.E04-01-0056; Blagburn JM, 1999, J COMP NEUROL, V404, P449; Casso D, 1999, MECH DEVELOP, V88, P229, DOI 10.1016/S0925-4773(99)00174-4; Chang M, 1996, DEV BIOL, V175, P50, DOI 10.1006/dbio.1996.0094; CROMPTON D, 1995, DEV BIOL, V170, P142, DOI 10.1006/dbio.1995.1203; Curtin KD, 2002, J NEUROSCI, V22, P7088; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Eberl DF, 2011, COLD SPRING HARB PRO; Engel JE, 1996, J NEUROSCI, V16, P3486; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fiorini C, 2004, J CELL SCI, V117, P4665, DOI 10.1242/jcs.01335; Firme CP, 2012, J NEUROSCI, V32, P14265, DOI 10.1523/JNEUROSCI.2693-12.2012; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holcroft CE, 2013, J CELL SCI, V126, P3823, DOI 10.1242/jcs.117994; HOMYK T, 1980, MOL GEN GENET, V177, P553; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kamikouchi A, 2010, EUR J NEUROSCI, V31, P697, DOI 10.1111/j.1460-9568.2010.07099.x; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; KRISHNAN SN, 1993, CELL, V73, P967, DOI 10.1016/0092-8674(93)90274-T; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lehmann C, 2006, MOL BIOL CELL, V17, P1676, DOI 10.1091/mbc.E05-11-1059; Lehnert BP, 2013, NEURON, V77, P115, DOI 10.1016/j.neuron.2012.11.030; Marks WD, 2014, J NEUROPHYSIOL, V111, P1383, DOI 10.1152/jn.00385.2013; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Mu LY, 2014, J EXP BIOL, V217, P2121, DOI 10.1242/jeb.099135; Mu LY, 2012, J NEUROSCI, V32, P6061, DOI 10.1523/JNEUROSCI.0221-12.2012; Naito Y, 2005, NUCLEIC ACIDS RES, V33, pW589, DOI 10.1093/nar/gki419; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Orr BO, 2014, J NEUROSCI, V34, P5416, DOI 10.1523/JNEUROSCI.3183-13.2014; Ostrowski K, 2008, CELL COMMUN ADHES, V15, P155, DOI 10.1080/15419060802013976; Pereda AE, 2014, NAT REV NEUROSCI, V15, P250, DOI 10.1038/nrn3708; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Pezier A, 2014, J NEUROSCI, V34, P11691, DOI 10.1523/JNEUROSCI.1939-14.2014; Pezier A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071419; Phelan P, 1998, TRENDS GENET, V14, P348, DOI 10.1016/S0168-9525(98)01547-9; Phelan P, 1996, J NEUROSCI, V16, P1101; Phelan P, 2008, CURR BIOL, V18, P1955, DOI 10.1016/j.cub.2008.10.067; Rabinowitch I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5442; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; SARTHY PV, 1991, J NEUROCHEM, V57, P1757, DOI 10.1111/j.1471-4159.1991.tb06378.x; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Sivan-Loukianova E, 2005, J COMP NEUROL, V491, P46, DOI 10.1002/cne.20687; Speder P, 2014, DEV CELL, V30, P309, DOI 10.1016/j.devcel.2014.05.021; Stebbings LA, 2002, MECH DEVELOP, V113, P197, DOI 10.1016/S0925-4773(02)00025-4; STRAUSFELD NJ, 1983, J NEUROCYTOL, V12, P971, DOI 10.1007/BF01153345; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; Tootoonian S, 2012, J NEUROSCI, V32, P787, DOI 10.1523/JNEUROSCI.5104-11.2012; von Reyn CR, 2014, NAT NEUROSCI, V17, P962, DOI 10.1038/nn.3741; Wan Y, 2012, IEEE PAC VIS SYMP, P201, DOI 10.1109/PacificVis.2012.6183592; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zhang Z, 1999, J NEUROBIOL, V40, P288, DOI 10.1002/(SICI)1097-4695(19990905)40:3<288::AID-NEU2>3.0.CO;2-O	60	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152211	10.1371/journal.pone.0152211	http://dx.doi.org/10.1371/journal.pone.0152211			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043822	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000373592100009
J	Tkowska, EP; Kopec, A; Biezanowska-Kopec, R; Pysz, M; Kapusta-Duch, J; Koronowicz, AA; Smolen, S; Skoczylas, L; Ledwozyw-Smolen, I; Rakoczy, R; Maslak, E				Tkowska, Ewa Pi; Kopec, Aneta; Biezanowska-Kopec, Renata; Pysz, Miroslaw; Kapusta-Duch, Joanna; Koronowicz, Aneta Agnieszka; Smolen, Sylwester; Skoczylas, Lukasz; Ledwozyw-Smolen, Iwona; Rakoczy, Roksana; Maslak, Edyta			The Impact of Carrot Enriched in Iodine through Soil Fertilization on Iodine Concentration and Selected Biochemical Parameters in Wistar Rats	PLOS ONE			English	Article							DIFFERENT COOKING METHODS; HORMONE RECEPTOR-ALPHA; THYROID-HORMONE; VAPOR GENERATION; DEFICIENCY; METABOLISM; TISSUES; VEGETABLES; OXIDATION; BROMINE	Iodine is one of the trace elements which are essential for mammalian life. The major objective of iodine biofortification of plants is to obtain food rich in this trace element, which may increase its consumption by various populations. Additionally, it may reduce the risk of iodine deficiency diseases. In this research for the first time we have assessed the bioavailability of iodine from raw or cooked carrot biofortified with this trace element on iodine concentration in selected tissues and various biochemical parameters as well as mRNA expression of some genes involved in iodine metabolism in Wistar rats. Statistically, a significantly higher iodine level was determined in urine, faeces and selected tissues of rats fed a diet containing biofortified raw carrot as compared to a diet without iodine and a diet containing control cooked carrot. Biofortified raw carrot significantly increased triiodothyronine concentration as compared to animals from other experimental groups. The highest thyroid stimulating hormone level was determined in rats fed control cooked carrots. mRNA expression of selected genes was affected by different dietary treatment in rats' hearts. Biofortified raw and cooked carrot could be taken into account as a potential source of iodine in daily diets to prevent iodine deficiency in various populations.	[Tkowska, Ewa Pi; Kopec, Aneta; Biezanowska-Kopec, Renata; Pysz, Miroslaw; Kapusta-Duch, Joanna; Koronowicz, Aneta Agnieszka] Agr Univ Krakow, Fac Food Technol, Dept Human Nutr, Balicka 122, PL-30149 Krakow, Poland; [Smolen, Sylwester; Rakoczy, Roksana] Agr Univ Krakow, Fac Biotechnol & Hort, Inst Plant Biol & Biotechnol, Unit Plant Nutr, Al 29 Listopada 54, PL-31425 Krakow, Poland; [Skoczylas, Lukasz] Agr Univ Krakow, Fac Food Technol, Dept Fruit Vegetable & Mushroom Proc, Balicka 122, PL-30149 Krakow, Poland; [Ledwozyw-Smolen, Iwona] Agr Univ Krakow, Fac Biotechnol & Hort, Inst Plant Biol & Biotechnol, Biochem Unit, Al 29 Listopada 54, PL-31425 Krakow, Poland; [Maslak, Edyta] Jagiellonian Univ, Jagiellonian Ctr Expt Therapeut, Bobrzynskiego 14, PL-30060 Krakow, Poland	Agricultural University Krakow; Agricultural University Krakow; Agricultural University Krakow; Agricultural University Krakow; Jagiellonian University	Tkowska, EP (corresponding author), Agr Univ Krakow, Fac Food Technol, Dept Human Nutr, Balicka 122, PL-30149 Krakow, Poland.	e.piatkowska@ur.krakow.pl	Smoleń, Sylwester/S-4081-2019; Kapusta-Duch, Joanna/AAF-9894-2019	Piatkowska, Ewa/0000-0003-3699-314X; Smolen, Sylwester/0000-0001-8093-3801; Ledwozyw-Smolen, Iwona/0000-0003-1419-1162; Skoczylas, Lukasz/0000-0002-8349-4477; Rakoczy-Lelek, Roksana/0000-0002-9782-3200	Polish National Science Center [DEC-2011/03/D/NZ9/05560]	Polish National Science Center	This work was financed by the 2012-2015 Polish National Science Center-grant no. DEC-2011/03/D/NZ9/05560 "I and Se biofortification of selected vegetables, including the influence of these microelements on yield quality as well as evaluation of iodine absorption and selected biochemical parameters in rats fed with vegetables biofortified with iodine".	Andersson M, 2010, BEST PRACT RES CL EN, V24, P1, DOI 10.1016/j.beem.2009.08.005; [Anonymous], 2008, USDA NATL DATABASE S; [Anonymous], 2007, ASS IOD DEF DIS MON; AOAC, 2006, AOAC OFF METH AN; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bochukova E, 2012, NEW ENGL J MED, V366, P243, DOI 10.1056/NEJMoa1110296; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Chantaro P, 2008, LWT-FOOD SCI TECHNOL, V41, P1987, DOI 10.1016/j.lwt.2007.11.013; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chien J, 2009, GYNECOL ONCOL, V114, P3, DOI 10.1016/j.ygyno.2009.04.002; Comandini P, 2013, INT J FOOD SCI NUTR, V64, P857, DOI 10.3109/09637486.2013.798270; Dai JL, 2004, BIOL TRACE ELEM RES, V101, P265, DOI 10.1385/BTER:101:3:265; De Steur H, 2015, APPETITE, V92, P295, DOI 10.1016/j.appet.2015.05.038; Delange F, 2000, THYROID FUNDAMENTAL, P743; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dong J, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-149; EBIHARA K, 1993, NUTR RES, V13, P1305, DOI 10.1016/S0271-5317(05)80815-2; El-Ghawi UM, 2006, BIOL TRACE ELEM RES, V111, P31, DOI 10.1385/BTER:111:1:31; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gawedzki J., 2010, HUMAN NUTR; Gloss B, 2001, ENDOCRINOLOGY, V142, P544, DOI 10.1210/en.142.2.544; Gullberg H, 2002, MOL ENDOCRINOL, V16, P1767, DOI 10.1210/me.2002-0009; Haldimann M, 2005, J FOOD COMPOS ANAL, V18, P461, DOI 10.1016/j.jfca.2004.06.003; Hamza RG, 2011, ISOTOPE RAD RES, V43, P479; He ML, 2002, J ANIM PHYSIOL AN N, V86, P97, DOI 10.1046/j.1439-0396.2002.00363.x; Hefferon KL, 2015, INT J MOL SCI, V16, P3895, DOI 10.3390/ijms16023895; Hong CL, 2008, AGRON SUSTAIN DEV, V28, P575, DOI 10.1051/agro:2008033; Hou XL, 1997, BIOL TRACE ELEM RES, V56, P225, DOI 10.1007/BF02785395; Ibrahim HS, 2008, J MED FOOD, V11, P551, DOI 10.1089/jmf.2007.0517; Johansson C, 1998, AM J PHYSIOL-REG I, V275, pR640, DOI 10.1152/ajpregu.1998.275.2.R640; KHAMIS F, 1991, ARAB J SCI APPL, V24, P19; Kirchgessner M, 1999, J ANIM PHYSIOL AN N, V82, P238, DOI 10.1046/j.1439-0396.1999.00232.x; Kmiecik W, 1997, TECHNOLOGIA ZYWNOSCI, V9, P67; Komolka P, 2012, ZYWN-NAUK TECHNOL JA, V19, P68; Kopec A, 2015, J FUNCT FOODS, V14, P479, DOI 10.1016/j.jff.2015.02.027; Kuiper GGJM, 2005, THYROID, V15, P787, DOI 10.1089/thy.2005.15.787; Laurberg P, 2010, BEST PRACT RES CL EN, V24, P13, DOI 10.1016/j.beem.2009.08.013; Lavado-Autric R, 2013, ENDOCRINOLOGY, V154, P529, DOI 10.1210/en.2012-1727; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Longvah T, 2012, FOOD CHEM, V130, P953, DOI 10.1016/j.foodchem.2011.08.024; Marounek M, 2007, PHYSIOL RES, V56, P433, DOI 10.33549/physiolres.930967; Nawirska A, 2005, FOOD CHEM, V91, P221, DOI 10.1016/j.foodchem.2003.10.005; OBA K, 1980, J NUTR SCI VITAMINOL, V26, P327, DOI 10.3177/jnsv.26.327; Patras A, 2011, LWT-FOOD SCI TECHNOL, V44, P299, DOI 10.1016/j.lwt.2010.06.019; Pearce EN, 2004, J CLIN ENDOCR METAB, V89, P3421, DOI 10.1210/jc.2003-032002; Pesce L, 2014, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2014-8; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Rana R, 2013, J FOOD SCI TECH MYS, V50, P1212, DOI 10.1007/s13197-011-0436-7; Reeves PG, 1997, J NUTR, V127, pS838; Robbins J., 2000, THYROID A FUNDAMENTA, V8th ed., P105; Sainmont J., 2014, STRATEGIES SUCCESS C; Smolen S, 2011, J ELEMENTOL, V16, P613, DOI 10.5601/jelem.2011.16.4.10; Tancevski I, 2009, J LIPID RES, V50, P938, DOI 10.1194/jlr.M800553-JLR200; Thomson BM, 2008, BRIT J NUTR, V99, P614, DOI 10.1017/S0007114507812001; Tonacchera M, 2013, J CLIN ENDOCR METAB, V98, pE694, DOI 10.1210/jc.2012-3509; Vtorushina EA, 2008, J ANAL CHEM+, V63, P643, DOI 10.1134/S1061934808070071; Vtorushina EA, 2009, J ANAL CHEM+, V64, P129, DOI 10.1134/S1061934809020063; Wachowicz I, 2004, ZYWNOSC NAUKA TECH S, V3, P204; Wang K, 2009, BIOL TRACE ELEM RES, V130, P72, DOI 10.1007/s12011-009-8315-z; Weiss RE, 1997, ENDOCRINOLOGY, V138, P3624, DOI 10.1210/en.138.9.3624; Wieczorek C., 2007, ZYWN-NAUK TECHNOL JA, V3, P159; Windisch W., 1999, J ANIMAL PHYSL ANIMA, V4, P205; Wolf G, 2002, NUTR REV, V60, P374, DOI 10.1301/00296640260385919; Yu XC, 1996, CARBOHYD RES, V292, P129; Yuan GF, 2009, J ZHEJIANG UNIV-SC B, V10, P580, DOI 10.1631/jzus.B0920051; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3; Zimmermann MB, 2012, CURR OPIN ENDOCRINOL, V19, P382, DOI 10.1097/MED.0b013e328357271a	68	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152680	10.1371/journal.pone.0152680	http://dx.doi.org/10.1371/journal.pone.0152680			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043135	Green Published, gold, Green Submitted			2022-12-26	WOS:000373592100026
J	He, XH; Zhu, W; Yuan, P; Jiang, S; Li, D; Zhang, HW; Liu, MF				He, X-H; Zhu, W.; Yuan, P.; Jiang, S.; Li, D.; Zhang, H-W; Liu, M-F			miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells	ONCOGENE			English	Article							TRANSCRIPTIONAL REPRESSION; MICRORNA-155 PROMOTES; CANCER; TUMOR; TARGETS; TRASTUZUMAB; EXPRESSION; GROWTH; HER2; OVEREXPRESSION	ErbB2 is a vital breast cancer gene and its overexpression has a decisive role in breast tumor initiation and malignant progression. However, the molecular mechanisms that underlie ErbB2 dysregulation in breast cancer cells remain incompletely understood. In this study, we found that ErbB2 expression is inversely correlated with the level of miR-155, a well-documented oncogenic miRNA, in ErbB2-positive breast tumors. We further determined that miR-155 potently suppresses ErbB2 in breast cancer cells. Mechanistically, miR-155 acts to downregulate ErbB2 via two distinct mechanisms. First, miR-155 represses ErbB2 transcription by targeting HDAC2, a transcriptional activator of ErbB2. Second, miR-155 directly targets ErbB2 via a regulatory element in its coding region. Intriguingly, miR-155 is upregulated by trastuzumab and in turn leads to a reduction of ErbB2 expression in trastuzumab-treated ErbB2-positive breast cancer cells. Functional studies showed that miR-155 inhibits ErbB2-induced malignant transformation of human breast epithelial cells. Thus, our findings reveal an intriguing miR-155-ErbB2 context in regulating the malignant transformation of breast epithelial cells, and thereby indicate a novel mode of action for miR-155 in ErbB2-positive breast cancer.	[He, X-H; Yuan, P.; Jiang, S.; Liu, M-F] Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Ctr RNA Res, State Key Lab Mol Biol, Shanghai, Peoples R China; [He, X-H; Yuan, P.; Jiang, S.; Liu, M-F] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Key Lab Mol Androl, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Zhu, W.; Zhang, H-W] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Li, D.] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai, Peoples R China; [Liu, M-F] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences; ShanghaiTech University	Liu, MF (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	mfliu@sibcb.ac.cn		Jiang, Shuai/0000-0002-0572-4660; liu, mo fang/0000-0003-1800-466X	Ministry of Science and Technology of China [2012CB910803, 2014CB943103, 2014CB964802]; National Natural Science Foundation of China [31325008, 91419307, 81502267, 31300656]; Science and Technology Commission of the Shanghai Municipality [13ZR1464300, 16XD1404900]; Chinese Academy of Sciences [KJZD-EW-L01-2, 2013KIP202]; Foundation of Key Laboratory of Gene Engineering of the Ministry of Education	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of the Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Academy of Sciences(Chinese Academy of Sciences); Foundation of Key Laboratory of Gene Engineering of the Ministry of Education	We thank Dr Gao-Xiang Ge for suggestions and critical comments on the manuscript. This work was supported by grants from the Ministry of Science and Technology of China (2012CB910803, 2014CB943103 and 2014CB964802), the National Natural Science Foundation of China (31325008, 91419307, 81502267, and 31300656), the Science and Technology Commission of the Shanghai Municipality (13ZR1464300 and 16XD1404900), and the Chinese Academy of Sciences (KJZD-EW-L01-2 and 2013KIP202) and Foundation of Key Laboratory of Gene Engineering of the Ministry of Education.	Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; American Type Culture Collection, 2007, ATCC TECHN B, V8; Babar IA, 2011, CANCER BIOL THER, V12, P908, DOI 10.4161/cbt.12.10.17681; Cai ZK, 2015, MOL MED REP, V11, P533, DOI 10.3892/mmr.2014.2744; Chang SH, 2011, NAT MED, V17, P1275, DOI 10.1038/nm.2459; Cheng CJ, 2015, NATURE, V518, P107, DOI 10.1038/nature13905; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dinami R, 2014, CANCER RES, V74, P4145, DOI 10.1158/0008-5472.CAN-13-2038; Eceles SA, 2001, J MAMMARY GLAND BIOL, V6, P393, DOI 10.1023/A:1014730829872; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Guarnieri DJ, 2008, ANN MED, V40, P197, DOI 10.1080/07853890701771823; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; Hicks DG, 2008, ARCH PATHOL LAB MED, V132, P1008, DOI 10.1043/1543-2165(2008)132[1008:TAATFE]2.0.CO;2; Higgs Gadareth, 2013, J Clin Bioinforma, V3, P17, DOI 10.1186/2043-9113-3-17; Huang SL, 2010, NUCLEIC ACIDS RES, V38, P7211, DOI 10.1093/nar/gkq564; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang S, 2012, EMBO J, V31, P1985, DOI 10.1038/emboj.2012.45; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kim YJ, 2013, ONCOGENE, V32, P2828, DOI 10.1038/onc.2013.32; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Koudelakova V, 2015, J MOL DIAGN, V17, P446, DOI 10.1016/j.jmoldx.2015.03.007; Krauss W C, 2000, Breast Dis, V11, P113; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mittendorf EA, 2009, CLIN CANCER RES, V15, P7381, DOI 10.1158/1078-0432.CCR-09-1735; Muller BM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-215; Nofech-Mozes S, 2005, ADV ANAT PATHOL, V12, P256, DOI 10.1097/01.pap.0000184177.65919.5e; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Pinto AC, 2013, BREAST, V22, pS152, DOI 10.1016/j.breast.2013.07.029; Pouliot LM, 2012, CANCER RES, V72, P5945, DOI 10.1158/0008-5472.CAN-12-1400; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Qin WX, 2013, FEBS LETT, V587, P1434, DOI 10.1016/j.febslet.2013.03.023; Sandhu SK, 2012, P NATL ACAD SCI USA, V109, P20047, DOI 10.1073/pnas.1213764109; Scott GK, 2002, MOL CANCER THER, V1, P385; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Wang L, 2014, CANCER RES, V74, P4720, DOI 10.1158/0008-5472.CAN-14-0960; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yarden Y, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055396; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhang XP, 2013, J CLIN ENDOCR METAB, V98, pE1305, DOI 10.1210/jc.2012-3602; Zhang YL, 2012, HEPATOLOGY, V56, P1631, DOI 10.1002/hep.25849; Zhao S, 2013, DEV CELL, V24, P13, DOI 10.1016/j.devcel.2012.12.006	50	28	28	1	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 17	2016	35	46					6015	6025		10.1038/onc.2016.132	http://dx.doi.org/10.1038/onc.2016.132			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED0CA	27065318				2022-12-26	WOS:000388509400008
J	Zhang, P; Feng, S; Liu, G; Wang, H; Fu, A; Zhu, H; Ren, Q; Wang, B; Xu, X; Bai, H; Dong, C				Zhang, P.; Feng, S.; Liu, G.; Wang, H.; Fu, A.; Zhu, H.; Ren, Q.; Wang, B.; Xu, X.; Bai, H.; Dong, C.			CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation	ONCOGENE			English	Article							COLON-CARCINOMA CELLS; BREAST-CANCER CELLS; V600E B-RAF; E-SELECTIN; ENDOTHELIAL-CELLS; VARIANT ISOFORMS; MESSENGER-RNA; BINDING-KINETICS; TUMOR-CELLS; VE-CADHERIN	Melanoma is one of the most lethal forms of skin cancer because of its early metastatic spread. The variant form of CD44 CD44v), a cell surface glycoprotein, is highly expressed on metastatic melanoma. The mechanisms of regulation of CD44 alternative splicing in melanoma and its pathogenic contributions are so far poorly understood. Here, we investigated the expression level of CD44 in a large set of melanocytic lesions at different stages. We found that the expression of CD44v8-10 and a splicing factor, U2AF2, is significantly increased during melanoma progression, whereas CD82/KAI1, a tetraspanin family of tumor suppressor, is reduced in metastatic melanoma. CD44v8-10 and U2AF2 expression levels, which are negatively correlated with CD82 levels, are markedly elevated in primary melanoma compared with dysplastic nevi and further increased in metastatic melanoma. We also showed that patients with higher CD44v8-10 and U2AF2 expression levels tended to have shorter survival. By using both in vivo and in vitro assays, we demonstrated that CD82 inhibits the production of CD44v8-10 on melanoma. Mechanistically, U2AF2 is a downstream target of CD82 and in malignant melanoma facilitates CD44v8-10 alternative splicing. U2AF2-mediated CD44 isoform switch is required for melanoma migration in vitro and lung and liver metastasis in vivo. Notably, overexpression of CD82 suppresses U2AF2 activity by inducing U2AF2 ubiquitination. In addition, our data suggested that enhancement of melanoma migration by U2AF2-dependent CD44v8-10 splicing is mediated by Src/focal adhesion kinase/RhoA activation and formation of stress fibers, as well as CD44-E-selectin binding reinforcement. These findings uncovered a hitherto unappreciated function of CD82 in severing the linkage between U2AF2-mediated CD44 alternative splicing and cancer aggressiveness, with potential prognostic and therapeutic implications in melanoma.	[Zhang, P.; Feng, S.; Fu, A.; Zhu, H.; Ren, Q.; Xu, X.; Bai, H.] Southwest Univ, Coll Pharmaceut Sci, Key Lab Luminescence & Real Time Analyt Chem, Minist Educ, Chongqing 400715, Peoples R China; [Zhang, P.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Liu, G.; Wang, H.] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai, Peoples R China; [Wang, B.] Chongqing Univ, Coll Bioengn, Chongqing, Peoples R China; [Dong, C.] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA	Southwest University - China; University of Alberta; Tongji University; Chongqing University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, P (corresponding author), Southwest Univ, Coll Pharmaceut Sci, Key Lab Luminescence & Real Time Analyt Chem, Minist Educ, Chongqing 400715, Peoples R China.	pu1@ualberta.ca			Fundamental Research Funds for the Central Universities [XDJK2014C176, XDJK2012B010, XDJK2015C154, XDJK2015C155]; Start-up Foundation of Southwest University [SWU114017]; National Natural Science Foundation of China (NSFC) [NSFC-81402393, NSFC-81572678, NSFC-81272433, NSFC-81472732, NSFC-81073084]; National Science Foundation [CBET-0729091]; NATIONAL CANCER INSTITUTE [R01CA125707] Funding Source: NIH RePORTER	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Start-up Foundation of Southwest University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Go J Yoshida (Tokyo Medical and Dental University) for helpful discussion. This study was funded by Fundamental Research Funds for the Central Universities (XDJK2014C176 to PZ, XDJK2012B010 to HFZ, XDJK2015C154 to QR and XDJK2015C155 to FS), the Start-up Foundation of Southwest University (SWU114017 to PZ), National Natural Science Foundation of China (NSFC) (NSFC-81402393 to PZ, NSFC-81572678 to PZ, NSFC-81272433 to GTL, NSFC-81472732 to GTL and NSFC-81073084 to HFZ) and National Science Foundation grants (CBET-0729091 to CD).	Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Fu CL, 2011, J BIOL CHEM, V286, P34777, DOI 10.1074/jbc.M111.281642; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jacobs PP, 2011, FEBS LETT, V585, P3148, DOI 10.1016/j.febslet.2011.07.039; Khanna P, 2014, ONCOGENE, V33, P2898, DOI 10.1038/onc.2013.249; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Konig H, 1996, EMBO J, V15, P4030, DOI 10.1002/j.1460-2075.1996.tb00776.x; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Liang SL, 2007, CANCER RES, V67, P5814, DOI 10.1158/0008-5472.CAN-06-4233; Mackereth CD, 2011, NATURE, V475, P408, DOI 10.1038/nature10171; Marzese DM, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12307; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Odintsova E, 2013, J BIOL CHEM, V288, P26323, DOI 10.1074/jbc.M112.439380; Okamoto I, 1998, J NATL CANCER I, V90, P307, DOI 10.1093/jnci/90.4.307; Okamoto Y, 1998, BIOCHEM BIOPH RES CO, V249, P872, DOI 10.1006/bbrc.1998.9247; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prochazka L, 2014, CELL SIGNAL, V26, P2234, DOI 10.1016/j.cellsig.2014.07.011; Reinke LM, 2012, J BIOL CHEM, V287, P36435, DOI 10.1074/jbc.M112.397125; Sharma A, 2006, CANCER RES, V66, P8200, DOI 10.1158/0008-5472.CAN-06-0809; Shirure VS, 2015, AM J PHYSIOL-CELL PH, V308, pC68, DOI 10.1152/ajpcell.00094.2014; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Subbaram S, 2014, J CELL SCI, V127, P1179, DOI 10.1242/jcs.131227; Takahashi K, 1995, ONCOGENE, V11, P2223; Takeo K, 2009, AM J PHYSIOL-CELL PH, V297, pC330, DOI 10.1152/ajpcell.00009.2009; Tsai YC, 2011, FEBS LETT, V585, P3166, DOI 10.1016/j.febslet.2011.08.031; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Wei Q, 2014, CIRCULATION, V130, P1493, DOI 10.1161/CIRCULATIONAHA.114.011096; Wei WJ, 2012, NUCLEIC ACIDS RES, V40, P8622, DOI 10.1093/nar/gks579; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Xiong FY, 2012, MOL BIOL REP, V39, P1935, DOI 10.1007/s11033-011-0940-x; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Zeng Y, 2013, CANCER RES, V73, P4123, DOI 10.1158/0008-5472.CAN-12-1343; Zhang P, 2015, AM J PHYSIOL-HEART C, V308, pH1205, DOI 10.1152/ajpheart.00005.2015; Zhang P, 2014, FEBS LETT, V588, P4573, DOI 10.1016/j.febslet.2014.10.027; Zhang P, 2014, FASEB J, V28, P4591, DOI 10.1096/fj.11-202747; Zhang P, 2011, J IMMUNOL, V186, P242, DOI 10.4049/jimmunol.1000494; Zhou B, 2004, CANCER RES, V64, P7455, DOI 10.1158/0008-5472.CAN-04-1574; Zhu S, 2016, ONCOGENE, V35, P1847, DOI 10.1038/onc.2015.250; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	52	22	23	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 22	2016	35	38					5056	5069		10.1038/onc.2016.67	http://dx.doi.org/10.1038/onc.2016.67			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW9GT	27041584	Green Accepted			2022-12-26	WOS:000383965300009
J	Gandhirajan, RK; Jain, M; Walla, B; Johnsen, M; Bartram, MP; Anh, MH; Rinschen, MM; Benzing, T; Schermer, B				Gandhirajan, Rajesh Kumar; Jain, Manaswita; Walla, Benedikt; Johnsen, Marc; Bartram, Malte P.; Minh Huynh Anh; Rinschen, Markus M.; Benzing, Thomas; Schermer, Bernhard			Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; OXYGEN SPECIES GENERATION; REACTIVE OXYGEN; OXIDATIVE-STRESS; KIDNEY-DISEASE; CANCER CELLS; REPERFUSION INJURY; PATHWAY; PROTEIN; BETA	Transcriptional co-activator with PDZ-binding motif (TAZ) and Yes-associated protein (YAP) are critical transcriptional co-activators downstream of the Hippo pathway involved in the regulation of organ size, tissue regeneration, proliferation, and apoptosis. Recent studies suggested common and distinct functions of TAZ and YAP and their diverse impact under several pathological conditions. Here we report differential regulation of TAZ and YAP in response to oxidative stress. H2O2 exposure leads to increased stability and activation of TAZ but not of YAP. H2O2 induces reversible S-glutathionylation at conserved cysteine residues within TAZ. We further demonstrate that TAZ S-glutathionylation is critical for reactive oxygen species (ROS)-mediated, TAZ-dependent TEA domain transcription factor (TEAD) trans-activation. Lysophosphatidic acid, a physiological activator of YAP and TAZ, induces ROS elevation and, subsequently, TAZ S-glutathionylation, which promotes TAZ-mediated target gene expression. TAZ expression is essential for renal homeostasis in mice, and we identify basal TAZ S-glutathionylation in murine kidney lysates, which is elevated during ischemia/reperfusion injury in vivo. This induced nuclear localization of TAZ and increased expression of connective tissue growth factor. These results describe a novel mechanism by which ROS sustains total cellular levels of TAZ. This preferential regulation suggests TAZ to be a redox sensor of the Hippo pathway.	[Gandhirajan, Rajesh Kumar; Jain, Manaswita; Walla, Benedikt; Johnsen, Marc; Bartram, Malte P.; Minh Huynh Anh; Rinschen, Markus M.; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany; [Gandhirajan, Rajesh Kumar; Jain, Manaswita; Walla, Benedikt; Johnsen, Marc; Bartram, Malte P.; Minh Huynh Anh; Rinschen, Markus M.; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Ctr Mol Med, D-50937 Cologne, Germany; [Gandhirajan, Rajesh Kumar; Jain, Manaswita; Walla, Benedikt; Johnsen, Marc; Bartram, Malte P.; Minh Huynh Anh; Rinschen, Markus M.; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany; [Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Syst Biol Ageing Cologne, D-50937 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne	Schermer, B (corresponding author), Univ Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany.	bernhard.schermer@uk-koeln.de	Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014; Rinschen, Markus/N-7283-2019	Schermer, Bernhard/0000-0002-5194-9000; Rinschen, Markus/0000-0002-9252-1342; Gandhirajan, Rajesh/0000-0002-0039-771X; Jain, Manaswita/0000-0002-5107-7505	Deutsche Forschungsgemeinschaft [SFB829, SCHE1562/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft Grant SFB829.; Supported by Deutsche Forschungsgemeinschaft Grant SCHE1562/2.	Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Bao YJ, 2011, J BIOCHEM, V150, P199, DOI 10.1093/jb/mvr063; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Goetzl Edward J, 2002, ScientificWorldJournal, V2, P324; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Habbig S, 2011, J CELL BIOL, V193, P633, DOI 10.1083/jcb.201009069; Hall AM, 2013, KIDNEY INT, V83, P72, DOI 10.1038/ki.2012.328; Hall AM, 2011, J AM SOC NEPHROL, V22, P1297, DOI 10.1681/ASN.2010101054; Happe H, 2011, BBA-MOL BASIS DIS, V1812, P1249, DOI 10.1016/j.bbadis.2011.05.005; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Jiang F, 2014, REDOX BIOL, V2, P267, DOI 10.1016/j.redox.2014.01.012; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kohli P, 2014, AM J PHYSIOL-CELL PH, V306, pC805, DOI 10.1152/ajpcell.00339.2013; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lin CC, 2013, BIOCHEM BIOPH RES CO, V440, P564, DOI 10.1016/j.bbrc.2013.09.104; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Okusa MD, 2003, AM J PHYSIOL-RENAL, V285, pF565, DOI 10.1152/ajprenal.00023.2003; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Saunders JA, 2010, FREE RADICAL BIO MED, V49, P2058, DOI 10.1016/j.freeradbiomed.2010.10.663; Shao D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4315; Su D, 2014, FREE RADICAL BIO MED, V67, P460, DOI 10.1016/j.freeradbiomed.2013.12.004; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Velu CS, 2007, BIOCHEMISTRY-US, V46, P7765, DOI 10.1021/bi700425y; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	42	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11596	11607		10.1074/jbc.M115.712539	http://dx.doi.org/10.1074/jbc.M115.712539			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27048650	hybrid, Green Published			2022-12-26	WOS:000377264800012
J	Paci, A; Liu, PXH; Zhang, LJ; Zhao, RM				Paci, Alexandr; Liu, Peter X. H.; Zhang, Lingjie; Zhao, Rongmin			The Proteasome Subunit Rpn8 Interacts with the Small Nucleolar RNA Protein (snoRNP) Assembly Protein Pih1 and Mediates Its Ubiquitin-independent Degradation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN THYMIDYLATE SYNTHASE; R2TP COMPLEX; 26S PROTEASOME; POLYMERASE-II; COCHAPERONE COMPLEX; REGULATORY PARTICLE; TERMINAL DOMAIN; HSP90 CHAPERONE; BUDDING YEAST; DEGRON	Pih1 is a scaffold protein of the Rvb1-Rvb2-Tah1-Pih1 (R2TP) protein complex, which is conserved in fungi and animals. The chaperone-like activity of the R2TP complex has been implicated in the assembly of multiple protein complexes, such as the small nucleolar RNA protein complex. However, the mechanism of the R2TP complex activity in vivo and the assembly of the complex itself are still largely unknown. Pih1 is an unstable protein and tends to aggregate when expressed alone. The C-terminal fragment of Pih1 contains multiple destabilization factors and acts as a degron when fused to other proteins. In this study, we investigated Pih1 interactors and identified a specific interaction between Pih1 and the proteasome subunit Rpn8 in yeast Saccharomyces cerevisiae when HSP90 co-chaperone Tah1 is depleted. By analyzing truncation mutants, we identified that the C-terminal 30 amino acids of Rpn8 are sufficient for the binding to Pih1 C terminus. With in vitro and in vivo degradation assays, we showed that the Pih1 C-terminal fragment Pih1(282-344) is able to induce a ubiquitin-independent degradation of GFP. Additionally, we demonstrated that truncation of the Rpn8 C-terminal disordered region does not affect proteasome assembly but specifically inhibits the degradation of the GFP-Pih1(282-344) fusion protein in vivo and Pih1 in vitro. We propose that Pih1 is a ubiquitin-independent proteasome substrate, and the direct interaction with Rpn8 C terminus mediates its proteasomal degradation.	[Paci, Alexandr; Liu, Peter X. H.; Zhang, Lingjie; Zhao, Rongmin] Univ Toronto, Dept Biol Sci, Toronto, ON M1C 1A4, Canada	University of Toronto	Zhao, RM (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	rzhao@utsc.utoronto.ca		Zhao, Rongmin/0000-0003-1300-5882	University of Toronto Connaught New Staff Matching Fund [487199]; NSERC [RGPIN-2014-05309]	University of Toronto Connaught New Staff Matching Fund; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by University of Toronto Connaught New Staff Matching Fund Grant 487199 and NSERC Discovery Grant RGPIN-2014-05309 (to R. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad Moaz, 2013, Communicative & Integrative Biology, V6, pe26005, DOI 10.4161/cib.26005; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Back R, 2013, STRUCTURE, V21, P1834, DOI 10.1016/j.str.2013.07.024; Ban Y, 2013, MOL CELL BIOL, V33, P4008, DOI 10.1128/MCB.00403-13; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Benbahouche NE, 2014, J BIOL CHEM, V289, P6236, DOI 10.1074/jbc.M113.499608; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Craxton A, 2012, CELL DEATH DIFFER, V19, P1424, DOI 10.1038/cdd.2012.16; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Dong FL, 2014, J CELL BIOL, V204, P203, DOI 10.1083/jcb.201304076; Eckert K, 2010, J BIOL CHEM, V285, P31304, DOI 10.1074/jbc.M110.138263; Enenkel C, 2014, BIOMOLECULES, V4, P940, DOI 10.3390/biom4040940; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; Forsthoefel AM, 2004, BIOCHEMISTRY-US, V43, P1972, DOI 10.1021/bi035894p; Ghaboosi N, 2007, MOL BIOL CELL, V18, P1953, DOI 10.1091/mbc.E06-10-0965; Godderz D, 2011, J MOL BIOL, V407, P354, DOI 10.1016/j.jmb.2011.01.051; Gu ZC, 2014, CELL MOL LIFE SCI, V71, P4729, DOI 10.1007/s00018-014-1699-8; Ha SW, 2012, BIOCHEM BIOPH RES CO, V419, P226, DOI 10.1016/j.bbrc.2012.01.152; Horejsi Z, 2014, CELL REP, V7, P19, DOI 10.1016/j.celrep.2014.03.013; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Hwang J, 2011, BBA-REV CANCER, V1816, P147, DOI 10.1016/j.bbcan.2011.05.005; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jimenez B, 2012, J BIOL CHEM, V287, P5698, DOI 10.1074/jbc.M111.287458; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Kakihara Yoshito, 2014, BioMolecular Concepts, V5, P513, DOI 10.1515/bmc-2014-0028; Kakihara Y, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0404-4; Kakihara Y, 2012, BBA-MOL CELL RES, V1823, P101, DOI 10.1016/j.bbamcr.2011.08.016; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Melo SP, 2011, J BIOL CHEM, V286, P36559, DOI 10.1074/jbc.M111.274258; Melo SP, 2010, BIOCHEM J, V432, P217, DOI 10.1042/BJ20101027; Meszaros B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035003; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Paci A, 2012, J BIOL CHEM, V287, P43205, DOI 10.1074/jbc.M112.408849; Pakay JL, 2012, ONCOGENE, V31, P1817, DOI 10.1038/onc.2011.375; Pal M, 2014, STRUCTURE, V22, P805, DOI 10.1016/j.str.2014.04.001; Ponsuksili S, 2014, INT J BIOL SCI, V10, P327, DOI 10.7150/ijbs.8134; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Prieto MB, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0037-5; Quinternet M, 2015, J MOL BIOL, V427, P2816, DOI 10.1016/j.jmb.2015.07.012; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; Rothe B, 2014, NUCLEIC ACIDS RES, V42, P10731, DOI 10.1093/nar/gku612; Rothe B, 2014, NUCLEIC ACIDS RES, V42, P2015, DOI 10.1093/nar/gkt1091; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; Shen XT, 2004, METHOD ENZYMOL, V377, P401; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stintzing S, 2014, CLIN CANCER RES, V20, P3064, DOI 10.1158/1078-0432.CCR-13-3175; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Winkler LL, 2013, J VIROL, V87, P4665, DOI 10.1128/JVI.03301-12; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Young MJ, 2008, YEAST, V25, P903, DOI 10.1002/yea.1644; Zhang MH, 2008, EMBO J, V27, P2789, DOI 10.1038/emboj.2008.190; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	71	3	3	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11761	11775		10.1074/jbc.M115.702043	http://dx.doi.org/10.1074/jbc.M115.702043			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27053109	Green Published, hybrid			2022-12-26	WOS:000377264800026
J	Ugarte-Berzal, E; Vandooren, J; Bailon, E; Opdenakker, G; Garcia-Pardo, A				Ugarte-Berzal, Estefania; Vandooren, Jennifer; Bailon, Elvira; Opdenakker, Ghislain; Garcia-Pardo, Angeles			Inhibition of MMP-9-dependent Degradation of Gelatin, but Not Other MMP-9 Substrates, by the MMP-9 Hemopexin Domain Blades 1 and 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; MATRIX-METALLOPROTEINASE-9 MMP-9; CELL-SURFACE; ALPHA-4-BETA-1 INTEGRIN; B-CELLS; MIGRATION; CANCER; DEGRADOMICS; BIOCHEMISTRY; CONSTITUTE	Degradation and remodeling of the extracellular matrix by matrix metalloproteinases (MMPs) plays important roles in normal development, inflammation, and cancer. MMP-9 efficiently degrades the extracellular matrix component gelatin, and the hemopexin domain of MMP-9 (PEX9) inhibits this degradation. To study the molecular basis of this inhibition, we generated GST fusion proteins containing PEX9 or truncated forms corresponding to specific structural blades (B1-B4) of PEX9. GST-PEX9 inhibited MMP-9-driven gelatin proteolysis, measured by gelatin zymography, FITC-gelatin conversion, and DQ-gelatin degradation assays. However, GST-PEX9 did not prevent the degradation of other MMP-9 substrates, such as a fluorogenic peptide, alpha B crystalline, or nonmuscular actin. Therefore, PEX9 may inhibit gelatin degradation by shielding gelatin and specifically preventing its binding to MMP-9. Accordingly, GST-PEX9 also abolished the degradation of gelatin by MMP-2, confirming that PEX9 is not an MMP-9 antagonist. Moreover, GST-B4 and, to a lesser extent, GST-B1 also inhibited gelatin degradation by MMP-9, indicating that these regions are responsible for the inhibitory activity of PEX9. Accordingly, ELISAs demonstrated that GST-B4 and GST-B1 specifically bound to gelatin. Our results establish new functions of PEX9 attributed to blades B4 and B1 and should help in designing specific inhibitors of gelatin degradation.	[Ugarte-Berzal, Estefania; Bailon, Elvira; Garcia-Pardo, Angeles] CSIC, Ctr Invest Biol, Cellular & Mol Med Dept, Ramiro Maeztu 9, Madrid 28040, Spain; [Ugarte-Berzal, Estefania; Vandooren, Jennifer; Opdenakker, Ghislain] Univ Leuven, KULeuven, Rega Inst Med Res, Dept Microbiol & Immunol, B-3000 Leuven, Belgium	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); KU Leuven	Garcia-Pardo, A (corresponding author), CSIC, Ctr Invest Biol, Cellular & Mol Med Dept, Ramiro Maeztu 9, Madrid 28040, Spain.	agarciapardo@cib.csic.es	Opdenakker, Ghislain/Q-3130-2017; Vandooren, Jennifer/H-5318-2019; Opdenakker, Ghislain/V-8562-2019; Vandooren, Jennifer/O-6424-2018	Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294; Vandooren, Jennifer/0000-0002-7157-3370	Ministry of Economy and Competitivity (Spain) [SAF2012-31613, RD12/0036/0061]; Comunidad de Madrid/European Union [S2010/BMD-2314]; Concerted Research Actions Grant GOA; fund for Scientific Research of Flanders; Ministry of Economy and Competitivity [SAF 2009-07035]; Rega Institute of KU Leuven; European Union [263307]; Junta de Ampliacion de Estudios program; CSIC/European Union; Ministry of Economy and Competitivity	Ministry of Economy and Competitivity (Spain); Comunidad de Madrid/European Union; Concerted Research Actions Grant GOA; fund for Scientific Research of Flanders(FWO); Ministry of Economy and Competitivity; Rega Institute of KU Leuven; European Union(European Commission); Junta de Ampliacion de Estudios program; CSIC/European Union(European Commission); Ministry of Economy and Competitivity	This work was supported by Grant SAF2012-31613 and Red Tematica de Investigacion Cooperativa en Cancer Grant RD12/0036/0061 from the Ministry of Economy and Competitivity (Spain) (to A. G.-P.); by Grant S2010/BMD-2314 (to A. G.-P.) from the Comunidad de Madrid/European Union; and by the Concerted Research Actions Grant GOA 2013-2015 and the fund for Scientific Research of Flanders (to G. O.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Fellowship SAF 2009-07035 from Ministry of Economy and Competitivity. Currently supported as a postdoctoral fellow at the Rega Institute of KU Leuven.; Supported by European Union Seventh Framework Programme FP7/2007 2013, under Grant Agreement 263307.; Supported by the Junta de Ampliacion de Estudios program, CSIC/European Union, and by Ministry of Economy and Competitivity.	Bailon E, 2014, J LEUKOCYTE BIOL, V96, P185, DOI 10.1189/jlb.3HI0913-521R; BICKETT DM, 1993, ANAL BIOCHEM, V212, P58, DOI 10.1006/abio.1993.1291; Burg-Roderfeld M, 2007, INT J ONCOL, V30, P985; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Garc~ia-Pardo A, 2015, METALLOPROTEINASES M, V2015, P19, DOI DOI 10.2147/MNM.S63629; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huesgen PF, 2012, PHYSIOL PLANTARUM, V145, P5, DOI 10.1111/j.1399-3054.2011.01536.x; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Nabeshima K, 2002, PATHOL INT, V52, P255, DOI 10.1046/j.1440-1827.2002.01343.x; Overall CM, 2004, BIOL CHEM, V385, P493, DOI 10.1515/BC.2004.058; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Roeb E, 2002, J BIOL CHEM, V277, P50326, DOI 10.1074/jbc.M207446200; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; Starckx S, 2003, J NEUROIMMUNOL, V141, P47, DOI 10.1016/S0165-5728(03)00217-0; Ugarte-Berzal E, 2014, J BIOL CHEM, V289, P15340, DOI 10.1074/jbc.M114.559187; Ugarte-Berzal E, 2012, J BIOL CHEM, V287, P27601, DOI 10.1074/jbc.M112.354670; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Vandooren J, 2015, BIOCHEM J, V465, P259, DOI 10.1042/BJ20140418; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren Jennifer, 2011, World J Biol Chem, V2, P14, DOI 10.4331/wjbc.v2.i1.14; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644	35	18	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11751	11760		10.1074/jbc.M115.708438	http://dx.doi.org/10.1074/jbc.M115.708438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27044750	Green Published, hybrid			2022-12-26	WOS:000377264800025
J	Karuppagounder, V; Giridharan, VV; Arumugam, S; Sreedhar, R; Palaniyandi, SS; Krishnamurthy, P; Quevedo, J; Watanabe, K; Konishi, T; Thandavarayan, RA				Karuppagounder, Vengadeshprabhu; Giridharan, Vijayasree V.; Arumugam, Somasundaram; Sreedhar, Remya; Palaniyandi, Suresh S.; Krishnamurthy, Prasanna; Quevedo, Joao; Watanabe, Kenichi; Konishi, Tetsuya; Thandavarayan, Rajarajan A.			Modulation of Macrophage Polarization and HMGB1-TLR2/TLR4 Cascade Plays a Crucial Role for Cardiac Remodeling in Senescence-Accelerated Prone Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; DAUNORUBICIN-INDUCED NEPHROTOXICITY; MYOCARDIAL-ISCHEMIA; ATOPIC-DERMATITIS; OXIDATIVE STRESS; HEART-DISEASE; HMGB1; INFLAMMATION; DYSFUNCTION; RECEPTOR	The aim of this study was to investigate the role of macrophage polarization in aging heart. Macrophage differentiation is pathogenically linked to many inflammatory and immune disorders. It is often preceded by myocardial inflammation, which is characterized by increased cardiac damage and pro-inflammatory cytokine levels. Therefore, we investigated the hypothesis that senescence accelerated-prone (SAMP8) mice cardiac tissue would develop macrophage polarization compared with senescence-resistant control (SAMR1) mice. Both SAMP8 and SAMR1 mice were sacrificed when they became six month old. We evaluated, histo-pathological changes and modifications in protein expression by Western blotting and immuno-histochemical staining for M1 and M2 macrophage markers, high mobility group protein (HMG) B1 and its cascade proteins, pro-inflammatory factors and inflammatory cytokines in cardiac tissue. We observed significant upregulation of HMGB1, toll-like receptor (TLR) 2, TLR4, nuclear factor (NF)kappa B p65, tumor necrosis factor (TNF) alpha, cyclooxygenase (COX) 2, interferon (IFN)gamma, interleukin (IL)-1 beta, IL-6 and M1 like macrophage specific marker cluster of differentiation (CD) 68 expressions in SAMP8 heart. In contrast, M2 macrophage specific marker CD36, and IL-10 expressions were down-regulated in SAMP8 mice. The results from the study demonstrated that, HMGB1-TLR2/TLR4 signaling cascade and induction of phenotypic switching to M1 macrophage polarization in SAMP8 mice heart would be one of the possible reasons behind the cardiac dysfunction and thus it could become an important therapeutic target to improve the age related cardiac dysfunction.	[Karuppagounder, Vengadeshprabhu; Arumugam, Somasundaram; Sreedhar, Remya; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata 9568603, Japan; [Giridharan, Vijayasree V.; Quevedo, Joao] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77054 USA; [Palaniyandi, Suresh S.] Henry Ford Hlth Syst, Div Hypertens & Vasc Res, Detroit, MI 48202 USA; [Krishnamurthy, Prasanna; Thandavarayan, Rajarajan A.] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA; [Konishi, Tetsuya] NUPALS Liaison RD Promot Div, Basic Studies Generat Funct Foods 2, Akiha Ku, Higashijima 265-1, Niigata, Japan; [Konishi, Tetsuya] Changchun Univ Chinese Med, Bosuo Rd 1035 Jingyue Econ Dev Dist, Changchun, Peoples R China	Niigata University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Henry Ford Health System; Henry Ford Hospital; The Methodist Hospital System; The Methodist Hospital - Houston; Changchun University of Chinese Medicine	Thandavarayan, RA (corresponding author), Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA.	atrajarajan@gmail.com	de Quevedo, João Luciano/E-5491-2013; Karuppagounder, Vengadeshprabhu/AAC-6623-2019; Arumugam, S./AAT-7570-2020	de Quevedo, João Luciano/0000-0003-3114-6611; KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364; Arumugam, Somasundaram/0000-0002-2096-2552; KARUPPA GOUNDER, VENGADESHPRABHU/0000-0003-1511-7810	Promotion and Mutual Aid Corporation for Private Schools, Japan; National Institutes of Health (NIH) grant [1R01HL116729]; AHA post-doctoral fellowship [15POST25710392]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Promotion and Mutual Aid Corporation for Private Schools, Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA post-doctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	TK was supported by The Promotion and Mutual Aid Corporation for Private Schools, Japan; PK was supported by National Institutes of Health (NIH) grant 1R01HL116729, RAT was supported by AHA post-doctoral fellowship 15POST25710392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Azzawi M, 2005, HISTOPATHOLOGY, V46, P314, DOI 10.1111/j.1365-2559.2005.02075.x; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Cucak H, 2015, INT IMMUNOPHARMACOL, V25, P30, DOI 10.1016/j.intimp.2015.01.003; de Haan JJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/206039; Favre J, 2007, ARTERIOSCL THROM VAS, V27, P1064, DOI 10.1161/ATVBAHA.107.140723; Forman K, 2011, J GERONTOL A-BIOL, V66, P823, DOI 10.1093/gerona/glr083; Gan W, 2012, FREE RADICAL BIO MED, V52, P1700, DOI 10.1016/j.freeradbiomed.2012.02.016; Gounder VK, 2014, INT IMMUNOPHARMACOL, V18, P282, DOI 10.1016/j.intimp.2013.11.018; Gullestad L, 2012, CARDIOLOGY, V122, P23, DOI 10.1159/000338166; Han XB, 2010, FASEB J, V24, P2869, DOI 10.1096/fj.09-148155; Hao QQ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/270930; Hosokawa M, 1997, EXP GERONTOL, V32, P111, DOI 10.1016/S0531-5565(96)00078-2; Jackaman C, 2013, AGING CELL, V12, P345, DOI 10.1111/acel.12062; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Karuppagounder V, 2015, INT IMMUNOPHARMACOL, V28, P154, DOI 10.1016/j.intimp.2015.05.050; Karuppagounder V, 2015, EXP DERMATOL, V24, P418, DOI 10.1111/exd.12685; Karuppagounder V, 2014, INT IMMUNOPHARMACOL, V23, P617, DOI 10.1016/j.intimp.2014.10.014; Ma YG, 2015, CARDIOVASC RES, V106, P421, DOI 10.1093/cvr/cvv128; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Moslehi J, 2012, CIRC RES, V110, P1226, DOI 10.1161/CIRCRESAHA.111.246868; Odden MC, 2011, AM J MED, V124, P827, DOI 10.1016/j.amjmed.2011.04.010; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Qiu YR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004011; Ranganathan PV, 2013, AM J PHYSIOL-RENAL, V304, pF948, DOI 10.1152/ajprenal.00580.2012; Reed AL, 2011, AM J PHYSIOL-HEART C, V301, pH824, DOI 10.1152/ajpheart.00407.2010; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saito H, 2001, J BIOL CHEM, V276, P29307, DOI 10.1074/jbc.M103740200; Shioi T, 2012, J CARDIOL, V60, P423, DOI 10.1016/j.jjcc.2012.07.015; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Takahashi M, 2008, CARDIOVASC RES, V80, P5, DOI 10.1093/cvr/cvn212; TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Wang WK, 2014, J CELL MOL MED, V18, P2311, DOI 10.1111/jcmm.12399; Xu H, 2010, J IMMUNOL, V184, P1492, DOI 10.4049/jimmunol.0902660	39	41	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152922	10.1371/journal.pone.0152922	http://dx.doi.org/10.1371/journal.pone.0152922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070323	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700020
J	Hanson, DL; Song, RG; Masciotra, S; Hernandez, A; Dobbs, TL; Parekh, BS; Owen, SM; Green, TA				Hanson, Debra L.; Song, Ruiguang; Masciotra, Silvina; Hernandez, Angela; Dobbs, Trudy L.; Parekh, Bharat S.; Owen, S. Michele; Green, Timothy A.			Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B	PLOS ONE			English	Article							TYPE-1 INCIDENCE; INFECTION; ASSAY; SURVEILLANCE	HIV incidence estimates are used to monitor HIV-1 infection in the United States. Use of laboratory biomarkers that distinguish recent from longstanding infection to quantify HIV incidence rely on having accurate knowledge of the average time that individuals spend in a transient state of recent infection between seroconversion and reaching a specified biomarker cutoff value. This paper describes five estimation procedures from two general statistical approaches, a survival time approach and an approach that fits binomial models of the probability of being classified as recently infected, as a function of time since seroconversion. We compare these procedures for estimating the mean duration of recent infection (MDRI) for two biomarkers used by the U.S. National HIV Surveillance System for determination of HIV incidence, the Aware BED EIA HIV-1 incidence test (BED) and the avidity-based, modified Bio-Rad HIV-1/HIV-2 plus O ELISA (BRAI) assay. Collectively, 953 specimens from 220 HIV-1 subtype B seroconverters, taken from 5 cohorts, were tested with a biomarker assay. Estimates of MDRI using the non-parametric survival approach were 198.4 days (SD 13.0) for BED and 239.6 days (SD 13.9) for BRAI using cutoff values of 0.8 normalized optical density and 30%, respectively. The probability of remaining in the recent state as a function of time since seroconversion, based upon this revised statistical approach, can be applied in the calculation of annual incidence in the United States.	[Hanson, Debra L.; Song, Ruiguang; Green, Timothy A.] Ctr Dis Control & Prevent, Quantitat Sci & Data Management Branch, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Masciotra, Silvina; Owen, S. Michele] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Hernandez, Angela] Ctr Dis Control & Prevent, HIV Incidence & Case Surveillance Branch, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Dobbs, Trudy L.; Parekh, Bharat S.] Ctr Dis Control & Prevent, Int Lab Branch, Div Global HIV & AIDS, Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Hanson, DL (corresponding author), Ctr Dis Control & Prevent, Quantitat Sci & Data Management Branch, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA.	dhanson@cdc.gov		PAREKH, BHARAT/0000-0002-1088-4263				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], EV BIOR GS HIV 1 HIV; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Burchell AN, 2003, INT J STD AIDS, V14, P601, DOI 10.1258/095646203322301059; Centers for Disease Control and Prevention, 2012, EST HIV INC US 2007; Centers for Disease Control and Prevention. HIV testing survey, 2002, 5 CDCP US DEP HHS; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Efron B, 1967, P 5 BERK S MATH STAT, P831; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hargrove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049661; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hauser A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098038; Hurvich CM, 1998, J ROY STAT SOC B, V60, P271, DOI 10.1111/1467-9868.00125; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Karon JM, 2008, STAT MED, V27, P4617, DOI 10.1002/sim.3144; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; Keating SM, 2012, J CLIN MICROBIOL, V50, P3968, DOI 10.1128/JCM.01454-12; Koblin BA, 1998, AIDS, V12, P785, DOI 10.1097/00002030-199807000-00015; Lansky A, 2007, PUBLIC HEALTH REP, V122, P24, DOI 10.1177/00333549071220S105; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; Oster Alexandra M., 2011, Morbidity and Mortality Weekly Report, V60, P694; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502	31	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152327	10.1371/journal.pone.0152327	http://dx.doi.org/10.1371/journal.pone.0152327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065005	gold, Green Submitted, Green Published			2022-12-26	WOS:000373891000010
J	Wu, ZZ; Bin, SY; He, HL; Wang, ZB; Li, M; Lin, JT				Wu, Zhongzhen; Bin, Shuying; He, Hualiang; Wang, Zhengbing; Li, Mei; Lin, Jintian			Differential Expression Analysis of Chemoreception Genes in the Striped Flea Beetle Phyllotreta striolata Using a Transcriptomic Approach	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; CANDIDATE CHEMOSENSORY GENES; CARBON-DIOXIDE DETECTION; RNA-SEQ DATA; ANTENNAL TRANSCRIPTOME; PHEROMONE-BINDING; MOLECULAR-BASIS; ANOPHELES-GAMBIAE; SOLUBLE-PROTEINS; MAXILLARY PALP	Olfactory transduction is a process by which olfactory sensory neurons (OSNs) transform odor information into neuronal electrical signals. This process begins with the binding of odor molecules to receptor proteins on olfactory receptor neuron (ORN) dendrites. The major molecular components involved in olfaction include odorant-binding proteins (OBPs), chemosensory proteins (CSPs), odorant receptors (ORs), gustatory receptors (GRs), ionotropic receptors (IRs), sensory neuron membrane proteins (SNMPs) and odorant-degrading enzymes (ODEs). More importantly, as potential molecular targets, chemosensory proteins are used to identify novel attractants or repellants for environmental-friendly pest management. In this study we analyzed the transcriptome of the flea beetle, Phyllotreta striolata (Coleoptera, Chrysomelidae), a serious pest of Brassicaceae crops, to better understand the molecular mechanisms of olfactory recognition in this pest. The analysis of transcriptomes from the antennae and terminal abdomens of specimens of both sexes identified transcripts from several key molecular components of chemoreception including 73 ORs, 36 GRs, 49 IRs, 2 SNMPs, 32 OBPs, 8 CSPs, and four candidate odorant degrading enzymes (ODEs): 143 cytochrome P450s (CYPs), 68 esterases (ESTs), 27 glutathione S-transferases (GSTs) and 8 UDP-glycosyltransferases (UGTs). Bioinformatic analyses indicated that a large number of chemosensory genes were up-regulated in the antennae. This was consistent with a potential role in olfaction. To validate the differential abundance analyses, the expression of 19 genes encoding various ORs, CSPs, and OBPs was assessed via qRT-PCR between non-chemosensory tissue and antennae. Consistent with the bioinformatic analyses, transcripts for all of the genes in the qRT-PCR subset were elevated in antennae. These findings provide the first insights into the molecular basis of chemoreception in the striped flea beetle.	[Wu, Zhongzhen; Bin, Shuying; He, Hualiang; Wang, Zhengbing; Li, Mei; Lin, Jintian] Zhongkai Univ Agr & Engn, Inst Management Invas Alien Species, 314 Yingdong Teaching Bldg, Guangzhou 510225, Guangdong, Peoples R China	Zhongkai University of Agriculture & Engineering	Lin, JT (corresponding author), Zhongkai Univ Agr & Engn, Inst Management Invas Alien Species, 314 Yingdong Teaching Bldg, Guangzhou 510225, Guangdong, Peoples R China.	linjtian@163.com		Wang, Zhengbing/0000-0003-4460-0369	National Natural Science Foundation of China [31272072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported financially by the National Natural Science Foundation of China (31272072).	Abdel-Latief M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001319; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Andersen CL, 2006, J ECON ENTOMOL, V99, P803, DOI 10.1603/0022-0493-99.3.803; Andersson MN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-501; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot J, 1998, BIOCHEM BIOPH RES CO, V253, P489, DOI 10.1006/bbrc.1998.9806; Boyle SM, 2013, ELIFE, V2, DOI 10.7554/eLife.01120; Bozzolan F, 2014, INSECT MOL BIOL, V23, P539, DOI 10.1111/imb.12100; Chen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114238; Choo YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067794; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Costa-da-Silva AL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-364; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; Dippel S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1141; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Gu XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125159; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Heikertinger F, 1941, KOLEOPTEROLOGISCHE R, V27, P69; Heikertinger F, 1941, KOLEOPTEROLOGISCHE R, V27, P15; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Ishida Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051779; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keeling CI, 2013, INSECT BIOCHEM MOLEC, V43, P1142, DOI 10.1016/j.ibmb.2013.10.001; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; LAZARD D, 1991, NATURE, V349, P790, DOI 10.1038/349790a0; Leal WS, 2013, P NATL ACAD SCI USA, V110, P18704, DOI 10.1073/pnas.1316059110; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.57; Li J, 2007, FUJIAN J AGR SCI, V22, P15; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Li X, 2015, PLOS ONE, V10; Li XM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2236-3; Liu CC, 2014, ARCH INSECT BIOCHEM, V85, P114, DOI 10.1002/arch.21150; Liu S, 2015, COMP BIOCHEM PHYS D, V13, P44, DOI 10.1016/j.cbd.2015.01.004; Liu YL, 2014, J EXP BIOL, V217, P1821, DOI 10.1242/jeb.102020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maibeche-Coisne M, 2004, P NATL ACAD SCI USA, V101, P11459, DOI 10.1073/pnas.0403537101; Mameli M, 1996, INSECT BIOCHEM MOLEC, V26, P875, DOI 10.1016/S0965-1748(96)00055-0; Mamidala P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056555; Marinotti O, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-15; Menuz K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004810; Merlin C, 2005, BIOCHEM BIOPH RES CO, V332, P4, DOI 10.1016/j.bbrc.2005.04.084; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Omondi BA, 2015, J EXP BIOL, V218, P2482, DOI 10.1242/jeb.116798; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Potter CJ, 2014, CELL, V156, P878, DOI 10.1016/j.cell.2014.02.003; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qiao R, 2009, J CHANGJIANG VEG, V6, P67; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rogers ME, 1999, J EXP BIOL, V202, P1625; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vogt R.G., 2005, P753; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wan XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17320; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Y, 2016, PLOS ONE, V11; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei JL, 2008, HUNAN AGR SCI, V3, P108; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Younus F, 2014, INSECT BIOCHEM MOLEC, V53, P30, DOI 10.1016/j.ibmb.2014.07.003; Zhang MX, 2000, PLANT PROT, V27, P1; Zhang YLV, 2013, SCIENCE, V340, P1334, DOI 10.1126/science.1234133; Zhou XH, 2013, BIOL CHEM, V394, P43, DOI 10.1515/hsz-2012-0114; Zhou XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002930; Zhu JY, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/491748	101	31	36	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153067	10.1371/journal.pone.0153067	http://dx.doi.org/10.1371/journal.pone.0153067			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064483	Green Submitted, Green Published, gold			2022-12-26	WOS:000373891000027
J	Zhu, H				Zhu, Hua			Biogeographical Evidences Help Revealing the Origin of Hainan Island	PLOS ONE			English	Article							PLANT GEOGRAPHY; CHINA; CONSERVATION; EOCENE; CEYLON; BASIN; LIGHT	Both the continental or island origin of Hainan, and the Indo-Malaysian or East Asian affinity of its flora, are debatable. In this study, 196 families, 1283 genera and 3894 species of Hainan plants were recognized. Patterns of seed plant distribution were quantified at the generic and the family levels. The floras of Vietnam, and the adjacent Guangxi and Guangdong provinces of mainland China, were compared with Hainan. The results showed that the flora of Hainan Island is dominated by families and genera with tropical distributions. Among its floristic elements, tropical Asian distributions make up 23.85% of the total flora, while East Asian distributions contribute only 3.74%. There are only 7 genera and c. 10% of species endemic to Hainan Island. The Hainan flora has strong similarities to the flora of Vietnam at the family and the generic levels, and also to the flora of Guangxi, but less with the adjacent Guangdong province. The main conclusions are: Hainan's flora is tropical in nature with a strongly tropical Asian affinity, and it has very low endemism at the generic and species levels, which implies a continental origin. We conjecture that Hainan Island could have been adjacent to northern Vietnam and the Guangxi at least in Eocene. This suggestion is supported by palaeobotanical, palaeomagnetic and volcanism studies.	[Zhu, Hua] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Zhu, H (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Kunming, Yunnan, Peoples R China.	zhuh@xtbg.ac.cn	Hua, Zhu/AFO-6233-2022		National Natural Science Foundation of China [41471051, 41071040, 31170195]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China, No. 41471051, 41071040, 31170195.	ASHTON PS, 1987, J BIOGEOGR, V14, P249, DOI 10.2307/2844895; Balakrishnan CN, 2003, MOL ECOL, V12, P1, DOI 10.1046/j.1365-294X.2003.01751.x; Carlquist S, 1980, HAWAII NATURAL HIST; Chan L. T., 1999, SOME BASIC CHARACTER; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Chu X. N., 1996, FEED IND MAGAZINE, V17, P17; Francisco-Ortega J, 2010, BOT REV, V76, P295, DOI 10.1007/s12229-010-9054-8; Francisco-Ortega J, 2010, BOT REV, V76, P346, DOI 10.1007/s12229-010-9055-7; [付璐露 FU Lulu], 2010, [地质学报, Acta Geologica Sinica], V84, P183; Guangdong Institute of Botany, 1976, VEG GUANGD, P41; GUNATILLEKE CVS, 1987, J BIOGEOGR, V14, P295, DOI 10.2307/2844940; GUNATILLEKE IAUN, 1990, CONSERV BIOL, V4, P21, DOI 10.1111/j.1523-1739.1990.tb00262.x; Guo K, 2014, FLORA VEGETATION GEO; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Jin Jian-hua, 2008, Xibei Zhiwu Xuebao, V28, P2125; Jin JH, 2009, REV PALAEOBOT PALYNO, V155, P80, DOI 10.1016/j.revpalbo.2009.02.003; Jin JH, 2009, REV PALAEOBOT PALYNO, V153, P150, DOI 10.1016/j.revpalbo.2008.07.010; LI ZX, 1995, GEOPHYS RES LETT, V22, P3071, DOI 10.1029/95GL03169; Liang G.H., 2013, ACTA GEOL SIN-ENGL, V87, P73; Lin XD., 1987, TROPICAL GEOGRAPHY Q, V7, P338; Liu YY, 1999, TECTONOPHYSICS, V301, P133, DOI 10.1016/S0040-1951(98)00216-9; [马云 Ma Yun], 2014, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V44, P1727; McShea WJ, 2005, BIOL CONSERV, V125, P101, DOI 10.1016/j.biocon.2005.03.013; Mo YQ., 1987, J NANJING UNIV NAT S, V23, P521; Qin HN, 2010, CHECKLIST VASCULAR P, P1; RANGIN C, 1995, TECTONOPHYSICS, V243, P209, DOI 10.1016/0040-1951(94)00207-P; Wu CY., 1996, P 1 INT S FLOR CHAR, P3, DOI DOI 10.1111/JSE.12037; Wu TeLin, 1996, Journal of Tropical and Subtropical Botany, V4, P1; Wu Z.Y., 2006, AREAL TYPES SEED PLA; Wu .Z.Y., 2010, FLORISTICS SEED PLAN; Wu Zheng-Yi, 2003, Acta Botanica Yunnanica, V25, P245; Wu Zhongliang, 1991, Acta Seismologica Sinica, V13, P1; Xing FW, 2012, INVENTORY PLANT SPEC, P1; Yan P, 2006, J ASIAN EARTH SCI, V27, P647, DOI 10.1016/j.jseaes.2005.06.005; Yao Q.Y., 1980, PHYSL MOL PLANT P GE, V1, P21; Yao YF, 2009, CLIMATIC CHANGE, V92, P169, DOI 10.1007/s10584-008-9457-2; Ye HG, 2005, CHECKLIST GUANGDONG, P1; Zhang CC, 1983, ACTA SCI NATURALIUM, V1983, P67; Zhang H., 1990, NE SEISMOLOGICAL RES, V6, P63; Zhang HD, 2001, ECOLOGIC SCI, V20, P1; Zhang HN, 1987, ACTA OCEANOL SIN, V9, P594; Zhang JW, 2015, REV PALAEOBOT PALYNO, V215, P57, DOI 10.1016/j.revpalbo.2014.11.006; Zhao Huan-ting, 2007, Marine Geology & Quaternary Geology, V27, P33; [赵炜 ZHAO Wei], 2009, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V39, P379; Zhu H., 2004, Telopea, V10, P639; [朱华 Zhu Hua], 2003, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V42, P98	46	55	67	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0151941	10.1371/journal.pone.0151941	http://dx.doi.org/10.1371/journal.pone.0151941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055236	gold, Green Published, Green Submitted			2022-12-26	WOS:000373608000009
J	Cheek, M; Challen, G; Lebbie, A; Banks, H; Barbera, P; Riina, R				Cheek, Martin; Challen, Gill; Lebbie, Aiah; Banks, Hannah; Barbera, Patricia; Riina, Ricarda			Discovering Karima (Euphorbiaceae), a New Crotonoid Genus from West Tropical Africa Long Hidden within Croton	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE	Croton scarciesii (Euphorbiaceae-Crotonoideae), a rheophytic shrub from West Africa, is shown to have been misplaced in Croton for 120 years, having none of the diagnostic characters of that genus, but rather a set of characters present in no known genus of the family. Pollen analysis shows that the new genus Karima belongs to the inaperturate crotonoid group. Analysis of a concatenated molecular dataset combining trnL-F and rbcL sequences positioned Karima as sister to Neoholstia from south eastern tropical Africa in a well-supported clade comprised of genera of subtribes Grosserineae and Neoboutonieae of the inaperturate crotonoid genera. Several morphological characters support the relationship of Karima with Neoholstia, yet separation is merited by numerous characters usually associated with generic rank in Euphorbiaceae. Quantitative ecological data and a conservation assessment supplement illustrations and descriptions of the taxon.	[Cheek, Martin; Challen, Gill; Banks, Hannah] Royal Bot Gardens, Dept Sci, Richmond, Surrey, England; [Lebbie, Aiah] Njala Univ, PMB, Dept Biol Sci, Natl Herbarium Sierra Leone, Freetown, Sierra Leone; [Barbera, Patricia; Riina, Ricarda] CSIC, RJB, Dept Biodivers & Conservat, Plaza Murillo, Madrid, Spain	Royal Botanic Gardens, Kew; Njala University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Cheek, M (corresponding author), Royal Bot Gardens, Dept Sci, Richmond, Surrey, England.; Riina, R (corresponding author), CSIC, RJB, Dept Biodivers & Conservat, Plaza Murillo, Madrid, Spain.	m.cheek@kew.org; rgriina@gmail.com	Riina, Ricarda/J-1032-2014; Barbera, Patricia/ABC-1793-2020	Riina, Ricarda/0000-0002-7423-899X; LEBBIE, AIAH/0000-0001-8725-3593	Joule Engineering; EU program Synthesys [NL-TAF-3710]; Spanish Government [CGL2012-32934, CGL2014-52787-C3-1-P]	Joule Engineering; EU program Synthesys; Spanish Government(Spanish GovernmentEuropean Commission)	The fieldwork which produced the specimen which triggered this study was ultimately funded by Joule Engineering as part of baseline studies for a hydroelectric dam at Bumbuna-Yiben, Sierra Leone. The funder of the fieldwork had no role in study design, data-collection and analysis, decision to publish or preparation of the manuscript. RR visit to WAG was supported by the EU program Synthesys (NL-TAF-3710). PB was supported by the Spanish Government through projects: Flora de Guinea Ecuatorial (CGL2012-32934) and Flora Iberica (CGL2014-52787-C3-1-P).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ake-Assi L., 2001, BOISSIERA, V57, P1; [Anonymous], 2014, TRACER V1 6; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; BERHAUT J, 1975, FLORE ILLUSTREE SENE; Berhaut J., 1967, FLORE DU SENEGAL; BURKHILL HM, 1994, USEFUL PLANTS W TROP, V2; Chevalier A.J.B., 1920, EXPLORATION BOT AFRI; Davis PH, 1963, PRINCIPLES ANGIOSPER; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hawthorne W.D., 2006, WOODY PLANTS W AFRIC; Hoffmann P., 2007, FLOWERING PLANT FAMI, P144; Hutchinson J, 1928, FLORA W TROPICAL AFR, V1, P276; Hutchinson J, 1913, FLORA TROPICAL AFRIC, V6, P609; Irvine FR, 1961, WOODY PLANTS GHANA; Keay R. W. J, 1958, FLORA W TROPICAL AFR, V2, P364; Lisowski S., 2009, SCRIPTA BOT BELGICA; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; McNeill J, 2012, REGNUM VEG, V154, P1; Nylander J. A. A., 2004, MRMODELTEST V2; Radcliffe-Smith A., 1996, FLORA ZAMBESICA, V9, P1; Radcliffe-Smith A., 2001, GENERA EUPHORBIACEAR; Riina R, 2014, SYST BOT, V39, P227, DOI 10.1600/036364414X678170; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scott-Elliot GF, 1895, J LINN SOC, V30, P64; Simmons MP, 2004, MOL PHYLOGENET EVOL, V31, P874, DOI 10.1016/j.ympev.2003.10.008; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thiers B., INDEX HERBARIORUM GL; van der Burgt XM, 2014, BUMBUNA PHASE UNPUB; van Ee BW, 2011, TAXON, V60, P791, DOI 10.1002/tax.603013; WEBSTER GL, 1993, TAXON, V42, P793, DOI 10.2307/1223265; Webster GL., 2014, FAMILIES GENERA VASC, P51, DOI [10.1007/978-3-642-39417-1_10, DOI 10.1007/978-3-642-39417-1_10]; Wurdack KJ, 2005, AM J BOT, V92, P1397, DOI 10.3732/ajb.92.8.1397; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811	37	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152110	10.1371/journal.pone.0152110	http://dx.doi.org/10.1371/journal.pone.0152110			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049519	gold, Green Submitted, Green Published			2022-12-26	WOS:000373603500025
J	Ferrario, A; Luna, M; Rucker, N; Wong, S; Lederman, A; Kim, J; Gomer, C				Ferrario, Angela; Luna, Marian; Rucker, Natalie; Wong, Sam; Lederman, Ariel; Kim, Jonathan; Gomer, Charles			Targeting Survivin Enhances Chemosensitivity in Retinoblastoma Cells and Orthotopic Tumors	PLOS ONE			English	Article							SEPANTRONIUM BROMIDE YM155; ANTITUMOR-ACTIVITY; CANCER CELL; LUNG-CANCER; THERAPEUTIC TARGET; BREAST-CANCER; PHASE I/II; SUPPRESSANT; APOPTOSIS; COMBINATION	Treatments for retinoblastoma (Rb) vary depending on the size and location of the intraocular lesions and include chemotherapy and radiation therapy. We examined whether agents used to treat Rb induce a pro-survival phenotype associated with increased expression of survivin, a member of the inhibitor of apoptosis family of proteins. We document that exposure to carboplatin, topotecan or radiation resulted in elevated expression of survivin in two human Rb cell lines but not in normal retinal pigmented epithelial (RPE) cells. Cellular levels of survivin were attenuated in Rb cells exposed to an imidazolium-based survivin suppressant, Sepantronium bromide (YM155). Protein expression patterns of survivin in RPE cells were not altered following treatment protocols involving exposure to YM155. Including YM155 with chemotherapy or radiation increased levels of apoptosis in Rb cells but not in RPE cells. Intraocular luciferase expressing Rb tumors were generated from the Rb cell lines and used to evaluate the effects of carboplatin and YM155 on in-vivo survivin expression and tumor growth. Carboplatin induced expression of survivin while carboplatin combined with YM155 reduced survivin expression in tumor bearing eyes. The combination protocol was also most effective in reducing the rate of tumor regrowth. These results indicate that targeted inhibition of the anti-apoptotic protein survivin provides a therapeutic advantage for Rb cells and tumors treated with chemotherapy.	[Ferrario, Angela; Luna, Marian; Rucker, Natalie; Wong, Sam; Lederman, Ariel; Kim, Jonathan; Gomer, Charles] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Kim, Jonathan] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90027 USA; [Gomer, Charles] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90027 USA; [Gomer, Charles] Univ So Calif, Keck Sch Med, Dept Radiat Oncol, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of Southern California	Gomer, C (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA.; Gomer, C (corresponding author), Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90027 USA.; Gomer, C (corresponding author), Univ So Calif, Keck Sch Med, Dept Radiat Oncol, Los Angeles, CA 90027 USA.	cgomer@chla.usc.edu			SC CTSI (NIH/NCRR/NCATS) [UL1TR000130]; ThinkCure; Las Madrinas Endowment for Experimental Therapeutics in Ophthalmology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER	SC CTSI (NIH/NCRR/NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ThinkCure; Las Madrinas Endowment for Experimental Therapeutics in Ophthalmology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported in part by SC CTSI (NIH/NCRR/NCATS) through grant UL1TR000130, a grant from ThinkCure, and from the Las Madrinas Endowment for Experimental Therapeutics in Ophthalmology.	Abramson DH, 2010, OPHTHALMOLOGY, V117, P1623, DOI 10.1016/j.ophtha.2009.12.030; Abramson DH, 1999, OPHTHALMOLOGY, V106, P1947, DOI 10.1016/S0161-6420(99)90406-2; Aliabadi HM, 2011, MOL PHARMACEUT, V8, P1821, DOI 10.1021/mp200176v; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Berry JL, 2014, BRIT J OPHTHALMOL, V98, P1061, DOI 10.1136/bjophthalmol-2013-304411; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P21, DOI 10.1136/bjo.2008.138750; Buitrago E, 2013, EXP EYE RES, V108, P103, DOI 10.1016/j.exer.2013.01.002; Carcaboso AM, 2010, INVEST OPHTH VIS SCI, V51, P2126, DOI 10.1167/iovs.09-4050; Carew JS, 2015, MOL CANCER THER, V14, P1404, DOI 10.1158/1535-7163.MCT-14-1036; Chantada Guillermo L, 2004, Ophthalmic Genet, V25, P37, DOI 10.1076/opge.25.1.37.28996; Chen J, 2013, BLOOD, V121, P2029, DOI 10.1182/blood-2012-05-427773; Coumar MS, 2013, CANCER TREAT REV, V39, P802, DOI 10.1016/j.ctrv.2013.02.002; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Duffy MJ, 2007, CANCER LETT, V249, P49, DOI 10.1016/j.canlet.2006.12.020; Elison JR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1269, DOI 10.1001/archopht.124.9.1269; Ferrario A, 2007, CANCER RES, V67, P4989, DOI 10.1158/0008-5472.CAN-06-4785; Francis JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072441; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Glaros TG, 2012, CANCER CHEMOTH PHARM, V70, P207, DOI 10.1007/s00280-012-1868-0; Guha M, 2009, CELL CYCLE, V8, P2708, DOI 10.4161/cc.8.17.9457; Houston Samuel K, 2011, Int Ophthalmol Clin, V51, P77, DOI 10.1097/IIO.0b013e3182010f29; Huang JC, 2015, AM J CANCER RES, V5, P20; Ikeguchi M, 2002, APOPTOSIS, V7, P23, DOI 10.1023/A:1013556727182; Iwasa T, 2010, BRIT J CANCER, V103, P36, DOI 10.1038/sj.bjc.6605713; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Jehanne M, 2009, PEDIATR BLOOD CANCER, V52, P637, DOI 10.1002/pbc.21898; Jiang LB, 2008, HISTOL HISTOPATHOL, V23, P827, DOI 10.14670/HH-23.827; Kawano H, 2014, EUR J PHARM BIOPHARM, V88, P283, DOI 10.1016/j.ejpb.2014.06.015; Kelly RJ, 2013, ANN ONCOL, V24, P2601, DOI 10.1093/annonc/mdt249; Kennedy SM, 2003, BRIT J CANCER, V88, P1077, DOI 10.1038/sj.bjc.6600776; Konduri S, 2009, MOL CANCER THER, V8, P533, DOI 10.1158/1535-7163.MCT-08-0405; Laurie NA, 2005, CLIN CANCER RES, V11, P7569, DOI 10.1158/1078-0432.CCR-05-0849; Leng T, 2010, RETINA, V30, P66; Li FZ, 2014, AM J CANCER RES, V4, P304; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lin P, 2009, AM J OPHTHALMOL, V148, P192, DOI 10.1016/j.ajo.2009.04.004; Marees T, 2008, J NATL CANCER I, V100, P1771, DOI 10.1093/jnci/djn394; Minematsu T, 2012, BIOPHARM DRUG DISPOS, V33, P160, DOI 10.1002/bdd.1781; Mouchess ML, 2006, J COMPUT ASSIST TOMO, V30, P525, DOI 10.1097/00004728-200605000-00030; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Rodel F, 2005, CANCER RES, V65, P4881, DOI 10.1158/0008-5472.CAN-04-3028; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Satoh T, 2009, CLIN CANCER RES, V15, P3872, DOI 10.1158/1078-0432.CCR-08-1946; Shehata HH, 2010, CLIN BIOCHEM, V43, P362, DOI 10.1016/j.clinbiochem.2009.10.056; Shen JJ, 2009, ACTA BIOCH BIOPH SIN, V41, P223, DOI 10.1093/abbs/gmp005; Shields CL, 2013, EYE, V27, P253, DOI 10.1038/eye.2012.175; Shields CL, 2006, OPHTHALMOLOGY, V113, P2276, DOI 10.1016/j.ophtha.2006.06.018; Smith AM, 2015, LEUKEMIA RES, V39, P435, DOI 10.1016/j.leukres.2015.01.005; Sudhakar J, 2013, PEDIATR BLOOD CANCER, V60, P1598, DOI 10.1002/pbc.24599; Theodoropoulou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052852; Tolcher AW, 2008, J CLIN ONCOL, V26, P5198, DOI 10.1200/JCO.2008.17.2064; Tong CT, 2005, BRIT J OPHTHALMOL, V89, P1217, DOI 10.1136/bjo.2004.064915; Turaka K, 2012, PEDIATR BLOOD CANCER, V59, P121, DOI 10.1002/pbc.23278; Wang QW, 2011, CANCER LETT, V302, P29, DOI 10.1016/j.canlet.2010.12.007; Yamanaka K, 2011, CLIN CANCER RES, V17, P5423, DOI 10.1158/1078-0432.CCR-10-3410; Yang P, 2007, INVEST OPHTH VIS SCI, V48, P3341, DOI 10.1167/iovs.06-1340; Yu CL, 2009, JNCI-J NATL CANCER I, V101, P581, DOI 10.1093/jnci/djp046	58	16	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153011	10.1371/journal.pone.0153011	http://dx.doi.org/10.1371/journal.pone.0153011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050416	Green Published, gold			2022-12-26	WOS:000373603500084
J	Jiang, W; Luo, T; Li, S; Zhou, Y; Shen, XY; He, F; Xu, J; Wang, HQ				Jiang, Wei; Luo, Tao; Li, Sheng; Zhou, Yue; Shen, Xiu-Yin; He, Feng; Xu, Jie; Wang, Hua-Qiao			Quercetin Protects against Okadaic Acid-Induced Injury via MAPK and PI3K/Akt/GSK3 beta Signaling Pathways in HT22 Hippocampal Neurons	PLOS ONE			English	Article							OXIDATIVE STRESS; ALZHEIMERS-DISEASE; MOUSE MODEL; CELL-DEATH; LONG-TERM; TAU; INDUCTION; EXPRESSION; HYPERPHOSPHORYLATION; PHOSPHORYLATION	Increasing evidence shows that oxidative stress and the hyperphosphorylation of tau protein play essential roles in the progression of Alzheimer's disease (AD). Quercetin is a major flavonoid that has anti-oxidant, anti-cancer and anti-inflammatory properties. We investigated the neuroprotective effects of quercetin to HT22 cells (a cell line from mouse hippocampal neurons). We found that Okadaic acid (OA) induced the hyperphosphorylation of tau protein at Ser199, Ser396, Thr205, and Thr231 and produced oxidative stress to the HT22 cells. The oxidative stress suppressed the cell viability and decreased the levels of lactate dehydrogenase (LDH), superoxide dismutase (SOD), mitochondria membrane potential (MMP) and Glutathione peroxidase (GSH-Px). It up-regulated malondialdehyde (MDA) production and intracellular reactive oxygen species (ROS). In addition, phosphoinositide 3 kinase/protein kinase B/Glycogen synthase kinase3 beta (PI3K/Akt/GSK3 beta) and mitogen activated protein kinase (MAPK) were also involved in this process. We found that pretreatment with quercetin can inhibited OA-induced the hyperphosphorylation of tau protein and oxidative stress. Moreover, pre-treatment with quercetin not only inhibited OA-induced apoptosis via the reduction of Bax, and up-regulation of cleaved caspase 3, but also via the inhibition of PI3K/Akt/GSK3 beta, MAPKs and activation of NF-kappa B p65. Our findings suggest the therapeutic potential of quercetin to treat AD.	[Jiang, Wei; Luo, Tao; Li, Sheng; Zhou, Yue; Shen, Xiu-Yin; Xu, Jie; Wang, Hua-Qiao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat & Neurobiol, Guangzhou 510080, Guangdong, Peoples R China; [Jiang, Wei] Zhaoqing Med Coll, Dept Anat & Histoembryol, Zhaoqing 526020, Guangdong, Peoples R China; [He, Feng] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wang, HQ (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat & Neurobiol, Guangzhou 510080, Guangdong, Peoples R China.; He, F (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.	hefeng@mail.sysu.edu.cn; wanghq@mail.sysu.edu.cn			National Key Development Program for Basic Research of China [2006cb500700]; Science and Technology Innovation Project of Guangdong Education Department [2012KJCX0089]; Medical Scientific Research Foundation of Guangdong Province [A2010222, A2015032]; Fundamental Research Founds for the Central Universities of China [14ykpy03]; National Natural Science Foundation of China [81173577, 81501093]; Natural Science Foundation of Guangdong Province [2015A030313066, 2015A030310251]; Science and Technology Planning Project of Guangdong Province [2014A020212622]	National Key Development Program for Basic Research of China(National Basic Research Program of China); Science and Technology Innovation Project of Guangdong Education Department; Medical Scientific Research Foundation of Guangdong Province; Fundamental Research Founds for the Central Universities of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province	This work was supported by National Key Development Program for Basic Research of China (No. 2006cb500700), Science and Technology Innovation Project of Guangdong Education Department (No. 2012KJCX0089), Medical Scientific Research Foundation of Guangdong Province (No. A2010222, A2015032), Fundamental Research Founds for the Central Universities of China (No. 14ykpy03), National Natural Science Foundation of China (No. 81173577, 81501093), Natural Science Foundation of Guangdong Province (No. 2015A030313066, 2015A030310251), and Science and Technology Planning Project of Guangdong Province (No. 2014A020212622).	Meraz-Rios MA, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/375968; Chen LQ, 2005, ANAT REC PART A, V287A, P1236, DOI 10.1002/ar.a.20241; Chen ZC, 2014, NEUROSCI BULL, V30, P271, DOI 10.1007/s12264-013-1423-y; Chung CW, 2003, NEUROBIOL DIS, V14, P557, DOI 10.1016/j.nbd.2003.08.017; Clausen A, 2012, J ALZHEIMERS DIS, V30, P183, DOI 10.3233/JAD-2012-111298; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Feng Y, 2013, J NEUROCHEM, V126, P234, DOI 10.1111/jnc.12285; Giridharan VV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142483; Hanana H, 2012, BIOL OPEN, V1, P1192, DOI 10.1242/bio.20122170; Hu SQ, 2013, NEUROCHEM INT, V62, P468, DOI 10.1016/j.neuint.2013.01.022; Hu WH, 2009, AM J PHYSIOL-CELL PH, V296, pC1310, DOI 10.1152/ajpcell.00573.2008; Islam MR, 2013, J YOUNG PHARM, V5, P173, DOI 10.1016/j.jyp.2013.11.005; Jiang W, 2015, CNS NEUROL DISORD-DR, V14, P1334, DOI 10.2174/1871527314666150821104455; Kamat PK, 2011, PHARMACOL BIOCHEM BE, V100, P311, DOI 10.1016/j.pbb.2011.08.019; Landrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021521; Liu J, 2009, LIFE SCI, V84, P267, DOI 10.1016/j.lfs.2008.12.008; Luo T, 2012, CNS NEUROL DISORD-DR, V11, P1030; Min KJ, 2011, CELL SIGNAL, V23, P1505, DOI 10.1016/j.cellsig.2011.05.013; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; Park SY, 2010, PLANTA MED, V76, P863, DOI 10.1055/s-0029-1240801; Post A, 2000, EUR J NEUROSCI, V12, P4331, DOI 10.1046/j.0953-816X.2000.01352.x; Swomley AM, 2014, BBA-MOL BASIS DIS, V1842, P1248, DOI 10.1016/j.bbadis.2013.09.015; Thal DR, 2013, EUR ARCH PSY CLIN N, V263, pS137, DOI 10.1007/s00406-013-0449-5; Valdiglesias V, 2011, TOXICON, V57, P882, DOI 10.1016/j.toxicon.2011.03.005; Wang DM, 2014, NEUROCHEM RES, V39, P1533, DOI 10.1007/s11064-014-1343-x; Xiao HF, 2013, J AGR FOOD CHEM, V61, P1509, DOI 10.1021/jf3050268; Yan FG, 2012, ENVIRON TOXICOL PHAR, V33, P181, DOI 10.1016/j.etap.2011.12.006; Zeng KW, 2011, EUR J PHARMACOL, V672, P45, DOI 10.1016/j.ejphar.2011.09.177; Zhang Z, 2010, BRAIN RES, V1359, P233, DOI 10.1016/j.brainres.2010.08.077; Zhao RP, 2011, J ETHNOPHARMACOL, V133, P1109, DOI 10.1016/j.jep.2010.11.054; Zhou SS, 2013, NEUROTOXICOLOGY, V38, P136, DOI 10.1016/j.neuro.2013.07.007; Zimmer ER, 2012, CURR ALZHEIMER RES, V9, P1182	32	42	42	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152371	10.1371/journal.pone.0152371	http://dx.doi.org/10.1371/journal.pone.0152371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050422	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500034
J	Lapenta, F; Silva, AM; Brandimarti, R; Lanzi, M; Gratani, FL; Gonzalez, PV; Perticarari, S; Hochkoeppler, A				Lapenta, Fabio; Silva, Alejandro Monton; Brandimarti, Renato; Lanzi, Massimiliano; Gratani, Fabio Lino; Gonzalez, Perceval Vellosillo; Perticarari, Sofia; Hochkoeppler, Alejandro			Escherichia coli DnaE Polymerase Couples Pyrophosphatase Activity to DNA Replication	PLOS ONE			English	Article							FAMILY-II PYROPHOSPHATASES; INORGANIC PYROPHOSPHATASE; DEOXYRIBONUCLEIC-ACID; EXONUCLEASE ACTIVITY; BACILLUS-SUBTILIS; STREPTOCOCCUS-GORDONII; QUATERNARY STRUCTURE; ENZYMATIC SYNTHESIS; GAMMA-SUBUNIT; PHP DOMAIN	DNA Polymerases generate pyrophosphate every time they catalyze a step of DNA elongation. This elongation reaction is generally believed as thermodynamically favoured by the hydrolysis of pyrophosphate, catalyzed by inorganic pyrophosphatases. However, the specific action of inorganic pyrophosphatases coupled to DNA replication in vivo was never demonstrated. Here we show that the Polymerase-Histidinol-Phosphatase (PHP) domain of Escherichia coli DNA Polymerase III a subunit features pyrophosphatase activity. We also show that this activity is inhibited by fluoride, as commonly observed for inorganic pyrophosphatases, and we identified 3 amino acids of the PHP active site. Remarkably, E. coli cells expressing variants of these catalytic residues of a subunit feature aberrant phenotypes, poor viability, and are subject to high mutation frequencies. Our findings indicate that DNA Polymerases can couple DNA elongation and pyrophosphate hydrolysis, providing a mechanism for the control of DNA extension rate, and suggest a promising target for novel antibiotics.	[Lapenta, Fabio; Silva, Alejandro Monton; Brandimarti, Renato; Gratani, Fabio Lino; Gonzalez, Perceval Vellosillo; Perticarari, Sofia; Hochkoeppler, Alejandro] Univ Bologna, Dept Pharm & Biotechnol, Viale Risorgimento 4, I-40136 Bologna, Italy; [Lanzi, Massimiliano] Univ Bologna, Dept Ind Chem, Viale Risorgimento 4, I-40136 Bologna, Italy; [Hochkoeppler, Alejandro] Univ Florence, CSGI, Via Lastruccia 3, I-50019 Sesto Fiorentino, FI, Italy	University of Bologna; University of Bologna; University of Florence	Hochkoeppler, A (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Viale Risorgimento 4, I-40136 Bologna, Italy.; Hochkoeppler, A (corresponding author), Univ Florence, CSGI, Via Lastruccia 3, I-50019 Sesto Fiorentino, FI, Italy.	a.hochkoeppler@unibo.it	Hochkoeppler, Alejandro/HGA-5916-2022; Lapenta, Fabio/T-3825-2017; Lanzi, Massimiliano/F-3973-2016; Lanzi, Massimiliano/AAV-7432-2020	Lanzi, Massimiliano/0000-0002-2466-2813; Lanzi, Massimiliano/0000-0002-2466-2813; Lapenta, Fabio/0000-0003-1195-3758; Vellosillo, Perceval/0000-0002-5998-6316; BRANDIMARTI, RENATO/0000-0003-3078-9009				Ahn S, 2001, J MOL BIOL, V313, P797, DOI 10.1006/jmbi.2001.5070; Ahsan MR, 2005, INDIAN J PURE AP PHY, V43, P89; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Banos B, 2008, NUCLEIC ACIDS RES, V36, P5736, DOI 10.1093/nar/gkn526; Barros T, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-8; Beckwith J, 1992, POWER BACTERIAL GENE, P4; BESSMAN MJ, 1958, J BIOL CHEM, V233, P171; Blasius M, 2006, MOL MICROBIOL, V60, P165, DOI 10.1111/j.1365-2958.2006.05077.x; BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bressanin D, 2009, BBA-PROTEINS PROTEOM, V1794, P1606, DOI 10.1016/j.bbapap.2009.07.011; CAMPBELL JL, 1972, P NATL ACAD SCI USA, V69, P2090, DOI 10.1073/pnas.69.8.2090; Conte E, 2011, BIOTECHNOL LETT, V33, P1815, DOI 10.1007/s10529-011-0624-6; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; DELUCIA P, 1969, NATURE, V224, P1164, DOI 10.1038/2241164a0; DEMEIS L, 1984, J BIOL CHEM, V259, P6090; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Fabrichniy IP, 2004, BIOCHEMISTRY-US, V43, P14403, DOI 10.1021/bi0484973; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; GEFTER ML, 1971, P NATL ACAD SCI USA, V68, P3150, DOI 10.1073/pnas.68.12.3150; Grigorieva OV, 2001, RUSS J BIOORG CHEM+, V27, P27, DOI 10.1023/A:1009574901422; Suarez ASG, 2012, BIOTECHNIQUES, V53, P99, DOI 10.2144/000113905; Hamdan S, 2002, BIOCHEMISTRY-US, V41, P5266, DOI 10.1021/bi0159480; Heikinheimo P, 2001, P NATL ACAD SCI USA, V98, P3121, DOI 10.1073/pnas.061612498; JOYCE CM, 1984, J BACTERIOL, V158, P636, DOI 10.1128/JB.158.2.636-643.1984; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Knippers A., 1970, NATURE, V228, P1050; Kornberg A., 1992, DNA REPLICATION; KORNBERG T, 1972, J BIOL CHEM, V247, P5369; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; LEHMAN IR, 1958, J BIOL CHEM, V233, P163; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Nakane S, 2009, NUCLEIC ACIDS RES, V37, P2037, DOI 10.1093/nar/gkp064; NUSSLEIN V, 1971, NATURE-NEW BIOL, V234, P285, DOI 10.1038/newbio234285a0; Parfenyev AN, 2001, J BIOL CHEM, V276, P24511, DOI 10.1074/jbc.M101829200; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Reuven NB, 1998, MOL CELL, V2, P191, DOI 10.1016/S1097-2765(00)80129-X; Rock JM, 2015, NAT GENET, V47, P677, DOI 10.1038/ng.3269; Scheibe P., 1974, METHODEN ENZYMATISCH, P1999; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silva AM, 2015, BIOCHEM BIOPH RES CO, V462, P14, DOI 10.1016/j.bbrc.2015.04.067; SKLYANKINA VA, 1990, EUR J BIOCHEM, V191, P195, DOI 10.1111/j.1432-1033.1990.tb19110.x; Standish AJ, 2013, BIOCHEM BIOPH RES CO, V430, P167, DOI 10.1016/j.bbrc.2012.11.049; Stano NM, 2006, NAT STRUCT MOL BIOL, V13, P458, DOI 10.1038/nsmb1078; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Young TW, 1998, MICROBIOL-SGM, V144, P2563, DOI 10.1099/00221287-144-9-2563	49	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152915	10.1371/journal.pone.0152915	http://dx.doi.org/10.1371/journal.pone.0152915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050298	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500066
J	Shi, XX; Yin, BS; Yang, P; Chen, H; Li, X; Su, LX; Fan, HG; Wang, HB				Shi, Xing-Xing; Yin, Bai-Shuang; Yang, Peng; Chen, Hao; Li, Xin; Su, Li-Xue; Fan, Hong-Gang; Wang, Hong-Bin			Xylazine Activates Adenosine Monophosphate-Activated Protein Kinase Pathway in the Central Nervous System of Rats	PLOS ONE			English	Article							AMP; ENERGY; PHOSPHORYLATION; RECEPTOR; PHARMACOKINETICS; INTOXICATION; DEPRIVATION; METABOLISM; UPSTREAM; KETAMINE	Xylazine is a potent analgesic extensively used in veterinary and animal experimentation. Evidence exists that the analgesic effect can be inhibited using adenosine 5'-monophosphate activated protein kinase (AMPK) inhibitors. Considering this idea, the aim of this study was to investigate whether the AMPK signaling pathway is involved in the central analgesic mechanism of xylazine in the rat. Xylazine was administrated via the intraperitoneal route. Sprague-Dawley rats were sacrificed and the cerebral cortex, cerebellum, hippocampus, thalamus and brainstem were collected for determination of liver kinase B1 (LKB1) and AMPK alpha mRNA expression using quantitative real-time polymerase chain reaction (qPCR), and phosphorylated LKB1 and AMPK alpha levels using western blot. The results of our study showed that compared with the control group, xylazine induced significant increases in AMPK activity in the cerebral cortex, hippocampus, thalamus and cerebellum after rats received xylazine (P < 0.01). Increased AMPK activities were accompanied with increased phosphorylation levels of LKB1 in corresponding regions of rats. The protein levels of phosphorylated LKB1 and AMPK alpha in these regions returned or tended to return to control group levels. However, in the brainstem, phosphorylated LKB1 and AMPK alpha protein levels were decreased by xylazine compared with the control (P < 0.05). In conclusion, our data indicates that xylazine alters the activities of LKB1 and AMPK in the central nervous system of rats, which suggests that xylazine affects the regulatory signaling pathway of the analgesic mechanism in the rat brain.	[Shi, Xing-Xing; Yang, Peng; Chen, Hao; Li, Xin; Su, Li-Xue; Fan, Hong-Gang; Wang, Hong-Bin] Northeast Agr Univ, Dept Vet Surg, Coll Vet Med, Harbin, Heilongjiang Pr, Peoples R China; [Yin, Bai-Shuang] Jilin Agr Sci & Technol Coll, Dept Vet Med, Jilin, Jilin Province, Peoples R China	Northeast Agricultural University - China	Wang, HB (corresponding author), Northeast Agr Univ, Dept Vet Surg, Coll Vet Med, Harbin, Heilongjiang Pr, Peoples R China.	hbwang1940@163.com			National Natural Science Foundation of China [31272617, 31472245, 31302150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China, grant numbers 31272617 and 31472245 (College of Veterinary Medicine, Northeast Agricultural University, HBW), and by the National Natural Science Foundation of China, grant number 31302150 (Department of Veterinary Medicine, Jilin Agriculture Science and Technology College, BSY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Bogdanov VB, 2015, BEHAV BRAIN RES, V281, P187, DOI 10.1016/j.bbr.2014.11.028; Cho KS, 2013, LIFE SCI, V92, P929, DOI 10.1016/j.lfs.2013.03.011; Daunt DA, 2002, VET CLIN N AM-EQUINE, V18, P39, DOI 10.1016/S0749-0739(02)00004-4; Delehant TM, 2003, VET THER, V4, P128; Doran GS, 2015, J CHROMATOGR B, V997, P81, DOI 10.1016/j.jchromb.2015.06.005; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Goodchild CS, 1996, BRIT J ANAESTH, V76, P544, DOI 10.1093/bja/76.4.544; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hoffmann U, 2001, J ANAL TOXICOL, V25, P245, DOI 10.1093/jat/25.4.245; Hu XY, 2016, COMP BIOCHEM PHYS B, V191, P146, DOI 10.1016/j.cbpb.2015.10.007; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim Sun Kwang, 2014, BMC Complement Altern Med, V14, P211, DOI 10.1186/1472-6882-14-211; Lei H, 2001, BRAIN RES, V913, P174, DOI 10.1016/S0006-8993(01)02786-X; Liangpunsakul S, 2009, ARCH BIOCHEM BIOPHYS, V485, P10, DOI 10.1016/j.abb.2009.02.006; Romero TRL, 2013, BRAIN RES, V1506, P58, DOI 10.1016/j.brainres.2013.02.030; Romero TRL, 2009, EUR J PHARMACOL, V608, P23, DOI 10.1016/j.ejphar.2009.02.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JQ, 2015, EXP CELL RES, V334, P194, DOI 10.1016/j.yexcr.2015.04.006; Mackenzie RWA, 2014, DIABETES METAB SYNDR, V7, P55, DOI 10.2147/DMSO.S48260; Park HG, 2011, PROG NEURO-PSYCHOPH, V35, P1933, DOI 10.1016/j.pnpbp.2011.09.008; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Price TJ, 2013, NEUROSCI LETT, V557, P9, DOI 10.1016/j.neulet.2013.06.060; Ruiz-Colon K, 2014, FORENSIC SCI INT, V240, P1, DOI 10.1016/j.forsciint.2014.03.015; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; SCHMITT H, 1974, NEUROPHARMACOLOGY, V13, P295, DOI 10.1016/0028-3908(74)90113-0; Seo JP, 2011, J VET SCI, V12, P281, DOI 10.4142/jvs.2011.12.3.281; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stillwell ME, 2003, FORENSIC SCI INT, V134, P25, DOI 10.1016/S0379-0738(03)00083-5; Sunkin SM, 2006, TRENDS GENET, V22, P211, DOI 10.1016/j.tig.2006.02.006; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; van Weenen JED, 2010, BIOCHEM PHARMACOL, V79, P1827, DOI 10.1016/j.bcp.2010.01.029; Veilleux-Lemieux D, 2013, J AM ASSOC LAB ANIM, V52, P567; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005	41	40	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153169	10.1371/journal.pone.0153169	http://dx.doi.org/10.1371/journal.pone.0153169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049320	Green Published, gold			2022-12-26	WOS:000373603500109
J	Suntharalingam, S; Stecker, FF; Guberina, N; Ringelstein, A; Schlosser, T; Theysohn, JM; Forsting, M; Nassenstein, K				Suntharalingam, Saravanabavaan; Stecker, Franz Ferdinand; Guberina, Nika; Ringelstein, Adrian; Schlosser, Thomas; Theysohn, Jens Matthias; Forsting, Michael; Nassenstein, Kai			How Much Is the Dose Varying between Follow-Up CT-Examinations Performed on the Same Scanner with the Same Imaging Protocol?	PLOS ONE			English	Article							DIAGNOSTIC REFERENCE LEVELS; TUBE VOLTAGE SELECTION; COMPUTED-TOMOGRAPHY; QUALITY; REDUCTION; OPTIMIZATION; ANGIOGRAPHY; STRATEGIES; IMPACT	Purpose To investigate the dose variation between follow-up CT examinations, when a patient is examined several times on the same scanner with the identical scan protocol which comprised automated exposure control. Material and Methods This retrospective study was approved by the local ethics committee. The volume computed tomography dose index (CTDIvol) and the dose-length-product (DLP) were recorded for 60 cancer patients (29 male, 31 female, mean age 60.1 years), who received 3 follow-up CT examinations each composed of a non-enhanced scan of the liver (LI-CT) and a contrast-enhanced scan of chest (CH-CT) and abdomen (AB-CT). Each examination was performed on the same scanner (Siemens Definition FLASH) equipped with automated exposure control (CARE Dose 4D and CARE KV) using the identical scan protocol. Results The median percentage difference in DLP between follow-up examinations was 9.6% for CH-CT, 10.3% for LI-CT, and 10.1% for AB-CT; the median percentage difference in CTDIvol 8.3% for CH-CT, 7.4% for LI-CT and 7.7% for AB-CT (p<0.0001 for all values). The maximum difference in DLP between follow-up examinations was 67.5% for CH-CT, 50.8% for LI-CT and 74.3% for AB-CT; the maximum difference in CTDIvol 62.9% for CH-CT, 47.2% for LI-CT, and 49% for AB-CT. Conclusion A significant variance in the radiation dose occurs between follow-up CT examinations when the same CT scanner and the identical imaging protocol are used in combination with automated exposure control.	[Suntharalingam, Saravanabavaan; Stecker, Franz Ferdinand; Guberina, Nika; Ringelstein, Adrian; Schlosser, Thomas; Theysohn, Jens Matthias; Forsting, Michael; Nassenstein, Kai] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany	University of Duisburg Essen	Suntharalingam, S (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	Saravanabavaan.Suntharalingam@uk-essen.de						Aldrich JE, 2006, CAN ASSOC RADIOL J, V57, P79; American Association of Physicists in Medicine (AAPM), 2011, REPORT AAPM TASK GRO; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Christner JA, 2010, AM J ROENTGENOL, V194, pW49, DOI 10.2214/AJR.09.2878; Dougeni E, 2012, EUR J RADIOL, V81, pE665, DOI 10.1016/j.ejrad.2011.05.025; Frellesen C, 2014, EUR RADIOL, V24, P1725, DOI 10.1007/s00330-014-3197-7; Harri PA, 2014, AM J ROENTGENOL, V203, P377, DOI 10.2214/AJR.13.11608; Hatziioannou K, 2003, BRIT J RADIOL, V76, P541, DOI 10.1259/bjr/60897046; Ibrahim M, 2014, AM J NEURORADIOL, V35, P619, DOI 10.3174/ajnr.A3473; Kaasalainen T, 2014, AM J ROENTGENOL, V203, P123, DOI 10.2214/AJR.13.12028; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; Koller CJ, 2003, BRIT J RADIOL, V76, P798, DOI 10.1259/bjr/33117342; Kordolaimi SD, 2013, J COMPUT ASSIST TOMO, V37, P924, DOI 10.1097/RCT.0b013e318282d95a; Krazinski AW, 2014, EUR RADIOL, V24, P2677, DOI 10.1007/s00330-014-3312-9; Lee EJ, 2009, AM J NEURORADIOL, V30, P1754, DOI 10.3174/ajnr.A1675; Lee S, 2011, ACTA RADIOL, V52, P1101, DOI 10.1258/ar.2011.100295; Marin JR, 2015, ACAD EMERG MED, V22, P1499, DOI 10.1111/acem.12822; McNitt-Gray MF, 2002, RADIOGRAPHICS, V22, P1541, DOI 10.1148/rg.226025128; Menke J, 2005, RADIOLOGY, V236, P565, DOI 10.1148/radiol.2362041327; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; NRCP National Council on Radiation Protection and Measurements, 2009, 160 NRCP; Raman SP, 2013, J AM COLL RADIOL, V10, P37, DOI 10.1016/j.jacr.2012.06.025; Russell MT, 2008, AM J NEURORADIOL, V29, P727, DOI 10.3174/ajnr.A0891; Schneider A, 2010, DTSCH ARZTEBL INT, V107, P776, DOI [10.3238/arztebl.2010.0799, 10.3238/arztebl.2010.0776]; Schueller-Weidekamm C, 2006, RADIOLOGY, V241, P899, DOI 10.1148/radiol.2413040128; Shrimpton PC, 2006, BRIT J RADIOL, V79, P968, DOI 10.1259/bjr/93277434; Tzedakis A, 2005, MED PHYS, V32, P1621, DOI 10.1118/1.1924309; Verdun FR, 2008, EUR RADIOL, V18, P1980, DOI 10.1007/s00330-008-0963-4; Winklehner A, 2015, EUR RADIOL, V25, P2346, DOI 10.1007/s00330-015-3632-4; Winklehner A, 2011, EUR RADIOL, V21, P2521, DOI 10.1007/s00330-011-2227-y	30	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152961	10.1371/journal.pone.0152961	http://dx.doi.org/10.1371/journal.pone.0152961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050659	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500072
J	Nicholson, KL; Arthur, SM; Horne, JS; Garton, EO; Del Vecchio, PA				Nicholson, Kerry L.; Arthur, Stephen M.; Horne, Jon S.; Garton, Edward O.; Del Vecchio, Patricia A.			Modeling Caribou Movements: Seasonal Ranges and Migration Routes of the Central Arctic Herd	PLOS ONE			English	Article							PETROLEUM DEVELOPMENT; RANGIFER-TARANDUS; WOODLAND CARIBOU; CALVING CARIBOU; MULE DEER; DYNAMICS; ALASKA; OIL; LANDSCAPE; PRODUCTIVITY	Migration is an important component of the life history of many animals, but persistence of large-scale terrestrial migrations is being challenged by environmental changes that fragment habitats and create obstacles to animal movements. In northern Alaska, the Central Arctic herd (CAH) of barren-ground caribou (Rangifer tarandus granti) is known to migrate over large distances, but the herd's seasonal distributions and migratory movements are not well documented. From 2003-2007, we used GPS radio-collars to determine seasonal ranges and migration routes of 54 female caribou from the CAH. We calculated Brownian bridges to model fall and spring migrations for each year and used the mean of these over all 4 years to identify areas that were used repeatedly. Annual estimates of sizes of seasonal ranges determined by 90% fixed kernel utilization distributions were similar between summer and winter ((X) over bar = 27,929 SE = 1,064 and (X) over bar = 26,585 SE = 4912 km(2), respectively). Overlap between consecutive summer and winter ranges varied from 3.3-18.3%. Percent overlap between summer ranges used during consecutive years ((X) over bar = 62.4% SE = 3.7%) was higher than for winter ranges ((X) over bar = 42.8% SE = 5.9%). Caribou used multiple migration routes each year, but some areas were used by caribou during all years, suggesting that these areas should be managed to allow for continued utilization by caribou. Restoring migration routes after they have been disturbed or fragmented is challenging. However, prior knowledge of movements and threats may facilitate maintenance of migratory paths and seasonal ranges necessary for long-term persistence of migratory species.	[Nicholson, Kerry L.; Horne, Jon S.; Garton, Edward O.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Nicholson, Kerry L.; Arthur, Stephen M.; Del Vecchio, Patricia A.] Alaska Dept Fish & Game, Div Wildlife Conservat, Fairbanks, AK USA; [Arthur, Stephen M.] US Fish & Wildlife Serv, Arctic Natl Wildlife Refuge, Fairbanks, AK USA; [Horne, Jon S.] Idaho Dept Fish & Game, Lewiston, ID USA; [Del Vecchio, Patricia A.] 1580 Ivans Alley, Fairbanks, AK USA	Idaho; University of Idaho; Alaska Department of Fish & Game; United States Department of the Interior; US Fish & Wildlife Service	Nicholson, KL (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.; Nicholson, KL (corresponding author), Alaska Dept Fish & Game, Div Wildlife Conservat, Fairbanks, AK USA.	kerry.nicholson@alaska.gov	Arthur, Stephen/AAP-1708-2021; Arthur, Stephen/GPX-2624-2022; Nicholson, Kerry/F-2077-2013	Nicholson, Kerry/0000-0001-9951-9897	U.S. Bureau of Land Management; Alaska Department of Fish and Game through Federal Aid in Wildlife Restoration Projects [3.46, 3.49]; National Institute of General Medical Sciences of the National Institutes of Health [P30 GM103324]; Bureau of Land Management ARRA [L10AC16256]; ConocoPhillips-Alaska, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103324] Funding Source: NIH RePORTER	U.S. Bureau of Land Management; Alaska Department of Fish and Game through Federal Aid in Wildlife Restoration Projects; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bureau of Land Management ARRA; ConocoPhillips-Alaska, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this study was provided by the U.S. Bureau of Land Management, ConocoPhillips-Alaska, Inc., and the Alaska Department of Fish and Game through Federal Aid in Wildlife Restoration Projects 3.46 and 3.49. Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P30 GM103324. Radiocollars were purchased by the Bureau of Land Management and U.S. Fish and Wildlife Service, and the U.S. National Park Service provided logistical support for winter surveys and caribou captures. Support for JSH was provided by Bureau of Land Management ARRA agreement L10AC16256. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this study was provided by the U.S. Bureau of Land Management, ConocoPhillips-Alaska, Inc., and the Alaska Department of Fish and Game through Federal Aid in Wildlife Restoration Projects 3.46 and 3.49. Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P30 GM103324. Radiocollars were purchased by the Bureau of Land Management and U.S. Fish and Wildlife Service, and the U.S. National Park Service provided logistical support for winter surveys and caribou captures. Support for JSH was provided by Bureau of Land Management ARRA agreement L10AC16256. C. Beddingfield and A. Everts of the Alaska State Troopers provided housing and aircraft facilities for field crews. We are especially grateful for the expertise of net gunners B. Miner, J. Lawler, and M. Kienzler and pilots R. Swisher, T. Cambier, A. Einer, M. Webb, S. Hamilton, P. Zaczkowski, L. Larrivee, and D. Miller. We thank L. Adams, S. Brainerd, L. Parrett, B. Taras, and K. Whitten for reviewing earlier drafts of the manuscript.	Alcock J., 2001, ANIMAL BEHAV EVOLUTI, V7th ed.; Anderson TA, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00010.1; Arthur S. M., 2009, W275 AL DEP FISH GAM; Arthur Stephen M., 1999, Ursus, V11, P139; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Berger J, 2008, PLOS BIOL, V6, P1365, DOI 10.1371/journal.pbio.0060165; Bergerud A. T., 2008, RETURN CARIBOU UNGAV; BERGERUD AT, 1990, ANIM BEHAV, V39, P360, DOI 10.1016/S0003-3472(05)80882-6; BERGERUD AT, 1986, CAN J ZOOL, V64, P1515, DOI 10.1139/z86-226; Bergerud AT, 1974, IUCN PUBLICATIONS, V24; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Blake S, 2013, J ANIM ECOL, V82, P310, DOI 10.1111/1365-2656.12020; Boertje RD, 2000, RANGIFER, V12, P17; Bolger DT, 2008, ECOL LETT, V11, P63; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Cameron R. D., 1995, Rangifer, V15, P3; Cameron R.D., 2002, ARCTIC REFUGE COASTA, P38; Cameron RD, 2005, ARCTIC, V58, P1; CAMERON RD, 1992, ARCTIC, V45, P338; CAMERON RD, 1979, CAN FIELD NAT, V93, P155; CAMERON RD, 1993, CAN J ZOOL, V71, P480, DOI 10.1139/z93-069; CAMERON RD, 1979, J WILDLIFE MANAGE, V43, P626, DOI 10.2307/3808740; CARRUTHERS DR, 1987, CAN FIELD NAT, V101, P423; CARRUTHERS DR, 1987, WILDLIFE SOC B, V15, P414; Christianson D, 2009, OECOLOGIA, V158, P603, DOI 10.1007/s00442-008-1200-1; Cronin MA, 2000, WILDLIFE SOC B, V28, P919; DUQUETTE LS, 1988, ARCTIC, V41, P143; DUQUETTE LS, 1987, CAN J ZOOL, V65, P164, DOI 10.1139/z87-023; FANCY SG, 1989, CAN J ZOOL, V67, P644, DOI 10.1139/z89-093; Fancy Steven, 1986, THESIS U ALASKA FAIR; Ferguson MAD, 2000, J WILDLIFE MANAGE, V64, P168, DOI 10.2307/3802987; Ferguson SH, 2004, BASIC APPL ECOL, V5, P465, DOI 10.1016/j.baae.2004.04.011; Grovenburg TW, 2011, J MAMMAL, V92, P534, DOI 10.1644/09-MAMM-A-407.1; Gunn A, 1986, RANGIFER, V6, P151, DOI 10.7557/2.6.2.640; Haskell SP, 2006, ARCTIC, V59, P179; Hemming JE., 1971, ALASKA DEP FISH GAME; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Horne JS, 2006, J WILDLIFE MANAGE, V70, P641, DOI 10.2193/0022-541X(2006)70[641:LCVLSC]2.0.CO;2; Kelsall J. P., 1968, MIGRATORY BARREN GRO; Lenart EA, 2009, CARIBOU MANAGEMENT R, P299; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Mahoney SP, 2002, J MAMMAL, V83, P957, DOI 10.1644/1545-1542(2002)083<0957:LTCIDA>2.0.CO;2; McCabe, 2002, ARCTIC REFUGE COASTA, P8; McKinley, 2000, ALCES, V36, P93, DOI DOI 10.7557/2.6.2.582; Mose VN, 2013, ECOL MODEL, V254, P43, DOI 10.1016/j.ecolmodel.2013.01.016; Nellemann C, 1998, CAN J ZOOL, V76, P1425, DOI 10.1139/cjz-76-8-1425; Nicholson MC, 1997, J MAMMAL, V78, P483, DOI 10.2307/1382900; Nielson R.M., 2011, BBMM BROWNIAN BRIDGE; OOSENBRUG SM, 1980, ARCTIC, V33, P59; Parker GR, 1972, CANADIAN WILDLIFE SE, V20; Person BT, 2007, ARCTIC, V60, P238; Pruitt WO., 1959, ARCTIC, V12, P158, DOI [10.14430/arctic3723, DOI 10.14430/ARCTIC3723]; PULLIAINEN E, 1974, Naturaliste Canadien (Quebec), V101, P379; Rankin MA, 1985, CONTRIBUTIONS MARINE, V27, P1; RODGERS AR, 2007, HRT HOME RANGE TOOLS; Russell DE, 1992, CANADIAN WILDLIFE SE; Russell DE, 1993, RANGIFER, V8, P3; Saher D. J., 2005, THESIS U ALBERTA EDM; Sawyer H, 2005, WILDLIFE SOC B, V33, P1266, DOI 10.2193/0091-7648(2005)33[1266:MDAPMI]2.0.CO;2; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sinclair A.R.E., 1983, P240; Singh NJ, 2010, BIOL CONSERV, V143, P1770, DOI 10.1016/j.biocon.2010.04.026; Singh NJ, 2011, J APPL ECOL, V48, P35, DOI 10.1111/j.1365-2664.2010.01905.x; Skoog RO, 1968, THESIS U CALIFORNIA; Smith WT, 1994, ALASKA DEP FISH GAME, V12; Taillon J, 2012, BIOL CONSERV, V147, P163, DOI 10.1016/j.biocon.2011.12.027; Valkenburg P., 1983, Acta Zoologica Fennica, P125; WALKER DA, 1985, ARCTIC ALPINE RES, V17, P321, DOI 10.2307/1551021; WALKER MD, 1994, J VEG SCI, V5, P843, DOI 10.2307/3236198; WHITE R G, 1975, Biological Papers of the University of Alaska Special Report, V2, P151; WHITE RG, 1983, OIKOS, V40, P377, DOI 10.2307/3544310; Whitten K, 1980, P 2 INT REIND CAR S; WHITTEN KR, 1992, J WILDLIFE MANAGE, V56, P201, DOI 10.2307/3808814; WHITTEN KR, 1983, CAN FIELD NAT, V97, P143; Whitten KR, 1985, ARCTIC NATL WILDLIFE, P515; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Wolfe SA., 2000, THESIS U ALASKA FAIR	80	42	43	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0150333	10.1371/journal.pone.0150333	http://dx.doi.org/10.1371/journal.pone.0150333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045587	Green Submitted, gold, Green Published			2022-12-26	WOS:000373599600001
J	Hanif, MU; Capareda, SC; Iqbal, H; Arazo, RO; Baig, MA				Hanif, Muhammad Usman; Capareda, Sergio C.; Iqbal, Hamid; Ortiz Arazo, Renato; Baig, Muhammad Anwar			Effects of Pyrolysis Temperature on Product Yields and Energy Recovery from Co-Feeding of Cotton Gin Trash, Cow Manure, and Microalgae: A Simulation Study	PLOS ONE			English	Article							RICE BRAN OIL; BIO-OIL; THERMOCHEMICAL CONVERSION; BIOMASS; LIQUID; BIOFUELS; ETHANOL; WASTE	The intensive search of new and cleaner energy catches interest in recent years due to huge consumption of fossil fuels coupled with the challenge of energy and environmental sustainability. Production of renewable and environmentally benign energy from locally available raw materials is coming in the frontline. In this work, conversion of the combined biomass (cotton gin trash, cow manure, and Microalgae [Nannochloropsis oculata]) through batch pyrolysis has been investigated. The effect of temperature to the production of energy fuels such as bio-oil, char, and biogas have been simulated considering the yield and energy content as responses. Result of the investigation generally revealed that the proportions of the different biomass did not significantly affect the product yield and energy recovery. Significant effect of temperature is evident in the simulation result of energy recovery whereby maximum conversion was achieved at 400 degrees C for char (91 wt%), 600 degrees C for syngas (22 wt%), and 551 degrees C for bio-oil (48 wt%). Overall energy conversion efficiency of 75.5% was obtained at 589 degrees C in which 15.6 MJ/kg of mixed biomass will be elevated to pyrolysis products.	[Hanif, Muhammad Usman; Capareda, Sergio C.; Ortiz Arazo, Renato] Texas A&M Univ, Biol & Agr Engn Dept, BETA Lab, College Stn, TX 77843 USA; [Hanif, Muhammad Usman; Iqbal, Hamid; Baig, Muhammad Anwar] Natl Univ Sci & Technol, Sch Civil & Environm Engn, Inst Environm Sci & Engn, Sect H-12, Islamabad 46000, Pakistan; [Ortiz Arazo, Renato] Misamis Oriental State Coll Agr & Technol, Inst Engn & Technol, Northern Mindanao 9004, Philippines	Texas A&M University System; Texas A&M University College Station; National University of Sciences & Technology - Pakistan	Hanif, MU (corresponding author), Texas A&M Univ, Biol & Agr Engn Dept, BETA Lab, College Stn, TX 77843 USA.; Hanif, MU (corresponding author), Natl Univ Sci & Technol, Sch Civil & Environm Engn, Inst Environm Sci & Engn, Sect H-12, Islamabad 46000, Pakistan.	usman_hanif90@live.com	Arazo, Renato Ortiz/F-9465-2018; Capareda, Sergio C/C-5843-2015; Iqbal, Hamid/AAV-5062-2021	Arazo, Renato Ortiz/0000-0003-2524-0900; Capareda, Sergio C/0000-0003-4720-8098; 				Agblevor FA, 2006, RESOUR CONSERV RECY, V46, P198, DOI 10.1016/j.resconrec.2005.07.002; Asadullah M, 2007, FUEL, V86, P2514, DOI 10.1016/j.fuel.2007.02.007; Ates F, 2012, FUEL, V102, P681, DOI 10.1016/j.fuel.2012.05.051; Ben HX, 2013, FUEL, V103, P1148, DOI 10.1016/j.fuel.2012.08.039; Bhaskar T, 2011, BIOMASS BIOF BIOCHEM, P51; Biradar CH, 2014, FUEL, V119, P81, DOI 10.1016/j.fuel.2013.11.035; Bridgwater AV, 2012, BIOMASS BIOENERG, V38, P68, DOI 10.1016/j.biombioe.2011.01.048; Cao YC, 2012, ENVIRON PROT ENG, V38, P77, DOI 10.5277/epe120207; Capareda S., 2013, INTRO BIOMASS ENERGY; Capunitan JA, 2012, FUEL, V95, P563, DOI 10.1016/j.fuel.2011.12.029; Chutia RS, 2014, BIORESOURCE TECHNOL, V165, P336, DOI 10.1016/j.biortech.2014.03.118; Fonts I, 2012, RENEW SUST ENERG REV, V16, P2781, DOI 10.1016/j.rser.2012.02.070; Froilan Ludana A., 2007, THESIS TEXAS A M U; Huang HJ, 2013, J ANAL APPL PYROL, V102, P60, DOI 10.1016/j.jaap.2013.04.002; Jahirul MI, 2012, ENERGIES, V5, P4952, DOI 10.3390/en5124952; Kim SW, 2013, FUEL PROCESS TECHNOL, V108, P118, DOI 10.1016/j.fuproc.2012.05.002; Lin L, 2009, APPL ENERG, V86, P681, DOI 10.1016/j.apenergy.2008.06.002; Lopez-Urionabarrenechea A, 2012, APPL ENERG, V98, P524, DOI 10.1016/j.apenergy.2012.04.021; Maguyon MCC, 2013, ENERG CONVERS MANAGE, V76, P764, DOI 10.1016/j.enconman.2013.08.033; Manara P, 2012, RENEW SUST ENERG REV, V16, P2566, DOI 10.1016/j.rser.2012.01.074; Montoya JI, 2015, J ANAL APPL PYROL, V112, P379, DOI 10.1016/j.jaap.2014.11.007; Park HJ, 2010, BIORESOURCE TECHNOL, V101, pS83, DOI 10.1016/j.biortech.2009.06.103; Placido J, 2013, BIORESOURCE TECHNOL, V139, P203, DOI 10.1016/j.biortech.2013.04.012; Sinha S, 2008, ENERG CONVERS MANAGE, V49, P1248, DOI 10.1016/j.enconman.2007.08.010; Ward J, 2014, PROCEDIA ENGINEER, V90, P669, DOI 10.1016/j.proeng.2014.11.791; Yoder J, 2011, BIOMASS BIOENERG, V35, P1851, DOI 10.1016/j.biombioe.2011.01.026; Yuan XZ, 2011, BIORESOURCE TECHNOL, V102, P4104, DOI 10.1016/j.biortech.2010.12.055; Zabaniotou AA, 2000, J ANAL APPL PYROL, V56, P47, DOI 10.1016/S0165-2370(00)00088-7	28	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152230	10.1371/journal.pone.0152230	http://dx.doi.org/10.1371/journal.pone.0152230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043929	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100010
J	Liu, PP; Liu, J; Jiang, WQ; Carew, JS; Ogasawara, MA; Pelicano, H; Croce, CM; Estrov, Z; Xu, RH; Keating, MJ; Huang, P				Liu, P-P; Liu, J.; Jiang, W-Q; Carew, J. S.; Ogasawara, M. A.; Pelicano, H.; Croce, C. M.; Estrov, Z.; Xu, R-H; Keating, M. J.; Huang, P.			Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline	ONCOGENE			English	Article							LIPOPROTEIN-LIPASE EXPRESSION; PROGNOSTIC-FACTOR; CLL CELLS; SURVIVAL; METABOLISM; ENERGY; APOPTOSIS; GENES; MITOCHONDRIA; CARDIOLIPIN	Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western countries and is currently incurable due, in part, to difficulty in eliminating the leukemia cells protected by stromal microenvironment. Based on previous observations that CLL cells exhibit mitochondrial dysfunction and altered lipid metabolism and that carnitine palmitoyltransferases (CPT) have a major role in transporting fatty acid into mitochondria to support cancer cell metabolism, we tested several clinically relevant inhibitors of lipid metabolism for their ability to eliminate primary CLL cells. We discovered that perhexiline, an antiangina agent that inhibits CPT, was highly effective in killing CLL cells in stromal microenvironment at clinically achievable concentrations. These effective concentrations caused low toxicity to normal lymphocytes and normal stromal cells. Mechanistic study revealed that CLL cells expressed high levels of CPT1 and CPT2. Suppression of fatty acid transport into mitochondria by inhibiting CPT using perhexiline resulted in a depletion of cardiolipin, a key component of mitochondrial membranes, and compromised mitochondrial integrity, leading to rapid depolarization and massive CLL cell death. The therapeutic activity of perhexiline was further demonstrated in vivo using a CLL transgenic mouse model. Perhexiline significantly prolonged the overall animal survival by only four drug injections. Our study suggests that targeting CPT using an antiangina drug is able to effectively eliminate leukemia cells in vivo, and is a novel therapeutic strategy for potential clinical treatment of CLL.	[Liu, P-P; Jiang, W-Q; Xu, R-H; Huang, P.] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Liu, P-P; Liu, J.; Ogasawara, M. A.; Pelicano, H.; Huang, P.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, 2130 West Holcombe Blvd, Houston, TX 77030 USA; [Carew, J. S.] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA; [Croce, C. M.] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Estrov, Z.; Keating, M. J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	State Key Lab Oncology South China; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; Cleveland Clinic Foundation; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center	Huang, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, 2130 West Holcombe Blvd, Houston, TX 77030 USA.	phuang@mdanderson.org	jiang, wen/GYI-9662-2022; Young, Richard A/F-6495-2012; Xu, Rui-Hua/AAW-4766-2021	Young, Richard A/0000-0001-8855-8647; Xu, Rui-Hua/0000-0001-9771-8534; Liu, Jinyun/0000-0002-4763-2684	Natural Science Foundation of China [81430060]; National Institutes of Health [CA085563, CA172724]; CLL Global Research Foundation; NATIONAL CANCER INSTITUTE [R35CA197706, P01CA081534, R01CA085563, R01CA172724] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLL Global Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank BA Hayes and R LaPushin for their assistance in handling CLL samples. This work was supported, in part, by a grant from Natural Science Foundation of China ( No. 81430060), Grants CA085563 and CA172724 from the National Institutes of Health, and a grant for the CLL Global Research Foundation.	Abreu C, 2013, LEUKEMIA LYMPHOMA, V54, P1844, DOI 10.3109/10428194.2013.796057; Bilban M, 2006, LEUKEMIA, V20, P1080, DOI 10.1038/sj.leu.2404220; Bui T, 2006, CANCER CELL, V9, P419, DOI 10.1016/j.ccr.2006.05.012; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Carew JS, 2004, LEUKEMIA, V18, P1934, DOI 10.1038/sj.leu.2403545; Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; DeFilippis RA, 2012, CANCER DISCOV, V2, P826, DOI 10.1158/2159-8290.CD-12-0107; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Garber K, 2004, J NATL CANCER I, V96, P1805, DOI 10.1093/jnci/96.24.1805; Grdisa M, 2003, LEUKEMIA RES, V27, P951, DOI 10.1016/S0145-2126(03)00028-6; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hegde GV, 2008, MOL CANCER RES, V6, P1928, DOI 10.1158/1541-7786.MCR-08-0142; Heintel D, 2005, LEUKEMIA, V19, P1216, DOI 10.1038/sj.leu.2403748; Huang P, 2000, LEUKEMIA, V14, P1405, DOI 10.1038/sj.leu.2401845; Kaderi MA, 2011, HAEMATOL-HEMATOL J, V96, P1153, DOI 10.3324/haematol.2010.039396; Lagneaux L, 1998, BLOOD, V91, P2387, DOI 10.1182/blood.V91.7.2387.2387_2387_2396; Liu J, 2014, LEUKEMIA, V28, P118, DOI 10.1038/leu.2013.125; Lupu R, 2006, CURR PHARM BIOTECHNO, V7, P483, DOI 10.2174/138920106779116928; Moreno P, 2013, LEUKEMIA, V27, P721, DOI 10.1038/leu.2012.212; NAKAHARA I, 1992, J NEUROSURG, V76, P244, DOI 10.3171/jns.1992.76.2.0244; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nikitin EA, 2007, LEUKEMIA LYMPHOMA, V48, P912, DOI 10.1080/10428190701245112; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Nuckel H, 2006, LEUKEMIA LYMPHOMA, V47, P1053, DOI 10.1080/10428190500464161; OKAYASU T, 1985, ARCH BIOCHEM BIOPHYS, V236, P638, DOI 10.1016/0003-9861(85)90668-X; Olivecrona T, 1997, P NUTR SOC, V56, P723, DOI 10.1079/PNS19970072; Oltra AM, 2001, FREE RADICAL BIO MED, V30, P1286, DOI 10.1016/S0891-5849(01)00521-4; Oppezzo P, 2005, BLOOD, V106, P650, DOI 10.1182/blood-2004-08-3344; Pallasch CP, 2008, LEUKEMIA, V22, P585, DOI 10.1038/sj.leu.2405058; Pandey PR, 2012, RECENT PAT ANTI-CANC, V7, P185; Pedersen IM, 2004, LEUKEMIA LYMPHOMA, V45, P2365, DOI 10.1080/10428190412331272703; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Porpaczy E, 2013, LEUKEMIA RES, V37, P631, DOI 10.1016/j.leukres.2013.02.008; Preiss-Landl K, 2002, CURR OPIN LIPIDOL, V13, P471, DOI 10.1097/00041433-200210000-00002; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Ros S, 2012, CANCER DISCOV, V2, P328, DOI 10.1158/2159-8290.CD-11-0234; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; SINGLAS E, 1978, EUR J CLIN PHARMACOL, V14, P195, DOI 10.1007/BF02089960; Stamatopoulos B, 2012, HAEMATOL-HEMATOL J, V97, P608, DOI 10.3324/haematol.2011.052779; Taylor WA, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-9; Trachootham D, 2008, BLOOD, V112, P1912, DOI 10.1182/blood-2008-04-149815; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; van't Veer MB, 2006, HAEMATOLOGICA, V91, P56; Vasconcelos Y, 2005, LEUKEMIA, V19, P2002, DOI 10.1038/sj.leu.2403865; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Woyach JA, 2012, LEUKEMIA, V26, P1442, DOI 10.1038/leu.2011.375; Zhang W, 2012, NAT CELL BIOL, V14, P276, DOI 10.1038/ncb2432; Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512	51	42	44	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 27	2016	35	43					5663	5673		10.1038/onc.2016.103	http://dx.doi.org/10.1038/onc.2016.103			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XP	27065330	Green Accepted			2022-12-26	WOS:000386998300009
J	Dolezal, AG; Carrillo-Tripp, J; Miller, WA; Bonning, BC; Toth, AL				Dolezal, Adam G.; Carrillo-Tripp, Jimena; Miller, W. Allen; Bonning, Bryony C.; Toth, Amy L.			Intensively Cultivated Landscape and Varroa Mite Infestation Are Associated with Reduced Honey Bee Nutritional State	PLOS ONE			English	Article							DEFORMED WING VIRUS; DIVISION-OF-LABOR; JUVENILE-HORMONE; HABITAT LOSS; PROTEIN; POLLEN; VITELLOGENIN; HYMENOPTERA; INFECTIONS; DESTRUCTOR	As key pollinators, honey bees are crucial to many natural and agricultural ecosystems. An important factor in the health of honey bees is the availability of diverse floral resources. However, inmany parts of the world, high-intensity agriculture could result in a reduction in honey bee forage. Previous studies have investigated how the landscape surrounding honey bee hives affects some aspects of honey bee health, but to our knowledge there have been no investigations of the effects of intensively cultivated landscapes on indicators of individual bee health such as nutritional physiology and pathogen loads. Furthermore, agricultural landscapes in different regions vary greatly in forage and land management, indicating a need for additional information on the relationship between honey bee health and landscape cultivation. Here, we add to this growing body of information by investigating differences in nutritional physiology between honey bees kept in areas of comparatively low and high cultivation in an area generally high agricultural intensity in the Midwestern United States. We focused on bees collected directly before winter, because overwintering stress poses one of the most serious problems for honey bees in temperate climates. We found that honey bees kept in areas of lower cultivation exhibited higher lipid levels than those kept in areas of high cultivation, but this effect was observed only in colonies that were free of Varroa mites. Furthermore, we found that the presence of mites was associated with lower lipid levels and higher titers of deformed wing virus (DWV), as well as a non-significant trend towards higher overwinter losses. Overall, these results show that mite infestation interacts with landscape, obscuring the effects of landscape alone and suggesting that the benefits of improved foraging landscape could be lost without adequate control of mite infestations.	[Dolezal, Adam G.; Toth, Amy L.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Carrillo-Tripp, Jimena; Miller, W. Allen] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Bonning, Bryony C.; Toth, Amy L.] Iowa State Univ, Dept Entomol, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Dolezal, AG (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA.	adolezal@gmail.com			United Stated Department of Agriculture-Agriculture and Food Research Initiative [2011-04894]; Iowa State University Center for Virus-Insect Interactions (CVII)	United Stated Department of Agriculture-Agriculture and Food Research Initiative; Iowa State University Center for Virus-Insect Interactions (CVII)	Funded by United Stated Department of Agriculture-Agriculture and Food Research Initiative #2011-04894 and Iowa State University Center for Virus-Insect Interactions (CVII). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Aronstein K, 2012, AM BEE J, V152, P789; Basualdo M, 2013, J ECON ENTOMOL, V106, P1553, DOI 10.1603/EC12466; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Bond J, 2014, EC RES SERVICE SITUA; Bowen-Walker PL, 2001, ENTOMOL EXP APPL, V101, P207, DOI 10.1023/A:1019254727879; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Caron D, 2011, AM BEE J, V151, P73; Carrillo-Tripp J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22265; Claassen R., 2011, 120 USDA EC RES SERV; Couvillon MJ, 2014, CURR BIOL, V24, P1212, DOI 10.1016/j.cub.2014.03.072; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1989, J INSECT PHYSIOL, V35, P595, DOI 10.1016/0022-1910(89)90121-2; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; De Jong D, 2009, J APICULT RES, V48, P34, DOI 10.3896/IBRA.1.48.1.08; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; DeGrandi-Hoffman G, 2015, CURR OPIN INSECT SCI, V10, P170, DOI 10.1016/j.cois.2015.05.007; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Doke MA, 2015, CURR OPIN INSECT SCI, V10, P185, DOI 10.1016/j.cois.2015.05.014; Donkersley P, 2014, ECOL EVOL, V4, P4195, DOI 10.1002/ece3.1293; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; Gallant AL, 2007, COPEIA, P967, DOI 10.1643/0045-8511(2007)7[967:GROHLA]2.0.CO;2; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hartzler RG, 2010, CROP PROT, V29, P1542, DOI 10.1016/j.cropro.2010.07.018; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hou CS, 2014, VIRUSES-BASEL, V6, P2012, DOI 10.3390/v6052012; Klowden M.J., 2007, PHYSL SYSTEMS INSECT; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; Lee K, 2010, AM BEE J, V150, P1151; Locke B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099998; Mattila HR, 2001, INSECT SOC, V48, P88, DOI 10.1007/PL00001764; Munch D, 2010, FEBS LETT, V584, P2496, DOI 10.1016/j.febslet.2010.04.007; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Nilsen KA, 2011, J EXP BIOL, V214, P1488, DOI 10.1242/jeb.050393; Odoux JF, 2014, J APICULT RES, V53, P57, DOI 10.3896/IBRA.1.53.1.05; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sande SO, 2009, BIOL CONSERV, V142, P2703, DOI 10.1016/j.biocon.2009.06.023; Schmehl DR, 2014, J INSECT PHYSIOL, V71, P177, DOI 10.1016/j.jinsphys.2014.10.002; SCHMIDT JO, 1987, ANN ENTOMOL SOC AM, V80, P176, DOI 10.1093/aesa/80.2.176; SEELEY TD, 1985, ECOL ENTOMOL, V10, P81, DOI 10.1111/j.1365-2311.1985.tb00537.x; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Sponsler DB, 2015, PEERJ, V3, DOI 10.7717/peerj.838; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wang Y, 2012, J EXP BIOL, V215, P124, DOI 10.1242/jeb.060889; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x	62	38	41	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153531	10.1371/journal.pone.0153531	http://dx.doi.org/10.1371/journal.pone.0153531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070422	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700077
J	Yetman, MJ; Fowler, SW; Jankowsky, JL				Yetman, Michael J.; Fowler, Stephanie W.; Jankowsky, Joanna L.			Humanized Tau Mice with Regionalized Amyloid Exhibit Behavioral Deficits but No Pathological Interaction	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; TRANSGENIC MICE; A-BETA; ANIMAL-MODELS; NEUROFIBRILLARY TANGLES; CASCADE HYPOTHESIS; GENETIC MODULATION; KNOCKOUT MICE; SYNAPSE LOSS	Alzheimer's disease (AD) researchers have struggled for decades to draw a causal link between extracellular A beta aggregation and intraneuronal accumulation of microtubule-associated protein tau. The amyloid cascade hypothesis posits that A beta deposition promotes tau hyperphosphorylation, tangle formation, cell loss, vascular damage, and dementia. While the genetics of familial AD and the pathological staging of sporadic disease support this sequence of events, attempts to examine the molecular mechanism in transgenic animal models have largely relied on models of other inherited tauopathies as the basis for testing the interaction with A beta. In an effort to more accurately model the relationship between A beta and wild-type tau in AD, we intercrossed mice that overproduce human A beta with a tau substitution model in which all 6 isoforms of the human protein are expressed in animals lacking murine tau. We selected an amyloid model in which pathology was biased towards the entorhinal region so that we could further examine whether the anticipated changes in tau phosphorylation occurred at the site of A beta deposition or in synaptically connected regions. We found that A beta and tau had independent effects on locomotion, learning, and memory, but found no behavioral evidence for an interaction between the two transgenes. Moreover, we saw no indication of amyloid-induced changes in the phosphorylation or aggregation of human tau either within the entorhinal area or elsewhere. These findings suggest that robust amyloid pathology within the medial temporal lobe has little effect on the metabolism of wild type human tau in this model.	[Yetman, Michael J.; Fowler, Stephanie W.; Jankowsky, Joanna L.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Jankowsky, Joanna L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Jankowsky, Joanna L.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Jankowsky, JL (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Jankowsky, JL (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.; Jankowsky, JL (corresponding author), Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA.	jankowsk@bcm.edu		Fowler, Stephanie/0000-0002-0785-4274	NIH training grant [T32 AG000183]; NATIONAL INSTITUTE ON AGING [T32AG000183] Funding Source: NIH RePORTER	NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH training grant T32 AG000183 (MJY) and by a gift from the Robert A. and Rene E. Belfer Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bailey RM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-8; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braidy N, 2015, CURR OPIN PSYCHIATR, V28, P155, DOI 10.1097/YCO.0000000000000137; Brich J, 2003, J NEUROSCI, V23, P187; Chabrier MA, 2014, NEUROBIOL DIS, V64, P107, DOI 10.1016/j.nbd.2014.01.007; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Coomaraswamy J, 2010, P NATL ACAD SCI USA, V107, P7969, DOI 10.1073/pnas.1001056107; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014; Fowler SW, 2014, J NEUROSCI, V34, P7871, DOI 10.1523/JNEUROSCI.0572-14.2014; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Guo QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080706; Hanes J, 2009, J NEUROCHEM, V108, P1167, DOI 10.1111/j.1471-4159.2009.05869.x; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikegami S, 2000, NEUROSCI LETT, V279, P129, DOI 10.1016/S0304-3940(99)00964-7; Janke C, 1999, MOL BRAIN RES, V68, P119, DOI 10.1016/S0169-328X(99)00079-0; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Kelleher I, 2007, J NEUROCHEM, V103, P2256, DOI 10.1111/j.1471-4159.2007.04930.x; KOWALL NW, 1992, NEUROBIOL AGING, V13, P537, DOI 10.1016/0197-4580(92)90053-Z; Lei P, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-29; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li ZY, 2014, NEUROBIOL AGING, V35, P2617, DOI 10.1016/j.neurobiolaging.2014.05.001; Ma QL, 2014, J NEUROSCI, V34, P7124, DOI 10.1523/JNEUROSCI.3439-13.2014; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Matsuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031152; Morris M, 2013, NEUROBIOL AGING, V34, P1523, DOI 10.1016/j.neurobiolaging.2012.12.003; Morris M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029257; Oddo S, 2007, J NEUROCHEM, V102, P1053, DOI 10.1111/j.1471-4159.2007.04607.x; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Pooler AM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0199-x; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sigurdsson EM, 1997, J NEUROPATH EXP NEUR, V56, P714; Sigurdsson EM, 1996, NEUROBIOL AGING, V17, P893, DOI 10.1016/S0197-4580(96)00169-8; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035; Yetman MJ, 2016, BRAIN STRUCT FUNCT, V221, P2231, DOI 10.1007/s00429-015-1040-9; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zou K, 2003, J NEUROCHEM, V87, P609, DOI 10.1046/j.1471-4159.2003.02018.x	61	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153724	10.1371/journal.pone.0153724	http://dx.doi.org/10.1371/journal.pone.0153724			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070146	Green Published, gold			2022-12-26	WOS:000373900700083
J	Schmidt, C; Pester, B; Schmid-Hertel, N; Witte, H; Wismuller, A; Leistritz, L				Schmidt, Christoph; Pester, Britta; Schmid-Hertel, Nicole; Witte, Herbert; Wismueller, Axel; Leistritz, Lutz			A Multivariate Granger Causality Concept towards Full Brain Functional Connectivity	PLOS ONE			English	Article							NETWORKS; MODELS	Detecting changes of spatially high-resolution functional connectivity patterns in the brain is crucial for improving the fundamental understanding of brain function in both health and disease, yet still poses one of the biggest challenges in computational neuroscience. Currently, classical multivariate Granger Causality analyses of directed interactions between single process components in coupled systems are commonly restricted to spatially low-dimensional data, which requires a pre-selection or aggregation of time series as a preprocessing step. In this paper we propose a new fully multivariate Granger Causality approach with embedded dimension reduction that makes it possible to obtain a representation of functional connectivity for spatially high-dimensional data. The resulting functional connectivity networks may consist of several thousand vertices and thus contain more detailed information compared to connectivity networks obtained from approaches based on particular regions of interest. Our large scale Granger Causality approach is applied to synthetic and resting state fMRI data with a focus on how well network community structure, which represents a functional segmentation of the network, is preserved. It is demonstrated that a number of different community detection algorithms, which utilize a variety of algorithmic strategies and exploit topological features differently, reveal meaningful information on the underlying network module structure.	[Schmidt, Christoph; Pester, Britta; Witte, Herbert; Leistritz, Lutz] Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Jena, Germany; [Schmid-Hertel, Nicole] Univ Jena, Jena Univ Hosp, Inst Anat 1, Jena, Germany; [Wismueller, Axel] Univ Rochester, Med Ctr, Dept Biomed Engn, Dept Imaging Sci, Rochester, NY 14642 USA	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Rochester	Pester, B (corresponding author), Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Jena, Germany.	Britta.Pester@med.uni-jena.de		Schmidt, Christoph/0000-0002-5442-551X	Federal Ministry of Education and Research (Germany) [01GQ1202]; NIH (USA) [1R01DA034977-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034977] Funding Source: NIH RePORTER	Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); NIH (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the grant 01GQ1202 of the Federal Ministry of Education and Research (Germany), as well as by the NIH grant 1R01DA034977-01 (USA).	Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Dasgupta S., 2006, ALGORITHMS; Dongen  S., 2000, PERFORMANCE CRITERIA; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Fleiss, 1981, MEASUREMENT INTERRAT, P223; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Garg R, 2011, NEUROIMAGE, V58, P416, DOI 10.1016/j.neuroimage.2011.02.074; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hemmelmann D, 2009, NEUROIMAGE, V45, P722, DOI 10.1016/j.neuroimage.2008.12.065; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Khalid A, 2014, NEUROIMAGE, V101, P351, DOI 10.1016/j.neuroimage.2014.07.040; Lee H, 2012, IEEE T MED IMAGING, V31, P2267, DOI 10.1109/TMI.2012.2219590; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Leistritz L, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0616; Leistritz L, 2013, PLOS ONE, P8; Leistritz L, 2016, P IEEE, V104, P262, DOI 10.1109/JPROC.2015.2497144; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liitkepohl H, 2007, NEW INTRO MULTIPLE T; Londei Alessandro, 2006, Cogn Process, V7, P42, DOI 10.1007/s10339-005-0019-5; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Pester B, 2013, BIOMEDICAL ENG; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Schelter B, 2006, J NEUROSCI METH, V152, P210, DOI 10.1016/j.jneumeth.2005.09.001; Schmidt C, 2014, IEEE ENG MED BIO, P2797, DOI 10.1109/EMBC.2014.6944204; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; Valdes-Sosa PA, 2004, NEUROINFORMATICS, V2, P239, DOI 10.1385/NI:2:2:239; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Warrens MJ, 2008, J CLASSIF, V25, P177, DOI 10.1007/s00357-008-9023-7; Zhou ZY, 2009, BRAIN RES, V1289, P22, DOI 10.1016/j.brainres.2009.06.096	45	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153105	10.1371/journal.pone.0153105	http://dx.doi.org/10.1371/journal.pone.0153105			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064897	Green Submitted, Green Published, gold			2022-12-26	WOS:000373891000031
J	Howcroft, J; Lemaire, ED; Kofman, J				Howcroft, Jennifer; Lemaire, Edward D.; Kofman, Jonathan			Wearable-Sensor-Based Classification Models of Faller Status in Older Adults	PLOS ONE			English	Article							LOCAL DYNAMIC STABILITY; MULTIVARIATE TIME-SERIES; GAIT STABILITY; RISK-ASSESSMENT; ACCELERATION PATTERNS; SPACE RECONSTRUCTION; NETWORK ANALYSIS; COMPLEX NETWORK; WALKING; VARIABILITY	Wearable sensors have potential for quantitative, gait-based, point-of-care fall risk assessment that can be easily and quickly implemented in clinical-care and older-adult living environments. This investigation generated models for wearable-sensor based fall-risk classification in older adults and identified the optimal sensor type, location, combination, and modelling method; for walking with and without a cognitive load task. A convenience sample of 100 older individuals (75.5 +/- 6.7 years; 76 non-fallers, 24 fallers based on 6 month retrospective fall occurrence) walked 7.62 m under single-task and dual-task conditions while wearing pressure-sensing insoles and tri-axial accelerometers at the head, pelvis, and left and right shanks. Participants also completed the Activities-specific Balance Confidence scale, Community Health Activities Model Program for Seniors questionnaire, six minute walk test, and ranked their fear of falling. Fall risk classification models were assessed for all sensor combinations and three model types: multi-layer perceptron neural network, naive Bayesian, and support vector machine. The best performing model was a multi-layer perceptron neural network with input parameters from pressure-sensing insoles and head, pelvis, and left shank accelerometers (accuracy = 84%, F1 score = 0.600, MCC score = 0.521). Head sensor-based models had the best performance of the single-sensor models for single-task gait assessment. Single-task gait assessment models outperformed models based on dual-task walking or clinical assessment data. Support vector machines and neural networks were the best modelling technique for fall risk classification. Fall risk classification models developed for point-of-care environments should be developed using support vector machines and neural networks, with a multi-sensor single-task gait assessment.	[Howcroft, Jennifer; Kofman, Jonathan] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada; [Lemaire, Edward D.] Ottawa Hosp, Res Inst, Ctr Rehabil Res & Dev, Ottawa, ON, Canada; [Lemaire, Edward D.] Univ Ottawa, Fac Med, Ottawa, ON, Canada	University of Waterloo; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Lemaire, ED (corresponding author), Ottawa Hosp, Res Inst, Ctr Rehabil Res & Dev, Ottawa, ON, Canada.; Lemaire, ED (corresponding author), Univ Ottawa, Fac Med, Ottawa, ON, Canada.	elemaire@toh.ca		Lemaire, Edward/0000-0003-4693-2623	Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Ministry of Training, Colleges and Universities; University of Waterloo	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Training, Colleges and Universities; University of Waterloo	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC); the Ontario Ministry of Training, Colleges and Universities; and the University of Waterloo.	ASHLEY M J, 1977, Age and Ageing, V6, P211, DOI 10.1093/ageing/6.4.211; Beauchet O, 2008, GERONTOLOGY, V54, P217, DOI 10.1159/000127318; Biswas A, 2008, J BIOMECH, V41, P1574, DOI 10.1016/j.jbiomech.2008.02.009; Bootsma-van der Wiel A, 2003, J AM GERIATR SOC, V51, P1466, DOI 10.1046/j.1532-5415.2003.51468.x; Caby B, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-1; Egret CI, 2003, INT J SPORTS MED, V24, P465; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Giansanti D, 2009, TELEMED J E-HEALTH, V15, P296, DOI 10.1089/tmj.2008.0106; Greene BR, 2014, PHYSIOL MEAS, V35, P2053, DOI 10.1088/0967-3334/35/10/2053; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hausdorff JM, 2008, J GERONTOL A-BIOL, V63, P1335, DOI 10.1093/gerona/63.12.1335; Hens AB, 2012, EXPERT SYST APPL, V39, P6774, DOI 10.1016/j.eswa.2011.12.057; Hou FZ, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/58001; Howcroft J, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-91; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; Kendell C, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-24; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kojima M, 2008, J PHYS THER SCI, V20, P243, DOI 10.1589/jpts.20.243; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lamoth CJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-2; Latt MD, 2009, J GERONTOL A-BIOL, V64, P700, DOI 10.1093/gerona/glp009; Lee RYW, 2011, AGE AGEING, V40, P690, DOI [10.1093/ageing/afr050, 10.1155/2011/653570]; Lehnertz K, 2014, PHYSICA D, V267, P7, DOI 10.1016/j.physd.2013.06.009; Li X, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.062901; Liu C, 2010, PHYSICA A, V389, P2675, DOI 10.1016/j.physa.2010.02.043; Liu J, 2008, IEEE T AUTOM SCI ENG, V5, P696, DOI 10.1109/TASE.2008.923821; Marschollek M, 2011, METHOD INFORM MED, V50, P420, DOI 10.3414/ME10-01-0040; Martin FC, 2011, CAN J AGING, V30, P33, DOI 10.1017/S0714980810000747; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Montero-Odasso M, 2014, J GERONTOL A-BIOL, V69, P1415, DOI 10.1093/gerona/glu155; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Rao SS, 2005, AM FAM PHYSICIAN, V72, P81; Rende B, 2002, NEUROPSYCHOLOGY, V16, P309, DOI 10.1037//0894-4105.16.3.309; Rispens SM, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.3931; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Siggiridou E, 2014, SENSORS-BASEL, V14, P12585, DOI 10.3390/s140712585; SMIDT GL, 1971, AMER J PHYSICAL MED, V50, P285; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126, DOI 10.1097/00005768-200107000-00010; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; Van Rijsbergen C, 1980, INFORM RETRIEVAL; van Schooten KS, 2015, J GERONTOL A-BIOL, V70, P608, DOI 10.1093/gerona/glu225; van Schooten KS, 2013, J BIOMECH, V46, P137, DOI 10.1016/j.jbiomech.2012.10.032; Weiss A, 2013, NEUROREHAB NEURAL RE, V27, P742, DOI 10.1177/1545968313491004; Winter DA., 1987, BIOMECHANICS MOTOR C; YACK HJ, 1993, J GERONTOL, V48, pM225, DOI 10.1093/geronj/48.5.M225; Zanin M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00630	52	40	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153240	10.1371/journal.pone.0153240	http://dx.doi.org/10.1371/journal.pone.0153240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054878	Green Published, gold			2022-12-26	WOS:000373608000110
J	Kundacina, N; Shi, MH; Pollack, GH				Kundacina, Nenad; Shi, Minghui; Pollack, Gerald H.			Effect of Local and General Anesthetics on Interfacial Water	PLOS ONE			English	Article							HYPOTHESIS	Background Water undergoes structural change as it interfaces with hydrophilic surfaces, including the many hydrophilic surfaces within the cell. This interfacial water has become known as "Exclusion Zone (EZ) water" or "fourth-phase water" [ 1]. Methods We tested the hypothesis that anesthetics diminish the amount of EZ water, and that this change may correlate with functional changes in anesthesia. By using the local anesthetics Lidocaine and Bupivacaine as well as a general inhalational anesthetic, Isoflurane, we tracked the EZ size as these anesthetics were introduced. Results All three anesthetics diminished EZ size in a concentration-dependent manner at concentrations of 0.18 mM and greater for Bupivacaine, 0.85 mM and greater for Lidocaine, and 0.2% for Isoflurane. At extremely low (micromolar) concentrations, however, all three anesthetics increased EZ size. Conclusions The sharp increase of EZ size associated with micromolar anesthetic concentrations follows a similar pattern to induction of general anesthesia, from the excitation stage (Stage II) to the depression and overdose stages of surgical anesthesia (Stages III and IV). The results are consistent with the hypothesis that anesthetics may act on water, a fundamental organizational component common to all cells.	[Kundacina, Nenad; Shi, Minghui; Pollack, Gerald H.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Pollack, Gerald H.] Univ Washington, Box 355061, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kundacina, N (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	nenadkundacina1@gmail.com			NIH [5 R01 GM093842]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093842] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Transformative Grant 5 R01 GM093842, Website: http://www.nih.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the advice of Philippe Housmans, Stuart Hameroff, and Walter Folger in the preparation and execution of this work, and support from NIH Transformative Grant 5 R01 GM093842.	Franks NP, NATURE, V300, P487; GIANELLY R, 1967, NEW ENGL J MED, V277, P1215, DOI 10.1056/NEJM196712072772301; KATOH T, 1992, BRIT J ANAESTH, V69, P259, DOI 10.1093/bja/69.3.259; Keil RL, 1996, MOL CELL BIOL, V16, P3446; Koblin DD, ANESTH ANALG, V79, P1043; Meyer H.H., 1899, ARCH EXP PATHOL PH, V42, P111; MILLER KW, 1973, MOL PHARMACOL, V9, P131; Overton C. E., 1901, STUDIEN NARKOSE ZUGL; Pauling L., SCIENCE, V7, P15; Pollack G., 2013, EDGESCIENCE; Pollack G.H., 2001, CELLS GELS ENGINES L; Rajaram S, 1999, GENETICS, V153, P1673; REYNOLDS F, 1971, BRIT J ANAESTH, V43, P567, DOI 10.1093/bja/43.6.567; Wang HJ, 2013, J PHYS CHEM B, V117, P12007, DOI 10.1021/jp407115j; Ypma RE, 2015, UNDERSEA HYPERBAR M, V42, P257; Zheng J, ADV COLLOID INTERFAC, V127, P19	16	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152127	10.1371/journal.pone.0152127	http://dx.doi.org/10.1371/journal.pone.0152127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054588	gold, Green Published, Green Submitted			2022-12-26	WOS:000373608000012
J	Liu, Y; Li, XM; Xie, C; Luo, XZ; Bao, YG; Wu, B; Hu, YC; Zhong, Z; Liu, C; Li, MJ				Liu, Yan; Li, Xuemei; Xie, Chen; Luo, Xiuzhen; Bao, Yonggang; Wu, Bin; Hu, Yuchi; Zhong, Zhong; Liu, Chang; Li, MinJie			Prevention Effects and Possible Molecular Mechanism of Mulberry Leaf Extract and its Formulation on Rats with Insulin-Insensitivity	PLOS ONE			English	Article							MORUS-ALBA L.; OXIDATIVE STRESS; IN-VIVO; GLUCOSE; DIET; EXPRESSION; 4-HYDROXYISOLEUCINE; STREPTOZOTOCIN; LIPOGENESIS; ADIPOCYTES	For centuries, mulberry leaf has been used in traditional Chinese medicine for the treatment of diabetes. This study aims to test the prevention effects of a proprietary mulberry leaf extract (MLE) and a formula consisting of MLE, fenugreek seed extract, and cinnamon cassia extract (MLEF) on insulin resistance development in animals. MLE was refined to contain 5% 1-deoxynojirimycin by weight. MLEF was formulated by mixing MLE with cinnamon cassia extract and fenugreek seed extract at a 6:5:3 ratio (by weight). First, the acute toxicity effects of MLE on ICR mice were examined at 5 g/kg BW dose. Second, two groups of normal rats were administrated with water or 150 mg/kg BW MLE per day for 29 days to evaluate MLE's effect on normal animals. Third, to examine the effects of MLE and MLEF on model animals, sixty SD rats were divided into five groups, namely, (1) normal, (2) model, (3) high-dose MLE (75 mg/kg BW) treatment; (4) low-dose MLE (15 mg/kg BW) treatment; and (5) MLEF (35 mg/kg BW) treatment. On the second week, rats in groups (2)-(5) were switched to high-energy diet for three weeks. Afterward, the rats were injected (ip) with a single dose of 105 mg/kg BW alloxan. After four more days, fasting blood glucose, post-prandial blood glucose, serum insulin, cholesterol, and triglyceride levels were measured. Last, liver lysates from animals were screened with 650 antibodies for changes in the expression or phosphorylation levels of signaling proteins. The results were further validated by Western blot analysis. We found that the maximum tolerance dose of MLE was greater than 5 g/kg in mice. The MLE at a 150 mg/kg BW dose showed no effect on fast blood glucose levels in normal rats. The MLE at a 75 mg/kg BW dose and MLEF at a 35 mg/kg BW dose, significantly (p < 0.05) reduced fast blood glucose levels in rats with impaired glucose and lipid metabolism. In total, 34 proteins with significant changes in expression and phosphorylation levels were identified. The changes of JNK, IRS1, and PDK1 were confirmed by western blot analysis. In conclusion, this study demonstrated the potential protective effects of MLE and MLEF against hyperglycemia induced by high-energy diet and toxic chemicals in rats for the first time. The most likely mechanism is the promotion of IRS1 phosphorylation, which leads to insulin sensitivity restoration.	[Liu, Yan; Li, MinJie] Res & Dev Ctr Amway China, Shanghai, Peoples R China; [Li, Xuemei; Hu, Yuchi] Beijing Ctr Hlth Food & Cosmet Control, Beijing Inst Drug Control, Beijing, Peoples R China; [Zhong, Zhong] Bot Century Beijing Co Ltd, Beijing, Peoples R China; [Bao, Yonggang] Beijing Pepnoch Co Ltd, Beijing, Peoples R China; [Xie, Chen; Luo, Xiuzhen; Wu, Bin; Liu, Chang] Chinese Acad Med Sci, Inst Med Plant Dev, 151 Malianwa North Rd, Beijing 100193, Peoples R China; [Xie, Chen; Luo, Xiuzhen; Wu, Bin; Liu, Chang] Peking Union Med Coll, 151 Malianwa North Rd, Beijing 100193, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, MJ (corresponding author), Res & Dev Ctr Amway China, Shanghai, Peoples R China.; Liu, C (corresponding author), Peking Union Med Coll, 151 Malianwa North Rd, Beijing 100193, Peoples R China.	cliu@implad.ac.cn; Liz.Li@amway.com	Liu, Chang/A-1148-2014		Botanic Century (Beijing) Co., Ltd.	Botanic Century (Beijing) Co., Ltd.	The authors YL and MJL are paid employees of Amway, China. The author YGB is a paid employee of Beijing Pepnoch Co., Ltd. The author Zhong Zhong is a paid employee of Botanic Century (Beijing) Co., Ltd. The funder provided support in the form of salaries for authors (YL, YGB, ZZ and MJL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andallu B, 2007, J MED FOOD, V10, P41, DOI 10.1089/jmf.2005.034; Andallu B, 2001, CLIN CHIM ACTA, V314, P47, DOI 10.1016/S0009-8981(01)00632-5; [Anonymous], 2012, METH EV ASS ANT FUNC; Bouderba S, 2014, J DIABETES, V6, P184, DOI 10.1111/1753-0407.12083; Broca C, 1999, AM J PHYSIOL-ENDOC M, V277, pE617, DOI 10.1152/ajpendo.1999.277.4.E617; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Fritsche L, 2008, CURR MED CHEM, V15, P1316, DOI 10.2174/092986708784534956; Jaiswal N, 2012, EUR J NUTR, V51, P893, DOI 10.1007/s00394-012-0374-9; Kimura T, 2007, J AGR FOOD CHEM, V55, P5869, DOI 10.1021/jf062680g; Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392; Lee YJ, 2011, AM J CHINESE MED, V39, P39, DOI 10.1142/S0192415X11008634; Leiter Edward H, 2013, Curr Protoc Mouse Biol, V3, P9; Lim HH, 2013, EXP BIOL MED, V238, P1160, DOI 10.1177/1535370213498982; Liu YN, 2014, NUTR RES, V34, P450, DOI 10.1016/j.nutres.2014.04.007; Lu ZL, 2011, PHYTOMEDICINE, V18, P298, DOI 10.1016/j.phymed.2010.08.008; Naowaboot J, 2012, AM J CHINESE MED, V40, P163, DOI 10.1142/S0192415X12500139; Pelech S, 2008, J PROTEOME RES, V7, P2860, DOI 10.1021/pr800082a; Qin B, 2010, HORM METAB RES, V42, P187, DOI 10.1055/s-0029-1242746; Qin BL, 2003, DIABETES RES CLIN PR, V62, P139, DOI 10.1016/S0168-8227(03)00173-6; Rowland AF, 2011, TRAFFIC, V12, P672, DOI 10.1111/j.1600-0854.2011.01178.x; Sauvaire Y, 1998, DIABETES, V47, P206, DOI 10.2337/diabetes.47.2.206; SHEPHERD PR, 1995, BIOCHEM J, V305, P25, DOI 10.1042/bj3050025; Verspohl EJ, 2005, PHYTOTHER RES, V19, P203, DOI 10.1002/ptr.1643; Yu Hai, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P1394	24	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152728	10.1371/journal.pone.0152728	http://dx.doi.org/10.1371/journal.pone.0152728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054886	Green Submitted, Green Published, gold			2022-12-26	WOS:000373608000038
J	Ma, J; Cheng, ZJ; Chen, J; Shen, JB; Zhang, BC; Ren, YL; Ding, Y; Zhou, YH; Zhang, H; Zhou, KN; Wang, JL; Lei, CL; Zhang, X; Guo, XP; Gao, H; Bao, YQ; Wan, JM				Ma, Jin; Cheng, Zhijun; Chen, Jun; Shen, Jinbo; Zhang, Baocai; Ren, Yulong; Ding, Yu; Zhou, Yihua; Zhang, Huan; Zhou, Kunneng; Wang, Jiu-Lin; Lei, Cailin; Zhang, Xin; Guo, Xiuping; Gao, He; Bao, Yiqun; Wan, Jian-Min			Phosphatidylserine Synthase Controls Cell Elongation Especially in the Uppermost Internode in Rice by Regulation of Exocytosis	PLOS ONE			English	Article							VACUOLAR SORTING RECEPTORS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; ANCHORED PROTEIN; ARABIDOPSIS; CELLULOSE; EXPRESSION; GENE; MUTANT; IDENTIFICATION	The uppermost internode is one of the fastest elongating organs in rice, and is expected to require an adequate supply of cell-wall materials and enzymes to the cell surface to enhance mechanical strength. Although it has been reported that the phenotype of shortened uppermost internode 1 (sui1) is caused by mutations in PHOSPHATIDYLSERINE SYNTHASE (OsPSS), the underlying mechanism remains unclear. Here we show that the OsPSS-1, as a gene expressed predominantly in elongating cells, regulates post-Golgi vesicle secretion to intercellular spaces. Mutation of OsPSS-1 leads to compromised delivery of CESA4 and secGFP towards the cell surface, resulting in weakened intercellular adhesion and disorganized cell arrangement in parenchyma. The phenotype of sui1-4 is caused largely by the reduction in cellulose contents in the whole plant and detrimental delivery of pectins in the uppermost internode. We found that OsPSS-1 and its potential product PS (phosphatidylserine) localized to organelles associated with exocytosis. These results together suggest that OsPSS-1 plays a potential role in mediating cell expansion by regulating secretion of cell wall components.	[Ma, Jin; Cheng, Zhijun; Chen, Jun; Ren, Yulong; Wang, Jiu-Lin; Lei, Cailin; Zhang, Xin; Guo, Xiuping; Wan, Jian-Min] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Shen, Jinbo; Ding, Yu] Chinese Univ Hong Kong, Ctr Cell & Dev Biol, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Baocai; Zhou, Yihua] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Zhang, Baocai; Zhou, Yihua] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Zhang, Huan; Zhou, Kunneng; Gao, He; Bao, Yiqun; Wan, Jian-Min] Nanjing Agr Univ, Jiangsu Plant Gene Engn Res Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese University of Hong Kong; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Nanjing Agricultural University	Cheng, ZJ; Wan, JM (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	chengzhijun@caas.cn; wanjianmin@caas.cn	Zhang, Baocai/AFS-9696-2022; Ren, Yulong/HHC-8217-2022; Zhang, Baocai/AFW-3565-2022; Ding, yu/GWV-1732-2022; Ding, Yu/AAE-8957-2021; Cheng, Zhijun/HDN-7780-2022; Jinbo, Shen/I-8162-2016	Zhang, Baocai/0000-0002-3239-7263; SHEN, Jinbo/0000-0002-0412-5586	National Natural Science Foundation of China [91535302, 31571629]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China, grant numbers: 91535302, 31571629 (http://www.nsfc.gov.cn/), to ZJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; BEVERS EM, 1982, EUR J BIOCHEM, V122, P429, DOI 10.1111/j.1432-1033.1982.tb05898.x; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Chong YT, 2010, NEW PHYTOL, V185, P401, DOI 10.1111/j.1469-8137.2009.03070.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; Cvrckova F, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00159; Delhaize E, 1999, J BIOL CHEM, V274, P7082, DOI 10.1074/jbc.274.11.7082; Dettmer J, 2011, CURR OPIN CELL BIOL, V23, P686, DOI 10.1016/j.ceb.2011.09.006; FADOK VA, 1992, J IMMUNOL, V148, P2207; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107; Guan HZ, 2011, CHINESE SCI BULL, V56, P1476, DOI 10.1007/s11434-011-4552-9; Guillotin SE, 2005, CARBOHYD POLYM, V60, P391, DOI 10.1016/j.carbpol.2005.02.001; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; HAMAMATSU S, 1994, FEBS LETT, V348, P33, DOI 10.1016/0014-5793(94)00576-1; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heu M. H., 1986, Rice genetics. Proceedings of the International Rice Genetics Symposium, 27-31 May, 1985, Manila, Philippines., P317, DOI 10.1142/9789812814265_0028; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hoshikawa K., 1989, GROWING RICE PLANT A; Iwai H, 2002, P NATL ACAD SCI USA, V99, P16319, DOI 10.1073/pnas.252530499; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Ketelaar T, 2003, PLANT CELL, V15, P285, DOI 10.1105/tpc.007039; Kim MJ, 2006, J GEN VIROL, V87, P3425, DOI 10.1099/vir.0.82252-0; KNOX JP, 1990, PLANTA, V181, P512, DOI 10.1007/BF00193004; Kong YZ, 2015, PLANT PHYSIOL, V167, P1296, DOI 10.1104/pp.114.255943; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Krupkova E, 2007, PLANT J, V50, P735, DOI 10.1111/j.1365-313X.2007.03123.x; Lam SK, 2007, PLANT CELL, V19, P296, DOI 10.1105/tpc.106.045708; Lee S, 2012, GENES CELLS, V17, P728, DOI 10.1111/j.1365-2443.2012.01622.x; Lei L, 2015, PLANT CELL, V27, P2926, DOI 10.1105/tpc.15.00442; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lindeboom J, 2008, J MICROSC-OXFORD, V231, P192, DOI 10.1111/j.1365-2818.2008.02035.x; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Maekawa M, 1986, RICE GENETICS NEWSLE, V3; Matsuo Y, 2007, EUKARYOT CELL, V6, P2092, DOI 10.1128/EC.00300-07; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Miao YS, 2006, PLANT PHYSIOL, V142, P945, DOI 10.1104/pp.106.083618; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Shen JB, 2013, PLANT J, V75, P1003, DOI 10.1111/tpj.12257; Shevell DE, 2000, PLANT CELL, V12, P2047, DOI 10.1105/tpc.12.11.2047; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Wang JA, 2010, PLANT CELL, V22, P4009, DOI 10.1105/tpc.110.080697; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Worden N, 2012, J INTEGR PLANT BIOL, V54, P875, DOI 10.1111/j.1744-7909.2012.01179.x; Wu B, 2012, PLANT PHYSIOL, V159, P1440, DOI 10.1104/pp.112.195529; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Xiao Hui-hai, 2007, Zhongguo Shuidao Kexue, V21, P537; Yamaoka Y, 2011, PLANT J, V67, P648, DOI 10.1111/j.1365-313X.2011.04624.x; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yin HF, 2013, PLANTA, V237, P15, DOI 10.1007/s00425-012-1736-5; Zhang BC, 2009, PLANT MOL BIOL, V71, P509, DOI 10.1007/s11103-009-9536-4; Zhang Y, 2010, J INTEGR PLANT BIOL, V52, P138, DOI 10.1111/j.1744-7909.2010.00929.x; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x; Zhou HL, 2006, PLANT MOL BIOL, V60, P137, DOI 10.1007/s11103-005-2972-x; Zhou YH, 2009, PLANT J, V57, P446, DOI 10.1111/j.1365-313X.2008.03703.x; Zhu L, 2011, PLANT MOL BIOL, V77, P475, DOI 10.1007/s11103-011-9825-6; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	72	8	10	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153119	10.1371/journal.pone.0153119	http://dx.doi.org/10.1371/journal.pone.0153119			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055010	gold, Green Published			2022-12-26	WOS:000373608000079
J	Mantaj, J; Jackson, PJM; Karu, K; Rahman, KM; Thurston, DE				Mantaj, Julia; Jackson, Paul J. M.; Karu, Kersti; Rahman, Khondaker M.; Thurston, David E.			Covalent Bonding of Pyrrolobenzodiazepines (PBDs) to Terminal Guanine Residues within Duplex and Hairpin DNA Fragments	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ANTITUMOR ANTIBIOTICS; POLYAMIDE CONJUGATE; REPAIR PATHWAYS; AGENT SJG-136; PHASE-I; SEQUENCE; BINDING; DRUG; ANTHRAMYCIN	Pyrrolobenzodiazepines (PBDs) are covalent-binding DNA-interactive agents with growing importance as payloads in Antibody Drug Conjugates (ADCs). Until now, PBDs were thought to covalently bond to C2-NH2 groups of guanines in the DNA-minor groove across a three-base-pair recognition sequence. Using HPLC/MS methodology with designed hairpin and duplex oligonucleotides, we have now demonstrated that the PBD Dimer SJG-136 and the C8-conjugated PBD Monomer GWL-78 can covalently bond to a terminal guanine of DNA, with the PBD skeleton spanning only two base pairs. Control experiments with the non-C8-conjugated anthramycin along with molecular dynamics simulations suggest that the C8-substituent of a PBD Monomer, or one-half of a PBD Dimer, may provide stability for the adduct. This observation highlights the importance of PBD C8-substituents, and also suggests that PBDs may bind to terminal guanines within stretches of DNA in cells, thus representing a potentially novel mechanism of action at the end of DNA strand breaks.	[Mantaj, Julia; Rahman, Khondaker M.; Thurston, David E.] Kings Coll London, Inst Pharmaceut Sci, 7 Trinity St, London SE1 1DB, England; [Jackson, Paul J. M.; Rahman, Khondaker M.; Thurston, David E.] Femtogenix Ltd, Britannia House,7 Trinity St, London SE1 1DB, England; [Karu, Kersti] UCL, Chem Mass Spectrometry Facil, Dept Chem, Christopher Ingold Bldg,20 Gordon St, London WC1H 0AJ, England	University of London; King's College London; University of London; University College London	Rahman, KM; Thurston, DE (corresponding author), Kings Coll London, Inst Pharmaceut Sci, 7 Trinity St, London SE1 1DB, England.; Rahman, KM; Thurston, DE (corresponding author), Femtogenix Ltd, Britannia House,7 Trinity St, London SE1 1DB, England.	k.miraz.rahman@kcl.ac.uk; david.thurston@kcl.ac.uk	Rahman, Miraz/M-2749-2017	Rahman, Miraz/0000-0001-8566-8648; MANTAJ, JULIA/0000-0002-1155-5664	Femtogenix Ltd; King's College London	Femtogenix Ltd; King's College London	The funder (Femtogenix Ltd) provided support (in part) in the form of salaries for Paul J. M. Jackson (PJMJ) and Julia Mantaj (JM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. David E. Thurston (DET) and Khondaker M. Rahman (KMR) received a full salary from King's College London, as did Kirsty Karu from Imperial College London. Paul Jackson (PJ) received the balance of his salary from King's College London, and Julia Mantaj was a self-funded PhD student during most of the period of the study.	Andreassen PR, 2009, CURR CANCER DRUG TAR, V9, P101, DOI 10.2174/156800909787314011; Antonow D, 2011, CHEM REV, V111, P2815, DOI 10.1021/cr100120f; Brucoli F, 2013, J MED CHEM, V56, P6339, DOI 10.1021/jm4001852; Case D.A., 2022, AMBER 2020; Cipolla L, 2009, ANTI-CANCER AGENT ME, V9, P1, DOI 10.2174/187152009787047743; Clingen PH, 2005, NUCLEIC ACIDS RES, V33, P3283, DOI 10.1093/nar/gki639; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gregson SJ, 2001, J MED CHEM, V44, P737, DOI 10.1021/jm001064n; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; HERTZBERG RP, 1986, BIOCHEMISTRY-US, V25, P1249, DOI 10.1021/bi00354a009; Hochhauser D, 2009, CLIN CANCER RES, V15, P2140, DOI 10.1158/1078-0432.CCR-08-1315; Hsieh MC, 2011, TOXICOL APPL PHARM, V255, P150, DOI 10.1016/j.taap.2011.06.008; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson PJM, 2014, ACS CHEM BIOL, V9, P2432, DOI 10.1021/cb5002203; Janjigian YY, 2010, CANCER CHEMOTH PHARM, V65, P833, DOI 10.1007/s00280-009-1088-4; Jeffrey SC, 2013, BIOCONJUGATE CHEM, V24, P1256, DOI 10.1021/bc400217g; JENKINS TC, 1994, J MED CHEM, V37, P4529, DOI 10.1021/jm00052a012; Kamal A, 2009, BIOORGAN MED CHEM, V17, P1557, DOI 10.1016/j.bmc.2008.12.068; Kamal Ahmed, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P215, DOI 10.2174/1568011023354119; KOPKA ML, 1985, J MOL BIOL, V183, P553, DOI 10.1016/0022-2836(85)90171-8; KOPKA ML, 1994, BIOCHEMISTRY-US, V33, P13593, DOI 10.1021/bi00250a011; Kotecha M, 2008, MOL CANCER THER, V7, P1319, DOI 10.1158/1535-7163.MCT-07-0475; Mantaj J, 2013, AM ASS CANC RES ANN; Martin C, 2005, BIOCHEMISTRY-US, V44, P4135, DOI 10.1021/bi0479813; Narayanaswamy M, 2008, ANAL BIOCHEM, V374, P173, DOI 10.1016/j.ab.2007.11.018; Narendran A, 2010, PEDIATR BLOOD CANCER, V54, P814; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PUVVADA MS, 1993, NUCLEIC ACIDS RES, V21, P3671, DOI 10.1093/nar/21.16.3671; Puvvada MS, 1997, BIOCHEMISTRY-US, V36, P2478, DOI 10.1021/bi952490r; Rahman KM, 2013, J MED CHEM, V56, P2911, DOI 10.1021/jm301882a; Rahman KM, 2011, J AM CHEM SOC, V133, P19376, DOI 10.1021/ja205395r; Rahman KM, 2011, NUCLEIC ACIDS RES, V39, P5800, DOI 10.1093/nar/gkr122; Rahman KM, 2011, ORG BIOMOL CHEM, V9, P1632, DOI 10.1039/c0ob00762e; Rahman KM, 2010, ACS MED CHEM LETT, V1, P427, DOI 10.1021/ml100131b; Rahman KM, 2009, J AM CHEM SOC, V131, P13756, DOI 10.1021/ja902986x; RAO SN, 1986, J MED CHEM, V29, P2484, DOI 10.1021/jm00162a011; Stein EM, 2014, 56 ASH ANN M EXP 6 9; Sutherland MSK, 2013, BLOOD, V122, P1455, DOI 10.1182/blood-2013-03-491506; Thurston D. E., 1993, MOL ASPECTS ANTICANC, P54; THURSTON DE, 1994, CHEM REV, V94, P433, DOI 10.1021/cr00026a006; Thurston DE, 2006, CHEM PHARM ANTICANCE, V1, P281; Wells G, 2006, J MED CHEM, V49, P5442, DOI 10.1021/jm051199z	43	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152303	10.1371/journal.pone.0152303	http://dx.doi.org/10.1371/journal.pone.0152303			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055050	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000015
J	Sontakke, P; Koczula, KM; Jaques, J; Wierenga, ATJ; Brouwers-Vos, AZ; Pruis, M; Gunther, UL; Vellenga, E; Schuringa, JJ				Sontakke, Pallavi; Koczula, Katarzyna M.; Jaques, Jennifer; Wierenga, Albertus T. J.; Brouwers-Vos, Annet Z.; Pruis, Maurien; Guenther, Ulrich L.; Vellenga, Edo; Schuringa, Jan Jacob			Hypoxia-Like Signatures Induced by BCR-ABL Potentially Alter the Glutamine Uptake for Maintaining Oxidative Phosphorylation	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; GENE-EXPRESSION; SELF-RENEWAL; ENFORCED EXPRESSION; UP-REGULATION; CELL-GROWTH; STEM-CELLS; SURVIVAL; PROLIFERATION; CARBOXYLATION	The Warburg effect is probably the most prominent metabolic feature of cancer cells, although little is known about the underlying mechanisms and consequences. Here, we set out to study these features in detail in a number of leukemia backgrounds. The transcriptomes of human CB CD34(+) cells transduced with various oncogenes, including BCR-ABL, MLL-AF9, FLT3-ITD, NUP98-HOXA9, STAT5A and KRAS(G12V) were analyzed in detail. Our data indicate that in particular BCR-ABL, KRAS(G12V) and STAT5 could impose hypoxic signaling under normoxic conditions. This coincided with an upregulation of glucose importers SLC2A1/3, hexokinases and HIF1 and 2. NMR-based metabolic profiling was performed in CB CD34(+) cells transduced with BCR-ABL versus controls, both cultured under normoxia and hypoxia. Lactate and pyruvate levels were increased in BCR-ABL-expressing cells even under normoxia, coinciding with enhanced glutaminolysis which occurred in an HIF1/2-dependent manner. Expression of the glutamine importer SLC1A5 was increased in BCR-ABL(+) cells, coinciding with an increased susceptibility to the glutaminase inhibitor BPTES. Oxygen consumption rates also decreased upon BPTES treatment, indicating a glutamine dependency for oxidative phosphorylation. The current study suggests that BCR-ABL-positive cancer cells make use of enhanced glutamine metabolism to maintain TCA cell cycle activity in glycolytic cells.	[Sontakke, Pallavi; Jaques, Jennifer; Wierenga, Albertus T. J.; Brouwers-Vos, Annet Z.; Pruis, Maurien; Vellenga, Edo; Schuringa, Jan Jacob] Univ Groningen, Univ Med Ctr Groningen, Canc Res Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands; [Koczula, Katarzyna M.; Guenther, Ulrich L.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Wierenga, Albertus T. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; University of Birmingham; University of Groningen	Schuringa, JJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Canc Res Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands.	j.j.schuringa@umcg.nl		Sontakke, Pallavi/0000-0001-5170-6271	Dutch Cancer society [2009-4411]; METAFLUX MarieCurie Initial Training Network from the EU [FP7-PEOPLE-2010-ITN-364780]	Dutch Cancer society(KWF Kankerbestrijding); METAFLUX MarieCurie Initial Training Network from the EU	This work was supported by a grant from Dutch Cancer society (2009-4411). Katarzyna M. Koczula was funded by the METAFLUX MarieCurie Initial Training Network (FP7-PEOPLE-2010-ITN-364780) from the EU held by ULG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL Dutch Cancer Foundation: https://www.kwf.nl/Pages/default.aspx. URL EU ITN: http://ec.europa.eu/research/mariecurieactions/about-msca/actions/itn/index_en.htm.	Ahmed W, 2013, CURR HEMATOL MALIG R, V8, P71, DOI 10.1007/s11899-012-0150-1; Alcalay M, 2005, BLOOD, V106, P899, DOI 10.1182/blood-2005-02-0560; Boren J, 2001, J BIOL CHEM, V276, P37747; Cea M, 2013, CURR CANCER DRUG TAR, V13, P711, DOI 10.2174/15680096113139990085; Chalandon Y, 2004, LEUKEMIA, V18, P1006, DOI 10.1038/sj.leu.2403335; Chalandon Y, 2002, BLOOD, V99, P3197, DOI 10.1182/blood.V99.9.3197; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Chung KY, 2005, BLOOD, V105, P77, DOI 10.1182/blood-2003-12-4445; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Emadi A, 2013, EXP HEMATOL; Emadi A, 2014, EXP HEMATOL, V42, P247, DOI 10.1016/j.exphem.2013.12.001; Fatrai S, 2011, BLOOD, V117, P3320, DOI 10.1182/blood-2010-08-303669; Fatrai S, 2011, J BIOL CHEM, V286, P6061, DOI 10.1074/jbc.M110.201848; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Horton SJ, 2013, LEUKEMIA, V27, P1116, DOI 10.1038/leu.2012.343; Kaluz S, 2008, CLIN CHIM ACTA, V395, P6, DOI 10.1016/j.cca.2008.05.002; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Ludwig C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-366; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; NOWELL PC, 1961, JNCI-J NATL CANCER I, V27, P1013; Oburoglu L, 2014, CELL STEM CELL; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rizo A, 2010, BLOOD, V116, P4621, DOI 10.1182/blood-2010-02-270660; Rouault-Pierre K, 2013, CELL STEM CELL, V13, P549, DOI 10.1016/j.stem.2013.08.011; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Schuringa JJ, 2004, STEM CELLS, V22, P1191, DOI 10.1634/stemcells.2004-0033; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Sinclair A, 2013, BRIT J PHARMACOL, V169, P1693, DOI 10.1111/bph.12183; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Van Etten RA, 2002, ONCOGENE, V21, P8643, DOI 10.1038/sj.onc.1206091; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wierenga ATJ, 2008, MOL CELL BIOL, V28, P6668, DOI 10.1128/MCB.01025-08; Wierenga ATJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093494; Wierenga ATJ, 2010, BLOOD, V115, P4367, DOI 10.1182/blood-2009-10-250894; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Woolthuis CM, 2012, LEUKEMIA, V26, P848, DOI 10.1038/leu.2011.277; Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022; Zhang HJ, 2012, BLOOD, V119, P2595, DOI 10.1182/blood-2011-10-387381; Zhao F, 2010, ONCOGENE, V29, P2962, DOI 10.1038/onc.2010.67	45	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153226	10.1371/journal.pone.0153226	http://dx.doi.org/10.1371/journal.pone.0153226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055152	Green Published, Green Submitted, gold			2022-12-26	WOS:000373608000104
J	Twabela, AT; Mweene, AS; Masumu, JM; Muma, JB; Lombe, BP; Hankanga, C				Twabela, Augustin Tshibwabwa; Mweene, Aaron Simanyengwe; Masumu, Justin Mulumbu; Muma, John Bwalya; Lombe, Boniface Pongombo; Hankanga, Careen			Overview of Animal Rabies in Kinshasa Province in the Democratic Republic of Congo	PLOS ONE			English	Article							AFRICA	Introduction Rabies is one of the major public health problems mostly affecting developing countries in Africa and Asia where 99.9% of all rabies related human deaths are recorded each year. In Democratic Republic of Congo, repeated outbreaks have been reported. Despite this, there is little reliable epidemiological data about rabies in the country for the development of effective control strategies. Materials and Methods A retrospective study was carried out in Kinshasa Province during a period of five years (2009-2013) to describe the proportion of rabid animals and the species involved in rabies transmission and maintenance. The survey also aimed at describing the spatial-temporal distribution of rabies. To gather information, the daily registers of institutions involved in rabies diagnosis were reviewed and each rabies case was traced back to area of occurrence for collection of geographic coordinates. Results and Discussion A total of 5,053 attacks were registered involving six animal species including dog, cat, monkey, rabbit, rat, and pig. Based on clinical observations, rabies was reported in dogs and cats while data obtained from the laboratory confirmed rabies cases included dogs, cats and a goat. The annual distribution showed a significant decrease of rabies cases from 2009 up to 2011 and a later increase up to 2013. There was no difference in rabies occurrence between seasons (p = 0.721). Rabies cases were three times higher in peri-urban zone than in urban zone OR = 3.4 (95% CI: 2.3-5.1). The positive proportion of rabies was 2.6% (95% CI: 2.1-3) based on clinical evidence and 65.9%(95% CI: 50-79.5) for laboratory confirmed cases. Conclusion and Suggestion This study confirms the endemicity of rabies in Kinshasa where occurrence of rabies cases was related to human population density and lifestyle. In order to control rabies, there is need to set up a surveillance program and implement efficient mass vaccination campaigns of susceptible animals.	[Twabela, Augustin Tshibwabwa; Masumu, Justin Mulumbu; Lombe, Boniface Pongombo] Vet Lab Kinshasa, Kinshasa, DEM REP CONGO; [Mweene, Aaron Simanyengwe; Muma, John Bwalya; Hankanga, Careen] Univ Zambia, Sch Vet Med, Lusaka, Zambia; [Masumu, Justin Mulumbu; Lombe, Boniface Pongombo] Univ Pedag Natl, Kinshasa, DEM REP CONGO	University of Zambia	Twabela, AT (corresponding author), Vet Lab Kinshasa, Kinshasa, DEM REP CONGO.	ttaugusha@yahoo.fr	Muma, John/R-9602-2019	Muma, John/0000-0001-6180-4051; TSHIBWABWA TWABELA, Augustin/0000-0003-0695-2734	Welcome Trust [WT087546MA]; Southern African Centre for Infectious Diseases Surveillance (SACIDS)	Welcome Trust(Wellcome Trust); Southern African Centre for Infectious Diseases Surveillance (SACIDS)	This work was supported by the Welcome Trust, Grant number WT087546MA; under the sponsorship of Southern African Centre for Infectious Diseases Surveillance (SACIDS); for a Master programme in One Health Analytical Epidemiology. SACIDS website: www.sacids.org. Welcome Trust website: www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha P. N., 1985, Rabies in the tropics. Proceedings of an international conference on rabies control in the tropics, Tunis, Oct. 3-6, 1983, P343; Alan CJ, 2007, HUMAN DIS, P309; Anderson Roy M, 1992, INFECT DIS HUMANS DY; [Anonymous], 1992, WHO TECH REP SER, P1; [Anonymous], 2012, AGA ACTION FAO TAKIN; [Anonymous], 2014, ANN STAT; Cliquet F, 2004, REV SCI TECH OIE, V23, P625, DOI 10.20506/rst.23.2.1514; Coetzee P, 2007, VIRUS RES, V126, P186, DOI 10.1016/j.virusres.2007.02.020; Deressa A, 2010, ETHIOP J HEALTH DEV, V24; Gsell AS, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-236; Hanlon C.A., 2007, RABIES, P201, DOI DOI 10.1016/B978-012369366-2/50007-5; Kitala PM, 2000, PREV VET MED, V44, P73, DOI 10.1016/S0167-5877(99)00114-2; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Munang'andu HM, 2011, ZOONOSES PUBLIC HLTH, V58, P21, DOI 10.1111/j.1863-2378.2010.01368.x; Muyila DI, 2014, PATHOG GLOB HEALTH, V108, P317, DOI 10.1179/2047773214Y.0000000161; Pauwels L, 1993, NZAYILU N TI GUIDE A; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; SEGANTI L, 1990, ACTA VIROL, V34, P155; Swai E S, 2010, Tanzan J Health Res, V12, P80	20	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0150403	10.1371/journal.pone.0150403	http://dx.doi.org/10.1371/journal.pone.0150403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054328	gold, Green Published, Green Submitted			2022-12-26	WOS:000373608000003
J	Gui, ZP; Yu, MZ; Yang, CW; Jiang, YF; Chen, SQ; Xia, JZ; Huang, QY; Liu, K; Li, ZL; Hassan, MA; Jin, BX				Gui, Zhipeng; Yu, Manzhu; Yang, Chaowei; Jiang, Yunfeng; Chen, Songqing; Xia, Jizhe; Huang, Qunying; Liu, Kai; Li, Zhenlong; Hassan, Mohammed Anowarul; Jin, Baoxuan			Developing Subdomain Allocation Algorithms Based on Spatial and Communicational Constraints to Accelerate Dust Storm Simulation	PLOS ONE			English	Article							PARALLEL; IMPLEMENTATION; SCHEME; MODEL	Dust storm has serious disastrous impacts on environment, human health, and assets. The developments and applications of dust storm models have contributed significantly to better understand and predict the distribution, intensity and structure of dust storms. However, dust storm simulation is a data and computing intensive process. To improve the computing performance, high performance computing has been widely adopted by dividing the entire study area into multiple subdomains and allocating each subdomain on different computing nodes in a parallel fashion. Inappropriate allocation may introduce imbalanced task loads and unnecessary communications among computing nodes. Therefore, allocation is a key factor that may impact the efficiency of parallel process. An allocation algorithm is expected to consider the computing cost and communication cost for each computing node to minimize total execution time and reduce overall communication cost for the entire simulation. This research introduces three algorithms to optimize the allocation by considering the spatial and communicational constraints: 1) an Integer Linear Programming (ILP) based algorithm from combinational optimization perspective; 2) a K-Means and Kernighan-Lin combined heuristic algorithm (K&K) integrating geometric and coordinate-free methods by merging local and global partitioning; 3) an automatic seeded region growing based geometric and local partitioning algorithm (ASRG). The performance and effectiveness of the three algorithms are compared based on different factors. Further, we adopt the K&K algorithm as the demonstrated algorithm for the experiment of dust model simulation with the non-hydrostatic mesoscale model (NMMdust) and compared the performance with the MPI default sequential allocation. The results demonstrate that K&K method significantly improves the simulation performance with better subdomain allocation. This method can also be adopted for other relevant atmospheric and numerical modeling.	[Gui, Zhipeng] Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan 430072, Hubei Province, Peoples R China; [Gui, Zhipeng; Yu, Manzhu; Yang, Chaowei; Jiang, Yunfeng; Xia, Jizhe; Huang, Qunying; Liu, Kai; Li, Zhenlong] George Mason Univ, Ctr Intelligent Spatial Comp, Fairfax, VA 22030 USA; [Chen, Songqing; Hassan, Mohammed Anowarul] George Mason Univ, Dept Comp Sci, Fairfax, VA 22030 USA; [Huang, Qunying] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Jin, Baoxuan] Yunnan Prov Geomat Ctr, Kunming, Yunnan, Peoples R China	Wuhan University; George Mason University; George Mason University; University of Wisconsin System; University of Wisconsin Madison	Yang, CW (corresponding author), George Mason Univ, Ctr Intelligent Spatial Comp, Fairfax, VA 22030 USA.	cyang3@gmu.edu	Yu, Manzhu/J-6953-2019; Yang, Chaowei/A-9881-2017; Gui, Zhipeng/I-1068-2019; Li, Zhenlong/M-1065-2017	Yu, Manzhu/0000-0001-6769-7517; Yang, Chaowei/0000-0001-7768-4066; Gui, Zhipeng/0000-0001-9467-9680; Li, Zhenlong/0000-0002-8938-5466	Federal Geographic Data Committee [G13PG00091]; Microsoft Research; NSF Cyber Polar, Innovation Center; Computer Network System Programs [PLR-1349259, IIP-1338925, CNS-1117300, ICER-1343759]; NASA [NNG12PP37I]; EarthCube; Direct For Computer & Info Scie & Enginr [1117300] Funding Source: National Science Foundation; Directorate For Geosciences [1541039] Funding Source: National Science Foundation	Federal Geographic Data Committee; Microsoft Research(Microsoft); NSF Cyber Polar, Innovation Center; Computer Network System Programs; NASA(National Aeronautics & Space Administration (NASA)); EarthCube(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research is supported by Federal Geographic Data Committee (G13PG00091), Microsoft Research, NSF Cyber Polar, Innovation Center, EarthCube and Computer Network System Programs (PLR-1349259, IIP-1338925, CNS-1117300, ICER-1343759) and NASA (NNG12PP37I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All research was conducted at George Mason University.	ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; ALPERT CJ, 1995, INTEGRATION, V19, P1, DOI 10.1016/0167-9260(95)00008-4; Arifin SMN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-290; Baillie C, 1997, PARALLEL COMPUT, V23, P2135, DOI 10.1016/S0167-8191(97)00104-X; Baillie C, 1995, P 4 INT C APPL HIGH; Banerjee Prithviraj, 1994, PARALLEL ALGORITHMS; Banos R, 2004, J HEURISTICS, V10, P315, DOI 10.1023/B:HEUR.0000026898.11874.e7; Banos R, 2003, LECT NOTES COMPUT SC, V2611, P143; BARNARD ST, 1994, CONCURRENCY-PRACT EX, V6, P101, DOI 10.1002/cpe.4330060203; BERGER MJ, 1987, IEEE T COMPUT, V36, P570, DOI 10.1109/TC.1987.1676942; Bergman T.L., 2011, FUNDAMENTALS HEAT MA, Vsixth; BERMAN F, 1987, J PARALLEL DISTR COM, V4, P439, DOI 10.1016/0743-7315(87)90018-9; BISWAS R, 1994, APPL NUMER MATH, V13, P437, DOI 10.1016/0168-9274(94)90007-8; BOKHARI SH, 1981, IEEE T COMPUT, V30, P207, DOI 10.1109/TC.1981.1675756; Bollinger S. W., 1988, Proceedings of the 1988 International Conference on Parallel Processing, P1; Bui TN, 1996, IEEE T COMPUT, V45, P841, DOI 10.1109/12.508322; Bui TN, 2002, P 4 ANN C GEN EV COM, P43; Dhillon I.S., 2004, P 10 ACM SIGKDD INT, P551, DOI DOI 10.1145/1014052.1014118; Dinh Q, 1988, COUPLING VISCOUS INV, P350; Du Q, 1999, SIAM REV, V41, P637, DOI 10.1137/S0036144599352836; DUNLOP AE, 1985, IEEE T COMPUT AID D, V4, P92, DOI 10.1109/TCAD.1985.1270101; FEO TA, 1995, J GLOBAL OPTIM, V6, P109, DOI 10.1007/BF01096763; Fiduccia C. M., 1982, P 19 IEEE DES AUT C, V19, P175, DOI DOI 10.1109/DAC.1982.1585498; Garey M. R., 1979, Computers and intractability. A guide to the theory of NP-completeness; Garey M. R., 1974, P 6 ANN ACM S THEOR, P47, DOI DOI 10.1145/800119.803884; Gibbs N. E., 1976, ACM Transactions on Mathematical Software, V2, P322, DOI 10.1145/355705.355707; GILBERT JR, 1987, INT J PARALLEL PROG, V16, P427, DOI 10.1007/BF01388998; Gilbert JR, 1998, SIAM J SCI COMPUT, V19, P2091, DOI 10.1137/S1064827594275339; Glover F., 1989, ORSA Journal on Computing, V1, P190, DOI [10.1287/ijoc.2.1.4, 10.1287/ijoc.1.3.190]; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Gong SL, 2008, ATMOS CHEM PHYS, V8, P2333, DOI 10.5194/acp-8-2333-2008; Gropp W., 1999, USING MPI PORTABLE P; Hammond SW, 1992, MAPPING UNSTRUCTURED; HANSEN JV, 1986, OPER RES LETT, V5, P137, DOI 10.1016/0167-6377(86)90086-6; Hongyuan Zha, 2001, Proceedings of the 2001 ACM CIKM. Tenth International Conference on Information and Knowledge Management, P25; Huang QY, 2013, INT J GEOGR INF SCI, V27, P765, DOI 10.1080/13658816.2012.715650; Huang S., 2006, J GRID COMPUT, V4, P71, DOI DOI 10.1007/S10723-005-9018-0; Jerrum M., 1993, Proceedings. 34th Annual Symposium on Foundations of Computer Science (Cat. No.93CH3368-8), P94, DOI 10.1109/SFCS.1993.366878; Kantorovich LV, 1940, DOKLADY AKAD SCI USS, V28, P211; Karypis G, 1998, SIAM J SCI COMPUT, V20, P359, DOI 10.1137/S1064827595287997; Karypis G, 1999, IEEE T VLSI SYST, V7, P69, DOI 10.1109/92.748202; Karypis G, 1999, SIAM REV, V41, P278, DOI 10.1137/S0036144598334138; Kernighan B.W., 1970, BELL SYST TECH J, V49, P291, DOI DOI 10.1002/J.1538-7305.1970.TB01770.X; Khandekar R, 2009, J ACM, V56, DOI 10.1145/1538902.1538903; Korosec P, 2003, INT J PURE APPL MATH, V5, P143; Lafon S, 2006, IEEE T PATTERN ANAL, V28, P1393, DOI 10.1109/TPAMI.2006.184; Leighton T, 1999, J ACM, V46, P787, DOI 10.1145/331524.331526; Lisser A, 2003, MATH PROGRAM, V95, P91, DOI 10.1007/s10107-002-0342-x; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; MANDEL J, 1993, COMMUN NUMER METH EN, V9, P233, DOI 10.1002/cnm.1640090307; Miller G., 1993, IMA VOLUMES MATH ITS, V56, P57; Mladenovic N, 1997, COMPUT OPER RES, V24, P1097, DOI 10.1016/S0305-0548(97)00031-2; MUNTEAN T, 1991, HIGH PERFORMANCE COMPUTING II, P71; Nickovic S, 2001, J GEOPHYS RES-ATMOS, V106, P18113, DOI 10.1029/2000JD900794; Nour-Omid B, 1987, PARALLEL COMPUT, P209; Ou CW, 1996, J SUPERCOMPUT, V10, P119, DOI 10.1007/BF00130706; Portugal D, 2011, IFIP ADV INF COMM TE, V349, P139; Raju MP, 2009, INT J COMPUTER SCI I, V5, P27; Ramanujam J., 1988, ICS 88. Third International Conference on Supercomputing. Proceedings, Supercomputing '88, P471; SADAYAPPAN P, 1990, PARALLEL COMPUT, V13, P1, DOI 10.1016/0167-8191(90)90115-P; Schloegel K, 2000, TR00018 ARM HIGH PER; Shan J, 2008, P 9 INT C COMP VIS P, P6; Shih FY, 2005, IMAGE VISION COMPUT, V23, P877, DOI 10.1016/j.imavis.2005.05.015; Smith B.F., 2004, DOMAIN DECOMPOSITION; Su X, 2014, AAAI WORKSH MULT INT, P7; TOSELLI A., 2005, DOMAIN DECOMPOSITION; Ucar B, 2006, J PARALLEL DISTR COM, V66, P32, DOI 10.1016/j.jpdc.2005.06.014; Van den Bout D E, 1990, IEEE Trans Neural Netw, V1, P192, DOI 10.1109/72.80231; WAGNER HM, 1959, J AM STAT ASSOC, V54, P206, DOI 10.2307/2282146; Walshaw C, 1995, LECT NOTES COMPUTER, P121; Xie JB, 2010, COMPUT ENVIRON URBAN, V34, P278, DOI 10.1016/j.compenvurbsys.2009.08.002; YAN JT, 1994, INFORM PROCESS LETT, V52, P259, DOI 10.1016/0020-0190(94)00148-0; Yang CW, 2011, P NATL ACAD SCI USA, V108, P5498, DOI 10.1073/pnas.0909315108	75	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152250	10.1371/journal.pone.0152250	http://dx.doi.org/10.1371/journal.pone.0152250			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044039	gold, Green Published, Green Submitted			2022-12-26	WOS:000373592100012
J	Katolikova, M; Khaitov, V; Vainola, R; Gantsevich, M; Strelkov, P				Katolikova, Marina; Khaitov, Vadim; Vainola, Risto; Gantsevich, Michael; Strelkov, Petr			Genetic, Ecological and Morphological Distinctness of the Blue Mussels Mytilus trossulus Gould and M-edulis L. in the White Sea	PLOS ONE			English	Article							HYBRID ZONE; REPRODUCTIVE ISOLATION; RECIPROCAL TRANSPLANTATIONS; PHENOTYPIC DIFFERENCES; FERTILIZATION SUCCESS; RELATIVE ABUNDANCE; NORTHWEST ATLANTIC; PATTERNS; POPULATION; GALLOPROVINCIALIS	Two blue mussel lineages of Pliocene origin, Mytilus edulis (ME) and M. trossulus (MT), co-occur and hybridize in several regions on the shores of the North Atlantic. The two species were distinguished from each other by molecular methods in the 1980s, and a large amount of comparative data on them has been accumulated since that time. However, while ME and MT are now routinely distinguished by various genetic markers, they tend to be overlooked in ecological studies since morphological characters for taxonomic identification have been lacking, and no consistent habitat differences between lineages have been reported. Surveying a recently discovered area of ME and MT co-occurrence in the White Sea and employing a set of allozyme markers for identification, we address the issue whether ME and MT are true biological species with distinct ecological characteristics or just virtual genetic entities with no matching morphological and ecological identities. We find that: (1) in the White Sea, the occurrence of MT is largely concentrated in harbors, in line with observations from other subarctic regions of Europe; (2) mixed populations of ME and MT are always dominated by purebred individuals, animals classified as hybrids constituting only ca. 18%; (3) in terms of shell morphology, 80% of MT bear a distinct uninterrupted dark prismatic strip under the ligament while 97% of ME lack this character; (4) at sites of sympatry MT is more common on algal substrates while ME mostly lives directly on the bottom. This segregation by the substrate may contribute to maintaining reproductive isolation and decreasing competition between taxa. We conclude that while ME and MT are not fully reproductively isolated, they do represent clearly distinguishable biological, ecological and morphological entities in the White Sea. It remains to be documented whether the observed morphological and ecological differences are of a local character, or whether they have simply been overlooked in other contact zones.	[Katolikova, Marina; Strelkov, Petr] St Petersburg State Univ, Dept Ichthyol & Hydrobiol, St Petersburg 199034, Russia; [Khaitov, Vadim] St Petersburg State Univ, Dept Invertebrate Zool, St Petersburg 199034, Russia; [Khaitov, Vadim] Kandalaksha State Nat Reserve, Kandalaksha, Murmansk Region, Russia; [Vainola, Risto] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Gantsevich, Michael] Moscow MV Lomonosov State Univ, Dept Invertebrate Zool, Moscow, Russia	Saint Petersburg State University; Saint Petersburg State University; University of Helsinki; Lomonosov Moscow State University	Katolikova, M (corresponding author), St Petersburg State Univ, Dept Ichthyol & Hydrobiol, St Petersburg 199034, Russia.	m.katolikova@spbu.ru	Strelkov, Petr/D-1606-2013; Gantsevich, Mikhail/B-4792-2012	Strelkov, Petr/0000-0002-6030-7034; Gantsevich, Mikhail/0000-0002-4854-2787; Khaitov, Vadim/0000-0001-5567-8554	Russian Foundation for Basic Research [08-04-01315-, 13-04-00394-a, N 15-29-02601]; St. Petersburg State University [1.38.253.2014, 1.42.1493.2015]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); St. Petersburg State University	This work was supported by Russian Foundation for Basic Research, http://www.rfbr.ru, Grants Nos. 08-04-01315-., 13-04-00394-a for PS, MK, VK, MG and N 15-29-02601 for MG; St. Petersburg State University, spbu.ru, Grants Nos. 1.38.253.2014, 1.42.1493.2015 for PS, MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Eric C., 2009, V17, P25; Babkov A., 1982, P ZOOL I LENINGRAD, P316; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bates JA, 1995, MAR BIOL, V124, P417, DOI 10.1007/BF00363915; Bayer TL., 1980, T BBS MGU, P124; Beaumont AR, 2008, J EXP MAR BIOL ECOL, V367, P100, DOI 10.1016/j.jembe.2008.08.021; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Bierne N, 2003, P ROY SOC B-BIOL SCI, V270, P1399, DOI 10.1098/rspb.2003.2404; Bierne N, 2003, MOL ECOL, V12, P447, DOI 10.1046/j.1365-294X.2003.01730.x; Boecklen WJ, 1997, ECOLOGY, V78, P2611, DOI 10.1890/0012-9658(1997)078[2611:GAOHZN]2.0.CO;2; Braby CE, 2006, MAR BIOL, V148, P1249, DOI 10.1007/s00227-005-0177-0; Brannock PM, 2009, MAR ECOL PROG SER, V383, P161, DOI 10.3354/meps07995; Comesana AS, 1999, MAR BIOL, V133, P213, DOI 10.1007/s002270050460; CURREY JD, 1974, J ZOOL, V173, P395; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dias PJ, 2009, AQUACULT INT, V17, P437, DOI 10.1007/s10499-008-9214-6; Dias PJ, 2009, AQUACULTURE, V295, P175, DOI 10.1016/j.aquaculture.2009.07.007; Fly EK, 2013, OECOLOGIA, V172, P35, DOI 10.1007/s00442-012-2486-6; Fox J., 2019, R COMPANION APPL REG, V.; Fraisse C, 2016, MOL ECOL, V25, P269, DOI 10.1111/mec.13299; Gardner JPA, 2009, BIOL J LINN SOC, V96, P875, DOI 10.1111/j.1095-8312.2008.01166.x; Gardner JPA, 1996, MAR BIOL, V125, P385, DOI 10.1007/BF00346319; Gardner JPA, 2001, J EXP MAR BIOL ECOL, V265, P119, DOI 10.1016/S0022-0981(01)00328-8; Gause GF, 1932, J EXP BIOL, V9, P389; Gilg MR, 2003, ECOLOGY, V84, P2989, DOI 10.1890/02-0498; Gosling E.M., 1992, Developments in Aquaculture and Fisheries Science, V25, P309; Harrison R.G., 1989, P111; Harrison RG, 1997, EVOLUTION, V51, P493, DOI 10.1111/j.1558-5646.1997.tb02437.x; Hayhurst S, 2009, J MOLLUS STUD, V75, P215, DOI 10.1093/mollus/eyp019; Innes DJ, 1999, MAR BIOL, V133, P691, DOI 10.1007/s002270050510; Ivanova MB, 1979, DVUSTVORCHATYE MOLLY, P58; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; JOHANNESSON K, 1990, MAR ECOL PROG SER, V59, P211, DOI 10.3354/meps059211; Kartavtsev YP, 2014, RUSS J MAR BIOL+, V40, P208, DOI 10.1134/S1063074014030055; KAUTSKY N, 1990, MAR ECOL PROG SER, V59, P203, DOI 10.3354/meps059203; KEPEL AA, 1992, ZOOL ZH, V71, P33; Khaitov VM, 2013, CHRONICLE NATURE K 1, P152; Klibansky LKJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108433; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; KOEHN RK, 1984, MAR BIOL, V79, P117, DOI 10.1007/BF00951820; KOEHN RK, 1991, AQUACULTURE, V94, P125, DOI 10.1016/0044-8486(91)90114-M; LEVITAN DR, 1991, BIOL BULL-US, V181, P261, DOI 10.2307/1542097; Liu GX, 2011, MAR ECOL-EVOL PERSP, V32, P480, DOI 10.1111/j.1439-0485.2011.00446.x; Lowen JB, 2013, MAR ECOL PROG SER, V475, P135, DOI 10.3354/meps10106; Lukanin V.V., 1985, P45; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; MALLET AL, 1995, CAN J FISH AQUAT SCI, V52, P1873, DOI 10.1139/f95-780; Maloy AP, 2003, J SHELLFISH RES, V22, P119; Mayr E, 1996, PHILOS SCI, V63, P262, DOI 10.1086/289912; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; MCDONALD JH, 1991, MAR BIOL, V111, P323, DOI 10.1007/BF01319403; MCDONALD JH, 1988, MAR BIOL, V99, P111, DOI 10.1007/BF00644984; Miranda MBB, 2010, BIOL BULL-US, V218, P266, DOI 10.1086/BBLv218n3p266; Moreau V, 2005, J SHELLFISH RES, V24, P545; Nikula R, 2008, MOL ECOL, V17, P1505, DOI 10.1111/j.1365-294X.2007.03688.x; Penney RW, 2008, J SHELLFISH RES, V27, P827, DOI 10.2983/0730-8000(2008)27[827:GVISTA]2.0.CO;2; Penney RW, 2007, N AM J AQUACULT, V69, P281, DOI 10.1577/A06-044.1; PENNINGTON JT, 1985, BIOL BULL-US, V169, P417, DOI 10.2307/1541492; Pinheiro J, 2020, R PACKAGE VERSION 31; Pritchard JK, 2000, GENETICS, V155, P945; Qiu JW, 2002, MAR ECOL PROG SER, V228, P143, DOI 10.3354/meps228143; R Development Core Team, R LANG ENV STAT COMP; Rawson PD, 2009, MAR BIOL, V156, P1857, DOI 10.1007/s00227-009-1218-x; Rawson PD, 2003, MAR BIOL, V143, P317, DOI 10.1007/s00227-003-1084-x; Rawson PD, 2001, J SHELLFISH RES, V20, P31; Reimer O, 1997, MAR FRESHW BEHAV PHY, V30, P251, DOI 10.1080/10236249709379029; Riginos C, 2005, MOL ECOL, V14, P381, DOI 10.1111/j.1365-294X.2004.02379.x; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Saavedra C, 1996, GENETICS, V143, P1359; Saez AG, 2005, NATURE, V433, P111, DOI 10.1038/433111a; SEED R, 1969, OECOLOGIA, V3, P317, DOI 10.1007/BF00390381; Slaughter C, 2008, BIOL BULL-US, V214, P57, DOI 10.2307/25066660; Smietanka B, 2013, MAR BIOL, V160, P1709, DOI 10.1007/s00227-013-2223-7; Toro JE, 2002, MAR BIOL, V141, P897, DOI 10.1007/s00227-002-0897-3; Toro JE, 2006, AQUAC RES, V37, P1703, DOI 10.1111/j.1365-2109.2006.01610.x; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; VAINOLA R, 1991, BIOL J LINN SOC, V43, P127, DOI 10.1111/j.1095-8312.1991.tb00589.x; Vainola R, 2003, MAR BIOL, V143, P935, DOI 10.1007/s00227-003-1137-1; Vainola R, 2011, MAR BIOL, V158, P817, DOI 10.1007/s00227-010-1609-z; VARVIO SL, 1988, MAR BIOL, V98, P51, DOI 10.1007/BF00392658; Wenne R, 2016, POLAR BIOL, V39, P343, DOI 10.1007/s00300-015-1785-x; Zbawicka M, 2014, AQUAT BIOL, V21, P25, DOI 10.3354/ab00566; Zbawicka M, 2010, GENE, V456, P45, DOI 10.1016/j.gene.2010.02.009; Zolotarev V.N., 2002, Visnyk Zhytomyrskoho Pedahohichnoho Universytetu, V10, P5; Zolotarev V.N., 1997, Biologiya Morya (Vladivostok), V23, P26; Zuur Alain F., 2009, P1	87	23	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152963	10.1371/journal.pone.0152963	http://dx.doi.org/10.1371/journal.pone.0152963			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044013	Green Published, gold, Green Submitted			2022-12-26	WOS:000373592100055
J	Pfeiffer, A; Stephanowitz, H; Krause, E; Volkwein, C; Hirsch, C; Jarosch, E; Sommer, T				Pfeiffer, Anett; Stephanowitz, Heike; Krause, Eberhard; Volkwein, Corinna; Hirsch, Christian; Jarosch, Ernst; Sommer, Thomas			A Complex of Htm1 and the Oxidoreductase Pdi1 Accelerates Degradation of Misfolded Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; ER-ASSOCIATED DEGRADATION; RETICULUM-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; CHAPERONE-LIKE ACTIVITY; N-LINKED GLYCANS; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; MASS-SPECTROMETRY	A quality control system in the endoplasmic reticulum (ER) efficiently discriminates polypeptides that are in the process of productive folding from conformers that are trapped in an aberrant state. Only the latter are transported into the cytoplasm and degraded in a process termed ER-associated protein degradation (ERAD). In the ER, an enzymatic cascade generates a specific-N-glycan structure of seven mannosyl and twoN-acetylglucosamine residues (Man(7)GlcNAc(2)) on misfolded glycoproteins to facilitate their disposal. We show that a complex encompassing the yeast lectin-like protein Htm1 and the oxidoreductase Pdi1 converts Man(8)GlcNAc(2) on glycoproteins into the Man(7)GlcNAc(2) signal. In vitro the Htm1-Pdi1 complex processes both unfolded and native proteins albeit with a preference for the former. In vivo, elevated expression ofHTM1causes glycan trimming on misfolded and folded proteins, but only degradation of the non-native species is accelerated. Thus, modification with a Man(7)GlcNAc(2) structure does not inevitably commit a protein for ER-associated protein degradation. The function of Htm1 in ERAD relies on its association with Pdi1, which appears to regulate the access to substrates. Our data support a model in which the balanced activities of Pdi1 and Htm1 are crucial determinants for the efficient removal of misfolded secretory glycoproteins.	[Pfeiffer, Anett; Volkwein, Corinna; Hirsch, Christian; Jarosch, Ernst; Sommer, Thomas] Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Stephanowitz, Heike; Krause, Eberhard] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Sommer, Thomas] Humboldt Univ, Inst Biol, Fac Life Sci, D-10099 Berlin, Germany; [Pfeiffer, Anett] Berlin Inst Hlth, Kapelle Ufer 2, D-10117 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Humboldt University of Berlin; Berlin Institute of Health	Hirsch, C; Jarosch, E; Sommer, T (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	christian.hirsch@bihealth.de; ejarosch@mdc-berlin.de; tsommer@mdc-berlin.de		Jarosch, Ernst/0000-0002-5897-3492	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) ( to T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Ausubel F. M., 1993, CURR PROTOC MOL BIOL; Bagola K, 2013, MOL CELL, V50, P528, DOI 10.1016/j.molcel.2013.04.005; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; BYRD JC, 1982, J BIOL CHEM, V257, P4657; CAI H, 1994, J BIOL CHEM, V269, P24550; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; FARQUHAR R, 1991, GENE, V108, P81, DOI 10.1016/0378-1119(91)90490-3; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; FU DT, 1994, CARBOHYD RES, V261, P173, DOI 10.1016/0008-6215(94)84015-6; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; GUNTHER R, 1991, J BIOL CHEM, V266, P24557; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Jaenicke LA, 2011, MOL BIOL CELL, V22, P2937, DOI 10.1091/mbc.E10-10-0832; Jakob CA, 2001, EMBO REP, V2, P423; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Mehnert M, 2014, NAT CELL BIOL, V16, P77, DOI 10.1038/ncb2882; MIZUNAGA T, 1990, J BIOCHEM, V108, P846, DOI 10.1093/oxfordjournals.jbchem.a123291; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Morelle W, 2007, NAT PROTOC, V2, P1585, DOI 10.1038/nprot.2007.227; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Sakoh-Nakatogawa M, 2009, J BIOL CHEM, V284, P11815, DOI 10.1074/jbc.M900813200; Satoh T, 2010, MOL CELL, V40, P905, DOI 10.1016/j.molcel.2010.11.017; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; TACHIKAWA H, 1991, J BIOCHEM, V110, P306, DOI 10.1093/oxfordjournals.jbchem.a123576; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0	59	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12195	12207		10.1074/jbc.M115.703256	http://dx.doi.org/10.1074/jbc.M115.703256			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27053108	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000378092800021
J	Taguchi, Y; Allende, ML; Mizukami, H; Cook, EK; Gavrilova, O; Tuymetova, G; Clarke, BA; Chen, WP; Olivera, A; Proia, RL				Taguchi, Yoshimitsu; Allende, Maria L.; Mizukami, Hiroki; Cook, Emily K.; Gavrilova, Oksana; Tuymetova, Galina; Clarke, Benjamin A.; Chen, Weiping; Olivera, Ana; Proia, Richard L.			Sphingosine-1-phosphate Phosphatase 2 Regulates Pancreatic Islet beta-Cell Endoplasmic Reticulum Stress and Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; TYPE-2 DIABETIC-PATIENTS; INSULIN-RESISTANCE; PHOSPHOHYDROLASE; SPHINGOLIPIDS; SPHINGOSINE; MASS; IDENTIFICATION; HOMEOSTASIS; METABOLISM	Sphingosine-1-phosphate (S1P) is a sphingolipid metabolite that regulates basic cell functions through metabolic and signaling pathways. Intracellular metabolism of S1P is controlled, in part, by two homologous S1P phosphatases (SPPases), 1 and 2, which are encoded by the Sgpp1 and Sgpp2 genes, respectively. SPPase activity is needed for efficient recycling of sphingosine into the sphingolipid synthesis pathway. SPPase 1 is important for skin homeostasis, but little is known about the functional role of SPPase 2. To identify the functions of SPPase 2 in vivo, we studied mice with the Sgpp2 gene deleted. In contrast to Sgpp1(-/)-mice, Sgpp2(-/)-mice had normal skin and were viable into adulthood. Unexpectedly, WT mice expressed Sgpp2 mRNA at high levels in pancreatic islets when compared with other tissues. Sgpp2(-/)-mice had normal pancreatic islet size; however, they exhibited defective adaptive beta-cell proliferation that was demonstrated after treatment with either a high-fat diet or the beta-cell-specific toxin, streptozotocin. Importantly, beta-cells from untreated Sgpp2(-/)-mice showed significantly increased expression of proteins characteristic of the endoplasmic reticulum stress response compared with beta-cells from WT mice, indicating a basal islet defect. Our results show that Sgpp2 deletion causes beta-cell endoplasmic reticulum stress, which is a known cause of beta-cell dysfunction, and reveal a juncture in the sphingolipid recycling pathway that could impact the development of diabetes.	[Taguchi, Yoshimitsu; Allende, Maria L.; Cook, Emily K.; Tuymetova, Galina; Clarke, Benjamin A.; Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, Bldg 10,Rm 9D-06,10 Ctr Dr MSC 1821, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, Bethesda, MD 20892 USA; [Chen, Weiping] NIDDK, Genom Core, Bethesda, MD 20892 USA; [Olivera, Ana] NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Mizukami, Hiroki] Hirosaki Univ, Grad Sch Med, Dept Pathol & Mol Med, Hirosaki, Aomori 0368562, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Hirosaki University	Proia, RL (corresponding author), NIDDK, Genet Dev & Dis Branch, Bldg 10,Rm 9D-06,10 Ctr Dr MSC 1821, Bethesda, MD 20892 USA.	proia@nih.gov	Chen, Wei/GZK-7348-2022; Proia, Richard L/A-7908-2012; Mizukami, Hiroki/ABE-7877-2021	Mizukami, Hiroki/0000-0003-2920-582X; Proia, Richard/0000-0003-0456-1270	Intramural Research Program of NIDDK, National Institutes of Health; Intramural Research Program of NIAID, National Institutes of Health; Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE [P20 RR017677]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001206, ZIAAI000965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056018, ZIADK056014, ZICDK070002, ZIADK056015] Funding Source: NIH RePORTER	Intramural Research Program of NIDDK, National Institutes of Health; Intramural Research Program of NIAID, National Institutes of Health; Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Programs of NIDDK and NIAID, National Institutes of Health; the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina ( Grant P30 CA138313); and the Lipidomics Core in the SC Lipidomics and Pathobiology COBRE ( Grant P20 RR017677). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allende ML, 2013, J BIOL CHEM, V288, P18381, DOI 10.1074/jbc.M113.478420; Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Engin F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04054; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Kamata K, 2014, AMYLOID, V21, P191, DOI 10.3109/13506129.2014.937857; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Le Stunff H, 2007, J BIOL CHEM, V282, P34372, DOI 10.1074/jbc.M703329200; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; Maceyka M, 2007, METHOD ENZYMOL, V434, P243, DOI 10.1016/S0076-6879(07)34013-5; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mandala SM, 2001, PROSTAG OTH LIPID M, V64, P143, DOI 10.1016/S0090-6980(01)00111-3; Mechtcheriakova D, 2007, FEBS LETT, V581, P3063, DOI 10.1016/j.febslet.2007.05.069; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mizukami H, 2014, DIABETES CARE, V37, P1966, DOI 10.2337/dc13-2018; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Schulze H, 2014, BBA-MOL CELL BIOL L, V1841, P799, DOI 10.1016/j.bbalip.2013.10.015; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	35	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12029	12038		10.1074/jbc.M116.728170	http://dx.doi.org/10.1074/jbc.M116.728170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27059959	Green Published, hybrid			2022-12-26	WOS:000378092800007
J	Malinverni, S; Libois, A; Gennotte, AF; La Morte, C; Mols, P				Malinverni, Stefano; Libois, Agnes; Gennotte, Anne-Francoise; La Morte, Cecile; Mols, Pierre			Prescription of Non-Occupational Post-Exposure HIV Prophylaxis by Emergency Physicians: An Analysis on Accuracy of Prescription and Compliance	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; ANTIRETROVIRAL THERAPY; INFECTION; ADHERENCE; METAANALYSIS; PREVENTION; MACAQUES; EXPOSURE; VICTIMS; IMPACT	We conducted a retrospective analysis of data from a prospective nPEP (non-Occupational Post Exposure Prophylaxis) registry based on patients consulting at one academic Emergency department located in Brussels, Belgium. We review here 1,357 cases consulting from January 2011 to December 2013. The objective of the study is to determine whether emergency physicians prescribe nPEP according to national guideline with support from IDS (infectious disease specialists). As this intervention has a high cost we wanted to verify correct allocation of treatment to high risk patients. Moreover we wanted to determine whether compliance to nPEP when prescribed by an Emergency Physician was different from literature reports. Finally we wanted to describe the population consulting for nPEP at our center. Emergency physicians prescribed nPEP more frequently in high risk exposures (98.6%) compared to intermediate risk exposures (53.2%); adequately allocating resources from a public health perspective. Appropriateness of prescription when evaluated according to nPEP Belgian guidelines was 98.8%. Compliance with nPEP prescribed by Emergency physicians was 60% in our study. Compliance was the highest in MSM (Men who have Sex with Men) while sexual assault victims showed the lowest compliance. Altogether this study suggests that Emergency physicians can safely and adequately prescribe nPEP when supported by a comprehensive guideline. Recognizing intrinsic differences within heterogeneous populations consulting for nPEP may improve compliance to this high-cost public health intervention.	[Malinverni, Stefano; Mols, Pierre] Univ Libre Bruxelles, Ctr Hosp Univ St Pierre, Dept Emergency Med, Brussels, Belgium; [Libois, Agnes; Gennotte, Anne-Francoise; La Morte, Cecile] Univ Libre Bruxelles, Ctr Hosp Univ St Pierre, Dept Infect Dis, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Malinverni, S (corresponding author), Univ Libre Bruxelles, Ctr Hosp Univ St Pierre, Dept Emergency Med, Brussels, Belgium.	stefano_malinverni@stpierre-bru.be	Libois, Agnès/AAQ-2077-2021	LIBOIS, Agnes/0000-0002-6078-878X; Malinverni, Stefano/0000-0003-3840-0491				Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Benn P, 2011, INT J STD AIDS, V22, P695, DOI 10.1258/ijsa.2011.171011; Bogoch II, 2015, CLIN INFECT DIS S3, V60, pS182; Bryant J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13140; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Chacko L, 2012, SEX TRANSM INFECT, V88, P335, DOI 10.1136/sextrans-2011-050371; Ford N, 2015, CLIN INFECT DIS, V60, pS182, DOI 10.1093/cid/civ093; Ford N, 2014, AIDS, V28, P2721, DOI 10.1097/QAD.0000000000000505; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kuhar DT, 2013, INFECT CONT HOSP EP, V34, P875, DOI 10.1086/672271; ROTHBAUM BO, 1992, J TRAUMA STRESS, V5, P455, DOI 10.1007/BF00977239; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Tucker JS, 2003, AM J MED, V114, P573, DOI 10.1016/S0002-9343(03)00093-7	16	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153021	10.1371/journal.pone.0153021	http://dx.doi.org/10.1371/journal.pone.0153021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070319	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700028
J	Bueno, C; Tabares-Seisdedos, R; Moraleda, JM; Martinez, S				Bueno, Carlos; Tabares-Seisdedos, Rafael; Moraleda, Jose M.; Martinez, Salvador			Rett Syndrome Mutant Neural Cells Lacks MeCP2 Immunoreactive Bands	PLOS ONE			English	Article							CHROMATIN; BINDING; PROTEIN; DNA; LOCALIZATION; EXPRESSION; COMPLEX; FORM	Dysfunctions of MeCP2 protein lead to various neurological disorders such as Rett syndrome and Autism. The exact functions of MeCP2 protein is still far from clear. At a molecular level, there exist contradictory data. MeCP2 protein is considered a single immunoreactive band around 75 kDa by western-blot analysis but several reports have revealed the existence of multiple MeCP2 immunoreactive bands above and below the level where MeCP2 is expected. MeCP2 immunoreactive bands have been interpreted in different ways. Some researchers suggest that multiple MeCP2 immunoreactive bands are unidentified proteins that cross-react with the MeCP2 antibody or degradation product of MeCP2, while others suggest that MeCP2 post-transcriptional processing generates multiple molecular forms linked to cell signaling, but so far they have not been properly analyzed in relation to Rett syndrome experimental models. The purpose of this study is to advance understanding of multiple MeCP2 immunoreactive bands in control neural cells and p. T158M MeCP2e1 mutant cells. We have generated stable wild-type and p. T158M MeCP2e1-RFP mutant expressing cells. Application of N- and C-terminal MeCP2 antibodies, and also, RFP antibody minimized concerns about nonspecific cross-reactivity, since they react with the same antigen at different epitopes. We report the existence of multiple MeCP2 immunoreactive bands in control cells, stable wild-type and p. T158M MeCP2e1-RFP mutant expressing cells. Also, MeCP2 immunoreactive bands differences were found between wild-type and p. T158M MeCP2e1-RFP mutant expressing cells. Slower migration phosphorylated band around 70kDa disappeared in p. T158M MeCP2e1-RFP mutant expressing cells. These data suggest that threonine 158 could represent an important phosphorylation site potentially involved in protein function. Our results clearly indicate that MeCP2 antibodies have no cross-reactivity with similar epitopes on others proteins, supporting the idea that MeCP2 may exist in multiple different molecular forms and that molecular pattern variations derived from altered post-transcriptional processing may underlay Rett syndrome physiophatology	[Bueno, Carlos; Martinez, Salvador] Univ Murcia, IMIB Arrixaca, Murcia, Spain; [Bueno, Carlos; Moraleda, Jose M.; Martinez, Salvador] Univ Murcia, Fac Med, Murcia, Spain; [Bueno, Carlos; Tabares-Seisdedos, Rafael; Martinez, Salvador] CIBERSAM, Murcia, Spain; [Moraleda, Jose M.; Martinez, Salvador] Univ Murcia, Hosp Univ Virgen de la Arrixaca, Cell Therapy Unit, IMIB Arrixaca, Murcia, Spain; [Tabares-Seisdedos, Rafael] Univ Valencia, Dept Med, Teaching Unit Psychiat & Psychol Med, Valencia, Spain; [Martinez, Salvador] UMH, CSIC, Inst Neurociencias, Alacant 03550, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; University of Murcia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Martinez, S (corresponding author), Univ Murcia, IMIB Arrixaca, Murcia, Spain.; Martinez, S (corresponding author), Univ Murcia, Fac Med, Murcia, Spain.; Martinez, S (corresponding author), CIBERSAM, Murcia, Spain.; Martinez, S (corresponding author), Univ Murcia, Hosp Univ Virgen de la Arrixaca, Cell Therapy Unit, IMIB Arrixaca, Murcia, Spain.; Martinez, S (corresponding author), UMH, CSIC, Inst Neurociencias, Alacant 03550, Spain.	smartinez@umh.es	Moraleda, José María/AAB-4119-2020; Tabares-Seisdedos, Rafael/H-6432-2013	Tabares-Seisdedos, Rafael/0000-0002-1089-2204	EUCOMMTOOLS [261492]; Spanish MICINN [BFU-2008-00588]; CONSOLIDER [CSD2007-00023];  [SAF2014-59347-C2-1-R]	EUCOMMTOOLS; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	This work was supported by the grants: EUCOMMTOOLS (Contract 261492), Spanish MICINN BFU-2008-00588, CONSOLIDER (CSD2007-00023) and SAF2014-59347-C2-1-R. Institute of Health Carlos III, TERCEL and CIBERSAM, Generalitat Valenciana (PROMETEO 2009/028 and 11/2011/042). Fundacion Alicia Koplowitz-2009.	Archer H, 2007, J MED GENET, V44, P148, DOI 10.1136/jmg.2006.045260; Ausio J, 2014, TRENDS MOL MED, V20, P487, DOI 10.1016/j.molmed.2014.03.004; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Bellini E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00236; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hite KC, 2009, BIOCHEM CELL BIOL, V87, P219, DOI 10.1139/O08-115; Jarrar MH, 2003, J CHILD NEUROL, V18, P675, DOI 10.1177/08830738030180101001; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kaddoum L, 2013, F1000RES; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Liyanage VRB, 2014, NEUROMOL MED, V16, P231, DOI 10.1007/s12017-014-8295-9; Lyst MJ, 2015, NAT REV GENET, V16, P261, DOI 10.1038/nrg3897; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Sigh J, 2008, NUCLEIC ACIDS RES, V36, P6035, DOI [10.1093/nar/gkn591, DOI 10.1093/NAR/GKN591]; Stuss DP, 2013, NUCLEIC ACIDS RES, V41, P4888, DOI 10.1093/nar/gkt213; Tai DJC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10552; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12	25	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153262	10.1371/journal.pone.0153262	http://dx.doi.org/10.1371/journal.pone.0153262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064487	gold, Green Submitted, Green Published			2022-12-26	WOS:000373891000039
J	Mueller, KL; Murray, JC; Michaelson, JJ; Christiansen, MH; Reilly, S; Tomblin, JB				Mueller, Kathryn L.; Murray, Jeffrey C.; Michaelson, Jacob J.; Christiansen, Morten H.; Reilly, Sheena; Tomblin, J. Bruce			Common Genetic Variants in FOXP2 Are Not Associated with Individual Differences in Language Development	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INHERITED SPEECH; CHILDHOOD APRAXIA; IMPAIRMENT; DELETION; SUSCEPTIBILITY; LINKAGE; TARGETS; FAMILY; AUTISM	Much of our current knowledge regarding the association of FOXP2 with speech and language development comes from singleton and small family studies where a small number of rare variants have been identified. However, neither genome-wide nor gene-specific studies have provided evidence that common polymorphisms in the gene contribute to individual differences in language development in the general population. One explanation for this inconsistency is that previous studies have been limited to relatively small samples of individuals with low language abilities, using low density gene coverage. The current study examined the association between common variants in FOXP2 and a quantitative measure of language ability in a population-based cohort of European decent (n = 812). No significant associations were found for a panel of 13 SNPs that covered the coding region of FOXP2 and extended into the promoter region. Power analyses indicated we should have been able to detect a QTL variance of 0.02 for an associated allele with MAF of 0.2 or greater with 80% power. This suggests that, if a common variant associated with language ability in this gene does exist, it is likely of small effect. Our findings lead us to conclude that while genetic variants in FOXP2 may be significant for rare forms of language impairment, they do not contribute appreciably to individual variation in the normal range as found in the general population.	[Mueller, Kathryn L.] Murdoch Childrens Inst, Hearing Language & Literacy, Melbourne, Vic, Australia; [Mueller, Kathryn L.; Tomblin, J. Bruce] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA USA; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Michaelson, Jacob J.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Christiansen, Morten H.] Cornell Univ, Dept Psychol, New York, NY 10021 USA; [Reilly, Sheena] Menzies Hlth Inst, Gold Coast, Qld, Australia	University of Iowa; University of Iowa; University of Iowa; Cornell University; Menzies Health Institute Queensland	Mueller, KL (corresponding author), Murdoch Childrens Inst, Hearing Language & Literacy, Melbourne, Vic, Australia.; Mueller, KL (corresponding author), Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA USA.	kathryn-mueller@uiowa.edu	Reilly, Sheena/A-7035-2016	Reilly, Sheena/0000-0001-6506-4767; Michaelson, Jacob/0000-0001-9713-0992	National Institute on Deafness and Other Communication Disorders [DC00496, DC02746]; National Health and Medical Research Council Centre of Research Excellence [APP1023493]; Victorian Government; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000496, P50DC002746] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Health and Medical Research Council Centre of Research Excellence; Victorian Government; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by grants DC00496 and DC02746 from the National Institute on Deafness and Other Communication Disorders. Dr Mueller is funded in part by the National Health and Medical Research Council Centre of Research Excellence Grant (APP1023493) and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis L, 2010, GENES BRAIN BEHAV, V9, P545, DOI 10.1111/j.1601-183X.2010.00583.x; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Alcock KJ, 2000, BRAIN LANG, V75, P17, DOI 10.1006/brln.2000.2322; Ayub Q, 2013, AM J HUM GENET, V92, P696, DOI 10.1016/j.ajhg.2013.03.019; Bartlett CW, 2004, HUM HERED, V57, P10, DOI 10.1159/000077385; Bartlett CW, 2002, AM J HUM GENET, V71, P45, DOI 10.1086/341095; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bruce HA, 2002, HUM GENET, V111, P136, DOI 10.1007/s00439-002-0768-5; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Culatta B., 1983, LANG SPEECH HEAR SER, V14, P66, DOI DOI 10.1044/0161-1461.1402.66; Dunn L.M., 2007, PEABODY PICTURE VOCA, DOI DOI 10.1037/T15144-000; Dunn L.M., 1981, PEABODY PICTURE VOCA; Eicher JD, 2013, GENES BRAIN BEHAV, V12, P792, DOI 10.1111/gbb.12085; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Falcaro M, 2008, GENES BRAIN BEHAV, V7, P393, DOI 10.1111/j.1601-183X.2007.00364.x; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; FLETCHER P, 1990, NATURE, V346, P226, DOI 10.1038/346226a0; French CA, 2012, MOL PSYCHIATR, V17, P1077, DOI 10.1038/mp.2011.105; Gialluisi A, 2014, GENES BRAIN BEHAV, V13, P686, DOI 10.1111/gbb.12158; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein BA, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1691; GOPNIK M, 1990, NATURE, V344, P715, DOI 10.1038/344715a0; Gopnik M., 1990, LANG ACQUIS, V1, P139, DOI DOI 10.1207/S15327817LA0102_1; Graham SA, 2013, CURR OPIN NEUROBIOL, V23, P43, DOI 10.1016/j.conb.2012.11.006; Harlaar N, 2014, J SPEECH LANG HEAR R, V57, P96, DOI 10.1044/1092-4388(2013/12-0303); Hoover H, 2001, IOWA TESTS INTERPRET; HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; Jorgensen TJ, 2009, AM J EPIDEMIOL, V170, P986, DOI 10.1093/aje/kwp242; Karolchik D, 2009, CURRENT PROTOCOLS BI; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Laffin JJS, 2012, GENET MED, V14, P928, DOI 10.1038/gim.2012.72; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lennon PA, 2007, AM J MED GENET A, V143A, P791, DOI 10.1002/ajmg.a.31632; Leonard LB, 2014, CHILDREN WITH SPECIFIC LANGUAGE IMPAIRMENT, 2ND EDITION, P1; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Lieberman P, 2002, YEARB PHYS ANTHROPOL, V45, P36, DOI 10.1002/ajpa.10171; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Liegeois F, 2011, EUR J PAEDIATR NEURO, V15, P283, DOI 10.1016/j.ejpn.2011.04.006; Luciano M, 2013, GENES BRAIN BEHAV, V12, P645, DOI 10.1111/gbb.12053; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; McKean C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134251; Meaburn E, 2002, NEUROREPORT, V13, P1075, DOI 10.1097/00001756-200206120-00020; Michaelson JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-502; Monaco AP, 2007, ANN HUM GENET, V71, P660, DOI 10.1111/j.1469-1809.2007.00361.x; Newbury DF, 2011, BEHAV GENET, V41, P90, DOI 10.1007/s10519-010-9424-3; Newbury DF, 2004, AM J HUM GENET, V74, P1225, DOI 10.1086/421529; Newbury DF, 2002, AM J HUM GENET, V70, P1318, DOI 10.1086/339931; Newbury DF, 2002, AM J HUM GENET, V70, P384; Newbury DF, 2014, GENES-BASEL, V5, P285, DOI 10.3390/genes5020285; Newcomer P. L., 1988, TEST LANGUAGE DEV 2; Nudel R, 2014, GENES BRAIN BEHAV, V13, P418, DOI 10.1111/gbb.12127; O'Brien EK, 2003, AM J HUM GENET, V72, P1536, DOI 10.1086/375403; Palka C, 2012, PEDIATRICS, V129, pE183, DOI 10.1542/peds.2010-2094; Peter B, 2011, J NEURODEV DISORD, V3, P39, DOI 10.1007/s11689-010-9065-0; PURCELL S, 2003, BIOINFORMATICS, V19, P149, DOI [DOI 10.1093/BIOINFORMATICS/19.1.149, 10.1093/bioinformatics/19.1.149]; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reimers-Kipping S, 2011, NEUROSCIENCE, V175, P75, DOI 10.1016/j.neuroscience.2010.11.042; Rice GM, 2012, AM J MED GENET A, V158A, P174, DOI 10.1002/ajmg.a.34354; Rice ML, 2009, J NEURODEV DISORD, V1, P264, DOI 10.1007/s11689-009-9031-x; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Schreiweis C, 2014, P NATL ACAD SCI USA, V111, P14253, DOI 10.1073/pnas.1414542111; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; St Pourcain B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5831; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Tomblin JB, 2006, J SPEECH LANG HEAR R, V49, P1193, DOI 10.1044/1092-4388(2006/086); Tomblin JB, 2009, J SPEECH LANG HEAR R, V52, P1157, DOI 10.1044/1092-4388(2009/07-0162); Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Tomblin JB, 1996, J SPEECH HEAR RES, V39, P1284, DOI 10.1044/jshr.3906.1284; Tomblin JB, 2014, UNDERSTANDING INDIVI; Tomblin JB, 2014, UNDERSTANDING INDIVI, P11; Turner SJ, 2013, AM J MED GENET A, V161, P2321, DOI 10.1002/ajmg.a.36055; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; VARGHAKHADEM F, 1990, NATURE, V346, P226, DOI 10.1038/346226c0; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Watkins KE, 1999, AM J HUM GENET, V65, P1215, DOI 10.1086/302631; Wechsler D., 1991, WISC 3 WECHSLER INTE; Weschler D., 1967, WECHSLER PRESCHOOL P; Whitehouse AJO, 2012, GENES BRAIN BEHAV, V11, P501, DOI 10.1111/j.1601-183X.2012.00806.x; Wiig E., 1992, CLIN EVALUATION LANG; Wiszniewski W, 2013, AM J HUM GENET, V93, P197, DOI 10.1016/j.ajhg.2013.05.027; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110; Zilina O, 2012, AM J MED GENET A, V158A, P254, DOI 10.1002/ajmg.a.34378	91	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152576	10.1371/journal.pone.0152576	http://dx.doi.org/10.1371/journal.pone.0152576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064276	gold, Green Published			2022-12-26	WOS:000373891000013
J	Cardinali, I; Lancioni, H; Giontella, A; Capodiferro, MR; Capomaccio, S; Buttazzoni, L; Biggio, GP; Cherchi, R; Albertini, E; Olivieri, A; Cappelli, K; Achilli, A; Silvestrelli, M				Cardinali, Irene; Lancioni, Hovirag; Giontella, Andrea; Capodiferro, Marco Rosario; Capomaccio, Stefano; Buttazzoni, Luca; Biggio, Giovanni Paolo; Cherchi, Raffaele; Albertini, Emidio; Olivieri, Anna; Cappelli, Katia; Achilli, Alessandro; Silvestrelli, Maurizio			An Overview of Ten Italian Horse Breeds through Mitochondrial DNA	PLOS ONE			English	Article							LOOP SEQUENCE VARIATION; GENETIC-ANALYSIS; MATERNAL LINES; DAM LINES; DIVERSITY; LINEAGES; ORIGINS; GENOMES; DOMESTICATION; POPULATIONS	Background The climatic and cultural diversity of the Italian Peninsula triggered, over time, the development of a great variety of horse breeds, whose origin and history are still unclear. To clarify this issue, analyses on phenotypic traits and genealogical data were recently coupled with molecular screening. Methodology To provide a comprehensive overview of the horse genetic variability in Italy, we produced and phylogenetically analyzed 407 mitochondrial DNA (mtDNA) control-region sequences from ten of the most important Italian riding horse and pony breeds: Bardigiano, Esperia, Giara, Lipizzan, Maremmano, Monterufolino, Murgese, Sarcidano, Sardinian Anglo-Arab, and Tolfetano. A collection of 36 Arabian horses was also evaluated to assess the genetic consequences of their common use for the improvement of some local breeds. Conclusions In Italian horses, all previously described domestic mtDNA haplogroups were detected as well as a high haplotype diversity. These findings indicate that the ancestral local mares harbored an extensive genetic diversity. Moreover, the limited haplotype sharing (11%) with the Arabian horse reveals that its impact on the autochthonous mitochondrial gene pools during the final establishment of pure breeds was marginal, if any. The only significant signs of genetic structure and differentiation were detected in the geographically most isolated contexts (i. e. Monterufolino and Sardinian breeds). Such a geographic effect was also confirmed in a wider breed setting, where the Italian pool stands in an intermediate position together with most of the other Mediterranean stocks. However, some notable exceptions and peculiar genetic proximities lend genetic support to historical theories about the origin of specific Italian breeds.	[Cardinali, Irene; Lancioni, Hovirag; Achilli, Alessandro] Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06100 Perugia, Italy; [Giontella, Andrea; Capomaccio, Stefano; Cappelli, Katia; Silvestrelli, Maurizio] Univ Perugia, Dipartimento Med Vet, Ctr Studio Cavallo Sport, I-06100 Perugia, Italy; [Capodiferro, Marco Rosario; Olivieri, Anna; Achilli, Alessandro] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Via Palestro 3, I-27100 Pavia, Italy; [Buttazzoni, Luca] Ctr Ric Prod Carni & Miglioramento Genet, Sede Cent Monterotondo, Rome, Italy; [Biggio, Giovanni Paolo; Cherchi, Raffaele] Agenzia Ric Agr AGRIS Sardegna, Sassari, Italy; [Albertini, Emidio] Univ Perugia, Dipartimento Sci Agr Alimentari & Ambientali, I-06100 Perugia, Italy	University of Perugia; University of Perugia; University of Pavia; University of Perugia	Achilli, A (corresponding author), Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06100 Perugia, Italy.; Achilli, A (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Via Palestro 3, I-27100 Pavia, Italy.	alessandro.achilli@unipv.it	Achilli, Alessandro/I-9236-2012; Albertini, Emidio/F-7393-2014; Cardinali, Irene/R-8751-2017; OLIVIERI, ANNA/I-9235-2012; Giontella, Andrea/O-2279-2017; Capomaccio, Stefano/K-6042-2015; Capodiferro, Marco Rosario/AAQ-4941-2020; Lancioni, Hovirag/F-9067-2014	Achilli, Alessandro/0000-0001-6871-3451; OLIVIERI, ANNA/0000-0002-3941-8098; Giontella, Andrea/0000-0003-3615-0978; Capomaccio, Stefano/0000-0002-0004-9272; Capodiferro, Marco Rosario/0000-0003-2494-5423; Lancioni, Hovirag/0000-0001-5514-1853; Albertini, Emidio/0000-0003-2585-5649	Italian Ministry of Education, University and Research [FIR2012-RBFR126B8I, PRIN2012-2012JA4BTY]; AGRIS Sardegna: "Monitoraggio delle caratteristiche dell'allevamento del cavallo sportivo in Sardegna e creazione della banca dati per gli indici genetici"; CRA-PCM: "Allevamento Statale Cavallo Lipizzano: conservazione e valorizzazione"	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); AGRIS Sardegna: "Monitoraggio delle caratteristiche dell'allevamento del cavallo sportivo in Sardegna e creazione della banca dati per gli indici genetici"; CRA-PCM: "Allevamento Statale Cavallo Lipizzano: conservazione e valorizzazione"	This study received support from the Italian Ministry of Education, University and Research: FIR2012-RBFR126B8I (to AA and AO) and PRIN2012-2012JA4BTY (to AA); AGRIS Sardegna: "Monitoraggio delle caratteristiche dell'allevamento del cavallo sportivo in Sardegna e creazione della banca dati per gli indici genetici"; CRA-PCM: "Allevamento Statale Cavallo Lipizzano: conservazione e valorizzazione".	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Alvarez I, 2013, SPAN J AGRIC RES, V11, P702, DOI 10.5424/sjar/2013113-4127; Bigi D, 2014, ANIM GENET, V45, P593, DOI 10.1111/age.12156; Bigi D, 2008, ATLANTE RAZZE AUTOCT; Bigi D, 2012, J HERED, V103, P134, DOI 10.1093/jhered/esr121; Bongianni, 1988, SIMON SCHUSTERS GUID; Bowling AT, 2000, ANIM GENET, V31, P1, DOI 10.1046/j.1365-2052.2000.00558.x; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Colli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2342-2; Cothran EG, 2005, GENET MOL BIOL, V28, P677, DOI 10.1590/S1415-47572005000500006; Cozzi MC, 2004, GENET SEL EVOL, V36, P663, DOI 10.1051/gse:2004023; Di Stasio L, 2008, ITAL J ANIM SCI, V7, P243; Dovc P, 2006, REPROD DOMEST ANIM, V41, P280, DOI 10.1111/j.1439-0531.2006.00726.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felicetti M, 2010, ANIM GENET, V41, P53, DOI 10.1111/j.1365-2052.2010.02102.x; Glazewska I, 2007, GENET SEL EVOL, V39, P609, DOI 10.1051/gse:2007025; Glazewska I, 2010, LIVEST SCI, V129, P49, DOI 10.1016/j.livsci.2009.12.009; Guastella AM, 2011, J HERED, V102, P753, DOI 10.1093/jhered/esr091; Hill EW, 2002, ANIM GENET, V33, P287, DOI 10.1046/j.1365-2052.2002.00870.x; Ivankovic A, 2009, CZECH J ANIM SCI, V54, P101, DOI 10.17221/1678-CJAS; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Kakoi H, 2007, BIOCHEM GENET, V45, P375, DOI 10.1007/s10528-007-9083-0; Kavar T, 2002, GENET SEL EVOL, V34, P635, DOI [10.1186/1297-9686-34-5-635, 10.1051/gse:2002028]; Khanshour AM, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-83; Lancioni H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073712; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindgren G, 2004, NAT GENET, V36, P335, DOI 10.1038/ng1326; Lippold S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1447; Lopes MS, 2005, ANIM GENET, V36, P196, DOI 10.1111/j.1365-2052.2005.01279.x; Maretto F, 2009, ITAL J ANIM SCI, V8, P95, DOI 10.4081/ijas.2009.s3.95; McGahern A, 2006, ANIM GENET, V37, P494, DOI 10.1111/j.1365-2052.2006.01495.x; Morelli L, 2014, GENET MOL RES, V13, P8241, DOI 10.4238/2014.October.20.1; Moridi M, 2013, ANIM GENET, V44, P209, DOI 10.1111/j.1365-2052.2012.02389.x; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Pieragostini E, 2005, ITAL J ANIM SCI, V4, P197; Royo LJ, 2005, J HERED, V96, P663, DOI 10.1093/jhered/esi116; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Vilstrup JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055950; Wallner B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060015; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; XU XF, 1994, GENE, V148, P357, DOI 10.1016/0378-1119(94)90713-7; Yue XP, 2012, ANIM GENET, V43, P624, DOI 10.1111/j.1365-2052.2011.02298.x; Zechner P, 2002, LIVEST PROD SCI, V77, P137, DOI 10.1016/S0301-6226(02)00079-9; Zuccaro A, 2009, ITAL J ANIM SCI, V8, P180, DOI 10.4081/ijas.2009.s2.180	46	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153004	10.1371/journal.pone.0153004	http://dx.doi.org/10.1371/journal.pone.0153004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054850	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000062
J	Diaz-Nieto, LM; D'Alessio, C; Perotti, MA; Beron, CM				Diaz-Nieto, Leonardo M.; D'Alessio, Cecilia; Perotti, M. Alejandra; Beron, Corina M.			Culex pipiens Development Is Greatly Influenced by Native Bacteria and Exogenous Yeast	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; GUT MICROBIOTA; CULICIDAE; MOSQUITOS; OVIPOSITION; MIDGUT; MICROORGANISMS; BEHAVIOR; VIRUS; FOOD	Culex pipiens is the most cosmopolitan mosquito of the Pipiens Assemblage. By studying the nature of interactions between this species and microorganisms common to its breeding environment we can unravel important pitfalls encountered during development. We tested the survival rate of larval stages, pupae and adults of a Cx. pipiens colony exposed to a variety of microorganisms in laboratory conditions and assessed the transmission to offspring (F1) by those organisms that secured development up to adulthood. Three complementary experiments were designed to: 1) explore the nutritional value of yeasts and other microorganisms during Cx. pipiens development; 2) elucidate the transstadial transmission of yeast to the host offspring; and 3) to examine the relevance of all these microorganisms in female choice for oviposition-substratum. The yeast Saccharomyces cerevisiae proved to be the most nutritional diet, but despite showing the highest survival rates, vertical transmission to F1 was never confirmed. In addition, during the oviposition trials, none of the gravid females was attracted to the yeast substratum. Notably, the two native bacterial strains, Klebsiella sp. and Aeromonas sp., were the preferred oviposition media, the same two bacteria that managed to feed neonates until molting into 2nd instar larvae. Our results not only suggest that Klebsiella sp. or Aeromonas sp. serve as attractants for oviposition habitat selection, but also nurture the most fragile instar, L1, to assure molting into a more resilient stage, L2, while yeast proves to be the most supportive diet for completing development. These experiments unearthed survival traits that might be considered in the future development of strategies of Cx. pipiens control. These studies can be extended to other members of the Pipiens Assemblage.	[Diaz-Nieto, Leonardo M.; Beron, Corina M.] Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Biotecnol INBIOTEC, Mar Del Plata, Buenos Aires, Argentina; [Diaz-Nieto, Leonardo M.; Beron, Corina M.] FIBA, Mar Del Plata, Buenos Aires, Argentina; [D'Alessio, Cecilia] Consejo Nacl Invest Cient & Tecn, IIBBA, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina; [D'Alessio, Cecilia] UBA, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Perotti, M. Alejandra] Univ Reading, Sch Biol Sci, Ecol & Evolutionary Biol, Reading, Berks, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires; University of Reading	Beron, CM (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Biotecnol INBIOTEC, Mar Del Plata, Buenos Aires, Argentina.; Beron, CM (corresponding author), FIBA, Mar Del Plata, Buenos Aires, Argentina.	cberon@fiba.org.ar	Nieto, Leonardo Díaz/AAK-8763-2020	Nieto, Leonardo Díaz/0000-0003-4661-7084; Beron, Corina/0000-0002-0365-3571; D'Alessio, Cecilia/0000-0001-7371-5080	Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT PICT-2013-0431]; Universidad Nacional de Mar del Plata [15/E692-EXA742]; CONICET [112 20110100963]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de Mar del Plata(National University of La Plata); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT-2013-0431) CMB, Universidad Nacional de Mar del Plata (15/E692-EXA742) CMB, and CONICET (PIP 2012 No 112 20110100963) CMB.	[Anonymous], 1992, BIOL MOSQUITOES DEV; [Anonymous], 2003, MOSQUITOES THEIR CON; Balestrino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091914; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Chavshin AR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-419; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Douglas AE, 2014, J MOL BIOL, V426, P3830, DOI 10.1016/j.jmb.2014.04.005; Duguma D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0475-8; Duguma D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072522; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; Gusmao DS, 2007, MEM I OSWALDO CRUZ, V102, P919, DOI 10.1590/S0074-02762007000800005; HOWLAND L. J., 1930, BULL ENT RES [LONDON], V21, P431, DOI 10.1017/S0007485300024779; IBM Corp, 2011, IBM SPSS STAT WIND V; Ignatova E. A., 1996, Mikrobiolohichnyi Zhurnal, V58, P12; Khan I, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-90; Laird M., 1988, NATURAL HIST LARVAL; Lam K, 2007, ANIM BEHAV, V74, P81, DOI 10.1016/j.anbehav.2006.11.013; Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008; Marten GG, 2007, J AM MOSQUITO CONTR, V23, P177, DOI 10.2987/8756-971X(2007)23[177:LA]2.0.CO;2; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Micieli MV, 2013, J MED ENTOMOL, V50, P853, DOI 10.1603/ME12226; Muturi EJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1299-6; Nikoh N, 2000, MOL BIOL EVOL, V17, P629, DOI 10.1093/oxfordjournals.molbev.a026341; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409; Rejmankova E, 2005, J MED ENTOMOL, V42, P95, DOI 10.1603/0022-2585(2005)042[0095:VSFLHM]2.0.CO;2; Rejmankova Eliska, 2000, Aquatic Ecology, V34, P413, DOI 10.1023/A:1011416006562; Ricci I, 2012, CURR OPIN MICROBIOL, V15, P278, DOI 10.1016/j.mib.2012.03.004; Ricci I, 2011, ENVIRON MICROBIOL, V13, P911, DOI 10.1111/j.1462-2920.2010.02395.x; Ricci I, 2011, ANTON LEEUW INT J G, V99, P43, DOI 10.1007/s10482-010-9532-3; Rippka R, 1988, METHOD ENZYMOL, V167, P3; Rossi Gustavo C., 2015, Check List, V11, P1712; Sambrook J., 2001, MOL CLONING LAB MANU; Flores FS, 2010, VECTOR-BORNE ZOONOT, V10, P999, DOI 10.1089/vbz.2009.0136; Smith TW, 1998, J AM MOSQUITO CONTR, V14, P72; Spinelli, 2002, DIPTEROS VECTORES CU; Stata Corp, 2015, STAT STAT SOFTW REL; Sumba Leunita A., 2004, International Journal of Tropical Insect Science, V24, P260, DOI 10.1079/IJT200433; Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2; THIERY I, 1991, APPL ENVIRON MICROB, V57, P1354, DOI 10.1128/AEM.57.5.1354-1359.1991; Trexler JD, 2003, J MED ENTOMOL, V40, P841, DOI 10.1603/0022-2585-40.6.841; Vega Fernando E., 2005, P211; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	50	28	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153133	10.1371/journal.pone.0153133	http://dx.doi.org/10.1371/journal.pone.0153133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055276	Green Published, Green Accepted, gold			2022-12-26	WOS:000373608000082
J	Gardner, SN; McLoughlin, K; Be, NA; Allen, J; Weaver, SC; Forrester, N; Guerbois, M; Jaing, C				Gardner, Shea N.; McLoughlin, Kevin; Be, Nicholas A.; Allen, Jonathan; Weaver, Scott C.; Forrester, Naomi; Guerbois, Mathilde; Jaing, Crystal			Characterization of Genetic Variability of Venezuelan Equine Encephalitis Viruses	PLOS ONE			English	Article							ENCEPHALOMYELITIS VIRUS; HIGH-ACCURACY; EMERGENCE; EVOLUTION; PANAMA; TREES	Venezuelan equine encephalitis virus (VEEV) is a mosquito-borne alphavirus that has caused large outbreaks of severe illness in both horses and humans. New approaches are needed to rapidly infer the origin of a newly discovered VEEV strain, estimate its equine amplification and resultant epidemic potential, and predict human virulence phenotype. We performed whole genome single nucleotide polymorphism (SNP) analysis of all available VEE antigenic complex genomes, verified that a SNP-based phylogeny accurately captured the features of a phylogenetic tree based on multiple sequence alignment, and developed a high resolution genome-wide SNP microarray. We used the microarray to analyze a broad panel of VEEV isolates, found excellent concordance between array-and sequence-based SNP calls, genotyped unsequenced isolates, and placed them on a phylogeny with sequenced genomes. The microarray successfully genotyped VEEV directly from tissue samples of an infected mouse, bypassing the need for viral isolation, culture and genomic sequencing. Finally, we identified genomic variants associated with serotypes and host species, revealing a complex relationship between genotype and phenotype.	[Gardner, Shea N.; McLoughlin, Kevin; Allen, Jonathan] Lawrence Livermore Natl Lab, Computat, Livermore, CA USA; [Be, Nicholas A.; Jaing, Crystal] Lawrence Livermore Natl Lab, Phys & Life Sci, Livermore, CA USA; [Weaver, Scott C.; Forrester, Naomi; Guerbois, Mathilde] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Weaver, Scott C.; Forrester, Naomi; Guerbois, Mathilde] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Weaver, Scott C.; Forrester, Naomi; Guerbois, Mathilde] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Jaing, C (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci, Livermore, CA USA.	jaing2@llnl.gov	Weaver, Scott C/D-6490-2011	Weaver, Scott C/0000-0001-8016-8556; Allen, Jonathan/0000-0002-4359-8263; Jaing, Crystal/0000-0001-9933-3005	Defense Threat Reduction Agency; Lawrence Livermore National Laboratory [DTRA10027IA-2359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI120942] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Defense Threat Reduction Agency under Interagency Agreement with Lawrence Livermore National Laboratory (DTRA10027IA-2359). CJ and SW received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2004, EMERG INFECT DIS, V10, P880, DOI 10.3201/eid1005.030634; Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103; BERGE TO, 1961, AM J HYG, V73, P209, DOI 10.1093/oxfordjournals.aje.a120178; Brault AC, 2002, J VIROL, V76, P1718, DOI 10.1128/JVI.76.4.1718-1730.2002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferro C, 2008, BIOMEDICA, V28, P234, DOI 10.7705/biomedica.v28i2.94; Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787; Gardner SN, 2013, J MICROBIOL METH, V94, P303, DOI 10.1016/j.mimet.2013.07.006; Gardner SN, 2010, J FORENSIC RES, V01, P2, DOI [10.4172/2157-7145.1000107, DOI 10.4172/2157-7145.1000107]; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jaing C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002163; JOHNSON KM, 1968, AM J TROP MED HYG, V17, P432, DOI 10.4269/ajtmh.1968.17.432; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Price M.N., FAST TREE COMP TOOLS; Quiroz E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000472; Team RC, 2014, R LANG ENV STAT COMP; Therneau T, MVPART MULTIVARIATE; Venables WN., 2002, MODERN APPL STAT S 4; Venkatachalam B, 2010, IEEE ACM T COMPUT BI, V7, P588, DOI 10.1109/TCBB.2010.57; Vilcarromero S, 2010, EMERG INFECT DIS, V16, P553, DOI 10.3201/eid1603.090970; Vilcarrornero S, 2009, EMERG INFECT DIS, V15, P323, DOI 10.3201/eid1502.081018; Watts DM, 1997, AM J TROP MED HYG, V56, P661, DOI 10.4269/ajtmh.1997.56.661; Watts DM, 1998, AM J TROP MED HYG, V58, P35, DOI 10.4269/ajtmh.1998.58.35; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; Weaver SC, 1999, AM J TROP MED HYG, V60, P441, DOI 10.4269/ajtmh.1999.60.441; Wolfe DN, 2014, AM J TROP MED HYG, V91, P442, DOI 10.4269/ajtmh.14-0055	27	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152604	10.1371/journal.pone.0152604	http://dx.doi.org/10.1371/journal.pone.0152604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054586	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000373608000028
J	Houmani, N; Garcia-Salicetti, S				Houmani, Nesma; Garcia-Salicetti, Sonia			On Hunting Animals of the Biometric Menagerie for Online Signature	PLOS ONE			English	Article								Individuals behave differently regarding to biometric authentication systems. This fact was formalized in the literature by the concept of Biometric Menagerie, defining and labeling user groups with animal names in order to reflect their characteristics with respect to biometric systems. This concept was illustrated for face, fingerprint, iris, and speech modalities. The present study extends the Biometric Menagerie to online signatures, by proposing a novel methodology that ties specific quality measures for signatures to categories of the Biometric Menagerie. Such measures are combined for retrieving automatically writer categories of the extended version of the Biometric Menagerie. Performance analysis with different types of classifiers shows the pertinence of our approach on the well-known MCYT-100 database.	[Houmani, Nesma] Univ Paris Saclay, Telecom SudParis, 9 Rue Charles Fourier, F-91011 Evry, France; [Garcia-Salicetti, Sonia] Univ Paris Saclay, CNRS, Telecom SudParis, SAMOVAR, 9 Rue Charles Fourier, F-91011 Evry, France	IMT - Institut Mines-Telecom; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); IMT - Institut Mines-Telecom; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay	Houmani, N (corresponding author), Univ Paris Saclay, Telecom SudParis, 9 Rue Charles Fourier, F-91011 Evry, France.	nesma.houmani@telecom-sudparis.eu						Ahmad SMS, 2010, P 10 INT C INF SCI S, V10.1109/ISSPA.2010.5605415, DOI DOI 10.1109/ISSPA.2010.5605415; Alonso-Fernandez F, 2007, IEEE IMAGE PROC, P369; Alonso-Fernandez F., 2008, THESIS U POLITECNICA; Alonso-Fernandez F., 2007, BIOMETRICS THEORY AP, P1, DOI [10.1109/BCC.2007.4430548, DOI 10.1109/BCC.2007.4430548]; [Anonymous], 1993, PRENTICE HALL SIGNAL; Bouletreau V, 1998, INT C PATT RECOG, P1758, DOI 10.1109/ICPR.1998.712067; Brault J.-J., 1989, Proceedings. 1989 International Carnahan Conference on Security Technology (Cat. No.89CH2774-8), P127, DOI 10.1109/CCST.1989.751966; BRAULT JJ, 1993, IEEE T SYST MAN CYB, V23, P400, DOI 10.1109/21.229453; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chen ZQ, 2014, ENTROPY-SWITZ, V16, P5416, DOI 10.3390/e16105416; Cover TM, 2006, ELEMENTS OF INFORMAT; Doddington G., 1998, P INT C SPOK LANG PR; Dudoit S, 2002, GENOME BIOL, V3; Fierrez-Aguilar J, 2005, LECT NOTES COMPUT SC, V3546, P523; Garcia S, 2009, EURASIP J EMBED SYST, DOI [10.1155/2009/574716, 10.1155/2009/964746]; Garcia-Salicetti S, 2008, P IEEE BIOM S, DOI [10.1109/BSYM.2008.4655527, DOI 10.1109/BSYM.2008.4655527]; Garcia-Salicetti S, 2009, GUIDE BIOMETRIC REFE, P125; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Holzinger Andreas, 2014, Interactive Knowledge Discovery and Data Mining in Biomedical Informatics. State-of-the-Art and Future Challenges: LNCS 8401, P209, DOI 10.1007/978-3-662-43968-5_12; Houmani N, 2012, PATTERN RECOGN, V45, P993, DOI 10.1016/j.patcog.2011.08.008; Houmani N, 2011, THESIS TELECOM SUDPA; Houmani N., 2014, SIGNAL IMAGE PROCESS, P255, DOI [DOI 10.1007/978-3-642-54080-6_10, 10.1007/978-3-642-54080-6_10]; Houmani N., 2011, 2011 INT JOINT C BIO, P1, DOI DOI 10.1109/IJCB.2011.6117487; Houmani N, 2008, P IEEE 2 INT C BIOM, DOI [10.1109/BTAS.2008.4699362, DOI 10.1109/BTAS.2008.4699362]; HUBERT L, 1976, BRIT J MATH STAT PSY, V29, P190, DOI 10.1111/j.2044-8317.1976.tb00714.x; Islam T, 2012, INT CONF FRONT HAND, P791, DOI 10.1109/ICFHR.2012.240; Jain A.K., 2008, HDB BIOMETRICS; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Ortega-Garcia J, 2003, IEE P-VIS IMAGE SIGN, V150, P395, DOI 10.1049/ip-vis:20031078; Ortega-Garcia J, 2010, IEEE T PATTERN ANAL, V32, P1097, DOI 10.1109/TPAMI.2009.76; Paone J, 2011, P IEEE INT WORKSH IN, P1, DOI [10.1109/WIFS.2011.6123158, DOI 10.1109/WIFS.2011.6123158]; Poh N, 2009, P 3 INT C ADV BIOM, P816; Poh N., 2010, P IEEE C COMP VIS PA, P38, DOI DOI 10.1109/CVPRW.2010.5543235; Poh N, 2006, P 2 WORKSH MULT US A; Poh N, 2008, 2008 BIOMETRICS SYMPOSIUM (BSYM), P17, DOI 10.1109/BSYM.2008.4655517; Tan P., 2006, INTRO DATA MINING; Wittman M, 2006, P IEEE C COMP VIS PA, DOI [10.1109/CVPRW.2006.71, DOI 10.1109/CVPRW.2006.71]; Yager N, 2007, P IEEE WORKSH AUT ID, DOI [10.1109/AUTOID.2007.380583, DOI 10.1109/AUTOID.2007.380583]; Yager N, 2010, IEEE T PATTERN ANAL, V32, P220, DOI 10.1109/TPAMI.2008.291; Yeung DY, 2004, LECT NOTES COMPUT SC, V3072, P16	40	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0151691	10.1371/journal.pone.0151691	http://dx.doi.org/10.1371/journal.pone.0151691			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054836	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000006
J	Sepulveda, D; Lorenzen, N				Sepulveda, Dagoberto; Lorenzen, Niels			Can VHS Virus Bypass the Protective Immunity Induced by DNA Vaccination in Rainbow Trout?	PLOS ONE			English	Article							VIRAL HEMORRHAGIC SEPTICEMIA; HEMATOPOIETIC NECROSIS VIRUS; ONCORHYNCHUS-MYKISS; FISH RHABDOVIRUS; EGTVED VIRUS; GENE; GLYCOPROTEIN; EXPRESSION; IMMUNIZATION; INJECTION	DNA vaccines encoding viral glycoproteins have been very successful for induction of protective immunity against diseases caused by rhabdoviruses in cultured fish species. However, the vaccine concept is based on a single viral gene and since RNA viruses are known to possess high variability and adaptation capacity, this work aimed at evaluating whether viral haemorrhagic septicaemia virus (VHSV), an RNA virus and member of Rhabdoviridae family, was able to evade the protective immune response induced by the DNA vaccination of rainbow trout. The experiments comprised repeated passages of a highly pathogenic VHSV isolate in a fish cell line in the presence of neutralizing fish serum (in vitro approach), and in rainbow trout immunized with the VHS DNA vaccine (in vivo approach). For the in vitro approach, the virus collected from the last passage (passaged virus) was as sensitive as the parental virus to serum neutralization, suggesting that the passaging did not promote the selection of virus populations able to bypass the neutralization by serum antibodies. Also, in the in vivo approach, where virus was passaged several times in vaccinated fish, no increased virulence nor increased persistence in vaccinated fish was observed in comparison with the parental virus. However, some of the vaccinated fish did get infected and could transmit the infection to naive cohabitant fish. The results demonstrated that the DNA vaccine induced a robust protection, but also that the immunity was non-sterile. It is consequently important not to consider vaccinated fish as virus free in veterinary terms.	[Sepulveda, Dagoberto; Lorenzen, Niels] Aarhus Univ, Dept Anim Sci, Aarhus, Denmark	Aarhus University	Lorenzen, N (corresponding author), Aarhus Univ, Dept Anim Sci, Aarhus, Denmark.	niels.lorenzen@anis.au.dk	; Lorenzen, Niels/L-3967-2017	Sepulveda, Dagoberto/0000-0001-8553-5861; Lorenzen, Niels/0000-0002-6946-3252	Chilean National Scholarship Program for Graduate Studies Conicyt; European Commission [FP7311993]	Chilean National Scholarship Program for Graduate Studies Conicyt; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by Chilean National Scholarship Program for Graduate Studies Conicyt for DS, and by the European Commission contract FP7311993 TargetFish.	AHNE W, 1986, J APPL ICHTHYOL, V2, P187, DOI 10.1111/j.1439-0426.1986.tb00427.x; Ammayappan A, 2011, J VIROL, V85, P8393, DOI 10.1128/JVI.00597-11; BEARZOTTI M, 1995, VET RES, V26, P413; Boudinot P, 1999, J VIROL, V73, P1846, DOI 10.1128/JVI.73.3.1846-1852.1999; Boudinot P, 1998, VIROLOGY, V249, P297, DOI 10.1006/viro.1998.9322; Boudinot P, 2001, FISH SHELLFISH IMMUN, V11, P383, DOI 10.1006/fsim.2000.0326; Castro R, 2014, VACCINE, V32, P1160, DOI 10.1016/j.vaccine.2013.11.062; DEKINKELIN P, 1995, VET RES, V26, P379; Domingo E, 2001, QUASISPECIES RNA VIR; Einer-Jensen K, 2009, VACCINE, V27, P1248, DOI 10.1016/j.vaccine.2008.12.007; Fijan N, 1983, ANN I PASTEUR VIROLO; Heppell J, 1998, FISH SHELLFISH IMMUN, V8, P271, DOI 10.1006/fsim.1997.0133; Huang CJ, 1996, J GEN VIROL, V77, P3033, DOI 10.1099/0022-1317-77-12-3033; JORGENSEN PEV, 1982, J FISH DIS, V5, P47, DOI 10.1111/j.1365-2761.1982.tb00455.x; Kim CH, 2000, J VIROL, V74, P7048, DOI 10.1128/JVI.74.15.7048-7054.2000; Kurath G., 2007, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V2, DOI 10.1079/PAVSNNR20072048; LaPatra SE, 2001, VACCINE, V19, P4011, DOI 10.1016/S0264-410X(01)00113-X; Lorenzen E, 2000, J AQUAT ANIM HEALTH, V12, P167, DOI 10.1577/1548-8667(2000)012&lt;0167:FVORTA&gt;2.0.CO;2; Lorenzen E, 2009, VACCINE, V27, P3870, DOI 10.1016/j.vaccine.2009.04.012; Lorenzen N, 2000, NAT BIOTECHNOL, V18, P1177, DOI 10.1038/81169; Lorenzen N, 1999, VIRUS RES, V63, P19, DOI 10.1016/S0168-1702(99)00054-4; Lorenzen N, 1999, AQUACULTURE, V172, P41, DOI 10.1016/S0044-8486(98)00443-8; LORENZEN N, 1990, J GEN VIROL, V71, P561, DOI 10.1099/0022-1317-71-3-561; Lorenzen N, 1998, FISH SHELLFISH IMMUN, V8, P261, DOI 10.1006/fsim.1997.0134; Lorenzen N, 2002, DEV COMP IMMUNOL, V26, P173, DOI 10.1016/S0145-305X(01)00059-3; Lorenzen N, 2001, FISH SHELLFISH IMMUN, V11, P585, DOI 10.1006/fsim.2001.0337; Lorenzen N, 1996, DEV BIOL STAND, V90, P201; McLauchlan PE, 2003, FISH SHELLFISH IMMUN, V15, P39, DOI 10.1016/S1050-4648(02)00137-7; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; Purcell MK, 2004, FISH SHELLFISH IMMUN, V17, P447, DOI 10.1016/j.fsi.2004.04.017; Read AF, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002198; Reading SA, 2007, ARCH VIROL, V152, P1047, DOI 10.1007/s00705-006-0923-8; REED L. J., 1938, AMER JOUR HYG, V27, P493; Salonius K, 2007, CURR OPIN INVEST DR, V8, P635; Schonherz AA, 2015, VET RES; Skall HF, 2005, J FISH DIS, V28, P509, DOI 10.1111/j.1365-2761.2005.00654.x; Sommerset I, 2003, VACCINE, V21, P4661, DOI 10.1016/S0264-410X(03)00526-7; Tafalla C, 2007, FISH SHELLFISH IMMUN, V23, P210, DOI 10.1016/j.fsi.2006.10.009; Utke K, 2008, DEV COMP IMMUNOL, V32, P239, DOI 10.1016/j.dci.2007.05.010; Walker P, 2000, 7 INT COMM TAX VIR; WOLF K, 1966, SCIENCE, V151, P1004, DOI 10.1126/science.151.3713.1004	41	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153306	10.1371/journal.pone.0153306	http://dx.doi.org/10.1371/journal.pone.0153306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054895	gold, Green Published			2022-12-26	WOS:000373608000118
J	Barsoumian, HB; Yolcu, ES; Shirwan, H				Barsoumian, Hampartsoum B.; Yolcu, Esma S.; Shirwan, Haval			4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4(+)CD25(+)FoxP3(+) T Regulatory Cell Suppression	PLOS ONE			English	Article							THERAPEUTIC CANCER VACCINES; MURINE DENDRITIC CELLS; GROWTH-FACTOR-BETA; IFN-GAMMA; MEDIATED APOPTOSIS; IMMUNE-RESPONSES; FOXP3 EXPRESSION; VIVO EXPANSION; CUTTING EDGE; COSTIMULATION	Costimulation with the recombinant SA-4-1BBL agonist of 4-1BB receptor on conventional CD4(+) T cells (Tconvs) overcomes the suppression mediated by naturally occurring CD4(+)CD25(+)FoxP3(+) T regulatory cells (Tregs). The mechanistic basis of this observation has remained largely unknown. Herein we show that Tconvs, but not Tregs, are the direct target of SA-4-1BBL-mediated evasion of Treg suppression. IL-2 produced by Tconvs in response to 4-1BB signaling is both necessary and sufficient for overcoming Treg suppression. Supernatant from Tconvs stimulated with SA-4-1BBL contains high levels of IL-2 and overcomes Treg suppression in ex vivo Tconv: Treg cocultures. Removal of IL-2 from such supernatant restores Treg suppression and repletion of Tconv: Treg cocultures with exogenous recombinant IL-2 overcomes suppression. This study establishes 4-1BB signaling as a key circuit that regulates physical and functional equilibrium between Tregs and Tconvs with important implications for immunotherapy for indications where a fine balance between Tregs and Teffs plays a decisive role.	[Yolcu, Esma S.; Shirwan, Haval] Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA; [Yolcu, Esma S.; Shirwan, Haval] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Yolcu, ES; Shirwan, H (corresponding author), Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA.; Yolcu, ES; Shirwan, H (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA.	esma.yolcu@louisville.edu; haval.shirwan@louisville.edu			Commonwealth of Kentucky Research Challenge Trust Fund; Keck Foundation	Commonwealth of Kentucky Research Challenge Trust Fund; Keck Foundation(W.M. Keck Foundation)	This work was supported by the Commonwealth of Kentucky Research Challenge Trust Fund and the Keck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins MB, 2002, SEMIN ONCOL, V29, P12, DOI 10.1053/sonc.2002.33077; Chang JH, 2009, EUR J IMMUNOL, V39, P1241, DOI 10.1002/eji.200838913; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi BK, 2009, J IMMUNOL, V182, P4107, DOI 10.4049/jimmunol.0800459; Choi BK, 2004, J LEUKOCYTE BIOL, V75, P785, DOI 10.1189/jlb.1003491; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Eljaafari A, 2009, J IMMUNOL, V183, P2932, DOI 10.4049/jimmunol.0804352; Elpek KG, 2007, J IMMUNOL, V179, P7295, DOI 10.4049/jimmunol.179.11.7295; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; Futagawa T, 2002, INT IMMUNOL, V14, P275, DOI 10.1093/intimm/14.3.275; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Hagness M, 2012, J IMMUNOL, V188, P5459, DOI 10.4049/jimmunol.1101367; Hamano R, 2011, EUR J IMMUNOL, V41, P2010, DOI 10.1002/eji.201041205; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Kawamoto K, 2012, AUTOIMMUNITY, V45, P310, DOI 10.3109/08916934.2012.664667; Kendal AR, 2011, J EXP MED, V208, P2043, DOI 10.1084/jem.20110767; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Kim YJ, 2005, BLOOD, V105, P274, DOI 10.1182/blood-2003-12-4343; Koenecke C, 2012, J IMMUNOL, V189, P2890, DOI 10.4049/jimmunol.1200413; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Kuang YL, 2012, ONCOL LETT, V3, P477, DOI 10.3892/ol.2011.506; Kwon BS, 2002, J IMMUNOL, V168, P5483, DOI 10.4049/jimmunol.168.11.5483; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Madireddi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042459; McCoy KD, 1999, IMMUNOL CELL BIOL, V77, P1, DOI 10.1046/j.1440-1711.1999.00795.x; Menoret A, 2006, J IMMUNOL, V177, P6091, DOI 10.4049/jimmunol.177.9.6091; Murawski MR, 2006, ANN NY ACAD SCI, V1079, P198, DOI 10.1196/annals.1375.031; Myers L, 2005, J IMMUNOL, V174, P7625, DOI 10.4049/jimmunol.174.12.7625; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schabowsky RH, 2007, CURR OPIN INVEST DR, V8, P1002; Schabowsky RH, 2009, VACCINE, V28, P512, DOI 10.1016/j.vaccine.2009.09.127; Sharma RK, 2010, CANCER GENE THER, V17, P730, DOI 10.1038/cgt.2010.29; Sharma RK, 2014, EXPERT REV VACCINES, V13, P387, DOI 10.1586/14760584.2014.880340; Sharma RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073145; Sharma RK, 2010, CANCER RES, V70, P3945, DOI 10.1158/0008-5472.CAN-09-4480; Sharma RK, 2009, CANCER RES, V69, P4319, DOI 10.1158/0008-5472.CAN-08-3141; Sitrin J, 2013, J EXP MED, V210, P1153, DOI 10.1084/jem.20122248; Smith SE, 2011, CANCER IMMUNOL IMMUN, V60, P1775, DOI 10.1007/s00262-011-1075-6; Srivastava AK, 2014, CANCER RES, V74, P6441, DOI 10.1158/0008-5472.CAN-14-1768-A; Srivastava AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048463; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Wilcox RA, 2002, J IMMUNOL, V168, P4262, DOI 10.4049/jimmunol.168.9.4262; Yang JC, 2003, J CLIN ONCOL, V21, P3127, DOI 10.1200/JCO.2003.02.122; Zhang P, 2007, SCAND J IMMUNOL, V66, P435, DOI 10.1111/j.1365-3083.2007.01994.x; Zheng GX, 2004, J IMMUNOL, V173, P2428, DOI 10.4049/jimmunol.173.4.2428; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	49	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153088	10.1371/journal.pone.0153088	http://dx.doi.org/10.1371/journal.pone.0153088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049955	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500097
J	Billard, MJ; Fitzhugh, DJ; Parker, JS; Brozowski, JM; McGinnis, MW; Timoshchenko, RG; Serafin, S; Lininger, R; Klauber-Demore, N; Sahagian, G; Truong, YK; Sassano, MF; Serody, JS; Tarrant, TK				Billard, Matthew J.; Fitzhugh, David J.; Parker, Joel S.; Brozowski, Jaime M.; McGinnis, Marcus W.; Timoshchenko, Roman G.; Serafin, Stephen; Lininger, Ruth; Klauber-Demore, Nancy; Sahagian, Gary; Truong, Young K.; Sassano, Maria F.; Serody, Jonathan S.; Tarrant, Teresa K.			G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL-LINES; BETA-ARRESTIN; CHEMOKINE RECEPTORS; DOWN-REGULATION; TUMOR NECROSIS; CXCR4; EXPRESSION; GROWTH; ACTIVATION	Triple negative breast cancer (TNBC) is a heterogeneous disease that has a poor prognosis and limited treatment options. Chemokine receptor interactions are important modulators of breast cancer metastasis; however, it is now recognized that quantitative surface expression of one important chemokine receptor, CXCR4, may not directly correlate with metastasis and that its functional activity in breast cancer may better inform tumor pathogenicity. G protein coupled receptor kinase 3 (GRK3) is a negative regulator of CXCR4 activity, and we show that GRK expression correlates with tumorigenicity, molecular subtype, and metastatic potential in human tumor microarray analysis. Using established human breast cancer cell lines and an immunocompetent in vivo mouse model, we further demonstrate that alterations in GRK3 expression levels in tumor cells directly affect migration and invasion in vitro and the establishment of distant metastasis in vivo. The effects of GRK3 modulation appear to be specific to chemokine-mediated migration behaviors without influencing tumor cell proliferation or survival. These data demonstrate that GRK3 dysregulation may play an important part in TNBC metastasis.	[Billard, Matthew J.; Fitzhugh, David J.; McGinnis, Marcus W.; Timoshchenko, Roman G.; Serafin, Stephen; Tarrant, Teresa K.] Univ N Carolina, Thurston Arthrit Res Ctr, Chapel Hill, NC 27599 USA; [Billard, Matthew J.; Fitzhugh, David J.; McGinnis, Marcus W.; Timoshchenko, Roman G.; Serafin, Stephen; Tarrant, Teresa K.] Univ N Carolina, Dept Med, Div Rheumatol Allergy & Immunol, Chapel Hill, NC 27599 USA; [Parker, Joel S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Parker, Joel S.; Lininger, Ruth; Klauber-Demore, Nancy; Serody, Jonathan S.; Tarrant, Teresa K.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Brozowski, Jaime M.; Tarrant, Teresa K.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Lininger, Ruth] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Klauber-Demore, Nancy] Univ N Carolina, Dept Surg, Div Surg Oncol, Chapel Hill, NC 27599 USA; [Serody, Jonathan S.] Univ N Carolina, Dept Med, Div Hematol Oncol, Chapel Hill, NC 27599 USA; [Sahagian, Gary] Tufts Univ, Dept Dev Mol & Chem Biol, Medford, MA 02155 USA; [Truong, Young K.] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Sassano, Maria F.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Tufts University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tarrant, TK (corresponding author), Univ N Carolina, Thurston Arthrit Res Ctr, Chapel Hill, NC 27599 USA.; Tarrant, TK (corresponding author), Univ N Carolina, Dept Med, Div Rheumatol Allergy & Immunol, Chapel Hill, NC 27599 USA.; Tarrant, TK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Tarrant, TK (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	Tarra002@med.unc.edu	Parker, Joel/AAG-1108-2019; , UNC Flow Cytometry Core/AGU-9839-2022	Tarrant, Teresa/0000-0003-4067-5363	North Carolina University Cancer Research Funds (UCRF) [K01 AI091863, K08 AI070684, R03AR059286]; NHLBI [F31HL128029]; UNC Thurston Arthritis Research Center (TARC) Funds; NSF [DMS-1106962]; UNC Clinical Translation Science Award [TR000083-05]; Cancer Center Core Support Grant [P30 CA016086]; NATIONAL CANCER INSTITUTE [P50CA058223, P30CA016086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL128029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI091863, K08AI070684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR059286] Funding Source: NIH RePORTER	North Carolina University Cancer Research Funds (UCRF); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UNC Thurston Arthritis Research Center (TARC) Funds; NSF(National Science Foundation (NSF)); UNC Clinical Translation Science Award; Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors wish to acknowledge the following funding sources in support of this research: North Carolina University Cancer Research Funds (UCRF) (TKT), K01 AI091863 (MJB), K08 AI070684 (TKT), R03AR059286 (TKT), NHLBI F31HL128029 (JMB), UNC Thurston Arthritis Research Center (TARC) Funds (TKT, MJB), NSF DMS-1106962 (YKT), and UNC Clinical Translation Science Award, Biostatistics Core TR000083-05 (YKT). The UNC Flow Cytometry Core Facility is supported in part by P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds195; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; BONFIL RD, 1988, CLIN EXP METASTAS, V6, P121, DOI 10.1007/BF01784843; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Chen HW, 2013, CURR MOL MED, V13, P410; Chu QYD, 2010, J SURG RES, V159, P689, DOI 10.1016/j.jss.2008.09.020; Cleere DW., 2010, COMMUNITY ONCOLOGY, V7; Costantini S, 2013, CYTOKINE, V64, P316, DOI 10.1016/j.cyto.2013.05.024; Desai AN, 2006, J PHARMACOL EXP THER, V317, P1027, DOI 10.1124/jpet.105.098996; Diaz-Montero CM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-39; Drury LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012895; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Duffy MJ, 2012, INT J CANCER, V131, P2471, DOI 10.1002/ijc.27632; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Gil M, 2013, P NATL ACAD SCI USA, V110, pE1291, DOI 10.1073/pnas.1220580110; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Holland JD, 2006, CANCER RES, V66, P4117, DOI 10.1158/0008-5472.CAN-05-1631; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; King DW, 2003, ENDOCRINE, V22, P135, DOI 10.1385/ENDO:22:2:135; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lapteva N, 2005, CANCER GENE THER, V12, P84, DOI 10.1038/sj.cgt.7700770; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Li F, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0180-8; Li J, 2004, ONCOGENE, V23, P9359, DOI 10.1038/sj.onc.1208039; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lipfert J, 2013, CELL MOL NEUROBIOL, V33, P111, DOI 10.1007/s10571-012-9876-5; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Martens K, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-162; McSherry EA, 2007, CELL MOL LIFE SCI, V64, P3201, DOI 10.1007/s00018-007-7388-0; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mirisola V, 2009, EUR J CANCER, V45, P2579, DOI 10.1016/j.ejca.2009.06.026; Mishan MA, 2015, IRAN J PUBLIC HEALTH, V44, P1353; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Norton KA, 2015, AM J CANCER RES, V5, P1295; Pang MF, 2016, ONCOGENE, V35, P748, DOI 10.1038/onc.2015.133; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Phoenix KN, 2010, BREAST CANCER RES TR, V123, P333, DOI 10.1007/s10549-009-0647-z; Prat A, 2013, BREAST CANCER RES TR, V142, P237, DOI 10.1007/s10549-013-2743-3; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Raghuwanshi SK, 2013, J IMMUNOL, V190, P5329, DOI 10.4049/jimmunol.1202058; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Salazar N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-198; Salim S, 2007, J PHARMACOL EXP THER, V321, P51, DOI 10.1124/jpet.106.116921; Sauve K, 2009, CANCER RES, V69, P5793, DOI 10.1158/0008-5472.CAN-08-4924; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Stacer AC, 2016, ONCOGENE, V35, P1716, DOI 10.1038/onc.2015.236; Stevens KN, 2013, CANCER RES, V73, P2025, DOI 10.1158/0008-5472.CAN-12-1699; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tarrant TK, 2013, J LEUKOCYTE BIOL, V94, P1243, DOI 10.1189/jlb.0213097; Tutunea-Fatan E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0306-4; Ueda Y, 2006, CANCER RES, V66, P5665, DOI 10.1158/0008-5472.CAN-05-3579; Wani NA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3665; Watts AO, 2013, BRIT J PHARMACOL, V168, P1662, DOI 10.1111/bph.12064; Woerner BM, 2012, MOL CANCER RES, V10, P156, DOI 10.1158/1541-7786.MCR-11-0411; Yang P, 2014, CURR MOL MED, V14, P174, DOI 10.2174/1566524013666131121115656; Yuan LP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-18; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; Zhu GQ, 2015, ONCOTARGET, V6, P43408, DOI 10.18632/oncotarget.6125	70	40	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152856	10.1371/journal.pone.0152856	http://dx.doi.org/10.1371/journal.pone.0152856			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049755	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500061
J	Pogorelko, GV; Kambakam, S; Nolan, T; Foudree, A; Zabotina, OA; Rodermel, SR				Pogorelko, Gennady V.; Kambakam, Sekhar; Nolan, Trevor; Foudree, Andrew; Zabotina, Olga A.; Rodermel, Steven R.			Impaired Chloroplast Biogenesis in Immutans, an Arabidopsis Variegation Mutant, Modifies Developmental Programming, Cell Wall Composition and Resistance to Pseudomonas syringae	PLOS ONE			English	Article							TERMINAL OXIDASE; PLASTID SIGNALS; GENE-EXPRESSION; WILD-TYPE; PHOTOSYNTHESIS; STRESS; WHITE; DIFFERENTIATION; MORPHOGENESIS; TRANSCRIPTION	The immutans (im) variegation mutation of Arabidopsis has green-and white-sectored leaves due to action of a nuclear recessive gene. IM codes for PTOX, a plastoquinol oxidase in plastid membranes. Previous studies have revealed that the green and white sectors develop into sources (green tissues) and sinks (white tissues) early in leaf development. In this report we focus on white sectors, and show that their transformation into effective sinks involves a sharp reduction in plastid number and size. Despite these reductions, cells in the white sectors have near-normal amounts of plastid RNA and protein, and surprisingly, a marked amplification of chloroplast DNA. The maintenance of protein synthesis capacity in the white sectors might poise plastids for their development into other plastid types. The green and white im sectors have different cell wall compositions: whereas cell walls in the green sectors resemble those in wild type, cell walls in the white sectors have reduced lignin and cellulose microfibrils, as well as alterations in galactomannans and the decoration of xyloglucan. These changes promote susceptibility to the pathogen Pseudomonas syringae. Enhanced susceptibility can also be explained by repressed expression of some, but not all, defense genes. We suggest that differences in morphology, physiology and biochemistry between the green and white sectors is caused by a reprogramming of leaf development that is coordinated, in part, by mechanisms of retrograde (plastid-to-nucleus) signaling, perhaps mediated by ROS. We conclude that variegation mutants offer a novel system to study leaf developmental programming, cell wall metabolism and host-pathogen interactions.	[Pogorelko, Gennady V.; Kambakam, Sekhar; Nolan, Trevor; Foudree, Andrew; Rodermel, Steven R.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Pogorelko, Gennady V.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Lab Funct Genom, Gubkina St 3, Moscow 119991, Russia; [Zabotina, Olga A.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Iowa State University	Rodermel, SR (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	rodermel@iastate.edu	Pogorelko, Gennady/K-2721-2018; Nolan, Trevor/AAB-5319-2022	Nolan, Trevor/0000-0003-1362-2557	Energy Biosciences [DF-FG02-94ER20147]; U.S. Department of Energy (Energy Biosciences) [DF-FG02-94ER20147]	Energy Biosciences; U.S. Department of Energy (Energy Biosciences)(United States Department of Energy (DOE))	This work was supported by Energy Biosciences, Grant DF-FG02-94ER20147.; This work was supported by the U.S. Department of Energy (Energy Biosciences; Grant DF-FG02-94ER20147 to S.R.R.). We thank Marena Bartz for her technical assistance in the manuscript preparation.	Aluru MR, 2007, PHOTOSYNTH RES, V91, P11, DOI 10.1007/s11120-005-9021-0; Aluru MR, 2006, J EXP BOT, V57, P1871, DOI 10.1093/jxb/erj008; Aluru MR, 2009, PLANT PHYSIOL, V150, P904, DOI 10.1104/pp.109.135780; Aluru MR, 2001, PLANT PHYSIOL, V127, P67, DOI 10.1104/pp.127.1.67; Bailey-Serres J, 2006, PLANT PHYSIOL, V141, P311, DOI 10.1104/pp.104.900191; Brautigam A, 2009, MOL PLANT, V2, P1247, DOI 10.1093/mp/ssp070; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Dietzel L, 2015, MOL PLANT, V8, P1237, DOI 10.1016/j.molp.2015.03.004; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Foudree A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00260; Fraser CM, 2011, THE PHENYLPROPANOID; Heyno E, 2009, J BIOL CHEM, V284, P31174, DOI 10.1074/jbc.M109.021667; HORNER HT, 1980, AM J BOT, V67, P1347, DOI 10.2307/2442137; Ivanov AG, 2012, PHOTOSYNTH RES, V113, P191, DOI 10.1007/s11120-012-9769-y; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jung HS, 2013, P NATL ACAD SCI USA, V110, P14474, DOI 10.1073/pnas.1311632110; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kato Y, 2007, PLANT PHYSIOL, V144, P952, DOI 10.1104/pp.107.099002; Kim CH, 2013, PHOTOSYNTH RES, V116, P455, DOI 10.1007/s11120-013-9876-4; Kim CH, 2013, MOL PLANT, V6, P1580, DOI 10.1093/mp/sst020; Leon P, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00304; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Lopez-Juez E, 2009, NEW PHYTOL, V182, P287, DOI 10.1111/j.1469-8137.2009.02808.x; McDonald AE, 2011, BBA-BIOENERGETICS, V1807, P954, DOI 10.1016/j.bbabio.2010.10.024; Meehan L, 1996, PLANT PHYSIOL, V112, P953, DOI 10.1104/pp.112.3.953; Miedes E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00358; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; MULLET JE, 1988, ANNU REV PLANT PHYS, V39, P475, DOI 10.1146/annurev.arplant.39.1.475; Okegawa Y, 2010, PLANT J, V63, P458, DOI 10.1111/j.1365-313X.2010.04252.x; Pang SL, 2014, GENET MOL RES, V13, P7217, DOI 10.4238/2014.September.5.7; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Peng LW, 2012, PLANT CELL, V24, P202, DOI 10.1105/tpc.111.090597; Petrillo E, 2014, RNA BIOL, V11, P1215, DOI 10.4161/15476286.2014.972852; Pfannschmidt T, 2003, ANTIOXID REDOX SIGN, V5, P95, DOI 10.1089/152308603321223586; Pitzschke A, 2009, MOL PLANT, V2, P120, DOI 10.1093/mp/ssn079; Ploscher M, 2011, J PROTEOMICS, V74, P1256, DOI 10.1016/j.jprot.2011.03.020; Pogorelko G, 2011, PLANT MOL BIOL, V77, P433, DOI 10.1007/s11103-011-9822-9; Putarjunan A, 2014, PLANT PHYSIOL, V166, P2115, DOI 10.1104/pp.114.250647; Putarjunan A, 2013, PHOTOSYNTH RES, V116, P437, DOI 10.1007/s11120-013-9855-9; Pyke K, 1999, CRIT REV PLANT SCI, V18, P527, DOI 10.1016/S0735-2689(99)00390-1; REDEI GP, 1963, SCIENCE, V139, P767, DOI 10.1126/science.139.3556.767; Rodermel S, 2001, TRENDS PLANT SCI, V6, P471, DOI 10.1016/S1360-1385(01)02085-4; Rosso D, 2006, PLANT PHYSIOL, V142, P574, DOI 10.1104/pp.106.085886; Rosso D, 2009, PLANT CELL, V21, P3473, DOI 10.1105/tpc.108.062752; Ruckle ME, 2007, PLANT CELL, V19, P3944, DOI 10.1105/tpc.107.054312; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Schiff H., 1866, LIEBIGS ANN CHEM, V140, P92, DOI DOI 10.1002/JLAC.18661400106; Schilmiller AL, 2009, PLANT J, V60, P771, DOI 10.1111/j.1365-313X.2009.03996.x; SMITH LG, 1992, PLANT CELL, V4, P1017, DOI 10.1105/tpc.4.9.1017; Sridharan Gokul, 2012, J Oral Maxillofac Pathol, V16, P251, DOI 10.4103/0973-029X.99081; Stessman D, 2002, PHOTOSYNTH RES, V72, P27, DOI 10.1023/A:1016043003839; Terry MJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00014; WETZEL CM, 1994, PLANT J, V6, P161, DOI 10.1046/j.1365-313X.1994.6020161.x; WIDHOLM JM, 1972, STAIN TECHNOL, V47, P189, DOI 10.3109/10520297209116483; Wu DY, 1999, PLANT CELL, V11, P43, DOI 10.1105/tpc.11.1.43; Yu F, 2007, PLANT CELL ENVIRON, V30, P350, DOI 10.1111/j.1365-3040.2006.01630.x; Yu QJ, 2014, BBA-BIOENERGETICS, V1837, P1284, DOI 10.1016/j.bbabio.2014.04.007; Zabotina OA, 2008, PLANT J, V56, P101, DOI 10.1111/j.1365-313X.2008.03580.x; Zhu SF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002318	61	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0150983	10.1371/journal.pone.0150983	http://dx.doi.org/10.1371/journal.pone.0150983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050746	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500004
J	Sansone, A; Tolika, E; Louka, M; Sunda, V; Deplano, S; Melchiorre, M; Anagnostopoulos, D; Chatgilialoglu, C; Formisano, C; Di Micco, R; Mennella, MRF; Ferreri, C				Sansone, Anna; Tolika, Evanthia; Louka, Maria; Sunda, Valentina; Deplano, Simone; Melchiorre, Michele; Anagnostopoulos, Dimitrios; Chatgilialoglu, Chryssostomos; Formisano, Cesare; Di Micco, Rosa; Mennella, Maria Rosaria Faraone; Ferreri, Carla			Hexadecenoic Fatty Acid Isomers in Human Blood Lipids and Their Relevance for the Interpretation of Lipidomic Profiles	PLOS ONE			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; ESTIMATED DESATURASE ACTIVITIES; PREPUBERTAL OBESE CHILDREN; STEAROYL-COA DESATURASE-1; HUMAN PLASMA; ADIPOSE-TISSUE; MASS-SPECTROMETRY; DOUBLE-BONDS; BIOMARKER; RISK	Monounsaturated fatty acids (MUFA) are emerging health biomarkers, and in particular the ratio between palmitoleic acid (9cis-16:1) and palmitic acid (16:0) affords the delta-9 desaturase index that is increased in obesity. Recently, other positional and geometrical MUFA isomers belonging to the hexadecenoic family (C16 MUFA) were found in circulating lipids, such as sapienic acid (6cis-16: 1), palmitelaidic acid (9trans-16:1) and 6trans-16:1. In this work we report: i) the identification of sapienic acid as component of human erythrocyte membrane phospholipids with significant increase in morbidly obese patients (n = 50) compared with age-matched lean controls (n = 50); and ii) the first comparison of erythrocyte membrane phospholipids (PL) and plasma cholesteryl esters (CE) in morbidly obese patients highlighting that some of their fatty acid levels have opposite trends: increases of both palmitic and sapienic acids with the decrease of linoleic acid (9cis, 12cis-18:2, omega-6) in red blood cell (RBC) membrane PL were reversed in plasma CE, whereas the increase of palmitoleic acid was similar in both lipid species. Consequentially, desaturase enzymatic indexes gave different results, depending on the lipid class used for the fatty acid content. The fatty acid profile of morbidly obese subjects also showed significant increases of stearic acid (C18:0) and C20 omega-6, as well as decreases of oleic acid (9cis-18:1) and docosahexaenoic acid (C22:6 omega-3) as compared with lean healthy controls. Trans monounsaturated and polyunsaturated fatty acids were also measured and found significantly increased in both lipid classes of morbidly obese subjects. These results highlight the C16 MUFA isomers as emerging metabolic marker provided that the assignment of the double bond position and geometry is correctly performed, thus identifying the corresponding lipidomic pathway. Since RBC membrane PL and plasma CE have different fatty acid trends, caution must also be used in the choice of lipid species for the interpretation of lipidomic profiles.	[Sansone, Anna; Tolika, Evanthia; Ferreri, Carla] CNR, ISOF, Bologna, Italy; [Louka, Maria; Sunda, Valentina; Deplano, Simone; Melchiorre, Michele] Lipinutragen Srl, Lipid Lab, Bologna, Italy; [Anagnostopoulos, Dimitrios; Chatgilialoglu, Chryssostomos] NCSR Demokritos, INN, Athens, Greece; [Formisano, Cesare; Di Micco, Rosa] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Mennella, Maria Rosaria Faraone] Univ Naples Federico II, Dept Biol, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); National Centre of Scientific Research "Demokritos"; University of Naples Federico II; University of Naples Federico II	Ferreri, C (corresponding author), CNR, ISOF, Bologna, Italy.	carla.ferreri@isof.cnr.it	Chatgilialoglu, Chryssostomos/A-1190-2013; FERRERI, CARLA/G-6821-2013; Chatgilialoglu, Chryssostomos/AAG-6193-2021; Sansone, Anna/AAX-5478-2020; Di Micco, Rosa/AAC-3067-2019	Chatgilialoglu, Chryssostomos/0000-0003-2626-2925; FERRERI, CARLA/0000-0002-1359-0869; Chatgilialoglu, Chryssostomos/0000-0003-2626-2925; Di Micco, Rosa/0000-0002-2575-8729; Louka, Maria/0000-0002-7008-2406; sansone, anna/0000-0003-0865-4861; faraone mennella, maria rosaria/0000-0003-1947-4700; FORMISANO, Cesare/0000-0002-6793-5631; Melchiorre, Michele/0000-0003-0536-907X	COST Action "Biomimetic Radical Chemistry" [1201]; Lipinutragen srl through the funding of Marie Sklodowska-Curie ITN project CLICKGENE [642023, MSCA-ITN-2014-ETN]	COST Action "Biomimetic Radical Chemistry"; Lipinutragen srl through the funding of Marie Sklodowska-Curie ITN project CLICKGENE	ET, DA and ML received grants for Short Term Scientific Mission from the COST Action 1201 "Biomimetic Radical Chemistry". ML received her salary from Lipinutragen srl through the funding of the MSCA-ITN-2014-ETN - Marie Sklodowska-Curie ITN project CLICKGENE (#642023) that supports research activity as part of her PhD training program. Lipinutragen srl provided support in the form of salaries for VS, SD and MM that were involved in data collection, membrane lipidomics and statistical analyses, but did not have any additional role in the study design, decision to publish, or writing of the manuscript. The specific roles of these authors are articulated in the "Author contributions" section. No other specific funding for this work has been received.	Abdelmagid SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116195; Burch TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134206; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chan KL, 2015, J BIOL CHEM, V290, P16979, DOI 10.1074/jbc.M115.646992; Chatgilialoglu C, 2014, CHEM REV, V114, P255, DOI 10.1021/cr4002287; Ferreri C, 2004, J AM CHEM SOC, V126, P1063, DOI 10.1021/ja038072o; Ferreri C, 2012, EXPERT REV MOL DIAGN, V12, P767, DOI [10.1586/erm.12.73, 10.1586/ERM.12.73]; Ghezzo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066418; Gil-Campos M, 2008, BRIT J NUTR, V99, P909, DOI 10.1017/S0007114507831722; Hauff S, 2009, J AGR FOOD CHEM, V57, P3423, DOI 10.1021/jf803665u; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hu CX, 2009, J CHROMATOGR B, V877, P2836, DOI 10.1016/j.jchromb.2009.01.038; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; Jove M, 2014, FASEB J, V28, P5163, DOI 10.1096/fj.14-253187; Karpe F, 2008, ARTERIOSCL THROM VAS, V28, pE152, DOI 10.1161/ATVBAHA.108.167718; Katan MB, 1997, J LIPID RES, V38, P2012; King IB, 2006, AM J CLIN NUTR, V83, P227; Klawitter J, 2014, ANAL BIOANAL CHEM, V406, P6399, DOI 10.1007/s00216-014-8020-4; Klem S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033874; Kunnen S, 2012, J LIPID RES, V53, P1783, DOI 10.1194/jlr.R024513; Larque E, 2006, INT J OBESITY, V30, P1488, DOI 10.1038/sj.ijo.0803403; Lu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041681; Ma WJ, 2015, AM J CLIN NUTR, V101, P153, DOI 10.3945/ajcn.114.092601; Ma XX, 2016, P NATL ACAD SCI USA, V113, P2573, DOI 10.1073/pnas.1523356113; Mahendran Y, 2014, AM J CLIN NUTR, V99, P79, DOI 10.3945/ajcn.113.069740; Melchiorre M, 2011, J AM CHEM SOC, V133, P15184, DOI 10.1021/ja205903h; Merino DM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-63; MOSS CW, 1989, J CLIN MICROBIOL, V27, P1467, DOI 10.1128/JCM.27.7.1467-1470.1989; Ng DS, 2012, BBA-MOL CELL BIOL L, V1821, P654, DOI 10.1016/j.bbalip.2011.12.012; Park HG, 2016, BBA-MOL CELL BIOL L, V1861, P91, DOI 10.1016/j.bbalip.2015.11.007; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Prouty S. M., 2015, LIPIDS SKIN HLTH, P139; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ruggles KV, 2013, ANNU REV NUTR, V33, P413, DOI 10.1146/annurev-nutr-071812-161254; Sansone A, 2013, CHEM RES TOXICOL, V26, P1703, DOI 10.1021/tx400287u; Sartore G, 2008, PROSTAG LEUKOTR ESS, V79, P55, DOI 10.1016/j.plefa.2008.07.001; Skeaff CM, 2006, J NUTR, V136, P565, DOI 10.1093/jn/136.3.565; Stamatikos AD, 2013, AM J PHYSIOL-ENDOC M, V305, pE767, DOI 10.1152/ajpendo.00268.2013; Steffen LM, 2008, INT J OBESITY, V32, P1297, DOI 10.1038/ijo.2008.89; Thompson AK, 2011, INT J OBESITY, V35, P315, DOI 10.1038/ijo.2010.141; Vinknes KJ, 2013, OBESITY, V21, pE512, DOI 10.1002/oby.20457; Wang LY, 2013, GENOME MED, V5, DOI 10.1186/gm443; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37	45	45	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152378	10.1371/journal.pone.0152378	http://dx.doi.org/10.1371/journal.pone.0152378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045677	gold, Green Published, Green Submitted			2022-12-26	WOS:000373599600017
J	Gao, JZ; Cui, W; Sheng, YJ; Ruan, JS; Kurgan, L				Gao, Jianzhao; Cui, Wei; Sheng, Yajun; Ruan, Jishou; Kurgan, Lukasz			PSIONplus: Accurate Sequence-Based Predictor of Ion Channels and Their Types	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; M2 PROTON CHANNELS; STRUCTURAL-CHANGES; BINDING PROTEINS; WEB-SERVER; POTASSIUM; DATABASE; INFORMATION; MEMBRANE; SURFACE	Ion channels are a class of membrane proteins that attracts a significant amount of basic research, also being potential drug targets. High-throughput identification of these channels is hampered by the low levels of availability of their structures and an observation that use of sequence similarity offers limited predictive quality. Consequently, several machine learning predictors of ion channels from protein sequences that do not rely on high sequence similarity were developed. However, only one of these methods offers a wide scope by predicting ion channels, their types and four major subtypes of the voltage-gated channels. Moreover, this and other existing predictors utilize relatively simple predictive models that limit their accuracy. We propose a novel and accurate predictor of ion channels, their types and the four subtypes of the voltage-gated channels called PSIONplus. Our method combines a support vector machine model and a sequence similarity search with BLAST. The originality of PSIONplus stems from the use of a more sophisticated machine learning model that for the first time in this area utilizes evolutionary profiles and predicted secondary structure, solvent accessibility and intrinsic disorder. We empirically demonstrate that the evolutionary profiles provide the strongest predictive input among new and previously used input types. We also show that all new types of inputs contribute to the prediction. Results on an independent test dataset reveal that PSIONplus obtains relatively good predictive performance and outperforms existing methods. It secures accuracies of 85.4% and 68.3% for the prediction of ion channels and their types, respectively, and the average accuracy of 96.4% for the discrimination of the four ion channel subtypes. Stand-alone version of PSIONplus is freely available from https://sourceforge.net/projects/psion/	[Gao, Jianzhao; Ruan, Jishou] Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China; [Gao, Jianzhao; Ruan, Jishou] Nankai Univ, LPMC, Tianjin 300071, Peoples R China; [Cui, Wei] Univ Calif Riverside, Dept Stat, Riverside, CA 92521 USA; [Sheng, Yajun] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China; [Ruan, Jishou] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Kurgan, Lukasz] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada; [Kurgan, Lukasz] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA USA	Nankai University; Nankai University; University of California System; University of California Riverside; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Nankai University; University of Alberta; Virginia Commonwealth University	Ruan, JS (corresponding author), Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China.; Ruan, JS (corresponding author), Nankai Univ, LPMC, Tianjin 300071, Peoples R China.; Ruan, JS (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Kurgan, L (corresponding author), Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada.; Kurgan, L (corresponding author), Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA USA.	jsruan@nankai.edu.cn; lkurgan@vcu.edu	Kurgan, Lukasz/B-5721-2009	Kurgan, Lukasz/0000-0002-7749-0314; Gao, Jianzhao/0000-0002-9943-4786	National Science Foundation of China (NSFC) [31050110432, 31150110577, 11101226]; Discovery grant from National Science and Engineering Research Council (NSERC) Canada [298328]; International Development Research Center, Ottawa, Canada [104519-010]; Specialized Research Fund for Doctoral Program of Higher Education (SRFDP) [20130031120001]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Discovery grant from National Science and Engineering Research Council (NSERC) Canada; International Development Research Center, Ottawa, Canada; Specialized Research Fund for Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	LK and JR were supported by the National Science Foundation of China (NSFC) grants 31050110432 and 31150110577. LK was also supported by the Discovery grant 298328 from National Science and Engineering Research Council (NSERC) Canada. JR was also supported by the International Development Research Center, Ottawa, Canada grant 104519-010. JG was supported by Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) grant 20130031120001 and by the National Science Foundation of China (NSFC) grant 11101226. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banghart MR, 2006, BIOCHEMISTRY-US, V45, P15129, DOI 10.1021/bi0618058; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Camerino DC, 2007, NEUROTHERAPEUTICS, V4, P184; Camerino DC, 2008, ADV GENET, V64, P81, DOI 10.1016/S0065-2660(08)00804-3; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S4; Chen W, 2012, COMPUT BIOL MED, V42, P504, DOI 10.1016/j.compbiomed.2012.01.003; Chou KC, 2004, J PROTEOME RES, V3, P856, DOI 10.1021/pr049931q; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Chung SH, 2002, BBA-BIOMEMBRANES, V1565, P267, DOI 10.1016/S0005-2736(02)00574-6; Consortium TU, 2012, NUCL ACIDS RES, V40; Corry B, 2006, MOL BIOSYST, V2, P527, DOI 10.1039/b610062g; Domene C, 2003, CURR OPIN DRUG DISC, V6, P611; Donizelli M, 2006, NUCLEIC ACIDS RES, V34, pD267, DOI 10.1093/nar/gkj104; Doyle DA, 2004, MOL MEMBR BIOL, V21, P221, DOI 10.1080/09687680410001716844; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Fodor AA, 2006, J GEN PHYSIOL, V127, P755, DOI 10.1085/jgp.200509419; Gabashvili IS, 2007, JARO-J ASSOC RES OTO, V8, P305, DOI 10.1007/s10162-007-0082-y; Gallin WJ, 2011, NUCLEIC ACIDS RES, V39, pD362, DOI 10.1093/nar/gkq1000; Gao JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040104; Ger MF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012827; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Konijnenberg A, 2014, P NATL ACAD SCI USA, V111, P17170, DOI 10.1073/pnas.1413118111; Kuhn LA, 1995, PROTEINS, V23, P536, DOI 10.1002/prot.340230408; Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061; Le Novere N, 2001, NUCLEIC ACIDS RES, V29, P294, DOI 10.1093/nar/29.1.294; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang Xin, 2010, Virologica Sinica, V25, P267, DOI 10.1007/s12250-010-3136-y; Lin H-T, 2007, MACH LEARN, V68, P10; Lin H, 2011, J THEOR BIOL, V269, P64, DOI 10.1016/j.jtbi.2010.10.019; Liu LX, 2006, ACTA BIOCH BIOPH SIN, V38, P363, DOI 10.1111/j.1745-7270.2006.00177.x; Liu WX, 2014, INT J MOL SCI, V15, P12940, DOI 10.3390/ijms150712940; Mizianty MJ, 2011, BIOINFORMATICS, V27, pI24, DOI 10.1093/bioinformatics/btr229; Ou YY, 2008, COMPUT BIOL CHEM, V32, P227, DOI 10.1016/j.compbiolchem.2008.03.002; Ou YY, 2010, PROTEINS, V78, P1789, DOI 10.1002/prot.22694; Platt JC, 2000, ADV NEUR IN, P61; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287; Saha Sudipto, 2006, Genomics Proteomics & Bioinformatics, V4, P253, DOI 10.1016/S1672-0229(07)60006-0; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; TABASSUM N, 2011, J APPL PHARM SCI, V1, P6; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; VIHINEN M, 1994, PROTEINS, V19, P141, DOI 10.1002/prot.340190207; Wang J, 2013, P NATL ACAD SCI USA, V110, P1315, DOI 10.1073/pnas.1216526110; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wu TF, 2004, J MACHINE LEARNING R, V5, P31; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Yan RX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02619; Zhang H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-388; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043575; Zheng C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-430	65	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152964	10.1371/journal.pone.0152964	http://dx.doi.org/10.1371/journal.pone.0152964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044036	Green Submitted, Green Published, gold			2022-12-26	WOS:000373592100056
J	Pepin, E; Al-Mass, A; Attane, C; Zhang, KZ; Lamontagne, J; Lussier, R; Madiraju, SRM; Joly, E; Ruderman, NB; Sladek, R; Prentki, M; Peyot, ML				Pepin, Emilie; Al-Mass, Anfal; Attane, Camille; Zhang, Kezhuo; Lamontagne, Julien; Lussier, Roxane; Madiraju, S. R. Murthy; Joly, Erik; Ruderman, Neil B.; Sladek, Robert; Prentki, Marc; Peyot, Marie-Line			Pancreatic beta-Cell Dysfunction in Diet-Induced Obese Mice: Roles of AMP-Kinase, Protein Kinase C epsilon, Mitochondrial and Cholesterol Metabolism, and Alterations in Gene Expression	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; FATTY-ACID OXIDATION; INSULIN-SECRETION; MALONYL-COA; GLUCOSE; FUEL; GLUCOLIPOTOXICITY; PHOSPHORYLATION; ACCUMULATION; DISSOCIATION	Diet induced obese (DIO) mice can be stratified according to their weight gain in response to high fat diet as low responders (LDR) and high responders (HDR). This allows the study of beta-cell failure and the transitions to prediabetes (LDR) and early diabetes (HDR). C57BL/6N mice were fed for 8 weeks with a normal chow diet (ND) or a high fat diet and stratified as LDR and HDR. Freshly isolated islets from ND, LDR and HDR mice were studied ex-vivo for mitochondrial metabolism, AMPK activity and signalling, the expression and activity of key enzymes of energy metabolism, cholesterol synthesis, and mRNA profiling. Severely compromised glucose-induced insulin secretion in HDR islets, as compared to ND and LDR islets, was associated with suppressed AMP-kinase activity. HDR islets also showed reduced acetyl-CoA carboxylase activity and enhanced activity of 3-hydroxy-3-methylglutaryl-CoA reductase, which led respectively to elevated fatty acid oxidation and increased cholesterol biosynthesis. HDR islets also displayed mitochondrial membrane hyperpolarization and reduced ATP turnover in the presence of elevated glucose. Expression of protein kinase C epsilon, which reduces both lipolysis and production of signals for insulin secretion, was elevated in DIO islets. Genes whose expression increased or decreased by more than 1.2-fold were minor between LDR and ND islets (17 differentially expressed), but were prominent between HDR and ND islets (1508 differentially expressed). In HDR islets, particularly affected genes were related to cell cycle and proliferation, AMPK signaling, mitochondrial metabolism and cholesterol metabolism. In conclusion, chronically reduced AMPK activity, mitochondrial dysfunction, elevated cholesterol biosynthesis in islets, and substantial alterations in gene expression accompany beta-cell failure in HDR islets. The beta-cell compensation process in the prediabetic state (LDR) is largely independent of transcriptional adaptive changes, whereas the transition to early diabetes (HDR) is associated with major alterations in gene expression.	[Pepin, Emilie; Al-Mass, Anfal; Attane, Camille; Lamontagne, Julien; Lussier, Roxane; Madiraju, S. R. Murthy; Joly, Erik; Prentki, Marc; Peyot, Marie-Line] CHUM, Montreal Diabet Res Ctr, Montreal, PQ, Canada; [Pepin, Emilie; Al-Mass, Anfal; Attane, Camille; Lamontagne, Julien; Lussier, Roxane; Madiraju, S. R. Murthy; Joly, Erik; Prentki, Marc; Peyot, Marie-Line] CHUM, Ctr Rech, Montreal, PQ, Canada; [Al-Mass, Anfal; Zhang, Kezhuo; Sladek, Robert] McGill Univ, Dept Med, Montreal, PQ, Canada; [Al-Mass, Anfal; Zhang, Kezhuo; Sladek, Robert] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Prentki, Marc] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Prentki, Marc] Univ Montreal, Fac Med, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Prentki, Marc] Univ Montreal, Fac Med, Dept Mol Med, Montreal, PQ H3C 3J7, Canada; [Ruderman, Neil B.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Ruderman, Neil B.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Ruderman, Neil B.] Boston Med Ctr, Diabet Unit, Boston, MA USA	Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Boston University; Boston University; Boston Medical Center	Prentki, M; Peyot, ML (corresponding author), CHUM, Montreal Diabet Res Ctr, Montreal, PQ, Canada.; Prentki, M; Peyot, ML (corresponding author), CHUM, Ctr Rech, Montreal, PQ, Canada.; Prentki, M (corresponding author), Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3C 3J7, Canada.; Prentki, M (corresponding author), Univ Montreal, Fac Med, Dept Biochem, Montreal, PQ H3C 3J7, Canada.; Prentki, M (corresponding author), Univ Montreal, Fac Med, Dept Mol Med, Montreal, PQ H3C 3J7, Canada.	marc.prentki@umontreal.ca; marie-line.peyot@crchum.qc.ca	Sladek, Robert/R-2391-2019	Sladek, Robert/0000-0002-2730-1204	Canadian Institutes of Health Research; National Institute of Health [RO1-DK19514]; Kuweit University; Canadian Diabetes Association; Universite de Montreal; Diabete Quebec and Fonds de Recherche du Quebec-Sante; Fonds de Recherche du Quebec-Sante; Diabete Quebec; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019514] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kuweit University; Canadian Diabetes Association; Universite de Montreal; Diabete Quebec and Fonds de Recherche du Quebec-Sante; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Diabete Quebec; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the Canadian Institutes of Health Research to MP and SRMM, and by grant RO1-DK19514 from the National Institute of Health to NR and MP. MP holds the Canada Research Chair in Diabetes and Metabolism. AA is supported by a fellowship from Kuweit University. CA was supported by a fellowship from the Canadian Diabetes Association, EP by fellowships from Universite de Montreal and Diabete Quebec, JL by fellowships from Diabete Quebec and Fonds de Recherche du Quebec-Sante, and RS by Chercheur Boursier award from the Fonds de Recherche du Quebec-Sante and a New Investigator Award from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos S, 2010, MOL CELL ENDOCRINOL, V316, P140, DOI 10.1016/j.mce.2009.09.031; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brunham LR, 2010, CURR DIABETES REP, V10, P55, DOI 10.1007/s11892-009-0090-x; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; Cenni V, 2002, BIOCHEM J, V545, P537; Cheng YS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005561; Collins SC, 2010, DIABETES, V59, P1192, DOI 10.2337/db09-0791; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Doliba NM, 2015, MOL METAB, V4, P926, DOI 10.1016/j.molmet.2015.09.010; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Fergusson G, 2014, MOL METAB, V3, P848, DOI 10.1016/j.molmet.2014.09.006; Fex M, 2009, DIABETOLOGIA, V52, P271, DOI 10.1007/s00125-008-1191-9; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Garcia-Ruiz C, 2009, HISTOL HISTOPATHOL, V24, P117, DOI 10.14670/HH-24.117; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Kim D, 2013, INT J MOL MED, V32, P1293, DOI 10.3892/ijmm.2013.1508; Kowluru A, 2001, DIABETES, V50, P1580, DOI 10.2337/diabetes.50.7.1580; Kruit JK, 2011, DIABETES, V60, P3186, DOI 10.2337/db11-0081; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; LEE SK, 1995, PANCREAS, V11, P206, DOI 10.1097/00006676-199508000-00016; Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Michelakis ED, 2008, CIRCULATION, V117, P2431, DOI 10.1161/CIRCULATIONAHA.108.775163; Mulder H, 2009, MOL CELL ENDOCRINOL, V297, P34, DOI 10.1016/j.mce.2008.05.015; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Peyot ML, 2010, DIABETES, V59, P2178, DOI 10.2337/db09-1452; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; Stiles L, 2012, BEST PRACT RES CL EN, V26, P725, DOI 10.1016/j.beem.2012.05.004; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tang C, 2007, DIABETES, V56, P2722, DOI 10.2337/db07-0279; Thomson DM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1572, DOI 10.1152/ajpendo.00371.2007; WENCEL HE, 1995, PHYSIOL BEHAV, V57, P1215, DOI 10.1016/0031-9384(95)00022-B; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Wojtaszewski JFP, 2002, BIOCHEM BIOPH RES CO, V298, P309, DOI 10.1016/S0006-291X(02)02465-8; Zhao S, 2015, MOL METAB, V4, P940, DOI 10.1016/j.molmet.2015.09.012; Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003; Zuniga-Hertz JP, 2015, J ENDOCRINOL, V224, P75, DOI 10.1530/JOE-14-0348	55	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153017	10.1371/journal.pone.0153017	http://dx.doi.org/10.1371/journal.pone.0153017			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043434	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100062
J	Thangakani, AM; Nagarajan, R; Kumar, S; Sakthivel, R; Velmurugan, D; Gromiha, MM				Thangakani, A. Mary; Nagarajan, R.; Kumar, Sandeep; Sakthivel, R.; Velmurugan, D.; Gromiha, M. Michael			CPAD, Curated Protein Aggregation Database: A Repository of Manually Curated Experimental Data on Protein and Peptide Aggregation	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; SEQUENCE DETERMINANTS; AMYLOID FIBRIL; PROPENSITY; PREDICTION; INSIGHTS; FEATURES	Accurate distinction between peptide sequences that can form amyloid-fibrils or amorphous beta-aggregates, identification of potential aggregation prone regions in proteins, and prediction of change in aggregation rate of a protein upon mutation(s) are critical to research on protein misfolding diseases, such as Alzheimer's and Parkinson's, as well as biotechnological production of protein based therapeutics. We have developed a Curated Protein Aggregation Database (CPAD), which has collected results from experimental studies performed by scientific community aimed at understanding protein/peptide aggregation. CPAD contains more than 2300 experimentally observed aggregation rates upon mutations in known amyloidogenic proteins. Each entry includes numerical values for the following parameters: change in rate of aggregation as measured by fluorescence intensity or turbidity, name and source of the protein, Uniprot and Protein Data Bank codes, single point as well as multiple mutations, and literature citation. The data in CPAD has been supplemented with five different types of additional information: (i) Amyloid fibril forming hexa-peptides, (ii) Amorphous beta-aggregating hexa-peptides, (iii) Amyloid fibril forming peptides of different lengths, (iv) Amyloid fibril forming hexa-peptides whose crystal structures are available in the Protein Data Bank (PDB) and (v) Experimentally validated aggregation prone regions found in amyloidogenic proteins. Furthermore, CPAD is linked to other related databases and resources, such as Uniprot, Protein Data Bank, PUBMED, GAP, TANGO, WALTZ etc. We have set up a web interface with different search and display options so that users have the ability to get the data in multiple ways. CPAD is freely available at http://www.iitm.ac.in/bioinfo/CPAD/. The potential applications of CPAD have also been discussed.	[Thangakani, A. Mary; Velmurugan, D.] Univ Madras, Ctr Adv Studies Crystallog & Biophys & Bioinforma, Madras 600025, Tamil Nadu, India; [Nagarajan, R.; Sakthivel, R.; Gromiha, M. Michael] Indian Inst Technol, Bhupat & Jyoti Metha Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Kumar, Sandeep] Pfizer Inc, Biotherapeut Pharmaceut Sci, 700 Chesterfield Pkwy West, Chesterfield, MO 63017 USA	University of Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Pfizer	Gromiha, MM (corresponding author), Indian Inst Technol, Bhupat & Jyoti Metha Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	gromiha@iitm.ac.in	Ramasamy, Sakthivel/AAU-7918-2020; Gromiha, Michael/H-8493-2019; Raju, Nagarajan/H-9157-2013	Raju, Nagarajan/0000-0003-3851-5520; Kumar, Sandeep/0000-0003-2840-6398; Michael, Gromiha/0000-0002-1776-4096	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by the Department of Biotechnology, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sandeep Kumar is an employee of Pfizer, Inc. This funder provided support in the form of salaries for authors [SK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Prof. Fabrizio Chiti for providing experimental data on Acylphosphatase. We thank the Bioinformatics facility, Department of Biotechnology and IIT Madras for computational facilities. The work was partially supported by Department of Biotechnology, Government of India.	Agrawal NJ, 2011, J PHARM SCI-US, V100, P5081, DOI 10.1002/jps.22705; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beerten J, 2015, BIOINFORMATICS, V31, P1698, DOI 10.1093/bioinformatics/btv027; Buck PM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003291; Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009; Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; Cohen E, 2012, RAMBAM MAIMONIDES ME, V3, DOI 10.5041/RMMJ.10088; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim W, 2008, J MOL BIOL, V377, P565, DOI 10.1016/j.jmb.2007.12.079; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Kumar S, 2015, DEVELOPABILITY OF BI; Kumar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22258; Lim J, 2015, DEV CELL, V32, P491, DOI 10.1016/j.devcel.2015.02.002; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Porcari R, 2015, J BIOL CHEM, V290, P2395, DOI 10.1074/jbc.M114.610527; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Sarkar A, 2012, CURR BIOINFORM, V7, P87, DOI 10.2174/157489312799304495; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Swart C, 2014, EXP GERONTOL, V58, P279, DOI 10.1016/j.exger.2014.09.003; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Thangakani AM, 2014, BIOINFORMATICS, V30, P1983, DOI 10.1093/bioinformatics/btu167; Thangakani AM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S8-S6; Thangakani AM, 2012, PROTEINS, V80, P1003, DOI 10.1002/prot.24002; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175	27	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152949	10.1371/journal.pone.0152949	http://dx.doi.org/10.1371/journal.pone.0152949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043825	Green Published, gold, Green Submitted			2022-12-26	WOS:000373592100053
J	Uppangala, S; Mathai, SE; Salian, SR; Kumar, D; Singh, VJ; D'Souza, F; Kalthur, G; Kamath, A; Adiga, SK				Uppangala, Shubhashree; Mathai, Sherine Eliza; Salian, Sujith Raj; Kumar, Dayanidhi; Singh, Vikram Jeet; D'Souza, Fiona; Kalthur, Guruprasad; Kamath, Asha; Adiga, Satish Kumar			Sperm Chromatin Immaturity Observed in Short Abstinence Ejaculates Affects DNA Integrity and Longevity In Vitro	PLOS ONE			English	Article							SEXUAL ABSTINENCE; SPERMATOZOA; DECREASES; DURATION; DAMAGE; ZINC; CRYOPRESERVATION; FRAGMENTATION; METHYLATION; QUALITY	Background The influence of ejaculatory abstinence (EA) on semen parameters and subsequent reproductive outcome is still debatable; hence understanding the impact of EA on sperm structural and functional integrity may provide a valuable information on predicting successful clinical outcome. Objective To understand the influence of EA on sperm chromatin maturity, integrity, longevity and global methylation status. Methods This experimental prospective study included 76 ejaculates from 19 healthy volunteers who provided ejaculates after observing 1, 3, 5 and 7 days of abstinence. Sperm chromatin maturity, DNA integrity and global methylation status were assessed in the neat ejaculate. Sperm motility, DNA integrity and longevity were assessed in the processed fraction of the fresh and frozen-thawed ejaculates to determine their association with the length of EA. Results Spermatozoa from 1 day ejaculatory abstinence (EA-1) displayed significantly higher level of sperm chromatin immaturity in comparison to EA-3 (P < 0.05) and EA-5 (P < 0.01) whereas; the number of 5-methyl cytosine immunostained spermatozoa did not vary significantly across groups. On the other hand, in vitro incubation of processed ejaculate from EA-1 resulted in approximately 20 and 40 fold increase in the DNA fragmented spermatozoa at the end of 6 and 24h respectively (P < 0.01-0.001). Conclusion Use of short-term EA for therapeutic fertilization would be a clinically valuable strategy to improve the DNA quality. However, use of such spermatozoa after prolonged incubation in vitro should be avoided as it can carry a substantial risk of transmitting DNA fragmentation to the oocytes.	[Uppangala, Shubhashree; Mathai, Sherine Eliza; Salian, Sujith Raj; Kumar, Dayanidhi; Singh, Vikram Jeet; D'Souza, Fiona; Kalthur, Guruprasad; Adiga, Satish Kumar] Manipal Univ, Kasturba Med Coll, Div Clin Embryol, Manipal 576104, Karnataka, India; [Kamath, Asha] Manipal Univ, Kasturba Med Coll, Dept Community Med, Manipal 576104, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Adiga, SK (corresponding author), Manipal Univ, Kasturba Med Coll, Div Clin Embryol, Manipal 576104, Karnataka, India.	satish.adiga@manipal.edu	Adiga, Satish Kumar/AAU-4386-2020; Uppangala, Shubhashree/AAA-4965-2021	Adiga, Satish Kumar/0000-0002-2897-4697; Uppangala, Shubhashree/0000-0002-5633-3977; Kumar, Dayanidhi/0000-0003-2832-0121; Kamath, Asha/0000-0003-0727-8067				Aoki VW, 2006, FERTIL STERIL, V86, P1541, DOI 10.1016/j.fertnstert.2006.04.023; Barratt CLR, 2010, HUM REPROD, V25, P824, DOI 10.1093/humrep/dep465; Bjorndahl L, 2010, MOL HUM REPROD, V16, P23, DOI 10.1093/molehr/gap099; BLACKWELL JM, 1992, FERTIL STERIL, V58, P798; Boitrelle F, 2012, J ANDROL, V33, P1371, DOI 10.2164/jandrol.112.016980; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; De Jonge C, 2004, FERTIL STERIL, V82, P57, DOI 10.1016/j.fertnstert.2004.03.014; Elzanaty S, 2005, HUM REPROD, V20, P221, DOI 10.1093/humrep/deh586; Fernandez JL, 2003, J ANDROL, V24, P59; FREUND M, 1963, J REPROD FERTIL, V6, P269; Gosalvez J, 2011, MOL REPROD DEV, V78, P951, DOI 10.1002/mrd.21394; Gosalvez J, 2011, FERTIL STERIL, V96, P1083, DOI 10.1016/j.fertnstert.2011.08.027; Jurema MW, 2005, FERTIL STERIL, V84, P678, DOI 10.1016/j.fertnstert.2005.03.044; Kotdawala AP, 2012, J ASSIST REPROD GEN, V29, P1447, DOI 10.1007/s10815-012-9894-8; Kumar D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069927; LELANNOU D, 1986, ARCH ANDROLOGY, V17, P35; Levitas E, 2005, FERTIL STERIL, V83, P1680, DOI 10.1016/j.fertnstert.2004.12.045; Marshbum PB, 2010, FERTIL STERIL, V93, P286, DOI 10.1016/j.fertnstert.2009.07.972; Montjean D, 2015, ANDROLOGY-US, V3, P235, DOI 10.1111/andr.12001; Pfeifer S, 2015, FERTIL STERIL, V103, pE44, DOI 10.1016/j.fertnstert.2015.03.019; Pons I, 2013, J ASSIST REPROD GEN, V30, P1211, DOI 10.1007/s10815-013-0089-8; Stoltenberg M, 1997, HISTOCHEM J, V29, P721, DOI 10.1023/A:1026413101443; Terquem A, 1993, THE SPERM CELL, P249; Tischner M., 1972, Acta Agraria et Silvestria, Zootechnica, V12, P77; Varshini J, 2012, ANDROLOGIA, V44, P642, DOI 10.1111/j.1439-0272.2011.01243.x; World Health Organization, 2010, WHO LAB MAN EX HUM S; Zhang XY, 2006, J ANDROL, V27, P414, DOI 10.2164/jandrol.05171	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152942	10.1371/journal.pone.0152942	http://dx.doi.org/10.1371/journal.pone.0152942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043437	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100051
J	Vaidyanathan, S; Cato, K; Tang, L; Pavey, S; Haass, NK; Gabrielli, BG; Duijf, PHG				Vaidyanathan, S.; Cato, K.; Tang, L.; Pavey, S.; Haass, N. K.; Gabrielli, B. G.; Duijf, P. H. G.			In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis	ONCOGENE			English	Article							GENE-EXPRESSION; CELL-CYCLE; CANCER; ANEUPLOIDY; COMPLEX/CYCLOSOME; P53; PROGRESSION; INHIBITOR; ORIGIN; LEADS	Cell cycle genes are often aberrantly expressed in cancer, but how their misexpression drives tumorigenesis mostly remains unclear. From S phase to early mitosis, EMI1 (also known as FBXO5) inhibits the anaphase-promoting complex/ cyclosome, which controls cell cycle progression through the sequential degradation of various substrates. By analyzing 7403 human tumor samples, we find that EMI1 overexpression is widespread in solid tumors but not in blood cancers. In solid cancers, EMI1 overexpression is a strong prognostic marker for poor patient outcome. To investigate causality, we generated a transgenic mouse model in which we overexpressed Emi1. Emi1-overexpressing animals develop a wide variety of solid tumors, in particular adenomas and carcinomas with inflammation and lymphocyte infiltration, but not blood cancers. These tumors are significantly larger and more penetrant, abundant, proliferative and metastatic than control tumors. In addition, they are highly aneuploid with tumor cells frequently being in early mitosis and showing mitotic abnormalities, including lagging and incorrectly segregating chromosomes. We further demonstrate in vitro that even though EMI1 overexpression may cause mitotic arrest and cell death, it also promotes chromosome instability (CIN) following delayed chromosome alignment and anaphase onset. In human solid tumors, EMI1 is co-expressed with many markers for CIN and EMI1 overexpression is a stronger marker for CIN than most well-established ones. The fact that Emi1 overexpression promotes CIN and the formation of solid cancers in vivo indicates that Emi1 overexpression actively drives solid tumorigenesis. These novel mechanistic insights have important clinical implications.	[Vaidyanathan, S.; Cato, K.; Tang, L.; Pavey, S.; Haass, N. K.; Gabrielli, B. G.; Duijf, P. H. G.] Univ Queensland, Translat Res Inst, Diamantina Inst, 37 Kent St, Brisbane, Qld 4102, Australia; [Tang, L.] Fudan Univ, Sch Basic Med Sci, Shanghai, Peoples R China	University of Queensland; Fudan University	Duijf, PHG (corresponding author), Univ Queensland, Translat Res Inst, Diamantina Inst, 37 Kent St, Brisbane, Qld 4102, Australia.	p.duijf@uq.edu.au	Haass, Nikolas K/M-8507-2015; Gabrielli, Brian/B-3655-2011; Duijf, Pascal/E-7110-2012	Haass, Nikolas K/0000-0002-3928-5360; Gabrielli, Brian/0000-0003-3933-1651; vaidyanathan, srividya/0000-0003-3931-5942; Duijf, Pascal/0000-0001-8646-9843	IPRS; University of Queensland (UQ) Centennial Scholarships; UQ Diamantina Institute; UQ; National Breast Cancer Foundation; National Breast Cancer Foundation [ECF-14-008] Funding Source: researchfish	IPRS; University of Queensland (UQ) Centennial Scholarships; UQ Diamantina Institute; UQ; National Breast Cancer Foundation; National Breast Cancer Foundation	We thank Robert Benezra for support, Kym French for animal husbandry, Andrew Brooks for plasmids, Sandrine Roy, Ali Ju, Loredana Spoerri, Yvette Chin and Nicole Chee for technical assistance, Kim-Anh Le Cao for statistical advice, Marianna Datseris for general support and Pulari Thangavelu and Mehlika Hazar-Rethinam for critically reading the manuscript. This work was supported by IPRS and University of Queensland (UQ) Centennial Scholarships (to SV), grants from UQ Diamantina Institute and UQ and a Career Development Fellowship from the National Breast Cancer Foundation (to PHGD).	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Dexter TJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-127; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Duijf PHG, 2013, ONCOGENE, V32, P4727, DOI 10.1038/onc.2012.616; Duijf PHG, 2013, INT J CANCER, V132, P2316, DOI 10.1002/ijc.27924; Foijer F, 2008, BBA-REV CANCER, V1786, P73, DOI 10.1016/j.bbcan.2008.07.004; Frye JJ, 2013, NAT STRUCT MOL BIOL, V20, P827, DOI 10.1038/nsmb.2593; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Harris TJR, 2010, NAT REV CLIN ONCOL, V7, P251, DOI 10.1038/nrclinonc.2010.41; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee H, 2006, MOL CELL BIOL, V26, P5373, DOI 10.1128/MCB.00043-06; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Malumbres M, 2011, CANCER CELL, V19, P691, DOI 10.1016/j.ccr.2011.05.023; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Manning AL, 2014, ONCOGENE, V33, P2487, DOI 10.1038/onc.2013.201; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Neelsen KJ, 2013, GENE DEV, V27, P2537, DOI 10.1101/gad.226373.113; Network TCGAR, 2014, NATURE, V511, P1; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Perez de Castro I, 2007, CARCINOGENESIS, V28, P899, DOI 10.1093/carcin/bgm019; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ricke RM, 2013, J CELL BIOL, V201, P11, DOI 10.1083/jcb.201301061; Robu ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047658; RUSSELL PJ, 1986, CANCER RES, V46, P2035; Schvartzman JM, 2011, CANCER CELL, V19, P701, DOI 10.1016/j.ccr.2011.04.017; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Verschuren EW, 2007, MOL CELL BIOL, V27, P7955, DOI 10.1128/MCB.00908-07; Wang WP, 2013, NAT CELL BIOL, V15, P797, DOI 10.1038/ncb2755; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266	48	41	41	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 13	2016	35	41					5446	5455		10.1038/onc.2016.94	http://dx.doi.org/10.1038/onc.2016.94			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA5QU	27065322				2022-12-26	WOS:000386677800010
J	Togi, S; Muromoto, R; Hirashima, K; Kitai, Y; Okayama, T; Ikeda, O; Matsumoto, N; Kon, S; Sekine, Y; Oritani, K; Matsuda, T				Togi, Sumihito; Muromoto, Ryuta; Hirashima, Koki; Kitai, Yuichi; Okayama, Taichiro; Ikeda, Osamu; Matsumoto, Naoki; Kon, Shigeyuki; Sekine, Yuichi; Oritani, Kenji; Matsuda, Tadashi			A New STAT3-binding Partner, ARL3, Enhances the Phosphorylation and Nuclear Accumulation of STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene transcription; nuclear translocation; protein phosphorylation; signal transduction; STAT3	NF-KAPPA-B; GUANINE-NUCLEOTIDE EXCHANGE; FUNCTIONAL INTERACTIONS; TRANSCRIPTIONAL CONTROL; CELL-GROWTH; ARF FAMILY; ACTIVATION; PROTEINS; BINDING; STAP-2	Signal transducer and activator of transcription 3 (STAT3) is involved in cell proliferation, differentiation, and cell survival during immune responses, hematopoiesis, neurogenesis, and other biological processes. STAT3 activity is regulated by a variety of mechanisms, including phosphorylation and nuclear translocation. To clarify the molecular mechanisms underlying the regulation of STAT3 activity, we performed yeast two-hybrid screening. We identified ARL3 (ADP-ribosylation factor-like 3) as a novel STAT3-binding partner. ARL3 recognizes the DNA-binding domain as well as the C-terminal region of STAT3 in vivo, and their binding was the strongest when both proteins were activated. Importantly, small interfering RNA-mediated reduction of endogenous ARL3 expression decreased IL-6-induced tyrosine phosphorylation, nuclear accumulation, and transcriptional activity of STAT3. These results indicate that ARL3 interacts with STAT3 and regulates the transcriptional activation of STAT3 by influencing its nuclear accumulation of STAT3.	[Togi, Sumihito; Muromoto, Ryuta; Hirashima, Koki; Kitai, Yuichi; Okayama, Taichiro; Ikeda, Osamu; Matsumoto, Naoki; Kon, Shigeyuki; Sekine, Yuichi; Matsuda, Tadashi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan; [Oritani, Kenji] Grad Sch Med, Dept Hematol & Oncol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan	Hokkaido University	Matsuda, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Matsuda, Tadashi/A-3835-2012; Sekine, Yuichi/S-8813-2019; Muromoto, Ryuta/E-4203-2012; Togi, Sumihito/ABH-6734-2020	Matsuda, Tadashi/0000-0002-3089-3757; Sekine, Yuichi/0000-0002-2861-603X; Muromoto, Ryuta/0000-0002-7474-493X; Togi, Sumihito/0000-0002-3189-8111	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [26461444] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; CAVENAGH MM, 1994, J BIOL CHEM, V269, P18937; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Ikeda O, 2008, MOL CELL BIOL, V28, P5027, DOI 10.1128/MCB.00194-08; Ikeda O, 2010, J BIOL CHEM, V285, P38093, DOI 10.1074/jbc.M110.162388; Jove R, 2000, ONCOGENE, V19, P2466, DOI 10.1038/sj.onc.1203549; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; Kamitani S, 2011, J IMMUNOL, V187, P2476, DOI 10.4049/jimmunol.1003243; Katanaev VL, 1998, J CELL SCI, V111, P1583; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; Muromoto R, 2006, ONCOGENE, V25, P2131, DOI 10.1038/sj.onc.1209235; Muromoto R, 2008, INT IMMUNOL, V20, P395, DOI 10.1093/intimm/dxm154; Muromoto R, 2006, J IMMUNOL, V177, P1160, DOI 10.4049/jimmunol.177.2.1160; Muromoto R, 2010, EUR J IMMUNOL, V40, P3570, DOI 10.1002/eji.201040688; Muromoto R, 2009, BIOCHEM BIOPH RES CO, V382, P63, DOI 10.1016/j.bbrc.2009.02.127; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V372, P475, DOI 10.1016/j.bbrc.2008.05.073; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sato N, 2005, INT IMMUNOL, V17, P1543, DOI 10.1093/intimm/dxh331; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Sekine Y, 2015, J BIOL CHEM, V290, P17462, DOI 10.1074/jbc.M115.658575; Sekine Y, 2009, J IMMUNOL, V183, P7966, DOI 10.4049/jimmunol.0902096; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Simon AR, 2000, SCIENCE, V290, P144, DOI 10.1126/science.290.5489.144; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tanaka T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001637; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952; Walker SR, 2010, MOL PHARMACOL, V78, P903, DOI 10.1124/mol.110.066316; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; ZHONG Z, 1994, P NATL ACAD SCI USA, V91, P4806, DOI 10.1073/pnas.91.11.4806; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	45	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11161	11171		10.1074/jbc.M116.724849	http://dx.doi.org/10.1074/jbc.M116.724849			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27048653	Green Published, hybrid			2022-12-26	WOS:000377042100019
J	Tang, YL; Ge, JJ; Liu, FT; Wu, P; Guo, SS; Liu, ZY; Wang, YX; Wang, Y; Ding, ZT; Wu, JJ; Zuo, CT; Wang, J				Tang, Yilin; Ge, Jingjie; Liu, Fengtao; Wu, Ping; Guo, Sisi; Liu, Zhenyang; Wang, Yixuan; Wang, Ying; Ding, Zhengtong; Wu, Jianjun; Zuo, Chuantao; Wang, Jian			Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease	PLOS ONE			English	Article							ORAL WORD-ASSOCIATION; GLUCOSE-METABOLISM; CHOLINERGIC FUNCTION; DIAGNOSTIC-CRITERIA; STROOP TEST; DEMENTIA; DISORDER; BRAIN; HYPOMETABOLISM; DOPAMINE	Purpose To characterize cerebral glucose metabolism associated with different cognitive states in Parkinson's disease (PD) using F-18-fluorodeoxyglucose (FDG) and Positron Emission Tomography (PET). Methods Three groups of patients were recruited in this study including PD patients with dementia (PDD; n = 10), with mild cognitive impairment (PD-MCI; n = 20), and with no cognitive impairment (PD-NC; n = 30). The groups were matched for age, sex, education, disease duration, motor disability, levodopa equivalent dose and Geriatric Depression Rating Scale (GDS) score. All subjects underwent a FDG-PET study. Maps of regional metabolism in the three groups were compared using statistical parametric mapping (SPM5). Results PD-MCI patients exhibited limited areas of hypometabolism in the frontal, temporal and parahippocampal gyrus compared with the PD-NC patients (p < 0.01). PDD patients had bilateral areas of hypometabolism in the frontal and posterior parietal-occipital lobes compared with PD-MCI patients (p < 0.01), and exhibited greater metabolic reductions in comparison with PD-NC patients (p < 0.01). Conclusions Compared with PD-NC patients, hypometabolism was much higher in the PDD patients than in PD-MCI patients, mainly in the posterior cortical areas. The result might suggest an association between posterior cortical hypometabolismand more severe cognitive impairment. PD-MCI might be important for early targeted therapeutic intervention and disease modification.	[Tang, Yilin; Liu, Fengtao; Guo, Sisi; Liu, Zhenyang; Wang, Yixuan; Wang, Ying; Ding, Zhengtong; Wu, Jianjun; Wang, Jian] Fudan Univ, Huashan Hosp, Dept Neurol, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China; [Ge, Jingjie; Wu, Ping; Zuo, Chuantao] Fudan Univ, Huashan Hosp, PET Ctr, 518 East Wuzhong Rd, Shanghai 200235, Peoples R China	Fudan University; Fudan University	Wang, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.; Zuo, CT (corresponding author), Fudan Univ, Huashan Hosp, PET Ctr, 518 East Wuzhong Rd, Shanghai 200235, Peoples R China.	zuoct_cn2000@126.com; wangjian_hs@fudan.edu.cn	wang, yixuan/GXW-2866-2022; Wang, Yixuan/GZK-6559-2022; Zuo, Chuantao/AAD-9940-2022; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Ping/0000-0002-2758-1218; Wu, Jian/0000-0002-3394-1507	National Natural Science Foundation of China [81071018, 81171189, 81371413, 81401135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by Grants (Nos. 81071018, 81171189, 81371413 and 81401135) from the National Natural Science Foundation of China.	Bohnen NI, 2003, ARCH NEUROL-CHICAGO, V60, P1745, DOI 10.1001/archneur.60.12.1745; Bohnen NI, 2011, J NUCL MED, V52, P848, DOI 10.2967/jnumed.111.089946; Broeders M, 2013, NEUROLOGY, V81, P346, DOI 10.1212/WNL.0b013e31829c5c86; Caffarra P, 2002, NEUROL SCI, V22, P443, DOI 10.1007/s100720200003; Caviness JN, 2007, MOVEMENT DISORD, V22, P1272, DOI 10.1002/mds.21453; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Emre M, 2003, LANCET NEUROL, V2, P229, DOI 10.1016/S1474-4422(03)00351-X; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Garcia-Garcia D, 2012, EUR J NUCL MED MOL I, V39, P1767, DOI 10.1007/s00259-012-2198-5; Gonzalez-Redondo R, 2014, BRAIN, V137, P2356, DOI 10.1093/brain/awu159; Guo QH, 2009, ALZ DIS ASSOC DIS, V23, P253, DOI 10.1097/WAD.0b013e3181999e92; [郭起浩 GUO Qihao], 2008, [中华神经科杂志, Chinese Journal of Neurology], V41, P234; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hilker R, 2005, NEUROLOGY, V65, P1716, DOI 10.1212/01.wnl.0000191154.78131.f6; Hosokai Y, 2009, MOVEMENT DISORD, V24, P854, DOI 10.1002/mds.22444; Huang C, 2008, NEUROLOGY, V70, P1470, DOI 10.1212/01.wnl.0000304050.05332.9c; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; KUHL DE, 1985, J NUCL MED, V26, pP69; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Lucas JA, 2005, CLIN NEUROPSYCHOL, V19, P243, DOI 10.1080/13854040590945337; Lyoo CH, 2010, EUR NEUROL, V64, P65, DOI 10.1159/000315036; Narayanan NS, 2013, REV NEUROSCIENCE, V24, P267, DOI 10.1515/revneuro-2013-0004; Narayanan NS, 2012, P NATL ACAD SCI USA, V109, P20726, DOI 10.1073/pnas.1211258109; Nobili F, 2009, MOVEMENT DISORD, V24, P414, DOI 10.1002/mds.22381; Pappata S, 2011, NEUROLOGY, V77, P1357, DOI 10.1212/WNL.0b013e3182315259; Pedersen KF, 2013, JAMA NEUROL, V70, P580, DOI 10.1001/jamaneurol.2013.2110; PEPPARD RF, 1992, ARCH NEUROL-CHICAGO, V49, P1262, DOI 10.1001/archneur.1992.00530360060019; PERRY RH, 1983, LANCET, V2, P789; SCATTON B, 1983, BRAIN RES, V275, P321, DOI 10.1016/0006-8993(83)90993-9; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; Shinotoh H, 2001, ADV NEUROL, V86, P249; Steinberg BA, 2005, CLIN NEUROPSYCHOL, V19, P329, DOI 10.1080/13854040590945210; Tard C, 2015, J PARKINSON DIS, V5, P569, DOI 10.3233/JPD-150583; VanderBorght T, 1997, J NUCL MED, V38, P797; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zhao QH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057333, 10.1371/journal.pone.0061140]; Zuo CT, 2013, J CEREBR BLOOD F MET, V33, P880, DOI 10.1038/jcbfm.2013.23	40	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152716	10.1371/journal.pone.0152716	http://dx.doi.org/10.1371/journal.pone.0152716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064684	Green Submitted, gold, Green Published			2022-12-26	WOS:000373891000017
J	Hou, DH; Chen, X; Zhang, LK				Hou, Dianhai; Chen, Xi; Zhang, Lei-Ke			Proteomic Analysis of Mamestra Brassicae Nucleopolyhedrovirus Progeny Virions from Two Different Hosts	PLOS ONE			English	Article							OCCLUSION-DERIVED VIRUS; SINGLE-NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; NUCLEAR POLYHEDROSIS-VIRUS; OS INFECTIVITY FACTOR; BUDDED-VIRUS; PROTEIN-COMPOSITION; VIRAL REPLICATION; GENE; IDENTIFICATION; BACULOVIRUSES	Mamestra brassicae nucleopolyhedrovirus (MabrNPV) has a wide host range replication in more than one insect species. In this study, a sequenced MabrNPV strain, MabrNPV-CTa, was used to perform proteomic analysis of both BVs and ODVs derived from two infected hosts: Helicoverpa armigera and Spodoptera exigua. A total of 82 and 39 viral proteins were identified in ODVs and BVs, respectively. And totally, 23 and 76 host proteins were identified as virion-associated with ODVs and BVs, respectively. The host proteins incorporated into the virus particles were mainly involved in cytoskeleton, signaling, vesicle trafficking, chaperone and metabolic systems. Some host proteins, such as actin, cyclophilin A and heat shock protein 70 would be important for viral replication. Several host proteins involved in immune response were also identified in BV, and a C-type lectin protein was firstly found to be associated with BV and its family members have been demonstrated to be involved in entry process of other viruses. This study facilitated the annotation of baculovirus genome, and would help us to understand baculovirus virion structure. Furthermore, the identification of host proteins associated with virions produced in vivo would facilitate investigations on the involvement of intriguing host proteins in virus replication.	[Hou, Dianhai; Zhang, Lei-Ke] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Chen, Xi] Wuhan Inst Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Zhang, LK (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	zhangleike@wh.iov.cn			National Science Foundation of China [31400142, 31500144]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Science Foundation of China 31400142 (DH Hou) and 31500144 (LK Zhang).	Adang MJ, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P405, DOI 10.1016/B978-0-12-382219-2.00081-8; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Braconi CT, 2014, J GEN VIROL, V95, P980, DOI 10.1099/vir.0.061127-0; BRAUNAGEL SC, 1994, VIROLOGY, V202, P315, DOI 10.1006/viro.1994.1348; Braunagel SC, 2003, P NATL ACAD SCI USA, V100, P9797, DOI 10.1073/pnas.1733972100; Braunagel SC, 1999, J VIROL, V73, P8559, DOI 10.1128/JVI.73.10.8559-8570.1999; Brudner M, 2013, LECTIN DEPENDENT ENH; Budatha M, 2007, BIOCHEM J, V405, P287, DOI 10.1042/BJ20070054; Caballero P., 1992, Biocontrol Science and Technology, V2, P35, DOI 10.1080/09583159209355215; Chen L, 2013, VIRUS RES, V173, P404, DOI 10.1016/j.virusres.2012.12.016; Chen L, 2012, ARCH VIROL, V157, P617, DOI 10.1007/s00705-011-1211-9; Choi JB, 2013, VIRUS GENES, V47, P133, DOI 10.1007/s11262-013-0922-2; Deng F, 2007, J VIROL, V81, P9377, DOI 10.1128/JVI.00632-07; DOYLE CJ, 1990, APPL ENVIRON MICROB, V56, P2704, DOI 10.1128/AEM.56.9.2704-2710.1990; Fang MG, 2009, J VIROL, V83, P12569, DOI 10.1128/JVI.01141-09; Gandhi KM, 2012, J GEN VIROL, V93, P1795, DOI 10.1099/vir.0.041848-0; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; HARRISON RL, 1995, J GEN VIROL, V76, P1451, DOI 10.1099/0022-1317-76-6-1451; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; Hou DH, 2013, J VIROL, V87, P829, DOI 10.1128/JVI.02329-12; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Li LL, 2006, VIRUS RES, V121, P42, DOI 10.1016/j.virusres.2006.03.014; Li LL, 2002, VIROLOGY, V297, P226, DOI 10.1006/viro.2002.1411; Li ZF, 2006, GENE, V372, P33, DOI 10.1016/j.gene.2005.11.029; Lin GY, 2002, J VIROL, V76, P5503, DOI 10.1128/JVI.76.11.5503-5514.2002; Liu XY, 2008, INTERVIROLOGY, V51, P369, DOI 10.1159/000193462; Makela AR, 2006, ADV VIRUS RES, V68, P91, DOI 10.1016/S0065-3527(06)68003-2; Marek M, 2011, J VIROL, V85, P5350, DOI 10.1128/JVI.00035-11; Masler EP, 1997, COMP BIOCHEM PHYS B, V116, P11, DOI 10.1016/S0305-0491(96)00194-0; Matsuno K, 2010, DIFFERENT POTENTIAL; McCarthy CB, 2008, VIROLOGY, V375, P277, DOI 10.1016/j.virol.2008.01.039; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; Ningshen TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079468; Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162; Ono C, 2012, VIRUS RES, V165, P197, DOI 10.1016/j.virusres.2012.02.016; PEARSON MN, 1988, VIROLOGY, V167, P407, DOI 10.1016/0042-6822(88)90102-X; Peng K, 2012, J VIROL, V86, P4981, DOI 10.1128/JVI.06801-11; Perera O, 2007, J VIROL, V81, P4585, DOI 10.1128/JVI.02391-06; Radhakrishnan A, 2010, MOL CELL PROTEOMICS, V9, P1829, DOI 10.1074/mcp.M110.001651; Saksena S, 2006, NAT STRUCT MOL BIOL, V13, P500, DOI 10.1038/nsmb1098; Shen HX, 2009, CURR MICROBIOL, V59, P65, DOI 10.1007/s00284-009-9399-6; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simon O, 2012, J INVERTEBR PATHOL, V109, P117, DOI 10.1016/j.jip.2011.10.010; Slack J, 2007, ADV VIRUS RES, V69, P99, DOI 10.1016/S0065-3527(06)69003-9; Sugiura N, 2011, J BIOL CHEM, V286, P29026, DOI 10.1074/jbc.M111.251157; Tang P, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-168; Tang Q, 2013, J INVERTEBR PATHOL, V113, P70, DOI 10.1016/j.jip.2013.01.006; TWEETEN KA, 1980, J VIROL, V33, P866, DOI 10.1128/JVI.33.2.866-876.1980; Wang LH, 2009, J GEN VIROL, V90, P1641, DOI 10.1099/vir.0.010397-0; Wang Q, 2008, J VIROL, V82, P4072, DOI 10.1128/JVI.02319-07; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Wang XF, 2011, J PROTEOME RES, V10, P2817, DOI 10.1021/pr2000804; Wu D, 2005, J GEN VIROL, V86, P2439, DOI 10.1099/vir.0.81110-0; Xi QY, 2007, VIRUS GENES, V34, P223, DOI 10.1007/s11262-006-0045-0; Xu F, 2011, VIRUS RES, V158, P1, DOI 10.1016/j.virusres.2011.02.014; Xu HJ, 2006, J BIOCHEM MOL BIOL, V39, P263; Yang M, 2014, J VIROL, V88, P12586, DOI 10.1128/JVI.01313-14; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Zheng FL, 2011, VIRUS RES, V155, P203, DOI 10.1016/j.virusres.2010.10.006; Zhou Z, 2013, ACTA BIOCH BIOPH SIN, V45, P465, DOI 10.1093/abbs/gmt027	61	8	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153365	10.1371/journal.pone.0153365	http://dx.doi.org/10.1371/journal.pone.0153365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058368	gold, Green Published, Green Submitted			2022-12-26	WOS:000373604800030
J	Kim, JH; Jeong, HS; Kim, KM; Lee, YJ; Jung, MH; Park, JJ; Kim, JP; Woo, SH				Kim, Jin Hyun; Jeong, Han-Sin; Kim, Kyung Mi; Lee, Ye Jin; Jung, Myeong Hee; Park, Jung Je; Kim, Jin Pyeong; Woo, Seung Hoon			Extra-Esophageal Pepsin from Stomach Refluxate Promoted Tonsil Hypertrophy	PLOS ONE			English	Article							RECURRENT TONSILLITIS; EPITHELIAL-CELLS; OTITIS-MEDIA; LARYNGOPHARYNGEAL REFLUX; GASTRIC PEPSIN; CHILDREN; INHIBITION; PREVALENCE; DISEASE; EAR	Background Gastroesophageal reflux is associated with numerous pathologic conditions of the upper aero-digestive tract. Gastric pepsin within reflux contributes to immunologic reactions in the tonsil. In this study, we aimed to find the relationships between pepsin and tonsillar hypertrophy. Methods and finding We explored the notion whether tonsillar hypertrophy was due to pepsin-mediated gastric reflux in tonsil hypertrophy. Fifty-four children with tonsil hypertrophy and 30 adults with tonsillitis were recruited before surgical treatment. Blood and tonsil tissues from each patient were harvested for analysis of changes in lymphocyte and macrophage numbers coupled with histological and biochemical analysis. Pepsin was expressed at different levels in tonsil tissues from each tonsillar hypertrophy. Pepsin-positive cells were found in the crypt epithelium, surrounding the lymphoid follicle with developing fibrosis, and also surrounding the lymphoid follicle that faced the crypt. And also, pepsin staining was well correlated with damaged tonsillar squamous epithelium and TGF-beta 1 and iNOS expression in the tonsil section. In addition, pepsin and TGF-beta 1-positive cells were co-localized with CD68-positive cells in the crypt and surrounding germinal centers. In comparison of macrophage responsiveness to pepsin, peripheral blood mononuclear cells (PBMNCs) were noticeably larger in the presence of activated pepsin in the child group. Furthermore, CD11c and CD163-positive cells were significantly increased by activated pepsin. However, this was not seen for the culture of PBMNCs from the adult group. Conclusions The lymphocytes and monocytes are in a highly proliferative state in the tonsillar hypertrophy and associated with increased expression of pro-inflammatory factors as a result of exposure to stomach reflux pepsin.	[Kim, Jin Hyun; Kim, Kyung Mi; Lee, Ye Jin; Jung, Myeong Hee] Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, Gyeongsangnamdo, South Korea; [Jeong, Han-Sin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Park, Jung Je; Kim, Jin Pyeong; Woo, Seung Hoon] Gyeongsang Natl Univ Hosp, Dept Otolaryngol, Jinju, Gyeongsangnamdo, South Korea; [Woo, Seung Hoon] Gyeongsang Natl Univ Hosp, Inst Hlth Sci, Jinju, Gyeongsangnamdo, South Korea	Gyeongsang National University; Gyeongsang National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University Hospital	Woo, SH (corresponding author), Gyeongsang Natl Univ Hosp, Dept Otolaryngol, Jinju, Gyeongsangnamdo, South Korea.; Woo, SH (corresponding author), Gyeongsang Natl Univ Hosp, Inst Hlth Sci, Jinju, Gyeongsangnamdo, South Korea.	lesaby@hanmail.net	Jeong, Han-Sin/C-4884-2011; Jeong, Han Sin/F-4597-2014	Jeong, Han-Sin/0000-0003-4652-0573; 	Basic Science Research Program, through the National Research Foundation of Korea (NRF); Ministry of Science, ICT, and Future Planning [2013R1A1A1012542]; Leading Foreign Research Institute Recruitment Program, through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2012K1A4A3053142]; biomedcal research institute fund from the Gyeongsang National University Hospital [GNUHBIF-2014-0009]	Basic Science Research Program, through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT, and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Leading Foreign Research Institute Recruitment Program, through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); biomedcal research institute fund from the Gyeongsang National University Hospital	This study was supported by the Basic Science Research Program, through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT, and Future Planning (2013R1A1A1012542). This study was further supported by the Leading Foreign Research Institute Recruitment Program, through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (MEST) (2012K1A4A3053142)). This work was supported by biomedcal research institute fund (GNUHBIF-2014-0009) from the Gyeongsang National University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-aziz MM, 2013, INT J PEDIATR OTORHI, V77, P1765, DOI 10.1016/j.ijporl.2013.08.014; AGREN K, 1995, ACTA OTO-LARYNGOL, V115, P689, DOI 10.3109/00016489509139388; Alatas N, 2008, ARCH OTOLARYNGOL, V134, P477, DOI 10.1001/archotol.134.5.477; Ameli F, 2014, ALLERGY RHINOL, V5, pE137, DOI 10.2500/ar.2014.5.0095; BIELUCH VM, 1989, ANN OTO RHINOL LARYN, V98, P332, DOI 10.1177/000348948909800503; Bothwell MR, 1999, OTOLARYNG HEAD NECK, V121, P255, DOI 10.1016/S0194-5998(99)70181-6; He ZP, 2008, CURR ALLERGY ASTHM R, V8, P513, DOI 10.1007/s11882-008-0094-7; HOLNESS CL, 1993, BLOOD, V81, P1607; Jiang Q, 2011, MOL CELL ENDOCRINOL, V331, P34, DOI 10.1016/j.mce.2010.07.023; Jiang T, 2014, KIDNEY INT, V85, P333, DOI 10.1038/ki.2013.343; Johnston N, 2004, LARYNGOSCOPE, V114, P2129, DOI 10.1097/01.mlg.0000149445.07146.03; Johnston N, 2012, LARYNGOSCOPE, V122, P1317, DOI 10.1002/lary.23307; Kaditis AG, 2004, PEDIATR PULM, V37, P499, DOI 10.1002/ppul.20002; Kelly EA, 2014, OTOLARYNG HEAD NECK, V150, P618, DOI 10.1177/0194599813517862; KOCH RJ, 1995, LARYNGOSCOPE, V105, P42, DOI 10.1288/00005537-199501000-00011; Kraus J, 2014, ACTA OTO-LARYNGOL, V134, P88, DOI 10.3109/00016489.2013.840924; Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; O'Reilly RC, 2015, JAMA OTOLARYNGOL, V141, P350, DOI 10.1001/jamaoto.2014.3581; Onal M, 2015, INT J PEDIATR OTORHI, V79, P191, DOI 10.1016/j.ijporl.2014.12.005; Roberts AL, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-3; Samuels TL, 2013, ANN OTO RHINOL LARYN, V122, P632, DOI 10.1177/000348941312201006; Southwood JE, 2015, ANN OTO RHINOL LARYN, V124, P957, DOI 10.1177/0003489415593556; Stapleton A, 2008, INT J PEDIATR OTORHI, V72, P409, DOI 10.1016/j.ijporl.2007.11.003; SUGIYAMA M, 1982, INT J PEDIATR OTORHI, V4, P193, DOI 10.1016/0165-5876(82)90001-5; Tasker A, 2002, LANCET, V359, P493, DOI 10.1016/S0140-6736(02)07665-1; Todorovic MM, 2013, BOSNIAN J BASIC MED, V13, P230; Xue XC, 2014, J MED VIROL, V86, P963, DOI 10.1002/jmv.23894; Zhang PC, 2003, CLIN OTOLARYNGOL, V28, P235, DOI 10.1046/j.1365-2273.2003.00697.x; Zhao WX, 2014, INT J MOL MED, V33, P687, DOI 10.3892/ijmm.2013.1613	30	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152336	10.1371/journal.pone.0152336	http://dx.doi.org/10.1371/journal.pone.0152336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058240	gold, Green Published, Green Submitted			2022-12-26	WOS:000373604800005
J	Hedley, RW				Hedley, Richard W.			Complexity, Predictability and Time Homogeneity of Syntax in the Songs of Cassin's Vireo (Vireo cassinii)	PLOS ONE			English	Article							SINGING PATTERNS; BIRD SONG; SEQUENCES; ORGANIZATION; CLASSIFICATION; PHYLOGENY; EVOLUTION; CONTEXT; WREN	Many species of animals deliver vocalizations in sequences presumed to be governed by internal rules, though the nature and complexity of these syntactical rules have been investigated in relatively few species. Here I present an investigation into the song syntax of fourteen male Cassin's Vireos (Vireo cassinii), a species whose song sequences are highly temporally structured. I compare their song sequences to three candidate models of varying levels of complexity-zero-order, first-order and second-order Markov models-and employ novel methods to interpolate between these three models. A variety of analyses, including sequence simulations, Fisher's exact tests, and model likelihood analyses, showed that the songs of this species are too complex to be described by a zero-order or first-order Markov model. The model that best fit the data was intermediate in complexity between a first-and second-order model, though I also present evidence that some transition probabilities are conditioned on up to three preceding phrases. In addition, sequences were shown to be predictable with more than 54% accuracy overall, and predictability was positively correlated with the rate of song delivery. An assessment of the time homogeneity of syntax showed that transition probabilities between phrase types are largely stable over time, but that there was some evidence for modest changes in syntax within and between breeding seasons, a finding that I interpret to represent changes in breeding stage and social context rather than irreversible, secular shifts in syntax over time. These findings constitute a valuable addition to our understanding of bird song syntax in free-living birds, and will contribute to future attempts to understand the evolutionary importance of bird song syntax in avian communication.	[Hedley, Richard W.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	University of California System; University of California Los Angeles	Hedley, RW (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA.	rhedley@ucla.edu			National Science Foundation [1125423]; Audubon society branch in Pasadena; Audubon society branch in Los Angeles; Audubon society branch in Santa Monica Bay; Div Of Information & Intelligent Systems [1125423] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Audubon society branch in Pasadena; Audubon society branch in Los Angeles; Audubon society branch in Santa Monica Bay; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was funded by National Science Foundation Award Number 1125423 (http://www.nsf.gov/) and was supplemented by three small grants from the Audubon society branches in Pasadena (http://www.pasadenaaudubon.org), Los Angeles (http://www.losangelesaudubon.org), and Santa Monica Bay (https://smbasblog.wordpress.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Arriaga JG, 2016, NEUROCOMPUTING, V175, P966, DOI 10.1016/j.neucom.2015.05.129; Arriaga JG, 2014, LECT NOTES COMPUT SC, V8495, P291, DOI 10.1007/978-3-319-07491-7_30; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Beecher MD, 2000, ANIM BEHAV, V59, P21, DOI 10.1006/anbe.1999.1276; Berwick RC, 2011, TRENDS COGN SCI, V15, P113, DOI 10.1016/j.tics.2011.01.002; Bolhuis JJ, 2013, BIRDSONG, SPEECH, AND LANGUAGE: EXPLORING THE EVOLUTION OF MIND AND BRAIN, P1; BORROR DJ, 1981, CONDOR, V83, P217, DOI 10.2307/1367311; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; CHATFIELD C, 1970, J THEOR BIOL, V29, P427, DOI 10.1016/0022-5193(70)90107-4; DESTAVOLA BL, 1988, J R STAT SOC C-APPL, V37, P242; DOBSON CW, 1977, BEHAVIOUR, V62, P277, DOI 10.1163/156853977X00144; DOBSON CW, 1979, BEHAVIOUR, V68, P86, DOI 10.1163/156853979X00250; FALLS JB, 1975, CAN J ZOOL, V53, P1165, DOI 10.1139/z75-135; Gentner TQ, 1998, ANIM BEHAV, V56, P579, DOI 10.1006/anbe.1998.0810; Gil D, 2000, BEHAVIOUR, V137, P759, DOI 10.1163/156853900502330; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hedley RW, 2016, J ORNITHOL, V157, P13, DOI 10.1007/s10336-015-1238-x; HOWESJONES D, 1985, CAN J ZOOL, V63, P2756, DOI 10.1139/z85-411; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; James LS, 2014, J NEUROPHYSIOL, V112, P2040, DOI 10.1152/jn.00217.2014; Jin DZ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001108; Jin DZ, 2013, PROGR COGNITIVE SCI; Jurafsky D., 2009, SPEECH LANGUAGE PROC; Katahira K, 2007, BIOL CYBERN, V97, P441, DOI 10.1007/s00422-007-0184-y; Katahira K, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0842; Katahira K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024516; Kershenbaum A, 2015, METHODS ECOL EVOL, V6, P1452, DOI 10.1111/2041-210X.12433; Kershenbaum A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1370; KROODSMA DE, 1975, CONDOR, V77, P294, DOI 10.2307/1366225; LANGMORE NE, 1992, ETHOLOGY, V90, P143; LEMON RE, 1973, ANIM BEHAV, V21, P28, DOI 10.1016/S0003-3472(73)80037-5; LEMON RE, 1993, ETHOLOGY, V93, P198; LEMON RE, 1971, ANIM BEHAV, V19, P1, DOI 10.1016/S0003-3472(71)80129-X; Li M, 1993, AN INTRODUCTION TO K; Margoliash D, 2002, J COMP PHYSIOL A, V188, P851, DOI 10.1007/s00359-002-0351-5; Markowitz JE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003052; MARTIN DJ, 1990, WILSON BULL, V102, P655; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Sakata JT, 2009, J NEUROPHYSIOL, V102, P2485, DOI 10.1152/jn.00340.2009; Sasahara K, 2006, CIC 2006: 15TH INTERNATIONAL CONFERENCE ON COMPUTING, PROCEEDINGS, P80; SLATER PJB, 1983, ANIM BEHAV, V31, P272, DOI 10.1016/S0003-3472(83)80197-3; SMITH WJ, 1978, ANIM BEHAV, V26, P862, DOI 10.1016/0003-3472(78)90153-7; Soma M, 2011, BEHAV ECOL, V22, P363, DOI 10.1093/beheco/arq219; STODDARD PK, 1992, CAN J ZOOL, V70, P1440, DOI 10.1139/z92-200; Tan B, 2002, EUR J OPER RES, V137, P524, DOI 10.1016/S0377-2217(01)00081-9; Tan LN, 2015, J ACOUST SOC AM, V137, P1069, DOI 10.1121/1.4906168; Tan LN, 2013, INT CONF ACOUST SPEE, P763, DOI 10.1109/ICASSP.2013.6637751; ten Cate C, 2012, PHILOS T R SOC B, V367, P1984, DOI 10.1098/rstb.2012.0055; Vehrencamp SL, 2007, BEHAV ECOL, V18, P849, DOI 10.1093/beheco/arm054; VERNER J, 1975, Living Bird, V14, P263; Warren TL, 2012, J NEUROSCI, V32, P15414, DOI 10.1523/JNEUROSCI.1254-12.2012; WITTEN IH, 1991, IEEE T INFORM THEORY, V37, P1085, DOI 10.1109/18.87000; Wolfram S., 2002, NEW KIND SCI	56	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0150822	10.1371/journal.pone.0150822	http://dx.doi.org/10.1371/journal.pone.0150822			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050537	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500002
J	Asaf, S; Khan, AL; Khan, AR; Waqas, M; Kang, SM; Khan, MA; Shahzad, R; Seo, CW; Shin, JH; Lee, IJ				Asaf, Sajjad; Khan, Abdul Latif; Khan, Abdur Rahim; Waqas, Muhammad; Kang, Sang-Mo; Khan, Muhammad Aaqil; Shahzad, Raheem; Seo, Chang-Woo; Shin, Jae-Ho; Lee, In-Jung			Mitochondrial Genome Analysis of Wild Rice (Oryza minuta) and Its Comparison with Other Related Species	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PHYLOGENETIC-RELATIONSHIPS; PHYSICAL STRUCTURE; NUCLEAR GENES; GENUS ORYZA; DNA; EVOLUTION; L.; REARRANGEMENT; SATIVA	Oryza minuta (Poaceae family) is a tetraploid wild relative of cultivated rice with a BBCC genome. O. minuta has the potential to resist against various pathogenic diseases such as bacterial blight (BB), white backed planthopper (WBPH) and brown plant hopper (BPH). Here, we sequenced and annotated the complete mitochondrial genome of O. minuta. The mtDNA genome is 515,022 bp, containing 60 protein coding genes, 31 tRNA genes and two rRNA genes. The mitochondrial genome organization and the gene content at the nucleotide level are highly similar (89%) to that of O. rufipogon. Comparison with other related species revealed that most of the genes with known function are conserved among the Poaceae members. Similarly, O. minuta mt genome shared 24 protein-coding genes, 15 tRNA genes and 1 ribosomal RNA gene with other rice species (indica and japonica). The evolutionary relationship and phylogenetic analysis revealed that O. minuta is more closely related to O. rufipogon than to any other related species. Such studies are essential to understand the evolutionary divergence among species and analyze common gene pools to combat risks in the current scenario of a changing environment.	[Asaf, Sajjad; Khan, Abdur Rahim; Waqas, Muhammad; Kang, Sang-Mo; Khan, Muhammad Aaqil; Shahzad, Raheem; Seo, Chang-Woo; Shin, Jae-Ho; Lee, In-Jung] Kyungpook Natl Univ, Sch Appl Biosci, Daegu 41566, South Korea; [Khan, Abdul Latif] Univ Nizwa, Chair Omans Med Plants & Marine Nat Prod, Nizwa 616, Oman; [Waqas, Muhammad] Abdul Wali Khan Univ Mardan, Dept Agr, Mardan, Pakistan	Kyungpook National University; University of Nizwa	Lee, IJ (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu 41566, South Korea.	ijlee@knu.ac.kr	Asaf, Sajjad/ABA-3647-2021; Shahzad, Raheem/AAG-8370-2019; Lee, In-Jung/GLS-0432-2022; Khan, Abdur Rahim/N-5836-2015; Khan, Muhammad Aqil/ABB-9797-2021	Shahzad, Raheem/0000-0002-6594-8287; Lee, In-Jung/0000-0001-7154-4820; Khan, Abdur Rahim/0000-0001-5370-6216; Khan, Abdul Latif/0000-0001-9700-8903	research fund from Ministry for Food, Agriculture, Forestry, and Fisheries, Republic of Korea [311058-05-3-CG000]	research fund from Ministry for Food, Agriculture, Forestry, and Fisheries, Republic of Korea	This study was supported by a research fund (311058-05-3-CG000) from the Ministry for Food, Agriculture, Forestry, and Fisheries, Republic of Korea.	Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; AMANTEBORDEOS A, 1992, THEOR APPL GENET, V84, P345, DOI 10.1007/BF00229493; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chang SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062323; CHANG TT, 1976, EUPHYTICA, V25, P425, DOI 10.1007/BF00041576; Chen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017662; CHETRIT P, 1984, CURR GENET, V8, P413, DOI 10.1007/BF00433907; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Cui P, 2009, J GENET, V88, P299, DOI 10.1007/s12041-009-0043-9; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darracq A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-233; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fujii S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-209; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Goremykin VV, 2012, PLANT J, V71, P615, DOI 10.1111/j.1365-313X.2012.05014.x; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Guo SB, 2013, RICE SCI, V20, P95, DOI 10.1016/S1672-6308(13)60111-0; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Li LB, 2009, J MOL EVOL, V68, P665, DOI 10.1007/s00239-009-9240-7; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025836; Matter F, 1988, PHILOS T R SOC LON B, V319; Michael TP, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0001in; Miyata S, 1998, CURR GENET, V34, P216, DOI 10.1007/s002940050389; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0; PALMER JD, 1987, CURR GENET, V11, P565, DOI 10.1007/BF00384620; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Rahman ML, 2009, THEOR APPL GENET, V119, P1237, DOI 10.1007/s00122-009-1125-z; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schnell J, 2015, TRANSGENIC RES, V24, P1, DOI 10.1007/s11248-014-9843-7; SCHUSTER W, 1994, ANNU REV PLANT PHYS, V45, P61, DOI 10.1146/annurev.pp.45.060194.000425; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; STERN DB, 1986, NUCLEIC ACIDS RES, V14, P5651, DOI 10.1093/nar/14.14.5651; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Vaughan DA, 1994, THE WILD RELATIVES O; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2; Wu ZH, 2014, BIG DATA RES, V1, P1, DOI 10.1016/j.bdr.2014.08.0022214; Wu ZQ, 2016, MITOCHONDRIAL DNA A, V27, P4155, DOI 10.3109/19401736.2014.1003890; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; Zhu T, 2014, MOL PHYLOGENET EVOL, V70, P348, DOI 10.1016/j.ympev.2013.10.008	52	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152937	10.1371/journal.pone.0152937	http://dx.doi.org/10.1371/journal.pone.0152937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045847	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600049
J	Liu, YL; Zhou, JA; Qu, YL; Yang, XG; Shi, GJ; Wang, XH; Hong, YZ; Drlica, K; Zhao, XL				Liu, Yuanli; Zhou, Jinan; Qu, Yilin; Yang, Xinguang; Shi, Guojing; Wang, Xiuhong; Hong, Yuzhi; Drlica, Karl; Zhao, Xilin			Resveratrol Antagonizes Antimicrobial Lethality and Stimulates Recovery of Bacterial Mutants	PLOS ONE			English	Article							CELL-DEATH; ERYTHROMYCIN RESISTANCE; GENOTOXIC EVALUATION; ESCHERICHIA-COLI; ANTIBIOTICS; INVOLVEMENT; CONSUMPTION; BIOAVAILABILITY; CIPROFLOXACIN; PATHWAYS	Reactive oxygen species (ROS; superoxide, peroxide, and hydroxyl radical) are thought to contribute to the rapid bactericidal activity of diverse antimicrobial agents. The possibility has been raised that consumption of antioxidants in food may interfere with the lethal action of antimicrobials. Whether nutritional supplements containing antioxidant activity are also likely to interfere with antimicrobial lethality is unknown. To examine this possibility, resveratrol, a popular antioxidant dietary supplement, was added to cultures of Escherichia coli and Staphylococcus aureus that were then treated with antimicrobial and assayed for bacterial survival and the recovery of mutants resistant to an unrelated antimicrobial, rifampicin. Resveratrol, at concentrations likely to be present during human consumption, caused a 2- to 3-fold reduction in killing during a 2-hr treatment with moxifloxacin or kanamycin. At higher, but still subinhibitory concentrations, resveratrol reduced antimicrobial lethality by more than 3 orders of magnitude. Resveratrol also reduced the increase in reactive oxygen species (ROS) characteristic of treatment with quinolone (oxolinic acid). These data support the general idea that the lethal activity of some antimicrobials involves ROS. Surprisingly, subinhibitory concentrations of resveratrol promoted (2- to 6-fold) the recovery of rifampicinresistant mutants arising from the action of ciprofloxacin, kanamycin, or daptomycin. This result is consistent with resveratrol reducing ROS to sublethal levels that are still mutagenic, while the absence of resveratrol allows ROS levels to high enough to kill mutagenized cells. Suppression of antimicrobial lethality and promotion of mutant recovery by resveratrol suggests that the antioxidant may contribute to the emergence of resistance to several antimicrobials, especially if new derivatives and/or formulations of resveratrol markedly increase bioavailability.	[Liu, Yuanli; Zhou, Jinan; Qu, Yilin; Yang, Xinguang; Shi, Guojing; Wang, Xiuhong] Harbin Med Univ, Dept Biochem & Mol Biol, Heilongjiang Prov Sci & Technol Innovat Team High, 194 Xuefu Rd, Harbin 150081, Heilongjiang Pr, Peoples R China; [Hong, Yuzhi; Drlica, Karl; Zhao, Xilin] Rutgers State Univ, Publ Hlth Res Inst, 225 Warren St, Newark, NJ 07103 USA; [Hong, Yuzhi; Drlica, Karl; Zhao, Xilin] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, 225 Warren St, Newark, NJ 07103 USA; [Zhao, Xilin] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, South Xiang An Rd, Xiamen 361102, Fujian Province, Peoples R China	Harbin Medical University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Xiamen University	Wang, XH (corresponding author), Harbin Med Univ, Dept Biochem & Mol Biol, Heilongjiang Prov Sci & Technol Innovat Team High, 194 Xuefu Rd, Harbin 150081, Heilongjiang Pr, Peoples R China.; Zhao, XL (corresponding author), Rutgers State Univ, Publ Hlth Res Inst, 225 Warren St, Newark, NJ 07103 USA.; Zhao, XL (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, 225 Warren St, Newark, NJ 07103 USA.; Zhao, XL (corresponding author), Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, South Xiang An Rd, Xiamen 361102, Fujian Province, Peoples R China.	wangxh700417@aliyun.com; zhaox5@njms.rutgers.edu		Zhao, Xilin/0000-0001-8375-8658; Hong, Yuzhi/0000-0003-4277-1834	National Institutes of Health [1DP2OD007423, 1R01AI073491, 1R21A03781, 1R01AI87671]; National Natural Science Foundation of China [30973596, 81473251]; Natural Science Foundation of Heilongjiang Province [QC2012C086]; Heilongjiang Postdoctoral Program [LBH-Z13147]; Research Project of Heilongjiang Department of Public Health [2012-756]; Natural Science Foundation of Fujian Province [2014J01139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073491, R21AI103781, R01AI087671] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Heilongjiang Postdoctoral Program; Research Project of Heilongjiang Department of Public Health; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by grants from the National Institutes of Health (1DP2OD007423, 1R01AI073491, 1R21A03781, and 1R01AI87671), National Natural Science Foundation of China (30973596 and 81473251), Natural Science Foundation of Heilongjiang Province (QC2012C086), Heilongjiang Postdoctoral Program (LBH-Z13147), Research Project of Heilongjiang Department of Public Health (2012-756), and Natural Science Foundation of Fujian Province (2014J01139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires V, 2015, CURR PHARM BIOTECHNO, V16, P219, DOI 10.2174/1389201016666150118132457; Amri A, 2012, J CONTROL RELEASE, V158, P182, DOI 10.1016/j.jconrel.2011.09.083; Arriaga-Alba M, 1998, ARCH MED RES, V29, P235; BASS DA, 1983, J IMMUNOL, V130, P1910; Bergman M, 2004, CLIN INFECT DIS, V38, P1251, DOI 10.1086/383309; Bergman M, 2009, ANTIMICROB AGENTS CH, V53, P912, DOI 10.1128/AAC.00856-08; Boyce A, 2004, J CHROMATOGR B, V802, P217, DOI 10.1016/j.jchromb.2003.10.057; BRANDT R, 1965, ANAL BIOCHEM, V11, P6, DOI 10.1016/0003-2697(65)90035-7; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Dorsey-Oresto A, 2013, CELL REP, V3, P528, DOI 10.1016/j.celrep.2013.01.026; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Dwyer DJ, 2015, ANNU REV PHARMACOL, V55, P313, DOI 10.1146/annurev-pharmtox-010814-124712; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Ferrandiz MJ, 2016, ANTIMICROB AGENTS CH, V60, P409, DOI 10.1128/AAC.02299-15; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; Granzotto A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00095; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Guo W, 2015, AM J INFECT CONTROL, V43, P358, DOI 10.1016/j.ajic.2014.12.010; Hoshino J, 2010, J MED CHEM, V53, P5033, DOI 10.1021/jm100274c; Hwang D, 2015, SCI REP-UK, V5, DOI 10.1038/srep10029; Isidori M, 2005, SCI TOTAL ENVIRON, V346, P87, DOI 10.1016/j.scitotenv.2004.11.017; Johnson JJ, 2011, MOL NUTR FOOD RES, V55, P1169, DOI 10.1002/mnfr.201100117; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Li LP, 2014, MBIO, V5, DOI 10.1128/mBio.01708-14; Liu YL, 2012, ANTIMICROB AGENTS CH, V56, P6048, DOI 10.1128/AAC.00754-12; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Livermore DM, 2011, J ANTIMICROB CHEMOTH, V66, P1941, DOI 10.1093/jac/dkr262; Long QX, 2015, ANTIMICROB AGENTS CH, V59, P1787, DOI 10.1128/AAC.04434-14; Malik M, 2014, J ANTIMICROB CHEMOTH, V69, P3227, DOI 10.1093/jac/dku285; Marathe SA, 2013, J ANTIMICROB CHEMOTH, V68, P139, DOI 10.1093/jac/dks375; Marshall DA, 2006, CAN J PUBLIC HEALTH, V97, P126, DOI 10.1007/BF03405330; Mosel M, 2013, ANTIMICROB AGENTS CH, V57, P5755, DOI 10.1128/AAC.00754-13; Patel KR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005870; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Sinha R, 2003, J Postgrad Med, V49, P222; Stivala L, 2001, J BIOL CHEM, V276; Su YL, 2014, MOLECULES, V19, P12630, DOI 10.3390/molecules190812630; Wang XH, 2010, J ANTIMICROB CHEMOTH, V65, P520, DOI 10.1093/jac/dkp486; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Yang X, 2014, ANTI-CANCER AGENT ME, V14, P806, DOI 10.2174/1871520614666140521121722; Zhao XL, 2015, J ANTIMICROB CHEMOTH, V70, P639, DOI 10.1093/jac/dku463; Zhao XL, 2014, CURR OPIN MICROBIOL, V21, P1, DOI 10.1016/j.mib.2014.06.008	48	28	31	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153023	10.1371/journal.pone.0153023	http://dx.doi.org/10.1371/journal.pone.0153023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045517	gold, Green Submitted, Green Published			2022-12-26	WOS:000373599600060
J	Makanya, AN; Dimova, I; Koller, T; Styp-Rekowska, B; Djonov, V				Makanya, Andrew Ndegwa; Dimova, Ivanka; Koller, Tobias; Styp-Rekowska, Beata; Djonov, Valentin			Dynamics of the Developing Chick Chorioallantoic Membrane Assessed by Stereology, Allometry, Immunohistochemistry and Molecular Analysis	PLOS ONE			English	Article							SHELL-LESS CULTURE; INTUSSUSCEPTIVE ANGIOGENESIS; CHORIONIC EPITHELIUM; VASCULAR NETWORK; EMBRYO; DIFFERENTIATION; ULTRASTRUCTURE; PROPAGATION; INCUBATION; EXPRESSION	The chick chorioallantoic membrane (CAM) is a widely used model for the study of angiogenesis, tumour growth, as well as drug efficacy. In spite of this, little is known about the developmental alteration from its appearance to the time of hatching. In the current study the CAM has been studied by classical stereology and allometry. Expression levels of selected angiogenesis-related molecules were estimated by RT-PCR and cell dynamics assessed by proliferation and apoptosis assays. Absolute CAM volume increased from a low of 0.47 +/- 0.11 cm(3) at embryonic day 8 (E8) to a high of 2.05 +/- 0.27 cm(3) at E18, and then decreased to 1.6 +/- 0.47 cm(3) at E20. On allometric analysis, three growth phases were identifiable. Between E8-13 (phase I), the CAM grew fastest; moderately in phase II (E13-18) but was regressing in phase III (E18-20). The chorion, the mesenchyme and the allantoic layers grew fastest in phase I, but moderately in phase II. The mesenchyme grew slowly in phase III while the chorion and allantois were regressing. Chorionic cell volume increased fastest in phase I and was regressing in phase III. Chorionic capillaries grew steadily in phase I and II but regressed in phase III. Both the chorion and the allantois grew by intrinsic cell proliferation as well as recruitment of cells from the mesenchyme. Cell proliferation was prominent in the allantois and chorion early during development, declined after E17 and apoptosis started mainly in the chorion from E14. VEGFR2 expression peaked at E11 and declined steadily towards E20, VEGF peaked at E13 and E20 while HIF 1 alpha had a peak at E11 and E20. Studies targeting CAM growth and angiogenesis need to take these growth phases into consideration	[Makanya, Andrew Ndegwa] Univ Nairobi, Dept Vet Anat & Physiol, Riverside Dr,Chiromo Campus,Box 30197, Nairobi 00100, Kenya; [Dimova, Ivanka] Med Univ Sofia, Dept Med Genet, Zdrave St 2, Sofia 1431, Bulgaria; [Koller, Tobias; Styp-Rekowska, Beata; Djonov, Valentin] Univ Bern, Inst Anat, Baltzerstr 2, CH-3000 Bern 9, Switzerland	University of Nairobi; Medical University Sofia; University of Bern	Makanya, AN (corresponding author), Univ Nairobi, Dept Vet Anat & Physiol, Riverside Dr,Chiromo Campus,Box 30197, Nairobi 00100, Kenya.	makanya@uonbi.ac.ke	Dimova, Ivanka/ABH-5382-2020; Makanya, Andrew N/F-4180-2012	Makanya, Andrew N/0000-0002-9983-785X; Djonov, Valentin/0000-0002-5062-1169	ERAfrica [RDS Control-NI-036]; Swiss National Science Foundation [31003A_135740]	ERAfrica; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by ERAfrica grant No. RDS Control-NI-036, http://www.erafrica.eu/, and Swiss National Science Foundation Grant No: 31003A_135740.	AUSPRUNK DH, 1974, DEV BIOL, V38, P237, DOI 10.1016/0012-1606(74)90004-9; Baum O, 2010, MICROCIRCULATION, V17, P447, DOI 10.1111/j.1549-8719.2010.00043.x; Bellairs R., 2005, ATLAS CHICK DEV, DOI DOI 10.1016/C2010-0-65149-2; Cimpean AM, 2008, ANGIOGENESIS, V11, P311, DOI 10.1007/s10456-008-9117-1; COLEMAN JR, 1970, EXP CELL RES, V63, P216, DOI 10.1016/0014-4827(70)90356-3; Davies JA, 1996, ACTA ANAT, V156, P187; DEFOUW DO, 1989, MICROVASC RES, V38, P136, DOI 10.1016/0026-2862(89)90022-8; Dimitropoulou C, 1998, Angiogenesis, V2, P255, DOI 10.1023/A:1009210918738; Dimova I, 2013, ANGIOGENESIS, V16, P921, DOI 10.1007/s10456-013-9366-5; Djonov V, 2000, CIRC RES, V86, P286, DOI 10.1161/01.RES.86.3.286; DUNN BE, 1979, DEV BIOL, V71, P216, DOI 10.1016/0012-1606(79)90165-9; FANCSI T, 1979, ZBL VET MED C, V8, P151, DOI 10.1111/j.1439-0264.1979.tb00687.x; Ferner K, 2011, RESP PHYSIOL NEUROBI, V178, P39, DOI 10.1016/j.resp.2011.03.029; Fitze-Gschwind VD., 1973, ENTWICKLUNG CHORIOAL; FRIED B, 1991, ADV PARASIT, V30, P107; Gabrielli MG, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/940741; Gabrielli MG, 2001, J ANAT, V198, P229, DOI 10.1046/j.1469-7580.2001.19820229.x; GANOTE CE, 1964, LAB INVEST, V13, P1575; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Guy James S., 2008, V454, P109, DOI 10.1007/978-1-59745-181-9_10; Hlushchuk R, 2011, ARTERIOSCL THROM VAS, V31, P2836, DOI 10.1161/ATVBAHA.111.231811; Konig MF, 1997, ADV EXP MED BIOL, V411, P353; LEESON TS, 1963, J ANAT, V97, P585; Little M, 2010, CURR TOP DEV BIOL, V90, P193, DOI 10.1016/S0070-2153(10)90005-7; Lusimbo WS, 2000, ANAT REC, V259, P25, DOI 10.1002/(SICI)1097-0185(20000501)259:1<25::AID-AR3>3.0.CO;2-Y; Makanya AN, 2009, ANGIOGENESIS, V12, P113, DOI 10.1007/s10456-009-9129-5; Maksimov VF, 2006, B EXP BIOL MED+, V142, P367, DOI 10.1007/s10517-006-0368-9; Marinaccio C, 2013, INT J DEV BIOL, V57, P907, DOI 10.1387/ijdb.130317dr; Matschke K, 2006, CELL TISSUE RES, V323, P395, DOI 10.1007/s00441-005-0112-1; Mortola JP, 2009, COMP BIOCHEM PHYS A, V153, P359, DOI 10.1016/j.cbpa.2009.02.041; NARBAITZ R, 1978, J EMBRYOL EXP MORPH, V45, P1; Reizis A, 2005, J EXP BIOL, V208, P2483, DOI 10.1242/jeb.01662; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Ribatti D, 2008, INT REV CEL MOL BIO, V270, P181, DOI 10.1016/S1937-6448(08)01405-6; Ribatti D, 2012, METHODS MOL BIOL, V843, P47, DOI 10.1007/978-1-61779-523-7_5; RIZZO V, 1993, TISSUE CELL, V25, P847, DOI 10.1016/0040-8166(93)90033-H; Romanoff A.L., 1960, AVIAN EMBRYO STRUCTU; SCHERLE W, 1970, Mikroskopie, V26, P57; Schlatter P, 1997, MICROVASC RES, V54, P65, DOI 10.1006/mvre.1997.2022; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; TAZAWA H, 1977, RESP PHYSIOL, V31, P203, DOI 10.1016/0034-5687(77)90103-7; TUAN RS, 1987, J EXP ZOOL, P1; WANGENSTEEN D, 1982, RESP PHYSIOL, V47, P1, DOI 10.1016/0034-5687(82)90089-5; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6	45	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152821	10.1371/journal.pone.0152821	http://dx.doi.org/10.1371/journal.pone.0152821			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046154	Green Published, Green Submitted, gold			2022-12-26	WOS:000373599600038
J	Manchope, MF; Calixto-Campos, C; Coelho-Silva, L; Zarpelon, AC; Pinho-Ribeiro, FA; Georgetti, SR; Baracat, MM; Casagrande, R; Verri, WA				Manchope, Marilia F.; Calixto-Campos, Cassia; Coelho-Silva, Leticia; Zarpelon, Ana C.; Pinho-Ribeiro, Felipe A.; Georgetti, Sandra R.; Baracat, Marcela M.; Casagrande, Rubia; Verri, Waldiceu A., Jr.			Naringenin Inhibits Superoxide Anion-Induced Inflammatory Pain: Role of Oxidative Stress, Cytokines, Nrf-2 and the NO-cGMP -PKG-K(ATP)Channel Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; ENDOTHELIN RECEPTOR ANTAGONIST; DOWN-REGULATION; FLAVONOID NARINGENIN; TRANSCRIPTION FACTOR; NEUROPATHIC PAIN; REACTIVE OXYGEN; SPINAL-CORD; MICE	In the present study, the effect and mechanism of action of the flavonoid naringenin were evaluated in superoxide anion donor (KO2)-induced inflammatory pain in mice. Naringenin reduced KO2-induced overt-pain like behavior, mechanical hyperalgesia, and thermal hyperalgesia. The analgesic effect of naringenin depended on the activation of the NO-cGMP-PKG -ATP-sensitive potassium channel (K-ATP) signaling pathway. Naringenin also reduced KO2-induced neutrophil recruitment (myeloperoxidase activity), tissue oxidative stress, and cytokine production. Furthermore, naringenin downregulated KO2-induced mRNA expression of gp91phox, cyclooxygenase (COX)-2, and preproendothelin-1. Besides, naringenin upregulated KO2-reduced nuclear factor (erythroid-derived 2)-like 2 (Nrf2) mRNA expression coupled with enhanced heme oxygenase (HO-1) mRNA expression. In conclusion, the present study demonstrates that the use of naringenin represents a potential therapeutic approach reducing superoxide anion-driven inflammatory pain. The antinociceptive, antiinflammatory and antioxidant effects are mediated via activation of the NO-cGMP-PKG-KATP channel signaling involving the induction of Nrf2/HO-1 pathway.	[Manchope, Marilia F.; Calixto-Campos, Cassia; Coelho-Silva, Leticia; Zarpelon, Ana C.; Pinho-Ribeiro, Felipe A.; Verri, Waldiceu A., Jr.] Univ Estadual Londrina, Ctr Ciencias Biol, Dept Ciencias Patol, Londrina, Brazil; [Georgetti, Sandra R.; Baracat, Marcela M.; Casagrande, Rubia] Univ Estadual Londrina, Ctr Ciencias Saude, Dept Ciencias Farmaceut, Londrina, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina	Verri, WA (corresponding author), Univ Estadual Londrina, Ctr Ciencias Biol, Dept Ciencias Patol, Londrina, Brazil.	waverri@uel.br	Georgetti, Sandra/AAA-6576-2020; de Pinho Ribeiro, Felipe Almeida/AAI-8107-2020; Casagrande, Rubia/U-6019-2019; WA, Verri/I-1330-2013; Casagrande, Rubia/I-1377-2013	de Pinho Ribeiro, Felipe Almeida/0000-0003-4264-9839; Casagrande, Rubia/0000-0002-2296-1668; WA, Verri/0000-0003-2756-9283; Georgetti, Sandra Regina/0000-0003-2580-8762; Fernandes Manchope, Marilia/0000-0003-2882-6536	Conselho Nacional de Desenvolvimento Cientifico e Teconologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Ministerio da Ciencias Tecnologia e Inovacao (MCTI); Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI); Fundacao Araucaria; Fundacao Araucaria/CAPES (Brazil); Parana State Government	Conselho Nacional de Desenvolvimento Cientifico e Teconologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministerio da Ciencias Tecnologia e Inovacao (MCTI); Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Fundacao Araucaria/CAPES (Brazil); Parana State Government	Regarding the authors' Funding Statement/Financial Disclosure, the authors inform that "Conselho Nacional de Desenvolvimento Cientifico e Teconologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Ministerio da Ciencias Tecnologia e Inovacao (MCTI), Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI), Fundacao Araucaria and Parana State Government grants supported this study (Brazil). A.C.Z. received a postdoctoral fellowship from Fundacao Araucaria/CAPES (Brazil)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Ministerio da Ciencias Tecnologia e Inovacao (MCTI), Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI), Fundacao Araucaria and Parana State Government grants supported this study (Brazil). A.C.Z. received a postdoctoral fellowship from Fundacao Araucaria/CAPES (Brazil).	Al-Rejaie SS, 2015, NEUROL RES, V37, P924, DOI 10.1179/1743132815Y.0000000079; Anderson G, 2014, CURR PHARM DESIGN, V20, P3812, DOI 10.2174/13816128113196660738; Anuja G I, 2014, ISRN Inflamm, V2014, P302089, DOI 10.1155/2014/302089; Borghi SM, 2015, EXP PHYSIOL, V100, P531, DOI 10.1113/EP085026; BOUGHTONSMITH NK, 1993, BRIT J PHARMACOL, V110, P1189, DOI 10.1111/j.1476-5381.1993.tb13940.x; Calixto-Campos C, 2015, J NAT PROD, V78, P1799, DOI 10.1021/acs.jnatprod.5b00246; Cavia-Saiz M, 2010, J SCI FOOD AGR, V90, P1238, DOI 10.1002/jsfa.3959; Chao CL, 2010, NUTR RES, V30, P858, DOI 10.1016/j.nutres.2010.10.011; Chen FQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143868; Chen SY, 2012, FOOD CHEM TOXICOL, V50, P3025, DOI 10.1016/j.fct.2012.06.006; Chtourou Y, 2015, CHEM-BIOL INTERACT, V239, P76, DOI 10.1016/j.cbi.2015.06.036; Closa D, 2004, IUBMB LIFE, V56, P185, DOI 10.1080/15216540410001701642; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Dean RT, 1997, BIOCH J, P324; Dou W, 2013, BRIT J NUTR, V110, P599, DOI 10.1017/S0007114512005594; DROYLEFAIX MT, 1991, FREE RADICAL RES COM, V12-3, P725, DOI 10.3109/10715769109145852; DUARTE IDG, 1992, EUR J PHARMACOL, V217, P225, DOI 10.1016/0014-2999(92)90881-4; Esmaeili MA, 2014, CLIN EXP PHARMACOL P, V41, P416, DOI 10.1111/1440-1681.12230; Fattori V, 2016, PHARMACOL RES, V112, P84, DOI 10.1016/j.phrs.2016.01.027; Fattori V, 2015, INFLAMM RES, V64, P993, DOI 10.1007/s00011-015-0885-y; Goto T, 2012, PEDIATR RES, V72, P600, DOI 10.1038/pr.2012.134; Guedes RP, 2006, NEUROCHEM RES, V31, P603, DOI 10.1007/s11064-006-9058-2; Hasanein P, 2014, J PHYSIOL BIOCHEM, V70, P997, DOI 10.1007/s13105-014-0369-5; Hohmann MSN, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/627046; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Jayaraman J, 2012, TOXICOL MECH METHOD, V22, P568, DOI 10.3109/15376516.2012.707255; Karuppagounder V, 2015, INT IMMUNOPHARMACOL, V28, P154, DOI 10.1016/j.intimp.2015.05.050; Katalinic V, 2005, COMP BIOCHEM PHYS C, V140, P47, DOI 10.1016/j.cca.2005.01.005; Kaulaskar Shyam, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P1482, DOI 10.3736/jcim20121223; Keeble JE, 2009, PAIN, V141, P135, DOI 10.1016/j.pain.2008.10.025; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kim SW, 2013, FREE RADICAL BIO MED, V65, P468, DOI 10.1016/j.freeradbiomed.2013.07.028; Lavich TR, 2005, BRAZ J MED BIOL RES, V38, P445, DOI 10.1590/S0100-879X2005000300016; Lee C, 2001, HIGH CHOLESTEROL FED, V688, P681, DOI [10.1006/bbrc.2001.5001, DOI 10.1006/BBRC.2001.5001]; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Lim R, 2013, MOL HUM REPROD, V19, P451, DOI 10.1093/molehr/gat015; Lou HY, 2014, NEUROPHARMACOLOGY, V79, P380, DOI 10.1016/j.neuropharm.2013.11.026; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; Magro DAC, 2013, BRAZ J MED BIOL RES, V46, P601, DOI 10.1590/1414-431X20132894; Maioli NA, 2015, BRAZ J MED BIOL RES, V48, P321, DOI [10.1590/1414-431X20144187, 10.1590/1414-431x20144187]; Martinez RM, 2015, J NAT PROD, V78, P1647, DOI 10.1021/acs.jnatprod.5b00198; Matata BM, 2002, J BIOL CHEM, V277, P2330, DOI 10.1074/jbc.M106393200; Moon SJ, 2012, OSTEOARTHR CARTILAGE, V20, P1426, DOI 10.1016/j.joca.2012.08.002; Navarro SA, 2013, PHARMACOL BIOCHEM BE, V105, P183, DOI 10.1016/j.pbb.2013.02.018; Ndengele MM, 2008, FASEB J, V22, P3154, DOI 10.1096/fj.08-108159; Pan H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/217580; Ramprasath T, 2014, J PHYSIOL BIOCHEM, V70, P407, DOI 10.1007/s13105-014-0318-3; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Raza SS, 2013, NEUROSCIENCE, V230, P157, DOI 10.1016/j.neuroscience.2012.10.041; Sachs D, 2004, P NATL ACAD SCI USA, V101, P3680, DOI 10.1073/pnas.0308382101; Salvemini D, 1999, SCIENCE, V286, P304, DOI 10.1126/science.286.5438.304; Salvemini D, 2011, FREE RADICAL BIO MED, V51, P951, DOI 10.1016/j.freeradbiomed.2011.01.026; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Serafim KGG, 2015, N-S ARCH PHARMACOL, V388, P1211, DOI 10.1007/s00210-015-1160-z; Shi Y, 2009, CAN J PHYSIOL PHARM, V87, P729, DOI [10.1139/y09-065, 10.1139/Y09-065]; So H, 2008, JARO-J ASSOC RES OTO, V9, P290, DOI 10.1007/s10162-008-0126-y; Tsai SH, 1999, BRIT J PHARMACOL, V126, P673, DOI 10.1038/sj.bjp.0702357; Tsai SJ, 2012, J AGR FOOD CHEM, V60, P514, DOI 10.1021/jf203259h; Ventura-Martinez R, 2004, EUR J PHARMACOL, V503, P43, DOI 10.1016/j.ejphar.2004.09.018; Verri WA, 2008, P NATL ACAD SCI USA, V105, P2723, DOI 10.1073/pnas.0712116105; Verri WA, 2007, BRAIN BEHAV IMMUN, V21, P535, DOI 10.1016/j.bbi.2006.11.005; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Verri WA, 2006, P NATL ACAD SCI USA, V103, P9721, DOI 10.1073/pnas.0603286103; Wang HK, 2012, J AGR FOOD CHEM, V60, P2171, DOI 10.1021/jf204625y; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; Yamacita-Borin FY, 2015, NEUROSCI LETT, V605, P53, DOI 10.1016/j.neulet.2015.08.015; Yang J, 2011, MOL CELL BIOCHEM, V351, P29, DOI 10.1007/s11010-010-0708-y; Yeligar SM, 2010, J BIOL CHEM, V285, P35359, DOI 10.1074/jbc.M110.138636; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Zamudio-Cuevas Y, 2015, CLIN RHEUMATOL, V34, P1667, DOI 10.1007/s10067-015-2933-y; Zarpelon AC, 2013, BRIT J PHARMACOL, V169, P90, DOI 10.1111/bph.12110; Zarpelon AC, 2016, FASEB J, V30, P54, DOI 10.1096/fj.14-267146	73	86	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153015	10.1371/journal.pone.0153015	http://dx.doi.org/10.1371/journal.pone.0153015			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045367	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600059
J	Robert, S; Gicquel, T; Bodin, A; Lagente, V; Boichot, E				Robert, Sacha; Gicquel, Thomas; Bodin, Aude; Lagente, Vincent; Boichot, Elisabeth			Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1 beta or TNF-alpha Release from Human Hepatic Stellate Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INDUCED LIVER-INJURY; ALCOHOLIC HEPATITIS; FACTOR RECEPTOR; NONALCOHOLIC STEATOHEPATITIS; CARBON-TETRACHLORIDE; DOUBLE-BLIND; TGF-BETA; FIBROSIS; MICE	Inflammation has an important role in the development of liver fibrosis in general and the activation of hepatic stellate cells (HSCs) in particular. It is known that HSCs are themselves able to produce cytokines and chemokines, and that this production may be a key event in the initiation of fibrogenesis. However, the direct involvement of cytokines and chemokines in HSC (self-)activation remains uncertain. In this study, the effects of pro-inflammatory cytokines IL-1 alpha and beta, TNF-alpha, and IL-8 on the activation state of HSCs were examined, in comparison to the pro-fibrogenic mediator TGF-beta 1. LX-2 cells were stimulated for 24 or 48 hours with recombinant human form of the pro-inflammatory cytokines IL-1 alpha and beta, TNF-alpha, and IL-8, and also the pro-fibrogenic mediator TGF-beta 1. Two drugs were also evaluated, the anti-TNF-alpha monoclonal antibody infliximab and the IL-1 receptor antagonist anakinra, regarding their inhibitory effects. In LX-2 human HSC, treatment with TGF-beta 1 are associated with downregulation of the metalloproteinase (MMP)-1 and MMP-3, with upregulation of tissue inhibitor of metalloproteinase (TIMP)-1, collagen type I alpha 1, collagen type IV alpha 1, alpha-SMA, endothelin-1 and PDGF-BB. Cytokines and chemokines expression were found to be downregulated, excepting IL-6. In contrast, we observed that LX-2 exposure to IL-1, TNF-alpha and IL-8 can reverse the phenotype of pro-fibrogenic activated cells. Indeed, MMP-1, MMP-3 and MMP-9 were found elevated, associated with downregulation of a-SMA and/or PDGF-BB, and a greater expression of IL-1 beta, IL-6, IL-8, CXCL1 and CCL2. Lastly, we found that infliximab and anakinra successfully inhibits effects of TNF-alpha and IL-1 respectively in LX-2 cells. Infliximab and anakinra may be of value in preclinical trials in chronic liver disease. Overall, our results suggest that (i) pro-inflammatory mediators exert complex effects in HSCs via an MMP/TIMP imbalance, and (ii) targeting IL-1 signaling may be a potentially valuable therapeutic strategy in chronic liver diseases.	[Robert, Sacha; Gicquel, Thomas; Bodin, Aude; Lagente, Vincent; Boichot, Elisabeth] Univ Rennes 1, INSERM, UMR991, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Robert, S (corresponding author), Univ Rennes 1, INSERM, UMR991, Rennes, France.	sacharobert35@gmail.com	Gicquel, Thomas/Q-1880-2019	Gicquel, Thomas/0000-0002-2354-1884; Lagente, Vincent/0000-0003-4920-009X; LORANT, Elisabeth/0000-0002-4914-0122				Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Cui QB, 2011, EUR J APPL PHYSIOL, V111, P1457, DOI 10.1007/s00421-010-1764-4; CZAJA MJ, 1995, GASTROENTEROLOGY, V108, P1849, DOI 10.1016/0016-5085(95)90149-3; Diehl Anna Mae, 2004, Clin Liver Dis, V8, P619, DOI 10.1016/j.cld.2004.04.012; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gabele E, 2009, BIOCHEM BIOPH RES CO, V378, P348, DOI 10.1016/j.bbrc.2008.10.155; Ghazwani M, 2014, PHYTOMEDICINE, V21, P254, DOI 10.1016/j.phymed.2013.09.014; Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008; Hayashi H, 2011, AM J PHYSIOL-GASTR L, V300, pG729, DOI 10.1152/ajpgi.00013.2011; Hellerbrand C, 1998, AM J PHYSIOL-GASTR L, V275, pG269, DOI 10.1152/ajpgi.1998.275.2.G269; HILL DB, 1993, HEPATOLOGY, V18, P576, DOI 10.1016/0270-9139(93)90358-T; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Ishikawa M, 2010, ALCOHOL CLIN EXP RES, V34, pS25, DOI 10.1111/j.1530-0277.2008.00850.x; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kitamura K, 2002, LAB INVEST, V82, P571, DOI 10.1038/labinvest.3780452; Knittel T, 1997, J HEPATOL, V27, P1067, DOI 10.1016/S0168-8278(97)80151-1; Koca SS, 2008, INFLAMMATION, V31, P91, DOI 10.1007/s10753-007-9053-z; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Liu XJ, 2006, LIVER INT, V26, P8, DOI 10.1111/j.1478-3231.2005.01192.x; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Mallat A, 2013, AM J PHYSIOL-CELL PH, V305, pC789, DOI 10.1152/ajpcell.00230.2013; MANCINI R, 1994, VIRCHOWS ARCH, V424, P25; MATSUOKA M, 1990, HEPATOLOGY, V11, P599, DOI 10.1002/hep.1840110412; Mortensen C, 2012, EUR J GASTROEN HEPAT, V24, P619, DOI 10.1097/MEG.0b013e328351db6e; Naveau S, 2004, HEPATOLOGY, V39, P1390, DOI 10.1002/hep.20206; Neuman Manuela G., 1998, Clinical and Investigative Medicine, V21, P283; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Odeh M, 2005, ANN MED, V37, P603, DOI 10.1080/07853890500317414; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; Osawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065251; Patil PB, 2014, CYTOTHERAPY, V16, P990, DOI 10.1016/j.jcyt.2014.03.001; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Salliot C, 2009, ANN RHEUM DIS, V68, P25, DOI 10.1136/ard.2007.083188; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809; Sudo K, 2005, CYTOKINE, V29, P236, DOI 10.1016/j.cyto.2004.11.001; Tarantino G, 2010, WORLD J GASTROENTERO, V16, P4773, DOI 10.3748/wjg.v16.i38.4773; Tarantino G, 2009, EUR J GASTROEN HEPAT, V21, P504, DOI 10.1097/MEG.0b013e3283229b40; Tilg H, 2003, J HEPATOL, V38, P419, DOI 10.1016/S0168-8278(02)00442-7; Varela-Rey M, 2007, CYTOKINE, V37, P212, DOI 10.1016/j.cyto.2007.03.013; Watanabe A, 2009, AM J PHYSIOL-GASTR L, V296, pG1248, DOI 10.1152/ajpgi.90223.2008; Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9; Yu Q, 2000, GENE DEV, V14, P163	50	99	111	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153118	10.1371/journal.pone.0153118	http://dx.doi.org/10.1371/journal.pone.0153118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046197	gold, Green Published, Green Submitted			2022-12-26	WOS:000373599600070
J	Tebbe, B; Wilde, B; Ye, Z; Wang, JY; Wang, XN; Jian, F; Dolff, S; Schedlowski, M; Hoyer, PF; Kribben, A; Witzke, O; Hoerning, A				Tebbe, Bastian; Wilde, Benjamin; Ye, Zeng; Wang, Junyu; Wang, Xinning; Jian, Fu; Dolff, Sebastian; Schedlowski, Manfred; Hoyer, Peter F.; Kribben, Andreas; Witzke, Oliver; Hoerning, Andre			Renal Transplant Recipients Treated with Calcineurin-Inhibitors Lack Circulating Immature Transitional CD19(+)CD24(hi)CD38(hi) Regulatory B-Lymphocytes	PLOS ONE			English	Article							KIDNEY ALLOGRAFT; CELL SUBSETS; B10 CELLS; TOLERANCE; HUMANS; AUTOIMMUNITY; EXPRESSION; PHENOTYPE; SIGNATURE; REJECTION	Background CD19(+)CD24(hi)CD38(hi) transitional immature B-lymphocytes have been demonstrated to play an important role in regulating the alloimmune response in transplant recipients. Here, we analyzed the effect of calcineurin inhibition on these peripherally circulating regulatory B-cells (Breg) in renal transplant recipients receiving cyclosporine A (CsA) or tacrolimus. Methods PBMCs from healthy subjects (HS) (n = 16) and renal transplant recipients (n = 46) were isolated. Flow cytometry was performed for CD19, CD24, CD38 and IL-10 either after isolation or after 72 hours of co-culture in presence of PMA/Ionomycin and TLR9-ligand in presence or absence of increasing concentrations of tacrolimus or CsA. Results The amount of CD19(+) B-cells among lymphocytes was similar to 9.1% in HS, similar to 3.6% in CsA (n = 11, p<0.05) and similar to 6.4% in TAC (n = 35, p<0.05) treated patients. Among B-cells, a distinct subset of Breg was found to be 4.7% in HS, 1.4% in tacrolimus treated patients and almost blunted in patients receiving CsA. Similarily, similar to 4% of B-cells in HS and even fewer in CsA or tacrolimus treated patients produced IL-10 (0.5% and 1.5%, p<0.05) and this was confirmed both in non-transplanted CsA-treated healthy subjects and in in vitro co-culture experiments. Among 29 patients with <1% of Breg, 9 cases (31%) displayed an allograft rejection in contrast to only one case of rejection (6%) among 17 patients with >1%. Conclusion Calcineurin inhibitors reduce number and IL-10 production of Bregs in the peripheral circulation of both renal transplant recipients and non-transplanted healthy subjects. CNI induced Breg reduction is not restricted to a solid organ transplant setting and is not mediated by co-medication with steroids or MPA. A low proportion of Breg cells is associated with an elevated frequency of allograft rejection events.	[Tebbe, Bastian; Wilde, Benjamin; Ye, Zeng; Wang, Junyu; Wang, Xinning; Jian, Fu; Dolff, Sebastian; Kribben, Andreas; Witzke, Oliver] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany; [Wang, Xinning; Hoyer, Peter F.; Hoerning, Andre] Univ Duisburg Essen, Childrens Hosp Essen, Dept Pediat Pediat Nephrol Gastroenterol Endocrin, Essen, Germany; [Schedlowski, Manfred] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany; [Dolff, Sebastian; Witzke, Oliver] Univ Duisburg Essen, Univ Hosp Essen, Dept Infect Dis, Essen, Germany; [Hoerning, Andre] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Pediat & Adolescent Med, D-91054 Erlangen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Erlangen Nuremberg	Hoerning, A (corresponding author), Univ Duisburg Essen, Childrens Hosp Essen, Dept Pediat Pediat Nephrol Gastroenterol Endocrin, Essen, Germany.; Hoerning, A (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Pediat & Adolescent Med, D-91054 Erlangen, Germany.	andre.hoerning@uk-erlangen.de	wang, yixuan/GXW-2866-2022; wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; Wilde, Benjamin/H-9986-2012	Wilde, Benjamin/0000-0002-5115-6799; Dolff, Sebastian/0000-0001-5549-1706				Albring A, 2015, CLIN TRANSPLANT, V29, P294, DOI 10.1111/ctr.12504; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Braza F, 2014, ALLERGY, V69, P1454, DOI 10.1111/all.12490; Chesneau M, 2014, AM J TRANSPLANT, V14, P144, DOI 10.1111/ajt.12508; Chesneau M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00497; Chung BH, 2014, TRANSPL IMMUNOL, V30, P159, DOI 10.1016/j.trim.2014.03.003; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Fillatreau S, 2013, ANN RHEUM DIS, V72, P80, DOI 10.1136/annrheumdis-2012-202253; Heidt S, 2008, TRANSPLANTATION, V86, P1292, DOI 10.1097/TP.0b013e3181874a36; Hoerning A, 2012, CLIN EXP IMMUNOL, V168, P251, DOI 10.1111/j.1365-2249.2012.04571.x; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jagannathan M, 2010, DIABETOLOGIA, V53, P1461, DOI 10.1007/s00125-010-1730-z; Kalampokis I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3907; Loupy A, 2012, NAT REV NEPHROL, V8, P348, DOI 10.1038/nrneph.2012.81; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; Nouel A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00011; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; Shabir S, 2015, AM J TRANSPLANT, V15, P1384, DOI 10.1111/ajt.13122; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Silva HM, 2012, MOL MED, V18, P733, DOI 10.2119/molmed.2011.00281; Traitanon O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129658; Wilde B, 2013, ANN RHEUM DIS, V72, P1416, DOI 10.1136/annrheumdis-2012-202986; Xiao S, 2012, P NATL ACAD SCI USA, V109, P12105, DOI 10.1073/pnas.1120914109; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	30	39	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153170	10.1371/journal.pone.0153170	http://dx.doi.org/10.1371/journal.pone.0153170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045291	gold, Green Published, Green Submitted			2022-12-26	WOS:000373599600073
J	Taylor, AD; Ohashi, K; Sheng, JY; Litvak, MK				Taylor, Andrew Douglas; Ohashi, Kyoko; Sheng, Jinyu; Litvak, Matthew Kenneth			Oceanic Distribution, Behaviour, and a Winter Aggregation Area of Adult Atlantic Sturgeon, Acipenser oxyrinchus oxyrinchus, in the Bay of Fundy, Canada	PLOS ONE			English	Article							CHOCTAWHATCHEE RIVER SYSTEM; SHORTNOSE STURGEON; HABITAT USE; MARINE DISTRIBUTION; GULF STURGEON; MINAS BASIN; MANAGEMENT; MIGRATION; ESTUARINE; PATTERNS	Seasonal distribution of adult Atlantic sturgeon was examined using pop-up satellite archival tags (PSATs) and ultrasonic transmitters deployed in the Saint John River, New Brunswick, Canada. Seven MK10 PSATs programmed for release in June 2012 and seven MiniPAT PSATs programmed for release in February and April 2013 were deployed in August 2011 and 2012, respectively. Eleven of 14 PSATs surfaced and transmitted depth and temperature data archived for the duration of their deployment (121-302 days). Among these eleven PSATs, five were recovered and 15-sec archival data was downloaded. Following exit from the Saint John River in the fall, tagged fish occupied a mean monthly depth of 76.3-81.6 m at temperatures as low as 4.9 degrees C throughout the winter before returning to shallower areas in the spring. The majority of ultrasonic detections occurred in the Bay of Fundy, but fish were detected as far as Riviere Saint-Jean, Quebec, approximately 1500 km from the Bay of Fundy (representing long-distance migratory rates of up to 44 km/day). All PSATs were first detected in the Bay of Fundy. Tags that released in February and April were found 5-21 km offshore of the Saint John Harbour, while tags that released in June were first detected in near shore areas throughout the Bay of Fundy. The substrate at winter tag release locations (estimated from backward numerical particle-tracking experiments) consisted primarily of moraines and postglacial mud substrate with low backscatter strength, indicative of soft or smooth seabed. Based on the proximity of winter tag release locations, the consistent depths observed between fish, and previous research, it is suspected that a winter aggregation exists in the Bay of Fundy. This study expands the understanding of the marine distribution and range of Atlantic sturgeon on the east coast of Canada.	[Taylor, Andrew Douglas; Litvak, Matthew Kenneth] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada; [Ohashi, Kyoko; Sheng, Jinyu] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada	Mount Allison University; Dalhousie University	Taylor, AD (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada.	adtaylor@mta.ca			Natural Sciences and Engineering Research Council of Canada: Strategic Network Grant-Ocean Tracking Network (1.2.3 Atlantic Sturgeon); Natural Sciences and Engineering Research PGS-M; Ocean Tracking Network; New Brunswick Wildlife Trust Fund; Natural Sciences and Engineering Research grants	Natural Sciences and Engineering Research Council of Canada: Strategic Network Grant-Ocean Tracking Network (1.2.3 Atlantic Sturgeon); Natural Sciences and Engineering Research PGS-M; Ocean Tracking Network; New Brunswick Wildlife Trust Fund; Natural Sciences and Engineering Research grants	Natural Sciences and Engineering Research Council of Canada: Strategic Network Grant-Ocean Tracking Network (1.2.3 Atlantic Sturgeon), http://www.nserc-crsng.gc.ca/index_eng.; We would like to thank Kevin Isherwood, Thane Jones, Christine Adams, Sima Usvyatsov and all other field assistants for help with this project. We would like to thank Dr. D. Lieske and C. Tardif for help with ArcGIS mapping. We would also like to thank Canadian Hydrographic Service and Natural Resources Canada for providing habitat data. This study was supported by a Natural Sciences and Engineering Research PGS-M to ADT and Ocean Tracking Network, New Brunswick Wildlife Trust Fund, and Natural Sciences and Engineering Research grants to MKL.	APOSTLE R, 2013, J INT WILDLIFE LAW P, V16, P170, DOI DOI 10.1080/13880292.2013.805062; ASSRT (Atlantic Sturgeon Status Review Team), 2007, STAT REV ATL STURG A; Bain M., 2000, Boletin Instituto Espanol de Oceanografia, V16, P43; Balazik MT, 2013, T AM FISH SOC, V142, P1640, DOI 10.1080/00028487.2013.824924; Collins M. R., 1997, J FISH MANAG, V17, P995; COSEWIC, 2011, COSEWIC ASS STAT REP; Crossman JA, 2013, N AM J FISH MANAGE, V33, P549, DOI 10.1080/02755947.2013.785994; DADSWELL MJ, 1979, CAN J ZOOL, V57, P2186, DOI 10.1139/z79-287; Damon-Randall K, 2010, NMFSNE215 NOAA, P64; DFO (Fisheries and Oceans Canada), 2013, 2013022 DFO CAN SCI; Dunton KJ, 2012, J FISH BIOL, V80, P207, DOI 10.1111/j.1095-8649.2011.03151.x; Dunton KJ, 2015, MAR COAST FISH, V7, P18, DOI 10.1080/19425120.2014.986348; Edwards RE, 2007, AM FISH S S, V56, P183; Erickson DL, 2011, J APPL ICHTHYOL, V27, P356, DOI 10.1111/j.1439-0426.2011.01690.x; Erickson DL, 2007, AM FISH S S, V56, P197; Fox DA, 2000, T AM FISH SOC, V129, P811, DOI 10.1577/1548-8659(2000)129<0811:GSSMAH>2.3.CO;2; Fox DA, 2002, AM FISH S S, V28, P111; Kynard B, 2000, T AM FISH SOC, V129, P487, DOI 10.1577/1548-8659(2000)129<0487:HUBSSI>2.0.CO;2; Kynard B, 1997, ENVIRON BIOL FISH, V48, P319, DOI 10.1023/A:1007372913578; Laney RW, 2007, AM FISH S S, V56, P167; McLean MF, 2013, J APPL ICHTHYOL, V29, P503, DOI 10.1111/jai.12175; NOAA (National Oceanic and Atmospheric Administration), 2012, FED REGISTER, V77, P5914; Savoy T, 2003, T AM FISH SOC, V132, P1, DOI 10.1577/1548-8659(2003)132<0001:MAIHOS>2.0.CO;2; Scott WB, 1988, CAN B FISH AQUAT SCI, P219; Secor DH, 2002, AM FISH S S, V28, P89; Shaw J., 2012, GEOLOGICAL SURVEY CA, DOI [10.4095/292047, DOI 10.4095/292047]; SMITH TIJ, 1985, ENVIRON BIOL FISH, V14, P61, DOI 10.1007/BF00001577; Smith TIJ, 1997, ENVIRON BIOL FISH, V48, P335, DOI 10.1023/A:1007307507468; Stein AB, 2004, T AM FISH SOC, V133, P527, DOI 10.1577/T02-151.1; Timoshkin V. P., 1968, J ICHTHYOL, V8, P598; Todd BJ, 2014, CONT SHELF RES, V83, P64, DOI 10.1016/j.csr.2013.11.017; U.S. Office of the Federal Register, 2012, FED REGISTER, V77, P5880; Vladykov VD, 1963, ORDER ACIPENSEROIDEI; Wirgin I, 2015, J FISH BIOL, V86, P1251, DOI 10.1111/jfb.12631; Wirgin I, 2012, T AM FISH SOC, V141, P1389, DOI 10.1080/00028487.2012.700899	35	15	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152470	10.1371/journal.pone.0152470	http://dx.doi.org/10.1371/journal.pone.0152470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043209	Green Published, gold, Green Submitted			2022-12-26	WOS:000373592100016
J	Lee, YU; Ruiz-Rosado, JD; Mahler, N; Best, CA; Tara, S; Yi, T; Shoji, T; Sugiura, T; Lee, AY; Robledo-Avila, F; Hibino, N; Pober, JS; Shinoka, T; Partida-Sanchez, S; Breuer, CK				Lee, Yong-Ung; Ruiz-Rosado, Juan de Dios; Mahler, Nathan; Best, Cameron A.; Tara, Shuhei; Yi, Tai; Shoji, Toshihiro; Sugiura, Tadahisa; Lee, Avione Y.; Robledo-Avila, Frank; Hibino, Narutoshi; Pober, Jordan S.; Shinoka, Toshiharu; Partida-Sanchez, Santiago; Breuer, Christopher K.			TGF-beta receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation	FASEB JOURNAL			English	Article						cell seeding; congenital heart defect; Fontan operation; regenerative medicine; inflammation	TO-MESENCHYMAL TRANSITION; VALVE ENDOTHELIAL-CELLS; NEOVESSEL FORMATION; NATURAL-HISTORY; INFLAMMATION; MACROPHAGES; FIBROSIS; TRANSFORMATION; FIBROCYTES; CYTOKINES	Stenosis is a critical problemin the long-term efficacy of tissue-engineered vascular grafts (TEVGs). We previously showed that host monocyte infiltration and activation within the graft drives stenosis and that TGF-beta receptor 1 (TGF-beta R1) inhibition can prevent it, but the latter effect was attributed primarily to inhibition of mesenchymal cell expansion. In this study, we assessed the effects of TGF-beta R1 inhibition on the host monocytes. Biodegradable TEVGs were implanted as inferior vena cava interposition conduits in 2 groups of C57BL/6mice (n = 25/group): unseeded grafts and unseeded grafts with TGF-beta R1 inhibitor systemic treatment for the first 2 wk. The TGF-beta R1 inhibitor treatment effectively improved TEVG patency at 6mo compared to the untreated control group (91.7 vs. 48%, P < 0.001), which is associated with a reduction in classic activation of mononuclear phagocytes. Consistent with these findings, the addition of rTGF-beta to LPS/IFN-gamma-stimulated monocytes enhanced secretion of inflammatory cytokines TNF-alpha, IL-12, and IL-6; this effect was blocked by TGF-beta R1 inhibition (P < 0.0001). These findings suggest that the TGF-beta signaling pathway contributes to TEVG stenosis by inducing classic activation of host monocytes. Furthermore, blocking monocyte activation by TGF-beta R1 inhibition provides a viable strategy for preventingTEVGstenosiswhilemaintainingneotissue formation.-Lee, Y.-U., de Dios Ruiz-Rosado, J., Mahler, N., Best, C. A., Tara, S., Yi, T., Shoji, T., Sugiura, T., Lee, A. Y., Robledo-Avila, F., Hibino, N., Pober, J. S., Shinoka, T., Partida-Sanchez, S., Breuer, C. K. TGF-beta receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation.	[Lee, Yong-Ung; Mahler, Nathan; Best, Cameron A.; Tara, Shuhei; Yi, Tai; Shoji, Toshihiro; Sugiura, Tadahisa; Lee, Avione Y.; Hibino, Narutoshi; Shinoka, Toshiharu; Breuer, Christopher K.] Nationwide Childrens Hosp, Tissue Engn Program, Columbus, OH 43205 USA; [Ruiz-Rosado, Juan de Dios; Robledo-Avila, Frank; Partida-Sanchez, Santiago] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Hibino, Narutoshi; Shinoka, Toshiharu] Nationwide Childrens Hosp, Ctr Heart, Dept Cardiothorac Surg, Columbus, OH 43205 USA; [Pober, Jordan S.] Yale Univ, Dept Immunobiol, New Haven, CT USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Yale University	Partida-Sanchez, S (corresponding author), Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	santiago.partida-sanchez@nationwidechildrens.org	Robledo-Avila, Frank/L-6013-2016; Partida-Sanchez, Santiago/B-7523-2008	Robledo-Avila, Frank/0000-0001-5583-9194; Partida-Sanchez, Santiago/0000-0003-2996-9440; Breuer, Christopher/0000-0003-0987-3898; RUIZ-ROSADO, JUAN DE DIOS/0000-0002-6429-9086	U.S National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01AI092117]; Pall Corporation; Gunze Ltd.;  [R01-HL098228]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098228, R01HL128847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092117] Funding Source: NIH RePORTER	U.S National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pall Corporation; Gunze Ltd.; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge J. Reinhardt, E. Heuer, A. Singh, E. Clark, and E. Onwuka (Tissue Engineering Program, Nationwide Children's Hospital) for their contributions to the preparation of histologic samples and surgical procedures. This research was supported by R01-HL098228 (to C.K.B.). S.P.-S. is supported by the U.S National Institutes of Health, National Institute of Allergy and Infectious Diseases (Grant R01AI092117). C.K.B. and T.S. have received grant support from the Pall Corporation and Gunze Ltd. None of the work presented in this article was funded by the Pall Corporation or Gunze Ltd.	Ashcroft GS, 1999, MICROBES INFECT, V1, P1275, DOI 10.1016/S1286-4579(99)00257-9; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Duncan DR, 2015, J AM COLL CARDIOL, V65, P512, DOI 10.1016/j.jacc.2014.08.057; Farrar EJ, 2014, ANN BIOMED ENG, V42, P149, DOI 10.1007/s10439-013-0894-3; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Lee Y. U., 2014, JOVE-J VIS EXP, V4, P51632; Mahler GJ, 2013, ARTERIOSCL THROM VAS, V33, P121, DOI 10.1161/ATVBAHA.112.300504; Merino A, 2012, NEPHROL DIAL TRANSPL, V27, P2907, DOI 10.1093/ndt/gfr767; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Naito Y, 2014, TISSUE ENG PT A, V20, P346, DOI [10.1089/ten.tea.2012.0613, 10.1089/ten.TEA.2012.0613]; Naito Y, 2012, CELLS TISSUES ORGANS, V195, P60, DOI 10.1159/000331405; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Rieder F, 2011, AM J PATHOL, V179, P2660, DOI 10.1016/j.ajpath.2011.07.042; Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Sadler T, 2013, INFLAMM BOWEL DIS, V19, P1354, DOI 10.1097/MIB.0b013e318281f37a; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Sridurongrit S, 2008, DEV BIOL, V322, P208, DOI 10.1016/j.ydbio.2008.07.038; Vargas R, 2012, BRAIN RES, V1453, P64, DOI 10.1016/j.brainres.2012.03.021; Yang YP, 2011, ACTA PHARMACOL SIN, V32, P1259, DOI 10.1038/aps.2011.95; Zeglinski MR, 2015, AM J PHYSIOL-HEART C, V308, pH75, DOI 10.1152/ajpheart.00453.2014	27	18	19	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2627	2636		10.1096/fj.201500179R	http://dx.doi.org/10.1096/fj.201500179R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27059717	Green Published			2022-12-26	WOS:000379249500017
J	Dyer, DP; Salanga, CL; Johns, SC; Valdambrini, E; Fuster, MM; Milner, CM; Day, AJ; Handel, TM				Dyer, Douglas P.; Salanga, Catherina L.; Johns, Scott C.; Valdambrini, Elena; Fuster, Mark M.; Milner, Caroline M.; Day, Anthony J.; Handel, Tracy M.			The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC-CELL TRAFFICKING; HYALURONAN-BINDING PROTEIN; COLLAGEN-INDUCED ARTHRITIS; MONOMER-DIMER EQUILIBRIUM; ALPHA-STIMULATED GENE-6; GLYCOSAMINOGLYCAN-BINDING; LINK MODULE; NEUTROPHIL MIGRATION; IFN-GAMMA; IN-VIVO	TNF-stimulated gene-6 (TSG-6) is a multifunctional protein secreted in response to pro-inflammatory stimuli by a wide range of cells, including neutrophils, monocytes, and endothelial cells. It has been shown to mediate anti-inflammatory and protective effects when administered in disease models, in part, by reducing neutrophil infiltration. Human TSG-6 inhibits neutrophil migration by binding CXCL8 through its Link module (Link_TSG6) and interfering with the presentation of CXCL8 on cell-surface glycosaminoglycans (GAGs), an interaction that is vital for the function of many chemokines. TSG-6 was also found to interact with chemokines CXCL11 and CCL5, suggesting the possibility that it may function as a broad specificity chemokine-binding protein, functionally similar to those encoded by viruses. This study was therefore undertaken to explore the ability of TSG-6 to regulate the function of other chemokines. Herein, we demonstrate that Link_TSG6 binds chemokines from both the CXC and CC families, including CXCL4, CXCL12, CCL2, CCL5, CCL7, CCL19, CCL21, and CCL27. We also show that the Link_TSG6-binding sites on chemokines overlap with chemokine GAG-binding sites, and that the affinities of Link_TSG6 for these chemokines (K-D values 1-85 nM) broadly correlate with chemokine-GAG affinities. Link_TSG6 also inhibits chemokine presentation on endothelial cells not only through a direct interaction with chemokines but also by binding and therefore masking the availability of GAGs. Along with previous work, these findings suggest that TSG-6 functions as a pluripotent regulator of chemokines by modulating chemokine/GAG interactions, which may be a major mechanism by which TSG-6 produces its anti-inflammatory effects in vivo.	[Dyer, Douglas P.; Salanga, Catherina L.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Dyer, Douglas P.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Johns, Scott C.; Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, Med Sect, La Jolla, CA 92093 USA; [Johns, Scott C.; Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, Res Sect, La Jolla, CA 92093 USA; [Johns, Scott C.; Fuster, Mark M.] Univ Calif San Diego, Dept Med, Div Pulm & Crit Care, La Jolla, CA 92093 USA; [Valdambrini, Elena; Milner, Caroline M.; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Valdambrini, Elena; Day, Anthony J.] Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England	University of California System; University of California San Diego; University of Glasgow; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of Manchester; University of Manchester	Handel, TM (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.; Milner, CM; Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	caroline.milner@manchester.ac.uk; anthony.day@manchester.ac.uk; thandel@ucsd.edu	Dyer, Douglas/J-2675-2015; Dyer, Douglas/L-9679-2019; Day, Anthony/O-1658-2015	Dyer, Douglas/0000-0001-5567-6241; Dyer, Douglas/0000-0001-5567-6241; Day, Anthony/0000-0002-1415-3134	Arthritis Research UK [18472, 20347]; Medical Research Council [J014621]; National Institutes of Health [R01AI37113, R01AI118985, R01HL107652]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113, R01AI118985] Funding Source: NIH RePORTER; Medical Research Council [MR/J014621/1] Funding Source: researchfish; Versus Arthritis [20347, 18472] Funding Source: researchfish; MRC [MR/J014621/1] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Arthritis Research UK Grants 18472 and 20347, Medical Research Council Grant J014621 (to C. M. M. and A. J. D.), National Institutes of Health Grants R01AI37113 and R01AI118985 (to T. M. H.) and Grant R01HL107652 (to M. M. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alexander-Brett JM, 2007, J EXP MED, V204, P3157, DOI 10.1084/jem.20071677; Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Allen SJ, 2011, CYTOKINE, V55, P168, DOI 10.1016/j.cyto.2011.05.002; Asquith DL, 2015, CURR OPIN RHEUMATOL, V27, P204, DOI 10.1097/BOR.0000000000000150; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Briggs DC, 2015, J BIOL CHEM, V290, P28708, DOI 10.1074/jbc.M115.669838; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; Coombes BK, 2001, INFECT IMMUN, V69, P1420, DOI 10.1128/IAI.69.3.1420-1427.2001; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Dougherty DA, 2013, ACCOUNTS CHEM RES, V46, P885, DOI 10.1021/ar300265y; Dyer DP, 2016, GLYCOBIOLOGY, V26, P312, DOI 10.1093/glycob/cwv100; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Foskett AM, 2014, AM J PHYSIOL-LUNG C, V306, pL120, DOI 10.1152/ajplung.00240.2013; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; Gasperini S, 1999, J IMMUNOL, V162, P4928; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Heidarieh H, 2015, VIRUS RES, V209, P67, DOI 10.1016/j.virusres.2015.02.028; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Higman VA, 2014, J BIOL CHEM, V289, P5619, DOI 10.1074/jbc.M113.542357; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hirose J, 2002, BBA-GEN SUBJECTS, V1571, P219, DOI 10.1016/S0304-4165(02)00232-5; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Jansma AL, 2010, J BIOL CHEM, V285, P14424, DOI 10.1074/jbc.M109.091108; Johnson LA, 2014, ANGIOGENESIS, V17, P335, DOI 10.1007/s10456-013-9407-0; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kato T, 2014, TRANSPLANTATION, V98, P277, DOI 10.1097/TP.0000000000000230; Kolarova H, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/694312; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Lawrance W, 2016, J BIOL CHEM, V291, P8014, DOI 10.1074/jbc.M115.708305; Lee HY, 2011, J IMMUNOL, V186, P4347, DOI 10.4049/jimmunol.1002068; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1993, J BIOL CHEM, V268, P6154; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; Nagakubo D, 2003, J IMMUNOL, V171, P553, DOI 10.4049/jimmunol.171.2.553; Nagyeri G, 2011, J BIOL CHEM, V286, P23559, DOI 10.1074/jbc.M111.222026; O'Boyle G, 2009, FASEB J, V23, P3906, DOI 10.1096/fj.09-134643; O'Hayre M, 2009, METHOD ENZYMOL, V460, P331, DOI 10.1016/S0076-6879(09)05216-1; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Park Y, 2016, BIOCHEMISTRY-US, V55, P262, DOI 10.1021/acs.biochem.5b01148; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Ruiz-Arguello MB, 2008, J VIROL, V82, P917, DOI 10.1128/JVI.02111-07; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Salanga CL, 2014, J BIOL CHEM, V289, P14896, DOI 10.1074/jbc.M114.547737; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Scapini P, 2002, EUR J IMMUNOL, V32, P3515, DOI 10.1002/1521-4141(200212)32:12<3515::AID-IMMU3515>3.0.CO;2-3; Schmidt EP, 2011, PHYSIOLOGY, V26, P334, DOI 10.1152/physiol.00011.2011; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang X, 2011, STRUCTURE, V19, P1138, DOI 10.1016/j.str.2011.06.001; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yang BG, 2007, J IMMUNOL, V179, P4376, DOI 10.4049/jimmunol.179.7.4376; Yoshimura T, 2007, J IMMUNOL, V179, P1942, DOI 10.4049/jimmunol.179.3.1942; Yu YH, 2005, J BIOL CHEM, V280, P32200, DOI 10.1074/jbc.M505738200; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	97	60	61	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12627	12640		10.1074/jbc.M116.720953	http://dx.doi.org/10.1074/jbc.M116.720953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27044744	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000378119900019
J	Meckler, X; Checler, F				Meckler, Xavier; Checler, Frederic			Presenilin 1 and Presenilin 2 Target gamma-Secretase Complexes to Distinct Cellular Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; BETA-APP; INTRACELLULAR DOMAIN; C-TERMINUS; IN-VIVO; TRANSMEMBRANE DOMAIN; RECEPTOR ACTIVATION; MISSENSE MUTATIONS; PLASMA-MEMBRANE	gamma-Secretase complexes achieve the production of amyloid peptides playing a key role in Alzheimer disease. These proteases have many substrates involved in important physiological functions. They are composed of two constant subunits, nicastrin and PEN2, and two variable ones, presenilin (PS1 or PS2) and APH1 (APH1aL, APH1aS, or APH1b). Whether the composition of a given gamma-secretase complex determines a specific cellular targeting remains unsolved. Here we combined a bidirectional inducible promoter and 2A peptide technology to generate constructs for the temporary, stoichiometric co-expression of six different combinations of the four gamma-secretase subunits including EGFP-tagged nicastrin. These plasmids allow for the formation of functional gamma-secretase complexes displaying specific activities and maturations. We show that PS1-containing gamma-secretase complexes were targeted to the plasma membrane, whereas PS2-containing ones were addressed to the trans-Golgi network, to recycling endosomes, and, depending on the APH1-variant, to late endocytic compartments. Overall, these novel constructs unravel a presenilin-dependent subcellular targeting of gamma-secretase complexes. These tools should prove useful to determine whether the cellular distribution of gamma-secretase complexes contributes to substrate selectivity and to delineate regulations of their trafficking.	[Meckler, Xavier; Checler, Frederic] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS UMR7275, Lab Excellence Distalz, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur	Checler, F (corresponding author), CNRS UMR7275, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr	Checler, Frederic/C-1241-2009	Checler, Frederic/0000-0003-2098-1750	French National Foundation for Alzheimer Disease and Related Disorders; European League against Alzheimer disease (LECMA); Hospital-University Federation (FHU Onco-Age); LABEX "Excellence Laboratory Program Investment for the Future" Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer disease (DISTALZ)	French National Foundation for Alzheimer Disease and Related Disorders; European League against Alzheimer disease (LECMA); Hospital-University Federation (FHU Onco-Age); LABEX "Excellence Laboratory Program Investment for the Future" Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer disease (DISTALZ)	This work was supported by the French National Foundation for Alzheimer Disease and Related Disorders (to X. M.) and by the European League against Alzheimer disease (LECMA) (to F. C.). This work has been developed and supported through the Hospital-University Federation (FHU Onco-Age) and the LABEX "Excellence Laboratory Program Investment for the Future" Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer disease (DISTALZ). The authors declare that they have no conflicts of interest with the contents of this article.	Acx H, 2014, J BIOL CHEM, V289, P4346, DOI 10.1074/jbc.M113.530907; Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Bohm C, 2015, MOL CELL NEUROSCI, V66, P3, DOI 10.1016/j.mcn.2015.02.016; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Capell A, 2003, J BIOL CHEM, V278, P52519, DOI 10.1074/jbc.C300435200; Chen FS, 2003, J BIOL CHEM, V278, P19974, DOI 10.1074/jbc.M210049200; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; Dauch P, 1997, NEUROSCI LETT, V221, P85; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Dumanchin C, 1999, HUM MOL GENET, V8, P1263, DOI 10.1093/hmg/8.7.1263; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fassler M, 2010, TRAFFIC, V11, P250, DOI 10.1111/j.1600-0854.2009.01014.x; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hansson EM, 2005, J NEUROCHEM, V92, P1010, DOI 10.1111/j.1471-4159.2004.02926.x; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Iwata H, 2001, J BIOL CHEM, V276, P21678, DOI 10.1074/jbc.M007989200; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Laboratory C.S.H., 2007, COLD SPRING HARB PRO, V291, DOI [10.1101/pdb.rec10913, DOI 10.1101/PDB.REC10913]; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lee J, 2011, BIOCHEMISTRY-US, V50, P4973, DOI 10.1021/bi200026m; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Marambaud P, 1998, BIOCHEM BIOPH RES CO, V252, P134, DOI 10.1006/bbrc.1998.9619; Marcello E, 2008, EUR J PHARMACOL, V585, P109, DOI 10.1016/j.ejphar.2007.11.083; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; Meckler X, 2014, J ALZHEIMERS DIS, V40, P161, DOI 10.3233/JAD-131268; Mikulca JA, 2014, J CLIN PHARM THER, V39, P25, DOI 10.1111/jcpt.12112; Morais VA, 2003, J BIOL CHEM, V278, P43284, DOI 10.1074/jbc.M305685200; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Petit A, 2001, NAT CELL BIOL, V3, P507, DOI 10.1038/35074581; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarzman AL, 1999, P NATL ACAD SCI USA, V96, P7932, DOI 10.1073/pnas.96.14.7932; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Takeda K, 2004, EUR J NEUROSCI, V19, P258, DOI 10.1111/j.0953-816X.2003.03135.x; Tam JHK, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0054-1; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zeitelhofer Manuel, 2009, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0432s47; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje	85	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12821	12837		10.1074/jbc.M115.708297	http://dx.doi.org/10.1074/jbc.M115.708297			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27059953	Green Published, hybrid			2022-12-26	WOS:000378119900033
J	Wohl, AP; Troilo, H; Collins, RF; Baldock, C; Sengle, G				Wohl, Alexander P.; Troilo, Helen; Collins, Richard F.; Baldock, Clair; Sengle, Gerhard			Extracellular Regulation of Bone Morphogenetic Protein Activity by the Microfibril Component Fibrillin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; TGF-BETA; SECONDARY STRUCTURE; MARFAN-SYNDROME; GROWTH; ACTIVATION; PRODOMAIN; RECEPTORS; SPECTRA; COMPETE	Since the discovery of bone morphogenetic proteins (BMPs) as pluripotent cytokines extractable from bone matrix, it has been speculated how targeting of BMPs to the extracellular matrix (ECM) modulates their bioavailability. Understanding these processes is crucial for elucidating pathomechanisms of connective tissue disorders characterized by ECM deficiency and growth factor dysregulation. Here, we provide evidence for a new BMP targeting and sequestration mechanism that is controlled by the ECM molecule fibrillin-1. We present the nanoscale structure of the BMP-7 prodomain-growth factor complex using electron microscopy, small angle x-ray scattering, and circular dichroism spectroscopy, showing that it assumes an open V-like structure when it is bioactive. However, upon binding to fibrillin-1, the BMP-7 complex is rendered into a closed ring shape, which also confers latency to the growth factor, as demonstrated by bioactivity measurements. BMP-7 prodomain variants were used to map the critical epitopes for prodomain-growth factor and prodomain-prodomain binding. Together, these data show that upon prodomain binding to fibrillin-1, the BMP-7 complex undergoes a conformational change, which denies access of BMP receptors to the growth factor.	[Wohl, Alexander P.; Sengle, Gerhard] Univ Cologne, Fac Med, Ctr Biochem, Joseph Stelzmann St 52, D-50931 Cologne, Germany; [Troilo, Helen; Baldock, Clair] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg, Manchester M13 9PT, Lancs, England; [Troilo, Helen; Collins, Richard F.; Baldock, Clair] Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England; [Sengle, Gerhard] Univ Cologne, CMMC, Robert Koch St 21, D-50931 Cologne, Germany	University of Cologne; University of Manchester; University of Manchester; University of Cologne	Sengle, G (corresponding author), Univ Cologne, Fac Med, Ctr Biochem, Joseph Stelzmann St 52, D-50931 Cologne, Germany.	gsengle@uni-koeln.de		Baldock, Clair/0000-0003-3497-1959; Troilo, Helen/0000-0003-0537-1786	NIGMS, National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/L00612X/1] Funding Source: researchfish; BBSRC [BB/L00612X/1] Funding Source: UKRI	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to Dr. Lynn Sakai for providing the BMP-7 complex-expressing cell line, the rF11 expression plasmid, and anti-fibrillin-1 polyclonal antibody 9543 and to Karolin Scharnetzki, Tobias Zbik, and Christian Meissner for excellent technical assistance. We thank the ESRF for access to beamline BM29 (Midland BAG Proposal MX-1483) and DESY for access to PetraIII beamline P12, and we thank Dr. Benoit Maillot (ESRF) and Dr. Cy Jefferies (DESY) for assistance during data collection. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California (San Francisco, CA) (supported by NIGMS, National Institutes of Health, Grant P41-GM103311).	Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Berry R, 2009, P NATL ACAD SCI USA, V106, P8561, DOI 10.1073/pnas.0812178106; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jiang H, 2016, J BIOL CHEM, V291, P2954, DOI 10.1074/jbc.M115.683292; Kienast Y, 2016, J BIOL CHEM, V291, P3395, DOI 10.1074/jbc.M115.680009; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Loeys BL, 2013, PEDIATR ENDOCR REV P, V10, P417; Loeys BL, 2003, ACTA CLIN BELG, V58, P3, DOI 10.1179/acb.2003.58.1.001; Massague J, 2000, GENE DEV, V14, P627; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Nistala H, 2010, J CELL BIOL, V190, P1107, DOI 10.1083/jcb.201003089; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sengle G, 2015, MATRIX BIOL, V47, P3, DOI 10.1016/j.matbio.2015.05.002; Sengle G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005340; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Wakefield LM, 1989, GROWTH FACTORS, V1, P203, DOI 10.3109/08977198908997997; Walton KL, 2010, J BIOL CHEM, V285, P17029, DOI 10.1074/jbc.M110.110288; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012	47	50	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12732	12746		10.1074/jbc.M115.704734	http://dx.doi.org/10.1074/jbc.M115.704734			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27059954	Green Published, hybrid			2022-12-26	WOS:000378119900026
J	Weissman, A; Ngak, S; Srean, C; Sansothy, N; Mills, S; Ferradini, L				Weissman, Amy; Ngak, Song; Srean, Chhim; Sansothy, Neth; Mills, Stephen; Ferradini, Laurent			HIV Prevalence and Risks Associated with HIV Infection among Transgender Individuals in Cambodia	PLOS ONE			English	Article							SUBSTANCE USE; SEXUAL RISK; WOMEN; BEHAVIORS; POWER; INTERVENTIONS; GENDER; LIFE	Introduction Recognizing transgender individuals have a high risk of HIV acquisition, and to inform policies and programming, we conducted an HIV prevalence and risk behaviors survey among transgender individuals in Cambodia. Methods Cross-sectional survey using a respondent driven sampling method with self-administered audio-computer assisted interviews. HIV testing was performed prior to the questionnaire with results available immediately after. Eligible participants were >= 18 years, identified as male at birth and self-identified/expressed as a different gender, and reported having sex with at least one male partner in past year. From six major urban centers of Cambodia, 891 transgender individuals were recruited. Results The majority of the 891 participants self-identified as third gender or female (94.5%), were young (median age 23, IQR [20-27]), had secondary education or higher (80.5%), not married (89.7%), and employed (90.2%). The majority had first sex before 18 years (66.8%), with a male (79.9%), 37.9% having been paid or paying for this first sex. The rate of HIV positivity among participants was found to be 4.15%. Consistent condom use with male and female partners was low with all partner types, but particularly low with male partners when paying for sex (20.3%). The majority of participants reported having experienced discrimination in their lifetime (54.8%) and 30.3% had been assaulted. Multivariate analysis revealed that older age (adjusted OR = 14.73 [4.20, 51.67] for age 35-44 and adjusted OR = 7.63 [2.55, 22.81] for age 30-34), only having a primary school education or no schooling at all (adjusted OR = 2.62 [1.18, 5.80], being a resident of Siem Reap (adjusted OR = 7.44 [2.37,23.29], receiving payment at first sex (adjusted OR = 2.26 [1.00, 5.11], having sex during/after using drugs (adjusted OR = 2.90 [1.09,7.73]), inconsistent condom use during last anal sex (adjusted OR = 3.84 [1.58, 9.33]), and reporting low self-esteem (adjusted OR = 3.25 [1.35,7.85]) were independently associated with HIV infection. Conclusions This study confirms transgender individuals as one of the highest-risk groups for HIV infection in Cambodia. It suggests the need for programmatic strategies that mitigate identified associated risks and facilitate access to HIV care for this population.	[Weissman, Amy; Ngak, Song; Srean, Chhim; Ferradini, Laurent] FHI 360, Phnom Penh, Cambodia; [Mills, Stephen] FHI 360, Bangkok, Thailand; [Sansothy, Neth] Natl Ctr HIV AIDS Dermatol & Sexually Transmitted, Phnom Penh, Cambodia; [Sansothy, Neth] Univ Hlth Sci, Phnom Penh, Cambodia; [Weissman, Amy] Save Children, Viangchan, Laos; [Mills, Stephen] WHO, Phnom Penh, Cambodia	Save the Children; World Health Organization	Weissman, A (corresponding author), FHI 360, Phnom Penh, Cambodia.; Weissman, A (corresponding author), Save Children, Viangchan, Laos.	aweissman@savechildren.org	; Chhim, Srean/E-8829-2016	Weissman, Amy/0000-0003-2510-3500; Chhim, Srean/0000-0003-1558-1875	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) [GHS-1-00-07-00007-00, FHI 360]; USAID LINKAGES Project [AID-OAA-14-00045]	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID LINKAGES Project(United States Agency for International Development (USAID))	This research was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) in Cambodia Contract No. GHS-1-00-07-00007-00 with FHI 360. Further support was provided by the USAID LINKAGES Project Cooperative Agreement No. AID-OAA-14-00045 to FHI 360. The content of this article does not necessarily reflect the views of USAID, the United States Government, nor FHI 360. The study was conducted by FHI 360 in collaboration with NCHADS under the PRASIT project.	Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Chhorvann C, 2007, BEHAV SURVEILLANCE S; FELMLEE DH, 1994, SEX ROLES, V31, P275, DOI 10.1007/BF01544589; FHI 360, 2000, BEH SURV SURV BSS GU; Girault P, 2004, AIDS EDUC PREV, V16, P31, DOI 10.1521/aeap.16.1.31.27727; Harvey SM, 2002, WOMEN HEALTH, V36, P69, DOI 10.1300/J013v36n04_06; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; Hotton AL, 2013, AIDS EDUC PREV, V25, P62, DOI 10.1521/aeap.2013.25.1.62; IPPF, 2008, PEOPL LIV HIV STIGM; Joint United Nations Programme on HIV/AIDS, 2011, UNAIDS TERM GUID; Keuroghlian AS, 2015, DRUG ALCOHOL DEPEN, V152, P139, DOI 10.1016/j.drugalcdep.2015.04.008; Liu K, 2010, BROS KHMER BEHAV RIS, P360; Lombardi EL, 2001, J HOMOSEXUAL, V42, P89, DOI 10.1300/J082v42n01_05; Melendez RM, 2007, CULT HEALTH SEX, V9, P233, DOI 10.1080/13691050601065909; National Center for HIV/AIDS Dermatology & STIs (NCHADS), 2013, BOOST CONT PREV CAR; National Center for HIV/AIDS Dermatology & STIs (NCHADS), 2013, BIOL BEH SURV STUD B; NCHADS, 2006, SER ASS HUM IMM VIR; Opeiario D, 2008, JAIDS-J ACQ IMM DEF, V48, P97, DOI 10.1097/QAI.0b013e31816e3971; Operario D, 2011, AIDS BEHAV, V15, P674, DOI 10.1007/s10461-010-9795-8; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Pulerwitz J, 2002, AIDS CARE, V14, P789, DOI 10.1080/0954012021000031868; Reback CJ, 2014, AIDS BEHAV, V18, P1359, DOI 10.1007/s10461-013-0657-z; Schenk K., 2005, ETHICAL APPROACHES G; Sevelius JM, 2009, AIDS EDUC PREV, V21, P113, DOI 10.1521/aeap.2009.21.2.113; SOPHEAB H, 2005, CAMBODIA STI PREVALE; UNDP, 2018, MAN MIN SUST DEV SOU; World Health Organization, 2011, PREVENTION TREATMENT; World Health Organization, 2014, POL BRIEF CONS GUID	30	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152906	10.1371/journal.pone.0152906	http://dx.doi.org/10.1371/journal.pone.0152906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27070152	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700019
J	Jacob, SP; Lakshmikanth, CL; Chaithra, VH; Kumari, TRS; Chen, CH; McIntyre, TM; Marathe, GK				Jacob, Shancy Petsel; Lakshmikanth, Chikkamenahalli Lakshminarayana; Chaithra, Vyala Hanumanthareddy; Kumari, Titus Ruth Shantha; Chen, Chu-Huang; McIntyre, Thomas M.; Marathe, Gopal Kedihitlu			Lipopolysaccharide Cross-Tolerance Delays Platelet-Activating Factor-Induced Sudden Death in Swiss Albino Mice: Involvement of Cyclooxygenase in Cross-Tolerance	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PHOSPHOLIPID OXIDATION-PRODUCTS; TOLL-LIKE RECEPTORS; NF-KAPPA-B; FACTOR-ACETYLHYDROLASE; LUNG INJURY; FACTOR PAF; SEPTIC SHOCK; ENDOTOXIN TOLERANCE; INDUCED HYPOTENSION	Lipopolysaccharide (LPS) signaling through Toll-like receptor-4 (TLR-4) has been implicated in the pathogenesis of many infectious diseases. Some believe that TLR-mediated pathogenicity is due, in part, to the lipid pro-inflammatory mediator platelet-activating factor (PAF), but this has been questioned. To test the direct contribution of PAF in endotoxemia in murine models, we injected PAF intraperitoneally into Swiss albino mice in the presence and absence of LPS. PAF alone (5 mu g/mouse) caused death within 15-20 min, but this could be prevented by pretreating mice with PAF-receptor (PAF-R) antagonists or PAF-acetylhydrolase (PAF-AH). A low dose of LPS (5 mg/kg body wt) did not impair PAF-induced death, whereas higher doses (10 or 20 mg/kg body wt) delayed death, probably via LPS cross-tolerance. Cross-tolerance occurred only when PAF was injected simultaneously with LPS or within 30 min of LPS injection. Tolerance does not appear to be due to an abundant soluble mediator. Histologic examination of lungs and liver and measurement of circulating TNF-alpha and IL-10 levels suggested that the inflammatory response is not diminished during cross-tolerance. Interestingly, aspirin, a non-specific cyclooxygenase (COX) inhibitor, partially blocked PAF-induced sudden death, whereas NS-398, a specific COX-2 inhibitor, completely protected mice from the lethal effects of PAF. Both COX inhibitors (at 20 mg/kg body wt) independently amplified the cross-tolerance exerted by higher dose of LPS, suggesting that COX-derived eicosanoids may be involved in these events. Thus, PAF does not seem to have a protective role in endotoxemia, but its effects are delayed by LPS in a COX-sensitive way. These findings are likely to shed light on basic aspects of the endotoxin cross-tolerance occurring in many disease conditions and may offer new opportunities for clinical intervention.	[Jacob, Shancy Petsel; Lakshmikanth, Chikkamenahalli Lakshminarayana; Chaithra, Vyala Hanumanthareddy; Marathe, Gopal Kedihitlu] Univ Mysore, Dept Studies Biochem, Mysuru 570006, Karnataka, India; [Kumari, Titus Ruth Shantha] St Philomenas Coll, Dept Zool, Mysuru 570015, Karnataka, India; [Chen, Chu-Huang] St Lukes Episcopal Hosp, Texas Heart Inst, Vasc & Med Res, Houston, TX 77225 USA; [McIntyre, Thomas M.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med NC10, 9500 Euclid Ave, Cleveland, OH 44195 USA	University of Mysore; Saint Lukes Episcopal Hospital; Texas Heart Institute; Cleveland Clinic Foundation	Marathe, GK (corresponding author), Univ Mysore, Dept Studies Biochem, Mysuru 570006, Karnataka, India.	marathe1962@gmail.com	Jacob, Shancy Petsel/J-6265-2019	Marathe, Gopal/0000-0002-0025-6677	University Grants Commission (UGC), India	University Grants Commission (UGC), India(University Grants Commission, India)	The authors thank the University Grants Commission (UGC), India (for Non NET fellowship, Basic Science Research fellowship, Major Research Project and Special Assistance Program) and the Vision Group of Science & Technology (VGST), Government of Karnataka, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Angus DC, 2001, AM J RESP CRIT CARE, V164, P1154, DOI 10.1164/ajrccm.164.7.2012126; Barnes PJ, TRENDS IN PHARMACOLO, V8, P285; Beishuizen A, 1999, ADV CLIN CHEM, V33, P55; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; BENVENISTE J, 1977, NATURE, V269, P170, DOI 10.1038/269170a0; BENVENISTE J, 1972, J EXP MED, V136, P1356, DOI 10.1084/jem.136.6.1356; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Cain BS, 2000, CRIT CARE MED, V28, P2164, DOI 10.1097/00003246-200006000-00100; CANNON JG, 1990, J INFECT DIS, V161, P79, DOI 10.1093/infdis/161.1.79; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CASALSSTENZEL J, 1987, EUR J PHARMACOL, V135, P117, DOI 10.1016/0014-2999(87)90602-9; Cavaillon J-M., 1994, J ENDOTOXIN RES, V1, P21, DOI 10.1177/096805199400100105; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; Chen JW, 2007, J LIPID RES, V48, P2365, DOI 10.1194/jlr.M700325-JLR200; Chosay JG, 1997, AM J PHYSIOL-GASTR L, V272, pG1195, DOI 10.1152/ajpgi.1997.272.5.G1195; Czermak BJ, 1999, AM J PATHOL, V154, P1057, DOI 10.1016/S0002-9440(10)65358-8; DEMOPOULOS CA, 1979, J BIOL CHEM, V254, P9355; DOEBBER TW, 1985, BIOCHEM BIOPH RES CO, V127, P799, DOI 10.1016/S0006-291X(85)80014-0; Elliott GT, 1998, J MOL CELL CARDIOL, V30, P3, DOI 10.1006/jmcc.1997.0586; Endo Y, 1999, BRIT J PHARMACOL, V128, P5, DOI 10.1038/sj.bjp.0702747; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Ferlito M, 2001, J LEUKOCYTE BIOL, V70, P821; Flach R, 1997, J ENDOTOXIN RES, V4, P241, DOI 10.1177/096805199700400401; Fukuda Y, 2000, EUR J PHARMACOL, V390, P203, DOI 10.1016/S0014-2999(99)00920-6; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; Giral M, 1996, BRIT J PHARMACOL, V118, P1223, DOI 10.1111/j.1476-5381.1996.tb15527.x; Gomes RN, 2006, SHOCK, V26, P41, DOI 10.1097/01.shk.0000209562.00070.1a; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; GRAHAM RM, 1994, CRIT CARE MED, V22, P204, DOI 10.1097/00003246-199402000-00009; Guo RF, 2007, ANTIOXID REDOX SIGN, V9, P1991, DOI 10.1089/ars.2007.1785; HANAHAN DJ, 1987, PROG LIPID RES, V26, P1, DOI 10.1016/0163-7827(87)90006-3; HANAHAN DJ, 1986, ANNU REV BIOCHEM, V55, P483, DOI 10.1146/annurev.bi.55.070186.002411; HANDLEY DA, 1986, IMMUNOPHARMACOLOGY, V12, P11, DOI 10.1016/0162-3109(86)90046-9; HASLETT C, 1987, AM REV RESPIR DIS, V136, P9, DOI 10.1164/ajrccm/136.1.9; Henderson WR, 2000, J IMMUNOL, V164, P3360, DOI 10.4049/jimmunol.164.6.3360; Hiki N, 2003, J TRAUMA, V54, P584, DOI 10.1097/01.TA.0000060180.29719.57; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; INARREA P, 1985, IMMUNOPHARMACOLOGY, V9, P45, DOI 10.1016/0162-3109(85)90046-3; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Ishii S, 1997, EMBO J, V16, P133, DOI 10.1093/emboj/16.1.133; JAESCHKE H, 1991, AM J PHYSIOL, V261, pG1051, DOI 10.1152/ajpgi.1991.261.6.G1051; Jeong YI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006503; Knapp S, 2007, J IMMUNOL, V178, P993, DOI 10.4049/jimmunol.178.2.993; KOLTAI M, 1993, J LIPID MEDIATOR, V6, P183; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kupfner JG, 2001, J IMMUNOL, V167, P7044, DOI 10.4049/jimmunol.167.12.7044; Kuzkov VV, 2006, CRIT CARE MED, V34, P1647, DOI 10.1097/01.CCM.0000218817.24208.2E; Lehner MD, 2001, J IMMUNOL, V166, P5161, DOI 10.4049/jimmunol.166.8.5161; Leitinger N, 1997, ADV EXP MED BIOL, V433, P379; Lopez-Bojorquez L, 2004, ARCH MED RES, V35, P465, DOI 10.1016/j.arcmed.2004.07.006; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marathe GK, 2000, FREE RADICAL BIO MED, V28, P1762, DOI 10.1016/S0891-5849(00)00234-3; Marathe GK, 2014, J LIPID RES, V55, P1847, DOI 10.1194/jlr.R045492; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; Mathiak G, 1997, SHOCK, V7, P391, DOI 10.1097/00024382-199706000-00001; Matute-Bello G, 2001, AM J RESP CRIT CARE, V163, P234, DOI 10.1164/ajrccm.163.1.9909034; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miotla JM, 1998, AM J RESP CELL MOL, V18, P197, DOI 10.1165/ajrcmb.18.2.2846; Moreno SE, 2006, J IMMUNOL, V177, P1264, DOI 10.4049/jimmunol.177.2.1264; MOZES T, 1991, J LIPID MEDIATOR, V4, P309; Murakami K, 1996, THROMB HAEMOSTASIS, V75, P965; Nagase T, 1999, J CLIN INVEST, V104, P1071, DOI 10.1172/JCI7727; Nakos G, 1998, INTENS CARE MED, V24, P296, DOI 10.1007/s001340050571; PAGE CP, 1987, INT J TISSUE REACT, V9, P27; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Qiu QM, 2011, WORLD J EMERG MED, V2, P302, DOI 10.5847/wjem.j.1920-8642.2011.04.011; RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887; Saturnino SF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-240; Schwarz NT, 2002, GASTROENTEROLOGY, V123, P586, DOI 10.1053/gast.2002.34777; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; SMITH WL, 1990, ADV PROSTAG THROMB L, V20, P14; Song W, 1996, BRIT J PHARMACOL, V118, P2157, DOI 10.1111/j.1476-5381.1996.tb15657.x; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223; Subbanagounder G, 1999, CIRC RES, V85, P311, DOI 10.1161/01.RES.85.4.311; Teixeira-da-Cunha MGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074567; Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; TJOELKER LW, 1995, J BIOL CHEM, V270, P25481, DOI 10.1074/jbc.270.43.25481; Tsoupras AB, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-17; Uhlig S, 2005, PHARMACOL REP, V57, P206; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; Varisco BM, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/254619; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Wang H, 1997, PEDIATR RES, V42, P597, DOI 10.1203/00006450-199711000-00008; Watanabe JJ, 2003, J BIOL CHEM, V278, P33161, DOI 10.1074/jbc.M305321200; Yost CC, 2010, BIOCHIMIE, V92, P692, DOI 10.1016/j.biochi.2010.02.011; Zheng GH, 2012, INFLAMMATION, V35, P1419, DOI 10.1007/s10753-012-9455-4	96	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153282	10.1371/journal.pone.0153282	http://dx.doi.org/10.1371/journal.pone.0153282			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064683	Green Submitted, Green Published, gold			2022-12-26	WOS:000373891000041
J	Jo, P; Konig, A; Schirmer, M; Kitz, J; Conradi, LC; Azizian, A; Bernhardt, M; Wolff, HA; Grade, M; Ghadimi, M; Strobel, P; Schildhaus, HU; Gaedcke, J				Jo, Peter; Koenig, Alexander; Schirmer, Markus; Kitz, Julia; Conradi, Lena-Christin; Azizian, Azadeh; Bernhardt, Markus; Wolff, Hendrik A.; Grade, Marian; Ghadimi, Michael; Stroebel, Philipp; Schildhaus, Hans-Ulrich; Gaedcke, Jochen			Heterogeneity of KRAS Mutation Status in Rectal Cancer	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; BRAF; CETUXIMAB; THERAPY; SPECIMENS; CHEMORADIOTHERAPY; CHEMOTHERAPY; EVOLUTION; IMPACT; SITES	Introduction Anti-EGFR targeted therapy is of increasing importance in advanced colorectal cancer and prior KRAS mutation testing is mandatory for therapy. However, at which occasions this should be performed is still under debate. We aimed to assess in patients with locally advanced rectal cancer whether there is intra-specimen KRAS heterogeneity prior to and upon preoperative chemoradiotherapy (CRT), and if there are any changes in KRAS mutation status due to this intervention. Materials and Methods KRAS mutation status analyses were performed in 199 tumor samples from 47 patients with rectal cancer. To evaluate the heterogeneity between different tumor areas within the same tumor prior to preoperative CRT, 114 biopsies from 34 patients (mean 3 biopsies per patient) were analyzed (pre-therapeutic intratumoral heterogeneity). For the assessment of heterogeneity after CRT residual tumor tissue (85 samples) from 12 patients (mean 4.2 tissue samples per patient) were analyzed (post-therapeutic intratumoral heterogeneity) and assessment of heterogeneity before and after CRT was evaluated in corresponding patient samples (interventional heterogeneity). Primer extension method (SNaPshot (TM)) was used for initial KRAS mutation status testing for Codon 12, 13, 61, and 146. Discordant results by this method were reevaluated by using the FDA-approved KRAS Pyro Kit 24, V1 and the RAS Extension Pyro Kit 24, V1 Kit (therascreen (R) KRAS test). Results For 20 (43%) out of the 47 patients, a KRAS mutation was detected. With 12 out of 20, the majority of these mutations affected codon 35. We did not obtained evidence that CRT results in changes of the KRAS mutation pattern. In addition, no intratumoral heterogeneity in the KRAS mutational status could be proven. This was true for both the biopsies prior to CRT and the resection specimens thereafter. The discrepancy observed in some samples when using the SNaPshot (TM) assay was due to insufficient sensitivity of this technique upon massive tumor regression by CRT as application of the therascreen (R) KRAS test revealed concordant results. Conclusion Our results indicate that the KRAS mutation status at the primary tumor site of rectal cancer is homogenous. Its assessment for therapeutic decisions is feasible in pre-therapeutic biopsies as well as in post-therapeutic resected specimens. The amount of viable tumor cells seems to be an important determinant for assay sensitivity and should thus be considered for selection of the analytical method.	[Jo, Peter; Conradi, Lena-Christin; Azizian, Azadeh; Bernhardt, Markus; Grade, Marian; Ghadimi, Michael; Gaedcke, Jochen] Univ Med Ctr Goettingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany; [Koenig, Alexander] Univ Med Ctr Goettingen, Dept Gastroenterol & Gastrointestinal Oncol, Gottingen, Germany; [Schirmer, Markus] Univ Med Ctr Goettingen, Dept Clin Pharmacol, Gottingen, Germany; [Kitz, Julia; Stroebel, Philipp; Schildhaus, Hans-Ulrich] Univ Med Ctr Goettingen, Dept Pathol, Gottingen, Germany; [Wolff, Hendrik A.] Radiotherapy & Radiol Munich, Munich, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Gottingen	Gaedcke, J (corresponding author), Univ Med Ctr Goettingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany.	jochen.gaedcke@med.uni-goettingen.de			Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work is part of the Clinical Research Unit (KFO 179) and was supported by the Deutsche Forschungsgemeinschaft (DFG).	Artale S, 2008, J CLIN ONCOL, V26, P4217, DOI 10.1200/JCO.2008.18.7286; Boissiere-Michot F, 2012, MODERN PATHOL, V25, P731, DOI 10.1038/modpathol.2011.210; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; Demes M, 2013, J GASTROINTEST ONCOL, V4, P182, DOI 10.3978/j.issn.2078-6891.2013.012; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Gaedcke J, 2010, RADIOTHER ONCOL, V94, P76, DOI 10.1016/j.radonc.2009.10.001; Gaiser T, 2013, INT J CANCER, V132, P1800, DOI 10.1002/ijc.27869; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Han CB, 2012, CANCER INVEST, V30, P741, DOI 10.3109/07357907.2012.732159; Hunt JL, 2004, ARCH PATHOL LAB MED, V128, P1372; Hurst Carolyn D, 2009, BMC Res Notes, V2, P66, DOI 10.1186/1756-0500-2-66; Imamura Y, 2012, CLIN CANCER RES, V18, P4753, DOI 10.1158/1078-0432.CCR-11-3210; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lamy A, 2011, MODERN PATHOL, V24, P1090, DOI 10.1038/modpathol.2011.60; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; Normanno N, 2015, ANN ONCOL, V26, P1710, DOI 10.1093/annonc/mdv176; Norton N, 2002, HUM GENET, V110, P471, DOI 10.1007/s00439-002-0706-6; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Ondrejka SL, 2011, AM J SURG PATHOL, V35, P1327, DOI 10.1097/PAS.0b013e3182253800; Queiros P, 2015, VIRCHOWS ARCH, V467, P383, DOI 10.1007/s00428-015-1823-7; Richman SD, 2011, ANAL CELL PATHOL, V34, P61, DOI [10.1155/2011/393521, 10.3233/ACP-2011-0005]; Rodel C, 2012, LANCET ONCOL, V13, P679, DOI 10.1016/S1470-2045(12)70187-0; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sherwood J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0207-9; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019	29	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153278	10.1371/journal.pone.0153278	http://dx.doi.org/10.1371/journal.pone.0153278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064574	Green Published, gold, Green Submitted			2022-12-26	WOS:000373891000040
J	Lee, DH; Lee, DW; Han, BS				Lee, Dong-Hoon; Lee, Do-Wan; Han, Bong-Soo			Possibility Study of Scale Invariant Feature Transform (SIFT) Algorithm Application to Spine Magnetic Resonance Imaging	PLOS ONE			English	Article							CORD	The purpose of this study is an application of scale invariant feature transform (SIFT) algorithm to stitch the cervical-thoracic-lumbar (C-T-L) spine magnetic resonance (MR) images to provide a view of the entire spine in a single image. All MR images were acquired with fast spin echo (FSE) pulse sequence using two MR scanners (1.5 T and 3.0 T). The stitching procedures for each part of spine MR image were performed and implemented on a graphic user interface (GUI) configuration. Moreover, the stitching process is performed in two categories; manual point-to-point (mPTP) selection that performed by user specified corresponding matching points, and automated point-to-point (aPTP) selection that performed by SIFT algorithm. The stitched images using SIFT algorithm showed fine registered results and quantitatively acquired values also indicated little errors compared with commercially mounted stitching algorithm in MRI systems. Our study presented a preliminary validation of the SIFT algorithm application to MRI spine images, and the results indicated that the proposed approach can be performed well for the improvement of diagnosis. We believe that our approach can be helpful for the clinical application and extension of other medical imaging modalities for image stitching.	[Lee, Dong-Hoon; Lee, Do-Wan] Johns Hopkins Univ, Sch Med, Dept Radiol, Div MR Res, Baltimore, MD 21205 USA; [Han, Bong-Soo] Yonsei Univ, Coll Hlth Sci, Dept Radiol Sci, Wonju, South Korea	Johns Hopkins University; Yonsei University	Han, BS (corresponding author), Yonsei Univ, Coll Hlth Sci, Dept Radiol Sci, Wonju, South Korea.	bshan@yonsei.ac.kr	Han, Bong Soo/AAL-6704-2020; Lee, Dong-Hoon/G-4959-2016	Lee, Dong-Hoon/0000-0002-5013-4440	"Leaders in INdustry-university Cooperation (LINC)" Project - Ministry of Education, Science and Technology (MEST) [2012-8-5299]	"Leaders in INdustry-university Cooperation (LINC)" Project - Ministry of Education, Science and Technology (MEST)	This research was supported by the "Leaders in INdustry-university Cooperation (LINC)" Project funded by the Ministry of Education, Science and Technology (MEST) (2012-8-5299). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103561; Baheti B., 2015, IEEE C PER COM, P1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown M, 2002, BRIT MACH VIS C, DOI DOI 10.5244/C.16.23; Chen Jian, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1437; Cheung W, 2009, IEEE T IMAGE PROCESS, V18, P2012, DOI 10.1109/TIP.2009.2024578; Daguang J, 2013, ADV INFORM SCI SERVI, V5, P164; Daliri MR, 2012, J MED SYST, V36, P995, DOI 10.1007/s10916-011-9738-6; Dzyubachyk O, 2013, MAGN RESON MED, V69, P1777, DOI 10.1002/mrm.24404; Filippi CG, 2010, EUR RADIOL, V20, P2194, DOI 10.1007/s00330-010-1797-4; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Harris C., 1988, P ALV VIS C MANCH UK, V15, P147, DOI [10.5244/C.2.23, DOI 10.5244/C.2.23]; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Nair G, 2010, NEUROIMAGE, V53, P576, DOI 10.1016/j.neuroimage.2010.06.060; Paganelli C, 2012, IEEE ENG MED BIO, P6543, DOI 10.1109/EMBC.2012.6347493; Paganelli C, 2013, MED PHYS, V40, DOI 10.1118/1.4822486; Paganelli C, 2013, PHYS MED BIOL, V58, P287, DOI 10.1088/0031-9155/58/2/287; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593, DOI 10.1109/CVPR.1994.323794; Wang DF, 2012, J NEUROSCI METH, V209, P371, DOI 10.1016/j.jneumeth.2012.06.026; Zhang XH, 2014, BIO-MED MATER ENG, V24, P2847, DOI 10.3233/BME-141103; Zhu J, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/926312	22	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153043	10.1371/journal.pone.0153043	http://dx.doi.org/10.1371/journal.pone.0153043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064404	gold, Green Published, Green Submitted			2022-12-26	WOS:000373891000026
J	Reddy, BL; Saier, MH				Reddy, Bhaskara L.; Saier, Milton H., Jr.			Properties and Phylogeny of 76 Families of Bacterial and Eukaryotic Organellar Outer Membrane Pore-Forming Proteins	PLOS ONE			English	Article							TRANSPORTER CLASSIFICATION DATABASE; RAFFINOSE PLASMID PRSD2; BETA-BARREL PROTEINS; WEB-BASED PROGRAM; CELL-WALL; FUNCTIONAL-CHARACTERIZATION; EVOLUTIONARY RELATIONSHIPS; CRYSTAL-STRUCTURE; X-RAY; CHANNEL	We here report statistical analyses of 76 families of integral outer membrane pore-forming proteins (OMPPs) found in bacteria and eukaryotic organelles. 47 of these families fall into one superfamily (SFI) which segregate into fifteen phylogenetic clusters. Families with members of the same protein size, topology and substrate specificities often cluster together. Virtually all OMPP families include only proteins that form transmembrane pores. Nine such families, all of which cluster together in the SFI phylogenetic tree, contain both alpha- and beta-structures, are multi domain, multi subunit systems, and transport macromolecules. Most other SFI OMPPs transport small molecules. SFII and SFV homologues derive from Actinobacteria while SFIII and SFIV proteins derive from chloroplasts. Three families of actinobacterial OMPPs and two families of eukaryotic OMPPs apparently consist primarily of alpha-helices (alpha-TMSs). Of the 71 families of (putative) beta-barrel OMPPs, only twenty could not be assigned to a superfamily, and these derived primarily from Actinobacteria (1), chloroplasts (1), spirochaetes (8), and proteobacteria (10). Proteins were identified in which two or three full length OMPPs are fused together. Family characteristic are described and evidence agrees with a previous proposal suggesting that many arose by adjacent beta-hairpin structural unit duplications.	[Reddy, Bhaskara L.; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Saier, MH (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	msaier@ucsd.edu		Saier, Milton/0000-0001-5530-0017	NIH [GM077402, GM109895]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109895, R01GM077402] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH (grant #GM077402 and GM109895). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aistleitner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055010; Albrecht R, 2006, ACTA CRYSTALLOGR F, V62, P415, DOI 10.1107/S1744309106010190; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altschul SF, 2009, NUCLEIC ACIDS RES, V37, P815, DOI 10.1093/nar/gkn981; Andersen C, 1998, EUR J BIOCHEM, V254, P679, DOI 10.1046/j.1432-1327.1998.2540679.x; Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Barth E, 2010, J BACTERIOL, V192, P786, DOI 10.1128/JB.01142-09; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beckwith CR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00332; BENZ R, 1993, BIOCHIM BIOPHYS ACTA, V1149, P224, DOI 10.1016/0005-2736(93)90205-E; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Bolla JM, 2004, ACTA CRYSTALLOGR D, V60, P2349, DOI 10.1107/S0907444904024795; Braun V, 2007, BIOMETALS, V20, P219, DOI 10.1007/s10534-006-9072-5; Buljan M, 2009, BIOCHEM SOC T, V37, P751, DOI 10.1042/BST0370751; Bushell SR, 2013, STRUCTURE, V21, P844, DOI 10.1016/j.str.2013.03.010; Chen JS, 2011, J MOL MICROB BIOTECH, V21, P83, DOI 10.1159/000334611; Chen SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118893; Chiang Z, 2015, BRIEF BIOINFORM, V16, P865, DOI 10.1093/bib/bbu053; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Collins RF, 2007, TRENDS MICROBIOL, V15, P96, DOI 10.1016/j.tim.2007.01.002; Condemine G, 2005, J BACTERIOL, V187, P1959, DOI 10.1128/JB.187.6.1959-1965.2005; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Costa-Riu N, 2003, MOL MICROBIOL, V50, P1295, DOI 10.1046/j.1365-2958.2003.03754.x; Cox K, 2008, EUR BIOPHYS J BIOPHY, V37, P131, DOI 10.1007/s00249-007-0185-8; Crook MB, 2013, J BACTERIOL, V195, P3663, DOI 10.1128/JB.00480-13; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Eren E, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001242; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Giacani L, 2015, INFECT IMMUN, V83, P2275, DOI 10.1128/IAI.00360-15; Goetze TA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0445-1; Gomolplitinant KM, 2011, J MEMBRANE BIOL, V240, P89, DOI 10.1007/s00232-011-9347-9; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086/648966; Grundy WN, 1996, COMPUT APPL BIOSCI, V12, P303; Hansel A, 1998, CURR MICROBIOL, V36, P321, DOI 10.1007/s002849900316; Hohle TH, 2011, P NATL ACAD SCI USA, V108, P15390, DOI 10.1073/pnas.1110137108; Huang HB, 2007, J BACTERIOL, V189, P1998, DOI 10.1128/JB.01548-06; Huang YH, 2009, P NATL ACAD SCI USA, V106, P7403, DOI 10.1073/pnas.0902789106; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hunten P, 2005, MICROBIOL-SGM, V151, P2429, DOI 10.1099/mic.0.27903-0; Hutter CAJ, 2014, ACTA CRYSTALLOGR D, V70, P1770, DOI 10.1107/S1399004714007147; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Kalmokoff ML, 2009, ANAEROBE, V15, P74, DOI 10.1016/j.anaerobe.2009.01.001; Kattner C, 2015, APPL BIOCHEM BIOTECH, V175, P2907, DOI 10.1007/s12010-014-1473-2; Khemiri A, 2008, FEMS MICROBIOL LETT, V278, P171, DOI 10.1111/j.1574-6968.2007.00985.x; Kim JS, 2015, MOL CELLS, V38, P180, DOI 10.14348/molcells.2015.2277; Korhonen TK, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00035; Korkmaz F, 2015, ARCH BIOCHEM BIOPHYS, V576, P73, DOI 10.1016/j.abb.2015.04.010; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; KUAN J, 1993, CRIT REV BIOCHEM MOL, V28, P209, DOI 10.3109/10409239309086795; Lam VH, 2011, BIOL CHEM, V392, P5, DOI 10.1515/BC.2011.018; Lee A, 2014, MICROBIOL-SGM, V160, P1679, DOI 10.1099/mic.0.077776-0; Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104; Lieberman JA, 2015, MBIO, V6, DOI 10.1128/mBio.00322-15; Lukatsky DB, 2007, J MOL BIOL, V365, P1596, DOI 10.1016/j.jmb.2006.11.020; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mazar J, 2007, TRENDS MICROBIOL, V15, P508, DOI 10.1016/j.tim.2007.10.005; Meli AC, 2006, J BIOL CHEM, V281, P158, DOI 10.1074/jbc.M508524200; Mertins B, 2014, BIOL CHEM, V395, P1435, DOI 10.1515/hsz-2014-0203; Modi N, 2013, BIOCHEMISTRY-US, V52, P5522, DOI 10.1021/bi400522b; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; Niederweis M, 2003, MOL MICROBIOL, V49, P1167, DOI 10.1046/j.1365-2958.2003.03662.x; Niederweis M, 2008, MICROBIOL-SGM, V154, P679, DOI 10.1099/mic.0.2007/012872-0; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2015, CURR OPIN STRUC BIOL, V31, P35, DOI 10.1016/j.sbi.2015.02.012; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paquet JY, 2001, J BACTERIOL, V183, P4839, DOI 10.1128/JB.183.16.4839-4847.2001; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Pavlenok M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038726; Pei XY, 2011, P NATL ACAD SCI USA, V108, P2112, DOI 10.1073/pnas.1012588108; Puntervoll P, 2002, MICROBIOL-SGM, V148, P3395, DOI 10.1099/00221287-148-11-3395; Ranquin A, 2004, RES MICROBIOL, V155, P611, DOI 10.1016/j.resmic.2004.05.007; Reddy A, 2014, J MOL MICROB BIOTECH, V24, P161, DOI 10.1159/000363506; Reddy BL, 2013, BBA-BIOMEMBRANES, V1828, P2654, DOI 10.1016/j.bbamem.2013.07.004; Reddy VS, 2012, FEBS J, V279, P2036, DOI 10.1111/j.1742-4658.2012.08590.x; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Rehman ZU, 2013, APPL ENVIRON MICROB, V79, P2002, DOI 10.1128/AEM.03960-12; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Remmert M, 2009, NUCLEIC ACIDS RES, V37, pW446, DOI 10.1093/nar/gkp325; Saier MH, 2003, MOL MICROBIOL, V48, P1145, DOI 10.1046/j.1365-2958.2003.03499.x; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Saier MH, 2008, MICROBE, P323; Saier MH, 2008, ADV APPL MICROBIOL, V65, P141, DOI 10.1016/S0065-2164(08)00606-0; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Simmerman RF, 2014, INT REV CEL MOL BIO, V308, P1, DOI 10.1016/B978-0-12-800097-7.00001-4; Soding J, 2003, BIOESSAYS, V25, P837, DOI 10.1002/bies.10321; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; Speer A, 2015, MOL MICROBIOL, V97, P881, DOI 10.1111/mmi.13073; Sun G, 2007, J BACTERIOL, V189, P6222, DOI 10.1128/JB.00552-07; Tamber S, 2007, J BACTERIOL, V189, P929, DOI 10.1128/JB.01296-06; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsirigos KD, 2011, NUCLEIC ACIDS RES, V39, pD324, DOI 10.1093/nar/gkq863; Tsu BV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137184; Tusnady GE, 2010, CURR PROTEIN PEPT SC, V11, P550; Ulmke C, 1997, J BACTERIOL, V179, P5783, DOI 10.1128/jb.179.18.5783-5788.1997; Ulrich T, 2015, INT J MED MICROBIOL, V305, P259, DOI 10.1016/j.ijmm.2014.12.009; van den Berg B, 2005, CURR OPIN STRUC BIOL, V15, P401, DOI 10.1016/j.sbi.2005.06.003; VANROSMALEN M, 1993, RES MICROBIOL, V144, P507, DOI 10.1016/0923-2508(93)90001-I; Viklund H, 2008, BIOINFORMATICS, V24, P2928, DOI 10.1093/bioinformatics/btn550; Vrljic M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P327; WALLIN E, 1993, COMPUT APPL BIOSCI, V9, P117; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Wang B, 2009, J MEMBRANE BIOL, V231, P1, DOI 10.1007/s00232-009-9200-6; Wang HG, 2016, MICROBIOL RES, V182, P109, DOI 10.1016/j.micres.2015.10.004; Wee SK, 2014, FEMS MICROBIOL LETT, V350, P90, DOI 10.1111/1574-6968.12304; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; Wetzler LM, 2010, FUTURE MICROBIOL, V5, P749, DOI 10.2217/FMB.10.41; Wirth C, 2009, J MOL BIOL, V394, P718, DOI 10.1016/j.jmb.2009.09.054; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Xiao Anthony Y, 2010, Int J Microbiol, V2010, P589391, DOI 10.1155/2010/589391; Ye JQ, 2004, EMBO J, V23, P3187, DOI 10.1038/sj.emboj.7600330; Yee DC, 2013, FEBS J, V280, P5780, DOI 10.1111/febs.12499; Yen MR, 2010, METHODS MOL BIOL, V637, P47, DOI 10.1007/978-1-60761-700-6_3; Yen MR, 2009, J MOL MICROB BIOTECH, V17, P163, DOI 10.1159/000239667; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5; Zhai YF, 2002, J MOL MICROB BIOTECH, V4, P69; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P501; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P285; Zheng WH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-98; Ziegler K, 2008, J MOL BIOL, V379, P482, DOI 10.1016/j.jmb.2008.04.017	131	15	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152733	10.1371/journal.pone.0152733	http://dx.doi.org/10.1371/journal.pone.0152733			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064789	Green Published, Green Submitted, gold			2022-12-26	WOS:000373891000018
J	Yokrattanasak, J; De Gaetano, A; Panunzi, S; Satiracoo, P; Lawton, WM; Lenbury, Y				Yokrattanasak, Jiraphat; De Gaetano, Andrea; Panunzi, Simona; Satiracoo, Pairote; Lawton, Wayne M.; Lenbury, Yongwimon			A Simple, Realistic Stochastic Model of Gastric Emptying	PLOS ONE			English	Article							DIFFERENTIAL-EQUATIONS; PARAMETER-ESTIMATION; KINETICS; VARIABILITY; ABSORPTION; INGESTION; MECHANISM; DYNAMICS; TRANSIT; HUMANS	Several models of Gastric Emptying (GE) have been employed in the past to represent the rate of delivery of stomach contents to the duodenum and jejunum. These models have all used a deterministic form (algebraic equations or ordinary differential equations), considering GE as a continuous, smooth process in time. However, GE is known to occur as a sequence of spurts, irregular both in size and in timing. Hence, we formulate a simple stochastic process model, able to represent the irregular decrements of gastric contents after a meal. The model is calibrated on existing literature data and provides consistent predictions of the observed variability in the emptying trajectories. This approach may be useful in metabolic modeling, since it describes well and explains the apparently heterogeneous GE experimental results in situations where common gastric mechanics across subjects would be expected.	[Yokrattanasak, Jiraphat; Satiracoo, Pairote; Lenbury, Yongwimon] Mahidol Univ, Dept Math, Bangkok 10400, Thailand; [Yokrattanasak, Jiraphat; Satiracoo, Pairote; Lenbury, Yongwimon] Ctr Excellence Math, Bangkok 10400, Thailand; [De Gaetano, Andrea; Panunzi, Simona] CNR, Inst Syst Anal & Informat IASI A Ruberti, Rome, Italy; [Lawton, Wayne M.] Univ Western Australia, Sch Math & Stat, Perth, WA 6009, Australia	Mahidol University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); University of Western Australia	Yokrattanasak, J (corresponding author), Mahidol Univ, Dept Math, Bangkok 10400, Thailand.; Yokrattanasak, J (corresponding author), Ctr Excellence Math, Bangkok 10400, Thailand.; Yokrattanasak, J (corresponding author), CNR, Inst Syst Anal & Informat IASI A Ruberti, Rome, Italy.	jibeau17@gmail.com	Panunzi, Simona/AAK-9337-2020; De Gaetano, Andrea/AAC-4805-2021	De Gaetano, Andrea/0000-0001-7712-056X; Panunzi, Simona/0000-0003-0956-8578; Lenbury, Yongwimon/0000-0002-8270-1980	Strategic Scholarships Fellowships Frontier Research Networks, the Office of the Commission on Higher Education, Thailand; Commission on Higher Education under the program Strategic Scholarships Fellowships Frontier Research Networks, Mahidol University; Centre of Excellence in Mathematics, Thailand	Strategic Scholarships Fellowships Frontier Research Networks, the Office of the Commission on Higher Education, Thailand; Commission on Higher Education under the program Strategic Scholarships Fellowships Frontier Research Networks, Mahidol University; Centre of Excellence in Mathematics, Thailand	JY received the funding from Strategic Scholarships Fellowships Frontier Research Networks, the Office of the Commission on Higher Education, Thailand (http://www.research.mua.go.th/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Appreciation is extended toward the Commission on Higher Education under the program Strategic Scholarships Fellowships Frontier Research Networks, Mahidol University, and the Centre of Excellence in Mathematics, Thailand, for financial support.	Abell TL, 2008, AM J GASTROENTEROL, V103, P753, DOI 10.1111/j.1572-0241.2007.01636.x; Bachar M, 2013, LECT NOTES MATH, V2058, P1, DOI 10.1007/978-3-642-32157-3; Berne RM, 2004, PHYSIOLOGY, P554; BROPHY CM, 1986, DIGEST DIS SCI, V31, P799, DOI 10.1007/BF01296046; Cuenod CA, 2011, MATH BIOSCI, V233, P68, DOI 10.1016/j.mbs.2011.06.006; Dalla Man C, 2006, IEEE T BIO-MED ENG, V53, P2472, DOI 10.1109/TBME.2006.883792; De Gaetano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070875; Ditlevsen S, 2005, MATH BIOSCI, V194, P49, DOI 10.1016/j.mbs.2004.12.007; Ditlevsen S, 2005, B MATH BIOL, V67, P547, DOI 10.1016/j.bulm.2004.09.005; Ditlevsen S., 2005, REVSTAT, V3, P137; Donnet S, 2013, ADV DRUG DELIVER REV, V65, P929, DOI 10.1016/j.addr.2013.03.005; Ferrante L, 2005, BIOMETRICAL J, V47, P309, DOI 10.1002/bimj.200410125; FRASER AG, 1995, BRIT J CLIN PHARMACO, V40, P387, DOI 10.1111/j.1365-2125.1995.tb04561.x; Gebraeel NZ, 2005, IIE TRANS, V37, P543, DOI 10.1080/07408170590929018; Goetze O, 2007, AM J PHYSIOL-GASTR L, V292, pG11, DOI 10.1152/ajpgi.00498.2005; Hiren MR, 2011, INT RES J PHARM, V2, P106; JOBLING M, 1986, ENVIRON BIOL FISH, V16, P35, DOI 10.1007/BF00005158; Kim I, 2010, STAT MED, V29, P1839, DOI 10.1002/sim.3956; Lamberton D., 1996, INTRO STOCHASTIC CAL; Locatelli I, 2009, PHARM RES-DORDR, V26, P1607, DOI 10.1007/s11095-009-9869-3; Mettetal JT, 2006, P NATL ACAD SCI USA, V103, P7304, DOI 10.1073/pnas.0509874103; Michael J, 2010, FUNDAMENTALS MED PHY, P430; MOCH KJ, 1993, Z ERNAHRUNGSWISS, V32, P2, DOI 10.1007/BF01610081; Modchang C, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/026008; Neisy A, 2011, WORLD APPL SCI J, V13, P2288; Ogungbenro K, 2012, EUR J PHARM SCI, V45, P302, DOI 10.1016/j.ejps.2011.11.020; Patton KT, 2009, ANATOMY PHYSL, P882; Pedersen JF, 2003, ACTA RADIOL, V44, P340, DOI 10.1034/j.1600-0455.2003.00055.x; Perri F, 2005, Eur Rev Med Pharmacol Sci, V9, P3; Picchini U, 2008, MATH MED BIOL, V25, P141, DOI 10.1093/imammb/dqn011; Picchini U, 2006, J MATH BIOL, V53, P771, DOI 10.1007/s00285-006-0032-z; Ramanathan M, 1999, PHARMACEUT RES, V16, P584, DOI 10.1023/A:1011910800110; ROSE EF, 1979, J FORENSIC SCI, V24, P200; Salinari S, 2011, AM J PHYSIOL-ENDOC M, V300, pE955, DOI 10.1152/ajpendo.00451.2010; Schirra J, 1996, J CLIN INVEST, V97, P92, DOI 10.1172/JCI118411; Sherwood L, 2010, HUMAN PHYSL CELLS SY, P591; Si XS, 2013, MECH SYST SIGNAL PR, V35, P219, DOI 10.1016/j.ymssp.2012.08.016; Si XS, 2011, EUR J OPER RES, V213, P1, DOI 10.1016/j.ejor.2010.11.018; SIEGEL JA, 1988, GUT, V29, P85, DOI 10.1136/gut.29.1.85; Srivastava R, 2002, J THEOR BIOL, V218, P309, DOI 10.1006/jtbi.2002.3078; Stamatakis M, 2009, BIOPHYS J, V96, P887, DOI 10.1016/j.bpj.2008.10.028; STUBBS DF, 1977, GUT, V18, P202, DOI 10.1136/gut.18.3.202; Tvrdonova M, 2009, BASIC CLIN PHARMACOL, V104, P35, DOI 10.1111/j.1742-7843.2008.00304.x; Vinik A, 2008, DIABETES CARE, V31, P2410, DOI 10.2337/dc08-1694; Yu LX, 1999, INT J PHARMACEUT, V186, P119, DOI 10.1016/S0378-5173(99)00147-7	45	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153297	10.1371/journal.pone.0153297	http://dx.doi.org/10.1371/journal.pone.0153297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27057750	Green Submitted, Green Published, gold			2022-12-26	WOS:000373604800027
J	Cardnell, RJ; Feng, Y; Mukherjee, S; Diao, LX; Tong, P; Stewart, CA; Masrorpour, F; Fan, YH; Nilsson, M; Shen, YQ; Heymach, JV; Wang, J; Byers, LA				Cardnell, Robert J.; Feng, Ying; Mukherjee, Seema; Diao, Lixia; Tong, Pan; Stewart, C. Allison; Masrorpour, Fatemeh; Fan, YouHong; Nilsson, Monique; Shen, Yuqiao; Heymach, John V.; Wang, Jing; Byers, Lauren A.			Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer	PLOS ONE			English	Article							DRUG-DRUG INTERACTIONS; BREAST-CANCER; PI3K INHIBITOR; DNA-REPAIR; POLY(ADP-RIBOSE) POLYMERASE; THERAPEUTIC TARGETS; IN-VITRO; TUMORS; CARCINOMA; RESISTANCE	Small cell lung cancer (SCLC) is an aggressive malignancy with limited treatment options. We previously found that PARP is overexpressed in SCLC and that targeting PARP reduces cell line and tumor growth in preclinical models. However, SCLC cell lines with PI3K/mTOR pathway activation were relatively less sensitive to PARP inhibition. In this study, we investigated the proteomic changes in PI3K/mTOR and other pathways that occur following PAPR inhibition and/or knockdown in vitro and in vivo. Using reverse-phase protein array, we found the proteins most significantly upregulated following treatment with the PARP inhibitors olaparib and rucaparib were in the PI3K/mTOR pathway (p-mTOR, p-AKT, and pS6) (p <= 0.02). Furthermore, amongst the most significantly down-regulated proteins were LKB1 and its targets AMPK and TSC, which negatively regulate the PI3K pathway (p <= 0.042). Following PARP knockdown in cell lines, phosphorylated mTOR, AKT and S6 were elevated and LKB1 signaling was diminished. Global ATP concentrations increased following PARP inhibition (p <= 0.02) leading us to hypothesize that the observed increased PI3K/mTOR pathway activation following PARP inhibition results from decreased ATP usage and a subsequent decrease in stress response signaling via LKB1. Based on these results, we then investigated whether co-targeting with a PARP and PI3K inhibitor (BKM-120) would work better than either single agent alone. A majority of SCLC cell lines were sensitive to BKM-120 at clinically achievable doses, and cMYC expression was the strongest biomarker of response. At clinically achievable doses of talazoparib (the most potent PARP inhibitor in SCLC clinical testing) and BKM-120, an additive effect was observed in vitro. When tested in two SCLC animal models, a greater than additive interaction was seen (p <= 0.008). The data presented here suggest that combining PARP and PI3K inhibitors enhances the effect of either agent alone in preclinical models of SCLC, warranting further investigation of such combinations in SCLC patients.	[Cardnell, Robert J.; Mukherjee, Seema; Stewart, C. Allison; Masrorpour, Fatemeh; Fan, YouHong; Nilsson, Monique; Heymach, John V.; Byers, Lauren A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Feng, Ying] Biomarin Pharmaceut Inc, Novato, CA USA; [Diao, Lixia; Tong, Pan; Shen, Yuqiao; Wang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; BioMarin Pharmaceutical Inc.; University of Texas System; UTMD Anderson Cancer Center	Byers, LA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	lbyers@mdanderson.org	Heymach, John/AAG-2361-2019	Heymach, John/0000-0001-9068-8942	MD Anderson Cancer Center Support Grant [NIH P30 CA016672]; University of Texas-Southwestern and MD Anderson Cancer Center Lung SPORE [5 P50 CA070907]; NIH [1R01 CA168484-01]; Rexanna's Foundation for Fighting Lung Cancer; MD Anderson Cancer Center Physician Scientist Award; Lee Clark Fellowship of The University of Texas MD Anderson Cancer Center - Jeane F. Shelby Scholarship Fund; NCI Cancer Clinical Investigator Team Leadership Award [P30 CA016672]; Sheikh Khalifa Bin Zayed Al Nahyan Institute for the Personalized Cancer Therapy's (IPCT's) Center for Professional Education and Training; National Lung Cancer Research Partnership; Lung Cancer Research Foundation; LUNGevity Foundation; Sidney Kimmel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA168484, P30CA016672] Funding Source: NIH RePORTER	MD Anderson Cancer Center Support Grant; University of Texas-Southwestern and MD Anderson Cancer Center Lung SPORE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rexanna's Foundation for Fighting Lung Cancer; MD Anderson Cancer Center Physician Scientist Award; Lee Clark Fellowship of The University of Texas MD Anderson Cancer Center - Jeane F. Shelby Scholarship Fund; NCI Cancer Clinical Investigator Team Leadership Award; Sheikh Khalifa Bin Zayed Al Nahyan Institute for the Personalized Cancer Therapy's (IPCT's) Center for Professional Education and Training; National Lung Cancer Research Partnership; Lung Cancer Research Foundation; LUNGevity Foundation; Sidney Kimmel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by MD Anderson Cancer Center Support Grant (NIH P30 CA016672); University of Texas-Southwestern and MD Anderson Cancer Center Lung SPORE (5 P50 CA070907); through generous philanthropic contributions to The University of Texas MD Anderson Lung Cancer Moon Shot Program; NIH 1R01 CA168484-01 (JVH); David Bruton, Jr., Endowed Chair (JVH); the Rexanna's Foundation for Fighting Lung Cancer (http://www.rexannasfoundation.org/) (JVH); MD Anderson Cancer Center Physician Scientist Award (LAB); Lee Clark Fellowship of The University of Texas MD Anderson Cancer Center, supported by the Jeane F. Shelby Scholarship Fund (LAB); an NCI Cancer Clinical Investigator Team Leadership Award (P30 CA016672) (LAB); The Sheikh Khalifa Bin Zayed Al Nahyan Institute for the Personalized Cancer Therapy's (IPCT's) Center for Professional Education and Training (LAB); the National Lung Cancer Research Partnership, made possible by the North Carolina Lung Cancer Partnership (http://www.freetobreathe.org/) (LAB); the Lung Cancer Research Foundation (http://www.lungcancerresearchfoundation.org/) (LAB); LUNGevity Foundation (http://www.lungevity.org/) (LAB); and The Sidney Kimmel Foundation for Cancer Research (http://kimmel.org/) (LAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addie M, 2013, J MED CHEM, V56, P2059, DOI 10.1021/jm301762v; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bouwman P, 2014, CLIN CANCER RES, V20, P540, DOI 10.1158/1078-0432.CCR-13-0225; Britten CD, 2013, CANCER CHEMOTH PHARM, V71, P1395, DOI 10.1007/s00280-013-2121-1; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Burger MT, 2011, ACS MED CHEM LETT, V2, P774, DOI 10.1021/ml200156t; Byers LA, 2015, CANCER-AM CANCER SOC, V121, P664, DOI 10.1002/cncr.29098; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Cardnell RJ, 2013, CLIN CANCER RES, V19, P6322, DOI 10.1158/1078-0432.CCR-13-1975; Cardnell RJG, 2015, CLIN CANCER RES, V21, P3480, DOI 10.1158/1078-0432.CCR-14-3286; Cascone T, 2011, J CLIN INVEST, V121, P1313, DOI 10.1172/JCI42405; Chen ZT, 2015, MOL MED REP, V12, P1868, DOI 10.3892/mmr.2015.3604; Dejan J., 2012, AACR 103 ANN M; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Ethier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047978; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hardie DG, 2014, ANNU REV NUTR, V34, P31, DOI 10.1146/annurev-nutr-071812-161148; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Juvekar A, 2012, CANCER DISCOV, V2, P1048, DOI 10.1158/2159-8290.CD-11-0336; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kong DX, 2014, INVEST NEW DRUG, V32, P1134, DOI 10.1007/s10637-014-0152-z; Korsse SE, 2013, BBA-REV CANCER, V1835, P194, DOI 10.1016/j.bbcan.2012.12.006; Matulonis U, AACR ANN M 2015 PHIL; Matulonis U, 2014, J CLIN ONCOL, V32, p5s; Mazumdar T, 2014, MOL CANCER THER, V13, P2738, DOI 10.1158/1535-7163.MCT-13-1090; Neeley ES, 2012, CANCER INFORM, V11, P77, DOI 10.4137/CIN.S9055; Owonikoko TK, 2015, LUNG CANCER, V89, P66, DOI 10.1016/j.lungcan.2015.04.015; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Shen YQ, 2015, J PHARMACOL EXP THER, V353, P446, DOI 10.1124/jpet.114.222448; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Tong P, 2015, BIOINFORMATICS, V31, P1692, DOI 10.1093/bioinformatics/btv028; U.S. Cancer Statistics Working Group, 2014, US CANC STAT 1999 20; Umemura S, 2014, J THORAC ONCOL, V9, P1324, DOI 10.1097/JTO.0000000000000250; Wainberg Z, 2014, J CLIN ONCOL S, V32, p5s; Walls M, 2014, CLIN CANCER RES, V20, P631, DOI 10.1158/1078-0432.CCR-13-1663; Wang LF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2565; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013662; Wojtalla A, 2013, CLIN CANCER RES, V19, P96, DOI 10.1158/1078-0432.CCR-12-1138; Zhou J, 2013, FEBS LETT, V587, P170, DOI 10.1016/j.febslet.2012.11.018	48	61	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152584	10.1371/journal.pone.0152584	http://dx.doi.org/10.1371/journal.pone.0152584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055253	Green Submitted, gold, Green Published			2022-12-26	WOS:000373608000025
J	Tobias, J; Von Mentzer, A; Frykberg, PL; Aslett, M; Page, AJ; Sjoling, A; Svennerholm, AM				Tobias, Joshua; Von Mentzer, Astrid; Frykberg, Patricia Loayza; Aslett, Martin; Page, Andrew J.; Sjoling, Asa; Svennerholm, Ann-Mari			Stability of the Encoding Plasmids and Surface Expression of CS6 Differs in Enterotoxigenic Escherichia coli (ETEC) Encoding Different Heat-Stable (ST) Enterotoxins (STh and STp)	PLOS ONE			English	Article							COLONIZATION FACTOR CS6; FACTOR-ANTIGEN-I; STRAINS; BINDING; CHILDREN; PROTEIN; ISOLATE; TOXINS	Enterotoxigenic Escherichia coli (ETEC), one of the most common reasons of diarrhea among infants and children in developing countries, causes disease by expression of either or both of the enterotoxins heat-labile (LT) and heat-stable (ST; divided into human-type [STh] and porcine-type [STp] variants), and colonization factors (CFs) among which CS6 is one of the most prevalent ETEC CFs. In this study we show that ETEC isolates expressing CS6+STh have higher copy numbers of the cssABCD operon encoding CS6 than those expressing CS6+STp. Long term cultivation of up to ten over-night passages of ETEC iso-lates harboring CS6+STh (n = 10) or CS6+STp (n = 15) showed instability of phenotypic expression of CS6 in a majority of the CS6+STp isolates, whereas most of the CS6+STh isolates retained CS6 expression. The observed instability was a correlated with loss of genes cssA and cssD as examined by PCR. Mobilization of the CS6 plasmid from an unstable CS6+STp isolate into a laboratory E. coli strain resulted in loss of the plasmid after a single over-night passage whereas the plasmid from an CS6+STh strain was retained in the laboratory strain during 10 passages. A sequence comparison between the CS6 plasmids from a stable and an unstable ETEC isolate revealed that genes necessary for plasmid stabilization, for example pemI, pemK, stbA, stbB and parM, were not present in the unstable ETEC isolate. Our results indicate that stable retention of CS6 may in part be affected by the stability of the plasmid on which both CS6 and STp or STh are located.	[Tobias, Joshua; Von Mentzer, Astrid; Frykberg, Patricia Loayza; Sjoling, Asa; Svennerholm, Ann-Mari] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, S-40530 Gothenburg, Sweden; [Aslett, Martin; Page, Andrew J.] Wellcome Trust Sanger Inst, Pathogen Genom, Cambridge CB10 1SA, England; [Sjoling, Asa] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden	University of Gothenburg; Wellcome Trust Sanger Institute; Karolinska Institutet	Tobias, J (corresponding author), Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, S-40530 Gothenburg, Sweden.	joshua.tobias@meduniwien.ac.at	von Mentzer, Astrid/I-5449-2018	von Mentzer, Astrid/0000-0002-2167-1394; Page, Andrew/0000-0001-6919-6062; Sjoling, Asa/0000-0003-1529-1720	Swedish Research Council; Swedish Foundation for Strategic Research [SB12-0072]; Wellcome Trust [WT 098051]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Swedish Research Council, the Swedish Foundation for Strategic Research (grant no SB12-0072) and the Wellcome Trust (grant WT 098051).	Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Debnath A, 2015, MICROBIOL-SGM, V161, P865, DOI 10.1099/mic.0.000038; ECHEVERRIA P, 1986, INFECT IMMUN, V51, P626, DOI 10.1128/IAI.51.2.626-630.1986; EVANS DG, 1979, INFECT IMMUN, V25, P738, DOI 10.1128/IAI.25.2.738-748.1979; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Helander A, 1997, J CLIN MICROBIOL, V35, P867, DOI 10.1128/JCM.35.4.867-872.1997; Hunt Martin, 2015, Genome Biol, V16, P294, DOI 10.1186/s13059-015-0849-0; Jansson L, 2006, INFECT IMMUN, V74, P3488, DOI 10.1128/IAI.02006-05; Jansson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004487; Munson GP, 2000, MOL MICROBIOL, V36, P1391, DOI 10.1046/j.1365-2958.2000.01957.x; MURRAY BE, 1983, J BACTERIOL, V153, P566, DOI 10.1128/JB.153.1.566-570.1983; Nagy B, 1999, VET RES, V30, P259; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nicklasson M, 2008, MICROB PATHOGENESIS, V44, P246, DOI 10.1016/j.micpath.2007.06.009; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Rodas C, 2009, J CLIN MICROBIOL, V47, P1218, DOI 10.1128/JCM.00316-09; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shaheen HI, 2009, J CLIN MICROBIOL, V47, P189, DOI 10.1128/JCM.01282-08; SOMMERFELT H, 1989, APMIS, V97, P436, DOI 10.1111/j.1699-0463.1989.tb00812.x; THOMAS LV, 1987, INFECT IMMUN, V55, P1929, DOI 10.1128/IAI.55.8.1929-1931.1987; Tobias J, 2008, VACCINE, V26, P5373, DOI 10.1016/j.vaccine.2008.07.091; Tobias J, 2011, VACCINE, V29, P8863, DOI 10.1016/j.vaccine.2011.09.096; Tobias J, 2010, VACCINE, V28, P6977, DOI 10.1016/j.vaccine.2010.08.047; Torres OR, 2015, EPIDEMIOL INFECT, V143, P1662, DOI 10.1017/S0950268814002295; von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145; Wajima T, 2013, PLASMID, V70, P343, DOI 10.1016/j.plasmid.2013.07.006; Wajima T, 2011, MICROB PATHOGENESIS, V51, P243, DOI 10.1016/j.micpath.2011.06.004; Wolf MK, 1997, FEMS MICROBIOL LETT, V148, P35, DOI 10.1016/S0378-1097(97)00009-8	28	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152899	10.1371/journal.pone.0152899	http://dx.doi.org/10.1371/journal.pone.0152899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054573	Green Submitted, Green Published, gold			2022-12-26	WOS:000373608000052
J	Huan, HB; Wen, XD; Chen, XJ; Wu, LL; Liu, WH; Habib, NA; Bie, P; Xia, F				Huan, Hongbo; Wen, Xudong; Chen, Xuejiao; Wu, Lili; Liu, Weihui; Habib, Nagy A.; Bie, Ping; Xia, Feng			C/EBP alpha Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/beta-Catenin Signaling Mediated EMT	PLOS ONE			English	Article							BINDING-PROTEIN-ALPHA; EPITHELIAL-MESENCHYMAL TRANSITION; PANCREATIC-CANCER; DOWN-REGULATION; BETA-CATENIN; EXPRESSION; GROWTH; MECHANISMS; PHENOTYPE; DIAGNOSIS	Hepatocellular carcinoma is associated with high mortality, and tumor metastasis is an important reason for poor prognosis. However, metastasis has not been effectively prevented in clinical therapy and the mechanisms underlying metastasis have not been fully characterized. CCAAT/enhancer-binding protein-alpha (C/EBP alpha) is a transcriptional regulator with an essential role in tumor metastasis. We used short-activating RNAs (saRNA) to enhance expression of C/EBP alpha. Intravenous injection of C/EBP alpha-saRNA in a nude mouse liver orthotopic xenograft tumor model inhibited intrahepatic and distant metastasis. C/EBP alpha-saRNA-treated mice showed increased serum levels of albumin and decreased alanine aminotransferase (ALT), glutamic-oxalacetic transaminase (AST), indicating a role of C/EBP alpha in improving liver function. Migration and invasion were inhibited in hepatoma cell lines transfected with C/EBP alpha-saRNA. We also observed an inhibition of epithelial-mesenchymal transition (EMT) and suppression of epidermal growth factor receptor (EGFR), EGFR phosphorylation, and beta-catenin in C/EBPa-saRNA-transfected cells. Our results suggested that C/EBP alpha-saRNA successfully inhibited HCC metastasis by inhibiting EGFR/beta-catenin signaling pathway mediated EMT in vitro and in vivo.	[Huan, Hongbo; Wen, Xudong; Wu, Lili; Bie, Ping; Xia, Feng] Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China; [Chen, Xuejiao] Third Mil Med Univ, Inst Pathol, Southwest Hosp, Lab Biotherapy Canc, Chongqing, Peoples R China; [Chen, Xuejiao] Third Mil Med Univ, Southwest Canc Ctr, Southwest Hosp, Chongqing, Peoples R China; [Liu, Weihui] Chengdu Mil Gen Hosp, Gen Surg Ctr, Chengdu, Sichuan Provinc, Peoples R China; [Habib, Nagy A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London, England	Army Medical University; Army Medical University; Army Medical University; Imperial College London	Xia, F (corresponding author), Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China.	txzzxf@163.com			National Natural Sciences Foundation of China [81272224]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Sciences Foundation of China (No. 81272224), which was won by FX. F X conceived and designed the experiments, and decided to submit the manuscript. http://www.nsfc.gov.cn	Banerjee P, 2016, STEM CELLS, V34, P334, DOI 10.1002/stem.2245; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheung CT, 2015, CARCINOGENESIS, V36, P914, DOI 10.1093/carcin/bgv069; Cicchini C, 2015, LIVER INT, V35, P302, DOI 10.1111/liv.12577; Claperon A, 2014, J HEPATOL, V61, P325, DOI 10.1016/j.jhep.2014.03.033; Das S, 2015, CURR PHARM DESIGN, V21, P1249, DOI 10.2174/1381612821666141211115234; Fan FT, 2014, ASIAN PAC J CANCER P, V15, P1961, DOI 10.7314/APJCP.2014.15.5.1961; Forner A, 2012, LANCET ONCOL, V13, P750, DOI 10.1016/S1470-2045(12)70271-1; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gao YZ, 2015, TUMOR BIOL, V36, P7409, DOI 10.1007/s13277-015-3408-0; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Hahn S, 2013, EMBO J, V32, P3079, DOI 10.1038/emboj.2013.236; Higashikawa K, 2007, CANCER RES, V67, P9207, DOI 10.1158/0008-5472.CAN-07-0932; Huang LH, 2015, ACTA PHARM SIN B, V5, P390, DOI 10.1016/j.apsb.2015.07.001; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Lindsey S, 2015, INT REV CEL MOL BIO, V314, P1, DOI 10.1016/bs.ircmb.2014.10.001; Liu WH, 2015, J CANCER RES CLIN, V141, P1767, DOI 10.1007/s00432-015-1943-0; Liu WS, 2015, ONCOTARGET, V6, P35522, DOI 10.18632/oncotarget.5849; Liu YN, 2004, ONCOGENE, V23, P278, DOI 10.1038/sj.onc.1207022; Lu GD, 2015, HEPATOLOGY, V61, P965, DOI 10.1002/hep.27593; Ming J, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150167; Muller C, 2010, EMBO J, V29, P897, DOI 10.1038/emboj.2009.404; Nakao K, 2014, J GASTROENTEROL, V49, P589, DOI 10.1007/s00535-014-0932-4; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Qi JJ, 2016, GUT, V65, P1690, DOI 10.1136/gutjnl-2014-307900; Reebye V, 2014, HEPATOLOGY, V59, P216, DOI 10.1002/hep.26669; Reebye V, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.23; Rhee KJ, 2015, INT J MOL SCI, V16, P30015, DOI 10.3390/ijms161226215; Shi DB, 2015, CANCER LETT, V369, P376, DOI 10.1016/j.canlet.2015.08.029; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Voutila J, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.20; Xue M, 2015, MOL MED REP, V12, P2121, DOI 10.3892/mmr.2015.3563; Yamamoto K, 2014, CARCINOGENESIS, V35, P2404, DOI 10.1093/carcin/bgu136; Yanaka Y, 2015, CARCINOGENESIS, V36, P1363, DOI 10.1093/carcin/bgv106; Ye LY, 2016, CANCER RES, V76, P818, DOI 10.1158/0008-5472.CAN-15-0977; Zeng CJ, 2015, STEM CELLS DEV, V24, P2467, DOI 10.1089/scd.2015.0202; Zhou JN, 2015, HEPATOLOGY, V62, P801, DOI 10.1002/hep.27887	39	32	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153117	10.1371/journal.pone.0153117	http://dx.doi.org/10.1371/journal.pone.0153117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050434	gold, Green Published			2022-12-26	WOS:000373603500103
J	MacDiarmid, JA; Langova, V; Bailey, D; Pattison, ST; Pattison, SL; Christensen, N; Armstrong, LR; Brahmbhatt, VN; Smolarczyk, K; Harrison, MT; Costa, M; Mugridge, NB; Sedliarou, I; Grimes, NA; Kiss, DL; Stillman, B; Hann, CL; Gallia, GL; Graham, RM; Brahmbhatt, H				MacDiarmid, Jennifer A.; Langova, Veronika; Bailey, Dale; Pattison, Scott T.; Pattison, Stacey L.; Christensen, Neil; Armstrong, Luke R.; Brahmbhatt, Vatsala N.; Smolarczyk, Katarzyna; Harrison, Matthew T.; Costa, Marylia; Mugridge, Nancy B.; Sedliarou, Ilya; Grimes, Nicholas A.; Kiss, Debra L.; Stillman, Bruce; Hann, Christine L.; Gallia, Gary L.; Graham, Robert M.; Brahmbhatt, Himanshu			Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model	PLOS ONE			English	Article							BLOOD-BRAIN; DRUG-DELIVERY; GLIOBLASTOMA-MULTIFORME; VASCULAR-PERMEABILITY; MALIGNANT GLIOMA; PET DOGS; CANCER; BARRIER; THERAPY; SYSTEMS	Background Cytotoxic chemotherapy can be very effective for the treatment of cancer but toxicity on normal tissues often limits patient tolerance and often causes long-term adverse effects. The objective of this study was to assist in the preclinical development of using modified, non-living bacterially-derived minicells to deliver the potent chemotherapeutic doxorubicin via epidermal growth factor receptor (EGFR) targeting. Specifically, this study sought to evaluate the safety and efficacy of EGFR targeted, doxorubicin loaded minicells (designated (EGFR)minicells(Dox)) to deliver doxorubicin to spontaneous brain tumors in 17 companion dogs; a comparative oncology model of human brain cancers. Methodology/Principle Findings (EGFR)minicells(Dox) were administered weekly via intravenous injection to 17 dogs with late-stage brain cancers. Biodistribution was assessed using single-photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI). Anti-tumor response was determined using MRI, and blood samples were subject to toxicology (hematology, biochemistry) and inflammatory marker analysis. Targeted, doxorubicin-loaded minicells rapidly localized to the core of brain tumors. Complete resolution or marked tumor regression (>90% reduction in tumor volume) were observed in 23.53% of the cohort, with lasting anti-tumor responses characterized by remission in three dogs for more than two years. The median overall survival was 264 days (range 49 to 973). No adverse clinical, hematological or biochemical effects were observed with repeated administration of (EGFR)minicells(Dox) (30 to 98 doses administered in 10 of the 17 dogs). Conclusions/Significance Targeted minicells loaded with doxorubicin were safely administered to dogs with late stage brain cancer and clinical activity was observed. These findings demonstrate the strong potential for clinical applications of targeted, doxorubicin-loaded minicells for the effective treatment of patients with brain cancer. On this basis, we have designed a Phase 1 clinical study of EGFR-targeted, doxorubicin-loaded minicells for effective treatment of human patients with recurrent glioblastoma.	[MacDiarmid, Jennifer A.; Pattison, Scott T.; Pattison, Stacey L.; Armstrong, Luke R.; Brahmbhatt, Vatsala N.; Smolarczyk, Katarzyna; Harrison, Matthew T.; Costa, Marylia; Mugridge, Nancy B.; Sedliarou, Ilya; Grimes, Nicholas A.; Kiss, Debra L.; Brahmbhatt, Himanshu] EnGeneIC Pty Ltd, Canc Therapeut, Sydney, NSW, Australia; [Langova, Veronika; Christensen, Neil] Small Anim Specialist Hosp, Sydney, NSW, Australia; [Bailey, Dale] Royal N Shore Hosp, Dept Nucl Med, Sydney, NSW, Australia; [Stillman, Bruce] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Hann, Christine L.; Gallia, Gary L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Gallia, Gary L.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Graham, Robert M.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Graham, Robert M.] Univ New S Wales, Sydney, NSW, Australia	Royal North Shore Hospital; University of Sydney; Cold Spring Harbor Laboratory; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Brahmbhatt, H (corresponding author), EnGeneIC Pty Ltd, Canc Therapeut, Sydney, NSW, Australia.	hbrahmbhatt@engeneic.com	Brahmbhatt, Himanshu/AAY-9997-2020; Bailey, Dale L/A-3359-2012	Sedliarou, Ilya/0000-0002-0001-2568; Christensen, Neil/0000-0003-3277-0344	EnGeneIC Pty Ltd; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER	EnGeneIC Pty Ltd; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	EnGeneIC Pty Ltd conceived, designed and funded this study. EnGeneIC Pty Ltd funded the salaries for authors JAM, STP, SLP, LRA, VNB, KS, MTH, MC, NBM, IS, NAG, DLK, HB. The specific role of these authors are articulated in the author contributions section.	ABE T, 1994, INT J CANCER, V58, P860; Afra D, 2002, LANCET, V359, P1011; Agarwal S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001888; [Anonymous], NEUROSURG FOCUS; Berens Michael E., 1999, Neoplasia (New York), V1, P107, DOI 10.1038/sj.neo.7900020; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Chen L, 2013, BBA-REV CANCER, V1836, P158, DOI 10.1016/j.bbcan.2013.04.003; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Dietrich Jorg, 2011, Expert Rev Clin Pharmacol, V4, P233, DOI 10.1586/ecp.11.1; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fokas E, 2013, BBA-REV CANCER, V1835, P61, DOI 10.1016/j.bbcan.2012.10.005; FOSTER ES, 1988, J VET INTERN MED, V2, P71, DOI 10.1111/j.1939-1676.1988.tb02796.x; Gabizon AA, 2006, J LIPOSOME RES, V16, P175, DOI 10.1080/08982100600848769; Gaillard PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082331; Gieger TL, 2000, J VET INTERN MED, V14, P277, DOI 10.1892/0891-6640(2000)014&lt;0277:TFASHE&gt;2.3.CO;2; Gordon I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000161; Groothuis DR, 2000, NEURO-ONCOLOGY, V2, P45, DOI 10.1093/neuonc/2.1.45; HEIDNER GL, 1991, J VET INTERN MED, V5, P219, DOI 10.1111/j.1939-1676.1991.tb00952.x; Heiss JD, 1996, J CLIN INVEST, V98, P1400, DOI 10.1172/JCI118927; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Juillerat-Jeanneret L, 2008, DRUG DISCOV TODAY, V13, P1099, DOI 10.1016/j.drudis.2008.09.005; Kemper EM, 2004, CANCER TREAT REV, V30, P415, DOI 10.1016/j.ctrv.2004.04.001; Kimmelman J, 2007, CANCER RES, V67, P4541, DOI 10.1158/0008-5472.CAN-06-3792; Koestner A., 2002, Tumors in domestic animals, P697, DOI 10.1002/9780470376928.ch14; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; Laquintana V, 2009, EXPERT OPIN DRUG DEL, V6, P1017, DOI 10.1517/17425240903167942; Lipsitz D, 2003, VET PATHOL, V40, P659, DOI 10.1354/vp.40-6-659; Liu Y, 2012, EXPERT OPIN DRUG DEL, V9, P671, DOI 10.1517/17425247.2012.682726; Lo Hui-Wen, 2010, Curr Mol Pharmacol, V3, P37; MacDiarmid JA, 2007, CANCER CELL, V11, P431, DOI 10.1016/j.ccr.2007.03.012; MacDiarmid JA, 2009, NAT BIOTECHNOL, V27, P643, DOI 10.1038/nbt.1547; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Muldoon LL, 2003, J NEURO-ONCOL, V65, P49, DOI 10.1023/A:1026234130830; Ong BYS, 2009, BIOMATERIALS, V30, P3189, DOI 10.1016/j.biomaterials.2009.02.030; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge WM, 2010, J DRUG TARGET, V18, P157, DOI 10.3109/10611860903548354; Pluhar GE, 2010, VACCINE, V28, P3371, DOI 10.1016/j.vaccine.2010.02.082; Rainov NG, 2000, J NEUROPATH EXP NEUR, V59, P607, DOI 10.1093/jnen/59.7.607; Ratain MJ, 2004, J CLIN ONCOL, V22, P4442, DOI 10.1200/JCO.2004.07.960; Roberts N.J., 2014, SCI TRANSL MED, V6, P249, DOI DOI 10.1126/SCITRANSLMED.3008982; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sarin H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-80; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Seki S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868345; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Syakalima M, 1998, VET QUART, V20, P18, DOI 10.1080/01652176.1998.9694829; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Taylor TE, 2012, CURR CANCER DRUG TAR, V12, P197; Veterinary Co-operative Oncology Group (VCOG), 2004, Vet Comp Oncol, V2, P195, DOI 10.1111/j.1476-5810.2004.0053b.x; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Yang Y, 2013, ACM T MULTIM COMPUT, V9, DOI 10.1145/2457450.2457456	54	49	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151832	10.1371/journal.pone.0151832	http://dx.doi.org/10.1371/journal.pone.0151832			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050167	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000373603500014
J	Yamamuro, K; Kimoto, S; Iida, J; Kishimoto, N; Nakanishi, Y; Tanaka, S; Ota, T; Makinodan, M; Kishimoto, T				Yamamuro, Kazuhiko; Kimoto, Sohei; Iida, Junzo; Kishimoto, Naoko; Nakanishi, Yoko; Tanaka, Shohei; Ota, Toyosaku; Makinodan, Manabu; Kishimoto, Toshifumi			Reduced Prefrontal Cortex Hemodynamic Response in Adults with Methamphetamine Induced Psychosis: Relevance for Impulsivity	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; OBSESSIVE-COMPULSIVE DISORDER; INHIBITORY CONTROL; BRAIN ACTIVATION; DEPENDENT INDIVIDUALS; STROOP COLOR; WORD TEST; STIMULANT PSYCHOSIS; YOUNG-CHILDREN; SCHIZOPHRENIA	Patients with methamphetamine abuse/dependence often exhibit high levels of impulsivity, which may be associated with the structural abnormalities and functional hypoactivities observed in the frontal cortex of these subjects. Although near-infrared spectroscopy (NIRS) is a simple and non-invasive method for characterizing the clinical features of various psychiatric illnesses, few studies have used NIRS to directly investigate the association between prefrontal cortical activity and inhibitory control in patients with methamphetamine-induced psychosis (MAP). Using a 24-channel NIRS system, we compared hemodynamic responses during the Stroop color-word task in 14 patients with MAP and 21 healthy controls matched for age, sex and premorbid IQ. In addition, we used the Barrett Impulsivity Scale-11 (BIS-11) to assess impulsivity between subject groups. The MAP group exhibited significantly less activation in the anterior and frontopolar prefrontal cortex accompanied by lower Stroop color-word task performance, compared with controls. Moreover, BIS-11 scores were significantly higher in the MAP group, and were negatively correlated with the hemodynamic responses in prefrontal cortex. Our data suggest that reduced hemodynamic responses in the prefrontal cortex might reflect higher levels of impulsivity in patients with MAP, providing new insights into disrupted inhibitory control observed in MAP.	[Yamamuro, Kazuhiko; Kimoto, Sohei; Kishimoto, Naoko; Nakanishi, Yoko; Tanaka, Shohei; Ota, Toyosaku; Makinodan, Manabu; Kishimoto, Toshifumi] Nara Med Univ, Sch Med, Dept Psychiat, Kashihara, Nara 634, Japan; [Iida, Junzo] Nara Med Univ, Sch Med, Fac Nursing, Kashihara, Nara 634, Japan	Nara Medical University; Nara Medical University	Kimoto, S (corresponding author), Nara Med Univ, Sch Med, Dept Psychiat, Kashihara, Nara 634, Japan.	sohei@naramed-u.ac.jp		Kimoto, Sohei/0000-0002-3148-690X				Akiyama K, 2006, ANN NY ACAD SCI, V1074, P125, DOI 10.1196/annals.1369.012; Asahi S, 2004, EUR ARCH PSY CLIN N, V254, P245, DOI 10.1007/s00406-004-0488-z; Batki SL, 2004, AM J ADDICTION, V13, P461, DOI 10.1080/10550490490512834; Bilder RM, 2002, AM J PSYCHIAT, V159, P1018, DOI 10.1176/appi.ajp.159.6.1018; Chen CK, 2003, PSYCHOL MED, V33, P1407, DOI 10.1017/S0033291703008353; Chmielewski WX, 2015, NEUROIMAGE, V112, P96, DOI 10.1016/j.neuroimage.2015.02.060; Crockett MJ, 2013, NEURON, V79, P391, DOI 10.1016/j.neuron.2013.05.028; Curran C, 2004, BRIT J PSYCHIAT, V185, P196, DOI 10.1192/bjp.185.3.196; Deng Xianhua, 2012, Shanghai Arch Psychiatry, V24, P271, DOI 10.3969/j.issn.1002-0829.2012.05.004; Ehlis AC, 2005, BIOL PSYCHOL, V69, P315, DOI 10.1016/j.biopsycho.2004.09.003; Fekete T, 2014, NEUROIMAGE, V85, P345, DOI 10.1016/j.neuroimage.2013.07.022; Goldberg TE, 1996, J CLIN PSYCHIAT, V57, P62; GOLDEN CJ, 1975, J PERS ASSESS, V39, P386, DOI 10.1207/s15327752jpa3904_10; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; Greenwald MK, 2013, ADDICT BIOL, V18, P836, DOI 10.1111/j.1369-1600.2011.00431.x; Hege MA, 2015, INT J OBESITY, V39, P353, DOI 10.1038/ijo.2014.99; Herz MI, 1997, AM J PSYCHIAT, V154, P1; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Hwang K, 2014, J NEUROSCI, V34, P9551, DOI 10.1523/JNEUROSCI.4889-13.2014; Inagaki A., 2006, JAPANESE J CLIN PSYC, V9, P1443; IWANAMI A, 1994, ACTA PSYCHIAT SCAND, V89, P428, DOI 10.1111/j.1600-0447.1994.tb01541.x; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kishimoto M, 2008, BIOL PSYCHIAT, V63, P191, DOI 10.1016/j.biopsych.2007.03.019; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Lee B, 2009, J NEUROSCI, V29, P14734, DOI 10.1523/JNEUROSCI.3765-09.2009; Leland DS, 2008, BIOL PSYCHIAT, V63, P184, DOI 10.1016/j.biopsych.2007.04.031; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Matsuzawa D, 2007, AM J PSYCHIAT, V164, P1105, DOI 10.1176/appi.ajp.164.7.1105; Mayer K, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0683-4; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Monterosso JR, 2005, DRUG ALCOHOL DEPEN, V79, P273, DOI 10.1016/j.drugalcdep.2005.02.002; Naruse Nobuya, 2015, Nihon Rinsho, V73, P1481; Navailles S, 2015, CEREB CORTEX, V25, P3167, DOI 10.1093/cercor/bhu112; Negoro H, 2010, CHILD PSYCHIAT HUM D, V41, P193, DOI 10.1007/s10578-009-0160-y; Nestor LJ, 2011, PSYCHIAT RES-NEUROIM, V194, P287, DOI 10.1016/j.pscychresns.2011.04.010; Ohmae E, 2006, NEUROIMAGE, V29, P697, DOI 10.1016/j.neuroimage.2005.08.008; Okada K, 2013, PROG NEURO-PSYCHOPH, V43, P7, DOI 10.1016/j.pnpbp.2012.11.013; Okada N, 2016, ADDICT BIOL, V21, P489, DOI 10.1111/adb.12224; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ota T, 2013, CHILD PSYCHIAT HUM D, V44, P265, DOI 10.1007/s10578-012-0323-0; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paulus MP, 2003, BIOL PSYCHIAT, V53, P65, DOI 10.1016/S0006-3223(02)01442-7; Paulus MP, 2002, NEUROPSYCHOPHARMACOL, V26, P53, DOI 10.1016/S0893-133X(01)00334-7; Payer DE, 2011, ARCH GEN PSYCHIAT, V68, P271, DOI 10.1001/archgenpsychiatry.2010.154; Prevor MB, 2005, COGNITIVE DEV, V20, P256, DOI 10.1016/j.cogdev.2005.04.001; Roberts W, 2011, ACTA PSYCHOL, V138, P419, DOI 10.1016/j.actpsy.2011.09.002; Roehr B, 2005, BRIT MED J, V331, P476, DOI 10.1136/bmj.331.7515.476; Salo R, 2002, PSYCHIAT RES, V111, P65, DOI 10.1016/S0165-1781(02)00111-7; Salo R, 2009, BIOL PSYCHIAT, V65, P706, DOI 10.1016/j.biopsych.2008.11.026; Schiffer B, 2010, BRAIN, V133, P3093, DOI 10.1093/brain/awq153; Schiller B, 2014, CEREB CORTEX, V24, P2430, DOI 10.1093/cercor/bht095; Schroeter ML, 2002, HUM BRAIN MAPP, V17, P61, DOI 10.1002/hbm.10052; Schweitzer JB, 2000, AM J PSYCHIAT, V157, P278, DOI 10.1176/appi.ajp.157.2.278; Shinba T, 2004, BIOL PSYCHIAT, V55, P154, DOI 10.1016/S0006-3223(03)00547-X; Simon SL, 2002, J ADDICT DIS, V21, P61; Simon SL, 2000, AM J ADDICTION, V9, P222; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Song YN, 2015, BEHAV BRAIN RES, V290, P187, DOI 10.1016/j.bbr.2015.04.047; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Stoeckel LE, 2013, BRAIN IMAGING BEHAV, V7, P116, DOI 10.1007/s11682-012-9201-4; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Tam A, 2015, BRAIN IMAGING BEHAV, V9, P609, DOI 10.1007/s11682-014-9323-y; Taniguchi K, 2012, J MED INVESTIG, V59, P45, DOI 10.2152/jmi.59.45; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; TREISMAN A, 1969, NATURE, V222, P437, DOI 10.1038/222437a0; TREMBLAY RE, 1994, ARCH GEN PSYCHIAT, V51, P732; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Ujike H, 2004, ANN NY ACAD SCI, V1025, P279, DOI 10.1196/annals.1316.035; Valdes IH, 2006, PSYCHIAT RES-NEUROIM, V147, P239, DOI 10.1016/j.pscychresns.2006.01.014; Villringer K, 1997, ADV EXP MED BIOL, V413, P149; Yamamuro K, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0472-3; Yang Y, 2009, MOL PSYCHIATR, V14, P561, DOI 10.1038/mp.2009.12; Zhang L, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.057012	78	11	12	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152373	10.1371/journal.pone.0152373	http://dx.doi.org/10.1371/journal.pone.0152373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050450	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500035
J	Zakeri, B; Carr, PA; Lu, TK				Zakeri, Bijan; Carr, Peter A.; Lu, Timothy K.			Multiplexed Sequence Encoding: A Framework for DNA Communication	PLOS ONE			English	Article							DIGITAL INFORMATION; STORAGE; PROTEIN; BOND	Synthetic DNA has great propensity for efficiently and stably storing non-biological information. With DNA writing and reading technologies rapidly advancing, new applications for synthetic DNA are emerging in data storage and communication. Traditionally, DNA communication has focused on the encoding and transfer of complete sets of information. Here, we explore the use of DNA for the communication of short messages that are fragmented across multiple distinct DNA molecules. We identified three pivotal points in a communication-data encoding, data transfer & data extraction-and developed novel tools to enable communication via molecules of DNA. To address data encoding, we designed DNA-based individualized keyboards (iKeys) to convert plaintext into DNA, while reducing the occurrence of DNA homopolymers to improve synthesis and sequencing processes. To address data transfer, we implemented a secret-sharing system-Multiplexed Sequence Encoding (MuSE)-that conceals messages between multiple distinct DNA molecules, requiring a combination key to reveal messages. To address data extraction, we achieved the first instance of chromatogram patterning through multiplexed sequencing, thereby enabling a new method for data extraction. We envision these approaches will enable more widespread communication of information via DNA.	[Zakeri, Bijan; Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Dept Biol Engn, Elect Res Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zakeri, Bijan; Carr, Peter A.; Lu, Timothy K.] MIT, Synthet Biol Ctr, 500 Technol Sq, Cambridge, MA 02139 USA; [Carr, Peter A.] MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02420 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Lincoln Laboratory; Massachusetts Institute of Technology (MIT)	Zakeri, B (corresponding author), MIT, Dept Elect Engn & Comp Sci, Dept Biol Engn, Elect Res Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zakeri, B; Carr, PA (corresponding author), MIT, Synthet Biol Ctr, 500 Technol Sq, Cambridge, MA 02139 USA.; Carr, PA (corresponding author), MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02420 USA.	bijan.zakeri@oxfordalumni.org; carr@ll.mit.edu			Defense Advanced Research Projects Agency under Air Force Contract [FA8721-05-C-0002]; NIH [1R01EB017755, 1DP2OD008435, 1P50GM098792]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F31ES027304, F32ES027306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008435] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency under Air Force Contract; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is sponsored by the Defense Advanced Research Projects Agency under Air Force Contract #FA8721-05-C-0002, and NIH grants 1R01EB017755, 1DP2OD008435, and 1P50GM098792.	Bancroft C, 2001, SCIENCE, V293, P1763; Blazej RG, 2006, P NATL ACAD SCI USA, V103, P7240, DOI 10.1073/pnas.0602476103; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Cox JPL, 2001, TRENDS BIOTECHNOL, V19, P247, DOI 10.1016/S0167-7799(01)01671-7; Ferguson N, 2010, CRYPTOGRAPHY ENG DES; Goldman N, 2013, NATURE, V494, P77, DOI 10.1038/nature11875; Grass RN, 2015, ANGEW CHEM INT EDIT, V54, P2552, DOI 10.1002/anie.201411378; Haughton D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-121; Heider D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-176; Kawano Tomonori, 2013, Commun Integr Biol, V6, pe23478, DOI 10.4161/cib.23478; Liss M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042465; San Millan AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6208; Sennels Lau, 2012, Artif DNA PNA XNA, V3, P109, DOI 10.4161/adna.22671; Stoddart D, 2009, P NATL ACAD SCI USA, V106, P7702, DOI 10.1073/pnas.0901054106; Tulpan D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/634832; Veggiani G, 2014, TRENDS BIOTECHNOL, V32, P506, DOI 10.1016/j.tibtech.2014.08.001; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Zakeri B, 2015, CURR OPIN CHEM BIOL, V28, P9, DOI 10.1016/j.cbpa.2015.05.020; Zakeri B, 2015, CHEMBIOCHEM, V16, P2277, DOI 10.1002/cbic.201500372; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zakeri B, 2010, J AM CHEM SOC, V132, P4526, DOI 10.1021/ja910795a	24	4	4	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152774	10.1371/journal.pone.0152774	http://dx.doi.org/10.1371/journal.pone.0152774			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050646	Green Published, gold			2022-12-26	WOS:000373603500055
J	Chen, H; Pu, JS; Liu, D; Yu, WS; Shao, YY; Yang, GW; Xiang, ZH; He, NJ				Chen, Hu; Pu, Junsong; Liu, Dan; Yu, Wansha; Shao, Yunying; Yang, Guangwei; Xiang, Zhonghuai; He, Ningjia			Anti-Inflammatory and Antinociceptive Properties of Flavonoids from the Fruits of Black Mulberry (Morus nigra L.)	PLOS ONE			English	Article							ANTIOXIDANT PROPERTIES; CHEMICAL-COMPOSITION; ALBA L.; RUBRA; EXTRACT; WOGONIN	We analyzed the anti-inflammatory and antinociceptive activities of total flavonoids (TF) found in black mulberry fruits. The TF content was 20.9 mg/g (dry weight). Two anthocyanins, cyanidin-3-O-glucoside (8.3 mg/g) and cyanidin-3-O-rutinoside (2.9 mg/g), were identified in the fruits by UPLC. The TF of black mulberry fruits had significant reducing power and radical (OH-, O-2(-), DPPH and ABTS) scavenging activities that was demonstrated in a dose-response curve. The TF had inhibitory activities on xylene-induced ear edema and carrageenan-induced paw edema in mice. In addition, TF had antinociceptive activities in the two nociceptive phases of formalin test. We used ELISA to detect the pro-inflammatory cytokines IL-1 beta, TNF-alpha, IFN-gamma, and NO in the serum of mice. These cytokines were significantly inhibited or scavenged by TF (50 and 100 mg/kg). The results demonstrated that TF of black mulberry possess anti-inflammatory and analgesic effects that might correlate to its antioxidant activities and inhibition of pro-inflammatory cytokines.	[Chen, Hu; Pu, Junsong; Liu, Dan; Yu, Wansha; Shao, Yunying; Yang, Guangwei; Xiang, Zhonghuai; He, Ningjia] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China	Southwest University - China	He, NJ (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	hejia@swu.edu.cn			National Hi-Tech Research and Development Program of China [2013AA100605-3]; Special Fund for Agro-scientific Research in Public Interest of China [201403064]; Fundamental Research Funds for Central Universities [2362014xk05]; "111" Project [B12006]	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in Public Interest of China; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); "111" Project(Ministry of Education, China - 111 Project)	This project was funded by the research grants from the National Hi-Tech Research and Development Program of China (No. 2013AA100605-3), Special Fund for Agro-scientific Research in the Public Interest of China (No. 201403064), the Fundamental Research Funds for the Central Universities (No. 2362014xk05), and the "111" Project (B12006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[陈虎 Chen Hu], 2014, [食品科学, Food Science], V35, P7; Chen JM, 2009, CHINA BREWING, P153; Chi YS, 2003, BIOCHEM PHARMACOL, V66, P1271, DOI 10.1016/S0006-2952(03)00463-5; Chou TC, 2003, ANESTH ANALG, V97, P1724, DOI 10.1213/01.ANE.0000087066.71572.3F; de Queiroz GT, 2012, FOOD CHEM TOXICOL, V50, P816, DOI 10.1016/j.fct.2011.12.014; Ercisli S, 2008, SCI HORTIC-AMSTERDAM, V116, P41, DOI 10.1016/j.scienta.2007.10.021; Ercisli S, 2007, FOOD CHEM, V103, P1380, DOI 10.1016/j.foodchem.2006.10.054; Fazio A, 2013, FOOD CHEM, V140, P817, DOI 10.1016/j.foodchem.2012.11.010; FERNANDEZLOPEZ JA, 1992, J SCI FOOD AGR, V58, P153, DOI 10.1002/jsfa.2740580127; Fletcher D, 1996, ANESTHESIOLOGY, V84, P1129, DOI 10.1097/00000542-199605000-00015; Gulcin I, 2010, INNOV FOOD SCI EMERG, V11, P210, DOI 10.1016/j.ifset.2009.07.002; Gundogdu M, 2011, SCI HORTIC-AMSTERDAM, V132, P37, DOI 10.1016/j.scienta.2011.09.035; He NJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3445; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Janisch KM, 2005, DEV OPHTHALMOL, V38, P59, DOI 10.1159/000082767; Jiang Y, 2015, FOOD CHEM, V174, P460, DOI 10.1016/j.foodchem.2014.11.083; Kowalski ML, 2015, J ALLERGY CLIN IMMUN, V136, P245, DOI 10.1016/j.jaci.2015.06.021; Lee SO, 2006, BIOCHEM BIOPH RES CO, V351, P118, DOI 10.1016/j.bbrc.2006.10.006; Li X, 2014, FOOD CHEM, V152, P531, DOI 10.1016/j.foodchem.2013.12.010; Ma Y.P, 2002, XINJIANG J TRADIT CH, V20, P83; Man SL, 2013, FOOD CHEM, V136, P513, DOI 10.1016/j.foodchem.2012.08.010; Morales-Cano D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114492; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Ozgen M, 2009, SCI HORTIC-AMSTERDAM, V119, P275, DOI 10.1016/j.scienta.2008.08.007; Gil ALAP, 2012, J ETHNOPHARMACOL, V144, P712, DOI 10.1016/j.jep.2012.10.018; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Riccioni G, 2005, EXPERT OPIN INV DRUG, V14, P1145, DOI 10.1517/13543784.14.9.1145; ROSA MD, 1971, J PHARM PHARMACOL, V23, P297, DOI 10.1111/j.2042-7158.1971.tb08661.x; Roth SH, 2012, DRUGS, V72, P873, DOI 10.2165/11633740-000000000-00000; Roubaud V, 1997, ANAL BIOCHEM, V247, P404, DOI 10.1006/abio.1997.2067; Sagnia B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103999; Sanchez-Salcedo EM, 2015, J FUNCT FOODS, V12, P399, DOI 10.1016/j.jff.2014.12.010; Santos BL, 2015, CHEM-BIOL INTERACT, V242, P123, DOI 10.1016/j.cbi.2015.07.014; Valkhoff VE, 2012, BEST PRACT RES CL GA, V26, P125, DOI 10.1016/j.bpg.2012.01.011; Wang Y, 2014, J ETHNOPHARMACOL, V151, P944, DOI 10.1016/j.jep.2013.12.003; [王元成 WANG Yuancheng], 2011, [食品科学, Food Science], V32, P135; Wang ZJ, 2009, CHIN J PUBLIC HLTH, P181; [肖更生 XIAO GengSheng], 2011, [蚕业科学, Acta Sericologica Sinica], V37, P600; Yamanishi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093818; Yoon JH, 2005, YONSEI MED J, V46, P585, DOI 10.3349/ymj.2005.46.5.585; Zhao P, 2015, J CHROMATOGR B, V1007, P8, DOI 10.1016/j.jchromb.2015.10.019	41	44	50	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153080	10.1371/journal.pone.0153080	http://dx.doi.org/10.1371/journal.pone.0153080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046026	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600066
J	Li, FH; Wang, H; Liu, JF; Lin, JB; Zeng, AB; Ai, WM; Wang, XD; Dahlgren, RA; Wang, HL				Li, Fanghui; Wang, Hui; Liu, Jinfeng; Lin, Jiebo; Zeng, Aibing; Ai, Weiming; Wang, Xuedong; Dahlgren, Randy A.; Wang, Huili			Immunotoxicity of beta-Diketone Antibiotic Mixtures to Zebrafish (Danio rerio) by Transcriptome Analysis	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; EXPRESSION; TOXICITY; MICE; METASTASIS; PATHWAY; EMBRYO; GROWTH; CELLS; MODEL	Fluoroquinolones and tetracyclines are known as beta-diketone antibiotics (DKAs) because of bearing a diketone group in their molecular structure. DKAs are the most widely used antibiotics to prevent generation of disease in humans and animals and to suppress bacterial growth in aquaculture. In recent years, overuse of DKAs has caused serious environmental risk due to their pseudo-persistence in the environment, even though their half-lives are not long. So far, no reports were concerned with the joint immunotoxicity of DKAs. Herein, we reported on the immunotoxicity of DKAs on zebrafish after a 3-month DKAs exposure using transcriptomic techniques. According to transcriptome sequencing, 10 differentially expressed genes were screened out among the genes related to KEGG pathways with high enrichment. The identified 7 genes showed to be consistent between RNA-seq and qRT-PCR. Due to DKAs exposure, the content or activity for a series of immune-related biomarkers (Complement 3, lysozyme, IgM and AKP) showed the inconsistent changing trends as compared with the control group. Histopathological observations showed that the number of goblet cells increased sharply, the columnar epithelial cells swelled, the nucleus became slender in intestinal villi, and numerous brown metachromatic granules occurred in spleens of DKAs-exposed groups. Overall, both detection of biomarkers and histopathological observation corroborated that chronic DKAs exposure could result in abnormal expression of immune genes and enzymes, and variable levels of damage to immune-related organs. These complex effects of DKAs may lead to zebrafish dysfunction and occurrence of diseases related to the immune system.	[Li, Fanghui; Liu, Jinfeng; Lin, Jiebo; Zeng, Aibing; Ai, Weiming; Wang, Huili] Wenzhou Med Univ, Sch Life Sci, Wenzhou, Peoples R China; [Wang, Hui; Wang, Xuedong; Dahlgren, Randy A.] Wenzhou Med Univ, Key Lab Watershed Sci & Hlth Zhejiang Prov, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Wang, HL (corresponding author), Wenzhou Med Univ, Sch Life Sci, Wenzhou, Peoples R China.; Wang, XD (corresponding author), Wenzhou Med Univ, Key Lab Watershed Sci & Hlth Zhejiang Prov, Wenzhou, Peoples R China.	zjuwxd@163.com; whuili@163.com	Wang, Xuedong/B-3279-2018; Wang, Huili/AAA-4941-2020	Wang, Huili/0000-0002-1359-9484; Dahlgren, Randy/0000-0002-8961-875X	National Natural Science Foundation of China [31270548, 21377100]; Natural Science Foundation of Zhejiang Province [LY15C030004, LY15B070009]; Zhejiang Provincial Xinmiao Talent Project [2015R413078]; Public Beneficial Project of Wenzhou City Sci Technol Bureau [H20150005, Y20150096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Xinmiao Talent Project; Public Beneficial Project of Wenzhou City Sci Technol Bureau	This work is jointly supported by the National Natural Science Foundation of China (31270548, and 21377100), the Natural Science Foundation of Zhejiang Province (LY15C030004 and LY15B070009), the Zhejiang Provincial Xinmiao Talent Project (2015R413078) and the Public Beneficial Project of Wenzhou City Sci & Technol Bureau (H20150005 and Y20150096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfosso F, 2001, J BIOL CHEM, V276, P1564, DOI 10.1074/jbc.M007065200; Bardin N, 1996, TISSUE ANTIGENS, V48, P531, DOI 10.1111/j.1399-0039.1996.tb02666.x; Bessone S, 1999, DEV BIOL, V214, P87, DOI 10.1006/dbio.1999.9379; Dagur PK, 2011, J AUTOIMMUN, V37, P319, DOI 10.1016/j.jaut.2011.09.003; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Driessen M, 2014, TOXICOL LETT, V230, P48, DOI 10.1016/j.toxlet.2014.06.844; Driessen M, 2013, ARCH TOXICOL, V87, P807, DOI 10.1007/s00204-013-1039-z; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hurov JB, 2001, MOL CELL BIOL, V21, P3206, DOI 10.1128/MCB.21.9.3206-3219.2001; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lindberg R, 2004, CHEMOSPHERE, V57, P1479, DOI 10.1016/j.chemosphere.2004.09.015; Meijer AH, 2005, MOL IMMUNOL, V42, P1185, DOI 10.1016/j.molimm.2004.11.014; Melvin SD, 2014, J TOXICOL ENV HEAL A, V77, P337, DOI 10.1080/15287394.2013.865107; Mulgaonkar A, 2012, EXPERT OPIN DRUG MET, V8, P553, DOI 10.1517/17425255.2012.674512; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Paul T, 2007, ENVIRON SCI TECHNOL, V41, P4720, DOI 10.1021/es070097q; Schlagbauer-Wadl H, 1999, INT J CANCER, V81, P951, DOI 10.1002/(SICI)1097-0215(19990611)81:6<951::AID-IJC18>3.0.CO;2-V; Segu L, 2008, NEUROBIOL AGING, V29, P231, DOI 10.1016/j.neurobiolaging.2006.10.014; Sheng ZG, 2013, TOXICOL APPL PHARM, V267, P74, DOI 10.1016/j.taap.2012.12.015; Shih IM, 1997, AM J PATHOL, V151, P745; Sipes NS, 2011, BIRTH DEFECTS RES C, V93, P256, DOI 10.1002/bdrc.20214; Suwa T, 2001, AM J RESP CRIT CARE, V163, P970, DOI 10.1164/ajrccm.163.4.2005132; van der Sar AM, 2009, MOL IMMUNOL, V46, P2317, DOI 10.1016/j.molimm.2009.03.024; Wang HL, 2016, ENVIRON TOXICOL, V31, P1357, DOI 10.1002/tox.22141; Wang HL, 2014, ENVIRON TOXICOL, V29, P1134, DOI 10.1002/tox.21843; Wang N, 2009, CHEMOSPHERE, V77, P1577, DOI 10.1016/j.chemosphere.2009.09.038; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P267; Wu GJ, 2004, GENE, V327, P201, DOI 10.1016/j.gene.2003.11.018; Xie SH, 1997, CANCER RES, V57, P2295; Yan XY, 2003, BLOOD, V102, P184, DOI 10.1182/blood-2002-04-1004; Yin HQ, 2006, TOXICOL SCI, V94, P206, DOI 10.1093/toxsci/kfl078; Yin XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102731; Zhang HC, 2005, ENVIRON SCI TECHNOL, V39, P4474, DOI 10.1021/es048166d; Zhang Q, 2015, ECOTOXICOLOGY, V24, P707, DOI 10.1007/s10646-015-1417-9; [张澍 ZHANG Shu], 2009, [中国实用外科杂志, Chinese Journal of Practical Surgery], V29, P395; Zhang Y, 2009, J CHIN MISDIAGN, V9, P7549; Zhang YN, 2016, ENVIRON TOXICOL, V31, P736, DOI 10.1002/tox.22087	39	13	14	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152530	10.1371/journal.pone.0152530	http://dx.doi.org/10.1371/journal.pone.0152530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046191	Green Submitted, Green Published, gold			2022-12-26	WOS:000373599600024
J	Lin, C; Chu, CM; Su, SL				Lin, Chin; Chu, Chi-Ming; Su, Sui-Lung			Epistasis Test in Meta-Analysis: A Multi-Parameter Markov Chain Monte Carlo Model for Consistency of Evidence	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; INDIVIDUAL PATIENT DATA; MISSING HERITABILITY; META-REGRESSION; ANGIOTENSIN-I; GSTM1; POLYMORPHISMS; CYP1A1; GSTT1; ALDOSTERONE	Conventional genome-wide association studies (GWAS) have been proven to be a successful strategy for identifying genetic variants associated with complex human traits. However, there is still a large heritability gap between GWAS and transitional family studies. The "missing heritability" has been suggested to be due to lack of studies focused on epistasis, also called gene-gene interactions, because individual trials have often had insufficient sample size. Meta-analysis is a common method for increasing statistical power. However, sufficient detailed information is difficult to obtain. A previous study employed a meta-regression-based method to detect epistasis, but it faced the challenge of inconsistent estimates. Here, we describe a Markov chain Monte Carlo-based method, called "Epistasis Test in Meta-Analysis" (ETMA), which uses genotype summary data to obtain consistent estimates of epistasis effects in meta-analysis. We defined a series of conditions to generate simulation data and tested the power and type I error rates in ETMA, individual data analysis and conventional meta-regression-based method. ETMA not only successfully facilitated consistency of evidence but also yielded acceptable type I error and higher power than conventional meta-regression. We applied ETMA to three real meta-analysis data sets. We found significant gene-gene interactions in the renin-angiotensin system and the polycyclic aromatic hydrocarbon metabolism pathway, with strong supporting evidence. In addition, glutathione S-transferase (GST) mu 1 and theta 1 were confirmed to exert independent effects on cancer. We concluded that the application of ETMA to real meta-analysis data was successful. Finally, we developed an R package, etma, for the detection of epistasis in meta-analysis [etma is available via the Comprehensive R Archive Network (CRAN) at https://cran.r-project.org/web/packages/etma/index.html].	[Lin, Chin; Chu, Chi-Ming; Su, Sui-Lung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chu, Chi-Ming; Su, Sui-Lung] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center	Chu, CM; Su, SL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Chu, CM; Su, SL (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	chuchiming@web.de; a131419@gmail.com	Lin, Chin/M-2832-2015	Lin, Chin/0000-0003-2337-2096; Su, Sui-Lung/0000-0003-3122-1116				Aros C, 2002, J HYPERTENS, V20, pS45; Baker WL, 2009, INT J CLIN PRACT, V63, P1426, DOI 10.1111/j.1742-1241.2009.02168.x; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Bhattacharjee P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02704; Bolt HM, 2006, CURR DRUG METAB, V7, P613, DOI 10.2174/138920006778017786; Caulfield M, 1996, HYPERTENSION, V28, P1123, DOI 10.1161/01.HYP.28.6.1123; Chen WJ, 2014, TOXICOL APPL PHARM, V279, P95, DOI 10.1016/j.taap.2014.05.011; Daniels MJ, 1997, STAT MED, V16, P1965, DOI 10.1002/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.3.CO;2-D; DEJONG JL, 1991, BIOCHEM BIOPH RES CO, V180, P15, DOI 10.1016/S0006-291X(05)81248-3; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Doran H., 2007, J STAT SOFTW, V20, P1, DOI [10.18637/jss.v020.i02, DOI 10.18637/JSS.V020.I02]; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Fang JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078707; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Hollenberg NK, 2004, KIDNEY INT, V66, P1, DOI 10.1111/j.1523-1755.2004.00701.x; Hung RJ, 2003, CARCINOGENESIS, V24, P875, DOI 10.1093/carcin/bgg026; Ioannidis JPA, 2002, AM J EPIDEMIOL, V156, P204, DOI 10.1093/aje/kwf031; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Lambert PC, 2002, J CLIN EPIDEMIOL, V55, P86, DOI 10.1016/S0895-4356(01)00414-0; Lin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124967; Lin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087604; Liu HT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000895; Liu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102372; Lodovici M, 2004, CANCER EPIDEM BIOMAR, V13, P1342; Lyman Gary H, 2005, BMC Med Res Methodol, V5, P14, DOI 10.1186/1471-2288-5-14; Mackay TFC, 2014, GENOME MED, V6, DOI 10.1186/gm561; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; Mizuiri S, 2001, KIDNEY INT, V60, P1124, DOI 10.1046/j.1523-1755.2001.0600031124.x; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Palla L, 2010, AM J EPIDEMIOL, V171, P1225, DOI 10.1093/aje/kwq051; Pawlik M, 2014, J RENIN-ANGIO-ALDO S, V15, P553, DOI 10.1177/1470320313489588; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; SEIDEGARD J, 1988, P NATL ACAD SCI USA, V85, P7293, DOI 10.1073/pnas.85.19.7293; Shaikh R, 2014, J RENIN-ANGIO-ALDO S, V15, P124, DOI 10.1177/1470320313512390; Shen YH, 2014, TUMOR BIOL, V35, P4007, DOI 10.1007/s13277-013-1524-2; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Su SL, 2014, SCI WORLD J, DOI 10.1155/2014/169798; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Udomsinprasert R, 2005, BIOCHEM J, V388, P763, DOI 10.1042/BJ20042015; Volk DE, 2003, BIOCHEMISTRY-US, V42, P1410, DOI 10.1021/bi026745u; Wei WH, 2014, NAT REV GENET, V15, P722, DOI 10.1038/nrg3747; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; WOLF G, 1993, J AM SOC NEPHROL, V3, P1531; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zhu HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106761; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	49	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152891	10.1371/journal.pone.0152891	http://dx.doi.org/10.1371/journal.pone.0152891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045371	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600044
J	Chu, ZJ; Wang, YJ; Ying, SH; Wang, XW; Feng, MG				Chu, Zhen-Jian; Wang, Yu-Jun; Ying, Sheng-Hua; Wang, Xiao-Wei; Feng, Ming-Guang			Genome-Wide Host-Pathogen Interaction Unveiled by Transcriptomic Response of Diamondback Moth to Fungal Infection	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; SCORPION NEUROTOXIN; SPODOPTERA-LITURA; GENE-EXPRESSION; VIRULENCE; PROTEASE; CUTICLE; INTEGRATION; MECHANISMS; MANAGEMENT	Genome-wide insight into insect pest response to the infection of Beauveria bassiana (fungal insect pathogen) is critical for genetic improvement of fungal insecticides but has been poorly explored. We constructed three pairs of transcriptomes of Plutella xylostella larvae at 24, 36 and 48 hours post treatment of infection (hpt(I)) and of control (hpt(C)) for insight into the host-pathogen interaction at genomic level. There were 2143, 3200 and 2967 host genes differentially expressed at 24, 36 and 48 hpt(I)/ hpt(C) respectively. These infection-responsive genes (similar to 15% of the host genome) were enriched in various immune processes, such as complement and coagulation cascades, protein digestion and absorption, and drug metabolism- cytochrome P450. Fungal penetration into cuticle and host defense reaction began at 24 hpt(I), followed by most intensive host immune response at 36 hpt(I) and attenuated immunity at 48 hpt(I). Contrastingly, 44% of fungal genes were differentially expressed in the infection course and enriched in several biological processes, such as antioxidant activity, peroxidase activity and proteolysis. There were 1636 fungal genes co-expressed during 24-48 hpt(I), including 116 encoding putative secretion proteins. Our results provide novel insights into the insect-pathogen interaction and help to probe molecular mechanisms involved in the fungal infection to the global pest.	[Chu, Zhen-Jian; Ying, Sheng-Hua; Feng, Ming-Guang] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Yu-Jun; Wang, Xiao-Wei] Zhejiang Univ, Coll Agr & Biotechnol, Inst Insect Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Feng, MG (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China.; Wang, XW (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Inst Insect Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xwwang@zju.edu.cn; mgfeng@zju.edu.cn			National Natural Science Foundation of China [31270537, 31572054, 31321063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the National Natural Science Foundation of China (Grants 31270537, 31572054 and 31321063) at http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai I, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.12501; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Da Silva WOB, 2010, FUNGAL BIOL-UK, V114, P911, DOI 10.1016/j.funbio.2010.08.007; Collette JR, 2011, CURR OPIN MICROBIOL, V14, P668, DOI 10.1016/j.mib.2011.09.007; Dissing M, 2001, EMBO J, V20, P2387, DOI 10.1093/emboj/20.10.2387; Donatti AC, 2008, CURR MICROBIOL, V56, P256, DOI 10.1007/s00284-007-9071-y; Fan YH, 2007, APPL ENVIRON MICROB, V73, P295, DOI 10.1128/AEM.01974-06; Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115; Fang WG, 2009, J INVERTEBR PATHOL, V102, P155, DOI 10.1016/j.jip.2009.07.013; Fang WG, 2005, APPL ENVIRON MICROB, V71, P363, DOI 10.1128/AEM.71.1.363-370.2005; Faria M, 2001, CROP PROT, V20, P767, DOI 10.1016/S0261-2194(01)00110-7; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; GUPTA SC, 1994, J INVERTEBR PATHOL, V64, P13, DOI 10.1006/jipa.1994.1062; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Holder DJ, 2007, MICROBIOL-SGM, V153; Hou CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091189; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim JS, 2010, FUNGAL BIOL-UK, V114, P120, DOI 10.1016/j.mycres.2009.10.011; Kirkland BH, 2004, J MED ENTOMOL, V41, P705, DOI 10.1603/0022-2585-41.4.705; LeMosy EK, 2001, P NATL ACAD SCI USA, V98, P5055, DOI 10.1073/pnas.081026598; Lewis MW, 2009, MICROBIOL-SGM, V155; Li F, 2015, FUNGAL GENET BIOL, V81, P160, DOI 10.1016/j.fgb.2014.09.006; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu YJ, 2013, APPL ENVIRON MICROB, V79, P6452, DOI 10.1128/AEM.01594-13; Lu DD, 2008, APPL MICROBIOL BIOT, V81, P515, DOI 10.1007/s00253-008-1695-8; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Montesinos-Matias R, 2011, WORLD J MICROB BIOT, V27; Pava-Ripoll M, 2008, J INVERTEBR PATHOL, V99, P220, DOI 10.1016/j.jip.2008.05.004; PENDLAND JC, 1993, J BACTERIOL, V175, P5962, DOI 10.1128/JB.175.18.5962-5969.1993; Qin Y, 2010, APPL ENVIRON MICROB, V76, P4611, DOI 10.1128/AEM.00302-10; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Shen DX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086436, 10.1371/journal.pone.0105709]; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wanchoo A, 2009, MICROBIOL-SGM, V155, P3121, DOI 10.1099/mic.0.029157-0; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; Wang CS, 2014, BIOL CONTROL, V68, P129, DOI 10.1016/j.biocontrol.2013.06.017; Wang Long-Jiang, 2010, Acta Entomologica Sinica, V53, P118; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZL, 2013, ENVIRON MICROBIOL, V15, P409, DOI 10.1111/j.1462-2920.2012.02848.x; Wang ZL, 2013, MICROB BIOTECHNOL, V6, P27, DOI 10.1111/j.1751-7915.2012.00351.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Xia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068185; Xiao GH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00483; Xie XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030298; Xie XQ, 2010, APPL MICROBIOL BIOT, V86, P1543, DOI 10.1007/s00253-010-2437-2; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhang L, 2014, BIOL CONTROL, V79, P8, DOI 10.1016/j.biocontrol.2014.08.001	57	26	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152908	10.1371/journal.pone.0152908	http://dx.doi.org/10.1371/journal.pone.0152908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043942	gold, Green Published			2022-12-26	WOS:000373592100043
J	Mateen, S; Moin, S; Khan, AQ; Zafar, A; Fatima, N				Mateen, Somaiya; Moin, Shagufta; Khan, Abdul Qayyum; Zafar, Atif; Fatima, Naureen			Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; PROTEIN CARBONYL GROUPS; LIPID-PEROXIDATION; DISEASE-ACTIVITY; GLUTATHIONE-REDUCTASE; SUPEROXIDE-DISMUTASE; DNA-DAMAGE; PLASMA; BLOOD; OXIDE	Background Rheumatoid arthritis (RA) is an autoimmune inflammatory disorder. Highly reactive oxygen free radicals are believed to be involved in the pathogenesis of the disease. In this study, RA patients were sub-grouped depending upon the presence or absence of rheumatoid factor, disease activity score and disease duration. RA Patients (120) and healthy controls (53) were evaluated for the oxidant-antioxidant status by monitoring ROS production, biomarkers of lipid peroxidation, protein oxidation and DNA damage. The level of various enzymatic and non-enzymatic antioxidants was also monitored. Correlation analysis was also performed for analysing the association between ROS and various other parameters. Methods Intracellular ROS formation, lipid peroxidation (MDA level), protein oxidation (carbonyl level and thiol level) and DNA damage were detected in the blood of RA patients. Antioxidant status was evaluated by FRAP assay, DPPH reduction assay and enzymatic (SOD, catalase, GST, GR) and non-enzymatic (vitamin C and GSH) antioxidants. Results RA patients showed a higher ROS production, increased lipid peroxidation, protein oxidation and DNA damage. A significant decline in the ferric reducing ability, DPPH radical quenching ability and the levels of antioxidants has also been observed. Significant correlation has been found between ROS and various other parameters studied. Conclusion RA patients showed a marked increase in ROS formation, lipid peroxidation, protein oxidation, DNA damage and decrease in the activity of antioxidant defence system leading to oxidative stress which may contribute to tissue damage and hence to the chronicity of the disease.	[Mateen, Somaiya; Moin, Shagufta; Fatima, Naureen] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Biochem, Aligarh, Uttar Pradesh, India; [Khan, Abdul Qayyum] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Orthoped Surg, Aligarh, Uttar Pradesh, India; [Zafar, Atif] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University	Mateen, S (corresponding author), Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Biochem, Aligarh, Uttar Pradesh, India.	smateen.amu@gmail.com	Fatima, Naureen/AFK-6203-2022; Fatima, Naureen/AAG-4508-2022	Fatima, Naureen/0000-0002-7839-8827; Fatima, Naureen/0000-0002-7839-8827				Aebi H, 1984, Methods Enzymol, V105, P121; Akyol O, 2001, JOINT BONE SPINE, V68, P311, DOI 10.1016/S1297-319X(01)00279-2; Ali AM, 2014, REV BRAS REUMATOL, P54; Altindag O, 2007, CLIN BIOCHEM, V40, P167, DOI 10.1016/j.clinbiochem.2006.10.006; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BIEMOND P, 1984, ARTHRITIS RHEUM-US, V27, P760, DOI 10.1002/art.1780270706; Bracht A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1671-1; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Buege J A, 1978, Methods Enzymol, V52, P302; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Comar JF, 2013, FREE RADICAL BIO MED, V58, P144, DOI 10.1016/j.freeradbiomed.2012.12.003; Cooke MS, 2006, CLIN CHIM ACTA, V365, P30, DOI 10.1016/j.cca.2005.09.009; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Demirbag R, 2005, CAN J CARDIOL, V21, P851; El-Barbary AM, 2011, EGYPT RHEUMATOL, V33, P179, DOI 10.1016/j.ejr.2011.07.002; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Haris ED, 1989, TXB RHEUMATOLOGY, P905; Hassan MQ, 2001, J APPL TOXICOL, V21, P69, DOI 10.1002/jat.736; Henrotin Y, 2005, OSTEOARTHR CARTILAGE, V13, P643, DOI 10.1016/j.joca.2005.04.002; Janaszewska A, 2002, SCAND J CLIN LAB INV, V62, P231, DOI 10.1080/003655102317475498; Jaswal S, 2003, CLIN CHIM ACTA, V338, P123, DOI 10.1016/j.cccn.2003.08.011; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Kalpakcioglu B, 2008, CLIN RHEUMATOL, V27, P141, DOI 10.1007/s10067-007-0746-3; Kamanh A, 2004, CELL BIOCHEM FUNCT, V22, P53, DOI 10.1002/cbf.1055; Keller A, 2004, FREE RADICAL RES, V38, P1257, DOI 10.1080/10715760400022145; KRANE SM, 1986, MED CLIN N AM, V70, P263, DOI 10.1016/S0025-7125(16)30953-1; Kundu S, 2012, FREE RADICAL RES, V46, P1482, DOI 10.3109/10715762.2012.727991; KYAW A, 1978, CLIN CHIM ACTA, V86, P153, DOI 10.1016/0009-8981(78)90128-6; Leonaviciene L, 2008, BIOLOGIJA, V54, P290, DOI DOI 10.2478/V10054-008-0059-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahajan A, 2004, J INDIAN RHEUMATOL A, V12, P139; Maki-Petaja KM, 2008, INT J CARDIOL, V129, P399, DOI 10.1016/j.ijcard.2008.02.011; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mazzetti I, 1996, INT J CLIN LAB RES, V26, P245, DOI 10.1007/BF02602957; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mulherin DM, 1996, ANN RHEUM DIS, V55, P837, DOI 10.1136/ard.55.11.837; Wendt MMN, 2015, EXP MOL PATHOL, V98, P549, DOI 10.1016/j.yexmp.2015.04.002; OLIVIERI O, 1991, J RHEUMATOL, V18, P1263; Ozgocmen S, 2006, RHEUMATOL INT, V26, P585, DOI 10.1007/s00296-005-0078-z; Ozturk HS, 1999, RHEUMATOL INT, V19, P35, DOI 10.1007/s002960050097; Renke J, 2000, FREE RADICAL BIO MED, V29, P101, DOI 10.1016/S0891-5849(00)00288-4; Reznick AZ, 1991, METHOD ENZYMOL, V233, P357; Sarban S, 2005, CLIN BIOCHEM, V38, P981, DOI 10.1016/j.clinbiochem.2005.08.003; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Seven A, 2008, CLIN BIOCHEM, V41, P538, DOI 10.1016/j.clinbiochem.2008.01.029; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Ueki Y, 1996, J RHEUMATOL, V23, P230; van der Linden MPM, 2011, ARTHRITIS RHEUM-US, V63, P37, DOI 10.1002/art.30100; VANDERHEIJDE DMFM, 1993, J RHEUMATOL, V20, P579; Vasanthi P, 2004, J INDIAN RHEUMATOL A, V12, P40; Veselinovic M, 2014, MOL CELL BIOCHEM, V391, P225, DOI 10.1007/s11010-014-2006-6; Vijayakumar D, 2006, INDIAN J CLIN BIOCHE, V21, P104, DOI 10.1007/BF02913075	54	209	223	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152925	10.1371/journal.pone.0152925	http://dx.doi.org/10.1371/journal.pone.0152925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043143	gold, Green Submitted, Green Published			2022-12-26	WOS:000373592100048
J	Nullens, S; Staessens, M; Peleman, C; Plaeke, P; Malhotra-Kumar, S; Francque, S; De Man, JG; De Winter, BY				Nullens, Sara; Staessens, Michael; Peleman, Cedric; Plaeke, Philip; Malhotra-Kumar, Surbhi; Francque, Sven; De Man, Joris G.; De Winter, Benedicte Y.			Beneficial Effects of Anti-Interleukin-6 Antibodies on Impaired Gastrointestinal Motility, Inflammation and Increased Colonic Permeability in a Murine Model of Sepsis Are Most Pronounced When Administered in a Preventive Setup	PLOS ONE			English	Article							TIGHT JUNCTION PERMEABILITY; INTERLEUKIN-6 IL-6; ANIMAL-MODELS; INTESTINAL PERMEABILITY; EPITHELIAL BARRIER; PROTEIN EXPRESSION; IMPROVES SURVIVAL; CECAL LIGATION; GUT; CYTOKINE	Background and Objectives During sepsis, gastrointestinal ileus, mucosal barrier dysfunction and bacterial translocation are accepted to be important triggers that can maintain or exacerbate the septic state. In the caecal ligation and puncture animal model of sepsis, we demonstrated that systemic and colonic interleukin-6 levels are significantly increased coinciding with an impaired colonic barrier function. We therefore aimed to study the effect of therapeutic or curative administration of anti-IL6 antibodies on overall GI motility, colonic permeability and translocation of intestinal bacteria in blood and mesenteric lymph nodes in the mouse caecal ligation and puncture model. Methods OF-1 mice were randomized to either the preventive or curative protocol, in which they received 1 mg/ kg of antibodies to interleukin-6, or its IgG isotype control solution. They subsequently underwent either the caecal ligation and puncture procedure, or sham-surgery. GI motility was assessed 48h following the procedure, as well as colonic permeability, serum and colon cytokines, colonic tight junction proteins at the mRNA level; cultures of blood and mesenteric lymph nodes were performed. Results Preventive administration of anti-interleukin-6 antibodies successfully counteracted the gastrointestinal motility disturbances and impaired colonic barrier function that could beobserved in vehicle-treated septic animals. Serum and colonic levels of proinflammatory cytokines were significantly lower when animals were preventively treated with anti-interleukin- 6 antibodies. A repetitive injection 24h later resulted in the most pronounced effects. Curative treatment significantly lowered systemic and colonic inflammation markers while the effects on transit and permeability were unfortunately no longer significant. Conclusions Caecal ligation and puncture resulted in septic ileus with an increased colonic permeability. Antibodies to interleukin-6 were able to ameliorate gastro-intestinal motility, suppress inflammation and normalize the permeability of the colonic wall, with the preventive administration combined with a repeat injection being far more efficacious than the sole preventive or curative one.	[Nullens, Sara; Staessens, Michael; Peleman, Cedric; Plaeke, Philip; Francque, Sven; De Man, Joris G.; De Winter, Benedicte Y.] Univ Antwerp, Div Gastroenterol, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium; [Malhotra-Kumar, Surbhi] Univ Antwerp, Lab Med Microbiol, B-2020 Antwerp, Belgium; [Francque, Sven] Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	De Winter, BY (corresponding author), Univ Antwerp, Div Gastroenterol, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium.	benedicte.dewinter@uantwerpen.be	De Winter, Benedicte Y/G-2616-2011	De Winter, Benedicte Y/0000-0003-0327-6304	Fund for Scientific Research (FWO), Flanders [11G7415N]; FWO [G028615N]; University of Antwerp [GOA-2013]	Fund for Scientific Research (FWO), Flanders(FWO); FWO(FWO); University of Antwerp	S. Nullens is an aspirant of the Fund for Scientific Research (FWO), Flanders (11G7415N). This work was supported financially by the FWO (G028615N), and by a GOA-2013 funding of the University of Antwerp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Anower AKMM, 2012, EUR J PHARMACOL, V688, P76, DOI 10.1016/j.ejphar.2012.05.007; Barkhausen T, 2011, CRIT CARE MED, V39, P1407, DOI 10.1097/CCM.0b013e318211ff56; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Costes LMM, 2014, AUTON NEUROSCI-BASIC, V185, P76, DOI 10.1016/j.autneu.2014.07.006; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Eadon MT, 2012, AM J PHYSIOL-RENAL, V303, pF821, DOI 10.1152/ajprenal.00023.2012; GENNARI R, 1994, ARCH SURG-CHICAGO, V129, P1191; GENNARI R, 1995, CRIT CARE MED, V23, P1945, DOI 10.1097/00003246-199512000-00002; Giannoudis PV, 2008, J TRAUMA, V65, P646, DOI 10.1097/TA.0b013e3181820d48; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Han XN, 2003, SHOCK, V19, P229, DOI 10.1097/00024382-200303000-00006; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Heylen M, 2013, INFLAMM BOWEL DIS; Kang SJ, 2015, INT IMMUNOL, V27, P21, DOI 10.1093/intimm/dxu081; Keita AV, 2010, NEUROGASTROENT MOTIL, V22, P718, DOI 10.1111/j.1365-2982.2010.01498.x; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; LANGE S, 1994, SCAND J GASTROENTERO, V29, P38, DOI 10.3109/00365529409090435; Ledeganck KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057016; Levy G, 2013, SHOCK, V39, P39, DOI 10.1097/SHK.0b013e31827b450d; Mangodt TC, 2015, PEDIATR RES, V78, P483, DOI 10.1038/pr.2015.143; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Masson S, 2014, CRIT CARE, V18, DOI 10.1186/cc13183; MATTHYS P, 1995, INFECT IMMUN, V63, P1158, DOI 10.1128/IAI.63.4.1158-1164.1995; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Nullens S, 2015, SHOCK; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Pallua N, 2003, CRIT CARE MED, V31, P1495, DOI 10.1097/01.CCM.0000065725.80882.BD; Paul R, 2003, BRAIN, V126, P1873, DOI 10.1093/brain/awg171; Pene F, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0050-3; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; SCHINDLER R, 1990, BLOOD, V75, P40; Seerden TC, 2007, NEUROGASTROENT MOTIL, V19, P856, DOI 10.1111/j.1365-2982.2007.00968.x; Stoffels B, 2013, GASTROENTEROLOGY, V22, P10; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tazuke Y, 2003, PEDIATR SURG INT, V19, P321, DOI 10.1007/s00383-003-1003-8; TILG H, 1994, BLOOD, V83, P113; van der Zanden EP, 2009, GASTROENTEROLOGY, V137, P1029, DOI 10.1053/j.gastro.2009.04.057; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Vyas D, 2005, AM J PHYSIOL-REG I, V289, pR1048, DOI 10.1152/ajpregu.00312.2005; Wang Q, 2001, AM J PHYSIOL-REG I, V281, pR1013, DOI 10.1152/ajpregu.2001.281.3.R1013; Yang RK, 2003, AM J PHYSIOL-GASTR L, V285, pG621, DOI 10.1152/ajpgi.00177.2003; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938	56	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152914	10.1371/journal.pone.0152914	http://dx.doi.org/10.1371/journal.pone.0152914			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044016	Green Published, gold			2022-12-26	WOS:000373592100044
J	Graham, BW; Tao, YQ; Dodge, KL; Thaxton, CT; Olaso, D; Young, NL; Marshall, AG; Trakselis, MA				Graham, Brian W.; Tao, Yeqing; Dodge, Katie L.; Thaxton, Carly T.; Olaso, Danae; Young, Nicolas L.; Marshall, Alan G.; Trakselis, Michael A.			DNA Interactions Probed by Hydrogen-Deuterium Exchang (HDX) Fourier Transform Ion Cyclotron Resonance Mass Spectrometry Confirm External Binding Sites on the Minichromosomal Maintenance (MCM) Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEAL MCM; HEXAMERIC HELICASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COMPLEX; STRAND; TRANSLOCATION; REPLICATION; MECHANISM; DOMAIN	The archaeal minichromosomal maintenance (MCM) helicase from Sulfolobus solfataricus (SsoMCM) is a model for understanding structural and mechanistic aspects of DNA unwinding. Although interactions of the encircled DNA strand within the central channel provide an accepted mode for translocation, interactions with the excluded strand on the exterior surface have mostly been ignored with regard to DNA unwinding. We have previously proposed an extension of the traditional steric exclusion model of unwinding to also include significant contributions with the excluded strand during unwinding, termed steric exclusion and wrapping (SEW). The SEW model hypothesizes that the displaced single strand tracks along paths on the exterior surface of hexameric helicases to protect single-stranded DNA (ssDNA) and stabilize the complex in a forward unwinding mode. Using hydrogen/deuterium exchange monitored by Fourier transform ion cyclotron resonance MS, we have probed the binding sites for ssDNA, using multiple substrates targeting both the encircled and excluded strand interactions. In each experiment, we have obtained >98.7% sequence coverage of SsoMCM from >650 peptides (5-30 residues in length) and are able to identify interacting residues on both the interior and exterior of SsoMCM. Based on identified contacts, positively charged residues within the external waist region were mutated and shown to generally lower DNA unwinding without negatively affecting the ATP hydrolysis. The combined data globally identify binding sites for ssDNA during SsoMCM unwinding as well as validating the importance of the SEW model for hexameric helicase unwinding.	[Graham, Brian W.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Tao, Yeqing; Marshall, Alan G.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Dodge, Katie L.; Thaxton, Carly T.; Olaso, Danae; Trakselis, Michael A.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA; [Young, Nicolas L.; Marshall, Alan G.] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Graham, Brian W.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Young, Nicolas L.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, One Baylor Plaza, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; Florida State University; Baylor University; State University System of Florida; Florida State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor College of Medicine	Trakselis, MA (corresponding author), One Bear Pl 97348, Waco, TX 76798 USA.	michael_trakselis@baylor.edu	Trakselis, Michael/V-3806-2019; Young, Nicolas/AAI-5242-2020	Young, Nicolas/0000-0002-3323-2815; Trakselis, Michael/0000-0001-7054-8475; Thaxton, Carly/0000-0001-9270-8708; Olaso, Danae/0000-0002-2070-6022	American Cancer Society Research Scholar Grant [RSG-11-049-01-DMC]; National Science Foundation Division of Materials Research Grant [DMR-11-57490]	American Cancer Society Research Scholar Grant(American Cancer Society); National Science Foundation Division of Materials Research Grant(National Science Foundation (NSF))	This work was supported by American Cancer Society Research Scholar Grant RSG-11-049-01-DMC (to M. A. T.) and National Science Foundation Division of Materials Research Grant DMR-11-57490 (to A. G. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aarattuthodiyil S, 2014, NUCLEIC ACIDS RES, V42, P11707, DOI 10.1093/nar/gku845; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bauer RJ, 2013, J MOL BIOL, V425, P1259, DOI 10.1016/j.jmb.2013.01.025; Berger JM, 2008, CELL, V134, DOI 10.1016/j.cell.2008.08.027; Blakney GT, 2011, INT J MASS SPECTROM, V306, P246, DOI 10.1016/j.ijms.2011.03.009; Brewster AS, 2008, P NATL ACAD SCI USA, V105, P20191, DOI 10.1073/pnas.0808037105; Costa A, 2008, EMBO J, V27, P2250, DOI 10.1038/emboj.2008.135; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Duderstadt KE, 2013, CURR OPIN STRUC BIOL, V23, P144, DOI 10.1016/j.sbi.2012.11.012; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fletcher RJ, 2006, BIOCHEMISTRY-US, V45, P462, DOI 10.1021/bi051754z; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Froelich CA, 2014, ELIFE, V3, DOI 10.7554/eLife.01993; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kazazic S, 2010, J AM SOC MASS SPECTR, V21, P550, DOI 10.1016/j.jasms.2009.12.016; Krajewski WW, 2014, NATURE, V508, P416, DOI 10.1038/nature13037; Li NN, 2015, NATURE, V524, P186, DOI 10.1038/nature14685; Liew LP, 2011, BIOCHEM J, V436, P409, DOI 10.1042/BJ20110084; Lisal J, 2006, VIROLOGY, V351, P73, DOI 10.1016/j.virol.2006.03.025; Liu W, 2008, NUCLEIC ACIDS RES, V36, P3235, DOI 10.1093/nar/gkn183; Manhart CM, 2015, J BIOL CHEM, V290, P10828, DOI 10.1074/jbc.M115.642066; Marshall AG, 1998, MASS SPECTROM REV, V17, P1, DOI 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Miller JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03433; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nevin P, 2015, DNA REPAIR, V29, P65, DOI 10.1016/j.dnarep.2015.01.012; Petojevic T, 2015, P NATL ACAD SCI USA, V112, pE249, DOI 10.1073/pnas.1422003112; Pirrone GF, 2015, ANAL CHEM, V87, P99, DOI 10.1021/ac5040242; Reynolds KA, 2015, BIOCHEMISTRY-US, V54, P4248, DOI 10.1021/acs.biochem.5b00214; Riera A, 2014, SEMIN CELL DEV BIOL, V30, P104, DOI 10.1016/j.semcdb.2014.03.008; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Sakakibara N, 2009, MOL MICROBIOL, V72, P286, DOI 10.1111/j.1365-2958.2009.06663.x; Satapathy AK, 2011, J BIOL CHEM, V286, P34468, DOI 10.1074/jbc.M111.283796; Schaub TM, 2008, ANAL CHEM, V80, P3985, DOI 10.1021/ac800386h; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Slaymaker IM, 2013, NUCLEIC ACIDS RES, V41, P3446, DOI 10.1093/nar/gkt022; Smith DL, 1997, J MASS SPECTROM, V32, P135, DOI 10.1002/(SICI)1096-9888(199702)32:2<135::AID-JMS486>3.0.CO;2-M; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; Wiedemann C, 2015, NUCLEIC ACIDS RES, V43, P2958, DOI 10.1093/nar/gkv120; Yuan ZN, 2016, NAT STRUCT MOL BIOL, V23, P217, DOI 10.1038/nsmb.3170; Zhang HM, 2009, J AM SOC MASS SPECTR, V20, P520, DOI 10.1016/j.jasms.2008.11.010; Zhang HM, 2008, ANAL CHEM, V80, P9034, DOI 10.1021/ac801417d; Zhang Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01247; Zhang Q, 2011, ANAL CHEM, V83, P7129, DOI 10.1021/ac201501z; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhang ZQ, 1997, PROTEIN SCI, V6, P2203; Zhang ZQ, 1997, TECH PROT CHEM, V8, P703, DOI 10.1016/S1080-8914(97)80069-5	53	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12467	12480		10.1074/jbc.M116.719591	http://dx.doi.org/10.1074/jbc.M116.719591			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27044751	Green Published, hybrid			2022-12-26	WOS:000378119900003
J	Burr, R; Stewart, EV; Shao, W; Zhao, S; Hannibal-Bach, HK; Ejsing, CS; Espenshade, PJ				Burr, Risa; Stewart, Emerson V.; Shao, Wei; Zhao, Shan; Hannibal-Bach, Hans Kristian; Ejsing, Christer S.; Espenshade, Peter J.			Mga2 Transcription Factor Regulates an Oxygen-responsive Lipid Homeostasis Pathway in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; SREBP CLEAVAGE; SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; MITOCHONDRIAL THIOREDOXIN; ENDOPLASMIC-RETICULUM; PH HOMEOSTASIS; FATTY-ACIDS	Eukaryotic lipid synthesis is oxygen-dependent with cholesterol synthesis requiring 11 oxygen molecules and fatty acid desaturation requiring 1 oxygen molecule per double bond. Accordingly, organisms evaluate oxygen availability to control lipid homeostasis. The sterol regulatory element-binding protein (SREBP) transcription factors regulate lipid homeostasis. In mammals, SREBP-2 controls cholesterol biosynthesis, whereas SREBP-1 controls triacylglycerol and glycerophospholipid biosynthesis. In the fission yeast Schizosaccharomyces pombe, the SREBP-2 homolog Sre1 regulates sterol homeostasis in response to changing sterol and oxygen levels. However, notably missing is an SREBP-1 analog that regulates triacylglycerol and glycerophospholipid homeostasis in response to low oxygen. Consistent with this, studies have shown that the Sre1 transcription factor regulates only a fraction of all genes up-regulated under low oxygen. To identify new regulators of low oxygen adaptation, we screened the S. pombe nonessential haploid deletion collection and identified 27 gene deletions sensitive to both low oxygen and cobalt chloride, a hypoxia mimetic. One of these genes, mga2, is a putative transcriptional activator. In the absence of mga2, fission yeast exhibited growth defects under both normoxia and low oxygen conditions. Mga2 transcriptional targets were enriched for lipid metabolism genes, and mga2 Delta cells showed disrupted triacylglycerol and glycerophospholipid homeostasis, most notably with an increase in fatty acid saturation. Indeed, addition of exogenous oleic acid to mga2 Delta cells rescued the observed growth defects. Together, these results establish Mga2 as a transcriptional regulator of triacylglycerol and glycerophospholipid homeostasis in S. pombe, analogous to mammalian SREBP-1.	[Burr, Risa; Stewart, Emerson V.; Shao, Wei; Zhao, Shan; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Hannibal-Bach, Hans Kristian; Ejsing, Christer S.] Univ Southern Denmark, VILLUM Ctr Bioanalyt Sci, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	Johns Hopkins University; University of Southern Denmark	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Physiol 107B, 725 N Wolfe St, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu	Burr, Risa/AGK-7711-2022; Ejsing, Christer S/R-5922-2016	Ejsing, Christer S./0000-0003-4963-0276; Shao, Wei/0000-0002-5966-4376; Burr, Risa/0000-0001-6851-2932	National Institutes of Health [HL077588]; VILLUM FONDEN Grant [VKR023439]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; Villum Fonden [00007363] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VILLUM FONDEN Grant(Villum Fonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Villum Fonden(Villum Fonden)	This work was supported by National Institutes of Health Grant HL077588 ( to P. J. E.) and VILLUM FONDEN Grant VKR023439 ( to C. S. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Bien CM, 2009, MOL MICROBIOL, V74, P672, DOI 10.1111/j.1365-2958.2009.06895.x; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; BLOOMFIELD DK, 1960, J BIOL CHEM, V235, P337; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Casanovas A, 2015, CHEM BIOL, V22, P412, DOI 10.1016/j.chembiol.2015.02.007; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; DuBois JC, 2016, MED MYCOL, V54, P40, DOI 10.1093/mmy/myv073; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Ferreira T, 2004, BIOCHEM J, V378, P899, DOI 10.1042/BJ20031064; Grahl N, 2012, EUKARYOT CELL, V11, P560, DOI 10.1128/EC.00031-12; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Ho JJD, 2012, J BIOL CHEM, V287, P29003, DOI 10.1074/jbc.M112.373365; Holic R, 2012, APPL MICROBIOL BIOT, V95, P179, DOI 10.1007/s00253-012-3959-6; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Husen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079736; JAHNKE L, 1983, J BACTERIOL, V155, P488, DOI 10.1128/JB.155.2.488-492.1983; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jiang YD, 2001, MOL CELL BIOL, V21, P6161, DOI 10.1128/MCB.21.18.6161-6169.2001; JOHNSON B, 1972, ANTON VAN LEE J M S, V38, P137, DOI 10.1007/BF02328085; Kandasamy P, 2004, J BIOL CHEM, V279, P36586, DOI 10.1074/jbc.M401557200; Kelley R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000488; Kim J, 2015, BIOCHEM BIOPH RES CO, V468, P606, DOI 10.1016/j.bbrc.2015.10.165; KLEIN HP, 1954, BIOCHIM BIOPHYS ACTA, V13, P591, DOI 10.1016/0006-3002(54)90382-0; Kuhl I, 2011, NUCLEIC ACIDS RES, V39, P8029, DOI 10.1093/nar/gkr511; Kwast KE, 1998, J EXP BIOL, V201, P1177; Dang K, 2015, INT J MOL SCI, V16, P6353, DOI 10.3390/ijms16036353; Lane S, 2015, EUKARYOT CELL, V14, P1114, DOI 10.1128/EC.00102-15; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Pancaldi V, 2012, G3-GENES GENOM GENET, V2, P453, DOI 10.1534/g3.111.001560; Prevorovsky M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137820; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rupaimoole R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6202; Ryuko S, 2012, MOL GENET GENOMICS, V287, P651, DOI 10.1007/s00438-012-0705-9; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; Song JY, 2006, EUKARYOT CELL, V5, P1857, DOI 10.1128/EC.00244-06; Song JY, 2008, EUKARYOT CELL, V7, P2160, DOI 10.1128/EC.00106-08; Spahr H, 2001, P NATL ACAD SCI USA, V98, P11985, DOI 10.1073/pnas.211253898; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; van den Beucken T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6203; Willger SD, 2012, EUKARYOT CELL, V11, P1557, DOI 10.1128/EC.00252-12; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yang WL, 2000, J BIOL CHEM, V275, P429, DOI 10.1074/jbc.275.1.429; Zhang SR, 1999, GENETICS, V151, P473	67	25	26	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12171	12183		10.1074/jbc.M116.723650	http://dx.doi.org/10.1074/jbc.M116.723650			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27053105	hybrid, Green Published			2022-12-26	WOS:000378092800019
J	Tanui, R; Tao, Z; Silverstein, N; Kanner, B; Grewer, C				Tanui, Rose; Tao, Zhen; Silverstein, Nechama; Kanner, Baruch; Grewer, Christof			Electrogenic Steps Associated with Substrate Binding to the Neuronal Glutamate Transporter EAAC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR GATE; NA+ BINDING; KINETICS; MECHANISM; AFFINITY; DYNAMICS; GLT-1; ELECTROSTATICS; TRANSLOCATION; DIRECTION	Glutamate transporters actively take up glutamate into the cell, driven by the co-transport of sodium ions down their transmembrane concentration gradient. It was proposed that glutamate binds to its binding site and is subsequently transported across the membrane in the negatively charged form. With the glutamate binding site being located partially within the membrane domain, the possibility has to be considered that glutamate binding is dependent on the transmembrane potential and, thus, is electrogenic. Experiments presented in this report test this possibility. Rapid application of glutamate to the wildtype glutamate transporter subtype EAAC1 (excitatory amino acid carrier 1) through photo-release from caged glutamate generated a transient inward current, as expected for the electrogenic inward movement of co-transported Na+. In contrast, glutamate application to a transporter with the mutation A334E induced transient outward current, consistent with movement of negatively charged glutamate into its binding site within the dielectric of the membrane. These results are in agreement with electrostatic calculations, predicting a valence for glutamate binding of -0.27. Control experiments further validate and rule out other possible explanations for the transient outward current. Electrogenic glutamate binding can be isolated in the mutant glutamate transporter because reactions, such as glutamate translocation and/or Na+ binding to the glutamate-bound state, are inhibited by the A334E substitution. Electrogenic glutamate binding has to be considered together with other voltage-dependent partial reactions to cooperatively determine the voltage dependence of steady-state glutamate uptake and glutamate buffering at the synapse.	[Tanui, Rose; Tao, Zhen; Grewer, Christof] SUNY Binghamton, Dept Chem, 4400 Vestal Pkwy E, Binghamton, NY 13902 USA; [Silverstein, Nechama; Kanner, Baruch] Hebrew Univ Jerusalem, Canada Fac Med, Inst Med Res Israel, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel; [Tao, Zhen] 14323 Woodcrest Dr, Rockville, MD 29853 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Hebrew University of Jerusalem	Grewer, C (corresponding author), SUNY Binghamton, Dept Chem, 4400 Vestal Pkwy E, Binghamton, NY 13902 USA.	cgrewer@binghamton.edu		TANUI, ROSE/0000-0001-6594-1854	National Science Foundation [1515028]; Binational Science Foundation (BSF) [2007051]	National Science Foundation(National Science Foundation (NSF)); Binational Science Foundation (BSF)(US-Israel Binational Science Foundation)	This work was supported by National Science Foundation Grant 1515028 (to C. G.) and Binational Science Foundation (BSF) Grant 2007051 (to C. G. and B. I. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Cater RJ, 2014, BIOPHYS J, V107, P621, DOI 10.1016/j.bpj.2014.05.046; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Diamond JS, 1997, J NEUROSCI, V17, P4672; Forster IC, 2002, PROG BIOPHYS MOL BIO, V80, P69, DOI 10.1016/S0079-6107(02)00015-9; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2000, BIOCHEMISTRY-US, V39, P2063, DOI 10.1021/bi9919652; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 1999, BIOPHYS J, V77, P727, DOI 10.1016/S0006-3495(99)76927-4; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Grewer C, 2014, BIOPHYS J, V107, P546, DOI 10.1016/j.bpj.2014.06.027; Grewer C, 2012, J BIOL CHEM, V287, P26921, DOI 10.1074/jbc.M112.364059; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Holmes WR, 1995, BIOPHYS J, V69, P1734, DOI 10.1016/S0006-3495(95)80043-3; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Li Y, 2015, J BIOL CHEM, V290, P31069, DOI 10.1074/jbc.M115.688275; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maier W, 2005, J NEUROSCI METH, V142, P1, DOI 10.1016/j.jneumeth.2004.07.006; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Mim C, 2007, BIOCHEMISTRY-US, V46, P9007, DOI 10.1021/bi7005465; Mwaura J, 2012, ACS CHEM NEUROSCI, V3, P1073, DOI 10.1021/cn300163p; Otis TS, 2000, J NEUROSCI, V20, P2749; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2010, J NEUROCHEM, V114, P565, DOI 10.1111/j.1471-4159.2010.06796.x; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Shabaneh M, 2014, J BIOL CHEM, V289, P11175, DOI 10.1074/jbc.M114.550277; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Silva JR, 2009, P NATL ACAD SCI USA, V106, P11102, DOI 10.1073/pnas.0904505106; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2000, J GEN PHYSIOL, V116, P609, DOI 10.1085/jgp.116.5.609; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104; Zhang Z, 2007, BIOCHEMISTRY-US, V46, P3872, DOI 10.1021/bi0620860	60	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11852	11864		10.1074/jbc.M116.722470	http://dx.doi.org/10.1074/jbc.M116.722470			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27044739	Green Published, hybrid			2022-12-26	WOS:000377264800034
J	Deng, AY; Chauvet, C; Menard, A				Deng, Alan Y.; Chauvet, Cristina; Menard, Annie			Alterations in Fibronectin Type III Domain Containing 1 Protein Gene Are Associated with Hypertension	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; G-BETA-GAMMA; BLOOD-PRESSURE; CRITICAL PERSPECTIVE; DAHL RATS; KNOCKOUT; RAT-CHROMOSOME-1; IDENTIFICATION; DISSECTION; CONNEXIN43	Multiple quantitative trait loci (QTLs) for blood pressure (BP) have been detected in rat models of human polygenic hypertension. Great challenges confronting us include molecular identifications of individual QTLs. We first defined the chromosome region harboring C1QTL1 to a segment of 1.9 megabases that carries 9 genes. Among them, we identified the gene encoding the fibronectin type III domain containing 1 protein (Fndc1)/activator of G protein signaling 8 (Ags8) to be the strongest candidate for C1QTL1, since numerous non-synonymous mutations are found. Moreover, the 5' Fndc1/Ags8 putative promoter contains numerous mutations that can account for its differential expression in kidneys and the heart, prominent organs in modulating BP, although the Fndc1/Ags8 protein was not detectable in these organs under our experimental conditions. This work has provided the premier evidence that Fndc1/Ags8 is a novel and strongest candidate gene for C1QTL1 without completely excluding other 8 genes in the C1QTL1-residing interval. If proven true by future in vivo function studies such as single-gene Fndc1/Ags8 congenics, transgenesis or targeted-gene modifications, it might represent a part of the BP genetic architecture that operates in the upstream position distant from the end-phase physiology of BP control, since it activates a Gbetagamma component in a signaling pathway. Its functional role could validate the concept that a QTL in itself can influence BP 'indirectly' by regulating other genes downstream in a pathway. The elucidation of the mechanisms initiated by Fndc/Ags8 variations will reveal novel insights into the BP modulation via a regulatory hierarchy.	[Deng, Alan Y.; Chauvet, Cristina; Menard, Annie] Univ Montreal, Dept Med, CRCHUM Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Deng, AY (corresponding author), Univ Montreal, Dept Med, CRCHUM Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ H3C 3J7, Canada.	alan.deng@umontreal.ca			Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	AYD received funding from Canadian Institutes of Health Research for the conduct of the experiments. CC is supported by a doctoral fellowship from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Caro C. G., 2012, MECH CIRCULATION, VSecond; Chauvet C, 2013, HUM MOL GENET, V22, P4451, DOI 10.1093/hmg/ddt294; Chauvet C, 2011, J HYPERTENS, V29, P1320, DOI 10.1097/HJH.0b013e32834705e4; Clemitson JR, 2007, CIRC RES, V100, P992, DOI 10.1161/01.RES.0000261961.41889.9c; Cowley AW, 2008, HYPERTENSION, V52, P777, DOI 10.1161/HYPERTENSIONAHA.107.092858; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Deng AY, 2007, HUM MOL GENET, V16, pR195, DOI 10.1093/hmg/ddm126; Deng AY, 2007, HYPERTENSION, V49, P740, DOI 10.1161/01.HYP.0000259105.09235.56; Deng AY, 2015, J HYPERTENS, V33, P669, DOI 10.1097/HJH.0000000000000479; Deng AY, 2013, PHYSIOL GENOMICS, V45, P1196, DOI 10.1152/physiolgenomics.00165.2013; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Haefliger JA, 1999, ARTERIOSCL THROM VAS, V19, P1615, DOI 10.1161/01.ATV.19.7.1615; Haefliger JA, 2006, J CLIN INVEST, V116, P405, DOI 10.1172/JCI23327; Joe B, 2003, J HYPERTENS, V21, P2077, DOI 10.1097/00004872-200311000-00017; Jones MB, 2004, MOL INTERV, V4, P200, DOI 10.1124/mi.4.4.4; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Liao Y, 2001, P NATL ACAD SCI USA, V98, P9989, DOI 10.1073/pnas.171305298; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2009, J BIOL CHEM, V284, P31431, DOI 10.1074/jbc.M109.014068; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Yagil C, 2005, CIRC RES, V96, P617, DOI 10.1161/01.RES.0000160556.52369.61	28	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0151399	10.1371/journal.pone.0151399	http://dx.doi.org/10.1371/journal.pone.0151399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064407	Green Published, Green Submitted, gold			2022-12-26	WOS:000373891000002
J	Kroll, AJ; Jones, JE; Stringer, AB; Meekins, DJ				Kroll, Andrew J.; Jones, Jay E.; Stringer, Angela B.; Meekins, Douglas J.			Multistate Models Reveal Long-Term Trends of Northern Spotted Owls in the Absence of a Novel Competitor	PLOS ONE			English	Article							SITE OCCUPANCY DYNAMICS; BARRED OWLS; MULTIPLE STATES; HABITAT; POPULATIONS; CLIMATE; OREGON; WASHINGTON; CALIFORNIA; RANGE	Quantifying spatial and temporal variability in population trends is a critical aspect of successful management of imperiled species. We evaluated territory occupancy dynamics of northern spotted owls (Strix occidentalis caurina), California, USA, 1990-2014. The study area possessed two unique aspects. First, timber management has occurred for over 100 years, resulting in dramatically different forest successional and structural conditions compared to other areas. Second, the barred owl (Strix varia), an exotic congener known to exert significant negative effects on spotted owls, has not colonized the study area. We used a Bayesian dynamic multistate model to evaluate if territory occupancy of reproductive spotted owls has declined as in other study areas. The state-space approach for dynamic multistate modeling imputes the number of territories for each nesting state and allows for the estimation of longer-term trends in occupied or reproductive territories from longitudinal studies. The multistate approach accounts for different detection probabilities by nesting state (to account for either inherent differences in detection or for the use of different survey methods for different occupancy states) and reduces bias in state assignment. Estimated linear trends in the number of reproductive territories suggested an average loss of approximately one half territory per year (-0.55, 90% CRI: -0.76, -0.33), in one management block and a loss of 0.15 per year (-0.15, 90% CRI: -0.24, -0.07), in another management block during the 25 year observation period. Estimated trends in the third management block were also negative, but substantial uncertainty existed in the estimate (-0.09, 90% CRI: -0.35, 0.17). Our results indicate that the number of territories occupied by northern spotted owl pairs remained relatively constant over a 25 year period (-0.07, 90% CRI: -0.20, 0.05; -0.01, 90% CRI: -0.19, 0.16; -0.16, 90% CRI: -0.40, 0.06). However, we cannot exclude small-to-moderate declines or increases in paired territory numbers due to uncertainty in our estimates. Collectively, we conclude spotted owl pair populations on this landscape managed for commercial timber production appear to be more stable and do not show sharp year-over-year declines seen in both managed and unmanaged landscapes with substantial barred owl colonization and persistence. Continued monitoring of reproductive territories can determine whether recent declines continue or whether trends reverse as they have on four previous occasions. Experimental investigations to evaluate changes to spotted owl occupancy dynamics when barred owl populations are reduced or removed entirely can confirm the generality of this conclusion.	[Kroll, Andrew J.; Jones, Jay E.] Weyerhaeuser, Fed Way, Washington, DC USA; [Stringer, Angela B.] Fire Mt Consulting LLC, Vancouver, WA USA; [Meekins, Douglas J.] Campbell Global LLC, Cathlamet, WA USA		Kroll, AJ (corresponding author), Weyerhaeuser, Fed Way, Washington, DC USA.	aj.kroll@weyerhaeuser.com	Kroll, Andrew/ABB-3724-2020	Kroll, Andrew/0000-0001-7747-830X	Hawthorne Timber Company; Usal Redwood Forest Company; Weyerhaeuser	Hawthorne Timber Company; Usal Redwood Forest Company; Weyerhaeuser	Surveys were funded by Hawthorne Timber Company and Usal Redwood Forest Company. Data compilation and analysis were unfunded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funders provided support in the form of salaries for authors (AS, DM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Weyerhaeuser provided support in the form of salaries for authors (AK, JJ). The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2010, R LANG ENV STAT COMP; Anthony R. G., 2006, WILDLIFE MONOGRAPHS, V163; Bailey LL, 2009, BIOL CONSERV, V142, P2983, DOI 10.1016/j.biocon.2009.07.028; CAREY AB, 1992, ECOL MONOGR, V62, P223, DOI 10.2307/2937094; Dugger KM, 2016, CONDOR, V118, P57, DOI 10.1650/CONDOR-15-24.1; Dugger KM, 2011, ECOL APPL, V21, P2459, DOI 10.1890/10-2142.1; Farber SL, 2012, J WILDLIFE MANAGE, V76, P1145, DOI 10.1002/jwmg.368; Fish U.S., 2012, EXPT REM BARR OWLS B; Forsman E.D., 1983, PNWGTR162 USDA FOR S; Forsman E.D., 1984, WILDLIFE MONOGR, V87, P64; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; Franklin J. F., 1973, NATURAL VEGETATION O; Gelman A., 2004, BAYESIAN DATA ANAL; Glenn EM, 2011, J WILDLIFE MANAGE, V75, P1279, DOI 10.1002/jwmg.177; Herter DR, 2000, J RAPTOR RES, V34, P279; Kelly EG, 2003, CONDOR, V105, P45, DOI 10.1650/0010-5422(2003)105[45:ABODSO]2.0.CO;2; Kroll AJ, 2010, J WILDLIFE MANAGE, V74, P1264, DOI 10.2193/2009-429; Kuehl R. O., 1999, DESIGN EXPT STAT PRI, V2nd; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; Nichols JD, 2007, ECOLOGY, V88, P1395, DOI 10.1890/06-1474; Olson GS, 2005, J WILDLIFE MANAGE, V69, P918, DOI 10.2193/0022-541X(2005)069[0918:MOSODF]2.0.CO;2; Olson GS, 2004, J WILDLIFE MANAGE, V68, P1039, DOI 10.2193/0022-541X(2004)068[1039:MDPONS]2.0.CO;2; Pavlacky DC, 2012, J WILDLIFE MANAGE, V76, P154, DOI 10.1002/jwmg.245; Plummer M., 2003, PROC 3 INT WORK DIST, P1; Rosenberg DK, 2003, CAN J ZOOL, V81, P1715, DOI 10.1139/Z03-167; Sawyer J. O., 2000, REDWOOD FOREST, P39; Su Y-S, R2JAGS PACKAGE RUNNI; TAYLOR AL, 1976, CONDOR, V78, P560, DOI 10.2307/1367110; Thomas JW, 1990, CONSERVATION STRATEG; U.S. Fish and Wildlife Service, 2004, NO SPOTT OWL 5 YEAR; United States Department of Agriculture, 1988, SPOTT OWLS INV MON H; United States Fish and Wildlife Service, 1992, PROT SURV PROP MAN A, V17; United States Fish and Wildlife Service, 2011, PROT SURV PROP MAN A; US Fish and Wildlife Service, 1990, FED REGISTER, V55, P26114; Western Regional Climate Center, FORT BRAGG 5 N; Yackulic CB, 2014, ECOLOGY, V95, P265, DOI 10.1890/13-0012.1	40	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152888	10.1371/journal.pone.0152888	http://dx.doi.org/10.1371/journal.pone.0152888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065016	Green Published, gold, Green Submitted			2022-12-26	WOS:000373891000022
J	Said, EA; Al-Reesi, I; Al-Riyami, M; Al-Naamani, K; Al-Sinawi, S; Al-Balushi, MS; Koh, CY; Al-Busaidi, JZ; Idris, MA; Al-Jabri, AA				Said, Elias A.; Al-Reesi, Iman; Al-Riyami, Marwa; Al-Naamani, Khalid; Al-Sinawi, Shadia; Al-Balushi, Mohammed S.; Koh, Crystal Y.; Al-Busaidi, Juma Z.; Idris, Mohamed A.; Al-Jabri, Ali A.			A Potential Inhibitory Profile of Liver CD68(+) Cells during HCV Infection as Observed by an Increased CD80 and PD-L1 but Not CD86 Expression	PLOS ONE			English	Article							CD8(+) T-CELLS; CHRONIC HEPATITIS; MACROPHAGE APOPTOSIS; DUCTULAR REACTION; KUPFFER CELLS; CTLA-4; RESPONSES; MICROPARTICLES; INDUCTION; CYTOKINES	Aim The lack of potent innate immune responses during HCV infection might lead to a delay in initiating adaptive immune responses. Kupffer cells (KCs) and liver-infiltrating monocytes/ macrophages (CD68(+) cells) are essential to establish effective anti-HCV responses. They express co-stimulatory molecules, CD80 and CD86. CD86 upregulation induces activator responses that are then potentially regulated by CD80. The relative levels of expression of CD80, CD86 and the inhibitory molecule, PD-L1, on CD68(+) cells modulate T cell activation. A few studies have explored CD80 and PD-L1 expression on KCs and infiltrating monocytes/ macrophages in HCV-infected livers, and none investigated CD86 expression in these cells. These studies have identified these cells based on morphology only. We investigated the stimulatory/ inhibitory profile of CD68(+) cells in HCV-infected livers based on the balance of CD80, CD86 and PD-L1 expression. Methods CD80, CD86 and PD-L1 expression by CD68(+) cells in the lobular and portal areas of the liver of chronic HCV-infected (n = 16) and control (n = 14) individuals was investigated using double staining immunohistochemistry. Results The count of CD68(+) KCs in the lobular areas of the HCV-infected livers was lower than that in the control (p = 0.041). The frequencies of CD68(+)CD80(+) cells and CD68(+)PD-L1(+) cells in both lobular and total areas of the liver were higher in HCV-infected patients compared with those in the control group (p = 0.001, 0.031 and 0.007 respectively). Moreover, in the lobular areas of the HCV-infected livers, the frequency of CD68(+)CD80(+) cells was higher than that of CD68(+)CD86(+) and CD68(+)PD-L1(+) cells. In addition, the frequencies of CD68(+)CD80(+) and CD68(+)CD86(+) cells were higher in the lobular areas than the portal areas. Conclusions Our results show that CD68(+) cells have an inhibitory profile in the HCV-infected livers. This might help explain the delayed T cell response and viral persistence during HCV infection.	[Said, Elias A.; Al-Reesi, Iman; Al-Balushi, Mohammed S.; Koh, Crystal Y.; Al-Busaidi, Juma Z.; Idris, Mohamed A.; Al-Jabri, Ali A.] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, POB 35,Code 123, Muscat, Oman; [Al-Riyami, Marwa; Al-Sinawi, Shadia] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Pathol, POB 35,Code 123, Muscat, Oman; [Al-Naamani, Khalid] Armed Forces Hosp, Dept Med, Muscat, Oman	Sultan Qaboos University; Sultan Qaboos University	Said, EA (corresponding author), Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, POB 35,Code 123, Muscat, Oman.	elias.said@gmail.com	Said, Elias/AAY-5557-2020					Boing AN, 2008, PLATELETS, V19, P96, DOI 10.1080/09537100701777295; Boltjes A, 2014, J HEPATOL, V61, P660, DOI 10.1016/j.jhep.2014.04.026; Burgio VL, 1998, HEPATOLOGY, V27, P1600, DOI 10.1002/hep.510270620; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5; Flynn JK, 2011, J VIRAL HEPATITIS, V18, P549, DOI 10.1111/j.1365-2893.2010.01335.x; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Gadd VL, 2013, LIVER INT, V33, P569, DOI 10.1111/liv.12050; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Huber LC, 2007, APOPTOSIS, V12, P363, DOI 10.1007/s10495-006-0622-7; Jeffery LE, 2014, IMMUNOLOGY, V143, P142; Kassel R, 2009, HEPATOLOGY, V50, P1625, DOI 10.1002/hep.23173; Kong LQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059771, 10.1371/journal.pone.0078275]; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Lim EJ, 2014, J GEN VIROL, V95, P2204, DOI 10.1099/vir.0.065862-0; Liu BS, 2011, J LEUKOCYTE BIOL, V89, P981, DOI 10.1189/jlb.1210680; Manzotti CN, 2006, EUR J IMMUNOL, V36, P1413, DOI 10.1002/eji.200535170; McGuinness PH, 2000, GUT, V46, P260, DOI 10.1136/gut.46.2.260; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Mochizuki K, 1997, HEPATOLOGY, V25, P713, DOI 10.1002/hep.510250337; Munteanu F, 2014, 2014 INTERNATIONAL CONFERENCE ON OPTIMIZATION OF ELECTRICAL AND ELECTRONIC EQUIPMENT (OPTIM), P756, DOI 10.1109/OPTIM.2014.6850917; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Reiser M, 1997, J HEPATOL, V26, P471, DOI 10.1016/S0168-8278(97)80409-6; Riezu-Boj JI, 2011, J HEPATOL, V54, P422, DOI 10.1016/j.jhep.2010.07.014; Romo-Tena J, 2013, AUTOIMMUN REV, V12, P1171, DOI 10.1016/j.autrev.2013.07.002; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Sangro B, 2013, J HEPATOL, V59, P81, DOI 10.1016/j.jhep.2013.02.022; Sansom DM, 2000, IMMUNOLOGY, V101, P169, DOI 10.1046/j.1365-2567.2000.00121.x; Shin EC, 2011, GASTROENTEROLOGY, V141, P686, DOI 10.1053/j.gastro.2011.05.006; Thimme R, 2012, FEMS MICROBIOL REV, V36, P663, DOI 10.1111/j.1574-6976.2011.00319.x; Wang ZQ, 2001, IMMUNOLOGY, V102, P331, DOI 10.1046/j.1365-2567.2001.01171.x; Xaus J, 2000, BLOOD, V95, P3823; Yadav D, 2007, MOL IMMUNOL, V44, P2616, DOI 10.1016/j.molimm.2006.12.008; Zhang Q, 2014, J IMMUNOL, V192, P2913, DOI 10.4049/jimmunol.1302951	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153191	10.1371/journal.pone.0153191	http://dx.doi.org/10.1371/journal.pone.0153191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065104	Green Published, Green Submitted, gold			2022-12-26	WOS:000373891000035
J	Fuchsl, AM; Reber, SO				Fuechsl, Andrea M.; Reber, Stefan O.			Chronic Psychosocial Stress and Negative Feedback Inhibition: Enhanced Hippocampal Glucocorticoid Signaling despite Lower Cytoplasmic GR Expression	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; RAT-BRAIN; MALE-MICE; HPA AXIS; CORTICOSTERONE; RECEPTOR; PITUITARY; PROTEIN	Chronic subordinate colony housing (CSC), a pre-clinically validated mouse model for chronic psychosocial stress, results in increased basal and acute stress-induced plasma adrenocorticotropic hormone (ACTH) levels. We assessed CSC effects on hippocampal glucocorticoid (GC) receptor (GR), mineralocorticoid receptor (MR), and FK506 binding protein (FKBP51) expression, acute heterotypic stressor-induced GR translocation, as well as GC effects on gene expression and cell viability in isolated hippocampal cells. CSC mice showed decreased GR mRNA and cytoplasmic protein levels compared with single-housed control (SHC) mice. Basal and acute stress-induced nuclear GR protein expression were comparable between CSC and SHC mice, as were MR and FKBP51 mRNA and/or cytoplasmic protein levels. In vitro the effect of corticosterone (CORT) on hippocampal cell viability and gene transcription was more pronounced in CSC versus SHC mice. In summary, CSC mice show an, if at all, increased hippocampal GC signaling capacity despite lower cytoplasmic GR protein expression, making negative feedback deficits in the hippocampus unlikely to contribute to the increased ACTH drive following CSC.	[Fuechsl, Andrea M.; Reber, Stefan O.] Univ Regensburg, Dept Behav & Mol Neurobiol, D-93053 Regensburg, Germany; [Fuechsl, Andrea M.; Reber, Stefan O.] Univ Ulm, Clin Psychosomat Med & Psychotherapy, Lab Mol Psychosomat, D-89081 Ulm, Germany	University of Regensburg; Ulm University	Reber, SO (corresponding author), Univ Ulm, Clin Psychosomat Med & Psychotherapy, Lab Mol Psychosomat, D-89081 Ulm, Germany.	stefan.reber@uniklinik-ulm.de			Deutsche Forschungsgemeinschaft/German Research Foundation [DFG-RE 2911/5-1]; German Research Foundation [DFG-RE 2911/5-1]	Deutsche Forschungsgemeinschaft/German Research Foundation(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft/German Research Foundation to SOR, DFG-RE 2911/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to N. Grunwald, N. Uschold-Schmidt, D. Langgartner, S. Peters, C. Stangl and V. Kufner for excellent technical and experimental assistance. Furthermore, the authors are grateful to the German Research Foundation for funding (DFG-RE 2911/5-1).	Adzic M, 2009, J ENDOCRINOL, V202, P87, DOI 10.1677/JOE-08-0509; Bartolomucci A, 2003, BRAIN RES BULL, V62, P173, DOI 10.1016/j.brainresbull.2003.09.009; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Conway-Campbell BL, 2010, J NEUROENDOCRINOL, V22, P1093, DOI 10.1111/j.1365-2826.2010.02051.x; Datson NA, 2008, EUR J PHARMACOL, V583, P272, DOI 10.1016/j.ejphar.2007.11.070; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; deLeon MJ, 1997, J CLIN ENDOCR METAB, V82, P3251, DOI 10.1210/jc.82.10.3251; DRAGUNOW M, 1985, EPILEPSIA, V26, P480, DOI 10.1111/j.1528-1157.1985.tb05684.x; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; ELLIOTT EM, 1992, J NEUROCHEM, V59, P1033, DOI 10.1111/j.1471-4159.1992.tb08345.x; ELLIOTT EM, 1993, BRAIN RES, V602, P84, DOI 10.1016/0006-8993(93)90245-I; Forray MI, 2004, BRAIN RES REV, V47, P145, DOI 10.1016/j.brainresrev.2004.07.011; Fuchsl AM, 2014, ENDOCRINOLOGY, V155, P117, DOI 10.1210/en.2013-1742; Fuchsl AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084161; Fuchsl AM, 2013, STRESS, V16, P461, DOI 10.3109/10253890.2013.793303; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Herman JP, 2006, BEHAV BRAIN RES, V174, P215, DOI 10.1016/j.bbr.2006.05.035; Hill MN, 2011, J NEUROSCI, V31, P10506, DOI 10.1523/JNEUROSCI.0496-11.2011; HUTCHISON KA, 1993, ANN NY ACAD SCI, V684, P35, DOI 10.1111/j.1749-6632.1993.tb32269.x; HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1; JOELS M, 1992, TRENDS NEUROSCI, V15, P25, DOI 10.1016/0166-2236(92)90345-9; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; Karst H, 2005, J NEUROPHYSIOL, V94, P3479, DOI 10.1152/jn.00143.2005; Kellendonk C, 2002, BRAIN RES BULL, V57, P73, DOI 10.1016/S0361-9230(01)00638-4; Kitraki E, 1999, NEUROENDOCRINOLOGY, V69, P331, DOI 10.1159/000054435; KOVACS KJ, 1988, BRAIN RES, V474, P205, DOI 10.1016/0006-8993(88)90435-0; Kudielka BM, 2006, BIOL PSYCHOL, V72, P147, DOI 10.1016/j.biopsycho.2005.09.001; Kumar R, 2008, BIOL-TARGETS THER, V2, P845; LANDFIELD PW, 1992, J NEUROBIOL, V23, P1247, DOI 10.1002/neu.480230914; Langgartner D, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00018; Lee T, 2009, NEUROREPORT, V20, P1554, DOI 10.1097/WNR.0b013e328332bb09; Martinez-Claros M, 2013, J CHEM NEUROANAT, V48-49, P23, DOI 10.1016/j.jchemneu.2013.01.001; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; MILLER AH, 1992, BIOL PSYCHIAT, V32, P850, DOI 10.1016/0006-3223(92)90175-Y; MOGUILEWSKY M, 1980, J STEROID BIOCHEM, V12, P309, DOI 10.1016/0022-4731(80)90285-X; Moosavi M, 2008, NEUROENDOCRINOLOGY, V88, P293, DOI 10.1159/000150441; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Peters S, 2012, STRESS, V15, P403, DOI 10.3109/10253890.2011.631232; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Retana-Marquez S, 2003, PSYCHONEUROENDOCRINO, V28, P207, DOI 10.1016/S0306-4530(02)00017-3; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; SAPOLSKY RM, 1988, BRAIN RES, V453, P367, DOI 10.1016/0006-8993(88)90180-1; SAPOLSKY RM, 1984, ENDOCRINOLOGY, V114, P287, DOI 10.1210/endo-114-1-287; Schmidt D, 2010, BRAIN BEHAV IMMUN, V24, P1097, DOI 10.1016/j.bbi.2010.04.014; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; Singewald GM, 2009, STRESS, V12, P58, DOI 10.1080/10253890802042082; SPENCER RL, 1991, BRAIN RES, V549, P236, DOI 10.1016/0006-8993(91)90463-6; SPENCER RL, 1990, NEUROENDOCRINOLOGY, V52, P481, DOI 10.1159/000125632; Spiga F, 2011, J PSYCHOPHARMACOL, V25, P211, DOI 10.1177/0269881109348175; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; Torner L, 2009, J NEUROSCI, V29, P1826, DOI 10.1523/JNEUROSCI.3178-08.2009; Tritos N, 1999, NEUROENDOCRINOLOGY, V69, P324, DOI 10.1159/000054434; Uschold-Schmidt N, 2012, PSYCHONEUROENDOCRINO; Uschold-Schmidt N, 2013, J ENDOCRINOL, V218, P193, DOI 10.1530/JOE-13-0027; Vallone D, 1997, EMBO J, V16, P5310, DOI 10.1093/emboj/16.17.5310; Wagner KV, 2012, NEUROPSYCHOPHARMACOL; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Weiser MJ, 2011, J NEUROENDOCRINOL, V23, P1231, DOI 10.1111/j.1365-2826.2011.02217.x; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200	65	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153164	10.1371/journal.pone.0153164	http://dx.doi.org/10.1371/journal.pone.0153164			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27057751	gold, Green Published, Green Submitted			2022-12-26	WOS:000373604800019
J	Bernardi, A; Nikolaou, A; Meneghesso, A; Morosinotto, T; Chachuat, B; Bezzo, F				Bernardi, Andrea; Nikolaou, Andreas; Meneghesso, Andrea; Morosinotto, Tomas; Chachuat, BenoOt; Bezzo, Fabrizio			High-Fidelity Modelling Methodology of Light-Limited Photosynthetic Production in Microalgae	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; ALGAL PHOTOSYNTHESIS; MECHANISTIC MODEL; FLUID-DYNAMICS; GROWTH; PHOTOINHIBITION; IDENTIFIABILITY; DESIGN; PHYTOPLANKTON; OPTIMIZATION	Reliable quantitative description of light-limited growth in microalgae is key to improving the design and operation of industrial production systems. This article shows how the capability to predict photosynthetic processes can benefit from a synergy between mathematical modelling and lab-scale experiments using systematic design of experiment techniques. A model of chlorophyll fluorescence developed by the authors [Nikolaou et al., J Biotechnol 194: 91-99, 2015] is used as starting point, whereby the representation of non-photochemical-quenching (NPQ) process is refined for biological consistency. This model spans multiple time scales ranging from milliseconds to hours, thus calling for a combination of various experimental techniques in order to arrive at a sufficiently rich data set and determine statistically meaningful estimates for the model parameters. The methodology is demonstrated for the microalga Nannochloropsis gaditana by combining pulse amplitude modulation (PAM) fluorescence, photosynthesis rate and antenna size measurements. The results show that the calibrated model is capable of accurate quantitative predictions under a wide range of transient light conditions. Moreover, this work provides an experimental validation of the link between fluorescence and photosynthesis-irradiance (PI) curves which had been theoricized.	[Bernardi, Andrea; Bezzo, Fabrizio] Univ Padua, Dept Ind Engn, CAPE Lab, Padua, Italy; [Bernardi, Andrea; Bezzo, Fabrizio] Univ Padua, Dept Ind Engn, PAR Lab, Padua, Italy; [Nikolaou, Andreas; Chachuat, BenoOt] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, Ctr Proc Syst Engn, London SW7 2AZ, England; [Meneghesso, Andrea; Morosinotto, Tomas] Univ Padua, Dept Biol, PAR Lab, Padua, Italy	University of Padua; University of Padua; Imperial College London; University of Padua	Bezzo, F (corresponding author), Univ Padua, Dept Ind Engn, CAPE Lab, Padua, Italy.; Bezzo, F (corresponding author), Univ Padua, Dept Ind Engn, PAR Lab, Padua, Italy.	fabrizio.bezzo@unipd.it	Chachuat, Benoit/AAT-7654-2021; Chachuat, Benoit/J-6899-2012; Morosinotto, Tomas/AAC-3188-2019	Chachuat, Benoit/0000-0003-4780-9686; Chachuat, Benoit/0000-0003-4780-9686; Morosinotto, Tomas/0000-0002-0803-7591; Bezzo, Fabrizio/0000-0003-1561-0584; Bernardi, Andrea/0000-0002-8102-2759; Meneghesso, Andrea/0000-0002-8970-8739	European Research Council (BIOLEAP) [309485]; University of Padova [CPDR147230]; Ministero dell'Istruzione, dell'Universita e della Ricerca project PRIN [2012XSAWYM]; European Research Council (DOP-ECOS) [PCIG09-GA-2011-293953]; PRIN "Improving biofuels and high added value molecules production from unicellular algae" [2012XSAWYM]	European Research Council (BIOLEAP); University of Padova; Ministero dell'Istruzione, dell'Universita e della Ricerca project PRIN; European Research Council (DOP-ECOS); PRIN "Improving biofuels and high added value molecules production from unicellular algae"	TM gratefully acknowledges financial support by the European Research Council (https://erc.europa.eu) starting grant 309485 (BIOLEAP). AB and FB gratefully acknowledge the University of Padova for financial support under project prot. CPDR147230. FB and TM gratefully acknowledge Ministero dell'Istruzione, dell'Universita e della Ricerca (http://www.istruzione.it) for financial support by project PRIN 2012 prot. 2012XSAWYM. AN and BC gratefully acknowledge financial support by the European Research Council (https://erc.europa.eu) career integration grant PCIG09-GA-2011-293953 (DOP-ECOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TM gratefully acknowledges financial support by ERC starting grant 309485 (BIOLEAP). AB and FB gratefully acknowledge the University of Padova for financial support under project "A model-based approach to enhance light use efficiency in the industrial production of microalgae" (prot. CPDR147230). FB and TM gratefully acknowledge financial support by project PRIN 2012 "Improving biofuels and high added value molecules production from unicellular algae" (prot. 2012XSAWYM). AN and BC gratefully acknowledge financial support by ERC career integration grant PCIG09-GA-2011-293953 (DOP-ECOS).	Adesanya VO, 2014, BIORESOURCE TECHNOL, V157, P293, DOI 10.1016/j.biortech.2014.01.032; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Bellu G, 2007, COMPUT METH PROG BIO, V88, P52, DOI 10.1016/j.cmpb.2007.07.002; Bernard O, 2016, ADV BIOCHEM ENG BIOT, V153, P59, DOI 10.1007/10_2014_287; Bernard O, 2012, BIORESOURCE TECHNOL, V123, P520, DOI 10.1016/j.biortech.2012.07.022; Bernard O, 2011, J PROCESS CONTR, V21, P1378, DOI 10.1016/j.jprocont.2011.07.012; Bernardi A, 2014, IND ENG CHEM RES, V53, P6738, DOI 10.1021/ie500523z; Bernardi A, 2015, COMPUT-AIDED CHEM EN, V37, P2483; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Chakrabarty A, 2013, WIRES SYST BIOL MED, V5, P181, DOI 10.1002/wsbm.1204; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Falkowski P. G., 1997, AQUATIC PHOTOSYNTHES, V256; Franceschini G, 2008, CHEM ENG SCI, V63, P4846, DOI 10.1016/j.ces.2007.11.034; Galvanin F, 2013, J PHARMACOKINET PHAR, V40, P451, DOI 10.1007/s10928-013-9321-5; Garcia-Camacho F, 2012, J THEOR BIOL, V304, P1, DOI 10.1016/j.jtbi.2012.03.021; Han BP, 2000, J PLANKTON RES, V22, P865, DOI 10.1093/plankt/22.5.865; Hartmann P., 2014, 19 WORLD C INT FED A; Huot Y, 2010, DEVEL APPL PHYCOL, V4, P31, DOI 10.1007/978-90-481-9268-7_3; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; KIEFER J, 1959, J ROY STAT SOC B, V21, P272; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P234, DOI 10.1016/0006-3002(56)90003-8; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Nauha EK, 2013, CHEM ENG J, V229, P559, DOI 10.1016/j.cej.2013.06.065; Nikolaou A, J THEOR BIO IN PRESS; Nikolaou A, 2015, J BIOTECHNOL, V194, P91, DOI 10.1016/j.jbiotec.2014.12.001; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Pinnola A, 2013, PLANT CELL, V25, P3519, DOI 10.1105/tpc.113.114538; Quinn J, 2011, BIORESOURCE TECHNOL, V102, P5083, DOI 10.1016/j.biortech.2011.01.019; Rubio FC, 2003, BIOTECHNOL BIOENG, V81, P459, DOI 10.1002/bit.10492; Simionato D, 2013, BIOPHYS CHEM, V182, P71, DOI 10.1016/j.bpc.2013.06.017; Simionato D, 2013, EUKARYOT CELL, V12, P665, DOI 10.1128/EC.00363-12; Suggett DJ, 2003, EUR J PHYCOL, V38, P371, DOI 10.1080/09670260310001612655; Walter E, 1997, COMMUN CONTR ENG, V8; Wu XX, 2001, CHEM ENG SCI, V56, P3527, DOI 10.1016/S0009-2509(01)00048-3	37	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152387	10.1371/journal.pone.0152387	http://dx.doi.org/10.1371/journal.pone.0152387			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055271	Green Published, gold			2022-12-26	WOS:000373608000018
J	Kuo, KL; Su, YF; Wu, CH; Tsai, CY; Chang, CH; Lin, CL; Tsai, TH				Kuo, Keng-Liang; Su, Yu-Feng; Wu, Chieh-Hsin; Tsai, Cheng-Yu; Chang, Chih-Hui; Lin, Chih-Lung; Tsai, Tai-Hsin			Assessing the Intraoperative Accuracy of Pedicle Screw Placement by Using a Bone-Mounted Miniature Robot System through Secondary Registration	PLOS ONE			English	Article							LUMBAR SPINE; FIXATION; GUIDANCE	Introduction Pedicle screws are commonly employed to restore spinal stability and correct deformities. The Renaissance robotic system was developed to improve the accuracy of pedicle screw placement. Purpose In this study, we developed an intraoperative classification system for evaluating the accuracy of pedicle screw placements through secondary registration. Furthermore, we evaluated the benefits of using the Renaissance robotic system in pedicle screw placement and postoperative evaluations. Finally, we examined the factors affecting the accuracy of pedicle screw implantation. Results Through use of the Renaissance robotic system, the accuracy of Kirschner-wire (K-wire) placements deviating <3 mm from the planned trajectory was determined to be 98.74%. According to our classification system, the robot-guided pedicle screw implantation attained an accuracy of 94.00% before repositioning and 98.74% after repositioning. However, the malposition rate before repositioning was 5.99%; among these placements, 4.73% were immediately repositioned using the robot system and 1.26% were manually repositioned after a failed robot repositioning attempt. Most K-wire entry points deviated caudally and laterally. Conclusion The Renaissance robotic system offers high accuracy in pedicle screw placement. Secondary registration improves the accuracy through increasing the precision of the positioning; moreover, intraoperative evaluation enables immediate repositioning. Furthermore, the K-wire tends to deviate caudally and laterally from the entry point because of skiving, which is characteristic of robot-assisted pedicle screw placement.	[Su, Yu-Feng; Tsai, Cheng-Yu; Chang, Chih-Hui; Lin, Chih-Lung] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Kuo, Keng-Liang; Wu, Chieh-Hsin; Lin, Chih-Lung; Tsai, Tai-Hsin] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Kuo, Keng-Liang; Su, Yu-Feng; Wu, Chieh-Hsin; Tsai, Cheng-Yu; Chang, Chih-Hui; Lin, Chih-Lung; Tsai, Tai-Hsin] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Lin, Chih-Lung; Tsai, Tai-Hsin] Kaohsiung Med Univ, Dept Neurosurg, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Lin, CL (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan.; Lin, CL; Tsai, TH (corresponding author), Kaohsiung Med Univ, Dept Neurosurg, Kaohsiung, Taiwan.	chihlung1@yahoo.com; geet810224@yahoo.com.tw		Kuo, Keng-Liang/0000-0001-7353-0967; Su, Yu-feng/0000-0003-0355-3981				Boos N, 1997, Eur Spine J, V6, P2, DOI 10.1007/BF01676569; Devito DP, 2010, SPINE, V35, P2109, DOI 10.1097/BRS.0b013e3181d323ab; DICK WT, 1988, CLIN ORTHOP RELAT R, P70; Hamill CL, 1996, SPINE, V21, P1241, DOI 10.1097/00007632-199605150-00020; Hu XB, 2013, EUR SPINE J, V22, P661, DOI 10.1007/s00586-012-2499-1; Kantelhardt S, 2011, EUR SPINE J, V20, P860, DOI 10.1007/s00586-011-1729-2; Kim YJ, 2004, SPINE, V29, P333, DOI 10.1097/01.BRS.0000109983.12113.9B; Kosmopoulos V, 2007, SPINE, V32, pE111, DOI 10.1097/01.brs.0000254048.79024.8b; Lee GW, 2015, SPINE J, V15, P1519, DOI 10.1016/j.spinee.2015.02.038; Lieberman IH, 2006, NEUROSURGERY, V59, P641, DOI 10.1227/01.NEU.0000229055.00829.5B; Lieberman IH, 2012, J SPINAL DISORD TECH, V25, P241, DOI 10.1097/BSD.0b013e318218a5ef; Lonstein JE, 1999, J BONE JOINT SURG AM, V81A, P1519, DOI 10.2106/00004623-199911000-00003; Pechlivanis I, 2009, SPINE, V34, P392, DOI 10.1097/BRS.0b013e318191ed32; Ringel F, 2012, SPINE, V37, pE496, DOI 10.1097/BRS.0b013e31824b7767; Roser F, 2013, NEUROSURGERY, V72, pA12, DOI 10.1227/NEU.0b013e318270d02c; Schizas C, 2012, ACTA ORTHOP BELG, V78, P240; SUK SI, 1995, SPINE, V20, P1399, DOI 10.1097/00007632-199506000-00012; Togawa D, 2007, NEUROSURGERY, V60, P129, DOI 10.1227/01.NEU.0000249257.16912.AA; YAHIRO MA, 1994, SPINE, V19, pS2297	19	41	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153235	10.1371/journal.pone.0153235	http://dx.doi.org/10.1371/journal.pone.0153235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054360	Green Submitted, Green Published, gold			2022-12-26	WOS:000373608000107
J	Wang, ZK; Wang, J; Liu, J; Ying, SH; Peng, XJ; Feng, MG				Wang, Zhi-Kang; Wang, Jie; Liu, Jing; Ying, Sheng-Hua; Peng, Xiao-Jun; Feng, Ming-Guang			Proteomic and Phosphoproteomic Insights into a Signaling Hub Role for Cdc14 in Asexual Development and Multiple Stress Responses in Beauveria bassiana	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MITOTIC EXIT; ASPERGILLUS-NIDULANS; TRICHODERMA-REESEI; SECRETOME ANALYSIS; PHOSPHATASE CDC14; ITRAQ; PHOSPHORYLATION; QUANTITATION; ENZYMES	Cdc14 is a dual-specificity phosphatase that regulates nuclear behavior by dephosphorylating phosphotyrosine and phosphoserine/phosphothreonine in fungi. Previously, Cdc14 was shown to act as a positive regulator of cytokinesis, asexual development and multiple stress responses in Beauveria bassiana, a fungal insect pathogen. This study seeks to gain deep insight into a pivotal role of Cdc14 in the signaling network of B. bassiana by analyzing the Cdc14-specific proteome and phosphoproteome generated by the 8-plex iTRAQ labeling and MS/MS analysis of peptides and phosphopeptides. Under normal conditions, 154 proteins and 86 phosphorylation sites in 67 phosphoproteins were upregulated in Delta cdc14 versus wild-type, whereas 117 proteins and 85 phosphorylation sites in 58 phosphoproteins were significantly downregulated. Co-cultivation of.cdc14 with NaCl (1 M), H2O2 (3 mM) and Congo red (0.15 mg/ml) resulted in the upregulation /downregulation of 23/63, 41/39 and 79/79 proteins and of 127/112, 52/47 and 105/226 phosphorylation sites in 85/92, 45/36 and 79/146 phosphoproteins, respectively. Bioinformatic analyses revealed that Cdc14 could participate in many biological and cellular processes, such as carbohydrate metabolism, glycerophospholipid metabolism, the MAP Kinase signaling pathway, and DNA conformation, by regulating protein expression and key kinase phosphorylation in response to different environmental cues. These indicate that in B. bassiana, Cdc14 is a vital regulator of not only protein expression but also many phosphorylation events involved in developmental and stress-responsive pathways. Fourteen conserved and novel motifs were identified in the fungal phosphorylation events.	[Wang, Zhi-Kang; Wang, Jie; Liu, Jing; Ying, Sheng-Hua; Feng, Ming-Guang] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China; [Peng, Xiao-Jun] Jingjie PTM Biolabs Hangzhou Co Ltd, Hangzhou 310018, Zhejiang, Peoples R China	Zhejiang University	Feng, MG (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China.	mgfeng@zju.edu.cn			National Natural Science foundation of China [31572054, 31270537, 31321063]; Jingjie PTM Biolabs (Hangzhou) Co., Ltd.	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Jingjie PTM Biolabs (Hangzhou) Co., Ltd.	The study was financially supported by the National Natural Science foundation of China (Grant Nos.: 31572054, 31270537 and 31321063) at http://www.nsfc.gov.cn/. The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, but Jingjie PTM Biolabs (Hangzhou) Co., Ltd. provided support in the form of salaries for a co-author (XJP) who carried out the iTRAQ labeling and MS/MS analysis only upon a service contract without any other interest.	Adav SS, 2015, J PROTEOMICS, V119, P154, DOI 10.1016/j.jprot.2015.02.007; Adav SS, 2013, J PROTEOMICS, V83, P180, DOI 10.1016/j.jprot.2013.03.023; Adav SS, 2010, J PROTEOME RES, V9, P3932, DOI 10.1021/pr100148j; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Cagas SE, 2011, ANTIMICROB AGENTS CH, V55, P146, DOI 10.1128/AAC.00884-10; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087948; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Clemente-Blanco A, 2006, J CELL SCI, V119, P1130, DOI 10.1242/jcs.02820; Cueille N, 2001, J CELL SCI, V114, P2649; Dumitrescu TP, 2002, CELL CYCLE, V1, P304, DOI 10.4161/cc.1.5.147; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Fong AMVA, 2003, MOL MICROBIOL, V50, P487, DOI 10.1046/j.1365-2958.2003.03735.x; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Geymonat M, 2002, CURR BIOL, V12, pR482, DOI 10.1016/S0960-9822(02)00963-6; Gouw JW, 2010, MOL CELL PROTEOMICS, V9, P11, DOI 10.1074/mcp.R900001-MCP200; Hall MC, 2008, J BIOL CHEM, V283, P10396, DOI 10.1074/jbc.M710011200; Hynes MJ, 2010, EUKARYOT CELL, V9, P1039, DOI 10.1128/EC.00080-10; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Manavalan A, 2011, J PROTEOMICS, V75, P642, DOI 10.1016/j.jprot.2011.09.001; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; Mocciaro A, 2010, J CELL SCI, V123, P2867, DOI 10.1242/jcs.074815; Parrou JL, 1999, YEAST, V15, P191, DOI 10.1002/(SICI)1097-0061(199902)15:3<191::AID-YEA358>3.0.CO;2-O; Pierce A, 2008, MOL CELL PROTEOMICS, V7, P853, DOI 10.1074/mcp.M700251-MCP200; Pottiez G, 2012, J PROTEOME RES, V11, P3774, DOI 10.1021/pr300414z; Ramsubramaniam N, 2014, PROTEOMICS, V14, P2454, DOI 10.1002/pmic.201400063; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Smits HP, 2000, YEAST, V16, P1325, DOI 10.1002/1097-0061(200010)16:14<1325::AID-YEA627>3.0.CO;2-E; Solar T, 2008, APPL MICROBIOL BIOT, V78, P613, DOI 10.1007/s00253-007-1339-4; Taylor RD, 2008, PROTEOMICS, V8, P2256, DOI 10.1002/pmic.200700610; Trautmann S, 2005, CURR BIOL, V15, P1384, DOI 10.1016/j.cub.2005.06.039; Valadi A, 2004, J BIOL CHEM, V279, P39677, DOI 10.1074/jbc.M403310200; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wang J, 2016, ENVIRON MICROBIOL, V18, P1037, DOI 10.1111/1462-2920.13197; Wang J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03086; Wang ZL, 2013, ENVIRON MICROBIOL, V15, P409, DOI 10.1111/j.1462-2920.2012.02848.x; Wiese S, 2007, PROTEOMICS, V7, P340, DOI 10.1002/pmic.200600422; Xiao GH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00483; Xie XQ, 2013, ENVIRON MICROBIOL, V15, P447, DOI 10.1111/j.1462-2920.2012.02871.x; Xie XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030298; Xiong Y, 2014, FUNGAL GENET BIOL, V72, P21, DOI 10.1016/j.fgb.2014.05.005; Yuste-Rojas M, 2000, MOL GEN GENET, V263, P60, DOI 10.1007/PL00008676; Zakrzewska A, 2003, APPL ENVIRON MICROB, V69, P4383, DOI 10.1128/AEM.69.8.4383-4389.2003; Zhang SZ, 2011, APPL ENVIRON MICROB, V77, P2676, DOI 10.1128/AEM.02747-10	51	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153007	10.1371/journal.pone.0153007	http://dx.doi.org/10.1371/journal.pone.0153007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055109	gold, Green Published			2022-12-26	WOS:000373608000064
J	Fukuyoshi, S; Kometani, M; Watanabe, Y; Hiratsuka, M; Yamaotsu, N; Hirono, S; Manabe, N; Takahashi, O; Oda, A				Fukuyoshi, Shuichi; Kometani, Masaharu; Watanabe, Yurie; Hiratsuka, Masahiro; Yamaotsu, Noriyuki; Hirono, Shuichi; Manabe, Noriyoshi; Takahashi, Ohgi; Oda, Akifumi			Molecular Dynamics Simulations to Investigate the Influences of Amino Acid Mutations on Protein Three-Dimensional Structures of Cytochrome P450 2D6.1, 2, 10, 14A, 51, and 62	PLOS ONE			English	Article							CYP2D6 ALLELIC VARIANTS; FUNCTIONAL-CHARACTERIZATION; NATURAL VARIANT; WILD-TYPE; SUPERFAMILY; SEQUENCES; GENETICS; ENZYMES; DRUGS; P450S	Many natural mutants of the drug metabolizing enzyme cytochrome P450 (CYP) 2D6 have been reported. Because the enzymatic activities of many mutants are different from that of the wild type, the genetic polymorphism of CYP2D6 plays an important role in drug metabolism. In this study, the molecular dynamics simulations of the wild type and mutants of CYP2D6, CYP2D6.1, 2, 10, 14A, 51, and 62 were performed, and the predictions of static and dynamic structures within them were conducted. In the mutant CYP2D6.10, 14A, and 61, dynamic properties of the F-G loop, which is one of the components of the active site access channel of CYP2D6, were different from that of the wild type. The F-G loop acted as the "hatch" of the channel, which was closed in those mutants. The structure of CYP2D6.51 was not converged by the simulation, which indicated that the three-dimensional structure of CYP2D6.51 was largely different from that of the wild type. In addition, the intramolecular interaction network of CYP2D6.10, 14A, and 61 was different from that of the wild type, and it is considered that these structural changes are the reason for the decrease or loss of enzymatic activities. On the other hand, the static and dynamic properties of CYP2D6.2, whose activity was normal, were not considerably different from those of the wild type.	[Fukuyoshi, Shuichi; Kometani, Masaharu; Watanabe, Yurie; Oda, Akifumi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan; [Hiratsuka, Masahiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Yamaotsu, Noriyuki; Hirono, Shuichi] Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan; [Manabe, Noriyoshi; Takahashi, Ohgi] Tohoku Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan; [Oda, Akifumi] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan	Kanazawa University; Tohoku University; Kitasato University; Tohoku Medical & Pharmaceutical University; Osaka University	Oda, A (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.; Oda, A (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	oda@p.kanazawa-u.ac.jp	Hiratsuka, Masahiro/AAO-8082-2020; Fukuyoshi, Shuichi/D-8388-2015; Yamaotsu, Noriyuki/AAW-2545-2020	Hiratsuka, Masahiro/0000-0002-3767-7686; Fukuyoshi, Shuichi/0000-0002-9015-0920; Yamaotsu, Noriyuki/0000-0002-4302-1085	Japan Society for the Promotion of Science [26460034, 15H01064]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for scientific research [26460034] and [15H01064] from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertilsson L, 2002, BRIT J CLIN PHARMACO, V53, P111, DOI 10.1046/j.0306-5251.2001.01548.x; Case DA, 2012, AMBER 12; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Waal PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108607; GOTOH O, 1992, J BIOL CHEM, V267, P83; Handa K, 2014, DRUG METAB PHARMACOK, V29, P52, DOI 10.2133/dmpk.DMPK-13-RG-044; Ito Y, 2008, J MOL GRAPH MODEL, V26, P947, DOI 10.1016/j.jmgm.2007.07.004; Klein K, 2007, DRUG METAB DISPOS, V35, P1247, DOI 10.1124/dmd.107.015149; Kobayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096789; Masuda K, 2005, CHIRALITY, V17, P37, DOI 10.1002/chir.20092; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Muroi Y, 2014, DRUG METAB PHARMACOK, V29, P360, DOI 10.2133/dmpk.DMPK-14-RG-014; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Niwa T, 2004, MOL BRAIN RES, V129, P117, DOI 10.1016/j.molbrainres.2004.06.030; Oda A, 2005, J COMPUT CHEM, V26, P818, DOI 10.1002/jcc.20221; Oda A, 2004, PHARM RES, V21, P2270, DOI 10.1007/s11095-004-7680-8; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakuyama K, 2008, DRUG METAB DISPOS, V36, P2460, DOI 10.1124/dmd.108.023242; Shaik S., 2005, CYTOCHROME P450 STRU, P45, DOI DOI 10.1007/0-387-27447-2_2; Teh LK, 2012, DRUG METAB PHARMACOK, V27, P55, DOI 10.2133/dmpk.DMPK-11-RV-121; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Wolkers J, 1998, AQUAT TOXICOL, V44, P103, DOI 10.1016/S0166-445X(98)00063-0	25	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152946	10.1371/journal.pone.0152946	http://dx.doi.org/10.1371/journal.pone.0152946			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046024	Green Submitted, Green Published, gold			2022-12-26	WOS:000373599600051
J	Ji, JZ; Liu, JD; Liang, PP; Zhang, AD				Ji, Junzhong; Liu, Jinduo; Liang, Peipeng; Zhang, Aidong			Learning Effective Connectivity Network Structure from fMRI Data Based on Artificial Immune Algorithm	PLOS ONE			English	Article							BAYESIAN NETWORKS; CAUSAL DISCOVERY; BRAIN; MODEL	Many approaches have been designed to extract brain effective connectivity from functional magnetic resonance imaging (fMRI) data. However, few of them can effectively identify the connectivity network structure due to different defects. In this paper, a new algorithm is developed to infer the effective connectivity between different brain regions by combining artificial immune algorithm (AIA) with the Bayes net method, named as AIAEC. In the proposed algorithm, a brain effective connectivity network is mapped onto an antibody, and four immune operators are employed to perform the optimization process of antibodies, including clonal selection operator, crossover operator, mutation operator and suppression operator, and finally gets an antibody with the highest K2 score as the solution. AIAEC is then tested on Smith's simulated datasets, and the effect of the different factors on AIAEC is evaluated, including the node number, session length, as well as the other potential confounding factors of the blood oxygen level dependent (BOLD) signal. It was revealed that, as contrast to other existing methods, AIAEC got the best performance on the majority of the datasets. It was also found that AIAEC could attain a relative better solution under the influence of many factors, although AIAEC was differently affected by the aforementioned factors. AIAEC is thus demonstrated to be an effective method for detecting the brain effective connectivity.	[Ji, Junzhong; Liu, Jinduo] Beijing Univ Technol, Coll Comp Sci & Technol, Beijing Municipal Key Lab Multimedia & Intelligen, Beijing, Peoples R China; [Liang, Peipeng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing Key Lab MRI & Brain Informat, Beijing, Peoples R China; [Zhang, Aidong] SUNY Buffalo, Dept Comp Sci & Engn, Buffalo, NY 14260 USA	Beijing University of Technology; Capital Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Liang, PP (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing Key Lab MRI & Brain Informat, Beijing, Peoples R China.	p.p.liang@163.com	Ji, Junzhong/GLU-8838-2022		NSFC Research Program [61375059, 61332016, 61473196]; National "973" Key Basic Research Program of China [2014CB744601]; Specialized Research Fund for the Doctoral Program of Higher Education [20121103110031]; Beijing Municipal Education Research Plan key project (Beijing Municipal Fund Class B) [KZ201410005004]; Div Of Information & Intelligent Systems [1218393] Funding Source: National Science Foundation	NSFC Research Program(National Natural Science Foundation of China (NSFC)); National "973" Key Basic Research Program of China(National Basic Research Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Beijing Municipal Education Research Plan key project (Beijing Municipal Fund Class B); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was partly supported by the NSFC Research Program (61375059, 61332016, 61473196), the National "973" Key Basic Research Program of China (2014CB744601), the Specialized Research Fund for the Doctoral Program of Higher Education (20121103110031), and the Beijing Municipal Education Research Plan key project (Beijing Municipal Fund Class B) (KZ201410005004).	Chickering D. M., 2003, Journal of Machine Learning Research, V3, P507, DOI 10.1162/153244303321897717; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Dasgupta D, 2003, IEEE C EVOL COMPUTAT, P123, DOI 10.1109/CEC.2003.1299565; Dasgupta D, 2011, APPL SOFT COMPUT, V11, P1574, DOI 10.1016/j.asoc.2010.08.024; Dauwels J, 2010, NEUROIMAGE, V49, P668, DOI 10.1016/j.neuroimage.2009.06.056; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Heckerman D, 2008, STUD COMPUT INTELL, V156, P33; Hofmeyr SA, 2000, EVOL COMPUT, V8, P443, DOI 10.1162/106365600568257; Hyvarinen A, 2013, J MACH LEARN RES, V14, P111; Ide JS, 2014, INT J APPROX REASON, V55, P23, DOI 10.1016/j.ijar.2013.03.013; Li KM, 2009, COMPUT MED IMAG GRAP, V33, P131, DOI 10.1016/j.compmedimag.2008.10.011; McIntosh A.R., 1994, HUM BRAIN MAPP, V2, P2, DOI DOI 10.1002/HBM.460020104; Meek C., 1995, P 11 C UNC ART INT, P403; Mumford JA, 2014, NEUROIMAGE, V86, P573, DOI 10.1016/j.neuroimage.2013.10.020; Patel RS, 2006, HUM BRAIN MAPP, V27, P267, DOI 10.1002/hbm.20182; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Rajapakse JC, 2007, NEUROIMAGE, V37, P749, DOI 10.1016/j.neuroimage.2007.06.003; Ramsey J, 2006, P 22 C UNC ART INT, P401; Ramsey JD, 2010, NEUROIMAGE, V49, P1545, DOI 10.1016/j.neuroimage.2009.08.065; Richardson TS, 1996, AUTOMATED DISCOVERY; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Shimizu S, 2008, J STAT PLAN INFER, V138, P3483, DOI 10.1016/j.jspi.2006.01.017; Shimizu S, 2006, J MACH LEARN RES, V7, P2003; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Wu X, 2014, NEURAL COMPUT APPL, V24, P91, DOI 10.1007/s00521-013-1465-0; Wu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134361; Xu LL, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00125; Zhang JJ, 2008, ARTIF INTELL, V172, P1873, DOI 10.1016/j.artint.2008.08.001; Zobay O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120123	34	10	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152600	10.1371/journal.pone.0152600	http://dx.doi.org/10.1371/journal.pone.0152600			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045295	gold, Green Published			2022-12-26	WOS:000373599600028
J	Hamaguchi-Hamada, K; Kurumata-Shigeto, M; Minobe, S; Fukuoka, N; Sato, M; Matsufuji, M; Koizumi, O; Hamada, S				Hamaguchi-Hamada, Kayoko; Kurumata-Shigeto, Mami; Minobe, Sumiko; Fukuoka, Nozomi; Sato, Manami; Matsufuji, Miyuki; Koizumi, Osamu; Hamada, Shun			Thrombospondin Type-1 Repeat Domain-Containing Proteins Are Strongly Expressed in the Head Region of Hydra	PLOS ONE			English	Article							SUPPRESSION SUBTRACTIVE HYBRIDIZATION; METAZOAN HYDRA; GENE FAMILY; NERVE RING; HYPOSTOME; ORGANIZER; MOLECULES; SYSTEMS; ROLES; AXIS	The head region of Hydra, the hypostome, is a key body part for developmental control and the nervous system. We herein examined genes specifically expressed in the head region of Hydra oligactis using suppression subtractive hybridization (SSH) cloning. A total of 1414 subtracted clones were sequenced and found to be derived from at least 540 different genes by BLASTN analyses. Approximately 25% of the subtracted clones had sequences encoding thrombospondin type-1 repeat (TSR) domains, and were derived from 17 genes. We identified 11 TSR domain-containing genes among the top 36 genes that were the most frequently detected in our SSH library. Whole-mount in situ hybridization analyses confirmed that at least 13 out of 17 TSR domain-containing genes were expressed in the hypostome of Hydra oligactis. The prominent expression of TSR domain-containing genes suggests that these genes play significant roles in the hypostome of Hydra oligactis.	[Hamaguchi-Hamada, Kayoko; Kurumata-Shigeto, Mami; Matsufuji, Miyuki; Hamada, Shun] Fukuoka Womens Univ, Int Coll Arts & Sci, Dept Food & Hlth Sci, Fukuoka, Japan; [Minobe, Sumiko; Fukuoka, Nozomi; Sato, Manami; Koizumi, Osamu] Fukuoka Womens Univ, Int Coll Arts & Sci, Dept Environm Sci, Fukuoka, Japan		Hamada, S (corresponding author), Fukuoka Womens Univ, Int Coll Arts & Sci, Dept Food & Hlth Sci, Fukuoka, Japan.	hamada@fwu.ac.jp			KAKENHI [24570089]; Japan Society for the Promotion of Science; Japan Society for the Promotion of Science (JSPS; KAKENHI) [24570089]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS; KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by KAKENHI Grant Number 24570089, The Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/ index.html, to SH. The funder had roles in study design, decision to publish and preparation of the manuscript.; This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS; KAKENHI Grant Number 24570089).	Adams JC, 2000, DEV DYNAM, V218, P280; Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Altincicek B, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-6; Augustin R, 2006, DEV BIOL, V296, P62, DOI 10.1016/j.ydbio.2006.04.003; Bielen H, 2007, DEVELOPMENT, V134, P4187, DOI 10.1242/dev.010173; BODE H, 1973, ROUX ARCH DEV BIOL, V171, P269, DOI 10.1007/BF00577725; Bode HR, 2012, INT J DEV BIOL, V56, P473, DOI 10.1387/ijdb.113448hb; Bode HR, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000463; Bosch TCG, 2007, DEV BIOL, V303, P421, DOI 10.1016/j.ydbio.2006.12.012; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Broun M, 2002, DEVELOPMENT, V129, P875; CAMPBELL RD, 1967, J MORPHOL, V121, P19, DOI 10.1002/jmor.1051210103; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; DAVIS LE, 1968, J EXP ZOOL, V167, P295, DOI 10.1002/jez.1401670305; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Gee L, 2010, DEV BIOL, V340, P116, DOI 10.1016/j.ydbio.2009.12.036; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Genikhovich G, 2006, DEV BIOL, V289, P466, DOI 10.1016/j.ydbio.2005.10.028; Grens A, 1996, DEV BIOL, V180, P473, DOI 10.1006/dbio.1996.0321; GRIMMELIKHUIJZEN CJP, 1985, CELL TISSUE RES, V241, P171, DOI 10.1007/BF00214639; Guder C, 2007, TSR CONTAINING PROTE; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Khalturin K, 2008, PLOS BIOL, V6, P2436, DOI 10.1371/journal.pbio.0060278; KINNAMON JC, 1981, J MORPHOL, V168, P321, DOI 10.1002/jmor.1051680308; KOIZUMI O, 1992, J COMP NEUROL, V326, P7, DOI 10.1002/cne.903260103; Koizumi O, 2007, BRAIN BEHAV EVOLUT, V69, P151, DOI 10.1159/000095204; Lengfeld T, 2009, DEV BIOL, V330, P186, DOI 10.1016/j.ydbio.2009.02.004; Lopez JA, 2011, GENE, V473, P119, DOI 10.1016/j.gene.2010.11.013; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Meinhardt H, 2012, INT J DEV BIOL, V56, P447, DOI 10.1387/ijdb.113483hm; Milde S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r8; PASSANO LM, 1964, J EXP BIOL, V41, P643; Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012; Schwarz RS, 2007, IMMUNOGENETICS, V59, P233, DOI 10.1007/s00251-006-0179-1; Siebert S, 2008, DEV BIOL, V313, P13, DOI 10.1016/j.ydbio.2007.09.007; Stout T, 2007, J BIOCHEM MOL BIOL, V40, P286; Swanson LW, 2012, FUNDAMENTAL NEUROSCI; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; YAO T, 1945, J EXP BIOL, V21, P147	44	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0151823	10.1371/journal.pone.0151823	http://dx.doi.org/10.1371/journal.pone.0151823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043211	gold, Green Submitted, Green Published			2022-12-26	WOS:000373592100005
J	Urrutia-Cordero, P; Ekvall, MK; Hansson, LA				Urrutia-Cordero, Pablo; Ekvall, Mattias K.; Hansson, Lars-Anders			Controlling Harmful Cyanobacteria: Taxa-Specific Responses of Cyanobacteria to Grazing by Large-Bodied Daphnia in a Biomanipulation Scenario	PLOS ONE			English	Article							BODY-SIZE; PHYTOPLANKTON; ZOOPLANKTON; TOLERANCE; CLADOCERA; HISTORY; GRAZERS; BLOOMS; GROWTH	Lake restoration practices based on reducing fish predation and promoting the dominance of large-bodied Daphnia grazers (i.e., biomanipulation) have been the focus of much debate due to inconsistent success in suppressing harmful cyanobacterial blooms. While most studies have explored effects of large-bodied Daphnia on cyanobacterial growth at the community level and/or on few dominant species, predictions of such restoration practices demand further understanding on taxa-specific responses in diverse cyanobacterial communities. In order to address these questions, we conducted three grazing experiments during summer in a eutrophic lake where the natural phytoplankton community was exposed to an increasing gradient in biomass of the large-bodied Daphnia magna. This allowed evaluating taxa-specific responses of cyanobacteria to Daphnia grazing throughout the growing season in a desired biomanipulation scenario with limited fish predation. Total cyanobacterial and phytoplankton biomasses responded negatively to Daphnia grazing both in early and late summer, regardless of different cyanobacterial densities. Large-bodied Daphnia were capable of suppressing the abundance of Aphanizomenon, Dolichospermum, Microcystis and Planktothrix bloom-forming cyanobacteria. However, the growth of the filamentous Dolichospermum crassum was positively affected by grazing during a period when this cyanobacterium dominated the community. The eutrophic lake was subjected to biomanipulation since 2005 and nineteen years of lake monitoring data (1996-2014) revealed that reducing fish predation increased the mean abundance (50%) and body-size (20%) of Daphnia, as well as suppressed the total amount of nutrients and the growth of the dominant cyanobacterial taxa, Microcystis and Planktothrix. Altogether our results suggest that lake restoration practices solely based on grazer control by large-bodied Daphnia can be effective, but may not be sufficient to control the overgrowth of all cyanobacterial diversity. Although controlling harmful cyanobacterial blooms should preferably include other measures, such as nutrient reductions, our experimental assessment of taxa-specific cyanobacterial responses to large-bodied Daphnia and long-term monitoring data highlights the potential of such biomanipulations to enhance the ecological and societal value of eutrophic water bodies.	[Urrutia-Cordero, Pablo; Ekvall, Mattias K.; Hansson, Lars-Anders] Lund Univ, Dept Biol, Ecol Bldg, SE-22362 Lund, Sweden; [Urrutia-Cordero, Pablo] Lund Univ, Ctr Environm & Climate Res, Ecol Bldg, SE-22362 Lund, Sweden	Lund University; Lund University	Urrutia-Cordero, P (corresponding author), Lund Univ, Dept Biol, Ecol Bldg, SE-22362 Lund, Sweden.; Urrutia-Cordero, P (corresponding author), Lund Univ, Ctr Environm & Climate Res, Ecol Bldg, SE-22362 Lund, Sweden.	pablo.urrutia_cordero@biol.lu.se	Hansson, Lars-Anders/HCI-2735-2022	Hansson, Lars-Anders/0000-0002-3035-1317; Urrutia Cordero, Pablo/0000-0001-9560-8374	collaborative strategic research area 'Biodiversity and Ecosystem Services in a Changing Climate (BECC)'; Royal Physiographic Society of Lund; European Union Interreg IV A project 'Algae be gone!'; LIMNOTIP through the ERA-Net BiodivERsA	collaborative strategic research area 'Biodiversity and Ecosystem Services in a Changing Climate (BECC)'; Royal Physiographic Society of Lund; European Union Interreg IV A project 'Algae be gone!'; LIMNOTIP through the ERA-Net BiodivERsA	This research was funded by the collaborative strategic research area 'Biodiversity and Ecosystem Services in a Changing Climate (BECC)', The Royal Physiographic Society of Lund, the European Union Interreg IV A project 'Algae be gone!' and LIMNOTIP through the ERA-Net BiodivERsA, with the national funder Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1998, ACTA OECOL, V19, P331, DOI 10.1016/S1146-609X(98)80037-4; Bergman E, 1999, HYDROBIOLOGIA, V404, P145, DOI 10.1023/A:1003788900521; BERGQUIST AM, 1986, ECOLOGY, V67, P1351, DOI 10.2307/1938691; Bernes C, 2015, ENVIRON EVID, V4, DOI 10.1186/s13750-014-0030-3; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; BURNS CW, 1968, LIMNOL OCEANOGR, V13, P675, DOI 10.4319/lo.1968.13.4.0675; Carpenter SR, 2011, TROPHIC CASCADES, P55; Chislock MF, 2013, ECOLOGY, V94, P2375, DOI 10.1890/13-0320.1; Chislock MF, 2013, WATER RES, V47, P1961, DOI 10.1016/j.watres.2012.12.038; Codd GA, 2005, TOXICOL APPL PHARM, V203, P264, DOI 10.1016/j.taap.2004.02.016; Declerck S, 1997, HYDROBIOLOGIA, V360, P265, DOI 10.1023/A:1003175929208; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Ekvall MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112956; Ekvall MK, 2013, FRESHWATER BIOL, V58, P2414, DOI 10.1111/fwb.12220; Ger KA, 2014, FRESHWATER BIOL, V59, P1783, DOI 10.1111/fwb.12393; GLIWICZ ZM, 1990, HYDROBIOLOGIA, V200, P83, DOI 10.1007/BF02530331; Gustafsson S, 2005, ECOLOGY, V86, P2561, DOI 10.1890/04-1710; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; Hansson LA, 1999, HYDROBIOLOGIA, V404, P1, DOI 10.1023/A:1003793019176; Hansson LA, 1998, ECOSYSTEMS, V1, P558, DOI 10.1007/s100219900051; Hansson LA, 1996, LIMNOL OCEANOGR, V41, P1312, DOI 10.4319/lo.1996.41.6.1312; Hansson LA, 2007, FRESHWATER BIOL, V52, P1290, DOI 10.1111/j.1365-2427.2007.01765.x; Hansson LA, 2013, NAT CLIM CHANGE, V3, P228, DOI 10.1038/NCLIMATE1689; Hudnell H.K., 2008, CYANOBACTERIAL HARMF; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Kasprzak P, 1999, J PLANKTON RES, V21, P2161, DOI 10.1093/plankt/21.11.2161; Kasprzak PH, 1997, J PLANKTON RES, V19, P1025, DOI 10.1093/plankt/19.8.1025; Lacerot G, 2013, FRESHWATER BIOL, V58, P494, DOI 10.1111/fwb.12075; Lebret K, 2012, LIMNOL OCEANOGR, V57, P727, DOI 10.4319/lo.2012.57.3.0727; LEHMAN JT, 1985, LIMNOL OCEANOGR, V30, P34, DOI 10.4319/lo.1985.30.1.0034; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Sarnelle O, 2007, LIMNOL OCEANOGR, V52, P2120, DOI 10.4319/lo.2007.52.5.2120; Sarnelle O, 2010, J PLANKTON RES, V32, P471, DOI 10.1093/plankt/fbp151; Shapiro J., 1975, WATER QUALITY MANAGE, P85; Urrutia-Cordero P, 2015, FRESHWATER BIOL, V60, P960, DOI 10.1111/fwb.12555; Urrutia-Cordero P, 2013, AQUAT TOXICOL, V130, P9, DOI 10.1016/j.aquatox.2012.12.019; Verspagen JMH, 2005, FRESHWATER BIOL, V50, P854, DOI 10.1111/j.1365-2427.2005.01368.x; Via-Ordorika L, 2004, SYST APPL MICROBIOL, V27, P592, DOI 10.1078/0723202041748163; Wetzel R.G., 2000, LIMNOLOGICAL ANAL, V3; Wilson AE, 2006, LIMNOL OCEANOGR, V51, P1915, DOI 10.4319/lo.2006.51.4.1915; Zillen L, 2010, BIOGEOSCIENCES, V7, P2567, DOI 10.5194/bg-7-2567-2010	46	35	35	7	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153032	10.1371/journal.pone.0153032	http://dx.doi.org/10.1371/journal.pone.0153032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043823	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100064
J	An, HT; Yoo, S; Ko, J				An, H-T; Yoo, S.; Ko, J.			alpha-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and beta-catenin stabilization in cervical cancer	ONCOGENE			English	Article							E-CADHERIN EXPRESSION; WNT SIGNALING PATHWAY; TRANSCRIPTION FACTOR; N-CADHERIN; DOWN-REGULATION; CELL-MIGRATION; OVARIAN-CANCER; KAPPA-B; INVASION; ACTININ-4	alpha-Actinin-4 (ACTN4) is frequently amplified and overexpressed in various cancers. Although ACTN4 functions in cancer cell migration and invasion, the roles of ACTN4 during the epithelial-to-mesenchymal transition (EMT) and cervical cancer tumorigenesis are unknown. In this study, we investigated the function of ACTN4 in the progression of cervical cancer and the mechanisms of EMT and tumorigenesis induced by ACTN4. We found that ACTN4 induced EMT by upregulating Snail, which was dependent on the Akt signaling pathway in cervical cancer. ACTN4 induced cell migration and invasion through Snail-mediated matrix metalloproteinase-9 expression. ACTN4 expression level was correlated with stabilization of beta-catenin. Accumulatioin of beta-catenin owing to ACTN4 induced tumorigenesis via upregulation of genes involved in cell proliferation, including cyclin D1 and c-myc. ACTN4 knockdown reduced cervical cancer cell proliferation and tumor formation in vivo. The expression level of ACTN4 is highly elevated in human cervical tumors, compared with that in normal cervical tissues. ACTN4-overexpressing MDCK cells induced tumor formation and metastatic nodules in nude mice. Our findings indicate that ACTN4 promotes EMT and tumorigenesis by regulating Snail expression and the Akt pathway in cervical cancer. We propose a novel mechanism for EMT and tumorigenesis in cervical cancer.	[An, H-T; Yoo, S.; Ko, J.] Korea Univ, Div Life Sci, 5-1 Anam Dong, Seoul 136701, South Korea	Korea University	Ko, J (corresponding author), Korea Univ, Div Life Sci, 5-1 Anam Dong, Seoul 136701, South Korea.	jesangko@korea.ac.kr		An, Hyoung-Tae/0000-0002-0732-2083	Basic Science Research Program [NRF-2014R1A2A2 A01002826]; Tunneling Nanotube Research Center through the National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2015R1A5A1009024]; Korea University Grant	Basic Science Research Program; Tunneling Nanotube Research Center through the National Research Foundation of Korea (NRF) - Korea government (MSIP); Korea University Grant	This work was supported by Basic Science Research Program (NRF-2014R1A2A2 A01002826) and Tunneling Nanotube Research Center (NRF-2015R1A5A1009024) through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) and the Korea University Grant.	Aksenova V, 2013, ONCOTARGET, V4, P362, DOI 10.18632/oncotarget.901; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; An HT, 2014, J BIOL CHEM, V289, P4969, DOI 10.1074/jbc.M113.515395; Babakov VN, 2008, EXP CELL RES, V314, P1030, DOI 10.1016/j.yexcr.2007.12.001; Barker N, 2000, BIOESSAYS, V22, P961; Bertelsen BI, 2006, INT J CANCER, V118, P1877, DOI 10.1002/ijc.21461; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bolshakova A, 2007, CELL BIOL INT, V31, P360, DOI 10.1016/j.cellbi.2007.01.021; Brognard J, 2001, CANCER RES, V61, P3986; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Chausovsky A, 2000, NAT CELL BIOL, V2, P797, DOI 10.1038/35041037; Di Croce L, 2003, EUR J CANCER, V39, P413, DOI 10.1016/S0959-8049(02)00815-8; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hayashida Y, 2005, CANCER RES, V65, P8836, DOI 10.1158/0008-5472.CAN-05-0718; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Ilyas M, 1997, J PATHOL, V182, P128; Jawhari A, 1997, GASTROENTEROLOGY, V112, P46, DOI 10.1016/S0016-5085(97)70218-X; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Kang H, 2011, J BIOL CHEM, V286, P42072, DOI 10.1074/jbc.M111.272302; Kumeta M, 2010, J CELL SCI, V123, P1020, DOI 10.1242/jcs.059568; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Nabeshima K, 2002, PATHOL INT, V52, P255, DOI 10.1046/j.1440-1827.2002.01343.x; Nakayama H, 2001, CANCER, V92, P3037, DOI 10.1002/1097-0142(20011215)92:12<3037::AID-CNCR10171>3.0.CO;2-#; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Polakis P, 2000, GENE DEV, V14, P1837; Prasad SB, 2014, J CANCER, V5, P655, DOI 10.7150/jca.6554; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Schmidt-Ott KM, 2007, DEVELOPMENT, V134, P3177, DOI 10.1242/dev.006544; Seidel B, 2004, ONCOGENE, V23, P5532, DOI 10.1038/sj.onc.1207718; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Xu DM, 2010, CANCER RES, V70, P6988, DOI 10.1158/0008-5472.CAN-10-0242; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	47	46	48	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2016	35	45					5893	5904		10.1038/onc.2016.117	http://dx.doi.org/10.1038/onc.2016.117			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EB7IR	27065319				2022-12-26	WOS:000387560800008
J	Adase, CA; Borkowski, AW; Zhang, LJ; Williams, MR; Sato, E; Sanford, JA; Gallo, RL				Adase, Christopher A.; Borkowski, Andrew W.; Zhang, Ling-juan; Williams, Michael R.; Sato, Emi; Sanford, James A.; Gallo, Richard L.			Non-coding Double-stranded RNA and Antimicrobial Peptide LL-37 Induce Growth Factor Expression from Keratinocytes and Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-3; HUMAN CATHELICIDIN LL-37; NF-KAPPA-B; HUMAN SKIN; DENDRITIC CELLS; IMMUNE-RESPONSES; EPITHELIAL-CELLS; INNATE IMMUNITY; MESSENGER-RNA; ACTIVATION	A critical function for skin is that when damaged it must simultaneously identify the nature of the injury, repair barrier function, and limit the intrusion of pathogenic organisms. These needs are carried out through the detection of damage-associated molecular patterns (DAMPs) and a response that includes secretion of cytokines, chemokines, growth factors, and antimicrobial peptides (AMPs). In this study, we analyzed how non-coding double-stranded RNA (dsRNAs) act as a DAMP in the skin and how the human cathelicidin AMP LL-37 might influence growth factor production in response to this DAMP. dsRNA alone significantly increased the expression of multiple growth factors in keratinocytes, endothelial cells, and fibroblasts. Furthermore, RNA sequencing transcriptome analysis found that multiple growth factors increase when cells are exposed to both LL-37 and dsRNA, a condition that mimics normal wounding. Quantitative PCR and/or ELISA validated that growth factors expressed by keratinocytes in these conditions included, but were not limited to, basic fibroblast growth factor (FGF2), heparin-binding EGF-like growth factor (HBEGF), vascular endothelial growth factor C (VEGFC), betacellulin (BTC), EGF, epiregulin (EREG), and other members of the transforming growth factor beta superfamily. These results identify a novel role for DAMPs and AMPs in the stimulation of repair and highlight the complex interactions involved in the wound environment.	[Adase, Christopher A.; Borkowski, Andrew W.; Zhang, Ling-juan; Williams, Michael R.; Sato, Emi; Sanford, James A.; Gallo, Richard L.] Univ Calif San Diego, Dept Dermatol, San Diego, CA 92093 USA	University of California System; University of California San Diego	Gallo, RL (corresponding author), Univ Calif San Diego, Dept Dermatol, San Diego, CA 92093 USA.	rgallo@ucsd.edu	Zhang, Ling-juan/V-6141-2019; Zhang, Lingjuan/K-3080-2017; Gallo, Richard L/A-8931-2009	Zhang, Ling-juan/0000-0001-6937-4578; Zhang, Lingjuan/0000-0001-6937-4578; Gallo, Richard L/0000-0002-1401-7861; Sanford, James/0000-0001-7901-5579; Sato, Emi/0000-0001-9394-653X	National Institutes of Health [R01 AR052728, R01 AR064781, R01 AI116576, R01 AI052453, T32 AR062496]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052453, R01AI116576, R37AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064781, T32AR062496, R01AR052728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants R01 AR052728, R01 AR064781, R01 AI116576, R01 AI052453 (to R. L. G.) and T32 AR062496 (to C. A. A. and M. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Borkowski AW, 2015, J INVEST DERMATOL, V135, P569, DOI 10.1038/jid.2014.354; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Filewod NCJ, 2009, FEMS IMMUNOL MED MIC, V56, P233, DOI 10.1111/j.1574-695X.2009.00571.x; Fischer S, 2011, THROMB HAEMOSTASIS, V105, P345, DOI 10.1160/TH10-06-0345; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Fulton C, 1997, LANCET, V350, P1750, DOI 10.1016/S0140-6736(05)63574-X; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Gronberg A, 2014, WOUND REPAIR REGEN, V22, P613, DOI 10.1111/wrr.12211; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hasan M, 2011, J IMMUNOL, V187, P5653, DOI 10.4049/jimmunol.1102144; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Hong SP, 2008, J INVEST DERMATOL, V128, P2880, DOI 10.1038/jid.2008.169; Kandler K, 2006, INT IMMUNOL, V18, P1729, DOI 10.1093/intimm/dxl107; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kim JE, 2005, J KOREAN MED SCI, V20, P649, DOI 10.3346/jkms.2005.20.4.649; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026632; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lin Q, 2012, J INVEST DERMATOL, V132, P2085, DOI 10.1038/jid.2012.120; Lin Q, 2011, J IMMUNOL, V186, P3710, DOI 10.4049/jimmunol.1003007; Maerki C, 2009, J IMMUNOL, V182, P507, DOI 10.4049/jimmunol.182.1.507; Mallbris L, 2005, J INVEST DERMATOL, V125, P1072, DOI 10.1111/j.0022-202X.2005.23872.x; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Nakagawa Y, 2015, J IMMUNOL, V194, P1274, DOI 10.4049/jimmunol.1402388; Schmid P, 2001, J INVEST DERMATOL, V116, P471, DOI 10.1046/j.1523-1747.2001.01279.x; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Seo SJ, 2001, J DERMATOL SCI, V27, P183, DOI 10.1016/S0923-1811(01)00135-9; Seya T, 2012, ONCOIMMUNOLOGY, V1, P917, DOI 10.4161/onci.21244; Singh D, 2014, J BIOL CHEM, V289, P27614, DOI 10.1074/jbc.M114.582973; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Sorensen OE, 2006, J CLIN INVEST, V116, P1878, DOI 10.1172/JCI28422; Takiguchi T, 2014, BRIT J DERMATOL, V171, P492, DOI 10.1111/bjd.12942; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; Yoshioka M, 2008, BIOL PHARM BULL, V31, P212, DOI 10.1248/bpb.31.212; Zhang LJ, 2012, J CELL SCI, V125, P5733, DOI 10.1242/jcs.108969; Zughaier SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013627	47	13	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11635	11646		10.1074/jbc.M116.725317	http://dx.doi.org/10.1074/jbc.M116.725317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27048655	Green Published, hybrid			2022-12-26	WOS:000377264800015
J	Stevens, JP; Baker, K; Howell, MD; Banzett, RB				Stevens, Jennifer P.; Baker, Kathy; Howell, Michael D.; Banzett, Robert B.			Prevalence and Predictive Value of Dyspnea Ratings in Hospitalized Patients: Pilot Studies	PLOS ONE			English	Article							SURVIVAL; MORTALITY; PAIN; CANCER; MANAGEMENT; SYMPTOMS; TEAM; COPD; ILL	Background Dyspnea (breathing discomfort) can be as powerfully aversive as pain, yet is not routinely assessed and documented in the clinical environment. Routine identification and documentation of dyspnea is the first step to improved symptom management and it may also identify patients at risk of negative clinical outcomes. Objective To estimate the prevalence of dyspnea and of dyspnea-associated risk among hospitalized patients. Design Two pilot prospective cohort studies. Setting Single academic medical center. Patients Consecutive patients admitted to four inpatient units: cardiology, hematology/oncology, medicine, and bariatric surgery. Measurements In Study 1, nurses documented current and recent patient-reported dyspnea at the time of the Initial Patient Assessment in 581 inpatients. In Study 2, nurses documented current dyspnea at least once every nursing shift in 367 patients. We describe the prevalence of burdensome dyspnea, and compare it to pain. We also compared dyspnea ratings with a composite of adverse outcomes: 1) receipt of care from the hospital's rapid response system, 2) transfer to the intensive care unit, or 3) death in hospital. We defined burdensome dyspnea as a rating of 4 or more on a 10-point scale. Results Prevalence of burdensome current dyspnea upon admission (Study 1) was 13% (77 of 581, 95% CI 11%-16%). Prevalence of burdensome dyspnea at some time during the hospitalization (Study 2) was 16% (57 of 367, 95% CI 12%-20%). Dyspnea was associated with higher odds of a negative outcome. Conclusions In two pilot studies, we identified a significant symptom burden of dyspnea in hospitalized patients. Patients reporting dyspnea may benefit from a more careful focus on symptom management and may represent a population at greater risk for negative outcomes.	[Stevens, Jennifer P.] Beth Israel Deaconess Med Ctr, Ctr Healthcare Delivery Sci, Boston, MA 02215 USA; [Stevens, Jennifer P.; Banzett, Robert B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Stevens, Jennifer P.; Banzett, Robert B.] Harvard Univ, Sch Med, Boston, MA USA; [Baker, Kathy] Beth Israel Deaconess Med Ctr, Dept Nursing, Boston, MA 02215 USA; [Howell, Michael D.] Univ Chicago, Dept Med, Sect Pulm & Crit Care, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Howell, Michael D.] Univ Chicago, Ctr Healthcare Delivery Sci & Innovat, Chicago, IL 60637 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Chicago; University of Chicago	Stevens, JP (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Healthcare Delivery Sci, Boston, MA 02215 USA.; Stevens, JP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA.; Stevens, JP (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	jpsteven@bidmc.harvard.edu			National Institute for Health's National Institute of Nursing Research [NR10006]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010006] Funding Source: NIH RePORTER	National Institute for Health's National Institute of Nursing Research; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was funded by the National Institute for Health's National Institute of Nursing Research, NR10006 (https://www.ninr.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidov A, 2005, NEW ENGL J MED, V353, P1889, DOI 10.1056/NEJMoa042741; [Anonymous], 1960, BMJ-BRIT MED J, V2, P1665; Baker K, 2013, AM J NURSING PENDING; Baker K, 2013, AM J NURS, V113, P42, DOI 10.1097/01.NAJ.0000437112.43059.a0; Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; Dalton J A, 2001, Pain Manag Nurs, V2, P54, DOI 10.1053/jpmn.2001.23918; de Rond M, 1999, J ADV NURS, V29, P436, DOI 10.1046/j.1365-2648.1999.00903.x; Desbiens NA, 1997, PAIN, V71, P149, DOI 10.1016/S0304-3959(97)03353-8; Djarv T, 2010, J CLIN ONCOL, V28, P1666, DOI 10.1200/JCO.2009.23.5143; Dorman S, 2007, PALLIATIVE MED; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Escalante CP, 1996, CANCER, V78, P1314, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1314::AID-CNCR21>3.0.CO;2-2; Escobar GJ, 2008, MED CARE, V46, P232, DOI 10.1097/MLR.0b013e3181589bb6; HARDY JR, 1994, EUR J CANCER, V30A, P284, DOI 10.1016/0959-8049(94)90242-9; Healy LA, 2008, DIS ESOPHAGUS, V21, P522, DOI 10.1111/j.1442-2050.2008.00814.x; Heyse-Moore LH, 1991, PALLIATIVE MED, V5, P20, DOI DOI 10.1177/026921639100500105; Howell MD, 2012, CRIT CARE MED, V40, P2562, DOI 10.1097/CCM.0b013e318259007b; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; MALTONI M, 1995, CANCER-AM CANCER SOC, V75, P2613, DOI 10.1002/1097-0142(19950515)75:10<2613::AID-CNCR2820751032>3.0.CO;2-1; Meek PM, 2003, HEART LUNG, V32, P335, DOI 10.1016/S0147-9563(03)00100-6; Meek PM, 2001, EUR RESPIR J, V18, P474, DOI 10.1183/09031936.01.00083501; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; Nishiyama O, 2010, EUR RESPIR J, V36, P1067, DOI 10.1183/09031936.00152609; O'Driscoll M, 1999, EUR J CANCER CARE, V8, P37; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Parshall MB, 2012, HEART LUNG, V41, P44, DOI 10.1016/j.hrtlng.2011.05.003; Onen ZP, 2007, RESP MED, V101, P1390, DOI 10.1016/j.rmed.2007.02.002; Schmidt M, 2014, INTENS CARE MED, V40, P1, DOI 10.1007/s00134-013-3117-3; Sha MC, 2005, AM J MED, V118, P301, DOI 10.1016/j.amjmed.2004.12.015; Shih FJ, 1999, HEART LUNG, V28, P41, DOI 10.1016/S0147-9563(99)70042-7; Thomas JR, 2002, LANCET ONCOL, V3, P223, DOI 10.1016/S1470-2045(02)00713-1; Twaddle ML, 2007, J PALLIAT MED, V10, P86, DOI 10.1089/jpm.2006.0048; Zhu LM, 2012, PAIN RES MANAG, V17, P173, DOI 10.1155/2012/586589	34	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152601	10.1371/journal.pone.0152601	http://dx.doi.org/10.1371/journal.pone.0152601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070144	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700011
J	Niu, C; Chauhan, U; Gargus, M; Shaker, A				Niu, Chao; Chauhan, Uday; Gargus, Matthew; Shaker, Anisa			Generation and Characterization of an Immortalized Human Esophageal Myofibroblast Line	PLOS ONE			English	Article							CELLS; TELOMERASE	Stromal cells with a myofibroblast phenotype present in the normal human esophagus are increased in individuals with gastro-esophageal reflux disease (GERD). We have previously demonstrated that myofibroblasts stimulated with acid and TLR4 agonists increase IL-6 and IL-8 secretion using primary cultures of myofibroblasts established from normal human esophagus. While primary cultures have the advantage of reflecting the in vivo environment, a short life span and unavoidable heterogeneity limits the usefulness of this model in larger scale in vitro cellular signaling studies. The major aim of this paper therefore was to generate a human esophageal myofibroblast line with an extended lifespan. In the work presented here we have generated and characterized an immortalized human esophageal myofibroblast line by transfection with a commercially available GFP-hTERT lentivirus. Immortalized human esophageal myofibroblasts demonstrate phenotypic, genotypic and functional similarity to primary cultures of esophageal myofibroblasts we have previously described. We found that immortalized esophageal myofibroblasts retain myofibroblast spindle-shaped morphology at low and high confluence beyond passage 80, and express alpha-SMA, vimentin, and CD90 myofibroblast markers. Immortalized human esophageal myofibroblasts also express the putative acid receptor TRPV1 and TLR4 and retain the functional capacity to respond to stimuli encountered in GERD with secretion of IL-6. Finally, immortalized human esophageal myofibroblasts also support the stratified growth of squamous esophageal epithelial cells in 3D organotypic cultures. This newly characterized immortalized human esophageal myofibroblast cell line can be used in future cellular signaling and co-culture studies.	[Niu, Chao; Chauhan, Uday; Gargus, Matthew; Shaker, Anisa] USC, Keck Sch Med, Dept Med, Div Gastroenterol & Hepatol, Los Angeles, CA USA	University of Southern California; University of Southern California Keck Hospital	Shaker, A (corresponding author), USC, Keck Sch Med, Dept Med, Div Gastroenterol & Hepatol, Los Angeles, CA USA.	ashaker@usc.edu			National Cancer Institute [KO8CA153036, R03CA198692]; USC Research Center for Liver Diseases (NIH grant) [P30 DK048522]; NATIONAL CANCER INSTITUTE [R03CA198692, K08CA153036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USC Research Center for Liver Diseases (NIH grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Cancer Institute KO8CA153036 (AS), National Cancer Institute R03CA198692 (AS); histology services were provided by the Liver Histology Core and RT-PCT, ELISA were performed at the Analytical-Metabolic-Instrumentation Core, both of the USC Research Center for Liver Diseases (NIH grant No. P30 DK048522).	Gargus M, 2015, AM J PHYSIOL-GASTR L, V308, pG904, DOI 10.1152/ajpgi.00333.2014; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Orlando Roy C., 2000, American Journal of Medicine, V108, p104S; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Shaker A, 2013, AM J PHYSIOL-GASTR L, V304, pG662, DOI 10.1152/ajpgi.00225.2012; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046	10	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153185	10.1371/journal.pone.0153185	http://dx.doi.org/10.1371/journal.pone.0153185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055018	Green Published, gold			2022-12-26	WOS:000373608000095
J	Valenciano, A; Baskin, JA; Abella, J; Perez-Ramos, A; Alvarez-Sierra, MA; Morales, J; Hartstone-Rose, A				Valenciano, Alberto; Baskin, Jon A.; Abella, Juan; Perez-Ramos, Alejandro; Angeles Alvarez-Sierra, M.; Morales, Jorge; Hartstone-Rose, Adam			Megalictis, the Bone-Crushing Giant Mustelid (Carnivora, Mustelidae, Oligobuninae) from the Early Miocene of North America	PLOS ONE			English	Article							BIOGEOGRAPHIC HISTORY; MAMMALIA; EVOLUTION; RECONSTRUCTION; PHYLOGENY; RADIATION; PLIOCENE; ORIGIN	We describe cranial and mandibular remains of three undescribed individuals of the giant mustelid Megalictis ferox Matthew, 1907 from the latest Arikareean (Ar4), Early Miocene mammal fauna of Nebraska, and Wyoming (USA) housed at the American Museum of Natural History (New York, USA). Our phylogenetic hypothesis indicates that Ar4 specimens assigned to M. ferox constitute a monophyletic group. We assign three additional species previously referred to Paroligobunis to Megalictis: M. simplicidens, M. frazieri, and "M." petersoni. The node containing these four species of Megalictis and Oligobunis forms the Oligobuninae. We test the hypothesis that Oligobuninae (Megalictis and Oligobunis) is a stem mustelid taxon. Our results indicate that the Oligobuninae form the sister clade to the crown extant mustelids. Based on the cranium, M. ferox is a jaguar-size mustelid and the largest terrestrial mustelid known to have existed. This new material also sheds light on a new ecomorphological interpretation of M. ferox as a bone-crushing durophage (similar to hyenas), rather than a cat-like hypercarnivore, as had been previously described. The relative large size of M. ferox, together with a stout rostrum and mandible made it one of the more powerful predators of the Early Miocene of the Great Plains of North America.	[Valenciano, Alberto; Angeles Alvarez-Sierra, M.] UCM, CSIC, Inst Geociencias, Dept Geol Sedimentaria & Cambio Medioambiental, Madrid, Spain; [Valenciano, Alberto; Angeles Alvarez-Sierra, M.] UCM, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain; [Baskin, Jon A.] Texas A&M Univ, Dept Biol & Hlth Sci, Kingsville, TX USA; [Abella, Juan] Univ Estatal Peninsula Santa Elena, La Libertad, Santa Elena, Ecuador; [Abella, Juan] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Edif ICP,Campus UAB, E-08193 Barcelona, Spain; [Perez-Ramos, Alejandro] Univ Malaga, Fac Ciencias, Dept Ecol & Geol, E-29071 Malaga, Spain; [Morales, Jorge] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Hartstone-Rose, Adam] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC USA; [Hartstone-Rose, Adam] Univ S Carolina, Dept Anthropol, Columbia, SC 29208 USA	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO); Complutense University of Madrid; Texas A&M University System; Texas A&M University Kingsville; Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Hartstone-Rose, A (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC USA.; Hartstone-Rose, A (corresponding author), Univ S Carolina, Dept Anthropol, Columbia, SC 29208 USA.	AdamHR@sc.edu	Vaquero, Alberto Valenciano/N-8757-2019; Morales, Jorge/L-1476-2014; Hartstone-Rose, Adam/AAU-3332-2020; Abella, Juan/AAB-1040-2020; Hartstone-Rose, Adam/I-3503-2016	Vaquero, Alberto Valenciano/0000-0003-1633-2248; Morales, Jorge/0000-0001-5170-5754; Abella, Juan/0000-0002-3433-6093; Hartstone-Rose, Adam/0000-0001-5307-5573; ALVAREZ SIERRA, MARIA DE LOS ANGELES/0000-0002-2649-5887; Perez-Ramos, Alejandro/0000-0003-1417-4338	European Union's Seventh Framework Programme (SYNTHESYS) [226506, SE-TAF-3637]; USC School of Medicine (Columbia, South Carolina, USA); AMNH (Collection Study Grant Program); International Travel Grant 2015 from Vertebrate Paleontology department of FLMNH from UF; CSIC program (CSIC program "Junta para la ampliacion de estudios") [JAE-PRE_CP2011]; European Social Fund; FPI fellowship [BES-2013-065469, CGL2012-37866]; Spanish Ministerio de Economia y Competitividad [CGL2015-68333, CGL2011-28877, CGL2011-28681]; University of South Carolina School of Medicine (Columbia, South Carolina, USA);  [BSCH-UCM 910607]	European Union's Seventh Framework Programme (SYNTHESYS); USC School of Medicine (Columbia, South Carolina, USA); AMNH (Collection Study Grant Program); International Travel Grant 2015 from Vertebrate Paleontology department of FLMNH from UF; CSIC program (CSIC program "Junta para la ampliacion de estudios"); European Social Fund(European Social Fund (ESF)); FPI fellowship(Spanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government); University of South Carolina School of Medicine (Columbia, South Carolina, USA); 	A.V. has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 226506 (SYNTHESYS; SE-TAF-3637), the USC School of Medicine (Columbia, South Carolina, USA), the AMNH (Collection Study Grant Program 2014) and the International Travel Grant 2015 from the Vertebrate Paleontology department of FLMNH from UF. A.V. is researcher in formation in the CSIC program JAE-PRE_CP2011 (CSIC program "Junta para la ampliacion de estudios"), co-funded by the European Social Fund. A.P.R. is a pre-doctoral FPI fellowship (BES-2013-065469) of the project CGL2012-37866. This study was also supported by the Spanish Ministerio de Economia y Competitividad (research project CGL2015-68333, CGL2011-28877 and CGL2011-28681), the research group BSCH-UCM 910607 and University of South Carolina School of Medicine (Columbia, South Carolina, USA).; We are indebted to J. Flynn, J. Meng and R. O'leary (AMNH) for access to the unpublished material of Megalictis ferox housed in the department of Vertebrate Paleontology at the AMNH. A.V. wants thank to the Collection Study Grant Program 2014 of AMNH and the International Travel Grant Vertebrate Paleontology Program 2015 FLMNH of UF that gave him the opportunity to study its extant and extinct carnivoran collections. We would also like to thank E. Westwig, J. Meng, R. O'Leary, J. Galkin, and the late R. Tedford of the AMNH, D. Kalthoff of the NRM, D. Lunde of the USNM, R. Hulbert Jr of the FLMNH and E. Lopez Errasquin and P. Perez Dios of the MNCN for access to comparative material under their care. We are grateful to L. Werdelin (NRM) for kindly allowing us to study the cast of the skull and mandibles of Ekorus ekakeran; G. Koufos (LGPUT) for providing us the measurements of Plesiogulo crassa from Perivolaki; K. Wellspring (ACM) and the Beneski Museum of Natural History at Amherst College, R. Hulbert JR (FLMNH) and the Florida Museum of Natural History, A.C. Henrici (CM) and the Carnegie Museum of Natural History for graciously sending us photographs of "Megalictis" petersoni, Megalictis frazieri and Megalictis simplicidens and the genotype of Aelurocyon brevifacies respectively. We thanks D. DeMiguel (ICP) his recommendations on the manuscript. A.V. is researcher in formation in the CSIC program JAE-PRE_CP2011 (CSIC program " Junta para la ampliacion de estudios"), co-funded by the European Social Fund. A.P.R. is a pre-doctoral FPI fellowship (BES-2013-065469) of the project CGL2012-37866. J.A. thanks the "Proyecto Prometeo" of the "Secretaria de Educacion Superior, Ciencia Tecnologia e Innovacion", Republic of Ecuador. We thank the editor Brian Lee Beatty and the reviewers Mieczyslaw Wolsan and two anonymous reviewers for their useful comments and suggestions, which greatly improved the original manuscript.	Albright LB, 2008, J GEOL, V116, P211, DOI 10.1086/587650; [Anonymous], 1981, SMITHSON CONTRIB PAL; [Anonymous], 1821, ANAL NATURAL CLASSIF; Barone R., 2000, ANATOMIE COMP MAMMIF, V2; Barone R., 1999, ANATOMIE COMP MAMMIF, V1; Baskin Jon A., 1998, P152, DOI 10.1017/CBO9780511529924.011; Cope ED, 1890, AM NAT, V24, P950; Cope ED, 1879, P ACAD NAT SCI PHILA, V31, P168; Elbroch M., 2006, ANIMAL SKULLS GUIDE; Evans H.E., 2010, MILLERS GUIDE DISSEC, VFourth; Evans H.E., 2013, MILLERS ANATOMY DOG; Ewer R.F., 1998, CARNIVORES; Finarelli JA, 2006, SYST BIOL, V55, P301, DOI 10.1080/10635150500541698; Finarelli J, 2008, J MAMM EVOL, V15, P231, DOI 10.1007/s10914-008-9074-x; Fisher G., 1817, MEM SOC IMP NATURALI, V5, P368; Frailey D, 1978, OCCASIONAL PAPERS MU, V75, P1; Geoffroy Saint-Hilaire ûÙ., 1833, REV ENCY, V59, P76; Geraads D, 2011, J VERTEBR PALEONTOL, V31, P447, DOI 10.1080/02724634.2011.550356; Ginsburg Leonard, 1999, P109; Hartstone-Rose A, 2011, J ZOOL, V285, P119, DOI 10.1111/j.1469-7998.2011.00821.x; Hartstone-Rose A, 2012, ANAT REC, V295, P1336, DOI 10.1002/ar.22518; Hartstone-Rose A, 2008, CR PALEVOL, V7, P629, DOI 10.1016/j.crpv.2008.09.015; HENDEY Q B, 1978, Annals of the South African Museum, V76, P329; Holliday JA, 2004, PALEOBIOLOGY, V30, P108, DOI 10.1666/0094-8373(2004)030<0108:EOHTEO>2.0.CO;2; Hunt Jr RM, 1996, U WYOMING CONTRIB GE, V31, P35; Hunt RM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)385<0001:NACMDF>2.0.CO;2; Kirpichnikov AA, 1955, VOPROSY GEOLOGII AZI, V2, P810; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; Koufos GD, 2006, PALAEONTOGR ABT A, V276, P39; Kretzoi M., 1943, FOLDTANY KOZLONY, V52, P10; Lariviere S, 2009, HDB MAMMALS WORLD, V1, P564; Li B, 2014, MOL PHYLOGENET EVOL, V80, P156, DOI 10.1016/j.ympev.2014.08.002; Loomis FB, 1932, AM J SCI, V24, P316; Martin JE, 2011, P S DAK ACAD SCI, V90, P37; Matthew WD, 1907, B AM MUS NAT HIST, V23, P169; Orlov YU, 1948, ACTA ZOOLOGICA, V29, P63; Orlov YU, 1933, T PALEONT I AKAD NAU, V2, P165; Ozansoy F, 1965, MEMOIRES SOC GEOLOGI, V44, P1; Peigne S, 2006, J VERTEBR PALEONTOL, V26, P788, DOI 10.1671/0272-4634(2006)26[788:ANMOTM]2.0.CO;2; Peterson O.A., 1907, ANN CARNEGIE MUS, V4, P21; Peterson O A, 1909, MEM CARNEGIE MUS, V4, P41; Peterson OA, 1910, ANN CARNEGIE MUS, V4, P205; Pomel A., 1846, B SOC GEOLOGIQUE FRA, V3, P353; RADINSKY LB, 1982, PALEOBIOLOGY, V8, P177, DOI 10.1017/S0094837300006928; Riggs ES, 1945, PUBL FIELD MUS NAT H, V9, P69; Riggs ES, 1942, FIELD MUS NAT HIST G, V7, P59; Rybczynski N, 2009, NATURE, V458, P1021, DOI 10.1038/nature07985; Sato JJ, 2012, MOL PHYLOGENET EVOL, V63, P745, DOI 10.1016/j.ympev.2012.02.025; Sato JJ, 2009, MOL PHYLOGENET EVOL, V53, P907, DOI 10.1016/j.ympev.2009.08.019; SAVAGE R. J. G., 1957, PROC ZOOL SOC LONDON, V129, P151; Scapino RP, 1968, THESIS U ILLINOIS; Schultz CB, 1938, AM J SCI, V35, P441; Smith JB, 2003, J VERTEBR PALEONTOL, V23, P1, DOI 10.1671/0272-4634(2003)23[1:APFAST]2.0.CO;2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TEDFORD RH, 1976, SYST ZOOL, V25, P363, DOI 10.2307/2412511; Tedford Richard H., 2004, P169; Teilhard de Chardin P., 1945, I GEOBIOL PEKING, V12, P1; TURNBULL WD, 1970, FIELDIANA GEOLOGY, V18, P149; Valenciano A, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.934570; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; Viret J., 1939, Travaux du Laboratoire de Geologie Lyon, V37, P1; Waibl H., 2005, NOMINA ANATOMICA VET; Wang X, 2008, DOG FAMILY CANIDAE T; Wang XM, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)483[0001:AAAACF]2.0.CO;2; WERDELIN L, 1996, CARNIVORE BEHAV ECOL, V2, P582; Werdelin Lars, 2003, P261; Willemsen GF, 1992, SCRIPTA GEOL, V101, P1; Wolsan M, 2005, PLEN S 9 INT MAMM C, P372; Wolsan M, 2013, ZOOL J LINN SOC-LOND, V167, P208, DOI 10.1111/j.1096-3642.2012.00868.x; Wolsan M, 2010, CLADISTICS, V26, P168, DOI 10.1111/j.1096-0031.2009.00281.x	70	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152430	10.1371/journal.pone.0152430	http://dx.doi.org/10.1371/journal.pone.0152430			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054570	Green Published, gold, Green Accepted			2022-12-26	WOS:000373608000020
J	Caron, MMJ; Emans, PJ; Sanen, K; Surtel, DAM; Cremers, A; Ophelders, D; van Rhijn, LW; Welting, TJM				Caron, Marjolein M. J.; Emans, Pieter J.; Sanen, Kathleen; Surtel, Don A. M.; Cremers, Andy; Ophelders, Daan; van Rhijn, Lodewijk W.; Welting, Tim J. M.			The Role of Prostaglandins and COX-Enzymes in Chondrogenic Differentiation of ATDC5 Progenitor Cells	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; IN-VITRO; CARTILAGE; LINE; E-2; PHOSPHORYLATION; CYCLOOXYGENASES; INHIBITION; RECEPTORS; PROTEINS	Objectives NSAIDs are used to relieve pain and decrease inflammation by inhibition of cyclooxygenase (COX)-catalyzed prostaglandin (PG) synthesis. PGs are fatty acid mediators involved in cartilage homeostasis, however the action of their synthesizing COX-enzymes in cartilage differentiation is not well understood. In this study we hypothesized that COX-1 and COX-2 have differential roles in chondrogenic differentiation. Methods ATDC5 cells were differentiated in the presence of COX-1 (SC-560, Mofezolac) or COX-2 (NS398, Celecoxib) specific inhibitors. Specificity of the NSAIDs and inhibition of specific prostaglandin levels were determined by EIA. Prostaglandins were added during the differentiation process. Chondrogenic outcome was determined by gene-and protein expression analyses. Results Inhibition of COX-1 prevented Col2a1 and Col10a1 expression. Inhibition of COX-2 resulted in decreased Col10a1 expression, while Col2a1 remained unaffected. To explain this difference expression patterns of both COX-enzymes as well as specific prostaglandin concentrations were determined. Both COX-enzymes are upregulated during late chondrogenic differentiation, whereas only COX-2 is briefly expressed also early in differentiation. PGD2 and PGE2 followed the COX-2 expression pattern, whereas PGF2a and TXA2 levels remained low. Furthermore, COX inhibition resulted in decreased levels of all tested PGs, except for PGD2 and PGF2a in the COX-1 inhibited condition. Addition of PGE2 and PGF2a resulted in increased expression of chondrogenic markers, whereas TXA2 increased expression of hypertrophic markers. Conclusions Our findings point towards a differential role for COX-enzymes and PG-production in chondrogenic differentiation of ATDC5 cells. Ongoing research is focusing on further elucidating the functional partition of cyclooxygenases and specific prostaglandin production.	[Caron, Marjolein M. J.; Emans, Pieter J.; Sanen, Kathleen; Surtel, Don A. M.; Cremers, Andy; Ophelders, Daan; van Rhijn, Lodewijk W.; Welting, Tim J. M.] Maastricht Univ, Med Ctr, Caphri Sch Publ Hlth & Primary Care, Dept Orthopaed Surg, NL-6200 MD Maastricht, Netherlands	Maastricht University	Caron, MMJ (corresponding author), Maastricht Univ, Med Ctr, Caphri Sch Publ Hlth & Primary Care, Dept Orthopaed Surg, NL-6200 MD Maastricht, Netherlands.	marjolein.caron@maastrichtuniversity.nl		Ophelders, Daan/0000-0001-7410-5102	Dutch Arthritis Association [LLP14]; Dutch Stichting Annafonds\NOREF [07/07, 08/42]; ReumaFonds [LLP-14] Funding Source: researchfish	Dutch Arthritis Association; Dutch Stichting Annafonds\NOREF; ReumaFonds	This work was financially supported by the Dutch Arthritis Association (grant LLP14) and the Dutch Stichting Annafonds vertical bar NOREF (grants 07/07 and 08/42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Brochhausen C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1948; Caron MMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033467; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Chen L, 2005, DIFFERENTIATION, V73, P350, DOI 10.1111/j.1432-0436.2005.00038.x; Clark CA, 2009, J ORTHOP RES, V27, P785, DOI 10.1002/jor.20805; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; DiBattista JA, 1996, MOL CELL ENDOCRINOL, V123, P27, DOI 10.1016/0303-7207(96)03887-7; Goldring Mary B., 1996, Am J Ther, V3, P9, DOI 10.1097/00045391-199601000-00003; Gualde N, 2004, IMMUNOL CELL BIOL, V82, P353, DOI 10.1111/j.0818-9641.2004.01251.x; Itoh S, 2012, J BIOL CHEM, V287, P29227, DOI 10.1074/jbc.M112.372086; Jakob M, 2004, RHEUMATOLOGY, V43, P852, DOI 10.1093/rheumatology/keh197; Kis B, 2006, INFLAMM RES, V55, P274, DOI 10.1007/s00011-006-0083-z; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lowe GN, 1996, ENDOCRINOLOGY, V137, P2208, DOI 10.1210/en.137.6.2208; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Mastbergen SC, 2008, ANN RHEUM DIS, V67, P52, DOI 10.1136/ard.2006.065946; Mastbergen SC, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1846; Miyamoto M, 2003, OSTEOARTHR CARTILAGE, V11, P644, DOI 10.1016/S1063-4584(03)00118-3; MOHAMEDALI H, 1995, RHEUMATOL INT, V14, P191, DOI 10.1007/BF00262297; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; Schwartz Z, 1998, ENDOCRINOLOGY, V139, P1825, DOI 10.1210/en.139.4.1825; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Warner TD, 2002, P NATL ACAD SCI USA, V99, P13371, DOI 10.1073/pnas.222543099; Welting T J M, 2011, Eur Cell Mater, V22, P420; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467	31	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153162	10.1371/journal.pone.0153162	http://dx.doi.org/10.1371/journal.pone.0153162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050768	Green Submitted, gold, Green Published			2022-12-26	WOS:000373603500107
J	den Haan, MC; van Zuylen, VL; Pluijmert, NJ; Schutte, CI; Fibbe, WE; Schalij, MJ; Roelofs, H; Atsma, DE				den Haan, Melina C.; van Zuylen, Vanessa-Leigh; Pluijmert, Niek J.; Schutte, Cindy I.; Fibbe, Willem E.; Schalij, Martin J.; Roelofs, Helene; Atsma, Douwe E.			Discrepant Results of Experimental Human Mesenchymal Stromal Cell Therapy after Myocardial Infarction: Are Animal Models Robust Enough?	PLOS ONE			English	Article							STEM-CELLS; IN-VIVO; ISCHEMIC-HEART; TRANSPLANTATION; DIFFERENTIATION; EXPRESSION; INJECTION; DISEASE; REPAIR	Background Human mesenchymal stromal cells (MSCs) have been reported to preserve cardiac function in myocardial infarction (MI) models. Previously, we found a beneficial effect of intra-myocardial injection of unstimulated human MSCs (uMSCs) on cardiac function after permanent coronary artery ligation. In the present study we aimed to extend this research by investigating the effect of intramyocardial injection of human MSCs pre-stimulated with the pro-inflammatory cytokine interferon-gamma (iMSCs), since pro-inflammatory priming has shown additional salutary effects in multiple experimental disease models. Methods MI was induced in NOD/Scid mice by permanent ligation of the left anterior descending coronary artery. Animals received intramyocardial injection of uMSCs, iMSCs or PBS. Sham-operated animals were used to determine baseline characteristics. Cardiac performance was assessed after 2 and 14 days using 7-Tesla magnetic resonance imaging and pressure-volume loop measurements. Histology and q-PCR were used to confirm MSC engraftment in the heart. Results Both uMSC and iMSC therapy had no significant beneficial effect on cardiac function or remodelling in contrast to our previous studies. Conclusions Animal models for cardiac MSC therapy appear less robust than initially envisioned.	[den Haan, Melina C.; van Zuylen, Vanessa-Leigh; Pluijmert, Niek J.; Schutte, Cindy I.; Schalij, Martin J.; Atsma, Douwe E.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [van Zuylen, Vanessa-Leigh; Fibbe, Willem E.; Roelofs, Helene] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Atsma, DE (corresponding author), Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands.	D.E.Atsma@lumc.nl	Pluijmert, Niek/ABE-5760-2020	Pluijmert, Niek/0000-0002-7251-5244	SmartCare project of the research program of the BioMedical Materials Program; Dutch Ministry of Economic Affairs; TeRM SmartMix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	SmartCare project of the research program of the BioMedical Materials Program; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); TeRM SmartMix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	This work was supported by the SmartCare project of the research program of the BioMedical Materials Program, co-funded by the Dutch Ministry of Economic Affairs. The authors gratefully acknowledge the support of the TeRM SmartMix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science.	Arminan A, 2010, J AM COLL CARDIOL, V55, P2244, DOI 10.1016/j.jacc.2009.08.092; Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066; Bollache E, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-63; Carr CA, 2008, AM J PHYSIOL-HEART C, V295, pH533, DOI 10.1152/ajpheart.00094.2008; Croitoru-Lamoury J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014698; Danilouchkine MG, 2005, J CARDIOVASC MAGN R, V7, P447, DOI 10.1081/JCMR-200053578; DelaRosa O, 2009, TISSUE ENG PT A, V15, P2795, DOI [10.1089/ten.tea.2008.0630, 10.1089/ten.TEA.2008.0630]; den Haan MC, 2012, J CELL MOL MED, V16, P1508, DOI 10.1111/j.1582-4934.2011.01468.x; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Dixon JA, 2009, CIRCULATION, V120, pS220, DOI 10.1161/CIRCULATIONAHA.108.842302; Duijvestein M, 2011, STEM CELLS, V29, P1549, DOI 10.1002/stem.698; Flynn A, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt127; Francois M, 2012, J CELL PHYSIOL, V227, P3535, DOI 10.1002/jcp.24081; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Grauss RW, 2008, STEM CELLS, V26, P1083, DOI 10.1634/stemcells.2007-0523; Grauss RW, 2007, AM J PHYSIOL-HEART C, V293, pH2438, DOI 10.1152/ajpheart.00365.2007; Hassan F, 2012, J PHARMACOL EXP THER, V343, P62, DOI 10.1124/jpet.112.196915; Hemeda H, 2010, STEM CELLS DEV, V19, P693, DOI 10.1089/scd.2009.0365; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Krause K, 2009, HEART, V95, P1145, DOI 10.1136/hrt.2008.155077; Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schuleri KH, 2009, EUR HEART J, V30, P2722, DOI 10.1093/eurheartj/ehp265; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; van der Bogt KEA, 2009, TRANSPLANTATION, V87, P642, DOI 10.1097/TP.0b013e31819609d9; van Ramshorst J, 2009, JAMA-J AM MED ASSOC, V301, P1997, DOI 10.1001/jama.2009.685; van Zuylen VL, 2015, CARDIOVASC DRUG THER, V29, P59, DOI 10.1007/s10557-014-6568-z; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Zuo S, 2012, STEM CELLS DEV, V21, P598, DOI 10.1089/scd.2011.0071	41	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152938	10.1371/journal.pone.0152938	http://dx.doi.org/10.1371/journal.pone.0152938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050443	Green Submitted, gold, Green Published			2022-12-26	WOS:000373603500070
J	Heidebrecht, CL; Podewils, LJ; Pym, A; Mthiyane, T; Cohen, T				Heidebrecht, Christine L.; Podewils, Laura J.; Pym, Alexander; Mthiyane, Thuli; Cohen, Ted			Assessing Local Risk of Rifampicin-Resistant Tuberculosis in KwaZulu-Natal, South Africa Using Lot Quality Assurance Sampling	PLOS ONE			English	Article							RAPID ASSESSMENT; APPLICABILITY; PREVALENCE	Background KwaZulu-Natal (KZN) has the highest burden of notified multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant (XDR) TB cases in South Africa. A better understanding of spatial heterogeneity in the risk of drug-resistancemay help to prioritize local responses. Methods Between July 2012 and June 2013, we conducted a two-way Lot Quality Assurance Sampling (LQAS) study to classify the burden of rifampicin (RIF)-resistant TB among incident TB cases notified within the catchment areas of seven laboratories in two northern and one southern district of KZN. Decision rules for classification of areas as having either a high-or low-risk of RIF resistant TB (based on proportion of RIF resistance among all TB cases) were based on consultation with local policy makers. Results We classified five areas as high-risk and two as low-risk. High-risk areas were identified in both Southern and Northern districts, with the greatest proportion of RIF resistance observed in the northernmost area, the Manguzi community situated on the Mozambique border. Conclusion Our study revealed heterogeneity in the risk of RIF resistant disease among incident TB cases in KZN. This study demonstrates the potential for LQAS to detect geographic heterogeneity in areas where access to drug susceptibility testing is limited.	[Heidebrecht, Christine L.] MRC, Clin & Biomed TB Res Unit, Durban, South Africa; [Podewils, Laura J.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Pym, Alexander] KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Mthiyane, Thuli] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Cohen, Ted] Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis, New Haven, CT USA	Centers for Disease Control & Prevention - USA; University of Kwazulu Natal; Yale University	Cohen, T (corresponding author), Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis, New Haven, CT USA.	theodore.cohen@yale.edu		Pym, Alexander/0000-0002-6260-8180; Mthiyane, Thuli/0000-0002-1782-5485; Cohen, Ted/0000-0002-8091-7198	Centers for Disease Control and Prevention [5 U51 PS000729-05, PA PS07-006]; South African Medical Research Council [5 U51 PS000729-05, PA PS07-006]; National Institute of General Medical Sciences [NIH U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This evaluation was supported by a cooperative agreement between the Centers for Disease Control and Prevention and the South African Medical Research Council (Cooperative Agreement 5 U51 PS000729-05, PA PS07-006). TC was supported by NIH U54GM088558 from the National Institute of General Medical Sciences.	Biedron C, 2010, INT J EPIDEMIOL, V39, P72, DOI 10.1093/ije/dyp363; Brooker S, 2005, TROP MED INT HEALTH, V10, P647, DOI 10.1111/j.1365-3156.2005.01446.x; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2013, J INFECT DIS, V207, P9, DOI 10.1093/infdis/jis631; Hedt BL, 2012, EPIDEMIOLOGY, V23, P293, DOI 10.1097/EDE.0b013e3182459455; Mushtaq MU, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-60; Myatt M, 2003, B WORLD HEALTH ORGAN, V81, P877; Olives C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001806; Pezzoli L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-415; Stevens W., 2012, 4 GLOB LAB IN PARTN; Vella V, 2011, INT J TUBERC LUNG D, V15, P1170, DOI 10.5588/ijtld.10.0781; Wallengren K, 2011, EMERG INFECT DIS, V17, P1913, DOI 10.3201/eid1710.100952; World Health Organization, 2015, WHOHTMTB201522; Zignol M, 2011, CLIN INFECT DIS, V52, P901, DOI 10.1093/cid/cir081	14	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153143	10.1371/journal.pone.0153143	http://dx.doi.org/10.1371/journal.pone.0153143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050561	Green Published, gold			2022-12-26	WOS:000373603500105
J	Pourzanjani, A; Quisel, T; Foschini, L				Pourzanjani, Arya; Quisel, Tom; Foschini, Luca			Adherent Use of Digital Health Trackers Is Associated with Weight Loss	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PROGRAMS; EXERCISE; PROGRESS; OBESITY	We study the association between weight fluctuation and activity tracking in an on-line population of thousands of individuals using digital health trackers (1,749 <= N <= 14,411, depending on the activity tracker considered) with millions of recorded activities (119,292 <= N <= 2,221,382) over the years 2013-2015. In a first between-subject analysis, we found a positive association between activity tracking frequency and weight loss. Users who log food with moderate frequency lost an additional 0.63% (CI [0.55, 0.72]; p < .001) of their body weight per month relative to low frequency loggers. Frequent workout loggers lost an additional 0.38%(CI [0.20, 0.56]; p < .001) and frequent weight loggers lost an additional 0.40% (CI [0.33, 0.47]; p < .001) as compared to infrequent loggers. In a subsequent within-subject analysis on a subset of the population (799 <= N <= 6,052) with sufficient longitudinal data, we used fixed effect models to explore the temporal relationship between a change in tracking adherence and weight change. We found that for the same individual, weight loss is significantly higher during periods of high adherence to tracking vs. periods of low adherence: +2.74% of body weight lost per month (CI [2.68, 2.81]; p < .001) during adherent weight tracking, +1.35% per month (CI [1.26, 1.43]; p < .001) during adherent food tracking, and +0.60% per month (CI [0.44, 0.76]; p < .001) during adherent workout tracking. The findings suggest that adherence to activity tracking can be utilized as a convenient real-time predictor of weight fluctuations, enabling large-scale, personalized intervention strategies.	[Pourzanjani, Arya; Quisel, Tom; Foschini, Luca] Evidat Hlth, Menlo Pk, CA USA		Pourzanjani, A (corresponding author), Evidat Hlth, Menlo Pk, CA USA.	lfoschini@evidation.com	Foschini, Luca/H-6876-2015	Foschini, Luca/0000-0001-9062-3647				[Anonymous], FUT BIOS WEAR; Bagchi R, 2011, J CONSUM RES, V37, P888, DOI 10.1086/656392; BAKER RC, 1993, BEHAV THER, V24, P377, DOI 10.1016/S0005-7894(05)80212-6; Baker RC, 1998, HEALTH PSYCHOL, V17, P367, DOI 10.1037/0278-6133.17.4.367; Boutelle KN, 1998, OBES RES, V6, P219, DOI 10.1002/j.1550-8528.1998.tb00340.x; Boutelle KN, 1999, HEALTH PSYCHOL, V18, P364, DOI 10.1037/0278-6133.18.4.364; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Burke LE, 2008, CONTEMP CLIN TRIALS, V29, P182, DOI 10.1016/j.cct.2007.07.004; Burke LE, 2012, AM J PREV MED, V43, P20, DOI 10.1016/j.amepre.2012.03.016; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Burke LE, 2009, QUAL HEALTH RES, V19, P815, DOI 10.1177/1049732309335395; Carels RA, 2005, ANN BEHAV MED, V30, P182, DOI 10.1207/s15324796abm3003_2; Carter MC, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2283; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Croissant Y., 2008, J STAT SOFTWARE, V27; Dionne MM, 2005, J NUTR EDUC BEHAV, V37, P315, DOI 10.1016/S1499-4046(06)60162-0; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Gokee-LaRose J, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-10; Helander EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113164; Helsel DL, 2007, J AM DIET ASSOC, V107, P1807, DOI 10.1016/j.jada.2007.07.014; Illner AK, 2012, INT J EPIDEMIOL, V41, P1187, DOI 10.1093/ije/dys105; John LK, 2011, J GEN INTERN MED, V26, P621, DOI 10.1007/s11606-010-1628-y; Khan L. K., 2009, RECOMMENDED COMMUNIT; McCarthy J, 2014, US ADULT OBESITY RAT; McGuire S, 2012, ADV NUTR, V3, P708, DOI 10.3945/an.112.002733; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Plank W., FUTURE WEARABLES MAR; Powell KE, 2011, ANNU REV PUBL HEALTH, V32, P349, DOI 10.1146/annurev-publhealth-031210-101151; R Core Team, 2013, R LANG ENV STAT COMP; Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7; VanWormer JJ, 2012, INT J BEHAV MED, V19, P351, DOI 10.1007/s12529-011-9178-1; VanWormer JJ, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-54; VanWormer JJ, 2009, AM J PREV MED, V36, P70, DOI 10.1016/j.amepre.2008.09.022; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883	36	28	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152504	10.1371/journal.pone.0152504	http://dx.doi.org/10.1371/journal.pone.0152504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27049859	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500045
J	Soares, B; Rajao, R; Merry, F; Rodrigues, H; Davis, J; Lima, L; Macedo, M; Coe, M; Carneiro, A; Santiago, L				Soares-Filho, Britaldo; Rajao, Raoni; Merry, Frank; Rodrigues, Hermann; Davis, Juliana; Lima, Leticia; Macedo, Marcia; Coe, Michael; Carneiro, Arnaldo; Santiago, Leonardo			Brazil's Market for Trading Forest Certificates	PLOS ONE			English	Article							AMAZON; DEFORESTATION; BIOMASS; CARBON	Brazil faces an enormous challenge to implement its revised Forest Code. Despite big losses for the environment, the law introduces new mechanisms to facilitate compliance and foster payment for ecosystem services (PES). The most promising of these is a market for trading forest certificates (CRAs) that allows landowners to offset their restoration obligations by paying for maintaining native vegetation elsewhere. We analyzed the economic potential for the emerging CRA market in Brazil and its implications for PES programs. Results indicate a potential market for trading 4.2 Mha of CRAs with a gross value of US$9.2 +/- 2.4 billion, with main regional markets forming in the states of Mato Grosso and Sao Paulo. This would be the largest market for trading forests in the world. Overall, the potential supply of CRAs in Brazilian states exceeds demand, creating an opportunity for additional PES programs to use the CRA market. This expanded market could provide not only monetary incentives to conserve native vegetation, but also environmental co-benefits by fostering PES programs focused on biodiversity, water conservation, and climate regulation. Effective implementation of the Forest Code will be vital to the success of this market and this hurdle brings uncertainty into the market. Long-term commitment, both within Brazil and abroad, will be essential to overcome the many challenges ahead.	[Soares-Filho, Britaldo; Rodrigues, Hermann; Davis, Juliana; Lima, Leticia] Univ Fed Minas Gerais, Ctr Sensoriamento Remoto, Belo Horizonte, MG, Brazil; [Rajao, Raoni; Santiago, Leonardo] Univ Fed Minas Gerais, Lab Gestao Serv Ambientais, Belo Horizonte, MG, Brazil; [Merry, Frank] Virginia Tech, Dept Forest Resources & Environm Conservat, Blacksburg, VA USA; [Lima, Leticia] Humboldt Univ, IRI THESys, Unter Linden 6, D-10099 Berlin, Germany; [Macedo, Marcia; Coe, Michael] Woods Hole Res Ctr, Falmouth, MA USA; [Carneiro, Arnaldo] Agroicone, Ave Gen Furtado do Nascimento, Sao Paulo, Brazil; [Santiago, Leonardo] Copenhagen Business Sch, Solbjerg Pl 3, Frederiksberg, Denmark	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Virginia Polytechnic Institute & State University; Humboldt University of Berlin; Woods Hole Research Center; Copenhagen Business School	Soares, B (corresponding author), Univ Fed Minas Gerais, Ctr Sensoriamento Remoto, Belo Horizonte, MG, Brazil.	britaldo@csr.ufmg.br	Santiago, Leonardo/G-3017-2011; Rajão, Raoni/GPX-3719-2022; Lima, Letícia Santos de/F-3694-2014; Macedo, Marcia N/N-3044-2017	Santiago, Leonardo/0000-0002-7041-7480; Rajão, Raoni/0000-0002-1133-4837; Lima, Letícia Santos de/0000-0002-0268-2055; Macedo, Marcia N/0000-0001-8102-5901	Climate and Land Use Alliance; Deutsche Gesellschaft fur Internationale Zusammenarbeit; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Servamb; Gordon and Betty Moore Foundation; AgroIcone	Climate and Land Use Alliance; Deutsche Gesellschaft fur Internationale Zusammenarbeit; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Servamb; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); AgroIcone	This work was supported by the Climate and Land Use Alliance, Deutsche Gesellschaft fur Internationale Zusammenarbeit, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Servamb, and the Gordon and Betty Moore Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AgroIcone provided support in the form of salary for one author [AC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], PROJ AGR BRAS 2013 2; Arrow Kenneth., 1993, FED REGISTER, V58, P4601, DOI DOI 10.1002/QJ.49703213905; Banco Nacional de Desenvolvimento Economico e Social do Brasil, 2015, IN BND MAT ATL; Bateman I., 2002, EC VALUATION STATED; Bernasconi P, 2013, THESIS U CAMPINAS; Bowman MS, 2012, LAND USE POLICY, V29, P558, DOI 10.1016/j.landusepol.2011.09.009; Chomitz Kenneth M., 2005, Rev. Econ. Sociol. Rural, V43, P657, DOI 10.1590/S0103-20032005000400003; Costa TL, 2014, PLANT SOIL, V378, P113, DOI 10.1007/s11104-013-2009-1; Costa WLS, 2013, THESIS U FEDERAL MIN; Empresa de Pesquisa Energetica, 2014, NOT TECN DEA 13 14 D; Escobar H, 2015, SCIENCE, V347, P812, DOI 10.1126/science.347.6224.812; Fearnside PM, 2009, FOREST ECOL MANAG, V258, P1968, DOI 10.1016/j.foreco.2009.07.042; FNP, 2014, CONSULTORIA COMERCLO; Young CEF, 2014, NAT CONSERVACAO, V12, P71, DOI 10.4322/natcon.2014.013; Fundacao SOS Mata Atlantica, 2014, ATL REM FLOR MAT ATL; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Gibbs HK, 2016, CONSERV LETT, V9, P32, DOI 10.1111/conl.12175; Gouvello C., 2010, BRAZIL LOW CARBON CO; Graca PMLDA, 1999, FOREST ECOL MANAG, V120, P179; Gupta A, 2012, CURR OPIN ENV SUST, V4, P726, DOI 10.1016/j.cosust.2012.10.004; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hissa LDV, 2014, T GIS, V18, P449, DOI 10.1111/tgis.12098; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; IBGE, 2012, MANUAL TECNICO DA VE; Industria Brasileira de Arvores, 2014, AN EST 2014; Instituto Brasileiro de Economia da Fundacao Getulio Vargas, IND PREC AGR RIO JAN; Instituto Brasileiro de Geografia e Estatistica, CENS DEM; Instituto Brasileiro de Geografia e Estatistica, PROD AGR MUN CULT TE; Instituto Brasileiro de Geografia e Estatistica, 2006, 01036157 I BRAS GEOG; Instituto Nacional de Pesquisas Espaciais, PROJ PRODES MON FLOR; Instituto Nacional de Pesquisas Espaciais, PROJ TERR; Instituto Nacional de Pesquisas Espaciais, SUG MON SAT IM; Laboratorio de Processamento de Imagens e Geoprocessamento, DAD VET AL DESM PER; Leite CC, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004133; Lima LS, 2012, P 17 C BRASILEIRO ME; Lopez-Gonzalez G., 2014, GLOBAL ECOL BIOGEOGR; Madsen B., 2011, UPDATE STATE BIODIVE; May P. H., 2015, CIFOR Occasional Paper; Millennium Ecosystem Assessment, 2005, 1597260401; Ministerio do Meio Ambiente, 2007, 9788577380763 MIN ME; Ministerio do Meio Ambiente, 2016, CADASTRO AMBIENTAL R; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Ottmar RD, 2001, STEREO PHOTO SERIES; Rajao R, 2015, SCIENCE, V350, P519, DOI 10.1126/science.350.6260.519-a; Rajao R, 2012, PUBLIC ADMIN DEVELOP, V32, P229, DOI 10.1002/pad.1620; Rosenfield MF, 2014, REV BIOL TROP, V62, P359, DOI 10.15517/rbt.v62i1.7923; Sampaio E.V.S.B., 2011, REV BRAS GEOGRAFIA F, V6, P1275, DOI DOI 10.26848/rbgf.v4i6.232783; SCHKADE DA, 1994, J ENVIRON ECON MANAG, V26, P88, DOI 10.1006/jeem.1994.1006; Schotter A, 2008, MICROECONOMICS MODEM; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Soares B, 2013, ENVIRON MODELL SOFTW, V43, P80, DOI 10.1016/j.envsoft.2013.01.010; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Soares-Filho BS, 2013, 9788561968045; Sonter LJ, 2014, CONSERV BIOL, V28, P1068, DOI 10.1111/cobi.12260; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; Terra FS, 2014, PESQUI AGROPECU BRAS, V45, P384; Vibrans A. C., 2010, Pesquisa Florestal Brasileira, V30, P291, DOI 10.4336/2010.pfb.30.64.291	59	48	48	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152311	10.1371/journal.pone.0152311	http://dx.doi.org/10.1371/journal.pone.0152311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050309	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500032
J	Ballesteros, Y; Polidori, C; Tormos, J; Banos-Picon, L; Asis, JD				Ballesteros, Yolanda; Polidori, Carlo; Tormos, Jose; Banos-Picon, Laura; Asis, Josep D.			Falling Victim to Wasps in the Air: A Fate Driven by Prey Flight Morphology?	PLOS ONE			English	Article							CERCERIS-ARENARIA HYMENOPTERA; GOLDEN DIGGER WASP; NEOTROPICAL BUTTERFLIES; NESTING-BEHAVIOR; PREDATION RISK; BODY-SIZE; DIET PREFERENCE; BEMBIX-MERCETI; MUSCLE RATIO; PERFORMANCE	In prey-predator systems where the interacting individuals are both fliers, the flight performance of both participants heavily influences the probability of success of the predator (the prey is captured) and of the prey (the predator is avoided). While the flight morphology (an estimate of flight performance) of predatory wasps has rarely been addressed as a factor that may contribute to explain prey use, how the flight morphology of potential prey influences the output of predator-prey encounters has not been studied. Here, we hypothesized that flight morphology associated with flight ability (flight muscle mass to body mass ratio (FMR) and body mass to wing area ratio (wing loading, WL)) of Diptera affect their probability of being captured by specialized Diptera-hunting wasps (Bembix merceti and B. zonata), predicting a better manoeuvrability and acceleration capacity achieved by higher FMR and lower WL, and flight speed achieved by higher WL. In addition, wasp species with better flight morphology should be less limited by an advantageous Diptera flight morphology. Overall, the abundance of dipterans in the environment explained an important part of the observed variance in prey capture rate. However, it was not the only factor shaping prey capture. First, higher prey abundance was associated with greater capture rate for one species (B. merceti), although not for the other one. Second, the interaction observed between the environmental dipteran availability and dipteran WL for B. zonata suggests that greater dipteran WL (this probably meaning high cruising speed) decreased the probability of being captured, as long as fly abundance was high in the environment. Third, greater dipteran FMR (which likely means high manoeuvrability and acceleration capacity) helped to reduce predation by B. merceti if, again, dipterans were abundant in the environment. Wasp WL only varied with body mass but not between species, thereby hardly accounting for interspecific differences in the wasps' predatory patterns. However, the greater FMR of B. zonata, which implies better flight performance and greater load-lifting capacity, may explain why the capture rate in the two wasp species is affected by different factor interactions. In conclusion, although prey availability remains the primary factor shaping prey use, prey flight morphology seems to gain an additional role under conditions of abundant prey, when wasps can avoid flies with better flight ability.	[Ballesteros, Yolanda; Tormos, Jose; Banos-Picon, Laura; Asis, Josep D.] Univ Salamanca, Fac Biol, Area Zool, E-37008 Salamanca, Spain; [Polidori, Carlo] Univ Castilla La Mancha, Inst Ciencias Ambientales ICAM, Ave Carlos 3 S-N, E-45071 Toledo, Spain; [Polidori, Carlo] Univ Lisbon, Ctr Environm & Marine Studies CESAM, Dept Biol Anim, Fac Ciencias, C2-P3 Campo Grande, P-1749016 Lisbon, Portugal	University of Salamanca; Universidad de Castilla-La Mancha; Universidade de Lisboa	Ballesteros, Y (corresponding author), Univ Salamanca, Fac Biol, Area Zool, E-37008 Salamanca, Spain.	ballesteros.y@outlook.com	Polidori, Carlo/G-4382-2010; Asís, Josep D/K-5623-2014; Baños-Picón, Laura/A-7675-2017	Polidori, Carlo/0000-0003-4834-0752; Asís, Josep D/0000-0001-8134-1875; Baños-Picón, Laura/0000-0003-0500-8231	Junta de Castilla y Leon [SA094A09, SA010A06]; MICINN [CGL2010-16730]; Universidad de Salamanca-Santander Bank grant; Universidad de Castilla La Mancha; FSE; FCT (Fundacao para a Ciencia e a Tecnologia) post-doctoral grant [SFRH/BPD/100460/2014]	Junta de Castilla y Leon(Junta de Castilla y Leon); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Universidad de Salamanca-Santander Bank grant; Universidad de Castilla La Mancha; FSE(European Social Fund (ESF)); FCT (Fundacao para a Ciencia e a Tecnologia) post-doctoral grant	This work was supported by the Projects SA094A09 and SA010A06 (Junta de Castilla y Leon) and CGL2010-16730 (MICINN). YB was funded by a Universidad de Salamanca-Santander Bank grant. CP was funded by a post-doctoral contract funded by Universidad de Castilla La Mancha and the FSE, and by a FCT (Fundacao para a Ciencia e a Tecnologia) post-doctoral grant (SFRH/BPD/100460/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman M, 2009, ECOL ENTOMOL, V34, P783, DOI 10.1111/j.1365-2311.2009.01126.x; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; ALDRIDGE HDJN, 1987, J EXP BIOL, V128, P419; ALEXANDER B, 1985, J NAT HIST, V19, P1139, DOI 10.1080/00222938500770711; Almbro M, 2009, BEHAV ECOL SOCIOBIOL, V63, P413, DOI 10.1007/s00265-008-0675-4; Almbro M, 2008, J EXP BIOL, V211, P24, DOI 10.1242/jeb.008219; Almbro M, 2012, J INSECT BEHAV, V25, P441, DOI 10.1007/s10905-011-9309-1; Asis JD, 2011, BEHAVIOUR, V148, P191, DOI 10.1163/000579510X551651; Asis JD, 2004, J NAT HIST, V38, P1799, DOI 10.1080/0022293031000156295; ASIS JD, 1992, DEUT ENTOMOL Z, V39, P221, DOI 10.1002/mmnd.19920390402; Asis JD, 2014, ETHOLOGY, V120, P340, DOI 10.1111/eth.12208; Ballesteros Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102325; Ballesteros Y, 2012, ANN SOC ENTOMOL FR, V48, P281, DOI 10.1080/00379271.2012.10697777; BEDNEKOFF PA, 1994, EVOL ECOL, V8, P36, DOI 10.1007/BF01237664; Bednekoff PA, 1996, P ROY SOC B-BIOL SCI, V263, P887, DOI 10.1098/rspb.1996.0131; Begon M., 2009, ECOLOGY INDIVIDUALS; BELWOOD JJ, 1976, CAN J ZOOL, V54, P1674, DOI 10.1139/z76-194; Bernard F., 1934, Bulletin de la Societe Entomologique de France Paris, V39, P247; Bernard F., 1935, Annales de la Societe Entomologique de France, V104, P31; Berwaerts K, 2004, OECOLOGIA, V141, P536, DOI 10.1007/s00442-004-1661-9; BROCKMANN HJ, 1985, J KANSAS ENTOMOL SOC, V58, P631; Burns JG, 2002, BEHAV ECOL SOCIOBIOL, V52, P128, DOI 10.1007/s00265-002-0494-y; CASEY TM, 1983, PHYSIOL ZOOL, V56, P160, DOI 10.1086/physzool.56.2.30156049; CHAI P, 1990, AM NAT, V135, P398; Coelho JR, 2008, J HYMENOPT RES, V17, P57; COELHO JR, 1995, FUNCT ECOL, V9, P171, DOI 10.2307/2390561; Coelho JR, 1999, ECOL ENTOMOL, V24, P480, DOI 10.1046/j.1365-2311.1999.00219.x; Coelho JR, UNPUB; Coello C., 2011, PREDATION HYMENOPTER, P23; Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Domenici P, 2001, COMP BIOCHEM PHYS A, V131, P169, DOI 10.1016/S1095-6433(01)00465-2; DUDLEY R, 1994, J EXP BIOL, V191, P125; DUDLEY R, 1990, J EXP BIOL, V150, P37; EHLINGER TJ, 1990, ECOLOGY, V71, P886, DOI 10.2307/1937360; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P79, DOI 10.1098/rstb.1984.0052; ELLINGTON CP, 1991, J EXP BIOL, V160, P71; Evans HE., 2007, SAND WASPS NATURAL H; GRIFFITHS D, 1975, ECOLOGY, V56, P1209, DOI 10.2307/1936161; Gurevitz JM, 2007, J MED ENTOMOL, V44, P186, DOI 10.1603/0022-2585(2007)44[186:FMDAHI]2.0.CO;2; Hastings JM, 2008, FLA ENTOMOL, V91, P657; HEDENSTROM A, 1992, J THEOR BIOL, V158, P535, DOI 10.1016/S0022-5193(05)80714-3; Hedenstrom A, 2001, BEHAV ECOL, V12, P150, DOI 10.1093/beheco/12.2.150; Herzner G, 2005, ANIM BEHAV, V70, P1411, DOI 10.1016/j.anbehav.2005.03.032; KALCOUNIS MC, 1995, CAN J ZOOL, V73, P89, DOI 10.1139/z95-011; Kullberg C, 2000, AUK, V117, P1034, DOI 10.1642/0004-8038(2000)117[1034:HMFLIP]2.0.CO;2; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Lind J, 1999, BEHAV ECOL SOCIOBIOL, V46, P65, DOI 10.1007/s002650050593; Linehan JE, 2001, J EXP MAR BIOL ECOL, V263, P25, DOI 10.1016/S0022-0981(01)00287-8; MARDEN JH, 1991, AM NAT, V138, P15, DOI 10.1086/285202; MARDEN JH, 1989, PHYSIOL ZOOL, V62, P505, DOI 10.1086/physzool.62.2.30156182; MARDEN JH, 1987, J EXP BIOL, V130, P235; Martin J, 2006, BEHAV ECOL SOCIOBIOL, V60, P778, DOI 10.1007/s00265-006-0221-1; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Norberg Ulla M., 1994, P205; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Polidori C, 2005, EUR J ENTOMOL, V102, P801, DOI 10.14411/eje.2005.111; Polidori C, 2009, J ZOOL, V279, P187, DOI 10.1111/j.1469-7998.2009.00605.x; Polidori C, 2011, PREDATION HYMENOPTER, P101; Polidori C, 2007, ZOOL STUD, V46, P83; Polidori C, 2015, CR BIOL, V338, P126, DOI 10.1016/j.crvi.2014.11.001; Polidori C, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-36; Polidori C, 2013, OIKOS, V122, P385, DOI 10.1111/j.1600-0706.2012.20387.x; Polidori C, 2010, BIOL J LINN SOC, V99, P544, DOI 10.1111/j.1095-8312.2009.01397.x; Polidori C, 2009, J NAT HIST, V43, P2985, DOI 10.1080/00222930903383511; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Riskin DK, 2010, J EXP BIOL, V213, P4110, DOI 10.1242/jeb.043091; RYDELL J, 1986, HOLARCTIC ECOL, V9, P272; Spataro T, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00133.1; SRYGLEY RB, 1990, OECOLOGIA, V84, P491, DOI 10.1007/BF00328165; SRYGLEY RB, 1993, J EXP BIOL, V174, P155; STARMER WT, 1989, BIOL J LINN SOC, V37, P247, DOI 10.1111/j.1095-8312.1989.tb01903.x; STUBBLEFIELD JW, 1993, PHILOS T R SOC B, V339, P397, DOI 10.1098/rstb.1993.0039; SWIFT SM, 1985, J ANIM ECOL, V54, P217, DOI 10.2307/4632; Vogel S, 2008, INTEGR COMP BIOL, V48, P702, DOI 10.1093/icb/icn014; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x	77	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152256	10.1371/journal.pone.0152256	http://dx.doi.org/10.1371/journal.pone.0152256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046238	Green Submitted, gold, Green Published			2022-12-26	WOS:000373599600011
J	Kim, JI; Park, S; Lee, I; Park, KS; Kwak, EJ; Moon, KM; Lee, CK; Bae, JY; Park, MS; Song, KJ				Kim, Jin Il; Park, Sehee; Lee, Ilseob; Park, Kwang Sook; Kwak, Eun Jung; Moon, Kwang Mee; Lee, Chang Kyu; Bae, Joon-Yong; Park, Man-Seong; Song, Ki-Joon			Genome-Wide Analysis of Human Metapneumovirus Evolution	PLOS ONE			English	Article							AVIAN METAPNEUMOVIRUS; GENETIC-VARIABILITY; YOUNG-CHILDREN; RNA VIRUSES; INFECTION; SEQUENCE; RECOMBINATION; CIRCULATION; PREVALENCE; DIVERSITY	Human metapneumovirus (HMPV) has been described as an important etiologic agent of upper and lower respiratory tract infections, especially in young children and the elderly. Most of school-aged children might be introduced to HMPVs, and exacerbation with other viral or bacterial super-infection is common. However, our understanding of the molecular evolution of HMPVs remains limited. To address the comprehensive evolutionary dynamics of HMPVs, we report a genome-wide analysis of the eight genes (N, P, M, F, M2, SH, G, and L) using 103 complete genome sequences. Phylogenetic reconstruction revealed that the eight genes from one HMPV strain grouped into the same genetic group among the five distinct lineages (A1, A2a, A2b, B1, and B2). A few exceptions of phylogenetic incongruence might suggest past recombination events, and we detected possible recombination breakpoints in the F, SH, and G coding regions. The five genetic lineages of HMPVs shared quite remote common ancestors ranging more than 220 to 470 years of age with the most recent origins for the A2b sublineage. Purifying selection was common, but most protein genes except the F and M2-2 coding regions also appeared to experience episodic diversifying selection. Taken together, these suggest that the five lineages of HMPVs maintain their individual evolutionary dynamics and that recombination and selection forces might work on shaping the genetic diversity of HMPVs.	[Kim, Jin Il; Park, Sehee; Lee, Ilseob; Park, Kwang Sook; Kwak, Eun Jung; Moon, Kwang Mee; Bae, Joon-Yong; Park, Man-Seong; Song, Ki-Joon] Korea Univ, Dept Microbiol, Inst Viral Dis, Seoul 136705, South Korea; [Kim, Jin Il; Park, Sehee; Lee, Ilseob; Park, Kwang Sook; Kwak, Eun Jung; Moon, Kwang Mee; Bae, Joon-Yong; Park, Man-Seong; Song, Ki-Joon] Korea Univ, Coll Med, Korea Bank Pathogen Viruses, Seoul 136705, South Korea; [Lee, Chang Kyu] Korea Univ, Coll Med, Dept Lab Med, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Song, KJ (corresponding author), Korea Univ, Dept Microbiol, Inst Viral Dis, Seoul 136705, South Korea.; Song, KJ (corresponding author), Korea Univ, Coll Med, Korea Bank Pathogen Viruses, Seoul 136705, South Korea.	songmicr@korea.ac.kr	Kim, Young-jin/GSD-3168-2022; Park, Man-Seong/AAF-1207-2020	Bae, Joon-Yong/0000-0002-2483-4208; Kim, Jin Il/0000-0001-8833-2138	Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [NRF-2010-0004691];  [PRJNA73051];  [PRJNA237298]	Bio & Medical Technology Development Program of the NRF - Korean government, MSIP; ; 	This research was supported by the Bio & Medical Technology Development Program of the NRF (http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi=sso-return2=none) funded by the Korean government, MSIP (NRF-2010-0004691). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Mortimer Poncz (University of Pennsylvania, Department of Pediatrics and Children's Hospital of Philadelphia, PA, USA) for comments on the manuscript. We also would like to thank Dr. John V. Williams and his colleagues for their contribution to providing abundant amount of HMPV complete genome sequences through BioProject PRJNA73051 and to thank Dr. David E. Wentworth and his colleagues for their contribution through BioProject PRJNA237298.	[Anonymous], TRACER V1 6; Bosis S, 2005, J MED VIROL, V75, P101, DOI 10.1002/jmv.20243; Buchholz U., 2012, NAMING CONVENTION HU; Buitendijk H, 2014, VIRUSES-BASEL, V6, P1442, DOI 10.3390/v6031442; Carneiro BM, 2009, J MED VIROL, V81, P1814, DOI 10.1002/jmv.21555; Chung JY, 2008, J MED VIROL, V80, P902, DOI 10.1002/jmv.21129; Collins PL, 2013, RESP SYNCYTIAL VIRUS; Cox RG, 2013, VIRUSES-BASEL, V5, P192, DOI 10.3390/v5010192; de Graaf M, 2008, J GEN VIROL, V89, P2933, DOI 10.1099/vir.0.2008/006957-0; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Domingo E, 1998, ADV EXP MED BIOL, V440, P721; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DUARTE E, 1992, P NATL ACAD SCI USA, V89, P6015, DOI 10.1073/pnas.89.13.6015; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Escobar C, 2009, J MED VIROL, V81, P340, DOI 10.1002/jmv.21399; Feuillet F, 2012, J CLIN VIROL, V53, P97, DOI 10.1016/j.jcv.2011.10.002; Gaunt E, 2015, J GEN VIROL, V96, P1067, DOI 10.1099/vir.0.000062; Govindarajan D, 2004, VIRUS RES, V105, P59, DOI 10.1016/j.virusres.2004.04.014; Heeney JL, 2006, SCIENCE, V313, P462, DOI 10.1126/science.1123016; Holmes EC, 2013, FIELDS VIROLOGY; Huck B, 2006, J CLIN MICROBIOL, V44, P2300, DOI 10.1128/JCM.00152-06; Hughes AL, 2007, GENE, V404, P117, DOI 10.1016/j.gene.2007.09.013; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kayali G, 2011, VECTOR-BORNE ZOONOT, V11, P1453, DOI 10.1089/vbz.2011.0637; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; Kim HR, 2012, J MOL DIAGN, V14, P61, DOI 10.1016/j.jmoldx.2011.09.004; Kim JH, 2009, IEEE INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN ROBOTICS AND AUTOMATION, P159; Lamb RA, 2013, PARAMYXOVIRIDAE; Li JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034544; Lo Presti A, 2011, NEW MICROBIOL, V34, P337; Lukashev AN, 2010, REV MED VIROL, V20, P327, DOI 10.1002/rmv.660; Lwamba HCM, 2005, VIRUS RES, V107, P83, DOI 10.1016/j.virusres.2004.07.002; Mackay IM, 2006, J INFECT DIS, V193, P1630, DOI 10.1086/504260; Melero JA, 2015, VIRUS RES, V209, P128, DOI 10.1016/j.virusres.2015.02.024; Meng J, 2014, MBIO, V5, DOI 10.1128/mBio.01704-14; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Neemuchwala A, 2015, J MED VIROL, V87, P269, DOI 10.1002/jmv.24024; Nei M., 2000, MOL EVOLUTION PHYLOG; Noh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064295; Opperdoes FR, 2009, PHYLOGENETIC HDB PRA; Padhi A, 2009, J VIROL, V83, P2015, DOI 10.1128/JVI.02047-08; Palacios G, 2011, EMERG INFECT DIS, V17, P711, DOI 10.3201/eid1704.100883; Papenburg J, 2013, J CLIN VIROL, V58, P541, DOI 10.1016/j.jcv.2013.08.029; Papenburg J, 2010, REV MED VIROL, V20, P245, DOI 10.1002/rmv.651; Perez-Losada M, 2015, INFECT GENET EVOL, V30, P296, DOI 10.1016/j.meegid.2014.12.022; Pizzorno A, 2010, J MED VIROL, V82, P861, DOI 10.1002/jmv.21752; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P419; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rappuoli R, 2014, P NATL ACAD SCI USA, V111, P12288, DOI 10.1073/pnas.1402981111; Ren J, 2015, J GEN VIROL, V96, P1515, DOI 10.1099/vir.0.000083; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Salemi M, 2009, PHYLOGENETIC HDB PRA, Vxxvi; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Schuster JE, 2013, PEDIATR REV, V34, P558, DOI 10.1542/pir.34-12-558; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Slater OM, 2014, EMERG INFECT DIS, V20, P2115, DOI 10.3201/eid2012.140408; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Rueda AJV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063070; Vrancken B, 2015, METHODS ECOL EVOL, V6, P67, DOI 10.1111/2041-210X.12293; Zappa A, 2011, J MED VIROL, V83, P156, DOI 10.1002/jmv.21940	67	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152962	10.1371/journal.pone.0152962	http://dx.doi.org/10.1371/journal.pone.0152962			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046055	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600052
J	Matsushima-Nishiwaki, R; Toyoda, H; Nagasawa, T; Yasuda, E; Chiba, N; Okuda, S; Maeda, A; Kaneoka, Y; Kumada, T; Kozawa, O				Matsushima-Nishiwaki, Rie; Toyoda, Hidenori; Nagasawa, Tomoaki; Yasuda, Eisuke; Chiba, Naokazu; Okuda, Seiji; Maeda, Atsuyuki; Kaneoka, Yuji; Kumada, Takashi; Kozawa, Osamu			Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-alpha-Induced Migration and Invasion of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							SIGNALING PATHWAY; EXPRESSION; HSP20; TRANSPLANTATION; PROGRESSION; METASTASIS; RECURRENCE; ACTIVATION; KINASES; SPREAD	Human hepatocellular carcinoma (HCC) is one of the major malignancies in the world. Small heat shock proteins (HSPs) are reported to play an important role in the regulation of a variety of cancer cell functions, and the functions of small HSPs are regulated by posttranslational modifications such as phosphorylation. We previously reported that protein levels of a small HSP, HSP20 (HSPB6), decrease in vascular invasion positive HCC compared with those in the negative vascular invasion. Therefore, in the present study, we investigated whether HSP20 is implicated in HCC cell migration and the invasion using human HCC-derived HuH7 cells. The transforming growth factor (TGF)-alpha-induced migration and invasion were suppressed in the wild-type-HSP20 overexpressed cells in which phosphorylated HSP20 was detected. Phospho-mimic-HSP20 overexpression reduced the migration and invasion compared with unphosphorylated HSP20 overexpression. Dibutyryl cAMP, which enhanced the phosphorylation of wild-type-HSP20, significantly reduced the TGF-alpha-induced cell migration of wild-type HSP20 overexpressed cells. The TGF-a-induced cell migration was inhibited by SP600125, a c-Jun N-terminal kinases (JNK) inhibitor. In phospho-mimic-HSP20 overexpressed HuH7 cells, TGF-alpha-stimulated JNK phosphorylation was suppressed compared with the unphosphorylated HSP20 overexpressed cells. Moreover, the level of phospho-HSP20 protein in human HCC tissues was significantly correlated with tumor invasion. Taken together, our findings strongly suggest that phosphorylated HSP20 inhibits TGF-a-induced HCC cell migration and invasion via suppression of the JNK signaling pathway.	[Matsushima-Nishiwaki, Rie; Nagasawa, Tomoaki; Chiba, Naokazu; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan; [Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu, Japan; [Yasuda, Eisuke] Suzuka Univ, Med Sci, Dept Radiol Technol, Suzuka, Mie, Japan; [Okuda, Seiji] Ogaki Municipal Hosp, Dept Med Technol, Ogaki, Gifu, Japan; [Maeda, Atsuyuki; Kaneoka, Yuji] Ogaki Municipal Hosp, Dept Surg, Ogaki, Gifu, Japan	Gifu University; Ogaki Municipal Hospital; Ogaki Municipal Hospital; Ogaki Municipal Hospital	Kozawa, O (corresponding author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan.	okozawa@gifu-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [25460989]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (25460989 to O.K.) from the Ministry of Education, Science, Sports and Culture of Japan. https://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Yumiko Kurokawa for her skillful technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research (25460989 to O.K.) from the Ministry of Education, Science, Sports and Culture of Japan.	Aravalli RN, 2013, ARCH TOXICOL, V87, P227, DOI 10.1007/s00204-012-0931-2; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; BOULIKAS T, 1995, CRIT REV EUKAR GENE, V5, P1; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Edwards HV, 2011, CELL SIGNAL, V23, P1447, DOI 10.1016/j.cellsig.2011.05.009; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Hou CH, 2014, BIOCHEM PHARMACOL, V89, P453, DOI 10.1016/j.bcp.2014.03.010; JASKIEWICZ K, 1995, ANTICANCER RES, V15, P559; JCMM, 2014, J CELL MOL MED, V18, P218, DOI DOI 10.1111/JCMM.12153; Kinoshita A, 2015, WORLD J HEPATOL, V7, P406, DOI 10.4254/wjh.v7.i3.406; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; Kozawa O, 2002, LIFE SCI, V72, P113, DOI 10.1016/S0024-3205(02)02144-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsuno H, 1998, FEBS LETT, V429, P327, DOI 10.1016/S0014-5793(98)00626-7; Matsushima-Nishiwaki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078440; Matsushima-Nishiwaki R, 2011, J CELL BIOCHEM, V112, P3430, DOI 10.1002/jcb.23270; Min LH, 2011, SEMIN CANCER BIOL, V21, P10, DOI 10.1016/j.semcancer.2010.10.011; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Nagasawa T, 2015, ARCH BIOCHEM BIOPHYS, V565, P1, DOI 10.1016/j.abb.2014.10.010; Nagasawa T, 2014, ONCOL REP, V32, P1291, DOI 10.3892/or.2014.3278; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; Niwa M, 2009, NEUROL RES, V31, P721, DOI 10.1179/174313209X380946; Noda T, 2007, ONCOL REP, V17, P1309; Poon RTP, 2007, ANN SURG, V245, P51, DOI 10.1097/01.sla.0000225255.01668.65; ROSENTHAL A, 1986, CELL, V46, P301, DOI 10.1016/0092-8674(86)90747-6; Sefton B M, 2001, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1401s00; Sneag DB, 2011, AM J ROENTGENOL, V197, pW658, DOI 10.2214/AJR.10.6402; Suzuki M, 2015, ARCH BIOCHEM BIOPHYS, V571, P40, DOI 10.1016/j.abb.2015.02.030; Toso C, 2011, AM J TRANSPLANT, V11, P2031, DOI 10.1111/j.1600-6143.2011.03689.x; Voll EA, 2014, ONCOTARGET, V5, P2648, DOI 10.18632/oncotarget.1917; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566; Yeh CB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079406, 10.1371/journal.pone.0056661]; YEH YC, 1987, CANCER RES, V47, P896; YUKI K, 1990, CANCER-AM CANCER SOC, V66, P2174, DOI 10.1002/1097-0142(19901115)66:10<2174::AID-CNCR2820661022>3.0.CO;2-A; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032765; Zhang Y, 2014, WORLD J GASTROENTERO, V20, P142, DOI 10.3748/wjg.v20.i1.142	40	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0151907	10.1371/journal.pone.0151907	http://dx.doi.org/10.1371/journal.pone.0151907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046040	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600007
J	Blanco-Perez, M; Perez-Canamas, M; Ruiz, L; Hernandez, C				Blanco-Perez, Marta; Perez-Canamas, Miryam; Ruiz, Leticia; Hernandez, Carmen			Efficient Translation of Pelargonium line pattern virus RNAs Relies on a TED-Like 3 '-Translational Enhancer that Communicates with the Corresponding 5 '-Region through a Long-Distance RNA-RNA Interaction	PLOS ONE			English	Article							CAP-INDEPENDENT TRANSLATION; TOBACCO NECROSIS VIRUS; PLANT VIRAL RNAS; SATELLITE TOBACCO; MESSENGER-RNA; UNTRANSLATED REGIONS; FAMILY TOMBUSVIRIDAE; GENOME ORGANIZATION; LOOP INTERACTIONS; STEM-LOOP	Cap-independent translational enhancers (CITEs) have been identified at the 3'-terminal regions of distinct plant positive-strand RNA viruses belonging to families Tombusviridae and Luteoviridae. On the bases of their structural and/or functional requirements, at least six classes of CITEs have been defined whose distribution does not correlate with taxonomy. The so-called TED class has been relatively under-studied and its functionality only confirmed in the case of Satellite tobacco necrosis virus, a parasitic subviral agent. The 3' untranslated region of the monopartite genome of Pelargonium line pattern virus (PLPV), the recommended type member of a tentative new genus (Pelarspovirus) in the family Tombusviridae, was predicted to contain a TED-like CITE. Similar CITEs can be anticipated in some other related viruses though none has been experimentally verified. Here, in the first place, we have performed a reassessment of the structure of the putative PLPV-TED through in silico predictions and in vitro SHAPE analysis with the full-length PLPV genome, which has indicated that the presumed TED element is larger than previously proposed. The extended conformation of the TED is strongly supported by the pattern of natural sequence variation, thus providing comparative structural evidence in support of the structural data obtained by in silico and in vitro approaches. Next, we have obtained experimental evidence demonstrating the in vivo activity of the PLPV-TED in the genomic (g) RNA, and also in the subgenomic (sg) RNA that the virus produces to express 3'-proximal genes. Besides other structural features, the results have highlighted the key role of long-distance kissing-loop interactions between the 3'-CITE and 5'-proximal hairpins for gRNA and sgRNA translation. Bioassays of CITE mutants have confirmed the importance of the identified 5'-3' RNA communication for viral infectivity and, moreover, have underlined the strong evolutionary constraints that may operate on genome stretches with both regulatory and coding functions.	[Blanco-Perez, Marta; Perez-Canamas, Miryam; Ruiz, Leticia; Hernandez, Carmen] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46022 Valencia, Spain; [Ruiz, Leticia] IFAPA, Crop Protect, La Mojonera, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Hernandez, C (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46022 Valencia, Spain.	cahernan@ibmcp.upv.es	Hernandez, C./R-2047-2018; Garcia, Leticia Ruiz/AAE-4291-2021	Hernandez, C./0000-0003-1192-6223; Garcia, Leticia Ruiz/0000-0002-8612-966X; BLANCO-PEREZ, MARTA/0000-0001-5200-014X; Perez-Canamas, Miryam/0000-0002-0767-277X	Ministerio de Investigacion, Ciencia e Innovacion (MICINN, Spain) [BFU2009-11699, BFU2012-36095]; Ministerio de Economia y Competitividad (MINECO, Spain); Generalitat Valenciana [ACOMP/2012/100]; predoctoral and postdoctoral (Juan de la Cierva program) from MICINN; predoctoral contract from MINECO	Ministerio de Investigacion, Ciencia e Innovacion (MICINN, Spain); Ministerio de Economia y Competitividad (MINECO, Spain)(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); predoctoral and postdoctoral (Juan de la Cierva program) from MICINN; predoctoral contract from MINECO	This work was supported by grants BFU2009-11699 and BFU2012-36095 from the Ministerio de Investigacion, Ciencia e Innovacion (MICINN, Spain, www.micinn.es) and the Ministerio de Economia y Competitividad (MINECO, Spain, http://www.mineco.gob.es), respectively, and ACOMP/2012/100 from the Generalitat Valenciana (http://www.gva.es) (to C.H.). MBP and LR were the recipients of a predoctoral and postdoctoral (Juan de la Cierva program) contract, respectively, from MICINN, and MPC was the recipient of a predoctoral contract from MINECO.	Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Batten JS, 2006, FEBS LETT, V580, P2591, DOI 10.1016/j.febslet.2006.04.006; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; Castano A, 2007, ACTA VIROL, V51, P271; Castano A, 2005, ARCH VIROL, V150, P949, DOI 10.1007/s00705-004-0464-y; Castano A, 2011, VIRUS RES, V155, P274, DOI 10.1016/j.virusres.2010.10.022; Castano A, 2009, VIROLOGY, V386, P417, DOI 10.1016/j.virol.2009.01.017; Chattopadhyay M, 2014, VIROLOGY, V458, P43, DOI 10.1016/j.virol.2014.03.027; Chattopadhyay M, 2011, VIROLOGY, V417, P113, DOI 10.1016/j.virol.2011.05.007; DANTHINNE X, 1993, MOL CELL BIOL, V13, P3340, DOI 10.1128/MCB.13.6.3340; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Fabian MR, 2006, RNA, V12, P1304, DOI 10.1261/rna.69506; Fabian MR, 2004, J BIOL CHEM, V279, P28862, DOI 10.1074/jbc.M401272200; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gallie DR, 1996, PLANT MOL BIOL, V32, P145, DOI 10.1007/BF00039381; Gazo BM, 2004, J BIOL CHEM, V279, P13584, DOI 10.1074/jbc.M311361200; Guo L, 2001, MOL CELL, V7, P1103, DOI 10.1016/S1097-2765(01)00252-0; Hermann T, 2000, STRUCTURE, V8, pR47, DOI 10.1016/S0969-2126(00)00110-6; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kinard GR, 2002, ACTA HORTIC, P17, DOI 10.17660/ActaHortic.2002.568.1; Komarova AV, 2009, ADV VIRUS RES, V73, P99, DOI 10.1016/S0065-3527(09)73003-9; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Liang XZ, 2002, J VIROL, V76, P12320, DOI 10.1128/JVI.76.23.12320-12324.2002; Lopez-Carrasco A, 2016, RNA BIOL, V13, P83, DOI 10.1080/15476286.2015.1119365; Martinez-Turino S, 2011, VIROLOGY, V413, P310, DOI 10.1016/j.virol.2011.03.001; Meulewaeter F, 2004, NUCLEIC ACIDS RES, V32, P1721, DOI 10.1093/nar/gkh338; Meulewaeter F, 1998, PLANT J, V14, P169, DOI 10.1046/j.1365-313X.1998.00104.x; Miller WA, 2007, BIOCHEM SOC T, V35, P1629, DOI 10.1042/BST0351629; Miras M, 2014, NEW PHYTOL, V202, P233, DOI 10.1111/nph.12650; Nicholson BL, 2013, J VIROL, V87, P1872, DOI 10.1128/JVI.02711-12; Nicholson BL, 2011, CURR OPIN VIROL, V1, P373, DOI 10.1016/j.coviro.2011.10.002; Nicholson BL, 2010, RNA, V16, P1402, DOI 10.1261/rna.2135210; Panavas T, 2002, VIROLOGY, V296, P263, DOI 10.1006/viro.2002.1423; Parsch J, 2000, GENETICS, V154, P909; Perez-Canamas M, 2015, J BIOL CHEM, V290, P3106, DOI 10.1074/jbc.M114.593707; Kneller ELP, 2006, VIRUS RES, V119, P63, DOI 10.1016/j.virusres.2005.10.010; Pogany J, 2003, EMBO J, V22, P5602, DOI 10.1093/emboj/cdg523; Rakotondrafara AM, 2006, RNA, V12, P1893, DOI 10.1261/rna.115606; Rico P, 2006, J VIROL, V80, P8124, DOI 10.1128/JVI.00603-06; Rochon D, 2014, ICTV TAXONOMIC PROPO; Rochon D., 2012, 9 REPORT INT COMMITT, P1111, DOI DOI 10.1007/S00705-003-0258-7; Scheets K, 2015, ICTV TAXONOMIC PROPO; Scheets K, 2015, ARCH VIROL, V160, P2385, DOI 10.1007/s00705-015-2500-5; Simon AE, 2013, ANNU REV MICROBIOL, V67, P21, DOI 10.1146/annurev-micro-092412-155609; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; SONG CZ, 1995, J MOL BIOL, V254, P6, DOI 10.1006/jmbi.1995.0594; Stupina VA, 2011, J VIROL, V85, P4638, DOI 10.1128/JVI.00005-11; TIMMER RT, 1993, J BIOL CHEM, V268, P9504; Truniger V, 2008, PLANT J, V56, P716, DOI 10.1111/j.1365-313X.2008.03630.x; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Van Lipzig R, 2002, RNA, V8, P229, DOI 10.1017/S1355838202018071; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wu BD, 1999, J VIROL, V73, P8982, DOI 10.1128/JVI.73.11.8982-8988.1999; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	11	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152593	10.1371/journal.pone.0152593	http://dx.doi.org/10.1371/journal.pone.0152593			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043436	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100018
J	Nguyen, C; Carlson, JM				Chantal Nguyen; Carlson, Jean M.			Optimizing Real-Time Vaccine Allocation in a Stochastic SIR Model	PLOS ONE			English	Article							FOOT	Real-time vaccination following an outbreak can effectively mitigate the damage caused by an infectious disease. However, in many cases, available resources are insufficient to vaccinate the entire at-risk population, logistics result in delayed vaccine deployment, and the interaction between members of different cities facilitates a wide spatial spread of infection. Limited vaccine, time delays, and interaction (or coupling) of cities lead to tradeoffs that impact the overall magnitude of the epidemic. These tradeoffs mandate investigation of optimal strategies that minimize the severity of the epidemic by prioritizing allocation of vaccine to specific subpopulations. We use an SIR model to describe the disease dynamics of an epidemic which breaks out in one city and spreads to another. We solve a master equation to determine the resulting probability distribution of the final epidemic size. We then identify tradeoffs between vaccine, time delay, and coupling, and we determine the optimal vaccination protocols resulting from these tradeoffs.	[Chantal Nguyen; Carlson, Jean M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Nguyen, C (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	cnguyen@physics.ucsb.edu		Nguyen, Chantal/0000-0001-7354-8147	David and Lucile Packard Foundation; Institute for Collaborative Biotechnologies from U.S. Army Research Office [W911NF-09-D-0001]; David and Lucile Packard Foundation; Institute for Collaborative Biotechnologies from U.S. Army Research Office [W911NF-09-D-0001]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Institute for Collaborative Biotechnologies from U.S. Army Research Office; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Institute for Collaborative Biotechnologies from U.S. Army Research Office	This work was supported by the David and Lucile Packard Foundation (https://www.packard.org/) and the Institute for Collaborative Biotechnologies (https://www.icb.ucsb.edu/) through contract no. W911NF-09-D-0001 from the U.S. Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN LJS, 1991, MATH BIOSCI, V105, P111, DOI 10.1016/0025-5564(91)90051-J; BAILEY NTJ, 1953, BIOMETRIKA, V40, P177, DOI 10.2307/2333107; Black AJ, 2015, J THEOR BIOL, V367, P159, DOI 10.1016/j.jtbi.2014.11.029; Black AJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1019; Borse RH, 2013, EMERG INFECT DIS, V19, P439, DOI 10.3201/eid1903.120394; Centers for Disease Control, 2009, ALL DISTR Q A; Earn DJD, 1998, P ROY SOC B-BIOL SCI, V265, P7, DOI 10.1098/rspb.1998.0256; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Hethcote H.W., 1973, Mathematical Biosci, V18, P365, DOI 10.1016/0025-5564(73)90011-4; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; House T, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2012.0436; Jenkinson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036160; Keeling MJ, 2012, EPIDEMICS-NETH, V4, P78, DOI 10.1016/j.epidem.2012.03.001; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Klepac P, 2011, P NATL ACAD SCI USA, V108, P14366, DOI 10.1073/pnas.1101694108; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Matrajt L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002964; Petrovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033285; Rhodes CJ, 1997, P ROY SOC B-BIOL SCI, V264, P1639, DOI 10.1098/rspb.1997.0228; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Yen C, 2015, LANCET INFECT DIS, V15, P340, DOI 10.1016/S1473-3099(14)70999-5; Yuan EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115826	25	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152950	10.1371/journal.pone.0152950	http://dx.doi.org/10.1371/journal.pone.0152950			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043931	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100054
J	Slatyer, RA; Schoville, SD				Slatyer, Rachel A.; Schoville, Sean D.			Physiological Limits along an Elevational Gradient in a Radiation of Montane Ground Beetles	PLOS ONE			English	Article							THERMAL TOLERANCE; WATER-LOSS; RANGE LIMITS; STRESS RESISTANCE; TEMPERATURE; COLEOPTERA; CARABIDAE; SURVIVAL; INSECTS; TRAITS	A central challenge in ecology and biogeography is to determine the extent to which physiological constraints govern the geographic ranges of species along environmental gradients. This study tests the hypothesis that temperature and desiccation tolerance are associated with the elevational ranges of 12 ground beetle species (genus Nebria) occurring on Mt. Rainier, Washington, U.S.A. Species from higher elevations did not have greater cold tolerance limits than lower-elevation species (all species ranged from -3.5 to -4.1 degrees C), despite a steep decline in minimum temperature with elevation. Although heat tolerance limits varied among species (from 32.0 to 37.0 degrees C), this variation was not generally associated with the relative elevational range of a species. Temperature gradients and acute thermal tolerance do not support the hypothesis that physiological constraints drive species turnover with elevation. Measurements of intraspecific variation in thermal tolerance limits were not significant for individuals taken at different elevations on Mt. Rainier, or from other mountains in Washington and Oregon. Desiccation resistance was also not associated with a species' elevational distribution. Our combined results contrast with previously-detected latitudinal gradients in acute physiological limits among insects and suggest that other processes such as chronic thermal stress or biotic interactions might be more important in constraining elevational distributions in this system.	[Slatyer, Rachel A.] Univ Melbourne, Sch Biosci, Parkville, Vic 3052, Australia; [Slatyer, Rachel A.] Univ Melbourne, Inst Bio21, Parkville, Vic 3052, Australia; [Schoville, Sean D.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Melbourne; University of Melbourne; University of Wisconsin System; University of Wisconsin Madison	Slatyer, RA (corresponding author), Univ Melbourne, Sch Biosci, Parkville, Vic 3052, Australia.; Slatyer, RA (corresponding author), Univ Melbourne, Inst Bio21, Parkville, Vic 3052, Australia.	rslatyer@gmail.com	Schoville, Sean D./J-8061-2012; Schoville, Sean D./AAY-5324-2020	Schoville, Sean D./0000-0001-7364-434X; Schoville, Sean D./0000-0001-7364-434X	National Geographic Young Explorer's Grant [9502-14]; Seattle City Light Wildlife Research Grant [2014-03]; University of Melbourne; University of Wisconsin	National Geographic Young Explorer's Grant(National Geographic Society); Seattle City Light Wildlife Research Grant; University of Melbourne(University of Melbourne); University of Wisconsin	Funding was provided by a National Geographic Young Explorer's Grant to RAS (#9502-14), a Seattle City Light Wildlife Research Grant to SDS (#2014-03), the University of Melbourne and the University of Wisconsin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Addo-Bediako A, 2001, J INSECT PHYSIOL, V47, P1377, DOI 10.1016/S0022-1910(01)00128-7; AHEARN GA, 1970, J EXP BIOL, V53, P573; Akaike H, 1973, 2 INT S INF THEOR, P276; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Bassler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065842; Bird JM, 2005, ECOL ENTOMOL, V30, P510, DOI 10.1111/j.0307-6946.2005.00719.x; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; BRETT JR, 1956, Q REV BIOL, V31, P75, DOI 10.1086/401257; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Cadena CD, 2007, ECOGRAPHY, V30, P491, DOI 10.1111/j.2007.0906-7590.05045.x; Cahill AE, 2014, J BIOGEOGR, V41, P429, DOI 10.1111/jbi.12231; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Chown SL, 2011, J INSECT PHYSIOL, V57, P1070, DOI 10.1016/j.jinsphys.2011.05.004; Crozier LG, 2004, OECOLOGIA, V141, P148, DOI 10.1007/s00442-004-1634-z; Cunningham HR, 2016, ECOGRAPHY, V39, P1, DOI 10.1111/ecog.01369; de lasVega G.J., 2015, ECOGRAPHY, V38, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10.1111/EC0G.01028; Drummond A., 2007, TRACER MCMC TRACE AN; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endler J.A., 1977, Monographs in Population Biology, pi; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Freckleton RP, 2009, J EVOLUTION BIOL, V22, P1367, DOI 10.1111/j.1420-9101.2009.01757.x; Freckleton RP, 2009, P ROY SOC B-BIOL SCI, V276, P21, DOI 10.1098/rspb.2008.0905; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Gaston KJ, 1999, OIKOS, V86, P584, DOI 10.2307/3546663; Geiger R., 1995, CLIMATE NEAR GROUND; GEREBEN BA, 1995, ARCTIC ALPINE RES, V27, P371, DOI 10.2307/1552030; Gifford ME, 2012, ECOGRAPHY, V35, P193, DOI 10.1111/j.1600-0587.2011.06866.x; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Greene SE, 1985, SOIL AIR TEMPERATURE, P50; Grinnell J, 1914, AM NAT, V48, P248, DOI 10.1086/279402; HADLEY NF, 1985, COMP BIOCHEM PHYS A, V80, P307, DOI 10.1016/0300-9629(85)90042-8; Hargreaves AL, 2014, AM NAT, V183, P157, DOI 10.1086/674525; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hayward SAL, 2001, J INSECT PHYSIOL, V47, P11, DOI 10.1016/S0022-1910(00)00088-3; Hazell SP, 2008, PHYSIOL ENTOMOL, V33, P389, DOI 10.1111/j.1365-3032.2008.00637.x; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; HUNTLEY B, 1989, J BIOGEOGR, V16, P551, DOI 10.2307/2845210; Hutchinson G.E., 1957, COLD SPRING HARBOR S; Jombart T., 2008, ADEPHYLO EXPLORATORY; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kamp J.W., 1973, BIOSYSTEMATICS GRYLL; Kavanaugh D.H., 1979, P369; Kavanaugh D.H., 1979, P35; Kavanaugh D.H, 1978, NEARCTIC SPECIES NEB; Kavanaugh D.H., 1985, TAXONOMY PHYLOGENY Z, P408; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Koivula MJ, 2011, ZOOKEYS, P287, DOI 10.3897/zookeys.100.1533; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Larsen TH, 2012, BIOTROPICA, V44, P82, DOI 10.1111/j.1744-7429.2011.00768.x; Lee JE, 2009, P ROY SOC B-BIOL SCI, V276, P1459, DOI 10.1098/rspb.2008.1240; MacArthur R.H., 1972, pvii; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; MacMillan HA, 2014, J EXP BIOL, V217, P2930, DOI 10.1242/jeb.107516; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Mani M. S., 1968, ECOLOGY BIOGEOGRAPHY, P71; MANN DH, 1980, ARCTIC ALPINE RES, V12, P359, DOI 10.2307/1550722; Mellanby K, 1939, PROC R SOC SER B-BIO, V127, P473, DOI 10.1098/rspb.1939.0035; MesoWest, 2014, MESOWEST DAT ARCH; Minder JR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013493; Monasterio C, 2011, ECOGRAPHY, V34, P1030, DOI 10.1111/j.1600-0587.2010.06905.x; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Neargarder G, 2003, FUNCT ECOL, V17, P213, DOI 10.1046/j.1365-2435.2003.00722.x; Normand S, 2009, GLOBAL ECOL BIOGEOGR, V18, P437, DOI 10.1111/j.1466-8238.2009.00451.x; Nylander J.A.A., 2008, MRMODELTEST V2; Orme D., 2018, R PACKAGE VERSION, V5, P1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parkash R, 2008, J INSECT PHYSIOL, V54, P1050, DOI 10.1016/j.jinsphys.2008.04.008; Rangel TF, 2015, EVOLUTION, V69, P1301, DOI 10.1111/evo.12644; Raso L, 2014, MOL ECOL, V23, P3744, DOI 10.1111/mec.12649; Renault D, 2011, ECOL ENTOMOL, V36, P36, DOI 10.1111/j.1365-2311.2010.01243.x; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Schiffer M, 2013, J EXP BIOL, V216, P3790, DOI 10.1242/jeb.085126; Schoville SD, 2015, J INSECT PHYSIOL, V78, P55, DOI 10.1016/j.jinsphys.2015.04.014; Schoville SD, 2012, BIOL J LINN SOC, V107, P95, DOI 10.1111/j.1095-8312.2012.01911.x; Siefert A, 2015, GLOBAL ECOL BIOGEOGR, V24, P581, DOI 10.1111/geb.12287; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Slatyer RA, 2016, ECOGRAPHY, V39, P572, DOI 10.1111/ecog.01616; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; Spence J.R., 1979, P525; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Sundqvist MK, 2013, ANNU REV ECOL EVOL S, V44, P261, DOI 10.1146/annurev-ecolsys-110512-135750; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Thiele H. -U., 1977, CARABID BEETLES THEI, DOI 10.1007/978-3-642-81154-8; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Williams JB, 2003, J EXP ZOOL PART A, V298A, P23, DOI 10.1002/jez.a.10264; Woods HA, 2015, J THERM BIOL, V54, P86, DOI 10.1016/j.jtherbio.2014.10.002; WORLAND MR, 1986, J INSECT PHYSIOL, V32, P579, DOI 10.1016/0022-1910(86)90075-2; Zalewski M, 2014, ANN ZOOL FENN, V51, P301, DOI 10.5735/086.051.0302	102	17	18	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0151959	10.1371/journal.pone.0151959	http://dx.doi.org/10.1371/journal.pone.0151959			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043311	gold, Green Submitted, Green Published			2022-12-26	WOS:000373592100006
J	Fong, KP; Zhu, H; Span, LM; Moore, DT; Yoon, K; Tamura, R; Yin, H; DeGrado, WF; Bennett, JS				Fong, Karen P.; Zhu, Hua; Span, Lisa M.; Moore, David T.; Yoon, Kyungchul; Tamura, Ryo; Yin, Hang; DeGrado, William F.; Bennett, Joel S.			Directly Activating the Integrin alpha IIb beta 3 Initiates Outside-In Signaling by Causing alpha IIb beta 3 Clustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; CALCIUM-BINDING DOMAIN; TALIN HEAD DOMAIN; GLANZMANN THROMBASTHENIA; TRANSMEMBRANE DOMAIN; SRC; FIBRINOGEN; ADHESION; PHOSPHORYLATION; ADHESIVENESS	alpha IIb beta 3 activation in platelets is followed by activation of the tyrosine kinase c-Src associated with the carboxyl terminus of the beta 3 cytosolic tail. Exogenous peptides designed to interact with the alpha IIb transmembrane (TM) domain activate single alpha IIb beta 3 molecules in platelets by binding to the alpha IIb TM domain and causing separation of the alpha IIb beta 3 TM domain heterodimer. Here we asked whether directly activating single alpha IIb beta 3 molecules in platelets using the designed peptide anti-alpha IIb TM also initiates alpha IIb beta 3-mediated outside-in signaling by causing activation of beta 3-associated c-Src. Anti-alpha IIb TM caused activation of beta 3-associated c-Src and the kinase Syk, but not the kinase FAK, under conditions that precluded extracellular ligand binding to alpha IIb beta 3. c-Src and Syk are activated by trans-autophosphorylation, suggesting that activation of individual alpha IIb beta 3 molecules can initiate alpha IIb beta 3 clustering in the absence of ligand binding. Consistent with this possibility, incubating platelets with anti-alpha IIb TM resulted in the redistribution of alpha IIb beta 3 from a homogenous ring located at the periphery of discoid platelets into nodular densities consistent with clustered alpha IIb beta 3. Thus, these studies indicate that not only is resting alpha IIb beta 3 poised to undergo a conformational change that exposes its ligand-binding site, but it is poised to rapidly assemble into intracellular signal-generating complexes as well.	[Fong, Karen P.; Zhu, Hua; Span, Lisa M.; Yoon, Kyungchul; Bennett, Joel S.] Univ Penn, Perelman Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Moore, David T.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Tamura, Ryo; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80030 USA; [Tamura, Ryo; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80030 USA; [DeGrado, William F.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Francisco	Bennett, JS (corresponding author), Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA.	bennetts@mail.med.upenn.edu			National Institutes of Health [HL40387, HL120846, GM54616, GM103843]; National Science Foundation [CHEM0954819]; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387, P01HL120846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103843, R01GM054616, R37GM054616] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Institutes of Health Grants HL40387, HL120846, GM54616, and GM103843; National Science Foundation Grant CHEM0954819; and bridge funding from the American Society of Hematology. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Basani RB, 1996, BLOOD, V88, P167; Basani RB, 2001, J BIOL CHEM, V276, P13975, DOI 10.1074/jbc.M011511200; Bennett JS, 2001, ANNU REV MED, V52, P161, DOI 10.1146/annurev.med.52.1.161; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bottcher RT, 2009, CURR OPIN CELL BIOL, V21, P670, DOI 10.1016/j.ceb.2009.05.008; Boylan B, 2008, BLOOD, V112, P2780, DOI 10.1182/blood-2008-02-142125; Brahme NN, 2013, J BIOL CHEM, V288, P35604, DOI 10.1074/jbc.M113.483016; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Caputo GA, 2008, BIOCHEMISTRY-US, V47, P8600, DOI 10.1021/bi800687h; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Choma C, 2000, NAT STRUCT BIOL, V7, P161; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Cristian L, 2005, J MOL BIOL, V348, P1225, DOI 10.1016/j.jmb.2005.03.053; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Fox JEB, 1996, J BIOL CHEM, V271, P7004, DOI 10.1074/jbc.271.12.7004; Gao J, 1997, EMBO J, V16, P6414, DOI 10.1093/emboj/16.21.6414; GOLDEN A, 1989, P NATL ACAD SCI USA, V86, P901, DOI 10.1073/pnas.86.3.901; Goult BT, 2013, J STRUCT BIOL, V184, P21, DOI 10.1016/j.jsb.2013.05.014; Gradler U, 2013, J MOL BIOL, V425, P309, DOI 10.1016/j.jmb.2012.11.007; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Jones CI, 2014, J THROMB HAEMOST, V12, P1342, DOI 10.1111/jth.12620; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Lam WA, 2011, NAT MATER, V10, P61, DOI 10.1038/NMAT2903; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; Liu J, 2008, J THROMB HAEMOST, V6, P1035, DOI 10.1111/j.1538-7836.2008.02958.x; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; PONCZ M, 1994, J CLIN INVEST, V93, P172, DOI 10.1172/JCI116942; Senis YA, 2014, BLOOD, V124, P2013, DOI 10.1182/blood-2014-01-453134; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Tang J, 2009, J AM CHEM SOC, V131, P3816, DOI 10.1021/ja809007f; TANIGUCHI T, 1993, J BIOL CHEM, V268, P2277; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wang W, 2011, J BIOL CHEM, V286, P1860, DOI 10.1074/jbc.M110.193797; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Woodside DG, 2001, CURR BIOL, V11, P1799, DOI 10.1016/S0960-9822(01)00565-6; Wu YB, 2015, J BIOL CHEM, V290, P15825, DOI 10.1074/jbc.M115.648428; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Zhu JQ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003576	53	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11706	11716		10.1074/jbc.M116.716613	http://dx.doi.org/10.1074/jbc.M116.716613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27056329	Green Published, hybrid			2022-12-26	WOS:000377264800021
J	Yamashita, D; Moriuchi, T; Osumi, T; Hirose, F				Yamashita, Daisuke; Moriuchi, Takanobu; Osumi, Takashi; Hirose, Fumiko			Transcription Factor hDREF Is a Novel SUMO E3 Ligase of Mi2 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; CELL-PROLIFERATION; CHROMATIN; COMPLEX; PROTEIN; SUMOYLATION; NURD; PROMOTERS; POLYCOMB; DREF	The human transcription factor DNA replication-related element-binding factor (hDREF) is essential for the transcription of a number of housekeeping genes. The mechanisms underlying constitutively active transcription by hDREF were unclear. Here, we provide evidence that hDREF possesses small ubiquitin-like modifier (SUMO) ligase activity and can specifically SUMOylate Mi2 alpha, an ATP-dependent DNA helicase in the nucleosome remodeling and deacetylation complex. Moreover, immunofluorescent staining and biochemical analyses showed that coexpression of hDREF and SUMO-1 resulted in dissociation of Mi2 alpha from chromatin, whereas a SUMOylation-defective Mi2 alpha mutant remained tightly bound to chromatin. Chromatin immunoprecipitation and quantitative RT-PCR analysis demonstrated that Mi2 alpha expression diminished transcription of the ribosomal protein genes, which are positively regulated by hDREF. In contrast, coexpression of hDREF and SUMO-1 suppressed the transcriptional repression by Mi2 alpha. These data indicate that hDREF might incite transcriptional activation by SUMOylating Mi2 alpha, resulting in the dissociation of Mi2 alpha from the gene loci. We propose a novel mechanism for maintaining constitutively active states of a number of hDREF target genes through SUMOylation.	[Yamashita, Daisuke; Moriuchi, Takanobu; Osumi, Takashi; Hirose, Fumiko] Univ Hyogo, Grad Sch Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan	University of Hyogo	Hirose, F (corresponding author), Univ Hyogo, Grad Sch Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan.	fhirose@sci.u-hyogo.ac.jp		Hirose, Fumiko/0000-0003-4586-4892; Yamashita, Daisuke/0000-0001-6054-5617	Japan Society for the Promotion of Science (JSPS) [KAKENHI 20570188]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant KAKENHI 20570188 (to F. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Aubry F, 1998, EUR J BIOCHEM, V254, P558, DOI 10.1046/j.1432-1327.1998.2540558.x; Basta J, 2015, TRANSL RES, V165, P36, DOI 10.1016/j.trsl.2014.05.003; Becker PB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017905; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bottardi S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004827; Dundr M, 2012, CURR OPIN CELL BIOL, V24, P415, DOI 10.1016/j.ceb.2012.03.010; Duprez E, 1999, J CELL SCI, V112, P381; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Hart CM, 1999, CHROMOSOMA, V108, P375, DOI 10.1007/s004120050389; Hirose F, 1996, J BIOL CHEM, V271, P3930; Hirose F, 2002, MOL CELL BIOL, V22, P5182, DOI 10.1128/MCB.22.14.5182-5193.2002; Hirose F, 2001, MOL CELL BIOL, V21, P7231, DOI 10.1128/MCB.21.21.7231-7242.2001; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kamitani T, 1997, J BIOL CHEM, V272, P14001, DOI 10.1074/jbc.272.22.14001; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Le Drean Y, 2002, ENDOCRINOLOGY, V143, P3482, DOI 10.1210/en.2002-220135; Lhoumaud P, 2014, EMBO J, V33, P1599, DOI 10.15252/embj.201385965; Liu HW, 2012, NUCLEIC ACIDS RES, V40, P10172, DOI 10.1093/nar/gks819; Luse DS, 2012, TRANSCR-AUSTIN, V3, P156, DOI 10.4161/trns.20725; Matsukage A, 2008, BBA-GENE REGUL MECH, V1779, P81, DOI 10.1016/j.bbagrm.2007.11.011; Meier K, 2014, EPIGENETICS-US, V9, P1485, DOI 10.4161/15592294.2014.971580; Ohshima N, 2003, J BIOL CHEM, V278, P22928, DOI 10.1074/jbc.M303109200; Ookawa K, 1997, ONCOGENE, V14, P1389, DOI 10.1038/sj.onc.1200976; Pirrotta V, 2012, CURR OPIN GENET DEV, V22, P101, DOI 10.1016/j.gde.2011.11.004; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Saether T, 2007, J BIOL CHEM, V282, P13994, DOI 10.1074/jbc.M700755200; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Schweikhard V, 2014, P NATL ACAD SCI USA, V111, P6642, DOI 10.1073/pnas.1405181111; Shimbo T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004028; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Torchy MP, 2015, CELL MOL LIFE SCI, V72, P2491, DOI 10.1007/s00018-015-1880-8; Trung N. T., 2014, J PROTEOM BIOINFORM, DOI [10.4172/jpb.1000306, DOI 10.4172/JPB.1000306]; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Vethantham Vasupradha, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5121; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yamashita D, 2007, MOL CELL BIOL, V27, P2003, DOI 10.1128/MCB.01462-06; Yamashita D, 2007, J BIOL CHEM, V282, P7563, DOI 10.1074/jbc.M607180200; Yan Q, 2010, P NATL ACAD SCI USA, V107, P21034, DOI 10.1073/pnas.1007866107; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383	55	18	18	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11619	11634		10.1074/jbc.M115.713370	http://dx.doi.org/10.1074/jbc.M115.713370			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27068747	Green Published, hybrid			2022-12-26	WOS:000377264800014
J	Yu, SY; Li, FY; Xing, SJ; Zhao, TY; Peng, WQ; Xue, HH				Yu, Shuyang; Li, Fengyin; Xing, Shaojun; Zhao, Tianyan; Peng, Weiqun; Xue, Hai-Hui			Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-catenin (-catenin); gene regulation; hematopoietic stem cells; transcription factor; Wnt pathway; leukemic stem cells; self-renewal	CHRONIC MYELOID-LEUKEMIA; BETA-CATENIN; SELF-RENEWAL; BONE-MARROW; IN-VIVO; WNT/BETA-CATENIN; OXIDATIVE STRESS; LONG-TERM; T-CELLS; WNT	Hematopoietic and leukemic stem cells (HSCs and LSCs) have self-renewal ability to maintain normal hematopoiesis and leukemia propagation, respectively. Tcf1 and Lef1 transcription factors are expressed in HSCs, and targeting both factors modestly expanded the size of the HSC pool due to diminished HSC quiescence. Functional defects of Tcf1/Lef1-deficient HSCs in multi-lineage blood reconstitution was only evident under competitive conditions or when subjected to repeated regenerative stress. These are mechanistically due to direct positive regulation of Egr and Tcf3 by Tcf1 and Lef1, and significantly, forced expression of Egr1 in Tcf1/Lef1-deficient HSCs restored HSC quiescence. In a preclinical CML model, loss of Tcf1/Lef1 did not show strong impact on leukemia initiation and progression. However, when transplanted into secondary recipients, Tcf1/Lef1-deficient LSCs failed to propagate CML. By induced deletion of Tcf1 and Lef1 in pre-established CML, we further demonstrated an intrinsic requirement for these factors in LSC self-renewal. When combined with imatinib therapy, genetic targeting of Tcf1 and Lef1 potently diminished LSCs and conferred better protection to the CML recipients. LSCs are therefore more sensitive to loss of Tcf1 and Lef1 than HSCs in their self-renewal capacity. The differential requirements in HSCs and LSCs thus identify Tcf1 and Lef1 transcription factors as novel therapeutic targets in treating hematological malignancies, and inhibition of Tcf1/Lef1-regulated transcriptional programs may thus provide a therapeutic window to eliminate LSCs with minimal side effect on normal HSC functions.	[Yu, Shuyang; Zhao, Tianyan] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Li, Fengyin; Xing, Shaojun; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	China Agricultural University; George Washington University; University of Iowa	Yu, SY (corresponding author), 51 Newton Rd BSB 3-772, Iowa City, IA 52246 USA.	ysy@cau.edu.cn	/AAI-2516-2019; Li, Fengyin/AAG-9476-2019	Xing, Shaojun/0000-0003-0777-2196; Peng, Weiqun/0000-0001-5521-9091; Xue, Hai-Hui/0000-0002-9163-7669	American Cancer Society [RSG-11-161-01-MPC]; National Institutes of Health [AI105351, AI112579, AI115149, AI119160, AI113806]; U. S. Department of Veteran Affairs [I01 BX002903]; Chinese Universities Scientific Fund [2014RC004]; National Natural Science Foundation of China [31422037, 31571522]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112579, R21AI119160, R21AI105351, R21AI115149] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002903] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Veteran Affairs(US Department of Veterans Affairs); Chinese Universities Scientific Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This study is supported in-part by grants from the American Cancer Society (RSG-11-161-01-MPC, to H.-H. X.), the National Institutes of Health (AI105351, AI112579, AI115149, and AI119160, to H.-H. X.), and the U. S. Department of Veteran Affairs (Merit Review Award I01 BX002903 to H.-H. X., Biomedical laboratory Research and Development Program). H.-H. X. is the founder of Cure-it LifeSciences, and this capacity has no roles in experimental design and data interpretation in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Veteran Affairs.; Supported by the Chinese Universities Scientific Fund (2014RC004) and National Natural Science Foundation of China (31422037 and 31571522). To whom correspondence may be addressed: 2 Yuanmingyuan West Rd., Haidian District, Beijing 100193, China. E-mail: ysy@cau.edu.cn.; Supported by a National Institutes of Health Grant AI113806.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Ashton JM, 2012, CELL STEM CELL, V11, P359, DOI 10.1016/j.stem.2012.05.024; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; Carleton M, 2002, J IMMUNOL, V168, P1649, DOI 10.4049/jimmunol.168.4.1649; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Edmaier KE, 2014, LEUKEMIA, V28, P227, DOI 10.1038/leu.2013.238; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Guo J, 2010, CELL METAB, V11, P161, DOI 10.1016/j.cmet.2009.12.007; Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261; Heidel FH, 2012, CELL STEM CELL, V10, P412, DOI 10.1016/j.stem.2012.02.017; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Lento W, 2014, GENE DEV, V28, P995, DOI 10.1101/gad.231944.113; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Luis TC, 2010, BLOOD, V116, P496, DOI 10.1182/blood-2010-04-282624; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Nemeth MJ, 2009, STEM CELLS, V27, P1109, DOI 10.1002/stem.32; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Petropoulos K, 2008, J EXP MED, V205, P515, DOI 10.1084/jem.20071875; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ross DM, 2010, LEUKEMIA, V24, P1719, DOI 10.1038/leu.2010.185; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Ruiz-Herguido C, 2012, J EXP MED, V209, P1457, DOI 10.1084/jem.20120225; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schaniel C, 2011, BLOOD, V118, P2420, DOI 10.1182/blood-2010-09-305664; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Steinke FC, 2014, IMMUNOL RES, V59, P45, DOI 10.1007/s12026-014-8545-9; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Tesio M, 2011, CELL STEM CELL, V9, P187, DOI 10.1016/j.stem.2011.08.005; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wu JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002565; Xu M, 2009, J IMMUNOL, V182, P751, DOI 10.4049/jimmunol.182.2.751; Yang Q, 2011, BLOOD, V117, P3529, DOI 10.1182/blood-2010-07-297689; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Yu SY, 2012, CELL STEM CELL, V11, P207, DOI 10.1016/j.stem.2012.05.021; Yu SY, 2011, BLOOD, V117, P2166, DOI 10.1182/blood-2010-09-306563; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	57	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11148	11160		10.1074/jbc.M116.717801	http://dx.doi.org/10.1074/jbc.M116.717801			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27044748	hybrid, Green Published			2022-12-26	WOS:000377042100018
J	Niu, JK; Miao, JR; Tang, Y; Nan, Q; Liu, Y; Yang, G; Dong, XQ; Huang, Q; Xia, SX; Wang, KH; Miao, YL				Niu, Junkun; Miao, Jiarong; Tang, Yuan; Nan, Qiong; Liu, Yan; Yang, Gang; Dong, Xiangqian; Huang, Qi; Xia, Shuxian; Wang, Kunhua; Miao, Yinglei			Identification of Environmental Factors Associated with Inflammatory Bowel Disease in a Southwestern Highland Region of China: A Nested Case-Control Study	PLOS ONE			English	Article							ULCERATIVE-COLITIS; RISK-FACTORS; HYGIENE HYPOTHESIS; CROHNS-DISEASE; APPENDECTOMY; POPULATION; LIFE; IBD; METAANALYSIS; ANTIBIOTICS	Background The aim of this study was to examine environmental factors associated with inflammatory bowel disease (IBD) in Yunnan Province, a southwestern highland region of China. Methods In this nested case-control study, newly diagnosed ulcerative colitis (UC) cases in 2 cities in Yunnan Province and Crohn's disease (CD) cases in 16 cities in Yunnan Province were recruited between 2008 and 2013. Controls were matched by geography, sex and age at a ratio of 1:4. Data were collected using the designed questionnaire. Conditional logistic regression models were used to estimate adjusted odds ratios (ORs). Results A total of 678 UC and 102 CD cases were recruited. For UC, various factors were associated with an increased risk of developing UC: dietary habits, including frequent irregular meal times; consumption of fried foods, salty foods and frozen dinners; childhood factors, including intestinal infectious diseases and frequent use of antibiotics; and other factors, such as mental labor, high work stress, use of non-aspirin non-steroidal anti-inflammatory drugs and allergies (OR > 1, p < 0.05). Other factors showed a protective effect: such as consumption of fruits, current smoking, physical activity, and drinking tea (OR < 1, p < 0.05). For CD, appendectomy and irregular meal times increased the disease risk (OR > 1, p < 0.05), whereas physical activity may have reduced this risk (OR < 1, p < 0.05). Conclusions This study is the first nested case-control study to analyze the association between environmental factors and IBD onset in a southwestern highland region of China. Certain dietary habits, lifestyles, allergies and childhood factors may play important roles in IBD, particularly UC.	[Niu, Junkun; Miao, Jiarong; Nan, Qiong; Liu, Yan; Yang, Gang; Dong, Xiangqian; Huang, Qi; Xia, Shuxian; Miao, Yinglei] Kunming Med Univ, Yunnan Inst Digest Dis, Affiliated Hosp 1, Dept Gastroenterol, Kunming, Yunnan Province, Peoples R China; [Tang, Yuan] First Peoples Hosp Qujing, Dept Gastroenterol, Qujing, Yunnan Province, Peoples R China; [Wang, Kunhua] Kunming Med Univ, Affiliated Hosp 1, Dept Gen Surg, Yunnan Inst Digest Dis, Kunming, Yunnan Province, Peoples R China	Kunming Medical University; Kunming Medical University	Miao, YL (corresponding author), Kunming Med Univ, Yunnan Inst Digest Dis, Affiliated Hosp 1, Dept Gastroenterol, Kunming, Yunnan Province, Peoples R China.; Wang, KH (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Gen Surg, Yunnan Inst Digest Dis, Kunming, Yunnan Province, Peoples R China.	wangkunhua1@medmail.com.cn; myldu@sina.com		Niu, Junkun/0000-0001-9458-0138	National Natural Science Foundation of China [81260074, 81160055]; Yunnan Institute of digestive disease [2014NS123]; Medical academic leader of Yunnan Provincial Bureau of Health [D-201215]; Social development of science and technology projects of Yunnan Province [2013CA021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Institute of digestive disease; Medical academic leader of Yunnan Provincial Bureau of Health; Social development of science and technology projects of Yunnan Province	This work was supported by National Natural Science Foundation of China (81260074, 81160055), Yunnan Institute of digestive disease (2014NS123), Medical academic leader of Yunnan Provincial Bureau of Health (D-201215), and Social development of science and technology projects of Yunnan Province (2013CA021).	Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Ananthakrishnan AN, 2012, ANN INTERN MED, V156, P350, DOI 10.7326/0003-4819-156-5-201203060-00007; Beaugerie L, 2010, INFLAMM BOWEL DIS, V16, P356, DOI 10.1002/ibd.21064; Bernstein CN, 2008, GUT, V57, P1185, DOI 10.1136/gut.2007.122143; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x; Burisch J, 2013, CURR OPIN GASTROEN, V29, P357, DOI 10.1097/MOG.0b013e32836229fb; Danese S, 2006, WORLD J GASTROENTERO, V12, P4807; De Vroey B, 2010, AM J GASTROENTEROL, V105, P2693, DOI 10.1038/ajg.2010.396; Dixon LJ, 2015, INFLAMM BOWEL DIS, V21, P912, DOI 10.1097/MIB.0000000000000289; Farzaei MH, 2015, CURR PHARM BIOTECHNO, V16, P196, DOI 10.2174/1389201016666150118131704; Gearry RB, 2010, J GASTROEN HEPATOL, V25, P325, DOI 10.1111/j.1440-1746.2009.06140.x; Gismera CS, 2008, WORLD J GASTROENTERO, V14, P5491, DOI 10.3748/wjg.14.5491; Guldan G S, 1995, J Hum Lact, V11, P11, DOI 10.1177/089033449501100116; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Kaplan GG, 2008, AM J GASTROENTEROL, V103, P2925, DOI 10.1111/j.1572-0241.2008.02118.x; Khalili H, 2013, GUT, V62, P1153, DOI 10.1136/gutjnl-2012-302362; Koloski NA, 2008, WORLD J GASTROENTERO, V14, P165, DOI 10.3748/wjg.14.165; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lerebours E, 2007, AM J GASTROENTEROL, V102, P122, DOI 10.1111/j.1572-0241.2006.00931.x; Li JK, 2013, EUR J CONTRACEP REPR, V18, P148, DOI 10.3109/13625187.2013.776673; Lopez-Serrano P, 2010, SCAND J GASTROENTERO, V45, P1464, DOI 10.3109/00365521.2010.510575; Luo CH, 2011, COLORECTAL DIS, V13, P166, DOI 10.1111/j.1463-1318.2009.02094.x; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Mosher William D, 2010, Vital Health Stat 23, P1; Naganuma M, 2001, AM J GASTROENTEROL, V96, P1123; Ng SC, 2014, GUT               S1, V146; Ng SC, 2015, J GASTROEN HEPATOL, V30, P440, DOI 10.1111/jgh.12859; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Radford-Smith GL, 2002, GUT, V51, P808, DOI 10.1136/gut.51.6.808; Roblin X, 2012, GUT, V61, P635, DOI 10.1136/gutjnl-2011-300576; Sakamoto N, 2005, INFLAMM BOWEL DIS, V11, P154, DOI 10.1097/00054725-200502000-00009; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Shaw SY, 2010, AM J GASTROENTEROL, V105, P2687, DOI 10.1038/ajg.2010.398	33	27	29	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153524	10.1371/journal.pone.0153524	http://dx.doi.org/10.1371/journal.pone.0153524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070313	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700076
J	Ghoddousi, A; Soofi, M; Hamidi, AK; Lumetsberger, T; Egli, L; Khorozyan, I; Kiabi, BH; Waltert, M				Ghoddousi, Arash; Soofi, Mahmood; Hamidi, Amirhossein Kh.; Lumetsberger, Tanja; Egli, Lukas; Khorozyan, Igor; Kiabi, Bahram H.; Waltert, Matthias			Assessing the Role of Livestock in Big Cat Prey Choice Using Spatiotemporal Availability Patterns	PLOS ONE			English	Article							LEOPARDS PANTHERA-PARDUS; NATIONAL-PARK; CAMERA TRAPS; PERSIAN LEOPARD; PREDATION; SELECTION; WILD; HABITAT; KILL; IDENTIFICATION	Livestock is represented in big cat diets throughout the world. Husbandry approaches aim to reduce depredation, which may influence patterns of prey choice, but whether felids have a preference for livestock or not often remains unclear as most studies ignore livestock availability. We assessed prey choice of the endangered Persian leopard (Panthera pardus saxicolor) in Golestan National Park, Iran, where conflict over livestock depredation occurs. We analyzed leopard diet (77 scats) and assessed wild and domestic prey abundance by line transect sampling (186 km), camera-trapping (2777 camera days), double-observer point-counts (64 scans) and questionnaire surveys (136 respondents). Based on interviews with 18 shepherds, we estimated monthly grazing time outside six villages with 96 conflict cases to obtain a small livestock (domestic sheep and goat) availability coefficient. Using this coefficient, which ranged between 0.40 and 0.63 for different villages, we estimated the numbers of sheep and goats available to leopard depredation. Leopard diet consisted mainly of wild boar (Sus scrofa) (50.2% biomass consumed), but bezoar goat (Capra aegagrus) was the most preferred prey species (I-j = 0.73), whereas sheep and goats were avoided (Ij = -0.54). When absolute sheep and goat numbers (similar to 11250) were used instead of the corrected ones (similar to 6392), avoidance of small livestock appeared to be even stronger (Ij = -0.71). We suggest that future assessments of livestock choice by felids should incorporate such case-specific corrections for spatiotemporal patterns of availability, which may vary with husbandry methods. Such an approach increases our understanding of human-felid conflict dynamics and the role of livestock in felid diets.	[Ghoddousi, Arash; Soofi, Mahmood; Lumetsberger, Tanja; Egli, Lukas; Khorozyan, Igor; Waltert, Matthias] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Workgrp Endangered Species, D-37073 Gottingen, Germany; [Soofi, Mahmood; Hamidi, Amirhossein Kh.] Persian Wildlife Heritage Fdn, Tehran, Iran; [Kiabi, Bahram H.] Shahid Beheshti Univ, Fac Biol Sci, GC, Tehran, Iran	University of Gottingen; Shahid Beheshti University	Ghoddousi, A (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Workgrp Endangered Species, D-37073 Gottingen, Germany.	arash.ghoddousi@stud.uni-goettingen.de	Waltert, Matthias/E-9134-2010; Soofi, Mahmood/AAL-5283-2021; Khorozyan, Igor/A-2510-2019; Ghoddousi, Arash/B-3914-2015	Waltert, Matthias/0000-0001-7053-0291; Soofi, Mahmood/0000-0002-6167-2527; Khorozyan, Igor/0000-0002-0657-7500; Ghoddousi, Arash/0000-0001-9605-3091	German Academic Exchange Service (DAAD) [91540556]; Panthera Kaplan Graduate Awards; Erasmus Mundus/SALAM from Alexander von Humboldt Foundation [2013-2437-001-001-EMA2, 1151598]; Mohammed bin Zayed Species Conservation Fund [12255025]; Open Access Grant Program of the German Research Foundation (DFG); Open Access Publication Fund of the University of Gottingen	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Panthera Kaplan Graduate Awards; Erasmus Mundus/SALAM from Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Mohammed bin Zayed Species Conservation Fund; Open Access Grant Program of the German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of the University of Gottingen	AG was supported by German Academic Exchange Service (DAAD; https://www.daad.de, project No. 91540556) and Panthera Kaplan Graduate Awards (http://www.panthera.org/). Erasmus Mundus/SALAM (http://portal.uw.edu.pl/en/web/salam/, project No. 2013-2437-001-001-EMA2) supports MS and IK receives funding from Alexander von Humboldt Foundation (http://www.humboldtfoundation.de/, project No. 1151598). Mohammed bin Zayed Species Conservation Fund supported IK & MS in collection of conflict data from study villages (http://www.speciesconservation.org/, project No. 12255025). This publication was supported financially by the Open Access Grant Program of the German Research Foundation (DFG) and the Open Access Publication Fund of the University of Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhani H., 2005, ILLUSTRATED FLORA GO, V1; Athreya V, 2016, ORYX, V50, P156, DOI 10.1017/S0030605314000106; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Buckland S.T., 2001, pi; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clements HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101054; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cusack JJ, 2015, J WILDLIFE MANAGE, V79, P1014, DOI 10.1002/jwmg.902; De Marinis AM, 2006, WILDLIFE BIOL, V12, P305, DOI 10.2981/0909-6396(2006)12[305:HIKOWA]2.0.CO;2; Firouz E., 2005, COMPLETE FAUNA IRAN; Gervasi V, 2014, J ZOOL, V292, P175, DOI 10.1111/jzo.12088; Ghoddousi A, 2016, ANIM CONSERV, V19, P273, DOI 10.1111/acv.12240; Ghoddousi A, 2010, ORYX, V44, P551, DOI 10.1017/S0030605310000827; Goshtasb H., 2001, THESIS ISLAMIC AZAD; Hamidi Amirhossein Kh., 2014, Cat News, V60, P12; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023607; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Johansson O, 2015, BIOL CONSERV, V184, P251, DOI 10.1016/j.biocon.2015.02.003; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Khorozyan I, 2015, BIOL CONSERV, V192, P268, DOI 10.1016/j.biocon.2015.09.031; Khorozyan I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129221; Kiabi B.H., 1978, THESIS MICHIGAN STAT; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Kuiper TR, 2015, BIOL CONSERV, V191, P546, DOI 10.1016/j.biocon.2015.08.012; Linnell JDC, 1999, WILDLIFE SOC B, V27, P698; Loveridge Andrew J., 2010, P161; Lumetsberger T., 2014, THESIS GEORG AUGUST; Miller JRB, 2015, BIODIVERS CONSERV, V24, P2887, DOI 10.1007/s10531-015-0993-6; Minnie L, 2015, AFR J WILDL RES, V45, P204, DOI 10.3957/056.045.0204; Moa PF, 2006, WILDLIFE BIOL, V12, P63, DOI 10.2981/0909-6396(2006)12[63:DTSDOL]2.0.CO;2; Mondal K, 2011, MAMMALIA, V75, P201, DOI 10.1515/MAMM.2011.011; Mukherjee S, 2013, BIOL REV, V88, P550, DOI 10.1111/brv.12014; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Odden J, 2008, J WILDLIFE MANAGE, V72, P276, DOI 10.2193/2005-537; OLI MK, 1993, J ZOOL, V231, P71, DOI 10.1111/j.1469-7998.1993.tb05354.x; Pitman RT, 2014, J ZOOL, V292, P18, DOI 10.1111/jzo.12078; Pitman RT, 2013, S AFR J WILDL RES, V43, P167, DOI 10.3957/056.043.0204; Podgorski T, 2013, J MAMMAL, V94, P109, DOI 10.1644/12-MAMM-A-038.1; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rowcliffe JM, 2011, METHODS ECOL EVOL, V2, P464, DOI 10.1111/j.2041-210X.2011.00094.x; Sangay T, 2008, BIOL CONSERV, V141, P1272, DOI 10.1016/j.biocon.2008.02.027; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Shams B, 2010, EUR J WILDLIFE RES, V56, P883; Sharbafi E, 2011, THESIS ISLAMIC AZAD; Shehzad W, 2015, ORYX, V49, P248, DOI 10.1017/S0030605313001026; Speicher J, 2013, THESIS GEORG AUGUST; Stephens D.W., 1986, pi; Suryawanshi KR, 2012, OECOLOGIA, V169, P581, DOI 10.1007/s00442-011-2237-0; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Tortato FR, 2015, ANIM CONSERV, V18, P539, DOI 10.1111/acv.12207; Wachter B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038066; Wang SW, 2006, BIOL CONSERV, V129, P558, DOI 10.1016/j.biocon.2005.11.024; Woodroffe R, 2007, BIODIVERS CONSERV, V16, P1245, DOI 10.1007/s10531-006-9124-8	54	36	36	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153439	10.1371/journal.pone.0153439	http://dx.doi.org/10.1371/journal.pone.0153439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064680	Green Published, gold, Green Submitted			2022-12-26	WOS:000373891000053
J	Berlanga, M; Llorens, C; Comas, J; Guerrero, R				Berlanga, Mercedes; Llorens, Carlos; Comas, Jaume; Guerrero, Ricardo			Gut Bacterial Community of the Xylophagous Cockroaches Cryptocercus punctulatus and Parasphaeria boleiriana	PLOS ONE			English	Article							WOOD-FEEDING COCKROACHES; H-2 PLUS CO2; TERMITE-GUT; MICROBIAL COMMUNITY; DIVERSITY; DICTYOPTERA; PHYLOGENY; HINDGUT; PROTISTS; 16S	Cryptocercus punctulatus and Parasphaeria boleiriana are two distantly related xylophagous and subsocial cockroaches. Cryptocercus is related to termites. Xylophagous cockroaches and termites are excellent model organisms for studying the symbiotic relationship between the insect and their microbiota. In this study, high-throughput 454 pyrosequencing of 16S rRNA was used to investigate the diversity of metagenomic gut communities of C. punctulatus and P. boleiriana, and thereby to identify possible shifts in symbiont allegiances during cockroaches evolution. Our results revealed that the hindgut prokaryotic communities of both xylophagous cockroaches are dominated by members of four Bacteria phyla: Bacteroidetes, Firmicutes, Proteobacteria, and Actinobacteria. Other identified phyla were Spirochaetes, Planctomycetes, candidatus Saccharibacteria (formerly TM7), and Acidobacteria, each of which represented 1-2% of the total population detected. Community similarity based on phylogenetic relatedness by unweighted UniFrac analyses indicated that the composition of the bacterial community in the two species was significantly different (P < 0.05). Phylogenetic analysis based on the characterized clusters of Bacteroidetes, Spirochaetes, and Deltaproteobacteria showed that many OTUs present in both cockroach species clustered with sequences previously described in termites and other cockroaches, but not with those from other animals or environments. These results suggest that, during their evolution, those cockroaches conserved several bacterial communities from the microbiota of a common ancestor. The ecological stability of those microbial communities may imply the important functional role for the survival of the host of providing nutrients in appropriate quantities and balance.	[Berlanga, Mercedes] Univ Barcelona, Fac Pharm, Dept Microbiol & Parasitol, Barcelona, Spain; [Llorens, Carlos; Comas, Jaume] Univ Barcelona CCiTUB, Unity Genom, Sci Ctr, Barcelona, Spain; [Llorens, Carlos; Comas, Jaume] Univ Barcelona CCiTUB, Unity Genom, Technol Ctr, Barcelona, Spain; [Llorens, Carlos] Biotechvana, Valencia, Spain; [Guerrero, Ricardo] Univ Barcelona, Fac Med, Lab Mol Microbiol & Antimicrobials, Dept Pathol & Expt Therapeut,IDIBELL, Barcelona 7, Spain; [Guerrero, Ricardo] Acad Europaea, Barcelona Knowledge Hub, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Berlanga, M (corresponding author), Univ Barcelona, Fac Pharm, Dept Microbiol & Parasitol, Barcelona, Spain.	mberlanga@ub.edu	Berlanga, Mercedes/I-4287-2016	Berlanga, Mercedes/0000-0002-7305-7046; Guerrero, Ricardo/0000-0001-5019-9933	Spanish Ministry of Science and Technology [CGL2009-08922]; Biotechvana	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Biotechvana	This study was funded by CGL2009-08922 (Spanish Ministry of Science and Technology) to Ricardo Guerrero. Author Carlos Llorens is employed by Biotechvana during the study. Biotechvana provided support in the form of salary for author CL, but did not provide specific funding for this study and did not have any additional role in the study design, data collection, decision to publish, or preparation of the manuscript. This specific role of this author is articulated in the 'author contributions' section.	Bauer E, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu028; Berlanga M, 2007, INT MICROBIOL, V10, P133, DOI 10.2436/20.1501.01.19; Berlanga M, 2011, INT MICROBIOL, V14, P83, DOI 10.2436/20.1501.01.138; Berlanga M, 2009, INT MICROBIOL, V12, P227, DOI 10.2436/20.1501.01.102; Bertino-Grimaldi D, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-609; Boucias DG, 2013, MOL ECOL, V22, P1836, DOI 10.1111/mec.12230; Brune A, 2015, ANNU REV MICROBIOL, V69, P145, DOI 10.1146/annurev-micro-092412-155715; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Carrasco P, 2014, INT MICROBIOL, V17, P99, DOI 10.2436/20.1501.01.212; Desai MS, 2012, ISME J, V6, P1302, DOI 10.1038/ismej.2011.194; Dietrich C, 2014, APPL ENVIRON MICROB, V80, P2261, DOI 10.1128/AEM.04206-13; Diouf M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140014; Droge S, 2005, J GEN APPL MICROBIOL, V51, P57, DOI 10.2323/jgam.51.57; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Futami R., 2011, BIOTECHVANA BIOINFOR; GIJZEN HJ, 1994, APPL ENVIRON MICROB, V60, P1822, DOI 10.1128/AEM.60.6.1822-1826.1994; Grandcolas P, 2002, T AM ENTOMOL SOC, V128, P23; Guerrero R, 2013, INT MICROBIOL, V16, P133, DOI 10.2436/20.1501.01.188; Hongoh Y, 2011, CELL MOL LIFE SCI, V68, P1311, DOI 10.1007/s00018-011-0648-z; Iida T, 2000, FEMS MICROBIOL ECOL, V34, P17, DOI 10.1111/j.1574-6941.2000.tb00750.x; Ikeda-Ohtsubo W, 2010, ENV MICROBIOL REP, V2, P554, DOI 10.1111/j.1758-2229.2009.00124.x; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; Kambhampati S, 2007, BIOL J LINN SOC, V90, P457, DOI 10.1111/j.1095-8312.2006.00734.x; Klass KD, 2008, MOL PHYLOGENET EVOL, V46, P809, DOI 10.1016/j.ympev.2007.11.028; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Lilburn TG, 1999, ENVIRON MICROBIOL, V1, P331; Lo N, 2003, MOL BIOL EVOL, V20, P907, DOI 10.1093/molbev/msg097; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lynn DH, 2013, J EUKARYOT MICROBIOL, V60, P335, DOI 10.1111/jeu.12037; Makonde HM, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1262-6; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Minard G, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00059; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; NALEPA CA, 1990, ANN ENTOMOL SOC AM, V83, P786, DOI 10.1093/aesa/83.4.786; Nalepa CA, 2015, ECOL ENTOMOL, V40, P323, DOI 10.1111/een.12197; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Noda S, 2006, ENVIRON MICROBIOL, V8, P11, DOI 10.1111/j.1462-2920.2005.00860.x; Noda S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-158; Ohkuma M, 2009, P ROY SOC B-BIOL SCI, V276, P239, DOI 10.1098/rspb.2008.1094; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Ohkuma M, 2015, P NATL ACAD SCI USA, V112, P10224, DOI 10.1073/pnas.1423979112; Otani S, 2014, MOL ECOL, V23, P4631, DOI 10.1111/mec.12874; Pellens R, 2002, CAN J ZOOL, V80, P350, DOI 10.1139/Z01-230; Pellens R, 2007, MOL PHYLOGENET EVOL, V43, P616, DOI 10.1016/j.ympev.2006.12.017; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rahman NA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0067-8; Rosengaus RB, 2011, APPL ENVIRON MICROB, V77, P4303, DOI 10.1128/AEM.01886-10; Rosenthal AZ, 2011, ISME J, V5, P1133, DOI 10.1038/ISMEJ.2011.3; Schauer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085861; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Scully ED, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1096; Shinzato N, 2007, BIOSCI BIOTECH BIOCH, V71, P906, DOI 10.1271/bbb.60540; Sudakaran S, 2012, MOL ECOL, V21, P6134, DOI 10.1111/mec.12027; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Tai V, 2015, APPL ENVIRON MICROB, V81, P1059, DOI 10.1128/AEM.02945-14; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Wada-Katsumata A, 2015, P NATL ACAD SCI USA, V112, P15678, DOI 10.1073/pnas.1504031112; Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001; Yuki M, 2015, ENVIRON MICROBIOL, V17, P4942, DOI 10.1111/1462-2920.12945; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14	66	23	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152400	10.1371/journal.pone.0152400	http://dx.doi.org/10.1371/journal.pone.0152400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054320	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000019
J	Qu, HY; Xing, WX; Wu, FF; Wang, YZ				Qu, Haiyong; Xing, Wenxi; Wu, Fenfen; Wang, Yongzhang			Rapid and Inexpensive Method of Loading Fluorescent Dye into Pollen Tubes and Root Hairs	PLOS ONE			English	Article							CALCIUM-CHANNELS; PYRUS-PYRIFOLIA; CA2+; CELLS; GROWTH; ARABIDOPSIS; GERMINATION; DYNAMICS; GRADIENT; CAMELEON	The most direct technique for studying calcium, which is an essential element for pollen tube growth, is Ca2+ imaging. Because membranes are relatively impermeable, the loading of fluorescent Ca2+ probes into plant cells is a challenging task. Thus, we have developed a new method of loading fluo-4 acetoxymethyl ester into cells that uses a cell lysis solution to improve the introduction of this fluorescent dye into pollen tubes. Using this method, the loading times were reduced to 15 min. Furthermore, loading did not have to be performed at low (4 degrees C) temperatures and was successful at room temperature, and pluronic F-127 was not required, which would theoretically allow for the loading of an unlimited number of cells. Moreover, the method can also be used to fluorescently stain root hairs.	[Qu, Haiyong] Qingdao Agr Univ, Coll Hort, 700 Changcheng Rd, Qingdao, Shandong Provin, Peoples R China; [Xing, Wenxi; Wu, Fenfen; Wang, Yongzhang] Qingdao Agr Univ, Dept Hort, Qingdao, Peoples R China	Qingdao Agricultural University; Qingdao Agricultural University	Qu, HY (corresponding author), Qingdao Agr Univ, Coll Hort, 700 Changcheng Rd, Qingdao, Shandong Provin, Peoples R China.	haiyongqu@126.com	Qu, Haiyong/AAG-6678-2020	Qu, Haiyong/0000-0002-5786-450X	Shandong province natural fund	Shandong province natural fund	The work was supported by Shandong province natural fund.	Bothwell JHF, 2006, PLANT J, V46, P327, DOI 10.1111/j.1365-313X.2006.02687.x; Brack KE, 2010, EXP PHYSIOL, V95, P80, DOI 10.1113/expphysiol.2009.048215; BREWBAKE JL, 1963, AM J BOT, V50, P859, DOI 10.2307/2439772; Cui YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145661; Fan JL, 2011, J PLANT PHYSIOL, V168, P1157, DOI 10.1016/j.jplph.2011.01.031; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; GELLI A, 1993, PLANT PHYSIOL, V102, P1139, DOI 10.1104/pp.102.4.1139; Hill AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036585; HINKLE PM, 1992, J BIOL CHEM, V267, P25553; Iwano M, 2004, PLANT PHYSIOL, V136, P3562, DOI 10.1104/pp.104.046961; Kanchiswamy CN, 2014, INT J MOL SCI, V15, P3842, DOI 10.3390/ijms15033842; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; KWAN CY, 1990, AM J PHYSIOL, V258, pC1006, DOI 10.1152/ajpcell.1990.258.6.C1006; Ling Y, 2013, PLANTA, V238, P831, DOI 10.1007/s00425-013-1938-5; MARUYAMA I, 1989, Journal of Toxicological Sciences, V14, P153; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; Michard E, 2008, SEX PLANT REPROD, V21, P169, DOI 10.1007/s00497-008-0076-x; Putney JW, 2014, CELL CALCIUM, V55, P290, DOI 10.1016/j.ceca.2014.01.001; Qu HY, 2007, NEW PHYTOL, V174, P524, DOI 10.1111/j.1469-8137.2007.02069.x; Sutachan JJ, 2006, BRAIN RES, V1068, P131, DOI 10.1016/j.brainres.2005.11.003; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Wang QL, 2005, PLANT PHYSIOL, V139, P1692, DOI 10.1104/pp.105.069765; Watahiki MK, 2004, SEX PLANT REPROD, V17, P125, DOI 10.1007/s00497-004-0224-x; Wu JY, 2012, ACTA PHYSIOL PLANT, V34, P969, DOI 10.1007/s11738-011-0893-7; Zhang WH, 1998, PLANT J, V15, P147, DOI 10.1046/j.1365-313X.1998.00188.x	26	15	16	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152320	10.1371/journal.pone.0152320	http://dx.doi.org/10.1371/journal.pone.0152320			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055240	Green Published, gold			2022-12-26	WOS:000373608000017
J	Templeman, NM; Mehran, AE; Johnson, JD				Templeman, Nicole M.; Mehran, Arya E.; Johnson, James D.			Hyper-Variability in Circulating Insulin, High Fat Feeding Outcomes, and Effects of Reducing Ins2 Dosage in Male Ins1-Null Mice in a Specific Pathogen-Free Facility	PLOS ONE			English	Article							DIET-INDUCED OBESITY; CHRONIC SOCIAL STRESS; GUT MICROBIOTA; GENE; RAT; HYPERINSULINEMIA; SECRETION; EXPOSURE; RELEASE; C57BL/6	Insulin is an essential hormone with key roles in energy homeostasis and body composition. Mice and rats, unlike other mammals, have two insulin genes: the rodent-specific Ins1 gene and the ancestral Ins2 gene. The relationships between insulin gene dosage and obesity has previously been explored in male and female Ins2(-/-) mice with full or reduced Ins1 dosage, as well as in female Ins1(-/-) mice with full or partial Ins2 dosage. We report herein unexpected hyper-variability in Ins1-null male mice, with respect to their circulating insulin levels and to the physiological effects of modulating Ins2 gene dosage. Two large cohorts of Ins1(-/-):Ins2(+/-) mice and their Ins1(-/-):Ins2(+/+) littermates were fed chow diet or high fat diet (HFD) from weaning, and housed in specific pathogen-free conditions. Cohort A and cohort B were studied one year apart. Contrary to female mice from the same litters, inactivating one Ins2 allele on the complete Ins1-null background did not consistently cause a reduction of circulating insulin in male mice, on either diet. In cohort A, all HFD-fed males showed an equivalent degree of insulin hypersecretion and weight gain, regardless of Ins2 dosage. In cohort B the effects of HFD appeared generally diminished, and cohort B Ins1(-/-):Ins2(+/-) males showed decreased insulin levels and body mass compared to Ins1(-/-):Ins2(+/+) littermates, on both diets. Although experimental conditions were consistent between cohorts, we found that HFD-fed Ins1(-/-):Ins2(+/-) mice with lower insulin levels had increased corticosterone. Collectively, these observations highlight the phenotypic characteristics that change in association with differences in circulating insulin and Ins2 gene dosage, particularly in male mice.	[Templeman, Nicole M.; Mehran, Arya E.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Johnson, JD (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	james.d.johnson@ubc.ca		Templeman, Nicole/0000-0003-2839-231X	Canadian Institutes of Health Research; Novo-Nordisk; Natural Science and Engineering Council of Canada Canadian Graduate Scholarship; University of British Columbia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Novo-Nordisk(Novo Nordisk); Natural Science and Engineering Council of Canada Canadian Graduate Scholarship; University of British Columbia	Financial support was provided by an operating grant from Canadian Institutes of Health Research and from an unrestricted investigator-initiated grant from Novo-Nordisk to JDJ. NMT was supported by Natural Science and Engineering Council of Canada Canadian Graduate Scholarship, and by a Four-Year Fellowship from the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; DAVIES PO, 1994, GENOMICS, V21, P665, DOI 10.1006/geno.1994.1334; Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743; DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527; DELTOUR L, 1995, DEV BIOL, V168, P686, DOI 10.1006/dbio.1995.1114; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Duvillie B, 1998, GENOMICS, V47, P52, DOI 10.1006/geno.1997.5070; EBBESEN P, 1992, ANN NY ACAD SCI, V673, P46, DOI 10.1111/j.1749-6632.1992.tb27435.x; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fernandez-Twinn DS, 2006, PHYSIOL BEHAV, V88, P234, DOI 10.1016/j.physbeh.2006.05.039; Finger BC, 2011, NEUROSCIENCE, V192, P351, DOI 10.1016/j.neuroscience.2011.06.072; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; Goodman PA, 1996, MOL CELL ENDOCRINOL, V120, P139, DOI 10.1016/0303-7207(96)03830-0; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Jeong IK, 2001, DIABETES RES CLIN PR, V51, P163, DOI 10.1016/S0168-8227(00)00229-1; Jhaveri KA, 2007, BRAIN BEHAV IMMUN, V21, P975, DOI 10.1016/j.bbi.2007.03.007; KHAN A, 1992, AM J PHYSIOL, V263, pE663, DOI 10.1152/ajpendo.1992.263.4.E663; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Lee KTY, 2011, ENDOCRINOLOGY, V152, P3005, DOI 10.1210/en.2011-0060; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Li CY, 2006, DIABETES CARE, V29, P2396, DOI 10.2337/dc06-0289; LINDE S, 1989, J CHROMATOGR, V462, P243, DOI 10.1016/S0021-9673(00)91351-7; Maniam J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00073; Mayer EJ, 1996, AM J EPIDEMIOL, V143, P323; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Mehran A, 2015, PREPRINT; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141; Meur G, 2011, J BIOL CHEM, V286, P13647, DOI 10.1074/jbc.M110.204248; Morimoto S, 2001, ENDOCRINOLOGY, V142, P1442, DOI 10.1210/en.142.4.1442; Mott R, 2014, CELL, V156, P332, DOI 10.1016/j.cell.2013.11.043; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; Pascuan CG, 2014, J IMMUNOTOXICOL, V11, P78, DOI 10.3109/1547691X.2013.800171; Peters J, 2014, NAT REV GENET, V15, P517, DOI 10.1038/nrg3766; Phillips TJ, 1999, PSYCHOPHARMACOLOGY, V147, P5, DOI 10.1007/s002130051128; Rasmussen S, 2009, J AM ASSOC LAB ANIM, V48, P363; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; SCHUMACHER MC, 1992, DIABETES, V41, P416, DOI 10.2337/diabetes.41.4.416; Shiao MS, 2008, GENETICS, V178, P1683, DOI 10.1534/genetics.108.087023; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Sterlemann V, 2008, HORM BEHAV, V53, P386, DOI 10.1016/j.yhbeh.2007.11.001; Templeman NM, 2015, DIABETOLOGIA, V58, P2392, DOI 10.1007/s00125-015-3676-7; THURLBY PL, 1979, BRIT J NUTR, V42, P377, DOI 10.1079/BJN19790127; WENTWORTH BM, 1992, MOL CELL ENDOCRINOL, V86, P177, DOI 10.1016/0303-7207(92)90142-S; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107; Zardooz H, 2006, LIFE SCI, V79, P57, DOI 10.1016/j.lfs.2005.12.032	57	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153280	10.1371/journal.pone.0153280	http://dx.doi.org/10.1371/journal.pone.0153280			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055260	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000114
J	Barreto, RR; de Farias, WKT; Andrade, H; Santana, FM; Lessa, R				Barreto, Rodrigo R.; de Farias, Wialla K. T.; Andrade, Humber; Santana, Francisco M.; Lessa, Rosangela			Age, Growth and Spatial Distribution of the Life Stages of the Shortfin Mako, Isurus oxyrinchus (Rafinesque, 1810) Caught in the Western and Central Atlantic	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; REPRODUCTIVE-BIOLOGY; PELAGIC SHARKS; VALIDATION; MATURITY; PACIFIC; COAST	The shortfin mako (Isurus oxyrinchus) is a highly migratory pelagic shark that preferentially inhabits oceanic regions in practically all oceans. The wide distribution range of this species renders it susceptible to coastal and oceanic fishing operations. The International Union for Conservation of Nature (IUCN) and the International Commission for the Conservation of Atlantic Tunas (ICCAT) consider this species to be highly vulnerable, especially due to its biological parameters, which are different from those of other sharks that occupy the same niche (e.g., Prionace glauca). Consequently, considerable declines in abundance have been detected over various parts of its range, most of which are linked to oceanic longline fishing. The species has conflicting life history parameters in studies conducted in the last 30 years, especially with regard to age and growth. The main discrepancies regard the interpretation of the periodicity of the deposition of band pairs (BPs) on vertebrae and the possibility of ontogenetic variations in growth. Shortfin mako sharks (n = 1325) were sampled by onboard observers of the Brazilian chartered pelagic longline fleet based in northeast Brazil from 2005 to 2011. Lengths were 79 to 250 and 73 to 296 cm (fork length, FL) for males and females, respectively, with a statistically significant difference in size between sexes and differences in the proportion of individuals in each size class. The onboard observers collected a subsample of vertebrae (n = 467), only 234 of which were suitable for analyses. Reliability between readings was satisfactory. However, it was not possible to validate periodicity in the formation of age bands in the sample. Thus, the von Bertalanffy growth function was used to calculate growth rates for the species through the interpretation of BPs in different scenarios: one BP per year (s1), two BPs per year (s2) and two BPs per year until five years of life (s3). Growth parameters varied for both females (Linf = 309.7[s3] to 441.6 [s1]; k = 0.04[s1] to 0.13[s3]; t0 = -7.08[s1] and -3.27[s3]) and males (Linf = 291.5[s3] to 340.2[s1]; k = 0.04[s1] to 0.13[s3]; t0 = -7.08[s1] and -3.27[s3]). To advance the understanding of the use of habitat, the first analysis of the spatial distribution of the life stages of the shortfin mako sharks caught by commercial longline fishing operations in the South Atlantic was performed. The findings indicate that the portion of the population exploited by the fleets is predominantly juvenile and future actions should take the following issues into account: improvements in the efficiency of data collection procedures, the reestablishment of the onboard observer program, emergency investments in studies that can contribute to a better understanding of habitat use and life history theory.	[Barreto, Rodrigo R.; de Farias, Wialla K. T.; Santana, Francisco M.; Lessa, Rosangela] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Lab Dinam Populacoes Marinhas DIMAR, Recife, PE, Brazil; [Andrade, Humber] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Lab Modelagem Estat MOE, Recife, PE, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal Rural de Pernambuco (UFRPE)	Barreto, RR (corresponding author), Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Lab Dinam Populacoes Marinhas DIMAR, Recife, PE, Brazil.	rodrigorpbarreto@gmail.com	Santana, Francisco/ABG-2693-2020; Barreto, Rodrigo/O-3089-2016; LESSA, ROSANGELA PAULA TEIXEIRA/D-5043-2013	Santana, Francisco/0000-0002-3225-8861; Barreto, Rodrigo/0000-0002-5737-9416; Lessa, Rosangela/0000-0002-9217-1215	Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco-FACEPE; CNPq (National Counsel of Technological and Scientific Development)	Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco-FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco-FACEPE (http://www.facepe.br/): Scholarship to R.B. This work was also supported in part by CNPq (National Counsel of Technological and Scientific Development): Productivity Grant to R.L.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Ardizzone D, 2006, ENVIRON BIOL FISH, V77, P355, DOI 10.1007/s10641-006-9106-4; Barreto R, 2016, CONSERV BIOL, V30, P792, DOI 10.1111/cobi.12663; BARTOO NW, 1983, FISH B-NOAA, V81, P91; Baum JK, 2010, FISH RES, V102, P229, DOI 10.1016/j.fishres.2009.11.006; Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; Bishop SDH, 2006, MAR FRESHWATER RES, V57, P143, DOI 10.1071/MF05077; Cailliet G.M., 1983, California Cooperative Oceanic Fisheries Investigations Reports, V24, P57; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Cailliet GM, 2009, DATABASE IUCN RED LI; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Campana SE, 2002, CAN J FISH AQUAT SCI, V59, P450, DOI 10.1139/F02-027; CAREY FG, 1981, PHYSIOL ZOOL, V54, P334, DOI 10.1086/physzool.54.3.30159948; Cerna F, 2009, MAR FRESHWATER RES, V60, P394, DOI 10.1071/MF08125; Clarke SC, 2013, CONSERV BIOL, V27, P197, DOI 10.1111/j.1523-1739.2012.01943.x; Cortes E., 2015, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V71, P2637; Cortes Enric, 2007, Gulf and Caribbean Research, V19, P37; Cortes E, 2010, AQUAT LIVING RESOUR, V23, P25, DOI 10.1051/alr/2009044; Dono F, 2015, ENVIRON BIOL FISH, V98, P517, DOI 10.1007/s10641-014-0284-1; Ebert DA., 2013, SHARKS WORLD; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; French RP, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov044; Goldman KJ, 2012, CRC MAR BIOL SER, P423; Haddon M., 2001, MODELING QUANTITATIV; HAZIN FHV, 2008, SHARKS OPEN OCEAN BI, P213; Hsu H.-H., 2003, THESIS NATL TAIWAN O, P107; Isermann DA, 2005, N AM J FISH MANAGE, V25, P1153, DOI 10.1577/M04-130.1; Joung SJ, 2005, ZOOL STUD, V44, P487; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Maia A, 2007, J APPL ICHTHYOL, V23, P246, DOI 10.1111/j.1439-0426.2007.00849.x; Mejuto J, 2013, COLLECT VOL SCI PAP, V69, P1657; Mejuto J, 2010, COLLECT VOL SCI PAP, V65, P2006; Mollet HF, 2000, FISH B-NOAA, V98, P299; Mourato BL, 2008, COLLECT VOL SCI PAP, V62, P1542; Musick J.A, 2005, MANAGEMENT TECHNIQUE; Natanson LJ, 2006, ENVIRON BIOL FISH, V77, P367, DOI 10.1007/s10641-006-9127-z; NATANSON LJ, 1995, FISH B-NOAA, V93, P116; Ogle D. H., 2015, INTRO FISHERIES ANAL; Pardo SA, 2013, METHODS ECOL EVOL, V4, P353, DOI 10.1111/2041-210x.12020; Pratt HL, 1983, P INT WORKSH AG DET, P175; Ribot-Carballal MC, 2005, FISH RES, V76, P14, DOI 10.1016/j.fishres.2005.05.004; Ricker W.E., 1979, BIOENERGETICS GROWTH, VVIII, P677, DOI DOI 10.1016/S1546-5098(08)60034-5; Semba Y, 2011, MAR FRESHWATER RES, V62, P20, DOI 10.1071/MF10123; Semba Y, 2009, ENVIRON BIOL FISH, V84, P377, DOI 10.1007/s10641-009-9447-x; Smith Susan E., 2008, Fish and Aquatic Resources Series, V13, P288; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Stevens J.D., 2008, SHARKS OPEN OCEAN BI, P87; STEVENS JD, 1983, COPEIA, P126, DOI 10.2307/1444706; Wells RJD, 2013, FISH B-NOAA, V111, P147, DOI 10.7755/FB.111.2.3; [No title captured]	51	8	9	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153062	10.1371/journal.pone.0153062	http://dx.doi.org/10.1371/journal.pone.0153062			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049319	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500092
J	Nakahashi, S; Yamada, T; Ogura, T; Nakajima, K; Suzuki, K; Imai, H				Nakahashi, Susumu; Yamada, Tomomi; Ogura, Toru; Nakajima, Ken; Suzuki, Kei; Imai, Hiroshi			Association of Patient Care with Ventilator-Associated Conditions in Critically Ill Patients: Risk Factor Analysis	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; EVENTS; PNEUMONIA; SURVEILLANCE; PREVENTION; PREVENTABILITY; IMPLEMENTATION; DEFINITION; GUIDELINE	Background Ventilator-associated conditions (VACs), for which new surveillance definitions and methods were issued by the Center for Disease Control and Prevention (CDC), are respiratory complications occurring in conjunction with the use of invasive mechanical ventilation and are related to adverse outcomes in critically ill patients. However, to date, risk factors for VACs have not been adequately established, leading to a need for developing a better understanding of the risks. The objective of this study was to explore care-related risk factors as a process indicator and provide valuable information pertaining to VAC preventive measures. Methods This retrospective, single-center, cohort study was conducted in the intensive-care unit (ICU) of a university hospital in Japan. Patient data were automatically sampled using a computerized medical records system and retrospectively analyzed. Management and care-related, but not host-related, factors were exhaustively analyzed using multivariate analysis for risks of VACs. VAC correlation to mortality was also investigated. Results Of the 3122 patients admitted in the ICU, 303 ventilated patients meeting CDC-specified eligibility criteria were included in the analysis. Thirty-seven VACs (12.2%) were found with a corresponding rate of 12.1 per 1000 ventilator days. Multivariate analysis revealed four variables related to patient care as risk factors for VACs: absence of intensivist participation in management of ventilated patients [adjusted HR (AHR): 7.325, P < 0.001)], using relatively higher driving pressure (AHR: 1.216, P < 0.001), development of edema (AHR: 2.145, P = 0.037), and a larger body weight increase (AHR: 0.058, P = 0.005). Furthermore, this research confirmed mortality differences in patients with VACs and statistically derived risks compared with those without VACs (HR: 2.623, P = 0.008). Conclusion Four risk factors related to patient care were clearly identified to be the key factors for VAC preventive measures.	[Nakahashi, Susumu; Suzuki, Kei; Imai, Hiroshi] Mie Univ Hosp, Dept Emergency, Tsu, Mie, Japan; [Nakahashi, Susumu; Suzuki, Kei; Imai, Hiroshi] Mie Univ Hosp, Crit Care Ctr, Tsu, Mie, Japan; [Yamada, Tomomi] Osaka Univ, Grad Sch Med, Dept Clin Epidemiol & Biostat, Suita, Osaka, Japan; [Ogura, Toru] Mie Univ Hosp, Clin Res Support Ctr, Tsu, Mie, Japan; [Nakajima, Ken] Mie Univ, Sch Med, Dept Radiol, Tsu, Mie 514, Japan	Mie University; Mie University; Osaka University; Mie University; Mie University	Nakahashi, S (corresponding author), Mie Univ Hosp, Dept Emergency, Tsu, Mie, Japan.; Nakahashi, S (corresponding author), Mie Univ Hosp, Crit Care Ctr, Tsu, Mie, Japan.	n14w4@s3.dion.ne.jp						Abbott CA, 2006, WORLDV EVID-BASED NU, V3, P139, DOI 10.1111/j.1741-6787.2006.00066.x; Al-Tawfiq JA, 2010, AM J INFECT CONTROL, V38, P552, DOI 10.1016/j.ajic.2010.01.008; Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Boyer AF, 2015, CHEST, V147, P68, DOI 10.1378/chest.14-0544; Caserta RA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-234; Chittawatanarat K, 2015, THER CLIN RISK MANAG, V11, P1097, DOI 10.2147/TCRM.S86409; Dessap AM, 2014, CHEST, V146, P58, DOI 10.1378/chest.13-2564; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Graf J, 2008, CURR OPIN CRIT CARE, V14, P44, DOI 10.1097/MCC.0b013e3282f2f4cb; Hawe CS, 2009, INTENS CARE MED, V35, P1180, DOI 10.1007/s00134-009-1461-0; Hayashi Y, 2013, CLIN INFECT DIS, V56, P471, DOI 10.1093/cid/cis926; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; Klompas M, 2015, AM J RESP CRIT CARE, V191, P292, DOI 10.1164/rccm.201407-1394OC; Klompas M, 2014, INFECT CONT HOSP EP, V35, P502, DOI 10.1086/675834; Klompas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018062; Klouwenberg PMCK, 2014, AM J RESP CRIT CARE, V189, P947, DOI 10.1164/rccm.201307-1376OC; Lewis SC, 2014, CRIT CARE MED, V42, P1839, DOI 10.1097/CCM.0000000000000338; Lilly CM, 2014, CRIT CARE MED, V42, P2019, DOI 10.1097/CCM.0000000000000396; Marini JJ, 2008, CRIT CARE MED, V36, P3252, DOI 10.1097/CCM.0b013e31818f0e68; Muscedere J, 2013, CHEST, V144, P1453, DOI 10.1378/chest.13-0853; (NHSN) CfDCaPNHSN, SURV VENT ASS EV; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Raoof S, 2014, AM J CRIT CARE, V23, P7, DOI 10.4037/ajcc2014469; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Sakr Y, 2005, CHEST, V128, P3098, DOI 10.1378/chest.128.5.3098; Shime N, 2012, CHEST, V141, P281, DOI 10.1378/chest.11-2387; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Stevens JP, 2014, CHEST, V146, P1612, DOI 10.1378/chest.13-2255; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153060	10.1371/journal.pone.0153060	http://dx.doi.org/10.1371/journal.pone.0153060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050836	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500091
J	Marcotuli, I; Houston, K; Schwerdt, JG; Waugh, R; Fincher, GB; Burton, RA; Blanco, A; Gadaleta, A				Marcotuli, Ilaria; Houston, Kelly; Schwerdt, Julian G.; Waugh, Robbie; Fincher, Geoffrey B.; Burton, Rachel A.; Blanco, Antonio; Gadaleta, Agata			Genetic Diversity and Genome Wide Association Study of beta-Glucan Content in Tetraploid Wheat Grains	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; OAT AVENA-SATIVA; POPULATION-STRUCTURE; (1,3/1,4)-BETA-D-GLUCAN SYNTHESIS; AMYLOSE CONTENT; DIETARY FIBER; CELL-WALLS; BARLEY; STARCH; CEREAL	Non-starch polysaccharides (NSPs) have many health benefits, including immunomodulatory activity, lowering serum cholesterol, a faecal bulking effect, enhanced absorption of certain minerals, prebiotic effects and the amelioration of type II diabetes. The principal components of the NSP in cereal grains are (1,3; 1,4)-beta-glucans and arabinoxylans. Although (1,3; 1,4)-beta-glucan (hereafter called beta-glucan) is not the most representative component of wheat cell walls, it is one of the most important types of soluble fibre in terms of its proven beneficial effects on human health. In the present work we explored the genetic variability of beta-glucan content in grains from a tetraploid wheat collection that had been genotyped with a 90k-iSelect array, and combined this data to carry out an association analysis. The beta-glucan content, expressed as a percentage w/w of grain dry weight, ranged from 0.18% to 0.89% across the collection. Our analysis identified seven genomic regions associated with a-glucan, located on chromosomes 1A, 2A (two), 2B, 5B and 7A (two), confirming the quantitative nature of this trait. Analysis of marker trait associations (MTAs) in syntenic regions of several grass species revealed putative candidate genes that might influence A-glucan levels in the endosperm, possibly via their participation in carbon partitioning. These include the glycosyl hydrolases endo-beta-(1,4)-glucanase (cellulase), beta-amylase, (1,4)-beta-xylan endohydrolase, xylanase inhibitor protein I, isoamylase and the glycosyl transferase starch synthase II.	[Marcotuli, Ilaria; Blanco, Antonio] Univ Bari Aldo Moro, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Via G Amendola 165-A, I-70126 Bari, Italy; [Houston, Kelly; Waugh, Robbie] James Hutton Inst, Dundee DD2 5DA, Scotland; [Schwerdt, Julian G.; Fincher, Geoffrey B.; Burton, Rachel A.] Univ Adelaide, Sch Agr Food & Wine, Australian Res Council Ctr Excellence Plant Cell, Waite Campus, Glen Osmond, SA 5064, Australia; [Gadaleta, Agata] Univ Bari Aldo Moro, Agr & Environm Sci, Via G Amendola 165-A, I-70126 Bari, Italy	Universita degli Studi di Bari Aldo Moro; James Hutton Institute; University of Adelaide; Universita degli Studi di Bari Aldo Moro	Gadaleta, A (corresponding author), Univ Bari Aldo Moro, Agr & Environm Sci, Via G Amendola 165-A, I-70126 Bari, Italy.	agata.gadaleta@uniba.it	Burton, Rachel A/C-4441-2011; Gadaleta, Agata/H-2627-2012	Burton, Rachel A/0000-0002-0638-4709; Gadaleta, Agata/0000-0002-6312-249X; Marcotuli, Ilaria/0000-0002-0146-5286	Ministero dell'Istruzione, dell'Universita e della Ricerca [PON-01_01145 ISCOCEM]; Biotechnology and Biological Sciences Research Council [BB/L026317/1, BB/J014869/1] Funding Source: researchfish; BBSRC [BB/J014869/1, BB/L026317/1] Funding Source: UKRI	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research project was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca, project 'PON-01_01145 ISCOCEM'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, J AM DIET ASSOC, V95, P493; Asoro FG, 2013, CROP SCI, V53, P542, DOI 10.2135/cropsci2012.01.0039; BACIC A, 1980, CARBOHYD RES, V82, P372, DOI 10.1016/S0008-6215(00)85713-4; BERESFORD G, 1983, J CEREAL SCI, V1, P111, DOI 10.1016/S0733-5210(83)80028-9; Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brennan CS, 2005, J CEREAL SCI, V42, P1, DOI 10.1016/j.jcs.2005.01.002; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Burton RA, 2008, PLANT PHYSIOL, V146, P1821, DOI 10.1104/pp.107.114694; Burton RA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00130; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; Christensen U, 2012, J CEREAL SCI, V55, P69, DOI 10.1016/j.jcs.2011.10.005; Clarke B, 2008, FUNCT INTEGR GENOMIC, V8, P211, DOI 10.1007/s10142-007-0070-7; Collins HM, 2010, CEREAL CHEM, V87, P272, DOI 10.1094/CCHEM-87-4-0272; Dabney A, 2010, QVALUE Q VALUE ESTIM; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Doblin MS, 2009, P NATL ACAD SCI USA, V106, P5996, DOI 10.1073/pnas.0902019106; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferguson LR, 2003, LANCET, V361, P1487, DOI 10.1016/S0140-6736(03)13219-9; Fincher G.B., 2004, ENCY GRAIN SCI, P206, DOI [10.1016/B0-12-765490-9/00107-5, DOI 10.1016/B0-12-765490-9/00107-5]; Fincher GB, 2009, CURR OPIN PLANT BIOL, V12, P140, DOI 10.1016/j.pbi.2009.01.002; Fincher GB, 2009, PLANT PHYSIOL, V149, P27, DOI 10.1104/pp.108.130096; Fujita N, 2003, PLANT CELL PHYSIOL, V44, P607, DOI 10.1093/pcp/pcg079; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; HAN F, 1995, THEOR APPL GENET, V91, P921, DOI 10.1007/BF00223901; Hodge AM, 2004, DIABETES CARE, V27, P2701, DOI 10.2337/diacare.27.11.2701; Houston K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-907; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Islamovic E, 2013, MOL BREEDING, V31, P15, DOI 10.1007/s11032-012-9764-1; Kianian SF, 2000, THEOR APPL GENET, V101, P1039, DOI 10.1007/s001220051578; Kim ED, 2012, TRENDS PLANT SCI, V17, P16, DOI 10.1016/j.tplants.2011.10.008; Kim HongSik, 2011, Journal of Crop Science and Biotechnology, V14, P239, DOI 10.1007/s12892-011-0045-z; Kim SJ, 2015, PLANT J, V81, P537, DOI 10.1111/tpj.12748; Konik-Rose C, 2007, THEOR APPL GENET, V115, P1053, DOI 10.1007/s00122-007-0631-0; Kooiker M, 2013, J EXP BOT, V64, P3681, DOI 10.1093/jxb/ert205; Lafiandra D, 2014, J CEREAL SCI, V59, P312, DOI 10.1016/j.jcs.2014.01.001; Li JZ, 2008, J CEREAL SCI, V48, P647, DOI 10.1016/j.jcs.2008.02.004; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Marcotuli I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132787; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; MCCLEARY BV, 1991, J SCI FOOD AGR, V55, P303, DOI 10.1002/jsfa.2740550215; Mohammadi M, 2014, MOL BREEDING, V34, P1229, DOI 10.1007/s11032-014-0112-5; Molina-Cano JL, 2007, MOL BREEDING, V19, P275, DOI 10.1007/s11032-006-9075-5; National Health and Medical Research Council, 2013, AUSTR DIET GUID; Newell MA, 2012, THEOR APPL GENET, V125, P1687, DOI 10.1007/s00122-012-1945-0; NYQUIST WE, 1991, CRIT REV PLANT SCI, V10, P235, DOI 10.1080/07352689109382313; Patron NJ, 2004, PLANT PHYSIOL, V135, P2088, DOI 10.1104/pp.104.045203; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; POWELL W, 1985, THEOR APPL GENET, V71, P461, DOI 10.1007/BF00251188; Pritchard JR, 2011, J SCI FOOD AGR, V91, P1298, DOI 10.1002/jsfa.4316; Pritchard JK, 2000, GENETICS, V155, P945; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team RC, 2012, R LANG ENV STAT COMP; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Utsumi Y UC, 2011, PLANT PHYSL, V156; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; WENZL H, 1981, Z PFLANZENK PFLANZEN, V88, P584; Wilson SM, 2015, PLANT CELL, V27, P754, DOI 10.1105/tpc.114.135970; Woodward J., 1983, CARBOHYD POLYM, V3, P143	68	31	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152590	10.1371/journal.pone.0152590	http://dx.doi.org/10.1371/journal.pone.0152590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045166	Green Submitted, Green Published, gold			2022-12-26	WOS:000373599600027
J	Xiang, KL; Wu, SD; Yu, SX; Liu, Y; Jabbour, F; Erst, AS; Zhao, L; Wang, W; Chen, ZD				Xiang, Kun-Li; Wu, Sheng-Dan; Yu, Sheng-Xian; Liu, Yang; Jabbour, Florian; Erst, Andrey S.; Zhao, Liang; Wang, Wei; Chen, Zhi-Duan			The First Comprehensive Phylogeny of Coptis (Ranunculaceae) and Its Implications for Character Evolution and Classification	PLOS ONE			English	Article							RHIZOMA-COPTIDIS; RIBOSOMAL DNA; ALKALOIDS; SEQUENCES; INFERENCE; CHLOROPLAST; JAPONICA; UTILITY	Coptis (Ranunculaceae) contains 15 species and is one of the pharmaceutically most important plant genera in eastern Asia. Understanding of the evolution of morphological characters and phylogenetic relationships within the genus is very limited. Here, we present the first comprehensive phylogenetic analysis of the genus based on two plastid and one nuclear markers. The phylogeny was reconstructed using Bayesian inference, as well as maximum parsimony and maximum likelihood methods. The Swofford-Olsen-Waddell-Hillis and Bayesian tests were used to assess the strength of the conflicts between traditional taxonomic units and those suggested by the phylogenetic inferences. Evolution of morphological characters was inferred using Bayesian method to identify synapomorphies for the infrageneric lineages. Our data recognize two strongly supported clades within Coptis. The first clade contains subgenus Coptis and section Japonocoptis of subgenus Metacoptis, supported by morphological characters, such as traits of the central leaflet base, petal color, and petal shape. The second clade consists of section Japonocoptis of subgenus Metacoptis. Coptis morii is not united with C. quinquefolia, in contrast with the view that C. morii is a synonym of C. quinquefolia. Two varieties of C. chinensis do not cluster together. Coptis groenlandica and C. lutescens are reduced to C. trifolia and C. japonica, respectively. Central leaflet base, sepal shape, and petal blade carry a strong phylogenetic signal in Coptis, while leaf type, sepal and petal color, and petal shape exhibit relatively higher levels of evolutionary flexibility.	[Xiang, Kun-Li; Yu, Sheng-Xian; Wang, Wei; Chen, Zhi-Duan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Xiang, Kun-Li] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wu, Sheng-Dan] Shanxi Normal Univ, Coll Life Sci, Linfen 041004, Peoples R China; [Liu, Yang] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Jabbour, Florian] Univ Paris 04, Museum Natl Hist Nat, Inst Systemat,EPHE, Evolut,Biodiversite,UMR 7205,ISYEB,MNHN,CNRS,UPMC, F-75005 Paris, France; [Erst, Andrey S.] Russian Acad Sci, Cent Siberian Bot Garden Siberian Branch, Zolotodolinskaya Str 101, Novosibirsk 630090, Russia; [Erst, Andrey S.] Natl Res Tomsk State Univ, Lab Systemat & Phylogeny Plants, Prospekt Lenina 36, Tomsk 634050, Russia; [Zhao, Liang] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanxi Normal University; University of Connecticut; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Central Siberian Botanical Garden; Russian Academy of Sciences; Tomsk State University; Northwest A&F University - China	Wang, W (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.	wangwei1127@ibcas.ac.cn	Erst, Andrey/M-3444-2016; Wu, Shengdan/ABE-3272-2020; Wu, Shengdan/L-7193-2019; Xiang, Kun-Li/X-1220-2018; Wu, Sheng-Dan/AAM-4003-2021	Wu, Shengdan/0000-0003-1481-4825; Xiang, Kun-Li/0000-0002-0800-6015; Liu, Yang/0000-0002-5942-839X	NSFC [31270269, 31590822, 31300158]; Youth Innovation Promotion Association Foundation of CAS; RFBR [16-54-53127]; PRF [7530.2016.4]; NSF [DEB-1240045]; Direct For Biological Sciences [1240045] Funding Source: National Science Foundation	NSFC(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association Foundation of CAS; RFBR(Russian Foundation for Basic Research (RFBR)); PRF; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was partially funded by grants NSFC (31270269, 31590822, and 31300158), the Youth Innovation Promotion Association Foundation of CAS, RFBR (16-54-53127), PRF (7530.2016.4), and NSF (DEB-1240045).	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Chen JH, 2008, ELECTROPHORESIS, V29, P2135, DOI 10.1002/elps.200700797; Chen ZD, 2004, INT J PLANT SCI, V165, P325, DOI 10.1086/382795; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE; Doh EJ, 2014, GENES GENOM, V36, P345, DOI 10.1007/s13258-014-0172-2; FERNALD M. L., 1929, RHODORA, V31, P136; Ford BA, 1996, FLORA N AM, V3, P242; Fu DZ, 2001, FLORA CHINA, V6, P309; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayata B, 1913, COPTIS ICON PI FORMO, V3, P9; He Y, 2014, BIOCHEM SYST ECOL, V56, P88, DOI 10.1016/j.bse.2014.05.002; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hoot SB, 1995, PLANT SYST EVOL, P241; Hsiao PG, 1979, FLORA REIPUBLICAE PO, V27, P592; Hulten E, 1937, FLORA ALEUTIAN ISLAN, P397; Hulten E, 1944, FLORA ALASKA YUKON, V4; Jensen U, 1995, PLANT SYST EVOL, P273; Kadota Y, 2006, FLORA JAPAN A, VIIa, P323; Kadota Yuichi, 2004, Journal of Japanese Botany, V79, P311; Kamath Shreya, 2009, Chin Med, V4, P17, DOI 10.1186/1749-8546-4-17; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuang HX., 2017, CHEM TRADITIONAL CHI; Lee DU, 2003, LIFE SCI, V73, P1401, DOI 10.1016/S0024-3205(03)00435-1; Li CY, 2009, J PHARMACEUT BIOMED, V49, P1272, DOI 10.1016/j.jpba.2009.02.028; Li RQ, 2004, INT J PLANT SCI, V165, P311, DOI 10.1086/381920; Liu Y, 2012, MOL PHYLOGENET EVOL, V62, P130, DOI 10.1016/j.ympev.2011.09.010; Pagel M, 2014, BAYESTRAITS V 2 0 RE; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qiao YL, 2009, J AOAC INT, V92, P663; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Rambaut A., 2007, TRACER V1 4; Ro KE, 1997, MOL PHYLOGENET EVOL, V8, P117, DOI 10.1006/mpev.1997.0413; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SATAKE YOSISUKE, 1949, JOUR JAPANESE BOT, V24, P69; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAMURA M, 1981, BOT MAG TOKYO, V94, P165, DOI 10.1007/BF02488274; TAMURA M, 1968, Science Reports College of General Education Osaka University, V17, P41; Tamura M., 1995, NATURL PFLANZ, V17, P444; Tamura M, 1978, J GEOBOT, V26, P2; Tamura M, 1982, WILD FLOWERS JAPAN, V2, P86; TAMURA MICHIO, 1958, ACTA PHYTOTAX ET GEOBOT, V17, P114; Taylor RL, 1968, FLORA QUEEN CHARLO 2, P148; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; [辜天琪 Tianqi Gu], 2007, [植物学通报, Chinese Bulletin of Botany], V24, P80; Torrey J, 1838, FLORA N AM, V1; Wang H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/798093; Wang W, 2005, PLANT SYST EVOL, V255, P41, DOI 10.1007/s00606-005-0339-z; Wang W, 2009, PERSPECT PLANT ECOL, V11, P81, DOI 10.1016/j.ppees.2009.01.001; Wang W, 2010, TAXON, V59, P1712, DOI 10.1002/tax.596006; Wu H, 2014, PHYTOMEDICINE, V21, P1373, DOI 10.1016/j.phymed.2014.05.002; Yang KC, 1996, FLORA TAIWAN, V2, P545; Yoshimatsu H, 1927, SUPPLEMENTA ICONUM P, V3, P25; Yu YF, 1999, PLANTS, V151, P3; Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493	62	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153127	10.1371/journal.pone.0153127	http://dx.doi.org/10.1371/journal.pone.0153127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044035	Green Published, gold, Green Submitted			2022-12-26	WOS:000373592100067
J	Zhao, L; Guo, H; Zhou, B; Feng, J; Li, Y; Han, T; Liu, L; Li, L; Zhang, S; Liu, Y; Shi, J; Zheng, D				Zhao, L.; Guo, H.; Zhou, B.; Feng, J.; Li, Y.; Han, T.; Liu, L.; Li, L.; Zhang, S.; Liu, Y.; Shi, J.; Zheng, D.			Long non-coding RNA SNHG5 suppresses gastric cancer progression by trapping MTA2 in the cytosol	ONCOGENE			English	Article							SNORNA U50; EXPRESSION; PROTEIN; GAS5; PROLIFERATION; CARCINOMA; APOPTOSIS; GROWTH; GENES	Recently, intriguing new roles for some small nucleolar RNA host genes (SNHGs) in cancer have emerged. In the present study, a panel of SNHGs was profiled to detect aberrantly expressed SNHGs in gastric cancer (GC). The expression of SNHG5 was significantly downregulated in GC and was significantly associated with the formation of a tumor embolus and with the tumor, node and metastasis stage. SNHG5 was a long non-coding RNA, which was a class of non-coding RNA transcripts longer than 200 nucleotides. SNHG5 suppressed GC cell proliferation and metastasis in vitro and in vivo. Furthermore, SNHG5 exerted its function through interacting with MTA2, preventing the translocation of MTA2 from the cytoplasm into the nucleus. SNHG5 overexpression led to significant increases in the acetylation levels of histone H3 and p53, indicating that SNHG5 might affect acetylation by trapping MTA2 in the cytosol, thereby interfering with the formation of the nucleosome remodeling and histone deacetylation complex. This study is the first to demonstrate that SNHG5 is a critical and powerful regulator that is involved in GC progression through trapping MTA2 in the cytosol. These results imply that SNHG5 may be a novel therapeutic target for the treatment of GC.	[Zhao, L.; Guo, H.; Li, Y.; Han, T.; Li, L.; Zhang, S.; Liu, Y.; Shi, J.; Zheng, D.] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Zhao, L.; Guo, H.; Li, Y.; Han, T.; Li, L.; Zhang, S.; Liu, Y.; Shi, J.; Zheng, D.] Peking Union Med Coll, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Zhao, L.; Liu, L.] Hebei Med Univ, Hosp 4, Res Ctr, Shijiazhuang, Peoples R China; [Zhou, B.] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin, Heilongjiang, Peoples R China; [Feng, J.] Chinese PLA, Bethune Int Peace Hosp, Dept Gastroenterol, Shijiazhuang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Hebei Medical University; Harbin Medical University	Shi, J; Zheng, D (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.; Shi, J; Zheng, D (corresponding author), Peking Union Med Coll, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	shijuantt@163.com; zhengdx@pumc.edu.cn		Guo, Hui/0000-0003-3901-6336	State Key Basic Research Program of China [2013CB530805]; Natural Science Foundation of China [81372200, 81572755]; PUMC Youth Fund; Fundamental Research Funds for Central Universities [3332013055, 3332014007]	State Key Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PUMC Youth Fund; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was partially supported by the State Key Basic Research Program of China (Grant No. 2013CB530805, to J Shi and D Zheng), the Natural Science Foundation of China (Grant No. 81372200, 81572755, to J Shi), the PUMC Youth Fund and the Fundamental Research Funds for the Central Universities (Grant No. 3332013055 and 3332014007, to J Shi).	Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Cao WJ, 2013, WORLD J GASTROENTERO, V19, P3658, DOI 10.3748/wjg.v19.i23.3658; Chaudhry MA, 2013, INT J MOL SCI, V14, P9099, DOI 10.3390/ijms14059099; Covington KR, 2013, BREAST CANCER RES TR, V141, P375, DOI 10.1007/s10549-013-2709-5; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Hudson WH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6395; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Lee H, 2009, J GASTROEN HEPATOL, V24, P1445, DOI 10.1111/j.1440-1746.2009.05965.x; Li JM, 2014, PROTEIN CELL, V5, P457, DOI 10.1007/s13238-014-0055-y; Liao JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-198; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Mizrahi I, 2015, J CANCER, V6, P105, DOI 10.7150/jca.10568; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Okugawa Y, 2017, GUT, V66, P107, DOI 10.1136/gutjnl-2015-309359; Okugawa Y, 2014, CARCINOGENESIS, V35, P2731, DOI 10.1093/carcin/bgu200; Scarpino S, 2013, THYROID, V23, P1127, DOI 10.1089/thy.2011.0421; Siprashvili Z, 2016, NAT GENET, V48, P53, DOI 10.1038/ng.3452; Sun M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-319; Tanaka R, 2000, GENES CELLS, V5, P277, DOI 10.1046/j.1365-2443.2000.00325.x; Williams GT, 2006, GENE THER MOL BIOL, V10B, P255; Wu M, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-1; Yang F, 2012, FEBS J, V279, P3159, DOI 10.1111/j.1742-4658.2012.08694.x; Zhou CF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-102	29	95	102	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 3	2016	35	44					5770	5780		10.1038/onc.2016.110	http://dx.doi.org/10.1038/onc.2016.110			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XQ	27065326				2022-12-26	WOS:000386998400008
J	Nadezhdin, KD; Garcia-Carpio, I; Goncharuk, SA; Mineev, KS; Arseniev, AS; Vilar, M				Nadezhdin, Kirill D.; Garcia-Carpio, Irmina; Goncharuk, Sergey A.; Mineev, Konstantin S.; Arseniev, Alexander S.; Vilar, Marcal			Structural Basis of p75 Transmembrane Domain Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; HELIX-HELIX INTERACTIONS; NEUROTROPHIN RECEPTOR; SYMPATHETIC NEURONS; MEMBRANE-PROTEINS; DIMERIC STRUCTURE; GAMMA-SECRETASE; DEATH RECEPTOR; GLYCOPHORIN-A; NGF RECEPTOR	Dimerization of single span transmembrane receptors underlies their mechanism of activation. p75 neurotrophin receptor plays an important role in the nervous system, but the understanding of p75 activation mechanism is still incomplete. The transmembrane (TM) domain of p75 stabilizes the receptor dimers through a disulfide bond, essential for the NGF signaling. Here we solved by NMR the three-dimensional structure of the p75-TM-WT and the functionally inactive p75-TM-C257A dimers. Upon reconstitution in lipid micelles, p75-TM-WT forms the disulfide-linked dimers spontaneously. Under reducing conditions, p75-TM-WT is in a monomer-dimer equilibrium with the Cys(257) residue located on the dimer interface. In contrast, p75-TM-C257A forms dimers through the AXXXG motif on the opposite face of the alpha-helix. Biochemical and cross-linking experiments indicate that AXXXG motif is not on the dimer interface of p75-TM-WT, suggesting that the conformation of p75-TM-C257A may be not functionally relevant. However, rather than mediating p75 homodimerization, mutagenesis of the AXXXG motif reveals its functional role in the regulated intramembrane proteolysis of p75 catalyzed by the gamma-secretase complex. Our structural data provide an insight into the key role of the Cys(257) in stabilization of the weak transmembrane dimer in a conformation required for the NGF signaling.	[Nadezhdin, Kirill D.; Goncharuk, Sergey A.; Mineev, Konstantin S.; Arseniev, Alexander S.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Garcia-Carpio, Irmina; Vilar, Marcal] Inst Salud Carlos III, Neurodegenerat Unit, Unidad Func Invest Enfermedades Cron, Madrid 28220, Spain	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC)	Arseniev, AS (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia.; Vilar, M (corresponding author), CSIC, Inst Biomed Valencia, C Jaume Roig 11, Valencia 46010, Spain.	aars@nmr.ru; mvilar@ibv.csic.es	Mineev, Konstantin/E-4151-2010; Mineev, Konstantin S/Q-3948-2018; Goncharuk, Sergey/Q-4481-2016; Nadezhdin, Kirill D/R-6757-2016; Vilar, Marçal/B-4581-2016; Mineev, Konstantin/AAC-6662-2019	Mineev, Konstantin/0000-0002-2418-9421; Mineev, Konstantin S/0000-0002-2418-9421; Vilar, Marçal/0000-0002-9376-6544; Mineev, Konstantin/0000-0002-2418-9421; Nadezhdin, Kirill/0000-0002-7140-0779; Garcia Carpio, Irmina/0000-0003-1054-1655; Goncharuk, Sergey/0000-0002-0263-6462	Russian Science Foundation [14-50-00131]; Spanish Ministry of Economy and Competitiveness (MINECO) Project [BFU2013-42746-P]; MINECO Formacion de Personal Investigador (FPI) Predoctoral Fellowship [BFU2010-15276]	Russian Science Foundation(Russian Science Foundation (RSF)); Spanish Ministry of Economy and Competitiveness (MINECO) Project; MINECO Formacion de Personal Investigador (FPI) Predoctoral Fellowship(German Research Foundation (DFG))	This work was supported in part by Russian Science Foundation Project 14-50-00131 ( to A. S. A.) (NMR structural studies) and Spanish Ministry of Economy and Competitiveness (MINECO) Project BFU2013-42746-P ( to M. V.). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.r Supported by MINECO Formacion de Personal Investigador (FPI) Predoctoral Fellowship BFU2010-15276.	Anastasia A, 2015, J NEUROSCI, V35, P11911, DOI 10.1523/JNEUROSCI.0591-15.2015; Aoki M, 2009, PROTEIN EXPRES PURIF, V68, P128, DOI 10.1016/j.pep.2009.07.017; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bocharov EV, 2007, J BIOL CHEM, V282, P16256, DOI 10.1074/jbc.M701745200; Bocharov EV, 2013, STRUCTURE, V21, P2087, DOI 10.1016/j.str.2013.08.026; Bocharov EV, 2012, BBA-BIOMEMBRANES, V1818, P2158, DOI 10.1016/j.bbamem.2012.05.001; Bothwell M, 2006, BRAIN BEHAV EVOLUT, V68, P124, DOI 10.1159/000094082; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chen LR, 2010, J AM CHEM SOC, V132, P3628, DOI 10.1021/ja910692u; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Fisher LE, 2003, BIOPHYS J, V85, P3097, DOI 10.1016/S0006-3495(03)74728-6; Fleming KG, 2002, J MOL BIOL, V323, P563, DOI 10.1016/S0022-2836(02)00920-8; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; Fu QS, 2016, MOL CELL, V61, P602, DOI 10.1016/j.molcel.2016.01.009; Goncharuk SA, 2011, ACTA NATURAE, V3, P77, DOI 10.32607/20758251-2011-3-3-77-84; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; GROB PM, 1983, P NATL ACAD SCI-BIOL, V80, P6819, DOI 10.1073/pnas.80.22.6819; Guntert Peter, 2004, Methods Mol Biol, V278, P353; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kai L, 2012, METHODS MOL BIOL, V800, P201, DOI 10.1007/978-1-61779-349-3_14; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Keller R., 2004, COMPUTER AIDED RESON, V1; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Lin Z, 2015, ELIFE, V4, DOI 10.7554/eLife.11692; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Mao GZ, 2009, J ALZHEIMERS DIS, V18, P167, DOI 10.3233/JAD-2009-1132; Mineev KS, 2011, ACTA NATURAE, V3, P90, DOI 10.32607/20758251-2011-3-2-90-98; Mineev KS, 2015, BIOCHEMISTRY-US, V54, P6295, DOI 10.1021/acs.biochem.5b00851; Mineev KS, 2015, BIOPHYS J, V109, P772, DOI 10.1016/j.bpj.2015.07.009; Mineev KS, 2014, BBA-BIOMEMBRANES, V1838, P164, DOI 10.1016/j.bbamem.2013.08.021; Nakano M, 2009, J AM CHEM SOC, V131, P8308, DOI 10.1021/ja9017013; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Polyansky AA, 2014, BIOINFORMATICS, V30, P889, DOI 10.1093/bioinformatics/btt645; Polyansky AA, 2012, J AM CHEM SOC, V134, P14390, DOI 10.1021/ja303483k; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Sulistijo ES, 2009, BIOCHEMISTRY-US, V48, P5106, DOI 10.1021/bi802245u; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Teese MG, 2015, BIOCHEMISTRY-US, V54, P5125, DOI 10.1021/acs.biochem.5b00495; Vicario A, 2015, J CELL SCI, V128, P1507, DOI 10.1242/jcs.161745; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 2001, CELL MOL LIFE SCI, V58, P748, DOI 10.1007/PL00000898; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita Toshihide, 2005, Anatomical Science International, V80, P37, DOI 10.1111/j.1447-073x.2005.00095.x; Zhou P, 2009, PROTEINS, V76, P151, DOI 10.1002/prot.22327	65	21	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12346	12357		10.1074/jbc.M116.723585	http://dx.doi.org/10.1074/jbc.M116.723585			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27056327	Green Published, hybrid			2022-12-26	WOS:000378092800033
J	Zattas, D; Berk, JM; Kreft, SG; Hochstrasser, M				Zattas, Dimitrios; Berk, Jason M.; Kreft, Stefan G.; Hochstrasser, Mark			A Conserved C-terminal Element in the Yeast Doa10 and Human MARCH6 Ubiquitin Ligases Required for Selective Substrate Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; INNER NUCLEAR-MEMBRANE; IN-VIVO DEGRADATION; ER QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; PROTEIN-DEGRADATION; TRANSCRIPTIONAL REGULATOR; MAT-ALPHA-2 REPRESSOR; MISFOLDED PROTEINS	Specific proteins are modified by ubiquitin at the endoplasmic reticulum (ER) and are degraded by the proteasome, a process referred to as ER-associated protein degradation. In Saccharomyces cerevisiae, two principal ER-associated protein degradation ubiquitin ligases (E3s) reside in the ER membrane, Doa10 and Hrd1. The membrane-embedded Doa10 functions in the degradation of substrates in the ER membrane, nuclear envelope, cytoplasm, and nucleoplasm. How most E3 ligases, including Doa10, recognize their protein substrates remains poorly understood. Here we describe a previously unappreciated but highly conserved C-terminal element (CTE) in Doa10; this cytosolically disposed 16-residue motif follows the final transmembrane helix. A conserved CTE asparagine residue is required for ubiquitylation and degradation of a subset of Doa10 substrates. Such selectivity suggests that the Doa10 CTE is involved in substrate discrimination and not general ligase function. Functional conservation of the CTE was investigated in the human ortholog of Doa10, MARCH6 (TEB4), by analyzing MARCH6 autoregulation of its own degradation. Mutation of the conserved Asn residue (N890A) in the MARCH6 CTE stabilized the normally short lived enzyme to the same degree as a catalytically inactivating mutation (C9A). We also report the localization of endogenous MARCH6 to the ER using epitope tagging of the genomic MARCH6 locus by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated genome editing. These localization and CTE analyses support the inference that MARCH6 and Doa10 are functionally similar. Moreover, our results with the yeast enzyme suggest that the CTE is involved in the recognition and/or ubiquitylation of specific protein substrates.	[Zattas, Dimitrios; Berk, Jason M.; Kreft, Stefan G.; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA; [Kreft, Stefan G.] Univ Konstanz, Dept Biol, Univ Str 10, D-78457 Constance, Germany; [Zattas, Dimitrios] Sloan Kettering Inst, Program Struct Biol, 1275 York Ave, New York, NY 10065 USA	Yale University; University of Konstanz; Memorial Sloan Kettering Cancer Center	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484	National Institutes of Health [R01 GM046904, F32 GM113456, T32 GM7223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM113456, R37GM046904, R01GM046904, T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM046904 ( to M. H.). Additional training support was provided by National Institutes of Health Grants F32 GM113456 ( to J. M. B.) and T32 GM7223 ( to D. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfassy OS, 2013, J BIOL CHEM, V288, P12645, DOI 10.1074/jbc.M113.453027; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Furth N, 2011, MOL BIOL CELL, V22, P4726, DOI 10.1091/mbc.E11-05-0463; Gilon T, 2000, MOL CELL BIOL, V20, P7214, DOI 10.1128/MCB.20.19.7214-7219.2000; Guthrie C, 1991, GUIDE YEAST GENETICS; Habeck G, 2015, J CELL BIOL, V209, P261, DOI 10.1083/jcb.201408088; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hickey CM, 2015, MOL BIOL CELL, V26, P3401, DOI 10.1091/mbc.E15-06-0436; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Khmelinskii A, 2014, NATURE, V516, P410, DOI 10.1038/nature14096; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Kreft SG, 2011, J BIOL CHEM, V286, P20163, DOI 10.1074/jbc.M110.196360; Laney Jeffrey D, 2002, Curr Protoc Protein Sci, VChapter 14, DOI 10.1002/0471140864.ps1405s29; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Pickart CM, 2000, NAT CELL BIOL, V2, pE139, DOI 10.1038/35019610; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Sahi C, 2013, MOL BIOL EVOL, V30, P985, DOI 10.1093/molbev/mst008; Sato T, 2012, MOL CELL, V47, P99, DOI 10.1016/j.molcel.2012.04.015; Shiber A, 2013, MOL BIOL CELL, V24, P2076, DOI 10.1091/mbc.E13-01-0010; SIKORSKI RS, 1989, GENETICS, V122, P19; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; van de Weijer ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4832; van den Boomen DJH, 2014, P NATL ACAD SCI USA, V111, P11425, DOI 10.1073/pnas.1409099111; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Zattas D, 2015, CRIT REV BIOCHEM MOL, V50, P1, DOI 10.3109/10409238.2014.959889; Zattas D, 2013, MOL BIOL CELL, V24, P890, DOI 10.1091/mbc.E12-11-0838; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	56	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12105	12118		10.1074/jbc.M116.726877	http://dx.doi.org/10.1074/jbc.M116.726877			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27068744	hybrid, Green Published			2022-12-26	WOS:000378092800013
J	Han, YM; Ripley, B; Serada, S; Naka, T; Fujimoto, M				Han, Yongmei; Ripley, Barry; Serada, Satoshi; Naka, Tetsuji; Fujimoto, Minoru			Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; INFLAMMATORY TH17 RESPONSES; COLLAGEN-INDUCED ARTHRITIS; AMELIORATES JOINT DISEASE; NECROSIS-FACTOR-ALPHA; MOUSE MODEL; FAMILIAL ALS; RECEPTOR; CELLS; BLOCKADE	Background & Aim Amyotrophic Lateral Sclerosis (ALS) is an adult-onset, progressive, motor neuron degenerative disease. Recent evidence indicates that inflammation is associated with many neuro-degenerative diseases including ALS. Previously, abnormal levels of inflammatory cytokines including IL-1 beta, IL-6 and TNF-alpha were described in ALS patients and/or in mouse ALS models. In addition, one study showed that blocking IL-1 beta could slow down progression of ALS-like symptoms in mice. In this study, we examined a role for IL-6 in ALS, using an animal model for familial ALS. Methods Mice with mutant SOD1 (G93A) transgene, a model for familial ALS, were used in this study. The expression of the major inflammatory cytokines, IL-6, IL-1 beta and TNF-alpha, in spinal cords of these SOD1 transgenic (TG) mice were assessed by real time PCR. Mice were then crossed with IL-6(-/-) mice to generate SOD1TG/IL-6(-/-) mice. SOD1 TG/IL-6(-/-) mice (n = 17) were compared with SOD1 TG/IL-6(+/-) mice (n = 18), SOD1 TG/IL-6(+/+) mice (n = 11), WT mice (n = 15), IL-6(+/-) mice (n = 5) and IL-6(-/-) mice (n = 8), with respect to neurological disease severity score, body weight and the survival. We also histologically compared the motor neuron loss in lumber spinal cords and the atrophy of hamstring muscles between these mouse groups. Results Levels of IL-6, IL-1 beta and TNF-alpha in spinal cords of SOD1 TG mice was increased compared to WT mice. However, SOD1 TG/IL-6(-/-) mice exhibited weight loss, deterioration in motor function and shortened lifespan (167.55 +/- 11.52 days), similarly to SOD1 TG/IL-6(+/+) mice (164.31 +/- 12.16 days). Motor neuron numbers and IL-1 beta and TNF-alpha levels in spinal cords were not significantly different in SOD1 TG/IL-6(-/-) mice and SOD1 TG/IL-6 (+/+) mice. Conclusion These results provide compelling preclinical evidence indicating that IL-6 does not directly contribute to motor neuron disease caused by SOD1 mutations.	[Han, Yongmei] Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan; [Han, Yongmei; Serada, Satoshi; Naka, Tetsuji; Fujimoto, Minoru] Natl Inst Biomed Innovat Hlth & Nutr, Lab Immune Signal, Osaka, Japan; [Ripley, Barry] Osaka Univ, Lab Immune Regulat, IFReC Res Bldg,3-1 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Fujimoto, M (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Immune Signal, Osaka, Japan.	mfujimoto@nibiohn.go.jp		Serada, Satoshi/0000-0001-6948-9009; Naka, Tetsuji/0000-0002-1269-3997; FUJIMOTO, MINORU/0000-0002-6390-8863				Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Audet JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034932; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Bendotti C, 2004, TRENDS MOL MED, V10, P393, DOI 10.1016/j.molmed.2004.06.009; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Fiala Milan, 2013, Am J Neurodegener Dis, V2, P129; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; Gabay C, 2001, ARTHRITIS RHEUM-US, V44, P451, DOI 10.1002/1529-0131(200102)44:2<451::AID-ANR64>3.3.CO;2-8; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; Goldbach-Mansky R, 2009, J ALLERGY CLIN IMMUN, V124, P1141, DOI 10.1016/j.jaci.2009.11.016; Gowing G, 2006, J NEUROSCI, V26, P11397, DOI 10.1523/JNEUROSCI.0602-06.2006; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Hohki S, 2010, EXP EYE RES, V91, P162, DOI 10.1016/j.exer.2010.04.009; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jeyachandran A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00462; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kunis G, 2015, J NEUROSCI, V35, P6381, DOI 10.1523/JNEUROSCI.3644-14.2015; Lincecum JM, 2010, NAT GENET, V42, P392, DOI 10.1038/ng.557; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Meissner F, 2010, P NATL ACAD SCI USA, V107, P13046, DOI 10.1073/pnas.1002396107; Mizwicki Mathew T, 2012, Am J Neurodegener Dis, V1, P305; Murdock BJ, 2015, NEUROBIOL DIS, V77, P1, DOI 10.1016/j.nbd.2015.02.017; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; Papadimitriou D, 2010, NEUROBIOL DIS, V37, P493, DOI 10.1016/j.nbd.2009.10.005; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pfohl Stephen R, 2015, J Neuromuscul Dis, V2, P137; PIGUET PF, 1992, IMMUNOLOGY, V77, P510; Rizzo F, 2014, CELL MOL LIFE SCI, V71, P999, DOI 10.1007/s00018-013-1480-4; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Schwartz M, 2014, J AUTOIMMUN, V54, P8, DOI 10.1016/j.jaut.2014.08.002; Sekizawa T, 1998, J NEUROL SCI, V154, P194, DOI 10.1016/S0022-510X(97)00228-1; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Tada S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-19; Takagi N, 1998, ARTHRITIS RHEUM, V41, P2117, DOI 10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.3.CO;2-G; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Terabe F, 2011, INFLAMM BOWEL DIS, V17, P491, DOI 10.1002/ibd.21384; THORBECKE GJ, 1992, P NATL ACAD SCI USA, V89, P7375, DOI 10.1073/pnas.89.16.7375; Vucic S, 2014, TRENDS NEUROSCI, V37, P433, DOI 10.1016/j.tins.2014.05.006; WILLIAMS RO, 1992, P NATL ACAD SCI USA, V89, P9784, DOI 10.1073/pnas.89.20.9784; Zhou C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-52	44	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153399	10.1371/journal.pone.0153399	http://dx.doi.org/10.1371/journal.pone.0153399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070121	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700059
J	Beaudreau, AH; Whitney, EJ				Beaudreau, Anne H.; Whitney, Emily J.			Historical Patterns and Drivers of Spatial Changes in Recreational Fishing Activity in Puget Sound, Washington	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; LOCAL KNOWLEDGE; FISHERIES; MANAGEMENT; CONSERVATION; IMPACTS; SPOTS	Small-scale fisheries are the primary users of many coastal fish stocks; yet, spatial and temporal patterns of recreational and subsistence fishing in coastal marine ecosystems are poorly documented. Knowledge about the spatial distribution of fishing activities can inform place-based management that balances species conservation with opportunities for recreation and subsistence. We used a participatory mapping approach to document changes in spatial fishing patterns of 80 boat-based recreational anglers from 1950 to 2010 in Puget Sound, Washington, USA. Hand-drawn fishing areas for salmon, rockfishes, flatfishes, and crabs were digitized and analyzed in a Geographic Information System. We found that recreational fishing has spanned the majority of Puget Sound since the 1950s, with the heaviest use limited to small areas of central and northern Puget Sound. People are still fishing in the same places they were decades ago, with relatively little change in specific locations despite widespread declines in salmon and bottomfish populations during the second half of the 20th century. While the location of core fishing areas remained consistent, the size of those areas and intensity of use changed over time. The size of fishing areas increased through the 2000s for salmon but declined after the 1970s and 1980s for rockfishes, flatfishes, and crabs. Our results suggest that the spatial extent of recreational bottomfishing increased after the 1960s, when the availability of motorized vessels and advanced fish-finding technologies allowed anglers to expand their scope beyond localized angling from piers and boathouses. Respondents offered a wide range of reasons for shifts in fishing areas over time, reflecting substantial individual variation in motivations and behaviors. Changes in fishing areas were most commonly attributed to changes in residence and declines in target species and least tied to fishery regulations, despite the implementation of at least 25 marine preserves since 1970.	[Beaudreau, Anne H.; Whitney, Emily J.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, 17101 Point Lena Loop Rd, Juneau, AK 99801 USA	University of Alaska System; University of Alaska Fairbanks	Beaudreau, AH (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, 17101 Point Lena Loop Rd, Juneau, AK 99801 USA.	abeaudreau@alaska.edu			U.S. Environmental Protection Agency [DW13923277]; Fidalgo Chapter of the Puget Sound Anglers Association; University of Alaska Fairbanks School of Fisheries and Ocean Sciences	U.S. Environmental Protection Agency(United States Environmental Protection Agency); Fidalgo Chapter of the Puget Sound Anglers Association; University of Alaska Fairbanks School of Fisheries and Ocean Sciences	This research was supported by the U.S. Environmental Protection Agency (http://www.epa.gov/, grant # DW13923277; AHB), the Fidalgo Chapter of the Puget Sound Anglers Association (http://www.psafidalgo.org/; AHB), and the University of Alaska Fairbanks School of Fisheries and Ocean Sciences (http://www.uaf.edu/sfos/; AHB, EJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlinghaus R, 2006, ENVIRON CONSERV, V33, P46, DOI 10.1017/S0376892906002700; Beaudreau AH, 2014, ECOL APPL, V24, P244, DOI 10.1890/13-0817.1; Beaudreau AH, 2011, CONSERV LETT, V4, P451, DOI 10.1111/j.1755-263X.2011.00199.x; Begossi A, 2001, REG ENVIRON CHANGE, V2, P1, DOI 10.1007/s101130100022; Begossi A, 2006, ECOL SOC, V11; Bergmann M, 2004, FISH RES, V66, P373, DOI 10.1016/j.fishres.2003.07.007; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bernard H. R., 2017, RES METHODS ANTHR; Bertrand S, 2008, PROG OCEANOGR, V79, P379, DOI 10.1016/j.pocean.2008.10.009; Blanchard JL, 2005, CAN J FISH AQUAT SCI, V62, P2001, DOI 10.1139/F05-109; Chambers JM., 1992, STAT MODELS S; Close CH, 2006, J ENVIRON MANAGE, V78, P341, DOI 10.1016/j.jenvman.2005.04.027; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Coll M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085670; Collie JS, 2000, J ANIM ECOL, V69, P785, DOI 10.1046/j.1365-2656.2000.00434.x; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; Davis A, 2003, HUM ECOL, V31, P463, DOI 10.1023/A:1025075923297; Daw TM, 2008, FISH RES, V90, P17, DOI 10.1016/j.fishres.2007.09.027; Erisman BE, 2011, CAN J FISH AQUAT SCI, V68, P1705, DOI 10.1139/F2011-090; Hall GB, 2007, FISH RES, V83, P11, DOI 10.1016/j.fishres.2006.08.015; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HILBORN R, 1985, CAN J FISH AQUAT SCI, V42, P2, DOI 10.1139/f85-001; HILBORN R, 1992; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 2012, ICES J MAR SCI, V69, P1053, DOI 10.1093/icesjms/fss050; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Kraig E, 2014, WASHINGTON STATE SPO; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Leopold M, 2014, ICES J MAR SCI, V71, P1781, DOI 10.1093/icesjms/fst204; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Love M. S., 2002, ROCKFISHES NE PACIFI; Miller B. S., 1980, GEOGRAPHICAL DISTRIB, V1-3; Moreno-Baez M, 2012, OCEAN COAST MANAGE, V55, P111, DOI 10.1016/j.ocecoaman.2011.10.001; Moreno-Baez M, 2010, B MAR SCI, V86, P339; National Oceanic and Atmospheric Administration (NOAA), RECR FISH STAT; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Neis B, 1999, CAN J FISH AQUAT SCI, V56, P1949, DOI 10.1139/cjfas-56-10-1949; Office of Financial Management (OFM), POPULATION; Pacunski R.E., 2008, MARINE HABITAT MAPPI, P109, DOI [10.4027/mhmta.2008.08, DOI 10.4027/MHMTA.2008.08]; Pacunski RE, 2013, PUBLICATION FPT; Palsson WA., 2009, BIOL ASSESSMENT ROCK; R Core Team, 2012, R LANG ENV STAT COMP; Sawchuk JH, 2015, MAR POLICY, V54, P98, DOI 10.1016/j.marpol.2014.12.014; Scholz A, 2004, MAR POLICY, V28, P335, DOI 10.1016/j.marpol.2003.09.003; St Martin K, 2001, ANN ASSOC AM GEOGR, V91, P122, DOI 10.1111/0004-5608.00236; U.S. Commission of Fish and Fisheries, 1892, REP COMM 16; WAND MP, 1994, COMPUTATION STAT, V9, P97; Washington Department of Natural Resources, 1972, N INL WAT, V1; Washington Department of Natural Resources, 1972, S INL WAT, V2; Weisberg S., 1985, APPL LINEAR REGRESSI; Williams GD, 2010, MAR POLICY, V34, P1010, DOI 10.1016/j.marpol.2010.02.008; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Yates KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068424	53	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152190	10.1371/journal.pone.0152190	http://dx.doi.org/10.1371/journal.pone.0152190			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054890	Green Submitted, Green Published, gold			2022-12-26	WOS:000373608000014
J	McDonald, KA; Stearne, SM; Alderson, JA; North, I; Pires, NJ; Rubenson, J				McDonald, Kirsty A.; Stearne, Sarah M.; Alderson, Jacqueline A.; North, Ian; Pires, Neville J.; Rubenson, Jonas			The Role of Arch Compression and Metatarsophalangeal Joint Dynamics in Modulating Plantar Fascia Strain in Running	PLOS ONE			English	Article							FOOT POSTURE INDEX; LONGITUDINAL ARCH; ACHILLES-TENDON; BIOMECHANICAL EVALUATION; MECHANICAL-PROPERTIES; WINDLASS MECHANISM; STANCE PHASE; WALK-RUN; APONEUROSIS; SUPPORT	Elastic energy returned from passive-elastic structures of the lower limb is fundamental in lowering the mechanical demand on muscles during running. The purpose of this study was to investigate the two length-modulating mechanisms of the plantar fascia, namely medial longitudinal arch compression and metatarsophalangeal joint (MPJ) excursion, and to determine how these mechanisms modulate strain, and thus elastic energy storage/return of the plantar fascia during running. Eighteen runners (9 forefoot and 9 rearfoot strike) performed three treadmill running trials; unrestricted shod, shod with restricted arch compression (via an orthotic-style insert), and barefoot. Three-dimensional motion capture and ground reaction force data were used to calculate lower limb kinematics and kinetics including MPJ angles, moments, powers and work. Estimates of plantar fascia strain due to arch compression and MPJ excursion were derived using a geometric model of the arch and a subject-specific musculoskeletal model of the plantar fascia, respectively. The plantar fascia exhibited a typical elastic stretch-shortening cycle with the majority of strain generated via arch compression. This strategy was similar in fore-and rear-foot strike runners. Restricting arch compression, and hence the elastic-spring function of the arch, was not compensated for by an increase in MPJ-derived strain. In the second half of stance the plantar fascia was found to transfer energy between the MPJ (energy absorption) and the arch (energy production during recoil). This previously unreported energy transfer mechanism reduces the strain required by the plantar fascia in generating useful positive mechanical work at the arch during running.	[McDonald, Kirsty A.; Stearne, Sarah M.; Alderson, Jacqueline A.; Pires, Neville J.; Rubenson, Jonas] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia; [North, Ian] Willetton Podiatry, Perth, WA, Australia; [Rubenson, Jonas] Penn State Univ, Dept Kinesiol, Biomech Lab, State Coll, PA USA	University of Western Australia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Rubenson, J (corresponding author), Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia.; Rubenson, J (corresponding author), Penn State Univ, Dept Kinesiol, Biomech Lab, State Coll, PA USA.	jonas@psu.edu	Alderson, Jacqueline/V-3491-2019; Stearne, Sarah/F-9865-2013	Alderson, Jacqueline/0000-0002-8866-0913; Rubenson, Jonas/0000-0003-2854-1776; Stearne, Sarah/0000-0001-5278-2532	Willetton Podiatry (Perth, Australia); Orthotech Laboratories (Melbourne, Australia); Frank Pyke Memorial Scholarship (The University of Western Australia)	Willetton Podiatry (Perth, Australia); Orthotech Laboratories (Melbourne, Australia); Frank Pyke Memorial Scholarship (The University of Western Australia)	Willetton Podiatry (Perth, Australia) provided support in the form of salaries for author I. N., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. Orthotech Laboratories (Melbourne, Australia) provided a substantial financial discount for the production of the orthotic inserts which were used in the current study but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. During the course of this research K. A.M. was awarded personal financial support in the form of the Frank Pyke Memorial Scholarship (The University of Western Australia).	Arangio GA, 1998, FOOT ANKLE INT, V19, P705, DOI 10.1177/107110079801901010; BASMAJIAN JV, 1963, J BONE JOINT SURG AM, V45, P1189, DOI 10.2106/00004623-196345060-00006; Besier TF, 2003, J BIOMECH, V36, P1159, DOI 10.1016/S0021-9290(03)00087-3; BOBBERT MF, 1988, J BIOMECH, V21, P249, DOI 10.1016/0021-9290(88)90175-3; BOJSENMOLLER F, 1979, J ANAT, V129, P165; Caravaggi P, 2009, J EXP BIOL, V212, P2491, DOI 10.1242/jeb.025767; Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; CAVAGNA GA, 1964, J APPL PHYSIOL, V19, P249, DOI 10.1152/jappl.1964.19.2.249; CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; Cheng HYK, 2008, J BIOMECH, V41, P1937, DOI 10.1016/j.jbiomech.2008.03.028; Denton JD, 2003, RUNNING TIMES, P80; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037/0096-1523.21.1.183; Endo K, 2009, INTELLIGENT ROBOTS S; Evans AM, 2003, J AM PODIAT MED ASSN, V93, P203, DOI 10.7547/87507315-93-3-203; Flanigan RM, 2007, FOOT ANKLE INT, V28, P815, DOI 10.3113/FAI.2007.0815; Gefen A, 2003, FOOT ANKLE INT, V24, P238, DOI 10.1177/107110070302400307; Hageman ER, 2011, FOOT ANKLE INT, V32, P623, DOI 10.3113/FAI.2011.0623; HICKS JH, 1954, J ANAT, V88, P25; HUANG CK, 1993, FOOT ANKLE, V14, P353, DOI 10.1177/107110079301400609; Kelly LA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1188; Kelly LA, 2012, CLIN BIOMECH, V27, P46, DOI 10.1016/j.clinbiomech.2011.07.013; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; KITAOKA HB, 1994, FOOT ANKLE INT, V15, P557, DOI 10.1177/107110079401501007; Kogler GF, 2001, FOOT ANKLE INT, V22, P433, DOI 10.1177/107110070102200513; Kogler GF, 1996, CLIN BIOMECH, V11, P243, DOI 10.1016/0268-0033(96)00019-8; Kristianslund E, 2012, J BIOMECH, V45, P666, DOI 10.1016/j.jbiomech.2011.12.011; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; Natali AN, 2010, CONNECT TISSUE RES, V51, P337, DOI 10.3109/03008200903389127; PANDY MG, 1991, J BIOMECH, V24, P1, DOI 10.1016/0021-9290(91)90321-D; Pavan PG, 2011, SURG RADIOL ANAT, V33, P905, DOI 10.1007/s00276-011-0873-z; Perl DP, 2012, MED SCI SPORT EXER, V44, P1335, DOI 10.1249/MSS.0b013e318247989e; Prilutsky BI, 2001, J EXP BIOL, V204, P2277; PRILUTSKY BI, 1994, J BIOMECH, V27, P25, DOI 10.1016/0021-9290(94)90029-9; Redmond AC, 2006, CLIN BIOMECH, V21, P89, DOI 10.1016/j.clinbiomech.2005.08.002; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; Salzler MJ, 2012, FOOT ANKLE INT, V33, P262, DOI 10.3113/FAI.2012.0262; Sasaki K, 2006, GAIT POSTURE, V23, P383, DOI 10.1016/j.gaitpost.2005.05.002; Sinclair J, 2014, FAOJ, V7, P7; SNOW SW, 1995, FOOT ANKLE INT, V16, P418, DOI 10.1177/107110079501600707; Stearne SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19403; Stearne SM, 2014, MED SCI SPORT EXER, V46, P1578, DOI 10.1249/MSS.0000000000000254; Stecco C, 2013, J ANAT, V223, P665, DOI 10.1111/joa.12111; Stefanyshyn DJ, 1997, J BIOMECH, V30, P1081, DOI 10.1016/S0021-9290(97)00081-X; THORDARSON DB, 1995, CLIN ORTHOP RELAT R, P165; WINTER DA, 1980, J BIOMECH, V13, P923, DOI 10.1016/0021-9290(80)90162-1	46	50	50	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152602	10.1371/journal.pone.0152602	http://dx.doi.org/10.1371/journal.pone.0152602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054319	Green Published, Green Submitted, gold			2022-12-26	WOS:000373608000027
J	Tsirogiannis, C; Sandel, B				Tsirogiannis, Constantinos; Sandel, Brody			Fast Computations for Measures of Phylogenetic Beta Diversity	PLOS ONE			English	Article							COMMUNITY STRUCTURE	For many applications in ecology, it is important to examine the phylogenetic relations between two communities of species. More formally, let T be a phylogenetic tree and let A and B be two samples of its tips, representing the examined communities. We want to compute a value that expresses the phylogenetic diversity between A and B in T. There exist several measures that can do this; these are the so-called phylogenetic beta diversity (beta-diversity) measures. Two popular measures of this kind are the Community Distance (CD) and the Common Branch Length (CBL). In most applications, it is not sufficient to compute the value of a beta diversity measure for two communities A and B; we also want to know if this value is relatively large or small compared to all possible pairs of communities in T that have the same size. To decide this, the ideal approach is to compute a standardised index that involves the mean and the standard deviation of this measure among all pairs of species samples that have the same number of elements as A and B. However, no method exists for computing exactly and efficiently this index for CD and CBL. We present analytical expressions for computing the expectation and the standard deviation of CD and CBL. Based on these expressions, we describe efficient algorithms for computing the standardised indices of the two measures. Using standard algorithmic analysis, we provide guarantees on the theoretical efficiency of our algorithms. We implemented our algorithms and measured their efficiency in practice. Our implementations compute the standardised indices of CD and CBL in less than twenty seconds for a hundred pairs of samples on trees with 7 . 10(4) tips. Our implementations are available through the R package PhyloMeasures.	[Tsirogiannis, Constantinos] Aarhus Univ, MADALGO, Aarhus, Denmark; Aarhus Univ, Dept Bios, Aarhus, Denmark	Aarhus University; Aarhus University	Tsirogiannis, C (corresponding author), Aarhus Univ, MADALGO, Aarhus, Denmark.	constant@madalgo.au.dk			Massive Data Algorithmics (MADALGO); Ecoinformatics and Biodiversity	Massive Data Algorithmics (MADALGO); Ecoinformatics and Biodiversity	This work was supported by Massive Data Algorithmics (MADALGO) (http://madalgo.au.dk/) and Ecoinformatics and Biodiversity (http://bios.au.dk/en/about-bioscience/organisation/ecoinformatics-andbiodiversity/ecoinformatics-researchprofile/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Chao A, 2015, METHODS ECOL EVOL, V6, P380, DOI 10.1111/2041-210X.12247; Cody M.L., 1975, P214; Eiserhardt WL, 2013, BOT J LINN SOC, V171, P244, DOI 10.1111/j.1095-8339.2012.01276.x; Feng G, 2015, SCI REP-UK, V5, DOI 10.1038/srep09337; Goloboff PA, 2009, CLADISTICS, V25, P211, DOI 10.1111/j.1096-0031.2009.00255.x; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Leprieur F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042760; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Nipperess DA, 2013, METHODS ECOL EVOL, V4, P566, DOI 10.1111/2041-210X.12042; O'Dwyer JP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002832; Peixoto FP, 2014, J BIOGEOGR, V41, P762, DOI 10.1111/jbi.12241; Pellissier L, 2013, ECOL LETT, V16, P600, DOI 10.1111/ele.12083; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P1152, DOI 10.1111/geb.12076; Ricotta C, 2015, J PLANT ECOL, V8, P12, DOI 10.1093/jpe/rtu008; Steel M, 2007, SYST ASSOC SPEC VOL, V72, P97; Swenson NG, 2012, ECOLOGY, V93, pS112, DOI 10.1890/11-0402.1; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Tsirogiannis Constantinos, 2012, Algorithms in Bioinformatics. Proceedings of the12th International Workshop, WABI 2012, P30, DOI 10.1007/978-3-642-33122-0_3; Tsirogiannis C, 2016, ECOGRAPHY, V39, P709, DOI 10.1111/ecog.01814; Tsirogiannis C, 2014, LECT N BIOINFORMAT, V8701, P187, DOI 10.1007/978-3-662-44753-6_15; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563	26	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0151167	10.1371/journal.pone.0151167	http://dx.doi.org/10.1371/journal.pone.0151167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054697	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000005
J	Guo, ZY; Xiao, D; Li, DL; Wang, XH; Wang, YY; Yan, TC; Wang, ZQ				Guo, Zuiyuan; Xiao, Dan; Li, Dongli; Wang, Xiuhong; Wang, Yayu; Yan, Tiecheng; Wang, Zhiqi			Predicting and Evaluating the Epidemic Trend of Ebola Virus Disease in the 2014-2015 Outbreak and the Effects of Intervention Measures	PLOS ONE			English	Article							MODEL; TRANSMISSION; SENSITIVITY; UNCERTAINTY; MALARIA	We constructed dynamic Ebola virus disease (EVD) transmission models to predict epidemic trends and evaluate intervention measure efficacy following the 2014 EVD epidemic in West Africa. We estimated the effective vaccination rate for the population, with basic reproduction number (R-0) as the intermediate variable. Periodic EVD fluctuation was analyzed by solving a Jacobian matrix of differential equations based on a SIR (susceptible, infective, and removed) model. A comprehensive compartment model was constructed to fit and predict EVD transmission patterns, and to evaluate the effects of control and prevention measures. Effective EVD vaccination rates were estimated to be 42% (31-50%), 45% (42-48%), and 51% (44-56%) among susceptible individuals in Guinea, Liberia and Sierra Leone, respectively. In the absence of control measures, there would be rapid mortality in these three countries, and an EVD epidemic would be likely recur in 2035, and then again 8 similar to 9 years later. Oscillation intervals would shorten and outbreak severity would decrease until the periodicity reached similar to 5.3 years. Measures that reduced the spread of EVD included: early diagnosis, treatment in isolation, isolating/monitoring close contacts, timely corpse removal, post-recovery condom use, and preventing or quarantining imported cases. EVD may re-emerge within two decades without control and prevention measures. Mass vaccination campaigns and control and prevention measures should be instituted to prevent future EVD epidemics.	[Guo, Zuiyuan; Li, Dongli; Wang, Xiuhong; Wang, Yayu; Yan, Tiecheng] Ctr Dis Control & Prevent Shenyang Mil Reg, Dept Dis Control, Shenyang, Liaoning Provin, Peoples R China; [Xiao, Dan] Fourth Mil Med Univ, Dept Epidemiol, Xian 710032, Shaanxi Prov, Peoples R China; [Wang, Zhiqi] Shenyang Jianzhu Univ, Coll Municipal & Environm Engn, Shenyang, Liaoning Provin, Peoples R China	Air Force Military Medical University; Shenyang Jianzhu University	Li, DL (corresponding author), Ctr Dis Control & Prevent Shenyang Mil Reg, Dept Dis Control, Shenyang, Liaoning Provin, Peoples R China.; Xiao, D (corresponding author), Fourth Mil Med Univ, Dept Epidemiol, Xian 710032, Shaanxi Prov, Peoples R China.	danxiao@fmmu.edu.cn; syjqcdc@sina.cn			China Postdoctoral Science Fund [2014T07967]	China Postdoctoral Science Fund(China Postdoctoral Science Foundation)	This work is supported by China Postdoctoral Science Fund (No. 2014T07967).	Althaus CL, 2015, PLOS CURR IN PRESS; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Breman JG, 2014, NEW ENGL J MED, V371, P1663, DOI 10.1056/NEJMp1410540; Busenderg S, 1990, J MATH BIOL, V28, P256; Carroll MW, 2015, NATURE IN PRESS; Cenciarelli O, 2015, INT J MICRO IN PRESS; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Chowell G, 2004, EMERG INFECT DIS, V10, P1258, DOI 10.3201/eid1007.030647; Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479; Chua AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003734; Deguen S, 2000, EUR J EPIDEMIOL, V16, P1177, DOI 10.1023/A:1010935317612; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Endo A, 2015, J THEOR BIOL, V380, P499, DOI 10.1016/j.jtbi.2015.06.024; Farrar JJ, 2014, NEW ENGL J MED, V371, P1545, DOI 10.1056/NEJMe1411471; Fast SM, 2015, PLOS CURR IN PRESS; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Fisman D, 2015, PLOS CURR IN PRESS; Kerkhove MD Van, 2015, SCI DATA IN PRESS; Kouadio KI, 2015, PLOS CURR IN PRESS; Lekone PE, 2006, BIOMETRICS, V62, P1170, DOI 10.1111/j.1541-0420.2006.00609.x; Luo ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126893; Luo T, 2011, EPIDEMIOL INFECT, V139, P257, DOI 10.1017/S0950268810001056; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Matua Gerald A, 2015, Sultan Qaboos Univ Med J, V15, pe171; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; McLeod RG, 2006, MATH BIOSCI ENG, V3, P527, DOI 10.3934/mbe.2006.3.527; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Seidu B, 2015, ACTA BIOTHEOR, V63, P151, DOI 10.1007/s10441-015-9255-y; Siettos C, 2015, PLOS CURR IN PRESS; Sinha S., 2014, AM J COMP APPL MATH, V4, P17; United Nations Department of Economic and Social Affairs, 2015, TOT POP BOTH SEX COM; United Nations Department of Economic and Social Affairs, 2015, RAT NAT INCR MAJ AR; United Nations Department of Economic and Social Affairs, 2015, CRUD DEATH RAT MAJ A; WHO, 2015, EB SIT REP; WHO, 2015, EB RESP ROADM, V7, P15; WHO Ebola Response Team, 2015, NEW ENGL J MED, V372, P584, DOI 10.1056/NEJMc1414992	37	10	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152438	10.1371/journal.pone.0152438	http://dx.doi.org/10.1371/journal.pone.0152438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049322	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500041
J	Seto, E; Hua, J; Wu, L; Shia, V; Eom, S; Wang, M; Li, Y				Seto, Edmund; Hua, Jenna; Wu, Lemuel; Shia, Victor; Eom, Sue; Wang, May; Li, Yan			Models of Individual Dietary Behavior Based on Smartphone Data: The Influence of Routine, Physical Activity, Emotion, and Food Environment	PLOS ONE			English	Article							ECOLOGICAL MOMENTARY ASSESSMENT; PORTION SIZE ESTIMATION; CONCEPTUAL-FRAMEWORK; OBESITY EPIDEMIC; ASSOCIATION; CHRONOTYPE; TYPOLOGY; MOOD; PREVENTION; MANAGEMENT	Introduction Smartphone applications (apps) facilitate the collection of data on multiple aspects of behavior that are useful for characterizing baseline patterns and for monitoring progress in interventions aimed at promoting healthier lifestyles. Individual-based models can be used to examine whether behavior, such as diet, corresponds to certain typological patterns. The objectives of this paper are to demonstrate individual-based modeling methods relevant to a person's eating behavior, and the value of such approach compared to typical regression models. Method Using a mobile app, 2 weeks of physical activity and ecological momentary assessment (EMA) data, and 6 days of diet data were collected from 12 university students recruited from a university in Kunming, a rapidly developing city in southwest China. Phone GPS data were collected for the entire 2-week period, from which exposure to various food environments along each subject's activity space was determined. Physical activity was measured using phone accelerometry. Mobile phone EMA was used to assess self-reported emotion/feelings. The portion size of meals and food groups was determined from voice-annotated videos of meals. Individual-based regression models were used to characterize subjects as following one of 4 diet typologies: those with a routine portion sizes determined by time of day, those with portion sizes that balance physical activity (energy balance), those with portion sizes influenced Results Ample compliance with the phone-based behavioral assessment was observed for all participants. Across all individuals, 868 consumed food items were recorded, with fruits, grains and dairy foods dominating the portion sizes. On average, 218 hours of accelerometry and 35 EMA responses were recorded for each participant. For some subjects, the routine model was able to explain up to 47% of the variation in portion sizes, and the energy balance model was able to explain over 88% of the variation in portion sizes. Across all our subjects, the food environment was an important predictor of eating patterns. Generally, grouping all subjects into a pooled model performed worse than modeling each individual separately. Conclusion A typological modeling approach was useful in understanding individual dietary behaviors in our cohort. This approach may be applicable to the study of other human behaviors, particularly those that collect repeated measures on individuals, and those involving smartphone- based behavioral measurement.	[Seto, Edmund] Univ Washington, Sch Publ Hlth, Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Hua, Jenna] Univ Calif Berkeley, Sch Publ Hlth, Environm Hlth Sci, Berkeley, CA 94720 USA; [Wu, Lemuel; Shia, Victor] Univ Calif Berkeley, Sch Engn, Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Eom, Sue] Seoul Natl Univ, Sch Publ Hlth, Publ Hlth Nutr, Seoul, South Korea; [Wang, May] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Community Hlth Sci, Los Angeles, CA USA; [Li, Yan] Kunming Med Univ, Sch Publ Hlth, Maternal & Child Hlth, Kunming, Peoples R China	University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Seoul National University (SNU); University of California System; University of California Los Angeles; Kunming Medical University	Hua, J (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Environm Hlth Sci, Berkeley, CA 94720 USA.	jenna_hua@berkeley.edu			Llewellyn Student Project Award - Center for Occupational and Environmental Health (COEH) at University of California Berkeley; Ruth L. Kirschstein National Research Service Award [F31, F31CA180477]; National Cancer Institute	Llewellyn Student Project Award - Center for Occupational and Environmental Health (COEH) at University of California Berkeley; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the Llewellyn Student Project Award given by Center for Occupational and Environmental Health (COEH) at University of California Berkeley (http://coeh.berkeley.edu/students/studentaward.htm), and the Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows (F31) and (F31CA180477) awarded by National Cancer Institute, (http://www.cancer.gov/grants-training/training/funding/f31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala GX, 2006, HEALTH EDUC RES, V21, P133, DOI 10.1093/her/cyh049; Barker RG, 1968, ECOLOGICAL PSYCHOL C, Vvi; BIRCH LL, 1987, LEARN MOTIV, V18, P301, DOI 10.1016/0023-9690(87)90017-8; Boone-Heinonen J, 2011, ARCH INTERN MED, V171, P1162, DOI 10.1001/archinternmed.2011.283; Buck HG, 2013, J CARDIOVASC NURS, V28, pE37, DOI 10.1097/JCN.0b013e31827fcc4c; Carter MC, 2013, BRIT J NUTR, V109, P539, DOI 10.1017/S0007114512001353; Caspi CE, 2012, HEALTH PLACE, V18, P1172, DOI 10.1016/j.healthplace.2012.05.006; CHRISTENSEN L, 1993, INT J EAT DISORDER, V14, P171, DOI [10.1002/1098-108X(199309)14:2<171::AID-EAT2260140207>3.0.CO;2-U, 10.1002/1098-108X(199309)14:2&lt;171::AID-EAT2260140207&gt;3.0.CO;2-U]; Collins LM, 2004, PREV SCI, V5, P185, DOI 10.1023/B:PREV.0000037641.26017.00; Courvoisier DS, 2010, EMOTION, V10, P115, DOI 10.1037/a0017813; Donaire-Gonzalez D, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2470; Ello-Martin JA, 2005, AM J CLIN NUTR, V82, p236S, DOI 10.1093/ajcn/82.1.236S; Fisher L, 2000, BEHAV MED, V26, P53, DOI 10.1080/08964280009595752; Fleig D, 2009, EAT BEHAV, V10, P115, DOI 10.1016/j.eatbeh.2009.03.002; Fletcher RR, 2011, PERV COMP TECHN HEAL; Friedman SL, 1999, MEASURING ENV LIFE S; Godwin SL, 2004, J AM DIET ASSOC, V104, P585, DOI 10.1016/j.jada.2004.01.006; Gruber R, 2010, SLEEP, V33, pA80; Hebden L, 2012, JMIR RES PROTOC, V1, DOI 10.2196/resprot.2205; Hensel DJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-75; Hernandez T, 2006, J FOOD COMPOS ANAL, V19, pS14, DOI 10.1016/j.jfca.2006.02.010; Hughes Deonna C, 2010, J Diabetes Sci Technol, V4, P429; Jon Noronha EH, 2011, P 24 ANN ACM S US IN; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; King AC, 2002, AM J PREV MED, V23, P15, DOI 10.1016/S0749-3797(02)00470-1; Kong FY, 2012, PERVASIVE MOB COMPUT, V8, P147, DOI 10.1016/j.pmcj.2011.07.003; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Kumanyika S, 2002, INT J OBESITY, V26, P425, DOI 10.1038/sj.ijo.0801938; Lakerveld J, 2016, OBES REV, V17, P5, DOI 10.1111/obr.12384; Lakerveld J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-793; LEATHWOOD PD, 1983, J PSYCHIATR RES, V17, P147, DOI 10.1016/0022-3956(82)90016-4; Ledikwe JH, 2005, J NUTR, V135, P905, DOI 10.1093/jn/135.4.905; Lillie EO, 2011, PERS MED, V8, P161, DOI 10.2217/PME.11.7; LUCAS F, 1995, J HUM NUTR DIET, V8, P65, DOI 10.1111/j.1365-277X.1995.tb00296.x; Lynch K., 1982, IMAGEN CITY; McSweeney FK, 2014, WILEY BLACKWELL HANDBOOK OF OPERANT AND CLASSICAL CONDITIONING, P1, DOI 10.1002/9781118468135; Montoliu R, 2010, P 9 INT C MOB UB MUL; Moore LV, 2009, AM J EPIDEMIOL, V170, P29, DOI 10.1093/aje/kwp090; Newman O, 1972, DEFENSIBLE SPACE CRI, Vxvii; O'Reilly GA, 2013, AM J PREV MED, V45, P501, DOI 10.1016/j.amepre.2013.05.012; Qiu H, 2009, CHINESE PRIMARY HLTH, V4; Rivera-Pelayo V, 2012, MOBILE LEARNING; Schoggen P, 1989, BEHAV SETTINGS REVIS, Vxii; Schubert E, 2008, APPETITE, V51, P501, DOI 10.1016/j.appet.2008.03.018; Seto E, 2010, PETRAE C WORKSH LIGH; Shaw RJ, 2003, PEDIATR TRANSPLANT, V7, P489, DOI 10.1046/j.1397-3142.2003.00117.x; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Silk JS, 2011, J EXP CHILD PSYCHOL, V110, P241, DOI 10.1016/j.jecp.2010.10.007; Six BL, 2010, J AM DIET ASSOC, V110, P74, DOI 10.1016/j.jada.2009.10.010; Stone AA, 1999, WELL BEING FDN HEDON, P26; Swan M, 2012, J SENS ACTUAR NETW, V1, P217, DOI 10.3390/jsan1030217; THOMPSON DA, 1988, MED SCI SPORT EXER, V20, P222, DOI 10.1249/00005768-198806000-00002; VERGER P, 1994, APPETITE, V22, P159, DOI 10.1006/appe.1994.1015; WHO, 2014, GLOB DAT BOD MASS IN; Williamson DA, 2003, J AM DIET ASSOC, V103, P1139, DOI 10.1016/S0002-8223(03)00974-X; Woo I, 2010, ELECT IMAGING SCI TE, V8, P1; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246; Zhu FQ, 2010, IEEE J-STSP, V4, P756, DOI 10.1109/JSTSP.2010.2051471; Zhu K, 2008, CHIN J CHILD HLTH CA, V16, P696	59	27	29	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153085	10.1371/journal.pone.0153085	http://dx.doi.org/10.1371/journal.pone.0153085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27049852	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500096
J	Zhao, CH; Lv, C; Li, H; Du, SJ; Liu, XL; Li, Z; Xin, WF; Zhang, WS				Zhao, Chunhui; Lv, Cui; Li, Hang; Du, Shijing; Liu, Xiaoli; Li, Zhi; Xin, Wenfeng; Zhang, Wensheng			Geniposide Protects Primary Cortical Neurons against Oligomeric A beta(1-42)-Induced Neurotoxicity through a Mitochondrial Pathway	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDES; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; A-BETA; ATTENUATES MITOCHONDRIAL; SYNAPTIC PLASTICITY; DNA FRAGMENTATION; INDUCED APOPTOSIS; OXIDATIVE DAMAGE; MEMORY DEFICITS	Mitochondrial dysfunction plays a key role in the progression of Alzheimer's disease (AD). The accumulation of amyloid-beta peptide (A beta) in the brains of AD patients is thought to be closely related to neuronal mitochondrial dysfunction and oxidative stress. Therefore, protecting mitochondria from A beta-induced neurotoxicity is an effective strategy for AD therapeutics. In a previous study, we found that geniposide, a pharmacologically active compound purified from gardenia fruit, has protective effects on oxidative stress and mitochondrial dysfunction in AD transgenic mouse models. However, whether geniposide has a protective effect on A beta-induced neuronal dysfunction remains unknown. In the present study, we demonstrate that geniposide protects cultured primary cortical neurons from A beta-mediated mitochondrial dysfunction by recovering ATP generation, mitochondrial membrane potential (MMP), and cytochrome c oxidase (CcO) and caspase 3/9 activity; by reducing ROS production and cytochrome c leakage; as well as by inhibiting apoptosis. These findings suggest that geniposide may attenuate A beta-induced neuronal injury by inhibiting mitochondrial dysfunction and oxidative stress.	[Zhao, Chunhui; Lv, Cui; Li, Hang; Du, Shijing; Zhang, Wensheng] Beijing Normal Univ, Beijing Area Major Lab Protect & Utilizat Tradit, Beijing 100875, Peoples R China; [Lv, Cui] Shandong Acad Sci, Shandong Anal & Test Ctr, Lab Immunol Environm & Hlth, Jinan, Peoples R China; [Zhao, Chunhui; Lv, Cui; Li, Hang; Du, Shijing; Zhang, Wensheng] Beijing Normal Univ, Coll Resources Sci Technol, Beijing 100875, Peoples R China; [Zhao, Chunhui; Li, Hang; Du, Shijing; Liu, Xiaoli; Li, Zhi; Xin, Wenfeng; Zhang, Wensheng] Beijing Normal Univ, Engn Res Ctr Nat Med, Minist Educ, Beijing 100875, Peoples R China; [Liu, Xiaoli; Xin, Wenfeng; Zhang, Wensheng] Engn Res Ctr Sanqi Biotechnol & Pharmaceut, Kunming, Yun Nan Provinc, Peoples R China	Beijing Normal University; Qilu University of Technology; Beijing Normal University; Beijing Normal University	Zhang, WS (corresponding author), Beijing Normal Univ, Beijing Area Major Lab Protect & Utilizat Tradit, Beijing 100875, Peoples R China.; Zhang, WS (corresponding author), Beijing Normal Univ, Coll Resources Sci Technol, Beijing 100875, Peoples R China.; Zhang, WS (corresponding author), Beijing Normal Univ, Engn Res Ctr Nat Med, Minist Educ, Beijing 100875, Peoples R China.; Zhang, WS (corresponding author), Engn Res Ctr Sanqi Biotechnol & Pharmaceut, Kunming, Yun Nan Provinc, Peoples R China.	zws@bnu.edu.cn	Liu, Xiaoli/HGE-7614-2022		National Natural Science Foundation of China [81274118]; Key New Drug Creation and Development Program of China [2012ZX09103-201]; National Key Technology R D Program [2012BAI29B08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key New Drug Creation and Development Program of China; National Key Technology R D Program(National Key Technology R&D Program)	This work was supported by grants by the National Natural Science Foundation of China (No. 81274118, http://www.nsfc.gov.cn/,WZ); The Key New Drug Creation and Development Program of China (No. 2012ZX09103-201, http://www.nmp.gov.cn/,WZ); and The National Key Technology R & D Program (No. 2012BAI29B08, http://www.most.gov.cn/kjgh/lskjgh/,WZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Broe M, 2001, ACTA NEUROPATHOL, V101, P616; Candela P, 2010, J ALZHEIMERS DIS, V22, P849, DOI 10.3233/JAD-2010-100462; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cavallucci V, 2013, CURR PHARM DESIGN, V19, P6440, DOI 10.2174/1381612811319360005; Chen JX, 2010, J ALZHEIMERS DIS, V20, pS569, DOI 10.3233/JAD-2010-100357; Chen YH, 2012, ONCOL REP, V27, P1233, DOI 10.3892/or.2012.1632; Chin D, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0397-3; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Colurso GJ, 2003, LIFE SCI, V73, P1795, DOI 10.1016/S0024-3205(03)00512-5; Daffu G, 2013, INT J MOL SCI, V14, P19891, DOI 10.3390/ijms141019891; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Devi L, 2012, NEUROBIOL DIS, V45, P417, DOI 10.1016/j.nbd.2011.09.001; Dragicevic N, 2010, J ALZHEIMERS DIS, V20, pS535, DOI 10.3233/JAD-2010-100342; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Eckert A, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt74; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Forlenza OV, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-89; Gao C, 2014, BRAIN PATHOL, V24, P261, DOI 10.1111/bpa.12116; Gotz J, 2011, CELL MOL LIFE SCI, V68, P3359, DOI 10.1007/s00018-011-0750-2; Han L, 2014, CELL REP, V7, P316, DOI 10.1016/j.celrep.2014.03.024; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kirkland RA, 2003, ANTIOXID REDOX SIGN, V5, P589, DOI 10.1089/152308603770310257; Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011; Kunnumakkara AB, 2010, CANCER RES, V70, P8695, DOI 10.1158/0008-5472.CAN-10-2318; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028033, 10.1371/journal.pone.0044670, 10.1371/journal.pone.0050296, 10.1186/1747-597X-7-11]; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li Z, 2015, CNS NEUROLOGICAL DIS; Liu JH, 2007, NEUROCHEM INT, V51, P361, DOI 10.1016/j.neuint.2007.04.021; Liu JH, 2013, ACTA BIOCH BIOPH SIN, V45, P787, DOI 10.1093/abbs/gmt069; Lv C, 2015, NEUROPHARMACOLOGY, V89, P175, DOI 10.1016/j.neuropharm.2014.09.019; Lv C, 2014, CURR ALZHEIMER RES, V11, P580, DOI 10.2174/1567205011666140618095925; Lv C, 2014, CURR ALZHEIMER RES, V11, P430, DOI 10.2174/1567205011666140514111204; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mennes E, 2014, J GERONTOL A-BIOL, V69, P1060, DOI 10.1093/gerona/glt156; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Peng CH, 2007, TOXICOLOGY, V238, P130, DOI 10.1016/j.tox.2007.05.029; Prezma T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.316; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Renault TT, 2015, MOL CELL, V57, P69, DOI 10.1016/j.molcel.2014.10.028; Robinson KS, 2011, ONCOGENE, V30, P2391, DOI 10.1038/onc.2010.636; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Silva DF, 2012, ADV PHARMACOL, V64, P83, DOI 10.1016/B978-0-12-394816-8.00003-9; Smilansky A, 2015, J BIOL CHEM, V290, P30670, DOI 10.1074/jbc.M115.691493; Spuch Carlos, 2012, J Aging Res, V2012, P324968, DOI 10.1155/2012/324968; Swerdlow RH, 2012, NEUROTOX RES, V22, P182, DOI 10.1007/s12640-011-9272-9; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Thinnes FP, 2009, MOL GENET METAB, V97, P241, DOI 10.1016/j.ymgme.2009.04.010; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yin F, 2011, NEUROCHEM INT, V58, P399, DOI 10.1016/j.neuint.2010.12.017	62	28	28	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152551	10.1371/journal.pone.0152551	http://dx.doi.org/10.1371/journal.pone.0152551			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046221	Green Submitted, gold, Green Published			2022-12-26	WOS:000373599600025
J	Fontana, C; Lambert, A; Benaroudj, N; Gasparini, D; Gorgette, O; Cachet, N; Bomchil, N; Picardeau, M				Fontana, Celia; Lambert, Ambroise; Benaroudj, Nadia; Gasparini, David; Gorgette, Olivier; Cachet, Nathalie; Bomchil, Natalia; Picardeau, Mathieu			Analysis of a Spontaneous Non-Motile and Avirulent Mutant Shows That FliM Is Required for Full Endoflagella Assembly in Leptospira interrogans	PLOS ONE			English	Article							BACTERIAL FLAGELLAR MOTOR; SWITCH PROTEIN; BORRELIA-BURGDORFERI; MOTILITY; VIRULENCE; INACTIVATION; EXPRESSION; COMPLEX; HOOK	Pathogenic Leptospira strains are responsible for leptospirosis, a worldwide emerging zoonotic disease. These spirochetes are unique amongst bacteria because of their corkscrew-like cell morphology and their periplasmic flagella. Motility is reported as an important virulence determinant, probably favoring entry and dissemination of pathogenic Leptospira in the host. However, proteins constituting the periplasmic flagella and their role in cell shape, motility and virulence remain poorly described. In this study, we characterized a spontaneous L. interrogans mutant strain lacking motility, correlated with the loss of the characteristic hook-shaped ends, and virulence in the animal model. Whole genome sequencing allowed the identification of one nucleotide deletion in the fliM gene resulting in a premature stop codon, thereby preventing the production of flagellar motor switch protein FliM. Genetic complementation restored cell morphology, motility and virulence comparable to those of wild type cells. Analyses of purified periplasmic flagella revealed a defect in flagella assembly, resulting in shortened flagella compared to the wild type strain. This also correlated with a lower amount of major filament proteins FlaA and FlaB. Altogether, these findings demonstrate that FliM is required for full and correct assembly of the flagella which is essential for motility and virulence.	[Fontana, Celia; Lambert, Ambroise; Benaroudj, Nadia; Picardeau, Mathieu] Inst Pasteur, Unite Biol Spirochetes, Paris, France; [Fontana, Celia; Cachet, Nathalie; Bomchil, Natalia] Lab Lyon Gerland, Lyon, France; [Gasparini, David] Ctr Rech Clin St Vulbas, Merial, St Vulbas, France; [Gorgette, Olivier] Inst Pasteur, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Merial SASU; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Picardeau, M (corresponding author), Inst Pasteur, Unite Biol Spirochetes, Paris, France.; Bomchil, N (corresponding author), Lab Lyon Gerland, Lyon, France.	natalia.bomchil@merial.com; mathieu.picardeau@pasteur.fr	LAMBERT, AMBROISE/AAH-1384-2021; Lambert, Ambroise/P-3792-2016	Lambert, Ambroise/0000-0002-3909-2948; Benaroudj, Nadia/0000-0002-6475-0041	Institut Pasteur [FUI 14]; Fonds Unique Interministeriel "COVALEPT"; BPI France; Association Nationale de la Recherche et de la Technologie; Merial SAS France	Institut Pasteur(European Commission); Fonds Unique Interministeriel "COVALEPT"; BPI France; Association Nationale de la Recherche et de la Technologie(French National Research Agency (ANR)); Merial SAS France	This work was funded by the Institut Pasteur (http://www.pasteur.fr), FUI 14 (Fonds Unique Interministeriel) "COVALEPT", BPI France (http://www.bpifrance.fr/), Association Nationale de la Recherche et de la Technologie (http://www.anrt.asso.fr/), and Merial SAS France (http://www.merial.com). The funder provided support in the form of salaries for authors [CF, DG, NC, N. Benaroudj, MP, N. Bomchil, OG, AL] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2015, CURR TOP MICROBIOL, V387, P1, DOI 10.1007/978-3-662-45059-8_1; Ahn DR, 2013, INT J BIOL MACROMOL, V54, P76, DOI 10.1016/j.ijbiomac.2012.12.003; Asuthkar S, 2007, INFECT IMMUN, V75, P4582, DOI 10.1128/IAI.00324-07; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BROMLEY DB, 1979, J BACTERIOL, V137, P1406, DOI 10.1128/JB.137.3.1406-1412.1979; Caimano MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004004; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Eshghi A, 2009, J PROTEOME RES, V8, P4564, DOI 10.1021/pr9004597; FAINE S, 1964, J BACTERIOL, V88, P1493, DOI 10.1128/JB.88.5.1493-1496.1964; Guyard C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072550; Huo LA, 2015, ADV DIFFER EQU-NY, DOI 10.1186/s13662-015-0394-x; Kojima S, 2004, INT REV CYTOL, V233, P93, DOI 10.1016/S0074-7696(04)33003-2; Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12; Li CH, 2000, J MOL MICROB BIOTECH, V2, P345; Li CH, 2010, MOL MICROBIOL, V75, P1563, DOI 10.1111/j.1365-2958.2010.07078.x; Liao SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-253; Lo M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000560; Lowenthal AC, 2009, J BACTERIOL, V191, P7147, DOI 10.1128/JB.00749-09; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Martinez-Garcia E, 2014, ENVIRON MICROBIOL, V16, P291, DOI 10.1111/1462-2920.12309; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Morimoto YV, 2014, BIOMOLECULES, V4, P217, DOI 10.3390/biom4010217; Motaleb MA, 2000, P NATL ACAD SCI USA, P97; Murray GL, 2015, CURR TOP MICROBIOL, V387, P139, DOI 10.1007/978-3-662-45059-8_7; Nally JE, 2001, INFECT IMMUN, V69, P400, DOI 10.1128/IAI.69.1.400-404.2001; Pallen MJ, 2005, TRENDS MICROBIOL, V13, P143, DOI 10.1016/j.tim.2005.02.008; Pappas CJ, 2015, APPL ENVIRON MICROBI; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x; Pinne M, 2011, JOVE-J VIS EXP, DOI 10.3791/2805; Sal MS, 2008, J BACTERIOL, V190, P1912, DOI 10.1128/JB.01421-07; SIMPSON CF, 1964, J INFECT DIS, V114, P69, DOI 10.1093/infdis/114.1.69; Slamti L, 2011, J BACTERIOL, V193, P6266, DOI 10.1128/JB.05695-11; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Toker AS, 1996, J BACTERIOL, V178, P7069, DOI 10.1128/jb.178.24.7069-7079.1996; Zhao XW, 2014, BIOCHEMISTRY-US, V53, P4323, DOI 10.1021/bi500059y; Zhong Y, 2011, CELL RES, V21, P1210, DOI 10.1038/cr.2011.46	42	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152916	10.1371/journal.pone.0152916	http://dx.doi.org/10.1371/journal.pone.0152916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044038	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100045
J	Bhatt, S; Stender, JD; Joshi, S; Wu, G; Katzenellenbogen, BS				Bhatt, S.; Stender, J. D.; Joshi, S.; Wu, G.; Katzenellenbogen, B. S.			OCT-4: a novel estrogen receptor-alpha collaborator that promotes tamoxifen resistance in breast cancer cells	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; STEM-CELLS; PROSTATE CARCINOGENESIS; MOLECULAR DETERMINANTS; ENDOCRINE RESISTANCE; ER-ALPHA; PHOSPHORYLATION; TRANSCRIPTION; THERAPY	Tamoxifen has shown great success in the treatment of breast cancer; however, long-term treatment can lead to acquired tamoxifen (TOT) resistance and relapse. TOT classically antagonizes estradiol (E2) -dependent breast cancer cell growth, but exerts partial agonist/antagonist behavior on gene expression. Although both E2 and TOT treatment of breast cancer cells results in recruitment of the estrogen receptor (ER) to common and distinct genomic sites, the mechanisms and proteins underlying TOT preferential recruitment of the ER remains poorly defined. To this end, we performed in silico motif-enrichment analyses within the ER-binding peaks in response to E2 or TOT, to identify factors that would specifically recruit ER to genomic binding sites in the presence of TOT as compared to E2. Intriguingly, we found Nkx3-1 and Oct-transcription factor homodimer motifs to be enriched in TOT preferential binding sites and confirmed the critical role of Oct-3/4 (aka Oct-4) in directing ER recruitment to TOT preferential genomic binding sites, by chromatin immunoprecipitation (ChIP) analyses. Further investigation revealed Oct-4 expression to be basally repressed by Nkx3-1 in MCF-7 cells and TOT treatment appeared to elevate Nkx3-1 degradation through a p38MAPK-dependent phosphorylation of the E3 ligase, Skp2 at serine-64 residue, as observed by quantitative mass-spectrometry analyses. Consistently, Oct-4 upon induction by phospho-Ser64-Skp2-mediated proteasomal degradation of Nkx3-1, participated in ER transcriptional complexes along with p38MAPK and Skp2 in a tamoxifen-dependent manner leading to TOT-dependent gene activation and cell proliferation of the TOT-resistant MCF-7-tam(r) breast cancer cells. Notably, Oct-4 levels were highly elevated in MCF-7-tam(r) cells, and appeared critical for their TOT sensitivity in cell proliferation assays. Furthermore, overexpression of Oct-4 enhanced tumor growth in the presence of tamoxifen in mice in vivo. Collectively, our work presents a novel mechanism for tamoxifen-specific gene activation by ER, secondary to its TOT preferential recruitment to genomic sites by specific activation of Oct-4, a phenomenon that appears to underlie tamoxifen resistance in breast cancer cells and in xenograft tumor models, and could be useful in designing therapeutic interventions to improve treatment outcome.	[Bhatt, S.; Stender, J. D.] Univ Illinois, Dept Biochem, Urbana, IL USA; [Joshi, S.] Agilent Technol, Cedar Creek, TX USA; [Wu, G.] Harvard Med Sch, Joslin Diabet Ctr, Res Div, Boston, MA USA; [Katzenellenbogen, B. S.] Univ Illinois, Mol & Integrat Physiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; Agilent Technologies; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Illinois System; University of Illinois Urbana-Champaign	Katzenellenbogen, BS (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 524 Burrill Hall,407 South Goodwin Ave, Urbana, IL 61801 USA.	katzenel@illinois.edu			NIH [5RO1 CA18119]; Breast Cancer Research Foundation; Juvenile Diabetes Research Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	We thank Dr Peter Yau, Biotechnology Core, UIUC, for contributions to the mass-spectrometry analyses. This work was supported by grants from the NIH 5RO1 CA18119 (BSK), The Breast Cancer Research Foundation (BSK) and Juvenile Diabetes Research Foundation (GW). SB conceived of, designed and executed the study, performed experiments, data analyses and interpretation and wrote the manuscript. JDS conceived the study, performed computational analysis and contributed to experimental data. GW and SJ contributed to experimental data. BSK conceived and designed the study, performed data analyses and interpretation and wrote the manuscript.	Allgood VE, 1997, BIOCHEMISTRY-US, V36, P224, DOI 10.1021/bi961125c; Bayliss J, 2007, CLIN CANCER RES, V13, P7029, DOI 10.1158/1078-0432.CCR-07-0587; Beelen K, 2012, NAT REV CLIN ONCOL, V9, P529, DOI 10.1038/nrclinonc.2012.121; Bergamaschi A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2913; Bhatt S, 2012, MOL CELL BIOL, V32, P1928, DOI 10.1128/MCB.06561-11; Bianco S, 2012, TRANSCR-AUSTIN, V3, P165, DOI 10.4161/trns.20496; Bowen C, 2000, CANCER RES, V60, P6111; Brueggemeier RW, 2005, ENDOCR REV, V26, P331, DOI 10.1210/er.2004-0015; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Connor CE, 2001, CANCER RES, V61, P2917; Coser KR, 2009, P NATL ACAD SCI USA, V106, P14536, DOI 10.1073/pnas.0907560106; de Leeuw R, 2013, ONCOGENE, V32, P3543, DOI 10.1038/onc.2012.361; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Herman ME, 1996, J STEROID BIOCHEM, V59, P121, DOI 10.1016/S0960-0760(96)00114-8; Holmes KA, 2008, CANCER RES, V68, P7380, DOI 10.1158/0008-5472.CAN-08-0133; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; Huber-Keener KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041333; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; JAIYESIMI IA, 1995, J CLIN ONCOL, V13, P513, DOI 10.1200/JCO.1995.13.2.513; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Katzenellenbogen BS, 2002, SCIENCE, V295, P2380, DOI 10.1126/science.1070442; Katzenellenbogen BS, 2004, SEMIN ONCOL, V31, P28, DOI 10.1053/j.seminoncol.2004.01.004; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kim MJ, 2002, CANCER RES, V62, P2999; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lupien M, 2009, ENDOCR-RELAT CANCER, V16, P381, DOI 10.1677/ERC-09-0038; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Ramos-Mejia V, 2005, DEV DYNAM, V232, P180, DOI 10.1002/dvdy.20211; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Wang LH, 2006, CANCER CELL, V10, P487, DOI 10.1016/j.ccr.2006.09.015; Welboren WJ, 2009, ENDOCR-RELAT CANCER, V16, P1073, DOI 10.1677/ERC-09-0086; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88	51	37	38	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 3	2016	35	44					5722	5734		10.1038/onc.2016.105	http://dx.doi.org/10.1038/onc.2016.105			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XQ	27065334				2022-12-26	WOS:000386998400004
J	Shi, X; Wang, Q; Gu, J; Xuan, Z; Wu, JI				Shi, X.; Wang, Q.; Gu, J.; Xuan, Z.; Wu, J. I.			SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development	ONCOGENE			English	Article							CHROMATIN REMODELING COMPLEX; TUMOR-SUPPRESSOR; CEREBELLAR DEVELOPMENT; NEURAL DEVELOPMENT; CELL-PROLIFERATION; HEDGEHOG PATHWAY; CANCER; TRANSCRIPTION; BRG1; ACTIVATION	Recent large-scale genomic studies have classified medulloblastoma into four subtypes: Wnt, Shh, Group 3 and Group 4. Each is characterized by specific mutations and distinct epigenetic states. Previously, we showed that a chromatin regulator SMARCA4/Brg1 is required for Gli-mediated transcription activation in Sonic hedgehog (Shh) signaling. We report here that Brg1 controls a transcriptional program that specifically regulates Shh-type medulloblastoma growth. Using a mouse model of Shh-type medulloblastoma, we deleted Brg1 in precancerous progenitors and primary or transplanted tumors. Brg1 deletion significantly inhibited tumor formation and progression. Genome-wide expression analyses and binding experiments indicate that Brg1 specifically coordinates with key transcription factors including Gli1, Atoh1 and REST to regulate the expression of both oncogenes and tumor suppressors that are required for medulloblastoma identity and proliferation. Shh-type medulloblastoma displays distinct H3K27me3 properties. We demonstrate that Brg1 modulates activities of H3K27me3 modifiers to regulate the expression of medulloblastoma genes. Brg1-regulated pathways are conserved in human Shh-type medulloblastoma, and Brg1 is important for the growth of a human medulloblastoma cell line. Thus, Brg1 coordinates a genetic and epigenetic network that regulates the transcriptional program underlying the Shh-type medulloblastoma development.	[Shi, X.; Wang, Q.; Wu, J. I.] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Gu, J.; Xuan, Z.] Univ Texas Dallas, Ctr Syst Biol, Dept Biol Sci, Richardson, TX 75083 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas	Wu, JI (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jiang9.wu@utsouthwestern.edu			March of Dimes Foundation; American Cancer Society; NIMH; Department of Defense Visionary postdoc fellowship	March of Dimes Foundation(March of Dimes); American Cancer Society(American Cancer Society); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Defense Visionary postdoc fellowship	We thank Drs Brent Orr (St. Jude Hospital), Wenzhe Niu and Zilai Zhang, and Mou Cao for technical support and Dr Chao Xing and the University of Texas Southwestern Sequencing Facility for performing the next-generation sequencing and RNA-seq analyses. We thank Drs Lin Gan and Jane Johnson for providing the Atoh1-Cre mice and Dr Ching-Ping Chang for providing human Brg1 shRNA constructs. This work was supported by grants from March of Dimes Foundation (JW), American Cancer Society (JW), NIMH (JW) and Department of Defense Visionary postdoc fellowship (XS).	Anne SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081769; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dakubo GD, 2006, J NEURO-ONCOL, V79, P221, DOI 10.1007/s11060-006-9132-2; Dietrich N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002494; Dubuc AM, 2013, ACTA NEUROPATHOL, V125, P373, DOI 10.1007/s00401-012-1070-9; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Flora A, 2009, SCIENCE, V326, P1424, DOI 10.1126/science.1181453; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hasselblatt M, 2014, ACTA NEUROPATHOL, V128, P453, DOI 10.1007/s00401-014-1323-x; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004524; Malatesta M, 2013, CANCER RES, V73, P6323, DOI 10.1158/0008-5472.CAN-12-4660; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Markant SL, 2013, CANCER RES, V73, P6310, DOI 10.1158/0008-5472.CAN-12-4258; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Moreno N, 2014, J NEUROSCI, V34, P13486, DOI 10.1523/JNEUROSCI.2560-14.2014; Natarajan S, 2013, CANCER RES, V73, P5381, DOI 10.1158/0008-5472.CAN-13-0033; Negrini S, 2013, TRENDS CELL BIOL, V23, P289, DOI 10.1016/j.tcb.2013.01.006; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Ooi L, 2006, J BIOL CHEM, V281, P38974, DOI 10.1074/jbc.M605370200; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Popov N, 2010, EPIGENETICS-US, V5, P685, DOI 10.4161/epi.5.8.12996; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Romero OA, 2014, CANCER DISCOV, V4, P292, DOI 10.1158/2159-8290.CD-13-0799; Rutkowski S, 2010, J CLIN ONCOL, V28, P4961, DOI 10.1200/JCO.2010.30.2299; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Sengupta R, 2012, CANCER RES, V72, P122, DOI 10.1158/0008-5472.CAN-11-1701; Sengupta S, 2014, ACTA NEUROPATHOL, V127, P593, DOI 10.1007/s00401-013-1205-7; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Shi XM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6425; Smits M, 2012, CLIN CANCER RES, V18, P4048, DOI 10.1158/1078-0432.CCR-12-0399; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Triscott J, 2013, CANCER RES, V73, P6734, DOI 10.1158/0008-5472.CAN-12-4331; Uziel T, 2006, CELL CYCLE, V5, P363, DOI 10.4161/cc.5.4.2475; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Wetmore C, 2001, CANCER RES, V61, P513; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Witkowski L, 2014, NAT GENET, V46, P438, DOI 10.1038/ng.2931; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yang H, 2010, GENESIS, V48, P407, DOI 10.1002/dvg.20633; Yu Y, 2013, CELL, V152, P248, DOI 10.1016/j.cell.2012.12.006; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108	76	28	28	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 3	2016	35	44					5746	5758		10.1038/onc.2016.108	http://dx.doi.org/10.1038/onc.2016.108			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XQ	27065321				2022-12-26	WOS:000386998400006
J	Li, J; Wu, H; Li, W; Yin, L; Guo, S; Xu, X; Ouyang, Y; Zhao, Z; Liu, S; Tian, Y; Tian, Z; Ju, J; Ni, B; Wang, H				Li, J.; Wu, H.; Li, W.; Yin, L.; Guo, S.; Xu, X.; Ouyang, Y.; Zhao, Z.; Liu, S.; Tian, Y.; Tian, Z.; Ju, J.; Ni, B.; Wang, H.			Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-kappa B signaling	ONCOGENE			English	Article							SPHINGOSINE KINASE 1; MESENCHYMAL TRANSITION; DUCTAL ADENOCARCINOMA; CISPLATIN RESISTANCE; MICRORNA EXPRESSION; TUMOR-SUPPRESSOR; NETWORK; SURVIVAL; GROWTH; PROLIFERATION	The aberrant expression of microRNAs (miRNAs) has emerged as an important hallmark of cancer. However, the molecular mechanisms underlying the changes in miRNA expression remain unclear. In this study, we discovered a novel epigenetic mechanism of miR-506 regulation and investigated its functional significance in pancreatic cancer. Sequencing analysis revealed that the miR-506 promoter is highly methylated in pancreatic cancer tissues compared with non-cancerous tissues. Reduced miR-506 expression was significantly associated with clinical stage, pathologic tumor status, distant metastasis and decreased survival of pancreatic cancer patients. miR-506 inhibited cell proliferation, induced cell cycle arrest at the G1/S transition and enhanced apoptosis and chemosensitivity of pancreatic cancer cells. Furthermore, we identified sphingosine kinase 1 (SPHK1) as a novel target of miR-506, the expression of which inhibited the SPHK1/Akt/NF-kappa B signaling pathway, which is activated in pancreatic cancer. High SPHK1 expression was significantly associated with poor survival in a large cohort of pancreatic cancer specimens. Our data suggest that miR-506 acts as a tumor suppressor miRNA and is epigenetically silenced in pancreatic cancer. The newly identified miR-506/SPHK1 axis represents a novel therapeutic strategy for future pancreatic cancer treatment.	[Li, J.; Yin, L.; Guo, S.; Xu, X.; Ouyang, Y.; Zhao, Z.; Liu, S.; Wang, H.] Third Mil Med Univ, Southwest Hosp, Inst Hepatopancreatobiliary Surg, 30 Gaotanyan St, Chongqing 400038, Peoples R China; [Wu, H.] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pancreat Surg, Wuhan, Peoples R China; [Li, W.] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Li, W.] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Tian, Y.; Tian, Z.; Ni, B.] Third Mil Med Univ, Inst Immunol PLA, Chongqing, Peoples R China; [Ju, J.] SUNY Stony Brook, Dept Pathol, Translat Res Lab, Stony Brook, NY USA; [Ni, B.] Third Mil Med Univ, Dept Pathophysiol & High Altitude Pathol, Chongqing, Peoples R China	Army Medical University; Huazhong University of Science & Technology; Army Medical University; Army Medical University; Army Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Army Medical University	Ju, J; Ni, B; Wang, H (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Hepatopancreatobiliary Surg, 30 Gaotanyan St, Chongqing 400038, Peoples R China.	jingfang.ju@stonybrookmedicine.edu; nibingxi@126.com; whuaizhi@gmail.com	Yin, Liangyu/AAE-4982-2021	Yin, Liangyu/0000-0001-8876-2680; Ni, Bing/0000-0002-4297-5346	National Natural Science Foundation of China [81372242]; National High Technology Research and Development Program of China (Program 863) [2012AA021105]; Research Special Fund for Public Welfare Industry of Health [201202007]; NATIONAL CANCER INSTITUTE [R01CA197098] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (Program 863)(National High Technology Research and Development Program of China); Research Special Fund for Public Welfare Industry of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Professor Renyi Qin from the Department of Biliary-Pancreatic Surgery (Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan) and Professor Yijun Zhao from the Department of Hepatobiliary Surgery (the First Affiliated Hospital of Anhui Medical University, Hefei) for providing human pancreatic cancer samples. This work was supported by the following grants: the National Natural Science Foundation of China (No. 81372242); the National High Technology Research and Development Program of China (Program 863; No. 2012AA021105); and the Research Special Fund for Public Welfare Industry of Health (No. 201202007).	Arora H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064273; Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bouchie A, 2013, NAT BIOTECHNOL, V31, P577, DOI 10.1038/nbt0713-577; Bracken CP, 2015, CANCER RES, V75, P2594, DOI 10.1158/0008-5472.CAN-15-0287; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Drayton RM, 2014, CLIN CANCER RES, V20, P1990, DOI 10.1158/1078-0432.CCR-13-2805; Frampton AE, 2015, EUR J CANCER, V51, P1389, DOI 10.1016/j.ejca.2015.04.006; Frampton AE, 2014, GASTROENTEROLOGY, V146, P268, DOI 10.1053/j.gastro.2013.10.010; Gao W, 2015, ONCOGENE, V34, P1629, DOI 10.1038/onc.2014.101; Garrido-Laguna I, 2015, NAT REV CLIN ONCOL, V12, P319, DOI 10.1038/nrclinonc.2015.53; Guillermet-Guibert J, 2009, MOL CANCER THER, V8, P809, DOI 10.1158/1535-7163.MCT-08-1096; Guo SX, 2014, CANCER LETT, V344, P40, DOI 10.1016/j.canlet.2013.10.009; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Lai NS, 2015, BRIT J CANCER, V112, P1241, DOI 10.1038/bjc.2015.91; Lennox KA, 2011, GENE THER, V18, P1111, DOI 10.1038/gt.2011.100; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li J, 2008, CLIN CANCER RES, V14, P6996, DOI 10.1158/1078-0432.CCR-08-0754; Li W, 2009, CLIN CANCER RES, V15, P1393, DOI 10.1158/1078-0432.CCR-08-1158; Liu G, 2014, J PATHOL, V233, P308, DOI 10.1002/path.4348; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Sakimura S, 2015, ANN SURG ONCOL, V22, pS1436, DOI 10.1245/s10434-015-4418-2; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Streicher KL, 2012, ONCOGENE, V31, P1558, DOI 10.1038/onc.2011.345; Su JA, 2010, INT J BIOCHEM CELL B, V42, P2047, DOI 10.1016/j.biocel.2010.09.009; Sun Y, 2015, J PATHOL, V235, P25, DOI 10.1002/path.4443; Tang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091551; Tong JL, 2011, FEBS LETT, V585, P3560, DOI 10.1016/j.febslet.2011.10.021; Wang P, 2014, ONCOGENE, V33, P514, DOI 10.1038/onc.2012.598; Wen SY, 2014, ONCOGENE, V34, P717, DOI DOI 10.1038/0NC.2014.9; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yin M, 2015, ONCOGENE, V34, P691, DOI 10.1038/onc.2013.597; Zhang SY, 2011, CARCINOGENESIS, V32, P1183, DOI 10.1093/carcin/bgr105	47	100	107	2	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 20	2016	35	42					5501	5514		10.1038/onc.2016.90	http://dx.doi.org/10.1038/onc.2016.90			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XO	27065335	hybrid, Green Published			2022-12-26	WOS:000386998200005
J	Tomilov, A; Tomilova, N; Shan, YX; Hagopian, K; Bettaieb, A; Kim, K; Pelicci, PG; Haj, F; Ramsey, J; Cortopassi, G				Tomilov, Alexey; Tomilova, Natalia; Shan, Yuxi; Hagopian, Kevork; Bettaieb, Ahmed; Kim, Kyoungmi; Pelicci, Pier Giuseppe; Haj, Fawaz; Ramsey, Jon; Cortopassi, Gino			p46Shc Inhibits Thiolase and Lipid Oxidation in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; LIFE-SPAN; PROTEIN COMPLEXES; BETA-OXIDATION; SHC PROTEINS; RAT-LIVER; 2-BROMOOCTANOATE; KETOGENESIS; MAMMALS; MUSCLE	Although the p46Shc isoform has been known to be mitochondrially localized for 11 years, its function in mitochondria has been a mystery. We confirmed p46Shc to be mitochondrially localized and showed that the major mitochondrial partner of p46Shc is the lipid oxidation enzyme 3-ketoacylCoA thiolase ACAA2, to which p46Shc binds directly and with a strong affinity. Increasing p46Shc expression inhibits, and decreasing p46Shc stimulates enzymatic activity of thiolase in vitro. Thus, we suggest p46Shc to be a negative mitochondrial thiolase activity regulator, and reduction of p46Shc expression activates thiolase. This is the first demonstration of a protein that directly binds and controls thiolase activity. Thiolase was thought previously only to be regulated by metabolite balance and steady-state flux control. Thiolase is the last enzyme of the mitochondrial fatty acid beta-oxidation spiral, and thus is important for energy metabolism. Mice with reduction of p46Shc are lean, resist obesity, have higher lipid oxidation capacity, and increased thiolase activity. The thiolase-p46Shc connection shown here in vitro and in organello may be an important underlying mechanism explaining the metabolic phenotype of Shc-depleted mice in vivo.	[Tomilov, Alexey; Tomilova, Natalia; Shan, Yuxi; Hagopian, Kevork; Bettaieb, Ahmed; Kim, Kyoungmi; Ramsey, Jon; Cortopassi, Gino] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA; [Kim, Kyoungmi] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Hagopian, Kevork; Haj, Fawaz; Ramsey, Jon] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Pelicci, Pier Giuseppe] IFOM IEO, European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO)	Cortopassi, G (corresponding author), Dept Mol Biosci, 1089 Vet Dr,3007 VM3B, Davis, CA 95616 USA.	gcortopassi@ucdavis.edu	Pelicci, Pier Giuseppe/AAL-6572-2020		National Institutes of Health [AG23311]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG023311, P01AG025532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant AG23311 (to G. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdiche YN, 2009, ANAL BIOCHEM, V386, P172, DOI 10.1016/j.ab.2008.11.038; Abdiche YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092451; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Hagopian K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124204; Hagopian K, 2012, METABOLISM, V61, P1703, DOI 10.1016/j.metabol.2012.05.007; Kiema TR, 2014, ACTA CRYSTALLOGR D, V70, P3212, DOI 10.1107/S1399004714023827; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; KUNZ WS, 1991, BIOMED BIOCHIM ACTA, V50, P1143; LATIPAA PM, 1986, BIOCHIM BIOPHYS ACTA, V875, P293, DOI 10.1016/0005-2760(86)90179-7; Ljubicic V, 2010, MECH AGEING DEV, V131, P79, DOI 10.1016/j.mad.2009.12.004; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; RAAKA BM, 1979, J BIOL CHEM, V254, P6755; RAAKA BM, 1979, J BIOL CHEM, V254, P3303; Ramsey JJ, 2014, J GERONTOL A-BIOL, V69, P1177, DOI 10.1093/gerona/glt198; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHULZ H, 1994, J NUTR, V124, P165, DOI 10.1093/jn/124.2.165; Smet J, 2011, J INHERIT METAB DIS, V34, P741, DOI 10.1007/s10545-011-9315-7; Tomilov A., 2014, AGING CELL, V26, P12267; Tomilov AA, 2011, AGING CELL, V10, P55, DOI 10.1111/j.1474-9726.2010.00641.x; Ventura A, 2004, J BIOL CHEM, V279, P2299, DOI 10.1074/jbc.M307655200; WANG HY, 1991, ARCH BIOCHEM BIOPHYS, V289, P274, DOI 10.1016/0003-9861(91)90472-U; Wilson JL, 2010, BIOCHEM MOL BIOL EDU, V38, P400, DOI 10.1002/bmb.20442; Wittig I, 2007, METHOD CELL BIOL, V80, P723, DOI 10.1016/S0091-679X(06)80033-6	29	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12575	12585		10.1074/jbc.M115.695577	http://dx.doi.org/10.1074/jbc.M115.695577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27059956	Green Published, hybrid			2022-12-26	WOS:000378119900015
J	Wong, MK; Guan, DG; Ng, KHC; Ho, VWS; An, XM; Li, RS; Ren, XL; Zhao, ZY				Wong, Ming-Kin; Guan, Daogang; Ng, Kaoru Hon Chun; Ho, Vincy Wing Sze; An, Xiaomeng; Li, Runsheng; Ren, Xiaoliang; Zhao, Zhongying			Timing of Tissue-specific Cell Division Requires a Differential Onset of Zygotic Transcription during Metazoan Embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; MAJOR DEVELOPMENTAL TRANSITION; EARLY DROSOPHILA DEVELOPMENT; EARLY XENOPUS-EMBRYOS; C.-ELEGANS; GENE-EXPRESSION; GATA-FACTOR; MIDBLASTULA TRANSITION; FATE SPECIFICATION; GERM-CELLS	Metazoan development demands not only precise cell fate differentiation but also accurate timing of cell division to ensure proper development. How cell divisions are temporally coordinated during development is poorly understood. Caenorhabditis elegans embryogenesis provides an excellent opportunity to study this coordination due to its invariant development and widespread division asynchronies. One of the most pronounced asynchronies is a significant delay of cell division in two endoderm progenitor cells, Ea and Ep, hereafter referred to as E2, relative to its cousins that mainly develop into mesoderm organs and tissues. To unravel the genetic control over the endoderm-specific E2 division timing, a total of 822 essential and conserved genes were knocked down using RNAi followed by quantification of cell cycle lengths using in toto imaging of C. elegans embryogenesis and automated lineage. Intriguingly, knockdown of numerous genes encoding the components of general transcription pathway or its regulatory factors leads to a significant reduction in the E2 cell cycle length but an increase in cell cycle length of the remaining cells, indicating a differential requirement of transcription for division timing between the two. Analysis of lineage-specific RNA-seq data demonstrates an earlier onset of transcription in endoderm than in other germ layers, the timing of which coincides with the birth of E2, supporting the notion that the endoderm-specific delay in E2 division timing demands robust zygotic transcription. The reduction in E2 cell cycle length is frequently associated with cell migration defect and gastrulation failure. The results suggest that a tissue-specific transcriptional activation is required to coordinate fate differentiation, division timing, and cell migration to ensure proper development.	[Wong, Ming-Kin; Guan, Daogang; Ng, Kaoru Hon Chun; Ho, Vincy Wing Sze; An, Xiaomeng; Li, Runsheng; Ren, Xiaoliang; Zhao, Zhongying] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Zhao, Zhongying] Hong Kong Baptist Univ, State Key Lab Environm & Biol Anal, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University; Hong Kong Baptist University	Zhao, ZY (corresponding author), Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China.	zyzhao@hkbu.edu.hk	Zhao, Zhongying/C-3261-2015; LI, Runsheng/AFR-9519-2022; Zhao, Zhongying/ABF-9458-2021	LI, Runsheng/0000-0003-1563-1844; Zhao, Zhongying/0000-0003-2743-9008; Guan, Daogang/0000-0002-3289-1448; Guan, Daogang/0000-0003-1414-0189	National Institutes of Health, Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health, Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Chung Wai Shing for logistic support and the members of the Zhao lab for helpful discussion and comments, in particular Khandker Khaldun Islam for critical reading of the manuscript. Some strains were provided by the CGC, which is funded by National Institutes of Health, Office of Research Infrastructure Programs, Grant P40 OD010440.	Arata Y, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00529; Bao ZR, 2008, DEV BIOL, V318, P65, DOI 10.1016/j.ydbio.2008.02.054; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Boeck ME, 2011, DEV BIOL, V358, P345, DOI 10.1016/j.ydbio.2011.08.002; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Bowerman B, 1997, DEVELOPMENT, V124, P3815; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Broitman-Maduro G, 2005, DEV CELL, V8, P427, DOI 10.1016/j.devcel.2005.01.014; Dong P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5750; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; EDGAR LG, 1994, DEVELOPMENT, V120, P443; EDGAR LG, 1988, CELL, V53, P589, DOI 10.1016/0092-8674(88)90575-2; Gonczy Pierre, 2005, WormBook, P1; Hashimshony T, 2015, NATURE, V519, P219, DOI 10.1038/nature13996; Hebeisen M, 2008, DEVELOPMENT, V135, P1259, DOI 10.1242/dev.014969; Ho Vincy Wing Sze, 2015, Mol Syst Biol, V11, P814, DOI 10.15252/msb.20145857; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; Knight JK, 1998, DEV BIOL, V198, P253, DOI 10.1006/dbio.1998.8894; Kruger AV, 2015, DEV BIOL, V398, P153, DOI 10.1016/j.ydbio.2014.10.014; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Li J, 2007, EMBO J, V26, P2284, DOI 10.1038/sj.emboj.7601667; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; Maduro MF, 2007, DEV BIOL, V301, P590, DOI 10.1016/j.ydbio.2006.08.029; Maduro MF, 2015, DEV BIOL, V404, P66, DOI 10.1016/j.ydbio.2015.04.025; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Nair G, 2013, DEVELOPMENT, V140, P3385, DOI 10.1242/dev.098012; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nogare DED, 2009, DEV BIOL, V326, P131, DOI 10.1016/j.ydbio.2008.11.002; PowellCoffman JA, 1996, DEV BIOL, V178, P472, DOI 10.1006/dbio.1996.0232; Robertson SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106309; Rose Lesilee, 2014, WormBook, P1, DOI 10.1895/wormbook.1.30.2; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Shao JF, 2013, J BIOL CHEM, V288, P33411, DOI 10.1074/jbc.M113.487975; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tavernier N, 2015, EXP CELL RES, V337, P243, DOI 10.1016/j.yexcr.2015.07.022; Wilson MA, 1999, BBA-GENE STRUCT EXPR, V1445, P99, DOI 10.1016/S0167-4781(99)00027-5; Yang Q, 2013, NAT CELL BIOL, V15, P519, DOI 10.1038/ncb2737; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954; Zhao ZY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001089; Zhao ZY, 2010, GENETICS, V184, P853, DOI 10.1534/genetics.109.110270; Zhu JW, 1997, GENE DEV, V11, P2883, DOI 10.1101/gad.11.21.2883	47	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12501	12513		10.1074/jbc.M115.705426	http://dx.doi.org/10.1074/jbc.M115.705426			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27056332	hybrid, Green Published			2022-12-26	WOS:000378119900005
J	Araye, A; Goudet, A; Barbier, J; Pichard, S; Baron, B; England, P; Perez, J; Zinn-Justin, S; Chenal, A; Gillet, D				Araye, Anne; Goudet, Amelie; Barbier, Julien; Pichard, Sylvain; Baron, Bruno; England, Patrick; Perez, Javier; Zinn-Justin, Sophie; Chenal, Alexandre; Gillet, Daniel			The Translocation Domain of Botulinum Neurotoxin A Moderates the Propensity of the Catalytic Domain to Interact with Membranes at Acidic pH	PLOS ONE			English	Article							TOXIN T-DOMAIN; LIGHT-CHAIN PROTEASE; DIPHTHERIA-TOXIN; SPECTROSCOPIC ANALYSIS; TETANUS; CHANNEL; IDENTIFICATION; INHIBITION; PROTEINS; BEHAVIOR	Botulinum neurotoxin A (BoNT/A) is composed of three domains: a catalytic domain (LC), a translocation domain (H-N) and a receptor-binding domain (H-C). Like most bacterial toxins BoNT/A is an amphitropic protein, produced in a soluble form that is able to interact, penetrate and/or cross a membrane to achieve its toxic function. During intoxication BoNT/A is internalized by the cell by receptor-mediated endocytosis. Then, LC crosses the membrane of the endocytic compartment and reaches the cytosol. This translocation is initiated by the low pH found in this compartment. It has been suggested that LC passes in an unfolded state through a transmembrane passage formed by H-N. We report here that acidification induces no major conformational change in either secondary or tertiary structures of LC and H-N of BoNT/A in solution. GdnHCl-induced denaturation experiments showed that the stability of LC and H-N increases as pH drops, and that H-N further stabilizes LC. Unexpectedly we found that LC has a high propensity to interact with and permeabilize anionic lipid bilayers upon acidification without the help of H-N. This property is downplayed when LC is linked to H-N. H-N thus acts as a chaperone for LC by enhancing its stability but also as a moderator of the membrane interaction of LC.	[Araye, Anne; Goudet, Amelie; Barbier, Julien; Pichard, Sylvain; Gillet, Daniel] Paris Saclay Univ, LabEx LERMIT, CEA Saclay, CEA,iBiTec S SIMOPRO, F-91191 Gif Sur Yvette, France; [Baron, Bruno; England, Patrick] Inst Pasteur, Proteopole, Plateforme Biophys Macromol & Leurs Interact PFBM, F-75724 Paris 15, France; [Perez, Javier] Synchrotron Soleil, F-91192 Gif Sur Yvette, France; [Zinn-Justin, Sophie] CEA Saclay, CEA, iBiTec S LBSR, F-91191 Gif Sur Yvette, France; [Chenal, Alexandre] Inst Pasteur, Unite Biochim Interact Macromol, UMR 3528, F-75724 Paris 15, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; SOLEIL Synchrotron; CEA; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gillet, D (corresponding author), Paris Saclay Univ, LabEx LERMIT, CEA Saclay, CEA,iBiTec S SIMOPRO, F-91191 Gif Sur Yvette, France.	daniel.gillet@cea.fr		Chenal, Alexandre/0000-0002-4959-1003; barbier, julien/0000-0003-2187-4973; ENGLAND, Patrick/0000-0001-6410-5918	joint ministerial program of R&D against CBRNE threats; Agence Nationale de la Recherche [ANR-10-LABX-33]; DGA; CEA	joint ministerial program of R&D against CBRNE threats; Agence Nationale de la Recherche(French National Research Agency (ANR)); DGA; CEA(French Atomic Energy Commission)	This work was funded by the joint ministerial program of R&D against CBRNE threats. SIMOPRO is a member of the Laboratory of Excellence LERMIT supported by a grant from the Agence Nationale de la Recherche (ANR-10-LABX-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Nicolas Durafourc and Maite Paternostre for help with LUV preparation. For help with protein production and purification we thank Cassandra Porebski. For help with AUC experiments we thank Bertrand Raynal. AA was supported by DGA and CEA. This work was funded by the joint ministerial program of R&D against CBRNE threats. SIMOPRO is a member of the Laboratory of Excellence LERMIT supported by a grant from the Agence Nationale de la Recherche (ANR-10-LABX-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baldwin MR, 2004, PROTEIN EXPRES PURIF, V37, P187, DOI 10.1016/j.pep.2004.05.009; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; Cai SW, 2006, PROTEIN J, V25, P455, DOI 10.1007/s10930-006-9028-1; Chassaing A, 2011, FEBS J, V278, P4516, DOI 10.1111/j.1742-4658.2011.08053.x; Chenal A, 2002, J BIOL CHEM, V277, P43425, DOI 10.1074/jbc.M204148200; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Eswaramoorthy S, 2004, BIOCHEMISTRY-US, V43, P2209, DOI 10.1021/bi035844k; Falguieres T, 2006, BIOL CELL, V98, P125, DOI 10.1042/BC20050001; Feld GK, 2012, PROTEIN SCI, V21, P606, DOI 10.1002/pro.2052; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Fu FN, 2002, BIOPHYS CHEM, V99, P17, DOI 10.1016/S0301-4622(02)00135-7; Fu ZJ, 2006, BIOCHEMISTRY-US, V45, P8903, DOI 10.1021/bi060786z; Galloux M, 2008, J BIOL CHEM, V283, P27668, DOI 10.1074/jbc.M802557200; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Hammond K, 2002, BIOCHEMISTRY-US, V41, P3243, DOI 10.1021/bi011163i; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Jiang JS, 2015, NATURE, V521, P545, DOI 10.1038/nature14247; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lai B, 2010, J MEMBRANE BIOL, V236, P191, DOI 10.1007/s00232-010-9292-z; Li L, 2000, BIOCHEMISTRY-US, V39, P6466, DOI 10.1021/bi992729u; Montagner C, 2007, BIOCHEMISTRY-US, V46, P1878, DOI 10.1021/bi602381z; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Montal M, 2009, TOXICON, V54, P565, DOI 10.1016/j.toxicon.2008.11.018; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; MONTECUCCO C, 1988, BIOCHEM J, V251, P379, DOI 10.1042/bj2510379; MONTECUCCO C, 1989, BIOCHEM J, V259, P47, DOI 10.1042/bj2590047; Nozaki Y, 1972, Methods Enzymol, V26, P43; Poulain B, 2008, BOTULINUM J, V1, P14, DOI DOI 10.1504/TBJ.2008.018951; Ren JH, 1999, SCIENCE, V284, P955, DOI 10.1126/science.284.5416.955; Rossetto Ornella, 2008, V184, P129; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; Rummel A, 2013, CURR TOP MICROBIOL, V364, P61, DOI 10.1007/978-3-642-33570-9_4; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHMID MF, 1993, NATURE, V364, P827, DOI 10.1038/364827a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Stura EA, 2012, J BIOL CHEM, V287, P33607, DOI 10.1074/jbc.M112.396697; Sun SH, 2012, BIOCHEMISTRY-US, V51, P5655, DOI 10.1021/bi3004928; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Wang Y, 1997, J BIOL CHEM, V272, P25091, DOI 10.1074/jbc.272.40.25091	45	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153401	10.1371/journal.pone.0153401	http://dx.doi.org/10.1371/journal.pone.0153401			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070312	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700060
J	Lee, KM; Song, JM; Cho, JH; Hwang, HS				Lee, Kyung-Min; Song, Jin-Myoung; Cho, Jin-Hyoung; Hwang, Hyeon-Shik			Influence of Head Motion on the Accuracy of 3D Reconstruction with Cone-Beam CT: Landmark Identification Errors in Maxillofacial Surface Model	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ARTIFACTS; CBCT; REDUCTION; SPACE	Purpose The purpose of this study was to investigate the influence of head motion on the accuracy of three-dimensional (3D) reconstruction with cone-beam computed tomography (CBCT) scan. Materials and Methods Fifteen dry skulls were incorporated into a motion controller which simulated four types of head motion during CBCT scan: 2 horizontal rotations (to the right/to the left) and 2 vertical rotations (upward/downward). Each movement was triggered to occur at the start of the scan for 1 second by remote control. Four maxillofacial surface models with head motion and one control surface model without motion were obtained for each skull. Nine landmarks were identified on the five maxillofacial surface models for each skull, and landmark identification errors were compared between the control model and each of the models with head motion. Results Rendered surface models with head motion were similar to the control model in appearance; however, the landmark identification errors showed larger values in models with head motion than in the control. In particular, the Porion in the horizontal rotation models presented statistically significant differences (P < .05). Statistically significant difference in the errors between the right and left side landmark was present in the left side rotation which was opposite direction to the scanner rotation (P < .05). Conclusions Patient movement during CBCT scan might cause landmark identification errors on the 3D surface model in relation to the direction of the scanner rotation. Clinicians should take this into consideration to prevent patient movement during CBCT scan, particularly horizontal movement.	[Lee, Kyung-Min; Song, Jin-Myoung; Cho, Jin-Hyoung] Chonnam Natl Univ, Dent Res Inst 4D, Sch Dent, Dept Orthodont, Gwangju, South Korea; [Hwang, Hyeon-Shik] Chonnam Natl Univ, Dent Sci Res Inst, Sch Dent, Dept Orthodont, Gwangju, South Korea	Chonnam National University; Chonnam National University	Hwang, HS (corresponding author), Chonnam Natl Univ, Dent Sci Res Inst, Sch Dent, Dept Orthodont, Gwangju, South Korea.	hhwang@chonnam.ac.kr			Chonnam National University [2012-0821]	Chonnam National University	This study was financially supported by Chonnam National University, 2012 (Grant number 2012-0821, URL: www.chonnam.ac.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboudara C, 2009, AM J ORTHOD DENTOFAC, V135, P468, DOI 10.1016/j.ajodo.2007.04.043; Alamri Hadi Mohammed, 2012, General Dentistry, V60, P390; Angelopoulos Christos, 2012, Atlas Oral Maxillofac Surg Clin North Am, V20, P1, DOI 10.1016/j.cxom.2011.12.008; Barghan Sevin, 2010, J Calif Dent Assoc, V38, P33; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Baumgaertel S, 2009, AM J ORTHOD DENTOFAC, V136, P19, DOI 10.1016/j.ajodo.2007.09.016; Bontempi M, 2008, INT J COMPUT ASS RAD, V3, P249, DOI 10.1007/s11548-008-0157-1; Cevidanes LHS, 2007, AM J ORTHOD DENTOFAC, V131, P44, DOI 10.1016/j.ajodo.2005.03.029; De Man B, 2004, PHYS MED BIOL, V49, P2463, DOI 10.1088/0031-9155/49/11/024; Dey J, 2010, MED PHYS, V37, P6453, DOI 10.1118/1.3517836; Donaldson K, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr/91866873; Dudic A, 2009, AM J ORTHOD DENTOFAC, V135, P434, DOI 10.1016/j.ajodo.2008.10.014; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Hanzelka T, 2013, OR SURG OR MED OR PA, V116, P769, DOI 10.1016/j.oooo.2013.08.010; Herzog H, 2005, J NUCL MED, V46, P1059; Honey OB, 2007, AM J ORTHOD DENTOFAC, V132, P429, DOI 10.1016/j.ajodo.2005.10.032; Lagravere MO, 2010, AM J ORTHOD DENTOFAC, V137, P598, DOI 10.1016/j.ajodo.2008.07.018; Lee CC, 1998, MAGN RESON MED, V39, P234, DOI 10.1002/mrm.1910390210; Li L, 2011, IEEE NUCL SCI CONF R, P2895, DOI 10.1109/NSSMIC.2011.6152513; Lo J, 2010, J ORAL MAXIL SURG, V68, P1444, DOI 10.1016/j.joms.2009.11.008; Lu W, 2005, MED PHYS, V32, P3295, DOI 10.1118/1.2074187; Mueller K, 1999, IEEE T MED IMAGING, V18, P519, DOI 10.1109/42.781017; Rodet T, 2004, MED PHYS, V31, P1972, DOI 10.1118/1.1759828; Schulze R, 2011, DENTOMAXILLOFAC RAD, V40, P265, DOI 10.1259/dmfr/30642039; Sun Y, 2013, J CRANIO MAXILL SURG, V41, P522, DOI 10.1016/j.jcms.2012.11.017; Wagner A, 2003, INVEST RADIOL, V38, P733, DOI 10.1097/01.rli.0000084889.92250.b0; Walker L, 2005, AM J ORTHOD DENTOFAC, V128, P418, DOI 10.1016/j.ajodo.2004.04.033	27	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153210	10.1371/journal.pone.0153210	http://dx.doi.org/10.1371/journal.pone.0153210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065238	gold, Green Published, Green Submitted			2022-12-26	WOS:000373891000036
J	Wang, KC; Huang, CH; Huang, CJ; Fang, SB				Wang, Ke-Chuan; Huang, Chih-Hung; Huang, Ching-Jou; Fang, Shiuh-Bin			Impacts of Salmonella enterica Serovar Typhimurium and Its speG Gene on the Transcriptomes of In Vitro M Cells and Caco-2 Cells	PLOS ONE			English	Article							INTESTINAL M-CELL; PATCH M-CELLS; FOLLICLE-ASSOCIATED EPITHELIUM; FACTOR SPI-B; STEM-CELLS; EXPRESSION; DIFFERENTIATION; ACTIVATION; INFECTION; TRANSPORT	Microfold or membranous (M) cells are specialized intestinal epithelial cells responsible for host immunity. The speG mutant of Salmonella Typhimurium (S. Typhimurium) is a nonreplicating strain within human cells to be a candidate vaccine vector for interacting with M cells. We conducted this study to identify the genes are differently expressed between in vitro M cells and Caco-2 cells, and to determine whether S. Typhimurium and speG affect the transcriptomes of both cell types. In vitro M cells and Caco-2 cells were infected with wild-type (WT) S. Typhimurium, its Delta speG mutant, or none for 1 h for RNA microarrays; the transcriptomes among the 6 pools were pairwisely compared. Genetic loci encoding scaffold (e.g., HSCHR7_CTG4_4, HSCHR9_CTG9_35), long noncoding RNA, membrane-associated protein (PITPNB), neuron-related proteins (OR8D1, OR10G9, and NTNG2), and transporter proteins (MICU2 and SLC28A1) were significantly upregulated in uninfected M cells compared with uninfected Caco-2 cells; and their encoding proteins are promising M-cell markers. Significantly upregulated HSCHR7_CTG4_4 of uninfected in vitro M cells were speG-independently downregulated by S. Typhimurium infection that is a remarkable change representing an important but unreported characteristic of M cells. The immune responses of in vitro M cells and Caco-2 cells can differ and reply on speG or not, with speG-dependent regulation of KYL4, SCTR, IL6, TNF, and CELF4 in Caco-2 cells, JUN, KLF6, and KCTD11 in M cells, or speG-independent modulation of ZFP36 in both cells. This study facilitates understanding of the immune responses of in vitro M cells after administering the S. Typhimurium Delta speG mutant as a future vaccine vector.	[Wang, Ke-Chuan; Huang, Ching-Jou; Fang, Shiuh-Bin] Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, Div Pediat Gastroenterol & Hepatol, Taipei, Taiwan; [Wang, Ke-Chuan; Huang, Ching-Jou; Fang, Shiuh-Bin] Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan; [Huang, Chih-Hung] Natl Taipei Univ Technol, Grad Inst Biochem & Biomed Engn, Taipei 106, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Taipei University of Technology	Fang, SB (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, Div Pediat Gastroenterol & Hepatol, Taipei, Taiwan.; Fang, SB (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan.	sbfang@tmu.edu.tw	Fang, Shiuh-Bin/J-4645-2014	Fang, Shiuh-Bin/0000-0003-2742-8886	Ministry of Science and Technology [102-2320-B-038-009-]; National Taipei University of Technology-Taipei Medical University Joint Research Program [NTUT-TMU-101-18, NTUT-TMU-102-09]; Career Development Grant, National Health Research Institutes, Taiwan [NHRI-EX103-10234SC]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taipei University of Technology-Taipei Medical University Joint Research Program; Career Development Grant, National Health Research Institutes, Taiwan	The work was supported by the following: Ministry of Science and Technology, formerly the National Science Council (NSC 102-2320-B-038-009-), https://www.most.gov.tw/en/public; National Taipei University of Technology-Taipei Medical University Joint Research Program (NTUT-TMU-101-18, NTUT-TMU-102-09), http://www-en.ntut.edu.tw/bin/home.php, http://www.tmu.edu.tw/english/main.php; and Career Development Grant, National Health Research Institutes, Taiwan (NHRI-EX103-10234SC), http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham R, 2015, CELL, V162, P1309, DOI 10.1016/j.cell.2015.08.027; Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226; Bayeva M, 2012, CELL METAB, V16, P645, DOI 10.1016/j.cmet.2012.10.001; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cosker KE, 2008, J CELL SCI, V121, P796, DOI 10.1242/jcs.019166; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Das Abhijit, 2011, Neural Syst Circuits, V1, P4, DOI 10.1186/2042-1001-1-4; de Lau W, 2012, MOL CELL BIOL, V32, P3639, DOI 10.1128/MCB.00434-12; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; ELDRIDGE JH, 1987, J IMMUNOL, V139, P2255; Fang SB, 2011, THESIS UCL; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Figueiredo JF, 2009, MICROBES INFECT, V11, P302, DOI 10.1016/j.micinf.2008.12.005; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Giannasca PJ, 1999, INFECT IMMUN, V67, P946, DOI 10.1128/IAI.67.2.946-953.1999; Gullberg E, 2000, BIOCHEM BIOPH RES CO, V279, P808, DOI 10.1006/bbrc.2000.4038; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Hondo T, 2011, AM J PHYSIOL-GASTR L, V300, pG442, DOI 10.1152/ajpgi.00345.2010; Huang FC, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/103890; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; JEPSON MA, 1992, HISTOCHEM J, V24, P33, DOI 10.1007/BF01043285; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Jones MA, 2007, AVIAN PATHOL, V36, P199, DOI 10.1080/03079450701264118; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Lapthorne S, 2012, IMMUNOLOGY, V136, P312, DOI 10.1111/j.1365-2567.2012.03581.x; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; Ma BY, 2012, J BIOL CHEM, V287, P19008, DOI 10.1074/jbc.M111.281873; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Martinez-Argudo I, 2008, MICROBIOL-SGM, V154, P3887, DOI 10.1099/mic.0.2008/021162-0; Mitsuyama K, 2006, CYTOKINE GROWTH F R, V17, P451, DOI 10.1016/j.cytogfr.2006.09.003; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pielage JF, 2007, INT J BIOCHEM CELL B, V39, P1886, DOI 10.1016/j.biocel.2007.05.009; Rajasekaran SA, 2008, BBA-BIOMEMBRANES, V1778, P757, DOI 10.1016/j.bbamem.2007.11.007; Sato S, 2013, MUCOSAL IMMUNOL, V6, P838, DOI 10.1038/mi.2012.122; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tahoun A, 2012, CELL HOST MICROBE, V12, P645, DOI 10.1016/j.chom.2012.10.009; Takeda K, 1998, J IMMUNOL, V161, P4652; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Verbrugghe P, 2006, J PATHOL, V209, P240, DOI 10.1002/path.1970; Yamamoto M, 2012, CURR TOP MICROBIOL, V354, P39, DOI 10.1007/82_2011_134	59	7	7	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153444	10.1371/journal.pone.0153444	http://dx.doi.org/10.1371/journal.pone.0153444			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064787	Green Published, gold			2022-12-26	WOS:000373891000054
J	Kim, YJ; Kim, DN				Kim, Young-Joo; Kim, Do-Nyun			Structural Basis for Elastic Mechanical Properties of the DNA Double Helix	PLOS ONE			English	Article							MAGNETIC TWEEZERS; SINGLE-MOLECULE; NUCLEIC-ACIDS; ROD MODEL; B-DNA; DEPENDENCE; STIFFNESS; TWIST; CONTINUUM; TENSION	In this article, we investigate the principal structural features of the DNA double helix and their effects on its elastic mechanical properties. We develop, in the pursuit of this purpose, a helical continuum model consisting of a soft helical core and two stiff ribbons wrapping around it. The proposed model can reproduce the negative twist-stretch coupling of the helix successfully as well as its global stretching, bending, and torsional rigidities measured experimentally. Our parametric study of the model using the finite element method further reveals that the stiffness of phosphate backbones is a crucial factor for the counterintuitive overwinding behavior of the duplex and its extraordinarily high torsional rigidity, the major-minor grooves augment the twist-stretch coupling, and the change of the helicity might be responsible for the transition from a negative to a positive twist-stretching coupling when a tensile force is applied to the duplex.	[Kim, Young-Joo; Kim, Do-Nyun] Seoul Natl Univ, Dept Mech & Aerosp Engn, Gwanak Ro 1, Seoul 08826, South Korea; [Kim, Do-Nyun] Seoul Natl Univ, Inst Adv Machines & Design, Gwanak Ro 1, Seoul 08826, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, DN (corresponding author), Seoul Natl Univ, Dept Mech & Aerosp Engn, Gwanak Ro 1, Seoul 08826, South Korea.; Kim, DN (corresponding author), Seoul Natl Univ, Inst Adv Machines & Design, Gwanak Ro 1, Seoul 08826, South Korea.	dnkim@snu.ac.kr			National Research Foundation of Korea [2013R1A1A1010626]; Ministry of Science, ICT and Future Planning [CAMM-2014M3A6B3063711]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	National Research Foundation of Korea (No. 2013R1A1A1010626, http://www.nrf.re.kr) supported DK and YK; and Ministry of Science, ICT and Future Planning (No. CAMM-2014M3A6B3063711, http://english.msip.go.kr) supported DK and YK.	Bai XC, 2012, P NATL ACAD SCI USA, V109, P20012, DOI 10.1073/pnas.1215713109; Balaeff A, 1999, PHYS REV LETT, V83, P4900, DOI 10.1103/PhysRevLett.83.4900; Balaeff A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031919; Balaeff A, 2004, PHILOS T R SOC A, V362, P1355, DOI 10.1098/rsta.2004.1384; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Bryant Z, 2012, CURR OPIN STRUC BIOL, V22, P304, DOI 10.1016/j.sbi.2012.04.007; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Chiang KN, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2163267; CRICK FHC, 1975, NATURE, V255, P530, DOI 10.1038/255530a0; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Forth S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.148301; Geggier S, 2010, P NATL ACAD SCI USA, V107, P15421, DOI 10.1073/pnas.1004809107; Gore J, 2006, NATURE, V442, P836, DOI 10.1038/nature04974; Gross P, 2011, NAT PHYS, V7, P731, DOI [10.1038/nphys2002, 10.1038/NPHYS2002]; Herrero-Galan E, 2013, J AM CHEM SOC, V135, P122, DOI 10.1021/ja3054755; HOGAN ME, 1987, NATURE, V329, P263, DOI 10.1038/329263a0; Lionnet T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.178102; Lipfert J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1450; Lipfert J, 2010, NAT METHODS, V7, P977, DOI [10.1038/nmeth.1520, 10.1038/NMETH.1520]; Lipfert J, 2010, NUCLEIC ACIDS RES, V38, P7122, DOI 10.1093/nar/gkq598; Ma L, 2009, BIOPHYS J, V96, P3543, DOI 10.1016/j.bpj.2009.01.047; Manning RS, 1996, J CHEM PHYS, V105, P5626, DOI 10.1063/1.472373; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; Moroz JD, 1997, P NATL ACAD SCI USA, V94, P14418, DOI 10.1073/pnas.94.26.14418; Munteanu MG, 1998, TRENDS BIOCHEM SCI, V23, P341, DOI 10.1016/S0968-0004(98)01265-1; Peters JP, 2013, NUCLEIC ACIDS RES, V41, P10593, DOI 10.1093/nar/gkt808; RHODES D, 1980, NATURE, V286, P573, DOI 10.1038/286573a0; Roychoudhury M, 2000, P NATL ACAD SCI USA, V97, P13608, DOI 10.1073/pnas.250476297; Salerno D, 2010, NUCLEIC ACIDS RES, V38, P7089, DOI 10.1093/nar/gkq597; Sanghani SR, 1996, NUCLEIC ACIDS RES, V24, P1632, DOI 10.1093/nar/24.9.1632; SCHLICK T, 1995, CURR OPIN STRUC BIOL, V5, P245, DOI 10.1016/0959-440X(95)80083-2; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; WANG JC, 1979, P NATL ACAD SCI USA, V76, P200, DOI 10.1073/pnas.76.1.200; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wenner JR, 2002, BIOPHYS J, V82, P3160, DOI 10.1016/S0006-3495(02)75658-0; WING R, 1980, NATURE, V287, P755, DOI 10.1038/287755a0; WU HM, 1981, P NATL ACAD SCI-BIOL, V78, P6808, DOI 10.1073/pnas.78.11.6808	40	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153228	10.1371/journal.pone.0153228	http://dx.doi.org/10.1371/journal.pone.0153228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055239	gold, Green Published, Green Submitted			2022-12-26	WOS:000373608000105
J	Kim, YJ; Lee, JH; Harn, CH; Kim, CG				Kim, Young-Joong; Lee, Joon-Ho; Harn, Chee Hark; Kim, Chang-Gi			Transgenic Cabbage Expressing Cry1Ac1 Does Not Affect the Survival and Growth of the Wolf Spider, Pardosa astrigera L. Koch (Araneae: Lycosidae)	PLOS ONE			English	Article							BT COTTON; CROPS; RICE; THERIDIIDAE; ARTHROPODS; RESISTANT; PROTEINS; ECOLOGY; FIELDS	Both herbivores that consume transgenic crops and their predators can be exposed to insecticidal proteins expressed in those crops. We conducted a tritrophic bioassay to evaluate the ecotoxicological impacts that Bt cabbage (Brassica oleracea var. capitata) expressing Cry1Ac1 protein might have on the wolf spider (Pardosa astrigera), a non-target generalist predator. Enzyme-Linked Immunosorbent Assays indicated that protein levels were 4.61 ng g(-1) dry weight in fruit flies (Drosophila melanogaster) fed with the transgenic cabbage and 1.86 ng g(-1) dry weight in the wolf spiders that preyed upon them. We also compared the life history traits of spiders collected from Bt versus non-Bt cabbage and found no significant differences in their growth, survival, and developmental rates. Because Bt cabbage did not affect the growth of fruit flies, we conclude that any indirect effects that this crop had on the wolf spider were probably not mediated by prey quality. Therefore, exposure to Cry1Ac1 protein when feeding upon prey containing that substance from transgenic cabbage has only a negligible influence on those non-target predatory spiders.	[Kim, Young-Joong; Kim, Chang-Gi] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongju 28116, South Korea; [Kim, Young-Joong; Lee, Joon-Ho] Seoul Natl Univ, Dept Agr Biotechnol, Entomol Program, Seoul 08826, South Korea; [Lee, Joon-Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea; [Harn, Chee Hark] Nongwoo Bio Co, R&D Headquarters, Yeoju 12648, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU)	Kim, CG (corresponding author), Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongju 28116, South Korea.	cgkim@kribb.re.kr	Kim, Chang-Gi/M-2984-2013	Kim, Chang-Gi/0000-0002-2588-8259	KRIBB Research Initiative Program; Export Promotion Technology Development Program, Ministry of Agriculture, Food and Rural Affairs; National Research Foundation of Korea (NRF) - MEST [20110028162]	KRIBB Research Initiative Program; Export Promotion Technology Development Program, Ministry of Agriculture, Food and Rural Affairs; National Research Foundation of Korea (NRF) - MEST(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was financially supported by the KRIBB Research Initiative Program and the Export Promotion Technology Development Program, Ministry of Agriculture, Food and Rural Affairs, and the National Research Foundation of Korea (NRF) funded by MEST (No. 20110028162).	Capinera JL., 2001, HDB VEGETABLE PESTS; Carpenter Janet E, 2011, GM Crops, V2, P7, DOI 10.4161/gmcr.2.1.15086; Chen M, 2009, ECOTOXICOLOGY, V18, P230, DOI 10.1007/s10646-008-0276-z; Clark BW, 2005, J AGR FOOD CHEM, V53, P4643, DOI 10.1021/jf040442k; Devos Y, 2012, TRANSGENIC RES, V21, P1, DOI 10.1007/s11248-011-9515-9; HAGSTRUM DW, 1971, ANN ENTOMOL SOC AM, V64, P757, DOI 10.1093/aesa/64.4.757; Han P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102980; Jespersen LB, 2003, FUNCT ECOL, V17, P737, DOI 10.1111/j.1365-2435.2003.00788.x; Jung MP, 2012, ENVIRON MONIT ASSESS, V184, P1773, DOI 10.1007/s10661-011-2077-8; Kim BM, 2014, THESIS; Kim YJ, 2015, J ASIA-PAC ENTOMOL, V18, P657, DOI 10.1016/j.aspen.2015.07.015; Lee SY, 2014, ENVIRON ENTOMOL, V43, P819, DOI 10.1603/EN12259; Liu Zhi-Cheng, 2003, Acta Entomologica Sinica, V46, P454; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Ludy C, 2006, BIOL CONTROL, V38, P314, DOI 10.1016/j.biocontrol.2006.05.010; Ludy C, 2006, ENTOMOL EXP APPL, V118, P145, DOI 10.1111/j.1570-7458.2006.00375.x; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; Meissle M, 2012, ENVIRON ENTOMOL, V41, P1037, DOI 10.1603/EN11321; Meissle M, 2009, PLANT BIOTECHNOL J, V7, P645, DOI 10.1111/j.1467-7652.2009.00431.x; Miyashita K., 1968, APPL ENTOMOL ZOOL, V3, P81, DOI [10.1303/aez.3.81, DOI 10.1303/AEZ.3.81]; Naranjo S.E., 2009, CAB REV, V4, DOI DOI 10.1079/PAVSNNR20094011; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1193, DOI 10.1603/0046-225X(2005)034[1193:LAOTEO]2.0.CO;2; NYFFELER M, 1987, J APPL ENTOMOL, V103, P321, DOI 10.1111/j.1439-0418.1987.tb00992.x; Peng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083663; Peterson JA, 2011, J ARACHNOL, V39, P1, DOI 10.1636/M10-98.1; Pickavance JR, 2001, J ARACHNOL, V29, P367, DOI 10.1636/0161-8202(2001)029[0367:LCOFSO]2.0.CO;2; Quan XY, 2011, B INSECTOL, V64, P223; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tian JC, 2010, ENVIRON ENTOMOL, V39, P1369, DOI 10.1603/EN10003; Tian JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035164; Torres JB, 2005, ENVIRON ENTOMOL, V34, P1242, DOI 10.1603/0046-225X(2005)034[1242:CAGPAI]2.0.CO;2; Torres JB, 2008, TRANSGENIC RES, V17, P345, DOI 10.1007/s11248-007-9109-8; Wei W, 2008, J APPL ENTOMOL, V132, P1, DOI 10.1111/j.1439-0418.2007.01242.x; Zhou Jingyu, 2014, ScientificWorldJournal, V2014, P530942, DOI 10.1155/2014/530942	39	4	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153395	10.1371/journal.pone.0153395	http://dx.doi.org/10.1371/journal.pone.0153395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055120	Green Published, Green Submitted, gold			2022-12-26	WOS:000373608000128
J	Zou, Y; Xie, JR; Wang, BH				Zou, You; Xie, Jiarong; Wang, Binghong			Evacuation of Pedestrians with Two Motion Modes for Panic System	PLOS ONE			English	Article							EMERGENCY EVACUATION; JAMMING TRANSITION; DYNAMICS; SIMULATION; FLOW; DERIVATION; NETWORKS; ESCAPE	In this paper, we have captured an underlying mechanism of emergence of collective panic in pedestrian evacuations by using a modification of the lattice-gas model. We classify the motion of pedestrians into two modes according to their moods. One is gentle (mode I), the other is flustered (mode II). First, to research the cause for crowd, we fix the motion modes of pedestrians and increase the proportion of pedestrians with motion mode II (rho(II)). The simulation results show that the pedestrians with motion mode II are lack of evacuation efficiency and cause more casualties. Further, we use the SIS (susceptible-infective-susceptible) model to describe the spreading of the panic mood. The system can be in the high-mix state when the infection probability lambda is greater than a fuzzy threshold. In addition, the distances S from wounded people to the exit are researched, the number of wounded people gets maximum at the internal S = 5 similar to 10, which is independent of rho(II) and lambda. This research can help us to understand and prevent the emergence of collective panic and reduce wounds in the real evacuation.	[Zou, You; Xie, Jiarong; Wang, Binghong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China; [Wang, Binghong] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Binghong] Southwest Univ Sci & Technol, Sch Sci, Mianyang 621010, Sichuan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Wenzhou University; Southwest University of Science & Technology - China	Wang, BH (corresponding author), Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China.; Wang, BH (corresponding author), Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou 325035, Zhejiang, Peoples R China.; Wang, BH (corresponding author), Southwest Univ Sci & Technol, Sch Sci, Mianyang 621010, Sichuan, Peoples R China.	bhwang@ustc.edu.cn			National Natural Science Foundation of China [11275186, 91024026, FOM2014OF001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (Grant Nos. 11275186, 91024026, FOM2014OF001). The funders had an important role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Burstedde C, 2001, PHYSICA A, V295, P507, DOI 10.1016/S0378-4371(01)00141-8; DALEY DJ, 1964, NATURE, V204, P1118, DOI 10.1038/2041118a0; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 1996, PHYSICA A, V233, P253, DOI 10.1016/S0378-4371(96)00228-2; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2000, PHYS REV LETT, V84, P1240, DOI 10.1103/PhysRevLett.84.1240; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Helbing D, 1996, PHYS REV E, V53, P2366, DOI 10.1103/PhysRevE.53.2366; HENDERSON LF, 1971, NATURE, V229, P381, DOI 10.1038/229381a0; Hoogendoorn S, 2003, OPTIM CONTR APPL MET, V24, P153, DOI 10.1002/oca.727; Huang HJ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021131; Lachapelle A, 2011, TRANSPORT RES B-METH, V45, P1572, DOI 10.1016/j.trb.2011.07.011; Ma PJ, 2013, PHYSICA A, V392, P215, DOI 10.1016/j.physa.2012.07.053; Miguel AF, 2009, PHYS LETT A, V373, P1734, DOI 10.1016/j.physleta.2009.03.020; Muramatsu H, 2000, PHYSICA A, V275, P281, DOI 10.1016/S0378-4371(99)00447-1; Muramatsu M, 1999, PHYSICA A, V267, P487, DOI 10.1016/S0378-4371(99)00018-7; Muramatsu M, 2000, PHYSICA A, V286, P377, DOI 10.1016/S0378-4371(00)00336-8; Nakayama A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016105; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Santos FC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056128; Shi DM, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022802; Tajima Y, 2001, PHYSICA A, V292, P545, DOI 10.1016/S0378-4371(00)00630-0; Tanimoto J, 2010, PHYSICA A, V389, P5611, DOI 10.1016/j.physa.2010.08.032; Yamamoto K, 2007, PHYSICA A, V379, P654, DOI 10.1016/j.physa.2007.02.040; Yu W, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046105; Yu WJ, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026112; Zheng XP, 2011, COMPUT MATH APPL, V62, P4627, DOI 10.1016/j.camwa.2011.10.048; Zheng XP, 2011, PHYSICA A, V390, P1042, DOI 10.1016/j.physa.2010.12.007	30	8	9	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153388	10.1371/journal.pone.0153388	http://dx.doi.org/10.1371/journal.pone.0153388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055024	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000127
J	Butler, JE; Godfrey, S; Thomas, CK				Butler, Jane E.; Godfrey, Sharlene; Thomas, Christine K.			Interlimb Reflexes Induced by Electrical Stimulation of Cutaneous Nerves after Spinal Cord Injury	PLOS ONE			English	Article							HUMAN SOLEUS MUSCLE; HUMAN ARM MUSCLES; PRESYNAPTIC INHIBITION; STRETCH REFLEXES; H-REFLEX; PROPRIOSPINAL SYSTEM; AFFERENT STIMULATION; SYNAPTIC PLASTICITY; RESPONSE PATTERNS; SPASTICITY	Whether interlimb reflexes emerge only after a severe insult to the human spinal cord is controversial. Here the aim was to examine interlimb reflexes at rest in participants with chronic (>1 year) spinal cord injury (SCI, n = 17) and able-bodied control participants (n = 5). Cutaneous reflexes were evoked by delivering up to 30 trains of stimuli to either the superficial peroneal nerve on the dorsum of the foot or the radial nerve at the wrist (5 pulses, 300 Hz, approximately every 30 s). Participants were instructed to relax the test muscles prior to the delivery of the stimuli. Electromyographic activity was recorded bilaterally in proximal and distal arm and leg muscles. Superficial peroneal nerve stimulation evoked interlimb reflexes in ipsilateral and contralateral arm and contralateral leg muscles of SCI and control participants. Radial nerve stimulation evoked interlimb reflexes in the ipsilateral leg and contralateral arm muscles of control and SCI participants but only contralateral leg muscles of control participants. Interlimb reflexes evoked by superficial peroneal nerve stimulation were longer in latency and duration, and larger in magnitude in SCI participants. Interlimb reflex properties were similar for both SCI and control groups for radial nerve stimulation. Ascending interlimb reflexes tended to occur with a higher incidence in participants with SCI, while descending interlimb reflexes occurred with a higher incidence in able-bodied participants. However, the overall incidence of interlimb reflexes in SCI and neurologically intact participants was similar which suggests that the neural circuitry underlying these reflexes does not necessarily develop after central nervous system injury.	[Butler, Jane E.; Godfrey, Sharlene] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Thomas, Christine K.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Thomas, Christine K.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Butler, Jane E.] Neurosci Res Australia, Sydney, NSW, Australia; [Butler, Jane E.] Univ New S Wales, Sydney, NSW, Australia	University of Miami; University of Miami; University of Miami; Neuroscience Research Australia; University of New South Wales Sydney	Butler, JE (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.; Butler, JE (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.; Butler, JE (corresponding author), Univ New S Wales, Sydney, NSW, Australia.	j.butler@neura.edu.au	Butler, Jane E/D-4186-2011	Butler, Jane/0000-0002-5834-8152	National Health & Medical Research Council of Australia; United States Public Health Service [NS-30226]; Miami Project to Cure Paralysis	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Miami Project to Cure Paralysis	This research was funded by: (1) the National Health & Medical Research Council of Australia (JEB), (2) United States Public Health Service grant NS-30226 (CKT) and (3) The Miami Project to Cure Paralysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Blanco S, 2009, EXP BRAIN RES, V195, P285, DOI 10.1007/s00221-009-1784-7; ASHBY P, 1974, J NEUROL NEUROSUR PS, V37, P1352, DOI 10.1136/jnnp.37.12.1352; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BROWN AG, 1987, J PHYSIOL-LONDON, V382, P331, DOI 10.1113/jphysiol.1987.sp016370; Burke D, 1988, Adv Neurol, V47, P401; BUSSEL B, 1989, BRAIN RES BULL, V22, P53, DOI 10.1016/0361-9230(89)90127-5; Butler JE, 2006, MUSCLE NERVE, V33, P637, DOI 10.1002/mus.20500; Calancie B, 1996, ELECTROMYOGR MOTOR C, V101, P304, DOI 10.1016/0924-980X(96)95194-2; CALANCIE B, 1991, EXP BRAIN RES, V85, P458; Calancie B, 2005, CLIN NEUROPHYSIOL, V116, P75, DOI 10.1016/j.clinph.2004.07.018; CALANCIE B, 1993, ELECTROEN CLIN NEURO, V89, P177, DOI 10.1016/0168-5597(93)90131-8; Calancie B, 2002, BRAIN, V125, P1150, DOI 10.1093/brain/awf114; Castro MJ, 1999, J APPL PHYSIOL, V86, P350, DOI 10.1152/jappl.1999.86.1.350; D'Amico JM, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00036; D'Amico JM, 2013, J NEUROPHYSIOL, V109, P1473, DOI 10.1152/jn.00821.2012; DELWAIDE PJ, 1977, J NEUROL NEUROSUR PS, V40, P616, DOI 10.1136/jnnp.40.6.616; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; DIMITRIJEVIC MR, 1967, BRAIN, V90, P333, DOI 10.1093/brain/90.2.333; Flynn JR, 2011, NEUROPHARMACOLOGY, V60, P809, DOI 10.1016/j.neuropharm.2011.01.016; Frigon A, 2004, J NEUROPHYSIOL, V91, P1516, DOI 10.1152/jn.00695.2003; GASSEL MM, 1973, J NEUROL NEUROSUR PS, V36, P282, DOI 10.1136/jnnp.36.2.282; Grey MJ, 2008, EXP BRAIN RES, V185, P189, DOI 10.1007/s00221-007-1142-6; Hager-Ross CK, 2006, J NEUROPHYSIOL, V96, P165, DOI 10.1152/jn.01339.2005; Haridas C, 2003, J NEUROPHYSIOL, V90, P2850, DOI 10.1152/jn.00531.2003; HARRISON PJ, 1984, J PHYSIOL-LONDON, V356, P245, DOI 10.1113/jphysiol.1984.sp015462; HAYES KC, 1994, J NEUROTRAUM, V11, P433, DOI 10.1089/neu.1994.11.433; HELGREN ME, 1993, EXP NEUROL, V123, P17, DOI 10.1006/exnr.1993.1137; Hiersemenzel LP, 2000, NEUROLOGY, V54, P1574, DOI 10.1212/WNL.54.8.1574; KEARNEY RE, 1979, BRAIN RES, V170, P214, DOI 10.1016/0006-8993(79)90958-2; KEARNEY RE, 1981, ELECTROEN CLIN NEURO, V52, P65, DOI 10.1016/0013-4694(81)90190-5; Kirkwood PA, 2002, ADV EXP MED BIOL, V508, P299; Kukulka CG, 2009, EXP BRAIN RES, V192, P167, DOI 10.1007/s00221-008-1566-7; Leis AA, 1996, NEUROLOGY, V47, P231, DOI 10.1212/WNL.47.1.231; LITTLE JW, 1985, ARCH PHYS MED REHAB, V66, P19; Little JW, 1999, ARCH PHYS MED REHAB, V80, P587, DOI 10.1016/S0003-9993(99)90204-6; LLOYD DPC, 1948, J NEUROPHYSIOL, V11, P455, DOI 10.1152/jn.1948.11.5.455; Marchand-Pauvert V, 2008, J PHYSIOL-LONDON, V586, P1247, DOI 10.1113/jphysiol.2007.145904; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; McNulty PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072725; MEINCK HM, 1981, EXP BRAIN RES, V43, P78; Mendell L M, 1988, Adv Neurol, V47, P337; Morita H, 2001, BRAIN, V124, P826, DOI 10.1093/brain/124.4.826; Nakazawa K, 2006, ARCH PHYS MED REHAB, V87, P71, DOI 10.1016/j.apmr.2005.08.122; NIELSEN J, 1993, EXP BRAIN RES, V97, P173; Oudega M, 2012, J PHYSIOL-LONDON, V590, P3647, DOI 10.1113/jphysiol.2012.233189; Petersen N, 1998, J PHYSIOL-LONDON, V512, P267, DOI 10.1111/j.1469-7793.1998.267bf.x; Pierrot-Deseilligny E, 2002, ADV EXP MED BIOL, V508, P273; Pierrot- Deseilligny E, 1989, PROG BRAIN RES, V80, P305; Pierrot- Deseilligny E., 1989, PROG BRAIN RES, V80, P295, DOI 2699370; Pierrot-Desilligney E, 2005, PROPRIOSPINAL RELAY, P452; PIESIURSTREHLOW B, 1980, ELECTROEN CLIN NEURO, V48, P673, DOI 10.1016/0013-4694(80)90424-1; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Raineteau O, 2002, EUR J NEUROSCI, V16, P1761, DOI 10.1046/j.1460-9568.2002.02243.x; Rank MM, 2015, J PHYSIOL-LONDON, V593, P331, DOI 10.1113/jphysiol.2014.282640; ROBYBRAMI A, 1990, EXP BRAIN RES, V81, P593, DOI 10.1007/BF02423509; ROBYBRAMI A, 1987, BRAIN, V110, P707, DOI 10.1093/brain/110.3.707; SARICA Y, 1985, BRAIN RES, V325, P299, DOI 10.1016/0006-8993(85)90327-0; Sherrington CS, 1903, J PHYSIOL-LONDON, V29, P58; Stevenson AJT, 2015, J PHYSIOL-LONDON, V593, P3657, DOI 10.1113/JP270422; STEWARD O, 1989, Journal of Neurotrauma, V6, P99, DOI 10.1089/neu.1989.6.99; Stubbs PW, 2011, MUSCLE NERVE, V43, P845, DOI 10.1002/mus.21964; Stubbs PW, 2011, J NEUROPHYSIOL, V105, P503, DOI 10.1152/jn.00786.2010; Stubbs PW, 2009, J NEUROPHYSIOL, V102, P3596, DOI 10.1152/jn.00667.2009; Weaver LC, 2001, J NEUROTRAUM, V18, P1107, DOI 10.1089/08977150152693782; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Willer J C, 1983, Adv Neurol, V39, P809; WILLER JC, 1981, PAIN, V10, P405, DOI 10.1016/0304-3959(81)90102-0; Zehr EP, 2001, EXP BRAIN RES, V140, P495; Zijdewind I, 2012, NEUROREHAB NEURAL RE, V26, P58, DOI 10.1177/1545968311417449	69	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153063	10.1371/journal.pone.0153063	http://dx.doi.org/10.1371/journal.pone.0153063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049521	Green Submitted, gold, Green Published			2022-12-26	WOS:000373603500093
J	Campos, CF; Cangussu, SD; Duz, ALC; Cartelle, CT; Noviello, MD; Veloso, VM; Bahia, MT; Almeida-Leite, CM; Arantes, RME				Campos, Camila Franca; Cangussu, Silvia Dantas; Duz, Ana Luiza Cassin; Cartelle, Christiane Teixeira; Noviello, Maria de Lourdes; Veloso, Vanja Maria; Bahia, Maria Terezinha; Almeida-Leite, Camila Megale; Esteves Arantes, Rosa Maria			Enteric Neuronal Damage, Intramuscular Denervation and Smooth Muscle Phenotype Changes as Mechanisms of Chagasic Megacolon: Evidence from a Long-Term Murine Model of Tripanosoma cruzi Infection	PLOS ONE			English	Article							GROWTH-ASSOCIATED PROTEIN; TRYPANOSOMA-CRUZI; NITRIC-OXIDE; INTESTINAL MOTILITY; DISEASE; BENZNIDAZOLE; INTERRUPTION; POPULATIONS; STRAINS; LESIONS	We developed a novel murine model of long-term infection with Trypanosoma cruzi with the aim to elucidate the pathogenesis of megacolon and the associated adaptive and neuromuscular intestinal disorders. Our intent was to produce a chronic stage of the disease since the early treatment should avoid 100% mortality of untreated animals at acute phase. Treatment allowed animals to be kept infected and alive in order to develop the chronic phase of infection with low parasitism as in human disease. A group of Swiss mice was infected with the Y strain of T. cruzi. At the 11th day after infection, a sub-group was euthanized (acute-phase group) and another sub-group was treated with benznidazole and euthanized 15 months after infection (chronic-phase group). Whole colon samples were harvested and used for studying the histopathology of the intestinal smooth muscle and the plasticity of the enteric nerves. In the acute phase, all animals presented inflammatory lesions associated with intense and diffuse parasitism of the muscular and submucosa layers, which were enlarged when compared with the controls. The occurrence of intense degenerative inflammatory changes and increased reticular fibers suggests inflammatory-induced necrosis of muscle cells. In the chronic phase, parasitism was insignificant; however, the architecture of Auerbach plexuses was focally affected in the inflamed areas, and a significant decrease in the number of neurons and in the density of intramuscular nerve bundles was detected. Other changes observed included increased thickness of the colon wall, diffuse muscle cell hypertrophy, and increased collagen deposition, indicating early fibrosis in the damaged areas. Mast cell count significantly increased in the muscular layers. We propose a model for studying the long-term (15 months) pathogenesis of Chagasic megacolon in mice that mimics the human disease, which persists for several years and has not been fully elucidated. We hypothesize that the long-term inflammatory process mediates neuronal damage and intramuscular and intramural denervation, leading to phenotypic changes in smooth muscle cells associated with fibrosis. These long-term structural changes may represent the basic mechanism for the formation of the Chagasic megacolon.	[Campos, Camila Franca; Duz, Ana Luiza Cassin; Cartelle, Christiane Teixeira; Noviello, Maria de Lourdes; Esteves Arantes, Rosa Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Cangussu, Silvia Dantas] Univ Fed Ouro Preto, Dept Ciencias Biol LAFEX, Ouro Preto, MG, Brazil; [Veloso, Vanja Maria; Bahia, Maria Terezinha] Univ Fed Ouro Preto, Dept Ciencias Biol NUPEB, Ouro Preto, MG, Brazil; [Almeida-Leite, Camila Megale] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais	Arantes, RME (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil.	rosa@icb.ufmg	Duz, Ana Luiza Cassin/AAK-1517-2021; Arantes, Rosa ME/C-5749-2013; Cangussú, Silvia/AAX-8526-2020	Arantes, Rosa ME/0000-0003-1428-9717; Cangussú, Silvia/0000-0002-1061-6445; Duz, Ana Luiza Cassin/0000-0002-4996-5992	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) [303338/2014-8, 458832/2014-6, 473013/2012-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) PNDN grant [2228/11]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (BR) [PPM-00346-14]; Programa de Apoio aos Nucleos de Excelencia-PRONEX; CAPES/UDELAR	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) PNDN grant(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (BR); Programa de Apoio aos Nucleos de Excelencia-PRONEX; CAPES/UDELAR	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) grant number: 303338/2014-8, URL: www.cnpq.br, Author: RMEA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) grant number: 458832/2014-6, URL: www.cnpq.br, Author: RMEA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) grant number: 473013/2012-6, URL: www.cnpq.br, Author: RMEA; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) PNDN grant number: 2228/11, URL: www.capes.gov.br, Author: RMEA; and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (BR) grant number: PPM-00346-14, URL: www.fapemig.br, Author: RMEA; Programa de Apoio aos Nucleos de Excelencia-PRONEX-URL: www.fapemig.br, Author: RMEA; CAPES/UDELAR-URL: www.capes.gov.br/cooperacao-internacional/uruguai/capes-udelar-projetos, author: RMEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adad SJ, 2001, VIRCHOWS ARCH, V438, P254, DOI 10.1007/s004280000319; ANDRADE SG, 1985, B WORLD HEALTH ORGAN, V63, P721; Arantes RME, 1997, CELL TISSUE RES, V290, P61, DOI 10.1007/s004410050908; Arantes RME, 2004, AM J PATHOL, V164, P1361, DOI 10.1016/S0002-9440(10)63222-1; Aufderheide AC, 2004, P NATL ACAD SCI USA, V101, P2034, DOI 10.1073/pnas.0307312101; BARBOSA AJA, 1985, REV I MED TROP, V27, P293, DOI 10.1590/S0036-46651985000600001; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Brener Z, 1976, Rev Inst Med Trop Sao Paulo, V18, P450; CALVERT RJ, 1989, J NUTR, V119, P1610, DOI 10.1093/jn/119.11.1610; Chagas C., 1909, TRYPANOSOMIASIS MENS, P5; CHAGAS Carlos, 1916, Memorias do Instituto Oswaldo Cruz, V8, P37; Correa-Oliveira R, 1999, MEM I OSWALDO CRUZ, V94, P253, DOI 10.1590/S0074-02761999000700042; Da Silveira ABM, 2008, PARASITOLOGY, V135, P1337, DOI 10.1017/S0031182008004770; da Silveira ABM, 2005, PARASITOLOGY, V131, P627, DOI 10.1017/S0031182005008061; De Giorgio R, 1996, Minerva Gastroenterol Dietol, V42, P83; de Oliveira GM, 2008, PARASITOL RES, V102, P747, DOI 10.1007/s00436-007-0829-8; de Souza AP, 2010, PARASITOL RES, V106, P1293, DOI 10.1007/s00436-010-1794-1; Dias J C, 1989, Rev Soc Bras Med Trop, V22, P147, DOI 10.1590/S0037-86821989000300007; Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092; FILARDI LS, 1987, T ROY SOC TROP MED H, V81, P755, DOI 10.1016/0035-9203(87)90020-4; Furness JB, 2000, GUT, V47, P60; Garcia SB, 1999, EXP PARASITOL, V93, P191, DOI 10.1006/expr.1999.4451; Gattuso JM, 1998, HISTOPATHOLOGY, V33, P34, DOI 10.1046/j.1365-2559.1998.00438.x; Gougeon PY, 2013, J NEUROSCI, V33, P3339, DOI 10.1523/JNEUROSCI.3564-12.2013; Granziera C, 2007, Open Neuroimag J, V1, P10, DOI 10.2174/1874440000701010010; Guillen-Pernia B, 2001, INVEST CLIN, P42; Gutierrez FRS, 2009, MEM I OSWALDO CRUZ, V104, P236, DOI 10.1590/S0074-02762009000900030; HOGABOAM CM, 1995, AM J PHYSIOL-GASTR L, V268, pG673, DOI 10.1152/ajpgi.1995.268.4.G673; Khare S, 2015, ANTIMICROB AGENTS CH, V59, P6385, DOI 10.1128/AAC.00689-15; KOBERLE F, 1963, GUT, V4, P399, DOI 10.1136/gut.4.4.399; Koberle F., 1968, Advances in Parasitology, V6, P63, DOI 10.1016/S0065-308X(08)60472-8; Lopes ER, 1987, BOGLIOLO PATOLOGIA, P1047; Marin-Neto JA, 2008, AM HEART J, V156, P37, DOI 10.1016/j.ahj.2008.04.001; Medeiros MD, 2010, PARASITOL RES, V107, P239, DOI 10.1007/s00436-010-1871-5; Moncayo A, 2003, MEM I OSWALDO CRUZ, V98, P577, DOI 10.1590/S0074-02762003000500001; da Siveira ABM, 2007, HUM PATHOL, V38, P1256, DOI 10.1016/j.humpath.2007.01.020; Moreira NM, 2011, AN ACAD BRAS CIENC, V83, P545, DOI 10.1590/S0001-37652011000200014; Ny L, 2008, AM J TROP MED HYG, V79, P760; Pedrosa RC, 2001, REDOX REP, V6, P265, DOI 10.1179/135100001101536328; Petkova SB, 2001, INT J PARASITOL, V31, P499, DOI 10.1016/S0020-7519(01)00168-0; Pinheiro Simone Wanderley, 2003, Rev. Soc. Bras. Med. Trop., V36, P461, DOI 10.1590/S0037-86822003000400005; Sanovic S, 1999, AM J PATHOL, V155, P1051, DOI 10.1016/S0002-9440(10)65207-8; Savidge TC, 2007, LAB INVEST, V87, P731, DOI 10.1038/labinvest.3700600; SHARKEY KA, 1990, NEUROSCIENCE, V38, P13, DOI 10.1016/0306-4522(90)90370-J; Silva JS, 2003, FRONT BIOSCI-LANDMRK, V8, pS314, DOI 10.2741/1012; TANOWITZ HB, 1992, CLIN MICROBIOL REV, V5, P400, DOI 10.1128/CMR.5.4.400-419.1992; TEIXEIRA ARL, 1975, AM J PATHOL, V80, P163; Vento P, 1999, J HISTOCHEM CYTOCHEM, V47, P1405, DOI 10.1177/002215549904701107; Villela MM, 2009, CAD SAUDE PUBLICA, V25, P907, DOI 10.1590/S0102-311X2009000400022; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; WHO, 2014, CHAG DIS AM TRYP; WHO, 2002, WHO TECHN REP SER, V912; World Health Organization, 2008, 62 WORLD HLTH ASS; Yamada M, 2006, NEUROSCI RES, V54, P261, DOI 10.1016/j.neures.2005.12.007; YOUNESCHENNOUFI AB, 1988, T ROY SOC TROP MED H, V82, P77, DOI 10.1016/0035-9203(88)90269-6	55	23	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153038	10.1371/journal.pone.0153038	http://dx.doi.org/10.1371/journal.pone.0153038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045678	Green Submitted, Green Published, gold			2022-12-26	WOS:000373599600062
J	Munoz-Esquerre, M; Lopez-Sanchez, M; Escobar, I; Huertas, D; Penin, R; Molina-Molina, M; Manresa, F; Dorca, J; Santos, S				Munoz-Esquerre, Mariana; Lopez-Sanchez, Marta; Escobar, Ignacio; Huertas, Daniel; Penin, Rosa; Molina-Molina, Maria; Manresa, Frederic; Dorca, Jordi; Santos, Salud			Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							INTIMAL HYPERPLASIA; CARDIOVASCULAR-DISEASE; INTERCOSTAL ARTERY; RADIAL ARTERY; RISK-FACTORS; COPD; ATHEROSCLEROSIS; HISTOPATHOLOGY; HYPERTENSION; CORONARY	Background Chronic Obstructive Pulmonary Disease (COPD) is associated with subclinical systemic atherosclerosis and pulmonary vascular remodelling characterized by intimal hyperplasia and luminal narrowing. We aimed to determine differences in the intimal thickening of systemic and pulmonary arteries in COPD subjects and smokers. Secondary aims include comparisons with a non-smokers group; determining the clinical variables associated with systemic and pulmonary intimal thickening, and the correlations between systemic and pulmonary remodelling changes. Methods All consecutive subjects undergoing lung resection were included and divided into 3 groups: 1) COPD, 2) smokers, and 3) non-smokers. Sections of the 5th intercostal artery and muscular pulmonary arteries were measured by histo-morphometry. Four parameters of intimal thickening were evaluated: 1) percentage of intimal area (%IA), 2) percentage of luminal narrowing, 3) intimal thickness index, and 4) intima-to-media ratio. Results In the adjusted analysis, the systemic arteries of COPD subjects showed greater intimal thickening (%IA) than those of smokers (15.6 +/- 1.5% vs. 14.2 +/- 1.6%, p = 0.038). In the pulmonary arteries, significant differences were observed for % IA between the 2 groups (37.3 +/- 2.2% vs. 29.3 +/- 2.3%, p = 0.016). Among clinical factors, metabolic syndrome, gender and COPD status were associated with the systemic intimal thickening, while only COPD status was associated with pulmonary intimal thickening. A correlation between the % IA of the systemic and pulmonary arteries was observed (Spearman's rho = 0.46, p = 0.008). Conclusions Greater intimal thickening in systemic and pulmonary arteries is observed in COPD patients than in smokers. There is a correlation between systemic and pulmonary vascular remodelling in the overall population.	[Munoz-Esquerre, Mariana; Lopez-Sanchez, Marta; Huertas, Daniel; Molina-Molina, Maria; Manresa, Frederic; Dorca, Jordi; Santos, Salud] Univ Barcelona, Bellvitge Univ Hosp IDIBELL, Dept Pulm Med, Barcelona, Spain; [Escobar, Ignacio] Univ Barcelona, Bellvitge Univ Hosp IDIBELL, Dept Thorac Surg, Barcelona, Spain; [Penin, Rosa] Univ Barcelona, Bellvitge Univ Hosp IDIBELL, Dept Pathol, Barcelona, Spain; [Molina-Molina, Maria; Santos, Salud] Biomed Res Networking Ctr Consortium Resp Dis CIB, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Santos, S (corresponding author), Univ Barcelona, Bellvitge Univ Hosp IDIBELL, Dept Pulm Med, Barcelona, Spain.; Santos, S (corresponding author), Biomed Res Networking Ctr Consortium Resp Dis CIB, Barcelona, Spain.	saludsantos@bellvitgehospital.cat	Dorca, Jordi/Q-3617-2016; Munoz-Esquerre, Mariana/F-7386-2012	Dorca, Jordi/0000-0002-8137-878X; Santos, Salud/0000-0002-5835-1028; MOLINA MOLINA, MARIA/0000-0002-1852-1723	Comite de Recerca de l'Hospital Universitari de Bellvitge; Sociedad Espanola de Neumologia y Cirugia Toracica SEPAR [081/2011]; Fundacio Catalana de Pneumologia FUCAP; Institut d'Investigacio de Bellvitge, IDIBELL	Comite de Recerca de l'Hospital Universitari de Bellvitge; Sociedad Espanola de Neumologia y Cirugia Toracica SEPAR; Fundacio Catalana de Pneumologia FUCAP; Institut d'Investigacio de Bellvitge, IDIBELL	This study was funded by Comite de Recerca de l'Hospital Universitari de Bellvitge, no 2012, http://www.bellvitgehospital.cat/;Sociedad Espanola de Neumologia y Cirugia Toracica SEPAR, No 081/2011, http://www.separ.es/; Fundacio Catalana de Pneumologia FUCAP No URIACH 2011, http://www.ccfundacions.cat/fundacions/fundacio-catalana- de-pneumologia-fucap; Institut d'Investigacio de Bellvitge, IDIBELL, No Predoctoral fellowship 2012, http://www.idibell.cat/. The study sponsors did not have any role in the study design, collection, analysis and interpretation of data, or in writing the report.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; ARNOLD M, 1972, J THORAC CARDIOV SUR, V64, P596; Barbera JA, 2003, EUR RESPIR J, V21, P892, DOI 10.1183/09031936.03.00115402; Barry M, 2007, SURG RADIOL ANAT, V29, P297, DOI 10.1007/s00276-007-0214-4; Chindhi S, 2015, LUNG INDIA, V32, P137, DOI 10.4103/0970-2113.152624; Chowdhury UK, 2004, ANN THORAC SURG, V78, P1614, DOI 10.1016/j.athoracsur.2004.03.105; Cizek SM, 2007, CARDIOVASC PATHOL, V16, P344, DOI 10.1016/j.carpath.2007.05.007; COOK TA, 1972, J PATHOL, V108, P119, DOI 10.1002/path.1711080205; Dugac AV, 2015, MED HYPOTHESES, V84, P155, DOI 10.1016/j.mehy.2014.11.017; Hole DJ, 1996, BRIT MED J, V313, P711; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Irzyk K, 2015, SCAND J RHEUMATOL, V44, P385, DOI 10.3109/03009742.2015.1021710; Iwamoto H, 2009, AM J RESP CRIT CARE, V179, P35, DOI 10.1164/rccm.200804-560OC; JOHN LCH, 1995, ANN THORAC SURG, V59, P190, DOI 10.1016/0003-4975(94)00715-J; Lahousse L, 2013, AM J RESP CRIT CARE, V187, P58, DOI 10.1164/rccm.201206-1046OC; MAGEE F, 1988, THORAX, V43, P183, DOI 10.1136/thx.43.3.183; Matsuoka S, 2011, ACAD RADIOL, V18, P40, DOI 10.1016/j.acra.2010.08.013; Mong K, 2002, ANN THORAC SURG, V74, P2126, DOI 10.1016/S0003-4975(02)03984-X; MOORE GW, 1982, ARCH PATHOL LAB MED, V106, P378; Ruengsakulrach P, 1999, CIRCULATION, V100, P139; Santos S, 2002, EUR RESPIR J, V19, P632, DOI 10.1183/09031936.02.00245902; Sin DD, 2005, CAN J PHYSIOL PHARM, V83, P8, DOI 10.1139/Y04-116; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; Subbotin VM, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-41; Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP; van Gestel YRBM, 2010, RESP MED, V104, P712, DOI 10.1016/j.rmed.2009.10.027; VANSON JAM, 1993, ANN THORAC SURG, V56, P1078, DOI 10.1016/0003-4975(95)90018-7; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; WRIGHT JL, 1992, LUNG, V170, P109	29	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152987	10.1371/journal.pone.0152987	http://dx.doi.org/10.1371/journal.pone.0152987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046203	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600055
J	Tomaszewski, D; Gorzkowska, A				Tomaszewski, Dominik; Gorzkowska, Angelika			Is Shape of a Fresh and Dried Leaf the Same?	PLOS ONE			English	Article							PLANT-SPECIES IDENTIFICATION; ELLIPTIC FOURIER-ANALYSIS; QUANTITATIVE-EVALUATION; LEAVES; MORPHOLOGY; DESCRIPTORS; OUTLINES; IMAGES	Plants kept as dried herbarium specimens share many characteristics with their living counterparts, but there are some substantial differences between them. Due to dehydration, leaves of herbarium specimens change not only their mass and colour, but in many cases change their dimensions, too. The present study aimed to determine whether leaf shape changes during the drying process. A total of 794 pairs of fresh and dried leaves or leaflets of 22 plant taxa were studied. The shape of the blades was quantified using elliptic Fourier analysis combined with principal component analysis. In addition, area and mass of the leaves were measured. Statistical tests were applied for comparing fresh and dried leaves. The results indicate that the preservation process of pressing and drying plants for herbarium purposes causes changes in leaf shape. In general, the shape changes were directional. As the shape of fresh and dried plants is different, it is strongly recommended that shape analyses should be performed on datasets containing either of the leaf types.	[Tomaszewski, Dominik] Polish Acad Sci, Inst Dendrol, Parkowa 5, PL-62035 Kornik, Poland; [Gorzkowska, Angelika] Poznan Univ Life Sci, Fac Forestry, Wojska Polskiego 71c, PL-60625 Poznan, Poland	Polish Academy of Sciences; Poznan University of Life Sciences	Tomaszewski, D (corresponding author), Polish Acad Sci, Inst Dendrol, Parkowa 5, PL-62035 Kornik, Poland.	dominito@man.poznan.pl	Tomaszewski, Dominik/B-5921-2008	Tomaszewski, Dominik/0000-0001-7768-5747	Institute of Dendrology of Polish Academy of Sciences in Kornik	Institute of Dendrology of Polish Academy of Sciences in Kornik	The research was financially supported by the Institute of Dendrology of the Polish Academy of Sciences in Kornik. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebowale A, 2012, BOT J LINN SOC, V170, P542, DOI 10.1111/j.1095-8339.2012.01308.x; Agarwal G, 2006, TAXON, V55, P597, DOI 10.2307/25065637; Andrade I. M., 2008, Kew Bulletin, V63, P193, DOI 10.1007/s12225-008-9032-z; Andrade I. M., 2010, Kew Bulletin, V65, P3, DOI 10.1007/s12225-010-9188-1; Beck C.B., 2010, INTRO PLANT STRUCTUR; Belhumeur PN, 2008, LECT NOTES COMPUT SC, V5305, P116, DOI 10.1007/978-3-540-88693-8_9; Blonder B, 2012, AM J BOT, V99, P1756, DOI 10.3732/ajb.1200062; Bruno OM, 2008, INFORM SCIENCES, V178, P2722, DOI 10.1016/j.ins.2008.01.023; Casanova D, 2009, INT J IMAG SYST TECH, V19, P236, DOI 10.1002/ima.20201; Chitwood DH, 2014, PLANT PHYSIOL, V164, P259, DOI 10.1104/pp.113.229708; Chitwood DH, 2012, PLANT CELL, V24, P2318, DOI 10.1105/tpc.112.098798; Claude J, 2008, MORPHOMETRICS R; Cope JS, 2012, EXPERT SYST APPL, V39, P7562, DOI 10.1016/j.eswa.2012.01.073; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Du JX, 2006, T I MEAS CONTROL, V28, P275, DOI 10.1191/0142331206tim176oa; Funk V. A., 2004, 100 USES HERBARIUM W; FURUTA N, 1995, BREEDING SCI, V45, P315; Hearn DJ, 2009, TAXON, V58, P934, DOI 10.1002/tax.583021; Hopkins W. G, 2008, INTRO PLANT PHYSL; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Iwata H, 2002, BREEDING SCI, V52, P89, DOI 10.1270/jsbbs.52.89; Jensen RJ, 2002, TAXON, V51, P475, DOI 10.2307/1554860; Jeong S, 2013, COMPUT GRAPH FORUM, V32, P204, DOI 10.1111/cgf.12009; Joly A, 2014, ECOL INFORM, V23, P22, DOI 10.1016/j.ecoinf.2013.07.006; Juneau KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042604; KINCAID DT, 1983, CAN J BOT, V61, P2333, DOI 10.1139/b83-256; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Kumar N, 2012, LECT NOTES COMPUT SC, V7573, P502, DOI 10.1007/978-3-642-33709-3_36; Neto JC, 2006, COMPUT ELECTRON AGR, V50, P121, DOI 10.1016/j.compag.2005.09.004; Parnell J, 2013, TAXON, V62, P1259, DOI 10.12705/626.3; Pereira LAM, 2012, COMPUT ELECTRON AGR, V87, P56, DOI 10.1016/j.compag.2012.05.015; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Queenborough SA, 2014, PLANT ECOL DIVERS, V7, P383, DOI 10.1080/17550874.2013.777483; Torres MAJ, 2008, PHILIPP AGRIC SCI, V91, P18; Torrez V, 2013, AUST J BOT, V61, P350, DOI 10.1071/BT12236; Viscosi V, 2009, PLANT BIOSYST, V143, P564, DOI 10.1080/11263500902723129; Viscosi V, 2011, NORD J BOT, V29, P632, DOI 10.1111/j.1756-1051.2011.01098.x; Wang B, 2015, INFORM SCIENCES, V302, P132, DOI 10.1016/j.ins.2014.07.028; WHITE RJ, 1988, CAN J BOT, V66, P450, DOI 10.1139/b88-070; WOOLLEY JT, 1973, PLANT PHYSIOL, V51, P815, DOI 10.1104/pp.51.4.815; Yanikoglu B, 2014, MACH VISION APPL, V25, P1369, DOI 10.1007/s00138-014-0612-7	41	16	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153071	10.1371/journal.pone.0153071	http://dx.doi.org/10.1371/journal.pone.0153071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045956	gold, Green Published, Green Submitted			2022-12-26	WOS:000373599600065
J	Wilmington, SR; Matouschek, A				Wilmington, Shameika R.; Matouschek, Andreas			An Inducible System for Rapid Degradation of Specific Cellular Proteins Using Proteasome Adaptors	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; GENE-EXPRESSION; HALF-LIFE; SACCHAROMYCES-CEREVISIAE; STRESSED CONDITIONS; MAMMALIAN-CELLS; MONOMERIC RED; UBIQUITIN; STABILITY; DEGRON	A common way to study protein function is to deplete the protein of interest from cells and observe the response. Traditional methods involve disrupting gene expression but these techniques are only effective against newly synthesized proteins and leave previously existing and stable proteins untouched. Here, we introduce a technique that induces the rapid degradation of specific proteins in mammalian cells by shuttling the proteins to the proteasome for degradation in a ubiquitin-independent manner. We present two implementations of the system in human culture cells that can be used individually to control protein concentration. Our study presents a simple, robust, and flexible technology platform for manipulating intracellular protein levels.	[Wilmington, Shameika R.; Matouschek, Andreas] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Wilmington, Shameika R.; Matouschek, Andreas] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	Northwestern University; University of Texas System; University of Texas Austin	Matouschek, A (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL USA.; Matouschek, A (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	matouschek@austin.utexas.edu	Matouschek, Andreas/L-9379-2013	Matouschek, Andreas/0000-0001-6016-2341	National Institute of General Medical Sciences [T32GM08061, R01GM63004]; Bill & Melinda Gates Foundation [GCE 8 OPP1061182]; Welch Foundation [F-1817]; Cancer Prevention and Research Institute of Texas [RP140328]; National Cancer Institute (NCI) [R21CA191664]; NATIONAL CANCER INSTITUTE [R21CA196456, R21CA191664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061, R01GM063004] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute of General Medical Sciences (https://www.nigms.nih.gov/Pages/default.aspx) (T32GM08061 SRW and R01GM63004 to AM); Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) (GCE 8 OPP1061182 to AM); the Welch Foundation (http://www.welch1.org) (F-1817 to AM); the Cancer Prevention and Research Institute of Texas (http://www.cprit.state.tx.us) (RP140328 to AM); and the National Cancer Institute (NCI) R21CA191664. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Bondeson D.P., 2015, NAT CHEM BIOL; Buckley DL, 2014, ANGEW CHEM INT EDIT, V53, P2312, DOI 10.1002/anie.201307761; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Chu BW, 2008, BIOORG MED CHEM LETT, V18, P5941, DOI 10.1016/j.bmcl.2008.09.043; Chung HK, 2015, NAT CHEM BIOL, V11, P713, DOI [10.1038/nchembio.1869, 10.1038/NCHEMBIO.1869]; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Fishbain S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1194; Gurtu V, 1996, IRES BICISTRONIC EXP, P1; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hatakeyama S, 2005, CANCER RES, V65, P7874, DOI 10.1158/0008-5472.CAN-05-1581; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Liberles SD, 1997, P NATL ACAD SCI USA, V94, P7825, DOI 10.1073/pnas.94.15.7825; Ma YH, 2013, MOL CANCER THER, V12, P286, DOI 10.1158/1535-7163.MCT-12-0650; Marangos P, 2008, NAT CELL BIOL, V10, P445, DOI 10.1038/ncb1707; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; Miyamoto T, 2012, NAT CHEM BIOL, V8, P465, DOI [10.1038/NCHEMBIO.922, 10.1038/nchembio.922]; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/NCHEMBIO.597, 10.1038/nchembio.597]; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Portnoff AD, 2014, J BIOL CHEM; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rakhit R, 2014, CHEM BIOL, V21, P1238, DOI 10.1016/j.chembiol.2014.08.011; Remington SJ, 2011, PROTEIN SCI, V20, P1509, DOI 10.1002/pro.684; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Schrader EK, 2010, CHEM BIOL, V17, P917, DOI 10.1016/j.chembiol.2010.09.004; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scire A, 2008, PROTEINS, V73, P839, DOI 10.1002/prot.22114; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shemiakina II, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2208; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tsien R, 1998, ANN REV BIOCH; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Wang XG, 2010, GENETICS, V184, P335, DOI 10.1534/genetics.109.112227; Wang XG, 2008, GENETICS, V180, P1945, DOI 10.1534/genetics.108.094524; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Xu HM, 2012, BBA-MOL CELL RES, V1823, P818, DOI 10.1016/j.bbamcr.2012.01.002	55	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152679	10.1371/journal.pone.0152679	http://dx.doi.org/10.1371/journal.pone.0152679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043013	Green Published, gold, Green Submitted			2022-12-26	WOS:000373592100025
J	Xie, XR; Qu, H; Liu, GS; Zhang, ML; Kurths, J				Xie, Xiurui; Qu, Hong; Liu, Guisong; Zhang, Malu; Kurths, Juergen			An Efficient Supervised Training Algorithm for Multilayer Spiking Neural Networks	PLOS ONE			English	Article							FUNCTIONAL ARCHITECTURE; LEARNING ALGORITHM; RECEPTIVE-FIELDS; MODEL; CLASSIFICATION; OSCILLATIONS	The spiking neural networks (SNNs) are the third generation of neural networks and perform remarkably well in cognitive tasks such as pattern recognition. The spike emitting and information processing mechanisms found in biological cognitive systems motivate the application of the hierarchical structure and temporal encoding mechanism in spiking neural networks, which have exhibited strong computational capability. However, the hierarchical structure and temporal encoding approach require neurons to process information serially in space and time respectively, which reduce the training efficiency significantly. For training the hierarchical SNNs, most existing methods are based on the traditional back-propagation algorithm, inheriting its drawbacks of the gradient diffusion and the sensitivity on parameters. To keep the powerful computation capability of the hierarchical structure and temporal encoding mechanism, but to overcome the low efficiency of the existing algorithms, a new training algorithm, the Normalized Spiking Error Back Propagation (NSEBP) is proposed in this paper. In the feedforward calculation, the output spike times are calculated by solving the quadratic function in the spike response model instead of detecting postsynaptic voltage states at all time points in traditional algorithms. Besides, in the feedback weight modification, the computational error is propagated to previous layers by the presynaptic spike jitter instead of the gradient decent rule, which realizes the layer-wised training. Furthermore, our algorithm investigates the mathematical relation between the weight variation and voltage error change, which makes the normalization in the weight modification applicable. Adopting these strategies, our algorithm outperforms the traditional SNN multi-layer algorithms in terms of learning efficiency and parameter sensitivity, that are also demonstrated by the comprehensive experimental results in this paper.	[Xie, Xiurui; Qu, Hong; Liu, Guisong; Zhang, Malu] Univ Elect Sci & Technol China, Dept Comp Sci & Engn, Chengdu 611731, Sichuan, Peoples R China; [Qu, Hong; Kurths, Juergen] Humboldt Univ, Dept Phys, D-12489 Berlin, Germany; [Qu, Hong; Kurths, Juergen] Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany	University of Electronic Science & Technology of China; Humboldt University of Berlin; Potsdam Institut fur Klimafolgenforschung	Qu, H (corresponding author), Univ Elect Sci & Technol China, Dept Comp Sci & Engn, Chengdu 611731, Sichuan, Peoples R China.; Qu, H (corresponding author), Humboldt Univ, Dept Phys, D-12489 Berlin, Germany.; Qu, H (corresponding author), Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany.	hongqu@uestc.edu.cn	Liu, Guisong/S-1263-2019	Liu, Guisong/0000-0003-2360-0466	National Science Foundation of China [61273308, 61573081]; China Scholarship Council [61273308, 61573081]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was partially supported by the National Science Foundation of China and the China Scholarship Council under Grants 61273308 and 61573081 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by the National Science Foundation of China under Grants 61273308 and 61573081, and the China Scholarship Council.	Bache Kevin, 2013, UCI MACHINE LEARNING; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bohte Sander M., 2004, Natural Computing, V3, P195, DOI 10.1023/B:NACO.0000027755.02868.60; Bohte SM, 2002, NEUROCOMPUTING, V48, P17, DOI 10.1016/S0925-2312(01)00658-0; Desimone R., 1989, HDB NEUROPSYCHOLOGY, P267; Fink CG, 2013, IEEE GLOB CONF SIG, P843, DOI 10.1109/GlobalSIP.2013.6737023; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Florian RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040233; Gerstner W, 2002, SPIKING NERUAL MODEL; Ghosh-Dastidar S, 2009, NEURAL NETWORKS, V22, P1419, DOI 10.1016/j.neunet.2009.04.003; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Hu J, 2013, NEURAL COMPUT, V25, P450, DOI 10.1162/NECO_a_00395; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Masquelier T, 2009, NEURAL COMPUT, V21, P1259, DOI 10.1162/neco.2008.06-08-804; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; McKennoch S, 2006, IEEE IJCNN, P3970; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mohemmed A, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S0129065712500128; Naveros F, 2015, IEEE T NEUR NET LEAR, V26, P1567, DOI 10.1109/TNNLS.2014.2345844; O'Brien MJ, 2013, NEURAL COMPUT, V25, P123, DOI 10.1162/NECO_a_00387; Ponulak F, 2011, ACTA NEUROBIOL EXP, V71, P409; Ponulak F, 2010, NEURAL COMPUT, V22, P467, DOI 10.1162/neco.2009.11-08-901; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; Snippe HP, 1996, NEURAL COMPUT, V8, P511, DOI 10.1162/neco.1996.8.3.511; Song WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057453; Sporea I, 2013, NEURAL COMPUT, V25, P473, DOI 10.1162/NECO_a_00396; THEUNISSEN F, 1995, J COMPUT NEUROSCI, V2, P149, DOI 10.1007/BF00961885; THORPE SJ, 1989, CONNECTIONISM IN PERSPECTIVE, P63; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Wade JJ, 2010, IEEE T NEURAL NETWOR, V21, P1817, DOI 10.1109/TNN.2010.2074212; WOLBERG WH, 1990, P NATL ACAD SCI USA, V87, P9193, DOI 10.1073/pnas.87.23.9193; Xu Y, 2013, NEURAL COMPUT, V25, P1472, DOI 10.1162/NECO_a_00450; Yu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078318; Zhang ZM, 2015, NEUROCOMPUTING, V151, P985, DOI 10.1016/j.neucom.2014.03.086	42	11	11	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0150329	10.1371/journal.pone.0150329	http://dx.doi.org/10.1371/journal.pone.0150329			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044001	Green Published, gold, Green Submitted			2022-12-26	WOS:000373592100001
J	Qin, H; Malek, S; Cowell, JK; Ren, M				Qin, H.; Malek, S.; Cowell, J. K.; Ren, M.			Transformation of human CD34+hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; EXPRESSION; DEK; T(6/9)(P23,Q34); PROTEIN; GENES; FGFR1	Acute myeloid leukemia (AML) is a heterogeneous disease comprising a large number of subtypes defined by specific chromosome abnormalities. One such subtype carries the t(6; 9)(p22;q34) chromosome rearrangement, which leads to expression of the DEK-NUP214 chimeric gene, and has a particularly poor outcome. To provide a better understanding of the molecular etiology of these relatively rare individual AML variants, it is necessary to generate in vivo models, which can also serve as a means to evaluate targeted therapies based on their specific genetic abnormalities. Here, we describe the development of a human cell AML, generated in CD34+ human hematopoietic progenitor cells xenografted into immunocompromised mice that express human myeloid cell growth factors. Within 6 months, these mice develop a human cell AML with phenotypic characteristics of the primary t(6; 9) disease and a CD45+CD13+CD34+CD38+ immunophenotype. Gene expression studies show that members of the HOX family of genes (HOXA9, 10, B3, B4 and PBX3) are highly upregulated in the AML from this mouse model as well as from primary human t(6; 9) AML. Gene expression analysis also identified several other significantly disregulated pathways involving KRAS, BRCA1 and ALK, for example. This is the first report of a humanized model of the DEK-NUP214 disease and provides a means to study the development and treatment of this particular subtype of AML.	[Qin, H.; Cowell, J. K.; Ren, M.] Georgia Regents Univ, Ctr Canc, CN2133,1120 15th St GRU, Augusta, GA 30912 USA; [Malek, S.] Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI 48109 USA	University System of Georgia; Augusta University; University of Michigan System; University of Michigan	Ren, M (corresponding author), Georgia Regents Univ, Ctr Canc, CN2133,1120 15th St GRU, Augusta, GA 30912 USA.	mren@gru.edu			NATIONAL CANCER INSTITUTE [R01CA076167] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA076167] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Ageberg M, 2006, HAEMATOL-HEMATOL J, V91, P268; Alharbi RA, 2013, LEUKEMIA, V27, P1000, DOI 10.1038/leu.2012.356; AVANZI GC, 1990, J CELL PHYSIOL, V145, P458, DOI 10.1002/jcp.1041450310; Balgobind BV, 2011, HAEMATOL-HEMATOL J, V96, P221, DOI 10.3324/haematol.2010.029660; Billerbeck E, 2011, BLOOD, V117, P3076, DOI 10.1182/blood-2010-08-301507; Hamaguchi H, 1998, BRIT J HAEMATOL, V102, P1249, DOI 10.1046/j.1365-2141.1998.00900.x; KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519; Mills KI, 2009, BLOOD, V114, P1063, DOI 10.1182/blood-2008-10-187203; Oancea C, 2010, LEUKEMIA, V24, P1910, DOI 10.1038/leu.2010.180; Oyarzo MP, 2004, AM J CLIN PATHOL, V122, P348, DOI 10.1309/5DGB59KQA527PD47; PALACIOS R, 1984, NATURE, V309, P126, DOI 10.1038/309126a0; Ren M, 2013, LEUKEMIA, V27, P32, DOI 10.1038/leu.2012.188; Ren MQ, 2013, BLOOD, V122, P1007, DOI 10.1182/blood-2013-03-489823; Ren MQ, 2011, BLOOD, V117, P6837, DOI 10.1182/blood-2010-07-295725; Riveiro-Falkenbach E, 2010, CLIN CANCER RES, V16, P2932, DOI 10.1158/1078-0432.CCR-09-2330; Saito Y, 2011, LEUKEMIA, V25, P921, DOI 10.1038/leu.2011.36; Sanden C, 2015, LEUKEMIA, V29, P1632, DOI 10.1038/leu.2015.72; Sanden C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-440; Slovak ML, 2006, LEUKEMIA, V20, P1295, DOI 10.1038/sj.leu.2404233; SOEKARMAN D, 1992, BLOOD, V79, P2990; Spencer DH, 2015, LEUKEMIA, V29, P1279, DOI 10.1038/leu.2015.6; Vinnedge LMP, 2013, CELL CYCLE, V12, P51, DOI 10.4161/cc.23121; Vinnedge LMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046985; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Wise-Draper TM, 2009, CANCER RES, V69, P1792, DOI 10.1158/0008-5472.CAN-08-2304; Yamauchi K, 2002, CANCER-AM CANCER SOC, V94, P1739, DOI 10.1002/cncr.10399	27	22	23	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 27	2016	35	43					5686	5691		10.1038/onc.2016.118	http://dx.doi.org/10.1038/onc.2016.118			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XP	27065320	Green Accepted			2022-12-26	WOS:000386998300011
J	Kafle, P; Amoh, AN; Reaves, JM; Suneby, EG; Tutunjian, KA; Tyson, RL; Schneider, TL				Kafle, Prapti; Amoh, Amanda N.; Reaves, Jocelyn M.; Suneby, Emma G.; Tutunjian, Kathryn A.; Tyson, Reed L.; Schneider, Tanya L.			Molecular Insights into the Impact of Oxidative Stress on the Quorum-Sensing Regulator Protein LasR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; DNA-BINDING; AUTOINDUCER; MECHANISM; VIRULENCE; BIOSYNTHESIS; SUSCEPTIBILITY; INHIBITION; ACTIVATION; EXPRESSION	The LasR regulator protein functions at the top of the Pseudomonas aeruginosa quorum-sensing hierarchy and is implicated in promoting bacterial virulence. Of note is recent evidence that this transcription factor may also respond to oxidative stress. Here, all cysteines in LasR were inspected to deduce their redox sensitivity and to probe the connection between stress response and LasR activity using purified LasR and individual LasR domains. Cys79 in the ligand binding domain of LasR appears to be important for ligand recognition and folding of this domain to potentiate DNA binding but does not seem to be sensitive to oxidative stress when bound to its native ligand. Two cysteines in the DNA binding domain of LasR do form a disulfide bond when treated with hydrogen peroxide, and formation of this Cys(201)-Cys(203) disulfide bond appears to disrupt the DNA binding activity of the transcription factor. Mutagenesis of either of these cysteines leads to expression of a protein that no longer binds DNA. A cell-based reporter assay linking LasR function with beta-galactosidase activity gave results consistent with those obtained with purified LasR. This work provides a possible mechanism for oxidative stress response by LasR and indicates that multiple cysteines within the protein may prove to be useful targets for disabling its activity.	[Kafle, Prapti; Amoh, Amanda N.; Reaves, Jocelyn M.; Suneby, Emma G.; Tutunjian, Kathryn A.; Tyson, Reed L.; Schneider, Tanya L.] Connecticut Coll, Dept Chem, 270 Mohegan Ave, New London, CT 06320 USA	Connecticut College	Schneider, TL (corresponding author), Connecticut Coll, Dept Chem, 270 Mohegan Ave, New London, CT 06320 USA.	tschneid@conncoll.edu	Kafle, Prapti/AAA-2125-2022	Kafle, Prapti/0000-0003-4682-2897	Research Corporation for Science Advancement; Keck Foundation; NSF-S-STEM [1153371]	Research Corporation for Science Advancement(Research Corporation for Science Advancement); Keck Foundation(W.M. Keck Foundation); NSF-S-STEM	This work was supported by a Cottrell College Science Award from the Research Corporation for Science Advancement. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Keck Foundation summer research fellowships.; Supported by NSF-S-STEM 1153371.	Amara N, 2009, J AM CHEM SOC, V131, P10610, DOI 10.1021/ja903292v; BARANGER AM, 1995, NATURE, V376, P606, DOI 10.1038/376606a0; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Bottomley MJ, 2007, J BIOL CHEM, V282, P13592, DOI 10.1074/jbc.M700556200; Castellanos-Serra L, 2006, NAT PROTOC, V1, P1544, DOI 10.1038/nprot.2006.233; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2011, ANTIOXID REDOX SIGN, V14, P1107, DOI 10.1089/ars.2010.3374; CHHABRA SR, 1993, J ANTIBIOT, V46, P441, DOI 10.7164/antibiotics.46.441; Churchill MEA, 2011, CHEM REV, V111, P68, DOI 10.1021/cr1000817; Davenport PW, 2015, J BACTERIOL, V197, P2072, DOI 10.1128/JB.02557-14; Deng X, 2013, CELL HOST MICROBE, V13, P358, DOI 10.1016/j.chom.2013.02.004; Drazic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075683; Dubern JF, 2008, MOL BIOSYST, V4, P882, DOI 10.1039/b803796p; Dubern JF, 2006, J BACTERIOL, V188, P2898, DOI 10.1128/JB.188.8.2898-2906.2006; El-Sayed AK, 2001, MICROBIOL-SGM, V147, P2127, DOI 10.1099/00221287-147-8-2127; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Galloway WRJD, 2011, CHEM REV, V111, P28, DOI 10.1021/cr100109t; Gerdt JP, 2015, ORG BIOMOL CHEM, V13, P1453, DOI 10.1039/c4ob02252a; Gerdt JP, 2014, CHEM BIOL, V21, P1361, DOI 10.1016/j.chembiol.2014.08.008; Geske GD, 2005, J AM CHEM SOC, V127, P12762, DOI 10.1021/ja0530321; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hudaiberdiev S, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00020; Ji QJ, 2012, J BIOL CHEM, V287, P21102, DOI 10.1074/jbc.M112.359737; Kim T, 2014, ACTA CRYSTALLOGR D, V70, P694, DOI 10.1107/S1399004713032355; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Mattmann ME, 2010, J ORG CHEM, V75, P6737, DOI 10.1021/jo101237e; Moore JD, 2015, J AM CHEM SOC, V137, P14626, DOI 10.1021/jacs.5b06728; Nagano N, 1999, FEBS LETT, V458, P69, DOI 10.1016/S0014-5793(99)01122-9; O'Brien KT, 2015, ACS MED CHEM LETT, V6, P162, DOI 10.1021/ml500459f; Passador L, 1996, J BACTERIOL, V178, P5995, DOI 10.1128/jb.178.20.5995-6000.1996; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Schaefer KN, 2015, BIOCHEMISTRY-US, V54, P932, DOI 10.1021/bi501424v; Schook POP, 2011, MOL MICROBIOL, V79, P846, DOI 10.1111/j.1365-2958.2010.07491.x; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Schuster M, 2004, P NATL ACAD SCI USA, V101, P15833, DOI 10.1073/pnas.0407229101; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Suarez-Moreno ZR, 2008, MICROBIOL-SGM, V154, P2048, DOI 10.1099/mic.0.2008/017780-0; Sun F, 2012, P NATL ACAD SCI USA, V109, P9095, DOI 10.1073/pnas.1200603109; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zou YZ, 2009, CHEM BIOL, V16, P961, DOI 10.1016/j.chembiol.2009.09.001	49	14	14	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11776	11786		10.1074/jbc.M116.719351	http://dx.doi.org/10.1074/jbc.M116.719351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27053110	Green Published, hybrid			2022-12-26	WOS:000377264800027
J	Dey, S; Sidor, A; O'Rourke, B				Dey, Swati; Sidor, Agnieszka; O'Rourke, Brian			Compartment-specific Control of Reactive Oxygen Species Scavenging by Antioxidant Pathway Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antioxidant; cell metabolism; glutathione peroxidase; mitochondria; peroxiredoxin; reactive oxygen species (ROS); redox regulation; thioredoxin; thioredoxin reductase; NADPH	MITOCHONDRIAL THIOREDOXIN; GLUTATHIONE-PEROXIDASE; CARDIOVASCULAR EVENTS; OXIDATIVE STRESS; TARGET PROTEINS; PEROXIREDOXIN 3; VITAMIN-E; IN-VIVO; REDOX; CATALASE	Oxidative stress arises from an imbalance in the production and scavenging rates of reactive oxygen species (ROS) and is a key factor in the pathophysiology of cardiovascular disease and aging. The presence of parallel pathways and multiple intracellular compartments, each having its own ROS sources and antioxidant enzymes, complicates the determination of the most important regulatory nodes of the redox network. Here we quantified ROS dynamics within specific intracellular compartments in the cytosol and mitochondria and determined which scavenging enzymes exert the most control over antioxidant fluxes in H9c2 cardiac myoblasts. We used novel targeted viral gene transfer vectors expressing redox-sensitive GFP fused to sensor domains to measure H2O2 or oxidized glutathione. Using genetic manipulation in heart-derived H9c2 cells, we explored the contribution of specific antioxidant enzymes to ROS scavenging and glutathione redox potential within each intracellular compartment. Our findings reveal that antioxidant flux is strongly dependent on mitochondrial substrate catabolism, with availability of NADPH as a major rate-controlling step. Moreover, ROS scavenging by mitochondria significantly contributes to cytoplasmic ROS handling. The findings provide fundamental information about the control of ROS scavenging by the redox network and suggest novel interventions for circumventing oxidative stress in cardiac cells.	[Dey, Swati; Sidor, Agnieszka; O'Rourke, Brian] Johns Hopkins Univ, Dept Med, Div Cardiol, 720 Rutland Ave,1060 Ross Bldg, Baltimore, MD 21205 USA	Johns Hopkins University	O'Rourke, B (corresponding author), Johns Hopkins Univ, Dept Med, Div Cardiol, 720 Rutland Ave,1060 Ross Bldg, Baltimore, MD 21205 USA.	bor@jhmi.edu		O'Rourke, Brian/0000-0002-5548-4853	NHLBI/National Institutes of Health [R01HL105216, R37HL54598]; Leducq Foundation; American Heart Association [14POST20380749]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105216, R01HL108917, R37HL054598] Funding Source: NIH RePORTER	NHLBI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leducq Foundation(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI/National Institutes of Health Grants R01HL105216 and R37HL54598 and the Leducq Foundation (to B. O.) and American Heart Association Postdoctoral Fellowship 14POST20380749 (to S. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200; Aon MA, 2012, J GEN PHYSIOL, V139, P479, DOI 10.1085/jgp.201210772; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216; Blair IA, 2006, CURR DRUG METAB, V7, P853, DOI 10.2174/138920006779010601; Brown DA, 2014, J CARDIOVASC PHARM T, V19, P121, DOI 10.1177/1074248413508003; Brown KK, 2008, FREE RADICAL BIO MED, V45, P494, DOI 10.1016/j.freeradbiomed.2008.04.030; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Cappola TP, 2001, CIRCULATION, V104, P2407, DOI 10.1161/hc4501.098928; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Cox AG, 2008, BIOCHEM PHARMACOL, V76, P1097, DOI 10.1016/j.bcp.2008.08.021; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; Fu YX, 1999, FREE RADICAL BIO MED, V27, P605, DOI 10.1016/S0891-5849(99)00104-5; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; HOEK JB, 1988, BIOCHEM J, V254, P1; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kaludercic N, 2014, ANTIOXID REDOX SIGN, V20, P267, DOI 10.1089/ars.2012.4616; Kaludercic N, 2010, CIRC RES, V106, P193, DOI 10.1161/CIRCRESAHA.109.198366; Kelner MJ, 2000, BIOCHEM BIOPH RES CO, V269, P366, DOI 10.1006/bbrc.2000.2267; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kim A, 2010, MAMM GENOME, V21, P534, DOI 10.1007/s00335-010-9299-x; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; Kudin AP, 2012, BBA-BIOENERGETICS, V1817, P1901, DOI 10.1016/j.bbabio.2012.02.023; Kumar V, 2009, FEBS LETT, V583, P997, DOI 10.1016/j.febslet.2009.02.018; Lee MY, 2008, ANTIOXID REDOX SIGN, V10, P1045, DOI 10.1089/ars.2007.1986; Lee S, 2013, ANTIOXID REDOX SIGN, V18, P1165, DOI 10.1089/ars.2011.4322; Liu T, 2014, CIRC RES, V115, P44, DOI 10.1161/CIRCRESAHA.115.303062; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; Nelson SK, 2006, FREE RADICAL BIO MED, V40, P341, DOI 10.1016/j.freeradbiomed.2005.08.043; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Qin FZ, 2010, CIRC-HEART FAIL, V3, P306, DOI 10.1161/CIRCHEARTFAILURE.109.864785; RADI R, 1991, J BIOL CHEM, V266, P22028; Roe ND, 2012, VASC PHARMACOL, V57, P168, DOI 10.1016/j.vph.2012.02.004; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Rydstrom J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008; Steinhubl SR, 2008, AM J CARDIOL, V101, p14D, DOI 10.1016/j.amjcard.2008.02.003; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461; Tepel M, 2003, CIRCULATION, V107, P992, DOI 10.1161/01.CIR.0000050628.11305.30; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Winterbourn CC, 2014, BBA-GEN SUBJECTS, V1840, P730, DOI 10.1016/j.bbagen.2013.05.004; Wu CG, 2014, MOL CELL PROTEOMICS, V13, P3507, DOI 10.1074/mcp.M114.040931; Wu CG, 2011, J PROTEOMICS, V74, P2498, DOI 10.1016/j.jprot.2011.06.001; Yamamoto M, 2003, J CLIN INVEST, V112, P1395, DOI 10.1172/JCI200317700; Yang KC, 2015, CIRC RES, V116, P1937, DOI 10.1161/CIRCRESAHA.116.304691; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zhang H, 2007, ARCH BIOCHEM BIOPHYS, V465, P119, DOI 10.1016/j.abb.2007.05.001; Zhang J, 2014, CURR MOL MED, V14, P772; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	67	71	72	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11185	11197		10.1074/jbc.M116.726968	http://dx.doi.org/10.1074/jbc.M116.726968			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27048652	Green Published, hybrid			2022-12-26	WOS:000377042100021
J	Xiu, FM; Anipindi, VC; Nguyen, PV; Boudreau, J; Liang, H; Wan, YH; Snider, DP; Kaushic, C				Xiu, Fangming; Anipindi, Varun C.; Nguyen, Philip V.; Boudreau, Jeanette; Liang, Hong; Wan, Yonghong; Snider, Denis P.; Kaushic, Charu			High Physiological Concentrations of Progesterone Reverse Estradiol-Mediated Changes in Differentiation and Functions of Bone Marrow Derived Dendritic Cells	PLOS ONE			English	Article							AUTOIMMUNE-DISEASE; HUMAN-PREGNANCY; SEX-DIFFERENCES; GM-CSF; RECEPTOR; MOUSE; IMMUNITY; HORMONES; ESTRIOL; MACROPHAGES	Female sex steroids, estradiol (E2) and progesterone (P4), play a key role in regulating immune responses in women, including dendritic cell (DC) development, and functions. Although the two hormones co-occur in the body of women throughout the reproductive years, no studies have explored their complex combinatorial effects on DCs, given their ability to regulate each other's actions. We examined murine bone marrow derived dendritic cells (BMDC) differentiation and functions, in the presence of a wide range of physiological concentrations of each hormone, as well as the combination of the two hormones. E2 (10(-12) to 10(-8)M) enhanced the differentiation of CD11b(+)CD11c(+)DCs from BM precursor cells, and promoted the expression of CD40 and MHC Class-II, in a dose-dependent manner. In contrast, P4 (10(-9) to 10(-5)M) inhibited DC differentiation, but only at the highest concentrations. These effects on BMDCs were observed both in the presence or absence of LPS. When both hormones were combined, higher concentrations of P4, at levels seen in pregnancy (10(-6)M) reversed the E2 effects, regardless of the concentration of E2, especially in the absence of LPS. Functionally, antigen uptake was decreased and pro-inflammatory cytokines, IL-12, IL-1 and IL-6 production by CD11b(+)CD11c(+)DCs, was increased in the presence of E2 and these effects were reversed by high concentrations of P4. Our results demonstrate the distinct effects of E2 and P4 on differentiation and functions of bone marrow myeloid DCs. The dominating effect of higher physiological concentrations of P4 provides insight into how DC functions could be modulated during pregnancy.	[Xiu, Fangming; Anipindi, Varun C.; Nguyen, Philip V.; Boudreau, Jeanette; Liang, Hong; Wan, Yonghong; Snider, Denis P.; Kaushic, Charu] McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Michael G DeGroote Ctr Learning & Discovery, Hamilton, ON L8N 3Z5, Canada	McMaster University	Kaushic, C (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Michael G DeGroote Ctr Learning & Discovery, Hamilton, ON L8N 3Z5, Canada.	kaushic@mcmaster.ca		Kaushic, Charu/0000-0002-7088-2569; Boudreau, Jeanette/0000-0003-0203-2180	Canadian Institutes of Health Research; Ontario HIV Treatment Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network	The work was supported by the following: Canadian Institutes of Health Research, http://www.cihr-irsc.gc.ca/e/193. html; and Ontario HIV Treatment Network, http://www.ohtn.on.ca/. Grants were awarded to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blois SM, 2004, BIOL REPROD, V70, P1018, DOI 10.1095/biolreprod.103.022640; Boudreau Jeanette, 2008, J Vis Exp, DOI 10.3791/769; Butts CL, 2010, MUCOSAL IMMUNOL, V3, P496, DOI 10.1038/mi.2010.28; Butts CL, 2007, INT IMMUNOL, V19, P287, DOI 10.1093/intimm/dxl145; Carreras E, 2008, J IMMUNOL, V180, P727, DOI 10.4049/jimmunol.180.2.727; Escribese MM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-118; Feinshtein V, 2010, ARCH GYNECOL OBSTET, V281, P387, DOI 10.1007/s00404-009-1125-x; Gillgrass AE, 2005, J VIROL, V79, P3117, DOI 10.1128/JVI.79.5.3117-3126.2005; Gillgrass AE, 2005, J VIROL, V79, P3107, DOI 10.1128/JVI.79.5.3107-3116.2005; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hughes GC, 2007, AUTOIMMUNITY, V40, P470, DOI 10.1080/08916930701464764; Hughes GC, 2012, AUTOIMMUN REV, V11, pA502, DOI 10.1016/j.autrev.2011.12.003; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; KATZENELLENBOGEN BS, 1984, J STEROID BIOCHEM, V20, P1033, DOI 10.1016/0022-4731(84)90015-3; KAUSHIC C, 1995, ENDOCRINOLOGY, V136, P2836, DOI 10.1210/en.136.7.2836; Kaushic C, 2011, J REPROD IMMUNOL; Keenihan SNH, 2004, BIOL REPROD, V70, P1562, DOI 10.1095/biolreprod.103.024794; Kovats S, 2012, HORM BEHAV, V62, P254, DOI 10.1016/j.yhbeh.2012.04.011; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Liang J, 2006, INT IMMUNOPHARMACOL, V6, P830, DOI 10.1016/j.intimp.2005.12.002; LORIAUX DL, 1972, J CLIN ENDOCR METAB, V35, P887, DOI 10.1210/jcem-35-6-887; Lutz MB, 1996, EUR J IMMUNOL, V26, P586, DOI 10.1002/eji.1830260313; Masiano S, 2001, ENDOCRINOLOGY PARTUR, P86; MAUVAISJARVIS P, 1986, ANN NY ACAD SCI, V464, P152, DOI 10.1111/j.1749-6632.1986.tb16002.x; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Miner JN, 2003, MOL ENDOCRINOL, V17, P117, DOI 10.1210/me.2002-0010; Nguyen P, 2014, CELLULAR MO IN PRESS; Paharkova-Vatchkova V, 2004, J IMMUNOL, V172, P1426, DOI 10.4049/jimmunol.172.3.1426; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Segerer SE, 2009, AM J REPROD IMMUNOL, V62, P165, DOI 10.1111/j.1600-0897.2009.00726.x; TULCHINSKY D, 1972, AM J OBSTET GYNECOL, V112, P1095, DOI 10.1016/0002-9378(72)90185-8; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; VIRGO BB, 1974, ENDOCRINOLOGY, V95, P1486, DOI 10.1210/endo-95-5-1486; WEISS G, 1975, OBSTET GYNECOL, V46, P557; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; WIRA CR, 1977, NATURE, V268, P534, DOI 10.1038/268534a0; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Xu YP, 2011, J REPROD IMMUNOL, V91, P17, DOI 10.1016/j.jri.2011.06.101	39	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153304	10.1371/journal.pone.0153304	http://dx.doi.org/10.1371/journal.pone.0153304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064901	Green Submitted, Green Published, gold			2022-12-26	WOS:000373891000043
J	Ishizuka, K; Kimura, H; Wang, CY; Xing, JR; Kushima, I; Arioka, Y; Oya-Ito, T; Uno, Y; Okada, T; Mori, D; Aleksic, B; Ozaki, N				Ishizuka, Kanako; Kimura, Hiroki; Wang, Chenyao; Xing, Jingrui; Kushima, Itaru; Arioka, Yuko; Oya-Ito, Tomoko; Uno, Yota; Okada, Takashi; Mori, Daisuke; Aleksic, Branko; Ozaki, Norio			Investigation of Rare Single-Nucleotide PCDH15 Variants in Schizophrenia and Autism Spectrum Disorders	PLOS ONE			English	Article							BIPOLAR DISORDER; INNER-EAR; MUTATIONS; DISEASE; GENES; IDENTIFICATION; CHILDREN; RISK	Both schizophrenia (SCZ) and autism spectrum disorders (ASD) are neuropsychiatric disorders with overlapping genetic etiology. Protocadherin 15 (PCDH15), which encodes a member of the cadherin super family that contributes to neural development and function, has been cited as a risk gene for neuropsychiatric disorders. Recently, rare variants of large effect have been paid attention to understand the etiopathology of these complex disorders. Thus, we evaluated the impacts of rare, single-nucleotide variants (SNVs) in PCDH15 on SCZ or ASD. First, we conducted coding exon-targeted resequencing of PCDH15 with next-generation sequencing technology in 562 Japanese patients (370 SCZ and 192 ASD) and detected 16 heterozygous SNVs. We then performed association analyses on 2,096 cases (1,714 SCZ and 382 ASD) and 1,917 controls with six novel variants of these 16 SNVs. Of these six variants, four (p. R219K, p. T281A, p. D642N, c. 3010-1G> C) were ultra-rare variants (minor allele frequency < 0.0005) that may increase disease susceptibility. Finally, no statistically significant association between any of these rare, heterozygous PCDH15 point variants and SCZ or ASD was found. Our results suggest that a larger sample size of resequencing subjects is necessary to detect associations between rare PCDH15 variants and neuropsychiatric disorders.	[Ishizuka, Kanako; Kimura, Hiroki; Wang, Chenyao; Xing, Jingrui; Kushima, Itaru; Arioka, Yuko; Oya-Ito, Tomoko; Uno, Yota; Okada, Takashi; Mori, Daisuke; Aleksic, Branko; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan	Nagoya University	Aleksic, B (corresponding author), Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan.	branko@med.nagoya-u.ac.jp	Mori, Daisuke/M-4952-2014; Aleksic, Branko/L-7851-2019; Aleksic, Branko/G-1540-2011; Ozaki, Norio/M-8908-2014; OKADA, Takashi/M-8902-2014	Mori, Daisuke/0000-0002-9072-2546; Aleksic, Branko/0000-0001-8982-4580; Aleksic, Branko/0000-0001-8982-4580; Ozaki, Norio/0000-0002-7360-4898; OKADA, Takashi/0000-0001-5580-9913; Kushima, Itaru/0000-0002-0018-5178; Arioka, Yuko/0000-0002-1792-8812	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan; Japan Agency for Medical Research and Development (AMED); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) project of AMED; Innovative Areas "Comprehensive Brain Science Network"	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) project of AMED; Innovative Areas "Comprehensive Brain Science Network"	The current research was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Ministry of Health, Labour, and Welfare of Japan; "Integrated research on neuropsychiatric disorders" carried out under the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and Development (AMED); the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) project of AMED; Grant-in-Aid for Scientific Research on Innovative Areas "Glial assembly: a new regulatory machinery of brain function and disorders"; and Innovative Areas "Comprehensive Brain Science Network."	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Brandwein AB, 2015, J AUTISM DEV DISORD, V45, P230, DOI 10.1007/s10803-014-2212-9; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; Dammeyer J, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-16; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Girard M, 2011, CLIN J PAIN, V27, P790, DOI 10.1097/AJP.0b013e31821d904c; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Hoischen A, 2014, NAT NEUROSCI, V17, P764, DOI 10.1038/nn.3703; Hommer RE, 2015, SCHIZOPHRENIA BULL, V41, P313, DOI 10.1093/schbul/sbu188; Hu X, 2014, MOL PSYCHIATR, V19, P857, DOI 10.1038/mp.2013.131; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Kenny EM, 2014, MOL PSYCHIATR, V19, P872, DOI 10.1038/mp.2013.127; Kimura H, 2015, SCHIZOPHRENIA BULL, V41, P744, DOI 10.1093/schbul/sbu147; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kushima I, 2012, SCHIZOPHRENIA BULL, V38, P552, DOI 10.1093/schbul/sbq118; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Matsuya A, 2008, NUCLEIC ACIDS RES, V36, pD787, DOI 10.1093/nar/gkm878; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Moens LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023450; Mowry BJ, 2013, MOL PSYCHIATR, V18, P38, DOI 10.1038/mp.2012.34; Murcia CL, 2001, MECH DEVELOP, V105, P163, DOI 10.1016/S0925-4773(01)00388-4; Nakashima M, 2014, J HUM GENET, V59, P471, DOI 10.1038/jhg.2014.51; Noor A, 2014, AM J MED GENET B, V165, P303, DOI 10.1002/ajmg.b.32232; Oikkonen J, 2015, MOL PSYCHIATR, V20, P275, DOI 10.1038/mp.2014.8; Pettersson E, 2016, MOL PSYCHIATR, V21, P717, DOI 10.1038/mp.2015.116; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Selten JP, 2015, JAMA PSYCHIAT, V72, P483, DOI 10.1001/jamapsychiatry.2014.3059; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Song WJ, 2008, BIOCHEM BIOPH RES CO, V367, P700, DOI 10.1016/j.bbrc.2007.12.117; Sorte HS, 2013, PSYCHIAT GENET, V23, P61, DOI 10.1097/YPG.0b013e32835d718b; Sotomayor M, 2012, NATURE, V492, P128, DOI 10.1038/nature11590; Stein JL, 2013, NEURON, V77, P209, DOI 10.1016/j.neuron.2013.01.010; Sullivan PF, 2012, ARCH GEN PSYCHIAT, V69, P1099, DOI 10.1001/archgenpsychiatry.2012.730; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Ye R, 2014, GENES BRAIN BEHAV, V13, P261, DOI 10.1111/gbb.12119; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	53	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153224	10.1371/journal.pone.0153224	http://dx.doi.org/10.1371/journal.pone.0153224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6JK	27058588	Green Submitted, Green Published, gold			2022-12-26	WOS:000373604800023
J	Iimura, Y; Sugano, H; Nakajima, M; Higo, T; Suzuki, H; Nakanishi, H; Arai, H				Iimura, Yasushi; Sugano, Hidenori; Nakajima, Madoka; Higo, Takuma; Suzuki, Hiroharu; Nakanishi, Hajime; Arai, Hajime			Analysis of Epileptic Discharges from Implanted Subdural Electrodes in Patients with Sturge-Weber Syndrome	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; REFRACTORY EPILEPSY; STROKE; CHILDREN; SEIZURES; MRI; ONSET; ELECTROENCEPHALOGRAPHY; DIAGNOSIS; PATTERNS	Objective Almost two-thirds of patients with Sturge-Weber syndrome (SWS) have epilepsy, and half of them require surgery for it. However, it is well known that scalp electroencephalography (EEG) does not demonstrate unequivocal epileptic discharges in patients with SWS. Therefore, we analyzed interictal and ictal discharges from intracranial subdural EEG recordings in patients treated surgically for SWS to elucidate epileptogenicity in this disorder. Methods Five intractable epileptic patients with SWS who were implanted with subdural electrodes for presurgical evaluation were enrolled in this study. We examined the following seizure parameters: seizure onset zone (SOZ), propagation speed of seizure discharges, and seizure duration by visual inspection. Additionally, power spectrogram analysis on some frequency bands at SOZ was performed from 60 s before the visually detected seizure onset using the EEG Complex Demodulation Method (CDM). Results We obtained 21 seizures from five patients for evaluation, and all seizures initiated from the cortex under the leptomeningeal angioma. Most of the patients presented with motionless staring and respiratory distress as seizure symptoms. The average seizure propagation speed and duration were 3.1 +/- 3.6 cm/min and 19.4 +/- 33.6 min, respectively. Significant power spectrogram changes at the SOZ were detected at 10-30 Hz from 15 s before seizure onset, and at 30-80 Hz from 5 s before seizure onset. Significance In patients with SWS, seizures initiate from the cortex under the leptomeningeal angioma, and seizure propagation is slow and persists for a longer period. CDM indicated beta to low gamma-ranged seizure discharges starting from shortly before the visually detected seizure onset. Our ECoG findings indicate that ischemia is a principal mechanism underlying ictogenesis and epileptogenesis in SWS.	[Iimura, Yasushi; Sugano, Hidenori; Nakajima, Madoka; Higo, Takuma; Suzuki, Hiroharu; Nakanishi, Hajime; Arai, Hajime] Juntendo Univ, Epilepsy Ctr, Dept Neurosurg, Tokyo, Japan	Juntendo University	Iimura, Y (corresponding author), Juntendo Univ, Epilepsy Ctr, Dept Neurosurg, Tokyo, Japan.	yiimura@juntendo.ac.jp	Nakajima, Madoka/AAU-6505-2021	Iimura, Yasushi/0000-0003-4263-5920				ARZIMANOGLOU A, 1992, ACTA NEUROL SCAND, V86, P18, DOI 10.1111/j.1600-0404.1992.tb04465.x; Aye SMM, 2013, LUPUS, V22, P510, DOI 10.1177/0961203312474705; Bauman JA, 2008, NEUROSURGERY, V62, P489, DOI [10.1227/01.neu.0000316252.47028.2d, 10.1227/01.NEU.0000148908.71296.FA]; BERK RA, 1979, J ABNORM CHILD PSYCH, V7, P113, DOI 10.1007/BF00924515; BODE H, 1992, EUR J PEDIATR, V151, P706, DOI 10.1007/BF01957579; BRENNER RP, 1976, NEUROLOGY, V26, P629, DOI 10.1212/WNL.26.7.629; CHIRON C, 1989, J NEUROL NEUROSUR PS, V52, P1402, DOI 10.1136/jnnp.52.12.1402; Coley SC, 1998, CHILD NERV SYST, V14, P693, DOI 10.1007/s003810050299; Comi AM, 2003, J CHILD NEUROL, V18, P509, DOI 10.1177/08830738030180080701; CURE JK, 1995, AM J NEURORADIOL, V16, P1539; Delalande O, 2007, NEUROSURGERY, V60, P19, DOI 10.1227/01.NEU.0000249246.48299.12; Di Rocco C, 2006, CHILD NERV SYST, V22, P909, DOI 10.1007/s00381-006-0143-2; Garcia-Morales I, 2002, J CLIN NEUROPHYSIOL, V19, P172, DOI 10.1097/00004691-200203000-00009; Ghatan S, 2014, J NEUROSURG-PEDIATR, V14, P58, DOI 10.3171/2014.3.PEDS13440; Griffiths PD, 1997, NEURORADIOLOGY, V39, P219, DOI 10.1007/s002340050398; Hata D, 1998, SEIZURE-EUR J EPILEP, V7, P505, DOI 10.1016/S1059-1311(98)80011-3; Hidenori S, 2009, CHILD NERV SYST, V25, P143, DOI [10.1007/s00381-008-0696-3, DOI 10.1007/S00381-008-0696-3]; Jansen FE, 2002, CLIN NEUROPHYSIOL, V113, P1025, DOI 10.1016/S1388-2457(02)00105-0; Maton B, 2010, EPILEPSIA, V51, P257, DOI 10.1111/j.1528-1167.2009.02304.x; Ohno K, 2014, BRAIN DEV, V26, P288; Okudaira Y, 1997, CHILD NERV SYST, V13, P214, DOI 10.1007/s003810050070; PASCUALCASTROVIEJO I, 1993, PEDIATR NEUROL, V9, P283, DOI 10.1016/0887-8994(93)90064-J; Perucca P, 2014, BRAIN, V137, P183, DOI 10.1093/brain/awt299; Pinton F, 1997, J NEUROL NEUROSUR PS, V63, P616, DOI 10.1136/jnnp.63.5.616; PROBST FP, 1980, NEURORADIOLOGY, V20, P73, DOI 10.1007/BF00339549; Rafay MF, 2009, STROKE, V40, P2402, DOI 10.1161/STROKEAHA.109.547281; Rando T, 2000, NEUROPEDIATRICS, V31, P202, DOI 10.1055/s-2000-7454; Srejic LR, 2013, J NEUROSURG, V118, P1098, DOI 10.3171/2013.1.JNS121059; Sugano H, 2014, EPILEPSIA, V55, P683, DOI 10.1111/epi.12547; SUJANSKY E, 1995, J CHILD NEUROL, V10, P49, DOI 10.1177/088307389501000113; Tay SKH, 2006, EPILEPSIA, V47, P1504, DOI 10.1111/j.1528-1167.2006.00623.x; Van Gompel JJ, 2008, NEUROSURGERY, V63, P498, DOI 10.1227/01.NEU.0000324996.37228.F8; van Mierlo P, 2013, EPILEPSIA, V54, P1409, DOI 10.1111/epi.12206; Walsh BH, 2011, DEV MED CHILD NEUROL, V53, P89, DOI 10.1111/j.1469-8749.2010.03837.x; Wu JL, 2011, J MAGN RESON IMAGING, V34, P791, DOI 10.1002/jmri.22687; Yu TW, 2007, EUR J PAEDIATR NEURO, V11, P96, DOI 10.1016/j.ejpn.2006.11.008	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152992	10.1371/journal.pone.0152992	http://dx.doi.org/10.1371/journal.pone.0152992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054715	Green Submitted, Green Published, gold			2022-12-26	WOS:000373608000061
J	Tagge, I; O'Connor, A; Chaudhary, P; Pollaro, J; Berlow, Y; Chalupsky, M; Bourdette, D; Woltjer, R; Johnson, M; Rooney, W				Tagge, Ian; O'Connor, Audrey; Chaudhary, Priya; Pollaro, Jim; Berlow, Yosef; Chalupsky, Megan; Bourdette, Dennis; Woltjer, Randy; Johnson, Mac; Rooney, William			Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CORPUS-CALLOSUM; MAGNETIZATION-TRANSFER; SUBVENTRICULAR ZONE; MULTIPLE-SCLEROSIS; WHITE-MATTER; IN-VIVO; REGIONAL HETEROGENEITY; BRAIN; MRI	Cuprizone administration in mice provides a reproducible model of demyelination and spontaneous remyelination, and has been useful in understanding important aspects of human disease, including multiple sclerosis. In this study, we apply high spatial resolution quantitative MRI techniques to establish the spatio-temporal patterns of acute demyelination in C57BL/6 mice after 6 weeks of cuprizone administration, and subsequent remyelination after 6 weeks of post-cuprizone recovery. MRI measurements were complemented with Black Gold II stain for myelin and immunohistochemical stains for associated tissue changes. Gene expression was evaluated using the Allen Gene Expression Atlas. Twenty-five C57BL/6 male mice were split into control and cuprizone groups; MRI data were obtained at baseline, after 6 weeks of cuprizone, and 6 weeks post-cuprizone. High-resolution (100 mu m isotropic) whole-brain coverage magnetization transfer ratio (MTR) parametric maps demonstrated concurrent caudal-to-rostral and medial-to-lateral gradients of MTR decrease within corpus callosum (CC) that correlated well with demyelination assessed histologically. Our results show that demyelination was not limited to the midsagittal line of the corpus callosum, and also that opposing gradients of demyelination occur in the lateral and medial CC. T-2-weighted MRI gray/white matter contrast was strong at baseline, weak after 6 weeks of cuprizone treatment, and returned to a limited extent after recovery. MTR decreases during demyelination were observed throughout the brain, most clearly in callosal white matter. Myelin damage and repair appear to be influenced by proximity to oligodendrocyte progenitor cell populations and exhibit an inverse correlation with myelin basic protein gene expression. These findings suggest that susceptibility to injury and ability to repair vary across the brain, and whole-brain analysis is necessary to accurately characterize this model. Whole-brain parametric mapping across time is essential for gaining a real understanding of disease processes in-vivo. MTR increases in healthy mice throughout adolescence and adulthood were observed, illustrating the need for appropriate age-matched controls. Elucidating the unique and site-specific demyelination in the cuprizone model may offer new insights into in mechanisms of both damage and repair in human demyelinating diseases.	[Tagge, Ian; O'Connor, Audrey; Pollaro, Jim; Berlow, Yosef; Rooney, William] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Tagge, Ian; Rooney, William] Oregon Hlth & Sci Univ, Biomed Engn, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Chaudhary, Priya; Bourdette, Dennis; Rooney, William] Oregon Hlth & Sci Univ, Neurol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Chalupsky, Megan; Woltjer, Randy] Oregon Hlth & Sci Univ, Pathol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Bourdette, Dennis] Portland VA Med Ctr, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Johnson, Mac] Vertex Pharmaceut Inc, 50 Northern Ave, Boston, MA 02210 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Vertex Pharmaceuticals	Tagge, I; Rooney, W (corresponding author), Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	taggei@ohsu.edu; rooneyw@ohsu.edu		Tagge, Ian/0000-0002-5260-7117; Chaudhary, Priya/0000-0001-6404-6049	Vertex Pharmaceuticals, Inc.; NIA [P30 AG008017]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008017] Funding Source: NIH RePORTER	Vertex Pharmaceuticals, Inc.(Vertex Pharmaceuticals); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The primary funder, Vertex Pharmaceuticals, Inc., provided a grant to investigate MRI biomarkers of myelination which supported experimental costs and partial salary support for authors AO'C, JP, IT, and WR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. MJ, on behalf of Vertex Pharmaceuticals, Inc., contributed to study design insofar as suggesting the use of cuprizone in mice to validate MRI biomarkers of myelin content in-vivo. The funders had no role in data acquisition, processing, or analysis. MJ reviewed the paper prior to submission and offered comments on presentation, but otherwise did not have a role in the decision to publish.; Evan Calkins, Danielle Galipeau, and David Clark provided excellent technical support in histological processing. We would like to express our thanks to the Advanced Light Microscopy Core (P30 NS061800) Facility at the Oregon Health & Science University. Immunohistochemical studies were performed in the laboratory of the Oregon Brain Bank and the Oregon Alzheimer's Disease Center (supported by NIA P30 AG008017).	Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Acs Peter, 2012, Methods Mol Biol, V900, P403, DOI 10.1007/978-1-60761-720-4_20; Allen Institute for Brain Science, 2015, ALL MOUS BRAIN ATL; Back S. A, 2014, PATHOPHYSIOLOGY GLIA; Baloch S, 2009, CEREB CORTEX, V19, P675, DOI 10.1093/cercor/bhn112; Beatrice B, 2015, BIOL OPEN, P1; Benetti F, 2010, NEUROTOXICOLOGY, V31, P509, DOI 10.1016/j.neuro.2010.05.008; Boretius S, 2012, NEUROIMAGE, V59, P2678, DOI 10.1016/j.neuroimage.2011.08.051; CARLTON WILLIAM W., 1967, LIFE SCI, V6, P11, DOI 10.1016/0024-3205(67)90356-6; CARLTON WW, 1966, TOXICOL APPL PHARM, V8, P512, DOI 10.1016/0041-008X(66)90062-7; Cate HS, 2010, J NEUROCHEM, V115, P11, DOI 10.1111/j.1471-4159.2010.06660.x; Donega M, 2013, NEURAL STEM CELLS NE, DOI 10.5772/55426; Falangola MF, 2014, NMR BIOMED, V27, P948, DOI 10.1002/nbm.3140; Fjaer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084162; Goldberg J, 2015, J MOL NEUROSCI; Goldberg J, 2013, CELL MOL NEUROBIOL, V33, P1087, DOI 10.1007/s10571-013-9975-y; Gudi V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00073; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Guglielmetti C, 2014, NEUROIMAGE, V86, P99, DOI 10.1016/j.neuroimage.2013.07.080; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Jarjour AA, 2004, NEUROSCIENTIST, V10, P99, DOI 10.1177/1073858403260751; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kaneko N, 2011, GENES-BASEL, V2, P107, DOI 10.3390/genes2010107; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Larvaron P, 2007, NMR BIOMED, V20, P413, DOI 10.1002/nbm.1082; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mason JL, 2000, J NEUROSCI RES, V61, P251, DOI 10.1002/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W; Mason JL, 2001, NEUROPATH APPL NEURO, V27, P50, DOI 10.1046/j.0305-1846.2001.00301.x; Merkler D, 2005, NMR BIOMED, V18, P395, DOI 10.1002/nbm.972; Mottershead JP, 2003, J NEUROL, V250, P1293, DOI 10.1007/s00415-003-0192-3; Pasquini LA, 2007, NEUROCHEM RES, V32, P279, DOI 10.1007/s11064-006-9165-0; Petratos S, 2004, GLIA, V48, P64, DOI 10.1002/glia.20056; Portnoy S, 2007, MAGN RESON MED, V58, P144, DOI 10.1002/mrm.21244; Prineas JW, 2012, ANN NEUROL, V72, P18, DOI 10.1002/ana.23634; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schmidt T, 2013, J MOL NEUROSCI, V49, P80, DOI 10.1007/s12031-012-9896-0; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Silvestroff L, 2010, J COMP NEUROL, V518, P2261, DOI 10.1002/cne.22330; Skripuletz T, 2010, BRAIN PATHOL, V20, P301, DOI 10.1111/j.1750-3639.2009.00271.x; Sled JG, 2001, MAGNET RESON MED, V46, P923, DOI 10.1002/mrm.1278; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Steelman AJ, 2012, NEUROSCI RES, V72, P32, DOI 10.1016/j.neures.2011.10.002; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Tardif CL, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/742018; Thiessen JD, 2013, NMR BIOMED, V26, P1562, DOI 10.1002/nbm.2992; Tobin JE, 2011, J NEUROPATH EXP NEUR, V70, P157, DOI 10.1097/NEN.0b013e31820937e4; Van Rossum G., 2007, USENIX ANN TECHN C; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Wergeland S, 2012, APMIS, V120, P648, DOI 10.1111/j.1600-0463.2012.02882.x; Wu QZ, 2008, J MAGN RESON IMAGING, V27, P446, DOI 10.1002/jmri.21111; Xie M, 2010, J NEUROPATHOL EXP NE, V69, P704; Yang HJ, 2009, BRAIN RES, V1270, P121, DOI 10.1016/j.brainres.2009.03.011; Yarnykh VL, 2012, MAGN RESON MED, V68, P166, DOI 10.1002/mrm.23224; Zaaraoui W, 2008, MAGN RESON MATER PHY, V21, P357, DOI 10.1007/s10334-008-0141-3; Zatta P, 2005, CELL MOL LIFE SCI, V62, P1502, DOI 10.1007/s00018-005-5073-8	60	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152480	10.1371/journal.pone.0152480	http://dx.doi.org/10.1371/journal.pone.0152480			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054832	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000021
J	Land, WM; Liu, BY; Cordova, A; Fang, M; Huang, YF; Yao, WX				Land, William M.; Liu, Binya; Cordova, Alberto; Fang, Ming; Huang, Yufei; Yao, Wan X.			Effects of Physical Practice and Imagery Practice on Bilateral Transfer in Learning a Sequential Tapping Task	PLOS ONE			English	Article							MENTAL PRACTICE; INTERMANUAL TRANSFER; MUSCLE-CONTRACTIONS; INTERLIMB TRANSFER; PERFORMANCE; INCREASES; STRENGTH; FORCE	Recent research on bilateral transfer suggests that imagery training can facilitate the transfer of motor skill from a trained limb to that of an untrained limb above and beyond that of physical practice. To further explore this effect, the present study examined the influence of practice duration and task difficulty on the extent to which imagery training and physical training influences bilateral transfer of a sequential key pressing task. In experiment 1, participants trained on the key pressing task using their non-dominant arm under one of three conditions (physical practice, imagery practice, and no practice). In a subsequent bilateral transfer test, participants performed the sequential task using their untrained dominant arm in either an original order or mirror-ordered sequence. In experiment 2, the same procedures were followed as in experiment 1 except that participants trained with their dominant arm and performed the bilateral transfer task with their non-dominant arm. Results indicated that with extended practice beyond what has been employed in previous studies, physical practice is more effective at facilitating bilateral transfer compared to training with imagery. Interestingly, significant bilateral transfer was only observed for transfer from the non-dominant to the dominant arm with no differences observed between performing the task in an original or mirror ordered sequence. Overall, these findings suggest that imagery training may benefit bilateral transfer primarily at the initial stages of learning, but with extended training, physical practice leads to larger influences on transfer.	[Land, William M.; Liu, Binya; Cordova, Alberto; Yao, Wan X.] Univ Texas San Antonio, Dept Kinesiol Hlth & Nutr, San Antonio, TX USA; [Huang, Yufei] Univ Texas San Antonio, Dept Elect & Comp Engn, San Antonio, TX USA; [Fang, Ming] Yangzhou Univ, Coll Phys Educ, Yangzhou 225009, Jiangsu, Peoples R China	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Yangzhou University	Yao, WX (corresponding author), Univ Texas San Antonio, Dept Kinesiol Hlth & Nutr, San Antonio, TX USA.	wanxiang.yao@utsa.edu	Huang, Yufei/AAU-2891-2021	Land, William/0000-0003-3244-1348				Amemiya K, 2010, BRAIN RES, V1343, P93, DOI 10.1016/j.brainres.2010.04.048; Arora S, 2011, ANN SURG, V253, P265, DOI 10.1097/SLA.0b013e318207a789; Ausenda CD, 2011, EUR J PHYS REHAB MED, V47, P417; Davis WW, 1898, STUD YALE PSYCHOL LA, V6, P18; Davis WW, 1900, STUDIES YALE PSYCHOL, V8, P64; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Fitts PM., 1967, HUM PERFORM; Frank C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095175; Gentile AM., 1972, QUEST, V17, P3, DOI [10.1080/00336297.1972.10519717, DOI 10.1080/00336297.1972.10519717]; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; HICKS RE, 1974, AM J PSYCHOL, V87, P667, DOI 10.2307/1421973; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; HIRD JS, 1991, J SPORT EXERCISE PSY, V13, P281, DOI 10.1123/jsep.13.3.281; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Lange K, 2006, EXP BRAIN RES, V168, P547, DOI 10.1007/s00221-005-0117-8; Lange RK, 2004, EXP BRAIN RES, V159, P161, DOI 10.1007/s00221-004-1942-x; LOGAN GD, 1988, HUM FACTORS, V30, P583, DOI 10.1177/001872088803000504; Lohse KR, 2010, J IMAGERY RES SPORT, V5, P1; PARLOW SE, 1990, BRAIN LANG, V39, P319, DOI 10.1016/0093-934X(90)90017-B; Sainburg RL, 2002, EXP BRAIN RES, V145, P437, DOI 10.1007/s00221-002-1140-7; SALTZMAN E, 1979, J MATH PSYCHOL, V20, P91, DOI 10.1016/0022-2496(79)90020-8; Teixeira LA, 2000, BRAIN COGNITION, V44, P455, DOI 10.1006/brcg.1999.1205; van Mier HI, 2006, NEUROPSYCHOLOGIA, V44, P939, DOI 10.1016/j.neuropsychologia.2005.08.010; Wang JS, 2004, J NEUROPHYSIOL, V92, P349, DOI 10.1152/jn.00960.2003; Wohldmann EL, 2008, J EXP PSYCHOL LEARN, V34, P823, DOI 10.1037/0278-7393.34.4.823; Yao WX, 2014, PERCEPT MOTOR SKILL, V118, P400, DOI 10.2466/23.25.PMS.118k19w1; Yao WX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00561; YUE G, 1992, J NEUROPHYSIOL, V67, P1114, DOI 10.1152/jn.1992.67.5.1114	29	13	13	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152228	10.1371/journal.pone.0152228	http://dx.doi.org/10.1371/journal.pone.0152228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27050168	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500031
J	Morden, E; Technau, KG; Giddy, J; Maxwell, N; Keiser, O; Davies, MA				Morden, Erna; Technau, Karl-Guenter; Giddy, Janet; Maxwell, Nicola; Keiser, Olivia; Davies, Mary-Ann			Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TO-CHILD TRANSMISSION; INFECTED MOTHERS; MORTALITY; BORN; WOMEN; MORBIDITY; CESSATION; SEVERITY; OUTCOMES	Background HIV-exposed uninfected (HEU) infants are a growing population in sub-Saharan Africa especially with the increasing coverage of more effective prevention of mother-to-child transmission (PMTCT) antiretroviral therapy regimens. This study describes the characteristics of South African HEU infants, investigates factors impacting birth weight and assesses their growth within the first 28 weeks of life. Methods This is a retrospective cohort based on routine clinical data from two South African PMTCT programmes. Data were collected between 2007 and 2013. Linear regression assessed factors affecting birth weight-for-age z-scores (WAZ) while growth (longitudinal WAZ) was assessed using mixed effects models. Results We assessed the growth of 2621 HEU infants (median birth WAZ was -0.65 (IQR -1.46; 0.0) and 51% were male). The feeding modalities practised were as follows: 0.5% exclusive breastfeeding, 7.9% breastfeeding with unknown exclusivity, 0.08% mixed breastfeeding and 89.2% formula feeding. Mothers with CD4 <200 cells/mu l delivered infants with a lower birth WAZ (adjusted beta-0.253 [95% CI -0.043; -0.072], p = 0.006) compared to mothers with aCD4 >= 500 cells/mu l. Similarly, mothers who did not receive antiretroviral drugs delivered infants with a lower birth WAZ (adjusted beta-0.39 [95% CI -0.67; -0.11], p = 0.007) compared to mothers who received antenatal antiretrovirals. Infants with a birth weight <2 500g (beta 0.070 [95% CI 0.061; 0.078], p < 0.0001) experienced faster growth within the first 28 weeks of life compared to infants with a birth weight >= 2 500g. Infants with any breastfeeding exposure experienced slower longitudinal growth compared to formula fed infants (adjusted beta -0.012 [95% CI 0.021; -0.003], p = 0.011). Conclusion Less severe maternal disease and the use of antiretrovirals positively impacts birth weight in this cohort of South African HEU infants. Formula feeding was common with breastfed infants experiencing marginally slower longitudinal growth.	[Morden, Erna; Maxwell, Nicola; Davies, Mary-Ann] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Technau, Karl-Guenter] Rahima Moosa Mother & Child Hosp, Johannesburg, South Africa; [Technau, Karl-Guenter] Univ Witwatersrand, Johannesburg, South Africa; [Giddy, Janet] McCord Hosp, Durban, South Africa; [Keiser, Olivia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Cape Town; University of Witwatersrand; University of Bern	Morden, E (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa.	erna.morden@alumni.uct.ac.za		Technau, Karl-Gunter/0000-0001-7367-7512	NIH (National Institute of Health) NIAID (National Institute of Allergy and Infectious Diseases) Eunice Kennedy Shriver NICHD (National Institute of Child Health and Human Development) [5U01AI069924]; National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	NIH (National Institute of Health) NIAID (National Institute of Allergy and Infectious Diseases) Eunice Kennedy Shriver NICHD (National Institute of Child Health and Human Development); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH (National Institute of Health) NIAID (National Institute of Allergy and Infectious Diseases) Eunice Kennedy Shriver NICHD (National Institute of Child Health and Human Development) Grant number 5U01AI069924 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. All children and their caregivers at participating sites. Staff at participating sites. Staff at the Universities of Cape Town and Bern.	Ahmed S, 2013, CURR OPIN HIV AIDS, V8, P474, DOI 10.1097/COH.0b013e328363a8f2; [Anonymous], 2013, 2012 NAT ANT SENT HI; Arpadi S, 2009, AM J CLIN NUTR, V90, P344, DOI 10.3945/ajcn.2009.27745; Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Fowler MG, 2015, C RETR OPP INF FEBR, P93; Goga A, 2012, EVALUATION EFFECTIVE; Goga AE, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-4; Heidari S, 2011, JAIDS-J ACQ IMM DEF, V57, P290, DOI 10.1097/QAI.0b013e318221c56a; Homsy J, 2010, JAIDS-J ACQ IMM DEF, V53, P28, DOI 10.1097/QAI.0b013e3181bdf65a; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kuhn L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001363; Kuhn L, 2010, CLIN INFECT DIS, V50, P437, DOI 10.1086/649886; Kuhn L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006059; Landes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047337; Mbori-Ngacha D, 2001, JAMA-J AM MED ASSOC, V286, P2413, DOI 10.1001/jama.286.19.2413; McGrath CJ, 2012, J NUTR, V142, P757, DOI 10.3945/jn.111.148874; Muhangi L, 2013, PUBLIC HEALTH NUTR, V16, P1548, DOI 10.1017/S1368980013000499; Natchu UCM, 2012, AM J CLIN NUTR, V96, P1071, DOI 10.3945/ajcn.111.024356; National Department of Health, 2011, S AFR J CLIN NUTR, V24, P214; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Patel D, 2010, AIDS, V24, P437, DOI 10.1097/QAD.0b013e3283345f91; Ramokolo V, 2014, J NUTR, V144, P42, DOI 10.3945/jn.113.178616; South Africa National Department of Health, 2008, POL GUID IMPL PMTCT; South Africa National Department of Health, 2010, CLIN GUID PMTCT PREV; South African National Department of Health, 2008, INF YOUNG CHILD FEED; Taha T, 2010, PEDIATR INFECT DIS J, V29, P514, DOI 10.1097/INF.0b013e3181cda531; Taha TE, 2011, CLIN INFECT DIS, V53, P388, DOI 10.1093/cid/cir413; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5	33	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151762	10.1371/journal.pone.0151762	http://dx.doi.org/10.1371/journal.pone.0151762			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049853	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500011
J	Chiu, HW; Hua, KF				Chiu, Huan-Wen; Hua, Kuo-Feng			Hepatoprotective Effect of Wheat-Based Solid-State Fermented Antrodia cinnamomea in Carbon Tetrachloride-Induced Liver Injury in Rat	PLOS ONE			English	Article							INFLAMMATORY MEDIATOR EXPRESSION; DEPRIVATION-INDUCED APOPTOSIS; NF-KAPPA-B; DEHYDROEBURICOIC ACID; SUBMERGED CULTURE; CAMPHORATA PROTECTS; LIPID-PEROXIDATION; HEPATIC-FIBROSIS; OXIDATIVE STRESS; FRUITING BODIES	Antrodia cinnamomea (A. cinnamomea) is an indigenous medical fungus in Taiwan and has multiple biological functions, including hepatoprotective and immune-modulatory effects. Currently, the commercially available A. cinnamomea are mainly liquid- and solid-state fermented A. cinnamomea. However, the hepatoprotective effect of solid-state fermented A. cinnamomea has never been reported. Here we evaluate the ability of air-dried, ground and non-extracted wheat-based solid-state fermented A. cinnamomea (WFAC) to protect against carbon tetrachloride (CCl4)-induced hepatic injury in vivo. The results showed that oral administration of WFAC dose dependently (180, 540 and 1080 mg/kg) ameliorated the increase in plasma aspartate aminotransferase and alanine aminotransferase levels caused by chronic repeated CCl4 intoxication in rats. WFAC significantly reduced the CCl4-induced increase in hepatic lipid peroxidation levels and hydroxyproline contents, as well as reducing the spleen weight and water content of the liver. WFAC also restored the hepatic soluble protein synthesis and plasma albumin concentration in CCl4-intoxicated rats, but it did not affect the activities of superoxide dismutase, catalase, or glutathione peroxidase. In addition, a hepatic morphological analysis showed that the hepatic fibrosis and necrosis induced by CCl4 were significantly ameliorated by WFAC. Furthermore, the body weights of control rats and WFAC-administered rats were not significantly different, and no adverse effects were observed in WFAC-administered rats. These results indicate that WFAC is a nontoxic hepatoprotective agent against chronic CCl4-induced hepatic injury.	[Chiu, Huan-Wen; Hua, Kuo-Feng] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Hua, Kuo-Feng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan	National Ilan University; National Defense Medical Center; Tri-Service General Hospital	Hua, KF (corresponding author), Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan.; Hua, KF (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan.	kuofenghua@gmail.com			Ministry of Science and Technology, Taiwan [102-2628-B-197-001-MY3, 103-2923-B-197-001-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/). Grant number: 102-2628-B-197-001-MY3 (KFH); 103-2923-B-197-001-MY3 (KFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Ao ZH, 2009, J ETHNOPHARMACOL, V121, P194, DOI 10.1016/j.jep.2008.10.039; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; CAMPS J, 1992, CLIN SCI, V83, P695, DOI 10.1042/cs0830695; Chen CC, 2006, J NAT PROD, V69, P689, DOI 10.1021/np0581263; Chen XW, 2013, INT IMMUNOPHARMACOL, V17, P543, DOI 10.1016/j.intimp.2013.08.006; Chen YC, 2011, ACTA PHARMACOL SIN, V32, P904, DOI 10.1038/aps.2011.36; Deng JS, 2013, J AGR FOOD CHEM, V61, P5064, DOI 10.1021/jf303820k; Dhiman RK, 2005, DIGEST DIS SCI, V50, P1807, DOI 10.1007/s10620-005-2942-9; Du YC, 2012, PHYTOMEDICINE, V19, P788, DOI 10.1016/j.phymed.2012.03.014; Garbuzenko DV, 2015, WORLD J GASTROENTERO, V21, P6117, DOI 10.3748/wjg.v21.i20.6117; Geethangili M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep108; Geng Y, 2016, HEPATOL RES, V46, pE15, DOI 10.1111/hepr.12516; HALL PD, 1994, J GASTROEN HEPATOL, V9, P250, DOI 10.1111/j.1440-1746.1994.tb01719.x; Han HF, 2006, CHEM PHARM BULL, V54, P496, DOI 10.1248/cpb.54.496; Hsiao G, 2003, J AGR FOOD CHEM, V51, P3302, DOI 10.1021/jf021159t; Hsieh YC, 2011, J AGR FOOD CHEM, V59, P10943, DOI 10.1021/jf202771d; Huang CH, 2010, J AGR FOOD CHEM, V58, P3859, DOI 10.1021/jf100530c; Huang GJ, 2014, J AGR FOOD CHEM, V62, P5321, DOI 10.1021/jf405113g; Huang GJ, 2013, FOOD CHEM, V141, P3020, DOI 10.1016/j.foodchem.2013.03.061; Huang YL, 2015, J AGR FOOD CHEM, V63, P4561, DOI 10.1021/jf5059304; Jacobs BP, 2002, AM J MED, V113, P506, DOI 10.1016/S0002-9343(02)01244-5; Kumar KJS, 2011, J ETHNOPHARMACOL, V136, P168, DOI 10.1016/j.jep.2011.04.030; Kuo YH, 2015, J AGR FOOD CHEM, V63, P10140, DOI 10.1021/acs.jafc.5b04400; Kuo YH, 2015, J AGR FOOD CHEM, V63, P2479, DOI 10.1021/acs.jafc.5b00073; Lee IH, 2002, FEMS MICROBIOL LETT, V209, P63, DOI 10.1111/j.1574-6968.2002.tb11110.x; Lee WT, 2015, FOOD CHEM TOXICOL, V78, P33, DOI 10.1016/j.fct.2015.01.012; LETTERON P, 1990, BIOCHEM PHARMACOL, V39, P2027, DOI 10.1016/0006-2952(90)90625-U; Liaw CC, 2013, J NAT PROD, V76, P489, DOI 10.1021/np300443p; LIEN HM, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1093/ECAM/NEP020; Lien HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105286; Liu DZ, 2007, BIOSCI BIOTECH BIOCH, V71, P23, DOI 10.1271/bbb.60268; Liu KJ, 2010, IMMUNOLOGY, V129, P351, DOI 10.1111/j.1365-2567.2009.03175.x; Liu Yen-Wenn, 2012, J Tradit Complement Med, V2, P284; Lu MK, 2008, J AGR FOOD CHEM, V56, P865, DOI 10.1021/jf072828b; Lu MK, 2006, LIFE SCI, V79, P252, DOI 10.1016/j.lfs.2005.12.042; Lu ZM, 2007, J ETHNOPHARMACOL, V110, P160, DOI 10.1016/j.jep.2006.09.029; Lu ZM, 2011, NAT PROD RES, V25, P684, DOI 10.1080/14786410802525487; Luper S, 1998, Altern Med Rev, V3, P410; MCCAY PB, 1984, J BIOL CHEM, V259, P2135; Meng LM, 2012, NUTRITION, V28, P942, DOI 10.1016/j.nut.2012.01.006; Muir AJ, 2015, CLIN THER; Muriel P, 2005, BASIC CLIN PHARMACOL, V96, P375, DOI 10.1111/j.1742-7843.2005.pto_06.x; Palmes D, 2004, BIOMATERIALS, V25, P1601, DOI 10.1016/S0142-9612(03)00508-8; Park DK, 2013, J MED FOOD, V16, P681, DOI 10.1089/jmf.2012.2605; Park DK, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/914524; PAULOVA J, 1990, VET MED-CZECH, V35, P629; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Song TY, 2003, J AGR FOOD CHEM, V51, P1571, DOI 10.1021/jf0209701; Sturgill MG, 1997, CLIN CHEM, V43, P1512; Toyoki Y, 1998, HEPATO-GASTROENTEROL, V45, P2261; Tsai PY, 2012, ARTHRITIS RHEUM-US, V64, P232, DOI 10.1002/art.33328; Tsai PY, 2011, FREE RADICAL BIO MED, V50, P1503, DOI 10.1016/j.freeradbiomed.2011.02.029; Tsai TC, 2015, J ETHNOPHARMACOL, V159, P113, DOI 10.1016/j.jep.2014.11.015; Vani MG, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/296082; Wang LC, 2013, APPL MICROBIOL BIOT, V97, P9955, DOI 10.1007/s00253-013-5214-1; Wang SC, 2014, J AGR FOOD CHEM, V62, P5625, DOI 10.1021/jf4056924; Wu MT, 2011, J AGR FOOD CHEM, V59, P4248, DOI 10.1021/jf104561h; Wu SH, 1997, BOT BULL ACAD SINICA, V38, P273; XIA EN, 1995, J NUTR, V125, P195; Yang PY, 2013, AM J CHINESE MED, V41, P1169, DOI 10.1142/S0192415X13500791; Yang SM, 2013, FREE RADICAL BIO MED, V61, P285, DOI 10.1016/j.freeradbiomed.2013.03.024; Yeh CT, 2013, CARCINOGENESIS, V34, P2918, DOI 10.1093/carcin/bgt255; Yeh CT, 2009, CANCER LETT, V285, P73, DOI 10.1016/j.canlet.2009.05.002; Yue PYK, 2013, CHIN MED-UK, V8, DOI 10.1186/1749-8546-8-21	65	35	35	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153087	10.1371/journal.pone.0153087	http://dx.doi.org/10.1371/journal.pone.0153087			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046059	Green Published, Green Submitted, gold			2022-12-26	WOS:000373599600067
J	Smallwood, J; Karapanagiotidis, T; Ruby, F; Medea, B; de Caso, I; Konishi, M; Wang, HT; Hallam, G; Margulies, DS; Jefferies, E				Smallwood, Jonathan; Karapanagiotidis, Theodoros; Ruby, Florence; Medea, Barbara; de Caso, Irene; Konishi, Mahiko; Wang, Hao-Ting; Hallam, Glyn; Margulies, Daniel S.; Jefferies, Elizabeth			Representing Representation: Integration between the Temporal Lobe and the Posterior Cingulate Influences the Content and Form of Spontaneous Thought	PLOS ONE			English	Article							DEFAULT MODE; EPISODIC MEMORY; WANDERING MINDS; BRAIN; NETWORK; ROBUST; CONNECTIVITY; OPTIMIZATION; REGISTRATION; ORGANIZATION	When not engaged in the moment, we often spontaneously represent people, places and events that are not present in the environment. Although this capacity has been linked to the default mode network (DMN), it remains unclear how interactions between the nodes of this network give rise to particular mental experiences during spontaneous thought. One hypothesis is that the core of the DMN integrates information from medial and lateral temporal lobe memory systems, which represent different aspects of knowledge. Individual differences in the connectivity between temporal lobe regions and the default mode network core would then predict differences in the content and form of people's spontaneous thoughts. This study tested this hypothesis by examining the relationship between seed-based functional connectivity and the contents of spontaneous thought recorded in a laboratory study several days later. Variations in connectivity from both medial and lateral temporal lobe regions was associated with different patterns of spontaneous thought and these effects converged on an overlapping region in the posterior cingulate cortex. We propose that the posterior core of the DMN acts as a representational hub that integrates information represented in medial and lateral temporal lobe and this process is important in determining the content and form of spontaneous thought.	[Smallwood, Jonathan; Karapanagiotidis, Theodoros; Ruby, Florence; Medea, Barbara; de Caso, Irene; Konishi, Mahiko; Wang, Hao-Ting; Hallam, Glyn; Jefferies, Elizabeth] Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England; [Medea, Barbara] Univ Roma La Sapienza, Dept Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Margulies, Daniel S.] Max Planck Inst Human & Cognit Brain Sci, Neuroanat & Connect Grp, Leipzig, Germany	University of York - UK; Sapienza University Rome; Max Planck Society	Smallwood, J (corresponding author), Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England.	jonny.smallwood@york.ac.uk	Konishi, Mahiko/AAF-5628-2019; Smallwood, Jonathan/ABE-8365-2020; Jefferies, Elizabeth/A-7981-2011; Margulies, Daniel/L-4719-2016	Konishi, Mahiko/0000-0001-8212-9964; Margulies, Daniel/0000-0002-8880-9204; Wang, Hao-Ting/0000-0003-4078-2038; Jefferies, Elizabeth/0000-0002-3826-4330; Karapanagiotidis, Theodoros/0000-0002-0813-1019; Smallwood, Jonathan/0000-0002-7298-2459; Hallam, Glyn Paul/0000-0002-8956-9054	Templeton Science of Prospection Award; BBSRC [BB/J006963/1]; European Research Council [SEMBIND - 283530]; Welcome Trust [103817/Z/14/Z]; John Templeton Foundation; Biotechnology and Biological Sciences Research Council [BB/J006963/1] Funding Source: researchfish	Templeton Science of Prospection Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Welcome Trust(Wellcome Trust); John Templeton Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Templeton Science of Prospection Award to the first author. EJ was supported by grants from BBSRC (BB/J006963/1) and the European Research Council (SEMBIND - 283530). DMS and JS also received upport from the Welcome Trust 103817/Z/14/Z. This publication was made possible through the support of a grant from the John Templeton Foundation, "Prospective Psychology Stage 2: A Research Competition" to Martin Seligman. The opinions expressed in this publication are those of the author(s) and do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Allen M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00743; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Andrews-Hanna JR, 2014, ANN NEW YORK ACAD SC; Baird B, 2015, J COGNITIVE NEUROSCI; Baird B, 2014, DECOUPLED MIND MIND; Baird B, 2013, J NEUROSCI, V33, P16657, DOI 10.1523/JNEUROSCI.0786-13.2013; Baird B, 2011, CONSCIOUS COGN, V20, P1604, DOI 10.1016/j.concog.2011.08.007; Baker DH, 2015, NEUROIMAGE, V119, P229, DOI 10.1016/j.neuroimage.2015.06.053; Barron E., 2011, PSYCHOL SCI; Beaty RE, 2016, TRENDS COGN SCI, V20, P87, DOI 10.1016/j.tics.2015.10.004; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Binney RJ, 2010, CEREB CORTEX, V20, P2728, DOI 10.1093/cercor/bhq019; Braga RM, 2013, J NEUROSCI, V33, P14031, DOI 10.1523/JNEUROSCI.0570-13.2013; Brewer JA, 2011, P NATL ACAD SCI USA, V108, P20254, DOI 10.1073/pnas.1112029108; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bzdok D, 2015, NEUROIMAGE, V106, P55, DOI 10.1016/j.neuroimage.2014.11.009; Bzdok D, 2013, NEUROIMAGE, V81, P381, DOI 10.1016/j.neuroimage.2013.05.046; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Davey J, 2015, J NEUROSCI, V35, P15230, DOI 10.1523/JNEUROSCI.4705-14.2015; Engert V, 2014, BIOL PSYCHOL, V103, P283, DOI 10.1016/j.biopsycho.2014.10.004; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Fox KCR, 2015, NEUROIMAGE, V111, P611, DOI 10.1016/j.neuroimage.2015.02.039; Gorgolewski KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097176; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2009, PHILOS T R SOC B, V364, P1263, DOI 10.1098/rstb.2008.0296; Iijima Yudai, 2012, Shinrigaku Kenkyu, V83, P232; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kucyi A, 2014, NEUROIMAGE, V100, P471, DOI 10.1016/j.neuroimage.2014.06.044; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Pagnoni G, 2012, J NEUROSCI, V32, P5242, DOI 10.1523/JNEUROSCI.4135-11.2012; Poerio GL, 2013, CONSCIOUS COGN, V22, P1412, DOI 10.1016/j.concog.2013.09.012; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ruby FJM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00962; Ruby FJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077554; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Seli P, 2013, FRONTIERS PSYCHOL, V4; Smallwood J., 2013, FRONTIERS HUMAN NEUR, V7; Smallwood J., 2013, PSYCHOL B; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2015, ANNU REV PSYCHOL, V66, P487, DOI 10.1146/annurev-psych-010814-015331; Smallwood J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00441; Smallwood J, 2013, PSYCHOL BULL, V139, P542, DOI 10.1037/a0031019; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044423; Stawarczyk D, 2015, HUMAN BRAIN MAPPING; Stawarczyk D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016997; Tusche A, 2014, NEUROIMAGE, V97, P107, DOI 10.1016/j.neuroimage.2014.03.076; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Visser M, 2010, J COGNITIVE NEUROSCI, V22, P1083, DOI 10.1162/jocn.2009.21309; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	65	87	87	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152272	10.1371/journal.pone.0152272	http://dx.doi.org/10.1371/journal.pone.0152272			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27045292	gold, Green Published, Green Accepted			2022-12-26	WOS:000373599600013
J	Zhang, Y; Liang, JL; Lin, Q; Hu, ZH				Zhang, Yan; Liang, Jiali; Lin, Qiang; Hu, Zhenghui			Exploiting Complexity Information for Brain Activation Detection	PLOS ONE			English	Article							APPROXIMATE ENTROPY ANALYSIS; SAMPLE ENTROPY; FMRI DATA; DATA SETS; SIGNALS; SYSTEM; IRREGULARITY; VARIABILITY; APEN	We present a complexity-based approach for the analysis of fMRI time series, in which sample entropy (SampEn) is introduced as a quantification of the voxel complexity. Under this hypothesis the voxel complexity could be modulated in pertinent cognitive tasks, and it changes through experimental paradigms. We calculate the complexity of sequential fMRI data for each voxel in two distinct experimental paradigms and use a nonparametric statistical strategy, the Wilcoxon signed rank test, to evaluate the difference in complexity between them. The results are compared with the well known general linear model based Statistical Parametric Mapping package (SPM12), where a decided difference has been observed. This is because SampEn method detects brain complexity changes in two experiments of different conditions and the data-driven method SampEn evaluates just the complexity of specific sequential fMRI data. Also, the larger and smaller SampEn values correspond to different meanings, and the neutral-blank design produces higher predictability than threat-neutral. Complexity information can be considered as a complementary method to the existing fMRI analysis strategies, and it may help improving the understanding of human brain functions from a different perspective.	[Zhang, Yan; Liang, Jiali] China Jiliang Univ, Coll Opt & Elect Technol, Hangzhou 310018, Peoples R China; [Lin, Qiang; Hu, Zhenghui] Zhejiang Univ Technol, Coll Sci, Ctr Opt & Optoelect Res, Hangzhou 310023, Zhejiang, Peoples R China	China Jiliang University; Zhejiang University of Technology	Hu, ZH (corresponding author), Zhejiang Univ Technol, Coll Sci, Ctr Opt & Optoelect Res, Hangzhou 310023, Zhejiang, Peoples R China.	zhenghui@zjut.edu.cn			National Basic Research Program of China [2013CB329501]; National High Technology Research and Development Program of China [2012AA011600]; National Natural Science Foundation of China [81271645]; Public Projects of Science Technology Department of Zhejiang Province [2013C33162, 2015C31102]; Zhejiang Provincial Natural Science Foundation of China [LY 12H18004]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Projects of Science Technology Department of Zhejiang Province; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work is supported in part by the National Basic Research Program of China under Grant 2013CB329501, in part by the National High Technology Research and Development Program of China under Grant 2012AA011600, in part by the National Natural Science Foundation of China under Grant 81271645, in part by the Public Projects of Science Technology Department of Zhejiang Province under Grant 2013C33162, in part by the Zhejiang Provincial Natural Science Foundation of China under Grant LY 12H18004, and in part by the Public Projects of Science Technology Department of Zhejiang Province under Grant 2015C31102.	Alcaraz R, 2010, COMPUT METH PROG BIO, V99, P124, DOI 10.1016/j.cmpb.2010.02.009; Beckmann CF, 2000, NEUROIMAGE, V11, pS643; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chen WT, 2009, MED ENG PHYS, V31, P61, DOI 10.1016/j.medengphy.2008.04.005; Chuang KH, 1999, IEEE T MED IMAGING, V18, P1117, DOI 10.1109/42.819322; De Maziere PA, 2007, J MAGN RESON, V185, P138, DOI 10.1016/j.jmr.2006.12.001; Duann JR, 2002, NEUROIMAGE, V15, P823, DOI 10.1006/nimg.2001.1049; Gupta L, 2014, NEUROIMAGE-CLIN, V5, P266, DOI 10.1016/j.nicl.2014.06.013; HARTMAN ML, 1994, J CLIN INVEST, V94, P1277, DOI 10.1172/JCI117446; Hollander M., 1973, NONPARAMETRIC STAT M; Hu X, 2008, MED ENG PHYS, V30, P631, DOI 10.1016/j.medengphy.2007.07.002; Hu ZH, 2006, REGULARITY COMPLEXIT, V3, P15; Kherif F, 2002, NEUROIMAGE, V16, P1068, DOI 10.1006/nimg.2002.1094; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Muhei-aldin O, 2014, J NEUROSCI METH, V227, P75, DOI 10.1016/j.jneumeth.2014.02.003; Noble B., 1988, APPL LINEAR ALGEBRA; PINCUS SM, 1992, COMMUN STAT THEORY, V21, P3061, DOI 10.1080/03610929208830963; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; PINCUS SM, 1992, AM J PHYSIOL, V262, pE741, DOI 10.1152/ajpendo.1992.262.5.E741; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rukhin AL, 2000, J APPL PROBAB, V37, P88, DOI 10.1017/S0021900200015278; Singer W, 2009, EUR REV, V17, P321, DOI 10.1017/S1062798709000751; Sokunbi MO, 2015, MED ENG PHYS, V37, P1082, DOI 10.1016/j.medengphy.2015.09.001; Sokunbi MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095146; Sokunbi MO, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00069; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Sun FT, 2005, NEUROIMAGE, V28, P227, DOI 10.1016/j.neuroimage.2005.05.043; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Xie HB, 2010, ANN BIOMED ENG, V38, P1483, DOI 10.1007/s10439-010-9933-5; Xiong GL, 2010, J ZHEJIANG UNIV-SC A, V11, P270, DOI 10.1631/jzus.A0900360; Yao Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02853; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Zhang J, 2008, NEUROIMAGE, V41, P1242, DOI 10.1016/j.neuroimage.2008.03.034; Zou Liang, 2013, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V35, P451, DOI 10.3881/j.issn.1000-503X.2013.04.018	36	5	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152418	10.1371/journal.pone.0152418	http://dx.doi.org/10.1371/journal.pone.0152418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045838	Green Published, Green Submitted, gold			2022-12-26	WOS:000373599600019
J	Carlson, ML; Bao, H; Duong, F				Carlson, Michael L.; Bao, Huan; Duong, Franck			Formation of a Chloride-conducting State in the Maltose ATP-binding Cassette (ABC) Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATION CHANNEL; FACING CONFORMATION; ALTERNATING ACCESS; MEMBRANE; WATER; MECHANISM; DRIVES; MODEL; FLUX	ATP-binding cassette transporters use an alternating access mechanism to move substrates across cellular membranes. This mode of transport ensures the selective passage of molecules while preserving membrane impermeability. The crystal structures of MalFGK(2), inward-and outward-facing, show that the transporter is sealed against ions and small molecules. It has yet to be determined whether membrane impermeability is maintained when MalFGK(2) cycles between these two conformations. Through the use of a mutant that resides in intermediate conformations close to the transition state, we demonstrate that not only is chloride conductance occurring, but also to a degree large enough to compromise cell viability. Introduction of mutations in the periplasmic gate lead to the formation of a channel that is quasi-permanently open. MalFGK(2) must therefore stay away from these ion-conducting conformations to preserve the membrane barrier; otherwise, a few mutations that increase access to the ion-conducting states are enough to convert an ATP-binding cassette transporter into a channel.	[Carlson, Michael L.; Bao, Huan; Duong, Franck] Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Bao, Huan] Wisconsin Inst Med Res, Dept Neurosci, Madison, WI 53705 USA	University of British Columbia	Duong, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fduong@mail.ubc.ca		Duong Van Hoa, Franck/0000-0001-7328-6124; Bao, Huan/0000-0002-4301-4627	Canadian Institutes of Health Research; Cellular Dynamics of Macromolecular Complexes NSERC-CREATE scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cellular Dynamics of Macromolecular Complexes NSERC-CREATE scholarship	This work is supported by operating grants from the Canadian Institutes of Health Research. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a Cellular Dynamics of Macromolecular Complexes NSERC-CREATE scholarship.	Bao H, 2014, J BIOL CHEM, V289, P9844, DOI 10.1074/jbc.M113.545525; Bao H, 2013, BBA-BIOMEMBRANES, V1828, P1723, DOI 10.1016/j.bbamem.2013.03.024; Bao H, 2013, J BIOL CHEM, V288, P3439, DOI 10.1074/jbc.M112.431932; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen TY, 2008, PHYSIOL REV, V88, P351, DOI 10.1152/physrev.00058.2006; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DeFelice LJ, 2007, ANNU REV PHYSIOL, V69, P87, DOI 10.1146/annurev.physiol.69.031905.164816; Duquette PP, 2001, P NATL ACAD SCI USA, V98, P3796, DOI 10.1073/pnas.071245198; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li J, 2015, CURR OPIN STRUC BIOL, V31, P96, DOI 10.1016/j.sbi.2015.04.001; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; MacAulay N, 2002, J PHYSIOL-LONDON, V542, P817, DOI 10.1113/jphysiol.2002.020586; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; MALONEY PC, 1974, P NATL ACAD SCI USA, V71, P3896, DOI 10.1073/pnas.71.10.3896; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Slotboom DJ, 2014, NAT REV MICROBIOL, V12, P79, DOI 10.1038/nrmicro3175; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; van der Does C, 2004, BIOL CHEM, V385, P927, DOI 10.1515/BC.2004.121; Wen PC, 2011, BIOPHYS J, V101, P680, DOI 10.1016/j.bpj.2011.06.031; WOODBURY DJ, 1990, BIOPHYS J, V58, P833, DOI 10.1016/S0006-3495(90)82429-2	33	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12119	12125		10.1074/jbc.M115.711622	http://dx.doi.org/10.1074/jbc.M115.711622			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27059961	Green Published, hybrid			2022-12-26	WOS:000378092800014
J	Naganuma, T; Takagi, S; Kanetake, T; Kitamura, T; Hattori, S; Miyakawa, T; Sassa, T; Kihara, A				Naganuma, Tatsuro; Takagi, Shuyu; Kanetake, Tsukasa; Kitamura, Takuya; Hattori, Satoko; Miyakawa, Tsuyoshi; Sassa, Takayuki; Kihara, Akio			Disruption of the Sjogren-Larsson Syndrome Gene Aldh3a2 in Mice Increases Keratinocyte Growth and Retards Skin Barrier Recovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY ALDEHYDE DEHYDROGENASE; 1-PHOSPHATE METABOLIC PATHWAY; SPHINGOSINE 1-PHOSPHATE; PERMEABILITY BARRIER; OXIDATIVE STRESS; SPHINGOSINE-1-PHOSPHATE LYASE; BIOCHEMICAL-CHARACTERIZATION; ENDOPLASMIC-RETICULUM; ALCOHOL METABOLISM; LIPID MODIFICATION	The fatty aldehyde dehydrogenase (FALDH) ALDH3A2 is the causative gene of Sjogren Larsson syndrome (SLS). To date, the molecular mechanism underlying the symptoms characterizing SLS has been poorly understood. Using Aldh3a2(-/-) mice, we found here that Aldh3a2 was the major FALDH active in undifferentiated keratinocytes. Long-chain base metabolism was greatly impaired in Aldh3a2(-/-) keratinocytes. Phenotypically, the intercellular spaces were widened in the basal layer of the Aldh3a2(-/-) epidermis due to hyperproliferation of keratinocytes. Furthermore, oxidative stress-induced genes were upregulated in Aldh3a2(-/-) keratinocytes. Upon keratinocyte differentiation, the activity of another FALDH, Aldh3b2, surpassed that of Aldh3a2. As a result, Aldh3a2(-/-) mice were indistinguishable from wild-type mice in terms of their whole epidermis FALDH activity, and their skin barrier function was uncompromised under normal conditions. However, perturbation of the stratum corneum caused increased transepidermal water loss and delayed barrier recovery in Aldh3a2(-/-) mice. In conclusion, Aldh3a2(-/-) mice replicated some aspects of SLS symptoms, especially at the basal layer of the epidermis. Our results suggest that hyperproliferation of keratinocytes via oxidative stress responses may partly contribute to the ichthyosis symptoms of SLS.	[Naganuma, Tatsuro; Takagi, Shuyu; Kanetake, Tsukasa; Kitamura, Takuya; Sassa, Takayuki; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Hattori, Satoko; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi 4701192, Japan; [Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Okazaki, Aichi 4448585, Japan	Hokkaido University; Fujita Health University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	SASSA, Takayuki/B-2519-2012; Hattori, Satoko/AAE-6873-2022; Miyakawa, Tsuyoshi/A-7741-2008; KIHARA, AKIO/A-3802-2012	SASSA, Takayuki/0000-0003-3145-9829; Hattori, Satoko/0000-0002-1047-6454; Miyakawa, Tsuyoshi/0000-0003-0137-8200; KIHARA, AKIO/0000-0001-5889-0788; Naganuma, Tatsuro/0000-0002-8653-5553	Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from the Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science (JSPS) [26251010]; JSPS [25744]; Grants-in-Aid for Scientific Research [26251010, 14J02202, 16H06276] Funding Source: KAKEN	Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Advanced Research and Development Programs for Medical Innovation (AMED-CREST) (to A. K.) from the Japan Agency for Medical Research and Development (AMED), by Grant-in-aid for Scientific Research (A) 26251010 (to A. K.) from the Japan Society for the Promotion of Science (JSPS), and by Grant-in-aid for JSPS Fellows 25744 (to T. N.) from JSPS. The authors declare that they have no conflicts of interest with the contents of this article.	ABEDINIA M, 1990, EXP EYE RES, V51, P419, DOI 10.1016/0014-4835(90)90154-M; Abiko Y, 2014, J AGR FOOD CHEM, V62, P10936, DOI 10.1021/jf5030592; Ashibe B, 2007, J BIOL CHEM, V282, P20763, DOI 10.1074/jbc.M611853200; BEAUCHAMP RO, 1985, CRC CR REV TOXICOL, V14, P309, DOI 10.3109/10408448509037461; Caldelari R, 2010, METHODS MOL BIOL, V633, P125, DOI 10.1007/978-1-59745-019-5_10; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Dreger H, 2010, CARDIOVASC RES, V85, P395, DOI 10.1093/cvr/cvp279; Feingold KR, 2014, BBA-MOL CELL BIOL L, V1841, P280, DOI 10.1016/j.bbalip.2013.11.007; George J, 2013, ISRN DERMATOL, V2013; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hernandez-Quintero M, 2006, CELL TISSUE RES, V325, P77, DOI 10.1007/s00441-006-0173-9; Ikeda M, 2004, BIOCHEM BIOPH RES CO, V325, P338, DOI 10.1016/j.bbrc.2004.10.036; Jackson Brian, 2011, Human Genomics, V5, P283; JAGELL S, 1982, CLIN GENET, V21, P243; Kariya Y, 2005, GENES CELLS, V10, P605, DOI 10.1111/j.1365-2443.2005.00862.x; Kelson TL, 1997, BBA-GEN SUBJECTS, V1335, P99, DOI 10.1016/S0304-4165(96)00126-2; Kihara A, 2003, J BIOL CHEM, V278, P14578, DOI 10.1074/jbc.M211416200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2014, BBA-MOL CELL BIOL L, V1841, P766, DOI 10.1016/j.bbalip.2013.08.014; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Kitamura T, 2013, BBA-MOL CELL BIOL L, V1831, P1395, DOI 10.1016/j.bbalip.2013.05.007; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kondo N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6338; Li DQ, 2012, J BIOL CHEM, V287, P10435, DOI 10.1074/jbc.M111.299669; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Marchitti SA, 2007, BIOCHEM BIOPH RES CO, V356, P792, DOI 10.1016/j.bbrc.2007.03.046; Matsumura H, 2004, BIOCHEM BIOPH RES CO, V321, P275, DOI 10.1016/j.bbrc.2004.06.139; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Mizutani Y, 2009, BIOCHIMIE, V91, P784, DOI 10.1016/j.biochi.2009.04.001; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Nakajima K, 2011, J DERMATOL SCI, V63, P64, DOI 10.1016/j.jdermsci.2011.03.009; Neuber C, 2014, ANAL CHEM, V86, P9065, DOI 10.1021/ac501677y; Ohkuni A, 2013, BIOCHEM BIOPH RES CO, V442, P195, DOI 10.1016/j.bbrc.2013.11.036; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Piatigorsky J, 2001, CORNEA, V20, P853, DOI 10.1097/00003226-200111000-00015; Rizzo WB, 2005, HUM MUTAT, V26, P1, DOI 10.1002/humu.20181; Rizzo WB, 2000, BBA-MOL BASIS DIS, V1535, P1, DOI 10.1016/S0925-4439(00)00077-6; Rizzo WB, 2000, J LIPID RES, V41, P1077; Rizzo WB, 2008, J LIPID RES, V49, P410, DOI 10.1194/jlr.M700469-JLR200; Rizzo WB, 2007, MOL GENET METAB, V90, P1, DOI 10.1016/j.ymgme.2006.08.006; Rizzo WB, 2014, BBA-MOL CELL BIOL L, V1841, P377, DOI 10.1016/j.bbalip.2013.09.001; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; STOFFEL W, 1970, H-S Z PHYSIOL CHEM, V351, P875, DOI 10.1515/bchm2.1970.351.2.875; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; van den Brink DM, 2004, MOL GENET METAB, V82, P33, DOI 10.1016/j.ymgme.2004.01.019; Verhoeven NM, 1998, FEBS LETT, V429, P225, DOI 10.1016/S0014-5793(98)00574-2; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869; WHITE FH, 1984, J ORAL PATHOL MED, V13, P244, DOI 10.1111/j.1600-0714.1984.tb01422.x; Willemsen MAAP, 2001, J NEUROL SCI, V183, P61, DOI 10.1016/S0022-510X(00)00474-3	55	21	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11676	11688		10.1074/jbc.M116.714030	http://dx.doi.org/10.1074/jbc.M116.714030			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27053112	Green Published, hybrid			2022-12-26	WOS:000377264800018
J	Selfridge, AC; Cavadas, MAS; Scholz, CC; Campbell, EL; Welch, LC; Lecuona, E; Colgan, SP; Barrett, KE; Sporn, PHS; Sznajder, JI; Cummins, EP; Taylor, CT				Selfridge, Andrew C.; Cavadas, Miguel A. S.; Scholz, Carsten C.; Campbell, Eric L.; Welch, Lynn C.; Lecuona, Emilia; Colgan, Sean P.; Barrett, Kim E.; Sporn, Peter H. S.; Sznajder, Jacob I.; Cummins, Eoin P.; Taylor, Cormac T.			Hypercapnia Suppresses the HIF-dependent Adaptive Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; NF-KAPPA-B; ERYTHROPOIETIN PRODUCTION; MURINE MODEL; OXYGEN; DEGRADATION; BAFILOMYCIN; CHLOROQUINE; INHIBITION; EXPRESSION	Molecular oxygen and carbon dioxide are the primary gaseous substrate and product of oxidative metabolism, respectively. Hypoxia (low oxygen) and hypercapnia (high carbon dioxide) are co-incidental features of the tissue microenvironment in a range of pathophysiologic states, including acute and chronic respiratory diseases. The hypoxia-inducible factor (HIF) is the master regulator of the transcriptional response to hypoxia; however, little is known about the impact of hypercapnia on gene transcription. Because of the relationship between hypoxia and hypercapnia, we investigated the effect of hypercapnia on the HIF pathway. Hypercapnia suppressed HIF-alpha protein stability and HIF target gene expression both in mice and cultured cells in a manner that was at least in part independent of the canonical O-2-dependent HIF degradation pathway. The suppressive effects of hypercapnia on HIF-alpha protein stability could be mimicked by reducing intracellular pH at a constant level of partial pressure of CO2. Bafilomycin A1, a specific inhibitor of vacuolar-type H+-ATPase that blocks lysosomal degradation, prevented the hypercapnic suppression of HIF-alpha protein. Based on these results, we hypothesize that hypercapnia counter-regulates activation of the HIF pathway by reducing intracellular pH and promoting lysosomal degradation of HIF-alpha subunits. Therefore, hypercapnia may play a key role in the pathophysiology of diseases where HIF is implicated.	[Selfridge, Andrew C.; Scholz, Carsten C.; Barrett, Kim E.; Cummins, Eoin P.; Taylor, Cormac T.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Selfridge, Andrew C.; Cavadas, Miguel A. S.; Scholz, Carsten C.; Barrett, Kim E.; Cummins, Eoin P.; Taylor, Cormac T.] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Cavadas, Miguel A. S.; Scholz, Carsten C.; Taylor, Cormac T.] Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Scholz, Carsten C.] Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Campbell, Eric L.; Colgan, Sean P.] Univ Colorado Denver, Anschutz Med Campus, Aurora, CO 80045 USA; [Welch, Lynn C.; Lecuona, Emilia; Sporn, Peter H. S.; Sznajder, Jacob I.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Sporn, Peter H. S.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Cavadas, Miguel A. S.] Inst Gulbenkian Ciencias, R Q Ta Grande 6, P-2780156 Oeiras, Portugal; [Barrett, Kim E.] Univ Calif San Diego, Sch Med, Dept Med & Biomed Sci, PhD Program,Div Gastroenterol, La Jolla, CA 92093 USA	University College Dublin; University College Dublin; University College Dublin; University of Zurich; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Instituto Gulbenkian de Ciencia; University of California System; University of California San Diego	Taylor, CT (corresponding author), Univ Coll Dublin, Conway Inst, Dublin 4, Ireland.	cormac.taylor@ucd.ie	Barrett, Kim/AAE-2794-2022; Barrett, Kim Elaine/AAE-7762-2019; Scholz, Carsten C./P-3185-2019; Cummins, Eoin/S-7554-2019; Campbell, Eric/N-5357-2015; Cavadas, Miguel/E-9815-2012	Barrett, Kim Elaine/0000-0002-6704-998X; Scholz, Carsten C./0000-0001-6579-8015; Cummins, Eoin/0000-0002-9346-8299; Sporn, Peter/0000-0002-1006-9437; Campbell, Eric/0000-0003-0744-6577; Cavadas, Miguel/0000-0003-3917-9880	Science Foundation Ireland [11/PI/1005]; National Institutes of Health [HL85534, HL71643, DK50189, HL107629]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085534, R01HL107629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103639, R37DK050189, R01DK095491, R01DK104713] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002182] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Science Foundation Ireland (Grant Number 11/PI/1005). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants HL85534 and HL71643.; Supportedby National Institutes of Health Grant DK50189.; Supported by National Institutes of Health Grant HL107629.	Ahmadi Z, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-30; BAKER R, 1984, ADV EXP MED BIOL, V169, P597; Barrett TD, 2011, MOL PHARMACOL, V79, P910, DOI 10.1124/mol.110.070508; Bautista AF, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-23; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; Bruning U, 2012, CELL MOL LIFE SCI, V69, P1319, DOI 10.1007/s00018-011-0876-2; Budweiser Stephan, 2008, Int J Chron Obstruct Pulmon Dis, V3, P605; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Casalino-Matsuda SM, 2015, J IMMUNOL, V194, P5388, DOI 10.4049/jimmunol.1500150; COHEN RA, 1981, EXP HEMATOL, V9, P513; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Contreras M, 2015, CURR OPIN ANESTHESIO, V28, P26, DOI 10.1097/ACO.0000000000000151; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2014, CELL MOL LIFE SCI, V71, P831, DOI 10.1007/s00018-013-1470-6; Cummins EP, 2010, J IMMUNOL, V185, P4439, DOI 10.4049/jimmunol.1000701; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; ECKARDT KU, 1990, AM J PHYSIOL, V258, pR678, DOI 10.1152/ajpregu.1990.258.3.R678; Egger ME, 2013, J SURG RES, V184, P274, DOI 10.1016/j.jss.2013.04.055; Ferreira JV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10210; Ferreira JV, 2013, AUTOPHAGY, V9, P1349, DOI 10.4161/auto.25190; Gates KL, 2013, AM J RESP CELL MOL, V49, P821, DOI 10.1165/rcmb.2012-0487OC; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hewitson KS, 2004, CURR PHARM DESIGN, V10, P821, DOI 10.2174/1381612043452884; Hubbi ME, 2014, P NATL ACAD SCI USA, V111, pE3325, DOI 10.1073/pnas.1412840111; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Iwata E, 2016, INT J ONCOL, V48, P1493, DOI 10.3892/ijo.2016.3380; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; KRIEGER J, 1989, CHEST, V96, P729, DOI 10.1378/chest.96.4.729; Lang KS, 2003, CELL PHYSIOL BIOCHEM, V13, P257, DOI 10.1159/000074540; MILLER ME, 1979, BLOOD CELLS, V5, P389; Oliver KM, 2012, J BIOL CHEM, V287, P14004, DOI 10.1074/jbc.M112.347971; Onishi Y, 2012, J CANC SCI THERAPY, V4, P7, DOI 10.4172/1948-5956.1000136; Onishi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049189; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rothman DH, 2002, P NATL ACAD SCI USA, V99, P4167, DOI 10.1073/pnas.022055499; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Schaible B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056491; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Semenza GL, 2006, MOL PHARMACOL, V70, P1841, DOI 10.1124/mol.106.031062; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shinojima T, 2007, CARCINOGENESIS, V28, P529, DOI 10.1093/carcin/bgl143; STIGTER D, 1991, P NATL ACAD SCI USA, V88, P4176, DOI 10.1073/pnas.88.10.4176; Takeda D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100530; Tambuwala MM, 2015, J CONTROL RELEASE, V217, P221, DOI 10.1016/j.jconrel.2015.09.022; Taylor CT, 2011, J PHYSIOL-LONDON, V589, P797, DOI 10.1113/jphysiol.2010.201467; To M, 2012, CHEST, V141, P1233, DOI 10.1378/chest.11-1536; Vadasz I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046696; Vohwinkel CU, 2015, J APPL PHYSIOL, V119, P1157, DOI 10.1152/japplphysiol.00226.2015; WOLFPRIESSNITZ J, 1978, BLOOD, V52, P153; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yan ZW, 2013, BIOCHEM BIOPH RES CO, V430, P926, DOI 10.1016/j.bbrc.2012.12.052; ZUCALI JR, 1978, J LAB CLIN MED, V92, P648	53	37	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11800	11808		10.1074/jbc.M116.713941	http://dx.doi.org/10.1074/jbc.M116.713941			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27044749	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000377264800029
J	Li, YL; Zhang, JL; Min, D; Zhou, HY; Lin, N; Li, QS				Li, Yun-lan; Zhang, Jiali; Min, Dong; Zhou Hongyan; Lin, Niu; Li, Qing-shan			Anticancer Effects of 1,3-Dihydroxy-2-Methylanthraquinone and the Ethyl Acetate Fraction of Hedyotis Diffusa Willd against HepG2 Carcinoma Cells Mediated via Apoptosis	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBERS; CYTOCHROME-C; CANCER; ANTHRAQUINONES; RUBIADIN; PATHWAY; ARREST; P53	Hedyotis Diffusa Willd, used in Traditional Chinese Medicine, is a treatment for various diseases including cancer, owing to its mild effectiveness and low toxicity. The aim of this study was to identify the main anticancer components in Hedyotis Diffusa Willd, and explore mechanisms underlying their activity. Hedyotis Diffusa Willd was extracted and fractionated using ethyl acetate to obtain the H-Ethyl acetate fraction, which showed higher anticancer activity than the other fractions obtained against HepG2 cells with sulforhodamine B assays. The active component of the H-Ethyl acetate fraction was identified to be 1,3-dihydroxy-2-methy-lanthraquinone (DMQ) with much high inhibitory rate up to 48.9 +/- 3.3% and selectivity rate up to 9.4 +/- 4.5 folds (p<0.01) at 125 mu mol/L. HepG2 cells treated with the fraction and DMQ visualized morphologically using light and fluorescence microscopy. Annexin V-fluorescein isothiocyanate / propidium iodide staining flow cytometry, DNA ladder and cell cycle distribution assays. Mechanistic studies showed up-regulation of caspase-3, -8, and -9 proteases activities (p<0.001), indicating involvement of mitochondrial apoptotic and death receptor pathways. Further studies revealed that reactive oxygen species in DMQ and the fraction treated HepG2 cells increased (p<0.01) while mitochondrial membrane potential reduced significantly (p<0.001) compared to the control by flow cytometry assays. Western blot analysis showed that Bax, p53, Fas, FasL, p21 and cytoplasmic cytochrome C were up-regulated (p<0.01), while Bcl-2, mitochondrial cytochrome C, cyclin E and CDK 2 were down-regulated dose-dependently (p<0.01). The reverse transcriptase-polymerase chain reaction showed that mRNA expressions of p53 and Bax increased (p<0.001) while that of Bcl-2 decreased (p<0.001). Pre-treatment with caspase-8 inhibitor Z-IETD-FMK, or caspase-9 inhibitor Z-LEHD-FMK, attenuated the growth-inhibitory and apoptosis-inducing effects of DMQ and the fraction on HepG2 cells. These results suggested that DMQ and the H-Ethyl acetate fraction of Hedyotis Diffusa Willd showed potential anticancer effects. Furthermore, the mechanisms of action may involve mitochondrial apoptotic and death receptor pathways.	[Li, Yun-lan; Zhang, Jiali; Min, Dong; Zhou Hongyan; Lin, Niu; Li, Qing-shan] Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan 030001, Peoples R China	Shanxi Medical University	Li, YL; Li, QS (corresponding author), Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan 030001, Peoples R China.	liyunlanrr@163.com; sxlqs2012@163.com			Natural Science Foundation of Shanxi Province [2014011027-1]; Program for Science and Technology of Shanxi Province [20130313021-9]; Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province; Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province; Foundation of Young Academic Leader in Shanxi Province; Shanxi Province Returnees Preferred Project; Education Reform and Research Project of the colleges and universities of Shanxi Province; Program for the Natural Science Foundation of Shanxi Province [2014011027-1]	Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); Program for Science and Technology of Shanxi Province; Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province; Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province; Foundation of Young Academic Leader in Shanxi Province; Shanxi Province Returnees Preferred Project; Education Reform and Research Project of the colleges and universities of Shanxi Province; Program for the Natural Science Foundation of Shanxi Province	This research was supported by the Natural Science Foundation of Shanxi Province (No. 2014011027-1), Program for Science and Technology of Shanxi Province (No. 20130313021-9), the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province, the Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province (2015), Foundation of Young Academic Leader in Shanxi Province, Shanxi Province Returnees Preferred Project in 2012, Education Reform and Research Project of the colleges and universities of Shanxi Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial supports form Program for the Natural Science Foundation of Shanxi Province (No. 2014011027-1), Program for Science and Technology of Shanxi Province (No. 20130313021-9), the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province, the Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province (2015), Foundation of Young Academic Leader in Shanxi Province, Shanxi Province Returnees Preferred Project in 2012, Education Reform and Research Project of the colleges and universities of Shanxi Province are gratefully acknowledged.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Bouillet P, 2002, J CELL SCI, V115, P1567; Cillessen SAGM, 2010, J PATHOL, V220, P509, DOI 10.1002/path.2670; Comini LR, 2011, PHYTOMEDICINE, V18, P1093, DOI 10.1016/j.phymed.2011.05.008; Ekert PG, 2005, CURR OPIN CELL BIOL, V17, P626, DOI 10.1016/j.ceb.2005.09.001; Gupta S, 2003, ARCH BIOCHEM BIOPHYS, V410, P177, DOI 10.1016/S0003-9861(02)00668-9; Harry A Rogoff, 2004, CELL CYCLE, V3, P845; Huang Wei-Hua, 2008, Zhongguo Zhong Yao Za Zhi, V33, P524; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Ju SM, 2015, PHARM BIOL, V53, P1002, DOI 10.3109/13880209.2014.952834; Kanokmedhakul K, 2005, J ETHNOPHARMACOL, V100, P284, DOI 10.1016/j.jep.2005.03.018; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kuo YJ, 2015, IN VIVO, V29, P453; Ledgerwood EC, 2009, CLIN CANCER RES, V15, P420, DOI 10.1158/1078-0432.CCR-08-1172; Newton HB, 2005, EXPERT REV ANTICANC, V5, P355, DOI 10.1586/14737140.5.2.355; Niu Y, 2013, J ASIAN NAT PROD RES, V15, P550, DOI 10.1080/10286020.2013.781589; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Rao GMM, 2006, J ETHNOPHARMACOL, V103, P484, DOI 10.1016/j.jep.2005.08.073; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Vittar NBR, 2014, PHOTODIAGN PHOTODYN, V11, P182, DOI 10.1016/j.pdpdt.2014.02.002; Sayers TJ, 2011, CANCER IMMUNOL IMMUN, V60, P1173, DOI 10.1007/s00262-011-1008-4; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Tripathi YB, 1997, INDIAN J BIOCHEM BIO, V34, P302; Trivedi R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.429; Weyhenmeyer B., 2012, Experimental Oncology, V34, P192; Zhao J, 2012, CANCER LETT, V314, P8, DOI 10.1016/j.canlet.2011.09.040; Zheng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118276	28	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0151502	10.1371/journal.pone.0151502	http://dx.doi.org/10.1371/journal.pone.0151502			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064569	Green Published, gold, Green Submitted			2022-12-26	WOS:000373891000004
J	Min, JJ; Kim, G; Lee, JH; Hong, KY; Kim, WS; Lee, YT				Min, Jeong Jin; Kim, Gahyun; Lee, Jong-Hwan; Hong, Kwan Young; Kim, Wook Sung; Lee, Young-Tak			Does the Type of Anesthetic Technique Affect In-Hospital and One-Year Outcomes after Off-Pump Coronary Arterial Bypass Surgery?	PLOS ONE			English	Article							PRESERVES MYOCARDIAL-FUNCTION; VOLATILE ANESTHETICS; ATRIAL-FIBRILLATION; PROPOFOL ANESTHESIA; CARDIAC-SURGERY; SEVOFLURANE; DESFLURANE; ISOFLURANE; PROTECTION; INJURY	Despite numerous previous studies, there is little data on the effects of anesthetics on clinical outcome after off-pump coronary arterial bypass grafting (OPCAB). Therefore, we retrospectively compared the effects of anesthetic choice on in-hospital major adverse events (MAEs) and one-year major adverse cardiovascular and cerebral events (MACCEs) in patients undergoing OPCAB. Electronic medical records were reviewed in 192 patients who received propofol-remifenanil total intravenous anesthesia (TIVA) and propensity score-matched 662 patients who received isoflurane anesthesia. The primary endpoints were in-hospital MAEs and one-year MACCEs. The components of in-hospital MAEs were in-hospital death, myocardial infarction (MI), coronary revascularization, stroke, renal failure, prolonged mechanical ventilation longer than 72 h, and postoperative new cardiac arrhythmia requiring treatment. One-year MACCEs was defined as a composite of all-cause mortality, MI, coronary revascularization, and stroke. There was no significant difference in risk of in-hospital MAEs (OR = 1.29, 95% CI = 0.88-1.88, P = 0.20) or one-year MACCEs (OR = 0.81; 95% CI = 0.46-1.42, P = 0.46) between the groups. The risk of postoperative new arrhythmia including new atrial fibrillation significantly increased in the TIVA group compared to the isoflurane anesthesia group (OR = 1.72, 95% CI = 1.12-2.63, P = 0.01). In conclusion, the choice between propofol-remifentanil TIVA and isoflurane anesthesia did not show differences in incidence of in-hospital MAEs or one-year MACCEs in patients undergoing OPCAB. However, further studies on the effects of anesthetics on development of in-hospital new arrhythmia will be needed.	[Min, Jeong Jin; Kim, Gahyun; Lee, Jong-Hwan; Hong, Kwan Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Kim, Wook Sung; Lee, Young-Tak] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	jonghwanlee75@gmail.com		Hong, Kwan Young/0000-0001-6213-1848				Almassi GH, 2012, J THORAC CARDIOV SUR, V143, P93, DOI 10.1016/j.jtcvs.2011.10.003; Baki ED, 2013, INFLAMMATION, V36, P1327, DOI 10.1007/s10753-013-9671-6; Bein B, 2005, ANESTH ANALG, V100, P610, DOI 10.1213/01.ANE.0000145012.27484.A7; Bignami E, 2013, J CARDIOTHOR VASC AN, V27, P50, DOI 10.1053/j.jvca.2012.06.007; Conzen PF, 2003, ANESTHESIOLOGY, V99, P826, DOI 10.1097/00000542-200310000-00013; Cope DK, 1997, ANESTHESIOLOGY, V86, P699, DOI 10.1097/00000542-199703000-00023; De Hert S, 2009, ANAESTHESIA, V64, P953, DOI 10.1111/j.1365-2044.2009.06008.x; De Hert SG, 2004, ANESTHESIOLOGY, V101, P299, DOI 10.1097/00000542-200408000-00009; De Hert SG, 2003, ANESTHESIOLOGY, V99, P314, DOI 10.1097/00000542-200308000-00013; De Hert SG, 2002, ANESTHESIOLOGY, V97, P42, DOI 10.1097/00000542-200207000-00007; Guarracino F, 2006, J CARDIOTHOR VASC AN, V20, P477, DOI 10.1053/j.jvca.2006.05.012; Orriach JLG, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.06.004; Helgadottir S, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-87; Kato R, 2002, CAN J ANAESTH, V49, P777, DOI 10.1007/BF03017409; Kehl F, 2002, ANESTHESIOLOGY, V96, P183, DOI 10.1097/00000542-200201000-00032; Landoni G, 2014, BRIT J ANAESTH, V113, P955, DOI 10.1093/bja/aeu290; Landoni G, 2013, BRIT J ANAESTH, V111, P886, DOI 10.1093/bja/aet231; Law-Koune JD, 2006, J CARDIOTHOR VASC AN, V20, P484, DOI 10.1053/j.jvca.2005.08.001; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Mrozinski P, 2014, ANAESTH INTENSIVE TH, V46, P4, DOI [10.5603/AIT.2014.002, 10.5603/AIT.2014.0002]; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Riess ML, 2004, AM J PHYSIOL-HEART C, V286, pH1603, DOI 10.1152/ajpheart.00963.2003; Sanchez-Conde P, 2008, ANESTH ANALG, V106, P371, DOI 10.1213/ane.0b013e318160580b; Sirvinskas E, 2015, PERFUSION; Subramaniam B, 2014, ANESTH ANALG, V118, P277, DOI 10.1213/ANE.0000000000000100; Symons JA, 2006, BRIT J ANAESTH, V97, P127, DOI 10.1093/bja/ael149; Tanaka K, 2002, AM J PHYSIOL-HEART C, V282, pH2018, DOI 10.1152/ajpheart.01130.2001; Tempe DK, 2011, J CARDIOTHOR VASC AN, V25, P59, DOI 10.1053/j.jvca.2010.03.002; Yoo YC, 2014, KIDNEY INT, V86, P414, DOI 10.1038/ki.2013.532; Zaman AG, 2000, CIRCULATION, V101, P1403, DOI 10.1161/01.CIR.101.12.1403	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152060	10.1371/journal.pone.0152060	http://dx.doi.org/10.1371/journal.pone.0152060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054364	gold, Green Published			2022-12-26	WOS:000373608000011
J	Preuss, A; Schaafs, LA; Werncke, T; Steffen, IG; Hamm, B; Elgeti, T				Preuss, Alexandra; Schaafs, Lars-Arne; Werncke, Thomas; Steffen, Ingo G.; Hamm, Bernd; Elgeti, Thomas			Run-Off Computed Tomography Angiography (CTA) for Discriminating the Underlying Causes of Intermittent Claudication	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; EXTRAVASCULAR INCIDENTAL FINDINGS; MULTIDETECTOR CT; ABDOMINAL-AORTA; LUMBAR SPINE; DIAGNOSIS; PREVALENCE; MANAGEMENT; SCANS	Aim To evaluate run-off computed tomography angiography (CTA) of abdominal aorta and lower extremities for detecting musculoskeletal pathologies and clinically relevant extravascular incidental findings in patients with intermittent claudication (IC) and suspected peripheral arterial disease (PAD). Does run-off CTA allow image-based therapeutic decision making by discriminating the causes of intermittent claudication in patients with suspected peripheral arterial disease PAD? Material and Methods Retrospective re-evaluation of CTAs performed in patients with acute or chronic intermittent claudication (i.e., Fontaine stages I to IIB) between January 2005 and October 2013. Allocation to one of three categories of underlying causes of IC symptoms: vascular, musculoskeletal (MSK) or both. Clinically relevant extravascular incidental findings were evaluated. Medical records were reviewed to verify specific therapies as well as main and incidental findings. Results While focused on vascular imaging, CTA image quality was sufficient for evaluation of the MSK system in all cases. The underlying cause of IC was diagnosed in run-off CTA as vascular, MSK and a combination in n = 138 (65%), n = 10 (4%), and n = 66 (31%) cases, respectively. Specific vascular or MSK therapy was recorded in n = 123 and n = 9 cases. In n = 82, no follow-up was possible. Clinically relevant extravascular incidental findings were detected in n = 65 patients (30%) with neoplasia, ascites and pleural effusion being the most common findings. Discussion Run-off CTA allows identification of vascular, MSK, and combined causes of IC in patients with suspected PAD and can guide specific therapy. CTA also allowed confident detection of crEVIF although detection did not necessarily trigger workup or treatment.	[Preuss, Alexandra; Schaafs, Lars-Arne; Steffen, Ingo G.; Hamm, Bernd; Elgeti, Thomas] Charite, Dept Radiol, D-13353 Berlin, Germany; [Werncke, Thomas] Hannover Med Sch, Inst Radiol, D-30623 Hannover, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School	Schaafs, LA (corresponding author), Charite, Dept Radiol, D-13353 Berlin, Germany.	lars-arne.schaafs@charite.de	Werncke, Thomas/AFV-2471-2022; Schaafs, Lars-Arne/ABC-5936-2021	Schaafs, Lars-Arne/0000-0002-2250-5419	Abbott; Actelion Pharmaceuticals; Bayer Schering Pharma; Bayer Vital; BRACCO Group; Bristol-Myers Squibb; Charite research organisation GmbH; Deutsche Krebshilfe; Dt. Stiftung fur Herzforschung; Essex Pharma; EU Programmes; Fibrex Medical Inc.; Focused Ultrasound Surgery Foundation; Fraunhofer Gesellschaft; Guerbet; INC Research; InSightec Ud.; IPSEN Pharma; Kendlel MorphoSys AG; Lilly GmbH; Lundbeck GmbH; MeVis Medical Solutions AG; Nexus Oncology; Novartis; Parexel Clinical Research Organisation Service; Perceptive; Pfizer GmbH; Philipps; Sanofis-Aventis S.A; Siemens; Spectranetics GmbH; Terumo Medical Corporation; TNS Healthcare GMbH; Toshiba; UCB Pharma; Wyeth Pharma; Zukunftsfond Berlin (TSB); Amgen; AO Foundation; BARD; BBraun; Boehring Ingelheimer; Brainsgate; PPD (Clinical Research Organisation); CELLACT Pharma; Celgene; CeloNova BioSciences; Covance; DC Deviees, Ine. USA; Ganymed; Gilead Sciences; Glaxo Smith Kline; ICON (Clinical Research Organisation); Jansen; LUX Bioseienees; MedPass; Merek; Mologen; Nuvisan; Pluristem; Quintiles; Roehe; Sehumaeher GmbH; Seattle Geneties; Symphogen; TauRx Therapeuties Ud.; Accovion; AIO: Arbeitsgemeinschaft Internistische Onkologie; ASR Advanced sleep research; Astellas; Theradex; Galena Biopharma; Chiltern; PRAint; Inspiremd; Medronic; Respicardia; Silena Therapeutics; Spectrum Pharmaceuticals; St. Jude	Abbott(Abbott Laboratories); Actelion Pharmaceuticals; Bayer Schering Pharma(Bayer AG); Bayer Vital(Bayer AG); BRACCO Group; Bristol-Myers Squibb(Bristol-Myers Squibb); Charite research organisation GmbH; Deutsche Krebshilfe(Deutsche Krebshilfe); Dt. Stiftung fur Herzforschung; Essex Pharma; EU Programmes; Fibrex Medical Inc.; Focused Ultrasound Surgery Foundation; Fraunhofer Gesellschaft; Guerbet; INC Research; InSightec Ud.; IPSEN Pharma(Ipsen); Kendlel MorphoSys AG; Lilly GmbH; Lundbeck GmbH(Lundbeck Corporation); MeVis Medical Solutions AG; Nexus Oncology; Novartis(Novartis); Parexel Clinical Research Organisation Service; Perceptive; Pfizer GmbH; Philipps; Sanofis-Aventis S.A; Siemens(Siemens AG); Spectranetics GmbH; Terumo Medical Corporation; TNS Healthcare GMbH; Toshiba; UCB Pharma(UCB Pharma SA); Wyeth Pharma(Wyeth); Zukunftsfond Berlin (TSB); Amgen(Amgen); AO Foundation; BARD(US-Israel Binational Science Foundation); BBraun; Boehring Ingelheimer; Brainsgate; PPD (Clinical Research Organisation); CELLACT Pharma(Dexcel Pharma); Celgene(Bristol-Myers SquibbCelgene Corporation); CeloNova BioSciences; Covance; DC Deviees, Ine. USA; Ganymed; Gilead Sciences(Gilead Sciences); Glaxo Smith Kline(GlaxoSmithKline); ICON (Clinical Research Organisation); Jansen; LUX Bioseienees; MedPass; Merek; Mologen; Nuvisan; Pluristem; Quintiles; Roehe; Sehumaeher GmbH; Seattle Geneties; Symphogen; TauRx Therapeuties Ud.; Accovion; AIO: Arbeitsgemeinschaft Internistische Onkologie; ASR Advanced sleep research; Astellas(Astellas Pharmaceuticals); Theradex; Galena Biopharma; Chiltern; PRAint; Inspiremd; Medronic; Respicardia; Silena Therapeutics; Spectrum Pharmaceuticals; St. Jude(St. Jude Medical)	BH has received research grants for the Department of Radiology, Charite - Universitatsmedizin Berlin from the following companies: 1. Abbott, 2. Actelion Pharmaceuticals, 3. Bayer Schering Pharma, 4. Bayer Vital, 5. BRACCO Group, 6. Bristol-Myers Squibb, 7. Charite research organisation GmbH, 8. Deutsche Krebshilfe, 9. Dt. Stiftung fur Herzforschung, 10. Essex Pharma, 11. EU Programmes, 12. Fibrex Medical Inc., 13. Focused Ultrasound Surgery Foundation, 14. Fraunhofer Gesellschaft, 15. Guerbet, 16. INC Research, 17. InSightec Ud., 18. IPSEN Pharma, 19. Kendlel MorphoSys AG, 20. Lilly GmbH, 21. Lundbeck GmbH, 22. MeVis Medical Solutions AG, 23. Nexus Oncology, 24. Novartis, 25. Parexel Clinical Research Organisation Service, 26. Perceptive, 27. Pfizer GmbH, 28. Philipps, 29. Sanofis-Aventis S.A, 30. Siemens, 31. Spectranetics GmbH, 32. Terumo Medical Corporation, 33. TNS Healthcare GMbH, 34. Toshiba, 35. UCB Pharma, 36. Wyeth Pharma, 37. Zukunftsfond Berlin (TSB), 38. Amgen, 39. AO Foundation, 40. BARD, 41. BBraun (Sponsoring eines Workshops), 42. Boehring Ingelheimer, 43. Brainsgate, 44. PPD (Clinical Research Organisation), 45. CELLACT Pharma, 46. Celgene, 47. CeloNova BioSciences, 48. Covance, 49. DC Deviees, Ine. USA, 50. Ganymed, 51. Gilead Sciences, 52. Glaxo Smith Kline, 53. ICON (Clinical Research Organisation), 54. Jansen, 55. LUX Bioseienees, 56. MedPass, 57. Merek, 58. Mologen, 59. Nuvisan, 60. Pluristem, 61. Quintiles, 62. Roehe, 63. Sehumaeher GmbH (Sponsoring eines Workshops), 64. Seattle Geneties, 65. Symphogen, 66. TauRx Therapeuties Ud., 67. Accovion, 68. AIO: Arbeitsgemeinschaft Internistische Onkologie, 69. ASR Advanced sleep research, 70. Astellas, 71. Theradex, 72. Galena Biopharma, 73. Chiltern, 74. PRAint, 75. Inspiremd, 76. Medronic, 77. Respicardia, 78. Silena Therapeutics, 79. Spectrum Pharmaceuticals, 80. St. Jude. The remaining authors have no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfaltrer P, 2012, AM J ROENTGENOL, V198, P939, DOI 10.2214/AJR.11.7231; Bendix K, 2011, EUR J RADIOL, V80, P109, DOI 10.1016/j.ejrad.2010.05.024; Berland LL, 2010, J AM COLL RADIOL, V7, P754, DOI 10.1016/j.jacr.2010.06.013; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Crockett MT, 2015, EUR J RADIOL, V84, P1569, DOI 10.1016/j.ejrad.2015.05.014; Duan YH, 2013, AM J ROENTGENOL, V201, pW906, DOI 10.2214/AJR.12.10209; Eun SS, 2012, J NEURORADIOLOGY, V39, P104, DOI 10.1016/j.neurad.2011.02.008; Fung HB, 2010, AM J GERIATR PHARMAC, V8, P47, DOI 10.1016/j.amjopharm.2010.01.003; Han SH, 2013, PAIN PHYSICIAN, V16, P513; HAWKES CH, 1978, J NEUROL SCI, V38, P337, DOI 10.1016/0022-510X(78)90140-5; Iezzi R, 2007, ABDOM IMAGING, V32, P489, DOI 10.1007/s00261-006-9136-6; Jeon CH, 2012, EUR SPINE J, V21, P1165, DOI 10.1007/s00586-011-2072-3; Kayhan A, 2012, EUR J RADIOL, V81, P542, DOI 10.1016/j.ejrad.2011.01.100; Kinder A, 2012, EUR J RADIOL, V81, pE561, DOI 10.1016/j.ejrad.2011.06.027; Levin David C, 2007, J Am Coll Radiol, V4, P457, DOI 10.1016/j.jacr.2007.02.011; Mamisch N, 2012, RADIOLOGY, V264, P174, DOI 10.1148/radiol.12111930; Met R, 2009, JAMA-J AM MED ASSOC, V301, P415, DOI 10.1001/jama.301.4.415; Nadeau M, 2013, CAN J SURG, V56, P372, DOI 10.1503/cjs.016512; Naidu SG, 2010, AM J ROENTGENOL, V194, P1630, DOI 10.2214/AJR.09.3538; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Ouwendijk R, 2005, RADIOLOGY, V236, P1094, DOI 10.1148/radiol.2363041140; Preuss A, 2015, CLIN RADIOL, V70, P622, DOI 10.1016/j.crad.2015.02.014; Schernthaner R, 2008, EUR RADIOL, V18, P665, DOI 10.1007/s00330-007-0822-8; Schernthaner R, 2007, AM J ROENTGENOL, V189, P1215, DOI 10.2214/AJR.07.2054; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; STANTON PE, 1987, AM SURGEON, V53, P71; Steurer J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-175; Suri P, 2010, JAMA-J AM MED ASSOC, V304, P2628, DOI 10.1001/jama.2010.1833; Uesugi K, 2012, J ORTHOP SCI, V17, P673, DOI 10.1007/s00776-012-0311-z; Werncke T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119900; WIESEL SW, 1984, SPINE, V9, P549, DOI 10.1097/00007632-198409000-00003	31	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152780	10.1371/journal.pone.0152780	http://dx.doi.org/10.1371/journal.pone.0152780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054846	Green Published, gold			2022-12-26	WOS:000373608000046
J	Wehbe, M; Anantha, M; Backstrom, I; Leung, A; Chen, K; Malhotra, A; Edwards, K; Bally, MB				Wehbe, Mohamed; Anantha, Malathi; Backstrom, Ian; Leung, Ada; Chen, Kent; Malhotra, Armaan; Edwards, Katarina; Bally, Marcel B.			Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development	PLOS ONE			English	Article							LARGE UNILAMELLAR VESICLES; REACTIVATES LATENT HIV-1; BREAST-CANCER CELLS; RNA-POLYMERASE I; SODIUM DIETHYLDITHIOCARBAMATE; LIPOSOMAL SYSTEMS; ANTICANCER AGENTS; PH GRADIENTS; DISULFIRAM; INHIBITION	The development of copper-drug complexes (CDCs) is hindered due to their very poor aqueous solubility. Diethyldithiocarbamate (DDC) is the primary metabolite of disulfiram, an approved drug for alcoholism that is being repurposed for cancer. The anticancer activity of DDC is dependent on complexation with copper to form copper bis-diethyldithiocarbamate (Cu(DDC)(2)), a highly insoluble complex that has not been possible to develop for indications requiring parenteral administration. We have resolved this issue by synthesizing Cu(DDC)(2) inside liposomes. DDC crosses the liposomal lipid bilayer, reacting with the entrapped copper; a reaction that can be observed through a colour change as the solution goes from a light blue to dark brown. This method is successfully applied to other CDCs including the anti-parasitic drug clioquinol, the natural product quercetin and the novel targeted agent CX-5461. Our method provides a simple, transformative solution enabling, for the first time, the development of CDCs as viable candidate anticancer drugs; drugs that would represent a brand new class of therapeutics for cancer patients.	[Wehbe, Mohamed; Anantha, Malathi; Backstrom, Ian; Leung, Ada; Chen, Kent; Malhotra, Armaan; Bally, Marcel B.] British Columbia Canc Res Ctr, Expt Therapeut, Vancouver, BC V5Z 1L3, Canada; [Wehbe, Mohamed; Bally, Marcel B.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Leung, Ada; Bally, Marcel B.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Edwards, Katarina] Uppsala Univ, Dept Chem, 3 Husargatan B7, Uppsala, Sweden; [Bally, Marcel B.] Ctr Drug Res & Dev, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; Uppsala University	Wehbe, M (corresponding author), British Columbia Canc Res Ctr, Expt Therapeut, Vancouver, BC V5Z 1L3, Canada.; Wehbe, M (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.	Mwehbe@bccrc.ca	Edwards, Katarina/AAR-7679-2021; Edwards, Katarina/A-1159-2012; Bracewell, Daniel/B-1988-2008	Edwards, Katarina/0000-0003-0674-2219; Edwards, Katarina/0000-0003-0674-2219; Bracewell, Daniel/0000-0003-3866-3304; Leung, Ada/0000-0002-8018-1248; Backstrom, Ian/0000-0003-2203-540X	Canadian Institutes of Health Research [MOP102611]; Canadian Cancer Society Research Institute [702491]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	The research described in this original paper was supported by grant funding from the Canadian Institutes of Health Research (MOP102611) http://www.cihr-irsc.gc.ca/e/193.html and the Canadian Cancer Society Research Institute (Award #702491) http://www.cancer.ca/en/research/grants-and-awards/current-funding-opportunities/innovationgrants/. Both grants were received by MB.	Abraham SA, 2005, METHOD ENZYMOL, V391, P71, DOI 10.1016/S0076-6879(05)91004-5; Abraham SA, 2004, J CONTROL RELEASE, V96, P449, DOI 10.1016/j.jconrel.2004.02.017; Allen C, 2002, BIOSCIENCE REP, V22, P225, DOI 10.1023/A:1020186505848; Bacher F, 2015, DALTON T, V44, P9071, DOI 10.1039/c5dt01076d; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Ceh B, 1997, J COLLOID INTERF SCI, V185, P9, DOI 10.1006/jcis.1996.4555; Chen D, 2007, CANCER RES, V67, P1636, DOI 10.1158/0008-5472.CAN-06-3546; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Chityala VK, 2014, BIOINORG CHEM APPL, V2014, DOI 10.1155/2014/691260; Creaven BS, 2010, INORG CHIM ACTA, V363, P4048, DOI 10.1016/j.ica.2010.08.009; CULLIS PR, 1991, TRENDS BIOTECHNOL, V9, P268, DOI 10.1016/0167-7799(91)90088-Y; Cvek B, 2008, J MED CHEM, V51, P6256, DOI 10.1021/jm8007807; Dicko A, 2007, INT J PHARMACEUT, V337, P219, DOI 10.1016/j.ijpharm.2007.01.004; Ding WQ, 2009, IUBMB LIFE, V61, P1013, DOI 10.1002/iub.253; Dos Santos N, 2004, BBA-BIOMEMBRANES, V1661, P47, DOI 10.1016/j.bbamem.2003.11.016; Doyon G, 2013, AIDS, V27, pF7, DOI 10.1097/QAD.0b013e3283570620; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Frezza M, 2010, CURR PHARM DESIGN, V16, P1813, DOI 10.2174/138161210791209009; Gou Y, 2015, J INORG BIOCHEM, V144, P47, DOI 10.1016/j.jinorgbio.2014.12.012; Haddach M, 2012, ACS MED CHEM LETT, V3, P602, DOI 10.1021/ml300110s; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; Hein N, 2013, CANCER RES, V73, DOI 10.1158/1538-7445.FBCR13-B16; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; JOHANSSON B, 1992, ACTA PSYCHIAT SCAND, V86, P15, DOI 10.1111/j.1600-0447.1992.tb03310.x; Kanchi S, 2014, ARAB J CHEM, V7, P11, DOI 10.1016/j.arabjc.2013.04.026; LAKOMAA EL, 1982, TOXICOL APPL PHARM, V65, P286, DOI 10.1016/0041-008X(82)90011-4; Liu P, 2012, BRIT J CANCER, V107, P1488, DOI 10.1038/bjc.2012.442; MADDEN TD, 1990, CHEM PHYS LIPIDS, V53, P37, DOI 10.1016/0009-3084(90)90131-A; Marzano C, 2009, ANTI-CANCER AGENT ME, V9, P185, DOI 10.2174/187152009787313837; MAYER LD, 1990, BIOCHIM BIOPHYS ACTA, V1025, P143, DOI 10.1016/0005-2736(90)90091-2; Moseley H W, 1934, Science, V79, P507, DOI 10.1126/science.79.2057.507-a; Palanimuthu D, 2013, J MED CHEM, V56, P722, DOI 10.1021/jm300938r; Rae C, 2013, J NUCL MED, V54, P953, DOI 10.2967/jnumed.112.113324; SANANDRES MP, 1994, TALANTA, V41, P179, DOI 10.1016/0039-9140(94)80105-3; Santini C, 2014, CHEM REV, V114, P815, DOI 10.1021/cr400135x; Schimmer AD, 2011, CURR CANCER DRUG TAR, V11, P325; Tripathy DR, 2011, FEBS LETT, V585, P3270, DOI 10.1016/j.febslet.2011.09.005; WILLMOTT PL, 1950, ANALYST, V75, P24, DOI 10.1039/an9507500024; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Zhang HJ, 2010, CANCER RES, V70, P3996, DOI 10.1158/0008-5472.CAN-09-3752	40	34	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153416	10.1371/journal.pone.0153416	http://dx.doi.org/10.1371/journal.pone.0153416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055237	Green Published, Green Submitted, gold			2022-12-26	WOS:000373608000129
J	Collin, A; Le Marec, F; Vandenhende, MA; Lazaro, E; Duffau, P; Cazanave, C; Gerard, Y; Dabis, F; Bruyand, M; Bonnet, F				Collin, Amandine; Le Marec, Fabien; Vandenhende, Marie-Anne; Lazaro, Estibaliz; Duffau, Pierre; Cazanave, Charles; Gerard, Yann; Dabis, Francois; Bruyand, Mathias; Bonnet, Fabrice		ANRS CO3 Aquitaine Cohort Study Gr	Incidence and Risk Factors for Severe Bacterial Infections in People Living with HIV. ANRS CO3 Aquitaine Cohort, 2000-2012	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MICROBIAL TRANSLOCATION; PNEUMONIA; MORTALITY; VIRUS; MORBIDITY; DISEASE; TRENDS; ERA	Severe non-AIDS bacterial infections (SBI) are the leading cause of hospital admissions among people living with HIV (PLHIV) in industrialized countries. We aimed to estimate the incidence of SBI and their risk factors in a large prospective cohort of PLHIV patients over a 13-year period in France. Patients followed up in the ANRS CO3 Aquitaine cohort between 2000 and 2012 were eligible; SBI was defined as a clinical diagnosis associated with hospitalization of >= 48 hours or death. Survival analysis was conducted to identify risk factors for SBI. Total follow-up duration was 39,256 person-years [PY] (31,370 PY on antiretroviral treatment [ART]). The incidence of SBI decreased from 26.7/1000 PY [95% CI: 22.9-30.5] over the period 2000-2002 to 11.9/1000 PY [10.1-13.8] in 2009-2012 (p <0.0001). Factors independently associated to increased risk of SBI were: plasma HIVRNA>50 copies/mL (Hazard Ratio [HR] = 5.1, 95% Confidence Interval: 4.2-6.2), CD4 count <500 cells/mm(3) and CD4/CD8 ratio <0.8 (with a dose-response relationship for both markers), history of cancer (HR = 1.4 [1.0-1.9]), AIDS stage (HR = 1.7 [1.3-2.1]) and HCV coinfection (HR = 1.4, [1.1-1.6]). HIV-positive patients with diabetes were more prone to SBI (HR = 1.6 [0.92.6]). Incidence of SBI decreased over a 13-year period due to the improvement in the virological and immune status of PLHIV on ART. Risk factors for SBI include low CD4 count and detectable HIV RNA, but also CD4/CD8 ratio, HCV coinfection, history of cancer and diabetes, comorbid conditions that have been frequent among PLHIV in recent years.	[Collin, Amandine; Vandenhende, Marie-Anne; Lazaro, Estibaliz; Duffau, Pierre; Cazanave, Charles; Gerard, Yann; Dabis, Francois; Bruyand, Mathias; Bonnet, Fabrice] Ctr Hosp Univ CHU Bordeaux, Coordinat Reg Lutte Infect VIH COREVIH, Bordeaux, France; [Collin, Amandine; Vandenhende, Marie-Anne; Duffau, Pierre; Bonnet, Fabrice] CHU Bordeaux, Serv Med Interne, Bordeaux, France; [Collin, Amandine; Vandenhende, Marie-Anne; Duffau, Pierre; Bonnet, Fabrice] CHU Bordeaux, Serv Malad Infect, Bordeaux, France; [Le Marec, Fabien; Vandenhende, Marie-Anne; Dabis, Francois; Bruyand, Mathias; Bonnet, Fabrice] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Rue Leo Saignat, Bordeaux, France; [Le Marec, Fabien; Vandenhende, Marie-Anne; Dabis, Francois; Bruyand, Mathias; Bonnet, Fabrice] Univ Bordeaux, INSERM, U897, Ctr Inserm Epidemiol & Biostat, Rue Leo Saignat, Bordeaux, France; [Lazaro, Estibaliz] CHU Bordeaux, Serv Med Interne & Malad Infect, Pessac, France; [Cazanave, Charles] CHU Bordeaux, Federat Malad Infect & Trop, Pessac, France; [Gerard, Yann] CH Dax, Serv Malad Infect, Dax, France	CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux	Bonnet, F (corresponding author), Ctr Hosp Univ CHU Bordeaux, Coordinat Reg Lutte Infect VIH COREVIH, Bordeaux, France.; Bonnet, F (corresponding author), CHU Bordeaux, Serv Med Interne, Bordeaux, France.; Bonnet, F (corresponding author), CHU Bordeaux, Serv Malad Infect, Bordeaux, France.; Bonnet, F (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Rue Leo Saignat, Bordeaux, France.; Bonnet, F (corresponding author), Univ Bordeaux, INSERM, U897, Ctr Inserm Epidemiol & Biostat, Rue Leo Saignat, Bordeaux, France.	fabrice.bonnet@chu-bordeaux.fr	Bonnet, Fabrice/T-3254-2019; Vandenhende, Marie-Anne/T-6625-2019; DABIS, FRANCOIS/S-9298-2019; Bruyand, Mathias/AAP-6177-2020; Cazanave, Charles/AHE-5492-2022	DABIS, FRANCOIS/0000-0002-1614-8857; 	France Recherche Nord&Sud Sida-HIV Hepatites (ANRS) [7 (AC7)]; Bordeaux University Hospital through the COREVIH Aquitaine [Inserm (U897)]; Bordeaux School of Public Health (ISPED)	France Recherche Nord&Sud Sida-HIV Hepatites (ANRS); Bordeaux University Hospital through the COREVIH Aquitaine; Bordeaux School of Public Health (ISPED)	This work is supported by a grant of France Recherche Nord&Sud Sida-HIV Hepatites (ANRS) within the Coordinated Action no. 7 (AC7). Other sources of support include the Bordeaux University Hospital through the COREVIH Aquitaine, Inserm (U897) and the Bordeaux School of Public Health (ISPED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida D, 2001, Braz J Infect Dis, V5, P136; [Anonymous], 2014, ALINEA PLUS; Benard A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008896; Bertoni AG, 2001, DIABETES CARE, V24, P1044, DOI 10.2337/diacare.24.6.1044; Bonnet F, 2007, HIV MED, V8, P547, DOI 10.1111/j.1468-1293.2007.00508.x; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Christou L, 2007, AM J GASTROENTEROL, V102, P1510, DOI 10.1111/j.1572-0241.2007.01286.x; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Domingo P, 2009, JAIDS-J ACQ IMM DEF, V51, P582, DOI 10.1097/QAI.0b013e3181adcb01; Ferry T, 2009, JAIDS-J ACQ IMM DEF, V51, P407, DOI 10.1097/QAI.0b013e3181acb65f; Ford N, 2015, LANCET; Grau I, 2005, ARCH INTERN MED, V165, P1533, DOI 10.1001/archinte.165.13.1533; Hessamfar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102671; Hodgson K, 2015, IMMUNOLOGY, V144, P171, DOI 10.1111/imm.12394; Hoen B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19034; Holland T, 2014, CLIN INFECT DIS, V59, pS331, DOI 10.1093/cid/ciu598; Huson MAM, 2015, LANCET INFECT DIS, V15, P95, DOI 10.1016/S1473-3099(14)70917-X; Huson MAM, 2014, CLIN INFECT DIS, V58, P79, DOI 10.1093/cid/cit596; Kohli R, 2006, CLIN INFECT DIS, V43, P90, DOI 10.1086/504871; Kosmidis CI, 2012, LEUKEMIA LYMPHOMA, V53, P8, DOI 10.3109/10428194.2011.602770; Landau DA, 2010, J RHEUMATOL, V37, P615, DOI 10.3899/jrheum.090790; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222; Nitzan O, 2015, DIABET METAB SYND OB, V8, P129, DOI 10.2147/DMSO.S51792; Pedersen RH, 2011, HIV MED, V12, P323, DOI 10.1111/j.1468-1293.2010.00892.x; Serrano-Villar S, 2014, PLOS ONE, V1; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Sogaard OS, 2013, J INFECTION, V66, P439, DOI 10.1016/j.jinf.2012.12.012; Sogaard OS, 2008, CLIN INFECT DIS, V47, P1345, DOI 10.1086/592692; Terrier B, 2011, ARTHRITIS RHEUM-US, V63, P1748, DOI 10.1002/art.30319; Thyrault M, 1997, INTENS CARE MED, V23, P1018, DOI 10.1007/s001340050451	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152970	10.1371/journal.pone.0152970	http://dx.doi.org/10.1371/journal.pone.0152970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050752	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500073
J	Doucette, A; Jiang, XH; Fryzek, J; Coalson, J; McLaurin, K; Ambrose, CS				Doucette, Abigail; Jiang, Xiaohui; Fryzek, Jon; Coalson, Jenna; McLaurin, Kimmie; Ambrose, Christopher S.			Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997-2012	PLOS ONE			English	Article							DOWN-SYNDROME; PALIVIZUMAB PROPHYLAXIS; YOUNG-CHILDREN; PREVENTION; INFECTION; DISEASE; OUTCOMES; BURDEN; EPIDEMIOLOGY; EXPERIENCE	Background Respiratory syncytial virus (RSV) causes significant pediatric morbidity and is the most common cause of bronchiolitis. Bronchiolitis hospitalizations declined among US infants from 2000. 2009; however, rates in infants at high risk for RSV have not been described. This study examined RSV and unspecified bronchiolitis (UB) hospitalization rates from 1997. 2012 among US high-risk infants. Methods The Kids' Inpatient Database (KID) infant annual RSV (ICD-9 079.6, 466.11, 480.1) and UB (ICD-9 466.19, 466.1) hospitalization rates were estimated using weighted counts. Denominators were based on birth hospitalizations with conditions associated with high-risk for RSV: chronic perinatal respiratory disease (chronic lung disease [CLD]); congenital airway anomalies (CAA); congenital heart disease (CHD); Down syndrome (DS); and other genetic, metabolic, musculoskeletal, and immunodeficiency conditions. Preterm infants could not be identified. Hospitalizations were characterized by mechanical ventilation, inpatient mortality, length of stay, and total cost (2015$). Poisson and linear regression were used to test statistical significance of trends. Results RSV and UB hospitalization rates were substantially elevated for infants with higher-risk CHD, CLD, CAA and DS without CHD compared with all infants. RSV rates declined by 47.0% in CLD and 49.7% in higher-risk CHD infants; no other declines in high-risk groups were observed. UB rates increased in all high-risk groups except for a 22.5% decrease among higher-risk CHD. Among high-risk infants, mechanical ventilation increased through 2012 to 20.4% and 13.5% of RSV and UB hospitalizations; geometric mean cost increased to $31,742 and $25,962, respectively, and RSV mortality declined to 0.9%. Conclusions Among high-risk infants between 1997 and 2012, RSV hospitalization rates declined among CLD and higher-risk CHD infants, coincident with widespread RSV immunoprophylaxis use in these populations. UB hospitalization rates increased in all high-risk groups except higher-risk CHD, suggesting improvement in the health status of higher-risk CHD infants, potentially due to enhanced surgical interventions. Mechanical ventilation use and RSV and UB hospitalization costs increased while RSV mortality declined.	[Doucette, Abigail; Jiang, Xiaohui; Fryzek, Jon; Coalson, Jenna] Epidstat, Ann Arbor, MI USA; [McLaurin, Kimmie; Ambrose, Christopher S.] AstraZeneca, Gaithersburg, MD USA	AstraZeneca	Ambrose, CS (corresponding author), AstraZeneca, Gaithersburg, MD USA.	AmbroseC@MedImmune.com	Coalson, Jenna/AAD-6653-2020	Coalson, Jenna/0000-0002-8591-5642; Ambrose, Christopher/0000-0003-4175-7336	AstraZeneca; Epidstat	AstraZeneca(AstraZeneca); Epidstat	This research was funded by AstraZeneca. Employees of AstraZeneca (KM, CSA) were involved in the study design, decision to publish, and preparation of the manuscript. The funder provided support in the form of salaries for authors (KM, CSA), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. AstraZeneca provided Epidstat with research support for this study. Employees of Epidstat were involved in the study design (JF), data analysis (AD, XJ, JC), and preparation of the manuscript (AD, XJ, JF, JC). Epidstat provided support in the form of salaries for authors (AD, XJ, JF, JC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Editorial assistance was provided by Complete Healthcare Communications, LLC (Chadds Ford, PA, USA) and funded by AstraZeneca.	Abramson JS, 2003, PEDIATRICS, V112, P1442; Arnold SR, 1999, PEDIATR INFECT DIS J, V18, P866, DOI 10.1097/00006454-199910000-00006; Bloemers BLP, 2007, PEDIATRICS, V120, pE1076, DOI 10.1542/peds.2007-0788; Centers for Disease Control and Prevention, RSV INFECTION AND IN; Checchia PA, 2011, PEDIATR CRIT CARE ME, V12, P580, DOI 10.1097/PCC.0b013e3182070990; Cohen SA, 2008, PEDIATR CARDIOL, V29, P382, DOI 10.1007/s00246-007-9039-5; Counihan ME, 2001, PEDIATR INFECT DIS J, V20, P646, DOI 10.1097/00006454-200107000-00003; Erikssen G, 2015, CIRCULATION, V131, P337, DOI 10.1161/CIRCULATIONAHA.114.012033; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Frogel M, 2008, J PERINATOL, V28, P511, DOI 10.1038/jp.2008.28; Groothuis Jessie R, 2011, Clin Epidemiol, V3, P245, DOI 10.2147/CLEP.S17189; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hasegawa K, 2013, PEDIATRICS, V132, P28, DOI 10.1542/peds.2012-3877; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Iwane MK, 2013, J INFECT DIS, V208, pS165, DOI 10.1093/infdis/jit484; Langley GF, 2011, PEDIATR INFECT DIS J, V30, P510, DOI 10.1097/INF.0b013e3182184ae7; Makari D, 2015, CLIN PEDIATR, V54, P594, DOI 10.1177/0009922814546040; Mitchell I, 2006, PEDIATR PULM, V41, P1167, DOI 10.1002/ppul.20507; Mori M, 2014, J INFECT CHEMOTHER, V20, P455, DOI 10.1016/j.jiac.2014.05.001; Mullins JA, 2003, PEDIATR INFECT DIS J, V22, P857, DOI 10.1097/01.inf.0000090921.21313.d3; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Parnes C, 2003, PEDIATR PULM, V35, P484, DOI 10.1002/ppul.10288; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Romero JR, 2003, PEDIATR INFECT DIS J, V22, pS46, DOI 10.1097/00006454-200302001-00007; Sample NNI, AGENCY HEALTHCARE RE; Simoes EAF, 2002, RESP RES, V3, DOI 10.1186/rr187; Sorrentino M, 2000, PEDIATR INFECT DIS J, V19, P1068, DOI 10.1097/00006454-200011000-00007; Stagliano DR, 2015, J PEDIATR-US, V166, P703, DOI 10.1016/j.jpeds.2014.11.058; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; Wonder C, NATALITY 2003 2006; Wonder C, 2007, NATALITY 2007 2013; Wonder C., NATALITY 1995 2002; Yi H, 2014, PEDIATRICS, V133, P1031, DOI 10.1542/peds.2013-3916; Zachariah P, 2012, J PEDIATR-US, V160, P827, DOI 10.1016/j.jpeds.2011.11.004; Zachariah P, 2011, PEDIATR INFECT DIS J, V30, P442, DOI 10.1097/INF.0b013e318201813b	39	51	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152208	10.1371/journal.pone.0152208	http://dx.doi.org/10.1371/journal.pone.0152208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050095	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500030
J	Edwards, HH; Martin, J; Deutsch, CJ; Muller, RG; Koslovsky, SM; Smith, AJ; Barlas, ME				Edwards, Holly H.; Martin, Julien; Deutsch, Charles J.; Muller, Robert G.; Koslovsky, Stacie M.; Smith, Alexander J.; Barlas, Margaret E.			Influence of Manatees' Diving on Their Risk of Collision with Watercraft	PLOS ONE			English	Article							ATLANTIC RIGHT WHALES; FLORIDA MANATEES; AERIAL SURVEYS; ABUNDANCE; PROBABILITY; FRAMEWORK; WINBUGS; MAMMALS	Watercraft pose a threat to endangered Florida manatees (Trichechus manatus latirostris). Mortality from watercraft collisions has adversely impacted the manatee population's growth rate, therefore reducing this threat is an important management goal. To assess factors that contribute to the risk of watercraft strikes to manatees, we studied the diving behavior of nine manatees carrying GPS tags and time-depth recorders in Tampa Bay, Florida, during winters 2002-2006. We applied a Bayesian formulation of generalized linear mixed models to depth data to model the probability (P-t) that manatees would be no deeper than 1.25 m from the water's surface as a function of behavioral and habitat covariates. Manatees above this threshold were considered to be within striking depth of a watercraft. Seventy-eight percent of depth records (individual range 62-86%) were within striking depth (mean = 1.09 m, max = 16.20 m), illustrating how vulnerable manatees are to strikes. In some circumstances manatees made consecutive dives to the bottom while traveling, even in areas >14 m, possibly to conserve energy. This is the first documentation of potential cost-efficient diving behavior in manatees. Manatees were at higher risk of being within striking depth in shallow water (<0.91 m), over seagrass, at night, and while stationary or moving slowly; they were less likely to be within striking depth when <= 50 m from a charted waterway. In shallow water the probability of a manatee being within striking depth was 0.96 (CI = 0.93-0.98) and decreased as water depth increased. The probability was greater over seagrass (P-t = 0.96, CI = 0.93-0.98) than over other substrates (P-t = 0.73, CI = 0.58-0.84). Quantitative approaches to assessing risk can improve the effectiveness of manatee conservation measures by helping identify areas for protection.	[Edwards, Holly H.; Muller, Robert G.; Koslovsky, Stacie M.; Smith, Alexander J.; Barlas, Margaret E.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, 100 Eighth Ave SE, St Petersburg, FL 33710 USA; [Martin, Julien] US Geol Survey, Southeast Ecol Sci Ctr, 7920 NW 71st St, Gainesville, FL 32653 USA; [Deutsch, Charles J.] Florida Fish & Wildlife Conservat Commiss, Wildlife Res Lab, Fish & Wildlife Res Inst, 1105 SW Williston Rd, Gainesville, FL 32610 USA; [Smith, Alexander J.] Ramboll ENVIRON Int Corp, 10150 Highland Manor Dr, Tampa, FL 33610 USA	Florida Fish & Wildlife Conservation Commission; United States Department of the Interior; United States Geological Survey; Florida Fish & Wildlife Conservation Commission	Edwards, HH (corresponding author), Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, 100 Eighth Ave SE, St Petersburg, FL 33710 USA.	holly.edwards@myfwc.com		Martin, Julien/0000-0002-7375-129X; Barlas, Margaret/0000-0002-2378-4296	Wildlife Foundation of Florida (Conserve Wildlife Tag Fund); U.S. Fish and Wildlife Service; Pinellas County Environmental Fund; Tampa Port Authority; FWC's Save the Manatee Trust Fund; National Sea Grant College Program of the USA; Department of Commerce's National Oceanic and Atmospheric Administration (NOAA) [NA 14OAR4170108]	Wildlife Foundation of Florida (Conserve Wildlife Tag Fund); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Pinellas County Environmental Fund; Tampa Port Authority; FWC's Save the Manatee Trust Fund; National Sea Grant College Program of the USA; Department of Commerce's National Oceanic and Atmospheric Administration (NOAA)	This work was funded by the Wildlife Foundation of Florida (Conserve Wildlife Tag Fund), U.S. Fish and Wildlife Service, the Pinellas County Environmental Fund, Tampa Port Authority, and FWC's Save the Manatee Trust Fund. Support was also provided by the National Sea Grant College Program of the USA. Department of Commerce's National Oceanic and Atmospheric Administration (NOAA) Grant No. NA 14OAR4170108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauduin S, 2013, BIOL CONSERV, V159, P127, DOI 10.1016/j.biocon.2012.10.031; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Calleson CS, 2014, ENDANGER SPECIES RES, V26, P127, DOI 10.3354/esr00638; Carlson P, 2011, SEAGRASS RECOVERY TA; Chilvers BL, 2004, J EXP MAR BIOL ECOL, V304, P203, DOI 10.1016/j.jembe.2003.12.010; Deutsch Charles J., 2012, P23; Deutsch CJ, 2006, CWT040512 WILDL FDN; Edwards HH, 2007, J WILDLIFE MANAGE, V71, P2052, DOI 10.2193/2005-645; Fonnesbeck CJ, 2009, ENVIRON ECOL STAT SE, V3, P563, DOI 10.1007/978-0-387-78151-8_24; FWC (Florida Fish and Wildlife Conservation Commission), 2007, FLOR MAN MAN PLAN TR; Hagihara R, 2014, MAR MAMMAL SCI, V30, P348, DOI 10.1111/mms.12041; Hess KW, 2001, 11 NOAA NOS CS; IRVINE AB, 1983, BIOL CONSERV, V25, P315; Kery M., 2010, INTRO WINBUGS ECOLOG; Laist DW, 2005, COAST MANAGE, V33, P279, DOI 10.1080/08920750590952018; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Marsh H., 2011, ECOLOGY CONSERVATION; Martin J, 2016, METHODS ECOL EVOL, V7, P42, DOI 10.1111/2041-210X.12447; Martin J, 2015, BIOL CONSERV, V186, P44, DOI 10.1016/j.biocon.2015.02.029; Parks SE, 2012, BIOL LETTERS, V8, P57, DOI 10.1098/rsbl.2011.0578; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; R Core Team, 2021, R LANGUAGE ENV STAT; Runge MC, 2007, 2007108634 US GEOL S; Rycyk A, 2013, THESIS FLORIDA STATE; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Sidman C, 2004, TP130 U FLOR SEA GRA; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Tampa Bay Estuary Program, 2006, 0606 TP TAMP BAY EST; van der Hoop JM, 2012, ECOL APPL, V22, P2021, DOI 10.1890/11-1841.1; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133; Williams TM, 2001, AM ZOOL, V41, P166, DOI 10.1668/0003-1569(2001)041[0166:ISBMAS]2.0.CO;2; Worthy GAJ, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P791, DOI 10.1201/9781420041637.ch36	35	13	14	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151450	10.1371/journal.pone.0151450	http://dx.doi.org/10.1371/journal.pone.0151450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049326	Green Published, gold			2022-12-26	WOS:000373603500007
J	Luter, HM; Duckworth, AR; Wolff, CW; Evans-Illidge, E; Whalan, S				Luter, Heidi M.; Duckworth, Alan R.; Wolff, Carsten W.; Evans-Illidge, Elizabeth; Whalan, Steve			Recruitment Variability of Coral Reef Sessile Communities of the Far North Great Barrier Reef	PLOS ONE			English	Article							BENTHIC ASSEMBLAGES; SPATIAL VARIABILITY; SETTLEMENT CUES; TORRES STRAIT; LIZARD ISLAND; PATTERNS; SCALES; ECOLOGY; INVERTEBRATES; POPULATIONS	One of the key components in assessing marine sessile organism demography is determining recruitment patterns to benthic habitats. An analysis of serially deployed recruitment tiles across depth (6 and 12 m), seasons (summer and winter) and space (meters to kilometres) was used to quantify recruitment assemblage structure (abundance and percent cover) of corals, sponges, ascidians, algae and other sessile organisms from the northern sector of the Great Barrier Reef (GBR). Polychaetes were most abundant on recruitment titles, reaching almost 50% of total recruitment, yet covered <5% of each tile. In contrast, mean abundances of sponges, ascidians, algae, and bryozoans combined was generally less than 20% of total recruitment, with percentage cover ranging between 15-30% per tile. Coral recruitment was very low, with <1 recruit per tile identified. A hierarchal analysis of variation over a range of spatial and temporal scales showed significant spatio-temporal variation in recruitment patterns, but the highest variability occurred at the lowest spatial scale examined (1 m -among tiles). Temporal variability in recruitment of both numbers of taxa and percentage cover was also evident across both summer and winter. Recruitment across depth varied for some taxonomic groups like algae, sponges and ascidians, with greatest differences in summer. This study presents some of the first data on benthic recruitment within the northern GBR and provides a greater understanding of population ecology for coral reefs.	[Luter, Heidi M.] NAMRA, Darwin, NT, Australia; [Luter, Heidi M.] Australian Inst Marine Sci, Arafura Timor Res Facil, Darwin, NT, Australia; [Luter, Heidi M.; Duckworth, Alan R.; Wolff, Carsten W.; Evans-Illidge, Elizabeth] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia; [Whalan, Steve] Cent Caribbean Marine Inst, Little Cayman, Cayman Islands, Cayman Islands; [Whalan, Steve] So Cross Univ, Marine Ecol Res Ctr, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia	Australian Institute of Marine Science; Australian Institute of Marine Science; Southern Cross University	Luter, HM (corresponding author), NAMRA, Darwin, NT, Australia.; Luter, HM (corresponding author), Australian Inst Marine Sci, Arafura Timor Res Facil, Darwin, NT, Australia.; Luter, HM (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	h.luter@aims.gov.au	Evans-Illidge, Libby/AAK-1521-2021; Duckworth, Alan/F-3290-2017; Luter, Heidi M/E-9519-2016	Duckworth, Alan/0000-0002-5451-7633; Luter, Heidi M/0000-0001-7810-7076; Whalan, Steve/0000-0001-6786-8945	Marine and Tropical Sciences Research Facility [1.3.2]	Marine and Tropical Sciences Research Facility	This study was funded by the Marine and Tropical Sciences Research Facility, Project 1.3.2: Ecological role and potential economic value of sponges to the Torres Strait.	Abdul Wahab MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098181; Abdul Wahab MA, 2011, CORAL REEFS, V30, P451, DOI 10.1007/s00338-011-0727-5; Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Ayre DJ, 2000, EVOLUTION, V54, P1590; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Bauman AG, 2014, MAR ECOL PROG SER, V499, P115, DOI 10.3354/meps10662; Bell JJ, 2014, CONSERV GENET RESOUR, V6, P105, DOI 10.1007/s12686-013-0015-5; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Colvard NB, 2011, J EXP MAR BIOL ECOL, V397, P153, DOI 10.1016/j.jembe.2010.11.015; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Doropoulos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128535; Duckworth AR, 2008, CONT SHELF RES, V28, P2168, DOI 10.1016/j.csr.2008.03.024; Duckworth AR, 2007, AQUACULTURE, V271, P188, DOI 10.1016/j.aquaculture.2007.06.037; Duckworth AR, 2016, MAR FRESHWATER RES, V67, P246, DOI 10.1071/MF14308; Dunstan PK, 1998, CORAL REEFS, V17, P71, DOI 10.1007/s003380050098; Edmunds PJ, 2015, MAR FRESHWATER RES, V66, P609, DOI 10.1071/MF14139; Edmunds PJ, 2010, MAR ECOL PROG SER, V414, P75, DOI 10.3354/meps08728; Ettinger-Epstein P, 2008, MAR ECOL PROG SER, V365, P103, DOI 10.3354/meps07503; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Glassom D, 2004, MAR BIOL, V144, P641, DOI 10.1007/s00227-003-1243-0; Green DH, 2011, J EXP MAR BIOL ECOL, V397, P220, DOI 10.1016/j.jembe.2010.12.004; Harriott VJ, 1999, CORAL REEFS, V18, P281, DOI 10.1007/s003380050195; HARRIOTT VJ, 1988, AUST J MAR FRESH RES, V39, P409; Haywood MDE, 2008, CONT SHELF RES, V28, P2304, DOI 10.1016/j.csr.2008.03.039; Holloway MG, 2002, ECOL APPL, V12, P1803, DOI 10.2307/3099939; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUTCHINGS PA, 1981, B MAR SCI, V31, P410; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Lasker HR, 2015, PEERJ, V3, DOI 10.7717/peerj.1019; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; MAIDA M, 1995, B MAR SCI, V56, P303; Martin R, 2014, P13AC00436; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Metaxas A, 2001, CAN J FISH AQUAT SCI, V58, P86, DOI 10.1139/cjfas-58-1-86; MULLINEAUX LS, 1990, LIMNOL OCEANOGR, V35, P409, DOI 10.4319/lo.1990.35.2.0409; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; O'Leary JK, 2011, CORAL REEFS, V30, P1013, DOI 10.1007/s00338-011-0789-4; OSMAN RW, 1977, ECOL MONOGR, V47, P37, DOI 10.2307/1942223; Palumbi SR, 2003, ECOL APPL, V13, pS146; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Ribas J, 2015, ZOOTAXA, V4019, P7, DOI 10.11646/zootaxa.4019.1.4; Shanks AL, 2003, ECOL APPL, V13, pS159; Smale DA, 2013, MAR ECOL PROG SER, V482, P29, DOI 10.3354/meps10273; SMALL AM, 1998, ATOLL RES B, V458, P1, DOI DOI 10.5479/SI.00775630.458.1; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; TODD CD, 1986, J EXP MAR BIOL ECOL, V99, P199, DOI 10.1016/0022-0981(86)90224-8; Tuya F, 2004, MAR ECOL PROG SER, V278, P157, DOI 10.3354/meps278157; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; Wahl M, 2001, J EXP MAR BIOL ECOL, V258, P101, DOI 10.1016/S0022-0981(00)00348-8; Watson DI, 2004, MAR BIOL, V145, P201, DOI 10.1007/s00227-003-1291-5; Welsh JQ, 2012, CORAL REEFS, V31, P991, DOI 10.1007/s00338-012-0922-z; Whalan S, 2008, MAR ECOL PROG SER, V368, P145, DOI 10.3354/meps07573; Whalan S, 2008, AQUAT BIOL, V3, P111, DOI 10.3354/ab00066; Whalan S, 2005, MAR BIOL, V146, P425, DOI 10.1007/s00227-004-1466-8; Whalan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04072; Whalan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117675; Whalan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030386; WILKINSON CR, 1989, CORAL REEFS, V8, P127, DOI 10.1007/BF00338268	66	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153184	10.1371/journal.pone.0153184	http://dx.doi.org/10.1371/journal.pone.0153184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049650	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500111
J	Tran, BX; Nguyen, LH; Nguyen, LP; Nguyen, CT; Phan, HTT; Latkin, CA				Bach Xuan Tran; Long Hoang Nguyen; Lan Phuong Nguyen; Cuong Tat Nguyen; Huong Thi Thu Phan; Latkin, Carl A.			Methadone Maintenance Treatment Promotes Referral and Uptake of HIV Testing and Counselling Services amongst Drug Users and Their Partners	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; QUALITY-OF-LIFE; PEER EDUCATION; INJECT DRUGS; PREVENTION; ATTITUDES; HIV/AIDS; ADULTS; WOMEN; DETERMINANTS	Background Methadone maintenance treatment (MMT) reduces HIV risk behaviors and improves access to HIV-related services among drug users. In this study, we assessed the uptake and willingness of MMT patients to refer HIV testing and counseling (HTC) service to their sexual partners and relatives. Methods Health status, HIV-related risk behaviors, and HTC uptake and referrals of 1,016 MMT patients in Hanoi and Nam Dinh were investigated. Willingness to pay (WTP) for HTC was elicited using a contingent valuation technique. Interval and logistic regression models were employed to determine associated factors. Results Most of the patients (94.2%) had received HTC, 6.6 times on average. The proportion of respondents willing to refer their partners, their relatives and to be voluntary peer educators was 45.7%, 35.3%, and 33.3%, respectively. Attending MMT integrated with HTC was a facilitative factor for HTC uptake, greater WTP, and volunteering as peer educators. Older age, higher education and income, and HIV positive status were positively related to willingness to refer partners or relatives, while having health problems (mobility, usual care, pain/discomfort) was associated with lower likelihood of referring others or being a volunteer. Over 90% patients were willing to pay an average of US $17.9 for HTC service. Conclusion The results highlighted the potential role of MMT patients as referrers to HTC and voluntary peer educators. Integrating HIV testing with MMT services and applying users' fee are potential strategies to mobilize resources and encourage HIV testing among MMT patients and their partners.	[Bach Xuan Tran; Long Hoang Nguyen] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi 100803, Vietnam; [Bach Xuan Tran; Latkin, Carl A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Long Hoang Nguyen] Vietnam Natl Univ, Sch Med & Pharm, Hanoi, Vietnam; [Lan Phuong Nguyen] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Cuong Tat Nguyen] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam; [Huong Thi Thu Phan] Minist Hlth, Author HIV AIDS Control, Hanoi, Vietnam	Hanoi Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Vietnam National University Hanoi; Harvard University; Harvard T.H. Chan School of Public Health; Duy Tan University	Tran, BX (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi 100803, Vietnam.; Tran, BX (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.	bach@jhu.edu	Nguyen, Long/E-6145-2015	Nguyen, Long/0000-0003-1658-2394				Achmad Yanni Melliandari, 2009, Acta Med Indones, V41 Suppl 1, P23; [Anonymous], 2014, HIV AIDS JUNPO 90 90; [Anonymous], 2013, ENSURING FINANCE HIV; Tran BX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142644; Tran BX, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0085-7; Tran BX, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0063-0; Tran BX, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0640-z; Tran BX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086267; Tran BX, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.20690; Tran BX, 2013, B WORLD HEALTH ORGAN, V91, P475, DOI 10.2471/BLT.12.115147; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051569; Tran BX, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-132; Tran BX, 2012, GLOB PUBLIC HEALTH, V7, P1080, DOI 10.1080/17441692.2012.736259; Tran BX, 2012, AIDS BEHAV, V16, P1988, DOI 10.1007/s10461-012-0271-5; Tran BX, 2012, QUAL LIFE RES, V21, P613, DOI 10.1007/s11136-011-9963-y; Tran BX, 2011, AIDS CARE, V23, P1236, DOI 10.1080/09540121.2011.555749; Becker J, 2009, PAN AFR MED J, V3, P1; Campbell C, 2002, SOC SCI MED, V55, P331, DOI 10.1016/S0277-9536(01)00289-1; Control VAoHA, 2015, ANN REV HIV AIDS CON; Control VAoHA, 2013, VIETN HIV AIDS EST P; Corbett EL, 2007, AIDS, V21, P483, DOI 10.1097/QAD.0b013e3280115402; Corneli A, 2008, INT J TUBERC LUNG D, V12, pS79; Cross MJ, 2000, RHEUMATOLOGY, V39, P1242, DOI 10.1093/rheumatology/39.11.1242; Day CA, 2008, AIDS CARE, V20, P116, DOI 10.1080/09540120701426524; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Group E, 2011, EQ 5D 5L US GUID BAS; Herriges JA, 1996, J ENVIRON ECON MANAG, V30, P112, DOI 10.1006/jeem.1996.0008; Hogben M, 2007, AM J PREV MED, V33, pS89, DOI 10.1016/j.amepre.2007.04.015; Hutchinson PL, 2006, AIDS CARE, V18, P446, DOI 10.1080/09540120500213511; Lang HC, 2010, VALUE HEALTH, V13, P743, DOI 10.1111/j.1524-4733.2010.00743.x; Lliyasu Z, 2006, J NATL MED ASSOC, V98, P1917; Nguyen LH, 2016, AIDS BEHAV, V20, P848, DOI 10.1007/s10461-015-1188-6; Luo J., 2014, ACAD MANAGEMENT P, V2014, DOI [10.5465/ambpp.2014.11518abstract, DOI 10.5465/AMBPP.2014.11518ABSTRACT, 10.5465/AMBPP.2014.11965abstract, DOI 10.5465/AMBPP.2014.11965ABSTRACT]; Ma W, 2007, AIDS, V21, pS129, DOI 10.1097/01.aids.0000304708.64294.3f; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Mahmoud MM, 2007, J MED VIROL, V79, P469, DOI 10.1002/jmv.20850; Markwick N, 2014, J EPIDEMIOL COMMUN H, V68, P675, DOI 10.1136/jech-2013-203707; Martin-Fernandez J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-287; Matovu JKB, 2005, AIDS, V19, P503, DOI 10.1097/01.aids.0000162339.43310.33; McQuoid-Mason D, 2007, SAMJ S AFR MED J, V97, P416; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Metsch L, 2015, JAIDS-J ACQ IMM DEF, V69, pS162, DOI 10.1097/QAI.0000000000000660; Minh Hoang Van, 2012, Value Health Reg Issues, V1, P36, DOI 10.1016/j.vhri.2012.03.012; Narbro K, 2000, INT J TECHNOL ASSESS, V16, P50, DOI 10.1017/S0266462300016159; National Committee for AIDS DaPPaC, 2012, NAT STRAT HIV AIDS P; Nguyen Tam T M, 2012, Adv Prev Med, V2012, P732484, DOI 10.1155/2012/732484; Nguyen TTH, 2011, AIDS EDUC PREV, V23, P30, DOI 10.1521/aeap.2011.23.3_supp.30; Nguyen TA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-37; Obermeyer CM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001329; Panda S, 2000, INT J STD AIDS, V11, P468, DOI 10.1258/0956462001916137; Rennie S, 2006, B WORLD HEALTH ORGAN, V84, P52, DOI 10.2471/BLT.05.025536; Rome A, 2010, SCAND J PUBLIC HEALT, V38, P151, DOI 10.1177/1403494809357099; Rosenberger RS, 2012, J FOREST ECON, V18, P271, DOI 10.1016/j.jfe.2012.06.003; Salam MA, 2006, ENVIRON MONIT ASSESS, V118, P165, DOI 10.1007/s10661-006-1488-4; SAXON AJ, 1991, J ACQ IMMUN DEF SYND, V4, P938; Seewald R, 2013, AM J DRUG ALCOHOL AB, V39, P247, DOI 10.3109/00952990.2013.798662; Sergeyev B, 1999, J DRUG ISSUES, V29, P777, DOI 10.1177/002204269902900403; Son VH, 2015, VIETN NAT AIDS C 201; Tang CH, 2007, HEALTH POLICY, V82, P251, DOI 10.1016/j.healthpol.2006.09.007; The Commission on AIDS in Asia, RED AIDS AS CRAFT EF; Tran BX, 2013, TROP MED INT HEALTH, V18, P212, DOI 10.1111/tmi.12032; Tran Bach Xuan, 2013, Int J Drug Policy, V24, pe105, DOI 10.1016/j.drugpo.2013.07.007; UNAIDS, 2014, VIETN NAT AIDS SPEND; Uzochukwu B, 2011, HEALTH POLICY, V99, P277, DOI 10.1016/j.healthpol.2010.11.007; van Dyk A C, 2003, Curationis, V26, P4; Nguyen VT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126659; Wang M, 2015, SUBST USE MISUSE, V50, P15, DOI 10.3109/10826084.2014.957768; Ward J, 1994, Drug Alcohol Rev, V13, P327, DOI 10.1080/09595239400185431; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO, 2015, CONSOLIDATED GUIDELI; Wimbush J, 1996, J SUBST ABUSE, V8, P263, DOI 10.1016/S0899-3289(96)90304-1; World Health Organization, 2012, SERV DEL APPR HIV TE; Xia YH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-899; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068906	75	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152804	10.1371/journal.pone.0152804	http://dx.doi.org/10.1371/journal.pone.0152804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27046029	Green Submitted, Green Published, gold			2022-12-26	WOS:000373599600036
J	Kang, E; Yousefi, M; Gruenheid, S				Kang, Eugene; Yousefi, Mitra; Gruenheid, Samantha			R-Spondins Are Expressed by the Intestinal Stroma and are Differentially Regulated during Citrobacter rodentium- and DSS-Induced Colitis in Mice	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; STRUCTURAL BASIS; STEM-CELLS; R-SPONDIN2; CATENIN; LGR5; IDENTIFICATION; RECOGNITION; TRANSCRIPTS; MAINTENANCE	The R-spondin family of proteins has recently been described as secreted enhancers of beta-catenin activation through the canonical Wnt signaling pathway. We previously reported that Rspo2 is a major determinant of susceptibility to Citrobacter rodentium-mediated colitis in mice and recent genome-wide association studies have revealed RSPO3 as a candidate Crohn's disease-specific inflammatory bowel disease susceptibility gene in humans. However, there is little information on the endogenous expression and cellular source of R-spondins in the colon at steady state and during intestinal inflammation. RNA sequencing and qRT-PCR were used to assess the expression of R-spondins at steady state and in two mouse models of colonic inflammation. The cellular source of R-spondins was assessed in specific colonic cell populations isolated by cell sorting. Data mining from publicly available datasets was used to assess the expression of R-spondins in the human colon. At steady state, colonic expression of R-spondins was found to be exclusive to non-epithelial CD45(-) lamina propria cells, and Rspo3/RSPO3 was the most highly expressed R-spondin in both mouse and human colon. R-spondin expression was found to be highly dynamic and differentially regulated during C. rodentium infection and dextran sodium sulfate (DSS) colitis, with notably high levels of Rspo3 expression during DSS colitis, and high levels of Rspo2 expression during C. rodentium infection, specifically in susceptible mice. Our data are consistent with the hypothesis that in the colon, R-spondins are expressed by subepithelial stromal cells, and that Rspo3/RSPO3 is the family member most implicated in colonic homeostasis. The differential regulation of the R-spondins in different models of intestinal inflammation indicate they respond to specific pathogenic and inflammatory signals that differ in the two models and provides further evidence that this family of proteins plays a key role in linking intestinal inflammation and homeostasis.	[Gruenheid, Samantha] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; McGill Univ, Complex Traits Grp, Montreal, PQ, Canada	McGill University; McGill University	Gruenheid, S (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	samantha.gruenheid@mcgill.ca		Gruenheid, Samantha/0000-0002-0908-6715	Canadian Institutes of Health Research grant [MOP 133580]	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR))	Funding for this work came from Canadian Institutes of Health Research grant # MOP 133580, http://cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2008, DEV GROWTH DIFFER, V50, P85, DOI 10.1111/j.1440-169x.2007.00978.x; Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Aoki R, 2016, CELL MOL GASTROENTER, V2, P175, DOI 10.1016/j.jcmgh.2015.12.004; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Chartier C, 2016, CANCER RES, V76, P713, DOI 10.1158/0008-5472.CAN-15-0561; Chen PH, 2013, GENE DEV, V27, P1345, DOI 10.1101/gad.219915.113; Cosin-Roger J, 2016, MUCOSAL IMMUNOL, V9, P986, DOI 10.1038/mi.2015.123; Diez E, 2011, GENES IMMUN, V12, P280, DOI 10.1038/gene.2010.76; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Jin YR, 2012, INT J BIOCHEM CELL B, V44, P2278, DOI 10.1016/j.biocel.2012.09.006; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Lei NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084651; Li X, 2007, PHYSIOL GENOMICS, V29, P290, DOI 10.1152/physiolgenomics.00269.2006; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Papapietro O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2816; Peng WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083110; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shinmura K, 2014, MOL BIOL REP, V41, P5375, DOI 10.1007/s11033-014-3409-x; Storm EE, 2016, NATURE, V529, P97, DOI 10.1038/nature16466; Teatero SA, 2011, GUT MICROBES, V2, P173, DOI 10.4161/gmic.2.3.16297; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Yamada W, 2009, BIOCHEM BIOPH RES CO, V381, P453, DOI 10.1016/j.bbrc.2009.02.066; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Zebisch M, 2015, J STRUCT BIOL, V191, P149, DOI 10.1016/j.jsb.2015.05.008; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	40	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152859	10.1371/journal.pone.0152859	http://dx.doi.org/10.1371/journal.pone.0152859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046199	Green Published, gold			2022-12-26	WOS:000373599600040
J	Kasai, S; Arakawa, N; Okubo, A; Shigeeda, W; Yasuhira, S; Masuda, T; Akasaka, T; Shibazaki, M; Maesawa, C				Kasai, Shuya; Arakawa, Nobuyuki; Okubo, Ayaka; Shigeeda, Wataru; Yasuhira, Shinji; Masuda, Tomoyuki; Akasaka, Toshihide; Shibazaki, Masahiko; Maesawa, Chihaya			NAD(P)H: Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG	PLOS ONE			English	Article							PHASE-II TRIAL; NRF2; COMBINATION; RESISTANCE; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; 17-DEMETHOXYGELDANAMYCIN; HEAT-SHOCK-PROTEIN-90; 17-ALLYLAMINO; GELDANAMYCIN; ACTIVATION	The KEAP1-NRF2 pathway regulates cellular redox homeostasis by transcriptional induction of genes associated with antioxidant synthesis and detoxification in response to oxidative stress. Previously, we reported that KEAP1 mutation elicits constitutive NRF2 activation and resistance to cisplatin (CDDP) and dacarbazine (DTIC) in human melanomas. The present study was conducted to clarify whether an HSP90 inhibitor, 17-AAG, efficiently eliminates melanoma with KEAP1 mutation, as the NRF2 target gene, NQO1, is a key enzyme in 17-AAG bioactivation. In melanoma and non-small cell lung carcinoma cell lines with or without KEAP1 mutations, NQO1 expression and 17-AAG sensitivity are inversely correlated. NQO1 is highly expressed in normal melanocytes and in several melanoma cell lines despite the presence of wild-type KEAP1, and the NQO1 expression is dependent on NRF2 activation. Because either CDDP or DTIC produces reactive oxygen species that activate NRF2, we determined whether these agents would sensitize NQO1-low melanoma cells to 17-AAG. Synergistic cytotoxicity of the 17-AAG and CDDP combination was detected in four out of five NQO1-low cell lines, but not in the cell line with KEAP1 mutation. These data indicate that 17-AAG could be a potential chemotherapeutic agent for melanoma with KEAP1 mutation or NQO1 expression.	[Kasai, Shuya; Arakawa, Nobuyuki; Okubo, Ayaka; Shigeeda, Wataru; Yasuhira, Shinji; Shibazaki, Masahiko; Maesawa, Chihaya] Iwate Med Univ, Inst Biomed Sci, Dept Tumor Biol, Morioka, Iwate, Japan; [Akasaka, Toshihide] Iwate Med Univ, Dept Dermatol, Morioka, Iwate, Japan; [Masuda, Tomoyuki] Iwate Med Univ, Sch Med, Dept Pathol, Morioka, Iwate, Japan; [Kasai, Shuya] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 980, Japan	Iwate Medical University; Iwate Medical University; Iwate Medical University; Tohoku University	Shibazaki, M (corresponding author), Iwate Med Univ, Inst Biomed Sci, Dept Tumor Biol, Morioka, Iwate, Japan.	mashiba@iwate-med.ac.jp	Kasai, Shuya/AAL-2157-2021	Kasai, Shuya/0000-0001-7171-4885; Yasuhira, Shinji/0000-0003-0041-3545	JSPS KAKENHI [24790391]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI, Grant Number# 24790391 (https://kaken.nii.ac.jp/d/p/26860243.ja.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babchia N, 2008, INVEST OPHTH VIS SCI, V49, P2348, DOI 10.1167/iovs.07-1305; Bagatell R, 2005, INT J CANCER, V113, P179, DOI 10.1002/ijc.20611; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Banerji U, 2008, MOL CANCER THER, V7, P737, DOI 10.1158/1535-7163.MCT-08-0145; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Cheng YB, 2010, ONCOL REP, V23, P973, DOI 10.3892/or_00000722; Choi TY, 2010, J INVEST DERMATOL, V130, P784, DOI 10.1038/jid.2009.280; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Faingold D, 2008, CLIN CANCER RES, V14, P847, DOI 10.1158/1078-0432.CCR-07-0926; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Guo WC, 2006, MOL PHARMACOL, V70, P1194, DOI 10.1124/mol.106.025643; Iyer G, 2012, CANCER CHEMOTH PHARM, V69, P1089, DOI 10.1007/s00280-011-1789-3; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Lu XY, 2012, BIOCHEM PHARMACOL, V83, P995, DOI 10.1016/j.bcp.2011.11.011; Mannisto PT, 1999, PHARMACOL REV, V51, P593; McCollum AK, 2008, MOL CANCER THER, V7, P3256, DOI 10.1158/1535-7163.MCT-08-0157; McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Miura S, 2014, J INVEST DERMATOL, V134, P553, DOI 10.1038/jid.2013.343; Nakamura Y, 2010, J DERMATOL SCI, V60, P187, DOI 10.1016/j.jdermsci.2010.09.009; Nemekaite-Ceniene A, 2005, ARCH BIOCHEM BIOPHYS, V441, P182, DOI 10.1016/j.abb.2005.07.002; Ohba S, 2010, J NEUROSURG, V112, P33, DOI 10.3171/2009.3.JNS081146; Pacey S, 2012, INVEST NEW DRUG, V30, P341, DOI 10.1007/s10637-010-9493-4; Rotblat B, 2012, ONCOTARGET, V3, P1272; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Shibata T, 2011, NEOPLASIA, V13, P864, DOI 10.1593/neo.11750; Siegel D, 2012, BIOCHEM PHARMACOL, V83, P1033, DOI 10.1016/j.bcp.2011.12.017; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; Solier S, 2012, P NATL ACAD SCI USA, V109, P12866, DOI 10.1073/pnas.1203617109; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Vaishampayan UN, 2010, CLIN CANCER RES, V16, P3795, DOI 10.1158/1078-0432.CCR-10-0503; Vasilevskaya IA, 2003, CANCER RES, V63, P3241; Woods D, 2013, CANCER BIOL THER, V14, P379, DOI 10.4161/cbt.23761	38	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153181	10.1371/journal.pone.0153181	http://dx.doi.org/10.1371/journal.pone.0153181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045471	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600075
J	Xu, L; Qiu, LL; Chang, GB; Guo, QX; Liu, XP; Bi, YL; Zhang, Y; Wang, HZ; Li, ZT; Guo, XM; Wan, F; Zhang, Y; Xu, Q; Chen, GH				Xu, Lu; Qiu, Lingling; Chang, Guobin; Guo, Qixin; Liu, Xiangping; Bi, Yulin; Zhang, Yu; Wang, Hongzhi; Li, Zhiteng; Guo, Xiaoming; Wan, Fang; Zhang, Yang; Xu, Qi; Chen, Guohong			Discovery of piRNAs Pathway Associated with Early-Stage Spermatogenesis in Chicken	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; PRIMORDIAL GERM-CELLS; MOUSE TESTES; DIFFERENTIATION; SPERMIOGENESIS; REPERTOIRE	Piwi-interacting RNAs (piRNAs) play a key role in spermatogenesis. Here, we describe the piRNAs profiling of primordial germ cells (PGCs), spermatogonial stem cells (SSCs), and the spermatogonium (Sp) during early-stage spermatogenesis in chicken. We obtained 31,361,989 reads from PGCs, 31,757,666 reads from SSCs, and 46,448,327 reads from Sp cells. The length distribution of piRNAs in the three samples showed peaks at 33 nt. The resulting genes were subsequently annotated against the Gene Ontology (GO) database. Five genes (RPL7A, HSPA8, Pum1, CPXM2, and PRKCA) were found to be involved in cellular processes. Interactive pathway analysis (IPA) further revealed three important pathways in early-stage spermatogenesis including the FGF, Wnt, and EGF receptor signaling pathways. The gene Pum1 was found to promote germline stem cell proliferation, but it also plays a role in spermatogenesis. In conclusion, we revealed characteristics of piRNAs during early spermatogonial development in chicken and provided the basis for future research.	[Xu, Lu; Qiu, Lingling; Chang, Guobin; Guo, Qixin; Bi, Yulin; Zhang, Yu; Li, Zhiteng; Guo, Xiaoming; Wan, Fang; Zhang, Yang; Xu, Qi; Chen, Guohong] Yangzhou Univ, Coll Anim Sci Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Liu, Xiangping; Wang, Hongzhi] Chinese Acad Agr Sci, Poultry Inst, Yangzhou 225003, Jiangsu, Peoples R China	Yangzhou University; Chinese Academy of Agricultural Sciences	Chang, GB; Chen, GH (corresponding author), Yangzhou Univ, Coll Anim Sci Technol, Yangzhou 225009, Jiangsu, Peoples R China.	passioncgb@163.com; ghchen@yzu.edu.cn	XU, Qi/AID-2262-2022		National Natural Science Foundation of China [31372297]; International Agricultural Cooperation and Exchange Programme of China; Six talent peaks project in Jiangsu Province [2015-NY-019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Agricultural Cooperation and Exchange Programme of China; Six talent peaks project in Jiangsu Province	This research was supported by the National Natural Science Foundation of China (31372297), International Agricultural Cooperation and Exchange Programme of China and the Six talent peaks project in Jiangsu Province (2015-NY-019). The authors would like to thank Guobing Chang for his help with the experimental design, and Wei Lu, Lichen Ren, Lingling Qiu and Qixin Guo for their help with sample preparation. The authors also wish to thank Guobin Chang for his help with manuscript preparation.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Caires K, 2010, J ENDOCRINOL, V205, P133, DOI 10.1677/JOE-09-0275; Chang GB, 2015, ANIM REPROD SCI, V162, P95, DOI 10.1016/j.anireprosci.2015.09.016; Chen D, 2012, CURR BIOL, V22, P420, DOI 10.1016/j.cub.2012.01.039; Chen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051724; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; Gebert D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124860; Goh WSS, 2015, GENE DEV, V29, P1032, DOI 10.1101/gad.260455.115; Gou LT, 2014, CELL RES, V24, P680, DOI 10.1038/cr.2014.41; Hirakata S, 2015, BIOCH BIOPHYS ACTA; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008; Li BC, 2010, MOL REPROD DEV, V77, P795, DOI 10.1002/mrd.21224; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Lim SL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005620; Liu G, 2012, PLOS ONE, V7; Mozdziak PE, 2005, POULTRY SCI, V84, P594, DOI 10.1093/ps/84.4.594; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Park TS, 2013, J REPROD DEVELOP, V59, P252, DOI 10.1262/jrd.2012-183; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Pramod RK, 2014, J ASSIST REPROD GEN, V31, P993, DOI 10.1007/s10815-014-0277-1; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Senti KA, 2015, GENE DEV, V29, P1747, DOI 10.1101/gad.267252.115; Song H. -W., 2012, SPERMATOGENESIS, V2, P238, DOI [10.4161/spmg.22069, DOI 10.4161/SPMG.22069]; Song N, 2011, ACTA HISTOCHEM CYTOC, V44, P183, DOI 10.1267/ahc.11027; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; Vourekas A, 2012, NAT STRUCT MOL BIOL, V19, P773, DOI 10.1038/nsmb.2347; Yu F, 2010, MOL REPROD DEV, V77, P340, DOI 10.1002/mrd.21147; Zhang CW, 2015, BIOCHEM BIOPH RES CO, V462, P8, DOI 10.1016/j.bbrc.2015.04.019; Zhang ZT, 2015, J BIOL CHEM, V290, P13605, DOI 10.1074/jbc.M114.601401	30	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0151780	10.1371/journal.pone.0151780	http://dx.doi.org/10.1371/journal.pone.0151780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045806	Green Published, gold			2022-12-26	WOS:000373599600004
J	Ahirwar, R; Vellarikkal, SK; Sett, A; Sivasubbu, S; Scaria, V; Bora, U; Borthakur, BB; Kataki, AC; Sharma, JD; Nahar, P				Ahirwar, Rajesh; Vellarikkal, Shamsudheen Karuthedath; Sett, Arghya; Sivasubbu, Sridhar; Scaria, Vinod; Bora, Utpal; Borthakur, Bibhuti Bhusan; Kataki, Amal Chandra; Sharma, Jagannath Dev; Nahar, Pradip			Aptamer-Assisted Detection of the Altered Expression of Estrogen Receptor Alpha in Human Breast Cancer	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; IN-VITRO; MONOCLONAL-ANTIBODIES; CONCANAVALIN-A; IMAGE-ANALYSIS; SELECTION; ENZYME; ASSAY; MULTICENTER; ENDOCRINE	An increase in the expression of estrogen receptors (ER) and the expanded population of ER-positive cells are two common phenotypes of breast cancer. Detection of the aberrantly expressed ER alpha in breast cancer is carried out using ER alpha-antibodies and radiolabelled ligands to make decisions about cancer treatment and targeted therapy. Capitalizing on the beneficial advantages of aptamer over the conventional antibody or radiolabelled ligand, we have identified a DNA aptamer that selectively binds and facilitates the detection of ERa in human breast cancer tissue sections. The aptamer is identified using the high throughput sequencing assisted SELEX screening. Biophysical characterization confirms the binding and formation of a thermodynamically stable complex between the identified DNA aptamer (ERaptD4) and ER alpha (Ka = 1.55 +/- 0.298x10(8) M-1; Delta H = 4.32x10(4)+/- 801.1 cal/mol; Delta S = -108 cal/mol/deg). Interestingly, the specificity measurements suggest that the ERaptD4 internalizes into ER alpha-positive breast cancer cells in a target-selective manner and localizes specifically in the nuclear region. To harness these characteristics of ERaptD4 for detection of ER alpha expression in breast cancer samples, we performed the aptamer-assisted histochemical analysis of ER alpha in tissue samples from breast cancer patients. The results were validated by performing the immunohistochemistry on same samples with an ER alpha-antibody. We found that the two methods agree strongly in assay output (kappa value = 0.930, pvalue <0.05 for strong ER alpha positive and the ER alpha negative samples; kappa value = 0.823, pvalue <0.05 for the weak/moderate ER+ve samples, n = 20). Further, the aptamer stain the ER alpha-positive cells in breast tissues without cross-reacting to ER alpha-deficient fibroblasts, adipocytes, or the inflammatory cells. Our results demonstrate a significant consistency in the aptamer-assisted detection of ER alpha in strong ER alpha positive, moderate ER alpha positive and ER alpha negative breast cancer tissues. We anticipate that the ERaptD4 aptamer targeting ER alpha may potentially be used for an efficient grading of ER alpha expression in cancer tissues.	[Ahirwar, Rajesh; Vellarikkal, Shamsudheen Karuthedath; Sivasubbu, Sridhar; Scaria, Vinod; Nahar, Pradip] CSIR Inst Genom & Integrat Biol, Dept Syst & Chem Biol, Delhi, India; [Ahirwar, Rajesh; Vellarikkal, Shamsudheen Karuthedath; Sivasubbu, Sridhar; Scaria, Vinod; Nahar, Pradip] CSIR Inst Genom & Integrat Biol, Acad Sci & Innovat Res, Delhi, India; [Sett, Arghya; Bora, Utpal] Indian Inst Technol, Dept Biosci & Bioengn, Gauhati, India; [Borthakur, Bibhuti Bhusan; Kataki, Amal Chandra; Sharma, Jagannath Dev] Dr Bhubaneswar Barooah Canc Inst, Gauhati, Assam, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Tata Memorial Centre (TMC); Dr. Bhubaneswar Borooah Cancer Institute	Nahar, P (corresponding author), CSIR Inst Genom & Integrat Biol, Dept Syst & Chem Biol, Delhi, India.; Nahar, P (corresponding author), CSIR Inst Genom & Integrat Biol, Acad Sci & Innovat Res, Delhi, India.	pnahar@igib.res.in	Karuthedath Vellarikkal, Shamsudheen/AAC-4142-2022; Scaria, Vinod/AAS-3151-2021; SETT, ARGHYA/Q-1857-2017; Ahirwar, Rajesh/AAY-1586-2021	Karuthedath Vellarikkal, Shamsudheen/0000-0002-6384-2948; Ahirwar, Rajesh/0000-0002-3406-7436; Scaria, Vinod/0000-0001-7644-7181; BORTHAKUR, BIBHUTI BHUSAN/0000-0002-8577-6590; SETT, ARGHYA/0000-0002-8356-5140	CARDIOMED task project of Council of Scientific and Industrial Research, Government of India [BSC0122]; Council of Scientific and Industrial Research, India	CARDIOMED task project of Council of Scientific and Industrial Research, Government of India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by the CARDIOMED task project of Council of Scientific and Industrial Research, Government of India, Project No. BSC0122 (http://www.csirhrdg.res.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R.A. thanks the Council of Scientific and Industrial Research, India for the award of research fellowship. Authors thank Smita Nahar for help in ITC, Vaibhav Jain for flow cytometry and Bijay Ranjan Pattnaik for his help in immunofluorescence experiments (all from CSIR-IGIB).	Ahirwar R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21285; Ahirwar R, 2016, ANAL BIOANAL CHEM, V408, P327, DOI 10.1007/s00216-015-9090-7; Ahirwar R, 2015, J CHROMATOGR B, V997, P105, DOI 10.1016/j.jchromb.2015.06.003; Ahirwar R, 2015, J AGR FOOD CHEM, V63, P4104, DOI 10.1021/acs.jafc.5b00784; Ahirwar R, 2014, ANALYST, V139, P2186, DOI 10.1039/c3an02402d; Hirata BKB, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/513158; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bora U, 2002, J IMMUNOL METHODS, V268, P171, DOI 10.1016/S0022-1759(02)00212-0; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; Dhingra K, 1999, INVEST NEW DRUG, V17, P285, DOI 10.1023/A:1006348907994; Driggers PH, 2002, TRENDS ENDOCRIN MET, V13, P422, DOI 10.1016/S1043-2760(02)00634-3; FABRIS G, 1987, J STEROID BIOCHEM, V27, P171, DOI 10.1016/0022-4731(87)90307-4; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Germer Katherine, 2013, Int J Biochem Mol Biol, V4, P27; Goussard J, 1998, CANCER LETT, V132, P61, DOI 10.1016/S0304-3835(98)00168-2; GOUSSARD J, 1986, CANCER RES, V46, P4282; He X, 2015, NUCLEIC ACID THER, V25, P152, DOI 10.1089/nat.2014.0521; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Keefe AD, 2008, CURR OPIN CHEM BIOL, V12, P448, DOI 10.1016/j.cbpa.2008.06.028; Kupakuwana GV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019395; Lacroix M, 2001, BREAST CANCER RES TR, V67, P263, DOI 10.1023/A:1017946810277; LECLERCQ G, 1986, CANCER RES, V46, P4233; LIPPMAN ME, 1980, CANCER, V46, P2829, DOI 10.1002/1097-0142(19801215)46:12+<2829::AID-CNCR2820461419>3.0.CO;2-M; Liu Z, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-148; Lou XH, 2009, P NATL ACAD SCI USA, V106, P2989, DOI 10.1073/pnas.0813135106; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Marx V, 2013, NAT METHODS, V10, P829, DOI 10.1038/nmeth.2607; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006; Moggs JG, 2001, EMBO REP, V2, P775, DOI 10.1093/embo-reports/kve185; NICHOLSON RI, 1986, CANCER RES, V46, P4299; Parise CA, 2009, BREAST J, V15, P593, DOI 10.1111/j.1524-4741.2009.00822.x; PERTSCHUK LP, 1990, CANCER, V66, P1663, DOI 10.1002/1097-0142(19901015)66:8<1663::AID-CNCR2820660802>3.0.CO;2-C; REMMELE W, 1993, PATHOL RES PRACT, V189, P862; Rio DC., 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Sawaki M, 2012, ONCOL LETT, V3, P61, DOI 10.3892/ol.2011.449; SHAFIE S, 1979, J LAB CLIN MED, V94, P784; Society AC, 2015, CANC FACTS FIG 2015; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Tombelli S, 2005, BIOSENS BIOELECTRON, V20, P2424, DOI 10.1016/j.bios.2004.11.006; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Viale G, 2012, ANN ONCOL, V23, P207, DOI 10.1093/annonc/mds326; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Xu DY, 2014, NUCLEIC ACID THER, V24, P226, DOI 10.1089/nat.2013.0474	47	19	19	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153001	10.1371/journal.pone.0153001	http://dx.doi.org/10.1371/journal.pone.0153001			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043307	Green Published, gold			2022-12-26	WOS:000373592100061
J	Barbelanne, M; Chiu, A; Qian, J; Tsang, WY				Barbelanne, M.; Chiu, A.; Qian, J.; Tsang, W. Y.			Opposing post-translational modifications regulate Cep76 function to suppress centriole amplification	ONCOGENE			English	Article							CYCLIN-DEPENDENT KINASES; CENTROSOME DUPLICATION; CELL-CYCLE; CHROMOSOMAL INSTABILITY; LYSINE ACETYLATION; MAMMALIAN-CELLS; PROTEIN; CDK2; REDUPLICATION; LOCALIZATION	Centrioles are critical for many cellular processes including cell division and cilia assembly. The number of centrioles within a cell is under strict control, and deregulation of centriole copy number is a hallmark of cancer. The molecular mechanisms that halt centriole amplification have not been fully elucidated. Here, we found that centrosomal protein of 76 kDa (Cep76), previously shown to restrain centriole amplification, interacts with cyclin-dependent kinase 2 (CDK2) and is a bona fide substrate of this kinase. Cep76 is preferentially phosphorylated by cyclin A/CDK2 at a single site S83, and this event is crucial to suppress centriole amplification in S phase. A novel Cep76 mutation S83C identified in a cancer patient fails to prevent centriole amplification. Mechanistically, Cep76 phosphorylation inhibits activation of polo-like kinase 1 (Plk1), thereby blocking premature centriole disengagement and subsequent amplification. Cep76 can also be acetylated, and enforced acetylation at K279 dampens the protein's ability to inhibit amplification and precludes S83 phosphorylation. Acetylation of Cep76 normally occurs in G2 phase and correlates with loss of protein function. Our data suggest that temporal changes in post-translational modifications of Cep76 during the cell cycle regulate its capacity to suppress centriole amplification, and its deregulation may contribute to malignancy.	[Barbelanne, M.; Chiu, A.; Qian, J.; Tsang, W. Y.] Inst Rech Clin Montreal, Cell Div & Centrosome Biol Res Unit, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada; [Barbelanne, M.; Tsang, W. Y.] Univ Montreal, Dept Pathol, Fac Med, Montreal, PQ, Canada; [Tsang, W. Y.] McGill Univ, Div Expt Med, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Tsang, WY (corresponding author), Inst Rech Clin Montreal, Cell Div & Centrosome Biol Res Unit, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	william.tsang@ircm.qc.ca		Tsang, William/0000-0002-1584-616X	Canadian Institutes of Health Research [MOP-115033]; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank all members of the Tsang laboratory for constructive advice, E Gomes and J Song for assistance with cloning, and Ross Tomaino and Denis Faubert for assistance with mass spectrometry. WYT is a Canadian Institutes of Health Research New Investigator and a Fonds de recherche Sante Junior 1 Research Scholar. This work was supported by the Canadian Institutes of Health Research (MOP-115033 to WYT) and the Natural Sciences and Engineering Research Council of Canada.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Adon AM, 2010, MOL CELL BIOL, V30, P694, DOI 10.1128/MCB.00253-09; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Barbelanne M, 2015, HUM MOL GENET, V24, P2185, DOI 10.1093/hmg/ddu738; Barbelanne M, 2013, HUM MOL GENET, V22, P2482, DOI 10.1093/hmg/ddt100; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Douthwright S, 2014, J CELL PHYSIOL, V229, P1427, DOI 10.1002/jcp.24579; Duensing A, 2006, ONCOGENE, V25, P2943, DOI 10.1038/sj.onc.1209310; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Errico A, 2010, ADV ENZYME REGUL, V50, P375, DOI 10.1016/j.advenzreg.2009.12.001; Ferguson RL, 2008, J CELL SCI, V121, P3224, DOI 10.1242/jcs.034702; Ferguson RL, 2010, J CELL SCI, V123, P2743, DOI 10.1242/jcs.073098; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Harper JW, 2001, CHEM REV, V101, P2511, DOI 10.1021/cr0001030; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Korzeniewski N, 2009, CANCER RES, V69, P6668, DOI 10.1158/0008-5472.CAN-09-1284; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Li LW, 2000, J BIOL CHEM, V275, P2410, DOI 10.1074/jbc.275.4.2410; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Merrick KA, 2011, MOL CELL, V42, P624, DOI 10.1016/j.molcel.2011.03.031; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; Nigg E A, 1991, Semin Cell Biol, V2, P261; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Nishimura T, 2005, GENES CELLS, V10, P75, DOI 10.1111/j.1365-2443.2005.00816.x; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Ovejero S, 2012, MOL BIOL CELL, V23, P4515, DOI 10.1091/mbc.E12-04-0260; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PAGANO M, 1993, J CELL BIOL, V121, P101, DOI 10.1083/jcb.121.1.101; Pascreau G, 2010, P NATL ACAD SCI USA, V107, P2932, DOI 10.1073/pnas.0914874107; Pihan GA, 2003, CANCER RES, V63, P1398; Pihan GA, 1998, CANCER RES, V58, P3974; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shiratsuchi G, 2015, EMBO J, V34, P97, DOI 10.15252/embj.201488979; TSAI LH, 1993, ONCOGENE, V8, P1593; Tsang WY, 2008, CELL CYCLE, V7, P702, DOI 10.4161/cc.7.6.5611; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Tsang WY, 2009, DEV CELL, V16, P649, DOI 10.1016/j.devcel.2009.03.004; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wu J, 2008, J CELL BIOL, V181, P475, DOI 10.1083/jcb.200710127; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; ZHU L, 1995, GENE DEV, V9, P1740, DOI 10.1101/gad.9.14.1740	63	12	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 13	2016	35	41					5377	5387		10.1038/onc.2016.74	http://dx.doi.org/10.1038/onc.2016.74			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA5QU	27065328	Green Accepted			2022-12-26	WOS:000386677800004
J	Croy, HE; Fuller, CN; Giannotti, J; Robinson, P; Foley, AVA; Yamulla, RJ; Cosgriff, S; Greaves, BD; von Kleeck, RA; An, HH; Powers, CM; Tran, JK; Tocker, AM; Jacob, KD; Davis, BK; Roberts, DM				Croy, Heather E.; Fuller, Caitlyn N.; Giannotti, Jemma; Robinson, Paige; Foley, Andrew V. A.; Yamulla, Robert J.; Cosgriff, Sean; Greaves, Bradford D.; von Kleeck, Ryan A.; An, Hyun Hyung; Powers, Catherine M.; Tran, Julie K.; Tocker, Aaron M.; Jacob, Kimberly D.; Davis, Beckley K.; Roberts, David M.			The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the beta-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOMATOUS POLYPOSIS-COLI; SMALL-MOLECULE INHIBITOR; CANCER CELLS; WNT PATHWAY; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; E3 LIGASE; DEGRADATION; PROTEIN; SIAH-1	Most colon cancer cases are initiated by truncating mutations in the tumor suppressor, adenomatous polyposis coli (APC). APC is a critical negative regulator of the Wnt signaling pathway that participates in a multi-protein "destruction complex" to target the key effector protein beta-catenin for ubiquitin-mediated proteolysis. Prior work has established that the poly(ADPribose) polymerase (PARP) enzyme Tankyrase (TNKS) antagonizes destruction complex activity by promoting degradation of the scaffold protein Axin, and recent work suggests that TNKS inhibition is a promising cancer therapy. We performed a yeast two-hybrid (Y2H) screen and uncovered TNKS as a putative binding partner of Drosophila APC2, suggesting that TNKS may play multiple roles in destruction complex regulation. We find that TNKS binds a C-terminal RPQPSG motif in Drosophila APC2, and that this motif is conserved in human APC2, but not human APC1. In addition, we find that APC2 can recruit TNKS into the beta-catenin destruction complex, placing the APC2/TNKS interaction at the correct intracellular location to regulate beta-catenin proteolysis. We further show that TNKS directly PARylates both Drosophila Axin and APC2, but that PARylation does not globally regulate APC2 protein levels as it does for Axin. Moreover, TNKS inhibition in colon cancer cells decreases beta-catenin signaling, which we find cannot be explained solely through Axin stabilization. Instead, our findings suggest that TNKS regulates destruction complex activity at the level of both Axin and APC2, providing further mechanistic insight into TNKS inhibition as a potential Wnt pathway cancer therapy.	[Croy, Heather E.; Fuller, Caitlyn N.; Giannotti, Jemma; Robinson, Paige; Foley, Andrew V. A.; Yamulla, Robert J.; Cosgriff, Sean; Greaves, Bradford D.; von Kleeck, Ryan A.; An, Hyun Hyung; Powers, Catherine M.; Tran, Julie K.; Tocker, Aaron M.; Jacob, Kimberly D.; Davis, Beckley K.; Roberts, David M.] Franklin & Marshall Coll, Dept Biol, POB 3003, Lancaster, PA 17604 USA	Franklin & Marshall College	Roberts, DM (corresponding author), Franklin & Marshall Coll, Dept Biol, POB 3003, Lancaster, PA 17604 USA.	david.roberts@fandm.edu		Yamulla, Robert/0000-0002-0276-3592	National Institutes of Health [R15 GM107796]; Franklin AMP; Marshall College; Undergraduate Science Education Award from the Howard Hughes Medical Institute to Franklin AMP; Marshall College [52007538]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM107796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin AMP; Marshall College; Undergraduate Science Education Award from the Howard Hughes Medical Institute to Franklin AMP; Marshall College; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R15 GM107796 (to D. M. R.), startup funds from Franklin & Marshall College (to D. M. R.), and an Undergraduate Science Education Award from the Howard Hughes Medical Institute to Franklin & Marshall College (52007538). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bao RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048670; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Casas-Selves M, 2012, CANCER RES, V72, P4154, DOI 10.1158/0008-5472.CAN-11-2848; Chandra SHV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034479; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Choi J, 2004, J BIOL CHEM, V279, P49188, DOI 10.1074/jbc.M404655200; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DaRosa PA, 2015, NATURE, V517, P223, DOI 10.1038/nature13826; de la Roche M, 2014, CANCER RES, V74, P1495, DOI 10.1158/0008-5472.CAN-13-2682; Delgado ER, 2014, AM J PATHOL, V184, P2111, DOI 10.1016/j.ajpath.2014.04.002; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fearon ER, 2009, CANCER CELL, V16, P366, DOI 10.1016/j.ccr.2009.10.007; Feng Y, 2014, CELL SIGNAL, V26, P1717, DOI 10.1016/j.cellsig.2014.04.014; Gwak J, 2009, BIOCHEM BIOPH RES CO, V387, P444, DOI 10.1016/j.bbrc.2009.07.027; Haikarainen T, 2014, CURR PHARM DESIGN, V20, P6472, DOI 10.2174/1381612820666140630101525; Haikarainen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065404; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; Tran H, 2012, J BIOL CHEM, V287, P28552, DOI 10.1074/jbc.M112.387878; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; James RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050457; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kunttas-Tatli E, 2014, MOL BIOL CELL, V25, P3424, DOI 10.1091/mbc.E14-04-0885; Lau T, 2013, CANCER RES, V73, P3132, DOI 10.1158/0008-5472.CAN-12-4562; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Mendoza-Topaz C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110013; Morrone S, 2012, P NATL ACAD SCI USA, V109, P1500, DOI 10.1073/pnas.1116618109; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Pronobis MI, 2015, ELIFE, V4, DOI 10.7554/eLife.08022; Riffell JL, 2012, NAT REV DRUG DISCOV, V11, P923, DOI 10.1038/nrd3868; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Schneikert J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068072; Scholer-Dahirel A, 2011, P NATL ACAD SCI USA, V108, P17135, DOI 10.1073/pnas.1104182108; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Thorvaldsen TE, 2015, MOL CANCER RES, V13, P1487, DOI 10.1158/1541-7786.MCR-15-0125; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336; Yamulla RJ, 2014, GENETICS, V197, P1285, DOI 10.1534/genetics.114.166496; Yu X, 1999, MECH DEVELOP, V84, P69, DOI 10.1016/S0925-4773(99)00072-6; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhou ZD, 2011, CELL ADHES MIGR, V5, P463, DOI 10.4161/cam.5.6.18356	47	24	24	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12747	12760		10.1074/jbc.M115.705442	http://dx.doi.org/10.1074/jbc.M115.705442			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27068743	Green Published, hybrid			2022-12-26	WOS:000378119900027
J	Delgado, DA; Doherty, K; Cheng, QH; Kim, H; Xu, DW; Dong, H; Grewer, C; Qiang, W				Delgado, Dennis A.; Doherty, Katelynne; Cheng, Qinghui; Kim, Hyeongeun; Xu, Dawei; Dong, He; Grewer, Christof; Qiang, Wei			Distinct Membrane Disruption Pathways Are Induced by 40-Residue beta-Amyloid Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; FORMS ION CHANNELS; ALZHEIMERS-DISEASE; LIPID-BILAYERS; A-BETA; FIBRIL GROWTH; PROTEIN; BRAIN; OLIGOMERS; FUSION	Cellular membrane disruption induced by beta-amyloid (A beta) peptides has been considered one of the major pathological mechanisms for Alzheimer disease. Mechanistic studies of the membrane disruption process at a high-resolution level, on the other hand, are hindered by the co-existence of multiple possible pathways, even in simplified model systems such as the phospholipid liposome. Therefore, separation of these pathways is crucial to achieve an in-depth understanding of theA beta-induced membrane disruption process. This study, which utilized a combination of multiple biophysical techniques, shows that the peptide-to-lipid (P:L) molar ratio is an important factor that regulates the selection of dominant membrane disruption pathways in the presence of 40-residue A beta peptides in liposomes. Three distinct pathways (fibrillation with membrane content leakage, vesicle fusion, and lipid uptake through a temporarily stable ionic channel) become dominant in model liposome systems under specific conditions. These individual systems are characterized by both the initial states of A beta peptides and the P:L molar ratio. Our results demonstrated the possibility to generate simplified A beta-membrane model systems with a homogeneous membrane disruption pathway, which will benefit high-resolution mechanistic studies in the future. Fundamentally, the possibility of pathway selection controlled by P:L suggests that the driving forces for A beta aggregation and A beta-membrane interactions may be similar at the molecular level.	[Delgado, Dennis A.; Doherty, Katelynne; Cheng, Qinghui; Kim, Hyeongeun; Grewer, Christof; Qiang, Wei] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Xu, Dawei; Dong, He] Clarkson Univ, Dept Chem & Biomol Sci, Potsdam, NY 13699 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Clarkson University	Qiang, W (corresponding author), SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA.	wqiang@binghamton.edu		Dong, He/0000-0002-8494-0475	National Science Foundation Major Research Instrumentation Program [NSF 0922815]	National Science Foundation Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The NMR facility at Binghamton University was supported by the National Science Foundation Major Research Instrumentation Program (NSF 0922815). We acknowledge support from Dr. Ming An for using the rotatory evaporator for sample preparation and the mass spectrometry facility from the University of Illinois.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Akinlolu RD, 2015, BIOCHEMISTRY-US, V54, P3416, DOI 10.1021/acs.biochem.5b00321; Bak M, 2000, J MAGN RESON, V147, P296, DOI 10.1006/jmre.2000.2179; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; CALDERON RO, 1995, J NEUROCHEM, V64, P424; Capone R, 2012, J CHEM THEORY COMPUT, V8, P1143, DOI 10.1021/ct200885r; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chiang PK, 2008, CURR MOL MED, V8, P580, DOI 10.2174/156652408785747951; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Connelly L, 2012, BIOCHEMISTRY-US, V51, P3031, DOI 10.1021/bi300257e; Drechsler A, 2010, BBA-BIOMEMBRANES, V1798, P244, DOI 10.1016/j.bbamem.2009.10.012; Eckert GP, 2010, CURR PROTEIN PEPT SC, V11, P319, DOI 10.2174/138920310791330668; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Fletcher TG, 1997, PROTEIN SCI, V6, P666; Funato H, 1998, AM J PATHOL, V152, P1633; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13489, DOI 10.1021/bi020369w; Hayashi H, 2000, BBA-MOL CELL BIOL L, V1483, P81, DOI 10.1016/S1388-1981(99)00174-2; Kawahara M, 1997, BIOPHYS J, V73, P67, DOI 10.1016/S0006-3495(97)78048-2; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Komatsu H, 2010, J BIOL CHEM, V285, P41843, DOI 10.1074/jbc.M110.165068; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; Mason RP, 1996, BIOCHEM BIOPH RES CO, V222, P78, DOI 10.1006/bbrc.1996.0699; McLaurin J, 1997, EUR J BIOCHEM, V245, P355, DOI 10.1111/j.1432-1033.1997.t01-2-00355.x; Moscho A, 1996, P NATL ACAD SCI USA, V93, P11443, DOI 10.1073/pnas.93.21.11443; MULLER WE, 1995, BRAIN RES, V674, P133, DOI 10.1016/0006-8993(94)01463-R; OBRIEN JS, 1965, J LIPID RES, V6, P537; Oshima N, 2001, AM J PATHOL, V158, P2209, DOI 10.1016/S0002-9440(10)64693-7; Ostroumova OS, 2011, FEBS J, V278, P461, DOI 10.1111/j.1742-4658.2010.07967.x; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Peters I, 2009, BBA-BIOMEMBRANES, V1788, P964, DOI 10.1016/j.bbamem.2009.01.012; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Potapov A, 2015, J AM CHEM SOC, V137, P8294, DOI 10.1021/jacs.5b04843; Qiang W, 2015, BBA-BIOMEMBRANES, V1848, P266, DOI 10.1016/j.bbamem.2014.04.011; Qiang W, 2014, BIOCHEMISTRY-US, V53, P7503, DOI 10.1021/bi501003n; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Qiang W, 2011, J AM CHEM SOC, V133, P4018, DOI 10.1021/ja109679q; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; Sengupta P, 2003, BIOCHEMISTRY-US, V42, P10506, DOI 10.1021/bi0341410; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Vestergaard MC, 2013, BBA-BIOMEMBRANES, V1828, P1314, DOI 10.1016/j.bbamem.2013.01.015; Wang T, 2012, BIOPHYS J, V102, P787, DOI 10.1016/j.bpj.2012.01.010; Widenbrant MJO, 2006, BIOPHYS J, V91, P4071, DOI 10.1529/biophysj.106.085944; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Yu X, 2013, PHYS CHEM CHEM PHYS, V15, P8878, DOI 10.1039/c3cp44448a; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	56	38	39	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12233	12244		10.1074/jbc.M116.720656	http://dx.doi.org/10.1074/jbc.M116.720656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27056326	Green Published, hybrid			2022-12-26	WOS:000378092800024
J	Barbosa, A; Balague, V; Valera, F; Martinez, A; Benzal, J; Motas, M; Diaz, JI; Mira, A; Pedros-Alio, C				Barbosa, Andres; Balague, Vanessa; Valera, Francisco; Martinez, Ana; Benzal, Jesus; Motas, Miguel; Diaz, Julia I.; Mira, Alex; Pedros-Alio, Carlos			Age-Related Differences in the Gastrointestinal Microbiota of Chinstrap Penguins (Pygoscelis antarctica)	PLOS ONE			English	Article							INTERSPECIFIC VARIATIONS; INTESTINAL MICROBIOTA; BACTERIAL PATHOGENS; CLOACAL BACTERIA; COMMUNITY; GROWTH; EVOLUTION; BIRDS	The gastrointestinal tract microbiota is known to play very important roles in the well being of animals. It is a complex community composed by hundreds of microbial species interacting closely among them and with their host, that is, a microbial ecosystem. The development of high throughput sequencing techniques allows studying the diversity of such communities in a realistic way and considerable work has been carried out in mammals and some birds such as chickens. Wild birds have received less attention and in particular, in the case of penguins, only a few individuals of five species have been examined with molecular techniques. We collected cloacal samples from Chinstrap penguins in the Vapour Col rookery in Deception Island, Antarctica, and carried out pyrosequencing of the V1-V3 region of the 16S rDNA in samples from 53 individuals, 27 adults and 26 chicks. This provided the first description of the Chinstrap penguin gastrointestinal tract microbiota and the most extensive in any penguin species. Firmicutes, Bacteoridetes, Proteobacteria, Fusobacteria, Actinobacteria, and Tenericutes were the main components. There were large differences between chicks and adults. The former had more Firmicutes and the latter more Bacteroidetes and Proteobacteria. In addition, adults had richer and more diverse bacterial communities than chicks. These differences were also observed between parents and their offspring. On the other hand, nests explained differences in bacterial communities only among chicks. We suggest that environmental factors have a higher importance than genetic factors in the microbiota composition of chicks. The results also showed surprisingly large differences in community composition with other Antarctic penguins including the congeneric Adelie and Gentoo penguins.	[Barbosa, Andres] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain; [Balague, Vanessa; Pedros-Alio, Carlos] CSIC, Inst Ciencies Mar, Dept Biol Marina & Oceanog, Barcelona, Spain; [Valera, Francisco; Benzal, Jesus] CSIC, Estn Expt Zonas Aridas, Dept Ecol Func & Evolut, Almeria, Spain; [Martinez, Ana] Univ Nacl Autonoma Mexico, Inst Invest Mat, Mexico City 04510, DF, Mexico; [Motas, Miguel] Univ Murcia, Fac Vet, Murcia, Spain; [Diaz, Julia I.] CCT La Plata CONICET UNLP, Ctr Estudios Parasitol & Vectores, La Plata, Buenos Aires, Argentina; [Mira, Alex] FISABIO Fdn, Ctr Adv Res Publ Hlth, Dept Genom & Hlth, Valencia, Spain; [Pedros-Alio, Carlos] CSIC, Ctr Nacl Biotecnol, Syst & Synthet Biol Program, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidad Nacional Autonoma de Mexico; University of Murcia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Pedros-Alio, C (corresponding author), CSIC, Ctr Nacl Biotecnol, Syst & Synthet Biol Program, Madrid, Spain.	cpedros@cnb.csic.es	Motas, Miguel/L-3061-2014; Benzal, Jesús/T-4555-2017; Barbosa, Andrés/C-3208-2008; Valera, Francisco/R-3437-2019; Valera, Francisco/J-5951-2014; Pedrós-Alió, Carlos/H-1222-2011; Mira, Alex/A-7244-2010	Motas, Miguel/0000-0002-2229-7779; Barbosa, Andrés/0000-0001-8434-3649; Valera, Francisco/0000-0003-2266-8899; Valera, Francisco/0000-0003-2266-8899; Pedrós-Alió, Carlos/0000-0003-1009-4277; Martinez, Ana/0000-0002-0515-1946; Mira, Alex/0000-0002-9127-3877	Ministerio de Economia y Competitividad (Espana) [CGL2007-60369, CTM2011-24427]; "Marine Gems" Ministerio de Economia y Competitividad (Espana) [CTM2010-20361]; "EcoBGM" Ministerio de Economia y Competitividad (Espana) [CTM2013-48292-C3-1-R]	Ministerio de Economia y Competitividad (Espana)(Spanish Government); "Marine Gems" Ministerio de Economia y Competitividad (Espana); "EcoBGM" Ministerio de Economia y Competitividad (Espana)	CGL2007-60369 Ministerio de Economia y Competitividad (Espana, http://www.mineco.gob.es/) AB, CTM2011-24427 Ministerio de Economia y Competitividad (Espana, http://www.mineco.gob.es/) AB, CTM2010-20361 "Marine Gems" Ministerio de Economia y Competitividad (Espana, http://www.mineco.gob.es) CPA, CTM2013-48292-C3-1-R "EcoBGM" Ministerio de Economia y Competitividad (Espana, http://ww.mineco.gob.es/) CPA.	Banks JC, 2009, ENVIRON MICROBIOL, V11, P577, DOI 10.1111/j.1462-2920.2008.01816.x; Barbosa A, 2009, POLAR BIOL, V32, P1095, DOI 10.1007/s00300-009-0640-3; Beier S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00149; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Berger S, 2003, J ORNITHOL, V144, P317, DOI 10.1007/BF02465631; Bonnedahl J, 2005, AMBIO, V34, P430, DOI 10.1639/0044-7447(2005)034[0430:ISOHBP]2.0.CO;2; BRITTINGHAM MC, 1988, J WILDLIFE DIS, V24, P299, DOI 10.7589/0090-3558-24.2.299; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Crespo BG, 2015, BIORXIV; Dewar ML, 2014, FEMS MICROBIOL ECOL, V89, P47, DOI 10.1111/1574-6941.12332; Dewar ML, 2013, MICROBIOLOGYOPEN, V2, P195, DOI 10.1002/mbo3.66; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gonzalez-Braojos S, 2014, INTERACCIONES ECOLOG; Gonzalez-Braojos S, 2015, J ORNITHOL, V156, P327, DOI 10.1007/s10336-014-1100-6; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Kohl KD, 2012, J COMP PHYSIOL B, V182, P591, DOI 10.1007/s00360-012-0645-z; Kyle PD, 1993, J WILDL REHABIL, V8; Lan Y, 2005, WORLD POULTRY SCI J, V61, P95, DOI 10.1079/WPS200445; Lefebvre KA, 2002, TOXICON, V40, P971, DOI 10.1016/S0041-0101(02)00093-4; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Lombardo MP, 1996, CONDOR, V98, P167, DOI 10.2307/1369521; Lucas FS, 2005, J AVIAN BIOL, V36, P510, DOI 10.1111/j.0908-8857.2005.03479.x; Meade GC, 1997, GASTROINTESTINAL MIC; Mills TK, 1999, AUK, V116, P947; Morales SE, 2009, APPL ENVIRON MICROB, V75, P668, DOI 10.1128/AEM.01757-08; Moreno J, 2003, AUK, V120, P784, DOI 10.1642/0004-8038(2003)120[0784:BEOCBO]2.0.CO;2; Nuttall Patricia A., 1997, P271; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Potti J, 2002, ECOL LETT, V5, P709, DOI 10.1046/j.1461-0248.2002.00375.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Ruiz-Rodriguez M, 2009, BIOL J LINN SOC, V96, P406, DOI 10.1111/j.1095-8312.2008.01127.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Salazar G, 2016, ISME J, V10, P596, DOI 10.1038/ismej.2015.137; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scupham AJ, 2007, FEMS MICROBIOL ECOL, V60, P136, DOI 10.1111/j.1574-6941.2006.00245.x; SIEBURTH JM, 1959, J BACTERIOL, V77, P521, DOI 10.1128/JB.77.5.521-531.1959; SOUCEK Z, 1970, APPL MICROBIOL, V20, P561, DOI 10.1128/AEM.20.4.561-566.1970; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Tanikawa T, 2011, POULTRY SCI, V90, P1004, DOI 10.3382/ps.2010-01153; Valles Y, 2012, CLIN MICROBIOL INFEC, V18, P21, DOI 10.1111/j.1469-0691.2012.03876.x; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; Vik U, 2013, SCI REP-UK, V3, DOI 10.1038/srep03471; Waite DW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00223; Williams TD, 1995, PENGUINS SPHENISCIDA; Yoshitomi B, 2012, CHEMOSPHERE, V86, P891, DOI 10.1016/j.chemosphere.2011.10.042; Zoetendal EG, 2004, J NUTR, V134, P465, DOI 10.1093/jn/134.2.465	51	50	51	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153215	10.1371/journal.pone.0153215	http://dx.doi.org/10.1371/journal.pone.0153215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055030	Green Published, Green Submitted, gold			2022-12-26	WOS:000373608000103
J	Flahault, A; Trystram, D; Fouchard, M; Knebelmann, B; Nataf, F; Joly, D				Flahault, Adrien; Trystram, Denis; Fouchard, Marie; Knebelmann, Bertrand; Nataf, Francois; Joly, Dominique			Screening for Unruptured Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Survey of 420 Nephrologists	PLOS ONE			English	Article							PHYSICIAN PRACTICE; PREVALENCE; MANAGEMENT; HEMORRHAGE; SURVIVAL; ADPKD; GENE	Background Despite a high prevalence of intracranial aneurysm (ICA) in autosomal dominant polycystic kidney disease (ADPKD), rupture events are rare. The current recommendations for ICA screening are based on expert opinions and studies with low levels of evidence. Objectives The aim of our study was to describe the attitudes of practicing nephrologists in Europe towards screening for ICA using magnetic resonance angiography (MRA). Methods We conducted a web-based survey among 1315 European French-speaking nephrologists and nephrology residents. An anonymous, electronic questionnaire including 24 independent questions related to ICA screening modalities, indications and participant profiles was sent by email between September and December 2014. Four hundred and twenty nephrologists (mostly from France) participated, including 31 nephrology residents; the response rate was 32%. Results Systematic screening for ICA was advocated by 28% of the nephrologists. A family history of ICA rupture, sudden death, stroke and migraine were consensual indications for screening (> 90% of the panel). In other clinical situations largely not covered by the recommendations (pregnancy, nephrectomy, kidney transplantation, cardiac or hepatic surgery, uncontrolled hypertension, lack of familial ADPKD history, at-risk activity, tobacco use), the attitudes towards screening were highly divergent. ICA screening was influenced by nephrologists experience with ADPKD and by their practice setting. The majority of participants (57%) would not repeat a normal ICA screening. Only a few participants (22%) knew that non-contrast MRA was the reference diagnostic tool for ICA screening, whereas most participants thought that contrast enhancement was necessary to screen for ICA. The results from the nephrology residents were analyzed separately and yielded similar results. Conclusion This practice survey revealed that most nephrologists follow the current recommendations for the initial screening of ICAs. However, more than a quarter of the panel was in favor of systematic ICA screening, most nephrologists did not know that contrast medium was not necessary to screen for ICA using MRA, and many areas of uncertainty remain.	[Flahault, Adrien; Fouchard, Marie; Knebelmann, Bertrand; Joly, Dominique] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Fac Med,Serv Nephrol, Paris, France; [Trystram, Denis] Univ Paris 05, Ctr Hosp St Anne, INSERM UMR 894, Serv Neuroradiol, Paris, France; [Nataf, Francois] Univ Paris 05, Ctr Hosp St Anne, INSERM UMR 894, Serv Neurochirurg, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Joly, D (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, AP HP, Fac Med,Serv Nephrol, Paris, France.	dominique.joly@aphp.fr	Flahault, Adrien/Q-4576-2017	Flahault, Adrien/0000-0003-4632-6332; Trystram, Denis/0000-0003-1496-222X				Belz MM, 2001, AM J KIDNEY DIS, V38, P770, DOI 10.1053/ajkd.2001.27694; Brown RD, 2014, LANCET NEUROL, V13, P393, DOI 10.1016/S1474-4422(14)70015-8; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; CHAUVEAU D, 1994, KIDNEY INT, V45, P1140, DOI 10.1038/ki.1994.151; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; Gibbs GF, 2005, J MAGN RESON IMAGING, V21, P97, DOI 10.1002/jmri.20247; Irazabal MV, 2011, CLIN J AM SOC NEPHRO, V6, P1274, DOI 10.2215/CJN.09731110; Kanaan N, 2014, NAT REV NEPHROL, V10, P455, DOI 10.1038/nrneph.2014.104; Levy M, 2000, KIDNEY INT, V58, P925, DOI 10.1046/j.1523-1755.2000.00250.x; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Perrone RD, 2001, AM J KIDNEY DIS, V38, P777, DOI 10.1053/ajkd.2001.27720; Pirson Y, 2002, J AM SOC NEPHROL, V13, P269, DOI 10.1681/ASN.V131269; Rossetti S, 2003, LANCET, V361, P2196, DOI 10.1016/S0140-6736(03)13773-7; Rozenfeld MN, 2014, AM J NEURORADIOL, V35, P3, DOI 10.3174/ajnr.A3437; SCHIEVINK WI, 1992, J AM SOC NEPHROL, V3, P88; Schrier RW, 2004, J AM SOC NEPHROL, V15, P1023, DOI 10.1097/01.ASN.0000118527.74850.66; Shiue I, 2012, J NEUROL SCI, V313, P92, DOI 10.1016/j.jns.2011.09.017; Spithoven EM, 2014, NEPHROL DIAL TRANSPL, V29, P15, DOI 10.1093/ndt/gfu017; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; United States Renal Data System, 2015, 2015 USRDS ANNUAL DA; Veloski J, 2005, AM J MED QUAL, V20, P151, DOI 10.1177/1062860605274520; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Xu HW, 2011, STROKE, V42, P204, DOI 10.1161/STROKEAHA.110.578740; Yoo DJ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-39	25	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153176	10.1371/journal.pone.0153176	http://dx.doi.org/10.1371/journal.pone.0153176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054719	Green Published, Green Submitted, gold			2022-12-26	WOS:000373608000093
J	Fonseca, F; Meneghel, J; Cenard, S; Passot, S; Morris, GJ				Fonseca, Fernanda; Meneghel, Julie; Cenard, Stephanie; Passot, Stephanie; Morris, G. John			Determination of Intracellular Vitrification Temperatures for Unicellular Micro Organisms under Conditions Relevant for Cryopreservation	PLOS ONE			English	Article							DELBRUECKII SUBSP BULGARICUS; GLASS-TRANSITION; ESCHERICHIA-COLI; FREEZING-INJURY; OSMOTIC-STRESS; CELL; CRYOTOLERANCE; SUSPENSIONS; BEHAVIOR; STORAGE	During cryopreservation ice nucleation and crystal growth may occur within cells or the intracellular compartment may vitrify. Whilst previous literature describes intracellular vitrification in a qualitative manner, here we measure the intracellular vitrification temperature of bacteria and yeasts under conditions relevant to cryopreservation, including the addition of high levels of permeating and nonpermeating additives and the application of rapid rates of cooling. The effects of growth conditions that are known to modify cellular freezing resistance on the intracellular vitrification temperature are also examined. For bacteria a plot of the activity on thawing against intracellular glass transition of the maximally freeze-concentrated matrix (Tg') shows that cells with the lowest value of intracellular Tg' survive the freezing process better than cells with a higher intracellular Tg'. This paper demonstrates the role of the physical state of the intracellular environment in determining the response of microbial cells to preservation and could be a powerful tool to be manipulated to allow the optimization of methods for the preservation of microorganisms.	[Fonseca, Fernanda; Meneghel, Julie; Cenard, Stephanie; Passot, Stephanie] Univ Paris Saclay, INRA, AgroParisTech, UMR GMPA, Thiverval Grignon, France; [Morris, G. John] Asymptote Ltd, St Johns Innovat Ctr, Cambridge CB4 0WS, England	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; St Johns Innovation Centre - UK	Fonseca, F (corresponding author), Univ Paris Saclay, INRA, AgroParisTech, UMR GMPA, Thiverval Grignon, France.	fonseca@grignon.inra.fr	Fonseca, Fernanda/AAR-9094-2020; FONSECA, FERNANDA/HDN-9451-2022	Fonseca, Fernanda/0000-0003-3394-182X; FONSECA, FERNANDA/0000-0002-0315-6479	National Institute of Agronomic Research (Paris, France)	National Institute of Agronomic Research (Paris, France)	This study was supported by the National Institute of Agronomic Research (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLETT S, 1992, J CHEM SOC FARADAY T, V88, P789, DOI 10.1039/ft9928800789; BANK H, 1973, J CELL BIOL, V57, P729, DOI 10.1083/jcb.57.3.729; CHANG BS, 1992, CRYOBIOLOGY, V29, P632, DOI 10.1016/0011-2240(92)90067-C; Clarke A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066207; Colandene JD, 2007, J PHARM SCI-US, V96, P1598, DOI 10.1002/jps.20812; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; Fonseca F, 2006, APPL ENVIRON MICROB, V72, P6474, DOI 10.1128/AEM.00998-06; Gao C, 2005, THERMOCHIM ACTA, V435, P38, DOI 10.1016/j.tca.2005.03.024; Gautier J, 2013, J DAIRY SCI, V96, P5591, DOI 10.3168/jds.2013-6802; Kilbride P, 2014, CRYOBIOLOGY, V69, P367, DOI 10.1016/j.cryobiol.2014.09.003; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; Mazur P, 2011, CRYOBIOLOGY, V62, P1, DOI 10.1016/j.cryobiol.2010.10.159; Meister E, 2009, J PHARM SCI-US, V98, P3072, DOI 10.1002/jps.21586; Miermont A, 2013, P NATL ACAD SCI USA, V110, P5725, DOI 10.1073/pnas.1215367110; Mika JT, 2011, CURR OPIN BIOTECH, V22, P117, DOI 10.1016/j.copbio.2010.09.009; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; Morris GJ, 2012, CRYOBIOLOGY, V64, P71, DOI 10.1016/j.cryobiol.2011.12.002; MORRIS GJ, 1988, CRYOBIOLOGY, V25, P471, DOI 10.1016/0011-2240(88)90055-7; Morris GJ, 2004, CRYOLETTERS, V25, P265; Mourao MA, 2014, BIOPHYS J, V107, P2761, DOI 10.1016/j.bpj.2014.10.051; Passot S, 2005, EUR J PHARM BIOPHARM, V60, P335, DOI 10.1016/j.ejpb.2005.02.013; Rapatz G, 1963, ELECT MICROSCOPY STU; Rapatz GL, 1966, CRYOBIOLOGY, P149; Seki S, 2009, CRYOBIOLOGY, V58, P157, DOI 10.1016/j.cryobiol.2008.11.011; SHALAEV EY, 1995, J CHEM SOC FARADAY T, V91, P1511, DOI 10.1039/ft9959101511; Slade L., 1989, PROTEIN QUALITY EFFE, P9; Sochacki KA, 2011, BIOPHYS J, V100, P22, DOI 10.1016/j.bpj.2010.11.044; SPINNLER HE, 1989, J DAIRY RES, V56, P755, DOI 10.1017/S0022029900029332; Streit F, 2007, J BIOTECHNOL, V128, P659, DOI 10.1016/j.jbiotec.2006.11.012; Sun WQ, 1997, COMP BIOCHEM PHYS A, V117, P327, DOI 10.1016/S0300-9629(96)00271-X; To BCS, 1997, J FOOD SCI, V62, P576, DOI 10.1111/j.1365-2621.1997.tb04434.x; To CSB, 1997, J FOOD SCI, V62, P585; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	33	27	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152939	10.1371/journal.pone.0152939	http://dx.doi.org/10.1371/journal.pone.0152939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055246	gold, Green Published			2022-12-26	WOS:000373608000057
J	Lee, YK; Hwang, SY; Shin, TG; Jo, IJ; Suh, GY; Jeon, K				Lee, Young Kun; Hwang, Sung Yeon; Shin, Tae Gun; Jo, Ik Joon; Suh, Gee Young; Jeon, Kyeongman			Prognostic Value of Lactate and Central Venous Oxygen Saturation after Early Resuscitation in Sepsis Patients	PLOS ONE			English	Article							GOAL-DIRECTED RESUSCITATION; SEPTIC SHOCK; CRITICALLY-ILL; MANAGEMENT; CLEARANCE; THERAPY; BUNDLE	The objective of this study was to evaluate the prognostic value of static and dynamic variables of central venous oxygen saturation (ScvO(2)) and lactate in patients with severe sepsis or septic shock who underwent early quantitative resuscitation. We also investigated whether ScvO(2) measured after initial resuscitation could provide additive prognostic value to that of lactate. We analyzed the sepsis registry for patients presenting to the emergency department and included patients with simultaneous measurements of lactate and ScvO(2) at the time of presentation (H0) and 6 hours (H6) after resuscitation. The primary outcome was 28-day mortality and multivariable logistic analysis was used to adjust for confounders. A total of 363 patients were included, and the overall 28-day mortality was 18%. The area under the receiver operator characteristic curve for predicting 28-day mortality was as follows: lactate (H6), 0.81; lactate (H0), 0.73; relative lactate change, 0.67; ScvO(2) (H6), 0.65; relative ScvO(2) change 0.59; ScvO(2) (H0), 0.58. Patients with lactate normalization showed significantly lower 28-day mortality compared to patients without lactate normalization (3% vs. 28%, P<0.01). However, in those who achieved ScvO(2) (H6) >= 70%, there was a significant difference in 28-mortality only in patients without lactate normalization (21% vs. 39%, P<0.01) but no difference in those with lactate normalization (4% vs. 3%, P = 0.71). Inmultivariable analysis, lactate normalization was significantly associated with 28-daymortality (adjusted odds ratio [OR] for 28-day mortality, 0.20; 95% confidence interval [CI], 0.07-0.54; P <0.01), but ScvO(2) (H6) >= 70% showed only a marginal association (the adjusted OR for 28-day mortality, 0.51; 95% CI, 0.26-1.01; P = 0.05). ScvO(2) (H6) >= 70% was associated with 28-day mortality only in cases without lactate normalization in subgroup analysis (adjusted OR 0.37, 95% CI, 0.18-0.79; P = 0.01). Six-hour lactate was the strongest predictor of 28-day mortality in patients with severe sepsis or septic shock. Six-hour ScvO(2) provided additional prognostic value only in cases where lactate values were not normalized after resuscitation.	[Lee, Young Kun; Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Lee, Young Kun; Hwang, Sung Yeon; Shin, Tae Gun; Jo, Ik Joon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Emergency Med, Seoul, South Korea; [Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea.; Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea.	kjeon@skku.edu	Shin, Tae Gun/GSD-5866-2022; Suh, Gee Young/O-3676-2019; Jeon, Kyeongman/F-5963-2019	Suh, Gee Young/0000-0001-5473-1712; Jeon, Kyeongman/0000-0002-4822-1772	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C0743]; Samsung Medical Center	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Samsung Medical Center(Samsung)	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C0743). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, Samsung Medical Center provided support in the form of salaries for all of authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; [Anonymous], 2014, NEW ENGL J MED, DOI DOI 10.1056/NEJMoa1401602; [Anonymous], IMPACT TIMELY ANTIBI; Arnold RC, 2009, SHOCK, V32, P35, DOI 10.1097/SHK.0b013e3181971d47; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Hernandez G, 2012, CURR OPIN CRIT CARE, V18, P280, DOI 10.1097/MCC.0b013e3283532c08; Hernandez G, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.09.007; Hwang SY, 2014, SHOCK, V42, P205, DOI 10.1097/SHK.0000000000000205; Jeon K, 2012, SHOCK, V37, P463, DOI 10.1097/SHK.0b013e31824c31d1; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Joshi R, 2014, J EMERG MED, V47, P493, DOI 10.1016/j.jemermed.2014.06.016; Kang MJ, 2012, SHOCK, V38, P474, DOI 10.1097/SHK.0b013e31826eea2b; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Levraut J, 2003, CRIT CARE MED, V31, P705, DOI 10.1097/01.CCM.0000045561.85810.45; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Park HY, 2012, CRIT CARE, V16, DOI 10.1186/cc10601; Park JH, 2014, LUNG, V192, P435, DOI 10.1007/s00408-014-9564-y; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Puskarich MA, 2013, CHEST, V143, P1548, DOI 10.1378/chest.12-0878; Puskarich MA, 2012, ACAD EMERG MED, V19, P252, DOI 10.1111/j.1553-2712.2012.01292.x; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers EP, 2011, CHEST, V140, P1408, DOI 10.1378/chest.11-2563; Shin TG, 2013, CRIT CARE, V17, DOI 10.1186/cc13047; Song YH, 2012, SHOCK, V38, P249, DOI 10.1097/SHK.0b013e3182613e33; Suetrong B, 2016, CHEST, V149, P252, DOI 10.1378/chest.15-1703; Vincent JL, 2014, CLIN EXP EMERG MED, V1, P3, DOI 10.15441/ceem.14.005; Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943	29	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153305	10.1371/journal.pone.0153305	http://dx.doi.org/10.1371/journal.pone.0153305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054713	Green Published, gold			2022-12-26	WOS:000373608000117
J	Tada, T; Miyoshi-Akiyama, T; Shimada, K; Shiroma, A; Nakano, K; Teruya, K; Satou, K; Hirano, T; Shimojima, M; Kirikae, T				Tada, Tatsuya; Miyoshi-Akiyama, Tohru; Shimada, Kayo; Shiroma, Akino; Nakano, Kazuma; Teruya, Kuniko; Satou, Kazuhito; Hirano, Takashi; Shimojima, Masahiro; Kirikae, Teruo			A Carbapenem-Resistant Pseudomonas aeruginosa Isolate Harboring Two Copies of bla(IMP-34) Encoding a Metallo-beta-Lactamase	PLOS ONE			English	Article							II TOPOISOMERASE MUTATIONS; GENE; STRAINS	A carbapenem-resistant strain of Pseudomonas aeruginosa, NCGM1984, was isolated in 2012 from a hospitalized patient in Japan. Immunochromatographic assay showed that the isolate was positive for IMP-type metallo-beta-lactamase. Complete genome sequencing revealed that NCGM1984 harbored two copies of bla(IMP-34), located at different sites on the chromosome. Each blaIMP-34 was present in the same structures of the class 1 integrons, tnpA(ISPa7)-intI1-qacG-bla(IMP-34)-aac(6')-Ib-qacEdelta1-sul1-orf5-tniBdelta-tniA. The isolate belonged to multilocus sequence typing ST235, one of the international high-risk clones. IMP-34, with an amino acid substitution (Glu126Gly) compared with IMP-1, hydrolyzed all beta-lactamases tested except aztreonam, and its catalytic activities were similar to IMP-1. This is the first report of a clinical isolate of an IMP-34-producing P. aeruginosa harboring two copies of blaI(MP-34) on its chromosome.	[Tada, Tatsuya; Miyoshi-Akiyama, Tohru; Shimada, Kayo; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Shinjuku Ku, 1-21-1 Toyama, Tokyo, Japan; [Miyoshi-Akiyama, Tohru] Natl Ctr Global Hlth & Med, Res Inst, Pathogen Microbe Lab, Shinjuku Ku, 1-21-1 Toyama, Tokyo, Japan; [Shiroma, Akino; Nakano, Kazuma; Teruya, Kuniko; Satou, Kazuhito; Hirano, Takashi] Okinawa Inst Adv Sci, Div Res & Dev, Okinawa, Japan; [Shimojima, Masahiro] BML Inc, Dept Accuracy Management, Kawagoe, Saitama, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; BML, Inc.	Kirikae, T (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Shinjuku Ku, 1-21-1 Toyama, Tokyo, Japan.	tkirikae@ri.ncgm.go.jp		Nakano, Kazuma/0000-0001-9908-6526	International Health Cooperation Research [27-S-1102, 26-A-103]; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED	International Health Cooperation Research; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	The study was supported by grants from International Health Cooperation Research (27-S-1102 and 26-A-103) and Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development, AMED. BML Inc. provided support in the form of salaries for the author [MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	Akasaka T, 2001, ANTIMICROB AGENTS CH, V45, P2263, DOI 10.1128/AAC.45.8.2263-2268.2001; [Anonymous], 2015, M100S25 CLSI; Boschi L, 2000, ANTIMICROB AGENTS CH, V44, P1538, DOI 10.1128/AAC.44.6.1538-1543.2000; Bush K, 2001, CLIN INFECT DIS, V32, P1085, DOI 10.1086/319610; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Crowder MW, 1998, ANTIMICROB AGENTS CH, V42, P921, DOI 10.1128/AAC.42.4.921; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Jovcic B, 2014, ANTON LEEUW INT J G, V105, P613, DOI 10.1007/s10482-013-0094-z; Jovcic B, 2013, ANTIMICROB AGENTS CH, V57, P3405, DOI 10.1128/AAC.02312-12; Jove T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000793; Kitao T, 2011, J MICROBIOL METH, V87, P330, DOI 10.1016/j.mimet.2011.09.011; Kitao T, 2010, J ANTIMICROB CHEMOTH, V65, P1382, DOI 10.1093/jac/dkq148; Mano Y, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0378-8; Mouneimne H, 1999, ANTIMICROB AGENTS CH, V43, P62, DOI 10.1128/AAC.43.1.62; NORMARK S, 1977, J BACTERIOL, V132, P912, DOI 10.1128/JB.132.3.912-922.1977; Notake S, 2013, J CLIN MICROBIOL, V51, P1762, DOI 10.1128/JCM.00234-13; Oliver A, 2015, DRUG RESIST UPDATE, V21-22, P41, DOI 10.1016/j.drup.2015.08.002; Papagiannitsis CC, 2009, ANTIMICROB AGENTS CH, V53, P277, DOI 10.1128/AAC.00912-08; Partridge SR, 2001, ANTIMICROB AGENTS CH, V45, P1263, DOI 10.1128/AAC.45.4.1263-1270.2001; Queenan AM, 2010, ANTIMICROB AGENTS CH, V54, P565, DOI 10.1128/AAC.01004-09; Shigemoto N, 2013, DIAGN MICR INFEC DIS, V76, P119, DOI 10.1016/j.diagmicrobio.2013.02.030; Tada T, 2012, J MICROBIOL METH; Tada T, 2015, ANTIMICROB AGENTS CH, V59, P7090, DOI 10.1128/AAC.01611-15; Tada T, 2013, ANTIMICROB AGENTS CH, V57, P4427, DOI 10.1128/AAC.00716-13; Tojo M, 2014, J INFECT CHEMOTHER, V20, P586, DOI 10.1016/j.jiac.2014.04.014; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Yamaguchi Y, 2005, J BIOL CHEM, V280, P20824, DOI 10.1074/jbc.M414314200	28	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0149385	10.1371/journal.pone.0149385	http://dx.doi.org/10.1371/journal.pone.0149385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055243	gold, Green Published			2022-12-26	WOS:000373608000001
J	Carlitz, EHD; Miller, R; Kirschbaum, C; Gao, W; Hanni, DC; van Schaik, CP				Carlitz, Esther H. D.; Miller, Robert; Kirschbaum, Clemens; Gao, Wei; Haenni, Daniel C.; van Schaik, Carel P.			Measuring Hair Cortisol Concentrations to Assess the Effect of Anthropogenic Impacts on Wild Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							FECAL GLUCOCORTICOID METABOLITES; PHYSIOLOGICAL STRESS; HORMONE CHALLENGE; HOWLER MONKEYS; FOREST; TOURISM; HABITUATION; RESPONSES; ANXIETY; VALIDATION	Non-human primates face major environmental changes due to increased human impacts all over the world. Although some species are able to survive in certain landscapes with anthropogenic impact, their long-term viability and fitness may be decreased due to chronic stress. Here we assessed long-term stress levels through cortisol analysis in chimpanzee hair obtained from sleeping nests in northwestern Uganda, in order to estimate welfare in the context of ecotourism, forest fragmentation with human-wildlife conflicts, and illegal logging with hunting activity (albeit not of primates), compared with a control without human contact or conflict. Concerning methodological issues, season [F(2,129) = 37.4, p < 0.0001, r(2) = 0.18] and the age of nests [F(2,178) = 20.3, p < 0.0001, r(2) = 0.11] significantly predicted hair cortisol concentrations (HCC). With regard to effects of anthropogenic impacts, our results neither showed elevation of HCC due to ecotourism, nor due to illegal logging compared to their control groups. We did, however, find significantly increased HCC in the fragment group compared to chimpanzees living in a nearby intact forest [F(1,88) = 5.0, p = 0.03, r(2) = 0.20]. In conclusion, our results suggest that hair cortisol analysis is a powerful tool that can help understanding the impact of anthropogenic disturbances on chimpanzee well-being and could be applied to other great ape species.	[Carlitz, Esther H. D.; Haenni, Daniel C.; van Schaik, Carel P.] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Carlitz, Esther H. D.; Miller, Robert; Kirschbaum, Clemens; Gao, Wei] Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany; [Carlitz, Esther H. D.; Haenni, Daniel C.] Jane Goodall Inst Switzerland, Zurich, Switzerland	University of Zurich; Technische Universitat Dresden	Carlitz, EHD (corresponding author), Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland.; Carlitz, EHD (corresponding author), Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany.; Carlitz, EHD (corresponding author), Jane Goodall Inst Switzerland, Zurich, Switzerland.	ecarlitz@janegoodall.ch	Miller, Robert/G-4473-2016; Miller, Robert/AAV-1829-2020; Kirschbaum, Clemens/AAB-1752-2020	Miller, Robert/0000-0002-8665-5248; Miller, Robert/0000-0002-8665-5248; 	Jane Goodall Institute Switzerland	Jane Goodall Institute Switzerland	Travel and research expenses in Uganda were funded by the Jane Goodall Institute Switzerland.	Aguilar-Melo AR, 2013, AM J PRIMATOL, V75, P1108, DOI 10.1002/ajp.22172; Arck PC, 2001, HUM REPROD, V16, P1505, DOI 10.1093/humrep/16.7.1505; Aronsen GP, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov006; Balestri M, 2013, STRESS HABITAT FRAGM; Behie AM, 2010, AM J PRIMATOL, V72, P600, DOI 10.1002/ajp.20813; Bertolani P, 2008, FOLIA PRIMATOL, V79, P162, DOI 10.1159/000111720; Boesch C, 2000, CHIMPANZEES TAI FORE; Carlitz EHD, 2015, GEN COMP ENDOCRINOL; Carlitz EHD, CORRES KEEPER REPORT; Carlitz EHD, 2014, GEN COMP ENDOCR, V195, P151, DOI 10.1016/j.ygcen.2013.11.002; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Cocks L, 2007, INT J PRIMATOL, V28, P421, DOI 10.1007/s10764-007-9116-x; Cooke SJ, 2014, PHYSIOL BIOCHEM ZOOL, V87, P1, DOI 10.1086/671165; COURTOIS M, 1995, BRIT J DERMATOL, V132, P86, DOI 10.1111/j.1365-2133.1995.tb08630.x; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Gonzalez-de-la-Vara MD, 2011, CAN J VET RES, V75, P216; Desmond J.S., 2014, PRIMATE TOURISM, P199, DOI DOI 10.1017/CBO9781139087407; Dettenborn L, 2010, PSYCHONEUROENDOCRINO, V35, P1404, DOI 10.1016/j.psyneuen.2010.04.006; Dettmer AM, 2012, PSYCHONEUROENDOCRINO, V37, P191, DOI 10.1016/j.psyneuen.2011.06.003; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Duchesne M, 2000, BIOL CONSERV, V96, P311, DOI 10.1016/S0006-3207(00)00082-3; Ellenberg U, 2007, GEN COMP ENDOCR, V152, P54, DOI 10.1016/j.ygcen.2007.02.022; Gao W, 2013, J CHROMATOGR B, V928, P1, DOI 10.1016/j.jchromb.2013.03.008; Gao W, 2010, CLIN BIOCHEM, V43, P677, DOI 10.1016/j.clinbiochem.2010.01.014; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hamel AF, 2011, CLIN CHIM ACTA, V412, P382, DOI 10.1016/j.cca.2010.10.019; Hill CM, 2010, AM J PRIMATOL, V72, P919, DOI 10.1002/ajp.20845; Hockings KJ, 2015, TRENDS ECOL EVOL, V30, P215, DOI 10.1016/j.tree.2015.02.002; Hockings Kimberley J., 2013, Primate Conservation, V26, P57; Hockings KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033391; Hockings KJ, 2012, ANIM BEHAV, V83, P801, DOI 10.1016/j.anbehav.2012.01.002; Hockings KJ, 2009, INTERACT STUD, V10, P183, DOI 10.1075/is.10.2.05hoc; Humle T, 2004, INT J PRIMATOL, V25, P551, DOI 10.1023/B:IJOP.0000023575.93644.f4; Hvenegaard GT, 2014, PRIMATE TOURISM TOOL, P259; Jaimez NA, 2012, ANIM CONSERV, V15, P242, DOI 10.1111/j.1469-1795.2011.00508.x; Johns BG, 1996, BIOL CONSERV, V78, P257, DOI 10.1016/S0006-3207(96)00044-4; Kerbiriou C, 2009, J APPL ECOL, V46, P657, DOI 10.1111/j.1365-2664.2009.01646.x; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; Kulp J, 2015, PRIMATES, P1; Li JF, 2012, CLIN CHIM ACTA, V413, P434, DOI 10.1016/j.cca.2011.10.024; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; Marechal L, 2011, BIOL CONSERV, V144, P2188, DOI 10.1016/j.biocon.2011.05.010; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; Mastromonaco GF, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou055; McLennan MR, 2012, J NAT CONSERV, V20, P219, DOI 10.1016/j.jnc.2012.03.002; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; Miller R, 2013, PSYCHONEUROENDOCRINO, V38, P941, DOI 10.1016/j.psyneuen.2012.09.013; Moya D, 2013, LIVEST SCI, V158, P138, DOI 10.1016/j.livsci.2013.10.007; Muehlenbein M, 2014, PRIMATE TOURISM TOOL, P278, DOI DOI 10.1017/CBO9781139087407.021; Muehlenbein MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033357; Nelson R.J., 2011, INTRO BEHAV ENDOCRIN; Newton-Fisher NE, 1999, AFR J ECOL, V37, P344, DOI 10.1046/j.1365-2028.1999.00186.x; R Core Team, 2013, R LANG ENV STAT COMP; Rangel-Negrin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112329; Rimbach R, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot031; Rimbach R, 2013, GEN COMP ENDOCR, V191, P13, DOI 10.1016/j.ygcen.2013.05.010; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Santos J, 2000, AM J PHYSIOL-GASTR L, V278, pG847, DOI 10.1152/ajpgi.2000.278.6.G847; Selye H, 1950, PHYSL PATHOLOGY EXPO; Shutt K, 2014, BIOL CONSERV, V172, P72, DOI 10.1016/j.biocon.2014.02.014; Shutt K, 2012, GEN COMP ENDOCR, V179, P167, DOI 10.1016/j.ygcen.2012.08.008; Skoluda N, 2012, PSYCHONEUROENDOCRINO, V37, P611, DOI 10.1016/j.psyneuen.2011.09.001; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; STERNBERG EM, 1992, ANN INTERN MED, V117, P854, DOI 10.7326/0003-4819-117-10-854; Steudte S, 2011, PSYCHIAT RES, V186, P310, DOI 10.1016/j.psychres.2010.09.002; Terwissen CV, 2013, GEN COMP ENDOCR, V194, P162, DOI 10.1016/j.ygcen.2013.09.010; Vanlangendonck N., 2015, J PRIMATOL, V4, P2; VANLAWIC.J, 1973, AM J PSYCHIAT, V130, P1; vanLawick-Goodall J., 1968, ANIM BEHAV MONOGR 3, V1; Williamson E. A., 2014, PRIMATE TOURISM TOOL, P292; Yamanashi Y, 2013, GEN COMP ENDOCR, V194, P55, DOI 10.1016/j.ygcen.2013.08.013	73	34	34	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151870	10.1371/journal.pone.0151870	http://dx.doi.org/10.1371/journal.pone.0151870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050418	Green Accepted, Green Published, gold			2022-12-26	WOS:000373603500017
J	Glei, DA; Goldman, N; Risques, RA; Rehkopf, DH; Dow, WH; Rosero-Bixby, L; Weinstein, M				Glei, Dana A.; Goldman, Noreen; Risques, Rosa Ana; Rehkopf, David H.; Dow, William H.; Rosero-Bixby, Luis; Weinstein, Maxine			Predicting Survival from Telomere Length versus Conventional Predictors: A Multinational Population-Based Cohort Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; OLDEST-OLD; ELDERLY-MEN; MORTALITY; ASSOCIATION; HEALTH; BIOMARKER; DEMENTIA; CELLS; IDENTIFICATION	Telomere length has generated substantial interest as a potential predictor of aging-related diseases and mortality. Some studies have reported significant associations, but few have tested its ability to discriminate between decedents and survivors compared with a broad range of well-established predictors that include both biomarkers and commonly collected self-reported data. Our aim here was to quantify the prognostic value of leukocyte telomere length relative to age, sex, and 19 other variables for predicting five-year mortality among older persons in three countries. We used data from nationally representative surveys in Costa Rica (N = 923, aged 61+), Taiwan (N = 976, aged 54+), and the U. S. (N = 2672, aged 60+). Our study used a prospective cohort design with all-cause mortality during five years post-exam as the outcome. We fit Cox hazards models separately by country, and assessed the discriminatory ability of each predictor. Age was, by far, the single best predictor of all-cause mortality, whereas leukocyte telomere length was only somewhat better than random chance in terms of discriminating between decedents and survivors. After adjustment for age and sex, telomere length ranked between 15th and 17th (out of 20), and its incremental contribution was small; nine self-reported variables (e.g., mobility, global self-assessed health status, limitations with activities of daily living, smoking status), a cognitive assessment, and three biological markers (C-reactive protein, serum creatinine, and glycosylated hemoglobin) were more powerful predictors of mortality in all three countries. Results were similar for cause-specific models (i.e., mortality from cardiovascular disease, cancer, and all other causes combined). Leukocyte telomere length had a statistically discernible, but weak, association with mortality, but it did not predict survival as well as age or many other self-reported variables. Although telomere length may eventually help scientists understand aging, more powerful and more easily obtained tools are available for predicting survival.	[Glei, Dana A.; Weinstein, Maxine] Georgetown Univ, Ctr Populat & Hlth, Washington, DC USA; [Goldman, Noreen] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Risques, Rosa Ana] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Rehkopf, David H.] Stanford Univ, Div Gen Med Disciplines, Sch Med, Stanford, CA 94305 USA; [Dow, William H.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Rosero-Bixby, Luis] Univ Costa Rica, Ctr Ctr Amer Poblac, San Jose, Costa Rica	Georgetown University; Princeton University; University of Washington; University of Washington Seattle; Stanford University; University of California System; University of California Berkeley; Universidad Costa Rica	Glei, DA (corresponding author), Georgetown Univ, Ctr Populat & Hlth, Washington, DC USA.	dag77@georgetown.edu		Rehkopf, David/0000-0002-7597-6513; Goldman, Noreen/0000-0003-2865-9491; Dow, William/0000-0002-4080-1668; Rosero-Bixby, Luis/0000-0002-3063-3111	National Institute on Aging [R01AG16790, R01AG16661, K01AG047280, R01AG031716, P30AG012839]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P2CHD047879]; Wellcome Trust [072406/Z/03/Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG047280, R01AG016661, R01AG031716, P30AG012839, R01AG016790] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (www.nia.nih.gov), grant numbers R01AG16790 (Princeton University, NG as PI), R01AG16661 (Georgetown University, MW as PI), K01AG047280 (Stanford University, DHR as PI), R01AG031716 (University of California, Berkeley, WHD as PI), P30AG012839 (University of California, Berkeley, WHD as PI); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov) grant number P2CHD047879; and the Wellcome Trust (www.wellcome.ac.uk), grant number 072406/Z/03/Z (Universidad de Costa Rica, LR-B. as PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, WAIS R MANUAL; Arai Y, EBIOMEDICIN IN PRESS; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Astrup AS, 2010, DIABETOLOGIA, V53, P45, DOI 10.1007/s00125-009-1542-1; Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Bendix L, 2014, J GERONTOL A-BIOL, V69, P231, DOI 10.1093/gerona/glt153; Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Boonekamp JJ, 2013, AGING CELL, V12, P330, DOI 10.1111/acel.12050; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Chang M, 2012, SOCIAL ENV BIOMARKER; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Curtin LR, 2012, NATL HLTH NUTR EXAMI; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Deelen J, 2014, INT J EPIDEMIOL; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Epel ES, 2009, AGING-US, V1, P81; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glei DA, 2015, J GERONTOL A-BIOL, V70, P1490, DOI 10.1093/gerona/glu191; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harris SE, 2006, NEUROSCI LETT, V406, P260, DOI 10.1016/j.neulet.2006.07.055; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; Honig LS, 2012, ARCH NEUROL-CHICAGO, V69, P1332, DOI 10.1001/archneurol.2012.1541; Houben JMJ, 2011, J GERONTOL A-BIOL, V66, P38, DOI 10.1093/gerona/glq164; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Kimura M, 2010, EXP HEMATOL, V38, P854, DOI 10.1016/j.exphem.2010.06.010; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, V5; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Long JS, 2004, MED CARE, V42, P19, DOI 10.1097/01.mlr.0000102293.37107.c5; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Martin-Ruiz CM, 2014, INT J EPIDEMIOL; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Needham BL, 2015, EPIDEMIOLOGY, V26, P528, DOI 10.1097/EDE.0000000000000299; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rehkopf DH, 2013, EXP GERONTOL, V48, P1266, DOI 10.1016/j.exger.2013.08.005; Rode L, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv074; Rosero-Bixby L, 2010, CRELES COSTA RICAN L; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Shay JW, 2007, J PATHOL, V211, P114, DOI 10.1002/path.2090; Soerensen M, 2012, AGING CELL, V11, P223, DOI 10.1111/j.1474-9726.2011.00775.x; Strandberg TE, 2011, J GERONTOL A-BIOL, V66, P815, DOI 10.1093/gerona/glr064; Svenson U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021485; Tulsky D, 1997, WAIS 3 WMS 3 TECHNIC; Wechsler D, 1997, ADMINISTRATION SCORI; Weischer M, 2012, ARTERIOSCL THROM VAS, V32, P822, DOI 10.1161/ATVBAHA.111.237271; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966; Zekry D, 2012, J NUTR HEALTH AGING, V16, P225, DOI 10.1007/s12603-011-0138-x; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207	60	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152486	10.1371/journal.pone.0152486	http://dx.doi.org/10.1371/journal.pone.0152486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049651	Green Published, gold			2022-12-26	WOS:000373603500043
J	Liu, T; Liu, SF; Zheng, MS; Chen, Q; Ni, JR				Liu, Tang; Liu, Shufeng; Zheng, Maosheng; Chen, Qian; Ni, Jinren			Performance Assessment of Full-Scale Wastewater Treatment Plants Based on Seasonal Variability of Microbial Communities via High-Throughput Sequencing	PLOS ONE			English	Article							POLYPHOSPHATE-ACCUMULATING ORGANISMS; ACTIVATED-SLUDGE; BACTERIAL COMMUNITY; RELATIVE ABUNDANCE; DIVERSITY; AMMONIA; TEMPERATURE; DYNAMICS; PATTERNS; SYSTEMS	Microbial communities of activated sludge (AS) play a key role in the performance of wastewater treatment processes. However, seasonal variability of microbial population in varying AS-based processes has been poorly correlated with operation of full-scale wastewater treatment systems (WWTSs). In this paper, significant seasonal variability of AS microbial communities in eight WWTSs located in the city of Guangzhou were revealed in terms of 16S rRNA-based Miseq sequencing. Furthermore, variation redundancy analysis (RDA) demonstrated that the microbial community compositions closely correlated with WWTS operation parameters such as temperature, BOD, NH4+-N and TN. Consequently, support vector regression models which reasonably predicted effluent BOD, SS and TN in WWTSs were established based on microbial community compositions. This work provided an alternative tool for rapid assessment on performance of full-scale wastewater treatment plants.	[Liu, Tang; Liu, Shufeng; Zheng, Maosheng; Chen, Qian; Ni, Jinren] Peking Univ, Dept Environm Engn, Beijing 100871, Peoples R China; [Liu, Tang; Liu, Shufeng; Zheng, Maosheng; Chen, Qian; Ni, Jinren] Minist Educ, Key Lab Water & Sediment Sci, Beijing 100871, Peoples R China	Peking University	Ni, JR (corresponding author), Peking Univ, Dept Environm Engn, Beijing 100871, Peoples R China.; Ni, JR (corresponding author), Minist Educ, Key Lab Water & Sediment Sci, Beijing 100871, Peoples R China.	nijinren@iee.pku.edu.cn	Liu, Shufeng/GXA-1430-2022		Guangzhou Scientific and Technologic Project for Water Service [GZSK-FW-1201]; National Natural Science Foundation of China [51208007]	Guangzhou Scientific and Technologic Project for Water Service; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Guangzhou Scientific and Technologic Project for Water Service (Grant No. GZSK-FW-1201) and National Natural Science Foundation of China (Grant No. 51208007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; Antony R, 2012, MICROBIOL RES, V167, P372, DOI 10.1016/j.micres.2012.03.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Community T, 2007, COMMUNITY ECOL PACKA, P631; Crocetti GR, 2000, APPL ENVIRON MICROB, V66, P1175, DOI 10.1128/AEM.66.3.1175-1182.2000; Dugan P, 2006, GENUS ZOOGLOEA PROKA, P960; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fortunato CS, 2012, ISME J, V6, P554, DOI 10.1038/ismej.2011.135; Gentile ME, 2007, ISME J, V1, P714, DOI 10.1038/ismej.2007.87; Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4; [郭红光 Guo Hongguang], 2015, [中国科学院大学学报, Journal of University of Chinese Academy of Sciences], V32, P1; Hai RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090175; He SM, 2011, MICROB BIOTECHNOL, V4, P603, DOI 10.1111/j.1751-7915.2011.00248.x; Hong YST, 2003, WATER RES, V37, P1608, DOI 10.1016/S0043-1354(02)00494-3; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Huang MZ, 2010, BIORESOURCE TECHNOL, V101, P1642, DOI 10.1016/j.biortech.2009.08.111; Ju F, 2015, ISME J, V9, P683, DOI 10.1038/ismej.2014.162; Ju F, 2014, ENVIRON MICROBIOL, V16, P2421, DOI 10.1111/1462-2920.12355; Kim DJ, 2006, BIORESOURCE TECHNOL, V97, P459, DOI 10.1016/j.biortech.2005.03.032; Kim TS, 2013, APPL MICROBIOL BIOT, V97, P1755, DOI 10.1007/s00253-012-4002-7; Koch H, 2015, P NATL ACAD SCI USA, V112, P11371, DOI 10.1073/pnas.1506533112; Kong YH, 2005, APPL ENVIRON MICROB, V71, P4076, DOI 10.1128/AEM.71.7.4076-4085.2005; Liu Y, 2005, BIORESOURCE TECHNOL, V96, P1205, DOI 10.1016/j.biortech.2004.11.003; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McIlroy SJ, 2016, ENVIRON MICROBIOL, V18, P50, DOI 10.1111/1462-2920.12614; Monteiro M, 2014, J MICROBIOL, V52, P537, DOI 10.1007/s12275-014-4114-0; Nadarajah N, 2007, WATER RES, V41, P2563, DOI 10.1016/j.watres.2007.02.002; Nelson CE, 2009, ISME J, V3, P13, DOI 10.1038/ismej.2008.81; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Ren SJ, 2004, ENVIRON INT, V30, P1151, DOI 10.1016/j.envint.2004.06.003; ROSSELLOMORA RA, 1995, APPL ENVIRON MICROB, V61, P702; Seshan H, 2014, WATER RES, V53, P282, DOI 10.1016/j.watres.2014.01.015; Singh KK, 2008, J HYDROL ENG, V13, P146, DOI 10.1061/(ASCE)1084-0699(2008)13:3(146); Slater FR, 2010, WATER RES, V44, P4908, DOI 10.1016/j.watres.2010.07.028; Tan TW, 2008, CHEMOSPHERE, V70, P387, DOI 10.1016/j.chemosphere.2007.07.003; Valentin-Vargas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042524; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; Xia SQ, 2010, ENVIRON SCI TECHNOL, V44, P7391, DOI 10.1021/es101554m; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	45	38	42	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152998	10.1371/journal.pone.0152998	http://dx.doi.org/10.1371/journal.pone.0152998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049964	Green Submitted, gold, Green Published			2022-12-26	WOS:000373603500080
J	Moore, AA; Neale, MC; Silberg, JL; Verhulst, B				Moore, Ashlee A.; Neale, Michael C.; Silberg, Judy L.; Verhulst, Brad			Substance Use and Depression Symptomatology: Measurement Invariance of the Beck Depression Inventory (BDI-II) among Non-Users and Frequent-Users of Alcohol, Nicotine and Cannabis	PLOS ONE			English	Article							PSYCHOMETRIC EVALUATION; MAJOR DEPRESSION; SELF-MEDICATION; USE DISORDERS; DRUG-ABUSE; COMORBIDITY; VALIDITY; AGE; HETEROGENEITY; MOOD	Depression is a highly heterogeneous condition, and identifying how symptoms present in various groups may greatly increase our understanding of its etiology. Importantly, Major Depressive Disorder is strongly linked with Substance Use Disorders, which may ameliorate or exacerbate specific depression symptoms. It is therefore quite plausible that depression may present with different symptom profiles depending on an individual's substance use status. Given these observations, it is important to examine the underlying construct of depression in groups of substance users compared to non-users. In this study we use a non-clinical sample to examine the measurement structure of the Beck Depression Inventory (BDI-II) in non-users and frequent-users of various substances. Specifically, measurement invariance was examined across those who do vs. do not use alcohol, nicotine, and cannabis. Results indicate strict factorial invariance across non-users and frequent-users of alcohol and cannabis, and metric invariance across non-users and frequent-users of nicotine. This implies that the factor structure of the BDI-II is similar across all substance use groups	[Moore, Ashlee A.] Virginia Commonwealth Univ, Ctr Clin & Translat Res, Richmond, VA USA; [Moore, Ashlee A.; Neale, Michael C.; Silberg, Judy L.; Verhulst, Brad] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Neale, Michael C.; Silberg, Judy L.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Neale, Michael C.; Verhulst, Brad] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Moore, AA (corresponding author), Virginia Commonwealth Univ, Ctr Clin & Translat Res, Richmond, VA USA.; Moore, AA (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA.	mooreaa2@vcu.edu	Moore, Ashlee A./AFX-7065-2022; Neale, Michael/AAD-5056-2020	Moore, Ashlee A./0000-0002-6577-3050; 	National Institutes of Health's National Center for Advancing Translational Sciences [TR000058]; National Institutes of Health's National Institute on Drug Abuse [DA018673, DA026119]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA018673, R25DA026119, R01DA018673] Funding Source: NIH RePORTER	National Institutes of Health's National Center for Advancing Translational Sciences; National Institutes of Health's National Institute on Drug Abuse; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health's National Center for Advancing Translational Sciences (www.ncats.nih.gov; AAM & JLS, grant number TR000058) and the National Institutes of Health's National Institute on Drug Abuse (www.nida.nih.gov; MCN & BV, grant numbers DA018673 and DA026119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggen SH, 2011, TWIN RES HUM GENET, V14, P524, DOI 10.1375/twin.14.6.524; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Apesoa-Varano EC, 2015, SOC SCI MED, V124, P1, DOI 10.1016/j.socscimed.2014.10.054; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; BROWN J, 1992, BRIT J ADDICT, V87, P1013; Buckley TC, 2001, J SUBST ABUSE TREAT, V20, P197, DOI 10.1016/S0740-5472(00)00169-0; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chen LS, 2000, J AFFECT DISORDERS, V59, P1, DOI 10.1016/S0165-0327(99)00132-9; Davis LL, 2005, COMPR PSYCHIAT, V46, P81, DOI 10.1016/j.comppsych.2004.07.025; Del Boca FK, 2000, ADDICTION, V95, pS347; Dozois DJA, 1998, PSYCHOL ASSESSMENT, V10, P83, DOI 10.1037/1040-3590.10.2.83; Dum M, 2008, ADDICT BEHAV, V33, P381, DOI 10.1016/j.addbeh.2007.09.017; GALLO JJ, 1994, J GERONTOL, V49, pP251, DOI 10.1093/geronj/49.6.P251; Ghaemi SN, 2011, ACTA PSYCHIAT SCAND, V124, P497, DOI 10.1111/j.1600-0447.2011.01746.x; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Husain MM, 2005, AM J GERIAT PSYCHIAT, V13, P852, DOI 10.1176/appi.ajgp.13.10.852; Johnson ME, 2006, ASSESSMENT, V13, P168, DOI 10.1177/1073191106286951; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550; Little R. J. A., 1987, STAT ANAL MISSING DA; Little TD, 1997, MULTIVAR BEHAV RES, V32, P53, DOI 10.1207/s15327906mbr3201_3; Mehta PD, 2004, PSYCHOL METHODS, V9, P301, DOI 10.1037/1082-989X.9.3.301; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Merikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8; Muthen L.K., 2012, MPLUS USERS GUIDE ST, DOI DOI 10.1111/J.1532-5415.2004.52225.X; Neale MC, 2015, PSYCHOMETRI IN PRESS; R Core Team, 2021, R LANGUAGE ENV STAT; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rice SM, INT J SOC P IN PRESS; Seignourel PJ, 2008, DRUG ALCOHOL DEPEN, V93, P271, DOI 10.1016/j.drugalcdep.2007.10.016; Skule C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088321; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Wilkowska-Chmielewska J, 2013, J AFFECT DISORDERS, V150, P142, DOI 10.1016/j.jad.2012.12.012; Basurto FZ, 2009, PSICOTHEMA, V21, P213	39	7	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152118	10.1371/journal.pone.0152118	http://dx.doi.org/10.1371/journal.pone.0152118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27046165	Green Submitted, Green Published, gold			2022-12-26	WOS:000373599600009
J	Qi, CX; Jia, XP; Lu, LL; Ma, P; Wei, M				Qi, Chunxia; Jia, Xiaopeng; Lu, Lingling; Ma, Ping; Wei, Min			HEK293T Cells Are Heterozygous for CCR5 Delta 32 Mutation	PLOS ONE			English	Article							CCR5-DELTA-32 MUTATION; HIV-1 INFECTION; RESISTANCE; CD4; INDIVIDUALS; CORECEPTOR; RETROVIRUS	C-C chemokine receptor 5 (CCR5) is a receptor for chemokines and a co-receptor for HIV-1 entry into the target CD4(+) cells. CCR5 delta 32 deletion is a loss-of-function mutation, resistant to HIV-1 infection. We tried to induce the CCR5 delta 32 mutation harnessing the genome editing technique, CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR and CRISPR associated protein 9, Cas9) in the commonly used cell line human embryonic kidney HEK 293T cells. Surprisingly, we found that HEK293T cells are heterozygous for CCR5 delta 32 mutation, in contrast to the wild type CCR5 cells, human acute T cell leukemia cell line Jurkat and human breast adenocarcinoma cell line MDA-MB-231 cells. This finding indicates that at least one human cell line is heterozygous for the CCR5 delta 32 mutation. We also found that in PCR amplification, wild type CCR5 DNA and mutant delta 32 DNA can form mismatched heteroduplex and move slowly in gel electrophoresis.	[Qi, Chunxia; Jia, Xiaopeng; Lu, Lingling; Wei, Min] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Ma, Ping] Tianjin Second Peoples Hosp, Dept Infect Dis, Tianjin, Peoples R China	Nankai University	Wei, M (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.	weimin@nankai.edu.cn			Nankai University Starting Fund [ZB15006101]; National Natural Science Foundation of China [81571991]	Nankai University Starting Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by Nankai University Starting Fund (ZB15006101) to M. W. and National Natural Science Foundation of China (81571991 to M. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers K, 2015, CURR OPIN VIROL, V14, P24, DOI 10.1016/j.coviro.2015.06.007; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Badia R, 2014, J ANTIMICROB CHEMOTH, V69, P1755, DOI 10.1093/jac/dku072; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Biloglav Z, 2009, CROAT MED J, V50, P34, DOI 10.3325/cmj.2009.50.34; Buell KG, 2016, AIDS CARE, V28, P242, DOI 10.1080/09540121.2015.1074653; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Heigele A, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0213-1; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Kang H, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.42; Lewin SR, 2013, LANCET, V381, P2057, DOI 10.1016/S0140-6736(13)61180-0; LIFSON JD, 1986, NATURE, V323, P725, DOI 10.1038/323725a0; LIFSON JD, 1986, SCIENCE, V232, P1123, DOI 10.1126/science.3010463; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lopalco L, 2010, VIRUSES-BASEL, V2, P574, DOI 10.3390/v2020574; OBrien TR, 1997, LANCET, V349, P1219, DOI 10.1016/S0140-6736(97)24017-1; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Saayman S, 2015, EXPERT OPIN BIOL TH, V15, P819, DOI 10.1517/14712598.2015.1036736; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Wainberg MA, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-31; Walli R, 1998, J ACQ IMMUN DEF SYND, V18, P229, DOI 10.1097/00042560-199807010-00005; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115987; Woollard SM, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S90580; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Zawicki P, 2008, INFECT GENET EVOL, V8, P146, DOI 10.1016/j.meegid.2007.11.003; Zhou Chi, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P485, DOI 10.3760/cma.j.issn.1003-9406.2012.04.024	28	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152975	10.1371/journal.pone.0152975	http://dx.doi.org/10.1371/journal.pone.0152975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27042825	gold, Green Published			2022-12-26	WOS:000373592100057
J	Ding, XT; Jiang, YP; Hao, T; Jin, HJ; Zhang, HM; He, LZ; Zhou, Q; Huang, DF; Hui, DF; Yu, JZ				Ding, Xiaotao; Jiang, Yuping; Hao, Ting; Jin, Haijun; Zhang, Hongmei; He, Lizhong; Zhou, Qiang; Huang, Danfeng; Hui, Dafeng; Yu, Jizhu			Effects of Heat Shock on Photosynthetic Properties, Antioxidant Enzyme Activity, and Downy Mildew of Cucumber (Cucumis sativus L.)	PLOS ONE			English	Article							OXIDATIVE STRESS; PSEUDOPERONOSPORA-CUBENSIS; CHLOROPHYLL FLUORESCENCE; MOLECULAR-MECHANISMS; HYDROGEN-PEROXIDE; SUPEROXIDE-DISMUTASE; ELECTRON-TRANSPORT; CO2 ASSIMILATION; PHOTOSYSTEM-II; ABIOTIC STRESS	Heat shock is considered an abiotic stress for plant growth, but the effects of heat shock on physiological responses of cucumber plant leaves with and without downy mildew disease are still not clear. In this study, cucumber seedlings were exposed to heat shock in greenhouses, and the responses of photosynthetic properties, carbohydrate metabolism, antioxidant enzyme activity, osmolytes, and disease severity index of leaves with or without the downy mildew disease were measured. Results showed that heat shock significantly decreased the net photosynthetic rate, actual photochemical efficiency, photochemical quenching coefficient, and starch content. Heat shock caused an increase in the stomatal conductance, transpiration rate, antioxidant enzyme activities, total soluble sugar content, sucrose content, soluble protein content and proline content for both healthy leaves and downy mildew infected leaves. These results demonstrate that heat shock activated the transpiration pathway to protect the photosystem from damage due to excess energy in cucumber leaves. Potential resistance mechanisms of plants exposed to heat stress may involve higher osmotic regulation capacity related to an increase of total accumulations of soluble sugar, proline and soluble protein, as well as higher antioxidant enzymes activity in stressed leaves. Heat shock reduced downy mildew disease severity index by more than 50%, and clearly alleviated downy mildew development in the greenhouses. These findings indicate that cucumber may have a complex physiological change to resist short-term heat shock, and suppress the development of the downy mildew disease.	[Ding, Xiaotao; Jiang, Yuping; Hao, Ting; Jin, Haijun; Zhang, Hongmei; He, Lizhong; Zhou, Qiang; Yu, Jizhu] Shanghai Acad Agr Sci, Inst Hort Res, Shanghai Key Lab Protected Hort Technol, Shanghai 201106, Peoples R China; [Ding, Xiaotao; Huang, Danfeng] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 202400, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37209 USA	Shanghai Academy of Agricultural Sciences; Shanghai Jiao Tong University; Tennessee State University	Yu, JZ (corresponding author), Shanghai Acad Agr Sci, Inst Hort Res, Shanghai Key Lab Protected Hort Technol, Shanghai 201106, Peoples R China.; Hui, DF (corresponding author), Tennessee State Univ, Dept Biol Sci, Nashville, TN 37209 USA.	dhui@tnstate.edu; woloveorange2011@163.com		Hui, Dafeng/0000-0002-5284-2897	National Natural Science Foundation of China [31301818]; Developmental Plan of the Shanghai Agriculture Commission [1-10, 1-42]; National Key Technology Support Program [2014BAD08B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Developmental Plan of the Shanghai Agriculture Commission; National Key Technology Support Program(National Key Technology R&D Program)	This work was supported by the National Natural Science Foundation of China (31301818), the Developmental Plan of the Shanghai Agriculture Commission (1-10, 2014; 1-42, 2015), and National Key Technology Support Program (2014BAD08B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeselmani M, 2006, PLANT SCI, V171, P382, DOI 10.1016/j.plantsci.2006.04.009; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bagi FF, 2014, CROP PROT, V61, P74, DOI 10.1016/j.cropro.2014.03.012; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Bitton S, 2014, PLANT PROTECTION MAN; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUYSSE J, 1993, J EXP BOT, V44, P1627, DOI 10.1093/jxb/44.10.1627; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Carmo-Silva AE, 2012, PLANTA, V236, P1433, DOI 10.1007/s00425-012-1691-1; Cohen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140015; Cohen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126103; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; Cui XH, 2008, J INSECT SCI, V8; Dai AH, 2012, ENVIRON EXP BOT, V79, P1, DOI 10.1016/j.envexpbot.2012.01.003; Ding XT, 2013, ACTA PHYSIOL PLANT, V35, P1427, DOI 10.1007/s11738-012-1182-9; Durner J, 1996, J BIOL CHEM, V271, P28492, DOI 10.1074/jbc.271.45.28492; Elad Y, 2014, ACTA HORTIC, V1015, P89; Fadzillah NM, 1996, PLANTA, V199, P552, DOI 10.1007/BF00195186; Faralli M, 2015, BIOL PLANTARUM, V59, P537, DOI 10.1007/s10535-015-0518-x; Gao Y, 2010, SCI HORTIC-AMSTERDAM, V126, P20, DOI 10.1016/j.scienta.2010.06.006; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Granke LL, 2014, PLANT DIS, V98, P674, DOI 10.1094/PDIS-05-13-0567-RE; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Jha UC, 2014, PLANT BREEDING, V133, P679, DOI 10.1111/pbr.12217; Jung SY, 2000, PLANT SCI, V153, P145, DOI 10.1016/S0168-9452(99)00259-9; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Koca H, 2007, ENVIRON EXP BOT, V60, P344, DOI 10.1016/j.envexpbot.2006.12.005; Lawlor DW, 2009, ANN BOT-LONDON, V103, P561, DOI [10.1093/aob/mcn244, 10.1093/aob/mcn256]; Lebeda A, 2007, ACTA HORTIC, P327, DOI 10.17660/ActaHortic.2007.731.44; Lebeda A, 2011, EUR J PLANT PATHOL, V129, P157, DOI 10.1007/s10658-010-9658-1; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; Li H, 2013, PLANT PHYSIOL BIOCH, V71, P1, DOI 10.1016/j.plaphy.2013.06.018; Lu CM, 2003, J EXP BOT, V54, P851, DOI 10.1093/jxb/erg080; Mathur S, 2014, J PHOTOCH PHOTOBIO B, V137, P116, DOI 10.1016/j.jphotobiol.2014.01.010; Matysik J, 2002, CURR SCI INDIA, V82, P525; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Neufeld KN, 2012, PLANT DIS, V96, P345, DOI 10.1094/PDIS-07-11-0560; Nostar O, 2013, PHYSIOL MOL PLANT P, V83, P84, DOI 10.1016/j.pmpp.2013.05.004; Qu AL, 2013, BIOCHEM BIOPH RES CO, V432, P203, DOI 10.1016/j.bbrc.2013.01.104; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Ruelland E, 2010, ENVIRON EXP BOT, V69, P225, DOI 10.1016/j.envexpbot.2010.05.011; Sato T, 2002, ACTA HORTIC, P165, DOI 10.17660/ActaHortic.2002.588.25; Scafaro AP, 2010, J EXP BOT, V61, P191, DOI 10.1093/jxb/erp294; Shao L, 2007, J INTEGR PLANT BIOL, V49, P1341, DOI 10.1111/j.1744-7909.2007.00527.x; SLOOTEN L, 1995, PLANT PHYSIOL, V107, P737, DOI 10.1104/pp.107.3.737; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wahid A, 2007, BIOL PLANTARUM, V51, P104, DOI 10.1007/s10535-007-0021-0; Widiastuti A, 2013, PHYSIOL MOL PLANT P, V84, P86, DOI 10.1016/j.pmpp.2013.08.003; Yamasaki H, 1996, ARCH BIOCHEM BIOPHYS, V332, P183, DOI 10.1006/abbi.1996.0331; Yang XT, 2007, NEW ZEAL J AGR RES, V50, P1261, DOI 10.1080/00288230709510411; Yuan YH, 2014, J PLANT GROWTH REGUL, V33, P798, DOI 10.1007/s00344-014-9427-z; Zhang J, 2012, BIOL PLANTARUM, V56, P780, DOI 10.1007/s10535-012-0136-9; Zhang R, 2009, PHOTOSYNTH RES, V100, P29, DOI 10.1007/s11120-009-9420-8; Zhou YH, 2004, PLANT CELL ENVIRON, V27, P1503, DOI 10.1111/j.1365-3040.2004.01255.x; Zushi K, 2012, SCI HORTIC-AMSTERDAM, V148, P39, DOI 10.1016/j.scienta.2012.09.022	60	36	38	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152429	10.1371/journal.pone.0152429	http://dx.doi.org/10.1371/journal.pone.0152429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065102	gold, Green Published, Green Submitted			2022-12-26	WOS:000373891000011
J	Avila-Flores, IJ; Hernandez-Diaz, JC; Gonzalez-Elizondo, MS; Prieto-Ruiz, JA; Wehenkel, C				Jaime Avila-Flores, Israel; Ciro Hernandez-Diaz, Jose; Socorro Gonzalez-Elizondo, Maria; Angel Prieto-Ruiz, Jose; Wehenkel, Christian			Degree of Hybridization in Seed Stands of Pinus engelmannii Carr. In the Sierra Madre Occidental, Durango, Mexico	PLOS ONE			English	Article							FRAGMENT-LENGTH POLYMORPHISMS; AFLP MARKERS; NATURAL HYBRIDIZATION; RETICULATE EVOLUTION; QUERCUS-CRASSIFOLIA; MOLECULAR EVIDENCE; HYBRID SPECIATION; GENETIC DIVERSITY; SIZE HOMOPLASY; ZONE	Hybridization is an important evolutionary force, because interspecific gene transfer can introduce more new genetic material than is directly generated by mutations. Pinus engel-mannii Carr. is one of the nine most common pine species in the pine-oak forest ecoregion in the state of Durango, Mexico. This species is widely harvested for lumber and is also used in reforestation programmes. Interspecific hybrids between P. engelmannii and Pinus arizonica Engelm. have been detected by morphological analysis. The presence of hybrids in P. engelmannii seed stands may affect seed quality and reforestation success. Therefore, the goals of this research were to identify introgressive hybridization between P. engelmannii and other pine species in eight seed stands of this species in Durango, Mexico, and to examine how hybrid proportion is related to mean genetic dissimilarity between trees in these stands, using Amplified Fragment Length Polymorphism (AFLP) markers and morphological traits. Differences in the average current annual increment of putative hybrids and pure trees were also tested for statistical significance. Morphological and genetic analyses of 280 adult trees were carried out. Putative hybrids were found in all the seed stands studied. The hybrids did not differ from the pure trees in vigour or robustness. All stands with putative P. engelmannii hybrids detected by both AFLPs and morphological traits showed the highest average values of the Tanimoto distance, which indicates: i) more heterogeneous genetic material, ii) higher genetic variation and therefore iii) the higher evolutionary potential of these stands, and iv) that the morphological differentiation (hybrid/not hybrid) is strongly associated with the Tanimoto distance per stand. We conclude that natural pairwise hybrids are very common in the studied stands. Both morphological and molecular approaches are necessary to confirm the genetic identity of forest reproductive material.	[Jaime Avila-Flores, Israel] Univ Juarez Estado Durango, Doctorado Inst Ciencias Agr & Forestales, Apdo Postal 741, Durango 34000, Durango, Mexico; [Ciro Hernandez-Diaz, Jose; Wehenkel, Christian] Univ Juarez Estado Durango, Inst Silvicultura & Ind Madera, Apdo Postal 741, Durango 34000, Durango, Mexico; [Socorro Gonzalez-Elizondo, Maria] Inst Politecn Nacl, CIIDIR Unidad Durango, Sigma 119 Fracc,20 Noviembre 2, Durango 34220, Durango, Mexico; [Angel Prieto-Ruiz, Jose] Univ Juarez Estado Durango, Fac Ciencias Forestales, Blvd Durango & Ave,Papaloapan S-N,Col Valle Sur, Durango 34120, Durango, Mexico	Universidad Juarez del Estado de Durango; Universidad Juarez del Estado de Durango; Instituto Politecnico Nacional - Mexico; Universidad Juarez del Estado de Durango	Wehenkel, C (corresponding author), Univ Juarez Estado Durango, Inst Silvicultura & Ind Madera, Apdo Postal 741, Durango 34000, Durango, Mexico.	wehenkel@ujed.mx	Gonzalez-Elizondo, M. Socorro/H-9143-2017	Gonzalez-Elizondo, M. Socorro/0000-0002-4047-154X				Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Althoff DM, 2007, SYST BIOL, V56, P477, DOI 10.1080/10635150701427077; Anderson E., 1949, INTROGRESSIVE HYBRID; ARNOLD ML, 1995, TRENDS ECOL EVOL, V10, P67, DOI 10.1016/S0169-5347(00)88979-X; ARNOLD ML, 1997, OXFORD SERIES ECOLOG; BARTON AM, 1993, AM J BOT, V80, P15, DOI 10.2307/2445115; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Chunco AJ, 2014, ECOL EVOL, V4, P2019, DOI 10.1002/ece3.1052; CONKLE MT, 1988, PONDEROSA PINE SPECI, V27, P43; Critchfield W. B., 1984, Madrono, V31, P144; CRITCHFIELD WILLIAM B., 1967, SILVAE GENET, V16, P89; Debreczy Z, 2011, CONIFERS WORLD, V1-2; DEICHSEL G, 1985, CLUSTERANALYSE DISKR; Delgado P, 2007, INT J PLANT SCI, V168, P861, DOI 10.1086/518260; EdwardsBurke MA, 1997, AM J BOT, V84, P879, DOI 10.2307/2446277; EHRENBERG C, 1955, HEREDITAS, V41, P291; Epperson BK, 2009, AM J BOT, V96, P707, DOI 10.3732/ajb.0800005; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fogelqvist J, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0461-7; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Garcia AA, 2003, PINACEAS DE DURANGO; Garrett Peter W, 1979, SPECIES HYBRIDIZATIO; Gernandt DS, 2009, SYST BOT, V34, P481, DOI 10.1600/036364409789271290; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gomez JM, 2015, BIODIVERS CONSERV, V24, P1843, DOI 10.1007/s10531-015-0909-5; Gompert Z, 2006, SCIENCE, V314, P1923, DOI 10.1126/science.1135875; Gort G, 2012, EUPHYTICA, V183, P389, DOI 10.1007/s10681-011-0368-3; Gregorius HR, 2007, SILVAE GENET, V56, P190, DOI 10.1515/sg-2007-0029; Guo YP, 2005, NEW PHYTOL, V166, P273, DOI 10.1111/j.1469-8137.2005.01315.x; HARRISON RG, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P3; HAVEY MJ, 1989, THEOR APPL GENET, V77, P395, DOI 10.1007/BF00305835; Hernandez LS, 2013, PLOS ONE, V8; Kaplan Z, 2007, ANN BOT-LONDON, V99, P1213, DOI 10.1093/aob/mcm072; Koerber GR, 2013, AUST SYST BOT, V26, P156, DOI 10.1071/SB12034; Krauss SL, 2000, MOL ECOL, V9, P1241, DOI 10.1046/j.1365-294x.2000.01001.x; Kuchma O, 2011, MUTAT RES-GEN TOX EN, V725, P29, DOI 10.1016/j.mrgentox.2011.07.003; Simental-Rodriguez SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111623; Linder CR, 1998, THEOR APPL GENET, V96, P339, DOI 10.1007/s001220050746; Little EL, 1965, BOT DESCRIPTIONS FOR; Liu ZJ, 2003, GENETICS, V165, P687; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Manly BFJ, 1997, RANDOMIZATION BOOTST; Penaloza-Ramirez JM, 2010, ANN BOT-LONDON, V105, P389, DOI 10.1093/aob/mcp301; MICHELMORE RW, 1987, ANNU REV PHYTOPATHOL, V25, P383, DOI 10.1146/annurev.py.25.090187.002123; Muhlfeld CC, 2014, NAT CLIM CHANGE, V4, P620, DOI [10.1038/NCLIMATE2252, 10.1038/nclimate2252]; O'Hanlon PC, 2000, MOL ECOL, V9, P815, DOI 10.1046/j.1365-294x.2000.00924.x; PELOQUIN RL, 1984, SOUTHWEST NAT, V29, P115, DOI 10.2307/3670776; Peloquin RL, 1971, THESIS U CALIF, P196; Pritchard JK, 2000, GENETICS, V155, P945; Quijada A, 1997, MOL ECOL, V6, P995, DOI 10.1046/j.1365-294X.1997.t01-1-00273.x; REHFELDT GE, 1993, AM J BOT, V80, P330, DOI 10.2307/2445357; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Roe AD, 2014, ECOL EVOL, V4, P1629, DOI 10.1002/ece3.1029; SanCristobal M, 2006, ANIM GENET, V37, P232, DOI 10.1111/j.1365-2052.2006.01440.x; Shasany AK, 2005, J HERED, V96, P542, DOI 10.1093/jhered/esi091; Silva-Flores R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105034; Skrede I, 2012, FUNGAL BIOL-UK, V116, P778, DOI 10.1016/j.funbio.2012.04.009; Gonzalez-Elizondo MS, 2012, ACTA BOT MEX, V101, P49; Gonzalez-Elizondo MS, 2012, ACTA BOT MEX, V100, P351, DOI 10.21829/abm100.2012.40; Gonzalez-Elizondo MS, 2012, ACTA BOT MEX, V99, P55, DOI 10.21829/abm99.2012.19; Stuber C.W., 1992, PLANT BREED REV, V9, P37; Styles B. T., 1993, Biological diversity of Mexico: origins and distribution., P397; Tovar-Sanchez E, 2006, OECOLOGIA, V147, P702, DOI 10.1007/s00442-005-0328-5; Tovar-Sanchez E, 2004, AM J BOT, V91, P1352, DOI 10.3732/ajb.91.9.1352; Ungerer MC, 1998, P NATL ACAD SCI USA, V95, P11757, DOI 10.1073/pnas.95.20.11757; Vargas-Mendoza CF, 2011, PHYLOGENETIC ANAL ME; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Villa-Salas AB, 1980, IUFRO MAB C RES MULT, P20; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vuylsteke M, 1999, THEOR APPL GENET, V99, P921, DOI 10.1007/s001220051399; Wehenkel C., 2015, Forstarchiv, V86, P194; WENDEL JF, 1991, EVOLUTION, V45, P694, DOI 10.1111/j.1558-5646.1991.tb04339.x; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011; Xu SQ, 2008, TREE GENET GENOMES, V4, P849, DOI 10.1007/s11295-008-0157-x; Zhou RC, 2005, MOL PHYLOGENET EVOL, V35, P595, DOI 10.1016/j.ympev.2005.03.012	77	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152651	10.1371/journal.pone.0152651	http://dx.doi.org/10.1371/journal.pone.0152651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064490	Green Published, gold, Green Submitted			2022-12-26	WOS:000373891000015
J	Sung, HY; Choi, BO; Jeong, JH; Kong, KA; Hwang, J; Ahn, JH				Sung, Hye Youn; Choi, Byung-Ok; Jeong, Jee Hyang; Kong, Kyoung Ae; Hwang, Jinha; Ahn, Jung-Hyuck			Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease	PLOS ONE			English	Article							DNA METHYLATION STATUS; PRECURSOR PROTEIN; GENE-EXPRESSION; CSF BIOMARKERS; DIAGNOSIS; BRAIN; ASTROGLIA; CANCER; TIME; TOOL	To identify epigenetically regulated genes involved in the pathogenesis of Alzheimer's disease (AD) we analyzed global mRNA expression and methylation profiles in amyloid precursor protein (APP)-Swedish mutant-expressing AD model cells, H4-sw and selected heme oxygenase-1 (HMOX1), which is associated with pathological features of AD such as neurofibrillary tangles and senile plaques. We examined the epigenetic regulatory mechanism of HMOX1 and its application as a diagnostic and prognostic biomarker for AD. Our results show that HMOX1 mRNA and protein expression was approximately 12.2-fold and 7.9-fold increased in H4-sw cells, respectively. Increased HMOX1 expression was also detected in the brain, particularly the hippocampus, of AD model transgenic mice. However, the methylation of specific CpG sites within its promoter, particularly at CpG located -374 was significantly decreased in H4-sw cells. Treatment of neuroglioma cells with the demethylating agent 5-aza-20-deoxycytidine resulted in reduced methylation of HMOX1 promoter accompanied by enhanced HMOX1 expression strongly supporting DNA methylation-dependent transcriptional regulation of HMOX1. Toxic A beta-induced aberrant hypomethylation of HMOX1 at -374 promoter CpG site was correlated with increased HMOX1 expression. In addition to neuroglioma cells, we also found A beta-induced epigenetic regulation of HMOX1 in human T lymphocyte Jurkat cells. We evaluated DNA methylation status of HMOX1 at -374 promoter CpG site in blood samples from AD patients, patients with mild cognitive impairment (MCI), and control individuals using quantitative methylation-specific polymerase chain reaction. We observed lower methylation of HMOX1 at the -374 promoter CpG site in AD patients compared to MCI and control individuals, and a correlation between Mini-Mental State Examination score and demethylation level. Receiver operating characteristics analysis revealed good discrimination of AD patients from MCI patients and control individuals. Our findings suggest that the methylation status of HMOX1 at a specific promoter CpG site is related to AD progression.	[Sung, Hye Youn; Ahn, Jung-Hyuck] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea; [Choi, Byung-Ok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Jeong, Jee Hyang] Ewha Womans Univ, Mokdong Hosp, Dept Neurol, Seoul, South Korea; [Kong, Kyoung Ae] Ewha Womans Univ, Med Ctr, Clin Trial Ctr, Seoul, South Korea; [Hwang, Jinha] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Ahn, Jung-Hyuck] Ewha Womans Univ, Sch Med, Tissue Injury Def Res Ctr, Dept Biochem, Seoul, South Korea	Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center; Ewha Womans University; Ewha Womans University; Seoul National University (SNU); Ewha Womans University	Ahn, JH (corresponding author), Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea.; Ahn, JH (corresponding author), Ewha Womans Univ, Sch Med, Tissue Injury Def Res Ctr, Dept Biochem, Seoul, South Korea.	ahnj@ewha.ac.kr		Ahn, Jung-Hyuck/0000-0001-9589-3881	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2060213, NRF-2012R1A1A2004214, NRF-2015R1A2A2A01003997]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2010-0027945]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2060213, NRF-2012R1A1A2004214 and NRF-2015R1A2A2A01003997), and this research was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2010-0027945). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2010, J KOREAN MED SCI, V25, P1071, DOI 10.3346/jkms.2010.25.7.1071; Barone E, 2014, NEUROBIOL DIS, V62, P144, DOI 10.1016/j.nbd.2013.09.018; Bock C, 2009, EPIGENOMICS-UK, V1, P99, DOI 10.2217/EPI.09.6; Calabrese V, 2007, NEUROCHEM RES, V32, P757, DOI 10.1007/s11064-006-9203-y; Chae SS, 2010, J NEUROSCI RES, V88, P1926, DOI 10.1002/jnr.22356; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Chen UL, 2009, BIOCHEM BIOPH RES CO, V378, P57, DOI 10.1016/j.bbrc.2008.10.173; Chopra K, 2011, EXPERT OPIN THER TAR, V15, P535, DOI 10.1517/14728222.2011.557363; Chouliaras L, 2010, PROG NEUROBIOL, V90, P498, DOI 10.1016/j.pneurobio.2010.01.002; Frankel D, 2000, J CELL PHYSIOL, V185, P80, DOI 10.1002/1097-4652(200010)185:1<80::AID-JCP7>3.0.CO;2-W; Fuso A, 2005, MOL CELL NEUROSCI, V28, P195, DOI 10.1016/j.mcn.2004.09.007; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Humpel C, 2011, TRENDS BIOTECHNOL, V29, P26, DOI 10.1016/j.tibtech.2010.09.007; Irizarry Michael C, 2004, NeuroRx, V1, P226; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kang Y., 1997, J KOREAN NEUROL ASS, V15, P300; Kennedy BP, 2004, J NEURAL TRANSM, V111, P547, DOI 10.1007/s00702-003-0096-5; Le W, 1999, J NEUROSCI RES, V56, P652; Lee J, 2010, BMB REP, V43, P649, DOI 10.5483/BMBRep.2010.43.10.649; Lopez OL, 2013, J ALZHEIMERS DIS, V33, pS427, DOI 10.3233/JAD-2012-129015; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mulero-Navarro S, 2008, CRIT REV ONCOL HEMAT, V68, P1, DOI 10.1016/j.critrevonc.2008.03.001; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Schipper HM, 2006, NEUROBIOL AGING, V27, P252, DOI 10.1016/j.neurobiolaging.2005.01.016; SCHIPPER HM, 1995, ANN NEUROL, V37, P758, DOI 10.1002/ana.410370609; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shin J-Y, BMB REP, V43, P704; Shin J, 2010, BMB REP, V43, P704, DOI [10.3858/BMBRep.2010.43.10.704, 10.5483/BMBRep.2010.43.10.704]; SMITH MA, 1994, AM J PATHOL, V145, P42; Song W, 2006, J CELL PHYSIOL, V206, P655, DOI 10.1002/jcp.20509; Sung HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099047; Sung HY, 2011, BIOCHEM BIOPH RES CO, V414, P700, DOI 10.1016/j.bbrc.2011.09.136; TANAKA J, 1989, ACTA NEUROL SCAND, V80, P554, DOI 10.1111/j.1600-0404.1989.tb03926.x; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Wang DY, 2015, J ALZHEIMERS DIS, V43, P519, DOI 10.3233/JAD-140567; West RL, 1995, J MOL NEUROSCI, V6, P141, DOI 10.1007/BF02736773; Yu UY, 2014, KOREAN J PHYSIOL PHA, V18, P155, DOI 10.4196/kjpp.2014.18.2.155; Yun SM, 2013, NEUROBIOL AGING, V34, P650, DOI 10.1016/j.neurobiolaging.2012.08.005; Zhou L, 2012, BIOCHEM BIOPH RES CO, V423, P697, DOI 10.1016/j.bbrc.2012.06.017; Zukor H, 2009, J NEUROCHEM, V109, P776, DOI 10.1111/j.1471-4159.2009.06007.x	44	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153156	10.1371/journal.pone.0153156	http://dx.doi.org/10.1371/journal.pone.0153156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058954	Green Published, Green Submitted, gold			2022-12-26	WOS:000373604800018
J	DiSilvestro, DJ; Melgar-Bermudez, E; Yasmeen, R; Fadda, P; Lee, LJ; Kalyanasundaram, A; Gilor, CL; Ziouzenkova, O				DiSilvestro, David J.; Melgar-Bermudez, Emiliano; Yasmeen, Rumana; Fadda, Paolo; Lee, L. James; Kalyanasundaram, Anuradha; Gilor, Chen L.; Ziouzenkova, Ouliana			Leptin Production by Encapsulated Adipocytes Increases Brown Fat, Decreases Resistin, and Improves Glucose Intolerance in Obese Mice	PLOS ONE			English	Article							VENTROMEDIAL HYPOTHALAMUS; PERIPHERAL-TISSUES; 3T3-L1 ADIPOCYTES; GENE-PRODUCT; BODY-WEIGHT; OB/OB MICE; OB RNA; INSULIN; SECRETION; THERAPY	The neuroendocrine effects of leptin on metabolism hold promise to be translated into a complementary therapy to traditional insulin therapy for diabetes and obesity. However, injections of leptin can provoke inflammation. We tested the effects of leptin, produced in the physiological adipocyte location, on metabolism in mouse models of genetic and dietary obesity. We generated 3T3-L1 adipocytes constitutively secreting leptin and encapsulated them in a poly-L-lysine membrane, which protects the cells from immune rejection. Ob/ob mice (OB) were injected with capsules containing no cells (empty, OB[Emp]), adipocytes (OB[3T3]), or adipocytes overexpressing leptin (OB[Lep]) into both visceral fat depots. Leptin was found in the plasma of OB[Lep], but not OB[Emp] and OB[3T3] mice at the end of treatment (72 days). The OB[Lep] and OB[3T3] mice have transiently suppressed appetite and weight loss compared to OB[Emp]. Only OB[Lep] mice have greater brown fat mass, metabolic rate, and reduced resistin plasma levels compared to OB[Emp]. Glucose tolerance was markedly better in OB[Lep] vs. OB[Emp] and OB[3T3] mice as well as in wild type mice with high-fat diet-induced obesity and insulin resistance treated with encapsulated leptin-producing adipocytes. Our proof-of-principle study provides evidence of long-term improvement of glucose tolerance with encapsulated adipocytes producing leptin.	[DiSilvestro, David J.; Melgar-Bermudez, Emiliano; Yasmeen, Rumana; Ziouzenkova, Ouliana] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA; [Fadda, Paolo] Ohio State Univ, Ctr Comprehens Canc, Genom Shared Resource, Columbus, OH 43210 USA; [Lee, L. James] Ohio State Univ, NSF Nanoscale Sci & Engn Ctr Affordable Nanoengn, Columbus, OH 43210 USA; [Kalyanasundaram, Anuradha] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Gilor, Chen L.] Ohio State Univ, Vet Clin Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; National Science Foundation (NSF); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ziouzenkova, O (corresponding author), Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA.	ziouzenkova.1@osu.edu	Ziouzenkova, Ouliana/B-3690-2012; Ziouzenkova, Ouliana/AAM-1971-2020	Ziouzenkova, Ouliana/0000-0003-2449-2591; 	American Egg Board [20020728]; Novo Nordisk Pharmaceuticals [10040042]; Food Innovation Center; National Center for Research Resources [R21OD017244, UL1TR001070, UL1RR025755, NCI P30CA16058]; Office of the Director (OD), National Institutes of Health; NIH Roadmap for Medical Research; National Center For Advancing Translational Sciences [UL1TR001070]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD017244] Funding Source: NIH RePORTER	American Egg Board; Novo Nordisk Pharmaceuticals(Novo Nordisk); Food Innovation Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Director (OD), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center For Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Award Number 20020728 from American Egg Board and Award Number 10040042 from Novo Nordisk Pharmaceuticals as well as by the Food Innovation Center. The project described was supported by Award Number R21OD017244 (O.Z.), UL1TR001070 (CCTS), UL1RR025755 and NCI P30CA16058 (OSUCCC) from the National Center for Research Resources, funded by the Office of the Director (OD), National Institutes of Health and supported by the NIH Roadmap for Medical Research. The project described was also supported by Award Number Grant UL1TR001070 from the National Center For Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo BA, 2014, DRUG SAFETY, V37, P921, DOI 10.1007/s40264-014-0226-z; BATCHELOR BR, 1975, METABOLISM, V24, P77, DOI 10.1016/0026-0495(75)90009-8; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bernotiene E, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2004; Costa A, 1997, NEUROREPORT, V8, P1131, DOI 10.1097/00001756-199703240-00014; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fujikawa T, 2013, CELL METAB, V18, P431, DOI 10.1016/j.cmet.2013.08.004; Gibson WT, 2004, J CLIN ENDOCR METAB, V89, P4821, DOI 10.1210/jc.2004-0376; Ginter E, 2013, ADV EXP MED BIOL, V771, P42; Glaum SR, 1996, MOL PHARMACOL, V50, P230; Gonzalez M, 2013, ATHEROSCLEROSIS, V228, P485, DOI 10.1016/j.atherosclerosis.2013.03.018; Haque MS, 1999, DIABETES, V48, P1706, DOI 10.2337/diabetes.48.9.1706; Harris RBS, 1998, ENDOCRINOLOGY, V139, P8, DOI 10.1210/en.139.1.8; Herrero L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122570; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Khan A, 2001, INT J OBESITY, V25, P816, DOI 10.1038/sj.ijo.0801628; Klebanov S, 2005, J ENDOCRINOL, V186, P203, DOI 10.1677/joe.1.06150; Kshatriya S, 2010, CURR OPIN NEPHROL HY, V19, P72, DOI 10.1097/MNH.0b013e328332fb49; Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598; MAFFEI M, 1995, P NATL ACAD SCI USA, V92, P6957, DOI 10.1073/pnas.92.15.6957; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Minokoshi Y, 1999, DIABETES, V48, P287, DOI 10.2337/diabetes.48.2.287; Mistry AM, 1997, J NUTR, V127, P2065; Morsy MA, 1998, GENE THER, V5, P8, DOI 10.1038/sj.gt.3300565; Muzzin P, 1996, P NATL ACAD SCI USA, V93, P14804, DOI 10.1073/pnas.93.25.14804; Norman D, 2003, MOL CELL ENDOCRINOL, V200, P99, DOI 10.1016/S0303-7207(02)00410-0; Ogden CL, 2012, NCHS DATA BRIEF; Oosman SN, 2008, MOL THER, V16, P1138, DOI 10.1038/mt.2008.62; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Orchard TJ, 2003, DIABETES CARE, V26, P1374, DOI 10.2337/diacare.26.5.1374; Pollock KE, 2015, ENDOCRINOLOGY, V156, P3777, DOI 10.1210/en.2015-1247; Qi Y, 2006, DIABETES, V55, P3083, DOI 10.2337/db05-0615; Satoh N, 1999, DIABETES, V48, P1787, DOI 10.2337/diabetes.48.9.1787; Soedling H, 2015, MOL METAB, V4, P619, DOI 10.1016/j.molmet.2015.06.007; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; SURWIT RS, 1985, PSYCHOSOM MED, V47, P565, DOI 10.1097/00006842-198511000-00006; Turner RT, 2015, J ENDOCRINOL, V227, P129, DOI 10.1530/JOE-15-0280; Unger RH, 2015, CELL METAB, V21, P15, DOI 10.1016/j.cmet.2014.10.011; Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953; Woods AJ, 1996, NATURE, V381, P745, DOI 10.1038/381745a0; Xu L, 2015, JOVE-J VIS EXP, DOI 10.3791/52806; Yang FP, 2012, BIOMATERIALS, V33, P5638, DOI 10.1016/j.biomaterials.2012.04.035; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yasmeen R, 2013, DIABETES, V62, P124, DOI 10.2337/db11-1779; Ye F, 2010, J ENDOCRINOL, V206, P27, DOI 10.1677/JOE-10-0090; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105; Zeigerer A, 2008, EXP CELL RES, V314, P2249, DOI 10.1016/j.yexcr.2008.04.003; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055; Zhang XL, 2008, BIOMATERIALS, V29, P4253, DOI 10.1016/j.biomaterials.2008.07.032	53	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153198	10.1371/journal.pone.0153198	http://dx.doi.org/10.1371/journal.pone.0153198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055280	gold, Green Published, Green Submitted			2022-12-26	WOS:000373608000098
J	Fleming, J; Farquhar, M; Brayne, C; Barclay, S				Fleming, Jane; Farquhar, Morag; Brayne, Carol; Barclay, Stephen		Cambridge City Over-75s Cohort	Death and the Oldest Old: Attitudes and Preferences for End-of-Life Care - Qualitative Research within a Population-Based Cohort Study	PLOS ONE			English	Article							SUSTAINING TREATMENT PREFERENCES; FAMILY CARERS; PEOPLE; PLACE; DEMENTIA; ADULTS; VIEWS; TRANSITIONS; HOMES; COMMUNICATION	Introduction Increasing longevity means more people will be dying in very old age, but little is known about the preferences of the 'oldest old' regarding their care at the end of life. Aims To understand very old people's preferences regarding care towards the end of life and attitudes towards dying, to inform policy and practice. Methods Qualitative data collection for n = 42 population-based cohort study participants aged 95101 (88% women, 42% in long-term-care): topic-guided interviews with n = 33 participants and n = 39 proxy informants, most with both (n = 30: 4 jointly + separate interviews for 26 dyads). Results Death was a part of life: these very old people mainly live day-to-day. Most were ready to die, reflecting their concerns regarding quality of life, being a nuisance, having nothing to live for and having lived long enough. Contrasting views were rare exceptions but voiced firmly. Most were not worried about death itself, but concerned more about the dying process and impacts on those left behind; a peaceful and pain-free death was a common ideal. Attitudes ranged from not wanting to think about death, through accepting its inevitable approach to longing for its release. Preferring to be made comfortable rather than have life-saving treatment if seriously ill, and wishing to avoid hospital, were commonly expressed views. There was little or no future planning, some consciously choosing not to. Uncertainty hampered end-of-life planning even when death was expected soon. Some stressed circumstances, such as severe dependency and others' likely decision-making roles, would influence choices. Carers found these issues harder to raise but felt they would know their older relatives' preferences, usually palliative care, although we found two discrepant views. Conclusions This study's rare data show >= 95-year-olds are willing to discuss dying and end-of-life care but seldom do. Formal documentation of wishes is extremely rare and may not be welcome. Although being "ready to die" and preferring a palliative approach predominated, these preferences cannot be assumed.	[Fleming, Jane; Brayne, Carol; Barclay, Stephen] Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge, England; [Fleming, Jane; Farquhar, Morag; Brayne, Carol; Barclay, Stephen; Cambridge City Over-75s Cohort] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Fleming, Jane; Farquhar, Morag; Barclay, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Fleming, J (corresponding author), Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge, England.; Fleming, J (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.; Fleming, J (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England.	jane.fleming@phpc.cam.ac.uk	Fleming, Jane/L-5300-2015; Brayne, Carol/AAA-4285-2020; Dening, Tom/E-1335-2013; Romero-Ortuno, Roman/AAP-9221-2020; Farquhar, Morag/C-5666-2015	Fleming, Jane/0000-0002-8127-2061; Brayne, Carol/0000-0001-5307-663X; Dening, Tom/0000-0003-3387-4241; Romero-Ortuno, Roman/0000-0002-3882-7447; Buck, Jackie/0000-0002-3598-2329; Farquhar, Morag/0000-0001-7991-7679	Abbeyfield Society; BUPA Foundation under Health and Care of Older People grant; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Abbeyfield Society; BUPA Foundation under Health and Care of Older People grant; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors thank all the past CC75C sponsors for financial support spanning two decades (see http://www.cc75c.group.cam.ac.uk/pages/grant/default.htm for full list of project grants), particularly the Abbeyfield Society for current funding and the BUPA Foundation for support under their Health and Care of Older People grant. CC75C was a member study of the National Institute for Health Research funded Collaboration for Leadership in Applied Health Research & Care (CLAHRC) for Cambridgeshire and Peterborough. All researchers were independent from funders. No funder sponsor played any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aaltonen M, 2014, J AM MED DIR ASSOC, V15, P643, DOI 10.1016/j.jamda.2014.04.018; Abba K, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-40; Barclay S, 2008, BRIT J GEN PRACT, V58, P229, DOI 10.3399/bjgp08X279724; Barclay S, 2014, BRIT J GEN PRACT, V64, pE576, DOI 10.3399/bjgp14X681397; Barclay S, 2009, BRIT J GEN PRACT, V59, P642, DOI 10.3399/bjgp09X454052; Bravell ME, 2010, PALLIAT SUPPORT CARE, V8, P335, DOI 10.1017/S1478951510000131; BruceJones P, 1996, J MED ETHICS, V22, P154, DOI 10.1136/jme.22.3.154; Carrese JA, 2002, BRIT MED J, V325, P125, DOI 10.1136/bmj.325.7356.125; Caswell G, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0032-0; Chan HYL, 2007, J CLIN NURS, V16, P2158, DOI 10.1111/j.1365-2702.2006.01891.x; Clarke A, 2010, J PAIN SYMPTOM MANAG, V40, P857, DOI 10.1016/j.jpainsymman.2010.02.027; Davidson S, 2013, END LIFE EVIDENCE RE; Davies E, 2004, BETTER PALLIATIVE CA; Dening KH, 2013, PALLIATIVE MED, V27, P409, DOI 10.1177/0269216312464094; Department of Health, 2008, END OF LIF CAR STRAT; Dickinson C, 2013, INT PSYCHOGERIATR, V25, P2011, DOI 10.1017/S1041610213001531; Ditto PH, 2006, MED DECIS MAKING, V26, P313, DOI 10.1177/0272989X06290494; Ditto PH, 2003, HEALTH PSYCHOL, V22, P605, DOI 10.1037/0278-6133.22.6.605; Ditto PH, 2001, ARCH INTERN MED, V161, P421, DOI 10.1001/archinte.161.3.421; Dowling-Castronovo A, 2002, GERONTOLOGIST, V42, P82, DOI 10.1093/geront/42.suppl_3.54; Downey L, 2013, J PAIN SYMPTOM MANAG, V46, P9, DOI 10.1016/j.jpainsymman.2012.07.002; Engelberg RA, 2005, J PAIN SYMPTOM MANAG, V30, P498, DOI 10.1016/j.jpainsymman.2005.06.006; Evans CJ, 2014, BMJ SUPPORT PALLIAT, V4, P111; Fleming J, 2007, INT J EPIDEMIOL, V36, P40, DOI 10.1093/ije/dyl293; Fleming J, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483959; Garavan R, 2009, J AM GERIATR SOC, V57, P750, DOI 10.1111/j.1532-5415.2009.02197.x; Goodman C, 2013, INT J NURS STUD, V50, P1639, DOI 10.1016/j.ijnurstu.2013.06.008; Gott M, 2004, PALLIATIVE MED, V18, P460, DOI 10.1191/0269216304pm889oa; Gott M, 2013, HLTH SERV DELIV RES, V1; Gott M, 2011, BMJ-BRIT MED J, P342; Gouvernement du Quebec, 2014, ACT RESP END LIF CAR; Hallberg IR, 2004, AGING CLIN EXP RES, V16, P87; Hanratty B, 2012, J PAIN SYMPTOM MANAG, V44, P74, DOI 10.1016/j.jpainsymman.2011.08.006; Hunt KJ, 2014, J PALLIAT MED, V17, P176, DOI 10.1089/jpm.2013.0385; Janssen DJA, 2013, J PAIN SYMPTOM MANAG, V46, P826, DOI 10.1016/j.jpainsymman.2013.01.007; Kayser-Jones Jeanie, 2002, Gerontologist, V42 Spec No 3, P11; Klinkenberg M, 2004, SOC SCI MED, V59, P2467, DOI 10.1016/j.socscimed.2004.04.006; Lakasing Edin, 2014, Br J Community Nurs, V19, P130; Leeson G.W, 2014, INT J POPULATION RES, P1, DOI [10.1155/2014/521523, DOI 10.1155/2014/521523]; Lloyd-Williams M, 2007, J PAIN SYMPTOM MANAG, V34, P60, DOI 10.1016/j.jpainsymman.2006.09.028; Mathie E, 2012, PALLIATIVE MED, V26, P734, DOI 10.1177/0269216311412233; Morris ZS, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-89; Nahm ES, 2001, NURS ETHICS, V8, P533; National Palliative and End of Life Care Partnership, 2015, AMB PALL END LIF CAR; Nicholson C, 2012, SOC SCI MED, V75, P1426, DOI 10.1016/j.socscimed.2012.06.011; Oliver D., 2014, MAKING OUR HLTH CARE; Pasman HRW, 2013, J AM GERIATR SOC, V61, P1722, DOI 10.1111/jgs.12450; Perrels AJ, 2014, PALLIATIVE MED, V28, P220, DOI 10.1177/0269216313510341; Petkova H., 2012, UNDERSTANDING PLACE; Piers RD, 2013, PATIENT EDUC COUNS, V90, P323, DOI 10.1016/j.pec.2011.07.008; Rao R, 1997, Int Psychogeriatr, V9, P213, DOI 10.1017/S1041610297004365; Ritchie J, 1994, ANAL QUALITATIVE DAT, P173, DOI DOI 10.4324/9780203413081; Seymour J, 2004, SOC SCI MED, V59, P57, DOI 10.1016/j.socscimed.2003.10.005; Seymour J., 2005, END OF LIFE CARE PRO; Seymour JE, 2011, PALLIATIVE MED, V25, P125, DOI 10.1177/0269216310387964; Sharp T, 2013, BRIT J GEN PRACT, V63, pE657, DOI 10.3399/bjgp13X673667; Tanner D., 2012, UNDERSTANDING IMPROV; Towsley GL, 2015, J PALLIATIVE MED, V18; van Eechoud IJ, 2014, J PAIN SYMPTOM MANAG, V47, P876, DOI 10.1016/j.jpainsymman.2013.06.007; van Wijngaarden E, 2015, SOC SCI MED, V138, P257, DOI 10.1016/j.socscimed.2015.05.015	60	55	58	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0150686	10.1371/journal.pone.0150686	http://dx.doi.org/10.1371/journal.pone.0150686			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27045734	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000373599600003
J	Phelps-Polirer, K; Abt, MA; Smith, D; Yeh, ES				Phelps-Polirer, Kendall; Abt, Melissa A.; Smith, Danzell; Yeh, Elizabeth S.			Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer	PLOS ONE			English	Article							CELL-SURVIVAL; TRASTUZUMAB RESISTANCE; SIGNALING AXIS; KINASE; JUN; INHIBITION; ACTIVATION; P53; PHOSPHORYLATION; EXPRESSION	Strategies for successful primary treatment of HER2-positive breast cancer include use of the HER2 inhibitors trastuzumab or lapatinib in combination with standard chemotherapy. While successful, many patients develop resistance to these HER2 inhibitors indicating an unmet need. Consequently, current research efforts are geared toward understanding mechanisms of resistance and the signaling modalities that regulate these mechanisms. We have undertaken a study to examine whether signaling molecules downstream of epidermal growth factor receptor, which often act as compensatory signaling outlets to circumvent HER2 inhibition, can be co-targeted to overcome resistance. We identified JNK signaling as a potential area of intervention and now show that inhibiting JNK using the pan-JNK inhibitor, SP600125, is effective in the HER2-positive, resistant JIMT-1 xenograft mammary tumor model. We also investigate potential combination strategies to bolster the effects of JNK inhibition and find that co-targeting of JNK and the protein kinase HUNK can prohibit tumor growth of resistant HER2-positive mammary tumors in vivo.	[Phelps-Polirer, Kendall] Clemson Univ, Dept Hlth Sci, Columbia, SC USA; [Abt, Melissa A.; Yeh, Elizabeth S.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Smith, Danzell] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA	Clemson University; Medical University of South Carolina; Medical University of South Carolina	Yeh, ES (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA.	yeh@musc.edu			NCI [R01- CA187305-01A1]; Concern Foundation; American Cancer Society Institutional Research Grant [IRG-97-219-14]; Department of Defense grant at MUSC [W81XWH-11-2-0229]; NIGMS [GM072643]; NATIONAL CANCER INSTITUTE [R01CA187305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072643] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Concern Foundation; American Cancer Society Institutional Research Grant(American Cancer Society); Department of Defense grant at MUSC; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the Yeh Lab is supported by R01- CA187305-01A1 from the NCI (to E.S.Y), a grant from the Concern Foundation (to E.S.Y), as well as previous pilot funds from an American Cancer Society Institutional Research Grant (IRG-97-219-14) awarded to the Hollings Cancer Center at MUSC and from a Department of Defense grant (W81XWH-11-2-0229) at MUSC. Danzell Smith is supported in part by GM072643 from the NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research in the Yeh Lab is supported by R01- CA187305-01A1 from the NCI (to E.S.Y), a grant from the Concern Foundation (to E.S.Y), as well as previous pilot funds from an American Cancer Society Institutional Research Grant (IRG-97-219-14) awarded to the Hollings Cancer Center at MUSC and from a Department of Defense grant (W81XWH-11-2-0229) at MUSC. Danzell Smith is supported in part by GM072643 from the NIGMS.	Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Bock C, 2012, NAT REV CANCER, V12, P494, DOI 10.1038/nrc3297; Bubici C, 2014, BRIT J PHARMACOL, V171, P24, DOI 10.1111/bph.12432; Bull SB, 2004, J CLIN ONCOL, V22, P86, DOI 10.1200/JCO.2004.09.128; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cellurale C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012469; Chandarlapaty S, 2012, CLIN CANCER RES, V18, P6784, DOI 10.1158/1078-0432.CCR-12-1785; Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443; Cufi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02469; Formisano L, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3650; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; Han JS, 2010, ANTICANCER RES, V30, P3407; Kaoud TS, 2011, ACS CHEM BIOL, V6, P658, DOI 10.1021/cb200017n; Kim JW, 2016, J CANCER RES CLIN, V142, P157, DOI 10.1007/s00432-015-2012-4; Klapper LN, 2000, CANCER RES, V60, P3384; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kumler I, 2014, CANCER TREAT REV, V40, P259, DOI 10.1016/j.ctrv.2013.09.002; Li YL, 2014, TOXICOL APPL PHARM, V274, P319, DOI 10.1016/j.taap.2013.11.018; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nakopoulou LL, 1996, J PATHOL, V179, P31, DOI 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O; Nasrazadani Azadeh, 2011, Genes Cancer, V2, P31, DOI 10.1177/1947601911400901; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; Potapova O, 2000, MOL CELL BIOL, V20, P1713, DOI 10.1128/MCB.20.5.1713-1722.2000; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Tanner M, 2004, MOL CANCER THER, V3, P1585; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xia WL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3480; Yamashita H, 2004, BREAST CANCER RES, V6, pR24, DOI 10.1186/bcr738; Yeh ES, 2015, BREAST CANCER RES TR, V149, P91, DOI 10.1007/s10549-014-3227-9; Yeh ES, 2013, P NATL ACAD SCI USA, V110, P6103, DOI 10.1073/pnas.1217415110; Yeh ES, 2011, J CLIN INVEST, V121, P866, DOI 10.1172/JCI42928; Young CD, 2015, MOL CELL PROTEOMICS, V14, P1959, DOI 10.1074/mcp.M115.049783; Zhou YY, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140141	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153025	10.1371/journal.pone.0153025	http://dx.doi.org/10.1371/journal.pone.0153025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045589	gold, Green Published, Green Submitted			2022-12-26	WOS:000373599600061
J	Chen, CH; Chang, WH; Su, KY; Ku, WH; Chang, GC; Hong, QS; Hsiao, YJ; Chen, HC; Chen, HY; Wu, R; Yang, PC; Chen, JJW; Yu, SL				Chen, C-H; Chang, W-H; Su, K-Y; Ku, W-H; Chang, G-C; Hong, Q-S; Hsiao, Y-J; Chen, H-C; Chen, H-Y; Wu, R.; Yang, P-C; Chen, J. J. W.; Yu, S-L			HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms	ONCOGENE			English	Article							CELL LUNG-CANCER; FAMILY KINASES; G-PROTEINS; PHASE-II; C-SRC; TYROSINE PHOSPHORYLATION; ACTIN CYTOSKELETON; TARGETING SRC; BETA-CATENIN; SH2 DOMAIN	HLJ1 (DNAJB4), a DNAJ/Hsp40 chaperone, has emerged as a novel prognostic marker in lung cancers; however, the molecular contribution and functionality in neoplastic diseases remain to be established. This study demonstrated that HLJ1 inhibits epithelial-mesenchymal transition in vitro and reduces lung cancer metastasis in vivo. Using shRNA silencing and ectopic expression of HLJ1, we found that HLJ1 not only suppresses catalytic activity of Src but also downregulates the formation of oncogenic complexes associated with the EGFR, FAK and STAT3 signaling pathways. A screen of specimens from HLJ1-knockout mice and lung cancer patients validated that HLJ1 expression is inversely correlated with Src activity. Mechanistically, HLJ1 protein directly bound to catalytic and protein-binding domains of Src through its amino acid Y172 and the P301/P304 motif. Following Src-induced HLJ1 phosphorylation at Y172, HLJ1-Src interaction was elevated, resulting in Src inhibition and malignancy suppression. Interestingly, both Src-binding regions also occurred in other DNAJB family members and contributed to anti-invasive activities of DNAJB proteins. We conclude that HLJ1 is an endogenous Src inhibitor that can suppress cancer metastasis through complex interacting mechanisms. This HLJ1-Src complex might provide a promising molecular model for developing new anticancer strategies.	[Chen, C-H; Wu, R.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; [Chen, C-H; Wu, R.] Univ Calif Davis, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA; [Chen, C-H] Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA; [Chang, W-H; Yang, P-C] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei, Taiwan; [Su, K-Y; Hong, Q-S; Hsiao, Y-J; Yu, S-L] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 100, Taiwan; [Su, K-Y; Yu, S-L] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Ku, W-H] Taipei Inst Pathol, Taipei, Taiwan; [Chang, G-C] Taichung Vet Gen Hosp, Div Chest Med, Taichung, Taiwan; [Chen, H-C] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Chen, H-Y] Acad Sinica, Inst Stat Sci, Taipei, Taiwan; [Yang, P-C] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Chen, J. J. W.] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, J. J. W.] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung, Taiwan; [Yu, S-L] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei, Taiwan; [Yu, S-L] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei, Taiwan; [Yu, S-L] Natl Taiwan Univ, Coll Med, Ctr Optoclect Biomed, Taipei, Taiwan	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Taichung Veterans General Hospital; National Chung Hsing University; Academia Sinica - Taiwan; National Taiwan University; National Chung Hsing University; National Chung Hsing University; National Taiwan University; National Taiwan University; National Taiwan University	Yu, SL (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 100, Taiwan.; Chen, JJW (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.	jwchen@dragon.nchu.cdu.tw; slyu@ntu.edu.tw	Chen, Hsuan-Yu/AAE-8428-2019; SU, KANG-YI/GNM-5753-2022	SU, KANG-YI/0000-0002-6538-9526; YU, SUNG-LIANG/0000-0003-4535-9036; Hsiao, Yi-Jing/0000-0001-8780-8800; Chang, Wen-Hsin/0000-0002-8027-302X; Chen, Jeremy J.W./0000-0003-1049-3825	Ministry of Science and Technology, Taiwan, ROC [NSC 98-2314-B-005-001-MY3, NSC 102-2911-I-002-303, NSC 103-2911-I-002-303]; National Taiwan University [102R7557, 103R7557]; Tobacco-Related Disease Research Program (TRDRP) [23FT-0104]; Ministry of Education, Taiwan, ROC	Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); Tobacco-Related Disease Research Program (TRDRP)(University of California System); Ministry of Education, Taiwan, ROC(Ministry of Education, Taiwan)	We thank Dr Po-Chao Chan (Department of Life Science, National Chung Hsing University, Taichung, Taiwan) and Dr Samuel Chung (Department of Internal Medicine, University of California Davis, Davis, CA, USA) for useful discussion; Dr Yung-Hao Wong (Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan) for the advice regarding protein docking; Dr Yu-Ching Lin (UNIMED Healthcare Inc., Taiwan) and the Center for Innovative Therapeutics Discovery of National Taiwan University for technological support in ForteBio system; and the Integrated Core Facility for Functional Genomics of the National Core Facility Program for Biotechnology (NCFPB) for technological support. This work was supported by grants from the Ministry of Science and Technology, Taiwan, ROC (NSC 98-2314-B-005-001-MY3, NSC 102-2911-I-002-303 and NSC 103-2911-I-002-303) and National Taiwan University (102R7557 and 103R7557), as well as in part by the Tobacco-Related Disease Research Program (TRDRP; 23FT-0104 to C-H Chen) and by the Ministry of Education, Taiwan, ROC under the ATU plan.	Ahn BY, 2010, ONCOGENE, V29, P1155, DOI 10.1038/onc.2009.413; Armaiz-Pena GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2413; BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Brunner AM, 2013, J THORAC ONCOL, V8, P1434, DOI 10.1097/JTO.0b013e3182a47162; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang TP, 2010, CANCER RES, V70, P1656, DOI 10.1158/0008-5472.CAN-09-2453; Chee CE, 2013, ONCOLOGIST, V18, P1091, DOI 10.1634/theoncologist.2013-0255; Chen CY, 2013, CANCER RES, V73, P4009, DOI 10.1158/0008-5472.CAN-12-4066; Chen CH, 2014, AM J RESP CRIT CARE, V190, P1127, DOI 10.1164/rccm.201408-1505OC; Chen CH, 2010, EXP CELL RES, V316, P2910, DOI 10.1016/j.yexcr.2010.06.027; Chen JJW, 2001, CANCER RES, V61, P5223; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Fincham VJ, 1996, J CELL BIOL, V135, P1551, DOI 10.1083/jcb.135.6.1551; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gonfloni S, 1999, NAT STRUCT BIOL, V6, P760; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Johnson FM, 2010, J CLIN ONCOL, V28, P4609, DOI 10.1200/JCO.2010.30.5474; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kraskouskaya D, 2013, CHEM SOC REV, V42, P3337, DOI 10.1039/c3cs35449k; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Liu Y, 2014, INT J CLIN EXP PATHO, V7, P969; Masaki T, 2003, EUR J CANCER, V39, P1447, DOI 10.1016/S0959-8049(03)00276-4; Mitra A, 2012, ONCOGENE, V31, P4472, DOI 10.1038/onc.2011.623; Mitra A, 2010, J BIOL CHEM, V285, P24686, DOI 10.1074/jbc.M109.094847; Mitra A, 2009, CLIN EXP METASTAS, V26, P559, DOI 10.1007/s10585-009-9255-x; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Rahmani Z, 2006, J CELL SCI, V119, P646, DOI 10.1242/jcs.02778; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Wang CC, 2005, ONCOGENE, V24, P4081, DOI 10.1038/sj.onc.1208573; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhou J, 2003, J BIOL CHEM, V278, P6936, DOI 10.1074/jbc.M210628200	46	18	18	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 27	2016	35	43					5674	5685		10.1038/onc.2016.106	http://dx.doi.org/10.1038/onc.2016.106			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XP	27065329				2022-12-26	WOS:000386998300010
J	Del Giudice, MG; Dohmer, PH; Spera, JM; Laporte, FT; Marchesini, MI; Czibener, C; Ugalde, JE				Giselda Del Giudice, Mariela; Hans Dohmer, Peter; Manuel Spera, Juan; Tomas Laporte, Fernando; Ines Marchesini, Maria; Czibener, Cecilia; Esteban Ugalde, Juan			VirJ Is a Brucella Virulence Factor Involved in the Secretion of Type IV Secreted Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA TRANSFER; ABORTUS; IDENTIFICATION; AGROBACTERIUM; PROTEIN; MACHINERY; HOMOLOG; SYSTEMS; SPP.; GENE	The VirB secretion apparatus in Brucella belongs to the type IV secretion systems present in many pathogenic bacteria and is absolutely necessary for the efficient evasion of the Brucella-containing vacuole from the phagocytic route in professional phagocytes. This system is responsible for the secretion of a plethora of effector proteins that alter the biology of the host cell and promote the intracellular replication process. Although many VirB substrates have been identified in Brucella, we still know very little about the secretion mechanism that mediates their translocation across the two membranes and the periplasmic space. In this manuscript, we describe the identification of a gene, virJ, that codes for a protein with periplasmic localization that is involved in the intracellular replication process and virulence in mice. Our analysis revealed that this protein is necessary for the secretion of at least two VirB substrates that have a periplasmic intermediate and that it directly interacts with them. We additionally show that VirJ also associates with the apparatus per se and that its absence affects the assembly of the complex. We hypothesize that VirJ is part of a secretion platform composed of the translocon and several secretion substrates and that it probably coordinates the proper assembly of this macromolecular complex.	[Giselda Del Giudice, Mariela; Hans Dohmer, Peter; Manuel Spera, Juan; Tomas Laporte, Fernando; Ines Marchesini, Maria; Czibener, Cecilia; Esteban Ugalde, Juan] Univ Nacl San Martin, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol IIB INTECH, Inst Invest Biotecnol Dr Rodolfo A Ugalde, RA-1650 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Czibener, C; Ugalde, JE (corresponding author), Univ Nacl San Martin, IIB INTECH, Inst Invest Biotecnol Dr Rodolfo A Ugalde, UNSAM, Avda 25 Mayo & Francia,Campus Miguelete, RA-1650 Buenos Aires, DF, Argentina.	czibener@iibintech.com.ar; jugalde@iibintech.com.ar		Marchesini, Ines/0000-0002-8540-2337	University of San Martin;  [PICT-PRH08-160];  [PICT-PRH08-230]	University of San Martin; ; 	This work was supported by Grants PICT-PRH08-160 and PICT-PRH08-230 ( to C. C. and J. E. U., respectively) and grants from the University of San Martin ( to C. C. and J. E. U.). The authors declare that they have no conflicts of interest with the contents of this article.	Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Cossart P, 2010, CURR OPIN CELL BIOL, V22, P547, DOI 10.1016/j.ceb.2010.05.006; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Czibener C, 2012, MICROBES INFECT, V14, P79, DOI 10.1016/j.micinf.2011.08.012; de Barsy M, 2011, CELL MICROBIOL, V13, P1044, DOI 10.1111/j.1462-5822.2011.01601.x; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Del Giudice MG, 2013, INFECT IMMUN, V81, P956, DOI 10.1128/IAI.01158-12; Dohmer PH, 2014, CELL MICROBIOL, V16, P396, DOI 10.1111/cmi.12224; Guidolin LS, 2015, J BACTERIOL, V197, P1640, DOI 10.1128/JB.00068-15; Marchesini MI, 2011, CELL MICROBIOL, V13, P1261, DOI 10.1111/j.1462-5822.2011.01618.x; Lacerda TLS, 2013, CURR OPIN MICROBIOL, V16, P45, DOI 10.1016/j.mib.2012.11.005; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; Myeni S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003556; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2001, EMBO J, V20, P5962, DOI 10.1093/emboj/20.21.5962; Nester EW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00730; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; PAN SQ, 1995, MOL MICROBIOL, V17, P259, DOI 10.1111/j.1365-2958.1995.mmi_17020259.x; Pantoja M, 2002, MOL MICROBIOL, V45, P1325, DOI 10.1046/j.1365-2958.2002.03098.x; Quanquin NM, 1999, INFECT IMMUN, V67, P4603, DOI 10.1128/IAI.67.9.4603-4612.1999; Salcedo S. P., 2013, CELL INFECT MICROBIO, V3, P28; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Ugalde JE, 2003, INFECT IMMUN, V71, P6264, DOI 10.1128/IAI.71.11.6264-6269.2003	28	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12383	12393		10.1074/jbc.M116.730994	http://dx.doi.org/10.1074/jbc.M116.730994			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27059960	hybrid, Green Published			2022-12-26	WOS:000378092800036
J	Chen, JF; Zhang, LY; Liu, ST; Li, ZM; Huang, RR; Li, YM; Cheng, HL; Li, XT; Zhou, B; Wu, SW; Chen, W; Wu, JY; Ding, JQ				Chen, Jiafa; Zhang, Luyan; Liu, Songtao; Li, Zhimin; Huang, Rongrong; Li, Yongming; Cheng, Hongliang; Li, Xiantang; Zhou, Bo; Wu, Suowei; Chen, Wei; Wu, Jianyu; Ding, Junqiang			The Genetic Basis of Natural Variation in Kernel Size and Related Traits Using a Four-Way Cross Population in Maize	PLOS ONE			English	Article							GENERATION INTER-CROSS; GRAIN-SIZE; YIELD COMPONENTS; MAGIC POPULATIONS; QTL DETECTION; TRADE-OFF; SEED SIZE; MAJOR QTL; RICE; ENCODES	Kernel size is an important component of grain yield in maize breeding programs. To extend the understanding on the genetic basis of kernel size traits (i.e., kernel length, kernel width and kernel thickness), we developed a set of four-way cross mapping population derived from four maize inbred lines with varied kernel sizes. In the present study, we investigated the genetic basis of natural variation in seed size and other components of maize yield (e.g., hundred kernel weight, number of rows per ear, number of kernels per row). In total, ten QTL affecting kernel size were identified, three of which (two for kernel length and one for kernel width) had stable expression in other components of maize yield. The possible genetic mechanism behind the trade-off of kernel size and yield components was discussed.	[Chen, Jiafa; Li, Zhimin; Huang, Rongrong; Li, Yongming; Cheng, Hongliang; Li, Xiantang; Zhou, Bo; Wu, Suowei; Chen, Wei; Wu, Jianyu; Ding, Junqiang] Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China; [Chen, Jiafa; Li, Zhimin; Huang, Rongrong; Li, Yongming; Cheng, Hongliang; Li, Xiantang; Zhou, Bo; Wu, Suowei; Chen, Wei; Wu, Jianyu] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China; [Zhang, Luyan] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100081, Peoples R China; [Zhang, Luyan] Chinese Acad Agr Sci, CIMMYT China Off, Beijing 100081, Peoples R China; [Liu, Songtao] Henan Vocat Coll Agr, Zhengzhou 450002, Peoples R China	Henan Agricultural University; Henan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences	Wu, JY; Ding, JQ (corresponding author), Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China.; Wu, JY (corresponding author), Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China.	henau1302@126.com; dingjunqiang1203@163.com	Wu, Suowei/AAW-4748-2021; li, yong/HDN-3885-2022	Wu, Jianyu/0000-0002-9090-2512; chen, jiafa/0000-0002-5684-6692	Henan Basic Research Program of China [142102110051]	Henan Basic Research Program of China	This work was supported by Henan Basic Research Program of China (142102110051).	Andrade FH, 2005, J CROP IMPROV, V14, P51, DOI 10.1300/J411v14n01_05; Austin DF, 1996, THEOR APPL GENET, V92, P817, DOI 10.1007/BF00221893; Bandillo N, 2013, RICE, V6, DOI 10.1186/1939-8433-6-11; BHAVE MR, 1990, PLANT CELL, V2, P581, DOI 10.1105/tpc.2.6.581; Cavanagh C, 2008, CURR OPIN PLANT BIOL, V11, P215, DOI 10.1016/j.pbi.2008.01.002; Chen JF, 2012, MOL BREEDING, V30, P1649, DOI 10.1007/s11032-012-9748-1; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Dell'Acqua M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0716-z; Ding JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141619; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gnan S, 2014, GENETICS, V198, P1751, DOI 10.1534/genetics.114.170746; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Huang BE, 2015, THEOR APPL GENET, V128, P999, DOI 10.1007/s00122-015-2506-0; Huang BE, 2012, PLANT BIOTECHNOL J, V10, P826, DOI 10.1111/j.1467-7652.2012.00702.x; Huang X, 2011, NAT GENET, P1; JIANG CJ, 1995, GENETICS, V140, P1111; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Li CH, 2013, EUPHYTICA, V193, P303, DOI 10.1007/s10681-013-0901-7; Li Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-143; Li YL, 2009, EUPHYTICA, V169, P273, DOI 10.1007/s10681-009-9966-8; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Li YongXiang, 2009, Scientia Agricultura Sinica, V42, P408; Liu Y, 2014, THEOR APPL GENET, V127, P1019, DOI 10.1007/s00122-014-2276-0; Martin A, 2006, PLANT CELL, V18, P3252, DOI 10.1105/tpc.106.042689; Neuffer MG, 1997, MUTANTS MAIZE; Pascual L, 2015, PLANT BIOTECHNOL J, V13, P565, DOI 10.1111/pbi.12282; Peng B, 2011, THEOR APPL GENET, V122, P1305, DOI 10.1007/s00122-011-1532-9; Ram R, 2014, GENETICS, V198, P75, DOI 10.1534/genetics.114.163014; Rebetzke GJ, 2014, PLANT BIOTECHNOL J, V12, P219, DOI 10.1111/pbi.12130; Sadras VO, 2007, FIELD CROP RES, V100, P125, DOI 10.1016/j.fcr.2006.07.004; Sannemann W, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0284-7; *SAS I, 1999, SAS US GUID STAT; SCHMIDT RJ, 1992, PLANT CELL, V4, P689, DOI 10.1105/tpc.4.6.689; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; VELDBOOM LR, 1994, THEOR APPL GENET, V89, P451, DOI 10.1007/BF00225380; Veldboom LR, 1996, CROP SCI, V36, P1310, DOI 10.2135/cropsci1996.0011183X003600050040x; VENABLE DL, 1992, AM NAT, V140, P287, DOI 10.1086/285413; Verbyla AP, 2014, THEOR APPL GENET, V127, P1753, DOI 10.1007/s00122-014-2337-4; Wang GF, 2012, PLANT CELL, V24, P3447, DOI 10.1105/tpc.112.101360; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Zhang L, 2015, J INTEGR PLANT BIOL; Zhang LY, 2015, G3-GENES GENOM GENET, V5, P427, DOI 10.1534/g3.114.016022; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110	52	30	35	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153428	10.1371/journal.pone.0153428	http://dx.doi.org/10.1371/journal.pone.0153428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070143	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700067
J	Kim, EB; Jin, GD; Lee, JY; Choi, YJ				Kim, Eun Bae; Jin, Gwi-Deuk; Lee, Jun-Yeong; Choi, Yun-Jaie			Genomic Features and Niche-Adaptation of Enterococcus faecium Strains from Korean Soybean-Fermented Foods	PLOS ONE			English	Article							DEGRADATION; PHYLOGENIES; ALIGNMENT; DOENJANG	Certain strains of Enterococcus faecium contribute beneficially to human health and food fermentation. However, other E. faecium strains are opportunistic pathogens due to the acquisition of virulence factors and antibiotic resistance determinants. To characterize E. faecium from soybean fermentation, we sequenced the genomes of 10 E. faecium strains from Korean soybean-fermented foods and analyzed their genomes by comparing them with 51 clinical and 52 non-clinical strains of different origins. Hierarchical clustering based on 13,820 orthologous genes from all E. faecium genomes showed that the 10 strains are distinguished from most of the clinical strains. Like non-clinical strains, their genomes are significantly smaller than clinical strains due to fewer accessory genes associated with antibiotic resistance, virulence, and mobile genetic elements. Moreover, we identified niche-associated gene gain and loss from the soybean strains. Thus, we conclude that soybean E. faecium strains might have evolved to have distinctive genomic features that may contribute to its ability to thrive during soybean fermentation.	[Kim, Eun Bae; Jin, Gwi-Deuk] Kangwon Natl Univ, Coll Anim Life Sci, Dept Anim Life Sci, Chunchon, Kangwon Do, South Korea; [Kim, Eun Bae] Kangwon Natl Univ, Coll Anim Life Sci, Div Appl Anim Sci, Chunchon, Kangwon Do, South Korea; [Lee, Jun-Yeong; Choi, Yun-Jaie] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Choi, Yun-Jaie] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Kangwon National University; Kangwon National University; Seoul National University (SNU); Seoul National University (SNU)	Kim, EB (corresponding author), Kangwon Natl Univ, Coll Anim Life Sci, Dept Anim Life Sci, Chunchon, Kangwon Do, South Korea.; Kim, EB (corresponding author), Kangwon Natl Univ, Coll Anim Life Sci, Div Appl Anim Sci, Chunchon, Kangwon Do, South Korea.	itanimal@kangwon.ac.kr		Lee, Jun-Yeong/0000-0002-4342-1863	Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea, multi-ministerial Genome Technology to Business Translation Program [914005-04]	Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea, multi-ministerial Genome Technology to Business Translation Program	This study was supported by a grant from the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea as part of the multi-ministerial Genome Technology to Business Translation Program (Grant ID: 914005-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea as part of the multi-ministerial Genome Technology to Business Translation Program (Grant ID: 914005-04). We appreciate KACC (Korean Agricultural Culture Collection) for donation of E. faecium strains for this study.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Authority EFS, 2012, EFSA J, V10, P10; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barbosa J, 2014, INT J FOOD MICROBIOL, V191, P144, DOI 10.1016/j.ijfoodmicro.2014.09.009; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; 김용상, 2011, [Korean Journal of Microbiology, 미생물학회지], V47, P275; Caryl JA, 2012, ANTIMICROB AGENTS CH, V56, P3378, DOI 10.1128/AAC.05957-11; Castillo-Rojas G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059491; de Regt MJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030319; Diaz M, 2003, APPL ENVIRON MICROB, V69, P1229, DOI 10.1128/AEM.69.2.1229-1236.2003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hammami R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-22; Hill C, 2012, J BACTERIOL, V194, P5725, DOI 10.1128/JB.00980-12; Jeong DW, 2014, J MICROBIOL BIOTECHN, V24, P648, DOI 10.4014/jmb.1401.01009; Jo YJ, 2011, J FOOD SCI, V76, pC368, DOI 10.1111/j.1750-3841.2011.02068.x; Kim EB, 2014, APPL ENVIRON MICROB, V80, P154, DOI 10.1128/AEM.03108-13; Kim MH, 2012, FOOD SCI BIOTECHNOL, V21, P9, DOI 10.1007/s10068-012-0002-8; Kopit LM, 2014, APPL ENVIRON MICROB, V80, P1899, DOI 10.1128/AEM.03859-13; Lam MMC, 2012, J BACTERIOL, V194, P2334, DOI 10.1128/JB.00259-12; Lebreton F, 2013, MBIO, V4, DOI 10.1128/mBio.00534-13; Leong D, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00683, 10.3389/fmicb.2014.00436, 10.3389/fmicb.2014.00241]; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Martinez-Villaluenga C, 2012, J AGR FOOD CHEM, V60, P10235, DOI 10.1021/jf302751m; Masood MI, 2011, CRIT REV MICROBIOL, V37, P91, DOI 10.3109/1040841X.2010.536522; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; 이영덕, 2012, [The Korean Journal of Food and Nutrition, 한국식품영양학회지], V25, P188; Rizk G, 2010, BIOINFORMATICS, V26, P2534, DOI 10.1093/bioinformatics/btq485; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shukla S, 2010, FOOD CHEM TOXICOL, V48, P2005, DOI 10.1016/j.fct.2010.04.034; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]	36	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153279	10.1371/journal.pone.0153279	http://dx.doi.org/10.1371/journal.pone.0153279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070419	gold, Green Published, Green Submitted			2022-12-26	WOS:000373900700045
J	Stiegel, MA; Pleil, JD; Sobus, JR; Madden, MC				Stiegel, Matthew A.; Pleil, Joachim D.; Sobus, Jon R.; Madden, Michael C.			Inflammatory Cytokines and White Blood Cell Counts Response to Environmental Levels of Diesel Exhaust and Ozone Inhalation Exposures	PLOS ONE			English	Article							AIR-POLLUTION; PARTICULATE MATTER; BREATH CONDENSATE; NO2 EMISSIONS; LUNG-FUNCTION; BIOMARKERS; DISEASE; DYSFUNCTION; VOLUNTEERS; PARTICLES	Epidemiological observations of urban inhalation exposures to diesel exhaust (DE) and ozone (O-3) have shown pre-clinical cardiopulmonary responses in humans. Identifying the key biological mechanisms that initiate these health bioindicators is difficult due to variability in environmental exposure in time and from person to person. Previously, environmentally controlled human exposure chambers have been used to study DE and O-3 dose-response patterns separately, but investigation of co-exposures has not been performed under controlled conditions. Because a mixture is a more realistic exposure scenario for the general public, in this study we investigate the relationships of urban levels of urban-level DE exposure (300 mu g/m(3)), O-3 (0.3 ppm), DE + O-3 co-exposure, and innate immune system responses. Fifteen healthy human volunteers were studied for changes in ten inflammatory cytokines (interleukins 1 beta, 2, 4, 5, 8, 10, 12p70 and 13, IFN-gamma, and TNF-alpha) and counts of three white blood cell types (lymphocytes, monocytes, and neutrophils) following controlled exposures to DE, O3, and DE+O-3. The results show subtle cytokines responses to the diesel-only and ozone-only exposures, and that a more complex (possibly synergistic) relationship exists in the combination of these two exposures with suppression of IL-5, IL-12p70, IFN-gamma, and TNF-alpha that persists up to 22-hours for IFN-gamma and TNF-alpha. The white blood cell differential counts showed significant monocyte and lymphocyte decreases and neutrophil increases following the DE + O3 exposure; lymphocytes and neutrophils changes also persist for at least 22-hours. Because human studies must be conducted under strict safety protocols at environmental levels, these effects are subtle and are generally only seen with detailed statistical analysis. This study indicates that the observed associations between environmental exposures and cardiopulmonary effects are possibly mediated by inflammatory response mechanisms.	[Stiegel, Matthew A.] Duke Univ, Med Ctr, Dept Occupat & Environm Safety, Div Occupat Hyg & Safety, Durham, NC USA; [Pleil, Joachim D.; Sobus, Jon R.] US EPA, Natl Exposure Res Lab, Human Exposure & Atmospher Sci Div, Res Triangle Pk, NC 27711 USA; [Madden, Michael C.] US EPA, Natl Hlth & Environm Effects Res Lab, Environm Publ Hlth Div, Chapel Hill, NC USA	Duke University; United States Environmental Protection Agency; United States Environmental Protection Agency	Pleil, JD (corresponding author), US EPA, Natl Exposure Res Lab, Human Exposure & Atmospher Sci Div, Res Triangle Pk, NC 27711 USA.	pleil.joachim@epa.gov		Sobus, Jon/0000-0003-0740-6604	US Government	US Government	The authors JDP, JRS, MCM and the study were fully funded by the US Government as part of their employment.	Alexis NE, 2010, INHAL TOXICOL, V22, P593, DOI 10.3109/08958371003596587; Alexis NE, 2009, J ALLERGY CLIN IMMUN, V124, P1222, DOI 10.1016/j.jaci.2009.07.036; Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/034001; Angrish MM, 2016, J TOXICOL ENV HLT 25, V25, P1; [Anonymous], 1998, GENDER DIFFERENCES S; Bao AH, 2013, FRONT BIOSCI-LANDMRK, V18, P838, DOI 10.2741/4147; Bar-Ilan A, 2010, J AIR WASTE MANAGE, V60, P977, DOI 10.3155/1047-3289.60.8.977; Bean HD, 2015, BIOMARKERS, V20, P1, DOI 10.3109/1354750X.2014.985254; Bosson J, 2008, EUR RESPIR J, V31, P1234, DOI 10.1183/09031936.00078407; Bosson J, 2009, INHAL TOXICOL, V21, P913, DOI 10.1080/08958370802657389; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Buzzard NA, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-13; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825; Cousins DJ, 2002, J IMMUNOL, V169, P2498, DOI 10.4049/jimmunol.169.5.2498; Devlin RB, 2012, CIRCULATION, V126, P104, DOI 10.1161/CIRCULATIONAHA.112.094359; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; EPA U.S, 2002, HLTH ASS DOC DIES EN; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Faustini A, 2013, EUR RESPIR J, V42, P304, DOI 10.1183/09031936.00128712; Gilliland FD, 2002, AM J RESP CRIT CARE, V166, P457, DOI 10.1164/rccm.2112064; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; HATCH GE, 1994, AM J RESP CRIT CARE, V150, P676, DOI 10.1164/ajrccm.150.3.8087337; Holgate Stephen T, 2003, Res Rep Health Eff Inst, P1; Huang YCT, 2012, INHAL TOXICOL, V24, P790, DOI 10.3109/08958378.2012.718809; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Kim CS, 2011, AM J RESP CRIT CARE, V183, P1215, DOI 10.1164/rccm.201011-1813OC; Knudsen Thomas, 2013, Methods Mol Biol, V947, P343, DOI 10.1007/978-1-62703-131-8_26; Kodavanti UP, 2011, ENVIRON HEALTH PERSP, V119, P312, DOI 10.1289/ehp.1002386; Kurtenbach Ralf, 2012, Environmental Sciences Europe, V24, P21, DOI 10.1186/2190-4715-24-21; Laskin Debra L, 2010, Res Rep Health Eff Inst, P3; Madden MC, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0037-5; Meso Scale Discovery, 2012, MSD BIOM ASS HUM TH1; Nordenhall C, 2000, EUR RESPIR J, V15, P1046, DOI 10.1034/j.1399-3003.2000.01512.x; Oakes JL, 2013, AM J RESP CELL MOL, V48, P27, DOI 10.1165/rcmb.2012-0187OC; Pleil JD, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/4/047108; Pleil JD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/029001; Pleil JD, 2013, ANAL CHEM, V85, P9984, DOI 10.1021/ac402306f; Pleil JD, 2012, J TOXICOL ENV HEAL B, V15, P264, DOI 10.1080/10937404.2012.672148; Pleil JD, 2011, BIOMARKERS, V16, P99, DOI 10.3109/1354750X.2010.541565; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Romagnani S, 2000, ANN ALLERG ASTHMA IM, V85, P9, DOI 10.1016/S1081-1206(10)62426-X; Saito Y, 2002, EXP LUNG RES, V28, P201, DOI 10.1080/019021402753570509; Sawyer K, 2010, J TOXICOL ENV HEAL A, V73, P41, DOI 10.1080/15287390903248901; SCHELEGLE ES, 1991, AM REV RESPIR DIS, V143, P1353, DOI 10.1164/ajrccm/143.6.1353; Stevens T, 2008, TOXICOL SCI, V102, P359, DOI 10.1093/toxsci/kfn006; Stevens T, 2009, TOXICOL SCI, V107, P522, DOI 10.1093/toxsci/kfn248; Stiegel MA, 2015, BIOMARKERS, V20, P35, DOI 10.3109/1354750X.2014.988646; Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330; Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Xu YY, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-60; Yang HM, 2001, ENVIRON HEALTH PERSP, V109, P515, DOI 10.2307/3454711	58	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152458	10.1371/journal.pone.0152458	http://dx.doi.org/10.1371/journal.pone.0152458			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058360	Green Published, gold, Green Submitted			2022-12-26	WOS:000373604800006
J	Lee, JE; Kim, Y; Kim, KH; Lee, DY; Lee, Y				Lee, Jung-Eun; Kim, Yunjung; Kim, Kyoung Heon; Lee, Do Yup; Lee, Youngseok			Contribution of Drosophila TRPA1 to Metabolism	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; CLUSTER-ANALYSIS; FATTY-ACIDS; METHIONINE; MELANOGASTER; RESTRICTION; HEAT; SUPPLEMENTATION; TOLERANCE; INCREASES	Transient receptor potential (TRP) cation channels are highly conserved in humans and insects. Some of these channels are expressed in internal organs and their functions remain incompletely understood. By direct knock-in of the GAL4 gene into the trpA1 locus in Drosophila, we identified the expression of this gene in the subesophageal ganglion (SOGs) region. In addition, the neurites present in the dorsal posterior region as well as the drosophila insulin-like peptide 2 (dILP2)-positive neurons send signals to the SOGs. The signal is sent to the crop, which is an enlarged organ of the esophagus and functions as a storage place for food in the digestive system. To systematically investigate the role of TRPA1 in metabolism, we applied non-targeted metabolite profiling analysis together with gas-chromatography/ time-of-flight mass spectrometry, with an aim to identify a wide range of primary metabolites. We effectively captured distinctive metabolomic phenotypes and identified specific metabolic dysregulation triggered by TRPA1 mutation based on reconstructed metabolic network analysis. Primarily, the network analysis pinpointed the simultaneous down-regulation of intermediates in the methionine salvation pathway, in contrast to the synchronized up-regulation of a range of free fatty acids. The gene dosage-dependent dynamics of metabolite levels among wild-type, hetero-and homozygous mutants, and their coordinated metabolic modulation under multiple gene settings across five different genotypes confirmed the direct linkages of TRPA1 to metabolism.	[Lee, Jung-Eun; Kim, Yunjung; Lee, Do Yup; Lee, Youngseok] Kookmin Univ, PLUS Project BK21, Dept Bio & Fermentat Convergence Technol, Seoul 02707, South Korea; [Kim, Kyoung Heon] Korea Univ, Grad Sch, Dept Biotechnol, Seoul, South Korea	Kookmin University; Korea University	Lee, DY; Lee, Y (corresponding author), Kookmin Univ, PLUS Project BK21, Dept Bio & Fermentat Convergence Technol, Seoul 02707, South Korea.	rome73@kookmin.ac.kr; ylee@kookmin.ac.kr	Kim, Kyoung Heon/F-1059-2013	Kim, Kyoung Heon/0000-0003-4600-8668; Lee, Youngseok/0000-0003-0459-1138	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012M3A9B2052525]; Basic Science Research Program of the NRF of Korea - Ministry of Education [2014R1A1A2058094]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) [NRF-2014M3A9B6069345, NRF 2013M3A9B6046519]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Basic Science Research Program of the NRF of Korea - Ministry of Education; Bio & Medical Technology Development Program of the National Research Foundation (NRF)	This work was supported by a grant to Y.L. from the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012M3A9B2052525), and the Basic Science Research Program of the NRF of Korea funded by the Ministry of Education (2014R1A1A2058094), and a grant to D.Y.L. from the Bio & Medical Technology Development Program of the National Research Foundation (NRF) (grant numbers: NRF-2014M3A9B6069345 and NRF 2013M3A9B6046519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Chen Z, 2013, J ANIM PLANT SCI-PAK, V23, P1634; Conrad T, 2012, SCIENCE, V337, P742, DOI 10.1126/science.1221428; Dhaunsi GS, 2005, CELL BIOCHEM FUNCT, V23, P65, DOI 10.1002/cbf.1173; Donner TW, 2010, NUTR RES, V30, P801, DOI 10.1016/j.nutres.2010.09.007; Du EJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005773; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Fiehn O, SETUP ANNOTATION MET; Fiehn O, 2011, J BIOL CHEM, V286, P23637, DOI 10.1074/jbc.R110.173617; Flatt T, 2009, NATURE, V462, P989, DOI 10.1038/462989a; Fowler MA, 2013, LIFE SCI, V92, P394, DOI 10.1016/j.lfs.2012.07.029; Gerich JE, 1999, DIABETES OBES METAB, V1, P257, DOI 10.1046/j.1463-1326.1999.00027.x; Goto SG, 2010, BIOCHEM BIOPH RES CO, V391, P1251, DOI 10.1016/j.bbrc.2009.12.053; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; HOTTIGER T, 1987, FEBS LETT, V220, P113, DOI 10.1016/0014-5793(87)80886-4; Huck JHJ, 2003, CLIN CHEM, V49, P1375, DOI 10.1373/49.8.1375; Islam R, 2013, J NEUROSCI, V33, P12306, DOI 10.1523/JNEUROSCI.5220-12.2013; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kupers R, 2009, PAIN, V142, P89, DOI 10.1016/j.pain.2008.12.008; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Lee BC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4592; Lee DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068831; Lee DY, 2012, MOL CELL PROTEOMICS, V11, P973, DOI 10.1074/mcp.M111.016733; Lee YM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/210604; Lee Y, 2013, J NEUROSCI, V33, P6716, DOI 10.1523/JNEUROSCI.4237-12.2013; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Liedtke WB., 2006, TRP ION CHANNEL FUNC; Mary C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052877; Mashima R, 2003, ANAL BIOCHEM, V313, P28, DOI 10.1016/S0003-2697(02)00537-7; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Min KJ, 2006, MECH AGEING DEV, V127, P643, DOI 10.1016/j.mad.2006.02.005; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Russell P, 2014, BIOL DYNAMIC SCI; Sabri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074656; Schauer R, 1997, N COMP BIOC B, V29, P243; Scholz M, SETUPX A PUBLIC STUD; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Troen AM, 2007, AGE, V29, P29, DOI 10.1007/s11357-006-9018-4; Vesala L, 2012, J EXP BIOL, V215, P2891, DOI 10.1242/jeb.069948; Virtanen JK, 2006, NUTR METAB CARDIOVAS, V16, P113, DOI 10.1016/j.numecd.2005.05.005	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152935	10.1371/journal.pone.0152935	http://dx.doi.org/10.1371/journal.pone.0152935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055172	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000056
J	Xu, Q; Li, X; Wang, S; Wang, C; Huang, FF; Gao, Q; Wu, LJ; Tao, LX; Guo, J; Wang, W; Guo, XH				Xu, Qin; Li, Xia; Wang, Shuo; Wang, Chao; Huang, Fangfang; Gao, Qi; Wu, Lijuan; Tao, Lixin; Guo, Jin; Wang, Wei; Guo, Xiuhua			Fine Particulate Air Pollution and Hospital Emergency Room Visits for Respiratory Disease in Urban Areas in Beijing, China, in 2013	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CASE-CROSSOVER; TIME-SERIES; GASEOUS-POLLUTANTS; COARSE PARTICLES; DAILY MORTALITY; INCREASED RISK; AMBIENT PM2.5; ADMISSIONS; MATTER	Background Heavy fine particulate matter (PM2.5) air pollution occurs frequently in China. However, epidemiological research on the association between short-term exposure to PM2.5 pollution and respiratory disease morbidity is still limited. This study aimed to explore the association between PM2.5 pollution and hospital emergency room visits (ERV) for total and cause-specific respiratory diseases in urban areas in Beijing. Methods Daily counts of respiratory ERV from Jan 1 to Dec 31, 2013, were obtained from ten general hospitals located in urban areas in Beijing. Concurrently, data on PM2.5 were collected from the Beijing Environmental Protection Bureau, including 17 ambient air quality monitoring stations. A generalized-additive model was used to explore the respiratory effects of PM2.5, after controlling for confounding variables. Subgroup analyses were also conducted by age and gender. Results A total of 92,464 respiratory emergency visits were recorded during the study period. The mean daily PM2.5 concentration was 102.1 +/- 73.6 mu g/m(3). Every 10 mu g/m(3) increase in PM2.5 concentration at lag(0) was associated with an increase in ERV, as follows: 0.23% for total respiratory disease (95% confidence interval [CI]: 0.11%-0.34%), 0.19% for upper respiratory tract infection (URTI) (95% CI: 0.04%-0.35%), 0.34% for lower respiratory tract infection (LRTI) (95% CI: 0.14%-0.53%) and 1.46% for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) (95% CI: 0.13%-2.79%). The strongest association wasidentified between AECOPD and PM2.5 concentration at lag(0-3) (3.15%, 95% CI: 1.39%-4.91%). The estimated effects were robust after adjusting for SO2, O-3, CO and NO2. Females and people 60 years of age and older demonstrated a higher risk of respiratory disease after PM2.5 exposure. Conclusion PM2.5 was significantly associated with respiratory ERV, particularly for URTI, LRTI and AECOPD in Beijing. The susceptibility to PM2.5 pollution varied by gender and age.	[Xu, Qin; Li, Xia; Wang, Chao; Huang, Fangfang; Gao, Qi; Wu, Lijuan; Tao, Lixin; Guo, Jin; Wang, Wei; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Xu, Qin; Li, Xia; Wang, Chao; Huang, Fangfang; Gao, Qi; Wu, Lijuan; Tao, Lixin; Guo, Jin; Wang, Wei; Guo, Xiuhua] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Li, Xia] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Wang, Shuo] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China; [Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia	Capital Medical University; University of Limerick; Capital Medical University; Edith Cowan University	Wang, W; Guo, XH (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.; Wang, W; Guo, XH (corresponding author), Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China.; Wang, W (corresponding author), Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia.	wei.wang@ecu.edu.au; statguo@ccmu.edu.cn	TAO, Li/HIR-4254-2022; Gao, Qi/N-8721-2019	Gao, Qi/0000-0002-5370-5536	National Natural Science Foundation of China [81530087, 81373099, 81302516]; National Science and Technology Major Project [2012ZX10005009-003]; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions [IDHT20130213]; MOE (Ministry of Education of the People's Republic of China) Project of Humanities, Social Sciences [7131002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions; MOE (Ministry of Education of the People's Republic of China) Project of Humanities, Social Sciences	XG is supported by National Natural Science Foundation of China (grant number: 81530087 and 81373099, http://www.nsfc.gov.cn/), National Science and Technology Major Project (grant number: 2012ZX10005009-003, http://www.nmp.gov.cn/). WW is supported by the Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions (grant number: IDHT20130213, http://www.beijing.gov.cn/). XL is supported by National Natural Science Foundation of China (grant number: 81302516, http://www.nsfc.gov.cn/), MOE (Ministry of Education of the People's Republic of China) Project of Humanities, Social Sciences (grant number: 7131002, http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Bell ML, 2015, EPIDEMIOLOGY, V26, P575, DOI 10.1097/EDE.0000000000000310; Belleudi V, 2010, EPIDEMIOLOGY, V21, P414, DOI 10.1097/EDE.0b013e3181d5c021; Cakmak S, 2006, J OCCUP ENVIRON MED, V48, P89, DOI 10.1097/01.jom.0000184878.11956.4b; Chen Y, 2005, INHAL TOXICOL, V17, P649, DOI 10.1080/08958370500189420; Cheng MH, 2014, J TOXICOL ENV HEAL A, V77, P1075, DOI 10.1080/15287394.2014.922387; Dai LZ, 2014, ENVIRON HEALTH PERSP, V122, P837, DOI 10.1289/ehp.1307568; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Dominici F, 2012, JAMA-J AM MED ASSOC, V307, P2100, DOI 10.1001/jama.2012.4601; Goldman GT, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-61; Guo YM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05509; Guo YM, 2010, SCI TOTAL ENVIRON, V409, P300, DOI 10.1016/j.scitotenv.2010.10.013; Halonen JI, 2008, THORAX, V63, P635, DOI 10.1136/thx.2007.091371; Halonen JI, 2009, EPIDEMIOLOGY, V20, P143, DOI 10.1097/EDE.0b013e31818c7237; Happo MS, 2010, INHAL TOXICOL, V22, P402, DOI 10.3109/08958370903527908; Host S, 2008, OCCUP ENVIRON MED, V65, P544, DOI 10.1136/oem.2007.036194; Ito K, 2007, J EXPO SCI ENV EPID, V17, pS45, DOI 10.1038/sj.jes.7500627; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Li L, 2014, INT J ENV RES PUB HE, V11, P8909, DOI 10.3390/ijerph110908909; Li MN, 2014, ENVIRON POLLUT, V189, P85, DOI 10.1016/j.envpol.2014.02.024; Li P, 2013, ENVIRON SCI POLLUT R, V20, P6433, DOI 10.1007/s11356-013-1688-8; Li Y, 2015, INT J BIOMETEOROL, V59, P1761, DOI 10.1007/s00484-015-0984-z; Lu F, 2015, ENVIRON RES, V136, P196, DOI 10.1016/j.envres.2014.06.029; Lv J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124586; Ma WJ, 2014, ENVIRON RES, V134, P127, DOI 10.1016/j.envres.2014.07.007; Qian ZM, 2010, J AIR WASTE MANAGE, V60, P481, DOI 10.3155/1047-3289.60.4.481; Qiu H, 2014, THORAX, V69, P1027, DOI 10.1136/thoraxjnl-2014-205429; Qiu H, 2013, INT J CARDIOL, V168, P500, DOI 10.1016/j.ijcard.2012.09.199; Samoli E, 2005, ENVIRON HEALTH PERSP, V113, P88, DOI 10.1289/ehp.7387; Samoli E, 2014, ENVIRON INT, V67, P54, DOI 10.1016/j.envint.2014.02.013; Schwartz J, 2002, ENVIRON HEALTH PERSP, V110, P1025, DOI 10.1289/ehp.021101025; Sunyer J, 2000, AM J EPIDEMIOL, V151, P50, DOI 10.1093/oxfordjournals.aje.a010121; Tian LW, 2014, AM J EPIDEMIOL, V180, P1159, DOI 10.1093/aje/kwu248; Tsai SS, 2014, J TOXICOL ENV HEAL A, V77, P1091, DOI 10.1080/15287394.2014.922388; Tsai SS, 2013, INT J ENV RES PUB HE, V10, P6015, DOI 10.3390/ijerph10116015; Wang YG, 2014, ENVIRON INT, V73, P413, DOI 10.1016/j.envint.2014.08.016; Winquist A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-68; Wong CM, 2001, ENVIRON HEALTH PERSP, V109, P335, DOI 10.2307/3454891; Xie WX, 2015, HEART, V101, P257, DOI 10.1136/heartjnl-2014-306165; Xiong QL, 2015, INT J ENV RES PUB HE, V12, P11880, DOI 10.3390/ijerph120911880; Xu MM, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-109; Yang CX, 2012, INT ARCH OCC ENV HEA, V85, P579, DOI 10.1007/s00420-011-0707-7; Zhao H, 2014, TOXICOLOGY, V325, P180, DOI 10.1016/j.tox.2014.09.006; Zheng S, 2013, INT J ENV RES PUB HE, V10, P462, DOI 10.3390/ijerph10020462; Zhou MG, 2015, ENVIRON RES, V136, P396, DOI 10.1016/j.envres.2014.09.038	46	124	137	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153099	10.1371/journal.pone.0153099	http://dx.doi.org/10.1371/journal.pone.0153099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054582	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000076
J	Galetti, M; Rodarte, RR; Neves, CL; Moreira, M; Costa-Pereira, R				Galetti, Mauro; Rodarte, Raisa Reis; Neves, Carolina Lima; Moreira, Marcelo; Costa-Pereira, Raul			Trophic Niche Differentiation in Rodents and Marsupials Revealed by Stable Isotopes	PLOS ONE			English	Article							BRAZILIAN ATLANTIC FOREST; SMALL MAMMALS; RAIN-FOREST; SYMPATRIC OPOSSUMS; FOOD-HABITS; BODY-SIZE; DIET; COMPETITION; MICROHABITAT; NITROGEN	Tropical rainforests support the greatest diversity of small mammals in the world, yet we have little understanding about the mechanisms that promote the coexistence of species. Diet partitioning can favor coexistence by lessening competition, and interspecific differences in body size and habitat use are usually proposed to be associated with trophic divergence. However, the use of classic dietary methods (e.g. stomach contents) is challenging in small mammals, particularly in community-level studies, thus we used stable isotopes (delta C-13 and delta N-15) to infer about trophic niche. We investigated i) how trophic niche is partitioned among rodent and marsupial species in three Atlantic forest sites and ii) if interspecific body size and locomotor habit inequalities can constitute mechanisms underlying the isotopic niche partitioning. We found that rodents occupied a broad isotopic niche space with species distributed in different trophic levels and relying on diverse basal carbon sources (C3 and C4 plants). Surprisingly, on the other hand, marsupials showed a narrow isotopic niche, both in delta C-13 and delta N-15 dimensions, which is partially overlapped with rodents, contradicting their description as omnivores and generalists proposed classic dietary studies. Although body mass differences did not explained the divergence in isotopic values among species, groups of species with different locomotor habit presented clear differences in the position of the isotopic niche space, indicating that the use of different forest strata can favor trophic niche partitioning in small mammals communities. We suggest that anthropogenic impacts, such as habitat modification (logging, harvesting), can simplify the vertical structure of ecosystems and collapse the diversity of basal resources, which might affect negatively small mammals communities in Atlantic forests.	[Galetti, Mauro; Rodarte, Raisa Reis; Neves, Carolina Lima] Univ Estadual Paulista UNESP, Dept Ecol, CP 199, BR-13506900 Sao Paulo, Brazil; [Rodarte, Raisa Reis] Casa Floresta Assessoria Ambiental Ltda, BR-13415030 Sao Paulo, Brazil; [Moreira, Marcelo] Univ Sao Paulo, CENA, BR-13416903 Sao Paulo, Brazil; [Costa-Pereira, Raul] Univ Estadual Paulista UNESP, Programa Posgrad Ecol & Biodiversidade, CP 199, BR-13506900 Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista	Galetti, M (corresponding author), Univ Estadual Paulista UNESP, Dept Ecol, CP 199, BR-13506900 Sao Paulo, Brazil.	mgaletti@rc.unesp.br	Costa-Pereira, Raul/A-5527-2018; Galetti, Mauro/M-8751-2013; Moreira, Marcelo Z/D-4622-2013	Costa-Pereira, Raul/0000-0003-2370-5866; Galetti, Mauro/0000-0002-8187-8696; Moreira, Marcelo Z/0000-0001-6769-5570	BIOTA/FAPESP [2007/03392-6, 2014/01986-0]; CNPq	BIOTA/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank BIOTA/FAPESP 2007/03392-6 and 2014/01986-0 for financial support. Fieldwork was carried out with help from R. Souza, P. Barros, F. Labecca, P. Tokumoto, M. Gotardi, S. Tomasin, D. Flores, C. Mendes and S. Nazareth. The authors are grateful to R. Duda for the identification of marsu-pials from genus Monodelphis. R. R. Rodarte received a CNPq fellowship, M. Galetti is supported by a research grant from CNPq and R. Costa-Pereira is grateful to Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2014/20924-5). Collecting permits was provided by Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renovaveis (IBAMA #14428-2, IBAMA #31941-1). The authors thank Fundacao Florestal for allowing them to work in the protected areas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; [Anonymous], 2012, OCCASIONAL PAPERS CO; AUGUST PV, 1983, ECOLOGY, V64, P1495, DOI 10.2307/1937504; Baltensperger AP, 2015, CANADIAN J ZOOLOGY; Ben-David M, 2012, J MAMMAL, V93, P312, DOI 10.1644/11-MAMM-S-166.1; Bloch CP, 2011, ECOGRAPHY, V34, P460, DOI 10.1111/j.1600-0587.2010.06270.x; Bonner J.T., 2011, WHY SIZE MATTERS BAC; BOWERS MA, 1982, ECOLOGY, V63, P391, DOI 10.2307/1938957; Brocardo CR, 2012, BIOTA NEOTROP, V12, P198, DOI 10.1590/S1676-06032012000400021; BROWN JH, 1977, SCIENCE, V196, P880, DOI 10.1126/science.196.4292.880; Caceres NC, 2004, MAMM BIOL, V69, P430, DOI 10.1078/1616-5047-00165; Caceres NC, 2002, MAMMALIA, V66, P331, DOI 10.1515/mamm.2002.66.3.331; Carvalho FMV, 2005, MAMM BIOL, V70, P366, DOI 10.1016/j.mambio.2005.08.003; Charles-Dominique P., 1983, Special Publication American Society of Mammalogists, P395; CHARLESDOMINIQUE P, 1981, TERRE VIE-REV ECOL A, V35, P341; Chase J.M., 2009, ECOLOGICAL NICHES LI; Dammhahn M, 2013, BIOTROPICA, V45, P111, DOI 10.1111/j.1744-7429.2012.00893.x; Di-Nizo CB, 2014, COMP CYTOGENET, V8, P11, DOI 10.3897/CompCytogen.v8i1.6430; Fry B, 2007, STABLE ISOTOPE ECOLO; Galetti M, 2015, BIOTROPICA, V47, P521, DOI 10.1111/btp.12246; Galetti M, 2015, BIOL CONSERV, V190, P2, DOI 10.1016/j.biocon.2015.04.032; GRAIPEL ME, 2003, MASTOZOOL NEOTROP, V10, P255; Herrera LG, 2002, OECOLOGIA, V133, P280, DOI 10.1007/s00442-002-1036-z; Hespenheide H., 1975, ECOLOGY EVOLUTION CO; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Hyodo F, 2010, J TROP ECOL, V26, P205, DOI 10.1017/S0266467409990502; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Kawanishi K, 2012, RAFFLES B ZOOL, V60, P233; Kluge M., 2012, CRASSULACEAN ACID ME; Leite YLR, 1996, J TROP ECOL, V12, P435, DOI 10.1017/S0266467400009640; Lira PK, 2012, J APPL ECOL, V49, P1325, DOI 10.1111/j.1365-2664.2012.02214.x; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; Martins EG, 2006, J ZOOL, V269, P21, DOI 10.1111/j.1469-7998.2006.00052.x; Martins EG, 2004, MAMM BIOL, V69, P58, DOI 10.1078/1616-5047-116; MEDINA E, 1980, OECOLOGIA, V45, P377, DOI 10.1007/BF00540209; Mendel SM, 2003, ACTA THERIOL, V48, P289, DOI 10.1007/BF03194169; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Paglia AP, 2012, LISTA ANOTADA MAMFER; Palmer TM, 2003, AM NAT, V162, pS63, DOI 10.1086/378682; Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Parnell A., 2015, R PACKAGE SIAR; PASCHOAL M, 1995, BIOTROPICA, V27, P268, DOI 10.2307/2389006; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Pinotti BT, 2011, STUD NEOTROP FAUNA E, V46, P1, DOI 10.1080/01650521.2010.535250; PRICE MV, 1978, ECOLOGY, V59, P910, DOI 10.2307/1938543; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Rocha-Mendes F, 2015, BIOTA NEOTROP, V15, DOI 10.1590/1676-06032014000814; Santori RT, 2012, ALIMENTACAO NUTR ADA, P385; Sare DTJ, 2005, CAN J ZOOL, V83, P717, DOI 10.1139/Z05-064; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; SCHOENER TW, 1974, AM NAT, V108, P332, DOI 10.1086/282911; Syvaranta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056094; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; TIESZEN LL, 1989, AFR J ECOL, V27, P219, DOI 10.1111/j.1365-2028.1989.tb01015.x; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Vieira EM, 2005, MAMM BIOL, V70, P359, DOI 10.1016/j.mambio.2005.08.002; Vieira EM, 2003, MAMMALIA, V67, P533; Vieira EM, 2003, J TROP ECOL, V19, P501, DOI 10.1017/S0266467403003559; Vieira EM, 2012, USO ESPACO VERTICAL, P347; Vieira MV, 2003, STUD NEOTROP FAUNA E, V38, P7, DOI 10.1076/snfe.38.1.7.14034; Winemiller KO, 2015, ECOL LETT, V18, P737, DOI 10.1111/ele.12462; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x	67	42	45	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152494	10.1371/journal.pone.0152494	http://dx.doi.org/10.1371/journal.pone.0152494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049763	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500044
J	Rademaker, M; Meijaard, E; Semiadi, G; Blokland, S; Neilson, EW; Rode-Margono, EJ				Rademaker, Mark; Meijaard, Erik; Semiadi, Gono; Blokland, Simen; Neilson, Eric W.; Rode-Margono, Eva Johanna			First Ecological Study of the Bawean Warty Pig (Sus blouchi), One of the Rarest Pigs on Earth	PLOS ONE			English	Article							SOUTH-EAST; HABITAT USE; ANIMAL DENSITY; CAMERA TRAPS; WILD; ABUNDANCE; SCROFA; FOREST; POPULATIONS; VERRUCOSUS	The Bawean warty pig (Sus blouchi) is an endemic pig species confined to the 192 km(2) large island of Bawean in the Java Sea, Indonesia. Due to a lack of quantitative ecological research, understanding of natural history and conservation requirements have so far been based solely on anecdotal information from interviews with local people and study of captive and museum specimens. In this study we provide the first assessment of population and habitat preferences for S. blouchi by using camera trapping. From the 4th of November 2014 to January 8th 2015, we placed camera traps at 100 locations in the forested protected areas on Bawean. In 690.31 camera days (16567.45 hours) we captured 92 independent videos showing S. blouchi. Variation in S. blouchi trapping rates with cumulative trap effort stabilized after 500 camera days. An important outcome is that, in contrast to the suggestion of previous assessments, only S. blouchi was detected and no S. scrofa was found, which excludes hybridization threats. We fitted a Random Encounter Model, which does not require the identification of individual animals, to our camera-trapping data and estimated 172-377 individuals to be present on the island. Activity patterns and habitat data indicate that S. blouchi is mainly nocturnal and prefers community forests and areas near forest borders. Next to this, we found a positive relationship between S. blouchi occupancy, distance to nearest border, litter depth and tree density in the highest ranking occupancy models. Although these relationships proved non-significant based on model averaging, their presence in the top ranking models suggests that these covariables do play a role in predicting S. blouchi occurrence on Bawean. The estimated amount of sites occupied reached 58%. Based on our results, especially the estimation of the population size and area of occupancy, we determine that the species is Endangered according to the IUCN/SSC Red List criteria.	[Rademaker, Mark; Blokland, Simen] VHL Univ Appl Sci, Dept Anim Management, Leeuwarden, Netherlands; [Rademaker, Mark; Blokland, Simen] Bawean Endem Conservat Initiat, Jakarta, Indonesia; [Rademaker, Mark; Meijaard, Erik; Semiadi, Gono; Rode-Margono, Eva Johanna] IUCN SSC Wild Pig Specialist Grp, Jakarta, Indonesia; [Meijaard, Erik] Univ Queensland, ARC Ctr Excellence Environm Decis CEED, Brisbane, Qld 4072, Australia; [Semiadi, Gono] Indonesian Inst Sci, Div Zool, Biol Res Ctr, Cibinong, Indonesia; [Neilson, Eric W.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Rode-Margono, Eva Johanna] Chester Zoo, North England Zool Soc, Chester, Cheshire, England	University of Queensland; Indonesian Institute of Sciences; University of Alberta	Rademaker, M (corresponding author), VHL Univ Appl Sci, Dept Anim Management, Leeuwarden, Netherlands.; Rademaker, M (corresponding author), Bawean Endem Conservat Initiat, Jakarta, Indonesia.; Rademaker, M (corresponding author), IUCN SSC Wild Pig Specialist Grp, Jakarta, Indonesia.	markrademaker02@gmail.com	Semiadi, Gono/G-4330-2018; Semiadi, Gono/D-3404-2015; Meijaard, Erik/A-2687-2016	Semiadi, Gono/0000-0002-9351-9746; Semiadi, Gono/0000-0002-9351-9746; Meijaard, Erik/0000-0001-8685-3685; Rademaker, Mark/0000-0001-9210-1164	Peoples Trust for Endangered Species; Die Zoologische Gesellsaft fur Arten-und Populationschutz; Los Angeles Zoo and Botanical Gardens; Stiftung Artenschutz	Peoples Trust for Endangered Species; Die Zoologische Gesellsaft fur Arten-und Populationschutz; Los Angeles Zoo and Botanical Gardens; Stiftung Artenschutz	This work was funded with the generous contribution of the Peoples Trust for Endangered Species (http://www.ptes.org/), Die Zoologische Gesellsaft fur Arten-und Populationschutz (http://www.zgap.de), the Los Angeles Zoo and Botanical Gardens (http://www.lazoo.org) and Stiftung Artenschutz (http://www.stiftung-artenschutz.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengsen AJ, 2011, J WILDLIFE MANAGE, V75, P1222, DOI 10.1002/jwmg.132; Blouch R.A., 1978, P49; BLOUCH RA, 1988, BIOL CONSERV, V43, P295, DOI 10.1016/0006-3207(88)90122-X; Blouch RA., 1983, JAVAN WARTY PIG DIST; Bowkett AE, 2008, AFR J ECOL, V46, P479, DOI 10.1111/j.1365-2028.2007.00881.x; Bracke MBM, 2011, APPL ANIM BEHAV SCI, V132, P1, DOI 10.1016/j.applanim.2011.01.002; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caley P, 1997, WILDLIFE RES, V24, P77, DOI 10.1071/WR94075; Cucchi T, 2009, INT J OSTEOARCHAEOL, V19, P508, DOI 10.1002/oa.974; D'Huart Jean-Pierre, 1993, P84; de Bruyn M, 2014, SYST BIOL, V63, P879, DOI 10.1093/sysbio/syu047; De Indische Courant. Bawean, 1935, INDISCHE COUR 4 1029; ESRI, 2013, CREAT FISHN DAT MAN; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Frantz L, 2015, ANN REV ANIM BIOSC, V4; Genov Peter V., 1996, P214; GRAVES HB, 1984, J ANIM SCI, V58, P482, DOI 10.2527/jas1984.582482x; Groves C, 2011, UNGULATE TAXONOMY; Groves C.P., 1981, ANCESTORS PIGS TAXON; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hamada JI, 2002, J METEOROL SOC JPN, V80, P285, DOI 10.2151/jmsj.80.285; Hancock PA, 2005, ECOL MODEL, V181, P123, DOI 10.1016/j.ecolmodel.2004.06.026; Hernowo J.B., 2008, MED KONSERV, V13, P90; Hill D., 2005, HDB BIODIVERSITY MET, DOI DOI 10.1017/CBO9780511542084; Horning B, 1999, ARTGEMASSE SCHWEINEH; Ickes K, 2001, BIOTROPICA, V33, P682, DOI 10.1111/j.1744-7429.2001.tb00225.x; IUCN, 2013, IUCN REDL THREAT SPE; Kays R, 2009, C LOCAL COMPUT NETW, P811, DOI 10.1109/LCN.2009.5355046; KU HH, 1966, J RES NBS C ENG INST, VC 70, P263, DOI 10.6028/jres.070C.025; Lucchini V, 2005, J ZOOL, V266, P25, DOI 10.1017/S0952836905006588; MacDonald Alastair A., 1993, P155; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacKinnon J., 1997, PROTECTED AREAS SYST; Massei G, 1997, J ZOOL, V242, P394; Mazerolle MJ., 2004, THESIS U LAVAL; MCGLONE JJ, 1999, S OUTD PIG PROD BRAZ; Meijaard E, 2003, J BIOGEOGR, V30, P1245, DOI 10.1046/j.1365-2699.2003.00890.x; Meijaard E., 2011, HDB MAMMALS WORLD HO, V2, P248; Meijaard Erik, 2014, Suiform Soundings, V12, P4; Meijaard Erik, 2014, Suiform Soundings, V12, P18; Meijaard Erik, 2006, Suiform Soundings, V6, P22; National Research Council Canada, ADV OPT SUN ANGL; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nijman V, 2006, BIRD CONSERV INT, V16, P131, DOI 10.1017/S0959270906000219; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; O'Brien Timothy G., 1996, Oryx, V30, P150, DOI 10.1017/S0030605300021530; Oliver WL., 1993, PIGS PECCARIES HIPPO; Passon C, 2012, 9 INT S WILD BOAR OT; Pauwels W, 1980, THESIS U BASEL SWITZ; Pfeffer P., 1959, Mammalia Paris, V23, P277, DOI 10.1515/mamm.1959.23.3.277; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Rovero F, 2013, J MAMMAL, V94, P792, DOI 10.1644/12-MAMM-A-235.1; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rowcliffe JM, 2014, METHODS ECOL EVOL, V5, P1170, DOI 10.1111/2041-210X.12278; Rowcliffe JM, 2013, J WILDLIFE MANAGE, V77, P876, DOI 10.1002/jwmg.533; Rowcliffe JM, 2011, METHODS ECOL EVOL, V2, P464, DOI 10.1111/j.2041-210X.2011.00094.x; Semiadi G, 2006, ORYX, V40, P50, DOI 10.1017/S003060530600007X; Semiadi G., 2013, STATUS BABI KUTIL SU; Semiadi G, 2008, IUCN 2013 IUCN RED L; Semiadi G, 2004, SURVEY JAVAN WARTY P; Semiadi Gono, 2009, Biodiversitas, V10, P124; SEYDACK AHW, 1992, OECOLOGIA, V90, P102, DOI 10.1007/BF00317815; Smit Sibbinga GL, 1947, TYDSCHRIFT KONINKLYK, V2, P572; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Thomas L., 2009, DISTANCE 6 0 RELEASE; Veth PJ, 1903, JAVA GEOGRAFISCH ETH; Yong D.L., 2010, Nature in Singapore, V3, P227	69	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151732	10.1371/journal.pone.0151732	http://dx.doi.org/10.1371/journal.pone.0151732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049756	gold, Green Published			2022-12-26	WOS:000373603500010
J	Van der Borght, L; Schevernels, H; Burle, B; Notebaert, W				Van der Borght, Liesbet; Schevernels, Hanne; Burle, Boris; Notebaert, Wim			Errors Disrupt Subsequent Early Attentional Processes	PLOS ONE			English	Article							CORTEX; TASK; ADJUSTMENTS; COMPONENTS; AWARENESS; RESPONSES; BLINK; WAVE	It has been demonstrated that target detection is impaired following an error in an unrelated flanker task. These findings support the idea that the occurrence or processing of unexpected error-like events interfere with subsequent information processing. In the present study, we investigated the effect of errors on early visual ERP components. We therefore combined a flanker task and a visual discrimination task. Additionally, the intertrial interval between both tasks was manipulated in order to investigate the duration of these negative after-effects. The results of the visual discrimination task indicated that the amplitude of the N1 component, which is related to endogenous attention, was significantly decreased following an error, irrespective of the intertrial interval. Additionally, P3 amplitude was attenuated after an erroneous trial, but only in the long-interval condition. These results indicate that low-level attentional processes are impaired after errors.	[Van der Borght, Liesbet; Schevernels, Hanne; Notebaert, Wim] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Burle, Boris] Aix Marseille Univ, CNRS, Lab Neurosci Cognit, UMR7291, Marseille, France	Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Notebaert, W (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	wim.notebaert@ugent.be		BURLE, Boris/0000-0001-8179-9034	FWO-Vlaanderen (FWO) [3G076911]; Ghent University Multidisciplinary Research Platform; European Research Council under the European Community's Seventh Framework Program (FP) [241077]	FWO-Vlaanderen (FWO)(FWO); Ghent University Multidisciplinary Research Platform; European Research Council under the European Community's Seventh Framework Program (FP)	The work of LVDB and WN is supported by FWO-Vlaanderen (FWO grant 3G076911, http://www.fwo.be/). The work of HS is supported by the Ghent University Multidisciplinary Research Platform "The integrative neuroscience of behavioral control" (http://www.ugent.be/neuroscience/en/about). The work of BB is supported by a European Research Council under the European Community's Seventh Framework Program (FP/2007-2013 Grant Agreement no. 241077, https://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain S, 2004, NEUROSCI LETT, V372, P161, DOI 10.1016/j.neulet.2004.09.036; Babiloni F, 2001, CLIN NEUROPHYSIOL, V112, P724, DOI 10.1016/S1388-2457(01)00494-1; Bombeke K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Burle B, 2015, INT J PSYCHOPHYSIOL, V97, P210, DOI 10.1016/j.ijpsycho.2015.05.004; Carp J, 2009, PSYCHOPHYSIOLOGY, V46, P336, DOI 10.1111/j.1469-8986.2008.00773.x; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; Danielmeier C, 2011, J NEUROSCI, V31, P1780, DOI 10.1523/JNEUROSCI.4299-10.2011; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Houtman F, 2013, COGNITION, V128, P228, DOI 10.1016/j.cognition.2013.04.003; Houtman F, 2012, J COGN PSYCHOL, V24, P278, DOI 10.1080/20445911.2011.617301; Jentzsch I, 2009, Q J EXP PSYCHOL, V62, P209, DOI 10.1080/17470210802240655; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Maier ME, 2011, NEUROIMAGE, V56, P2339, DOI 10.1016/j.neuroimage.2011.03.083; Most SB, 2011, PSYCHOL SCI, V22, P300, DOI 10.1177/0956797610397665; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; RABBITT P, 1979, BRIT J PSYCHOL, V70, P305, DOI 10.1111/j.2044-8295.1979.tb01687.x; Ries S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058197; Segalowitz SJ, 2010, PSYCHOPHYSIOLOGY, V47, P260, DOI 10.1111/j.1469-8986.2009.00942.x; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Shalgi S, 2009, EUR J NEUROSCI, V29, P1522, DOI 10.1111/j.1460-9568.2009.06690.x; Steinborn MB, 2012, Q J EXP PSYCHOL, V65, P624, DOI 10.1080/17470218.2012.660962; Stevens M, 2006, BEHAV RES METHODS, V38, P280, DOI 10.3758/BF03192779; Van der Borght L, 2016, BIOL PSYCHOL, V115, P78, DOI 10.1016/j.biopsycho.2016.01.013; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Wang L, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00187, 10.3389/fpsyg.2012.00438]; Wessel JR, 2011, J COGNITIVE NEUROSCI, V23, P3021, DOI 10.1162/jocn.2011.21635	34	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151843	10.1371/journal.pone.0151843	http://dx.doi.org/10.1371/journal.pone.0151843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27050303	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500015
J	Wallace, ZP; Kennedy, PL; Squires, JR; Oakleaf, RJ; Olson, LE; Dugger, KM				Wallace, Zachary P.; Kennedy, Patricia L.; Squires, John R.; Oakleaf, Robert J.; Olson, Lucretia E.; Dugger, Katie M.			Re-Occupancy of Breeding Territories by Ferruginous Hawks in Wyoming: Relationships to Environmental and Anthropogenic Factors	PLOS ONE			English	Article							ENERGY DEVELOPMENT; SPOTTED OWLS; HABITAT USE; POPULATIONS; SELECTION; RAPTORS; CONSERVATION; DISTURBANCE; DYNAMICS; AVIFAUNA	Grassland and shrubland birds are declining globally due in part to anthropogenic habitat modification. Because population performance of these species is also influenced by non-anthropogenic factors, it is important to incorporate all relevant ecological drivers into demographic models. We used design-based sampling and occupancy models to test relationships of environmental factors that influence raptor demographics with re-occupancy of breeding territories by ferruginous hawks (Buteo regalis) across Wyoming, USA, 2011-2013. We also tested correlations of territory re-occupancy with oil and gas infrastructure-a leading cause of habitat modification throughout the range of this species of conservation concern. Probability of re-occupancy was not related to any covariates we investigated in 2011, had a strong negative relationship with cover of sagebrush (Artemisia spp.) in 2012, was slightly higher for territories with artificial platforms than other nest substrates in 2013, and had a positive relationship with abundance of ground squirrels (Urocitellus spp.) that was strong in 2012 and weak in 2013. Associations with roads were weak and varied by year, road-type, and scale: in 2012, re-occupancy probability had a weak positive correlation with density of roads not associated with oil and gas fields at the territory-scale; however, in 2013 re-occupancy had a very weak negative correlation with density of oil and gas field roads near nest sites (<= 500 m). Although our results indicate re-occupancy of breeding territories by ferruginous hawks was compatible with densities of anthropogenic infrastructure in our study area, the lack of relationships between oil and gas well density and territory re-occupancy may have occurred because pre-treatment data were unavailable. We used probabilistic sampling at a broad spatial extent, methods to account for imperfect detection, and conducted extensive prey sampling; nonetheless, future research using before-after-control-impact designs is needed to fully assess impacts of oil and gas development on ferruginous hawks.	[Wallace, Zachary P.; Kennedy, Patricia L.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Wallace, Zachary P.; Kennedy, Patricia L.] Oregon State Univ, Eastern Oregon Agr & Nat Resource Program, Union, OR USA; [Squires, John R.; Olson, Lucretia E.] US Forest Serv, USDA, Rocky Mt Res Stn, Missoula, MT USA; [Oakleaf, Robert J.] Wyoming Game & Fish Dept, Lander, WY USA; [Dugger, Katie M.] Oregon State Univ, Dept Fisheries & Wildlife, US Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Wallace, Zachary P.] Eagle Environm Inc, Taos, NM USA	Oregon State University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; Oregon State University; United States Department of the Interior; United States Geological Survey	Wallace, ZP (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.; Wallace, ZP (corresponding author), Oregon State Univ, Eastern Oregon Agr & Nat Resource Program, Union, OR USA.; Wallace, ZP (corresponding author), Eagle Environm Inc, Taos, NM USA.	zach@eagleenvironmental.net		Olson, Lucretia/0000-0002-5703-3351	U.S. Forest Service Rocky Mountain Research Station; Wyoming Game and Fish Department; Bureau of Land Management; Wyoming Wildlife Heritage Foundation; Wyoming Governor's Office; PacifiCorp; Pathfinder Renewable Wind Energy; Oregon State University Department of Fisheries and Wildlife; Eastern Oregon Agriculture & Natural Resource Program	U.S. Forest Service Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); Wyoming Game and Fish Department; Bureau of Land Management; Wyoming Wildlife Heritage Foundation; Wyoming Governor's Office; PacifiCorp; Pathfinder Renewable Wind Energy; Oregon State University Department of Fisheries and Wildlife; Eastern Oregon Agriculture & Natural Resource Program	The U.S. Forest Service Rocky Mountain Research Station, Wyoming Game and Fish Department, and Bureau of Land Management provided funding and assisted with study design and data collection. Additional funding was provided by the Wyoming Wildlife Heritage Foundation, Wyoming Governor's Office, PacifiCorp, and Pathfinder Renewable Wind Energy, none of whom were involved in research design, collection and analysis of data, decision to publish, or preparation of the manuscript.; We thank the U.S. Forest Service Rocky Mountain Research Station, Wyoming Game and Fish Department, Oregon State University Department of Fisheries and Wildlife, and Eastern Oregon Agriculture & Natural Resource Program for providing field and administrative support. We thank Ricardo Mata-Gonzalez for advice on study design; pilots Bobby Laird, Dave Stinson, Neil Cadwell, and Ken Overfield; field technicians Justin Broderick, Raymond Buchheit, Justin Caraway, Joseph Ceradini, David Chrismon, Nick Dobric, Andrew Greenawalt, Tia Hunter, Allyson Larned, Rod Lawrence, Jon Lipke, Peter Mahoney, Ryan Mong, Brennan Price, Mary Raikes, Sam Sellers, Edward Whitehead, Matthew Wilson, and Robert Wiltzen; and all private land owners who granted access for field work. Review by David Weins and two anonymous referees greatly improved the manuscript. The use of trade names or products does not constitute endorsement by the U.S. Government.	Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Ayers LW, 1999, J WILDLIFE MANAGE, V63, P85, DOI 10.2307/3802489; Bechard M. J., 1995, BIRDS N AM; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Booms TL, 2010, J RAPTOR RES, V44, P175, DOI 10.3356/JRR-09-70.1; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Coates PS, 2014, CONDOR, V116, P341, DOI 10.1650/CONDOR-13-126.1; Collier BA, 2012, DIVERS DISTRIB, V18, P158, DOI 10.1111/j.1472-4642.2011.00831.x; Committee on the Status of Endangered Wildlife in Canada (COSEWIC), 2008, COSEWIC ASS UPD STAT; Copeland Holly E., 2011, P7; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Dreitz VJ, 2012, AVIAN CONSERV ECOL, V7, DOI 10.5751/ACE-00519-070106; Dugger KM, 2011, ECOL APPL, V21, P2459, DOI 10.1890/10-2142.1; ESRI, 2011, ARCGIS DESKT REL 10; FGDC Cadastral Subcommittee PLSS Work Group, 2011, STAND PLSS DAT SET C; Gilbert MM, 2011, J WILDLIFE MANAGE, V75, P816, DOI 10.1002/jwmg.123; GILMER DS, 1983, J WILDLIFE MANAGE, V47, P146, DOI 10.2307/3808061; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Harmata AR, 2001, J FIELD ORNITHOL, V72, P389, DOI 10.1648/0273-8570-72.3.389; Harmata AR, 1991, IMPACTS OIL GAS DEV; Hennenlan C, 2007, J WILDLIFE MANAGE, V71, P526, DOI 10.2193/2006-013; Hethcoat MG, 2015, BIOL CONSERV, V184, P327, DOI 10.1016/j.biocon.2015.02.009; Homer CG, 2012, INT J APPL EARTH OBS, V14, P233, DOI 10.1016/j.jag.2011.09.012; JANES SW, 1994, CONDOR, V96, P52, DOI 10.2307/1369063; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Keeley WH, 2011, J WILDLIFE MANAGE, V75, P1034, DOI 10.1002/jwmg.140; Keinath D. A., 2010, RANGE MODELED DISTRI; KENNEDY P L, 1980, Wildlife Society Bulletin, V8, P129; Kennedy PL, 2014, CONDOR, V116, P435, DOI 10.1650/CONDOR-12-174.1; KEOUGH H.L., 2006, THESIS UTAH STATE U; Keough HL, 2012, J RAPTOR RES, V46, P378, DOI 10.3356/JRR-12-07.1; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Knight D.H., 2014, MOUNTAINS PLAINS ECO; Kotliar NB, 2007, ECOL APPL, V17, P491, DOI 10.1890/06-0253; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Lohmus A, 2003, ECOGRAPHY, V26, P545, DOI 10.1034/j.1600-0587.1999.03575.x; LOKEMOEN JT, 1976, CONDOR, V78, P464, DOI 10.2307/1367095; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MACLAREN PA, 1988, GREAT BASIN NAT, V48, P548; Martinez-Abrain A, 2010, BASIC APPL ECOL, V11, P312, DOI 10.1016/j.baae.2009.12.011; MILLSAP B A, 1988, Journal of Raptor Research, V22, P8; Naugle DE, 2011, STUD AVIAN BIOL, P489; Neal M. C., 2010, ARTIFICIAL NEST STRU; Newton I, 2010, POPULATION ECOLOGY R; Newton I., 1998, POPULATION LIMITATIO; Noss R.F., 1995, ENDANGERED ECOSYSTEM; Oakleaf RJ, 2014, WYOMING GAME FISH DE; OLENDORFF R.R., 1993, STATUS BIOL MANAGEME; Olson GS, 2005, J WILDLIFE MANAGE, V69, P918, DOI 10.2193/0022-541X(2005)069[0918:MOSODF]2.0.CO;2; Ramsey F.L., 2002, STAT SLEUTH; RESTANI M, 1991, CONDOR, V93, P1007, DOI 10.2307/3247736; Richardson CT, 1997, WILDLIFE SOC B, V25, P634; Roth SD, 1998, T KANSAS ACAD SCI, V92, P132; SCHMUTZ JK, 1987, J RANGE MANAGE, V40, P438, DOI 10.2307/3899606; SCHMUTZ JK, 1984, J WILDLIFE MANAGE, V48, P1009, DOI 10.2307/3801458; SCHMUTZ JK, 1989, CAN J ZOOL, V67, P2596, DOI 10.1139/z89-366; SCHMUTZ JK, 1989, CONDOR, V91, P362, DOI 10.2307/1368315; Schmutz JK, 2008, J WILDLIFE MANAGE, V72, P1352, DOI 10.2193/2007-231; SCHUECK LS, 1995, J WILDLIFE MANAGE, V59, P674, DOI 10.2307/3801943; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; SMITH DG, 1981, CONDOR, V83, P52, DOI 10.2307/1367602; Smith J. P., 2010, ASSESSMENT EFFECTS O; STEENHOF K, 1985, OECOLOGIA, V66, P6, DOI 10.1007/BF00378546; Steenhof Karen, 2007, P181; Stewart BP, 2013, J WILDLIFE MANAGE, V77, P957, DOI 10.1002/jwmg.535; Tigner James R., 1996, P137, DOI 10.1016/B978-012100130-8/50017-1; U.S. Fish and Wildlife Service, 1992, FED REGISTER, V57, P37507; U.S. Geological Survey, 2010, LANDFIRE LANDFIRE 1; VAN HORN R. C., 1993, THESIS MONTANA STATE; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; WAKELEY JS, 1978, CONDOR, V80, P316, DOI 10.2307/1368042; Wallace ZP, 2016, J WILDLIFE MANAGE, V80, P78, DOI 10.1002/jwmg.1000; WHITE CM, 1985, CONDOR, V87, P14, DOI 10.2307/1367125; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zelenak JR, 1997, CAN J ZOOL, V75, P1035, DOI 10.1139/z97-124	81	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152977	10.1371/journal.pone.0152977	http://dx.doi.org/10.1371/journal.pone.0152977			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049324	Green Published, gold			2022-12-26	WOS:000373603500075
J	Kaido, M; Toda, I; Oobayashi, T; Kawashima, M; Katada, Y; Tsubota, K				Kaido, Minako; Toda, Ikuko; Oobayashi, Tomoo; Kawashima, Motoko; Katada, Yusaku; Tsubota, Kazuo			Reducing Short-Wavelength Blue Light in Dry Eye Patients with Unstable Tear Film Improves Performance on Tests of Visual Acuity	PLOS ONE			English	Article							BREAK-UP TIME; SYSTEM	Purpose To investigate whether suppression of blue light can improve visual function in patients with short tear break up time (BUT) dry eye (DE). Methods Twenty-two patients with short BUT DE (10 men, 12 women; mean age, 32.4 +/- 6.4 years; age range, 23-43 years) and 18 healthy controls (10 men, 8 women; mean age, 30.1 +/- 7.4 years; age range, 20-49 years) underwent functional visual acuity (VA) examinations with and without wearing eyeglasses with 50% blue light blocked lenses. The functional VA parameters were starting VA, functional VA, and visual maintenance ratio. Results The baseline mean values (logarithm of the minimum angle of resolution, logMAR) of functional VA and the visual maintenance ratio were significantly worse in the DE patients than in the controls (P < 0.05), while no significant difference was observed in the baseline starting VA (P > 0.05). The DE patients had significant improvement in mean functional VA and visual maintenance ratio while wearing the glasses (P < 0.05), while there were no significant changes with and without the glasses in the control group (P > 0.05), Conclusions Protecting the eyes from short-wavelength blue light may help to ameliorate visual impairment associated with tear instability in patients with DE. This finding represents a new concept, which is that the blue light exposure might be harmful to visual function in patients with short BUT DE.	[Kaido, Minako; Kawashima, Motoko; Katada, Yusaku; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Shinanomachi, Tokyo, Japan; [Kaido, Minako] Wada Eye Clin, Tateyama, Chiba, Japan; [Toda, Ikuko; Oobayashi, Tomoo] Minamiaoyama Eye Clin, Minato Ku, Tokyo, Japan	Keio University	Kaido, M (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Shinanomachi, Tokyo, Japan.; Kaido, M (corresponding author), Wada Eye Clin, Tateyama, Chiba, Japan.	fwiw1193@mb.infoweb.ne.jp			Medical School Faculty and Alumni Grants of Keio University Medical School, Tokyo, Japan; Kowa Co., Ltd. Japan; JINS Co., Ltd, Tokyo; Department of Ophthalmology of Keio University School of Medicine	Medical School Faculty and Alumni Grants of Keio University Medical School, Tokyo, Japan; Kowa Co., Ltd. Japan; JINS Co., Ltd, Tokyo; Department of Ophthalmology of Keio University School of Medicine	This study was supported by a grant from the Medical School Faculty and Alumni Grants of Keio University Medical School, Tokyo, Japan. Keio University School of Medicine also provided support in the form of salaries for authors M. Kawashima, YK, and KT. Wada Eye Clinic provided support in the form of salaries for author M. Kaito. Minamiaoyama Eye Clinic provided support in the form of salaries for authors IT and TO. Kowa Co., Ltd. Japan and JINS Co., Ltd, Tokyo, Japan provided a monetary grant for research unrelated to the current study to the Department of Ophthalmology of Keio University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaras A, 1997, ERGONOMICS, V40, P1255, DOI 10.1080/001401397187496; Abib AH, 1998, OCCUP ERGON, V1, P285; Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; [Anonymous], 2002, S009E CIE; [Anonymous], 2005, 62471 IEC; Brainard GC, 2008, J BIOL RHYTHM, V23, P379, DOI 10.1177/0748730408323089; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Holzman DC, 2010, ENVIRON HEALTH PERSP, V118, pA22, DOI 10.1289/ehp.118-a22; Kaido M, 2007, CORNEA, V26, pS29, DOI 10.1097/ICO.0b013e31812f6913; Kaido M, 2015, BRIT J OPHTHALMOL, V99, P1488, DOI 10.1136/bjophthalmol-2015-306640; Kaido M, 2014, INVEST OPHTH VIS SCI, V55, P3275, DOI 10.1167/iovs.13-13000; Kaido M, 2013, J OCUL PHARMACOL TH, V29, P595, DOI 10.1089/jop.2012.0246; Kaido M, 2006, AM J OPHTHALMOL, V142, P917, DOI 10.1016/j.ajo.2006.07.055; Kitchel E, 2000, J VISUAL IMPAIR BLIN, V94, P399, DOI 10.1177/0145482X0009400606; Kobashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082427; Koh S, 2008, INVEST OPHTH VIS SCI, V49, P133, DOI 10.1167/iovs.07-0762; LERMAN S, 1988, NEW ENGL J MED, V319, P1475, DOI 10.1056/NEJM198812013192208; LIU IY, 1989, AM J PUBLIC HEALTH, V79, P765, DOI 10.2105/AJPH.79.6.765; Montes-Mico R, 2005, INVEST OPHTH VIS SCI, V46, P1615, DOI 10.1167/iovs.05-0017; Shimazaki S., 2006, J EYE, V24, P181; Taylor H R, 1990, Trans Am Ophthalmol Soc, V88, P163; Thorud HMS, 2012, OPTOMETRY VISION SCI, V89, pE452, DOI 10.1097/OPX.0b013e31824c1801; TODA I, 1995, OPHTHALMOLOGY, V102, P302; TODA I, 1993, ACTA OPHTHALMOL, V71, P347, DOI 10.1111/j.1755-3768.1993.tb07146.x; VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; Yokoi N, 2015, AM J OPHTHALMOL, V159, P748, DOI 10.1016/j.ajo.2014.12.019	27	30	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152936	10.1371/journal.pone.0152936	http://dx.doi.org/10.1371/journal.pone.0152936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27045760	Green Submitted, Green Published, gold			2022-12-26	WOS:000373599600048
J	Zeng, QC; Dong, YH; An, SS				Zeng, Quanchao; Dong, Yanghong; An, Shaoshan			Bacterial Community Responses to Soils along a Latitudinal and Vegetation Gradient on the Loess Plateau, China	PLOS ONE			English	Article							MICROBIAL COMMUNITY; ORGANIC-CARBON; DIVERSITY; FOREST; CONVERSION; NITROGEN; BOREAL; LITTER; ALTERS	Soil bacterial communities play an important role in nutrient recycling and storage in terrestrial ecosystems. Loess soils are one of the most important soil resources for maintaining the stability of vegetation ecosystems and are mainly distributed in northwest China. Estimating the distributions and affecting factors of soil bacterial communities associated with various types of vegetation will inform our understanding of the effect of vegetation restoration and climate change on these processes. In this study, we collected soil samples from 15 sites from north to south on the Loess Plateau of China that represent different ecosystem types and analyzed the distributions of soil bacterial communities by high-throughput 454 pyrosequencing. The results showed that the 142444 sequences were grouped into 36816 operational taxonomic units (OTUs) based on 97% similarity. The results of the analysis showed that the dominant taxonomic phyla observed in all samples were Actinobacteria, Proteobacteria, Chloroflexi, Acidobacteria and Planctomycetes. Actinobacteria and Proteobacteria were the two most abundant groups in all samples. The relative abundance of Actinobacteria increased from 14.73% to 40.22% as the ecosystem changed from forest to sandy, while the relative abundance of Proteobacteria decreased from 35.35% to 21.40%. Actinobacteria and Proteobacteria had significant correlations with mean annual precipitation (MAP), pH, and soil moisture and nutrients. MAP was significantly correlated with soil chemical and physical properties. The relative abundance of Actinobacteria, Proteobacteria and Planctomycetes correlated significantly with MAP, suggesting that MAP was a key factor that affected the soil bacterial community composition. However, along with the MAP gradient, Chloroflexi, Bacteroidetes and Cyanobacteria had narrow ranges that did not significantly vary with the soil and environmental factors. Overall, we conclude that the edaphic properties and/or vegetation types are driving bacterial community composition. MAP was a key factor that affects the composition of the soil bacteria on the Loess Plateau of China.	[Zeng, Quanchao; Dong, Yanghong; An, Shaoshan] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China; [An, Shaoshan] Northwest A&F Univ, State Key Lab Soil Eros & Dry Land Farming Loess, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	An, SS (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.; An, SS (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dry Land Farming Loess, Yangling, Shaanxi, Peoples R China.	shan@ms.iswc.ac.cn		quanchao, zeng/0000-0003-1272-0227	National Natural Sciences Foundation of China [41171226, 41101254]; Program for New Century Excellent Talents in University [NCET-12-0479]; Demonstration of Key Technologies for Soil and Water Conservation and Restoring and Ecorestructing for Damaged Regional Ecosystem of the Shanxi-Shaanxi-Inner Mongolia energy source base [KZCX2-XB3-13]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Demonstration of Key Technologies for Soil and Water Conservation and Restoring and Ecorestructing for Damaged Regional Ecosystem of the Shanxi-Shaanxi-Inner Mongolia energy source base	This study was supported by the National Natural Sciences Foundation of China (41171226, 41101254), the Program for New Century Excellent Talents in University (NCET-12-0479) and the Demonstration of Key Technologies for Soil and Water Conservation and Restoring and Ecorestructing for Damaged Regional Ecosystem of the Shanxi-Shaanxi-Inner Mongolia energy source base (KZCX2-XB3-13). All the funding were Shaoshan An's and he conceived and designed the experiments.; This study was supported by the National Natural Sciences Foundation of China (41171226, 41101254), the Program for New Century Excellent Talents in University (NCET-12-0479) and the Demonstration of Key Technologies for Soil and Water Conservation and Restoring and Eco-restructing for Damaged Regional Ecosystem of the Shanxi-Shaanxi-Inner Mongolia energy source base (KZCX2-XB3-13).	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Aneja MK, 2004, J MICROBIOL METH, V59, P223, DOI 10.1016/j.mimet.2004.07.005; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; Chan OC, 2008, FEMS MICROBIOL ECOL, V64, P449, DOI 10.1111/j.1574-6941.2008.00488.x; Chan OC, 2006, FEMS MICROBIOL ECOL, V58, P247, DOI 10.1111/j.1574-6941.2006.00156.x; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Cleveland CC, 2002, ECOSYSTEMS, V5, P680, DOI 10.1007/s10021-002-0202-9; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; DeForest JL, 2012, BIOGEOCHEMISTRY, V109, P189, DOI 10.1007/s10533-011-9619-6; Deng L, 2014, GLOBAL CHANGE BIOL, V20, P3544, DOI 10.1111/gcb.12508; Ehlers K, 2010, SOIL BIOL BIOCHEM, V42, P558, DOI 10.1016/j.soilbio.2009.11.025; Evans SE, 2014, ECOL LETT, V17, P155, DOI 10.1111/ele.12206; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; FIERER N, 2008, ACCESSING UNCULTIVAT, P95; Fuchslueger L, 2014, NEW PHYTOL, V201, P916, DOI 10.1111/nph.12569; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Hart SC, 2005, FOREST ECOL MANAG, V220, P166, DOI 10.1016/j.foreco.2005.08.012; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Higgins KL, 2007, MOL PHYLOGENET EVOL, V42, P543, DOI 10.1016/j.ympev.2006.07.012; Hillebrand H, 2001, ECOGRAPHY, V24, P251, DOI 10.1034/j.1600-0587.2001.240302.x; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; KALEMBASA SJ, 1973, J SCI FOOD AGR, V24, P1085, DOI 10.1002/jsfa.2740240910; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Levin S., 1995, PROBLEM PATTERN SCAL; Liu JJ, 2014, SOIL BIOL BIOCHEM, V70, P113, DOI 10.1016/j.soilbio.2013.12.014; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Long T, 2009, MICROB ECOL, V58, P262, DOI 10.1007/s00248-009-9510-3; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Nielsen UN, 2010, J BIOGEOGR, V37, P1317, DOI 10.1111/j.1365-2699.2010.02281.x; OConnell D, 1975, TECHNICAL B MINISTRY; Pankratov TA, 2011, ENVIRON MICROBIOL, V13, P1800, DOI 10.1111/j.1462-2920.2011.02491.x; Papatheodorou EM, 2004, PEDOBIOLOGIA, V48, P329, DOI 10.1016/j.pedobi.2004.04.002; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Russo SE, 2012, SOIL BIOL BIOCHEM, V55, P48, DOI 10.1016/j.soilbio.2012.05.021; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sowerby A, 2005, SOIL BIOL BIOCHEM, V37, P1805, DOI 10.1016/j.soilbio.2005.02.023; Stegen JC, 2013, ISME J, V7, P2069, DOI 10.1038/ismej.2013.93; Terhonen E, 2011, SILVA FENN, V45, P301, DOI 10.14214/sf.104; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wang QK, 2014, SOIL BIOL BIOCHEM, V71, P13, DOI 10.1016/j.soilbio.2014.01.004; Wu XD, 2012, PERMAFROST PERIGLAC, V23, P162, DOI 10.1002/ppp.1740; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhang XF, 2013, J APPL MICROBIOL, V114, P1054, DOI 10.1111/jam.12106; Zhang XF, 2014, RES MICROBIOL, V165, P128, DOI 10.1016/j.resmic.2014.01.002; Zhang XY, 2007, PEDOSPHERE, V17, P19, DOI 10.1016/S1002-0160(07)60003-4	52	59	76	7	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152894	10.1371/journal.pone.0152894	http://dx.doi.org/10.1371/journal.pone.0152894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045518	gold, Green Submitted, Green Published			2022-12-26	WOS:000373599600045
J	Lai, CH; Lai, YJJ; Chou, FP; Chang, HHD; Tseng, CC; Johnson, MD; Wang, JK; Lin, CY				Lai, Chih-Hsin; Lai, Ying-Jung J.; Chou, Feng-Pai; Chang, Hsiang-Hua D.; Tseng, Chun-Che; Johnson, Michael D.; Wang, Jehng-Kang; Lin, Chen-Yong			Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPIDERMAL BARRIER FUNCTION; SERINE-PROTEASE; ZYMOGEN ACTIVATION; EPITHELIAL-CELLS; HUMAN TISSUES; INHIBITOR; EXPRESSION; LOCALIZATION; PURIFICATION	Significant proteolysis may occur during milk synthesis and secretion, as evidenced by the presence of protease-protease inhibitor complex containing the activated form of the type 2 transmembrane serine protease matriptase and the transmembrane Kunitz-type serine protease inhibitor HAI-1. In order to identify other proteolysis events that may occur during lactation, human milk was analyzed for species containing HAI-1 and HAI-2 which is closely related to HAI-1. In addition to the previously demonstrated matriptase-HAI-1 complex, HAI-1 was also detected in complex with prostasin, a glycosylphosphatidylinositol (GPI)-anchored serine protease. HAI-2 was also detected in complexes, the majority of which appear to be part of higher-order complexes, which do not bind to ionic exchange columns or immunoaffinity columns, suggesting that HAI-2 and its target proteases may be incorporated into special protein structures during lactation. The small proportion HAI-2 species that could be purified contain matriptase or prostasin. Human mammary epithelial cells are the likely cellular sources for these HAI-1 and HAI-2 complexes with matriptase and prostasin given that these protease-inhibitor complexes with the exception of prostasin-HAI-2 complex were detected in milk-derived mammary epithelial cells. The presence of these protease-inhibitor complexes in human milk provides in vivo evidence that the proteolytic activity of matriptase and prostasin are significantly elevated at least during lactation, and possibly contribute to the process of lactation, and that they are under tight control by HAI-1 and HAI-2.	[Lai, Chih-Hsin] Taipei City Hosp, Renai Branch, Dept Dent, Taipei, Taiwan; [Lai, Chih-Hsin; Wang, Jehng-Kang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lai, Ying-Jung J.; Chou, Feng-Pai; Chang, Hsiang-Hua D.; Tseng, Chun-Che; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA; [Chang, Hsiang-Hua D.; Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan	Taipei City Hospital; National Defense Medical Center; Georgetown University; National Defense Medical Center	Wang, JK (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Lin, CY (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA.; Wang, JK (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.	jkwang@ndmctsgh.edu.tw; lincy@georgetown.edu	Feng-Pai, Chou/AGS-4250-2022; Lin, Chen/GRR-2799-2022	Tseng, Chun-che/0000-0001-9637-4127; johnson, Michael/0000-0001-6260-7586	National Cancer Institute (NCI) Grant [RO1 CA 123223]; Ministry of Science and Technology, Taiwan [MOST 103-2320-B-016-022]; Department of Defense, Taiwan [103-M018, MAB-104-026]; Department of Health [10401-62-065]; Taipei City Government, Taiwan; Taipei City Hospital [TPCH-104-030]; NATIONAL CANCER INSTITUTE [R01CA123223, P30CA051008] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Grant; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Department of Defense, Taiwan(United States Department of Defense); Department of Health; Taipei City Government, Taiwan; Taipei City Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grant RO1 CA 123223 (to MDJ and CYL), Grant (MOST 103-2320-B-016-022) from the Ministry of Science and Technology, Taiwan, (to JKW), Grant (103-M018 and MAB-104-026) from the Department of Defense, Taiwan (to JKW), Grant (10401-62-065) from the Department of Health, Taipei City Government, Taiwan (to CHL), and grant (TPCH-104-030) from Taipei City Hospital (to CHL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; BARTEK J, 1991, P NATL ACAD SCI USA, V88, P3520, DOI 10.1073/pnas.88.9.3520; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Chang HHD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120489; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062826; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Holt C, 2013, J DAIRY SCI, V96, P6127, DOI 10.3168/jds.2013-6831; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kataoka H, 2000, CANCER LETT, V148, P127, DOI 10.1016/S0304-3835(99)00322-5; Lai YJJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132163; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tseng IC, 2008, AM J PHYSIOL-CELL PH, V295, pC423, DOI 10.1152/ajpcell.00164.2008; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009	28	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152904	10.1371/journal.pone.0152904	http://dx.doi.org/10.1371/journal.pone.0152904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043831	Green Submitted, gold, Green Published			2022-12-26	WOS:000373592100042
J	Tabe, S; Hikiji, H; Ariyoshi, W; Hashidate-Yoshida, T; Shindou, H; Okinaga, T; Shimizu, T; Tominaga, K; Nishihara, T				Tabe, Shirou; Hikiji, Hisako; Ariyoshi, Wataru; Hashidate-Yoshida, Tomomi; Shindou, Hideo; Okinaga, Toshinori; Shimizu, Takao; Tominaga, Kazuhiro; Nishihara, Tatsuji			Lysophosphatidylethanolamine acyltransferase 1/membrane-bound O-acyltransferase 1 regulates morphology and function of P19C6 cell-derived neurons	FASEB JOURNAL			English	Article						remodeling pathway; lysophospholipid; neuronal differentiation; phospholipid metabolism; oleoyl-CoA	LYSOPHOSPHOLIPID ACYLTRANSFERASES; MAMMALIAN-CELLS; MEMBRANE; DIFFERENTIATION; EXPRESSION; DIVERSITY; RECEPTOR; PROTEIN; PHOSPHOLIPIDS; METABOLISM	Glycerophospholipids, which are components of biomembranes, are formed de novo by the Kennedy pathway and subsequently mature through the Lands cycle. Lysophospholipid acyltransferases (LPLATs) are key enzymes in both pathways and influence the fatty acid composition of biomembranes. Neuronal differentiation is characterized by neurite outgrowth, which requires biomembrane biosynthesis. However, the role of LPLATs in neuronal differentiation remains unknown. In this study, we examined whether LPLATs are involved in neuronal differentiation using all-trans-retinoic acid (ATRA)-treated P19C6 cells. In these cells, mRNA levels of lysophosphatidylethanolamine acyltransferase (LPEAT)-1/membrane-bound O-acyltransferase (MBOAT)-1 were higher than those in undifferentiated cells. LPEAT enzymatic activity increased with 16: 0- and 18: 1-CoA as acyl donors. When LPEAT1/MBOAT1 was knocked down with small interfering RNA (siRNA), outgrowth of neurites and expression of neuronal markers decreased in ATRA-treated P19C6 cells. Voltage-dependent calcium channel activity was also suppressed in these cells transfected with LPEAT1/MBOAT1 siRNA. These results suggest that LPEAT1/MBOAT1 plays an important role in neurite outgrowth and function.	[Tabe, Shirou; Ariyoshi, Wataru; Okinaga, Toshinori; Nishihara, Tatsuji] Kyushu Dent Univ, Dept Hlth Promot, Div Infect & Mol Biol, Kitakyushu, Fukuoka, Japan; [Tabe, Shirou; Tominaga, Kazuhiro] Kyushu Dent Univ, Div Oral & Maxillofacial Surg, Dept Sci Phys Funct, Kitakyushu, Fukuoka, Japan; [Hikiji, Hisako] Kyushu Dent Univ, Dept Oral Funct Management, Kitakyushu, Fukuoka, Japan; [Hashidate-Yoshida, Tomomi; Shindou, Hideo; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Res Inst, Tokyo, Japan; [Shindou, Hideo] Agcy Med Res & Dev Core Res Evolutionary Sci & Te, Tokyo, Japan; [Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Tokyo, Japan	Kyushu Dental University; Kyushu Dental University; Kyushu Dental University; National Center for Global Health & Medicine - Japan; University of Tokyo	Hikiji, H (corresponding author), Kyushu Dent Univ, Dept Oral Funct Management, Sch Oral Hlth Sci, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka, Japan.	r09hikiji@fa.kyu-dent.ac.jp	Shimizu, Takao/AAV-7052-2021	Nishihara, Tatsuji/0000-0001-7075-9678	Japan Society for the Promotion of Science (JSPS) (KAKENHI) [23390467, 24659841, 24229003, 26460380, 26870879]; Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST); Shimadzu Corp.; Ono Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research [15K15746, 15K11083] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); Shimadzu Corp.; Ono Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI; 23390467) (to H.H.), 24659841 (to T.N.), 24229003 (to T.S.), 26460380 (to H.S.), and 26870879 (to T.H.Y.); and by the Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) (to H.S.). The Department of Biochemistry and Molecular Biology (Lipidomics), Faculty of Medicine (The University of Tokyo) is financially supported by Shimadzu Corp., and Ono Pharmaceutical Co., Ltd. The authors declare no conflicts of interest.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; CHEUN JE, 1991, INT J DEV NEUROSCI, V9, P391, DOI 10.1016/0736-5748(91)90061-P; Dauwerse JG, 2007, EUR J HUM GENET, V15, P743, DOI 10.1038/sj.ejhg.5201833; DINSMORE JH, 1991, CELL, V64, P817, DOI 10.1016/0092-8674(91)90510-6; Dustin P., 1984, MICROTUBULES; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; FERREIRA A, 1989, DEV BRAIN RES, V49, P215, DOI 10.1016/0165-3806(89)90023-0; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Hao N, 2013, NUCLEIC ACIDS RES, V41, P5626, DOI 10.1093/nar/gkt206; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Hishikawa D, 2013, FASEB J, V27, P5131, DOI 10.1096/fj.13-237941; Huang HS, 2012, J NEUROCHEM, V120, P667, DOI 10.1111/j.1471-4159.2011.07332.x; Iga M, 1997, BIOCHEM BIOPH RES CO, V231, P852, DOI 10.1006/bbrc.1997.6202; Imae R, 2012, J LIPID RES, V53, P335, DOI 10.1194/jlr.M018655; Ishibashi M, 2013, ARTERIOSCL THROM VAS, V33, P1171, DOI 10.1161/ATVBAHA.112.300812; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kolossov E, 1998, J CELL BIOL, V143, P2045, DOI 10.1083/jcb.143.7.2045; Kuge H, 2014, J BIOL CHEM, V289, P26783, DOI 10.1074/jbc.M114.571075; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lin PX, 1996, J NEUROCHEM, V66, P233; Nishina A, 2006, J LIPID RES, V47, P1434, DOI 10.1194/jlr.M600045-JLR200; Park KS, 2007, FEBS LETT, V581, P4411, DOI 10.1016/j.febslet.2007.08.014; Park SW, 2005, J NEUROSCI, V25, P3350, DOI 10.1523/JNEUROSCI.0186-05.2005; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Tang K, 2002, BIOCHEM BIOPH RES CO, V293, P167, DOI 10.1016/S0006-291X(02)00215-2; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Viviani B, 1996, BIOCHEM BIOPH RES CO, V223, P712, DOI 10.1006/bbrc.1996.0960; Voronova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019174; Xu J, 2008, J NEUROSCI, V28, P4521, DOI 10.1523/JNEUROSCI.5382-07.2008; Yamada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056997; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1	43	4	4	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2591	2601		10.1096/fj.201500097R	http://dx.doi.org/10.1096/fj.201500097R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27048541				2022-12-26	WOS:000379249500014
J	Yang, DH; de Graaf, C; Yang, LL; Song, GJ; Dai, AT; Cai, XQ; Feng, Y; Reedtz-Runge, S; Hanson, MA; Yang, HY; Jiang, HL; Stevens, RC; Wang, MW				Yang, Dehua; de Graaf, Chris; Yang, Linlin; Song, Gaojie; Dai, Antao; Cai, Xiaoqing; Feng, Yang; Reedtz-Runge, Steffen; Hanson, Michael A.; Yang, Huaiyu; Jiang, Hualiang; Stevens, Raymond C.; Wang, Ming-Wei			Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING-FACTOR; 2ND TRANSMEMBRANE HELIX; LIGAND-BINDING; AMINO-TERMINUS; SPATIAL APPROXIMATIONS; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; DRUG TARGETS; RESIDUES; ACTIVATION	The glucagon-like peptide-1 receptor (GLP-1R) belongs to the secretin-like (class B) family of G protein-coupled receptors. Members of the class B family are distinguished by their large extracellular domain, which works cooperatively with the canonical seven-transmembrane (7TM) helical domain to signal in response to binding of various peptide hormones. We have combined structure-based site-specific mutational studies with molecular dynamics simulations of a full-length model of GLP-1R bound to multiple peptide ligand variants. Despite the high sequence similarity between GLP-1R and its closest structural homologue, the glucagon receptor (GCGR), nearly half of the 62 stably expressed mutants affected GLP-1R in a different manner than the corresponding mutants in GCGR. The molecular dynamics simulations of wild-type and mutant GLP-1R center dot ligand complexes provided molecular insights into GLP-1R-specific recognition mechanisms for the N terminus of GLP-1 by residues in the 7TM pocket and explained how glucagon-mimicking GLP-1 mutants restored binding affinity for (GCGR-mimicking) GLP-1R mutants. Structural analysis of the simulations suggested that peptide ligand binding mode variations in the 7TM binding pocket are facilitated by movement of the extracellular domain relative to the 7TM bundle. These differences in binding modes may account for the pharmacological differences between GLP-1 peptide variants.	[Yang, Dehua; Dai, Antao; Cai, Xiaoqing; Feng, Yang; Wang, Ming-Wei] Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai Inst Mat Med, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China; [Yang, Dehua; Dai, Antao; Cai, Xiaoqing; Feng, Yang; Wang, Ming-Wei] Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China; [de Graaf, Chris] Vrije Univ Amsterdam, AIMMS, Div Med Chem, Fac Sci, De Boelelaan 1083, NL-1081 HV Amsterdam, Netherlands; [Yang, Linlin; Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China; [Song, Gaojie; Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, 99 Haike Rd, Shanghai 201203, Peoples R China; [Reedtz-Runge, Steffen] Novo Nordisk, Dept Prot Struct, Novo Nordisk Pk, DK-2760 Malov, Denmark; [Hanson, Michael A.] GPCR Consortium, San Marcos, CA 92078 USA; [Stevens, Raymond C.] Univ Southern Calif, Dept Biol Sci, Bridge Inst, Los Angeles, CA 90089 USA; [Stevens, Raymond C.] Univ Southern Calif, Dept Chem, Bridge Inst, Los Angeles, CA 90089 USA; [Wang, Ming-Wei] Fudan Univ, Sch Pharm, 826 Zhang Heng Rd, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Vrije Universiteit Amsterdam; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; ShanghaiTech University; Novo Nordisk; University of Southern California; University of Southern California; Fudan University	Wang, MW (corresponding author), Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai Inst Mat Med, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.; Wang, MW (corresponding author), Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	mwwang@simm.ac.cn	Yang, Dehua/M-5789-2019; Stevens, Raymond/K-7272-2015; Yang, Dehua/S-6156-2017; de Graaf, Chris/J-8549-2017	Stevens, Raymond/0000-0002-4522-8725; de Graaf, Chris/0000-0002-1226-2150	Ministry of Science and Technology of China [2012CB518005, 2012AA020302, 2013ZX09507001, 91313000]; National Natural Science Foundation of China [81573479, 81373463, 21422208, 81230076, 21210003]; National Health and Family Planning Commission of China [2013ZX09507001, 2012ZX09304-011, 2013ZX09401003-005, 2013ZX09507-002]; Shanghai Science and Technology Development Fund [15DZ2291600, 14431901200]; National Institutes of Health [U54 GM094618]; European Cooperation in Science and Technology Action [CM1207]; Netherlands eScience Center (NLeSC)/Netherlands Organisation for Scientific Research (NWO) Enabling Technologies Project, 3D-e-Chem [027.014.201]; CAS-Novo Nordisk Research Fund; SA-SIBS Scholarship Program; Thousand Talents Program in China (Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission of China; Shanghai Science and Technology Development Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Cooperation in Science and Technology Action; Netherlands eScience Center (NLeSC)/Netherlands Organisation for Scientific Research (NWO) Enabling Technologies Project, 3D-e-Chem; CAS-Novo Nordisk Research Fund; SA-SIBS Scholarship Program; Thousand Talents Program in China (Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Ministry of Science and Technology of China Grants 2012CB518005 (to H. Y.), 2012AA020302, 2013ZX09507001, and 91313000 (to H. J.), National Natural Science Foundation of China Grants 81573479 and 81373463 (to D. Y.), 21422208 (to H. Y.), and 81230076 and 21210003 (to H. J.), National Health and Family Planning Commission of China Grants 2012ZX09304-011, 2013ZX09401003-005, 2013ZX09507001, and 2013ZX09507-002 (to M.-W. W.), Shanghai Science and Technology Development Fund 15DZ2291600 and 14431901200 (to M.-W. W.), National Institutes of Health Grant U54 GM094618 (to R. C. S.), European Cooperation in Science and Technology Action CM1207 (GPCR-Ligand Interactions, Structures, and Transmembrane Signaling: A European Research Network (GLISTEN)) (to C. dG.), and Netherlands eScience Center (NLeSC)/Netherlands Organisation for Scientific Research (NWO) Enabling Technologies Project, 3D-e-Chem, 027.014.201 (to C. dG.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by CAS-Novo Nordisk Research Fund.r Supported by SA-SIBS Scholarship Program.r Supported by the Thousand Talents Program in China (Chinese Academy of Sciences).	Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRAUN W, 1983, J MOL BIOL, V169, P921, DOI 10.1016/S0022-2836(83)80143-0; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Ceraudo E, 2012, FASEB J, V26, P2060, DOI 10.1096/fj.11-196444; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Di Paolo E, 1999, RECEPTOR CHANNEL, V6, P309; Di Paolo E, 1998, FEBS LETT, V424, P207, DOI 10.1016/S0014-5793(98)00175-6; Dods RL, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150253; Dong MQ, 2012, FASEB J, V26, P5092, DOI 10.1096/fj.12-212399; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gardella TJ, 2001, TRENDS ENDOCRIN MET, V12, P210, DOI 10.1016/S1043-2760(01)00409-X; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hinke SA, 2001, BBA-PROTEIN STRUCT M, V1547, P143, DOI 10.1016/S0167-4838(01)00181-9; HJORTH SA, 1994, J BIOL CHEM, V269, P30121; Hoang HN, 2015, J MED CHEM, V58, P4080, DOI 10.1021/acs.jmedchem.5b00166; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inooka H, 2001, NAT STRUCT BIOL, V8, P161, DOI 10.1038/84159; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Mathi SK, 1997, MOL ENDOCRINOL, V11, P424, DOI 10.1210/me.11.4.424; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MOJSOV S, 1992, INT J PEPT PROT RES, V40, P333; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Moon MJ, 2015, J BIOL CHEM, V290, P5696, DOI 10.1074/jbc.M114.612606; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Neumann JM, 2008, TRENDS BIOCHEM SCI, V33, P314, DOI 10.1016/j.tibs.2008.05.001; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Perret J, 2002, BIOCHEM J, V362, P389, DOI 10.1042/0264-6021:3620389; RIVIER J, 1984, SCIENCE, V224, P889, DOI 10.1126/science.6326264; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Runge S, 2007, BIOCHEMISTRY-US, V46, P5830, DOI 10.1021/bi062309m; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Solano RM, 2001, J BIOL CHEM, V276, P1084, DOI 10.1074/jbc.M007686200; Tseng CC, 1997, BIOCHEM BIOPH RES CO, V232, P96, DOI 10.1006/bbrc.1997.6231; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; UNSON CG, 1989, PEPTIDES, V10, P1171, DOI 10.1016/0196-9781(89)90010-7; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Yaqub T, 2010, MOL PHARMACOL, V77, P547, DOI 10.1124/mol.109.060111	59	39	41	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12991	13004		10.1074/jbc.M116.721977	http://dx.doi.org/10.1074/jbc.M116.721977			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27059958	hybrid, Green Published			2022-12-26	WOS:000379770500009
J	van de Weerd, R; Boot, M; Maaskant, J; Sparrius, M; Verboom, T; van Leeuwen, LM; Burggraaf, MJ; Paauw, NJ; Dainese, E; Manganelli, R; Bitter, W; Appelmelk, B; Geurtsen, J				van de Weerd, Robert; Boot, Maikel; Maaskant, Janneke; Sparrius, Marion; Verboom, Theo; van Leeuwen, Lisanne M.; Burggraaf, Maroeska J.; Paauw, Nanne J.; Dainese, Elisa; Manganelli, Riccardo; Bitter, Wilbert; Appelmelk, Ben J.; Geurtsen, Jeroen			Inorganic Phosphate Limitation Modulates Capsular Polysaccharide Composition in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT REGULATORY SYSTEM; STRINGENT RESPONSE; ALPHA-GLUCAN; CELL-WALL; POLYPHOSPHATE KINASE; POSITIVE FEEDBACK; GENE-EXPRESSION; STRESS-RESPONSE; SIGMA-FACTOR; TUBERCULOSIS	Mycobacterium tuberculosis is protected by an unusual and highly impermeable cell envelope that is critically important for the successful colonization of the host. The outermost surface of this cell envelope is formed by capsular polysaccharides that play an important role in modulating the initial interactions once the bacillus enters the body. Although the bioenzymatic steps involved in the production of the capsular polysaccharides are emerging, information regarding the ability of the bacterium to modulate the composition of the capsule is still unknown. Here, we study the mechanisms involved in regulation of mycobacterial capsule biosynthesis using a high throughput screen for gene products involved in capsular alpha-glucan production. Utilizing this approach we identified a group of mutants that all carried mutations in the ATP-binding cassette phosphate transport locus pst. These mutants collectively exhibited a strong overproduction of capsular polysaccharides, including alpha-glucan and arabinomannan, suggestive of a role for inorganic phosphate (Pi) metabolism in modulating capsular polysaccharide production. These findings were corroborated by the observation that growth under low Pi conditions as well as chemical activation of the stringent response induces capsule production in a number of mycobacterial species. This induction is, in part, dependent on sigma factor E. Finally, we show that Mycobacterium marinum, a model organism for M. tuberculosis, encounters Pi stress during infection, which shows the relevance of our findings in vivo.	[van de Weerd, Robert; Boot, Maikel; Maaskant, Janneke; Sparrius, Marion; Verboom, Theo; van Leeuwen, Lisanne M.; Burggraaf, Maroeska J.; Bitter, Wilbert; Appelmelk, Ben J.; Geurtsen, Jeroen] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands; [Paauw, Nanne J.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, POB 7057, NL-1007 MB Amsterdam, Netherlands; [Bitter, Wilbert] Vrije Univ Amsterdam, Dept Mol Microbiol, Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands; [Dainese, Elisa; Manganelli, Riccardo] Univ Padua, Dept Mol Med, Via Gabelli 63, I-35121 Padua, Italy; [Geurtsen, Jeroen] Crucell Holland BV, Janssen Pharmaceut Companies Johnson & Johnson, Bacterial Vaccines Discovery & Early Dev, Archimedesweg 4-6, NL-2333 CN Leiden, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Padua; Johnson & Johnson; Janssen Pharmaceuticals	Appelmelk, B (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands.	bj.appelmelk@vumc.nl	Manganelli, Riccardo/A-7361-2009; Bitter, Wilbert/ABG-3726-2020; Bitter, W/CAJ-5778-2022; Bitter, Wilbert/AAA-6872-2019	Manganelli, Riccardo/0000-0003-0940-7336; Bitter, Wilbert/0000-0001-8347-6511; 	Netherlands Organization of Scientific Research (NWO) [V-ICI_81902004]; Innovative Medicines Initiative Joint Undertaking Grant [115337]; European Union; European Federation of Pharmaceutical Industries and Associations companies'	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Innovative Medicines Initiative Joint Undertaking Grant; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations companies'	This work was supported by Netherlands Organization of Scientific Research (NWO) Grant V-ICI_81902004 (to R. v. d. W.), Innovative Medicines Initiative Joint Undertaking Grant Agreement 115337 (to M. B.), and further resources composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations companies' in kind contribution. The authors declare no conflict of interest.	Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; CHAPMAN GB, 1959, J BACTERIOL, V77, P205, DOI 10.1128/JB.77.2.205-211.1959; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Chuang YM, 2015, MBIO, V6, DOI 10.1128/mBio.02428-14; Connolly LE, 2009, CELL HOST MICROBE, V6, P1, DOI 10.1016/j.chom.2009.07.001; Cywes C, 1997, INFECT IMMUN, V65, P4258, DOI 10.1128/IAI.65.10.4258-4266.1997; Daffe M., 1999, Tubercle and Lung Disease, V79, P153, DOI 10.1054/tuld.1998.0200; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dinadayala P, 2008, GLYCOBIOLOGY, V18, P502, DOI 10.1093/glycob/cwn031; Elliott SR, 2016, MOL MICROBIOL, V100, P510, DOI 10.1111/mmi.13332; Ferraris DM, 2014, PROTEINS, V82, P2268, DOI 10.1002/prot.24548; Gagliardi MC, 2007, CELL MICROBIOL, V9, P2081, DOI 10.1111/j.1462-5822.2007.00940.x; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Glover RT, 2007, J BACTERIOL, V189, P5495, DOI 10.1128/JB.00190-07; HANKS J H, 1961, Int J Lepr, V29, P84; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; James JN, 2012, MICROBIOL-SGM, V158, P2724, DOI 10.1099/mic.0.060319-0; Kanjee U, 2012, MOL MICROBIOL, V85, P1029, DOI 10.1111/j.1365-2958.2012.08177.x; LEMASSU A, 1994, BIOCHEM J, V297, P351, DOI 10.1042/bj2970351; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Manganelli R, 2010, MOL MICROBIOL, V75, P538, DOI 10.1111/j.1365-2958.2009.07009.x; Pashley CA, 2003, FEMS MICROBIOL LETT, V229, P211, DOI 10.1016/S0378-1097(03)00823-1; Peirs P, 2005, INFECT IMMUN, V73, P1898, DOI 10.1128/IAI.73.3.1898-1902.2005; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sanyal S, 2013, MICROBIOL-SGM, V159, P2074, DOI 10.1099/mic.0.068452-0; Sharma UK, 2010, FEMS MICROBIOL REV, V34, P646, DOI 10.1111/j.1574-6976.2010.00223.x; Starosta AL, 2014, FEMS MICROBIOL REV, V38, P1172, DOI 10.1111/1574-6976.12083; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; Stoop EJM, 2011, DIS MODEL MECH, V4, P526, DOI 10.1242/dmm.006676; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Tischler AD, 2013, INFECT IMMUN, V81, P317, DOI 10.1128/IAI.01136-12; van de Weerd R, 2015, CHEMBIOCHEM, V16, P977, DOI 10.1002/cbic.201402713; Vanzembergh F, 2010, TUBERCULOSIS, V90, P338, DOI 10.1016/j.tube.2010.09.004; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zhang Y, 2012, ANTIMICROB AGENTS CH, V56, P2223, DOI 10.1128/AAC.06288-11	44	15	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11787	11799		10.1074/jbc.M116.722454	http://dx.doi.org/10.1074/jbc.M116.722454			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27044743	Green Published, hybrid			2022-12-26	WOS:000377264800028
J	Best, PB; Photopoulou, T				Best, Peter B.; Photopoulou, Theoni			Identifying the "demon whale-biter": Patterns of scarring on large whales attributed to a cookie-cutter shark Isistius sp	PLOS ONE			English	Article							SQUALOID SHARK; KILLER WHALES; SOUTH-AFRICA; BRASILIENSIS; MOVEMENTS; CETACEANS; TRANSPORT; FISHES; WOUNDS; HAWAII	The presence of crater-like wounds on cetaceans and other large marine vertebrates and invertebrates has been attributed to various organisms. We review the evidence for the identity of the biting agent responsible for crater wounds on large whales, using data collected from sei (Balaenoptera borealis), fin (B. physalus), inshore and offshore Bryde's (B. brydeii sp) and sperm whales (Physeter macrocephalus) examined at the Donkergat whaling station, Saldanha Bay, South Africa between March and October 1963. We then analyse the intensity and trends in its predation on large whales. Despite the scarcity of local records, we conclude that a cookie-cutter shark Isistius sp is the most likely candidate. We make inferences about the trends in (1) total counts of unhealed bitemarks, and (2) the proportion of unhealed bitemarks that were recent. We use day of the year; reproductive class, social grouping or sex; depth interval and body length as candidate covariates. The models with highest support for total counts of unhealed bitemarks involve the day of the year in all species. Depth was an important predictor in all species except offshore Bryde's whales. Models for the proportion of recent bites were only informative for sei and fin whales. We conclude that temporal scarring patterns support what is currently hypothesized about the distribution and movements of these whale species, given that Isistius does not occur in the Antarctic and has an oceanic habitat. The incidence of fresh bites confirms the presence of Isistius in the region. The lower numbers of unhealed bites on medium-sized sperm whales suggests that this group spends more time outside the area in which bites are incurred, providing a clue to one of the biggest gaps in our understanding of the movements of mature and maturing sperm males.	[Best, Peter B.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Photopoulou, Theoni] Univ Cape Town, Dept Stat Sci, Ctr Stat Ecol Environm & Conservat, ZA-7700 Rondebosch, South Africa	University of Pretoria; University of Cape Town	Photopoulou, T (corresponding author), Univ Cape Town, Dept Stat Sci, Ctr Stat Ecol Environm & Conservat, ZA-7700 Rondebosch, South Africa.	theoni.photopoulou@gmail.com	Photopoulou, Theoni/E-3994-2012	Photopoulou, Theoni/0000-0001-9616-9940				Barton K., 2013, MUMIN MULTIMODEL INF; Bass AJ, 1976, SHARKS E COAST SO AF; Berzin A, 1972, ISR PROGR SCI TRANSL; Best P, 2007, WHALES DOLPHINS SO A; Best P.B., 1979, Behavior of Marine Animals, V3, P227; Best PB, 2001, MAR ECOL PROG SER, V220, P277, DOI 10.3354/meps220277; Best PB, 1999, S AFR J MARINE SCI, V21, P393; BEST PB, 1977, REPORTS INT WHALING, V1, P10; Best Peter B., 1996, Report of the International Whaling Commission, V46, P315; Best Peter B., 2001, Journal of Cetacean Research and Management Special Issue, V2, P161; CLARKE MR, 1972, J MAR BIOL ASSOC UK, V52, P599, DOI 10.1017/S0025315400021603; Collett R, 1886, P ZOOL SOC LOND, V18, P243; Dwyer SL, 2011, AQUAT MAMM, V37, P111, DOI 10.1578/AM.37.2.2011.111; Fristrup KM, 2002, MAR MAMMAL SCI, V18, P42, DOI 10.1111/j.1748-7692.2002.tb01017.x; Goodall Thomas B., 1913, Zoologist London, V17; Hoyos-Padilla M, 2013, PAC SCI, V67, P129, DOI 10.2984/67.1.10; International Whaling Commission, 1946, SCHED INT CONV REG W; ISOUCHI T, 1970, Japanese Journal of Ichthyology, V17, P124; Ivashin M, 1978, REP INT WHAL COMM, V199; JAHN AE, 1988, BIOL OCEANOGR, V5, P297, DOI DOI 10.1080/01965581.1987.10749519; JONES EC, 1971, FISH BULL NATL OC AT, V69, P791; Krefft G., 1953, Zoologischer Anzeiger, V150, P275; Mackintosh N. A., 1929, Discovery Reports Cambridge, V1, P257; Mate BR, 2011, MAR MAMMAL SCI, V27, P455, DOI 10.1111/j.1748-7692.2010.00412.x; MATTHEWS L. HARRISON, 1938, DISCOVERY REPTS [GOVT DEPENDENCIES FALKLAND ISLANDS], V17, P183; MATTHEWS L. HARRISON, 1938, DISCOVERY REPTS [GOVT DEPENDENCIES FALKLAND ISLANDS], V17, P93; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; Moore Michael, 2003, Aquatic Mammals, V29, P383, DOI 10.1578/01675420360736569; North American Cartographic Information Society, 2013, NAT EARTH DAT; Olsen O, 1913, P ZOOL SOC LOND, V1913, P1073; Papastamatiou YP, 2010, ENVIRON BIOL FISH, V88, P361, DOI 10.1007/s10641-010-9649-2; Penry G, 2010, BIOL S AFRICAN BRYDE; PIKE G. C., 1951, JOUR FISH RES BD CANADA, V8, P275; de la Gala-Hernandez SR, 2008, CAN J ZOOL, V86, P307, DOI 10.1139/Z07-141; Sherchenko V., 1970, PRIRODA, V6, P72; SHEVCHENKO V. I., 1971, T ALANTNIRO, V39, P67; Shevchenko VI, 1977, REP INT WHAL COMM REP INT WHAL COMM, P130; Souto Luciano Raimundo Alardo, 2007, Biotemas, V20, P19; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Whitehead H., 2003, SPERM WHALES SOCIAL; Widder EA, 1998, ENVIRON BIOL FISH, V53, P267, DOI 10.1023/A:1007498915860; Williams R, 2009, MAR MAMMAL SCI, V25, P327, DOI 10.1111/j.1748-7692.2008.00255.x; Wiseman N., 2008, GENETIC IDENTITY ECO; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	44	16	18	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152643	10.1371/journal.pone.0152643	http://dx.doi.org/10.1371/journal.pone.0152643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055057	gold, Green Published			2022-12-26	WOS:000373608000031
J	Emsens, WJ; Aggenbach, CJS; Schoutens, K; Smolders, AJP; Zak, D; van Diggelen, R				Emsens, Willem-Jan; Aggenbach, Camiel J. S.; Schoutens, Ken; Smolders, Alfons J. P.; Zak, Dominik; van Diggelen, Rudy			Soil Iron Content as a Predictor of Carbon and Nutrient Mobilization in Rewetted Fens	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; WATER-TABLE FLUCTUATIONS; PHOSPHORUS MOBILIZATION; PHOSPHATE SORPTION; FERRIC IRON; RICH FENS; REDUCTION; AMMONIUM; PEAT; SEDIMENT	Rewetted, previously drained fens often remain sources rather than sinks for carbon and nutrients. To date, it is poorly understood which soil characteristics stimulate carbon and nutrient mobilization upon rewetting. Here, we assess the hypothesis that a large pool of iron in the soil negatively affects fen restoration success, as flooding-induced iron reduction (Fe3+ to Fe2+) causes a disproportionate breakdown of organic matter that is coupled with a release of inorganic compounds. We collected intact soil cores in two iron-poor and two iron-rich drained fens, half of which were subjected to a rewetting treatment while the other half was kept drained. Prolonged drainage led to the mobilization of nitrate (NO3-, > 1 mmol L-1) in all cores, regardless of soil iron content. In the rewetted iron-rich cores, a sharp increase in pore water iron (Fe) concentrations correlated with concentrations of inorganic carbon (TIC, > 13 mmol L-1) and dissolved organic carbon (DOC, > 16 mmol L-1). Additionally, ammonium (NH4+) accumulated up to phytotoxic concentrations of 1 mmol L-1 in the pore water of the rewetted iron-rich cores. Disproportionate mobilization of Fe, TIC, DOC and NH4+ was absent in the rewetted iron-poor cores, indicating a strong interaction between waterlogging and iron-mediated breakdown of organic matter. Concentrations of dissolved phosphorus (P) rose slightly in all cores upon rewetting, but remained low throughout the experiment. Our results suggest that large pools of iron in the top soil of drained fens can hamper the restoration of the fen's sink-service for ammonium and carbon upon rewetting. We argue that negative effects of iron should be most apparent in fens with fluctuating water levels, as temporary oxygenation allows frequent regeneration of Fe3+. We conclude that rewetting of iron-poor fens may be more feasible for restoration.	[Emsens, Willem-Jan; Aggenbach, Camiel J. S.; Schoutens, Ken; van Diggelen, Rudy] Univ Antwerp, Dept Biol, Ecosyst Management Res Grp, Univ Pl 1C, B-2610 Antwerp, Belgium; [Aggenbach, Camiel J. S.] KWR Watercycle Res Inst, POB 1072, NL-3430 BB Nieuwegein, Netherlands; [Smolders, Alfons J. P.] Radboud Univ Nijmegen, Inst Wetland & Water Res, Dept Aquat Ecol & Environm Biol, Heyendaalseweg 135 1, NL-6525 ED Nijmegen, Netherlands; [Smolders, Alfons J. P.] B WARE Res Ctr, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands; [Zak, Dominik] Leibniz Inst Freshwater Ecol & Inland Fisheries, Chem Analyt & Biogeochem, Muggelseedamm 301, D-12587 Berlin, Germany; [Zak, Dominik] Aarhus Univ, Dept Biosci, DK-8600 Vejlsovej, Silkeborg, Denmark	University of Antwerp; KWR Watercycle Research Institute; Radboud University Nijmegen; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Aarhus University	Emsens, WJ (corresponding author), Univ Antwerp, Dept Biol, Ecosyst Management Res Grp, Univ Pl 1C, B-2610 Antwerp, Belgium.	willem-jan.emsens@uantwerpen.be	Smolders, Alfons J.P./H-2583-2012; Aggenbach, Camiel/AAE-3298-2021; Zak, Dominik Henrik/GFL-5719-2022; Emsens, Willem-Jan/AAW-1162-2020; Schoutens, Ken/AEQ-1606-2022	Zak, Dominik Henrik/0000-0002-1229-5294; Emsens, Willem-Jan/0000-0002-2667-237X; van Diggelen, Rudy/0000-0001-8053-945X; Aggenbach, Camiel/0000-0002-2617-3909	FWO Fonds Wetenschappelijk Onderzoek [11M0414N]; OBN Research Program [OBN178-BE]	FWO Fonds Wetenschappelijk Onderzoek(FWO); OBN Research Program	This work was supported by FWO Fonds Wetenschappelijk Onderzoek (11M0414N to WJE); www.fwo.be, OBN Research Program (OBN178-BE to university of Antwerp); www.natuurkennis.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTNICH C, 1995, BIOL FERT SOILS, V19, P65, DOI 10.1007/BF00336349; Aggenbach CJS, 2013, PRESLIA, V85, P405; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Clement JC, 2005, SOIL BIOL BIOCHEM, V37, P2323, DOI 10.1016/j.soilbio.2005.03.027; Estop-Aragones C, 2012, SOIL BIOL BIOCHEM, V47, P1, DOI 10.1016/j.soilbio.2011.12.008; Evans MG, 1999, J HYDROL, V221, P141, DOI 10.1016/S0022-1694(99)00085-2; Fenner N, 2011, HYDROBIOLOGIA, V674, P51, DOI 10.1007/s10750-011-0733-1; Freeman C, 2004, NATURE, V430, P195, DOI 10.1038/nature02707; Geurts JJM, 2008, FRESHWATER BIOL, V53, P2101, DOI 10.1111/j.1365-2427.2008.02038.x; Geurts JJM, 2009, ENVIRON POLLUT, V157, P2072, DOI 10.1016/j.envpol.2009.02.024; Grootjans AP, 2006, APPL VEG SCI, V9, P175, DOI 10.1658/1402-2001(2006)9[175:HLSOBF]2.0.CO;2; Hansen HCB, 1996, ENVIRON SCI TECHNOL, V30, P2053, DOI 10.1021/es950844w; Heiberg L, 2012, J ENVIRON QUAL, V41, P938, DOI 10.2134/jeq2011.0067; Heiberg L, 2010, J ENVIRON QUAL, V39, P734, DOI 10.2134/jeq2009.0222; Holden J, 2005, PHILOS T R SOC A, V363, P2891, DOI 10.1098/rsta.2005.1671; Hughes S, 1998, SOIL USE MANAGE, V14, P248, DOI 10.1111/j.1475-2743.1998.tb00161.x; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kasimir-Klemedtsson A, 1997, SOIL USE MANAGE, V13, P245, DOI 10.1111/j.1475-2743.1997.tb00595.x; Kusel K, 2008, BIOGEOSCIENCES, V5, P1537; Lal R., 1997, SOIL PROCESSES CARBO, VVolume 11; Lamers L.P.M., 2014, BIOL REV; Li YC, 2012, J SOIL SEDIMENT, V12, P683, DOI 10.1007/s11368-012-0507-z; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; Lucassen ECHET, 2005, PLANT SOIL, V269, P109, DOI 10.1007/s11104-004-0554-3; Lucassen ECHET, 2006, J VEG SCI, V17, P425, DOI 10.1111/j.1654-1103.2006.tb02463.x; Lucassen ECHET, 2009, FRESHWATER BIOL, V54, P2300, DOI 10.1111/j.1365-2427.2009.02264.x; Murphy Tom, 2001, Limnology, V2, P119, DOI 10.1007/s102010170007; Parkhurst D.L., 1999, 994259 US GEOL SURV, VVolume 312, P99; Pastor J, 2003, OIKOS, V100, P380, DOI 10.1034/j.1600-0706.2003.11774.x; PATRICK WH, 1974, SCIENCE, V186, P53, DOI 10.1126/science.186.4158.53; Preston MD, 2011, SCI TOTAL ENVIRON, V409, P1235, DOI 10.1016/j.scitotenv.2010.12.027; Richert M, 2000, RESTOR ECOL, V8, P186, DOI 10.1046/j.1526-100x.2000.80026.x; Riedel T, 2013, P NATL ACAD SCI USA, V110, P10101, DOI 10.1073/pnas.1221487110; Russow R, 2013, ISOT ENVIRON HEALT S, V49, P438, DOI 10.1080/10256016.2013.831089; Sakadevan K, 1998, WATER RES, V32, P393, DOI 10.1016/S0043-1354(97)00271-6; Schlotzhauer SM, 1999, WATER RESOUR RES, V35, P3675, DOI 10.1029/1999WR900126; Smolders AJP, 2006, CHEM ECOL, V22, P93, DOI 10.1080/02757540600579730; Smolders AJP, 1995, FRESHWATER BIOL, V34, P559, DOI 10.1111/j.1365-2427.1995.tb00913.x; Van Bodegom PM, 2005, BIOGEOCHEMISTRY, V76, P69, DOI 10.1007/s10533-005-2053-x; van de Riet BP, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1440-5; Van Dijk J, 2004, BIOGEOCHEMISTRY, V71, P317, DOI 10.1007/s10533-004-0079-0; Venterink HO, 2002, PLANT SOIL, V243, P119, DOI 10.1023/A:1019993510737; Walpersdorf E, 2013, GEODERMA, V193, P189, DOI 10.1016/j.geoderma.2012.10.003; Zak D, 2008, EUR J SOIL SCI, V59, P1191, DOI 10.1111/j.1365-2389.2008.01081.x; Zak D, 2007, BIOGEOCHEMISTRY, V85, P141, DOI 10.1007/s10533-007-9122-2; Zak D, 2010, ECOL APPL, V20, P1336, DOI 10.1890/08-2053.1	47	21	21	7	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153166	10.1371/journal.pone.0153166	http://dx.doi.org/10.1371/journal.pone.0153166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050837	Green Published, gold			2022-12-26	WOS:000373603500108
J	Wen, J; Yan, M; Liu, Y; Li, J; Xie, YM; Lu, YF; Kamata, M; Chen, ISY				Wen, Jing; Yan, Ming; Liu, Yang; Li, Jie; Xie, Yiming; Lu, Yunfeng; Kamata, Masakazu; Chen, Irvin S. Y.			Specific Elimination of Latently HIV-1 Infected Cells Using HIV-1 Protease-Sensitive Toxin Nanocapsules	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; PROTON SPONGE; RICIN; INFECTION; IMMUNOTOXINS; PERSISTENCE; CHAIN; COMBINATION; RESERVOIRS	Anti-retroviral drugs suppress HIV-1 plasma viremia to undetectable levels; however, latent HIV-1 persists in reservoirs within HIV-1-infected patients. The silent provirus can be activated through the use of drugs, including protein kinase C activators and histone deacetylase inhibitors. This "shock" approach is then followed by "kill" of the producing cells either through direct HIV-1-induced cell death or natural immune mechanisms. However, these mechanisms are relatively slow and effectiveness is unclear. Here, we develop an approach to specifically target and kill cells that are activated early in the process of virus production. We utilize a novel nanocapsule technology whereby the ricin A chain is encapsulated in an inactive form within a polymer shell. Specificity for release of the ricin A toxin is conferred by peptide crosslinkers that are sensitive to cleavage by HIV-1 protease. By using well-established latent infection models, J-Lat and U1 cells, we demonstrate that only within an HIV-1-producing cell expressing functional HIV-1 protease will the nanocapsule release its ricin A cargo, shutting down viral and cellular protein synthesis, and ultimately leading to rapid death of the producer cell. Thus, we provide proof of principle for a novel technology to kill HIV-1-producing cells without effects on non-target cells.	[Wen, Jing; Yan, Ming; Xie, Yiming; Chen, Irvin S. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Kamata, Masakazu] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Liu, Yang; Li, Jie; Lu, Yunfeng] Univ Calif Los Angeles, Dept Biomol & Chem Engn, Los Angeles, CA USA; [Lu, Yunfeng] Univ Calif Los Angeles, CNSI, Los Angeles, CA USA; [Chen, Irvin S. Y.] UCLA AIDS Inst, Los Angeles, CA USA; [Yan, Ming] Calimmune Inc, Pasadena, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Chen, ISY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Kamata, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA.; Chen, ISY (corresponding author), UCLA AIDS Inst, Los Angeles, CA USA.	masa3k@ucla.edu; syuchen@mednet.ucla.edu	Liu, Yang/AAY-7115-2020; Wen, Jing/F-1949-2019; KAMATA, MASAKAZU/E-7550-2017; Li, Jie/I-5695-2015	Liu, Yang/0000-0001-5752-5180; Wen, Jing/0000-0002-6127-6276; Li, Jie/0000-0003-0189-2787; Kamata, Masakazu/0000-0003-0323-3742	U.S. National Institutes of Health (NIH) R21 grant [AI114433]; NIH [AI028697]; James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114433, P30AI028697] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) R21 grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. National Institutes of Health (NIH) R21 grant (AI114433 to ISYC). p24 ELISA was performed in the CFAR Virology core laboratory supported by NIH grant (AI028697). MACSQuant Flow Cytometer and a part of Fortessa Cytometry system were supported by James B. Pendleton Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Barouch DH, 2014, SCIENCE, V345, P169, DOI 10.1126/science.1255512; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Behr JP, 1997, CHIMIA, V51, P34; Berger EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000803; BLAKEY DC, 1986, CANC DRUG DEL, V3, P189, DOI 10.1089/cdd.1986.3.189; Blanco R, 2003, J BIOL CHEM, V278, P1086, DOI 10.1074/jbc.M205636200; Bosque A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002288; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Casazza JP, 2013, J INFECT DIS, V207, P1829, DOI 10.1093/infdis/jit098; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2015, NAT IMMUNOL, V16, P584, DOI 10.1038/ni.3152; Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; CUSHLEY W, 1984, TOXICON, V22, P265, DOI 10.1016/0041-0101(84)90027-8; Darcis G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005063; DAVEY RT, 1994, J INFECT DIS, V170, P1180, DOI 10.1093/infdis/170.5.1180; Denton PW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003872; El-Nikhely N, 2007, PROTEIN J, V26, P481, DOI 10.1007/s10930-007-9088-x; ENDO Y, 1988, J BIOL CHEM, V263, P8735; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; FitzGerald DJ, 2011, CANCER RES, V71, P6300, DOI 10.1158/0008-5472.CAN-11-1374; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682; Gu Z, 2009, NANO LETT, V9, P4533, DOI 10.1021/nl902935b; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; JIMENEZ A, 1985, ANNU REV MICROBIOL, V39, P649, DOI 10.1146/annurev.mi.39.100185.003245; Johansson S, 2006, AIDS, V20, P1911, DOI 10.1097/01.aids.0000247111.58961.60; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Kennedy PE, 2006, J LEUKOCYTE BIOL, V80, P1175, DOI 10.1189/jlb.0306139; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Liang M, 2010, J GENE MED, V12, P255, DOI 10.1002/jgm.1440; Liu CY, 2015, ADV MATER, V27, P292, DOI 10.1002/adma.201403387; Martins LJ, 2015, AIDS RES HUM RETROVI; Nagata S, 2001, Tanpakushitsu Kakusan Koso, V46, P540; Nie Z, 2007, J VIROL, V81, P6947, DOI 10.1128/JVI.02798-06; Olesen R, 2015, J VIROL; OLSNES S, 1973, BIOCHEMISTRY-US, V12, P3121, DOI 10.1021/bi00740a028; Pache L, 2015, CELL HOST MICROBE, V18, P345, DOI 10.1016/j.chom.2015.08.009; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pettit SC, 2002, J VIROL, V76, P10226, DOI 10.1128/JVI.76.20.10226-10233.2002; Pincus SH, 1996, ANTIVIR RES, V33, P1, DOI 10.1016/S0166-3542(96)00995-3; RAMACHANDRAN RV, 1994, J INFECT DIS, V170, P1009, DOI 10.1093/infdis/170.4.1009; Ruff CT, 2002, J VIROL, V76, P9481, DOI 10.1128/JVI.76.18.9481-9492.2002; Sanchez-Duffhues G, 2011, CURR DRUG TARGETS, V12, P348, DOI 10.2174/138945011794815266; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shirakawa K, 2013, TRENDS MICROBIOL, V21, P277, DOI 10.1016/j.tim.2013.02.005; Sigal A, 2012, CELL HOST MICROBE, V12, P132, DOI 10.1016/j.chom.2012.07.005; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Thrush GR, 1996, ANNU REV IMMUNOL, V14, P49, DOI 10.1146/annurev.immunol.14.1.49; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; UCKUN FM, 1989, BLOOD, V74, P2445; VALLERA DA, 1983, SCIENCE, V222, P512, DOI 10.1126/science.6353579; VANOOSTERHOUT YVJM, 1992, CANCER RES, V52, P5921; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; Weber IT, 2009, VIRUSES-BASEL, V1, P1110, DOI 10.3390/v1031110; WELLNER RB, 1995, J TOXICOL-TOXIN REV, V14, P483, DOI 10.3109/15569549509016439; Wen J, 2011, ADV MATER, V23, P4549, DOI 10.1002/adma.201101771; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Yan M, 2006, J AM CHEM SOC, V128, P11008, DOI 10.1021/ja064126t; Yan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127986; Yan M, 2012, J AM CHEM SOC, V134, P13542, DOI 10.1021/ja304649a; Yan M, 2010, NAT NANOTECHNOL, V5, P48, DOI [10.1038/NNANO.2009.341, 10.1038/nnano.2009.341]; Zhang P, 2015, P NATL ACAD SCI USA, V112, P12046, DOI 10.1073/pnas.1512465112	73	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151572	10.1371/journal.pone.0151572	http://dx.doi.org/10.1371/journal.pone.0151572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049645	Green Published, gold			2022-12-26	WOS:000373603500009
J	Senarathna, SMDKG; Page-Sharp, M; Crowe, A				Senarathna, S. M. D. K. Ganga; Page-Sharp, Madhu; Crowe, Andrew			The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation	PLOS ONE			English	Article							NEW-GUINEAN CHILDREN; IN-VITRO; METHYLENE-BLUE; CELL-CULTURE; CACO-2; ARTEMISININ; ARTESUNATE; AMODIAQUINE; PHARMACOKINETICS; COMBINATION	The combination of passive drug permeability, affinity for uptake and efflux transporters as well as gastrointestinal metabolism defines net drug absorption. Efflux mechanisms are often overlooked when examining the absorption phase of drug bioavailability. Knowing the affinity of antimalarials for efflux transporters such as P-glycoprotein (P-gp) may assist in the determination of drug absorption and pharmacokinetic drug interactions during oral absorption in drug combination therapies. Concurrent administration of P-gp inhibitors and P-gp substrate drugs may also result in alterations in the bioavailability of some antimalarials. In-vitro Caco-2 cell monolayers were used here as a model for potential drug absorption related problems and P-gp mediated transport of drugs. Artemisone had the highest permeability at around 50 x 10(-6) cm/sec, followed by amodiaquine around 20 x 10(-6) cm/sec; both mefloquine and artesunate were around 10 x 10(-6) cm/sec. Methylene blue was between 2 and 6 x 10(-6) cm/sec depending on the direction of transport. This 3 fold difference was able to be halved by use of P-gp inhibition. MRP inhibition also assisted the consolidation of the methylene blue transport. Mefloquine was shown to be a P-gp inhibitor affecting our P-gp substrate, Rhodamine 123, although none of the other drugs impacted upon rhodamine123 transport rates. In conclusion, mefloquine is a P-gp inhibitor and methylene blue is a partial substrate; methylene blue may have increased absorption if co-administered with such Pgp inhibitors. An upregulation of P-gp was observed when artemisone and dihydroartemisinin were co-incubated with mefloquine and amodiaquine.	[Senarathna, S. M. D. K. Ganga; Page-Sharp, Madhu; Crowe, Andrew] Curtin Univ, Sch Pharm, Perth, WA 6102, Australia; [Senarathna, S. M. D. K. Ganga; Crowe, Andrew] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia	Curtin University; Curtin University	Crowe, A (corresponding author), Curtin Univ, Sch Pharm, Perth, WA 6102, Australia.; Crowe, A (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia.	a.p.crowe@curtin.edu.au			Curtin Strategic International Research Scholarship	Curtin Strategic International Research Scholarship	This project was funded internally from PhD funds awarded to the school to maintain the PhD student's project. S M D K Ganga Senarathna was a recipient of Curtin Strategic International Research Scholarship.; We are thankful to the supervisory support of Dr. Kevin Batty, School of Pharmacy, Curtin University. S MD K Ganga Senarathna was a recipient of Curtin Strategic International Research Scholarship.	ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; ARTURSSON P, 1990, J PHARM SCI-US, V79, P476, DOI 10.1002/jps.2600790604; Augustijns P, 1996, J PHARM SCI, V85, P577, DOI 10.1021/js960001i; Ayesh S, 1996, BBA-MOL BASIS DIS, V1316, P8, DOI 10.1016/0925-4439(96)00008-7; Bailey CA, 1996, ADV DRUG DELIVER REV, V22, P85, DOI 10.1016/S0169-409X(96)00416-4; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; Batty KT, 1996, J PHARM PHARMACOL, V48, P22, DOI 10.1111/j.2042-7158.1996.tb05870.x; BOUDREAU EF, 1982, LANCET, V2, P1335; Burk O, 2005, MOL PHARMACOL, V67, P1954, DOI 10.1124/mol.104.009019; Coulibaly B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005318; Creek DJ, 2013, J INFECT DIS, V207, P1646, DOI 10.1093/infdis/jit078; Crivori P, 2006, MOL PHARMACEUT, V3, P33, DOI 10.1021/mp050071a; Crowe A, 2004, DRUG DEV IND PHARM, V30, P449, DOI 10.1081/DDC-120037471; Crowe A, 1998, PHARMACEUT RES, V15, P1666, DOI 10.1023/A:1011940108365; Crowe A, 2006, J DRUG TARGET, V14, P291, DOI 10.1080/10611860600720814; Crowe A, 2012, TOXICOL APPL PHARM, V260, P294, DOI 10.1016/j.taap.2012.03.008; Davis TME, 2007, ANTIMICROB AGENTS CH, V51, P1099, DOI 10.1128/AAC.01253-06; Debrus B, 2011, J CHROMATOGR A, V1218, P5205, DOI 10.1016/j.chroma.2011.05.102; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; European Medicines Agency, 2014, ASS REP METH CHLOR P; Gasasira AF., 2010, THESIS UC BERKELEY; German P, 2007, CLIN INFECT DIS, V44, P889, DOI 10.1086/511882; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; GUSTAFSSON LL, 1983, BRIT J CLIN PHARMACO, V15, P471, DOI 10.1111/j.1365-2125.1983.tb01532.x; Hayeshi R, 2006, EUR J PHARM SCI, V29, P70, DOI 10.1016/j.ejps.2006.05.009; Haynes RK, 2006, ANGEW CHEM, V118, P2136, DOI DOI 10.1002/ange.200503071; Hosoya K, 1996, PHARMACEUT RES, V13, P885, DOI 10.1023/A:1016005212640; Impert O, 2003, DALTON T, P348, DOI 10.1039/b205786g; KARBWANG J, 1994, B WORLD HEALTH ORGAN, V72, P83; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Lan LB, 1996, CANCER CHEMOTH PHARM, V38, P181, DOI 10.1007/s002800050468; Lennernas H, 1996, INT J PHARM, V127, P103, DOI 10.1016/0378-5173(95)04204-0; Lin JH, 2003, ADV DRUG DELIVER REV, V55, P53, DOI 10.1016/S0169-409X(02)00171-0; Manning L, 2011, ANTIMICROB AGENTS CH, V55, P5027, DOI 10.1128/AAC.00375-11; Meissner PE, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-45; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Nair A, 2012, J PHARM SCI-US, V101, P4390, DOI 10.1002/jps.23312; Nontprasert A, 1998, AM J TROP MED HYG, V59, P519, DOI 10.4269/ajtmh.1998.59.519; Oga EF, 2012, AM J TROP MED HYG, V87, P64, DOI 10.4269/ajtmh.2012.11-0817; Osterberg T, 2000, EUR J PHARM SCI, V10, P295, DOI 10.1016/S0928-0987(00)00077-4; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Peters W, 1975, HDB ANIMAL MODELS IN; Pham YT, 2000, BBA-GEN SUBJECTS, V1524, P212, DOI 10.1016/S0304-4165(00)00160-4; PUSSARD E, 1986, J CHROMATOGR, V374, P111, DOI 10.1016/S0378-4347(00)83258-2; Reungpatthanaphong P, 2002, BIOL PHARM BULL, V25, P1555, DOI 10.1248/bpb.25.1555; Riffkin CD, 1996, BIOCHEM PHARMACOL, V52, P1545, DOI 10.1016/S0006-2952(96)00556-4; Salman S, 2012, ANTIMICROB AGENTS CH, V56, P3288, DOI 10.1128/AAC.06232-11; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Scholtz JC, 2010, THESIS N W U POTCHEF; Senarathna SMDKG, 2015, PHARMAZIE, V70, P798, DOI 10.1691/ph.2015.5106; Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003; Vivas L, 2007, J ANTIMICROB CHEMOTH, V59, P658, DOI 10.1093/jac/dkl563; Walter-Sack I, 2009, EUR J CLIN PHARMACOL, V65, P179, DOI 10.1007/s00228-008-0563-x; WHO, 2010, GUID TREATM MAL, V2nd; WILS P, 1994, CELL BIOL TOXICOL, V10, P393, DOI 10.1007/BF00755788; WINSTANLEY P, 1987, BRIT J CLIN PHARMACO, V23, P1	57	21	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152677	10.1371/journal.pone.0152677	http://dx.doi.org/10.1371/journal.pone.0152677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045516	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600030
J	Trost, B; Kusalik, A; Napper, S				Trost, Brett; Kusalik, Anthony; Napper, Scott			Computational Analysis of the Predicted Evolutionary Conservation of Human Phosphorylation Sites	PLOS ONE			English	Article							PROTEIN-PHOSPHORYLATION; DATABASE; KINASES; INFORMATION; RESOURCES; HOMOLOGY; COMPLEX; KINOME; GENOME; MOUSE	Protein kinase-mediated phosphorylation is among the most important post-translational modifications. However, few phosphorylation sites have been experimentally identified for most species, making it difficult to determine the degree to which phosphorylation sites are conserved. The goal of this study was to use computational methods to characterize the conservation of human phosphorylation sites in a wide variety of eukaryotes. Using experimentally-determined human sites as input, homologous phosphorylation sites were predicted in all 432 eukaryotes for which complete proteomes were available. For each pair of species, we calculated phosphorylation site conservation as the number of phosphorylation sites found in both species divided by the number found in at least one of the two species. A clustering of the species based on this conservation measure was concordant with phylogenies based on traditional genomic measures. For a subset of the 432 species, phosphorylation site conservation was compared to conservation of both protein kinases and proteins in general. Protein kinases exhibited the highest degree of conservation, while general proteins were less conserved and phosphorylation sites were least conserved. Although preliminary, these data tentatively suggest that variation in phosphorylation sites may play a larger role in explaining phenotypic differences among organisms than differences in the complements of protein kinases or general proteins.	[Trost, Brett; Kusalik, Anthony] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK S7N 0W0, Canada; [Trost, Brett; Napper, Scott] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Napper, Scott] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Trost, B (corresponding author), Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK S7N 0W0, Canada.; Trost, B (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada.	brett.trost@usask.ca	Trost, Brett/K-4127-2016	Trost, Brett/0000-0003-4863-7273	Genome Canada	Genome Canada(Genome Canada)	Funding was provided by Genome Canada (http://www.genomecanada.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by Genome Canada.	Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Ba ANN, 2010, MOL BIOL EVOL, V27, P2027, DOI 10.1093/molbev/msq090; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Dou YC, 2014, AMINO ACIDS, V46, P1459, DOI 10.1007/s00726-014-1711-5; Freschi L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004062; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Hahn MW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r141; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jimenez JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r90; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim SH, 2011, EUR J IMMUNOL, V41, P461, DOI 10.1002/eji.201040668; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Lienhard GE, 2008, TRENDS BIOCHEM SCI, V33, P351, DOI 10.1016/j.tibs.2008.05.004; Malik R, 2008, BIOINFORMATICS, V24, P1426, DOI 10.1093/bioinformatics/btn197; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Moses AM, 2007, P NATL ACAD SCI USA, V104, P17713, DOI 10.1073/pnas.0700997104; Nakedi KC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00237; Rinschen MM, 2015, PROTEOMICS, V15, P1326, DOI 10.1002/pmic.201400235; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Trost B, 2015, BRIEF BIOINFORM, V16, P820, DOI 10.1093/bib/bbu040; Trost B, 2013, BIOINFORMATICS, V29, P1693, DOI 10.1093/bioinformatics/btt265; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Xue Y, 2010, CURR PROTEIN PEPT SC, V11, P485, DOI 10.2174/138920310791824138; Zhao BY, 2012, PROTEOMICS, V12, P3299, DOI 10.1002/pmic.201200189	34	7	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152809	10.1371/journal.pone.0152809	http://dx.doi.org/10.1371/journal.pone.0152809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046079	gold, Green Published, Green Submitted			2022-12-26	WOS:000373599600037
J	Villegas, L; Otero, L; Sterling, TR; Huaman, MA; Van der Stuyft, P; Gotuzzo, E; Seas, C				Villegas, Leonela; Otero, Larissa; Sterling, Timothy R.; Huaman, Moises A.; Van der Stuyft, Patrick; Gotuzzo, Eduardo; Seas, Carlos			Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru	PLOS ONE			English	Article							MONORESISTANT TUBERCULOSIS; DRUG-RESISTANCE; UNITED-STATES	Background Isoniazid and rifampicin are the two most efficacious first-line agents for tuberculosis (TB) treatment. We assessed the prevalence of isoniazid and rifampicin mono-resistance, associated risk factors, and the association of mono-resistance on treatment outcomes. Methods A prospective, observational cohort study enrolled adults with a first episode of smear-positive pulmonary TB from 34 health facilities in a northern district of Lima, Peru, from March 2010 through December 2011. Participants were interviewed and a sputum sample was cultured on Lowenstein-Jensen (LJ) media. Drug susceptibility testing was performed using the proportion method. Medication regimens were documented for each patient. Our primary outcomes were treatment outcome at the end of treatment. The secondary outcome included recurrent episodes among cured patients within two years after completion of the treatment. Results Of 1292 patients enrolled, 1039 (80%) were culture-positive. From this subpopulation, isoniazid mono-resistance was present in 85 (8%) patients and rifampicin mono-resistance was present in 24 (2%) patients. In the multivariate logistic regression model, isoniazid mono-resistance was associated with illicit drug use (adjusted odds ratio (aOR) = 2.10; 95% confidence interval (CI): 1.1-4.1), and rifampicin mono-resistance was associated with HIV infection (aOR = 9.43; 95% CI: 1.9-47.8). Isoniazid mono-resistant patients had a higherrisk of poor treatment outcomes including treatment failure (2/85, 2%, p-value<0.01) and death (4/85, 5%, p<0.02). Rifampicin mono-resistant patients had a higher risk of death (2/24,8%, p<0.01). Conclusion A high prevalence of isoniazid and rifampicin mono-resistance was found among TB patients in our low HIV burden setting which were similar to regions with high HIV burden. Patients with isoniazid and rifampicin mono-resistance had an increased risk of poor treatment outcomes.	[Villegas, Leonela; Sterling, Timothy R.; Huaman, Moises A.] Vanderbilt Univ, Sch Med, A2209 Med Ctr North, Nashville, TN 37212 USA; [Otero, Larissa; Gotuzzo, Eduardo; Seas, Carlos] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Van der Stuyft, Patrick] Inst Trop Med, Dept Publ Hlth, Unit Gen Epidemiol & Dis Control, B-2000 Antwerp, Belgium; [Van der Stuyft, Patrick] Univ Ghent, Fac Med, Dept Publ Hlth, B-9000 Ghent, Belgium; [Villegas, Leonela] Vanderbilt Univ, Sch Med, Div Infect Dis, A2209 Med Ctr North, Nashville, TN 37212 USA	Vanderbilt University; Universidad Peruana Cayetano Heredia; Institute of Tropical Medicine (ITM); Ghent University; Vanderbilt University	Villegas, L (corresponding author), Vanderbilt Univ, Sch Med, A2209 Med Ctr North, Nashville, TN 37212 USA.; Villegas, L (corresponding author), Vanderbilt Univ, Sch Med, Div Infect Dis, A2209 Med Ctr North, Nashville, TN 37212 USA.	Leonela.a.villegas@vanderbilt.edu		Seas, Carlos/0000-0001-7067-9141; Huaman, Moises/0000-0002-6839-5809; Villegas, Leonela/0000-0003-1937-7353; Otero, Larissa/0000-0002-8348-4340	Institute of Tropical Medicine in Antwerp, Belgium (FA3); Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru; FOGARTY INTERNATIONAL CENTER [R25TW009343] Funding Source: NIH RePORTER	Institute of Tropical Medicine in Antwerp, Belgium (FA3); Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Belgian Cooperation (www.dg-d.be) through a project of institutional collaboration between the Institute of Tropical Medicine in Antwerp, Belgium (FA3) and the Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, PERU, V53, P1854; Arentz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076533; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Bonilla Asalde Cesar, 2008, Acta méd. peruana, V25, P163; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Chien JY, 2015, CLIN MICROBIOL INFEC, V21, P59, DOI 10.1016/j.cmi.2014.08.008; Clark CM, 2005, INT J TUBERC LUNG D, V9, P964; Cox HS, 2007, CLIN INFECT DIS, V44, P1421, DOI 10.1086/517536; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Hoopes AJ, 2008, ARCH INTERN MED, V168, P1984, DOI 10.1001/archinte.168.18.1984; Instituto Nacional de Estadistica e Informatica, 2014, POBL LIM METR 2014; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; LoBue PA, 2005, INT J TUBERC LUNG D, V9, P501; MENZIES D, 2009, PLOS MED, V6, P1, DOI DOI 10.1371/journal.pmed.0060001; Meyssonnier V, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-18; Mukinda FK, 2012, INT J TUBERC LUNG D, V16, P196, DOI 10.5588/ijtld.11.0116; Mulenga C, 2010, TUBERC RES TREAT, V2010; Organization WH, 2014, 4 WHO; Otero L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026276; Sandgren A, 2012, EUR J MICROBIOL IMMU, V2, P292, DOI 10.1556/EuJMI.2.2012.4.8; Sandman L, 1999, AM J RESP CRIT CARE, V159, P468, DOI 10.1164/ajrccm.159.2.9805097; Timperi R, 2005, INT J TUBERC LUNG D, V9, P175; Villa-Rosas C L-LR, SALUD PUBLICA MEX, V57, P177; Wang TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086316	27	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152933	10.1371/journal.pone.0152933	http://dx.doi.org/10.1371/journal.pone.0152933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045684	Green Published, gold			2022-12-26	WOS:000373599600047
J	Groves, NJ; Bradford, D; Sullivan, RKP; Conn, KA; Aljelaify, RF; McGrath, JJ; Burne, THJ				Groves, Natalie J.; Bradford, DanaKai; Sullivan, Robert K. P.; Conn, Kyna-Anne; Aljelaify, Rasha Fahad; McGrath, John J.; Burne, Thomas H. J.			Behavioural Effects of Adult Vitamin D Deficiency in BALB/c Mice Are not Associated with Proliferation or Survival of Neurons in the Adult Hippocampus	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; COGNITIVE DECLINE; FORCED SWIM; NEUROGENESIS; DEPRESSION; ANTIDEPRESSANT; EXERCISE; SYSTEM; FLUOXETINE; STATE	Epidemiological studies have shown that up to one third of adults have insufficient levels of vitamin D and there is an association between low vitamin D concentrations and adverse brain outcomes, such as depression. Vitamin D has been shown to be involved in processes associated with neurogenesis during development. Therefore, the aim of this study was to test the hypothesis that adult vitamin D (AVD) deficiency in BALB/c mice was associated with (a) adult hippocampal neurogenesis at baseline, b) following 6 weeks of voluntary wheel running and (c) a depressive-like phenotype on the forced swim test (FST), which may be linked to alterations in hippocampal neurogenesis. We assessed proliferation and survival of adult born hippocampal neurons by counting the number of cells positive for Ki67 and doublecortin (DCX), and incorporation of 5-Bromo-2'-Deoxyuridine (BrdU) within newly born mature neurons using immunohistochemistry. There were no significant effects of diet on number of Ki67(+), DCX+ or BrdU(+) cells in the dentate gyrus. All mice showed significantly increased number of Ki67+ cells and BrdU incorporation, and decreased immobility time in the FST, after voluntary wheel running. A significant correlation was found in control mice between immobility time in the FST and level of hippocampal neurogenesis, however, no such correlation was found for AVD-deficient mice. We conclude that AVD deficiency was not associated with impaired proliferation or survival of adult born neurons in BALB/c mice and that the impact on rodent behaviour may not be due to altered neurogenesis per se, but to altered function of new hippocampal neurons or processes independent of adult neurogenesis.	[Groves, Natalie J.; Bradford, DanaKai; Sullivan, Robert K. P.; Conn, Kyna-Anne; Aljelaify, Rasha Fahad; McGrath, John J.; Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [McGrath, John J.; Burne, Thomas H. J.] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia; [McGrath, John J.] Univ Queensland, Discipline Psychiat, St Lucia, Qld, Australia; [Bradford, DanaKai] CSIRO, Queensland Ctr Adv Technol, Pullenvale, Qld, Australia	University of Queensland; Queensland Centre for Mental Health Research; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Burne, THJ (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.; Burne, THJ (corresponding author), Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia.	t.burne@uq.edu.au	Burne, Thomas H/C-5656-2009; Groves, Natalie/S-4541-2016; Sullivan, Robert KP/A-8639-2012; Bradford, DanaKai/B-7561-2017; McGrath, John Joseph/G-5493-2010	Burne, Thomas H/0000-0003-3502-9789; Groves, Natalie/0000-0003-3769-8185; Sullivan, Robert KP/0000-0003-3414-2448; Bradford, DanaKai/0000-0002-2939-3018; McGrath, John Joseph/0000-0002-4792-6068; Aljelaify, Rasha/0000-0003-1923-1936; Conn, Kyna-Anne/0000-0003-2244-7885	National Health and Medical Research Council of Australia [APP1070081]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this study was provided by the National Health and Medical Research Council of Australia, Grant number APP1070081. The funders had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; Banerjee P, 2003, MOL CELL BIOCHEM, V253, P247, DOI 10.1023/A:1026072118217; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Briones TL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-244; CHAO MV, 1994, J NEUROBIOL, V25, P1373, DOI 10.1002/neu.480251106; Clark PJ, 2011, GENES BRAIN BEHAV, V10, P345, DOI 10.1111/j.1601-183X.2010.00674.x; Cui XY, 2007, INT J DEV NEUROSCI, V25, P227, DOI 10.1016/j.ijdevneu.2007.03.006; Cui XY, 2013, AM J CLIN NUTR, V97, P907, DOI 10.3945/ajcn.113.061176; Cunha MP, 2013, MED SCI SPORT EXER, V45, P851, DOI 10.1249/MSS.0b013e31827b23e6; Daly RM, 2012, CLIN ENDOCRINOL, V77, P26, DOI 10.1111/j.1365-2265.2011.04320.x; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; Eyles D, 2009, CLIN CHIM ACTA, V403, P145, DOI 10.1016/j.cca.2009.02.005; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Groves NJ, 2013, BEHAV BRAIN RES, V241, P120, DOI 10.1016/j.bbr.2012.12.001; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; Karolewicz B, 2001, EUR J PHARMACOL, V415, P197, DOI 10.1016/S0014-2999(01)00830-5; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Ko P, 2004, DEV BRAIN RES, V153, P61, DOI 10.1016/j.devbrainres.2004.07.013; KORSCHING S, 1985, EMBO J, V4, P1389, DOI 10.1002/j.1460-2075.1985.tb03791.x; Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; Miller BR, 2015, CURR OPIN NEUROBIOL, V30, P51, DOI 10.1016/j.conb.2014.08.012; Mozaffari-Khosravi H, 2013, J CLIN PSYCHOPHARM, V33, P378, DOI 10.1097/JCP.0b013e31828f619a; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; TOMAC A, 1995, P NATL ACAD SCI USA, V92, P8274, DOI 10.1073/pnas.92.18.8274; Torres-Lista V, 2014, BEHAV PROCESS, V106, P118, DOI 10.1016/j.beproc.2014.05.001; Tyler CR, 2014, NEUROTOXICOLOGY, V44, P98, DOI 10.1016/j.neuro.2014.06.006; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Ylikomi T, 2002, VITAM HORM, V64, P357, DOI 10.1016/S0083-6729(02)64010-5; Zhu Y, 2012, HIPPOCAMPUS, V22, P421, DOI 10.1002/hipo.20908	37	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152328	10.1371/journal.pone.0152328	http://dx.doi.org/10.1371/journal.pone.0152328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043014	gold, Green Published, Green Submitted			2022-12-26	WOS:000373592100014
J	Hiemenz, MC; Kadauke, S; Lieberman, DB; Roth, DB; Zhao, JH; Watt, CD; Daber, RD; Morrissette, JJD				Hiemenz, Matthew C.; Kadauke, Stephan; Lieberman, David B.; Roth, David B.; Zhao, Jianhua; Watt, Christopher D.; Daber, Robert D.; Morrissette, Jennifer J. D.			Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; KRAS MUTATIONS; RARE MUTATIONS; VALIDATION; PARALLEL; RESISTANCE; SURVIVAL; PCR	Next-generation sequencing (NGS) is a powerful platform for identifying cancer mutations. Routine clinical adoption of NGS requires optimized quality control metrics to ensure accurate results. To assess the robustness of our clinical NGS pipeline, we analyzed the results of 304 solid tumor and hematologic malignancy specimens tested simultaneously by NGS and one or more targeted single-gene tests (EGFR, KRAS, BRAF, NPM1, FLT3, and JAK2). For samples that passed our validated tumor percentage and DNA quality and quantity thresholds, there was perfect concordance between NGS and targeted single-gene tests with the exception of two FLT3 internal tandem duplications that fell below the stringent preestablished reporting threshold but were readily detected by manual inspection. In addition, NGS identified clinically significant mutations not covered by single-gene tests. These findings confirm NGS as a reliable platform for routine clinical use when appropriate quality control metrics, such as tumor percentage and DNA quality cutoffs, are in place. Based on our findings, we suggest a simple workflow that should facilitate adoption of clinical oncologic NGS services at other institutions.	[Hiemenz, Matthew C.; Lieberman, David B.; Roth, David B.; Zhao, Jianhua; Watt, Christopher D.; Daber, Robert D.; Morrissette, Jennifer J. D.] Hosp Univ Penn, Dept Pathol & Lab Med, Ctr Personalized Diagnost, 3400 Spruce St, Philadelphia, PA 19104 USA; [Kadauke, Stephan] Univ Penn, Perelman Sch Med, Med Scientist Training Program, Philadelphia, PA USA; [Hiemenz, Matthew C.; Daber, Robert D.] BioReference Labs, Elmwood Pk, NJ USA; [Kadauke, Stephan] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital	Morrissette, JJD (corresponding author), Hosp Univ Penn, Dept Pathol & Lab Med, Ctr Personalized Diagnost, 3400 Spruce St, Philadelphia, PA 19104 USA.	Jennifer.Morrissette@uphs.upenn.edu	Kadauke, Stephan/V-6197-2019	Kadauke, Stephan/0000-0003-2996-8034				Aisner DL, 2013, DIAGN CYTOPATHOL, V41, P316, DOI 10.1002/dc.21851; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aziz N, 2015, ARCH PATHOL LAB MED, V139, P481, DOI 10.5858/arpa.2014-0250-CP; Bauml J, 2013, CLIN LUNG CANCER, V14, P581, DOI 10.1016/j.cllc.2013.05.002; Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Casbon JA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr217; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; Daber R, 2013, CANCER GENET-NY, V206, P441, DOI 10.1016/j.cancergen.2013.11.005; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Endris V, 2013, J MOL DIAGN, V15, P765, DOI 10.1016/j.jmoldx.2013.06.002; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Frank R, 2014, ENDOCR PATHOL, V25, P236, DOI 10.1007/s12022-013-9289-0; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Gowin K, 2013, EXPERT OPIN INV DRUG, V22, P1603, DOI 10.1517/13543784.2013.832199; Grossmann V, 2013, J MOL DIAGN, V15, P473, DOI 10.1016/j.jmoldx.2013.03.003; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Kanagal-Shamanna R, 2014, MODERN PATHOL, V27, P314, DOI 10.1038/modpathol.2013.122; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; McCourt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069604; Mesa RA, 2012, NAT REV DRUG DISCOV, V11, P103, DOI 10.1038/nrd3652; Nikiforova MN, 2013, J CLIN ENDOCR METAB, V98, pE1852, DOI 10.1210/jc.2013-2292; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pritchard CC, 2014, J MOL DIAGN, V16, P56, DOI 10.1016/j.jmoldx.2013.08.004; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Spencer DH, 2013, J MOL DIAGN, V15, P81, DOI 10.1016/j.jmoldx.2012.08.001; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; West H, 2009, J THORAC ONCOL, V4, pS1029, DOI 10.1097/JTO.0b013e3181b27170; Wilson MA, 2014, CANCER GENET-NY, V207, P272, DOI 10.1016/j.cancergen.2014.06.022	44	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152851	10.1371/journal.pone.0152851	http://dx.doi.org/10.1371/journal.pone.0152851			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043212	Green Published, gold, Green Submitted			2022-12-26	WOS:000373592100038
J	Peng, Y; Wang, J; Zhang, M; Niu, PP; Yang, MY; Yang, YL; Zhao, Y				Peng, Ya; Wang, Jun; Zhang, Miao; Niu, Panpan; Yang, Mengya; Yang, Yilin; Zhao, Ying			Inactivation of Semicarbazide-Sensitive Amine Oxidase Stabilizes the Established Atherosclerotic Lesions via Inducing the Phenotypic Switch of Smooth Muscle Cells	PLOS ONE			English	Article							VASCULAR ADHESION PROTEIN-1; MACROPHAGE-LIKE CELLS; CHOLESTEROL; VULNERABILITY; FORMALDEHYDE; PROGRESSION	Given that the elevated serum semicarbazide-sensitive amine oxidase (SSAO) activity is associated with the severity of carotid atherosclerosis in clinic, the current study aims to investigate whether SSAO inactivation by semicarbazide is beneficial for established atherosclerotic lesions in LDLr knockout mice on a high-fat/high-cholesterol Western-type diet or after dietary lipid lowering. Despite no impact on plasma total cholesterol levels, the infiltration of circulating monocytes into peripheral tissues, and the size of atherosclerotic lesions, abrogation of SSAO activity resulted in the stabilization of established lesions as evidenced by the increased collagen contents under both conditions. Moreover, SSAO inactivation decreased Ly6C(high) monocytosis and lesion macrophage contents in hypercholesterolemic mice, while no effect was observed in mice after normalization of hypercholesterolemia by dietary lipid lowering. Strikingly, abrogation of SSAO activity significantly increased not only the absolute numbers of smooth muscle cells (SMCs), but also the percent of SMCs with a synthetic phenotype in established lesions of mice regardless of plasma cholesterol levels. Overall, our data indicate that SSAO inactivation in vivo stabilizes the established plaques mainly via inducing the switch of SMCs from a contractile to a synthetic phenotype. Targeting SSAO activity thus may represent a potential treatment for patients with atherosclerosis.	[Peng, Ya; Niu, Panpan; Yang, Mengya; Yang, Yilin] Soochow Univ, Peoples Hosp Changzhou 1, Dept Neurosurg, Changzhou 213003, Peoples R China; [Wang, Jun] Soochow Univ, Inst Biol, Suzhou 215123, Peoples R China; [Wang, Jun] Soochow Univ, Inst Med Sci, Suzhou 215123, Peoples R China; [Zhang, Miao; Zhao, Ying] Soochow Univ, Dept Pathophysiol, Suzhou 215123, Peoples R China; [Yang, Yilin] Soochow Univ, Peoples Hosp Changzhou 1, Modern Med Res Ctr, Changzhou 213003, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Yang, YL (corresponding author), Soochow Univ, Peoples Hosp Changzhou 1, Dept Neurosurg, Changzhou 213003, Peoples R China.; Zhao, Y (corresponding author), Soochow Univ, Dept Pathophysiol, Suzhou 215123, Peoples R China.; Yang, YL (corresponding author), Soochow Univ, Peoples Hosp Changzhou 1, Modern Med Res Ctr, Changzhou 213003, Peoples R China.	yilinyang.czfph@gmail.com; yzhao@suda.edu.cn	Zhao, Ying/C-3916-2011; Wang, Jun/B-2414-2009; Wang, Jun/AGJ-1311-2022; Zhao, Ying/AAS-7970-2021	Wang, Jun/0000-0002-4458-3741; Wang, Jun/0000-0002-4458-3741; , Miao/0000-0002-5656-2227	National Natural Science Foundation of China [31400768/81470564, 31200672/31370871, 31071046]; Jiangsu Natural Science Foundation [BK20130339]; Jiangsu Provincial Special Program of Medical Science [BL2012004/BL2014051, BL2014035]; Changzhou Applied Basic Science Project [CJ20140059]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial Special Program of Medical Science; Changzhou Applied Basic Science Project; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from National Natural Science Foundation of China (31400768/81470564 (YZ); 31200672/31370871 (JW); 31071046 (YY), Jiangsu Natural Science Foundation (BK20130339 (YZ)), Jiangsu Provincial Special Program of Medical Science (BL2012004/BL2014051 (YZ); BL2014035 (YY)), Changzhou Applied Basic Science Project (CJ20140059 (YP), and a project (JW and YZ) funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Ballantyne CM, 2008, CIRCULATION, V117, P2458, DOI 10.1161/CIRCULATIONAHA.108.773747; Bots ML, 2009, J INTERN MED, V265, P698, DOI 10.1111/j.1365-2796.2009.02073.x; Bour S, 2009, AM J PATHOL, V174, P1075, DOI 10.2353/ajpath.2009.080612; Chaabane C, 2014, CURR OPIN LIPIDOL, V25, P374, DOI 10.1097/MOL.0000000000000113; Chhatriwalla AK, 2009, J AM COLL CARDIOL, V53, P1110, DOI 10.1016/j.jacc.2008.09.065; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; El Hadri K, 2002, ARTERIOSCL THROM VAS, V22, P89, DOI 10.1161/hq0102.101550; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Gray K, 2015, CIRC RES, V116, P816, DOI 10.1161/CIRCRESAHA.116.304921; Karadi I, 2002, CLIN CHIM ACTA, V323, P139, DOI 10.1016/S0009-8981(02)00189-4; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Lee RT, 1997, ARTERIOSCL THROM VAS, V17, P1859, DOI 10.1161/01.ATV.17.10.1859; Li HY, 2009, CLIN CHIM ACTA, V403, P97, DOI 10.1016/j.cca.2009.01.027; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Lutgens E, 2003, ARTERIOSCL THROM VAS, V23, P2123, DOI 10.1161/01.ATV.0000097783.01596.E2; Mercader J, 2011, J OBES, V2011, DOI 10.1155/2011/475786; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Sung HJ, 2005, ANN BIOMED ENG, V33, P1546, DOI 10.1007/s10439-005-7545-2; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Yu PH, 1998, ATHEROSCLEROSIS, V140, P357, DOI 10.1016/S0021-9150(98)00142-7; Yu PH, 1996, ATHEROSCLEROSIS, V120, P189, DOI 10.1016/0021-9150(95)05701-3; Zhao Y, 2011, AM J PATHOL, V179, P1522, DOI 10.1016/j.ajpath.2011.05.020	26	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152758	10.1371/journal.pone.0152758	http://dx.doi.org/10.1371/journal.pone.0152758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043821	Green Published, gold, Green Submitted			2022-12-26	WOS:000373592100031
J	Liu, F; Yuan, JH; Huang, JF; Yang, F; Wang, TT; Ma, JZ; Zhang, L; Zhou, CC; Wang, F; Yu, J; Zhou, WP; Sun, SH				Liu, F.; Yuan, J-H; Huang, J-F; Yang, F.; Wang, T-T; Ma, J-Z; Zhang, L.; Zhou, C-C; Wang, F.; Yu, J.; Zhou, W-P; Sun, S-H			Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a	ONCOGENE			English	Article							INACTIVATION CENTER REGION; CHROMATIN-STRUCTURE; MIRNA PROMOTERS; LIVER-CANCER; SURVIVAL; DISEASE; EPIDEMIOLOGY; PROGRESSION; ACTIVATION; EXPRESSION	It has long been known that males are more susceptible than females to hepatocellular carcinoma (HCC), but the reason remains elusive. In this study, we investigated the expression and function of the long noncoding RNA FTX (lnc-FTX), an X-inactive-specific transcript (XIST) regulator transcribed from the X chromosome inactivation center, in both HCC and HCC gender disparity. lnc-FTX is expressed at higher levels in female livers than in male livers and is significantly downregulated in HCC tissues compared with normal liver tissues. Patients with higher lnc-FTX expression exhibited longer survival, suggesting that lnc-FTX is a useful prognostic factor for HCC patients. lnc-FTX inhibits HCC cell growth and metastasis both in vitro and in vivo. Mechanistically, lnc-FTX represses Wnt/beta-catenin signaling activity by competitively sponging miR-374a and inhibits HCC cell epithelial-mesenchymal transition and invasion. In addition, lnc-FTX binds to the DNA replication licensing factor MCM2, thereby impeding DNA replication and inhibiting proliferation in HCC cells. In conclusion, these findings suggest that lnc-FTX may act as a tumor suppressor in HCC through physically binding miR-374a and MCM2. It may also be one of the reasons for HCC gender disparity and may potentially contribute to HCC treatment.	[Liu, F.; Yuan, J-H; Huang, J-F; Yang, F.; Wang, T-T; Ma, J-Z; Zhang, L.; Zhou, C-C; Wang, F.; Sun, S-H] Second Mil Med Univ, Dept Med Genet, 800 Xiang Yin Rd, Shanghai 200433, Peoples R China; [Yu, J.; Zhou, W-P] Second Mil Med Univ, Eastern Hepatobiliary Hosp, Dept Hepat Surg 3, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Sun, SH (corresponding author), Second Mil Med Univ, Dept Med Genet, 800 Xiang Yin Rd, Shanghai 200433, Peoples R China.	shsun@vip.sina.com	Ma, Jinzhao/M-6520-2014; Yuan, Ji-hang/AAH-4918-2021; Yang, Fu/C-3786-2008; Yang, Fu/L-8441-2019; Zhou, Weiping/AGI-5344-2022	Ma, Jinzhao/0000-0002-9367-6602; Yang, Fu/0000-0003-2459-3923; , Jin-Feng/0000-0002-4757-3418	State Key Program of National Natural Science Foundation of China [81330037]; National Key Basic Research Program of China (973 Program) [2015CB554004]; National Natural Science Foundation of China [31201025, 81301831, 81301692, 81472691, 81402269]; National Natural Science Foundation of Shanghai [13ZR1448300]	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shanghai	We thank Dr Le Qu and Mr Zhi-peng Xu from Department of Urology, Shanghai Changzheng Hospital and Dr Sheng-Xian Yuan and Dr Qi-Fei Tao from the Third Department of Hepatic Surgery, Eastern Hepatobiliary Hospital for technical assistance. This work was supported by grants from the State Key Program of National Natural Science Foundation of China (grant nos 81330037), the National Key Basic Research Program of China (973 Program) (grant nos 2015CB554004), the National Natural Science Foundation of China (grant nos 31201025, 81301831, 81301692, 81472691 and 81402269, and the National Natural Science Foundation of Shanghai (13ZR1448300).	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Buch SC, 2008, HEPATOL INT, V2, P95, DOI 10.1007/s12072-007-9041-2; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Chureau C, 2011, HUM MOL GENET, V20, P705, DOI 10.1093/hmg/ddq516; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dohmen K, 2003, J GASTROEN HEPATOL, V18, P267, DOI 10.1046/j.1440-1746.2003.02936.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Giaginis C, 2010, HISTOL HISTOPATHOL, V25, P351, DOI 10.14670/HH-25.351; Giaginis C, 2009, DIGEST DIS SCI, V54, P282, DOI 10.1007/s10620-008-0305-z; Hartwell HJ, 2014, P NATL ACAD SCI USA, V111, P11455, DOI 10.1073/pnas.1404267111; Hou J, 2014, CANCER CELL, V25, P49, DOI 10.1016/j.ccr.2013.11.011; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ma Y, 2015, GUT; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Quaglia A, 2006, LIVER INT, V26, P424, DOI 10.1111/j.1478-3231.2006.01242.x; Reena RMZ, 2008, ANN DIAGN PATHOL, V12, P340, DOI 10.1016/j.anndiagpath.2008.04.001; Reiche K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106076; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shechter D, 2004, J BIOL CHEM, V279, P45586, DOI 10.1074/jbc.M407772200; Shi L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-93; Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Sun Meiqian, 2010, Front Biosci (Elite Ed), V2, P829; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Xu D, 2013, HEPATOLOGY, V58, P739, DOI 10.1002/hep.26361; Yang DY, 2014, CANCER-AM CANCER SOC, V120, P3707, DOI 10.1002/cncr.28912; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	39	142	145	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 13	2016	35	41					5422	5434		10.1038/onc.2016.80	http://dx.doi.org/10.1038/onc.2016.80			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA5QU	27065331				2022-12-26	WOS:000386677800008
J	Kim, YE; Kim, DH; Roh, YK; Ju, SY; Yoon, YJ; Nam, GE; Nam, HY; Choi, JS; Lee, JE; Sang, JE; Han, K; Park, YG				Kim, Young-Eun; Kim, Do-Hoon; Roh, Yong-Kyun; Ju, Sang-Yhun; Yoon, Yeo-Joon; Nam, Ga-Eun; Nam, Hyo-Yun; Choi, Jun-Seok; Lee, Jong-Eun; Sang, Jung-Eun; Han, Kyungdo; Park, Yong-Gyu			Relationship between Serum Ferritin Levels and Dyslipidemia in Korean Adolescents	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; CARDIOVASCULAR RISK-FACTORS; EXAMINATION SURVEY KNHANES; METABOLIC SYNDROME; NATIONAL-HEALTH; INSULIN-RESISTANCE; DIABETES-MELLITUS; FREE-RADICALS; ASSOCIATION; MEN	Background Ferritin is associated with various cardiometabolic risk factors such as dyslipidemia, hypertension, obesity, and insulin resistance in adults. We aimed to study the association between serum ferritin levels and dyslipidemia in adolescents, because dyslipidemia is considered an important modifiable cardiovascular risk factor in the young. Methods We analyzed 1,879 subjects (1,026 boys and 853 girls) from the 2009-2010 Korean National Health and Nutrition Examination Survey IV. Subjects were categorized into quartiles according to their lipid parameters, which were classified according to age and gender. Those in the highest quartile groups for total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglyceride concentrations were diagnosed as having dyslipidemia. Those in the lowest quartile for high-density lipoprotein cholesterol (HDL-C) values were diagnosed with abnormal levels. Results In boys, total cholesterol, LDL-C, and triglyceride concentrations were significantly correlated with serum ferritin levels. In both boys and girls, serum ferritin levels were negatively associated with HDL-C values, even after adjusting for all covariates. Furthermore, there was no significant correlation between serum ferritin levels and total cholesterol, LDL, and triglyceride concentrations in girls. Conclusion Serum ferritin levels were significantly associated with major dyslipidemia parameters, more prominently in boys than in girls, and this association represents a cardiometabolic risk factor.	[Kim, Young-Eun; Kim, Do-Hoon; Yoon, Yeo-Joon; Nam, Ga-Eun; Nam, Hyo-Yun; Choi, Jun-Seok; Lee, Jong-Eun; Sang, Jung-Eun] Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea; [Roh, Yong-Kyun] Hallym Univ, Coll Med, Dept Family Med, Chunchon, South Korea; [Ju, Sang-Yhun] Catholic Univ, Dept Family Med, Coll Med, Seoul, South Korea; [Han, Kyungdo; Park, Yong-Gyu] Catholic Univ, Coll Med, Dept Biostat, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Hallym University; Catholic University of Korea; Catholic University of Korea	Kim, DH (corresponding author), Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea.; Park, YG (corresponding author), Catholic Univ, Coll Med, Dept Biostat, Seoul, South Korea.	kmcfm@hanmail.net; ygpark@catholic.ac.kr	Nam, Ga Eun/AAU-6055-2020; Ju, Sang Yhun/Q-2946-2019; Nam, Ga Eun/AAA-1577-2021	Ju, Sang Yhun/0000-0002-0553-7128; Nam, Ga Eun/0000-0002-6739-9904; Kim, Do Hoon/0000-0001-7421-4501; Park, Yong Gyu/0000-0002-8721-3230; Kim, Young-Eun/0000-0003-0694-6844				Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Chang JS, 2013, ASIA PAC J CLIN NUTR, V22, P400, DOI 10.6133/apjcn.2013.22.3.07; Children NCEPEPoBCLi, 1991, HIGHL REP EXP PAN BL; Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Ferrannini E, 2000, LANCET, V355, P2181, DOI 10.1016/S0140-6736(00)02397-7; Ford ES, 1999, DIABETES CARE, V22, P1978, DOI 10.2337/diacare.22.12.1978; Gillum RF, 2001, INT J OBESITY, V25, P639, DOI 10.1038/sj.ijo.0801561; Han LL, 2014, MOL NUTR FOOD RES, V58, P2189, DOI 10.1002/mnfr.201400088; Iwasaki T, 2005, DIABETES CARE, V28, P2486, DOI 10.2337/diacare.28.10.2486; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Jeon Yeon Jin, 2013, Ann Pediatr Endocrinol Metab, V18, P141, DOI 10.6065/apem.2013.18.3.141; Kalantar-Zadeh K, 2006, CLIN J AM SOC NEPHRO, V1, pS9, DOI 10.2215/CJN.01390406; Kang HT, 2012, CLIN CHIM ACTA, V413, P636, DOI 10.1016/j.cca.2011.12.011; Kavey REW, 2003, CIRCULATION, V107, P1562, DOI 10.1161/01.CIR.0000061521.15730.6E; Kim CW, 2012, METABOLISM, V61, P1182, DOI 10.1016/j.metabol.2012.01.007; Kim CH, 2011, METABOLISM, V60, P414, DOI 10.1016/j.metabol.2010.03.007; Kim DW, 2015, PUBLIC HEALTH NUTR, V18, P1369, DOI 10.1017/S1368980014001712; Kim HM, 2006, AM J EPIDEMIOL, V164, P787, DOI 10.1093/aje/kwj251; Kouda K, 2004, J EPIDEMIOL, V14, P78, DOI 10.2188/jea.14.78; LAUER RM, 1992, PEDIATRICS, V89, P495; Lee BK, 2011, METABOLISM, V60, P1416, DOI 10.1016/j.metabol.2011.02.008; Lee Hye-Ja, 2014, Osong Public Health Res Perspect, V5, P204, DOI 10.1016/j.phrp.2014.06.005; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074168; Liao Y, 2008, ACTA PAEDIATR, V97, P1449, DOI 10.1111/j.1651-2227.2008.00946.x; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P1998, DOI 10.1161/01.ATV.20.8.1998; McGill HC, 2001, CIRCULATION, V103, P1546; Mittendorfer B, 2005, CURR OPIN CLIN NUTR, V8, P367, DOI 10.1097/01.mco.0000172574.64019.98; Moran A, 2002, J CLIN ENDOCR METAB, V87, P4817, DOI 10.1210/jc.2002-020517; Moriarty-Kelsey M, 2010, J PEDIATR ENDOCR MET, V23, P1281, DOI 10.1515/jpem.2010.202; Pham NM, 2013, METABOLISM, V62, P561, DOI 10.1016/j.metabol.2012.07.025; Nishizawa H, 2002, DIABETES, V51, P2734, DOI 10.2337/diabetes.51.9.2734; Park SK, 2012, DIABETES CARE, V35, P2521, DOI 10.2337/dc12-0543; Piperno A, 2002, J HYPERTENS, V20, P1513, DOI 10.1097/00004872-200208000-00013; Tsimihodimos Vasilis, 2006, Metabolic Syndrome and Related Disorders, V4, P196, DOI 10.1089/met.2006.4.196; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang W, 2010, BBA-GEN SUBJECTS, V1800, P760, DOI 10.1016/j.bbagen.2010.03.011; Williams MJA, 2002, ATHEROSCLEROSIS, V165, P179, DOI 10.1016/S0021-9150(02)00233-2; Wilson JG, 2003, AM J MED SCI, V325, P332, DOI 10.1097/00000441-200306000-00004; WOLFF SP, 1993, BRIT MED BULL, V49, P642, DOI 10.1093/oxfordjournals.bmb.a072637; Yalta K, 2011, INT J CARDIOL, V153, P225, DOI 10.1016/j.ijcard.2011.09.057; Yao DC, 2005, FREE RADICAL BIO MED, V39, P1385, DOI 10.1016/j.freeradbiomed.2005.07.015; Yoo KD, 2012, CLIN ENDOCRINOL, V77, P233, DOI 10.1111/j.1365-2265.2011.04248.x; Zandman-Goddard G, 2007, AUTOIMMUN REV, V6, P457, DOI 10.1016/j.autrev.2007.01.016; Zelber-Sagi S, 2007, J HEPATOL, V46, P700, DOI 10.1016/j.jhep.2006.09.018	45	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153167	10.1371/journal.pone.0153167	http://dx.doi.org/10.1371/journal.pone.0153167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070153	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700035
J	Worstell, NC; Krishnan, P; Weatherston, JD; Wu, HJ				Worstell, Nolan C.; Krishnan, Pratik; Weatherston, Joshua D.; Wu, Hung-Jen			Binding Cooperativity Matters: A GM(1)-Like Ganglioside-Cholera Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; CELL-SURFACE; GM1; MICROARRAY; AFFINITY; MEMBRANES; RECEPTOR; SPECIFICITY; DERIVATIVES; EXPRESSION	Protein-glycan recognition is often mediated by multivalent binding. These multivalent bindings can be further complicated by cooperative interactions between glycans and individual glycan binding subunits. Here we have demonstrated a nanocube-based lipid bilayer array capable of quantitatively elucidating binding dissociation constants, maximum binding capacity, and binding cooperativity in a high-throughput format. Taking cholera toxin B subunit (CTB) as a model cooperativity system, we studied both GM(1) and GM(1)-like gangliosides binding to CTB. We confirmed the previously observed CTB-GM(1) positive cooperativity. Surprisingly, we demonstrated fucosyl-GM(1) has approximately 7 times higher CTB binding capacity than GM(1). In order to explain this phenomenon, we hypothesized that the reduced binding cooperativity of fucosyl-GM(1) caused the increased binding capacity. This was unintuitive, as GM(1) exhibited higher binding avidity (16 times lower dissociation constant). We confirmed the hypothesis using a theoretical stepwise binding model of CTB. Moreover, by taking a mixture of fucosyl-GM(1) and GM(2), we observed the mild binding avidity fucosyl-GM(1) activated GM(2) receptors enhancing the binding capacity of the lipid bilayer surface. This was unexpected as GM(2) receptors have negligible binding avidity in pure GM(2) bilayers. These unexpected discoveries demonstrate the importance of binding cooperativity in multivalent binding mechanisms. Thus, quantitative analysis of multivalent protein-glycan interactions in heterogeneous glycan systems is of critical importance. Our user-friendly, robust, and high-throughput nanocube-based lipid bilayer array offers an attractive method for dissecting these complex mechanisms.	[Worstell, Nolan C.; Krishnan, Pratik; Weatherston, Joshua D.; Wu, Hung-Jen] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Wu, HJ (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.	hjwu@tamu.edu	; Wu, Hung-Jen/H-3769-2016	Weatherston, Joshua/0000-0002-7946-1218; Wu, Hung-Jen/0000-0003-3082-7431	National Science Foundation [DBI-0116835]	National Science Foundation(National Science Foundation (NSF))	We would like to acknowledge the Microscopy & Imaging Center at Texas A&M University for use of their FEI Technai G2 F20 FE-TEM, FEI Vitrobot, and FEI Quanta 600 FE-SEM. The FE-SEM acquisition was supported in part by the National Science Foundation under Grant No. DBI-0116835.	Arnaud J, 2013, CHEM SOC REV, V42, P4798, DOI 10.1039/c2cs35435g; Castellana ET, 2007, BIOINTERPHASES, V2, P57, DOI 10.1116/1.2732312; Cecioni S, 2015, CHEM REV, V115, P525, DOI 10.1021/cr500303t; Dawson G, 2015, BBA-MOL CELL BIOL L, V1851, P1026, DOI 10.1016/j.bbalip.2015.02.007; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Giuliani A, 1995, MOL CELL BIOCHEM, V152, P103, DOI 10.1007/BF01076072; Hu S, 2009, PROTEOM CLIN APPL, V3, P148, DOI 10.1002/prca.200800153; Iwabuchi K, 2012, BIOFACTORS, V38, P275, DOI 10.1002/biof.1017; Jung H, 2009, J STRUCT BIOL, V168, P90, DOI 10.1016/j.jsb.2009.05.010; Kim CS, 2012, ANAL CHEM, V84, P6884, DOI 10.1021/ac301511t; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; Lauer S, 2002, BIOCHEMISTRY-US, V41, P1742, DOI 10.1021/bi0112816; Leney AC, 2014, ANAL CHEM, V86, P5271, DOI 10.1021/ac4041179; Lin H, 2014, J AM SOC MASS SPECTR, V25, P104, DOI 10.1007/s13361-013-0751-5; Ma Y, 2012, ANAL BIOANAL CHEM, V404, P51, DOI 10.1007/s00216-012-6096-2; MacKenzie CR, 1997, J BIOL CHEM, V272, P5533, DOI 10.1074/jbc.272.9.5533; MASSERINI M, 1992, BIOCHEMISTRY-US, V31, P2422, DOI 10.1021/bi00123a030; Mikhalyov I, 2011, BBA-BIOMEMBRANES, V1808, P1930, DOI 10.1016/j.bbamem.2011.04.002; Molander-Melin M, 2005, J NEUROCHEM, V92, P171, DOI 10.1111/j.1471-4159.2004.02849.x; Mornet S, 2005, NANO LETT, V5, P281, DOI 10.1021/nl048153y; Niitsoo O, 2011, J COLLOID INTERF SCI, V354, P887, DOI 10.1016/j.jcis.2010.11.013; Palma AS, 2014, CURR OPIN CHEM BIOL, V18, P87, DOI 10.1016/j.cbpa.2014.01.007; Park S, 2013, CHEM SOC REV, V42, P4310, DOI 10.1039/c2cs35401b; Pukin AV, 2007, CHEMBIOCHEM, V8, P1500, DOI 10.1002/cbic.200700266; Rinaldi S, 2009, GLYCOBIOLOGY, V19, P789, DOI 10.1093/glycob/cwp049; SCHENGRUND CL, 1989, J BIOL CHEM, V264, P13233; SCHON A, 1989, BIOCHEMISTRY-US, V28, P5019, DOI 10.1021/bi00438a017; Schwarz A, 1997, J HISTOCHEM CYTOCHEM, V45, P611, DOI 10.1177/002215549704500413; Sheikh KA, 1999, BRAIN, V122, P449, DOI 10.1093/brain/122.3.449; Shi JJ, 2007, J AM CHEM SOC, V129, P5954, DOI 10.1021/ja069375w; Sly KL, 2014, ANAL CHEM, V86, P11045, DOI 10.1021/ac500094v; Sun YG, 2003, NANO LETT, V3, P955, DOI 10.1021/nl034312m; Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164; Tao A, 2006, ANGEW CHEM INT EDIT, V45, P4597, DOI 10.1002/anie.200601277; Tao SC, 2008, GLYCOBIOLOGY, V18, P761, DOI 10.1093/glycob/cwn063; Terrell J, 2008, J LIPOSOME RES, V18, P21, DOI [10.1080/08982100801893929, 10.1080/08982100801893929 ]; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Turnbull WB, 2004, J AM CHEM SOC, V126, P1047, DOI 10.1021/ja0378207; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang LL, 2014, GLYCOBIOLOGY, V24, P507, DOI 10.1093/glycob/cwu019; Wang R, 2011, J DISPER SCI TECHNOL, V32, P532, DOI 10.1080/01932691003757082; Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272; Winter EM, 2006, ANAL CHEM, V78, P174, DOI 10.1021/ac0514927; Wu HJ, 2012, NAT METHODS, V9, P1189, DOI [10.1038/NMETH.2211, 10.1038/nmeth.2211]; Yamazaki V, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-18; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yanagisawa M, 2006, GLYCOBIOLOGY, V16, p19G, DOI 10.1093/glycob/cwl003; Zhu XY, 2009, J AM CHEM SOC, V131, P13646, DOI 10.1021/ja902783n	48	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153265	10.1371/journal.pone.0153265	http://dx.doi.org/10.1371/journal.pone.0153265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070150	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700043
J	Xie, BK; Qin, ZX; Liu, S; Nong, SQ; Ma, QY; Chen, BJ; Liu, MJ; Pan, TB; Liao, DJ				Xie, Bingkun; Qin, Zhaoxian; Liu, Shuai; Nong, Suqun; Ma, Qingyan; Chen, Baojian; Liu, Mingjun; Pan, Tianbiao; Liao, D. Joshua			Cloning of Porcine Pituitary Tumor Transforming Gene 1 and Its Expression in Porcine Oocytes and Embryos	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION FUNCTION; SOMATIC-CELL CLONING; MATERNAL EFFECT GENE; PROTEIN-SYNTHESIS; TRANSCOMPLEMENTARY ACTIVATION; CHROMATID SEPARATION; CLONED EMBRYOS; BINDING-FACTOR; MOUSE EMBRYO; IN-VITRO	Thematernal-to-embryonic transition (MET) is a complex process that occurs during early mammalian embryogenesis and is characterized by activation of the zygotic genome, initiation of embryonic transcription, and replacement of maternal mRNA with embryonic mRNA. The objective of this study was to reveal the temporal expression and localization patterns of PTTG1 during early porcine embryonic development and to establish a relationship between PTTG1 and the MET. To achieve this goal, reverse transcription-polymerase chain reaction (RT-PCR) was performed to clone porcine PTTG1. Subsequently, germinal vesicle (GV)- and metaphase II (MII)-stage oocytes, zygotes, 2-, 4-, and 8-cell-stage embryos, morulas, and blastocysts were produced in vitro and their gene expression was analyzed. The results revealed that the coding sequence of porcine PTTG1 is 609-bp in length and that it encodes a 202-aa polypeptide. Using qRT-PCR, PTTG1 mRNA expression was observed to be maintained at high levels in GV-and MII-stage oocytes. The transcript levels in oocytes were also significantly higher than those in embryos from the zygote to blastocyst stages. Immunohistochemical analyses revealed that porcine PTTG1 was primarily localized to the cytoplasm and partially localized to the nucleus. Further more, the PTTG1 protein levels in MII-stage oocytes and zygotes were significantly higher than those in embryos from the 2-cell to blastocyst stage. After fertilization, the level of this protein began to decrease gradually until the blastocyst stage. The results of our study suggest that porcine PTTG1 is a new candidate maternal effect gene (MEG) that may participate in the processes of oocyte maturation and zygotic genome activation during porcine embryogenesis.	[Xie, Bingkun; Qin, Zhaoxian; Nong, Suqun; Ma, Qingyan; Chen, Baojian; Liu, Mingjun; Pan, Tianbiao] Guangxi Inst Anim Sci, Guangxi Key Lab Livestock Genet Improvement, Nanning, Guangxi, Peoples R China; [Liu, Shuai] Hebei Res Inst Family Planning, Shijiazhuang, Hebei, Peoples R China; [Liao, D. Joshua] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA	University of Minnesota System	Xie, BK (corresponding author), Guangxi Inst Anim Sci, Guangxi Key Lab Livestock Genet Improvement, Nanning, Guangxi, Peoples R China.	bkxie@163.com			National Natural Science Foundation of China [31360544]; Guangxi Natural Science Foundation [2013GXNSFBA019117, 2011GXNSFA018109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was supported by the National Natural Science Foundation of China (Grant No. 31360544) and Guangxi Natural Science Foundation (2013GXNSFBA019117, 2011GXNSFA018109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal JA, 2008, CELL DEATH DIFFER, V15, P202, DOI 10.1038/sj.cdd.4402254; BOUNIOL C, 1995, EXP CELL RES, V218, P57, DOI 10.1006/excr.1995.1130; Bradshaw C, 2007, HISTOL HISTOPATHOL, V22, P219, DOI 10.14670/HH-22.219; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; BrawTal R, 1997, J REPROD FERTIL, V109, P165, DOI 10.1530/jrf.0.1090165; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Chien WW, 2000, J BIOL CHEM, V275, P19422, DOI 10.1074/jbc.M910105199; CROSBY IM, 1988, J REPROD FERTIL, V82, P769, DOI 10.1530/jrf.0.0820769; Dankert D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108907; Davis D L, 1985, J Reprod Fertil Suppl, V33, P115; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; El-Sayed A, 2006, PHYSIOL GENOMICS, V28, P84, DOI 10.1152/physiolgenomics.00111.2006; Evsikov AV, 2009, MOL REPROD DEV, V76, P805, DOI 10.1002/mrd.21038; Fair T, 1997, ANAT EMBRYOL, V195, P327, DOI 10.1007/s004290050052; FREI RE, 1989, J REPROD FERTIL, V86, P637, DOI 10.1530/jrf.0.0860637; Ghanem N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-90; Kim Kyeoung-Hwa, 2014, Clin Exp Reprod Med, V41, P47, DOI 10.5653/cerm.2014.41.2.47; LATHAM KE, 1991, DEVELOPMENT, V112, P921; Li L, 2013, MOL ASPECTS MED, V34, P919, DOI 10.1016/j.mam.2013.01.003; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Li ZC, 2013, CELL REPROGRAM, V15, P459, DOI 10.1089/cell.2013.0010; McCabe CJ, 1999, J ENDOCRINOL, V162, P163, DOI 10.1677/joe.0.1620163; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Pei L, 2000, J BIOL CHEM, V275, P31191, DOI 10.1074/jbc.M002451200; Pierconti F, 2015, ANDROLOGIA, V47, P427, DOI 10.1111/and.12283; RAM PT, 1993, DEV BIOL, V156, P552, DOI 10.1006/dbio.1993.1101; Ramos-Morales F, 2000, ONCOGENE, V19, P403, DOI 10.1038/sj.onc.1203320; Samiec M, 2012, THERIOGENOLOGY, V78, P1855, DOI 10.1016/j.theriogenology.2012.06.029; Samiec M, 2012, POL J VET SCI, V15, P509, DOI 10.2478/v10181-012-0078-3; Samiec M, 2011, POL J VET SCI, V14, P317, DOI 10.2478/v10181-011-0050-7; Samiec M, 2011, POL J VET SCI, V14, P329, DOI 10.2478/v10181-011-0051-6; Samiec M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/814686; Samiec M, 2014, REPROD BIOL, V14, P128, DOI 10.1016/j.repbio.2013.12.006; Samiec M, 2012, ANIM SCI PAP REP, V30, P383; Sangalli JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101022; Sirard MA, 2001, THERIOGENOLOGY, V55, P1241, DOI 10.1016/S0093-691X(01)00480-0; Smith VE, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001699; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Su JM, 2015, J PINEAL RES, V59, P455, DOI 10.1111/jpi.12275; Tong Y, 2007, ONCOGENE, V26, P5596, DOI 10.1038/sj.onc.1210339; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Wang ZY, 2000, J BIOL CHEM, V275, P7459, DOI 10.1074/jbc.275.11.7459; Yao YQ, 2003, BIOCHEM BIOPH RES CO, V304, P60, DOI 10.1016/S0006-291X(03)00537-0; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	49	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153189	10.1371/journal.pone.0153189	http://dx.doi.org/10.1371/journal.pone.0153189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058238	gold, Green Published			2022-12-26	WOS:000373604800021
J	Li, L; Meng, FL; Hu, XY; Qiao, L; Sun, CQ; Tian, HW; Zheng, WT				Li, Lei; Meng, Fanling; Hu, Xiaoying; Qiao, Liang; Sun, Chang Q.; Tian, Hongwei; Zheng, Weitao			TiO2 Band Restructuring by B and P Dopants	PLOS ONE			English	Article							PHOTOCATALYTIC ACTIVITY; VISIBLE-LIGHT; DOPED TIO2; OPTICAL-PROPERTIES; ELECTRONIC-STRUCTURES; TITANIUM-DIOXIDE; BORON; GAP; DEGRADATION; DEFECTS	An examination of the effect of B- and P-doping and codoping on the electronic structure of anatase TiO2 by performing density functional theory calculations revealed the following: (i) B-or P-doping effects are similar to atomic undercoordination effects on local bond relaxation and core electron entrapment; (ii) the locally entrapped charge adds impurity levels within the band gap that could enhance the utilization of TiO2 to absorb visible light and prolong the carrier lifetime; (iii) the core electron entrapment polarizes nonbonding electrons in the upper edges of the valence and conduction bands, which reduces not only the work function but also the band gap; and (iv) work function reduction enhances the reactivity of the carriers and band gap reduction promotes visible-light absorption. These observations may shed light on effective catalyst design and synthesis.	[Li, Lei; Meng, Fanling; Tian, Hongwei; Zheng, Weitao] Jilin Univ, MOE, Dept Mat Sci, Changchun 130023, Peoples R China; [Li, Lei; Meng, Fanling; Tian, Hongwei; Zheng, Weitao] Jilin Univ, MOE, Key Lab Automobile Mat, Changchun 130023, Peoples R China; [Li, Lei; Meng, Fanling; Tian, Hongwei; Zheng, Weitao] Jilin Univ, State Key Lab Superhard Mat, Changchun 130023, Peoples R China; [Hu, Xiaoying; Qiao, Liang] Changchun Univ, Coll Sci, Changchun, Peoples R China; [Sun, Chang Q.] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore	Jilin University; Jilin University; Jilin University; Changchun University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tian, HW; Zheng, WT (corresponding author), Jilin Univ, MOE, Dept Mat Sci, Changchun 130023, Peoples R China.; Tian, HW; Zheng, WT (corresponding author), Jilin Univ, MOE, Key Lab Automobile Mat, Changchun 130023, Peoples R China.; Tian, HW; Zheng, WT (corresponding author), Jilin Univ, State Key Lab Superhard Mat, Changchun 130023, Peoples R China.	tianhw@jlu.edu.cn; wtzheng@jlu.edu.cn	SUN, CHANG/GXM-3680-2022; Hu, Xiaoying/E-2530-2017; Tian, Hongwei/D-4592-2011; Changqing, Sun/B-8698-2008; zheng, weitao/HCH-5112-2022	Hu, Xiaoying/0000-0002-1754-6697; Tian, Hongwei/0000-0002-4111-1087; Changqing, Sun/0000-0003-2076-1133; zheng, weitao/0000-0002-9028-278X	National Natural Science Foundation of China [51472106, 51202017, 51372095]; Natural Science Foundation of Jilin Province [20140101107JC, 20140101092JC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	H.T. was supported by National Natural Science Foundation of China (Grant Nos. 51472106, 51202017 and 51372095, URLs: http://www.nsfc.gov.cn/) and Natural Science Foundation of Jilin Province (Grant Nos. 20140101107JC and 20140101092JC, URLs: http://kjt.jl.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JP, 2014, PHYS CHEM CHEM PHYS, V16, P21016, DOI 10.1039/c4cp01083c; Andrei C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109836; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Asahi R, 2000, PHYS REV B, V61, P7459, DOI 10.1103/PhysRevB.61.7459; BURDETT JK, 1987, J AM CHEM SOC, V109, P3639, DOI 10.1021/ja00246a021; Chen D, 2006, IND ENG CHEM RES, V45, P4110, DOI 10.1021/ie0600902; Feng ND, 2011, J PHYS CHEM C, V115, P2709, DOI 10.1021/jp108008a; Finazzi E, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2996362; Fittipaldi M, 2008, INORG CHIM ACTA, V361, P3980, DOI 10.1016/j.ica.2008.03.052; Gai YQ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.036402; Geng H, 2006, J PHYS-CONDENS MAT, V18, P87, DOI 10.1088/0953-8984/18/1/006; Giannakas AE, 2013, APPL CATAL B-ENVIRON, V132, P460, DOI 10.1016/j.apcatb.2012.12.017; Grabowska E, 2009, PROCEDIA CHEM, V1, P1553, DOI 10.1016/j.proche.2009.11.003; Hou QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122620; Hu ZP, 2011, J PHYS CHEM C, V115, P5841, DOI 10.1021/jp111350u; Huang J, 2012, ANGEW CHEM INT EDIT, V51, P12711, DOI 10.1002/anie.201204341; Li C, 2014, PHYS CHEM CHEM PHYS, V16, P21446, DOI 10.1039/c4cp03587a; Li L, 2015, PHYS CHEM CHEM PHYS, V17, P9867, DOI 10.1039/c4cp05985a; Li L, 2014, APPL SURF SCI, V317, P568, DOI 10.1016/j.apsusc.2014.08.078; Lin L, 2007, APPL CATAL B-ENVIRON, V76, P196, DOI 10.1016/j.apcatb.2007.05.023; Lin YM, 2013, J MATER CHEM A, V1, P4516, DOI 10.1039/c3ta01298k; Liu G, 2008, ANGEW CHEM INT EDIT, V47, P5277, DOI 10.1002/anie.200705633; Liu Y, 2015, J PHYS CHEM C; Patel N, 2015, J PHYS CHEM C, V119, P18581, DOI 10.1021/acs.jpcc.5b05290; Perdew J, CHAPTER UNIFIED THEO; Schrauben JN, 2012, SCIENCE, V336, P1298, DOI 10.1126/science.1220234; Segall MD, 2002, J PHYS-CONDENS MAT, V14, P2717, DOI 10.1088/0953-8984/14/11/301; Sun C. Q., 2014, RELAXATION CHEM BOND; Sun C.Q., 2010, USA patent: publication: US, Patent No. [20130090865, US20130090865]; Wang P, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.193103; Weiher N, 2007, J AM CHEM SOC; Wendt S, 2008, SCIENCE, V320, P1755, DOI 10.1126/science.1159846; Wu YM, 2010, APPL CATAL B-ENVIRON, V97, P182, DOI 10.1016/j.apcatb.2010.03.038; Yang DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024788; Yang KS, 2007, J PHYS CHEM C, V111, P18985, DOI 10.1021/jp0756350; Yu DD, 2015, PHYS LETT A, V379, P1666, DOI 10.1016/j.physleta.2015.04.044; Zaleska A, 2009, APPL CATAL B-ENVIRON, V89, P469, DOI 10.1016/j.apcatb.2009.01.005; Zhao W, 2004, J AM CHEM SOC, V126, P4782, DOI 10.1021/ja0396753; Zhu HX, 2014, PHYS LETT A, V378, P2719, DOI 10.1016/j.physleta.2014.07.029	39	8	8	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152726	10.1371/journal.pone.0152726	http://dx.doi.org/10.1371/journal.pone.0152726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054763	Green Published, gold			2022-12-26	WOS:000373608000037
J	Nair, M; Kurinczuk, JJ; Knight, M				Nair, Manisha; Kurinczuk, Jennnifer J.; Knight, Marian			Establishing a National Maternal Morbidity Outcome Indicator in England: A Population-Based Study Using Routine Hospital Data	PLOS ONE			English	Article							RISK-FACTORS; PERIPARTUM HYSTERECTOMY; POSTPARTUM HEMORRHAGE; CESAREAN DELIVERY; HEALTH FACILITIES; PREGNANCY; CHILDBIRTH; MANAGEMENT; UK; COMPLICATIONS	Introduction As maternal deaths become rarer, monitoring near-miss or severe maternal morbidity becomes important as a tool to measure changes in care quality. Many calls have been made to use routinely available hospital administration data to monitor the quality of maternity care. We investigated 1) the feasibility of developing an English Maternal Morbidity Outcome Indicator (EMMOI) by reproducing an Australian indicator using routinely available hospital data, 2) the impact of modifications to the indicator to address potential data quality issues, 3) the reliability of the indicator. Methods We used data from 6,389,066 women giving birth in England from April 2003 to March 2013 available in the Hospital Episode Statistics (HES) database of the Health and Social care Information centre (HSCIC). A composite indicator, EMMOI, was generated from the diagnoses and procedure codes. Rates of individual morbid events included in the EMMOI were compared with the rates in the UK reported by population-based studies. Results EMMOI included 26 morbid events (17 diagnosis and 9 procedures). Selection of the individual morbid events was guided by the Australian indicator and published literature for conditions associated with maternal morbidity and mortality in the UK, but was mainly driven by the quality of the routine hospital data. Comparing the rates of individual morbid events of the indicator with figures from population-based studies showed that the possibility of false positive and false negative cases cannot be ruled out. Conclusion While routine English hospital data can be used to generate a composite indicator to monitor trends in maternal morbidity during childbirth, the quality and reliability of this monitoring indicator depends on the quality of the hospital data, which is currently inadequate.	[Nair, Manisha; Kurinczuk, Jennnifer J.; Knight, Marian] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England	University of Oxford	Nair, M (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England.	manisha.nair@npeu.ox.ac.uk	Knight, Marian/B-6225-2009	Knight, Marian/0000-0002-1984-4575; Nair, Manisha/0000-0003-0660-5054	National Institute for Health Research (NIHR) Research Professorship [NIHR-RP-011-032]; National Institute for Health Research [RP-PG-0608-10038] Funding Source: researchfish	National Institute for Health Research (NIHR) Research Professorship; National Institute for Health Research(National Institute for Health Research (NIHR))	Knight is funded by a National Institute for Health Research (NIHR) Research Professorship (NIHR-RP-011-032). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001672; Audit Commission, 2002, DAT REM IMPR QUAL PA; Bose P, 2006, BJOG-INT J OBSTET GY, V113, P919, DOI 10.1111/j.1471-0528.2006.01018.x; Bush N, 2013, EUR J PREV CARDIOL, V20, P12, DOI 10.1177/1741826711432117; Chappell LC, 2013, BMJ-BRIT MED J, P346; Chu SY, 2008, AM J OBSTET GYNECOL, V199, pE18, DOI [10.1016/j.ajog.2008.02.038, 10.1016/j.ajog.2007.12.020]; Collins K, 2015, BEST PRACT RES CLIN; Das J., 2014, ARE I BIRTHS I DEATH; Fitzpatrick KE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001184; Fitzpatrick KE, 2015, BJOG INT J OBSTET GY; Gupta S, 2015, J OBSTET GYN INDIA, V65, P23, DOI 10.1007/s13224-014-0558-8; Halder A, 2014, J TURK-GER GYNECOL A, V15, P222, DOI 10.5152/jtgga.2014.14076; Health & Social Care Information Centre, HOSP EP STAT; Hollowel J, 2011, 4 NIHR SERV DEL ORG; Hospital Episode Statistics, 2010, DAT DICT INP; Johanson R, 2002, BRIT MED J, V324, P892, DOI 10.1136/bmj.324.7342.892; Kayem G, 2011, BJOG-INT J OBSTET GY, V118, P856, DOI 10.1111/j.1471-0528.2011.02921.x; Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1072, DOI 10.1111/j.1471-0528.2007.01423.x; Knight M, 2008, BJOG-INT J OBSTET GY, V115, P453, DOI 10.1111/j.1471-0528.2007.01622.x; Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1380, DOI 10.1111/j.1471-0528.2007.01507.x; Knight M, 2014, SAVING LIVES IMPROVI, P2014; Kurinczuk Jennifer J., 2015, SAVING LIVES IMPROVI; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Morris S, 2003, BRIT MED J, V327, P1277, DOI 10.1136/bmj.327.7426.1277; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; O'Dowd A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5785; Oteng-Ntim E, 2015, BRIT J HAEMATOL, V169, P129, DOI 10.1111/bjh.13270; Paul BK, 2002, SOC SCI MED, V54, P1755, DOI 10.1016/S0277-9536(01)00148-4; Quality Information Committee, 2013, 1 NAT DAT QUAL REP H; Quinn AC, 2012, BRIT J ANAESTHESIA; Rajasekar D, 1997, BRIT J OBSTET GYNAEC, V104, P731, DOI 10.1111/j.1471-0528.1997.tb11986.x; Randive B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067452; Roberts CL, 2008, MED CARE, V46, P786, DOI 10.1097/MLR.0b013e318178eae4; Roberts CL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-7; Royal College of Obstetricians and Gynaecologists, 2013, PATT MAT CAR ENGL NH; Scott CA, 2012, OBSTET GYNECOL, V120, P318, DOI 10.1097/AOG.0b013e31825f287c; SCOTT DB, 1990, BRIT J ANAESTH, V64, P537, DOI 10.1093/bja/64.5.537; Selo-Ojeme Dan O., 2005, Archives of Gynecology and Obstetrics, V271, P154, DOI 10.1007/s00404-004-0715-x; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Smith J, 2007, J OBSTET GYNAECOL, V27, P44, DOI 10.1080/01443610601016925; Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129; Spencer SA, 2011, HOSP EPISODE STAT HE; Statistics E, 2014, ANN REPORT; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Wen SW, 2005, CAN MED ASSOC J, V173, P759, DOI 10.1503/cmaj.045156; Wyber R, 2015, B WORLD HEALTH ORGAN, V93, P203, DOI 10.2471/BLT.14.139022; Zelop C, 2004, CLIN OBSTET GYNECOL, V47, P386, DOI 10.1097/00003081-200406000-00012	48	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153370	10.1371/journal.pone.0153370	http://dx.doi.org/10.1371/journal.pone.0153370			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054761	Green Published, gold			2022-12-26	WOS:000373608000125
J	Alexandrou, AJ; Brown, AR; Chapman, ML; Estacion, M; Turner, J; Mis, MA; Wilbrey, A; Payne, EC; Gutteridge, A; Cox, PJ; Doyle, R; Printzenhoff, D; Lin, ZX; Marron, BE; West, C; Swain, NA; Storer, RI; Stupple, PA; Castle, NA; Hounshell, JA; Rivara, M; Randall, A; Dib-Hajj, SD; Krafte, D; Waxman, SG; Patel, MK; Butt, RP; Stevens, EB				Alexandrou, Aristos J.; Brown, Adam R.; Chapman, Mark L.; Estacion, Mark; Turner, Jamie; Mis, Malgorzata A.; Wilbrey, Anna; Payne, Elizabeth C.; Gutteridge, Alex; Cox, Peter J.; Doyle, Rachel; Printzenhoff, David; Lin, Zhixin; Marron, Brian E.; West, Christopher; Swain, Nigel A.; Storer, R. Ian; Stupple, Paul A.; Castle, Neil A.; Hounshell, James A.; Rivara, Mirko; Randall, Andrew; Dib-Hajj, Sulayman D.; Krafte, Douglas; Waxman, Stephen G.; Patel, Manoj K.; Butt, Richard P.; Stevens, Edward B.			Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release	PLOS ONE			English	Article							NA(V)1.7 SODIUM-CHANNELS; ACTION-POTENTIAL PROPAGATION; CLOSED-STATE INACTIVATION; ALPHA-SUBUNIT; MEMBRANE-PROPERTIES; VOLTAGE SENSOR; DORSAL-HORN; PAIN; EXPRESSION; NEURONS	Human genetic studies show that the voltage gated sodium channel 1.7 (Na(v)1.7) is a key molecular determinant of pain sensation. However, defining the Na(v)1.7 contribution to nociceptive signalling has been hampered by a lack of selective inhibitors. Here we report two potent and selective arylsulfonamide Na(v)1.7 inhibitors; PF-05198007 and PF-05089771, which we have used to directly interrogate Na(v)1.7's role in nociceptor physiology. We report that Na(v)1.7 is the predominant functional TTX-sensitive Na-v in mouse and human nociceptors and contributes to the initiation and the upstroke phase of the nociceptor action potential. Moreover, we confirm a role for Na(v)1.7 in influencing synaptic transmission in the dorsal horn of the spinal cord as well as peripheral neuropeptide release in the skin. These findings demonstrate multiple contributions of Na(v)1.7 to nociceptor signalling and shed new light on the relative functional contribution of this channel to peripheral and central noxious signal transmission.	[Alexandrou, Aristos J.; Brown, Adam R.; Turner, Jamie; Mis, Malgorzata A.; Wilbrey, Anna; Payne, Elizabeth C.; Gutteridge, Alex; Cox, Peter J.; Butt, Richard P.; Stevens, Edward B.] Pfizer Neusentis, Portway Buiding,Granta Pk, Cambridge CB21 6GS, England; [Chapman, Mark L.; Printzenhoff, David; Lin, Zhixin; Marron, Brian E.; West, Christopher; Castle, Neil A.; Krafte, Douglas] Pfizer Neusentis, 4222 Emperor Blvd, Durham, NC 27703 USA; [Hounshell, James A.; Rivara, Mirko; Patel, Manoj K.] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22911 USA; [Swain, Nigel A.; Storer, R. Ian; Stupple, Paul A.] Pfizer Neusentis, Worldwide Med Chem, Portway Bldg,Granta Pk, Cambridge CB21 6GS, England; [Doyle, Rachel] Pfizer Global R&D, Ramsgate Rd, Sandwich CT13 9NJ, Kent, England; [Estacion, Mark; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, West Haven, CT 06516 USA; [Estacion, Mark; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Affairs Hosp, West Haven, CT 06516 USA; [Randall, Andrew] Univ Exeter, Sch Med, Hatherly Bldg,Prince Wales Rd, Exeter EX4 4PS, Devon, England; [Chapman, Mark L.; Printzenhoff, David; Lin, Zhixin; Marron, Brian E.; West, Christopher; Castle, Neil A.; Krafte, Douglas] Icagen, 4222 Emperor Blvd, Durham, NC 27703 USA; [Rivara, Mirko] Univ Parma, Dipartimento Farm, I-43100 Parma, Italy; [Doyle, Rachel] Tetrad Discovery Ltd Innovat House Discovery Pk, Ramsgate Rd, Sandwich CT13 9ND, Kent, England; [Mis, Malgorzata A.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Stupple, Paul A.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville Campus,381 Royal Parade, Parkville, Vic 3052, Australia	Pfizer; Pfizer; University of Virginia; Pfizer; Pfizer; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Exeter; University of Parma; Pfizer; University of Bristol; Monash University	Butt, RP; Stevens, EB (corresponding author), Pfizer Neusentis, Portway Buiding,Granta Pk, Cambridge CB21 6GS, England.	Richard.Butt@pfizer.com; Edward.Stevens@pfizer.com	Rivara, Mirko/P-6855-2019; Waxman, Stephen/Z-2507-2019; Estacion, Mark/H-2444-2011; Rivara, Mirko/R-3505-2017	Waxman, Stephen/0000-0001-5718-7177; Estacion, Mark/0000-0002-7271-1165; Rivara, Mirko/0000-0001-6809-0020; Gutteridge, Alex/0000-0001-7515-634X; Randall, Andrew/0000-0001-8852-3671	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075157] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [1099809] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Bagal SK, 2014, BIOORG MED CHEM LETT, V24, P3690, DOI 10.1016/j.bmcl.2014.06.038; Bennett DLH, 2014, LANCET NEUROL, V13, P587, DOI 10.1016/S1474-4422(14)70024-9; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; Black JA, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-82; Blair NT, 2002, J NEUROSCI, V22, P10277; Castle N, 2009, COMB CHEM HIGH T SCR, V12, P107, DOI 10.2174/138620709787047993; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Davidson S, 2014, PAIN, V155, P1861, DOI 10.1016/j.pain.2014.06.017; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Drenth JPH, 2007, J CLIN INVEST, V117, P3603, DOI 10.1172/JCI33297; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Fukuoka T, 2008, J COMP NEUROL, V510, P188, DOI 10.1002/cne.21786; Fukuoka T, 2011, NEUROSCI RES, V70, P164, DOI 10.1016/j.neures.2011.01.020; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Ho C, 2011, MOL CELL NEUROSCI, V46, P159, DOI 10.1016/j.mcn.2010.08.017; JACKSON MB, 1995, J PHYSIOL-LONDON, V483, P597, DOI 10.1113/jphysiol.1995.sp020609; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Klede M, 2003, J NEUROPHYSIOL, V90, P353, DOI 10.1152/jn.01136.2002; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; McCormack K, 2013, P NATL ACAD SCI USA, V110, pE2724, DOI 10.1073/pnas.1220844110; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Muroi Y, 2011, J PHYSIOL-LONDON, V589, P5663, DOI 10.1113/jphysiol.2011.215384; NAGY JI, 1983, J COMP NEUROL, V218, P145, DOI 10.1002/cne.902180203; Passmore Gayle M., 2005, Journal of Pharmacological and Toxicological Methods, V51, P201, DOI 10.1016/j.vascn.2004.08.007; PEARCE RJ, 1994, NEUROSCIENCE, V63, P1041, DOI 10.1016/0306-4522(94)90571-1; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; Raymond CK, 2004, J BIOL CHEM, V279, P46234, DOI 10.1074/jbc.M406387200; RIBEIRODASILVA A, 1989, J COMP NEUROL, V281, P497, DOI 10.1002/cne.902810402; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vasylyev DV, 2014, J NEUROPHYSIOL, V111, P1429, DOI 10.1152/jn.00763.2013; Wilson MJ, 2011, P NATL ACAD SCI USA, V108, P10302, DOI 10.1073/pnas.1107027108; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	44	114	114	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152405	10.1371/journal.pone.0152405	http://dx.doi.org/10.1371/journal.pone.0152405			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050761	Green Published, gold			2022-12-26	WOS:000373603500038
J	Brandtneris, VW; Brandt, ME; Glynn, PW; Gyory, J; Smith, TB				Brandtneris, Viktor W.; Brandt, Marilyn E.; Glynn, Peter W.; Gyory, Joanna; Smith, Tyler B.			Seasonal Variability in Calorimetric Energy Content of Two Caribbean Mesophotic Corals	PLOS ONE			English	Article							REEF CORAL; SCLERACTINIAN CORALS; MONTASTRAEA-CAVERNOSA; ENVIRONMENTAL-STRESS; PORITES-ASTREOIDES; BLEACHED CORALS; MORTALITY RISK; CLIMATE-CHANGE; RED-SEA; TEMPERATURE	Energetic responses of zooxanthellate reef corals along depth gradients have relevance to the refugia potential of mesophotic coral ecosystems (MCEs). Previous observations suggested that MCEs in the Caribbean are thermally buffered during the warmest parts of the year and occur within or just below the chlorophyll maximum, suggesting abundant trophic resources. However, it is not known if mesophotic corals can maintain constant energy needs throughout the year with changing environmental and biological conditions. The energetic content of tissues from the stony coral species Orbicella faveolata and Agaricia lamarcki was measured on the southern insular shelf of St. Thomas, US Virgin Islands (USVI), using micro-bomb calorimetry. Three sites for each species, at depths of 6m, 25m, 38m and 63m, were selected to capture energetic differences across the major vertical range extent of both species in the USVI-and sampled over five periods from April 2013 to April 2014. Mesophotic colonies of O. faveolata exhibited a significant reduction in energetic content during the month of September 2013 compared to mid-depth and shallow colonies (p = 0.032), whereas A. lamarcki experienced similar energetic variability, but with a significant reduction in energy content that occurred in July 2013 for colonies at sites deeper than 25m (p = 0.014). The results of calorimetric analyses indicate that O. faveolata may be at risk during late summer stress events, possibly due to the timing of reproductive activities. The low-point of A. lamarcki energy content, which may also coincide with reproduction, occurs prior to seasonal stress events, indicating contrasting, species-specific responses to environmental variability on MCEs.	[Brandtneris, Viktor W.; Brandt, Marilyn E.; Smith, Tyler B.] Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA; [Glynn, Peter W.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Gyory, Joanna] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA	University of the Virgin Islands; University of Miami; Tulane University	Brandtneris, VW (corresponding author), Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA.	vwbrandt@gmail.com			Black Coral Penalty Fund (US Justice Departments); Virgin Islands Experimental Program to Stimulate Competitive Research (National Science Foundation) [0814417]; Lana Vento Charitable Trust	Black Coral Penalty Fund (US Justice Departments); Virgin Islands Experimental Program to Stimulate Competitive Research (National Science Foundation); Lana Vento Charitable Trust	Funding was provided by the Black Coral Penalty Fund (US Justice Departments), the Virgin Islands Experimental Program to Stimulate Competitive Research (National Science Foundation #0814417) and the Lana Vento Charitable Trust. No funding agency participated in the design or interpretation of the research.	Alamaru A, 2009, GEOCHIM COSMOCHIM AC, V73, P5333, DOI 10.1016/j.gca.2009.06.018; Allemand D, CORAL REFS ECOSYSTEM, P119; Anlauf H, 2011, J EXP MAR BIOL ECOL, V397, P13, DOI 10.1016/j.jembe.2010.11.009; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; BAKER PA, 1975, PHYS EARTH PLANET IN, V10, P135, DOI 10.1016/0031-9201(75)90031-X; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140297; Bongaerts P, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-205; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; Crandall JB, 2016, J EXP MAR BIOL ECOL, V474, P133, DOI 10.1016/j.jembe.2015.10.010; Crook ED, 2013, P NATL ACAD SCI USA, V110, P11044, DOI 10.1073/pnas.1301589110; Edmunds PJ, 2001, MAR BIOL, V139, P981; Gleason DF, 2006, MAR BIOL, V148, P503, DOI 10.1007/s00227-005-0098-y; Glynn PW, 2011, B MAR SCI, V87, P767, DOI 10.5343/bms.2010.1025; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; GOLLEY FB, 1961, ECOLOGY, V42, P581, DOI 10.2307/1932247; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hoegh-Guldberg O, 2011, SCIENCE, V334, P1494, DOI 10.1126/science.334.6062.1494-b; Holstein DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12407; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Leichter JJ, 2006, MAR ECOL PROG SER, V316, P95, DOI 10.3354/meps316095; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lesser MP, 2000, LIMNOL OCEANOGR, V45, P76, DOI 10.4319/lo.2000.45.1.0076; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; NOAA, 2006, TROP OC COR BLEACH I; PAINE RT, 1966, LIMNOL OCEANOGR, V11, P126, DOI 10.4319/lo.1966.11.1.0126; Palardy JE, 2008, J EXP MAR BIOL ECOL, V367, P180, DOI 10.1016/j.jembe.2008.09.015; Palardy JE, 2006, J EXP MAR BIOL ECOL, V331, P99, DOI 10.1016/j.jembe.2005.10.001; Pratchett MS, 2015, OCEANOGR MAR BIOL, V53, P215; Putnam HM, 2008, BIOL BULL-US, V215, P135, DOI 10.2307/25470694; RICHMOND RH, 1987, B MAR SCI, V41, P594; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; Richmond RH, 1981, P 4 INT COR REEF S M; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Smith TB, 2014, US VIRGIN ISLANDS TE; Smith TB, 2016, GLOBAL CHANGE BIOL, V22, P2756, DOI 10.1111/gcb.13175; STEINER SCC, 1995, B MAR SCI, V56, P899; Steneck RS, 2014, MAR ECOL PROG SER, V506, P115, DOI 10.3354/meps10764; Szmant AM, 1997, MAR BIOL, V129, P561, DOI 10.1007/s002270050197; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Thomas CJ, 2015, DIVERS DISTRIB, V21, P1254, DOI 10.1111/ddi.12360; Thornhill DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029535; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; van Moorsel GWNM, 1982, P 4 INT COR REEF S M; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; Yamashiro H, 2005, FISHERIES SCI, V71, P448, DOI 10.1111/j.1444-2906.2005.00983.x; Ziegler M, 2014, CORAL REEFS, V33, P1115, DOI 10.1007/s00338-014-1192-8	56	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151953	10.1371/journal.pone.0151953	http://dx.doi.org/10.1371/journal.pone.0151953			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050430	Green Submitted, gold, Green Published			2022-12-26	WOS:000373603500018
J	Chiner, E; Llombart, M; Valls, J; Pastor, E; Sancho-Chust, JN; Andreu, AL; Sanchez-de-la-Torre, M; Barbe, F				Chiner, Eusebi; Llombart, Monica; Valls, Joan; Pastor, Esther; Sancho-Chust, Jose N.; Luz Andreu, Ada; Sanchez-de-La-Torre, Manuel; Barbe, Ferran			Association between Obstructive Sleep Apnea and Community-Acquired Pneumonia	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; GASTROESOPHAGEAL-REFLUX; QUANTITATIVE ASPIRATION; RISK; INFLAMMATION; POPULATION; PREVALENCE; HYPOPNEA; OUTCOMES; MODEL	Background We hypothesized that obstructive sleep apnea (OSA) can predispose individuals to lower airway infections and community-acquired pneumonia (CAP) due to upper airway microaspiration. This study evaluated the association between OSA and CAP. Methods We performed a case-control study that included 82 patients with CAP and 41 patients with other infections (control group). The controls were matched according to age, sex and body mass index (BMI). A respiratory polygraph (RP) was performed upon admission for patients in both groups. The severity of pneumonia was assessed according to the Pneumonia Severity Index (PSI). The associations between CAP and the Epworth Sleepiness Scale (ESS), OSA, OSA severity and other sleep-related variables were evaluated using logistic regression models. The associations between OSA, OSA severity with CAP severity were evaluated with linear regression models and non-parametric tests. Findings No significant differences were found between CAP and control patients regarding anthropometric variables, toxic habits and risk factors for CAP. Patients with OSA, defined as individuals with an Apnea-Hypopnea Index (AHI) >= 10, showed an increased risk of CAP (OR = 2.86, 95% CI 1.29-6.44, p = 0.01). Patients with severe OSA (AHI >= 30) also had a higher risk of CAP (OR = 3.18, 95% CI 1.11-11.56, p = 0.047). In addition, OSA severity, defined according to the AHI quartile, was also significantly associated with CAP (p = 0.007). Furthermore, OSA was significantly associated with CAP severity (p = 0.0002), and OSA severity was also associated with CAP severity (p = 0.0006). Conclusions OSA and OSA severity are associated with CAP when compared to patients admitted to the hospital for non-respiratory infections. In addition, OSA and OSA severity are associated with CAP severity. These results support the potential role of OSA in the pathogenesis of CAP and could have clinical implications. This link between OSA and infection risk should be explored to investigate the relationships among gastroesophageal reflux, silent aspiration, laryngeal sensory dysfunction and CAP.	[Chiner, Eusebi; Llombart, Monica; Pastor, Esther; Sancho-Chust, Jose N.; Luz Andreu, Ada] Hosp Univ St Joan dAlacant, Resp Dept, Alacant, Spain; [Valls, Joan] IRB Lleida, Biostat & Epidemiol Unit, Catalonia, Spain; [Sanchez-de-La-Torre, Manuel; Barbe, Ferran] Univ Lleida, IRB Lleida, Resp Dept, Hosp Univ Arnau de Vilanova & Santa Maria, Catalonia, Spain; [Sanchez-de-La-Torre, Manuel; Barbe, Ferran] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain	Institut de Recerca Biomedica - IRB Lleida; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Chiner, E (corresponding author), Hosp Univ St Joan dAlacant, Resp Dept, Alacant, Spain.; Barbe, F (corresponding author), Univ Lleida, IRB Lleida, Resp Dept, Hosp Univ Arnau de Vilanova & Santa Maria, Catalonia, Spain.; Barbe, F (corresponding author), Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain.	echinervives@gmail.com; febarbe.lleida.ics@gencat.cat	Barbé, Ferran/A-5988-2010; de la Torre, Manuel Sanchez/B-5578-2009; Sánchez-de-la-Torre, Manuel/AAC-9514-2022; Sancho-Chust, Jose N./ABH-5025-2020; Chiner, Eusebi/AAM-5120-2020; Sanchez-de-la-Torre, Manuel/AAP-2663-2020; Valls, Joan/GXM-6532-2022	Barbé, Ferran/0000-0002-2340-8928; de la Torre, Manuel Sanchez/0000-0002-5695-348X; Sanchez-de-la-Torre, Manuel/0000-0002-5695-348X; Valls, Joan/0000-0002-4806-7568; Sancho-Chust, Jose N./0000-0002-3028-0715				Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Beal M, 2004, LARYNGOSCOPE, V114, P965, DOI 10.1097/00005537-200406000-00002; Campos-Rodriguez F, 2013, AM J RESP CRIT CARE, V187, P99, DOI 10.1164/rccm.201209-1671OC; Chiner E, 1999, Arch Bronconeumol, V35, P422; Chiner E, 2003, AM J RESP CRIT CARE, V167, pA403; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Friedman M, 2007, ANN OTO RHINOL LARYN, V116, P805, DOI 10.1177/000348940711601103; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Goldbart AD, 2012, CHEST, V141, P1210, DOI 10.1378/chest.11-1998; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Jean RE, 2015, J CRIT CARE, V30, P778, DOI 10.1016/j.jcrc.2015.03.016; Konermann M, 2002, AM J OTOLARYNG, V23, P20, DOI 10.1053/ajot.2002.28775; Lindam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129836; Lindenauer PK, 2014, CHEST, V145, P1032, DOI 10.1378/chest.13-1544; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; MARTIN RJ, 1982, AM REV RESPIR DIS, V125, P175; Menendez R, 2010, ARCH BRONCONEUMOL, V46, P543, DOI 10.1016/j.arbres.2010.06.014; Moreno-Indias I, 2015, EUR RESPIR J, V45, P1055, DOI 10.1183/09031936.00184314; Nacher M, 2007, RESP PHYSIOL NEUROBI, V155, P93, DOI 10.1016/j.resp.2006.06.004; Payne RJ, 2006, OTOLARYNG HEAD NECK, V134, P836, DOI 10.1016/j.otohns.2006.01.012; Ramsey D, 2005, DYSPHAGIA, V20, P218, DOI 10.1007/s00455-005-0018-9; Ravelli AM, 2006, CHEST, V130, P1520, DOI 10.1378/chest.130.5.1520; Sanchez-de-la-Torre M, 2013, LANCET RESP MED, V1, P61, DOI 10.1016/S2213-2600(12)70051-6; Santos-Silva R, 2009, SLEEP, V32, P629, DOI 10.1093/sleep/32.5.629; Schindler A, 2014, DYSPHAGIA, V29, P44, DOI 10.1007/s00455-013-9474-9; Su VYF, 2014, CAN MED ASSOC J, V186, P415, DOI 10.1503/cmaj.131547; SULLIVAN CE, 1979, J APPL PHYSIOL, V47, P17, DOI 10.1152/jappl.1979.47.1.17; Suurna MV, 2008, OTOLARYNG HEAD NECK, V139, P286, DOI 10.1016/j.otohns.2008.03.012; Valbuza JS, 2011, SLEEP BREATH, V15, P209, DOI 10.1007/s11325-010-0474-9; Wang HD, 1998, CHEST, V114, P1496, DOI 10.1378/chest.114.5.1496-a	31	30	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152749	10.1371/journal.pone.0152749	http://dx.doi.org/10.1371/journal.pone.0152749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050437	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500053
J	Iguchi-Manaka, A; Okumura, G; Kojima, H; Cho, Y; Hirochika, R; Bando, H; Sato, T; Yoshikawa, H; Hara, H; Shibuya, A; Shibuya, K				Iguchi-Manaka, Akiko; Okumura, Genki; Kojima, Hiroshi; Cho, Yukiko; Hirochika, Rei; Bando, Hiroko; Sato, Toyomi; Yoshikawa, Hiroyuki; Hara, Hisato; Shibuya, Akira; Shibuya, Kazuko			Increased Soluble CD155 in the Serum of Cancer Patients	PLOS ONE			English	Article							POLIOVIRUS RECEPTOR CD155; NK CELL RECOGNITION; DNAM-1 CD226; ADHESION MOLECULE; FAMILY LIGANDS; POOR-PROGNOSIS; NECTIN-2 CD112; CUTTING EDGE; PVR CD155; EXPRESSION	Emerging evidence suggests that DNAM-1 (CD226) play an important role in the recognition of tumor cells and their lysis by cytotoxic T lymphocytes (CTL) and NK cells. Although the DNAM-1 ligand CD155 is ubiquitously expressed in various tissues, many human tumors significantly upregulate the expression of CD155; DNAM-1 on CTL and NK cells may be involved in tumor immunity. However, unlike those in mice, human tissues also express soluble isoforms of CD155 (sCD155) that lack the transmembrane region. Here, we show that sCD155 levels were significantly higher in the sera of 262 patients with lung, gastrointestinal, breast, and gynecologic cancers than in sera from healthy donors. In addition, the sCD155 levels were significantly higher in patients with early stage (stages 1 and 2) gastric cancer than in healthy donors, and were significantly higher in patients with advanced stage (stages 3 and 4) disease than in patients in those with early stage disease and healthy donors. Moreover, the sCD155 levels were significantly decreased after surgical resection of cancers. Thus, sCD155 level in serum may be potentially useful as a biomarker for cancer development and progression.	[Iguchi-Manaka, Akiko; Bando, Hiroko; Hara, Hisato] Univ Tsukuba, Fac Med, Dept Breast & Endocrine Surg, Tsukuba, Ibaraki, Japan; [Iguchi-Manaka, Akiko; Okumura, Genki; Hirochika, Rei; Shibuya, Akira; Shibuya, Kazuko] Univ Tsukuba, Fac Med, Immunol, Tsukuba, Ibaraki, Japan; [Kojima, Hiroshi] Univ Tsukuba Hosp, Ibaraki Clin Educ & Training Ctr, Tsukuba, Ibaraki, Japan; [Kojima, Hiroshi; Cho, Yukiko] Ibaraki Cent Hosp, Dept Clin Oncol, Kasama, Ibaraki, Japan; [Sato, Toyomi; Yoshikawa, Hiroyuki] Univ Tsukuba, Obstet & Gynecol, Fac Med, Tsukuba, Ibaraki, Japan; [Shibuya, Akira] Univ Tsukuba, Japan Sci & Technol Agcy, CREST, Tsukuba, Ibaraki, Japan; [Shibuya, Akira] Univ Tsukuba, Life Sci Ctr, TARA, Tsukuba, Ibaraki, Japan; [Shibuya, Akira] Japan Agcy Med Res & Dev, AMED, AMED CREST, Tokyo, Japan; [Yoshikawa, Hiroyuki] Ibaraki Cent Hosp, Kasama, Ibaraki 3091793, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tsukuba	Shibuya, K (corresponding author), Univ Tsukuba, Fac Med, Immunol, Tsukuba, Ibaraki, Japan.	kazukos@md.tsukuba.ac.jp		Iguchi, Akiko/0000-0002-0338-130X	Ministry of Education, Culture, Sports, Science and Technology of Japan [26861038, 24249021, 25114701]; Grants-in-Aid for Scientific Research [15K15659, 25293091, 16K14629] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by grants provided by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant number 26861038, 24249021 and 25114701 to AI-M, AS, and KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baury W, 2003, BIOCHEM BIOPH RES CO, V309, P175, DOI 10.1016/S0006-291X(03)01560-2; Bevelacqua V, 2012, ONCOTARGET, V3, P879; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Carlsten M, 2007, CANCER RES, V67, P1317, DOI 10.1158/0008-5472.CAN-06-2264; Castriconi R, 2004, CANCER RES, V64, P9180, DOI 10.1158/0008-5472.CAN-04-2682; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; El-Sherbiny YM, 2007, CANCER RES, V67, P8444, DOI 10.1158/0008-5472.CAN-06-4230; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Iwasaki A, 2002, J INFECT DIS, V186, P585, DOI 10.1086/342682; Kakunaga S, 2004, J BIOL CHEM, V279, P36419, DOI 10.1074/jbc.M406340200; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; Kojima H, 2003, J BIOL CHEM, V278, P36748, DOI 10.1074/jbc.M300702200; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Midis GP, 1996, CANCER RES, V56, P3870; Nakai R, 2010, CANCER SCI, V101, P1326, DOI 10.1111/j.1349-7006.2010.01530.x; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Pauken KE, 2014, CANCER CELL, V26, P785, DOI 10.1016/j.ccell.2014.11.016; Pende D, 2005, BLOOD, V105, P2066, DOI 10.1182/blood-2004-09-3548; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Tahara-Hanaoka S, 2005, BIOCHEM BIOPH RES CO, V329, P996, DOI 10.1016/j.bbrc.2005.02.067; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Ugurel S, 2001, CLIN CANCER RES, V7, P1282; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674	38	62	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152982	10.1371/journal.pone.0152982	http://dx.doi.org/10.1371/journal.pone.0152982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049654	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500077
J	Liu, J; Yan, HF; Ge, XJ				Liu, Juan; Yan, Hai-Fei; Ge, Xue-Jun			The Use of DNA Barcoding on Recently Diverged Species in the Genus Gentiana (Gentianaceae) in China	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACERS; NUCLEOTIDE-SEQUENCES; PHYLOGENY; PLANTS; ITS2; IDENTIFICATION; BIOGEOGRAPHY; EVOLUTION; CRUCIATA; LOCI	DNA barcoding of plants poses particular challenges, especially in differentiating, recently diverged taxa. The genus Gentiana (Gentianaceae) is a species-rich plant group which rapidly radiated in the Himalaya-Hengduan Mountains in China. In this study, we tested the core plant barcode (rbcL + matK) and three promising complementary barcodes (trnH-psbA, ITSand ITS2) in 30 Gentiana species across 6 sections using three methods (the genetic distance-based method, Best CloseMatch and tree-based method). rbcL had the highest PCR efficiency and sequencing success (100%), while the lowest sequence recoverability was from ITS (68.35%). The presence of indels and inversions in trnH-psbA in Gentiana led to difficulties in sequence alignment. When using a single region for analysis, ITS exhibited the highest discriminatory power (60%-74.42%). Of the combinations, matK + ITS provided the highest discrimination success (71.43%-88.24%) and is recommended as the DNA barcode for the genus Gentiana. DNA barcoding proved effective in assigning most species to sections, though it performed poorly in some closely related species in sect. Cruciata because of hybridization events. Our analysis suggests that the status of G. pseudosquarrosa needs to be studied further. The utility of DNA barcoding was also verified in authenticating 'Qin-Jiao' Gentiana medicinal plants (G. macrophylla, G. crassicaulis, G. straminea, and G. dahurica), which can help ensure safe and correct usage of these well-known Chinese traditional medicinal herbs.	[Liu, Juan] Jiangxi Agr Univ, Collaborat Innovat Ctr Jiangxi Typ Trees Cultivat, Nanchang, Peoples R China; [Yan, Hai-Fei; Ge, Xue-Jun] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China	Jiangxi Agricultural University; Chinese Academy of Sciences; South China Botanical Garden, CAS	Ge, XJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	xjge@scbg.ac.cn	Ge, Xue-Jun/AAP-5967-2020	Ge, Xue-Jun/0000-0002-5008-9475; Liu, Juan/0000-0002-6912-1068	National Key Basic Research Program of China (973 Program) [2014CB954100]; Ministry of Science and Technology of the People's Republic of China (MOST) [2011FY120200]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China)	This work was funded by National Key Basic Research Program of China (973 Program) (Grant No. 2014CB954100) [http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm]; the Ministry of Science and Technology of the People's Republic of China (MOST Grant No. 2011FY120200) [http://www.most.gov.cn/eng/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Clement WL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-73; Codes G, 2000, SEQUENCHER VERSION 4; Costion C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026841; Crawford AJ, 2013, MOL ECOL RESOUR, V13, P1005, DOI 10.1111/1755-0998.12054; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dunning LT, 2010, BOT J LINN SOC, V164, P1, DOI 10.1111/j.1095-8339.2010.01071.x; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Gao T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-324; Garcia-Robledo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052967; Graham SW, 2000, INT J PLANT SCI, V161, pS83, DOI 10.1086/317583; Han JP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/741476; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ho T.N., 2001, WORLDWIDE MONOGRAPH; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lanfear R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2836; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Li Xiao-Juan, 2007, Acta Botanica Yunnanica, V29, P91; Liu J, 2015, DIVERS DISTRIB, V21, P188, DOI 10.1111/ddi.12276; Liu ZH, 2012, GENE, V499, P76, DOI 10.1016/j.gene.2012.02.016; Mahadani P, 2013, PHARMACOGN MAG, V9, P255, DOI 10.4103/0973-1296.113284; Mankga LT, 2013, ZOOKEYS, P215, DOI 10.3897/zookeys.365.5730; Miller AM, 2010, P GAT COM ENV WORKSH; Mishiba K, 2009, BREEDING SCI, V59, P119, DOI 10.1270/jsbbs.59.119; Nalawade SM, 2003, BOT BULL ACAD SINICA, V44, P79; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Pang XH, 2013, J NAT MED-TOKYO, V67, P571, DOI 10.1007/s11418-012-0715-2; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Parmentier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054921; Rambaut A, 2007, SE AL VERSION2 0A11; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Saarela JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077982; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010; Wang YM, 2013, J ETHNOPHARMACOL, V147, P341, DOI 10.1016/j.jep.2013.03.016; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Wong KL, 2013, CHIN MED-UK, V8, DOI 10.1186/1749-8546-8-16; Wu LH, 2012, BIOCHEM SYST ECOL, V43, P152, DOI 10.1016/j.bse.2012.03.008; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x; Xin Tian-yi, 2012, Yaoxue Xuebao, V47, P1098; Yan HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122903; Yan HF, 2011, J SYST EVOL, V49, P225, DOI 10.1111/j.1759-6831.2011.00115.x; Yan HF, 2010, J SYST EVOL, V48, P123, DOI 10.1111/j.1759-6831.2010.00068.x; Yan LJ, 2015, MOL ECOLOGY RESOURCE, V10; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Yuan YM, 1996, AM J BOT, V83, P641, DOI 10.2307/2445924; Yuan YM, 1997, BOT J LINN SOC, V123, P25, DOI 10.1006/bojl.1996.0071; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x; Zhang DQ, 2014, BIOCHEM SYST ECOL, V52, P14, DOI 10.1016/j.bse.2013.10.004; Zhang XL, 2006, ACTA PHYTOTAXON SIN, V44, P627, DOI 10.1360/aps06059; Zhang XL, 2009, TAXON, V58, P862, DOI 10.1002/tax.583014; Zheng P, 2011, BIOCHEM SYST ECOL, V39, P704, DOI 10.1016/j.bse.2011.06.002	64	24	35	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153008	10.1371/journal.pone.0153008	http://dx.doi.org/10.1371/journal.pone.0153008			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050315	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500083
J	Martinez-Levasseur, LM; Furgal, CM; Hammill, MO; Burness, G				Martinez-Levasseur, Laura M.; Furgal, Chris M.; Hammill, Mike O.; Burness, Gary			Towards a Better Understanding of the Effects of UV on Atlantic Walruses, Odobenus rosmarus rosmarus: A Study Combining Histological Data with Local Ecological Knowledge	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; TRADITIONAL KNOWLEDGE; CLIMATE-CHANGE; FRESH-WATER; RESISTANCE; ERYTHEMA	Walruses, Odobenus rosmarus, play a key role in the Arctic ecosystem, including northern Indigenous communities, which are reliant upon walruses for aspects of their diet and culture. However, walruses face varied environmental threats including rising sea-water temperatures and decreasing ice cover. An underappreciated threat may be the large amount of solar ultraviolet radiation (UV) that continues to reach the Arctic as a result of ozone loss. UV has been shown to negatively affect whales. Like whales, walrus skin is unprotected by fur, but in contrast, walruses spend long periods of time hauled-out on land. In this study, we combined the results of histological analyses of skin sections from five Atlantic walruses, Odobenus rosmarus rosmarus, collected in Nunavik (Northern Quebec, Canada) with qualitative data obtained through the interviews of 33 local walrus hunters and Inuit Elders. Histological analyses allowed us to explore UV-induced cellular lesions and interviews with experienced walrus hunters and Elders helped us to study the incidences and temporal changes of UV-induced gross lesions in walruses. At the microscopic scale, we detected a range of skin abnormalities consistent with UV damage. However, currently such UV effects do not seem to be widely observed at the whole-animal level (i.e., absence of skin blistering, erythema, eye cataract) by individuals interviewed. Although walruses may experience skin damage under normal everyday UV exposure, the long-term data from local walrus hunters and Inuit Elders did not report a relation between the increased sun radiation secondary to ozone loss and walrus health.	[Martinez-Levasseur, Laura M.; Burness, Gary] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Martinez-Levasseur, Laura M.; Furgal, Chris M.] Trent Univ, Dept Indigenous Studies, Peterborough, ON K9J 7B8, Canada; [Furgal, Chris M.] Trent Univ, Environm Resource Studies & Sci, Peterborough, ON K9J 7B8, Canada; [Hammill, Mike O.] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Mont Joli, PQ G5H 3Z4, Canada	Trent University; Trent University; Trent University; Fisheries & Oceans Canada	Martinez-Levasseur, LM; Burness, G (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.; Martinez-Levasseur, LM (corresponding author), Trent Univ, Dept Indigenous Studies, Peterborough, ON K9J 7B8, Canada.	lmmartinezlevasseur@gmail.com; garyburness@trentu.ca	Burness, Gary/ABB-4937-2020	Martinez-Levasseur, Laura M./0000-0001-8909-5250	Nunavik Marine Region Wildlife Board; Department of Fisheries and Oceans Canada; Foreign Affairs and International Trade Canada; Trent University NSERC Internal Grant; Symons Trust Fund for Canadian Studies; Canadian Foundation for Innovation; Ontario Innovation Trust	Nunavik Marine Region Wildlife Board; Department of Fisheries and Oceans Canada; Foreign Affairs and International Trade Canada; Trent University NSERC Internal Grant; Symons Trust Fund for Canadian Studies; Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust	This project was supported by the Nunavik Marine Region Wildlife Board, Department of Fisheries and Oceans Canada, Foreign Affairs and International Trade Canada, Trent University NSERC Internal Grant, Symons Trust Fund for Canadian Studies and the Canadian Foundation for Innovation and Ontario Innovation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzurro E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024885; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Berkes F, 2007, COAST MANAGE, V35, P143, DOI 10.1080/08920750600970487; Blaustein AR, 2003, DIVERS DISTRIB, V9, P123, DOI 10.1046/j.1472-4642.2003.00015.x; Born EW, 2001, POLAR BIOL, V24, P713; Cockell CS, 2001, PHOTOCHEM PHOTOBIOL, V74, P570, DOI 10.1562/0031-8655(2001)074<0570:EOAFST>2.0.CO;2; Colitz CMH, 2010, JAVMA-J AM VET MED A, V237, P429, DOI 10.2460/javma.237.4.429; Creswell J.W., 2003, RES DESIGN QUALQUAN, DOI DOI 10.2307/1523157; Dahms HU, 2010, AQUAT TOXICOL, V97, P3, DOI 10.1016/j.aquatox.2009.12.002; Anadon JD, 2009, CONSERV BIOL, V23, P617, DOI 10.1111/j.1523-1739.2008.01145.x; Davis A, 2003, HUM ECOL, V31, P463, DOI 10.1023/A:1025075923297; De Fabo Edward C, 2005, Int J Circumpolar Health, V64, P509; Fay F., 1982, N AM FAUNA, P279; Furgal C, 2012, SYNTHESIS CRITICAL R; Gago-Ferrero P, 2013, ENVIRON SCI TECHNOL, V47, P5619, DOI 10.1021/es400675y; Garlich-Miller J., 2011, FIELD REPORT WALRUS; Gilchrist G, 2005, ECOL SOC, V10; Goertz C., 2012, PROCEEDINGS OF THE A; GOETTSCH W, 1994, TOXICOL LETT, V72, P359, DOI 10.1016/0378-4274(94)90049-3; Goettsch W, 1996, PHOTOCHEM PHOTOBIOL, V64, P581, DOI 10.1111/j.1751-1097.1996.tb03108.x; Golden AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098036; Hader DP, 2015, PHOTOCH PHOTOBIO SCI, V14, P108, DOI 10.1039/c4pp90035a; Harrison GI, 2002, METHODS, V28, P14, DOI 10.1016/S1046-2023(02)00205-0; Huntington H, 2006, CHANGING ARCTIC INDI, P61; Huntington HP, 2013, DEEP-SEA RES PT II, V94, P312, DOI 10.1016/j.dsr2.2013.03.016; Huntington HP, 2011, NATURE, V478, P182, DOI 10.1038/478182a; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; Huntington HP, 2004, ENVIRON CONSERV, V31, P177, DOI 10.1017/S0376892904001559; Ishii Y, 1997, HISTOL HISTOPATHOL, V12, P383; Krupnik I, 2007, DEEP-SEA RES PT II, V54, P2946, DOI 10.1016/j.dsr2.2007.08.011; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lindqvist C, 2009, ZOOL SCR, V38, P113, DOI 10.1111/j.1463-6409.2008.00364.x; Mallory ML, 2003, ARCTIC, V56, P293; Manney GL, 2011, NATURE, V478, P469, DOI 10.1038/nature10556; Martinez-Levasseur LM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02386; Martinez-Levasseur LM, 2011, P ROY SOC B-BIOL SCI, V278, P1581, DOI 10.1098/rspb.2010.1903; Nakaseko H, 2003, BRIT J DERMATOL, V148, P122, DOI 10.1046/j.1365-2133.2003.04898.x; Nickels S., 2006, UNIKKAAQATIGIIT PUTT; NOAA, 2014, NORTHERN PINNIPEDS U; Noaa U.S. Fish and Wildlife Service, 2012, UPDAT UNUSUAL MORTAL, P2; Norval M, 2011, PHOTOCH PHOTOBIO SCI, V10, P199, DOI 10.1039/c0pp90044c; Norval M, 2008, PHOTOCHEM PHOTOBIOL, V84, P19, DOI 10.1111/j.1751-1097.2007.00239.x; Orellana C, 2002, LANCET ONCOL, V3, P132, DOI 10.1016/S1470-2045(02)00670-8; Ortonne JP, 1990, BRIT J DERMATOL, V122, P1365; Reeb D, 2007, ANAT REC, V290, P596, DOI 10.1002/ar.20535; Reist JD, 2006, AMBIO, V35, P402, DOI 10.1579/0044-7447(2006)35[402:EOCCAU]2.0.CO;2; SAYRE RM, 1981, J AM ACAD DERMATOL, V5, P439, DOI 10.1016/S0190-9622(81)70106-3; Seidman I., 2006, INTERVIEWING QUALITA; Service CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101595; Sheehan JM, 2002, PHOTOCH PHOTOBIO SCI, V1, P365, DOI 10.1039/b108291d; SPEARMAN RI, 1972, J ANAT, V113, P373; Sweet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041989; Thornton TF, 2012, ECOL SOC, V17, DOI 10.5751/ES-04714-170308; Tobias T. N., 2009, LIVING PROOF ESSENTI; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turco KR, 1991, THESIS U ALASKA FAIR; Turvey ST, 2013, BIOL CONSERV, V157, P352, DOI 10.1016/j.biocon.2012.07.016; WMO (World Meteorological Organization), 2011, 52 WMO GLOB OZ RES M, P438	58	7	8	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152122	10.1371/journal.pone.0152122	http://dx.doi.org/10.1371/journal.pone.0152122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049757	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500027
J	Shuster, Y; Steiner-Mordoch, S; Cudkowicz, NA; Schuldiner, S				Shuster, Yonatan; Steiner-Mordoch, Sonia; Cudkowicz, Noemie Alon; Schuldiner, Shimon			A Transporter Interactome Is Essential for the Acquisition of Antimicrobial Resistance to Antibiotics	PLOS ONE			English	Article							ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE; EFFLUX PUMPS; FLUOROQUINOLONE RESISTANCE; TOPOISOMERASE MUTATIONS; MOLECULAR-MECHANISMS; CHROMOSOMAL GENES; EXPRESSION; STRESS; INHIBITION	Awareness of the problem of antimicrobial resistance (AMR) has escalated and drug-resistant infections are named among the most urgent problems facing clinicians today. Our experiments here identify a transporter interactome and portray its essential function in acquisition of antimicrobial resistance. By exposing E. coli cells to consecutive increasing concentrations of the fluoroquinolone norfloxacin we generated in the laboratory highly resistant strains that carry multiple mutations, most of them identical to those identified in clinical isolates. With this experimental paradigm, we show that the MDTs function in a coordinated mode to provide an essential first-line defense mechanism, preventing the drug reaching lethal concentrations, until a number of stable efficient alterations occur that allow survival. Single-component efflux transporters remove the toxic compounds from the cytoplasm to the periplasmic space where TolC-dependent transporters expel them from the cell. We postulate a close interaction between the two types of transporters to prevent rapid leak of the hydrophobic substrates back into the cell. The findings change the prevalent concept that in Gram-negative bacteria a single multidrug transporter, AcrAB-TolC type, is responsible for the resistance. The concept of a functional interactome, the process of identification of its members, the elucidation of the nature of the interactions and its role in cell physiology will change the existing paradigms in the field. We anticipate that our work will have an impact on the present strategy searching for inhibitors of AcrAB-TolC as adjuvants of existing antibiotics and provide novel targets for this urgent undertaking.	[Shuster, Yonatan; Steiner-Mordoch, Sonia; Cudkowicz, Noemie Alon; Schuldiner, Shimon] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	shimon.schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237	Israel Science Foundation [97/12]; Rosetrees Trust [A1004]; Rosetrees Trust [M497] Funding Source: researchfish	Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Rosetrees Trust(Rosetrees Trust)	This work was funded by Israel Science Foundation 97/12 to SS (http://www.isf.org.il/#/) and Rosetrees Trust A1004 to SS (http://www.rosetreestrust.co.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIZA RR, 1995, J BACTERIOL, V177, P1655, DOI 10.1128/jb.177.7.1655-1661.1995; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; Blair JMA, 2015, P NATL ACAD SCI USA, V112, P3511, DOI 10.1073/pnas.1419939112; Blair JMA, 2015, J ANTIMICROB CHEMOTH, V70, P424, DOI 10.1093/jac/dku380; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Brill S, 2012, P NATL ACAD SCI USA, V109, P16894, DOI 10.1073/pnas.1211831109; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Carlet J, 2011, LANCET, V378, P369, DOI 10.1016/S0140-6736(11)60401-7; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Du DJ, 2015, CURR OPIN STRUC BIOL, V33, P76, DOI 10.1016/j.sbi.2015.07.015; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Federowicz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004264; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Inokuchi H, 2013, J BIOL CHEM, V288, P32952, DOI 10.1074/jbc.M113.507772; Jellen-Ritter AS, 2001, ANTIMICROB AGENTS CH, V45, P1467, DOI 10.1128/AAC.45.5.1467-1472.2001; Johnson JR, 2015, ANTIMICROB AGENTS CH, V59, P4471, DOI 10.1128/AAC.00673-15; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Lindgren PK, 2003, ANTIMICROB AGENTS CH, V47, P3222, DOI 10.1128/AAC.47.10.3222-3232.2003; Lomovskaya O, 1999, ANTIMICROB AGENTS CH, V43, P1340, DOI 10.1128/AAC.43.6.1340; Marcusson LL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000541; Markham PN, 1996, ANTIMICROB AGENTS CH, V40, P2673, DOI 10.1128/AAC.40.11.2673; Morgan-Linnell SK, 2007, ANTIMICROB AGENTS CH, V51, P4205, DOI 10.1128/AAC.00647-07; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2008, J ANTIBIOT, V61, P120, DOI 10.1038/ja.2008.120; Oethinger M, 2000, ANTIMICROB AGENTS CH, V44, P10, DOI 10.1128/AAC.44.1.10-13.2000; Pruteanu M, 2009, RES MICROBIOL, V160, P677, DOI 10.1016/j.resmic.2009.08.012; Redgrave LS, 2014, TRENDS MICROBIOL, V22, P438, DOI 10.1016/j.tim.2014.04.007; Rosner JL, 2013, J BACTERIOL, V195, P1042, DOI 10.1128/JB.01996-12; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sand O, 2003, MICROBIOL-SGM, V149, P2107, DOI 10.1099/mic.0.26363-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tal N, 2009, P NATL ACAD SCI USA, V106, P9051, DOI 10.1073/pnas.0902400106; US Department of Health and Human Services Centers for Disease Control and Prevention., 2013, ANT RES THREATS US; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Zayed AAF, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.4	42	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152917	10.1371/journal.pone.0152917	http://dx.doi.org/10.1371/journal.pone.0152917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050393	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500067
J	Zabeen, B; Craig, ME; Virk, SA; Pryke, A; Chan, AKF; Cho, YH; Benitez-Aguirre, PZ; Hing, S; Donaghue, KC				Zabeen, Bedowra; Craig, Maria E.; Virk, Sohaib A.; Pryke, Alison; Chan, Albert K. F.; Cho, Yoon Hi; Benitez-Aguirre, Paul Z.; Hing, Stephen; Donaghue, Kim C.			Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality	PLOS ONE			English	Article							GLYCEMIC VARIABILITY; DIABETES-MELLITUS; ADVERSE EVENTS; ADOLESCENTS; INFUSION; COMPLICATIONS; CHILDREN; INJECTIONS; SAFETY	Objective To compare rates of microvascular complications in adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI). Research Design and Methods Prospective cohort of 989 patients (aged 12-20 years; diabetes duration >5 years) treated with CSII or MDI for >12 months. Microvascular complications were assessed from 200014: early retinopathy (seven-field fundal photography), peripheral nerve function (thermal and vibration threshold testing), autonomic nerve abnormality (heart rate variability analysis of electrocardiogram recordings) and albuminuria (albumin creatinine ratio/timed overnight albumin excretion). Generalized estimating equations (GEE) were used to examine the relationship between treatment and complications rates, adjusting for socio-economic status (SES) and known risk factors including HbA(1)c and diabetes duration. Results Comparing CSII with MDI: HbA1C was 8.6% [70mmol/mol] vs. 8.7% [72 mmol/mol]) (p = 0.7), retinopathy 17% vs. 22% (p = 0.06); microalbuminuria 1% vs. 4% (p = 0.07), peripheral nerve abnormality 27% vs. 33% (p = 0.108) and autonomic nerve abnormality 24% vs. 28% (p = 0.401). In multivariable GEE, CSII use was associated with lower rates of retinopathy (OR 0.66, 95% CI 0.45-0.95, p = 0.029) and peripheral nerve abnormality (OR 0.63, 95% CI 0.42-0.95, p = 0.026), but not albuminuria (OR 0.46, 95% CI 0.10-2.17, p = 0.33). SES was not associated with any of the complication outcomes. Conclusions In adolescents, CSII use is associated with lower rates of retinopathy and peripheral nerve abnormality, suggesting an apparent benefit of CSII over MDI independent of glycemic control or SES.	[Zabeen, Bedowra; Craig, Maria E.; Virk, Sohaib A.; Pryke, Alison; Chan, Albert K. F.; Cho, Yoon Hi; Benitez-Aguirre, Paul Z.; Donaghue, Kim C.] Childrens Hosp Westmead, Inst Endocrinol & Diabet, Sydney, NSW, Australia; [Zabeen, Bedowra] Bangladesh Inst Res & Rehabil Diabet Endocrine &, Dept Paediat, Dhaka, Bangladesh; [Zabeen, Bedowra] Bangladesh Inst Res & Rehabil Diabet Endocrine &, Changing Diabet Children Program, Dhaka, Bangladesh; [Craig, Maria E.; Virk, Sohaib A.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Craig, Maria E.; Cho, Yoon Hi; Benitez-Aguirre, Paul Z.; Donaghue, Kim C.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Hing, Stephen] Childrens Hosp Westmead, Dept Ophthalmol, Sydney, NSW, Australia	University of Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney	Donaghue, KC (corresponding author), Childrens Hosp Westmead, Inst Endocrinol & Diabet, Sydney, NSW, Australia.; Donaghue, KC (corresponding author), Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia.	kim.donaghue@health.nsw.gov.au	Cho, Yoon Hi/AFQ-6512-2022	Craig, Maria E/0000-0001-6004-576X; Cho, Yoon Hi/0000-0001-6568-8991				[Anonymous], 1995, DIABETES, V44, P968; [Anonymous], 1987, PEDIATRICS, V79, P1; Australian Bureau of Statistic, 2006, SEIFA SOC IND AR; Bragd J, 2008, DIABETES METAB, V34, P612, DOI 10.1016/j.diabet.2008.04.005; Ceriello A, 2003, DIABETOLOGIA, V46, pM9, DOI 10.1007/s00125-002-0931-5; Ceriello A, 2010, DIABETIC MED, V27, P862, DOI 10.1111/j.1464-5491.2010.02967.x; Cho YH, 2015, DIABETES CARE, V38, P676, DOI 10.2337/dc14-1848; Cho YH, 2014, CLIN ENDOCRINOL, V80, P818, DOI 10.1111/cen.12238; DAVIES AG, 1988, ARCH DIS CHILD, V63, P329, DOI 10.1136/adc.63.3.329; Downie E, 2011, DIABETES CARE, V34, P2368, DOI 10.2337/dc11-0102; Hirsch IB, 2015, DIABETES CARE, V38, P1610, DOI 10.2337/dc14-2898; Hoogma RPLM, 2006, DIABETIC MED, V23, P141, DOI 10.1111/j.1464-5491.2005.01738.x; Jeitler K, 2008, DIABETOLOGIA, V51, P941, DOI 10.1007/s00125-008-0974-3; Johnson SR, 2013, DIABETOLOGIA, V56, P2392, DOI 10.1007/s00125-013-3007-9; KLEIN R, 1990, AUST NZ J OPHTHALMOL, V18, P19, DOI 10.1111/j.1442-9071.1990.tb00579.x; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; Lenhard MJ, 2001, ARCH INTERN MED, V161, P2293, DOI 10.1001/archinte.161.19.2293; MECKLENBURG RS, 1982, NEW ENGL J MED, V307, P513, DOI 10.1056/NEJM198208263070901; Mohsin F, 2005, DIABETES CARE, V28, P1974, DOI 10.2337/diacare.28.8.1974; Monami M, 2010, ACTA DIABETOL, V47, pS77, DOI 10.1007/s00592-009-0132-5; Plotnick LP, 2003, DIABETES CARE, V26, P1142, DOI 10.2337/diacare.26.4.1142; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Steineck I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3234; Weissberg-Benchell J, 2003, DIABETES CARE, V26, P1079, DOI 10.2337/diacare.26.4.1079; Wheeler BJ, 2014, DIABETES TECHNOL THE, V16, P558, DOI 10.1089/dia.2013.0388; Wheeler BJ, 2014, DIABETES TECHNOL THE, V16, P204, DOI 10.1089/dia.2013.0315; Yeh HC, 2012, ANN INTERN MED, V157, P336, DOI 10.7326/0003-4819-157-5-201209040-00508	27	55	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153033	10.1371/journal.pone.0153033	http://dx.doi.org/10.1371/journal.pone.0153033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050468	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500087
J	Adapala, NS; Kim, HKW				Adapala, Naga Suresh; Kim, Harry K. W.			Comprehensive Genome-Wide Transcriptomic Analysis of Immature Articular Cartilage following Ischemic Osteonecrosis of the Femoral Head in Piglets	PLOS ONE			English	Article							CALVE-PERTHES DISEASE; LARGE GENE LISTS; EPIPHYSEAL CARTILAGE; GROWTH-PLATE; IN-VITRO; EXPRESSION; NECROSIS; CHONDROCYTES; INFLAMMATION; HYPOXIA	Objective Ischemic osteonecrosis of the femoral head (ONFH) in piglets results in an ischemic injury to the immature articular cartilage. The molecular changes in the articular cartilage in response to ONFH have not been investigated using a transcriptomic approach. The purpose of this study was to perform a genome-wide transcriptomic analysis to identify genes that are upregulated in the immature articular cartilage following ONFH. Methods ONFH was induced in the right femoral head of 6-week old piglets. The unoperated femoral head was used as the normal control. At 24 hours (acute ischemic-hypoxic injury), 2 weeks (avascular necrosis in the femoral head) and 4 weeks (early repair) after surgery (n = 4 piglets/time point), RNA was isolated from the articular cartilage of the femoral head. A microarray analysis was performed using Affymetrix Porcine GeneChip Array. An enrichment analysis and functional clustering of the genes upregulated due to ONFH were performed using DAVID and STRING software, respectively. The increased expression of selected genes was confirmed by a real-time qRTPCR analysis. Results Induction of ONFH resulted in the upregulation of 383 genes at 24 hours, 122 genes at 2 weeks and 124 genes at 4 weeks compared to the normal controls. At 24 hours, the genes involved in oxidoreductive, cell-survival, and angiogenic responses were significantly enriched among the upregulated genes. These genes were involved in HIF-1, PI3K-Akt, and MAPK signaling pathways. At 2 weeks, secretory and signaling proteins involved in angiogenic and inflammatory responses, PI3K-Akt and matrix-remodeling pathways were significantly enriched. At 4 weeks, genes that represent inflammatory cytokines and chemokine signaling pathways were significantly enriched. Several index genes (genes that are upregulated at more than one time point following ONFH and are known to be important in various biological processes) including HIF-1A, VEGFA, IL-6, IL6R, IL-8, CCL2, FGF2, TGFB2, MMP1, MMP3, ITGA5, FN and Col6A1 were upregulated in the immature articular cartilage following ONFH. A qRTPCR analysis of selected genes confirmed the upregulated expression observed in the microarray analysis. Conclusion Immature articular cartilage responds to ONFH by the upregulation of genes involved in hypoxic stress response, angiogenesis, matrix remodeling and inflammation. This study provides novel insights into the multi-faceted role of immature articular cartilage, with inflammation as a key component, following ONFH in piglets.	[Adapala, Naga Suresh; Kim, Harry K. W.] Texas Scottish Rite Hosp Children, Ctr Excellence Hip Disorders, Dallas, TX 75219 USA; [Adapala, Naga Suresh; Kim, Harry K. W.] Univ Texas SW Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kim, HKW (corresponding author), Texas Scottish Rite Hosp Children, Ctr Excellence Hip Disorders, Dallas, TX 75219 USA.; Kim, HKW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA.	Harry.Kim@tsrh.org	Kim, Harry/AAE-1892-2020; Kim, Harry/AAF-7176-2020	Kim, Harry/0000-0002-0330-4777; 	Texas Scottish Rite Hospital for Children	Texas Scottish Rite Hospital for Children	This study was supported by an intramural grant from the Texas Scottish Rite Hospital for Children, awarded to HKWK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CARLSON CS, 1991, J ORTHOP RES, V9, P317, DOI 10.1002/jor.1100090303; Maranho DAC, 2013, J BONE JOINT SURG AM, V95A, P256, DOI 10.2106/JBJS.K.01039; CATTERALL A, 1982, J BONE JOINT SURG BR, V64, P269, DOI 10.1302/0301-620X.64B3.6807991; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066611; GUERNE PA, 1990, J IMMUNOL, V144, P499; Houard X, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0375-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JENSEN OM, 1976, J BONE JOINT SURG BR, V58, P332, DOI 10.1302/0301-620X.58B3.956251; Kamiya N, 2015, J BONE MINER RES, V30, P1009, DOI 10.1002/jbmr.2435; Kamiya N, 2013, BONE, V53, P239, DOI 10.1016/j.bone.2012.11.023; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kim HKW, 2012, J BONE JOINT SURG AM, V94A, P659, DOI 10.2106/JBJS.J.01834; Kim HKW, 2009, BONE, V45, P280, DOI 10.1016/j.bone.2009.03.665; Kim HKW, 2009, J BONE JOINT SURG AM, V91A, P1149, DOI 10.2106/JBJS.H.00654; Kim HKW, 2004, J BONE MINER RES, V19, P2041, DOI 10.1359/JBMR.040911; Kim HKW, 2004, J BONE JOINT SURG AM, V86A, P129, DOI 10.2106/00004623-200401000-00019; Kim HKW, 2001, J BONE JOINT SURG AM, V83A, P688, DOI 10.2106/00004623-200105000-00007; Kim HKW, 2002, J BONE JOINT SURG AM, V84A, P1329, DOI 10.2106/00004623-200208000-00007; Knight DM, 2008, J PEDIATR ORTHOP B, V17, P73, DOI 10.1097/BPB.0b013e3282f1dd18; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; MCANDREW MP, 1984, J BONE JOINT SURG AM, V66A, P860, DOI 10.2106/00004623-198466060-00006; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Pringle D, 2004, J ORTHOPAED RES, V22, P122, DOI 10.1016/S0736-0266(03)00135-9; Pulai JI, 2005, J IMMUNOL, V174, P5781, DOI 10.4049/jimmunol.174.9.5781; Sandell LJ, 2008, OSTEOARTHR CARTILAGE, V16, P1560, DOI 10.1016/j.joca.2008.04.027; Sato T, 2006, ARTHRITIS RHEUM-US, V54, P808, DOI 10.1002/art.21638; Schlichting N, 2014, MOL PHARMACEUT, V11, P2092, DOI 10.1021/mp5000554; STULBERG SD, 1981, J BONE JOINT SURG AM, V63, P1095, DOI 10.2106/00004623-198163070-00006; Szllarczyk D, 2015, NUCLEIC ACIDS RES, pD447, DOI [10.1093/nar/gku1003, DOI 10.1093/NAR/GKU1003]; Zhang C., 2010, SYNTHESIS LECT COMPU, V2, P1, DOI DOI 10.1038/SREP00650; Zhang C, 2011, BONE, V48, P507, DOI 10.1016/j.bone.2010.10.006	37	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153174	10.1371/journal.pone.0153174	http://dx.doi.org/10.1371/journal.pone.0153174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045355	Green Submitted, Green Published, gold			2022-12-26	WOS:000373599600074
J	Kikutake, C; Yahara, K				Kikutake, Chie; Yahara, Koji			Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis	PLOS ONE			English	Article							CANCER-CELLS; HISTONE DEACETYLASES; COLORECTAL-CANCER; PROSTATE-CANCER; GASTRIC-CANCER; EXPRESSION; GENE; METHYLATION; BREAST; GROWTH	Epigenetic mechanisms such as DNA methylation or histone modifications are essential for the regulation of gene expression and development of tissues. Alteration of epigenetic modifications can be used as an epigenetic biomarker for diagnosis and as promising targets for epigenetic therapy. A recent study explored cancer-cell specific epigenetic biomarkers by examining different types of epigenetic modifications simultaneously. However, it was based on microarrays and reported biomarkers that were also present in normal cells at a low frequency. Here, we first analyzed multi-omics data (including ChIP-Seq data of six types of histone modifications: H3K27ac, H3K4me1, H3K9me3, H3K36me3, H3K27me3, and H3K4me3) obtained from 26 lung adenocarcinoma cell lines and a normal cell line. We identified six genes with both H3K27ac and H3K4me3 histone modifications in their promoter regions, which were not present in the normal cell line, but present in >= 85% (22 out of 26) and <= 96% (25 out of 26) of the lung adenocarcinoma cell lines. Of these genes, NUP210 (encoding a main component of the nuclear pore complex) was the only gene in which the two modifications were not detected in another normal cell line. RNA-Seq analysis revealed that NUP210 was aberrantly overexpressed among the 26 lung adenocarcinoma cell lines, although the frequency of NUP210 overexpression was lower (19.3%) in 57 lung adenocarcinoma tissue samples studied and stored in another database. This study provides a basis to discover epigenetic biomarkers highly specific to a certain cancer, based on multi-omics data at the cell population level.	[Kikutake, Chie] Kurume Univ, Sch Med, Div Biostat, Fukuoka, Japan; [Yahara, Koji] Kurume Univ, Biostat Ctr, Kurume, Fukuoka 830, Japan; [Yahara, Koji] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales	Kurume University; Kurume University; Swansea University	Yahara, K (corresponding author), Kurume Univ, Biostat Ctr, Kurume, Fukuoka 830, Japan.; Yahara, K (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.	koji_yahara@med.kurume-u.ac.jp						Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Akhtar MM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-145; Barneda-Zahonero B, 2012, MOL ONCOL, V6, P579, DOI 10.1016/j.molonc.2012.07.003; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Beltran A, 2007, ONCOGENE, V26, P2791, DOI 10.1038/sj.onc.1210072; Blank MBaV, 2015, CANC RES; Brown R, 2014, NAT REV CANCER, V14, P747, DOI 10.1038/nrc3819; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; de las Heras JI, 2013, SEMIN CANCER BIOL, V23, P125, DOI 10.1016/j.semcancer.2012.01.008; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Findeis-Hosey JJ, 2011, HUM PATHOL, V42, P303, DOI 10.1016/j.humpath.2010.06.003; Forde PM, 2014, CLIN CANCER RES, V20, P2244, DOI 10.1158/1078-0432.CCR-13-2088; Galgano MT, 2009, HUM PATHOL, V40, P1434, DOI 10.1016/j.humpath.2009.02.008; Gomez-Cavazos JS, 2015, J CELL BIOL, V208, P671, DOI 10.1083/jcb.201410047; Gu BN, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-39; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Jilg CA, 2014, ONCOTARGET, V5, P12646, DOI 10.18632/oncotarget.2653; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lederer M, 2014, SEMIN CANCER BIOL, V29, P3, DOI 10.1016/j.semcancer.2014.07.006; Liang G, 2002, CANCER RES, V62, P961; Liu FN, 2009, INT J CANCER, V125, P2511, DOI 10.1002/ijc.24588; Luo YX, 2011, INT J CLIN PRACT, V65, P1313, DOI 10.1111/j.1742-1241.2011.02800.x; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Miller GJ, 2003, CANCER RES, V63, P5879; Nagashio R, 2011, INT J CANCER, V129, P1170, DOI 10.1002/ijc.26061; Nakabayashi K, 2004, J MED GENET, V41, P601, DOI 10.1136/jmg.2003.014142; Nakamura J, 2014, WORLD J GASTROENTERO, V20, P11991, DOI 10.3748/wjg.v20.i34.11991; Natarajan TG, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-13; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ribarska T, 2014, EPIGENETICS-US, V9, P704, DOI 10.4161/epi.28006; Salbaum JM, 2000, GENOMICS, V64, P15, DOI 10.1006/geno.2000.6114; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shortridge-Baggett L M, 1996, J N Y State Nurses Assoc, V27, P9; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Suzuki A, 2015, NUCLEIC ACIDS RES, V43, pD87, DOI 10.1093/nar/gku1080; Suzuki A, 2014, NUCLEIC ACIDS RES, V42, P13557, DOI 10.1093/nar/gku885; Takeshima H, 2015, CARCINOGENESIS, V36, P192, DOI 10.1093/carcin/bgu238; Vieira FQ, 2015, ONCOTARGET, V6, P13644, DOI 10.18632/oncotarget.3767; Wan Q, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav019; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; WOZNIAK RW, 1992, J CELL BIOL, V119, P1441, DOI 10.1083/jcb.119.6.1441; Yang H, 2013, CAN J GASTROENTEROL, V27, P467, DOI 10.1155/2013/258030; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145	53	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152918	10.1371/journal.pone.0152918	http://dx.doi.org/10.1371/journal.pone.0152918			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27042856	Green Published, gold, Green Submitted			2022-12-26	WOS:000373592100046
J	Pant, V; Xiong, S; Chau, G; Tsai, K; Shetty, G; Lozano, G				Pant, V.; Xiong, S.; Chau, G.; Tsai, K.; Shetty, G.; Lozano, G.			Distinct downstream targets manifest p53-dependent pathologies in mice	ONCOGENE			English	Article							EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; P53 INHIBITION; MDM2; EXPRESSION; DIFFERENTIATION; INACTIVATION; ACTIVATION; MUTATIONS; STABILITY	Mdm2, the principal negative regulator of p53, is critical for survival, a fact clearly demonstrated by the p53-dependent death of germline or conditional mice following deletion of Mdm2. On the other hand, Mdm2 hypomorphic (Mdm2(Puro Delta 7-12)) or heterozygous (Mdm2(+/-)) mice that express either 30 or 50% of normal Mdm2 levels, respectively, are viable but present distinct phenotypes because of increased p53 activity. Mdm2 levels are also transcriptionally regulated by p53. We evaluated the significance of this reciprocal relationship in a new hypomorphic mouse model inheriting an aberrant Mdm2 allele with insertion of the neomycin cassette and deletion of 184-bp sequence in intron 3. These mice also carry mutations in the Mdm2 P2-promoter and thus express suboptimal levels of Mdm2 entirely encoded from the P1-promoter. Resulting mice exhibit abnormalities in skin pigmentation and reproductive tissue architecture, and are subfertile. Notably, all these phenotypes are rescued on a p53-null background. Furthermore, these phenotypes depend on distinct p53 downstream activities as genetic ablation of the pro-apoptotic gene Puma reverts the reproductive abnormalities but not skin hyperpigmentation, whereas deletion of cell cycle arrest gene p21 does not rescue either phenotype. Moreover, p53-mediated upregulation of Kitl influences skin pigmentation. Altogether, these data emphasize tissue-specific p53 activities that regulate cell fate.	[Pant, V.; Xiong, S.; Chau, G.; Lozano, G.] Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Tsai, K.] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA; [Shetty, G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lozano, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gglozano@mdanderson.org	Xiong, Shunbin/AAR-5823-2021	Chau, Gilda/0000-0002-7907-3290; Shetty, Gunapala/0000-0001-5786-0667; Pant, Vinod/0000-0002-3286-1804	NCI Cancer Center Support Grant [CA16672]; NIH grant [CA47296]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA047296] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Mdm2<SUP>PND/PND</SUP> mice were made by the GEM Facility at the MDACC funded by an NCI Cancer Center Support Grant (CA16672). The studies were supported by NIH grant CA47296 to GL.	ALMON E, 1993, DEV BIOL, V156, P107, DOI 10.1006/dbio.1993.1062; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BARAK Y, 1994, COLD SPRING HARB SYM, V59, P225, DOI 10.1101/SQB.1994.059.01.027; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Liu G, 2007, J PATHOL, V213, P360, DOI 10.1002/path.2238; LUNA RMD, 1995, NATURE, V378, P203; Marino S, 2000, GENE DEV, V14, P994; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; McGowan KA, 2011, BLOOD, V118, P3622, DOI 10.1182/blood-2010-11-318584; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Mendrysa SM, 2000, MOL CELL BIOL, V20, P2023, DOI 10.1128/MCB.20.6.2023-2030.2000; OKURA M, 1995, J INVEST DERMATOL, V105, P322, DOI 10.1111/1523-1747.ep12319939; Pant V, 2014, ONCOTARGET, V5, P1149, DOI 10.18632/oncotarget.1797; Pant V, 2013, GENE DEV, V27, P1857, DOI 10.1101/gad.227249.113; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Post SM, 2010, CANCER CELL, V18, P220, DOI 10.1016/j.ccr.2010.07.010; Shetty G, 2001, ENDOCRINOLOGY, V142, P2789, DOI 10.1210/en.142.7.2789; Steingrimsson E, 2006, DEV DYNAM, V235, P2401, DOI 10.1002/dvdy.20840; Sullivan JM, 2012, RADIAT RES, V177, P307, DOI 10.1667/RR2545.1; Terzian T, 2007, MOL CELL BIOL, V27, P5479, DOI 10.1128/MCB.00555-06; Terzian T, 2011, J PATHOL, V224, P540, DOI 10.1002/path.2891; Vanover JC, 2009, PIGM CELL MELANOMA R, V22, P827, DOI 10.1111/j.1755-148X.2009.00617.x; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103; Zeron-Medina J, 2013, CELL, V155, P410, DOI 10.1016/j.cell.2013.09.017; Zhang Y, 2014, J PATHOL, V233, P380, DOI 10.1002/path.4368	37	15	15	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 3	2016	35	44					5713	5721		10.1038/onc.2016.111	http://dx.doi.org/10.1038/onc.2016.111			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XQ	27065327	Green Accepted			2022-12-26	WOS:000386998400003
J	Hobbs, RP; Batazzi, AS; Han, MC; Coulombe, PA				Hobbs, R. P.; Batazzi, A. S.; Han, M. C.; Coulombe, P. A.			Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo	ONCOGENE			English	Article							ATYPICAL SQUAMOUS-CELLS; INTRAEPITHELIAL NEOPLASIA; UNDETERMINED SIGNIFICANCE; DIAGNOSTIC-VALUE; GENE-EXPRESSION; RESERVE CELLS; MARKER; CYTOKERATIN-17; CANCER; CARCINOMA	Despite preventive human papilloma virus (HPV) vaccination efforts, cervical cancer remains a leading cause of death in women worldwide. Development of therapeutic approaches for cervical cancer are hampered by a lack of mechanistic insight during tumorigenesis. The cytoskeletal protein Keratin 17 (KRT17;K17) is robustly expressed in a broad array of carcinomas, including in cervical tumors, where it has both diagnostic and prognostic value. In this study, we have established multiple functional roles for K17 in the promotion of cervical tumorigenesis in vivo using the established HPV16(tg) mouse model for cervical squamous cell carcinoma. In HPV16tg/+;Krt17(-/-)relative to HPV16(tg/+) reference female mice, onset of cervical lesions is delayed and closely paralleled by marked reductions in hyperplasia, dysplasia and vascularization. In addition, loss of Krt17 is associated with a cytokine polarization and recruitment of effector immune cells to lesion-prone cervical epithelia. Further, we observed marked enhancement of terminal differentiation in HPV16(tg/+); Krt17(-/-)cervical epithelium accompanied by a stimulation and expansion in the expression of p63, a known basal/reserve cell marker in this tissue. Altogether, the data suggest that the loss of Krt17 may foster an overall protective environment for lesion-prone cervical tissue. In addition to providing new insights into the immunomodulatory and cellular mechanisms of cervical tumorigenesis, these findings may help guide the development of future therapies including vaccines.	[Hobbs, R. P.; Batazzi, A. S.; Han, M. C.; Coulombe, P. A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 North Wolfe St, Baltimore, MD 21205 USA; [Coulombe, P. A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Coulombe, P. A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Coulombe, P. A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Coulombe, P. A.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canccr Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 North Wolfe St, Baltimore, MD 21205 USA.	coulombe@jhu.edu			NIH [CA160255, AR44232]; NIH training grant from the National Institutes of Health [CA009110]; NATIONAL CANCER INSTITUTE [R01CA160255, T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank members of the Coulombe laboratory for support, Dr Michelle Kerns for critical reading of the manuscript and Drs Janice Evans, Hyo Lee and TC Wu for advice and assistance. These studies were supported by NIH research grants CA160255 and AR44232 (to PAC) and NIH training grant CA009110 (to RH) from the National Institutes of Health.	Arbeit JM, 1996, P NATL ACAD SCI USA, V93, P2930, DOI 10.1073/pnas.93.7.2930; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chen Y, 2011, ONCOLOGY-BASEL, V80, P333, DOI 10.1159/000329098; Chung BM, 2015, J CELL BIOL, V208, P613, DOI 10.1083/jcb.201408026; Chung SH, 2010, TRENDS ENDOCRIN MET, V21, P504, DOI 10.1016/j.tem.2010.03.005; Cohen-Kerem R, 2004, ANN OTO RHINOL LARYN, V113, P821, DOI 10.1177/000348940411301008; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Escobar-Hoyos LF, 2015, CANCER RES, V75, P3650, DOI 10.1158/0008-5472.CAN-15-0293; Escobar-Hoyos LF, 2014, MODERN PATHOL, V27, P621, DOI 10.1038/modpathol.2013.166; Feng DQ, 2009, ONCOL REP, V22, P1129, DOI 10.3892/or_00000545; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Helt AM, 2002, J VIROL, V76, P10559, DOI 10.1128/JVI.76.20.10559-10568.2002; Herfs M, 2013, J PATHOL, V229, P460, DOI 10.1002/path.4110; Hobbs RP, 2015, NAT GENET, V47, P933, DOI 10.1038/ng.3355; Hopman AHN, 2006, J PATHOL, V210, P412, DOI 10.1002/path.2070; Hopman AHN, 2004, J PATHOL, V202, P23, DOI 10.1002/path.1490; Ide M, 2012, ANN SURG ONCOL, V19, P3506, DOI 10.1245/s10434-012-2437-9; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Lee BN, 2004, CLIN DIAGN LAB IMMUN, V11, P239, DOI 10.1128/CDLI.11.2.239-244.2004; Martens J, 1999, CANCER CYTOPATHOL, V87, P87, DOI 10.1002/(SICI)1097-0142(19990425)87:2<87::AID-CNCR8>3.0.CO;2-L; Martens JE, 2004, ANTICANCER RES, V24, P771; Martens JE, 2009, INT J GYNECOL PATHOL, V28, P381, DOI 10.1097/PGP.0b013e31819932f8; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Mighty KK, 2014, RECENT RESULTS CANC, V193, P135, DOI 10.1007/978-3-642-38965-8_8; MITCHELL MF, 1994, CANCER EPIDEM BIOMAR, V3, P619; Patterson AL, 2013, CELL CYCLE, V12, P2888, DOI 10.4161/cc.25917; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Rodriguez R, 2008, INT J GYNECOL PATHOL, V27, P108, DOI 10.1097/pgp.0b013e31804216b8; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Sankar S, 2013, MOL CELL BIOL, V33, P4448, DOI 10.1128/MCB.00241-13; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; SMEDTS F, 1992, AM J PATHOL, V140, P601; Sun B, 2015, INT J CLIN EXP PATHO, V8, P1783; Thomas M, 1999, ONCOGENE, V18, P7690, DOI 10.1038/sj.onc.1202953; Toyoshima T, 2008, J CANCER RES CLIN, V134, P515, DOI 10.1007/s00432-007-0308-8; Van de Putte G, 2003, GYNECOL ONCOL, V89, P140, DOI 10.1016/S0090-8258(03)00010-6; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Wang YF, 2013, TUMOR BIOL, V34, P1685, DOI 10.1007/s13277-013-0703-5	41	37	37	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 27	2016	35	43					5653	5662		10.1038/onc.2016.102	http://dx.doi.org/10.1038/onc.2016.102			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XP	27065324	Green Accepted			2022-12-26	WOS:000386998300008
J	Hu, PP; Morales, R; Duran-Aniotz, C; Moreno-Gonzalez, I; Khan, U; Soto, C				Hu, Ping Ping; Morales, Rodrigo; Duran-Aniotz, Claudia; Moreno-Gonzalez, Ines; Khan, Uffaf; Soto, Claudio			Role of Prion Replication in the Strain-dependent Brain Regional Distribution of Prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; MISFOLDING CYCLIC AMPLIFICATION; CELL PANEL ASSAY; INFECTIOUS PRIONS; MOLECULAR-BASIS; IN-VITRO; SCRAPIE; PROTEIN; HAMSTERS; DISEASE	One intriguing feature of prion diseases is their strain variation. Prion strains are differentiated by the clinical consequences they generate in the host, their biochemical properties, and their potential to infect other animal species. The selective targeting of these agents to specific brain structures have been extensively used to characterize prion strains. However, the molecular basis dictating strain-specific neurotropism are still elusive. In this study, isolated brain structures from animals infected with four hamster prion strains (HY, DY, 139H, and SSLOW) were analyzed for their content of protease-resistant PrPSc. Our data show that these strains have different profiles of PrP deposition along the brain. These patterns of accumulation, which were independent of regional PrPC production, were not reproduced by in vitro replication when different brain regions were used as substrate for the misfolding-amplification reaction. On the contrary, our results show that in vitro replication efficiency depended exclusively on the amount of PrPC present in each part of the brain. Our results suggest that the variable regional distribution of PrPSc in distinct strains is not determined by differences on prion formation, but on other factors or cellular pathways. Our findings may contribute to understand the molecular mechanisms of prion pathogenesis and strain diversity.	[Hu, Ping Ping; Morales, Rodrigo; Duran-Aniotz, Claudia; Moreno-Gonzalez, Ines; Khan, Uffaf; Soto, Claudio] Univ Texas Houston, Sch Med, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77030 USA; [Hu, Ping Ping] Chongqing Univ, Innovat Drug Res Ctr, Chongqing 401331, Peoples R China; [Duran-Aniotz, Claudia; Soto, Claudio] Univ Los Andes, Fac Med, Ave San Carlos de Apoquindo 2200, Santiago, Chile	University of Texas System; University of Texas Health Science Center Houston; Chongqing University; Universidad de los Andes - Chile	Soto, C (corresponding author), Univ Texas Med Sch, 6431 Fannin St MSE R422, Houston, TX 77030 USA.	Claudio.Soto@uth.tmc.edu	Moreno-Gonzalez, Ines/AAA-2222-2019; Morales, Rodrigo/K-7173-2015; Moreno-Gonzalez, Ines/AAO-1694-2021	Moreno-Gonzalez, Ines/0000-0003-3875-0889; Duran-Aniotz, Claudia/0000-0003-2503-8366	National Institutes of Health [R01NS049173, P01AI077774, P01AI106705]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774, P01AI106705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078745, R01NS049173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grants R01NS049173, P01AI077774, and P01AI106705 (to C. S.). C. S. is the inventor on several patents related to the PMCA technology and is currently Founder, Chief Scientific Officer and Vice-President of Amprion Inc, a bio-tech company focusing on the commercial utilization of PMCA for prion diagnosis. R. M. is the inventor in some patent applications related to the PMCA technique. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bartz JC, 2005, J VIROL, V79, P11858, DOI 10.1128/JVI.79.18.11858-11863.2005; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Falsig J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002985; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Jeffrey M, 2014, NEUROPATH APPL NEURO, V40, P296, DOI 10.1111/nan.12053; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Moudjou M, 2014, MBIO, V5, DOI 10.1128/mBio.00829-13; PATTISON IH, 1961, J COMP PATHOL THERAP, V71, P101, DOI 10.1016/S0368-1742(61)80013-1; Piro JR, 2009, J VIROL, V83, P5321, DOI 10.1128/JVI.02502-08; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa P, 2012, J VIROL, V86, P10494, DOI 10.1128/JVI.01286-12; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0	37	6	6	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12880	12887		10.1074/jbc.M115.681791	http://dx.doi.org/10.1074/jbc.M115.681791			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27056328	Green Published, hybrid			2022-12-26	WOS:000378119900038
J	Dai, RJ; Lu, R; Ahmed, SA				Dai, Rujuan; Lu, Ran; Ahmed, S. Ansar			The Upregulation of Genomic Imprinted DLK1-Dio3 miRNAs in Murine Lupus Is Associated with Global DNA Hypomethylation	PLOS ONE			English	Article							CD4(+) T-CELLS; AUTOIMMUNE-DISEASES; MICRORNA CLUSTER; INTERFERON-GAMMA; NITRIC-OXIDE; METHYLATION; ERYTHEMATOSUS; DOMAIN; EXPRESSION; CANCER	Epigenetic factors such as DNA methylation and microRNAs (miRNAs) are now increasingly recognized as vital contributors to lupus etiology. In this study, we investigated the potential interaction of these two epigenetic factors in lupus-prone MRL-lpr mice. We recently reported dysregulated expression of miRNAs in splenocytes of MRL-lpr mice. Here, we report that a majority of the upregulated miRNAs in MRL-lpr mice is located at the genomic imprinted DLK1-Dio3 domain. Further, we show a differential magnitude of upregulation of DLK1-Dio3 miRNA cluster in purified splenic CD4(+) T, CD19(+) B, and splenic CD4(-)CD19(-) cells from MRL-lpr lupus mice when compared to control MRL mice. MRL-lpr splenocytes (especially CD19(+) and CD4(-)CD19(-) subsets) were hypomethylated compared to cells from control, MRL mice. We further show that deliberate demethylation of splenocytes from control MRL mice, but not from MRL-lpr lupus mice, with specific DNA methylation inhibitor 5-Aza-2'-deoxycytidine significantly augmented DLK1-Dio3 miRNAs expression. These findings strongly indicate that the upregulation of DLK1-Dio3 miRNAs in lupus splenic cell subsets is associated with reduced global DNA methylation levels in lupus cells. There was a differential upregulation of DLK-Dio3 miRNAs among various demethylated splenic cell subsets, which implies varied sensitivity of DLK1-Dio3 miRNA cluster in these cell subsets to DNA hypomethylation. Finally, inhibition of select DLK1-Dio3 miRNA such as miR-154, miR-379 and miR-300 with specific antagomirs significantly reduced the production of lupus-relevant IFN gamma, IL-1 beta, IL-6, and IL-10 in lipopolysaccharide (LPS) activated splenocytes from MRL-lpr mice. Our study is the first to show that DNA methylation regulates genomic imprinted DLK1-Dio3 miRNAs in autoimmune lupus, which suggests a connection of DNA methylation, miRNA and genomic imprinting in lupus pathogenesis.	[Dai, Rujuan; Lu, Ran; Ahmed, S. Ansar] Virginia Tech, Infect Dis Res Facil IDRF, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med VMCVM, Blacksburg, VA USA	Virginia Polytechnic Institute & State University	Dai, RJ; Ahmed, SA (corresponding author), Virginia Tech, Infect Dis Res Facil IDRF, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med VMCVM, Blacksburg, VA USA.	rdai05@vt.edu; ansrahms@vt.edu	lu, ran/HHC-8613-2022		Virginia-Maryland College of Veterinary Medicine (VMCVM); Intramural Research Competition Grant [IRC 175185]; Alliance for Lupus Research (ALR) [219631]	Virginia-Maryland College of Veterinary Medicine (VMCVM); Intramural Research Competition Grant; Alliance for Lupus Research (ALR)	This work was supported by Virginia-Maryland College of Veterinary Medicine (VMCVM, http://www.vetmed.vt.edu/) Intramural Research Competition Grant (IRC 175185) and Alliance for Lupus Research (ALR, http://www.lupusresearch.org/; Award ID: 219631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Balada E, 2007, ANN NY ACAD SCI, V1108, P127, DOI 10.1196/annals.1422.015; Beebe AM, 2002, CYTOKINE GROWTH F R, V13, P403, DOI 10.1016/S1359-6101(02)00025-4; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Carr MS, 2007, GENOMICS, V89, P280, DOI 10.1016/j.ygeno.2006.10.005; Ceribelli A, 2011, ARTHRITIS RHEUM-US, V63, P1177, DOI 10.1002/art.30192; Chafin CB, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/430239; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Coit P, 2013, J AUTOIMMUN, V43, P78, DOI 10.1016/j.jaut.2013.04.003; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Dai R, 2007, J IMMUNOL, V179, P1776, DOI 10.4049/jimmunol.179.3.1776; Dai RJ, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-19; Dai RJ, 2014, THER CLIN RISK MANAG, V10, P151, DOI 10.2147/TCRM.S33517; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005; Hewagama A, 2013, J AUTOIMMUN, V41, P60, DOI 10.1016/j.jaut.2012.12.006; Hewagama A, 2009, J AUTOIMMUN, V33, P3, DOI 10.1016/j.jaut.2009.03.007; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Karpuzoglu E, 2006, ENDOCRINOLOGY, V147, P662, DOI 10.1210/en.2005-0829; Khan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068753; Kono DH, 2006, SPRINGER SEMIN IMMUN, V28, P83, DOI 10.1007/s00281-006-0030-7; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manodoro F, 2014, BLOOD, V123, P2066, DOI 10.1182/blood-2012-12-469833; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Patel DR, 2010, CURR OPIN RHEUMATOL, V22, P478, DOI 10.1097/BOR.0b013e32833ae915; QUDDUS J, 1993, J CLIN INVEST, V92, P38, DOI 10.1172/JCI116576; Richardson Bruce, 2012, Methods Mol Biol, V900, P169, DOI 10.1007/978-1-60761-720-4_8; Richardson BC, 2014, NAT REV RHEUMATOL, V10, P72, DOI 10.1038/nrrheum.2013.211; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sawalha AH, 2007, EUR J IMMUNOL, V37, P1407, DOI 10.1002/eji.200636872; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Shen N, 2012, NAT REV RHEUMATOL, V8, P701, DOI 10.1038/nrrheum.2012.142; Steshina EY, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-44; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Vinuesa CG, 2009, INT REV IMMUNOL, V28, P112, DOI 10.1080/08830180902934909; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Xin CG, 2014, MOL CELL BIOCHEM, V387, P271, DOI 10.1007/s11010-013-1892-3; Yan Sheng, 2014, Immune Netw, V14, P138, DOI 10.4110/in.2014.14.3.138; Yu JS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-121; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zeng TB, 2014, FEBS LETT, V588, P4665, DOI 10.1016/j.febslet.2014.10.038; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhao S, 2011, ARTHRITIS RHEUM-US, V63, P1376, DOI 10.1002/art.30196	55	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153509	10.1371/journal.pone.0153509	http://dx.doi.org/10.1371/journal.pone.0153509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070142	gold, Green Published, Green Submitted			2022-12-26	WOS:000373900700075
J	Leong, KH; Looi, CY; Loong, XM; Cheah, FK; Supratman, U; Litaudon, M; Mustafa, MR; Awang, K				Leong, Kok Hoong; Looi, Chung Yeng; Loong, Xe-Min; Cheah, Foo Kit; Supratman, Unang; Litaudon, Marc; Mustafa, Mohd Rais; Awang, Khalijah			Cycloart-24-ene-26-ol-3-one, a New Cycloartane Isolated from Leaves of Aglaia exima Triggers Tumour Necrosis Factor-Receptor 1-Mediated Caspase-Dependent Apoptosis in Colon Cancer Cell Line	PLOS ONE			English	Article							P53; PROLIFERATION; ACTIVATION; EXPRESSION; COMPLEXES; MECHANISM; PRB	Plants in the Meliaceae family are known to possess interesting biological activities, such as antimalaral, antihypertensive and antitumour activities. Previously, our group reported the plant-derived compound cycloart-24-ene-26-ol-3-one isolated from the hexane extracts of Aglaia exima leaves, which shows cytotoxicity towards various cancer cell lines, in particular, colon cancer cell lines. In this report, we further demonstrate that cycloart-24-ene-26-ol-3-one, from here forth known as cycloartane, reduces the viability of the colon cancer cell lines HT-29 and CaCO-2 in a dose-and time-dependent manner. Further elucidation of the compound's mechanism showed that it binds to tumour necrosis factor-receptor 1 (TNF-R1) leading to the initiation of caspase-8 and, through the activation of Bid, in the activation of caspase-9. This activity causes a reduction in mitochondrial membrane potential (MMP) and the release of cytochrome-C. The activation of caspase-8 and -9 both act to commit the cancer cells to apoptosis through downstream caspase-3/7 activation, PARP cleavage and the lack of NFkB translocation into the nucleus. A molecular docking study showed that the cycloartane binds to the receptor through a hydrophobic interaction with cysteine-96 and hydrogen bonds with lysine-75 and - 132. The results show that further development of the cycloartane as an anti-cancer drug is worthwhile.	[Leong, Kok Hoong; Cheah, Foo Kit] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Leong, Kok Hoong; Mustafa, Mohd Rais; Awang, Khalijah] Univ Malaya, Dept Chem, Fac Sci, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur 59100, Malaysia; [Looi, Chung Yeng; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Loong, Xe-Min; Awang, Khalijah] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia; [Supratman, Unang] Padjadjaran State Univ, Fac Math & Nat Sci, Dept Chem, Jatinangor, Indonesia; [Litaudon, Marc] CNRS 1, Ctr Rech Gif, Inst Chim Subst Nat, Ave Terrasse, Gif Sur Yvette, France	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universitas Padjadjaran; Centre National de la Recherche Scientifique (CNRS)	Awang, K (corresponding author), Univ Malaya, Dept Chem, Fac Sci, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur 59100, Malaysia.; Awang, K (corresponding author), Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia.	khalijah@um.edu.my	Leong, Kok Hoong/J-1956-2015; Leong, Kok Hoong/D-9505-2012; Mustafa, Mohamed R/B-1647-2009; AWANG, KHALIJAH/B-8781-2010; Supratman, Unang/P-2028-2018	Leong, Kok Hoong/0000-0002-7317-6117; Leong, Kok Hoong/0000-0002-7317-6117; Mustafa, Mohamed R/0000-0002-7864-5189; AWANG, KHALIJAH/0000-0001-5971-6570; Supratman, Unang/0000-0003-1104-2321	University of Malaya [RP001/2012A, RP001A-13BIO]; University Malaya High Impact Research [H-20001-E00002]; Ministry of Higher Education of Malaysia [FP006-2011A]	University of Malaya(Universiti Malaya); University Malaya High Impact Research; Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia)	This work was supported by the University of Malaya [grants RP001/2012A, RP001A-13BIO]; University Malaya High Impact Research [grant H-20001-E00002]; and the Ministry of Higher Education of Malaysia [grant FP006-2011A]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awang K, 2012, FITOTERAPIA, V83, P1391, DOI 10.1016/j.fitote.2012.10.004; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Baron DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114158; Breidenbach M, 2003, ANTI-CANCER DRUG, V14, P341, DOI 10.1097/00001813-200306000-00003; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Chau H, 2011, EXP CELL RES, V317, P1841, DOI 10.1016/j.yexcr.2011.05.015; Davis CD, 2010, SEMIN ONCOL, V37, P243, DOI 10.1053/j.seminoncol.2010.05.001; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Farzaneh V, 2015, IND CROP PROD, V65, P247, DOI 10.1016/j.indcrop.2014.10.057; Gannon PO, 2013, EUR J CANCER, V49, P2441, DOI 10.1016/j.ejca.2013.02.026; Ioachim E, 2008, INT J CLIN PRACT, V62, P1736, DOI 10.1111/j.1742-1241.2006.01105.x; Ioachim EE, 1999, ANTICANCER RES, V19, P2147; Iwatsuki M, 2010, INT J CANCER, V126, P1828, DOI 10.1002/ijc.24879; Khazir J, 2014, PHYTOCHEM LETT, V7, P173, DOI 10.1016/j.phytol.2013.11.010; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Liew SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087286; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Liu XH, 2010, BIOORG MED CHEM LETT, V20, P5705, DOI 10.1016/j.bmcl.2010.08.017; Looi CY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-166; MAJNO G, 1995, AM J PATHOL, V146, P3; Milner AE, 2009, CELL DEATH DIFFER, V9, P287; Pan L, 2013, J NAT PROD, V76, P394, DOI 10.1021/np3007588; Pan Li, 2012, Front Biosci (Schol Ed), V4, P142; Paydar M, 2014, DRUG DES DEV THER, V8, P719, DOI 10.2147/DDDT.S58178; Pereira DM, 2012, CURR PHARM BIOTECHNO, V13, P632, DOI 10.2174/138920112799857530; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Sheikh MS, 2003, CELL CYCLE, V2, P550, DOI 10.4161/cc.2.6.566; Shi J, 2008, BIOCHEM PHARMACOL, V75, P1729, DOI 10.1016/j.bcp.2008.01.021; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530	33	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152652	10.1371/journal.pone.0152652	http://dx.doi.org/10.1371/journal.pone.0152652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070314	Green Published, gold			2022-12-26	WOS:000373900700012
J	Xi, XJ; Zhu, YG; Tong, YP; Yang, XL; Tang, NN; Ma, SM; Li, S; Cheng, Z				Xi, Xiu-Jie; Zhu, Yun-Guo; Tong, Ying-Peng; Yang, Xiao-Ling; Tang, Nan-Nan; Ma, Shu-Min; Li, Shan; Cheng, Zhou			Assessment of the Genetic Diversity of Different Job's Tears (Coix lacryma-jobi L.) Accessions and the Active Composition and Anticancer Effect of Its Seed Oil	PLOS ONE			English	Article							MA-YUEN-STAPF; BREAST-CANCER CELLS; FATTY-ACID-COMPOSITION; LACHRYMA-JOBI; LINOLEIC-ACID; ISSR MARKERS; ADLAY SEED; IN-VITRO; PRENEOPLASTIC LESIONS; ETHANOLIC EXTRACT	Job's tears (Coix lachryma-jobi L.) is an important crop used as food and herbal medicine in Asian countries. A drug made of Job's tears seed oil has been clinically applied to treat multiple cancers. In this study, the genetic diversity of Job's tears accessions and the fatty acid composition, triglyceride composition, and anti-proliferative effect of Job's tears seed oil were analyzed using morphological characteristics and ISSR markers, GC-MS, HPLC-ELSD, and the MTT method. ISSR analysis demonstrated low genetic diversity of Job's tears at the species level (h = 0.21, l = 0.33) and the accession level (h = 0.07, l = 0.10), and strong genetic differentiation (G(ST) = 0.6702) among all accessions. It also clustered the 11 accessions into three cultivated clades corresponding with geographical locations and two evidently divergent wild clades. The grouping patterns based on morphological characteristics and chemical profiles were in accordance with those clustered by ISSR analysis. Significant differences in morphological characteristics, fatty acid composition, triglyceride composition, and inhibition rates of seed oil were detected among different accessions, which showed a highly significant positive correlation with genetic variation. These results suggest that the seed morphological characteristics, fatty acid composition, and triglyceride composition may be mainly attributed to genetic factors. The proportion of palmitic acid and linoleic acid to oleic acid displayed a highly significant positive correlation with the inhibition rates of Job's tears seed oil for T24 cells, and thus can be an important indicator for quality control for Job's tears.	[Xi, Xiu-Jie; Zhu, Yun-Guo; Yang, Xiao-Ling; Tang, Nan-Nan; Ma, Shu-Min; Li, Shan; Cheng, Zhou] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Tong, Ying-Peng] Zhejiang Univ Technol, Coll Pharm, Hangzhou, Zhejiang, Peoples R China	Tongji University; Zhejiang University of Technology	Cheng, Z (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	lishanbio@tongji.edu.cn; chengzhou@tongji.edu.cn		CHENG, Zhou/0000-0001-5866-748X	Natural Science Foundation of Shanghai [12ZR1432900]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was sponsored by Natural Science Foundation of Shanghai (12ZR1432900) (http://www.stcsm.gov.cn/gk/ywgz/bgxz/kyjh/ghxfasb/292351.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Agostini G, 2008, PLANT SYST EVOL, V274, P135, DOI 10.1007/s00606-008-0037-8; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; ARORA RK, 1977, ECON BOT, V31, P358, DOI 10.1007/BF02866887; Beeharry N, 2003, MUTAT RES-FUND MOL M, V530, P27, DOI 10.1016/S0027-5107(03)00134-9; Beyer H, 2015, J APPL BOT FOOD QUAL, V88, P192, DOI 10.5073/JABFQ.2015.088.027; Bruschi P, 2003, ANN BOT-LONDON, V91, P707, DOI 10.1093/aob/mcg075; Casiva PV, 2002, AM J BOT, V89, P843, DOI 10.3732/ajb.89.5.843; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chang HC, 2003, J AGR FOOD CHEM, V51, P3656, DOI 10.1021/jf021142a; Chavez-Pesqueira M, 2014, AM J BOT, V101, P1092, DOI 10.3732/ajb.1400051; Chen ChengBin, 2008, Southwest China Journal of Agricultural Sciences, V21, P792; Chen HJ, 2012, FOOD CHEM TOXICOL, V50, P3808, DOI 10.1016/j.fct.2012.07.011; Chen HJ, 2011, FOOD CHEM, V126, P1741, DOI 10.1016/j.foodchem.2010.12.074; [陈勇 CHEN Yong], 2005, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V22, P246; Chung CP, 2011, J AGR FOOD CHEM, V59, P6025, DOI 10.1021/jf2009556; Chung CP, 2010, J AGR FOOD CHEM, V58, P7616, DOI 10.1021/jf101084e; [丁怡 Ding Yi], 2004, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V24, P249; Doyle J. J., 1987, PHYTOCHEM B, P11; Egesel CO, 2011, ACTA SCI-AGRON, V33, P613, DOI 10.4025/actasciagron.v33i4.11031; EXCOFFIER L, 1992, GENETICS, V131, P479; FALCONER JS, 1994, BRIT J CANCER, V69, P826, DOI 10.1038/bjc.1994.161; Figueiredo AC, 2008, FLAVOUR FRAG J, V23, P213, DOI 10.1002/ffj.1875; [高微微 GAO Weiwei], 2006, [中草药, Chinese Traditional and Herbal Drugs], V37, P293; George S, 2009, AM J BOT, V96, P2022, DOI 10.3732/ajb.0800368; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hardy S, 2000, CANCER RES, V60, P6353; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; Hawkins RA, 1998, J PATHOL, V185, P61; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Hsu HY, 2003, J AGR FOOD CHEM, V51, P3763, DOI 10.1021/jf021154w; [华海清(综述) Hua Haiqing], 2012, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V39, P1143; Huang BW, 2005, PHYTOMEDICINE, V12, P433, DOI 10.1016/j.phymed.2004.02.010; Huang DW, 2009, J AGR FOOD CHEM, V57, P10651, DOI 10.1021/jf9028514; Huang DW, 2009, J AGR FOOD CHEM, V57, P2259, DOI 10.1021/jf803255p; HUANG H, 1995, CROP GERMPLASM, V4, P4; Hung WC, 2003, J AGR FOOD CHEM, V51, P7333, DOI 10.1021/jf0340512; Javidfar F, 2006, PLANT BREEDING, V125, P65, DOI 10.1111/j.1439-0523.2006.01187.x; Karron JD, 1987, EVOL ECOL, V1, P47, DOI 10.1007/BF02067268; Kuo CC, 2001, J AGR FOOD CHEM, V49, P1564, DOI 10.1021/jf001215v; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Li A, 2001, ANN BOT-LONDON, V87, P585, DOI 10.1006/anbo.2001.1390; [李春花 LI Chunhua], 2015, [植物遗传资源学报, Journal of Plant Genetic Resources], V16, P277; Li Da-Peng, 2007, Zhongguo Xinyao yu Linchuang Zazhi, V26, P778; Li DP, 1999, TRADITIONAL CHINESE, V10, P99, DOI [10.3321/j.issn:1003-9783.1999.02.012, DOI 10.3321/J.ISSN:1003-9783.1999.02.012]; [李峻岭(综述) Li Junling], 2012, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V39, P1139; Li SC, 2011, J SCI FOOD AGR, V91, P547, DOI 10.1002/jsfa.4219; Li XH, 2001, GENET RESOUR CROP EV, V48, P189, DOI 10.1023/A:1011282109563; [李玉升 Li Yusheng], 2012, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V39, P1158; Li Z., 2012, ELECT J DIFFERENTIAL, V2012, P1, DOI DOI 10.3969/J.ISSN.1674-1161.2012.01.028; Liang Y, 2006, GUANGXI AGR SCI, V37, P341, DOI [10.3969/j.issn.2095-1191.2006.04.001, DOI 10.3969/J.ISSN.2095-1191.2006.04.001]; Lim TK, 2012, EDIBLE MED NONMEDICA, V5, P243, DOI [10.1007/978-94-007-5653-3_14, DOI 10.1007/978-94-007-5653-3_14]; Lu XF, 2010, J ZHEJIANG UNIV-SC B, V11, P923, DOI 10.1631/jzus.B1000125; Lu XF, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-106; Ma KH, 2010, BIOL PLANTARUM, V54, P272, DOI 10.1007/s10535-010-0047-6; Ma X, 2008, BIOCHEM SYST ECOL, V36, P514, DOI 10.1016/j.bse.2008.03.003; MANTEL N, 1967, CANCER RES, V27, P209; MELLO LV, 1995, EUPHYTICA, V81, P217, DOI 10.1007/BF00025436; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; NUMATA M, 1994, PLANTA MED, V60, P356, DOI 10.1055/s-2006-959500; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Rao PN, 2010, NUCLEUS CALCUTTA, V53, P13, DOI 10.1007/s13237-010-0013-x; Rodrigues L, 2013, BIOCHEM SYST ECOL, V50, P51, DOI 10.1016/j.bse.2013.03.007; Saidi M, 2013, MOL BIOL REP, V40, P6501, DOI 10.1007/s11033-013-2768-z; Sato K, 2010, FOOD SCI TECHNOL RES, V16, P613, DOI 10.3136/fstr.16.613; SCHAAFFHAUSEN REIMAR v., 1952, ECON BOT, V6, P216, DOI 10.1007/BF02985062; Sood A, 2015, PLANT PHYSIOL BIOCH, V94, P253, DOI 10.1016/j.plaphy.2015.06.015; Su H., 2012, FUJIAN NONGYE XUEBAO, V27, P695, DOI 10.3969/j.issn.1008-0384.2012.07.007; Tian B, 2012, GENET RESOUR CROP EV, V59, P901, DOI 10.1007/s10722-011-9732-3; Wang LF, 2012, MOLECULES, V17, P8886, DOI 10.3390/molecules17088886; [王硕 Wang Shuo], 2015, [中草药, Chinese Traditional and Herbal Drugs], V46, P112; Wang Shuo, 2013, Journal of Yunnan Agricultural University, V28, P157; [王筱菁 WANG Xiaojing], 2007, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V13, P542; Wright S, 1931, GENETICS, V16, P0097; Xiang Zhi-Min, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1436; Yeh PH, 2006, INT J VITAM NUTR RES, V76, P299, DOI 10.1024/0300-9831.76.5.299; Yue W, 2008, LISHIZHEN MED MAT ME, V19, P314, DOI [10.3969/j.issn.1008-0805.2008.02.028, DOI 10.3969/J.ISSN.1008-0805.2008.02.028]; Zhang QX, 2013, BIOCHEM SYST ECOL, V48, P248, DOI 10.1016/j.bse.2012.12.024; Zhou LL, 2010, PLANT MOL BIOL, V74, P631, DOI 10.1007/s11103-010-9705-5	81	33	42	7	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153269	10.1371/journal.pone.0153269	http://dx.doi.org/10.1371/journal.pone.0153269			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070310	Green Published, gold			2022-12-26	WOS:000373900700044
J	Marquez-Ibarra, A; Huerta, M; Villalpando-Hernandez, S; Rios-Silva, M; Diaz-Reval, MI; Cruzblanca, H; Mancilla, E; Trujillo, X				Marquez-Ibarra, Adriana; Huerta, Miguel; Villalpando-Hernandez, Salvador; Rios-Silva, Monica; Diaz-Reval, Maria I.; Cruzblanca, Humberto; Mancilla, Evelyn; Trujillo, Xochitl			The Effects of Dietary Iron and Capsaicin on Hemoglobin, Blood Glucose, Insulin Tolerance, Cholesterol, and Triglycerides, in Healthy and Diabetic Wistar Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; OVERLOAD; ANEMIA; STORES; MODEL; METABOLISM; INCREASES; RECEPTOR; LIPIDS; LIVER	Objective Our aim was to assess the effects of dietary iron, and the compound capsaicin, on hemoglobin as well as metabolic indicators including blood glucose, cholesterol, triglycerides, insulin, and glucose tolerance. Materials and Methods Our animal model was the Wistar rat, fed a chow diet, with or without experimentally induced diabetes. Diabetic males were fed control, low, or high-iron diets, the latter, with or without capsaicin. Healthy rats were fed identical diets, but without the capsaicin supplement. We then measured the parameters listed above, using the Student t-test and ANOVA, to compare groups. Results Healthy rats fed a low-iron diet exhibited significantly reduced total cholesterol and triglyceride levels, compared with rats fed a control diet. Significantly reduced blood lipid was also provoked by low dietary iron in diabetic rats, compared with those fed a control diet. Insulin, and glucose tolerance was only improved in healthy rats fed the low-iron diet. Significant increases in total cholesterol were found in diabetic rats fed a high-iron diet, compared with healthy rats fed the same diet, although no statistical differences were found for triglycerides. Hemoglobin levels, which were not statistically different in diabetic versus healthy rats fed the high-iron diet, fell when capsaicin was added. Capsaicin also provoked a fall in the level of cholesterol and triglycerides in diabetic animals, versus diabetics fed with the high iron diet alone. In conclusion, low levels of dietary iron reduced levels of serum triglycerides, hemoglobin, and cholesterol, and significantly improved insulin, and glucose tolerance in healthy rats. In contrast, a high-iron diet increased cholesterol significantly, with no significant changes to triglyceride concentrations. The addition of capsaicin to the high-iron diet (for diabetic rats) further reduced levels of hemoglobin, cholesterol, and triglycerides. These results suggest that capsaicin, may be suitable for the treatment of elevated hemoglobin, in patients.	[Marquez-Ibarra, Adriana; Huerta, Miguel; Rios-Silva, Monica; Diaz-Reval, Maria I.; Cruzblanca, Humberto; Mancilla, Evelyn; Trujillo, Xochitl] Univ Colima, Ctr Univ Invest Biomed, Unidad Invest Dr Enrico Stefani, Colima, Colima, Mexico; [Villalpando-Hernandez, Salvador] Inst Nacl Salud Publ, Ctr Invest Nutr & Salud, Univ 655 Colonia Santa Maria Ahuacatitlan, Cuernavaca, Morelos, Mexico	Universidad de Colima; Instituto Nacional de Salud Publica	Trujillo, X (corresponding author), Univ Colima, Ctr Univ Invest Biomed, Unidad Invest Dr Enrico Stefani, Colima, Colima, Mexico.	rosio@ucol.mx	Villalpando, Salvador/AAS-3874-2021; Trujillo, Xóchitl/AHC-2100-2022; Huerta, Miguel/AEP-0820-2022; Trujillo, Xochitl/P-7020-2017	Villalpando, Salvador/0000-0001-6429-3816; Trujillo, Xóchitl/0000-0001-8146-5667; Huerta, Miguel/0000-0001-8515-0777; Trujillo, Xochitl/0000-0001-7506-1674	FRABA-Universidad de Colima-Mexico; CONACyT-Mexico	FRABA-Universidad de Colima-Mexico; CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	FRABA-Universidad de Colima-Mexico to XT and MH, provided partial sponsorship of this research. Part of these results were part of AMI's PhD Thesis at Faculty of Medicine, Universidad de Colima, Mexico. AMI received a fellowship for PhD studies from CONACyT-Mexico.	Abd Allah Eman S H, 2014, Pathophysiology, V21, P293, DOI 10.1016/j.pathophys.2014.06.002; Alexandrakis MG, 2012, ISRN HEMATOL, DOI [10.5402/2012/246915, DOI 10.5402/2012/246915]; BOREL MJ, 1993, AM J PHYSIOL, V264, pE380, DOI 10.1152/ajpendo.1993.264.3.E380; Brunet S, 1999, HEPATOLOGY, V29, P1809, DOI 10.1002/hep.510290612; Cherng JY, 2005, LIFE SCI, V76, P3001, DOI 10.1016/j.lfs.2004.10.055; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; de Almeida MM, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-200; Dongiovanni P, 2013, AM J PATHOL, V182, P2254, DOI 10.1016/j.ajpath.2013.02.019; Fernandez-Real JM, 2002, DIABETES, V51, P2348, DOI 10.2337/diabetes.51.8.2348; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Graham RM, 2010, HEPATOLOGY, V52, P462, DOI 10.1002/hep.23712; Huang JY, 2011, DIABETES, V60, P80, DOI 10.2337/db10-0593; Ikeda Y, 2013, AM J PHYSIOL-RENAL, V304, pF1028, DOI 10.1152/ajprenal.00473.2012; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kamei A, 2010, PHYSIOL GENOMICS, V42, P149, DOI 10.1152/physiolgenomics.00150.2009; Kempaiah RK, 2005, MOL CELL BIOCHEM, V275, P7, DOI 10.1007/s11010-005-7643-3; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kundu D, 2013, NIGER J CLIN PRACT, V16, P100, DOI 10.4103/1119-3077.106776; Lee CG, 2011, DIABETES CARE, V34, P2381, DOI 10.2337/dc11-1032; Lee CYJ, 2003, PHYTOTHER RES, V17, P454, DOI 10.1002/ptr.1172; Maaroufi K, 2009, NEUROBIOL LEARN MEM, V92, P345, DOI 10.1016/j.nlm.2009.04.002; Mehdad A, 2015, J NUTR HEALTH AGING, V19, P846, DOI 10.1007/s12603-015-0541-9; Merono T, 2011, MEDICINA-BUENOS AIRE, V71, P566; Minamiyama Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1140, DOI 10.1152/ajpendo.00620.2009; Miron VR, 2007, MOL CELL BIOCHEM, V298, P101, DOI 10.1007/s11010-006-9357-6; Panjeta Mirsad, 2015, Mater Sociomed, V27, P144, DOI 10.5455/msm.2015.27.144-148; Prakash UNS, 2013, J TRACE ELEM MED BIO, V27, P184, DOI 10.1016/j.jtemb.2012.11.003; Rajpathak SN, 2009, BBA-GEN SUBJECTS, V1790, P671, DOI 10.1016/j.bbagen.2008.04.005; Rios-Silva M, 2014, INT J MED SCI, V11, P448, DOI 10.7150/ijms.8034; Salonen JT, 1998, BRIT MED J, V317, P727, DOI 10.1136/bmj.317.7160.727; Smotra S, 2008, JK SCI, V10, P170; SRINIVASAN MR, 1992, INDIAN J MED RES-B, V96, P133; TAI MM, 1994, DIABETES CARE, V17, P152, DOI 10.2337/diacare.17.2.152; Tang N, 2014, FOOD FUNCT, V5, P390, DOI 10.1039/c3fo60292c; Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164; Thompson K, 2006, TOXICOL APPL PHARM, V210, P17, DOI 10.1016/j.taap.2005.05.014; Uchida K, 2011, ENDOCR J, V58, P1021, DOI 10.1507/endocrj.EJ11-0130; Whittaker P, 2001, BRIT J NUTR, V86, P587, DOI 10.1079/BJN2001439; Zhang SY, 2014, OBES SURG, V24, P405, DOI 10.1007/s11695-013-1103-z; Zhao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041641; ZHOU XF, 1990, BRIT J PHARMACOL, V100, P523, DOI 10.1111/j.1476-5381.1990.tb15840.x; Zolghadri Y, 2014, INT J MOL CELL MED, V3, P255	42	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152625	10.1371/journal.pone.0152625	http://dx.doi.org/10.1371/journal.pone.0152625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064411	gold, Green Published, Green Submitted			2022-12-26	WOS:000373891000014
J	Vera, F; Rivera, R; Romero-Maltrana, D; Villanueva, J				Vera, Francisco; Rivera, Rodrigo; Romero-Maltrana, Diego; Villanueva, Jaime			Negative Pressures and the First Water Siphon Taller than 10.33 Meters	PLOS ONE			English	Article							SURFACE-TENSION; PATTERNS; SAP	A siphon is a device that is used to drain a container, with water rising inside a hose in the form of an inverted U and then going down towards a discharge point placed below the initial water level. The siphon is the first of a number of inventions of the ancients documented about 2.000 years ago by Hero of Alexandria in his treatise Pneumatics, and although the explanation given by Hero was essentially correct, there is nowadays a controversy about the underlying mechanism that explains the working of this device. Discussions concerning the physics of a siphon usually refer to concepts like absolute negative pressures, the strength of liquid's cohesion and the possibility of a siphon working in vacuum or in the presence of bubbles. Torricelli understood the working principle of the barometer and the impossibility of pumping water out of wells deeper than 10.33 m. Following Torricelli's ideas it would also not be possible to build a siphon that drives pure water to ascend higher than 10.33 m. In this work, we report the first siphon that drives water (with surfactant) to ascend higher than the Torricellian limit. Motivated by the rising of sap in trees, we built a 15.4 m siphon that shows that absolute negative pressures are not prohibited, that cohesion plays an important role in transmitting forces through a fluid, and that surfactants can help to the transport of water in a metastable regime of negative pressures.	[Vera, Francisco; Rivera, Rodrigo; Romero-Maltrana, Diego; Villanueva, Jaime] Pontificia Univ Catolica Valparaiso, Inst Fis, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso	Vera, F (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Fis, Valparaiso, Chile.	francisco.vera.ucv@gmail.com		Maltrana, Diego/0000-0003-2550-5243; Vera, Francisco/0000-0002-6272-7390	FONDECYT [1151257, 1151169]; DGIP-PUCV	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DGIP-PUCV	The authors would like to acknowledge financial support from FONDECYT Projects 1151257 and 1151169, and DGIP-PUCV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boatwright AL, 2011, J CHEM EDUC, V88, P1547, DOI 10.1021/ed2001818; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Brown HR, 2013, PHYS PERSPECT, V15, P320, DOI 10.1007/s00016-013-0117-1; Caupin F, 2006, CR PHYS, V7, P1000, DOI 10.1016/j.crhy.2006.10.015; Christensen-Dalsgaard KK, 2011, TREE PHYSIOL, V31, P361, DOI 10.1093/treephys/tpr018; Dikici B, 2014, J THERM ANAL CALORIM, V116, P1387, DOI 10.1007/s10973-013-3634-x; Domec JC, 2011, TREE PHYSIOL, V31, P359, DOI 10.1093/treephys/tpr039; Duane W, 1902, SCIENCE, V15, P152, DOI 10.1126/science.15.369.152; HAYWARD ATJ, 1971, AM SCI, V59, P434; HAYWARD ATJ, 1970, NATURE, V225, P376, DOI 10.1038/225376b0; Hetsroni G, 2001, INT J HEAT MASS TRAN, V44, P485, DOI 10.1016/S0017-9310(00)00099-5; Holbrook NM, 2008, PHYS TODAY, V76; Hughes Stephen W., 2010, Physics Education, V45, P162, DOI 10.1088/0031-9120/45/2/006; Hughes S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04741; KELL GS, 1983, AM J PHYS, V51, P1038, DOI 10.1119/1.13353; Liger-Belair G, 2005, J PHYS CHEM B, V109, P14573, DOI 10.1021/jp051650y; Minor R. S, 1914, SCH SCI MATH, V12, P152, DOI [10.1111/j.1949-8594.1914.tb16014.x, DOI 10.1111/J.1949-8594.1914.TB16014.X]; Planinsic Gorazd, 2010, Physics Education, V45, P356, DOI 10.1088/0031-9120/45/4/005; Polidori G, 2009, AM SCI, V97, P294, DOI 10.1511/2009.79.294; Potter A., 1971, Physics Education, V6, P362, DOI 10.1088/0031-9120/6/5/005; Ramette Joshua J., 2011, Physics Education, V46, P412, DOI 10.1088/0031-9120/46/4/006; Richert Alex, 2011, Physics Teacher, V49, P78, DOI 10.1119/1.3543576; Tyree M. T., 2002, SPR S WOOD; Tyree MT, 2003, NATURE, V423, P923, DOI 10.1038/423923a; Woodcroft B., 1851, PNEUMATICS HERO ALEX, P11; Wright K, 2003, DISCOVERY MAGAZI MAR; Zwieniecki MA, 2009, TRENDS PLANT SCI, V14, P530, DOI 10.1016/j.tplants.2009.07.002	27	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153055	10.1371/journal.pone.0153055	http://dx.doi.org/10.1371/journal.pone.0153055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054847	Green Published, gold			2022-12-26	WOS:000373608000070
J	Wen, Y; Alshikho, MJ; Herbert, MR				Wen, Ya; Alshikho, Mohamad J.; Herbert, Martha R.			Pathway Network Analyses for Autism Reveal Multisystem Involvement, Major Overlaps with Other Diseases and Convergence upon MAPK and Calcium Signaling	PLOS ONE			English	Article							PROTEIN-KINASE-C; SET ENRICHMENT ANALYSIS; SPECTRUM DISORDERS; SFARI GENE; RISK; DYSFUNCTION; ACTIVATION; PREVALENCE; METABOLISM; MUTATIONS	We used established databases in standard ways to systematically characterize gene ontologies, pathways and functional linkages in the large set of genes now associated with autism spectrum disorders (ASDs). These conditions are particularly challenging-they lack clear pathognomonic biological markers, they involve great heterogeneity across multiple levels (genes, systemic biological and brain characteristics, and nuances of behavioral manifestations)-and yet everyone with this diagnosis meets the same defining behavioral criteria. Using the human gene list from Simons Foundation Autism Research Initiative (SFARI) we performed gene set enrichment analysis with the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway Database, and then derived a pathway network from pathway-pathway functional interactions again in reference to KEGG. Through identifying the GO (Gene Ontology) groups in which SFARI genes were enriched, mapping the coherence between pathways and GO groups, and ranking the relative strengths of representation of pathway network components, we 1) identified 10 disease-associated and 30 function-associated pathways 2) revealed calcium signaling pathway and neuroactive ligand-receptor interaction as themost enriched, statistically significant pathways from the enrichment analysis, 3) showed calcium signaling pathways and MAPK signaling pathway to be interactive hubs with other pathways and also to be involved with pervasively present biological processes, 4) found convergent indications that the process "calcium-PRC (protein kinase C)-Ras-Raf-MAPK/ERK" is likely a major contributor to ASD pathophysiology, and 5) noted that perturbations associated with KEGG's category of environmental information processing were common. These findings support the idea that ASD-associated genes may contribute not only to core features of ASD themselves but also to vulnerability to other chronic and systemic problems potentially including cancer, metabolic conditions and heart diseases. ASDsmay thus arise, or emerge, from underlying vulnerabilities related to pleiotropic genes associated with pervasively important molecular mechanisms, vulnerability to environmental input andmultiple systemic co-morbidities.	[Wen, Ya; Alshikho, Mohamad J.; Herbert, Martha R.] Massachusetts Gen Hosp, Dept Neurol, TRANSCEND Res, Charlestown, MA USA; [Wen, Ya; Alshikho, Mohamad J.; Herbert, Martha R.] Harvard Univ, Sch Med, Boston, MA USA; [Wen, Ya; Herbert, Martha R.] Higher Synth Fdn, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wen, Y; Herbert, MR (corresponding author), Massachusetts Gen Hosp, Dept Neurol, TRANSCEND Res, Charlestown, MA USA.; Wen, Y; Herbert, MR (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Wen, Y; Herbert, MR (corresponding author), Higher Synth Fdn, Cambridge, MA USA.	ywen3@mgh.harvard.edu; martha.herbert@mgh.harvard.edu	Wen, Ya/M-6341-2016	Wen, Ya/0000-0003-0134-8853; /0000-0002-5420-4223				Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Adviento B, 2014, J MED GENET, V51, P10, DOI 10.1136/jmedgenet-2013-101951; Araki SI, 2003, J AM SOC NEPHROL, V14, P2015, DOI 10.1097/01.ASN.0000077347.27669.5C; Banerjee-Basu S, 2010, DIS MODEL MECH, V3, P133, DOI 10.1242/dmm.005439; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bilder DA, 2013, PEDIATRICS, V132, pE1276, DOI 10.1542/peds.2013-1188; Cartwright EJ, 2011, BIOFACTORS, V37, P175, DOI 10.1002/biof.149; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chibber R, 2003, DIABETES, V52, P1519, DOI 10.2337/diabetes.52.6.1519; Corrales MA, 2011, AUTISM ENV GENOMICS; Cristino AS, 2014, MOL PSYCHIATR, V19, P294, DOI 10.1038/mp.2013.16; Darling N.J., 2014, SCI REP-UK, V1843, P2150, DOI DOI 10.1016/J.BBAMCR.2014.01.009; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Dhandapany PS, 2014, NAT GENET, V46, P635, DOI 10.1038/ng.2963; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Egan AM, 2013, CHILD OBES, V9, P125, DOI 10.1089/chi.2012.0028; Faridar A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-57; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; Hoischen A, 2014, NAT NEUROSCI, V17, P764, DOI 10.1038/nn.3703; Idris I, 2001, DIABETOLOGIA, V44, P659, DOI 10.1007/s001250051675; Kalkman HO, 2012, NEUROSCI BIOBEHAV R, V36, P2206, DOI 10.1016/j.neubiorev.2012.07.008; King M, 2009, INT J EPIDEMIOL, V38, P1224, DOI 10.1093/ije/dyp261; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Kranias E. G., 2007, V45, P523; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Li L, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1155/2013/467245; Liebmann C, 2001, CELL SIGNAL, V13, P777, DOI 10.1016/S0898-6568(01)00192-9; Lu ATH, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-18; Mascia F, 2012, J INVEST DERMATOL, V132, P811, DOI 10.1038/jid.2011.406; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Ming X, 2005, BRAIN DEV-JPN, V27, P509, DOI 10.1016/j.braindev.2005.01.003; Ouwenga RL, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0008-1; Pao GM, 2014, P NATL ACAD SCI USA, V111, pE1240, DOI 10.1073/pnas.1400783111; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pucilowska J, 2015, J NEUROSCI, V35, P3190, DOI 10.1523/JNEUROSCI.4864-13.2015; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Ronan JL, 2013, NAT REV GENET, V14, P440, DOI 10.1038/nrg3508; Rossignol DA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.4; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Shao B, 2013, DIABETES OBES METAB, V15, P993, DOI 10.1111/dom.12120; Skafidas E, 2014, MOL PSYCHIATR, V19, P504, DOI 10.1038/mp.2012.126; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tyler CV, 2011, AJIDD-AM J INTELLECT, V116, P371, DOI 10.1352/1944-7558-116.5.371; Vivar JC, 2013, OMICS, V17, P414, DOI 10.1089/omi.2012.0083; Wallace JA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00087; Wittkowski KM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.124	54	80	83	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153329	10.1371/journal.pone.0153329	http://dx.doi.org/10.1371/journal.pone.0153329			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27055244	Green Published, gold			2022-12-26	WOS:000373608000121
J	Imamura, Y; Haruta, M; Tomita, Y; Matsumura, K; Ikeda, T; Yuno, A; Hirayama, M; Nakayama, H; Mizuta, H; Nishimura, Y; Senju, S				Imamura, Yuya; Haruta, Miwa; Tomita, Yusuke; Matsumura, Keiko; Ikeda, Tokunori; Yuno, Akira; Hirayama, Masatoshi; Nakayama, Hideki; Mizuta, Hiroshi; Nishimura, Yasuharu; Senju, Satoru			Generation of Large Numbers of Antigen-Expressing Human Dendritic Cells Using CD14-ML Technology	PLOS ONE			English	Article							CANCER PATIENTS; PEPTIDE VACCINE; IDENTIFICATION; EPITOPES; MATURATION; RESPONSES; MELANOMA; TRIAL; LUNG; CTL	We previously reported a method to expand human monocytes through lentivirus-mediated introduction of cMYC and BMI1, and we named the monocyte-derived proliferating cells, CD14-ML. CD14-ML differentiated into functional DC (CD14-ML-DC) upon addition of IL-4, resulting in the generation of a large number of DC. One drawback of this method was the extensive donor-dependent variation in proliferation efficiency. In the current study, we found that introduction of BCL2 or LYL1 along with cMYC and BMI1 was beneficial. Using the improved method, we obtained CD14-ML from all samples, regardless of whether the donors were healthy individuals or cancer patients. In vitro stimulation of peripheral blood T cells with CD14-ML-DC that were loaded with cancer antigen-derived peptides led to the establishment of CD4(+) and CD8(+) T cell lines that recognized the peptides. Since CD14-ML was propagated for more than 1 month, we could readily conduct genetic modification experiments. To generate CD14-ML-DC that expressed antigenic proteins, we introduced lentiviral antigen-expression vectors and subjected the cells to 2 weeks of culture for drug-selection and expansion. The resulting antigen-expressing CD14-ML-DC successfully induced CD8+ T cell lines that were reactive to CMVpp65 or MART1/MelanA, suggesting an application in vaccination therapy. Thus, this improved method enables the generation of a sufficient number of DC for vaccination therapy from a small amount of peripheral blood from cancer patients. Information on T cell epitopes is not necessary in vaccination with cancer antigen-expressing CD14-ML-DC; therefore, all patients, irrespective of HLA type, will benefit from anti-cancer therapy based on this technology.	[Imamura, Yuya; Haruta, Miwa; Tomita, Yusuke; Matsumura, Keiko; Ikeda, Tokunori; Yuno, Akira; Hirayama, Masatoshi; Nishimura, Yasuharu; Senju, Satoru] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan; [Imamura, Yuya; Mizuta, Hiroshi] Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Kumamoto, Japan; [Tomita, Yusuke] Kumamoto Univ, Fac Life Sci, Dept Resp Med, Kumamoto, Japan; [Ikeda, Tokunori] Kumamoto Univ, Fac Life Sci, Dept Neurol, Kumamoto, Japan; [Yuno, Akira; Hirayama, Masatoshi; Nakayama, Hideki] Kumamoto Univ, Fac Life Sci, Dept Oral & Maxillofacal Surg, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University	Senju, S (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan.	senjusat@gpo.kumamoto-u.ac.jp	Ikeda, Tokunori/S-6043-2019		Japan Society for the Promotion of Science [24300334, 26290057, 15H04311, 23650609, 25640091]; Grants-in-Aid for Scientific Research [25640091, 16H06498] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (24300334, 26290057, 15H04311) and Grant-in-Aid for the Challenging Exploratory Research from Japan Society for the Promotion of Science (23650609, 25640091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FREUDENTHAL PS, 1990, P NATL ACAD SCI USA, V87, P7698, DOI 10.1073/pnas.87.19.7698; Harao M, 2008, INT J CANCER, V123, P2616, DOI 10.1002/ijc.23823; Hardy MY, 2009, IMMUNOL CELL BIOL, V87, P606, DOI 10.1038/icb.2009.44; Haruta M, 2013, HUM IMMUNOL, V74, P1400, DOI 10.1016/j.humimm.2013.05.017; Imai K, 2011, BRIT J CANCER, V104, P300, DOI 10.1038/sj.bjc.6606052; Itoh T, 2003, CANCER IMMUNOL IMMUN, V52, P207, DOI 10.1007/s00262-002-0337-8; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Kotsakis A, 2014, LUNG CANCER, V86, P59, DOI 10.1016/j.lungcan.2014.07.018; Kuroki H, 2003, CANCER IMMUNOL IMMUN, V52, P561, DOI 10.1007/s00262-003-0394-7; Kuzushima K, 2001, BLOOD, V98, P1872, DOI 10.1182/blood.V98.6.1872; Kyte JA, 2006, CANCER GENE THER, V13, P905, DOI 10.1038/sj.cgt.7700961; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nakahara S, 2003, CANCER RES, V63, P4112; Orsini G, 2013, INT J MOL SCI, V14, P22022, DOI 10.3390/ijms141122022; Osawa R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/848042; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Senju S, 2011, GENE THER, V18, P874, DOI 10.1038/gt.2011.22; Staff C, 2011, VACCINE, V29, P6817, DOI 10.1016/j.vaccine.2010.12.063; Su Z, 2003, CANCER RES, V63, P2127; Suda T, 2007, CANCER SCI, V98, P1803, DOI 10.1111/j.1349-7006.2007.00603.x; Sundarasetty BS, 2015, GENE THER, V22, P707, DOI 10.1038/gt.2015.43; Tabata H, 1998, HUM IMMUNOL, V59, P549, DOI 10.1016/S0198-8859(98)00050-0; Tomita Y, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28100; Tomita Y, 2014, INT J CANCER, V134, P352, DOI 10.1002/ijc.28376; Tomita Y, 2013, CLIN CANCER RES, V19, P4508, DOI 10.1158/1078-0432.CCR-13-0197; Tomita Y, 2011, CANCER SCI, V102, P71, DOI 10.1111/j.1349-7006.2010.01780.x; Triozzi PL, 2005, J IMMUNOTHER, V28, P382, DOI 10.1097/01.cji.0000162779.88687.4c; Uemura Y, 2003, J IMMUNOL, V170, P947, DOI 10.4049/jimmunol.170.2.947; VANVOORHIS WC, 1982, J EXP MED, V155, P1172, DOI 10.1084/jem.155.4.1172; Yoshikawa T, 2011, CANCER SCI, V102, P918, DOI 10.1111/j.1349-7006.2011.01896.x; Yoshitake Y, 2015, CLIN CANCER RES, V21, P312, DOI 10.1158/1078-0432.CCR-14-0202	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152384	10.1371/journal.pone.0152384	http://dx.doi.org/10.1371/journal.pone.0152384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050553	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500036
J	Kodumudi, KN; Siegel, J; Weber, AM; Scott, E; Sarnaik, AA; Pilon-Thomas, S				Kodumudi, Krithika N.; Siegel, Jessica; Weber, Amy M.; Scott, Ellen; Sarnaik, Amod A.; Pilon-Thomas, Shari			Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy	PLOS ONE			English	Article							T-LYMPHOCYTES; LAG-3; LIVER	Tumor-infiltrating lymphocytes (TIL) has been associated with improved survival in cancer patients. Within the tumor microenvironment, regulatory cells and expression of co-inhibitory immune checkpoint molecules can lead to the inactivation of TIL. Hence, there is a need to develop strategies that disrupt these negative regulators to achieve robust antitumor immune responses. We evaluated the blockade of immune checkpoints and their effect on T cell infiltration and function. We examined the ability of TIL to induce tumor-specific immune responses in vitro and in vivo. TIL isolated from tumor bearing mice were tumor-specific and expressed co-inhibitory immune checkpoint molecules. Administration of monoclonal antibodies against immune checkpoints led to a significant delay in tumor growth. However, anti-PD-L1 antibody treated mice had a significant increase in T cell infiltration and IFN-gamma production compared to other groups. Adoptive transfer of in vitro expanded TIL from tumors of anti-PD-L1 antibody treated mice led to a significant delay in tumor growth. Blockade of co-inhibitory immune checkpoints could be an effective strategy to improve TIL infiltration and function.	[Kodumudi, Krithika N.; Siegel, Jessica; Weber, Amy M.; Scott, Ellen; Sarnaik, Amod A.; Pilon-Thomas, Shari] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, 12902 Magnolia Dr,SRB 3,Room 24314, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Pilon-Thomas, S (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, 12902 Magnolia Dr,SRB 3,Room 24314, Tampa, FL 33612 USA.	Shari.Pilon-Thomas@moffitt.org	Sarnaik, Amod/W-5536-2019	Scott, Ellen/0000-0003-1933-9779	Phi Beta Psi sorority award; Flow Cytometry Core Facility at the H. Lee Moffitt Cancer Center & Research Institute; an NCI designated Comprehensive Cancer Center [P30-CA076292]; NCI-K23 award [K23 CA178083-01]; Miles for Moffitt award; NATIONAL CANCER INSTITUTE [P30CA076292, K23CA178083] Funding Source: NIH RePORTER	Phi Beta Psi sorority award; Flow Cytometry Core Facility at the H. Lee Moffitt Cancer Center & Research Institute; an NCI designated Comprehensive Cancer Center; NCI-K23 award; Miles for Moffitt award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the research grant to Krithika Kodumudi by a Phi Beta Psi sorority award and in part by the Flow Cytometry Core Facility at the H. Lee Moffitt Cancer Center & Research Institute; an NCI designated Comprehensive Cancer Center (P30-CA076292). This work was also supported, in part, by a NCI-K23 award (Amod Sarnaik, K23 CA178083-01) and Miles for Moffitt award to Shari Pilon-Thomas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko K, 2013, CLIN CANCER RES, V19, P1363, DOI 10.1158/1078-0432.CCR-12-2199; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Camisaschi C, 2014, J INVEST DERMATOL, V134, P1893, DOI 10.1038/jid.2014.29; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Chacon JA, ONCOIMMUNOLOGY, V2; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Demeure CE, 2001, EUR J CANCER, V37, P1709, DOI 10.1016/S0959-8049(01)00184-8; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Katz SC, 2009, ANN SURG ONCOL, V16, P2524, DOI 10.1245/s10434-009-0585-3; Kocak E, 2006, CANCER RES, V66, P7276, DOI 10.1158/0008-5472.CAN-05-2128; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Mocellin S, 1836, BIOCHIM BIOPHYS ACTA, P187; Pilon-Thomas S, J IMMUNOTHER, V35, P615; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Serriari NE, 2010, J IMMUNOL, V185, P3140, DOI 10.4049/jimmunol.0902487; Son CH, J IMMUNOTHER, V37, P1; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Triebel F, 2003, TRENDS IMMUNOL, V24, P619, DOI 10.1016/j.it.2003.10.001; Turcotte S, 2014, CLIN CANCER RES, V20, P331, DOI 10.1158/1078-0432.CCR-13-1736; Turcotte S, 2013, J IMMUNOL, V191, P2217, DOI 10.4049/jimmunol.1300538; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Weber J, CANC IMMUN, V13, P7; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Wu X, 2014, BRIT J CANCER, V111, P1391, DOI 10.1038/bjc.2014.416; Yu P, 2010, CLIN CANCER RES, V16, P6019, DOI 10.1158/1078-0432.CCR-10-1966	33	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153053	10.1371/journal.pone.0153053	http://dx.doi.org/10.1371/journal.pone.0153053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050669	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500089
J	Branche, AR; Walsh, EE; Jadhav, N; Karmally, R; Baran, A; Peterson, DR; Falsey, AR				Branche, Angela R.; Walsh, Edward E.; Jadhav, Nagesh; Karmally, Rachel; Baran, Andrea; Peterson, Derick R.; Falsey, Ann R.			Provider Decisions to Treat Respiratory Illnesses with Antibiotics: Insights from a Randomized Controlled Trial	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; TRACT INFECTIONS; CHEST RADIOGRAPHS; SYNCYTIAL VIRUS; RAPID DIAGNOSIS; PROCALCITONIN; BACTERIAL; SEPSIS; ADULTS; CARE	Rationale Lower respiratory tract illness (LRTI) frequently causes adult hospitalization and antibiotic overuse. Procalcitonin (PCT) treatment algorithms have been used successfully in Europe to safely reduce antibiotic use for LRTI but have not been adopted in the United States. We recently performed a feasibility study for a randomized clinical trial (RCT) of PCT and viral testing to guide therapy for non-pneumonic LRTI. Objective The primary objective of the current study was to understand factors influencing PCT algorithm adherence during the RCT and evaluate factors influencing provider antibiotic prescribing practices for LRTI. Study Design From October 2013-April 2014, 300 patients hospitalized at a community teaching hospital with non-pneumonic LRTI were randomized to standard or PCT-guided care with viral PCR testing. Algorithm adherence data was collected and multivariate stepwise logistic regression of clinical variables used to model algorithm compliance. 134 providers were surveyed anonymously before and after the trial to assess knowledge of biomarkers and viral testing and antibiotic prescribing practices. Results Diagnosis of pneumonia on admission was the only variable significantly associated with non-adherence [7%(adherence) vs. 26% (nonadherence), p = 0.01]. Surveys confirmed possible infiltrate on chest radiograph as important for provider decisions, as were severity of illness, positive sputum culture, abnormal CBC and fever. However, age, patient expectations and medical-legal concerns were also at least somewhat important to prescribing practices. Physician agreement with the importance of viral and PCT testing increased from 42% to 64% (p = 0.007) and 49% to 74% (p = 0.001), respectively, after the study. Conclusions Optimal algorithm adherence will be important for definitive PCT intervention trials in the US to determine if PCT guided algorithms result in better outcomes than reliance on traditional clinical variables. Factors influencing treatment decisions such as patient age, presence of fever, patient expectations and medical legal concerns may be amenable to education to improve PCT algorithm compliance for LRTI.	[Branche, Angela R.; Walsh, Edward E.; Falsey, Ann R.] Univ Rochester, Dept Med, Rochester, NY USA; [Walsh, Edward E.; Jadhav, Nagesh; Karmally, Rachel; Falsey, Ann R.] Rochester Gen Hosp, Dept Med, Rochester, NY 14621 USA; [Baran, Andrea; Peterson, Derick R.] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA	University of Rochester; Rochester General Hospital; University of Rochester	Branche, AR (corresponding author), Univ Rochester, Dept Med, Rochester, NY USA.	angela_branche@urmc.rochester.edu	Peterson, Derick/W-5240-2019	Peterson, Derick/0000-0001-8603-660X; Baran, Andrea/0000-0002-7975-8919; JADHAV, NAGESH/0000-0001-8993-3947	RGH KIDD Fund; National Institutes of Health, NIAID [HHSN27220120005C]	RGH KIDD Fund; National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the RGH KIDD Fund and National Institutes of Health, NIAID; Contract # HHSN27220120005C. BioFire, Inc, Salt Lake City, UT provided the FilmArray Respiratory Panel Instrument to conduct the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2012, ARCH INTERN MED, V172, P715, DOI 10.1001/archinternmed.2012.770; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Bartlett JG, 2011, CLIN INFECT DIS, V52, pS296, DOI 10.1093/cid/cir045; Basi SK, 2004, AM J MED, V117, P305, DOI 10.1016/j.amjmed.2004.03.029; Boersma WG, 2006, RESP MED, V100, P926, DOI 10.1016/j.rmed.2005.06.018; Branche AR, 2015, J INFECT DIS, V212, P1692, DOI 10.1093/infdis/jiv252; Chandra A, 2010, AM J EMERG MED, V28, P862, DOI 10.1016/j.ajem.2009.04.014; Chapin KC, 1999, MANUAL CLIN MICROBIO, P1677; Charani E, 2011, CLIN INFECT DIS, V53, P651, DOI 10.1093/cid/cir445; Dubos F, 2008, ARCH PEDIAT ADOL MED, V162, P1157, DOI 10.1001/archpedi.162.12.1157; Dusemund F, 2013, EUR J CLIN MICROBIOL, V32, P51, DOI 10.1007/s10096-012-1713-8; Falsey AR, 2007, ARCH INTERN MED, V167, P354, DOI 10.1001/archinte.167.4.ioi60207; Falsey AR, 2013, J INFECT DIS, V208, P432, DOI 10.1093/infdis/jit190; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fowlkes A, 2014, J INFECT DIS, V209, P1715, DOI 10.1093/infdis/jit806; Gilbert DN., 2011, CLIN INFECT DIS, V52, pS362; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Kanwar M, 2007, CHEST, V131, P1865, DOI 10.1378/chest.07-0164; Kenealy T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub3; Kruger S, 2008, EUR RESPIR J, V31, P349, DOI 10.1183/09031936.00054507; Leroy S, 2005, PEDIATRICS, V115, pE706, DOI 10.1542/peds.2004-1631; Lidman C, 2002, SCAND J INFECT DIS, V34, P873, DOI 10.1080/0036554021000026967; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Muller B, 2007, BMC INFECT DIS, P7; Musher DM, 2004, CLIN INFECT DIS, V39, P165, DOI 10.1086/421497; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Nolte FS, 2008, CLIN INFECT DIS, V47, pS123, DOI 10.1086/591392; Oosterheert JJ, 2005, CLIN INFECT DIS, V41, P1438, DOI 10.1086/497134; Paterson DL, 2004, CLIN INFECT DIS, V38, pS341, DOI 10.1086/382690; Roque F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1276; Ruiz-Alvarez M J, 2009, J Intensive Care Med, V24, P63, DOI 10.1177/0885066608327095; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Shiley KT, 2010, INFECT CONT HOSP EP, V31, P1177, DOI 10.1086/656596; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; Suarez NM, 2015, J INFECT DIS, V212, P213, DOI 10.1093/infdis/jiv047; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; Tonkin-Crine S, 2011, J ANTIMICROB CHEMOTH, V66, P2215, DOI 10.1093/jac/dkr279; van der Velden AW, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659268; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Walsh EE, 2013, J HOSP MED, V8, P61, DOI 10.1002/jhm.1984; Welker JA, 2008, ARCH INTERN MED, V168, P351, DOI 10.1001/archinternmed.2007.84; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Yang S, 2005, J CLIN MICROBIOL, V43, P3221, DOI 10.1128/JCM.43.7.3221-3226.2005; Yardley L, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-134; Zimmerman RK, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0806-2	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152986	10.1371/journal.pone.0152986	http://dx.doi.org/10.1371/journal.pone.0152986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043012	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100058
J	Kunz, M; Hennig, J; Karmann, AJ; Lautenbacher, S				Kunz, Miriam; Hennig, Juergen; Karmann, Anna J.; Lautenbacher, Stefan			Relationship of 5-HTTLPR Polymorphism with Various Factors of Pain Processing: Subjective Experience, Motor Responsiveness and Catastrophizing	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; HEALTHY-INDIVIDUALS; REGULATORY REGION; ASSOCIATIONS; DEPRESSION; MODULATION; METAANALYSIS; RESPONSES; ANXIETY; SCALE	Although serotonin is known to play an important role in pain processing, the relationship between the polymorphism in 5-HTTLPR and pain processing is not well understood. To examine the relationship more comprehensively, various factors of pain processing having putative associations with 5-HT functioning were studied, namely the subjective pain experience (pain threshold, rating of experimental pain), catastrophizing about pain (Pain Catastrophizing Scale = PCS) and motor responsiveness (facial expression of pain). In 60 female and 67 male participants, heat pain stimuli were applied by a contact thermode to assess pain thresholds, supra-threshold ratings and a composite score of pain-relevant facial responses. Participants also completed the PCS and were grouped based on their 5-HTTLPR genotype (bi-allelic evaluation) into a group with s-allele carriers (ss, sl) and a second group without (ll). S-allele carriers proved to have lower pain thresholds and higher PCS scores. These two positive findings were unrelated to each other. No other difference between genotype groups became significant. In all analyses, "age" and "gender" were controlled for. In s-allele carriers the subjective pain experience and the tendency to catastrophize about pain was enhanced, suggesting that the s-allele might be a risk factor for the development and maintenance of pain. This risk factor seems to act via two independent routes, namely via the sensory processes of subjective pain experiences and via the booster effects of pain catastrophizing.	[Kunz, Miriam] Univ Groningen, Univ Med Ctr Groningen, Geriatr Sect, Dept Gen Practice, NL-9713 AV Groningen, Netherlands; [Kunz, Miriam; Karmann, Anna J.; Lautenbacher, Stefan] Univ Bamberg, Dept Psychol, Physiol Psychol, Bamberg, Germany; [Hennig, Juergen] Univ Giessen, Dept Psychol, Personal Psychol & Individual Differences, D-35390 Giessen, Germany	University of Groningen; Otto Friedrich University Bamberg; Justus Liebig University Giessen	Kunz, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Geriatr Sect, Dept Gen Practice, NL-9713 AV Groningen, Netherlands.; Kunz, M (corresponding author), Univ Bamberg, Dept Psychol, Physiol Psychol, Bamberg, Germany.	m.kunz@umcg.nl	Kunz, Miriam/P-8160-2016	Kunz, Miriam/0000-0002-0740-6738; , Stefan/0000-0002-2829-347X	Deutsche Forschungsgemeinschaft (DFG) [Ku2294/6]; FNK grant of the University of Bamberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); FNK grant of the University of Bamberg	The study was supported by a research grant from the Deutsche Forschungsgemeinschaft (DFG, Ku2294/6) and by a FNK grant of the University of Bamberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no financial or other relationships that might lead to a conflict of interest.	Alexander N, 2009, PSYCHONEUROENDOCRINO, V34, P1294, DOI 10.1016/j.psyneuen.2009.03.017; Baum C, 2011, PERCEPT MOTOR SKILL, V112, P926, DOI 10.2466/02.09.22.PMS.112.3.926-946; Campbell CM, 2010, J PAIN, V11, P443, DOI 10.1016/j.jpain.2009.08.009; Edwards RR, 2011, NAT REV RHEUMATOL, V7, P216, DOI 10.1038/nrrheum.2011.2; Ekman P., 2002, FACIAL ACTION CODING; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Hooten WM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-78; Horjales-Araujo E, 2013, PAIN, V154, P1469, DOI 10.1016/j.pain.2013.05.011; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Karmann AJ, 2015, BIOL PSYCHOL, V104, P82, DOI 10.1016/j.biopsycho.2014.11.016; Kesic M, 2015, EUR J PAIN, V19, P508, DOI 10.1002/ejp.574; Kunz M, 2008, PAIN, V140, P127, DOI 10.1016/j.pain.2008.07.019; Kunz M, 2007, PAIN, V133, P221, DOI 10.1016/j.pain.2007.09.007; Kunz M, 2011, J NEUROSCI, V31, P8730, DOI 10.1523/JNEUROSCI.0217-11.2011; Landro NI, 2015, NEUROSCI LETT, V584, P109, DOI 10.1016/j.neulet.2014.10.006; Lerman SF, 2015, PSYCHOSOM MED, V77, P333, DOI 10.1097/PSY.0000000000000158; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lindstedt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017752; Meyer K, 2008, J PSYCHOSOM RES, V64, P469, DOI 10.1016/j.jpsychores.2007.12.004; Millan MJ, 1995, SEMIN NEUROSCI, V7, P409, DOI 10.1016/1044-5765(95)90005-5; Offenbaecher M, 1999, ARTHRITIS RHEUM-US, V42, P2482, DOI 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B; Palit S, 2011, BIOL PSYCHOL, V86, P360, DOI 10.1016/j.biopsycho.2011.01.008; Park JW, 2004, HEADACHE, V44, P1005, DOI 10.1111/j.1526-4610.2004.04194.x; Potvin S, 2010, EUR J PAIN, V14, P742, DOI 10.1016/j.ejpain.2009.12.004; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; Schaldemose EL, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-76; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Treister R, 2011, J PAIN, V12, P875, DOI 10.1016/j.jpain.2011.02.348; Trost Z, 2015, PAIN, V156, P514, DOI 10.1097/01.j.pain.0000460326.02891.fc; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0	31	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153089	10.1371/journal.pone.0153089	http://dx.doi.org/10.1371/journal.pone.0153089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27043930	gold, Green Published, Green Submitted			2022-12-26	WOS:000373592100065
J	Pak, K; Lee, SH; Lee, JG; Seok, JW; Kim, IJ				Pak, Kyoungjune; Lee, Seung Hun; Lee, Jeong Gyu; Seok, Ju Won; Kim, In Joo			Comparison of Visceral Fat Measures with Cardiometabolic Risk Factors in Healthy Adults	PLOS ONE			English	Article							INCIDENT CARDIOVASCULAR-DISEASE; SUBCUTANEOUS ADIPOSE-TISSUE; OBESITY; ASSOCIATION; AREA; QUALITY; CANCER; FDG	We aimed to evaluate the associations of visceral adiposity with cardiometabolic risk factors in normal subjects with integrated F-18-Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT). A total of 58 normal subjects who underwent F-18-FDG PET/CT scan for cancer screening were included in this study. Volume and average Hounsfield unit (HU) of visceral adipose tissue (VAT) was measured from CT components of integrated PET/CT. Standardized uptake values (SUVmax) of liver, spleen, lumbar spine and ascending aorta (AA) were measured from PET components of integrated PET/CT. Body mass index (coefficient 78.25, p = 0.0259), glucose (37.62, p<0.0001), insulin (348.90, p = 0.0011), logarithmic transformation of homeostatic model assessment indexinsulin resistance (-2118.37, p = 0.0007), and VAT HU (-134.99, p<0.0001) were independently associated with VAT volume. Glucose (0.1187, p = 0.0098) and VAT volume (-0.004, p<0.0001) were found to be associated with VAT HU. Both VAT volume and VAT HU of whole abdominal cavity is significantly associated with cardiometabolic risk factors.	[Pak, Kyoungjune; Kim, In Joo] Pusan Natl Univ Hosp, Dept Nucl Med, Busan, South Korea; [Pak, Kyoungjune; Lee, Seung Hun; Lee, Jeong Gyu; Kim, In Joo] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Lee, Seung Hun; Lee, Jeong Gyu] Pusan Natl Univ Hosp, Dept Family Med, Busan, South Korea; [Seok, Ju Won] Chung Ang Univ, Coll Med, Dept Nucl Med, Seoul 156756, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Chung Ang University; Chung Ang University Hospital	Kim, IJ (corresponding author), Pusan Natl Univ Hosp, Dept Nucl Med, Busan, South Korea.; Kim, IJ (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.	pnuhnm@gmail.com	Pak, Kyoungjune/CAE-5230-2022; Pak, Kyoungjune/F-3004-2013	Pak, Kyoungjune/0000-0001-5051-1894; 	Pusan National University Hospital	Pusan National University Hospital(Pusan National University)	This work was supported by clinical research grant from Pusan National University Hospital in 2014.	Abbasi SA, 2015, NUTR METAB CARDIOVAS, V25, P667, DOI 10.1016/j.numecd.2015.03.016; Alvey NJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000788; [Anonymous], 2013, PREV KCFDCA; Baba S, 2010, J NUCL MED, V51, P246, DOI 10.2967/jnumed.109.068775; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027; Demerath EW, 2007, OBESITY, V15, P2984, DOI 10.1038/oby.2007.356; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Greenfield JR, 2002, OBES RES, V10, P260, DOI 10.1038/oby.2002.35; Han JH, 2008, DIABETIC MED, V25, P106, DOI 10.1111/j.1464-5491.2007.02317.x; Haraguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111990; Henninger AMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105262; Heusch P, 2013, EUR J RADIOL, V82, P870, DOI 10.1016/j.ejrad.2013.01.008; Irlbeck T, 2010, INT J OBESITY, V34, P781, DOI 10.1038/ijo.2009.279; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Joshy G, 2014, INT J OBESITY, V38, P848, DOI 10.1038/ijo.2013.192; Kanaya AM, 2004, DIABETES CARE, V27, P1375, DOI 10.2337/diacare.27.6.1375; Kim D, 2016, CLIN GASTROENTEROL H, V14, P132, DOI 10.1016/j.cgh.2015.07.024; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Maurovich-Horvat P, 2007, INT J OBESITY, V31, P500, DOI 10.1038/sj.ijo.0803454; Murphy RA, 2014, AM J CLIN NUTR, V99, P1059, DOI 10.3945/ajcn.113.080796; Nakamura K, 2011, ONCOL REP, V26, P65, DOI 10.3892/or.2011.1259; Rosenquist KJ, 2015, J CLIN ENDOCR METAB, V100, P227, DOI 10.1210/jc.2013-4296; Rosenquist KJ, 2013, JACC-CARDIOVASC IMAG, V6, P762, DOI 10.1016/j.jcmg.2012.11.021; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76; Saijo Y, 2004, DIABETES OBES METAB, V6, P249, DOI 10.1111/j.1462-8902.2003.0342.x; Shah Ravi V, 2014, JACC Cardiovasc Imaging, V7, P1221, DOI 10.1016/j.jcmg.2014.07.017; Shen W, 2007, INT J OBESITY, V31, P763, DOI 10.1038/sj.ijo.0803474; Tahara N, 2015, J CLIN ENDOCR METAB, V100, pE739, DOI 10.1210/jc.2014-3896; Visscher TLS, 2004, ARCH INTERN MED, V164, P1413, DOI 10.1001/archinte.164.13.1413; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Zhuang HM, 2002, SEMIN NUCL MED, V32, P47, DOI 10.1053/snuc.2002.29278	36	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153031	10.1371/journal.pone.0153031	http://dx.doi.org/10.1371/journal.pone.0153031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043708	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100063
J	Hashimoto, Y; Toyama, Y; Kusakari, S; Nawa, M; Matsuoka, M				Hashimoto, Yuichi; Toyama, Yuka; Kusakari, Shinya; Nawa, Mikiro; Matsuoka, Masaaki			An Alzheimer Disease-linked Rare Mutation Potentiates Netrin Receptor Uncoordinated-5C-induced Signaling That Merges with Amyloid beta Precursor Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; HEREDITARY CEREBRAL-HEMORRHAGE; N-TERMINAL KINASE; SKIN PROTEIN; DAP-KINASE; NADPH-OXIDASE; DUTCH TYPE; HUMANIN; ACTIVATION; APOPTOSIS	A missense mutation (T835M) in the uncoordinated-5C (UNC5C) netrin receptor gene increases the risk of late-onset Alzheimer disease (AD) and also the vulnerability of neurons harboring the mutation to various insults. The molecular mechanisms underlying T835M-UNC5C-induced death remain to be elucidated. In this study, we show that overexpression of wildtype UNC5C causes low-grade death, which is intensified by an AD-linked mutation T835M. An AD-linked survival factor, calmodulin-like skin protein (CLSP), and a natural ligand of UNC5C, netrin1, inhibit this death. T835M-UNC5C-induced neuronal cell death is mediated by an intracellular death-signaling cascade, consisting of death-associated protein kinase 1/protein kinase D/apoptosis signal-regulating kinase 1 (ASK1)/JNK/NADPH oxidase/caspases, which merges at ASK1 with a death-signaling cascade, mediated by amyloid beta precursor protein (APP). Notably, netrin1 also binds to APP and partially inhibits the death-signaling cascade, induced by APP. These results may provide new insight into the amyloid beta-independent pathomechanism of AD.	[Hashimoto, Yuichi; Toyama, Yuka; Kusakari, Shinya; Nawa, Mikiro; Matsuoka, Masaaki] Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan; [Matsuoka, Masaaki] Tokyo Med Univ, Dept Dermatol Neurosci, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan	Tokyo Medical University; Tokyo Medical University	Matsuoka, M (corresponding author), Tokyo Med Univ, Dept Pharmacol & Dermatol Neurosci, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	sakimatu@tokyo-med.ac.jp	Hashimoto, Yuichi/N-1508-2015	Hashimoto, Yuichi/0000-0001-5863-3618	Japan Society for the Promotion of Science [15H04689, 25460343]; Naito Foundation Natural Science Scholarship; Akaeda Medical Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation Natural Science Scholarship; Akaeda Medical Research Foundation	This work was supported in part by Grant-in-aid for Scientific Research (B) 15H04689 ( to M. M.) and Grant-in-aid for Scientific Research (C) 25460343 ( to Y. H.) from the Japan Society for the Promotion of Science, by a Naito Foundation Natural Science Scholarship ( to M. M.), and by a research grant from Akaeda Medical Research Foundation to ( to M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ansari MA, 2011, FREE RADICAL BIO MED, V51, P171, DOI 10.1016/j.freeradbiomed.2011.03.025; Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Barbero-Camps E, 2013, HUM MOL GENET, V22, P3460, DOI 10.1093/hmg/ddt201; BODMER S, 1990, BIOCHEM BIOPH RES CO, V171, P890, DOI 10.1016/0006-291X(90)91229-L; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Dennis J, 2013, ANN NEUROL, V74, P328, DOI 10.1002/ana.24001; Eisenberg-Lerner A, 2007, CELL DEATH DIFFER, V14, P1908, DOI 10.1038/sj.cdd.4402212; Fujita Y, 2014, APOPTOSIS, V19, P339, DOI 10.1007/s10495-013-0917-4; Guenebeaud C, 2010, MOL CELL, V40, P863, DOI 10.1016/j.molcel.2010.11.021; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto Y, 2005, MOL CELL BIOL, V25, P9304, DOI 10.1128/MCB.25.21.9304-9317.2005; Hashimoto Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.80; Hashimoto Y, 2014, J NEUROCHEM, V130, P291, DOI 10.1111/jnc.12717; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hayashi M, 2014, NEUROREPORT, V25, P725, DOI 10.1097/WNR.0b013e328362d9fe; Hernandes MS, 2012, CURR NEUROPHARMACOL, V10, P321, DOI 10.2174/157015912804143540; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kim BM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.216; Larrieu-Lahargue F, 2012, TRENDS CARDIOVAS MED, V22, P44, DOI 10.1016/j.tcm.2012.06.010; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Lourenco FC, 2009, CELL DEATH DIFFER, V16, P655, DOI 10.1038/cdd.2008.191; Matsuoka M, 2015, MOL NEUROBIOL, V51, P1232, DOI 10.1007/s12035-014-8799-1; Matsuoka M, 2010, MOL NEUROBIOL, V41, P22, DOI 10.1007/s12035-009-8090-z; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Moore SW, 2007, ADV EXP MED BIOL, V621, P17, DOI 10.1007/978-0-387-76715-4_2; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; Rohn TT, 2010, APOPTOSIS, V15, P1403, DOI 10.1007/s10495-010-0463-2; Savage MJ, 2002, J NEUROSCI, V22, P3376; Selkoe DJ, 2013, CELL, V154, P468, DOI 10.1016/j.cell.2013.07.003; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shiloh R, 2014, APOPTOSIS, V19, P286, DOI 10.1007/s10495-013-0924-5; Tachi N, 2012, BIOCHEM J, V442, P413, DOI 10.1042/BJ20100993; Takeshita Y, 2013, J BIOL CHEM, V288, P24691, DOI 10.1074/jbc.M113.469692; Tayeb HO, 2013, EXPERT OPIN BIOL TH, V13, P1075, DOI 10.1517/14712598.2013.789856; WATTENDORFF AR, 1995, J NEUROL NEUROSUR PS, V58, P699, DOI 10.1136/jnnp.58.6.699; Wetzel-Smith MK, 2014, NAT MED, V20, P1452, DOI 10.1038/nm.3736; Williams ME, 2003, J BIOL CHEM, V278, P17483, DOI 10.1074/jbc.M300415200; Yamatsuji T, 1996, SCIENCE, V272, P1349, DOI 10.1126/science.272.5266.1349; Zhou Q, 2015, ANN NEUROL, V77, P637, DOI 10.1002/ana.24361	42	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12282	12293		10.1074/jbc.M115.698092	http://dx.doi.org/10.1074/jbc.M115.698092			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27068745	Green Published, hybrid			2022-12-26	WOS:000378092800028
J	Dashtsoodol, N; Shigeura, T; Ozawa, R; Harada, M; Kojo, S; Watanabe, T; Koseki, H; Nakayama, M; Ohara, O; Taniguchi, M				Dashtsoodol, Nyambayar; Shigeura, Tomokuni; Ozawa, Ritsuko; Harada, Michishige; Kojo, Satoshi; Watanabe, Takashi; Koseki, Haruhiko; Nakayama, Manabu; Ohara, Osamu; Taniguchi, Masaru			Generation of Novel Traj18-Deficient Mice Lacking V alpha 14 Natural Killer T Cells with an Undisturbed T Cell Receptor alpha-Chain Repertoire	PLOS ONE			English	Article							NKT CELLS; INNATE; MOUSE; IDENTIFICATION; DIVERSITY	Invariant V alpha 14 natural killer T (NKT) cells, characterized by the expression of a single invariant T cell receptor (TCR) a chain encoded by rearranged Trav11 (V alpha 14)-Traj18 (J alpha 18) gene segments in mice, and TRAV10 (V alpha 24)-TRAJ18 (J alpha 18) in humans, mediate adjuvant effects to activate various effector cell types in both innate and adaptive immune systems that facilitates the potent antitumor effects. It was recently reported that the J alpha 18-deficient mouse described by our group in 1997 harbors perturbed TCRa repertoire, which raised concerns regarding the validity of some of the experimental conclusions that have been made using this mouse line. To resolve this concern, we generated a novel Traj18-deficient mouse line by specifically targeting the Traj18 gene segment using Cre-Lox approach. Here we showed the newly generated Traj18-deficient mouse has, apart from the absence of Traj18, an undisturbed TCR alpha chain repertoire by using next generation sequencing and by detecting normal generation of V alpha 19J alpha 33 expressing mucosal associated invariant T cells, whose development was abrogated in the originally described J alpha 18-KO mice. We also demonstrated here the definitive requirement for NKT cells in the protection against tumors and their potent adjuvant effects on antigen-specific CD8 T cells.	[Dashtsoodol, Nyambayar; Shigeura, Tomokuni; Ozawa, Ritsuko; Harada, Michishige; Kojo, Satoshi; Taniguchi, Masaru] RIKEN, Ctr Integrat Med Sci IMS, Lab Immune Regulat, Yokohama, Kanagawa 2300045, Japan; [Watanabe, Takashi; Ohara, Osamu] RIKEN, Ctr Integrat Med Sci IMS, Lab Integrat Genom, Yokohama, Kanagawa 2300045, Japan; [Koseki, Haruhiko] RIKEN, Ctr Integrat Med Sci IMS, Lab Dev Genet, Yokohama, Kanagawa 2300045, Japan; [Nakayama, Manabu] Kazusa DNA Res Inst, Dept Human Genome Res, Kisarazu, Chiba 2920818, Japan; [Dashtsoodol, Nyambayar] Mongolian Natl Univ Med Sci MNUMS, Core Res Lab, Ulaanbaatar 14210, Mongolia	RIKEN; RIKEN; RIKEN; Kazusa DNA Research Institute; Mongolian National University of Medical Sciences	Taniguchi, M (corresponding author), RIKEN, Ctr Integrat Med Sci IMS, Lab Immune Regulat, Yokohama, Kanagawa 2300045, Japan.	masaru.taniguchi@riken.jp	Kojo, Satoshi/N-7135-2018; Ohara, Osamu/G-5448-2015	Kojo, Satoshi/0000-0002-9263-8831; Ohara, Osamu/0000-0002-3328-9571; Dashtsoodol, Nyambayar/0000-0003-4890-9267	JSPS KAKENHI Grants [24790490, 15K08291, 23229005]; Grants-in-Aid for Scientific Research [23229005] Funding Source: KAKEN	JSPS KAKENHI Grants; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grants 24790490 to ND; 15K08291 to SK; and 23229005 to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedel R, 2012, NAT IMMUNOL, V13, P705, DOI 10.1038/ni.2347; Chandra S, 2015, NAT IMMUNOL, V16, P799, DOI 10.1038/ni.3203; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dashtsoodol N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003688; Fujii S, 2010, SEMIN IMMUNOL, V22, P97, DOI 10.1016/j.smim.2009.10.002; Li S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3333; Moro K, 2015, NAT PROTOC, V10, P792, DOI 10.1038/nprot.2015.047; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Taniguchi M, 2010, INT IMMUNOL, V22, P1, DOI 10.1093/intimm/dxp104; Toura I, 1999, J IMMUNOL, V163, P2387; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; Watarai H, 2010, BLOOD, V115, P230, DOI 10.1182/blood-2009-04-217729	15	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153347	10.1371/journal.pone.0153347	http://dx.doi.org/10.1371/journal.pone.0153347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064277	Green Published, Green Submitted, gold			2022-12-26	WOS:000373891000049
J	Sreedhar, R; Tiku, PK				Sreedhar, Roopesh; Tiku, Purnima Kaul			Cupincin: A Unique Protease Purified from Rice (Oryza sativa L.) Bran Is a New Member of the Cupin Superfamily	PLOS ONE			English	Article							SOYBEAN BETA-CONGLYCININ; SEED STORAGE PROTEINS; SECONDARY STRUCTURE; SWISS-MODEL; ASPARTIC PROTEINASE; EVOLUTION; MOBILIZATION; ACIDIFICATION; CONSERVATION; DEGRADATION	Cupin superfamily is one of the most diverse super families. This study reports the purification and characterization of a novel cupin domain containing protease from rice bran for the first time. Hypothetical protein OsI_13867 was identified and named as cupincin. Cupincin was purified to 4.4 folds with a recovery of 4.9%. Cupincin had an optimum pH and temperature of pH 4.0 and 60 degrees C respectively. Cupincin was found to be a homotrimer, consisting of three distinct subunits with apparent molecular masses of 33.45 kDa, 22.35 kDa and 16.67 kDa as determined by MALDI-TOF, whereas it eluted as a single unit with an apparent molecular mass of 135.33 +/- 3.52 kDa in analytical gel filtration and migrated as a single band in native page, suggesting its homogeneity. Sequence identity of cupincin was deduced by determining the amino-terminal sequence of the polypeptide chains and by and de novo sequencing. For understanding the hydrolysing mechanism of cupincin, its three-dimensional model was developed. Structural analysis indicated that cupincin contains His313, His326 and Glu318 with zinc ion as the putative active site residues, inhibition of enzyme activity by 1,10-phenanthroline and atomic absorption spectroscopy confirmed the presence of zinc ion. The cleavage specificity of cupincin towards oxidized B-chain of insulin was highly specific; cleaving at the Leu(15)-Tyr(16) position, the specificity was also determined using neurotensin as a substrate, where it cleaved only at the Glu(1)-Tyr(2) position. Limited proteolysis of the protease suggests a specific function for cupincin. These results demonstrated cupincin as a completely new protease.	[Sreedhar, Roopesh; Tiku, Purnima Kaul] CSIR Cent Food Technol Res Inst, Dept Prot Chem & Technol, Mysuru, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Tiku, PK (corresponding author), CSIR Cent Food Technol Res Inst, Dept Prot Chem & Technol, Mysuru, Karnataka, India.	purnima@cftri.res.in	Tiku, Purnima Kaul/I-7930-2019		Council of Scientific and Industrial Research (CSIR), INDIA [BSC0202]; Indian Council of Medical Research, New Delhi	Council of Scientific and Industrial Research (CSIR), INDIA(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This work was financially supported by Council of Scientific and Industrial Research (CSIR), INDIA through 12th Five year plan project WELFO (BSC0202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Director, CSIR-Central Food Technological Research Institute (CFTRI), Mysuru for his support and encouragement. The authors wish to thank Dr. V. Prakash, former Director, CSIR-CFTRI and Dr. Lalitha R Gowda, former scientist CSIR-CFTRI for their valuable support and suggestions during the initial part of this work. Authors thank Dr. Asha Martin for technical help in Amino-terminal sequencing and Gerd Vegarud, Professor, Norwegian University of Life Sciences for MS/MS analysis. We thank Dr. Sridevi A. Singh for help in CD analysis and team Schrodinger for providing the free trial version of the software. Roopesh S acknowledges the Senior Research Fellowship award from Indian Council of Medical Research, New Delhi.	Adachi M, 2001, J MOL BIOL, V305, P291, DOI 10.1006/jmbi.2000.4310; Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ASAKURA T, 1995, EUR J BIOCHEM, V232, P77, DOI 10.1111/j.1432-1033.1995.tb20783.x; ASAKURA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1793, DOI 10.1271/bbb.59.1793; Asakura T, 1997, J AGR FOOD CHEM, V45, P1070, DOI 10.1021/jf960582x; Barrett A J, 2000, NATURE ENCY LIFE SCI, DOI [10.1038/npg.els.0000670, DOI 10.1038/NPG.ELS.0000670]; Baumlein H, 1995, J MOL EVOL, V41, P1070, DOI 10.1007/BF00173188; Bleukx W, 2000, J CEREAL SCI, V32, P31, DOI 10.1006/jcrs.2000.0300; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Chen JJ, 2009, GENE, V442, P108, DOI 10.1016/j.gene.2009.04.021; Copley SD, 2012, J BIOL CHEM, V287, P3, DOI 10.1074/jbc.R111.254714; Devaraj KB, 2008, PHYTOCHEMISTRY, V69, P647, DOI 10.1016/j.phytochem.2007.09.003; Dominguez F, 1999, PLANT PHYSIOL, V119, P81, DOI 10.1104/pp.119.1.81; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Felicioli R, 1997, ANAL BIOCHEM, V244, P176, DOI 10.1006/abio.1996.9917; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; FOX JW, 1991, ACS SYM SER, V460, P62; Garcia-Lorenzo M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-30; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gerlt JA, 2012, J BIOL CHEM, V287, P29, DOI 10.1074/jbc.R111.240945; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He FL, 2007, J EXP BOT, V58, P1059, DOI 10.1093/jxb/erl267; Huang JY, 2013, J EXP BOT, V64, P3351, DOI 10.1093/jxb/ert173; Igarashi Y, 2009, NUCLEIC ACIDS RES, V37, pD611, DOI 10.1093/nar/gkn683; Ivanisenko VA, 2004, NUCLEIC ACIDS RES, V32, pW549, DOI 10.1093/nar/gkh439; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Ko TP, 2000, ACTA CRYSTALLOGR D, V56, P411, DOI 10.1107/S0907444900002237; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1994, J MOL BIOL, V238, P748, DOI 10.1006/jmbi.1994.1333; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Martinez-Camacho JL, 2004, J PLANT PHYSIOL, V161, P1289, DOI 10.1016/j.jplph.2004.05.010; Maruyama N, 2003, BBA-PROTEINS PROTEOM, V1648, P99, DOI 10.1016/S1570-9639(03)00113-4; Maruyama N, 2001, EUR J BIOCHEM, V268, P3595, DOI 10.1046/j.1432-1327.2001.02268.x; Maruyama Y, 2004, ACTA CRYSTALLOGR D, V60, P289, DOI 10.1107/S0907444903027367; Meng EC, 2011, CURR OPIN STRUC BIOL, V21, P391, DOI 10.1016/j.sbi.2011.03.007; Muntz K, 1996, J EXP BOT, V47, P605, DOI 10.1093/jxb/47.5.605; Natarajan S, 2007, J PLANT PHYSIOL, V164, P756, DOI 10.1016/j.jplph.2006.05.014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poldermans B., 1990, PROTEOLYTIC ENZYMES; QI XQ, 1992, PLANT PHYSIOL, V99, P725, DOI 10.1104/pp.99.2.725; Qureshi TM, 2012, DAIRY SCI TECHNOL, V92, P613, DOI 10.1007/s13594-012-0078-1; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; SATAKE M, 1963, J BIOCHEM-TOKYO, V53, P438, DOI 10.1093/oxfordjournals.jbchem.a127720; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shutov AD, 2003, J EXP BOT, V54, P1645, DOI 10.1093/jxb/erg165; SHUTOV AD, 1987, PHYTOCHEMISTRY, V26, P1557, DOI 10.1016/S0031-9422(00)82245-1; Shutov A, 2012, J PLANT PHYSIOL, V169, P1227, DOI 10.1016/j.jplph.2012.06.004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Straganz GD, 2006, CHEMBIOCHEM, V7, P1536, DOI 10.1002/cbic.200600152; Tan-Wilson AL, 2012, PHYSIOL PLANTARUM, V145, P140, DOI 10.1111/j.1399-3054.2011.01535.x; Tandang-Silvas MRG, 2010, BBA-PROTEINS PROTEOM, V1804, P1432, DOI 10.1016/j.bbapap.2010.02.016; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Uhlig H, 1998, INDUSTRIAL ENZYMES T; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036	61	8	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152819	10.1371/journal.pone.0152819	http://dx.doi.org/10.1371/journal.pone.0152819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064905	gold, Green Published, Green Submitted			2022-12-26	WOS:000373891000019
J	Llopis-Torregrosa, V; Husekova, B; Sychrova, H				Llopis-Torregrosa, Vicent; Husekova, Barbora; Sychrova, Hana			Potassium Uptake Mediated by Trk1 Is Crucial for Candida glabrata Growth and Fitness	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CATION HOMEOSTASIS; INTRACELLULAR PH; AFFINITY POTASSIUM; NA+/H+ ANTIPORTER; GENE DISRUPTION; YEAST; TRANSPORT; SODIUM; TOLERANCE	The maintenance of potassium homeostasis is crucial for all types of cells, including Candida glabrata. Three types of plasma-membrane systems mediating potassium influx with different transport mechanisms have been described in yeasts: the Trk1 uniporter, the Hak cation-proton symporter and the Acu ATPase. The C. glabrata genome contains only one gene encoding putative system for potassium uptake, the Trk1 uniporter. Therefore, its importance in maintaining adequate levels of intracellular potassium appears to be critical for C. glabrata cells. In this study, we first confirmed the potassium-uptake activity of the identified gene's product by heterologous expression in a suitable S. cerevisiae mutant, further we generated a corresponding deletion mutant in C. glabrata and analysed its phenotype in detail. The obtained results show a pleiotropic effect on the cell physiology when CgTRK1 is deleted, affecting not only the ability of trk1 Delta to grow at low potassium concentrations, but also the tolerance to toxic alkali-metal cations and cationic drugs, as well as the membrane potential and intracellular pH. Taken together, our results find the sole potassium uptake system in C. glabrata cells to be a promising target in the search for its specific inhibitors and in developing new antifungal drugs.	[Llopis-Torregrosa, Vicent; Husekova, Barbora; Sychrova, Hana] Acad Sci Czech Republ, Inst Physiol, Dept Membrane Transport, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Llopis-Torregrosa, V (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Membrane Transport, Prague, Czech Republic.	Vicent.LlopisTorregrosa@fgu.cas.cz	Llopis, Vicent/AAW-2467-2021; Sychrova, Hana/B-1350-2012	Llopis, Vicent/0000-0003-1041-9676; Sychrova, Hana/0000-0001-5967-5019	Czech National Science Foundation [GA CR 302/12/1151, 16-03398S]; European Commission [MC-ITN-2013-606786 ImResFun]	Czech National Science Foundation(Grant Agency of the Czech Republic); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Czech National Science Foundation (GA CR 302/12/1151 and 16-03398S) and the European Commission Framework 7 Programme (MC-ITN-2013-606786 ImResFun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arino J, 2014, ADV MICROB PHYSIOL, V64, P1, DOI 10.1016/B978-0-12-800143-1.00001-4; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Baev D, 2004, J BIOL CHEM, V279, P55060, DOI 10.1074/jbc.M411031200; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; Benito B, 2004, EUKARYOT CELL, V3, P359, DOI 10.1128/EC.3.2.359-368.2004; Bertl A, 2003, MOL MICROBIOL, V47, P767, DOI 10.1046/j.1365-2958.2003.03335.x; Bihler H, 2002, BBA-BIOMEMBRANES, V1558, P109, DOI 10.1016/S0005-2736(01)00414-X; Bolotin-Fukuhara M, 2014, YEAST, V31, P279, DOI 10.1002/yea.3019; Borst A, 2005, ANTIMICROB AGENTS CH, V49, P783, DOI 10.1128/AAC.49.2.783-787.2005; CAMACHO M, 1981, CURR MICROBIOL, V6, P295, DOI 10.1007/BF01566880; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Elicharova H, 2014, MICROBIOL-SGM, V160, P1705, DOI 10.1099/mic.0.078600-0; Enjalbert B, 2009, MOL MICROBIOL, V72, P216, DOI 10.1111/j.1365-2958.2009.06640.x; Gabaldon T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-623; Gaskova D, 1998, YEAST, V14, P1189, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1189::AID-YEA320>3.3.CO;2-B; Gelis S, 2015, MICROBIOL-SGM, V161, P1260, DOI 10.1099/mic.0.000078; Gomez MJ, 1996, FEMS MICROBIOL LETT, V135, P157, DOI 10.1016/0378-1097(95)00441-6; Hendrych T, 2009, BBA-BIOMEMBRANES, V1788, P717, DOI 10.1016/j.bbamem.2008.12.001; Herrera R, 2014, BBA-BIOMEMBRANES, V1838, P127, DOI 10.1016/j.bbamem.2013.08.022; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Ho HL, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov066; Husekova B, 2016, CAN J MICROBIOL, V62, P394, DOI 10.1139/cjm-2015-0766; JUST G, 1989, MYCOSES, V32, P47; Kahm M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002548; Kinclova O, 2001, MOL MICROBIOL, V40, P656, DOI 10.1046/j.1365-2958.2001.02412.x; Kinclova O, 2001, FEBS LETT, V504, P11, DOI 10.1016/S0014-5793(01)02755-7; Kodedova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139306; Krauke Y, 2011, FEMS YEAST RES, V11, P29, DOI 10.1111/j.1567-1364.2010.00686.x; Krauke Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-80; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Maresova L, 2010, YEAST, V27, P317, DOI 10.1002/yea.1755; Martinez JL, 2011, FUNGAL GENET BIOL, V48, P177, DOI 10.1016/j.fgb.2010.06.013; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miranda M, 2009, FEMS YEAST RES, V9, P278, DOI 10.1111/j.1567-1364.2008.00471.x; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Navarrete C, 2010, FEMS YEAST RES, V10, P508, DOI 10.1111/j.1567-1364.2010.00630.x; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Petrezselyova S, 2011, FOLIA MICROBIOL, V56, P23, DOI 10.1007/s12223-011-0009-1; Pohl Hana R, 2013, Met Ions Life Sci, V13, P29, DOI 10.1007/978-94-007-7500-8_2; Ramos J, 2011, FEMS MICROBIOL LETT, V317, P1, DOI 10.1111/j.1574-6968.2011.02214.x; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Roetzer A, 2011, FEMS MICROBIOL LETT, V314, P1, DOI 10.1111/j.1574-6968.2010.02102.x; Stribny J, 2012, CURR GENET, V58, P255, DOI 10.1007/s00294-012-0381-7; Szczerba MW, 2009, J PLANT PHYSIOL, V166, P447, DOI 10.1016/j.jplph.2008.12.009; Ullah A, 2013, MICROBIOL-SGM, V159, P803, DOI 10.1099/mic.0.063610-0; Vale-Silva LA, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov025; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005; Zimmermannova O, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov029	52	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153374	10.1371/journal.pone.0153374	http://dx.doi.org/10.1371/journal.pone.0153374			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058598	Green Published, gold, Green Submitted			2022-12-26	WOS:000373604800031
J	Issop, L; Ostuni, MA; Lee, S; Laforge, M; Peranzi, G; Rustin, P; Benoist, JF; Estaquier, J; Papadopoulos, V; Lacapere, JJ				Issop, Leeyah; Ostuni, Mariano A.; Lee, Sunghoon; Laforge, Mireille; Peranzi, Gabriel; Rustin, Pierre; Benoist, Jean-Francois; Estaquier, Jerome; Papadopoulos, Vassilios; Lacapere, Jean-Jacques			Translocator Protein-Mediated Stabilization of Mitochondrial Architecture during Inflammation Stress in Colonic Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PERIPHERAL BENZODIAZEPINE-RECEPTOR; MANGANESE SUPEROXIDE-DISMUTASE; COLORECTAL-CANCER; BOWEL-DISEASE; 18 KDA; ANTISENSE KNOCKOUT; QUALITY-CONTROL; BINDING-SITES; IN-VITRO	Chronic inflammation of the gastrointestinal tract increasing the risk of cancer has been described to be linked to the high expression of the mitochondrial translocator protein (18 kDa; TSPO). Accordingly, TSPO drug ligands have been shown to regulate cytokine production and to improve tissue reconstruction. We used HT-29 human colon carcinoma cells to evaluate the role of TSPO and its drug ligands in tumor necrosis factor (TNF)-induced inflammation. TNF-induced interleukin (IL)-8 expression, coupled to reactive oxygen species (ROS) production, was followed by TSPO overexpression. TNF also destabilized mitochondrial ultrastructure, inducing cell death by apoptosis. Treatment with the TSPO drug ligand PK 11195 maintained the mitochondrial ultrastructure, reducing IL-8 and ROS production and cell death. TSPO silencing and overexpression studies demonstrated that the presence of TSPO is essential to control IL-8 and ROS production, so as to maintain mitochondrial ultrastructure and to prevent cell death. Taken together, our data indicate that inflammation results in the disruption of mitochondrial complexes containing TSPO, leading to cell death and epithelia disruption. Significance: This work implicates TSPO in the maintenance of mitochondrial membrane integrity and in the control of mitochondrial ROS production, ultimately favoring tissue regeneration.	[Issop, Leeyah; Peranzi, Gabriel; Lacapere, Jean-Jacques] Univ Paris 06, Ecole Normale Super, PSL Res Univ, Sorbonne Univ,Dept Chim,CNRS,UMR 7203,LBM, 4 Pl Jussieu, F-75005 Paris, France; [Issop, Leeyah; Lee, Sunghoon; Papadopoulos, Vassilios] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H4A 3J1, Canada; [Issop, Leeyah; Lee, Sunghoon; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada; [Ostuni, Mariano A.] Univ Paris 07, Inst Natl Transfus Sanguine, INSERM, UMRS 1134, 6 Rue Alexandre Cabanel, F-75015 Paris, France; [Laforge, Mireille; Estaquier, Jerome] Univ Paris 05, CNRS FR 3636, Paris, France; [Rustin, Pierre; Benoist, Jean-Francois] Hop Robert Debre, INSERM, UMR 1141, F-75019 Paris, France; [Rustin, Pierre; Benoist, Jean-Francois] Univ Paris 07, F-75019 Paris, France; [Estaquier, Jerome] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1V 06A, Canada	Arts et Metiers Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); McGill University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Laval University	Lacapere, JJ (corresponding author), Univ Paris 06, Ecole Normale Super, PSL Res Univ, Sorbonne Univ,Dept Chim,CNRS,UMR 7203,LBM, 4 Pl Jussieu, F-75005 Paris, France.	jean-jacqueslacapere@upmc.fr	Papadopoulos, Vassilios/AAI-2613-2019; , ESTAQUIER/AAR-7799-2020; OSTUNI, Mariano/J-2930-2015	Papadopoulos, Vassilios/0000-0002-1183-8568; , ESTAQUIER/0000-0002-9432-8044; OSTUNI, Mariano/0000-0001-6769-3786; benoist, jean-francois/0000-0002-5389-8585; ISSOP, LEEYAH/0000-0002-2359-7722	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universities (UPMC, Paris Diderot); Agence Nationale de la Recherche [ANR BLAN-0190-01]; Ministere de la Recherche; Association contre les Maladies Mitochondriales (AMMi); Canadian Institutes of Health Research [MOP-125983]; Canada Research Chair in Biochemical Pharmacology	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universities (UPMC, Paris Diderot); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Association contre les Maladies Mitochondriales (AMMi); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemical Pharmacology	The authors are supported by the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universities (UPMC, Paris Diderot), and grants from the Agence Nationale de la Recherche (ANR BLAN-0190-01 to JJL); the Ministere de la Recherche (fellowship to LI); Association contre les Maladies Mitochondriales (AMMi) to PR; and the Canadian Institutes of Health Research (MOP-125983) and the Canada Research Chair in Biochemical Pharmacology to VP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147; Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; AUGERON C, 1984, CANCER RES, V44, P3961; Bae KR, 2014, J NEUROIMMUNE PHARM, V9, P424, DOI 10.1007/s11481-014-9540-6; Batarseh A, 2010, BIOCHEMISTRY-US, V49, P4766, DOI 10.1021/bi100020e; Bribes E, 2004, J HISTOCHEM CYTOCHEM, V52, P19, DOI 10.1177/002215540405200103; Bruno MEC, 2005, J IMMUNOL, V174, P7278, DOI 10.4049/jimmunol.174.11.7278; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Da Cruz S, 2008, BBA-MOL CELL RES, V1783, P904, DOI 10.1016/j.bbamcr.2008.02.006; Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gatliff J, 2014, AUTOPHAGY, V10, P2279, DOI 10.4161/15548627.2014.991665; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Guillery O, 2008, BIOL CELL, V100, P315, DOI 10.1042/BC20070110; HACKENBROCK CR, 1971, J CELL BIOL, V51, P123, DOI 10.1083/jcb.51.1.123; Han ZQ, 2003, J RECEPT SIG TRANSD, V23, P225, DOI 10.1081/RRS-120025210; Hanna AN, 2001, MOL BIOL CELL, V12, P3618, DOI 10.1091/mbc.12.11.3618; Ho-Pun-Cheung A, 2008, ANN BIOL CLIN-PARIS, V66, P121, DOI 10.1684/abc.2008.0204; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Jawad N, 2011, RECENT RESULTS CANC, V185, P99, DOI 10.1007/978-3-642-03503-6_6; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; KATZ Y, 1988, EUR J PHARMACOL, V148, P483, DOI 10.1016/0014-2999(88)90135-5; KATZ Y, 1990, ONCOLOGY, V47, P139; Kelly-Hershkovitz E, 1998, J BIOL CHEM, V273, P5478, DOI 10.1074/jbc.273.10.5478; Konigsrainer I, 2007, EUR SURG RES, V39, P359, DOI 10.1159/000106380; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Kraus S, 2009, CURR OPIN PHARMACOL, V9, P405, DOI 10.1016/j.coph.2009.06.006; Levin E, 2005, BIOCHEMISTRY-US, V44, P9924, DOI 10.1021/bi050150s; Li W, 2007, BIOCHEM PHARMACOL, V73, P491, DOI 10.1016/j.bcp.2006.10.025; Lukas M, 2010, DIGEST DIS, V28, P619, DOI 10.1159/000320276; Maaser K, 2002, CLIN CANCER RES, V8, P3205; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Morales A, 1997, J BIOL CHEM, V272, P30371, DOI 10.1074/jbc.272.48.30371; Murail S, 2008, BIOCHIM BIOPHYS ACTA, V1778, P375; O'Neill LAJ, 2014, NATURE, V515, P350, DOI 10.1038/nature13941; Ostuni MA, 2007, BIOL CELL, V99, P639, DOI 10.1042/BC20070048; Ostuni MA, 2010, INFLAMM BOWEL DIS, V16, P1476, DOI 10.1002/ibd.21250; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Peranzi G, 2010, METHODS MOL BIOL, V654, P221, DOI 10.1007/978-1-60761-762-4_12; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ramonaite R, 2014, WORLD J GASTROENTERO, V20, P12533, DOI 10.3748/wjg.v20.i35.12533; Reisinger V, 2008, J PROTEOMICS, V71, P277, DOI 10.1016/j.jprot.2008.05.004; ROUSSET M, 1986, BIOCHIMIE, V68, P1035, DOI 10.1016/S0300-9084(86)80177-8; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Shoukrun R, 2008, PHARMACOGENET GENOM, V18, P977, DOI 10.1097/FPC.0b013e3283117d52; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Vallette G, 1997, BRIT J PHARMACOL, V121, P187, DOI 10.1038/sj.bjp.0701118; VISNER GA, 1990, J BIOL CHEM, V265, P2856; Weisinger G, 2004, BIOCHEMISTRY-US, V43, P12315, DOI 10.1021/bi030251v; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; ZENTELLA A, 1993, CYTOKINE, V5, P436, DOI 10.1016/1043-4666(93)90033-2; Zisman TL, 2008, WORLD J GASTROENTERO, V14, P2662, DOI 10.3748/wjg.14.2662	62	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152919	10.1371/journal.pone.0152919	http://dx.doi.org/10.1371/journal.pone.0152919			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054921	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000054
J	Kim, Y; Aw, TG; Rose, JB				Kim, Yiseul; Aw, Tiong Gim; Rose, Joan B.			Transporting Ocean Viromes: Invasion of the Aquatic Biosphere	PLOS ONE			English	Article							VIRAL COMMUNITIES; BALLAST WATER; VIRUSES; PHYTOPLANKTON; DIVERSITY; SHIPS	Studies of marine viromes (viral metagenomes) have revealed that DNA viruses are highly diverse and exhibit biogeographic patterns. However, little is known about the diversity of RNA viruses, which are mostly composed of eukaryotic viruses, and their biogeographic patterns in the oceans. A growth in global commerce and maritime traffic may accelerate spread of diverse and non-cosmopolitan DNA viruses and potentially RNA viruses from one part of the world to another. Here, we demonstrated through metagenomic analyses that failure to comply with mid-ocean ballast water exchange regulation could result in movement of viromes including both DNA viruses and RNA viruses (including potential viral pathogens) unique to geographic and environmental niches. Furthermore, our results showed that virus richness (known and unknown viruses) in ballast water is associated with distance between ballast water exchange location and its nearest shoreline as well as length of water storage time in ballast tanks (voyage duration). However, richness of only known viruses is governed by local environmental conditions and different viral groups have different responses to environmental variation. Overall, these results identified ballast water as a factor contributing to ocean virome transport and potentially increased exposure of the aquatic bioshpere to viral invasion.	[Kim, Yiseul; Rose, Joan B.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Aw, Tiong Gim; Rose, Joan B.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Kim, Y (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	kimyise2@msu.edu			National Science Foundation, Partnerships for International Research and Education [OISE-0530174]	National Science Foundation, Partnerships for International Research and Education(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was supported by the National Science Foundation, Partnerships for International Research and Education (OISE-0530174).	de Carcer DA, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400127; Amalfitano S, 2015, HYDROBIOLOGIA, V746, P13, DOI 10.1007/s10750-014-2002-6; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Balique F, 2015, VIRUSES-BASEL, V7, P2074, DOI 10.3390/v7042074; BOEHME J, 1993, MAR ECOL PROG SER, V97, P1, DOI 10.3354/meps097001; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Bunge J, 2012, BIOINFORMATICS, V28, P1045, DOI 10.1093/bioinformatics/bts075; COCHLAN WP, 1993, MAR ECOL PROG SER, V92, P77, DOI 10.3354/meps092077; Culley AI, 2002, LIMNOL OCEANOGR, V47, P1508, DOI 10.4319/lo.2002.47.5.1508; Danovaro R, 2011, FEMS MICROBIOL REV, V35, P993, DOI 10.1111/j.1574-6976.2010.00258.x; David M, 2015, SPRINGER SERIES INVA, V8, P59; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Djikeng A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007264; Drake LA, 2007, MAR POLLUT BULL, V55, P333, DOI 10.1016/j.marpolbul.2006.11.007; Fancello L, 2013, ISME J, V7, P359, DOI 10.1038/ismej.2012.101; Garigliany MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07552; GEF-UNDP-IMO GloBallast Partnerships IOI, 2009, GLOBALLAST MONOGRAPH, V17; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; International Maritime Organization, 2004, INT CONV CONTR MAN S; Ito T, 2013, J GEN VIROL, V94, P2094, DOI 10.1099/vir.0.052902-0; Jaykus LA, 1996, APPL ENVIRON MICROB, V62, P2074, DOI 10.1128/AEM.62.6.2074-2080.1996; Kim Y, 2015, ENVIRON SCI TECHNOL, V49, P8396, DOI 10.1021/acs.est.5b01633; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leichsenring J, 2011, MAR POLLUT BULL, V62, P1103, DOI 10.1016/j.marpolbul.2011.01.034; Litchman E, 2010, ECOL LETT, V13, P1560, DOI 10.1111/j.1461-0248.2010.01544.x; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Martinez JM, 2014, ISME J, V8, P1079, DOI 10.1038/ismej.2013.214; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; R Development Core Team, 2010, R A LANGUAGE AND ENV; Roux S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-76; Roux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033641; Ruiz GM, 2000, NATURE, V408, P49, DOI 10.1038/35040695; Smits SL, 2013, EMERG INFECT DIS, V19, P1511, DOI 10.3201/eid1909.130404; Tseng CH, 2013, ISME J, V7, P2374, DOI 10.1038/ismej.2013.118; Van Tan L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03967; Walker PJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010022; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Williamson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042047; Winter C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100600; Wommack KE, 2015, J MICROBIOL, V53, P181, DOI 10.1007/s12275-015-5068-6	43	17	19	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152671	10.1371/journal.pone.0152671	http://dx.doi.org/10.1371/journal.pone.0152671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055282	gold, Green Published, Green Submitted			2022-12-26	WOS:000373608000034
J	Liew, KL; Jee, JM; Yap, I; Yong, PVC				Liew, Kah Leong; Jee, Jap Meng; Yap, Ivan; Yong, Phelim Voon Chen			In Vitro Analysis of Metabolites Secreted during Infection of Lung Epithelial Cells by Cryptococcus neoformans	PLOS ONE			English	Article							O-ACETYLATION; VIRULENCE; PATHWAY; BIOSYNTHESIS; METABOLOMICS; ADAPTATION; ANTIBODY; REVEALS; ACID	Cryptococcus neoformans is an encapsulated basidiomycetous yeast commonly associated with pigeon droppings and soil. The opportunistic pathogen infects humans through the respiratory system and the metabolic implications of C. neoformans infection have yet to be explored. Studying the metabolic profile associated with the infection could lead to the identification of important metabolites associated with pulmonary infection. Therefore, the aim of the study was to simulate cryptococcal infection at the primary site of infection, the lungs, and to identify the metabolic profile and important metabolites associated with the infection at low and high multiplicity of infections (MOI). The culture supernatant of lung epithelial cells infected with C. neoformans at MOI of 10 and 100 over a period of 18 hours were analysed using gas chromatography mass spectrometry. The metabolic profiles obtained were further analysed using multivariate analysis and the pathway analysis tool, MetaboAnalyst 2.0. Based on the results from the multivariate analyses, ten metabolites were selected as the discriminatory metabolites that were important in both the infection conditions. The pathways affected during early C. neoformans infection of lung epithelial cells were mainly the central carbon metabolism and biosynthesis of amino acids. Infection at a higher MOI led to a perturbance in the beta-alanine metabolism and an increase in the secretion of pantothenic acid into the growth media. Pantothenic acid production during yeast infection has not been documented and the beta-alanine metabolism as well as the pantothenate and CoA biosynthesis pathways may represent underlying metabolic pathways associated with disease progression. Our study suggested that a-alanine metabolism and the pantothenate and CoA biosynthesis pathways might be the important pathways associated with cryptococcal infection.	[Liew, Kah Leong; Jee, Jap Meng; Yong, Phelim Voon Chen] Taylors Univ, Sch Biosci, Subang Jaya, Selangor Darul, Malaysia; [Yap, Ivan] Int Med Univ, Dept Life Sci, Kuala Lumpur 57000, Malaysia	Taylor's University; International Medical University Malaysia	Yong, PVC (corresponding author), Taylors Univ, Sch Biosci, Subang Jaya, Selangor Darul, Malaysia.	phelimvoonchen.yong@taylors.edu.my	Yap, Ivan Kok Seng/ABD-4843-2020; Yong, Phelim VC/M-5961-2015	Yap, Ivan Kok Seng/0000-0002-7523-5352; Yong, Phelim VC/0000-0002-5817-7381	Exploratory Research Grant Scheme [ERGS/1/2012/STG03/TAYLOR/03/1]; Taylor's University Postgraduate Research Scholarship Programme	Exploratory Research Grant Scheme; Taylor's University Postgraduate Research Scholarship Programme	This work was supported by grants from Exploratory Research Grant Scheme (ERGS/1/2012/STG03/TAYLOR/03/1) to PVCY and Taylor's University Postgraduate Research Scholarship Programme to KLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque P, 2014, MBIO, V5, DOI 10.1128/mBio.00986-13; Aliferis KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111930; Arora S, 2006, INFECT IMMUN, V74, P4339, DOI 10.1128/IAI.01989-05; Bai YN, 2014, CLIN CHIM ACTA, V436, P207, DOI 10.1016/j.cca.2014.05.022; Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Bien CM, 2009, MOL MICROBIOL, V74, P672, DOI 10.1111/j.1365-2958.2009.06895.x; Birungi G, 2010, J PROTEOME RES, V9, P6523, DOI 10.1021/pr100727m; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Choi JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041654; Choo KhiKhi, 2015, British Microbiology Research Journal, V7, P100, DOI 10.9734/BMRJ/2015/16464; COGLIATI M, 2013, SCIENTIFICA, DOI DOI 10.1155/2013/675213; David J, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00080; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1111/j.1574-6976.2000.tb00553.x; Gostincar C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00390; Griffiths EJ, 2012, MOL MICROBIOL, V86, P1404, DOI 10.1111/mmi.12065; Guimaraes AJ, 2010, CELL MICROBIOL, V12, P740, DOI 10.1111/j.1462-5822.2010.01430.x; Hu GG, 2008, MOL MICROBIOL, V69, P1456, DOI 10.1111/j.1365-2958.2008.06374.x; Janbon G, 2001, MOL MICROBIOL, V42, P453, DOI 10.1046/j.1365-2958.2001.02651.x; Kentner D, 2014, P NATL ACAD SCI USA, V111, P9929, DOI 10.1073/pnas.1406694111; Kouskoumvekaki I, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/525497; Kozel TR, 2003, INFECT IMMUN, V71, P2868, DOI 10.1128/IAI.71.5.2868-2875.2003; Kretschmer M, 2012, EUKARYOT CELL, V11, P1042, DOI 10.1128/EC.00128-12; Kronstad J, 2012, EUKARYOT CELL, V11, P109, DOI 10.1128/EC.05273-11; Lebeer S, 2007, J BACTERIOL, V189, P860, DOI 10.1128/JB.01394-06; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; Liew KahLeong, 2012, African Journal of Biotechnology, V11, P10469; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Mapelli V, 2008, TRENDS BIOTECHNOL, V26, P490, DOI 10.1016/j.tibtech.2008.05.008; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Patel D, 2013, MBIO, V4, DOI 10.1128/mBio.00400-13; Robertson EJ, 2009, APPL ENVIRON MICROB, V75, P2528, DOI 10.1128/AEM.02846-08; Rude TH, 2002, INFECT IMMUN, V70, P5684, DOI 10.1128/IAI.70.10.5684-5694.2002; Saha DC, 2008, INDIAN J MED RES, V127, P483; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; Tay ST, 2010, MYCOSES, V53, P509, DOI 10.1111/j.1439-0507.2009.01750.x; White WH, 2001, J BIOL CHEM, V276, P10794, DOI 10.1074/jbc.M009804200; Zhang AH, 2013, CLIN CHIM ACTA, V418, P86, DOI 10.1016/j.cca.2012.12.024	38	20	21	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153356	10.1371/journal.pone.0153356	http://dx.doi.org/10.1371/journal.pone.0153356			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054608	Green Submitted, gold, Green Published			2022-12-26	WOS:000373608000124
J	Wen, XY; Zhang, HW				Wen, Xinyu; Zhang, Huawei			Photoelectrochemical Properties of CuS-GeO2-TiO2 Composite Coating Electrode	PLOS ONE			English	Article							PHOTOCATALYTIC DECOMPOSITION; TITANIUM-DIOXIDE; TIO2; FILMS; DEGRADATION; NANOPARTICLES; DEPOSITION	The ITO (indium tin oxide) conductive glass-matrix CuS-GeO2-TiO2 composite coating was generated via EPD (electrophoretic deposition) and followed by a sintering treatment at 450 degrees C for 40 minutes. Characterizations of the CuS-GeO2-TiO2 composite coating were taken by SEM (scanning electron microscope), XRD (X-ray diffraction), EDX (energy dispersive X-ray), UV-Vis DRS (ultraviolet-visible diffuse reflection spectrum), and FT-IR (Fourier transform infrared spectroscopy). Results showed that CuS and GeO2 had dispersed in this CuS-GeO2-TiO2 composite coating (mass percentages for CuS and GeO2 were 1.23% and 2.79%, respectively). The electrochemical studies (cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS) and Tafel polarization) of this CuS-GeO2-TiO2 composite coating electrode were performed in pH = 9.51 Na2CO3-NaHCO3 buffer solution containing 0.50 mol/L CH3OH under the conditions of visible light, ultraviolet light (lambda = 365 nm), and dark (without light irradiation as control), respectively. Electrochemical studies indicated that this CuS-GeO2-TiO2 composite coating electrode had better photoelectrocatalytic activity than the pure TiO2 electrode in the electrocatalysis of methanol under visible light.	[Wen, Xinyu; Zhang, Huawei] Yunnan Normal Univ, Sch Tourism & Geog Sci, Kunming 650500, Peoples R China; [Wen, Xinyu] Fujian Normal Univ, Coll Chem & Chem Engn, Fuzhou 350117, Peoples R China	Yunnan Normal University; Fujian Normal University	Zhang, HW (corresponding author), Yunnan Normal Univ, Sch Tourism & Geog Sci, Kunming 650500, Peoples R China.	hwzhang@ynnu.edu.cn	Zhang, Huawei/H-1924-2016	Zhang, Huawei/0000-0002-8701-4266	College of Chemistry and Chemical Engineering	College of Chemistry and Chemical Engineering	The authors thank the College of Chemistry and Chemical Engineering for the support of this work. The authors also thank Guangchao Liang for his suggestion and comments of this contribution.	Bessekhouad Y, 2004, J PHOTOCH PHOTOBIO A, V163, P569, DOI 10.1016/j.jphotochem.2004.02.006; Butterfield IM, 1997, J APPL ELECTROCHEM, V27, P385, DOI 10.1023/A:1018453402332; Devi LG, 2009, CATAL COMMUN, V10, P794, DOI 10.1016/j.catcom.2008.11.041; Erokhina S, 2003, LANGMUIR, V19, P766, DOI 10.1021/la026433s; Feng JM, 2009, PROG ORG COAT, V64, P268, DOI 10.1016/j.porgcoat.2008.08.022; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Grzechulska J, 2000, WATER RES, V34, P1638, DOI 10.1016/S0043-1354(99)00275-4; Hu C, 2001, APPL CATAL B-ENVIRON, V30, P277; Kamat PV, 2002, CURR OPIN COLLOID IN, V7, P282, DOI 10.1016/S1359-0294(02)00069-9; Kang MG, 1999, J PHOTOCH PHOTOBIO A, V125, P119, DOI 10.1016/S1010-6030(99)00092-1; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Liu SX, 2007, J HAZARD MATER, V143, P257, DOI 10.1016/j.jhazmat.2006.09.026; Liu YH, 2008, J MATER SCI, V43, P5005, DOI 10.1007/s10853-008-2740-9; Lo SC, 2004, J HAZARD MATER, V114, P183, DOI 10.1016/j.jhazmat.2004.08.007; Molinari R, 2002, CATAL TODAY, V75, P77, DOI 10.1016/S0920-5861(02)00047-0; Moskalewicz T, 2002, SURF COAT TECH, V201, P7467; Murugan AV, 2006, MATER LETT, V60, P479, DOI 10.1016/j.matlet.2005.09.017; Peng F, 2003, CHINESE J CATAL+, V24, P243; Subasri R, 2003, ELECTROCHEM COMMUN, V5, P897, DOI 10.1016/j.elecom.2003.08.016; SUN SG, 1987, J ELECTROANAL CHEM, V236, P95, DOI 10.1016/0022-0728(87)88021-X; Takeuchi M, 2000, CATAL LETT, V67, P135, DOI 10.1023/A:1019065521567; Tang FQ, 2004, MATER RES BULL, V39, P2155, DOI 10.1016/j.materresbull.2004.08.012; Wang YQ, 1999, ACTA PHYS-CHIM SIN, V15, P222, DOI 10.3866/PKU.WHXB19990306; Wu Peng-fei, 2005, Corrosion Science and Protection Technology, V17, P104; Xu B., 2010, GUANGZHOU HUAGONG, V38, P147; Yamashita H, 2002, J PHOTOCH PHOTOBIO A, V148, P257, DOI 10.1016/S1010-6030(02)00051-5; Zacharias M, 1997, APPL PHYS LETT, V71, P380, DOI 10.1063/1.119543; Zhang ZX, 2000, J WUHAN U NAT SCI ED, V46, P84; Zhong LS, 2007, CHEM MATER, V19, P4557, DOI 10.1021/cm0714032	29	9	9	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152862	10.1371/journal.pone.0152862	http://dx.doi.org/10.1371/journal.pone.0152862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055277	Green Published, Green Submitted, gold			2022-12-26	WOS:000373608000050
J	Cubillos, S; Krieg, N; Norgauer, J				Cubillos, Susana; Krieg, Nadine; Norgauer, Johannes			Effect of Vitamin D on Peripheral Blood Mononuclear Cells from Patients with Psoriasis Vulgaris and Psoriatic Arthritis	PLOS ONE			English	Article							RESISTANT ACID-PHOSPHATASE; BONE-RESORPTION; 1,25-DIHYDROXYVITAMIN D-3; CATHEPSIN-K; IN-VITRO; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; OSTEOCLASTS; EXPRESSION; DIFFERENTIATION	Background Psoriasis, a chronic skin disease with or without joint inflammation, has increased circulating proinflammatory cytokine levels. Vitamin D is involved in calcium homeostasis, bone formation, osteoclastogenesis and osteoclast activity, as well as regulation of immune response. We aimed to study osteoclast differentiation and cytokine secretion of peripheral blood mononuclear cells (PBMCs) from patients with psoriasis vulgaris and psoriatic arthritis, in response to 1,25(OH)(2)D-3. Methods Serum levels of bone turnover markers were measured by ELISA in patients with psoriasis vulgaris and psoriatic arthritis, and healthy controls. PBMCs were isolated and cultured with or without RANKL/M-CSF and 1,25(OH)(2)D-3. Osteoclast differentiation and cytokine secretion were assessed. Results Psoriatic arthritis patients had lower osteocalcin, as well as higher C-telopeptide of type I collagen and cathepsin K serum levels compared with psoriasis vulgaris patients and controls. RANKL/M-CSF-stimulated PBMCs from psoriatic arthritis patients produced higher proinflammatory cytokine levels and had a differential secretion profile in response to 1,25 (OH)(2)D-3, compared with psoriasis vulgaris and control PBMCs. Conclusions Our data confirmed altered bone turnover in psoriatic arthritis patients, and demonstrated increased osteoclastogenic potential and proinflammatory cytokine secretion capacity of these PBMCs compared with psoriasis vulgaris and controls. 1,25(OH)(2)D-3 abrogated these effects.	[Cubillos, Susana; Krieg, Nadine; Norgauer, Johannes] Jena Univ Hosp, Dept Dermatol, Jena, Thuringen, Germany	Friedrich Schiller University of Jena	Cubillos, S (corresponding author), Jena Univ Hosp, Dept Dermatol, Jena, Thuringen, Germany.	s_cubillos@yahoo.com						ADAMS JS, 1990, J BONE MINER RES, V5, P1265; ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Atkins GJ, 2007, BONE, V40, P1517, DOI 10.1016/j.bone.2007.02.024; Bose F, 2014, CLIN EXP DERMATOL, V39, P385, DOI 10.1111/ced.12251; Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Choe YB, 2012, BRIT J DERMATOL, V167, P762, DOI 10.1111/j.1365-2133.2012.11038.x; Chulalongkorn University (Sponsor), EFF VIT D3 TREATM CH; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Dalbeth N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3123; DELUCA HF, 1976, ANNU REV BIOCHEM, V45, P631, DOI 10.1146/annurev.bi.45.070176.003215; Ekman AK, 2013, ACTA DERM-VENEREOL, V93, P525, DOI 10.2340/00015555-1545; EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853; Finamor DC, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.24808; FRIEDMAN J, 1965, SCIENCE, V150, P1465, DOI 10.1126/science.150.3702.1465; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Gaal J, 2009, ACTA DERM-VENEREOL, V89, P140, DOI 10.2340/00015555-0555; Garnero P, 2003, J BONE MINER RES, V18, P859, DOI 10.1359/jbmr.2003.18.5.859; Gisondi P, 2012, BRIT J DERMATOL, V166, P505, DOI 10.1111/j.1365-2133.2011.10699.x; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Grassi F, 2011, J CELL PHYSIOL, V226, P982, DOI 10.1002/jcp.22411; Grazio S, 2015, AM J MED SCI, V349, P46, DOI 10.1097/MAJ.0000000000000340; Gu JH, 2015, J STEROID BIOCHEM, V152, P25, DOI 10.1016/j.jsbmb.2015.04.003; Hao L, 2015, FEBS LETT, V589, P1331, DOI 10.1016/j.febslet.2015.04.008; Hata TR, 2014, J EUR ACAD DERMATOL, V28, P781, DOI 10.1111/jdv.12176; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Heine G, 2008, EUR J IMMUNOL, V38, P2210, DOI 10.1002/eji.200838216; Hirai T, 2013, J IMMUNOL, V190, P4805, DOI 10.4049/jimmunol.1200901; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; HOLTROP ME, 1981, ENDOCRINOLOGY, V108, P2293, DOI 10.1210/endo-108-6-2293; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; HUCKINS D, 1990, ARTHRITIS RHEUM, V33, P1723, DOI 10.1002/art.1780331117; Ikic M, 2014, INT ORTHOP, V38, P183, DOI 10.1007/s00264-013-2121-0; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Janckila AJ, 2005, J LEUKOCYTE BIOL, V77, P209, DOI 10.1189/jlb.0504287; Kogawa M, 2010, J STEROID BIOCHEM, V121, P277, DOI 10.1016/j.jsbmb.2010.03.048; Kogawa M, 2010, ENDOCRINOLOGY, V151, P4613, DOI 10.1210/en.2010-0334; Komano Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2046; Lari R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2616; Lee SK, 2002, J IMMUNOL, V169, P2374, DOI 10.4049/jimmunol.169.5.2374; LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S; Li HY, 2010, BLOOD, V116, P210, DOI 10.1182/blood-2009-11-255026; Lim HW, 2015, J AM ACAD DERMATOL, V72, P1078, DOI 10.1016/j.jaad.2015.03.017; MAGARO M, 1989, CLIN RHEUMATOL, V8, P494, DOI 10.1007/BF02032102; Suarez-Varela MM, 2014, INT J ENV RES PUB HE, V11, P12108, DOI 10.3390/ijerph111212108; MULLER K, 1991, IMMUNOL LETT, V28, P115, DOI 10.1016/0165-2478(91)90108-M; Nakajima H, 2011, ARCH DERMATOL RES, V303, P451, DOI 10.1007/s00403-011-1159-3; NICHOLSON GC, 1986, J CLIN INVEST, V78, P355, DOI 10.1172/JCI112584; OKeefe RJ, 1997, LAB INVEST, V76, P457; Pappalardo A, 2015, BONE, V71, P180, DOI 10.1016/j.bone.2014.10.019; Pontificia Universidad Catolica de Chile (Sponsor), EFF VIT D SUPPL MET; RAHIMI P, 1995, ENDOCRINOLOGY, V136, P2752, DOI 10.1210/en.136.6.2752; RAISZ LG, 1972, SCIENCE, V175, P768, DOI 10.1126/science.175.4023.768; Raychaudhuri S, 2014, INDIAN J DERMATOL, V59, P116, DOI 10.4103/0019-5154.127668; REICHEL H, 1987, J BIOL CHEM, V262, P10931; Ritchlin CT, 2003, J CLIN INVEST, V111, P821, DOI 10.1172/JCI200316069; Rothe L, 1998, ENDOCRINOLOGY, V139, P4353, DOI 10.1210/en.139.10.4353; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Scragg R., 2015, J STEROID BIOCH MOL; Shinki T, 1999, P NATL ACAD SCI USA, V96, P8253, DOI 10.1073/pnas.96.14.8253; Soleymani T, 2015, INT J DERMATOL, V54, P383, DOI 10.1111/ijd.12790; Szentpetery A, 2013, J RHEUMATOL, V40, P653, DOI 10.3899/jrheum.120397; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; TAKAMOTO S, 1986, CALCIFIED TISSUE INT, V39, P360, DOI 10.1007/BF02555172; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Touma Z, 2011, ARTHRIT CARE RES, V63, P1440, DOI 10.1002/acr.20530; Wallach S, 1999, BONE, V25, P509, DOI 10.1016/S8756-3282(99)00200-8; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759	70	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153094	10.1371/journal.pone.0153094	http://dx.doi.org/10.1371/journal.pone.0153094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050092	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500098
J	Weidner, C; Rousseau, M; Plauth, A; Wowro, SJ; Fischer, C; Abdel-Aziz, H; Sauer, S				Weidner, Christopher; Rousseau, Morten; Plauth, Annabell; Wowro, Sylvia J.; Fischer, Cornelius; Abdel-Aziz, Heba; Sauer, Sascha			Iberis amara Extract Induces Intracellular Formation of Reactive Oxygen Species and Inhibits Colon Cancer	PLOS ONE			English	Article							ANTIINFLAMMATORY PROPERTIES; STW-5 IBEROGAST(R); PLANT POLYPHENOLS; ANTIOXIDANTS; THERAPY; HEALTH; CELLS; PROLIFERATION; CHEMOTHERAPY; ANTICANCER	Massively increasing global incidences of colorectal cancer require efficient treatment and prevention strategies. Here, we report unexpected anticancerogenic effects of hydroethanolic Iberis amara extract (IAE), which is known as a widely used phytomedical product for treating gastrointestinal complaints. IAE significantly inhibited the proliferation of HT-29 and T84 colon carcinoma cells with an inhibitory concentration (IC50) of 6 and 9 mu g/ml, respectively, and further generated inhibitory effects in PC-3 prostate and MCF7 breast cancer cells. Inhibition of proliferation in HT-29 cells was associated with a G2/M phase cell cycle arrest including reduced expression of various regulatory marker proteins. Notably, in HT-29 cells IAE further induced apoptosis by intracellular formation of reactive oxygen species (ROS). Consistent with predictions derived from our in vitro experiments, bidaily oral gavage of 50 mg/kg of IAE over 4 weeks resulted in significant inhibition of tumor growth in a mouse HT-29 tumor xenograft model. Taken together, Iberis amara extracts could become useful alternatives for preventing and treating the progression of colon cancer.	[Weidner, Christopher; Rousseau, Morten; Plauth, Annabell; Wowro, Sylvia J.; Fischer, Cornelius; Sauer, Sascha] Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 73, D-14195 Berlin, Germany; [Abdel-Aziz, Heba] Steigerwald Arzneimittelwerk GmbH, Dept Sci, Darmstadt, Germany; [Sauer, Sascha] Univ Wurzburg, CU Syst Med, D-97070 Wurzburg, Germany	Max Planck Society; Bayer AG; Steigerwald Pharmaceutical Factory GmbH; University of Wurzburg	Sauer, S (corresponding author), Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 73, D-14195 Berlin, Germany.; Sauer, S (corresponding author), Univ Wurzburg, CU Syst Med, D-97070 Wurzburg, Germany.	sauer@molgen.mpg.de		Wowro, Sylvia/0000-0003-1728-9210; Plauth, Annabell/0000-0002-4521-1368	German Ministry for Education and Research (BMBF) [0315082, 01EA1303]; Steigerwald Arzneimittelwerk GmbH	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Steigerwald Arzneimittelwerk GmbH	This work was supported by the German Ministry for Education and Research (BMBF, grant numbers 0315082, 01EA1303). Author HAA was supported by Steigerwald Arzneimittelwerk GmbH in the form of salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammon HPT, 2006, PHYTOMEDICINE, V13, P67, DOI 10.1016/j.phymed.2006.08.004; Bonaterra GA, 2013, PHYTOMEDICINE, V20, P691, DOI 10.1016/j.phymed.2013.02.011; Bouayed J, 2010, OXID MED CELL LONGEV, V3, P228, DOI 10.4161/oxim.3.4.12858; Braun Michael S, 2011, Ther Adv Med Oncol, V3, P43, DOI 10.1177/1758834010388342; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Dinkova-Kostova AT, 2012, TRENDS MOL MED, V18, P337, DOI 10.1016/j.molmed.2012.04.003; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Forester SC, 2011, MOL NUTR FOOD RES, V55, P844, DOI 10.1002/mnfr.201000641; Fuhr L, 2015, J NAT PROD, V78, P1160, DOI 10.1021/np500747y; Germann I, 2006, PHYTOMEDICINE, V13, P45, DOI 10.1016/j.phymed.2006.03.018; Halliwell B, 2008, ARCH BIOCHEM BIOPHYS, V476, P107, DOI 10.1016/j.abb.2008.01.028; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8; Hoensch Harald P, 2005, Int J Gastrointest Cancer, V35, P187, DOI 10.1385/IJGC:35:3:187; Khan HY, 2012, CURR DRUG TARGETS, V13, P1738; Ko JSK, 2013, CURR PHARM DESIGN, V19, P48, DOI 10.2174/13816128130109; Kong YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103760; Kroll U, 2006, PHYTOMEDICINE, V13, P12, DOI 10.1016/j.phymed.2006.03.016; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Schempp H, 2006, PHYTOMEDICINE, V13, P36, DOI 10.1016/j.phymed.2006.03.017; Shekhar MPV, 2011, CURR CANCER DRUG TAR, V11, P613; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Weidner C, 2015, PHYTOMEDICINE, V22, P262, DOI 10.1016/j.phymed.2014.12.008; Weidner C, 2014, MOL NUTR FOOD RES, V58, P903, DOI 10.1002/mnfr.201300477; Weidner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080335; Yang Y, 2013, CURR MED CHEM, V20, P3677, DOI 10.2174/0929867311320999165	28	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152398	10.1371/journal.pone.0152398	http://dx.doi.org/10.1371/journal.pone.0152398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050665	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500037
J	Hatasa, Y; Chikazawa, M; Furuhashi, M; Nakashima, F; Shibata, T; Kondo, T; Akagawa, M; Hamagami, H; Tanaka, H; Tachibana, H; Uchida, K				Hatasa, Yukinori; Chikazawa, Miho; Furuhashi, Mai; Nakashima, Fumie; Shibata, Takahiro; Kondo, Tatsuhiko; Akagawa, Mitsugu; Hamagami, Hiroki; Tanaka, Hiroshi; Tachibana, Hirofumi; Uchida, Koji			Oxidative Deamination of Serum Albumins by (-)-Epigallocatechin-3-O-Gallate: A Potential Mechanism for the Formation of Innate Antigens by Antioxidants	PLOS ONE			English	Article							METAL-CATALYZED OXIDATION; NATURAL ANTIBODIES; PROTEIN OXIDATION; GREEN TEA; PRODUCTS; IDENTIFICATION; SEMIALDEHYDES; DERIVATIVES; RESIDUES; ACROLEIN	(-)-Epigallocatechin-3-O-gallate (EGCG), the most abundant polyphenol in green tea, mediates the oxidative modification of proteins, generating protein carbonyls. However, the underlying molecular mechanism remains unclear. Here we analyzed the EGCG-derived intermediates generated upon incubation with the human serum albumin (HSA) and established that EGCG selectively oxidized the lysine residues via its oxidative deamination activity. In addition, we characterized the EGCG-oxidized proteins and discovered that the EGCG could be an endogenous source of the electrically-transformed proteins that could be recognized by the natural antibodies. When HSA was incubated with EGCG in the phosphate-buffered saline (pH 7.4) at 37 degrees C, the protein carbonylation was associated with the formation of EGCG-derived products, such as the protein-bound EGCG, oxidized EGCG, and aminated EGCG. The aminated EGCG was also detected in the sera from the mice treated with EGCG in vivo. EGCG selectively oxidized lysine residues at the EGCG-binding domains in HSA to generate an oxidatively deaminated product, aminoadipic semialdehyde. In addition, EGCG treatment results in the increased negative charge of the protein due to the oxidative deamination of the lysine residues. More strikingly, the formation of protein carbonyls by EGCG markedly increased its cross-reactivity with the natural IgM antibodies. These findings suggest that many of the beneficial effects of EGCG may be partly attributed to its oxidative deamination activity, generating the oxidized proteins as a target of natural antibodies.	[Hatasa, Yukinori; Chikazawa, Miho; Furuhashi, Mai; Nakashima, Fumie; Shibata, Takahiro; Kondo, Tatsuhiko; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shibata, Takahiro] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Akagawa, Mitsugu] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Dept Biol Chem, Sakai, Osaka 591, Japan; [Hamagami, Hiroki; Tanaka, Hiroshi] Tokyo Inst Technol, Grad Sch Sci & Engn, Tokyo 152, Japan; [Tachibana, Hirofumi] Kyushu Univ, Fac Agr, Fukuoka 812, Japan	Nagoya University; Japan Science & Technology Agency (JST); Osaka Metropolitan University; Tokyo Institute of Technology; Kyushu University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Tanaka, Hiroshi/I-2402-2012; Shibata, Takahiro/I-6872-2014	Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	Ministry of Education, Sciences, Sports, Technology (MEXT), Japan [26252018, 26111011]; grant from JST PRESTO program; Grants-in-Aid for Scientific Research [15H02448] Funding Source: KAKEN	Ministry of Education, Sciences, Sports, Technology (MEXT), Japan; grant from JST PRESTO program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (A) (No. 26252018) (K.U.) and Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" (No. 26111011) (K.U.) of the Ministry of Education, Sciences, Sports, Technology (MEXT), Japan; a grant from the JST PRESTO program (T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akagawa M, 2005, J AGR FOOD CHEM, V53, P8019, DOI 10.1021/jf050843f; Akagawa M, 2001, EUR J BIOCHEM, V268, P1953, DOI 10.1046/j.1432-1327.2001.02068.x; Akagawa M, 2006, CHEM RES TOXICOL, V19, P1059, DOI 10.1021/tx060026p; AMICI A, 1989, J BIOL CHEM, V264, P3341; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; CASE DA, 2002, AMBER 7 COMPUTER PRO; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Dunlop RA, 2009, IUBMB LIFE, V61, P522, DOI 10.1002/iub.189; Furuhata A, 2002, J BIOL CHEM, V277, P27919, DOI 10.1074/jbc.M202794200; Gibbons TE, 2014, BEHAV BRAIN RES, V272, P131, DOI 10.1016/j.bbr.2014.05.049; Ichihashi K, 2001, J BIOL CHEM, V276, P23903, DOI 10.1074/jbc.M101947200; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Ishii T, 2011, BIOSCI BIOTECH BIOCH, V75, P100, DOI 10.1271/bbb.100600; Ishii T, 2010, BIOORGAN MED CHEM, V18, P4892, DOI 10.1016/j.bmc.2010.06.021; Kumano-Kuramochi M, 2012, BIOCHEM J, V442, P171, DOI 10.1042/BJ20111029; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7; Maiti TK, 2006, PROTEINS, V64, P355, DOI 10.1002/prot.20995; MEUCCI E, 1991, J BIOL CHEM, V266, P4692; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Sancataldo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084552; Sargeant LA, 2001, EUR J CLIN NUTR, V55, P342, DOI 10.1038/sj.ejcn.1601162; Srividhya R, 2009, INT J DEV NEUROSCI, V27, P223, DOI 10.1016/j.ijdevneu.2009.01.003; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Uchida K, 2014, FREE RADICAL BIO MED, V72, P156, DOI 10.1016/j.freeradbiomed.2014.03.016; Uchida K, 2013, REDOX BIOL, V1, P94, DOI 10.1016/j.redox.2012.12.005; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Yano S, 2007, J AGR FOOD CHEM, V55, P7144, DOI 10.1021/jf071176o	36	19	19	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153002	10.1371/journal.pone.0153002	http://dx.doi.org/10.1371/journal.pone.0153002			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046229	gold, Green Submitted, Green Published			2022-12-26	WOS:000373599600056
J	He, X; Garza, D; Nigam, SK; Chang, G				He, Xiao; Garza, Denisse; Nigam, Sanjay K.; Chang, Geoffrey			Multispecific Organic Cation Transporter 1 (OCT1) from Bos taurus Has High Affinity and Slow Binding Kinetics towards Prostaglandin E2	PLOS ONE			English	Article							ANION TRANSPORTERS; SECRETION; SYSTEMS; FAMILY; OAT1	Organic cation transporter 1 (OCT1, SLC22A1), like many solute carrier 22 (SLC22) family members, is important for the disposition of clinically important drugs, metabolites and signaling molecules. Several studies suggest that SLC22 family (eg. organic anion transporters or OATs and OCTs) bind and possibly transport prostaglandins with relatively high affinity (submicromolar). The affinities of OCT1 and OATs toward PGE2 and PGF2a reported in these cell-based transport studies are considerably greater than for xenobiotics and natural metabolite substrates-in many cases over 100-fold higher. This raises the possibility that prostaglandins are key endogenous substrates and/or that they act on the transporter in a manner different from other substrates such as xenobiotics and lower affinity metabolites. To further investigate OCT1-prostaglandin interactions, we designed biophysical studies using purified bovine OCT1 (Bos taurus, btOCT1/SLC22A1) with PGE2 analogs, in fluorescently labeled and label-free formats. Using fluorescence polarization (FP), we detected a binding of btOCT1 to the PGE2-Rhodamine conjugate at submicromolar affinity, consistent with affinity data for PGE2 from cells over-expressing the related human OCT1. Using purified native btOCT1 as analyte and biotinylated PGE2 analog as ligand, our data from surface plasmon resonance (SPR) revealed that btOCT1 specifically interacts to PGE2 with K-D values in the hundred nanomolar range. BtOCT1 also demonstrated a slow association (k(a)) in the range of 10(3) M(-1)s(-1) and an even slower dissociation rate (k(d)) in the range of 10(-4) s(-1) for PGE2, suggesting the possibility of a different mode of binding compared to other structurally unrelated transported substrates of low-affinity (eg. drugs, metabolites). Our results complement in vitro transport studies and provide direct evidence that OCT1-which is normally expressed in liver and other tissues-interacts with prostaglandin analogs. While it is not entirely clear from the published literature whether OCTs function as major prostaglandin transporters, the tight binding of the naturally occurring PGE2, as well as the slow dissociation rate, could conceivably affect the transport of lower affinity substrates such as drugs and metabolites by SLC22 transporters. More research is necessary to establish the extent to which individual SLC22 family members actually function as PG transporters in vitro and in vivo and to investigate whether PGs can, independent of being directly transported, alter the ability of SLC22 transporters to handle drugs and other substrates.	[He, Xiao; Garza, Denisse; Chang, Geoffrey] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Med & Cellular & Mol Med, La Jolla, CA 92093 USA; [Chang, Geoffrey] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Chang, G (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.; Chang, G (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	g1chang@ucsd.edu			National Institutes of Health [GM104098, GM94610, DK58251]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK058251, R01DK058251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094610, R01GM104098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM104098, GM94610, and DK58251 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Ciarimboli G, 2008, XENOBIOTICA, V38, P936, DOI [10.1080/00498250701882482, 10.1080/00498250701882482 ]; Ciarimboli G, 2012, CLIN CANCER RES, V18, P1101, DOI 10.1158/1078-0432.CCR-11-2503; Decouture B, 2015, BLOOD, V126, P1823, DOI 10.1182/blood-2015-02-631044; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gose T, 2016, PROSTAG OTH LIPID M, V122, P10, DOI 10.1016/j.prostaglandins.2015.12.003; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; Jonker JW, 2003, MOL CELL BIOL, V23, P7902, DOI 10.1128/MCB.23.21.7902-7908.2003; Kimura H, 2002, J PHARMACOL EXP THER, V301, P293, DOI 10.1124/jpet.301.1.293; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Lee SC, 2014, WILEY SER DRUG DISC, P473; Levanon NL, 2014, JOVE-J VIS EXP, DOI 10.3791/51937; Minuesa G, 2009, J PHARMACOL EXP THER, V329, P252, DOI 10.1124/jpet.108.146225; Morrissey KM, 2012, CLIN PHARMACOL THER, V92, P545, DOI 10.1038/clpt.2012.44; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Raucy JL, 2010, CURR DRUG METAB, V11, P806; Riedmaier AE, 2012, PHARMACOL REV, V64, P421, DOI 10.1124/pr.111.004614; Rios A, 2012, PROSTAG OTH LIPID M, V98, P86, DOI 10.1016/j.prostaglandins.2011.11.004; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Saito H, 2010, PHARMACOL THERAPEUT, V125, P79, DOI 10.1016/j.pharmthera.2009.09.008; Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159; Sinha C, 2015, CELL SIGNAL, V27, P1345, DOI 10.1016/j.cellsig.2015.03.022; Tzvetkov MV, 2013, BIOCHEM PHARMACOL, V86, P666, DOI 10.1016/j.bcp.2013.06.019; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Wu ZC, METHODS MOL BIOL, V10332013, P157; You G, 2014, WILEY SER DRUG DISC, P1, DOI 10.1002/9781118705308	33	1	1	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152969	10.1371/journal.pone.0152969	http://dx.doi.org/10.1371/journal.pone.0152969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046168	gold, Green Published, Green Submitted			2022-12-26	WOS:000373599600054
J	Stone, BC; Kas, A; Billman, ZP; Fuller, DH; Fuller, JT; Shendure, J; Murphy, SC				Stone, Brad C.; Kas, Arnold; Billman, Zachary P.; Fuller, Deborah H.; Fuller, James T.; Shendure, Jay; Murphy, Sean C.			Complex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell Antigens	PLOS ONE			English	Article							MHC CLASS-I; CIRCUMSPOROZOITE PROTEIN; PROTECTIVE IMMUNITY; ANTIBODY-RESPONSES; DNA IMMUNIZATION; MALARIA; FALCIPARUM; SPOROZOITE; MICE; SURFACE	Development of a subunit vaccine targeting liver-stage Plasmodium parasites requires the identification of antigens capable of inducing protective T cell responses. However, traditional methods of antigen identification are incapable of evaluating T cell responses against large numbers of proteins expressed by these parasites. This bottleneck has limited development of subunit vaccines against Plasmodium and other complex intracellular pathogens. To address this bottleneck, we are developing a synthetic minigene technology for multi-antigen DNA vaccines. In an initial test of this approach, pools of long (150 bp) antigen-encoding oligonucleotides were synthesized and recombined into vectors by ligation-independent cloning to produce two DNA minigene library vaccines. Each vaccine encoded peptides derived from 36 (vaccine 1) and 53 (vaccine 2) secreted or transmembrane pre-erythrocytic P. yoelii proteins. BALB/cj mice were vaccinated three times with a single vaccine by biolistic particle delivery (gene gun) and screened for interferon-.-producing T cell responses by ELISPOT. Library vaccination induced responses against four novel antigens. Naive mice exposed to radiation-attenuated sporozoites mounted a response against only one of the four novel targets (PyMDH, malate dehydrogenase). The response to PyMDH could not be recalled by additional homologous sporozoite immunizations but could be partially recalled by heterologous cross-species sporozoite exposure. Vaccination against the dominant PyMDH epitope by DNA priming and recombinant Listeria boosting did not protect against sporozoite challenge. Improvements in library design and delivery, combined with methods promoting an increase in screening sensitivity, may enable complex minigene screening to serve as a high-throughput system for discovery of novel T cell antigens.	[Stone, Brad C.; Kas, Arnold; Billman, Zachary P.; Murphy, Sean C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Stone, Brad C.; Kas, Arnold; Billman, Zachary P.; Murphy, Sean C.] Univ Washington, Ctr Emerging & Re Emerging Infect Dis, Seattle, WA 98195 USA; [Fuller, Deborah H.; Fuller, James T.; Murphy, Sean C.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Murphy, Sean C.] Fred Hutchinson Canc Res Ctr, Seattle Malaria Clin Trials Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Murphy, Sean C.] Ctr Infect Dis Res, Human Challenge Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR)	Stone, BC; Murphy, SC (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.; Stone, BC; Murphy, SC (corresponding author), Univ Washington, Ctr Emerging & Re Emerging Infect Dis, Seattle, WA 98195 USA.; Murphy, SC (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.; Murphy, SC (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle Malaria Clin Trials Ctr, 1124 Columbia St, Seattle, WA 98104 USA.; Murphy, SC (corresponding author), Ctr Infect Dis Res, Human Challenge Ctr, Seattle, WA USA.	stoneb4@uw.edu; murphysc@uw.edu	Billman, Zachary/AAE-4245-2019; Shendure, Jay/AAU-3684-2021; Murphy, Sean C./AAC-7531-2019	Murphy, Sean C./0000-0002-2048-0131; Fuller, Deborah/0000-0001-7315-2441	NIH [1K08AI097238]; Bill and Melinda Gates Foundation [OPP1069993]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI097238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially funded by the NIH (1K08AI097238 to S.C.M., https://www.niaid.nih.gov) and the Bill and Melinda Gates Foundation (OPP1069993 to B.C.S. and S.C.M., http://www.gatesfoundation.org). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Aguiar Joao C, 2015, PLoS One, V10, pe0136109, DOI 10.1371/journal.pone.0136109; Arrington J, 2002, J VIROL, V76, P4536, DOI 10.1128/JVI.76.9.4536-4546.2002; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bergmann-Leitner ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012294; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Dobano C, 2007, IMMUNOL LETT, V111, P92, DOI 10.1016/j.imlet.2007.05.007; Doll K, 2014, J IMMUNOL, V192; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Doolan DL, 1996, J EXP MED, V183, P1739, DOI 10.1084/jem.183.4.1739; Duffy PE, 2012, EXPERT REV VACCINES, V11, P1261, DOI [10.1586/ERV.12.92, 10.1586/erv.12.92]; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Ferraro B, 2013, INFECT IMMUN, V81, P3709, DOI 10.1128/IAI.00180-13; FIDOCK DA, 1994, MOL BIOCHEM PARASIT, V64, P219, DOI 10.1016/0166-6851(94)00012-3; Frevert U, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00482; Fu TM, 1998, VACCINE, V16, P1711, DOI 10.1016/S0264-410X(98)00134-0; Fuller DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033715; Goldwich A, 2008, J IMMUNOL, V180, P372, DOI 10.4049/jimmunol.180.1.372; GUERINMARCHAND C, 1987, NATURE, V329, P164, DOI 10.1038/329164a0; Guo HL, 2008, VIRAL IMMUNOL, V21, P61, DOI 10.1089/vim.2007.0082; Hassan IA, 2014, PARASITE IMMUNOL, V36, P674, DOI 10.1111/pim.12146; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hoffman SL, 2015, VACCINE, V33, pD13, DOI 10.1016/j.vaccine.2015.07.091; Hoffman SL, 2015, AM J PREV MED, V49, pS319, DOI 10.1016/j.amepre.2015.09.011; Hooper JW, 2003, VIROLOGY, V306, P181, DOI 10.1016/S0042-6822(02)00038-7; Hooper JW, 2000, VIROLOGY, V266, P329, DOI 10.1006/viro.1999.0096; Hospers GAP, 2009, VACCINE, V28, P386, DOI 10.1016/j.vaccine.2009.10.036; Imai T, 2008, BIOCHEM BIOPH RES CO, V365, P758, DOI 10.1016/j.bbrc.2007.11.034; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2005.05024.x; Keitany GJ, 2014, INFECT IMMUN, V82, P5143, DOI 10.1128/IAI.02320-14; KHUSMITH S, 1991, SCIENCE, V252, P715, DOI 10.1126/science.1827210; KUMAR S, 1988, NATURE, V334, P258, DOI 10.1038/334258a0; La Motte RN, 1998, J IMMUNOL, V161, P6552; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mishra S, 2011, VACCINE, V29, P7335, DOI 10.1016/j.vaccine.2011.07.081; MOELANS IIMD, 1991, MOL BIOCHEM PARASIT, V45, P193, DOI 10.1016/0166-6851(91)90086-L; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mullbacher A, 1999, SCAND J IMMUNOL, V49, P563; Murphy SC, 2013, P NATL ACAD SCI USA, V110, P6055, DOI 10.1073/pnas.1303834110; Novotny LA, 2003, J IMMUNOL, V171, P1978, DOI 10.4049/jimmunol.171.4.1978; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; PERTMER TM, 1995, VACCINE, V13, P1427, DOI 10.1016/0264-410X(95)00069-D; Putrianti ED, 2009, J INFECT DIS, V199, P899, DOI 10.1086/597121; Reguzova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116412; Reyes-Sandoval A, 2009, CURR OPIN MOL THER, V11, P72; ROBSON KJH, 1988, NATURE, V335, P79, DOI 10.1038/335079a0; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; SANCHEZ GI, 1994, EXP PARASITOL, V79, P59, DOI 10.1006/expr.1994.1060; Schwartz JJ, 2012, NAT METHODS, V9, P913, DOI 10.1038/nmeth.2137; Sedegah M, 2004, GENES IMMUN, V5, P553, DOI 10.1038/sj.gene.6364125; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; Sedegah M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106241; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Spring M, 2013, VACCINE, V31, P4975, DOI 10.1016/j.vaccine.2013.08.007; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Van Braeckel-Budimir N, 2015, J IMMUNOL S, V194; Van Braeckel-Budimir N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00272; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; von Seidlein L, 2013, ARCH DIS CHILD, V98, P981, DOI 10.1136/archdischild-2013-304173; Wang RB, 2005, EUR J IMMUNOL, V35, P1859, DOI 10.1002/eji.200425807; Wang RB, 2005, INFECT IMMUN, V73, P2863, DOI 10.1128/IAI.73.5.2863-2872.2005; Wang RB, 1998, INFECT IMMUN, V66, P4193; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Zhang YW, 2014, METHODS MOL BIOL, V1116, P235, DOI 10.1007/978-1-62703-764-8_16; ZHU JD, 1991, MOL BIOCHEM PARASIT, V48, P223, DOI 10.1016/0166-6851(91)90117-O	69	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153449	10.1371/journal.pone.0153449	http://dx.doi.org/10.1371/journal.pone.0153449			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070430	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700069
J	Candela, S; Dito, R; Casolla, B; Silvestri, E; Sette, G; Filippi, F; Taurino, M; Brancadoro, D; Orzi, F				Candela, Serena; Dito, Raffaele; Casolla, Barbara; Silvestri, Emanuele; Sette, Giuliano; Filippi, Federico; Taurino, Maurizio; Brancadoro, Domitilla; Orzi, Francesco			Hypothermia during Carotid Endarterectomy: A Safety Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; MILD HYPOTHERMIA; BRAIN; STENOSIS; NEUROPROTECTION; OUTCOMES; RISK; RAT	Background CEA is associated with peri-operative risk of brain ischemia, due both to emboli production caused by manipulation of the plaque and to potentially noxious reduction of cerebral blood flow by carotid clamping. Mild hypothermia (34-35 degrees C) is probably the most effective approach to protect brain from ischemic insult. It is therefore a substantial hypothesis that hypothermia lowers the risk of ischemic brain damage potentially associated with CEA. Purpose of the study is to test whether systemic endovascular cooling to a target of 34.5-35 degrees C, initiated before and maintained during CEA, is feasible and safe. Methods The study was carried out in 7 consecutive patients referred to the Vascular Surgery Unit and judged eligible for CEA. Cooling was initiated 60-90 min before CEA, by endovascular approach (Zoll system). The target temperature was maintained during CEA, followed by passive, controlled rewarming (0.4 degrees C/h). The whole procedure was carried out under anesthesia. Results All the patients enrolled had no adverse events. Two patients exhibited a transient bradycardia (heart rate 30 beats/min). There were no significant differences in the clinical status, laboratory and physiological data measured before and after CEA. Conclusions Systemic cooling to 34.5-35.0 degrees C, initiated before and maintained during carotid clamping, is feasible and safe.	[Candela, Serena; Casolla, Barbara; Sette, Giuliano; Orzi, Francesco] Univ Roma La Sapienza, Sch Med & Psychol, St Andrea Hosp, NESMOS Neurosci Mental Hlth & Sensory Organs Dept, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Dito, Raffaele; Filippi, Federico; Taurino, Maurizio] Univ Roma La Sapienza, Sch Med & Psychol, St Andrea Hosp, Cardiothorac Vasc Sci Dept, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Silvestri, Emanuele; Brancadoro, Domitilla] Univ Roma La Sapienza, Sch Med & Psychol, St Andrea Hosp, Surg Anesthet Sci Dept, Piazzale Aldo Moro 5, I-00185 Rome, Italy	Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Candela, S (corresponding author), Univ Roma La Sapienza, Sch Med & Psychol, St Andrea Hosp, NESMOS Neurosci Mental Hlth & Sensory Organs Dept, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	serena.candela@uniroma1.it	Casolla, Barbara/ABD-1372-2020	TAURINO, Maurizio/0000-0001-5853-9410; Sette, Giuliano/0000-0002-8324-4371	Movi Spa	Movi Spa	The Movi Spa (www.movigroup.com) was the source of support for the study, providing the equipment and paying for the patient's health insurance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; Go C, 2015, ANN VASC SURG, V29, P1265, DOI 10.1016/j.avsg.2015.03.031; Grotta JC, 2013, NEW ENGL J MED, V369, P1143, DOI 10.1056/NEJMcp1214999; Gupta PK, 2013, J VASC SURG, V57, P318, DOI 10.1016/j.jvs.2012.08.116; KAMME F, 1995, EUR J NEUROSCI, V7, P2007, DOI 10.1111/j.1460-9568.1995.tb00623.x; Kang JW, 2014, J VASC SURG, V59, P944, DOI [10.1016/j.jvs.2013.10.059, 10.1016/j.jvs.2014.02.014]; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100, DOI 10.1097/00004647-199601000-00012; Lee JH, 2014, ANN SURG TREAT RES, V86, P39, DOI 10.4174/astr.2014.86.1.39; Li J, 2011, J NEUROTRAUM, V28, P1281, DOI 10.1089/neu.2011.1751; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; STEEN PA, 1983, ANESTHESIOLOGY, V58, P527, DOI 10.1097/00000542-198306000-00009; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wu TC, 2013, LANCET NEUROL, V12, P275, DOI 10.1016/S1474-4422(13)70013-9; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Yenari M, 2008, STROKE, V39, P2910, DOI 10.1161/STROKEAHA.108.514471; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174	20	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152658	10.1371/journal.pone.0152658	http://dx.doi.org/10.1371/journal.pone.0152658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058874	gold, Green Published			2022-12-26	WOS:000373604800009
J	Chen, JJ; Zheng, ZY; Chen, Y; Li, JQ; Qian, SH; Shi, YF; Sun, L; Han, YX; Zhang, SH; Yu, K				Chen, Jingjing; Zheng, Zhouyi; Chen, Yi; Li, Jiaqi; Qian, Shanhu; Shi, Yifen; Sun, Lan; Han, Yixiang; Zhang, Shenghui; Yu, Kang			Histone Deacetylase Inhibitors Trichostatin A and MCP30 Relieve Benzene-Induced Hematotoxicity via Restoring Topoisomerase II alpha	PLOS ONE			English	Article							HEMATOPOIETIC STEM; TRANSCRIPTIONAL ACTIVATION; DEPENDENT REGULATION; GENE-EXPRESSION; DNA METHYLATION; CELL; CANCER; MICE; APOPTOSIS; HYDROQUINONE	Dysfunction of histone acetylation inhibits topoisomerase II alpha (Topo II alpha), which is implicated in benzene-induced hematotoxicity in patients with chronic benzene exposure. Whether histone deacetylase (HDAC) inhibitors can relieve benzene-induced hematotoxicity remains unclear. Here we showed that hydroquinone, a main metabolite of benzene, increased the HDAC activity, decreased the Topo II alpha expression and induced apoptosis in human bone marrow mononuclear cells in vitro, and treatment with two HDAC inhibitors, namely trichostatin A (TSA) or a mixture of ribosome-inactivating proteins MCP30, almost completely reversed these effects. We further established a benzene poisoning murine model by inhaling benzene vapor in a container and found that benzene poisoning decreased the expression and activity of Topo II alpha, and impaired acetylation of histone H4 and H3. The analysis of regulatory factors of Topo II alpha promoter found that benzene poisoning decreased the mRNA levels of SP1 and C-MYB, and increased the mRNA level of SP3. Both TSA and MCP30 significantly enhanced the acetylation of histone H3 and H4 in Topo II alpha promoter and increased the expression and activity of Topo II alpha in benzene poisoning mice, which contributed to relieve the symptoms of hematotoxicity. Thus, treatment with HDAC inhibitors represents an attractive approach to reduce benzene-induced hematotoxicity.	[Chen, Jingjing; Zheng, Zhouyi; Chen, Yi; Li, Jiaqi; Qian, Shanhu; Shi, Yifen; Sun, Lan; Zhang, Shenghui; Yu, Kang] Wenzhou Med Univ, Dept Hematol, Affiliated Hosp 1, Wenzhou 325015, Peoples R China; [Han, Yixiang] Wenzhou Med Univ, Lab Internal Med, Affiliated Hosp 1, Wenzhou 325015, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zhang, SH; Yu, K (corresponding author), Wenzhou Med Univ, Dept Hematol, Affiliated Hosp 1, Wenzhou 325015, Peoples R China.	shenghuizhang1@126.com; yukang62@126.com	Zhang, Shenghui/AAI-7388-2021; chen, JJ/HGB-6029-2022		National Natural Science Foundation of China [81100355, 81172613, 81300430]; Zhejiang Provincial Natural Science Foundation of China [LQ12H08002, Y2111000, LY16H080007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China (No.81100355, 81172613, 81300430), and Zhejiang Provincial Natural Science Foundation of China (No. LQ12H08002, Y2111000, LY16H080007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSOY M, 1989, ENVIRON HEALTH PERSP, V82, P193, DOI 10.2307/3430775; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Baker RK, 2001, BLOOD, V98, P830, DOI 10.1182/blood.V98.3.830; Beerman I, 2014, EXP CELL RES, V329, P192, DOI 10.1016/j.yexcr.2014.09.013; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Brandt TL, 1997, J BIOL CHEM, V272, P6278, DOI 10.1074/jbc.272.10.6278; Chow PW, 2015, TOXICOL APPL PHARM, V284, P8, DOI 10.1016/j.taap.2015.01.016; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Faiola B, 2004, STEM CELLS, V22, P750, DOI 10.1634/stemcells.22-5-750; FORNI AM, 1971, ARCH ENVIRON HEALTH, V23, P385, DOI 10.1080/00039896.1971.10666024; Fung J, 2004, J APPL TOXICOL, V24, P183, DOI 10.1002/jat.960; Gao A, 2011, CELL BIOL INT, V35, P391, DOI 10.1042/CBI20100256; Gieseler F, 1999, LEUKEMIA, V13, P1859, DOI 10.1038/sj.leu.2401570; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Han YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136484; Hirabayashi Yoko, 2004, Toxicol Pathol, V32 Suppl 2, P12, DOI 10.1080/01926230490451725; Hopfner R, 2002, ANTICANCER RES, V22, P3165; Ji Z, 2010, LEUKEMIA, V24, P986, DOI 10.1038/leu.2010.43; Kumar P, 2014, J BIOL CHEM, V289, P6991, DOI 10.1074/jbc.M113.511444; Lezama RV, 2001, TOXICOLOGY, V162, P179, DOI 10.1016/S0300-483X(01)00371-7; Linet MS, 2015, INT J CANCER, V137, P2184, DOI 10.1002/ijc.29591; Louis M, 2004, INT J ONCOL, V25, P1701; Mahal K, 2015, EXP CELL RES, V336, P263, DOI 10.1016/j.yexcr.2015.06.008; Pogorelnik B, 2013, CURR PHARM DESIGN, V19, P2474, DOI 10.2174/1381612811319130016; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413; SNYDER R, 1993, ENVIRON HEALTH PERSP, V100, P293, DOI 10.2307/3431535; Son MY, 2002, CANCER LETT, V184, P81, DOI 10.1016/S0304-3835(02)00160-X; Sonnemann J, 2012, BRIT J HAEMATOL, V158, P664, DOI 10.1111/j.1365-2141.2012.09187.x; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323; Wang LP, 2012, CHEM RES TOXICOL, V25, P1303, DOI 10.1021/tx3001169; WARD CO, 1985, AM J IND MED, V7, P457, DOI 10.1002/ajim.4700070510; Williams KE, 2002, MOL CELL PROTEOMICS, V1, P885, DOI 10.1074/mcp.M200067-MCP200; Xiong SD, 2009, INT J CANCER, V125, P774, DOI 10.1002/ijc.24325; Yoon JH, 1999, BIOCHEM J, V344, P367, DOI 10.1042/0264-6021:3440367; Yu K, 2007, INT J TOXICOL, V26, P315, DOI 10.1080/10915810701489697; Yu K, 2011, TOXICOL LETT, V203, P111, DOI 10.1016/j.toxlet.2011.02.020; Zhang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046853	40	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153330	10.1371/journal.pone.0153330	http://dx.doi.org/10.1371/journal.pone.0153330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058040	gold, Green Published, Green Submitted			2022-12-26	WOS:000373604800028
J	Grogan, SM; Brown-Guedira, G; Haley, SD; McMaster, GS; Reid, SD; Smith, J; Byrne, PF				Grogan, Sarah M.; Brown-Guedira, Gina; Haley, Scott D.; McMaster, Gregory S.; Reid, Scott D.; Smith, Jared; Byrne, Patrick F.			Allelic Variation in Developmental Genes and Effects on Winter Wheat Heading Date in the US Great Plains	PLOS ONE			English	Article							VERNALIZATION RESPONSE; RHT-1 LOCI; REGISTRATION; PHOTOPERIOD; PPD-D1; TOLERANCE; CULTIVARS; VRN-A1; GROWTH; TIME	Heading date in wheat (Triticum aestivum L.) and other small grain cereals is affected by the vernalization and photoperiod pathways. The reduced-height loci also have an effect on growth and development. Heading date, which occurs just prior to anthesis, was evaluated in a population of 299 hard winter wheat entries representative of the U.S. Great Plains region, grown in nine environments during 2011-2012 and 2012-2013. The germplasm was evaluated for candidate genes at vernalization (Vrn-A1, Vrn-B1, and Vrn-D1), photoperiod (Ppd-A1, Ppd-B1 and Ppd-D1), and reduced-height (Rht-B1 and Rht-D1) loci using polymerase chain reaction (PCR) and Kompetitive Allele Specific PCR (KASP) assays. Our objectives were to determine allelic variants known to affect flowering time, assess the effect of allelic variants on heading date, and investigate changes in the geographic and temporal distribution of alleles and haplotypes. Our analyses enhanced understanding of the roles developmental genes have on the timing of heading date in wheat under varying environmental conditions, which could be used by breeding programs to improve breeding strategies under current and future climate scenarios. The significant main effects and two-way interactions between the candidate genes explained an average of 44% of variability in heading date at each environment. Among the loci we evaluated, most of the variation in heading date was explained by Ppd-D1, Ppd-B1, and their interaction. The prevalence of the photoperiod sensitive alleles Ppd-A1b, Ppd-B1b, and Ppd-D1b has gradually decreased in U.S. Great Plains germplasm over the past century. There is also geographic variation for photoperiod sensitive and reduced-height alleles, with germplasm from breeding programs in the northern Great Plains having greater incidences of the photoperiod sensitive alleles and lower incidence of the semi-dwarf alleles than germplasm from breeding programs in the central or southern plains.	[Grogan, Sarah M.; Haley, Scott D.; Reid, Scott D.; Byrne, Patrick F.] Colorado State Univ, Soil & Crop Sci, Ft Collins, CO 80523 USA; [Brown-Guedira, Gina; Smith, Jared] USDA ARS, Reg Small Grains Genotyping Lab, Raleigh, NC 27695 USA; [McMaster, Gregory S.] USDA ARS, Agr Syst Res Unit, Raleigh, NC 27695 USA	Colorado State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Byrne, PF (corresponding author), Colorado State Univ, Soil & Crop Sci, Ft Collins, CO 80523 USA.	Patrick.Byrne@colostate.edu	Byrne, Patrick/AFP-4228-2022; Haley, Scott/C-1228-2013	Haley, Scott/0000-0002-1996-9570; Bratschun, Sarah/0000-0001-5918-8480	USDA National Institute of Food and Agriculture AFRI grant [2011-68002-30029]	USDA National Institute of Food and Agriculture AFRI grant	Funding was provided by the USDA National Institute of Food and Agriculture AFRI grant to the Triticeae-CAP project (2011-68002-30029, http://www.triticeaecap.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baenziger PS, 2011, J PLANT REGIST, V5, P75, DOI 10.3198/jpr2010.02.0084crc; Barton K., 2015, MUMIN MULTIMODEL INF; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Beaujean AA, 2012, BAYLOREDPSYCH R PACK; Beniston M, 2007, CLIMATIC CHANGE, V81, P71, DOI 10.1007/s10584-006-9226-z; Boden SA, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2014.16, 10.1038/nplants.2014.16]; Brown HE, 2013, ANN BOT-LONDON, V112, P1683, DOI 10.1093/aob/mct224; BUSH MG, 1988, FIELD CROP RES, V18, P243, DOI 10.1016/0378-4290(88)90018-4; Cane K, 2013, CROP PASTURE SCI, V64, P100, DOI 10.1071/CP13086; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen YH, 2009, THEOR APPL GENET, V118, P881, DOI 10.1007/s00122-008-0946-5; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; Eagles HA, 2010, CROP PASTURE SCI, V61, P721, DOI 10.1071/CP10121; Eagles HA, 2011, PLANT BREEDING, V130, P413, DOI 10.1111/j.1439-0523.2011.01856.x; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Fox J., 2019, R COMPANION APPL REG, V.; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Grogan S, 2015, THESIS COLORADO STAT; Guedira M, 2010, CROP SCI, V50, P1811, DOI 10.2135/cropsci2009.10.0626; Guedira M, 2014, CROP SCI, V54, P1960, DOI 10.2135/cropsci2013.12.0833; Guo ZA, 2010, NEW PHYTOL, V185, P841, DOI 10.1111/j.1469-8137.2009.03099.x; Guttieri MJ, 2015, CROP SCI, V55, P1035, DOI 10.2135/cropsci2014.07.0506; Haley SD, 2009, J PLANT REGIST, V3, P181, DOI 10.3198/jpr2008.12.0727crc; Haley SD, 2005, CROP SCI, V45, P2654, DOI 10.2135/cropsci2005.0030; Johnson JW, 2002, CROP SCI, V42, P661, DOI 10.2135/cropsci2002.0661; Kamran A, 2014, PLANT BREEDING, V133, P321, DOI 10.1111/pbr.12149; Kamran A, 2014, EUPHYTICA, V197, P1, DOI 10.1007/s10681-014-1075-7; Kiss T, 2014, MOL BREEDING, V34, P297, DOI 10.1007/s11032-014-0034-2; LAW CN, 1976, HEREDITY, V36, P49, DOI 10.1038/hdy.1976.5; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Li AX, 2013, J INTEGR PLANT BIOL, V55, P1026, DOI 10.1111/jipb.12103; Littell RC, 2006, SAS MIXED MODELS, P437; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Marshall D, 1999, CROP SCI, V39, P1532, DOI 10.2135/cropsci1999.3951507x; Marshall DS, 1998, CROP SCI, V38; McMaster GS, 1997, ADV AGRON, V59, P63, DOI 10.1016/S0065-2113(08)60053-X; Merker A., 1982, Cereal Research Communications, V10, P105; Milec Z, 2012, MOL BREEDING, V30, P317, DOI 10.1007/s11032-011-9621-7; Miralles DJ, 2000, AUST J PLANT PHYSIOL, V27, P931, DOI 10.1071/PP00021; Murphy JP, 2004, CROP SCI, V44, P1479, DOI 10.2135/cropsci2004.1479; Nishida H, 2013, MOL BREEDING, V31, P27, DOI 10.1007/s11032-012-9765-0; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; R Core Team, 2013, R LANG ENV STAT COMP; Riede CR, 1996, CROP SCI, V36, P905, DOI 10.2135/cropsci1996.0011183X0036000400015x; Roussel V, 2005, THEOR APPL GENET, V111, P162, DOI 10.1007/s00122-005-2014-8; Rudd JC, 2012, J PLANT REGIST, V6, P60, DOI 10.3198/jpr2011.01.0045crc; Santra DK, 2009, PLANT BREEDING, V128, P576, DOI 10.1111/j.1439-0523.2009.01681.x; Schmitz C, 2014, AGR ECON-BLACKWELL, V45, P69, DOI 10.1111/agec.12090; Sears RG, 1997, CROP SCI, V37, P1010, DOI 10.2135/cropsci1997.0011183X003700030062x; Shcherban AB, 2014, PLANT BREEDING, P1; Slafer G., 2012, APPL PHYSL WHEAT BRE, P109; SMITH EL, 1985, CROP SCI, V25, P367, DOI 10.2135/cropsci1985.0011183X002500020052x; Tanio M, 2007, BREEDING SCI, V57, P65, DOI 10.1270/jsbbs.57.65; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Trevaskis B, 2010, FUNCT PLANT BIOL, V37, P479, DOI 10.1071/FP10056; Wilhelm EP, 2013, THEOR APPL GENET, V126, P2233, DOI 10.1007/s00122-013-2130-9; Wilhelm EP, 2013, THEOR APPL GENET, V126, P1733, DOI 10.1007/s00122-013-2088-7; Wilhelm EP, 2013, THEOR APPL GENET, V126, P1321, DOI 10.1007/s00122-013-2055-3; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; Worland AJ, 1998, EUPHYTICA, V100, P385, DOI 10.1023/A:1018327700985; Worland T., 2001, WORLD WHEAT BOOK HIS, P59; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhu J, 2014, THEOR APPL GENET, V127, P1183, DOI 10.1007/s00122-014-2290-2; Zhu XK, 2011, MOL BREEDING, V27, P501, DOI 10.1007/s11032-010-9447-8	71	46	49	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152852	10.1371/journal.pone.0152852	http://dx.doi.org/10.1371/journal.pone.0152852			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058239	Green Published, Green Submitted, gold			2022-12-26	WOS:000373604800013
J	Chae, YK; Gagliato, DD; Pai, SG; Carneiro, B; Mohindra, N; Giles, FJ; Ramakrishnan-Geethakumari, P; Sohn, J; Liu, SY; Chen, HQ; Ueno, N; Hortobagyi, G; Gonzalez-Angulo, AM				Chae, Young Kwang; Gagliato, Debora de Melo; Pai, Sachin Gopalkrishna; Carneiro, Benedito; Mohindra, Nisha; Giles, Francis Joseph; Ramakrishnan-Geethakumari, Praveen; Sohn, Joohyuk; Liu, Shuying; Chen, Huiqin; Ueno, Naoto; Hortobagyi, Gabriel; Gonzalez-Angulo, Ana Maria			The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; RANDOMIZED PHASE-II; C-MET; LUNG-CANCER; CELLS; THERAPY; AMPLIFICATION; COMBINATION; RESISTANCE; CETUXIMAB	EGFR and cMET cross-talk is involved in breast cancer (BC) progression and resistance to different targeted therapies, however little is known about the co-expression patterns of EGFR and cMET or its prognostic significance in BC. Protein levels of EGFR, cMET and their phosphorylated proteins were measured in 825 BC samples using reverse phase protein array (RPPA). Given unimodal distribution of proteins, the median was selected as a cut-off after sensitivity analyses. Kaplan-Meier survival curves were used to estimate relapse-free (RFS) and overall survival (OS). Cox-proportional hazards models were utilized to determine associations between EGFR and cMET with outcomes. Mean age was 58 years with 457 (55%) hormone receptor (HR) positive, 211 (26%) triple-negative (TN) and 148 (18%) HER2 positive tumors (HER2+). HER2+ was associated with higher EGFR expression and phosphorylation, compared to HR and TN (p<0.05). High EGFR expression was associated with higher phosphorylated-cMET (p-cMET) but not cMET (ANOVA p-cMET p<0.001; cMET p = 0.34). The same association was found with high phosphorylated-EGFR (p-EGFR) group at Tyr992 and Tyr1068 (both p<0.001). High expressions in either of two p-EGFRs were linked with higher cMET as well (all p<0.001). For the TN subtype, high expression in EGFR and p-EGFR at Tyr992 but not at Tyr1068 was associated with higher p-cMET (p<0.00, p = 0.012, p = 0.4 respectively). Only high expression in pEGFR at Tyr992 was linked with higher expression of cMET (p = 0.02). In contrast, among HER2 subtype, high expression in p-EGFR at Tyr1068 but not at Tyr992 was associated with higher cMET and p-cMET (cMET p = 0.023; p-cMET p<0.001). Four subgroups of patients defined by dichotomized EGFR/ p-EGFR and cMET/p-cMET level demonstrated no significant differences in survival. In multivariate analyses, neither cMET nor EGFR expression/activation was found to be an independent prognostic factor in survival outcome.	[Chae, Young Kwang; Gagliato, Debora de Melo; Ramakrishnan-Geethakumari, Praveen; Sohn, Joohyuk; Liu, Shuying; Chen, Huiqin; Ueno, Naoto; Hortobagyi, Gabriel; Gonzalez-Angulo, Ana Maria] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Chae, Young Kwang; Pai, Sachin Gopalkrishna; Carneiro, Benedito; Giles, Francis Joseph] Northwestern Univ, Northwestern Med Dev Therapeut Inst, Chicago, IL 60611 USA; [Chae, Young Kwang; Pai, Sachin Gopalkrishna; Carneiro, Benedito; Mohindra, Nisha; Giles, Francis Joseph] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Chae, Young Kwang; Pai, Sachin Gopalkrishna; Carneiro, Benedito; Mohindra, Nisha; Giles, Francis Joseph] Northwestern Univ, Div Hematol & Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Gagliato, Debora de Melo] Hosp Sirio Libanes, Dept Clin Oncol, Sao Paulo, SP, Brazil; [Gagliato, Debora de Melo] ICESP, Sao Paulo, SP, Brazil	University of Texas System; UTMD Anderson Cancer Center; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Hospital Sirio Libanes	Chae, YK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA.; Chae, YK (corresponding author), Northwestern Univ, Northwestern Med Dev Therapeut Inst, Chicago, IL 60611 USA.; Chae, YK (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.; Chae, YK (corresponding author), Northwestern Univ, Div Hematol & Oncol, Feinberg Sch Med, Chicago, IL 60611 USA.	young.chae@northwestern.edu	Pai, Sachin/K-7689-2019	Pai, Sachin/0000-0002-6755-3895	NCI NIH HHS [P30 CA016672, P30 CA060553] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA060553] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baselga J, 2013, J CLIN ONCOL, V31, P2586, DOI 10.1200/JCO.2012.46.2408; Bergstrom JD, 2000, EXP CELL RES, V259, P293, DOI 10.1006/excr.2000.4967; Beviglia L, 1997, INT J CANCER, V74, P301, DOI 10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO;2-E; Blumenschein GR, 2012, J CLIN ONCOL, V30, P3287, DOI 10.1200/JCO.2011.40.3774; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; Chia SK, 2007, CANCER, V110, P973, DOI 10.1002/cncr.22867; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gagliato DD, 2014, CLIN BREAST CANCER, V14, P468, DOI 10.1016/j.clbc.2014.06.001; Garnett J, 2013, NEOPLASIA, V15, P73, DOI 10.1593/neo.121536; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hammond ME, 2011, J CLIN ONCOL, V29, pE458, DOI 10.1200/JCO.2011.35.2245; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Kim YJ, 2014, INT J CANCER, V134, P2424, DOI 10.1002/ijc.28566; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; Liska D, 2011, CLIN CANCER RES, V17, P472, DOI 10.1158/1078-0432.CCR-10-0568; Martin TA, 2010, ANTI-CANCER AGENT ME, V10, P2, DOI 10.2174/1871520611009010002; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; Moerkens M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-283; NICHOLSON RI, 1994, BREAST CANCER RES TR, V29, P117, DOI 10.1007/BF00666187; NICHOLSON RI, 1993, EUR J CANCER, V29A, P1018, DOI 10.1016/S0959-8049(05)80215-1; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Park HS, 2014, MODERN PATHOL, V27, P1212, DOI 10.1038/modpathol.2013.251; Paulson AK, 2013, MOL CANCER RES, V11, P1112, DOI 10.1158/1541-7786.MCR-13-0042; Raghav KP, 2012, CLIN CANCER RES, V18, P2269, DOI 10.1158/1078-0432.CCR-11-2830; Tengs T, 2006, CANCER LETT, V239, P227, DOI 10.1016/j.canlet.2005.08.007; Tredan O, 2015, CLIN BREAST CANCER, V15, P8, DOI 10.1016/j.clbc.2014.07.007; Xu AM, 2010, CANCER RES, V70, P3857, DOI 10.1158/0008-5472.CAN-10-0163; Yan SC, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0296-y; Zeng ZS, 2008, CANCER LETT, V265, P258, DOI 10.1016/j.canlet.2008.02.049	37	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152585	10.1371/journal.pone.0152585	http://dx.doi.org/10.1371/journal.pone.0152585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055285	Green Published, gold			2022-12-26	WOS:000373608000026
J	Lindmark, A; van Rompaye, B; Goetghebeur, E; Glader, EL; Eriksson, M				Lindmark, Anita; van Rompaye, Bart; Goetghebeur, Els; Glader, Eva-Lotta; Eriksson, Marie			The Importance of Integrating Clinical Relevance and Statistical Significance in the Assessment of Quality of Care-Illustrated Using the Swedish Stroke Register	PLOS ONE			English	Article							PROFILING HOSPITAL PERFORMANCE; INSTITUTIONAL PERFORMANCE; RISK-ADJUSTMENT; ISCHEMIC-STROKE; FUNNEL PLOTS; OUTCOMES; ISSUES; MODELS	Background When profiling hospital performance, quality inicators are commonly evaluated through hospital-specific adjusted means with confidence intervals. When identifying deviations from a norm, large hospitals can have statistically significant results even for clinically irrelevant deviations while important deviations in small hospitals can remain undiscovered. We have used data from the Swedish Stroke Register (Riksstroke) to illustrate the properties of a benchmarking method that integrates considerations of both clinical relevance and level of statistical significance. Methods The performance measure used was case-mix adjusted risk of death or dependency in activities of daily living within 3 months after stroke. A hospital was labeled as having outlying performance if its case-mix adjusted risk exceeded a benchmark value with a specified statistical confidence level. The benchmark was expressed relative to the population risk and should reflect the clinically relevant deviation that is to be detected. A simulation study based on Riksstroke patient data from 2008-2009 was performed to investigate the effect of the choice of the statistical confidence level and benchmark value on the diagnostic properties of the method. Results Simulations were based on 18,309 patients in 76 hospitals. The widely used setting, comparing 95% confidence intervals to the national average, resulted in low sensitivity (0.252) and high specificity (0.991). There were large variations in sensitivity and specificity for different requirements of statistical confidence. Lowering statistical confidence improved sensitivity with a relatively smaller loss of specificity. Variations due to different benchmark values were smaller, especially for sensitivity. This allows the choice of a clinically relevant benchmark to be driven by clinical factors without major concerns about sufficiently reliable evidence. Conclusions The study emphasizes the importance of combining clinical relevance and level of statistical confidence when profiling hospital performance. To guide the decision process a web-based tool that gives ROC-curves for different scenarios is provided.	[Lindmark, Anita; van Rompaye, Bart; Eriksson, Marie] Umea Univ, Dept Stat, Umea Sch Business & Econ, S-90187 Umea, Sweden; [van Rompaye, Bart; Goetghebeur, Els] Univ Ghent, Dept Appl Math Comp Sci & Stat, B-9000 Ghent, Belgium; [Glader, Eva-Lotta] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden	Umea University; Ghent University; Umea University	Lindmark, A (corresponding author), Umea Univ, Dept Stat, Umea Sch Business & Econ, S-90187 Umea, Sweden.	anita.lindmark@umu.se	Eriksson, Marie/H-2452-2012; Glader, Eva-Lotta/AGR-3015-2022; Eriksson, Marie/AAB-6215-2019; Goetghebeur, Els J/H-7939-2016	Eriksson, Marie/0000-0003-3298-1555; Eriksson, Marie/0000-0003-3298-1555; Lindmark, Anita/0000-0002-4600-0060	Swedish Research Council [2012-5934]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by the Swedish Research Council (http://www.vr.se/), grant no. 2012-5934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplund K, 2011, INT J STROKE, V6, P99, DOI 10.1111/j.1747-4949.2010.00557.x; Austin PC, 2003, MED DECIS MAKING, V23, P526, DOI 10.1177/0272989X03258443; Austin PC, 2001, J EVAL CLIN PRACT, V7, P35, DOI 10.1046/j.1365-2753.2001.00261.x; Centers for Medicare & Medicaid Services, 2014, HOSP COMP; DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO;2-D; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325; Hubbard RA, 2015, STAT MED, V34, P93, DOI 10.1002/sim.6318; Katzan IL, 2014, STROKE, V45, P918, DOI 10.1161/01.str.0000441948.35804.77; Kolfschoten NE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088737; Kunadian B, 2009, CATHETER CARDIO INTE, V73, P589, DOI 10.1002/ccd.21893; NHS Improving Quality, NAT PEER REV PROGR 2; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; Paddock SM, 2014, HEALTH SERV RES, V49, P1056, DOI 10.1111/1475-6773.12149; Riksstroke, 2013, RISKS STROK ARSR 201; Schulman J, 2008, J PERINATOL, V28, P588, DOI 10.1038/jp.2008.67; Shahian DM, 2008, CIRCULATION, V117, P1955, DOI 10.1161/CIRCULATIONAHA.107.747873; Shahian DM, 2015, BMJ QUAL SAF, V24, P95, DOI 10.1136/bmjqs-2015-003934; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Sweden The National Board of Health and Welfare & Swedish Association of Local Authorities and Regions, 2013, OPPNA JAMFORELSER 20; The Swedish Association of Local Authorities and Regions, 2015, MOT 61 PERS VARD K N; van Dishoeck AM, 2011, BMJ QUAL SAF, V20, P651, DOI 10.1136/bmjqs.2009.035881; Varewyck M, 2016, STAT MED, V35, P227, DOI 10.1002/sim.6634; Varewyck M, 2014, BIOSTATISTICS, V15, P651, DOI 10.1093/biostatistics/kxu019; World Health Organization (WHO). Division of Country Health Systems, PERF ASS TOOL QUAL I	26	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153082	10.1371/journal.pone.0153082	http://dx.doi.org/10.1371/journal.pone.0153082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054326	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000075
J	Moen, ST; Hatcher, CL; Singh, AK				Moen, Scott T.; Hatcher, Christopher L.; Singh, Anup K.			A Centrifugal Microfluidic Platform That Separates Whole Blood Samples into Multiple Removable Fractions Due to Several Discrete but Continuous Density Gradient Sections	PLOS ONE			English	Article							MONONUCLEAR-CELLS; SEDIMENTATION; MONOCYTES; VOLUME	We present a miniaturized centrifugal platform that uses density centrifugation for separation and analysis of biological components in small volume samples (similar to 5 mu L). We demonstrate the ability to enrich leukocytes for on-disk visualization via microscopy, as well as recovery of viable cells from each of the gradient partitions. In addition, we simplified the traditional Modified Wright-Giemsa staining by decreasing the time, volume, and expertise involved in the procedure. From a whole blood sample, we were able to extract 95.15% of leukocytes while excluding 99.8% of red blood cells. This platform has great potential in both medical diagnostics and research applications as it offers a simpler, automated, and inexpensive method for biological sample separation, analysis, and downstream culturing.	[Moen, Scott T.; Singh, Anup K.] Sandia Natl Labs, Livermore, CA USA; [Moen, Scott T.; Hatcher, Christopher L.; Singh, Anup K.] Univ Texas Med Branch, Galveston, TX 77555 USA	United States Department of Energy (DOE); Sandia National Laboratories; University of Texas System; University of Texas Medical Branch Galveston	Moen, ST (corresponding author), Sandia Natl Labs, Livermore, CA USA.; Moen, ST (corresponding author), Univ Texas Med Branch, Galveston, TX 77555 USA.	stmoen@utmb.edu			National Institute of Allergy and Infectious Diseases [R01AI0988530]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]; NIH-NIAID [R01AI0988530]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098853] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by National Institute of Allergy and Infectious Diseases (Grant R01AI0988530). Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000 (STM).; This research was funded by NIH-NIAID grant number R01AI0988530. Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. We would also like to thank Greg Berry and Mardelle Susman for their editing services.	Andre MC, 2012, J LEUKOCYTE BIOL, V91, P977, DOI 10.1189/jlb.0911474; BERTHOLD F, 1981, BLUT, V43, P367, DOI 10.1007/BF00320315; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Cho H, 2007, J COLLOID INTERF SCI, V306, P379, DOI 10.1016/j.jcis.2006.10.077; Cho Y-K, 2007, TRANSDUCERS 2007 200, P387, DOI [10.1109/SENSOR.2007.4300149, DOI 10.1109/SENSOR.2007.4300149]; COLOTTA F, 1994, AM J PATHOL, V144, P975; De Boer BA, 1998, CLIN EXP IMMUNOL, V114, P252; Fogeda M, 1999, J VIROL, V73, P4052, DOI 10.1128/JVI.73.5.4052-4061.1999; Hoeboer SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065564; Kinahan DJ, 2014, SENSOR ACTUAT A-PHYS, V215, P71, DOI 10.1016/j.sna.2013.11.010; Klinken SP, 2002, INT J BIOCHEM CELL B, V34, P1513, DOI 10.1016/S1357-2725(02)00087-0; Leidinger P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-474; Meyer HS, 2001, JAMA-J AM MED ASSOC, P95; Park JM, 2014, ANAL CHEM, V86, P3735, DOI 10.1021/ac403456t; Park JM, 2012, ANAL CHEM, V84, P7400, DOI 10.1021/ac3011704; Pitts KL, 2013, J MECH BEHAV BIOMED, V17, P333, DOI 10.1016/j.jmbbm.2012.07.007; POPPE LJ, 1988, COMPUT GEOSCI, V14, P541, DOI 10.1016/0098-3004(88)90034-9; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; RAGHUPRASAD PK, 1982, J IMMUNOL, V129, P2128; Ratner BD, 2004, CHEM ENG; Rosina J, 2007, PHYSIOL RES, V56, pS93, DOI 10.33549/physiolres.931306; Traves SL, 2004, J LEUKOCYTE BIOL, V76, P441, DOI 10.1189/jlb.1003495; ZIPURSKY A, 1976, BLOOD, V48, P361	24	15	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153137	10.1371/journal.pone.0153137	http://dx.doi.org/10.1371/journal.pone.0153137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054764	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000085
J	Hasne, MP; Soysa, R; Ullman, B				Hasne, Marie-Pierre; Soysa, Radika; Ullman, Buddy			The Trypanosoma cruzi Diamine Transporter Is Essential for Robust Infection of Mammalian Cells	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; CHAGAS-DISEASE; ORNITHINE-DECARBOXYLASE; POLYAMINE METABOLISM; BRUCEI-BRUCEI; TRYPANOTHIONE; GENE; PUTRESCINE; SPERMIDINE; DIFLUOROMETHYLORNITHINE	Trypanosoma cruzi is incapable of synthesizing putrescine or cadaverine de novo, and, therefore, salvage of polyamines from the host milieu is an obligatory nutritional function for the parasite. A high-affinity diamine transporter (TcPOT1) from T. cruzi has been identified previously that recognizes both putrescine and cadaverine as ligands. In order to assess the functional role of TcPOT1 in intact parasites, a Delta tcpot1 null mutant was constructed by targeted gene replacement and characterized. The Delta tcpot1 mutant lacked high-affinity putrescine-cadaverine transport capability but retained the capacity to transport diamines via a non-saturable, low-affinity mechanism. Transport of spermidine and arginine was not impacted by the Delta tcpot1 lesion. The Delta tcpot1 cell line exhibited a significant but not total defect in its ability to subsist in Vero cells, although initial infection rates were not affected by the lesion. These findings reveal that TcPOT1 is the sole high-affinity diamine permease in T. cruzi, that genetic obliteration of TcPOT1 impairs the ability of the parasite to maintain a robust infection in mammalian cells, and that a secondary low-affinity uptake mechanism for this key parasite nutrient is operative but insufficient for optimal infection.	[Hasne, Marie-Pierre; Soysa, Radika; Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Soysa, Radika] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle	Hasne, MP (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.	hasnem@ohsu.edu			National Institute of Allergy and Infectious Disease [AI041622]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI041622, R01AI041622] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Disease, Grant AI041622 (https://www.niaid.nih.gov/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algranati ID, 2010, AMINO ACIDS, V38, P645, DOI 10.1007/s00726-009-0425-6; Apt W, 2010, DRUG DES DEV THER, V4, P243, DOI 10.2147/DDDT.S8338; Ariyanayagam MR, 1997, MOL BIOCHEM PARASIT, V84, P111, DOI 10.1016/S0166-6851(96)02788-0; Ariyanayagam MR, 2003, J BIOL CHEM, V278, P27612, DOI 10.1074/jbc.M302750200; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; Bacchi CJ, 2009, ANTIMICROB AGENTS CH, V53, P3269, DOI 10.1128/AAC.00076-09; Barker RH, 2009, ANTIMICROB AGENTS CH, V53, P2052, DOI 10.1128/AAC.01674-08; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11; Birkholtz LM, 2011, BIOCHEM J, V438, P229, DOI 10.1042/BJ20110362; BITONTI AJ, 1990, ANTIMICROB AGENTS CH, V34, P1485, DOI 10.1128/AAC.34.8.1485; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burri C, 2003, PARASITOL RES, V90, pS49, DOI 10.1007/s00436-002-0766-5; BYERS TL, 1991, BIOCHEM J, V274, P527, DOI 10.1042/bj2740527; CARNIERI EGS, 1993, MOL BIOCHEM PARASIT, V61, P79, DOI 10.1016/0166-6851(93)90160-Y; Carrillo C, 1999, FEBS LETT, V454, P192, DOI 10.1016/S0014-5793(99)00804-2; Carrillo C, 2006, BIOCHEM BIOPH RES CO, V344, P936, DOI 10.1016/j.bbrc.2006.03.215; CASTELLANI O, 1967, J PROTOZOOL, V14, P447, DOI 10.1111/j.1550-7408.1967.tb02024.x; DANZIN C, 1990, BIOCHEM PHARMACOL, V40, P1499, DOI 10.1016/0006-2952(90)90446-R; Camara MD, 2013, FOLIA PARASIT, V60, P406, DOI 10.14411/fp.2013.042; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Docampo R, 2003, PARASITOL RES, V90, pS10, DOI 10.1007/s00436-002-0752-y; DROCOURT D, 1990, NUCLEIC ACIDS RES, V18, P4009, DOI 10.1093/nar/18.13.4009; EBONG S, 1993, COMP BIOCHEM PHYS C, V106, P483, DOI 10.1016/0742-8413(93)90167-J; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FAIRLAMB AH, 1987, MOL BIOCHEM PARASIT, V24, P185, DOI 10.1016/0166-6851(87)90105-8; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Hasne MP, 2010, MOL MICROBIOL, V76, P78, DOI 10.1111/j.1365-2958.2010.07081.x; Heby O, 2007, AMINO ACIDS, V33, P359, DOI 10.1007/s00726-007-0537-9; Hirth B, 2009, BIOORG MED CHEM LETT, V19, P2916, DOI 10.1016/j.bmcl.2009.04.096; Hotez PJ, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002300, 10.1371/journal.pntd.0002570]; HUNTER KJ, 1994, EUR J BIOCHEM, V226, P1019, DOI 10.1111/j.1432-1033.1994.t01-1-01019.x; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Jiang YQ, 1999, J BIOL CHEM, V274, P3781, DOI 10.1074/jbc.274.6.3781; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; KELLY JM, 1995, PARASITOL TODAY, V11, P447, DOI 10.1016/0169-4758(95)80057-3; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; LeQuesne SA, 1996, BIOCHEM J, V316, P481; Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110; MARTON LJ, 1973, CLIN CHEM, V19, P923; NOGUEIRA N, 1975, J EXP MED, V142, P224, DOI 10.1084/jem.142.1.224; Pegg A E, 1980, Adv Enzyme Regul, V19, P427; PEGG AE, 1970, BIOCHEM J, V117, P17, DOI 10.1042/bj1170017; PEGG AE, 1987, BIOCHEM J, V241, P305, DOI 10.1042/bj2410305; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Persson K, 1998, BIOCHEM J, V333, P527, DOI 10.1042/bj3330527; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TEIXEIRA ARL, 1989, AM J TROP MED HYG, V40, P165, DOI 10.4269/ajtmh.1989.40.165; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Willert EK, 2009, MOL BIOCHEM PARASIT, V168, P1, DOI 10.1016/j.molbiopara.2009.05.009	52	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152715	10.1371/journal.pone.0152715	http://dx.doi.org/10.1371/journal.pone.0152715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050410	Green Published, gold			2022-12-26	WOS:000373603500050
J	Ihlow, F; Vamberger, M; Flecks, M; Hartmann, T; Cota, M; Makchai, S; Meewattana, P; Dawson, JE; Kheng, L; Rodder, D; Fritz, U				Ihlow, Flora; Vamberger, Melita; Flecks, Morris; Hartmann, Timo; Cota, Michael; Makchai, Sunchai; Meewattana, Pratheep; Dawson, Jeffrey E.; Kheng, Long; Roedder, Dennis; Fritz, Uwe			Integrative Taxonomy of Southeast Asian Snail-Eating Turtles (Geoemydidae: Malayemys) Reveals a New Species and Mitochondrial Introgression	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; MICROSATELLITE MARKERS; POPULATION-STRUCTURE; MOLECULAR PHYLOGENY; HERMANNS TORTOISE; TESTUDO-HERMANNI; SEA LEVELS; RIVER; PHYLOGEOGRAPHY; GENETICS	Based on an integrative taxonomic approach, we examine the differentiation of Southeast Asian snail-eating turtles using information from 1863 bp of mitochondrial DNA, 12 microsatellite loci, morphology and a correlative species distribution model. Our analyses reveal three genetically distinct groups with limited mitochondrial introgression in one group. All three groups exhibit distinct nuclear gene pools and distinct morphology. Two of these groups correspond to the previously recognized species Malayemys macrocephala (Chao Phraya Basin) and M. subtrijuga (Lower Mekong Basin). The third and genetically most divergent group from the Khorat Basin represents a previously unrecognized species, which is described herein. Although Malayemys are extensively traded and used for religious release, only few studied turtles appear to be translocated by humans. Historic fluctuations in potential distributions were assessed using species distribution models (SDMs). The Last Glacial Maximum (LGM) projection of the predictive SDMs suggests two distinct glacial distribution ranges, implying that the divergence of M. macrocephala and M. subtrijuga occurred in allopatry and was triggered by Pleistocene climate fluctuations. Only the projection derived from the global circulation model MIROC reveals a distinct third glacial distribution range for the newly discovered Malayemys species.	[Ihlow, Flora; Flecks, Morris; Hartmann, Timo; Roedder, Dennis] Zool Forschungsmuseum Alexander Koenig, Herpetol Sect, Bonn, Germany; [Vamberger, Melita; Fritz, Uwe] Senckenberg Dresden, Museum Zool, Dresden, Germany; [Cota, Michael; Makchai, Sunchai] Thailand Nat Hist Museum, Natl Sci Museum, Khlong Luang, Pathum Thani, Thailand; [Cota, Michael; Meewattana, Pratheep] Phranakhon Rajabhat Univ, Bangkok, Thailand; [Dawson, Jeffrey E.] St Louis Zoo, Charles H Hoessle Herpetarium, St Louis, MO USA; [Kheng, Long] Minist Environm, Gen Dept Adm Nat Conservat & Protect, Chamkar Mon, Phnom Penh, Cambodia	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Senckenberg Gesellschaft fur Naturforschung (SGN); Phranakhon Rajabhat University	Ihlow, F (corresponding author), Zool Forschungsmuseum Alexander Koenig, Herpetol Sect, Bonn, Germany.	F.Ihlow@ZFMK.de	Fritz, Uwe/AAC-4029-2019; Rödder, Dennis/AAT-8644-2021	Fritz, Uwe/0000-0002-6740-7214; Rödder, Dennis/0000-0002-6108-1639; Vamberger, Melita/0000-0002-1404-2469; Ihlow, Flora/0000-0002-0460-4210	Alexander Koenig Gesellschaft; British Chelonia Group; German Academic Exchange Service; Schildkroten-Interessengemeinschaft Schweiz; International Turtle Association	Alexander Koenig Gesellschaft; British Chelonia Group; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Schildkroten-Interessengemeinschaft Schweiz; International Turtle Association	FI's research was partly funded by the Alexander Koenig Gesellschaft (https://www.zfmk.de/de/akg), the British Chelonia Group (http://www.britishcheloniagroup.org.uk/), the German Academic Exchange Service (https://www.daad.de/en/), the Schildkroten-Interessengemeinschaft Schweiz (http://www.sigs.ch/), and the International Turtle Association (http://www.isv.or.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adamson EAS, 2009, J FISH BIOL, V75, P1371, DOI 10.1111/j.1095-8649.2009.02369.x; [Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barth D, 2004, ZOOL SCR, V33, P213, DOI 10.1111/j.0300-3256.2004.00150.x; Blonder B, 2014, HYPERVOLUME HIGH DIM; Braconnot P, 2012, NAT CLIM CHANGE, V2, P417, DOI 10.1038/NCLIMATE1456; Brophy Timothy R., 2004, Hamadryad, V29, P63; Brophy Timothy R., 2005, Bulletin of the Chicago Herpetological Society, V40, P21; Brophy TR, 2002, THESIS G MASON U; Ceballos CP, 2013, EVOL BIOL, V40, P194, DOI 10.1007/s11692-012-9199-y; Ciofi C, 2009, MOL ECOL RESOUR, V9, P189, DOI 10.1111/j.1755-0998.2008.02205.x; Claude J, 2011, ANN PALEONTOL, V97, P113, DOI 10.1016/j.annpal.2011.08.002; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coyne J.A., 2004, SPECIATION; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ernst C. H., 1989, TURTLES WORLD; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fontaine H, 1978, P 3 REG C GEOL MIN R, P541; Forlani A, 2005, MOL ECOL NOTES, V5, P228, DOI 10.1111/j.1471-8286.2005.00890.x; Fritz U, 2008, ZOOL SCR, V37, P367, DOI 10.1111/j.1463-6409.2008.00332.x; Fritz Uwe, 2007, Vertebrate Zoology, V57, P149; Fritz U, 2006, ZOOL SCR, V35, P531, DOI 10.1111/j.1463-6409.2006.00242.x; Fritz U, 2014, VERTEBR ZOOL, V64, P229; Fritz U, 2014, ZOOTAXA, V3795, P501, DOI 10.11646/zootaxa.3795.5.1; Fritz U, 2012, J ZOOL SYST EVOL RES, V50, P125, DOI 10.1111/j.1439-0469.2011.00647.x; Fritz U, 2010, ORG DIVERS EVOL, V10, P227, DOI 10.1007/s13127-010-0007-1; Gibbons JW, 1990, HERPETOL MONOGR, V4, P29; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Glaubrecht M, 2004, BIOL J LINN SOC, V82, P275, DOI 10.1111/j.1095-8312.2004.00361.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graham MR, 2012, ZOOL MIDDLE EAST, V55, P95, DOI 10.1080/09397140.2012.10648924; Halamkova L, 2013, BIOL J LINN SOC, V108, P396, DOI 10.1111/j.1095-8312.2012.02015.x; Hall Robert, 1998, P99; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASUMI H, 2004, 1 U TOK CTR CLIM SYS; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hurwood DA, 2008, ECOL FRESHW FISH, V17, P273, DOI 10.1111/j.1600-0633.2007.00278.x; Int Commission Zoological Nomencla, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.219.3944; Iverson JB, 1992, REVISED CHECKLIST DI; KIERS HAL, 1991, PSYCHOMETRIKA, V56, P197, DOI 10.1007/BF02294458; Kindler C, 2016, BIOL J LINN SOC, V117, P305, DOI 10.1111/bij.12647; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lindeman PV, 2008, HERPETOLOGICA, V64, P32, DOI 10.1655/07-025.1; Lukoschek V, 2011, ECOL EVOL, V1, P330, DOI 10.1002/ece3.29; Mantziou G, 2005, MOL ECOL NOTES, V5, P727, DOI 10.1111/j.1471-8286.2005.01046.x; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mertens R, 1961, ZOOL JB ABT SYST OEK, V83, P323; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Perez M, 2006, MOL ECOL NOTES, V6, P1096, DOI 10.1111/j.1471-8286.2006.01445.x; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Petzold A, 2014, ZOOTAXA, V3795, P523, DOI 10.11646/zootaxa.3795.5.2; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Praschag P, 2009, ZOOTAXA, P57, DOI 10.11646/zootaxa.2233.1.3; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Rainboth W.J., 1996, FISHES CAMBODIAN MEK; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Roques S, 2004, CAN J ZOOL, V82, P153, DOI 10.1139/Z03-228; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schwartz TS, 2003, MOL ECOL NOTES, V3, P283, DOI 10.1046/j.1471-8286.2003.00428.x; Spinks PQ, 2012, MOL PHYLOGENET EVOL, V63, P656, DOI 10.1016/j.ympev.2012.02.014; Spinks PQ, 2012, ZOOL J LINN SOC-LOND, V164, P811, DOI 10.1111/j.1096-3642.2011.00788.x; Spinks Phillip Q., 2009, Zootaxa, V2018, P56; Spinks PQ, 2004, MOL PHYLOGENET EVOL, V32, P164, DOI 10.1016/j.ympev.2003.12.015; Stuart BL, 2004, MOL PHYLOGENET EVOL, V31, P164, DOI 10.1016/S1055-7903(03)00258-6; Stuckas H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057116; Stuckas H, 2011, J ZOOL SYST EVOL RES, V49, P335, DOI 10.1111/j.1439-0469.2011.00632.x; Suzuki D, 2015, CURR HERPETOL, V34, P112, DOI 10.5358/hsj.34.112; Svenning JC, 2011, QUATERNARY SCI REV, V30, P2930, DOI 10.1016/j.quascirev.2011.06.012; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teynie Alexandre, 2004, Hamadryad, V29, P33; Underwood EB, 2013, HERPETOLOGICA, V69, P397; Vamberger M, 2015, ZOOL SCR, V44, P233, DOI 10.1111/zsc.12102; Vamberger M, 2011, AMPHIBIA-REPTILIA, V32, P9, DOI 10.1163/017353710X541869; VANDIJK PP, 2014, CHELONIAN RES MONOGR, V5, P329, DOI DOI 10.3854/CRM.5.000.CHECKLIST.V7.2014; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Woodruff DS, 2010, BIODIVERS CONSERV, V19, P919, DOI 10.1007/s10531-010-9783-3	88	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153108	10.1371/journal.pone.0153108	http://dx.doi.org/10.1371/journal.pone.0153108			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050302	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500100
J	Infante, J; Rosalen, PL; Lazarini, JG; Franchin, M; de Alencar, SM				Infante, Juliana; Rosalen, Pedro Luiz; Lazarini, Josy Goldoni; Franchin, Marcelo; de Alencar, Severino Matias			Antioxidant and Anti-Inflammatory Activities of Unexplored Brazilian Native Fruits	PLOS ONE			English	Article							NEUTROPHILS; CAPACITIES	Brazilian native fruits are unmatched in their variety, but a poorly explored resource for the development of food and pharmaceutical products. The aim of this study was to evaluate the phenolic composition as well as the antioxidant and anti-inflammatory activities of the extracts of leaves, seeds, and pulp of four Brazilian native fruits (Eugenia leitonii, Eugenia involucrata, Eugenia brasiliensis, and Eugenia myrcianthes). GC-MS analyses of the ethanolic extracts showed the presence of epicatechin and gallic acid as the major compounds in these fruits. Antioxidant activity was measured using synthetic DPPH free-radical scavenging, beta-carotene bleaching assay, and reactive oxygen species (ROO center dot, O-2 center dot(-), and HOCl). The fruit extracts also exhibited antioxidant effect against biologically relevant radicals such as peroxyl, superoxide, and hypochlorous acid. In general, the pulps were the fruit fractions that exhibited the lowest antioxidant activities, whereas the leaves showed the highest ones. The anti-inflammatory activity was assessed in an in vivo model using the carrageenan-induced neutrophil migration assay, which evaluates the inflammatory response in the acute phase. The pulp, seeds, and leaves of these fruits reduced the neutrophil influx by 40% to 64%. Based on these results, we suggest that the anti-inflammatory activity of these native fruits is related to the modulation of neutrophil migration, through the inhibition of cytokines, chemokines, and adhesion molecules, as well as to the antioxidant action of their ethanolic extracts in scavenging the free-radicals released by neutrophils. Therefore, these native fruits can be useful to produce food additives and functional foods.	[Infante, Juliana; de Alencar, Severino Matias] Univ Sao Paulo, Dept Agrifood Ind Food & Nutr, Luiz de Queiroz Coll Agr, Padua Dias Ave,POB 9, BR-13418900 Piracicaba, SP, Brazil; [Rosalen, Pedro Luiz; Lazarini, Josy Goldoni; Franchin, Marcelo] Univ Estadual Campinas, Dept Physiol Sci, Piracicaba Dent Sch, 901 Limeira Ave, BR-13414903 Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	de Alencar, SM (corresponding author), Univ Sao Paulo, Dept Agrifood Ind Food & Nutr, Luiz de Queiroz Coll Agr, Padua Dias Ave,POB 9, BR-13418900 Piracicaba, SP, Brazil.	smalencar@usp.br	Lazarini, Josy Goldoni/L-3477-2016; Rosalen, Pedro Luiz/I-3718-2012; Franchin, Marcelo/M-7636-2017; Alencar, Severino Matias/B-7743-2012	Lazarini, Josy Goldoni/0000-0002-3498-8243; Rosalen, Pedro Luiz/0000-0003-0812-4027; Franchin, Marcelo/0000-0001-5613-2756; Alencar, Severino Matias/0000-0002-6637-7973	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/13190-2, 2014/50235-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Grant number: 2013/13190-2 - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - JI; and Grant number: 2014/50235-7 - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - SMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyropoulou A, 2013, NAT PROD REP, V30, P1412, DOI 10.1039/c3np70031c; Delfanian M, 2015, FOOD SCI NUTR, V3, P613, DOI [10.1002/fsn3.201, 10.1002/fsn3.320]; Denny C, 2014, J FUNCT FOODS, V8, P292, DOI 10.1016/j.jff.2014.03.016; Edreva A, 2005, AGR ECOSYST ENVIRON, V106, P119, DOI 10.1016/j.agee.2004.10.022; Emmons CL, 1999, J AGR FOOD CHEM, V47, P4894, DOI 10.1021/jf990530i; Folmer F, 2014, PHYTOCHEM REV, V13, P295, DOI 10.1007/s11101-013-9319-z; Food and Agriculture Organization of the United Nations, 2009, FEED WORLD 2050 HIGH; Fraga CG, 2011, FREE RADICAL BIO MED, V51, P813, DOI 10.1016/j.freeradbiomed.2011.06.002; Rodriguez-Roque MJ, 2016, FOOD FUNCT, V7, P380, DOI [10.1039/c5fo01060h, 10.1039/C5FO01060H]; JOLY C.A., 2011, REV USP, V89, P114; Locatelli C, 2013, EUR J MED CHEM, V60, P233, DOI 10.1016/j.ejmech.2012.10.056; Ma MM, 2015, INFLAMMATION, V38, P1669, DOI 10.1007/s10753-015-0144-y; Marinovic MP, 2015, TOXICOL IN VITRO, V29, P1766, DOI 10.1016/j.tiv.2015.07.014; Massarioli AP, 2013, J FOOD AGRIC ENVIRON, V11, P288; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Melo PS, 2015, FOOD CHEM, V181, P160, DOI 10.1016/j.foodchem.2015.02.087; Nemeth T, 2012, IMMUNOL LETT, V143, P9, DOI 10.1016/j.imlet.2012.01.013; Oldoni TLC, 2011, SEP PURIF TECHNOL, V77, P208, DOI 10.1016/j.seppur.2010.12.007; Patthamakanokporn O, 2008, J FOOD COMPOS ANAL, V21, P241, DOI 10.1016/j.jfca.2007.10.002; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Tiveron AP, 2012, INT J MOL SCI, V13, P8943, DOI 10.3390/ijms13078943; Wang SY, 2011, INT J FOOD SCI TECH, V46, P2482, DOI 10.1111/j.1365-2621.2011.02771.x; Wang SY, 2000, J AGR FOOD CHEM, V48, P140, DOI 10.1021/jf9908345; Wong SH, 2004, ARCH IMMUNOL THER EX, V52, P379; Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w	26	52	54	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152974	10.1371/journal.pone.0152974	http://dx.doi.org/10.1371/journal.pone.0152974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050817	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500074
J	Paul, P; Dhandapani, V; Rameneni, JJ; Li, X; Sivanandhan, G; Choi, SR; Pang, W; Im, S; Lim, YP				Paul, Parameswari; Dhandapani, Vignesh; Rameneni, Jana Jeevan; Li, Xiaonan; Sivanandhan, Ganesan; Choi, Su Ryun; Pang, Wenxing; Im, Subin; Lim, Yong Pyo			Genome-Wide Analysis and Characterization of Aux/IAA Family Genes in Brassica rapa	PLOS ONE			English	Article							TRANSCRIPTOME ANALYSIS; AUXIN; RESPONSES	Auxins are the key players in plant growth development involving leaf formation, phototropism, root, fruit and embryo development. Auxin/Indole-3-Acetic Acid (Aux/IAA) are early auxin response genes noted as transcriptional repressors in plant auxin signaling. However, many studies focus on Aux/ARF gene families and much less is known about the Aux/IAA gene family in Brassica rapa (B. rapa). Here we performed a comprehensive genome-wide analysis and identified 55 Aux/IAA genes in B. rapa using four conserved motifs of Aux/IAA family (PF02309). Chromosomal mapping of the B. rapa Aux/IAA (BrIAA) genes facilitated understanding cluster rearrangement of the crucifer building blocks in the genome. Phylogenetic analysis of BrIAA with Arabidopsis thaliana, Oryza sativa and Zea mays identified 51 sister pairs including 15 same species (BrIAA-BrIAA) and 36 cross species (BrIAA-AtIAA) IAA genes. Among the 55 BrIAA genes, expression of 43 and 45 genes were verified using Gene-bank B. rapa ESTs and in home developed microarray data from mature leaves of Chiifu and RcBr lines. Despite their huge morphological difference, tissue specific expression analysis of BrIAA genes between the parental lines Chiifu and RcBr showed that the genes followed a similar pattern of expression during leaf development and a different pattern during bud, flower and siliqua development stages. The response of the BrIAA genes to abiotic and auxin stress at different time intervals revealed their involvement in stress response. Single Nucleotide Polymorphisms between IAA genes of reference genome Chiifu and RcBr were focused and identified. Our study examines the scope of conservation and divergence of Aux/IAA genes and their structures in B. rapa. Analyzing the expression and structural variation between two parental lines will significantly contribute to functional genomics of Brassica crops and we belive our study would provide a foundation in understanding the Aux/IAA genes in B. rapa.	[Paul, Parameswari; Dhandapani, Vignesh; Rameneni, Jana Jeevan; Li, Xiaonan; Sivanandhan, Ganesan; Choi, Su Ryun; Pang, Wenxing; Im, Subin; Lim, Yong Pyo] Chungnam Natl Univ, Dept Hort, Mol Genet & Genom Lab, Daejeon 305764, South Korea	Chungnam National University	Lim, YP (corresponding author), Chungnam Natl Univ, Dept Hort, Mol Genet & Genom Lab, Daejeon 305764, South Korea.	yplim@cnu.ac.kr	Dhandapani, Vignesh/X-6677-2019; Pang, Wenxing/GLR-9367-2022; Paul, Parameswari/AAB-5707-2019; 최, 수련/AHE-1934-2022; Sivanandhan, Ganeshan/H-8864-2015	Dhandapani, Vignesh/0000-0002-5745-2409; Sivanandhan, Ganeshan/0000-0001-7917-2371	Golden Seed Project [213002-04-4-SBI30]; Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS)	Golden Seed Project; Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS)	This research was supported by the Golden Seed Project (No. 213002-04-4-SBI30), Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS).	ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; AINLEY WM, 1988, J BIOL CHEM, V263, P10658; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Cakir B, 2013, ACTA PHYSIOL PLANT, V35, P365, DOI 10.1007/s11738-012-1079-7; Dhandapani V, 2012, GENES GENOM, V34, P671, DOI 10.1007/s13258-012-0015-y; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P47, DOI 10.1007/s10142-005-0005-0; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P36, DOI 10.1007/s10142-005-0142-5; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Kang L, 2003, P NATL ACAD SCI USA, V100, P3519, DOI 10.1073/pnas.0637377100; Lee SC, 2008, MOL CELLS, V26, P595; Li SB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00119; Muto H, 2007, PLANT SIGNAL BEHAV, V2, P390, DOI 10.4161/psb.2.5.4264; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Ramchiary N, 2011, DNA RES, V18, P305, DOI 10.1093/dnares/dsr017; Rinaldi MA, 2012, PLANT MOL BIOL, V79, P359, DOI 10.1007/s11103-012-9917-y; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; WALKER JC, 1982, P NATL ACAD SCI-BIOL, V79, P7185, DOI 10.1073/pnas.79.23.7185; Wang SK, 2010, FUNCT INTEGR GENOMIC, V10, P533, DOI 10.1007/s10142-010-0174-3; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang YJ, 2010, MOL BIOL REP, V37, P3991, DOI 10.1007/s11033-010-0058-6; Wu J, 2012, MOL GENET GENOMICS, V287, P295, DOI 10.1007/s00438-012-0675-y	27	19	25	6	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151522	10.1371/journal.pone.0151522	http://dx.doi.org/10.1371/journal.pone.0151522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049520	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500008
J	Tabuchi, T; Colwell, B				Tabuchi, Takahiro; Colwell, Brian			Disparity and Trends in Secondhand Smoke Exposure among Japanese Employees, Particularly Smokers vs. Non-Smokers	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; AREAS	Background Monitoring disparities in secondhand smoke (SHS) exposure is important for tailoring smoke-free policies to the needs of different groups. We examined disparity and trends in SHS exposure among both nonsmokers and smokers at Japanese workplaces between 2002 and 2012. Methods A total of 32,940 employees in nationally representative, population-based, repeated cross-sectional surveys in 2002, 2007 and 2012 in Japan was analyzed. Adjusted rate ratios for workplace SHS exposure from other people ("everyday" and "everyday or sometimes") were calculated according to covariates, using log-binomial regression models with survey weights. In this survey, employees who do not smoke at workplace are defined as workplace-nonsmokers; and those smoke at workplace are used as workplace-smokers. SHS exposure for smokers does not involve their own SHS. Results While everyday SHS exposure prevalence in workplace-nonsmokers decreased markedly (33.2% to 11.4%), that in workplace-smokers decreased only slightly (63.3% to 55.6%). Workplace-smokers were significantly more likely to report everyday SHS exposure than workplace-nonsmokers, and the degree of association increased over time: compared with the nonsmokers (reference), covariates-adjusted rate ratio (95% confidence interval) for the smokers increased from 1.70 (1.62-1.77) in 2002 to 4.16 (3.79-4.56) in 2012. Similar results were observed for everyday or sometimes SHS exposure. Compared with complete workplace smoking bans, partial and no bans were consistently and significantly associated with high SHS exposure among both nonsmokers and smokers. We also observed disparities in SHS exposure by employee characteristics, such as age group and worksite scale. Conclusions Although overall SHS exposure decreased among Japanese employees between 2002 and 2012, the SHS exposure disparity between nonsmokers and smokers widened. Because smokers reported more frequent SHS exposure than nonsmokers, subsequent mortality due to SHS exposure may be higher in smokers than in nonsmokers. This information may be useful for advocating workplace smoke-free policies.	[Tabuchi, Takahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Osaka, Japan; [Colwell, Brian] Texas A&M Sch Publ Hlth, Dept Hlth Promot & Community Hlth Sci, College Stn, TX USA	Osaka Medical Center for Cancer & Cardiovascular Diseases; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Tabuchi, T (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Osaka, Japan.	tabuchitak@gmail.com	Colwell, Gregory Brian/E-2713-2018; Colwell, Brian/AAT-7009-2021; Matsuo, Keitaro/H-6758-2019	Colwell, Gregory Brian/0000-0002-9338-2778; Colwell, Brian/0000-0002-9338-2778; Matsuo, Keitaro/0000-0003-1761-6314; Tabuchi, Takahiro/0000-0002-1050-3125	Japan Agency for Medical Research and Development [27310201]; Ministry of Health, Labour and Welfare: Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus [H25-010]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare: Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus	This work was supported by the Japan Agency for Medical Research and Development (Grant number; 27310201) and the Ministry of Health, Labour and Welfare: Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus (Grant number; H25-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; Cains T, 2004, TOB CONTROL, V13, P17, DOI 10.1136/tc.2003.005488; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Chapman S, 2007, PUBLIC HEALTH ADVOCACY AND TOBACCO CONTROL: MAKING SMOKING HISTORY, P1, DOI 10.1002/9780470692479; Drope J, 2004, TOB CONTROL, V13, P41, DOI 10.1136/tc.2003.004101; Eriksen M, 2012, TOBACCO ATLAS; Eriksen M, 2015, THE TOBACCO ATLAS; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; International Agency for Research on Cancer, 2009, IARC HDB CANC PREV T, V13; Johansson A, 2005, ANN EPIDEMIOL, V15, P453, DOI 10.1016/j.annepidem.2004.09.012; Joossens L, 2014, TOBACCO CONTROL SCAL; Katanoda K, 2014, TOB CONTROL, V23, P359, DOI 10.1136/tobaccocontrol-2012-050852; Kungskulniti N, 2015, TOB CONTROL, V24, P532, DOI 10.1136/tobaccocontrol-2013-051313; Lai HK, 2009, PEDIATRICS, V124, P1306, DOI 10.1542/peds.2009-0669; Lam TH, 2005, TOB CONTROL, V14, P307, DOI 10.1136/tc.2005.011775; Lonergan BJ, 2014, NICOTINE TOB RES, V16, P1121, DOI 10.1093/ntr/ntu046; McNabola A, 2012, ENVIRON INT, V44, P68, DOI 10.1016/j.envint.2012.01.012; Murata Y, 2012, ENVIRONMENTAL RESEAR; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Piccardo MT, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-5; Pion M, 2004, TOB CONTROL, V13, P37, DOI 10.1136/tc.2003.005447; Reis MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102421; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Tabuchi T, 2015, NICOTINE TOB RES; Tabuchi T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/303917; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; World Health Organization, 2015, MPOWER; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152096	10.1371/journal.pone.0152096	http://dx.doi.org/10.1371/journal.pone.0152096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050819	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500023
J	Leehr, EJ; Schag, K; Brinkmann, A; Ehlis, AC; Fallgatter, AJ; Zipfel, S; Giel, KE; Dresler, T				Leehr, Elisabeth J.; Schag, Kathrin; Brinkmann, Amelie; Ehlis, Ann-Christine; Fallgatter, Andreas J.; Zipfel, Stephan; Giel, Katrin E.; Dresler, Thomas			Alleged Approach-Avoidance Conflict for Food Stimuli in Binge Eating Disorder	PLOS ONE			English	Article							FACIAL REACTIONS; ELECTROMYOGRAPHIC ACTIVITY; APPROACH BIAS; RESPONSES; CUES; EXPOSURE; OBESITY; PEOPLE; REWARD	Objective Food stimuli are omnipresent and naturally primary reinforcing stimuli. One explanation for the intake of high amounts of food in binge eating disorder (BED) is a deviant valuation process. Valuation of food stimuli is supposed to influence approach or avoidance behaviour towards food. Focusing on self-reported and indirect (facial electromyography) valuation process, motivational aspects in the processing of food stimuli were investigated. Methods We compared an overweight sample with BED (BED+) with an overweight sample without BED (BED-) and with normal weight controls (NWC) regarding their self-reported and indirect (via facial electromyography) valuation of food versus non-food stimuli. Results Regarding the self-reported valuation, the BED+ sample showed a significantly stronger food-bias compared to the BED-sample, as food stimuli were rated as significantly more positive than the non-food stimuli in the BED+ sample. This self-reported valuation pattern could not be displayed in the indirect valuation. Food stimuli evoked negative indirect valuation in all groups. The BED+ sample showed the plainest approach-avoidance conflict marked by a diverging self-reported (positive) and indirect (negative) valuation of food stimuli. Conclusions BED+ showed a deviant self-reported valuation of food as compared to BED-. The valuation process of the BED+ sample seems to be characterized by a motivational ambivalence. This ambivalence should be subject of further studies and may be of potential use for therapeutic interventions.	[Leehr, Elisabeth J.; Schag, Kathrin; Brinkmann, Amelie; Zipfel, Stephan; Giel, Katrin E.] Univ Hosp Tuebingen, Dept Psychosomat Med & Psychotherapy, Internal Med 6, Tubingen, Germany; [Ehlis, Ann-Christine; Fallgatter, Andreas J.; Dresler, Thomas] Univ Hosp Tuebingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Fallgatter, Andreas J.; Dresler, Thomas] Univ Tubingen, LEAD Grad Sch, Tubingen, Germany; [Giel, Katrin E.] Univ Heidelberg Hosp, Ctr Psychosocial Med, Dept Med & Psychosomat, Heidelberg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg	Leehr, EJ (corresponding author), Univ Hosp Tuebingen, Dept Psychosomat Med & Psychotherapy, Internal Med 6, Tubingen, Germany.	elisabeth.leehr@med.uni-tuebingen.de		Ehlis, Ann-Christine/0000-0002-8142-9743; Zipfel, Stephan/0000-0003-1659-4440	"Studienstiftung des deutschen Volkes"; Ministry of Science Baden-Wuerttemberg; European Social Fund; Athene programme; project of the Excellence Initiative of the German federal and state governments [GSC1028]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen; project of the Excellence Initiative of the German federal and state governments; LEAD graduate school	"Studienstiftung des deutschen Volkes"; Ministry of Science Baden-Wuerttemberg; European Social Fund(European Social Fund (ESF)); Athene programme; project of the Excellence Initiative of the German federal and state governments; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen; project of the Excellence Initiative of the German federal and state governments; LEAD graduate school	EJL receives a grant by the "Studienstiftung des deutschen Volkes" (https://www.studienstiftung.de/). There is no grant number. KEG receives a grant by the Ministry of Science Baden-Wuerttemberg and the European Social Fund and is partly supported by the Athene programme, a project of the Excellence Initiative of the German federal and state governments. TD was partly supported by the LEAD graduate school [GSC1028], a project of the Excellence Initiative of the German federal and state governments. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balodis IM, 2013, OBESITY, V21, P367, DOI 10.1002/oby.20068; Becker D, 2015, APPETITE, V85, P58, DOI 10.1016/j.appet.2014.11.017; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Blechert J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00617; Brockmeyer T, 2015, APPETITE, V95, P197, DOI 10.1016/j.appet.2015.07.013; Brockmeyer T, 2015, EUR EAT DISORD REV, V23, P352, DOI 10.1002/erv.2382; Brooks S, 2011, CLIN PSYCHOL REV, V31, P37, DOI 10.1016/j.cpr.2010.09.006; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Dalbert C., 1992, Z F R DIFFERENTIELLE, V13, P207; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; Dimberg U, 1997, J PSYCHOPHYSIOL, V11, P115; DIMBERG U, 1990, PSYCHOPHYSIOLOGY, V27, P481, DOI 10.1111/j.1469-8986.1990.tb01962.x; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; Drobes DJ, 2001, BIOL PSYCHOL, V57, P153, DOI 10.1016/S0301-0511(01)00093-X; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Friederich HC, 2006, PSYCHOL MED, V36, P1327, DOI 10.1017/S0033291706008129; Garcia-Garcia I, 2013, EUR EAT DISORD REV, V21, P89, DOI 10.1002/erv.2216; Geliebter A, 2006, APPETITE, V46, P31, DOI 10.1016/j.appet.2005.09.002; Giel KE, 2011, BIOL PSYCHIAT, V69, P661, DOI 10.1016/j.biopsych.2010.09.047; Giel KE, 2011, INT J EAT DISORDER, V44, P105, DOI 10.1002/eat.20785; Goschke T, 2014, INT J METH PSYCH RES, V23, P41, DOI 10.1002/mpr.1410; GRAND S, 1968, J EXP PSYCHOL, V77, P31, DOI 10.1037/h0025759; Hautzinger M., 2006, BECK DEPRESSIONSINVE; Hawk LW, 2004, APPETITE, V43, P285, DOI 10.1016/j.appet.2004.06.008; Hege M.A., 2014, INT J OBES LOND; Hilbert A, 2004, DIAGNOSTICA, V50, P98, DOI 10.1026/0012-1924.50.2.98; Karhunen LJ, 2000, PSYCHIAT RES-NEUROIM, V99, P29, DOI 10.1016/S0925-4927(00)00053-6; Kuhner C, 2007, NERVENARZT, V78, P651, DOI 10.1007/s00115-006-2098-7; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Meule A, 2012, APPETITE, V58, P88, DOI 10.1016/j.appet.2011.09.010; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Schag K, 2013, OBES REV, V14, P477, DOI 10.1111/obr.12017; Schag K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076542; Schienle A, 2009, BIOL PSYCHIAT, V65, P654, DOI 10.1016/j.biopsych.2008.09.028; Soussignan R, 2015, BIOL PSYCHOL, V104, P173, DOI 10.1016/j.biopsycho.2014.12.006; Svaldi J, 2014, INT J EAT DISORD; Svaldi J, 2010, APPETITE, V55, P685, DOI 10.1016/j.appet.2010.10.002; Treasure J, 2012, EUR EAT DISORD REV, V20, pe42, DOI 10.1002/erv.1090; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x; Weygandt M, 2012, HUM BRAIN MAPP, V33, P2135, DOI 10.1002/hbm.21345; Wittchen H., 1997, SKID 1 SKID 2 STRUKT	45	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152271	10.1371/journal.pone.0152271	http://dx.doi.org/10.1371/journal.pone.0152271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27045169	gold, Green Published, Green Submitted			2022-12-26	WOS:000373599600012
J	Wilson, DP				Wilson, David P.			Protruding Features of Viral Capsids Are Clustered on Icosahedral Great Circles	PLOS ONE			English	Article							X-RAY CRYSTALLOGRAPHY; STRUCTURAL TRANSITIONS; CRYSTAL-STRUCTURE; VIRUS; PROTEIN; PARTICLE; REVEALS	Spherical viruses are remarkably well characterized by the Triangulation (T) number developed by Casper and Klug. The T-number specifies how many viral capsid proteins are required to cover the virus, as well as how they are further subdivided into pentamer and hexamer subunits. The T-number however does not constrain the orientations of these proteins within the subunits or dictate where the proteins should place their protruding features. These protrusions often take the form of loops, spires and helices, and are significant because they aid in stability of the capsid as well as recognition by the host organism. Until now there has be no overall understanding of the placement of protrusions for spherical viruses, other than they have icosahedral symmetry. We constructed a set of gauge points based upon the work affine extensions of Keef and Twarock, which have fixed relative angular locations with which to measure the locations of these features. This work adds a new element to our understanding of the geometric arrangement of spherical viral capsid proteins; chiefly that the locations of protruding features are not found stochastically distributed in an icosahedral manner across the viral surface, but instead these features are found only in specific locations along the 15 icosahedral great circles. We have found that this result holds true as the T number and viral capsids size increases, suggesting an underlying geometric constraint on their locations. This is in spite of the fact that the constraints on the pentamers and hexamer orientations change as a function of T-number, as you need to accommodate more hexamers in the same solid angle between pentamers. The existence of this angular constraint of viral capsids suggests that there is a fitness or energetic benefit to the virus placing its protrusions in this manner. This discovery may have profound impacts on identifying and eliminating viral pathogens, understanding evolutionary constraints as well as bioengineering for capsid drug delivery systems. This result also suggests that in addition to biochemical attachment restrictions, there are additional geometric constraints that should be adhered to when modifying protein capsids.	[Wilson, David P.] Albion Coll, Dept Phys, 611 E Porter St, Albion, MI 49224 USA	Albion College	Wilson, DP (corresponding author), Albion Coll, Dept Phys, 611 E Porter St, Albion, MI 49224 USA.	davewilson13@gmail.com						Bourne CR, 2006, J VIROL, V80, P11055, DOI 10.1128/JVI.00933-06; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; Caspar DLD, 1962, S QUANTITATIVE BIOL, V27, DOI [10.1101/SQB.1962.027.001.005, DOI 10.1101/SQB.1962.027.001.005]; DUDA RL, 1995, J MOL BIOL, V247, P618, DOI 10.1016/S0022-2836(05)80143-3; Gan L, 2006, STRUCTURE, V14, P1655, DOI 10.1016/j.str.2006.09.006; Gipson P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5278; GOLMOHAMMADI R, 1993, J MOL BIOL, V234, P620, DOI 10.1006/jmbi.1993.1616; Hubert H, 1998, NATURE, V391, P376, DOI 10.1038/34885; Janner A, 2013, ACTA CRYSTALLOGR A, V69, P151, DOI 10.1107/S0108767312047162; Keef T, 2009, J MATH BIOL, V59, P287, DOI 10.1007/s00285-008-0228-5; Keef T, 2013, ACTA CRYSTALLOGR A, V69, P140, DOI 10.1107/S0108767312047150; Larson SB, 1998, J MOL BIOL, V277, P37, DOI 10.1006/jmbi.1997.1570; Liepold LO, 2005, PHYS BIOL, V2, pS166, DOI 10.1088/1478-3975/2/4/S11; Liu HJ, 2003, J STRUCT BIOL, V142, P356, DOI 10.1016/S1047-8477(03)00028-5; Luque D, 2010, J VIROL, V84, P7256, DOI 10.1128/JVI.00432-10; May ER, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.188101; Munshi S, 1996, J MOL BIOL, V261, P1, DOI 10.1006/jmbi.1996.0437; Naitow H, 2002, NAT STRUCT BIOL, V9, P725, DOI 10.1038/nsb844; OLSON AJ, 1983, J MOL BIOL, V171, P61, DOI 10.1016/S0022-2836(83)80314-3; Perotti La, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.058101; Raupp C, 2012, J VIROL, V86, P9396, DOI 10.1128/JVI.00209-12; SALFELD J, 1989, J VIROL, V63, P798, DOI 10.1128/JVI.63.2.798-808.1989; SALLBERG M, 1991, J MED VIROL, V33, P248, DOI 10.1002/jmv.1890330407; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; Speir JA, 2012, CRYSTAL STRUCT UNPUB; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Szolajska E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046075; Tama F, 2002, J MOL BIOL, V318, P733, DOI 10.1016/S0022-2836(02)00135-3; Tang L, 2001, NAT STRUCT BIOL, V8, P77, DOI 10.1038/83089; Tars K, 1997, J MOL BIOL, V271, P759, DOI 10.1006/jmbi.1997.1214; Venkataraman S, 2008, STRUCTURE, V16, P1555, DOI 10.1016/j.str.2008.07.013; Wardman JP, 2012, THESIS U; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152319	10.1371/journal.pone.0152319	http://dx.doi.org/10.1371/journal.pone.0152319			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045511	Green Published, Green Submitted, gold			2022-12-26	WOS:000373599600015
J	Cauquil, L; Hue, T; Hurlin, JC; Mitchell, G; Searle, K; Skuce, P; Zadoks, R				Cauquil, Laura; Huee, Thomas; Hurlin, Jean-Claude; Mitchell, Gillian; Searle, Kate; Skuce, Philip; Zadoks, Ruth			Prevalence and Sequence-Based Identity of Rumen Fluke in Cattle and Deer in New Caledonia	PLOS ONE			English	Article							CALICOPHORON-DAUBNEYI; PARAMPHISTOMOSIS; BOVINE; INTENSITY; ABATTOIR; DNA	An abattoir survey was performed in the French Melanesian archipelago of New Caledonia to determine the prevalence of paramphistomes in cattle and deer and to generate material for molecular typing at species and subspecies level. Prevalence in adult cattle was high at animal level (70% of 387 adult cattle) and batch level (81%). Prevalence was lower in calves at both levels (33% of 484 calves, 51% at batch level). Animals from 2 of 7 deer farms were positive for rumen fluke, with animal-level prevalence of 41.4%(29/70) and 47.1%(33/70), respectively. Using ITS-2 sequencing, 3 species of paramphistomes were identified, i.e. Calicophoron calicophorum, Fischoederius elongatus and Orthocoelium streptocoelium. All three species were detected in cattle as well as deer, suggesting the possibility of rumen fluke transmission between the two host species. Based on heterogeneity in ITS-2 sequences, the C. calicophorum population comprises two clades, both of which occur in cattle as well as deer. The results suggest two distinct routes of rumen fluke introduction into this area. This approach has wider applicability for investigations of the origin of rumen fluke infections and for the possibility of parasite transmission at the livestock-wildlife interface.	[Cauquil, Laura; Huee, Thomas; Hurlin, Jean-Claude] Inst Agron Neocaledonien Connaissance & Ameliorat, Lab Parasitol, BP 73, Paita 98890, Nouvelle Caledo, New Caledonia; [Mitchell, Gillian; Skuce, Philip; Zadoks, Ruth] Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland; [Searle, Kate] Ctr Ecol & Hydrol, Bush Estate, Penicuik EH26 0QB, Midlothian, Scotland; [Zadoks, Ruth] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G61 1QH, Lanark, Scotland	Moredun Research Institute; UK Centre for Ecology & Hydrology (UKCEH); University of Glasgow	Skuce, P (corresponding author), Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland.	philip.skuce@moredun.ac.uk	; Searle, Kate/F-4922-2011	Zadoks, Ruth/0000-0002-1164-8000; Searle, Kate/0000-0003-4624-9023	Biotechnological and Biological Sciences Research Council Industrial Partnership Award [BBSRC-IPA BB/K015591/1]; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); BBSRC [BB/K015230/1, BB/K015346/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K015346/1, BB/K015230/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Biotechnological and Biological Sciences Research Council Industrial Partnership Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors would like to acknowledge financial support from the Biotechnological and Biological Sciences Research Council Industrial Partnership Award (BBSRC-IPA BB/K015591/1; KS) and the Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS; GM, PJS and RNZ).; The authors would like to thank the agents of the Office de Commercialisation et d'Entreposage Frigorifique for permission to sample at the abattoir. We would also like to acknowledge financial support from the Biotechnological and Biological Sciences Research Council Industrial Partnership Award (BBSRC-IPA BB/K015591/1; KS) and the Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS; GM, PJS and RNZ).	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bunza MDA., 2008, NIGERIAN J BASIC APP, V16, P287; Ferreras MC, 2014, VET PARASITOL, V199, P268, DOI 10.1016/j.vetpar.2013.10.019; Desvals M, 1993, SCI TECH REV OFFICE, V12, P171; Dube S, 2010, ZIMB J SCI TECH, V5, P12; EDUARDO S L, 1980, Systematic Parasitology, V1, P203, DOI 10.1007/BF00009846; Euzeby J, 2008, GRAND DICT ILLUSTRE; Franc A., 1953, MEMOIRES MUSEUM NATL, V13, P1; Gonzalez-Warleta M, 2013, VET PARASITOL, V191, P252, DOI 10.1016/j.vetpar.2012.09.006; Gordon DK, 2013, VET PARASITOL, V195, P65, DOI 10.1016/j.vetpar.2013.01.014; HORAK IVAN GERARD, 1967, ONDERSTE POORT J VET RES, V34, P451; Itagaki T, 2003, J VET MED SCI, V65, P931, DOI 10.1292/jvms.65.931; KELLY J D, 1973, Tropical Animal Health and Production, V5, P192, DOI 10.1007/BF02251389; Loock N., 2003, THESIS ECOLE NATL VE; Malrait K, 2015, VET PARASITOL, V207, P134, DOI 10.1016/j.vetpar.2014.10.033; Martinez-Ibeas AM, 2013, VET PARASITOL, V195, P57, DOI 10.1016/j.vetpar.2012.12.048; Mason C, 2012, VET REC, V170, DOI 10.1136/vr.e2368; McCann CM, 2010, VET REC, V166, P612, DOI 10.1136/vr.b4836; Millar M, 2012, VET REC, V171, DOI 10.1136/vr.e7738; O'Toole A, 2014, PARASITOL RES, V113, P4097, DOI 10.1007/s00436-014-4078-3; Prasitirat P., 1997, PARASITOL HUNG, V29-30, P27; Rangel-Ruiz LJ, 2003, VET PARASITOL, V116, P217, DOI 10.1016/j.vetpar.2003.07.002; Raza MA, 2009, PAK VET J, V29, P214; Rinaldi L, 2005, VET PARASITOL, V131, P247, DOI 10.1016/j.vetpar.2005.04.035; ROBERTS F. H. S., 1939, JOUR COMP PATH AND THERAP, V52, P160, DOI 10.1016/S0368-1742(39)80015-7; ROLFE PF, 1987, AUST VET J, V64, P328, DOI 10.1111/j.1751-0813.1987.tb06060.x; ROLFE PF, 1991, INT J PARASITOL, V21, P813, DOI 10.1016/0020-7519(91)90150-6; Serrano M., 1984, THESIS U PHILIPPINES; Shylla JA, 2011, PARASITOL RES, V108, P1027, DOI 10.1007/s00436-010-2148-8; Sintayehu Melaku, 2012, Global Veterinaria, V8, P315; Spence SA, 1996, AUST VET J, V74, P456, DOI 10.1111/j.1751-0813.1996.tb07569.x; Sripalwit P, 2007, EXP PARASITOL, V115, P98, DOI 10.1016/j.exppara.2006.05.005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor MA, VET PARASITOLOGY, P53; Titi A, 2014, PARASITE, V21, DOI 10.1051/parasite/2014041; Toolan DP, 2015, VET PARASITOL, V212, P168, DOI 10.1016/j.vetpar.2015.07.040; Vaidyanathan S. N., 1941, INDIAN JOUR VET SCI AND ANIMAL HUSBANDRY, V11, P243; Zintl A, 2014, VET PARASITOL, V204, P199, DOI 10.1016/j.vetpar.2014.05.024	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152603	10.1371/journal.pone.0152603	http://dx.doi.org/10.1371/journal.pone.0152603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043709	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000373592100019
J	Kwon, J; Jeong, SM; Choi, I; Kim, NH				Kwon, Jeongwoo; Jeong, Sung-min; Choi, Inchul; Kim, Nam-Hyung			ADAM10 Is Involved in Cell Junction Assembly in Early Porcine Embryo Development	PLOS ONE			English	Article							BRAIN MYELIN MEMBRANES; MOLECULE-LIKE PROTEIN; E-CADHERIN; ADENOVIRUS RECEPTOR; TIGHT JUNCTIONS; TRANSENDOTHELIAL MIGRATION; CRYSTAL-STRUCTURES; BETA-CATENIN; ADHESION; ARCHITECTURE	ADAM10 (A Disintegrin and Metalloprotease domain-containing protein 10) is a cell surface protein with a unique structure possessing both potential adhesion and protease domains. However, the role of ADAM10 in preimplantation stage embryos is not clear. In this study, we examined the expression patterns and functional roles of ADAM10 in porcine parthenotes during preimplantation development. The transcription level of ADAM10 dramatically increased from the morula stage onward. Immunostaining revealed that ADAM10 was present in both the nucleus and cytoplasm in early cleavage stage embryos, and localized to the apical region of the outer cells in morula and blastocyst embryos. Knockdown (KD) of ADAM10 using double strand RNA did not alter preimplantation embryo development until morula stage, but resulted in significantly reduced development to blastocyst stage. Moreover, the KD blastocyst showed a decrease in gene expression of adherens and tight junction (AJ/TJ), and an increase in trophectoderm TJ permeability by disrupting TJ assembly. Treatment with an ADAM10 specific chemical inhibitor, GI254023X, at the morula stage also inhibited blastocyst development and led to disruption of TJ assembly. An in situ proximity ligation assay demonstrated direct interaction of ADAM10 with coxsackie virus and adenovirus receptor (CXADR), supporting the involvement of ADAM10 in TJ assembly. In conclusion, our findings strongly suggest that ADADM10 is important for blastocyst formation rather than compaction, particularly for TJ assembly and stabilization in preimplantation porcine parthenogenetic development.	[Kwon, Jeongwoo; Jeong, Sung-min; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungcheongbuk, South Korea; [Choi, Inchul] Chungnam Natl Univ, Coll Agr & Life Sci, Dept Anim & Dairy Sci, Daejeon 34134, South Korea	Chungbuk National University; Chungnam National University	Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungcheongbuk, South Korea.; Choi, I (corresponding author), Chungnam Natl Univ, Coll Agr & Life Sci, Dept Anim & Dairy Sci, Daejeon 34134, South Korea.	icchoi@cnu.ac.kr; nhkim@chungbuk.ac.kr	Choi, Inchul/AAF-6264-2021	Choi, Inchul/0000-0001-5011-2658	Next-Generation BioGreen21 Program (CABX) [PJ011213, PJ011126]; Rural Development Administration (RDA); Republic of Korea	Next-Generation BioGreen21 Program (CABX); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Republic of Korea	Next-Generation BioGreen21 Program (CABX, Project No. PJ011213 to IC, and PJ011126 to NHK), Rural Development Administration (RDA), Republic of Korea http://www.rda.go.kr/foreign/eng/.	Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; CHANTRY A, 1990, BIOCHEM J, V268, P245, DOI 10.1042/bj2680245; CHANTRY A, 1989, J BIOL CHEM, V264, P21603; Choi Inchul, 2012, Development, V139, P4623, DOI 10.1242/dev.086645; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Ebsen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102899; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fernandez-Borja M, 2010, CARDIOVASC RES, V86, P202, DOI 10.1093/cvr/cvq003; Garrido-Urbani S, 2014, CELL TISSUE RES, V355, P701, DOI 10.1007/s00441-014-1820-1; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Groot AJ, 2012, ADV EXP MED BIOL, V727, P15, DOI 10.1007/978-1-4614-0899-4_2; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guo YL, 2009, ARTERIOSCL THROM VAS, V29, P75, DOI 10.1161/ATVBAHA.108.177717; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Houri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073296; Igarashi T, 2007, FEBS LETT, V581, P2416, DOI 10.1016/j.febslet.2007.04.057; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Ito K, 1999, ONCOGENE, V18, P7080, DOI 10.1038/sj.onc.1203191; Jo YJ, 2015, J CELL SCI, V128, P160, DOI 10.1242/jcs.163576; Kleino I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121301; Krivega M, 2014, REPRODUCTION, V148, P531, DOI 10.1530/REP-14-0253; Kwon JW, 2016, REPRODUCTION, V151, P297, DOI 10.1530/REP-15-0397; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Lunn CA, 1997, FEBS LETT, V400, P333, DOI 10.1016/S0014-5793(96)01410-X; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Michta ML, 2010, J VIROL, V84, P11696, DOI 10.1128/JVI.01555-10; Morton PE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02889; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Noy PJ, 2016, J BIOL CHEM, V291, P3145, DOI 10.1074/jbc.M115.703058; Powers ME, 2012, J INFECT DIS, V206, P352, DOI 10.1093/infdis/jis192; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	41	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152921	10.1371/journal.pone.0152921	http://dx.doi.org/10.1371/journal.pone.0152921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043020	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100047
J	Yang, Y; Huycke, MM; Herman, TS; Wang, X				Yang, Y.; Huycke, M. M.; Herman, T. S.; Wang, X.			Glutathione S-transferase alpha 4 induction by activator protein 1 in colorectal cancer	ONCOGENE			English	Article							FAECALIS-INFECTED MACROPHAGES; TRANSCRIPTION FACTOR; C-JUN; OXIDATIVE STRESS; CELL-LINES; GENETIC-POLYMORPHISM; SIGNALING PATHWAY; EPITHELIAL-CELLS; RESPONSE ELEMENT; HUMAN TISSUES	Glutathione S-transferase alpha 4 (GSTA4) is a phase II detoxifying enzyme that metabolizes electrophiles and carcinogens including 4-hydroxy-2-nonenal (4-HNE), an endogenous carcinogen that contributes to colorectal carcinogenesis. In this study, we investigated GSTA4 expression and regulation in murine primary colonic epithelial cells, microbiome-driven murine colitis and human carcinomas. Exposure of YAMC cells to 4-HNE induced Gsta4 expression. Using an inflammation-associated model of colorectal cancer (CRC), Gsta4 expression increased in vivo in colon macrophages and serum after 2 weeks of colonization of IL-10 deficient (Il10(-/-)) mice with Enterococcus faecalis. Increased expression was noted after 9 months of colonization in colon macrophages and epithelia in areas of inflammation. In human colon biopsies, immunohistochemistry showed no GSTA4 expression in normal epithelial cells, whereas GSTA4 was strongly expressed in the neoplastic epithelia of invasive carcinomas. For tubular adenomas, increased expression was primarily noted in stromal macrophages. Increased GSTA4 was confirmed in established human CRC cell lines and associated with 4-HNE-protein adducts in human colon adenomas and CRC. Next, we showed that 4-HNE induced activation of c-Jun and Nrf2, two components of the oncogenic transcription factor AP-1. AP-1 inhibitors and gene-specific small interfering RNAs partially suppressed GSTA4 expression. Co-immunoprecipitation confirmed interactions between c-Jun and Nrf2 supporting a role for AP-1 in regulating 4-HNE-induced GSTA4 expression. These findings demonstrate GSTA4 activation during 4-HNE-induced neoplastic transformation in colorectal carcinogenesis. GSTA4 is a potential surrogate biomarker for CRC screening and should provide novel approaches for chemoprevention.	[Yang, Y.; Herman, T. S.; Wang, X.] Univ Oklahoma, Hlth Sci Ctr, Dept Radiat Oncol, Oklahoma City, OK USA; [Yang, Y.; Huycke, M. M.; Wang, X.] Oklahoma City VA Hlth Care Syst, Muchmore Labs Infect Dis Res, Oklahoma City, OK USA; [Huycke, M. M.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Wang, X (corresponding author), Univ Oklahoma, Dept Radiat Oncol, Hlth Sci Ctr, VA Med Ctr, 921 NE 13th St,Room 3R-109, Oklahoma City, OK 73104 USA.	xingmin-wang@ouhsc.edu	Huycke, Mark M./AAG-9384-2020; Wang, Xingmin/GOV-6306-2022	Huycke, Mark/0000-0002-6110-5629	Oklahoma Center for the Advancement of Science and Technology [HR10-032]; Francis Duffy Endowment	Oklahoma Center for the Advancement of Science and Technology; Francis Duffy Endowment	We thank Jim Henthorn in the Flow Cytometry and Imaging Laboratory, the Histology and Immunohistochemistry Core in the Peggy and Charles Stephenson Cancer Center (NIH GM103639) at the University of Oklahoma Health Sciences Center for technical assistance. Supported in part by Oklahoma Center for the Advancement of Science and Technology grant HR10-032 (XW) and Francis Duffy Endowment.	Abel EL, 2010, JNCI-J NATL CANCER I, V102, P1663, DOI 10.1093/jnci/djq392; Apidianakis Y, 2012, FASEB J, V26, P730, DOI 10.1096/fj.11-192484; Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Bakuradze T, 2010, MOL NUTR FOOD RES, V54, P1734, DOI 10.1002/mnfr.201000147; Barrera G, 2004, FREE RADICAL BIO MED, V37, P597, DOI 10.1016/j.freeradbiomed.2004.05.023; Chaudhary P, 2013, J BIOL CHEM, V288, P20532, DOI 10.1074/jbc.M113.467662; Cheng JZ, 2001, BIOCHEM BIOPH RES CO, V282, P1268, DOI 10.1006/bbrc.2001.4707; Coles BF, 2005, METHOD ENZYMOL, V401, P9, DOI 10.1016/S0076-6879(05)01002-5; Dang DT, 2005, CANCER RES, V65, P9485, DOI 10.1158/0008-5472.CAN-05-1930; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Desmots F, 2005, FEBS LETT, V579, P5691, DOI 10.1016/j.febslet.2005.08.088; Desmots F, 2001, J HISTOCHEM CYTOCHEM, V49, P1573, DOI 10.1177/002215540104901211; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; Edalat M, 2004, HISTOCHEM CELL BIOL, V122, P151, DOI 10.1007/s00418-004-0688-7; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Engle MR, 2004, TOXICOL APPL PHARM, V194, P296, DOI 10.1016/j.taap.2003.10.001; Feng ZH, 2004, P NATL ACAD SCI USA, V101, P8598, DOI 10.1073/pnas.0402794101; Fontana MF, 2015, J IMMUNOL, V194, P177, DOI 10.4049/jimmunol.1401595; Giera S, 2010, TOXICOL SCI, V115, P22, DOI 10.1093/toxsci/kfq033; Hasselblatt P, 2008, ONCOGENE, V27, P6102, DOI 10.1038/onc.2008.211; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Johns LE, 2000, MUTAGENESIS, V15, P399, DOI 10.1093/mutage/15.5.399; Kalinina EV, 2012, B EXP BIOL MED+, V154, P64, DOI 10.1007/s10517-012-1876-4; Kumagai T, 2004, J BIOL CHEM, V279, P48389, DOI 10.1074/jbc.M409935200; Levy S, 2009, FREE RADICAL BIO MED, V47, P1172, DOI 10.1016/j.freeradbiomed.2009.07.036; Matsumura T, 2013, FASEB J, V27, P3198, DOI 10.1096/fj.12-222745; Miller DP, 2003, EPIDEMIOLOGY, V14, P545, DOI 10.1097/01.ede.0000073120.46981.24; Mitrunen K, 2001, CANCER EPIDEM BIOMAR, V10, P229; Miyanishi K, 2001, GASTROENTEROLOGY, V121, P865, DOI 10.1053/gast.2001.27982; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nobuoka A, 2004, GASTROENTEROLOGY, V127, P428, DOI 10.1053/j.gastro.2004.05.021; Nomani H, 2005, CLIN BIOCHEM, V38, P621, DOI 10.1016/j.clinbiochem.2005.04.004; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Ritchie KJ, 2009, P NATL ACAD SCI USA, V106, P20859, DOI 10.1073/pnas.0911351106; Sawers L, 2014, BRIT J CANCER, V111, P1150, DOI 10.1038/bjc.2014.386; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; Searchfield L, 2011, HISTOPATHOLOGY, V58, P180, DOI 10.1111/j.1365-2559.2010.03733.x; Sharma A, 2008, ARCH BIOCHEM BIOPHYS, V480, P85, DOI 10.1016/j.abb.2008.09.016; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Shimizu T, 2010, CANCER SCI, V101, P1093, DOI 10.1111/j.1349-7006.2010.01508.x; Shireman LM, 2010, ARCH BIOCHEM BIOPHYS, V504, P182, DOI 10.1016/j.abb.2010.09.005; Sirota R, 2015, REDOX BIOL, V4, P48, DOI 10.1016/j.redox.2014.11.012; Sweeney C, 2002, TOXICOLOGY, V181, P83, DOI 10.1016/S0300-483X(02)00259-7; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Wang XM, 2015, GUT, V64, P459, DOI 10.1136/gutjnl-2014-307213; Wang XM, 2013, CANCER PREV RES, V6, P206, DOI 10.1158/1940-6207.CAPR-12-0350; Wang XM, 2012, GASTROENTEROLOGY, V142, P543, DOI 10.1053/j.gastro.2011.11.020; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; West JD, 2005, CHEM RES TOXICOL, V18, P1642, DOI 10.1021/tx050211n; Yang YH, 2013, TRANSL ONCOL, V6, P596, DOI 10.1593/tlo.13412; Zarrouki B, 2007, FEBS LETT, V581, P2394, DOI 10.1016/j.febslet.2007.04.048; ZHONG S, 1993, CARCINOGENESIS, V14, P1821, DOI 10.1093/carcin/14.9.1821	55	15	15	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 3	2016	35	44					5795	5806		10.1038/onc.2016.113	http://dx.doi.org/10.1038/onc.2016.113			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XQ	27065323	Green Accepted			2022-12-26	WOS:000386998400010
J	Wu, J; Lu, M; Li, Y; Shang, YK; Wang, SJ; Meng, Y; Wang, Z; Li, ZS; Chen, H; Chen, ZN; Bian, H				Wu, J.; Lu, M.; Li, Y.; Shang, Y-K; Wang, S-J; Meng, Y.; Wang, Z.; Li, Z-S; Chen, H.; Chen, Z-N; Bian, H.			Regulation of a TGF-beta 1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; TUMOR-INITIATING CELLS; CANCER STEM-CELLS; CELLULAR PLASTICITY; CLONAL EVOLUTION; EMT/MET DYNAMICS; PROMOTES; DEDIFFERENTIATION; METASTASIS	Cellular plasticity has an important role in the progression of hepatocellular carcinoma (HCC). In this study, the involvement of a TGF-beta 1-CD147 self-sustaining network in the regulation of the dedifferentiation progress was fully explored in HCC cell lines, hepatocyte-specific basigin/CD147-knockout mice and human HCC tissues. We demonstrated that TGF-beta 1 stimulation upregulated CD147 expression and mediated the dedifferentiation of HCC cells, whereas all-trans-retinoic acid induced the downregulation of CD147 and promoted differentiation in HCC cells. Overexpression of CD147 induced the dedifferentiation and enhanced the malignancy of HCC cells, and increased the transcriptional expression of TGF-beta 1 by activating beta-catenin. CD147-induced matrix metalloproteinase (MMP) production activated pro-TGF-beta 1. The activated TGF-beta 1 signaling subsequently repressed the HNF4a expression via Smad-Snail1 signaling and enhanced the dedifferentiation progress. Hepatocyte-specific basigin/CD147-knockout mice decreased the susceptibility to N-nitrosodiethylamine-induced tumorigenesis by suppressing TGF-beta 1-CD147 signaling and inhibiting dedifferentiation in hepatocytes during tumor progression. CD147 was positively correlated with TGF-beta 1 and negatively correlated with HNF4a in human HCC tissues. Positive CD147 staining and lower HNF4a levels in tumor tissues were significantly associated with poor survival of patients with HCC. The overexpression of HNF4a and Smad7 and the deletion of CD147 by lentiviral vectors jointly reprogrammed the expression profile of hepatocyte markers and attenuated malignant properties including proliferation, cell survival and tumor growth of HCC cells. Our results highlight the important role of the TGF-beta 1-CD147 self-sustaining network in driving HCC development by regulating differentiation plasticity, which provides a strong basis for further investigations of the differentiation therapy of HCC targeting TGF-beta 1 and CD147.	[Wu, J.; Lu, M.; Shang, Y-K; Wang, S-J; Meng, Y.; Chen, Z-N; Bian, H.] Fourth Mil Med Univ, Cell Engn Res Ctr, State Key Lab Canc Biol, Dept Cell Biol, 169,Changle West Rd, Xian 710032, Shaanxi, Peoples R China; [Li, Y.] PLA 323 Hosp, Dept Oncol, Xian, Peoples R China; [Wang, Z.; Li, Z-S] Fourth Mil Med Univ, Dept Pathol, Xian, Peoples R China; [Chen, H.] Peking Univ, Canc Hosp, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Peking University	Chen, ZN; Bian, H (corresponding author), Fourth Mil Med Univ, Cell Engn Res Ctr, State Key Lab Canc Biol, Dept Cell Biol, 169,Changle West Rd, Xian 710032, Shaanxi, Peoples R China.	znchen@fmmu.edu.cn; hjbian@fmmu.edu.cn		Chen, Zhi-Nan/0000-0001-5512-4623	National Natural Science Foundation of China [31401222, 31571434, 31401190, 81172144]; National Science and Technology Major Project [2012ZX10002-015, 2012AA020806, 2015CB553701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project	We thank professor Mien-Chie Hung (Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA) for providing pEGFP-Snail1, and we thank professor Ye-Guang Chen (School of Life Science, Tsinghua University) for providing pcDNA-Flag-Smad7. This work was supported by grants from the National Natural Science Foundation of China (No. 31401222, 31571434, 31401190 and 81172144) and the National Science and Technology Major Project (No. 2012ZX10002-015, 2012AA020806 and 2015CB553701).	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Ber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030759; Bitting RL, 2014, CANCER METAST REV, V33, P441, DOI 10.1007/s10555-013-9483-z; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Chui MH, 2013, INT J CANCER, V132, P1487, DOI 10.1002/ijc.27745; Cicchini C, 2015, BBA-GENE REGUL MECH, V1849, P919, DOI 10.1016/j.bbagrm.2015.05.005; Cicchini C, 2015, LIVER INT, V35, P302, DOI 10.1111/liv.12577; Cozzolino AM, 2013, J HEPATOL, V58, P65, DOI 10.1016/j.jhep.2012.08.023; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033; Erez N, 2013, NATURE, V500, P37, DOI 10.1038/nature12459; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243; Giannelli G, 2011, BBA-REV CANCER, V1815, P214, DOI 10.1016/j.bbcan.2010.11.004; Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grusch M, 2010, CURR CANCER DRUG TAR, V10, P849, DOI 10.2174/156800910793357943; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Janiszewska M, 2015, CELL STEM CELL, V16, P11, DOI 10.1016/j.stem.2014.12.011; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khayati F, 2015, ONCOTARGET, V6, P9766, DOI 10.18632/oncotarget.2870; Kim SC, 2014, HEPATOLOGY, V59, P1750, DOI 10.1002/hep.26699; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Liu Y, 2015, ONCOGENE, V34, P5524, DOI 10.1038/onc.2015.7; Lu M, 2015, J MOL HISTOL, V46, P79, DOI 10.1007/s10735-014-9602-3; Makarova-Rusher OV, 2015, J HEPATOL, V62, P1420, DOI 10.1016/j.jhep.2015.02.038; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Meyer C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.204; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Pisco AO, 2015, BRIT J CANCER, V112, P1725, DOI 10.1038/bjc.2015.146; Salomao M, 2012, DIAGN HISTOPATHOL, V18, P37; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Sidhu SS, 2010, ONCOGENE, V29, P4145, DOI 10.1038/onc.2010.166; Sun BC, 2008, CELL CYCLE, V7, P934, DOI 10.4161/cc.7.7.5622; Suzuki T, 2002, J GASTROEN HEPATOL, V17, P994, DOI 10.1046/j.1440-1746.2002.02774.x; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tang J, 2012, CELL DEATH DIFFER, V19, P1779, DOI 10.1038/cdd.2012.60; Tschaharganeh DF, 2014, CELL, V158, P579, DOI 10.1016/j.cell.2014.05.051; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; Varga J, 2014, FEBS LETT, V588, P2422, DOI 10.1016/j.febslet.2014.06.019; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Wei Q, 2016, ONCOGENE, V35, P2655, DOI 10.1038/onc.2015.328; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149; Wu K, 2012, HEPATOLOGY, V56, P2255, DOI 10.1002/hep.26007; Yao H, 2014, INT J BIOL SCI, V10, P43, DOI 10.7150/ijbs.6818; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; Zeng X, 2011, HEPATOLOGY, V54, P2036, DOI 10.1002/hep.24647; Zhang HX, 2013, STEM CELLS, V31, P433, DOI 10.1002/stem.1298; Zhang Y, 2013, J HEPATOL, V59, P1255, DOI 10.1016/j.jhep.2013.07.009; Zhao P, 2011, HEPATOLOGY, V54, P2012, DOI 10.1002/hep.24592; Zhu D, 2015, NAT MED, V21, P572, DOI 10.1038/nm.3867; Zulehner G, 2010, AM J PATHOL, V176, P472, DOI 10.2353/ajpath.2010.090300	56	26	26	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 20	2016	35	42					5468	5479		10.1038/onc.2016.89	http://dx.doi.org/10.1038/onc.2016.89			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XO	27041581				2022-12-26	WOS:000386998200002
J	Mao, X; Gauche, C; Coughtrie, MWH; Bui, C; Gulberti, S; Merhi-Soussi, F; Ramalanjaona, N; Bertin-Jung, I; Diot, A; Dumas, D; Caires, ND; Thompson, AM; Bourdon, JC; Ouzzine, M; Fournel-Gigleux, S				Mao, X.; Gauche, C.; Coughtrie, M. W. H.; Bui, C.; Gulberti, S.; Merhi-Soussi, F.; Ramalanjaona, N.; Bertin-Jung, I.; Diot, A.; Dumas, D.; Caires, N. De Freitas; Thompson, A. M.; Bourdon, J-C; Ouzzine, M.; Fournel-Gigleux, S.			The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer	ONCOGENE			English	Article							FIBROBLAST-GROWTH-FACTOR; EXPRESSION; RECEPTOR; CELLS; PROTEOGLYCANS; METHYLATION; MAMMARY; HYPERMETHYLATION; BIOSYNTHESIS; SPECIFICITY	Heparan sulfate (HS) proteoglycan chains are key components of the breast tumor microenvironment that critically influence the behavior of cancer cells. It is established that abnormal synthesis and processing of HS play a prominent role in tumorigenesis, albeit mechanisms remain mostly obscure. HS function is mainly controlled by sulfotransferases, and here we report a novel cellular and pathophysiological significance for the 3-O-sulfotransferase 3-OST3A (HS3ST3A), catalyzing the final maturation step of HS, in breast cancer. We show that 3-OST3A is epigenetically repressed in all breast cancer cell lines of a panel representative of distinct molecular subgroups, except in human epidermal growth factor receptor 2-positive (HER2+) sloan-kettering breast cancer (SKBR3) cells. Epigenetic mechanisms involved both DNA methylation and histone modifications, producing different repressive chromatin environments depending on the cell molecular signature. Gain and loss of function experiments by cDNA and siRNA transfection revealed profound effects of 3-OST3A expression on cell behavior including apoptosis, proliferation, response to trastuzumab in vitro and tumor growth in xenografted mice. 3-OST3A exerted dual activities acting as tumor-suppressor in lumA-michigan cancer foundation (MCF)-7 and triple negative-MD Anderson (MDA) metastatic breast (MB)-231 cells, or as an oncogenic factor in HER2+-SKBR3 cells. Mechanistically, fluorescence-resonance energy transfer-fluorescence-lifetime imaging microscopy experiments indicated that the effects of 3-OST3A in MCF-7 cells were mediated by altered interactions between HS and fibroblast growth factor-7 (FGF-7). Further, this interplay between HS and FGF-7 modulated downstream ERK, AKT and p38 cascades, suggesting that altering 3-O-sulfation affects FGFR2IIIb-mediated signaling. Corroborating our cellular data, a clinical study conducted in a cohort of breast cancer patients uncovered that, in HER2+ patients, high level expression of 3-OST3A in tumors was associated with reduced relapse-free survival. Our findings define 3-OST3A as a novel regulator of breast cancer pathogenicity, displaying tumor-suppressive or oncogenic activities in a cell-and tumor-dependent context, and demonstrate the clinical value of the HS-O-sulfotransferase 3-OST3A as a prognostic marker in HER2+ patients.	[Mao, X.; Gauche, C.; Bui, C.; Gulberti, S.; Merhi-Soussi, F.; Ramalanjaona, N.; Bertin-Jung, I.; Dumas, D.; Ouzzine, M.; Fournel-Gigleux, S.] Univ Lorraine IMoPA, CNRS, UMR 7365, MolCelTEG Team, Vandoeuvre Les Nancy, France; [Mao, X.; Gauche, C.; Bui, C.; Gulberti, S.; Merhi-Soussi, F.; Ramalanjaona, N.; Bertin-Jung, I.; Dumas, D.; Ouzzine, M.; Fournel-Gigleux, S.] Univ Lorraine, Fac Med, Glycofluo Platform, Biopole, Campus Biol Sante, Vandoeuvre Les Nancy, France; [Mao, X.] Luxembourg Inst Hlth, Lab Expt Canc Res, Luxembourg, Luxembourg; [Coughtrie, M. W. H.; Diot, A.; Bourdon, J-C] Univ Dundee, Med Res Inst, Div Canc Res, Dundee, Scotland; [Coughtrie, M. W. H.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Dumas, D.] PTIBC IBISA Nancy, Cellular & Tissular Core Imaging Facil, Vandoeuvre Les Nancy, France; [Caires, N. De Freitas] INSERM, U1019E11, Lille, France; [Thompson, A. M.] Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; Universite de Lorraine; Luxembourg Institute of Health; University of Dundee; University of British Columbia; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Texas System; UTMD Anderson Cancer Center	Fournel-Gigleux, S (corresponding author), Univ Lorraine, Univ Lorraine IMoPA, MolCelTEG Team, UMR 7365,CNRS,Biopole,Fac Med, Campus Biol Sante,CS 50184, F-54505 Vandoeuvre Les Nancy, Lorraine, France.	sylvie.fournel-gigleux@univ-lorraine.fr	Ouzzine, Mohamed/G-4368-2013; Coughtrie, Michael/C-3855-2009; JC, Bourdon/A-4439-2008	Coughtrie, Michael/0000-0003-1989-1416; JC, Bourdon/0000-0003-4623-9386; GULBERTI, Sandrine/0000-0002-9378-4697; OUZZINE, Mohamed/0000-0003-0058-4950	Agence Nationale de la Recherche (ANR-GAG Network) [ANR-08-PCVI-0023]; Royal Society; Region Lorraine; Lorraine University; International Associated Laboratory (SFGEN); Cancer Research UK (CRUK); NHS Tayside through the Chief Scientist Office; Agence Nationale de la Recherche (ANR Meca-GT) [ANR-13-BSV8-0011-01]; NHS Tayside through Health Sciences Scotland; Breast Cancer Campaign; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (ANR-GAG Network)(French National Research Agency (ANR)); Royal Society(Royal Society of London); Region Lorraine(Region Grand-Est); Lorraine University; International Associated Laboratory (SFGEN); Cancer Research UK (CRUK)(Cancer Research UK); NHS Tayside through the Chief Scientist Office; Agence Nationale de la Recherche (ANR Meca-GT)(French National Research Agency (ANR)); NHS Tayside through Health Sciences Scotland; Breast Cancer Campaign; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Philippe Lassalle (INSERM U1019E11, Campus Institut Pasteur de Lille, Lille, France) is gratefully acknowledged for support with the xenograft experiments and for helpful discussion. Matthieu Chabel and Anne Robert are acknowledged for excellent technical assistance and Xiaomeng Pang is acknowledged for performing methylation analysis. This work was supported by Agence Nationale de la Recherche (ANR-GAG Network ANR-08-PCVI-0023 and ANR Meca-GT ANR-13-BSV8-0011-01), a Royal Society International Joint grant (to MWHC and SF-G), grants from Region Lorraine and Lorraine University to SF-G and to NR, and was carried out under auspices of the International Associated Laboratory (SFGEN) funded between CNRS-UL (SF-G) and University of Dundee (J-CB and MWHC). Tayside Tissue Bank is supported by Breast Cancer Campaign, Cancer Research UK (CRUK) and by NHS Tayside through the Chief Scientist Office and Health Sciences Scotland (formerly the Scottish Academic Health Science Collaboration, AHSC).	Bai AL, 2010, CANCER RES, V70, P7630, DOI 10.1158/0008-5472.CAN-10-1489; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Bui C, 2010, FASEB J, V24, P436, DOI 10.1096/fj.09-136291; Cha JY, 2008, MOL CANCER RES, V6, P435, DOI 10.1158/1541-7786.MCR-07-0187; Cha JYY, 2009, J BIOL CHEM, V284, P6227, DOI 10.1074/jbc.M803998200; Delehedde M, 2001, J MAMMARY GLAND BIOL, V6, P253, DOI 10.1023/A:1011367423085; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dieci MV, 2013, CANCER DISCOV, V3, P264, DOI 10.1158/2159-8290.CD-12-0362; FOURNELGIGLEUX S, 1991, MOL PHARMACOL, V39, P177; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Girardin EP, 2005, J BIOL CHEM, V280, P38059, DOI 10.1074/jbc.M507997200; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hervouet E, 2013, EPIGENETICS-US, V8, P237, DOI 10.4161/epi.23790; Hwang JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079634; Jacquemier J, 1998, J PATHOL, V186, P269, DOI 10.1002/(SICI)1096-9896(1998110)186:3<269::AID-PATH187>3.0.CO;2-G; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kitsberg DI, 1996, ONCOGENE, V13, P2507; Kloten V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3375; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Lofgren L, 2007, ANTICANCER RES, V27, P3045; Luo YD, 2006, J BIOL CHEM, V281, P21052, DOI 10.1074/jbc.M601559200; Marcel V, 2014, CELL DEATH DIFFER, V21, P1377, DOI 10.1038/cdd.2014.73; Mehta M, 2010, ANTICANCER RES, V30, P4883; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Nieto L, 2013, CHEMBIOCHEM, V14, P1732, DOI 10.1002/cbic.201300313; Nurcombe V, 2000, J BIOL CHEM, V275, P30009, DOI 10.1074/jbc.M003038200; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Purdie CA, 2010, HISTOPATHOLOGY, V56, P702, DOI 10.1111/j.1365-2559.2010.03533.x; Raman Karthik, 2010, Curr Chem Biol, V4, P20; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shukla S, 2006, EPIGENETICS-US, V1, P88, DOI 10.4161/epi.1.2.2679; Song K, 2011, CANCER BIOL THER, V12, P388, DOI 10.4161/cbt.12.5.15957; Staub J, 2007, ONCOGENE, V26, P4969, DOI 10.1038/sj.onc.1210300; Thacker BE, 2014, MATRIX BIOL, V35, P60, DOI 10.1016/j.matbio.2013.12.001; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Xu RY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.398826; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Zang XP, 2004, CLIN EXP METASTAS, V21, P437, DOI 10.1007/s10585-004-2051-8	48	20	20	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 22	2016	35	38					5043	5055		10.1038/onc.2016.44	http://dx.doi.org/10.1038/onc.2016.44			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW9GT	27041583	Green Submitted			2022-12-26	WOS:000383965300008
J	Ghosh, S; Taylor, A; Chin, M; Huang, HR; Conery, AR; Mertz, JA; Salmeron, A; Dakle, PJ; Mele, D; Cote, A; Jayaram, H; Setser, JW; Poy, F; Hatzivassiliou, G; DeAlmeida-Nagata, D; Sandy, P; Hatton, C; Romero, FA; Chiang, E; Reimer, T; Crawford, T; Pardo, E; Watson, VG; Tsui, V; Cochran, AG; Zawadzke, L; Harmange, JC; Audia, JE; Bryant, BM; Cummings, RT; Magnuson, SR; Grogan, JL; Bellon, SF; Albrecht, BK; Sims, RJ; Lora, JM				Ghosh, Srimoyee; Taylor, Alexander; Chin, Melissa; Huang, Hon-Ren; Conery, Andrew R.; Mertz, Jennifer A.; Salmeron, Andres; Dakle, Pranal J.; Mele, Deanna; Cote, Alexandre; Jayaram, Hari; Setser, Jeremy W.; Poy, Florence; Hatzivassiliou, Georgia; DeAlmeida-Nagata, Denise; Sandy, Peter; Hatton, Charlie; Romero, F. Anthony; Chiang, Eugene; Reimer, Thornik; Crawford, Terry; Pardo, Eneida; Watson, Venita G.; Tsui, Vickie; Cochran, Andrea G.; Zawadzke, Laura; Harmange, Jean-Christophe; Audia, James E.; Bryant, Barbara M.; Cummings, Richard T.; Magnuson, Steven R.; Grogan, Jane L.; Bellon, Steve F.; Albrecht, Brian K.; Sims, Robert J., III; Lora, Jose M.			Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-IMMUNOTHERAPY; IMMUNE-RESPONSES; BREAST-CANCER; P300; CHROMATIN; FOXP3; ACETYLTRANSFERASES; LYMPHOCYTES; ACTIVATION; CBP/P300	Covalent modification of histones is a fundamental mechanism of regulated gene expression in eukaryotes, and interpretation of histone modifications is an essential feature of epigenetic control. Bromodomains are specialized binding modules that interact with acetylated histones, linking chromatin recognition to gene transcription. Because of their ability to function in a domain-specific fashion, selective disruption of bromodomain: acetylated histone interactions with chemical probes serves as a powerful means for understanding biological processes regulated by these chromatin adaptors. Here we describe the discovery and characterization of potent and selective small molecule inhibitors for the bromodomains of CREBBP/EP300 that engage their target in cellular assays. We use these tools to demonstrate a critical role for CREBBP/EP300 bromodomains in regulatory T cell biology. Because regulatory T cell recruitment to tumors is a major mechanism of immune evasion by cancer cells, our data highlight the importance of CREBBP/EP300 bromodomain inhibition as a novel, small molecule-based approach for cancer immunotherapy.	[Ghosh, Srimoyee; Taylor, Alexander; Chin, Melissa; Huang, Hon-Ren; Conery, Andrew R.; Mertz, Jennifer A.; Salmeron, Andres; Dakle, Pranal J.; Mele, Deanna; Cote, Alexandre; Jayaram, Hari; Setser, Jeremy W.; Poy, Florence; Sandy, Peter; Hatton, Charlie; Pardo, Eneida; Watson, Venita G.; Zawadzke, Laura; Harmange, Jean-Christophe; Audia, James E.; Bryant, Barbara M.; Cummings, Richard T.; Bellon, Steve F.; Albrecht, Brian K.; Sims, Robert J., III; Lora, Jose M.] Constellat Pharmaceut Inc, 215 First St, Cambridge, MA 02142 USA; [Hatzivassiliou, Georgia; DeAlmeida-Nagata, Denise; Romero, F. Anthony; Chiang, Eugene; Reimer, Thornik; Crawford, Terry; Tsui, Vickie; Cochran, Andrea G.; Magnuson, Steven R.; Grogan, Jane L.] Genentech Inc, San Francisco, CA 94080 USA; [Chin, Melissa] Editas Med Inc, Cambridge, MA USA; [Huang, Hon-Ren] Intellia Therapeut, Cambridge, MA USA; [Salmeron, Andres] Potenza Therapeut, Cambridge, MA USA; [Dakle, Pranal J.; Mele, Deanna] AstraZeneca, Waltham, MA USA; [Sandy, Peter] Evelo Therapeut, Cambridge, MA USA; [Zawadzke, Laura] EMD Serono, Billerica, MA USA; [Harmange, Jean-Christophe] Third Rock Ventures, Boston, MA USA	Roche Holding; Genentech; AstraZeneca	Sims, RJ; Lora, JM (corresponding author), Constellat Pharmaceut Inc, 215 First St, Cambridge, MA 02142 USA.	robert.sims@constellationpharma.com; jose.lora@constellationpharma.com	Romero, F. Anthony/S-8530-2018	Romero, F. Anthony/0000-0001-7917-1459; CONERY, ANDREW/0000-0003-3638-7633; Bryant, Barbara/0000-0003-2707-1186; Cochran, Andrea/0000-0001-6469-795X; Hatton, Charlie/0000-0001-9903-4291				Anderson AC, 2014, CANCER IMMUNOL RES, V2, P393, DOI 10.1158/2326-6066.CIR-14-0039; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Chen JH, 2011, EPIGENETICS-US, V6, P957, DOI 10.4161/epi.6.8.16065; Chen JH, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12224; Ciceri P, 2014, NAT CHEM BIOL, V10, P305, DOI 10.1038/nchembio.1471; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Conery AR, 2016, ELIFE, V5, DOI [10.7554/eLife.10483, 10.7554/eLife.19432]; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Goodman RH, 2000, GENE DEV, V14, P1553; Hammitzsch A, 2015, P NATL ACAD SCI USA, V112, P10768, DOI 10.1073/pnas.1501956112; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huang H.-R., 2014, Patent No. [WO2014144303A1, 2014144303]; Jain N, 2010, P NATL ACAD SCI USA, V107, P1524, DOI 10.1073/pnas.0910341107; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Josling GA, 2012, GENES-BASEL, V3, P320, DOI 10.3390/genes3020320; Kono K, 2006, CANCER IMMUNOL IMMUN, V55, P1064, DOI 10.1007/s00262-005-0092-8; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Liu YJ, 2014, MOL CELL BIOL, V34, P3993, DOI 10.1128/MCB.00919-14; Liu YJ, 2013, NAT MED, V19, P1173, DOI 10.1038/nm.3286; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Picaud S., 2015, CANC RES, V75, P5106; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rothbart SB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00489; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Savage PA, 2013, TRENDS IMMUNOL, V34, P33, DOI 10.1016/j.it.2012.08.005; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Taylor A. M., 2016, ACS MED CHE IN PRESS; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	46	45	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13014	13027		10.1074/jbc.M115.708560	http://dx.doi.org/10.1074/jbc.M115.708560			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27056325	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000379770500011
J	Schulman, JJ; Wright, FA; Han, XB; Zluhan, EJ; Szczesniak, LM; Wojcikiewicz, RJH				Schulman, Jacqualyn J.; Wright, Forrest A.; Han, Xiaobing; Zluhan, Eric J.; Szczesniak, Laura M.; Wojcikiewicz, Richard J. H.			The Stability and Expression Level of Bok Are Governed by Binding to Inositol 1,4,5-Trisphosphate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBER BOK; ENDOPLASMIC-RETICULUM STRESS; BCL-2 PROTEIN FAMILY; UBIQUITIN LIGASE; GENE-EXPRESSION; BH4 DOMAIN; CELL-DEATH; APOPTOSIS; MEMBRANE; DEGRADATION	Bok is a member of the Bcl-2 protein family that governs the intrinsic apoptosis pathway, although the role that Bok plays in this pathway is unclear. We have shown previously in cultured cell lines that Bok interacts strongly with inositol 1,4,5-trisphosphate receptors (IP(3)Rs), suggesting that it may contribute to the structural integrity or stability of IP3R tetramers. Here we report that Bok is similarly IP3R-assocated in mouse tissues, that essentially all cellular Bok is IP3R bound, that it is the helical nature of the Bok BH4 domain, rather than specific amino acids, that mediates binding to IP(3)Rs, that Bok is dramatically stabilized by binding to IP(3)Rs, that unbound Bok is ubiquitinated and degraded by the proteasome, and that binding to IP(3)Rs limits the pro-apoptotic effect of overexpressed Bok. Agents that stimulate IP3R activity, apoptosis, phosphorylation, and endoplasmic reticulum stress did not trigger the dissociation of mature Bok from IP(3)Rs or Bok degradation, indicating that the role of proteasome-mediated Bok degradation is to destroy newly synthesized Bok that is not IP3R associated. The existence of this unexpected proteolytic mechanism that is geared toward restricting Bok to that which is bound to IP(3)Rs, implies that unbound Bok is deleterious to cell viability and helps explain the current uncertainty regarding the cellular role of Bok.	[Schulman, Jacqualyn J.; Wright, Forrest A.; Han, Xiaobing; Zluhan, Eric J.; Szczesniak, Laura M.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Szczesniak, Laura/0000-0001-5321-9821; Schulman, Jacqualyn/0000-0001-6659-3388	National Institutes of Health [DK049194]; Carol M. Baldwin Breast Cancer Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049194, R29DK049194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carol M. Baldwin Breast Cancer Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK049194 and the Carol M. Baldwin Breast Cancer Research Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors-and does not necessarily represent the official views of the National Institutes of Health.	Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Carpio MA, 2016, P NATL ACAD SCI USA, V113, pE494, DOI 10.1073/pnas.1521979113; Carpio MA, 2015, P NATL ACAD SCI USA, V112, P7201, DOI 10.1073/pnas.1421063112; Carroll RG, 2014, CELL REP, V9, P1538, DOI 10.1016/j.celrep.2014.10.046; Chen HC, 2015, NAT CELL BIOL, V17, P1270, DOI 10.1038/ncb3236; Chi XK, 2014, BBA-MOL CELL RES, V1843, P2100, DOI 10.1016/j.bbamcr.2014.06.002; Distelhorst CW, 2011, CELL CALCIUM, V50, P234, DOI 10.1016/j.ceca.2011.05.011; Echeverry N, 2013, CELL DEATH DIFFER, V20, P785, DOI 10.1038/cdd.2013.10; Fernandez-Marrero Y, 2016, P NATL ACAD SCI USA, V113, pE492, DOI 10.1073/pnas.1516347113; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Inohara N, 1998, J BIOL CHEM, V273, P8705, DOI 10.1074/jbc.273.15.8705; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kawahara H, 2013, J BIOCHEM, V153, P147, DOI 10.1093/jb/mvs149; Ke F, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.304; Ke F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.176; Ke F, 2012, CELL DEATH DIFFER, V19, P915, DOI 10.1038/cdd.2011.210; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Lavik AR, 2015, ONCOTARGET, V6, P27388, DOI 10.18632/oncotarget.4489; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Lein ES, 2005, J COMP NEUROL, V485, P1, DOI 10.1002/cne.20426; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Miller RL, 2013, AM J PHYSIOL-RENAL, V304, pF177, DOI 10.1152/ajprenal.00431.2012; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; Monaco G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073386; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rooswinkel RW, 2014, BLOOD, V123, P2806, DOI 10.1182/blood-2013-08-519470; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schulman JJ, 2013, J BIOL CHEM, V288, P25340, DOI 10.1074/jbc.M113.496570; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Wang L., 2015, J PHYSL IN PRESS; Wang P, 2013, CELL SIGNAL, V25, P2320, DOI 10.1016/j.cellsig.2013.07.016; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wilfling F, 2012, CELL DEATH DIFFER, V19, P1328, DOI 10.1038/cdd.2012.9; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wright FA, 2015, J BIOL CHEM, V290, P13948, DOI 10.1074/jbc.M115.655043; Yang J, 2016, P NATL ACAD SCI USA, V113, pE1953, DOI 10.1073/pnas.1517935113; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	52	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11820	11828		10.1074/jbc.M115.711242	http://dx.doi.org/10.1074/jbc.M115.711242			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27053113	hybrid, Green Published			2022-12-26	WOS:000377264800031
J	Mohan, V; Pandey, A; Sreelakshmi, Y; Sharma, R				Mohan, Vijee; Pandey, Arun; Sreelakshmi, Yellamaraju; Sharma, Rameshwar			Neofunctionalization of Chromoplast Specific Lycopene Beta Cyclase Gene (CYC-B) in Tomato Clade	PLOS ONE			English	Article							PROVIDES INSIGHTS; GENOME SEQUENCE; FRUIT; CHLOROPLAST; EVOLUTION; PATTERNS; ELEMENTS; ORGAN; COLOR; RIN	The ancestor of tomato underwent whole genome triplication ca. 71 Myr ago followed by widespread gene loss. However, few of the triplicated genes are retained in modern day tomato including lycopene beta cyclase that mediates conversion of lycopene to beta-carotene. The fruit specific beta-carotene formation is mediated by a chromoplast-specific paralog of lycopene beta cyclase (CYC-B) gene. Presently limited information is available about how the variations in CYC-B gene contributed to its neofunctionalization. CYC-B gene in tomato clade contained several SNPs and In-Dels in the coding sequence (33 haplotypes) and promoter region (44 haplotypes). The CYC-B gene coding sequence in tomato appeared to undergo purifying selection. The transit peptide sequence of CYC-B protein was predicted to have a stronger plastid targeting signal than its chloroplast specific paralog indicating a possible neofunctionalization. In promoter of two B-og (Beta old gold) mutants, a NUPT (nuclear plastid) DNA fragment of 256 bp, likely derived from a S. chilense accession, was present. In transient expression assay, this promoter was more efficient than the "Beta type" promoter. CARGATCONSENSUS box sequences are required for the binding of the MADS-box regulatory protein RIPENING INHIBITOR (RIN). The loss of CARGATCONSENSUS box sequence from CYC-B promoter in tomato may be related to attenuation of its efficiency to promote higher accumulation of beta-carotene than lycopene during fruit ripening.	[Mohan, Vijee; Pandey, Arun; Sreelakshmi, Yellamaraju; Sharma, Rameshwar] Univ Hyderabad, Dept Plant Sci, Repository Tomato Genom Resources, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Sharma, R (corresponding author), Univ Hyderabad, Dept Plant Sci, Repository Tomato Genom Resources, Hyderabad 500134, Andhra Pradesh, India.	rameshwar.sharma@gmail.com	Mohan, Vijee/AAQ-4436-2021	Mohan, Vijee/0000-0001-6472-0187	Department of Biotechnology, India [BT/PR/5275/AGR/16/465/2004]; International Atomic Energy Agency, Vienna; Council of Scientific and Industrial Research, India (research fellowship)	Department of Biotechnology, India(Department of Biotechnology (DBT) India); International Atomic Energy Agency, Vienna(International Atomic Energy Agency); Council of Scientific and Industrial Research, India (research fellowship)	This work was supported by the Department of Biotechnology, India (grant no. BT/PR/5275/AGR/16/465/2004;) to RS and YS, International Atomic Energy Agency, Vienna to YS and Council of Scientific and Industrial Research, India (research fellowship to VM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Anderson LK, 2010, CYTOGENET GENOME RES, V129, P24, DOI 10.1159/000313850; Azari R, 2010, BIOTECHNOL ADV, V28, P108, DOI 10.1016/j.biotechadv.2009.10.003; Bouvier F, 2000, EUR J BIOCHEM, V267, P6346, DOI 10.1046/j.1432-1327.2000.01722.x; Busch BL, 2011, PLANT CELL, V23, P3595, DOI 10.1105/tpc.111.087981; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Egea I, 2011, ANN BOT-LONDON, V108, P291, DOI 10.1093/aob/mcr140; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enfissi EMA, 2010, PLANT CELL, V22, P1190, DOI 10.1105/tpc.110.073866; FINER JJ, 1992, PLANT CELL REP, V11, P323, DOI 10.1007/BF00233358; Garcia-Closas R, 2004, BRIT J NUTR, V91, P1005, DOI 10.1079/BJN20041130; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Knapp S., 2009, SYST BOT, V84, P1; Liu SL, 2011, GENOME BIOL EVOL, V3, P1419, DOI 10.1093/gbe/evr114; Marques AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r54; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Mialoundama AS, 2010, PLANT PHYSIOL, V153, P970, DOI 10.1104/pp.110.155440; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Peters SA, 2012, PLANT J, V71, P602, DOI 10.1111/j.1365-313X.2012.05012.x; RICK CM, 1953, AM NAT, V87, P359, DOI 10.1086/281796; Rick CM, 1961, REPORT TOMATO GENETI, V11, P21; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Silletti MF, 2013, MOL BREEDING, V31, P665, DOI 10.1007/s11032-012-9824-6; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Sreelakshmi Y, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor NE, 2003, NUCLEIC ACIDS RES, V31, P3808, DOI 10.1093/nar/gkg574; Thorup TA, 2000, P NATL ACAD SCI USA, V97, P11192, DOI 10.1073/pnas.97.21.11192; Till BJ, 2006, NAT PROTOC, V1, P2465, DOI 10.1038/nprot.2006.329; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; WILLSON MF, 1990, AM NAT, V136, P790, DOI 10.1086/285132; Woischnik M, 2002, GENOME RES, V12, P885, DOI 10.1101/gr.227202; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Yoshida T, 2014, DNA RES, V21, P127, DOI 10.1093/dnares/dst045; Yuan Q, 2002, MOL GENET GENOMICS, V267, P713, DOI 10.1007/s00438-002-0706-1; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462	46	12	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153333	10.1371/journal.pone.0153333	http://dx.doi.org/10.1371/journal.pone.0153333			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070417	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700053
J	Lacerda, ALF; Kersanach, R; Cortinhas, MCS; Prata, PFS; Dumont, LFC; Proietti, MC; Maggioni, R; D'Incao, F				Figueiredo Lacerda, Ana Luzia; Kersanach, Ralf; Silva Cortinhas, Maria Cristina; Sanmartin Prata, Pedro Fernandes; Cestari Dumont, Luiz Felipe; Proietti, Maira Carneiro; Maggioni, Rodrigo; D'Incao, Fernando			High Connectivity among Blue Crab (Callinectes sapidus) Populations in the Western South Atlantic	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; CHINESE MITTEN CRAB; MICROSATELLITE MARKERS; GENETIC DIFFERENTIATION; COALESCENT APPROACH; ERIOCHEIR-SINENSIS; CHESAPEAKE BAY; 1896 DECAPODA; BRAZIL; PORTUNIDAE	Population connectivity in the blue crab Callinectes sapidus was evaluated along 740 km of the Western South Atlantic coast. Blue crabs are the most exploited portunid in Brazil. Despite their economic importance, few studies report their ecology or population structure. Here we sampled four estuarine areas in southern Brazil during winter 2013 and summer 2014 in order to evaluate diversity, gene flow and structure of these populations. Nine microsatellite markers were evaluated for 213 adult crabs, with identification of seven polymorphic loci and 183 alleles. Pairwise FST values indicated low population structure ranging from -0.00023 to 0.01755. A Mantel test revealed that the geographic distance does not influence genetic (r = -0.48), and structure/migration rates confirmed this, showing that even the populations located at the opposite extremities of our covered region presented low FST and exchanged migrants. These findings show that there is a significant amount of gene flow between blue crab populations in South Brazil, likely influenced by local current dynamics that allow the transport of a high number of larvae between estuaries. Considering the elevated gene flow, the populations can be considered a single genetic stock. However, further information on population size and dynamics, as well as fishery demands and impacts at different regions, are necessary for harvest management purposes.	[Figueiredo Lacerda, Ana Luzia; Silva Cortinhas, Maria Cristina; Sanmartin Prata, Pedro Fernandes; Cestari Dumont, Luiz Felipe; Proietti, Maira Carneiro; D'Incao, Fernando] Univ Fed Rio Grande, Inst Oceanog, Rio Grande Do Sul, RS, Brazil; [Kersanach, Ralf] Univ Fed Rio Grande, Inst Ciencias Biol, Rio Grande Do Sul, RS, Brazil; [Maggioni, Rodrigo] Univ Fed Ceara, Inst Ciencias Mar, Fortaleza, Ceara, Brazil	Universidade Federal do Rio Grande; Universidade Federal do Rio Grande; Universidade Federal do Ceara	Lacerda, ALF (corresponding author), Univ Fed Rio Grande, Inst Oceanog, Rio Grande Do Sul, RS, Brazil.	analuzialacerda@gmail.com	Maggioni, Rodrigo/E-5948-2011; Dumont, Luiz/D-4870-2014	Maggioni, Rodrigo/0000-0002-1119-1020; Dumont, Luiz/0000-0001-8575-4167; Proietti, Maira/0000-0002-5504-5770; Lacerda, Ana Luzia/0000-0001-6654-5597	Universidade Federal do Rio Grande-FURG; Coordenacao de Aperfeicoamento Pessoal de Nivel Superior-CAPES	Universidade Federal do Rio Grande-FURG; Coordenacao de Aperfeicoamento Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by grants from Universidade Federal do Rio Grande-FURG (http://www.furg.br) and Coordenacao de Aperfeicoamento Pessoal de Nivel Superior-CAPES (http://www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboim MA, 2003, MOL ECOL NOTES, V3, P18, DOI 10.1046/j.1471-8286.2003.00337.x; Aguilar R, 2005, J EXP MAR BIOL ECOL, V319, P117, DOI 10.1016/j.jembe.2004.08.030; Azuma N, 2008, MAR BIOTECHNOL, V10, P39, DOI 10.1007/s10126-007-9033-1; Beacham TD, 2008, J SHELLFISH RES, V27, P901, DOI 10.2983/0730-8000(2008)27[901:PSODCC]2.0.CO;2; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Brooker AL, 2000, MAR BIOL, V136, P149, DOI 10.1007/s002270050017; Chang YM, 2008, J GENET GENOMICS, V35, P171, DOI 10.1016/S1673-8527(08)60023-5; Chiessi CM, 2014, PALAEOGEOGR PALAEOCL, V415, P28, DOI 10.1016/j.palaeo.2013.12.005; COSTLOW JD, 1967, HELGOLAND WISS MEER, V15, P84, DOI 10.1007/BF01618611; COSTLOW JD, 1959, BIOL BULL, V116, P373, DOI 10.2307/1538947; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; D'Incao F., 1991, ATLANTICA, V13, P159; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forward RB, 2003, MAR BIOL, V142, P747, DOI 10.1007/s00227-002-0966-7; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; HINES AH, 1987, MAR ECOL PROG SER, V36, P55, DOI 10.3354/meps036055; Hines AH, 2003, B MAR SCI, V72, P287; Hines AH, 2010, BIOL MANAGEMENT EXPL, DOI [10.4027/bmecpcc.2010.22, DOI 10.4027/BMECPCC.2010.22]; Kennedy VS, BLUE CRAB CALLINECTE; KORDOS LM, 1993, MAR BIOL, V117, P227, DOI 10.1007/BF00345667; Ma HY, 2012, J EXP BIOL, V215, P3120, DOI 10.1242/jeb.071654; Marques WC, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006190; Matano RP, 2010, OCEAN SCI, V6, P983, DOI 10.5194/os-6-983-2010; Matano RP, 1993, J PHYS OCEANOGRAPGHY, V23, P79; MCMILLENJACKSON AL, 1994, MAR BIOL, V118, P53, DOI 10.1007/BF00699219; Mendonca JT, 2010, BRAZ J BIOL, V70, P37, DOI 10.1590/S1519-69842010000100007; NOAA. National Oceanographic and Atmospheric Administration National Marine Fisheries Service Office of Science and Technology Commercial Fisheries, 2014, COMM FISH ANN COMM L; Pascoal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007268; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Piola AR, 2010, OCEAN SCI, V6, P345, DOI 10.5194/os-6-345-2010; Pritchard JK, 2000, GENETICS, V155, P945; Rodrigues MA, 2008, IHERINGIA SER ZOOL, V98, P372, DOI 10.1590/S0073-47212008000300012; Rodrigues Marcos Alaniz, 2011, Atlantica, V33, P141; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sambrook KJ, 1989, MOL CLONING LAB MANU; Seeliger U, 1998, ECOSSISTEMAS COSTEIR; Severino-Rodrigues E, 2013, REV BIOL TROP, V61, P595; Silveira I.C.A., 2000, REV BRAS OCEANOGR, V48, P171, DOI [10.1590/S1413-77392000000200008, DOI 10.1590/S1413-77392000000200008]; Steven CR, 2005, J EXP MAR BIOL ECOL, V319, P3, DOI 10.1016/j.jembe.2004.04.020; STRAMMA L, 1991, J MAR RES, V49, P281, DOI 10.1357/002224091784995864; Thorrold SR, 2002, B MAR SCI, V70, P291; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Weber LI, 2000, HYDROBIOLOGIA, V420, P203, DOI 10.1023/A:1003992630229; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yednock BK, 2014, MAR BIOL, V161, P871, DOI 10.1007/s00227-013-2387-1; Zavialov PO, 1998, J PHYS OCEANOGR, V28, P545, DOI 10.1175/1520-0485(1998)028<0545:AIMFSC>2.0.CO;2	52	16	16	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153124	10.1371/journal.pone.0153124	http://dx.doi.org/10.1371/journal.pone.0153124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064977	gold, Green Published, Green Submitted			2022-12-26	WOS:000373891000032
J	Liao, TL; Lin, CH; Chen, YM; Chang, CL; Chen, HH; Chen, DY				Liao, Tsai-Ling; Lin, Ching-Heng; Chen, Yi-Ming; Chang, Chia-Li; Chen, Hsin-Hua; Chen, Der-Yuan			Different Risk of Tuberculosis and Efficacy of Isoniazid Prophylaxis in Rheumatoid Arthritis Patients with Biologic Therapy: A Nationwide Retrospective Cohort Study in Taiwan	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR ANTAGONISTS; INFECTION; MYCOBACTERIAL; RITUXIMAB; REACTIVATION; MULTICENTER; COMORBIDITY; INHIBITORS; DISEASES	Increasing evidence indicates an increased risk of tuberculosis (TB) for rheumatoid arthritis (RA) patients receiving biologic therapy, and the effectiveness of isoniazid prophylaxis (INHP) in TB prevention. We aimed to examine 1) the incidence rate (IR) and risk factors for TB among RA patients receiving different therapies; 2) INHP effectiveness for TB prevention; 3) mortality rates after TB diagnosis in patients receiving different therapies. This retrospective study was conducted using a nationwide database: 168,720 non-RA subjects and a total of 42,180 RA patients including 36,162 csDMARDs-exposed, 3,577 etanercept-exposed, 1,678 adalimumab-exposed and 763 rituximab-exposed patients. TB risk was 2.7-fold higher in RA cohort compared with non-RA group, with an adjusted hazard ratio (aHR) of 2.58. Advanced age, male, the use of corticosteroids >= 5mg/day, and the presence of diabetes mellitus (DM), chronic obstructive pulmonary disease and chronic kidney disease were risk factors for developing TB. Using csDMARDs-exposed group as reference, aHR of TB was the highest with adalimumab treatment (1.52), followed by etanercept (1.16), and the lowest with rituximab (0.08). INHP could effectively reduce TB risk in biologics-exposed patients. Mortality rates after TB diagnosis were higher in RA patients, particularly the elderly and those with DM, with lower rates in adalimumab-exposed patients compared with csDMARDs-exposed patients. In conclusion, TB risk was increased in patients receiving TNF-alpha inhibitors, but the risk associated with rituximab therapy was relatively low. With the effectiveness of INHP shown in the prevention of biologics-associated TB, stricter implementation of INHP should be beneficial. The mortality from biologics-associated TB may be efficiently reduced through increased awareness.	[Liao, Tsai-Ling; Lin, Ching-Heng; Chen, Yi-Ming; Chang, Chia-Li; Chen, Hsin-Hua; Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan; [Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Der-Yuan] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Der-Yuan] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan; [Lin, Ching-Heng] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua; Chen, Der-Yuan] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taipei, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua; Chen, Der-Yuan] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Chen, Der-Yuan] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan	Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; National Taipei University of Nursing & Health Science (NTUNHS); Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University	Chen, DY (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan.; Chen, DY (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.; Chen, DY (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan.; Chen, DY (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taipei, Taiwan.; Chen, DY (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan.; Chen, DY (corresponding author), Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan.	dychen@vghtc.gov.tw	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065	Taichung Veterans General Hospital, Taiwan [TCVGH-NHRI10307]	Taichung Veterans General Hospital, Taiwan	This study was supported in part by grants from Taichung Veterans General Hospital, Taiwan (TCVGH-NHRI10307) [http://www.vghtc.gov.tw]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkema EV, 2015, ANN RHEUM DIS, V74, P1212, DOI 10.1136/annrheumdis-2013-204960; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Brassard P, 2009, ARTHRIT RHEUM-ARTHR, V61, P300, DOI 10.1002/art.24476; Brode SK, 2014, CHEST, V146, P563, DOI 10.1378/chest.13-2058; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Centers for Disease Control R. O. C. (Taiwan), 2013, TAIW TUB CONTR REP 2; Chen DY, 2012, ANN RHEUM DIS, V71, P231, DOI 10.1136/annrheumdis-2011-200489; Chen YM, 2013, RHEUMATOLOGY, V52, P697, DOI 10.1093/rheumatology/kes365; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2294, DOI 10.1002/art.10529; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gomez-Reino JJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P756, DOI 10.1002/art.22768; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Jou RW, 2009, EMERG INFECT DIS, V15, P1525, DOI 10.3201/eid1509.081336; Kourbeti IS, 2014, CLIN INFECT DIS, V58, P1649, DOI 10.1093/cid/ciu185; Ledingham J, 2005, RHEUMATOLOGY, V44, P157, DOI 10.1093/rheumatology/keh464; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037978; Lee H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119260; Lee JH, 2014, KOREAN J INTERN MED, V29, P76, DOI 10.3904/kjim.2014.29.1.76; Liao TL, 2015, EMERG INFECT DIS, V21, P1387, DOI 10.3201/eid2108.141846; Lin CH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-5; Lobue P, 2010, RESPIROLOGY, V15, P603, DOI 10.1111/j.1440-1843.2010.01751.x; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Navarra SV, 2014, INT J RHEUM DIS, V17, P291, DOI 10.1111/1756-185X.12188; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Schluger NW, 2002, CHEST, V121, P1733, DOI 10.1378/chest.121.6.1733; Tubach F, 2009, ARTHRITIS RHEUM-US, V60, P1884, DOI 10.1002/art.24632; van Vollenhoven RF, 2013, ANN RHEUM DIS, V72, P1496, DOI 10.1136/annrheumdis-2012-201956; WHO, 2009, GLOBAL TUBERCULOSIS; WHO, 2014, GLOB TUB REP 2014; Winthrop KL, 2013, ANN RHEUM DIS, V72, P37, DOI 10.1136/annrheumdis-2011-200690; Winthrop KL, 2008, CLIN INFECT DIS, V46, P1738, DOI 10.1086/587989; Winthrop KL, 2013, NAT REV RHEUMATOL, V9, P524, DOI 10.1038/nrrheum.2013.82; Yamada T, 2006, ANN RHEUM DIS, V65, P1661, DOI 10.1136/ard.2005.047274; Yeh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110922; Zellweger JP, 2015, AM J RESP CRIT CARE	45	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153217	10.1371/journal.pone.0153217	http://dx.doi.org/10.1371/journal.pone.0153217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064275	gold, Green Submitted, Green Published			2022-12-26	WOS:000373891000037
J	Zhang, LH; Li, J; Li, X; Nasir, K; Zhang, HB; Wu, YJ; Hu, S; Wang, Q; Downing, NS; Desai, NR; Masoudi, FA; Spertus, JA; Krumholz, HM; Jiang, LX				Zhang, Lihua; Li, Jing; Li, Xi; Nasir, Khurram; Zhang, Haibo; Wu, Yongjian; Hu, Shuang; Wang, Qing; Downing, Nicholas S.; Desai, Nihar R.; Masoudi, Frederick A.; Spertus, John A.; Krumholz, Harlan M.; Jiang, Lixin		China PEACE Collaborative Grp	National Assessment of Statin Therapy in Patients Hospitalized with Acute Myocardial Infarction: Insight from China PEACE-Retrospective AMI Study, 2001, 2006, 2011	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; ASSOCIATION TASK-FORCE; ST-ELEVATION; WRITING COMMITTEE; AMERICAN-COLLEGE; CARDIOVASCULAR ANGIOGRAPHY; PULMONARY REHABILITATION; EMERGENCY PHYSICIANS; GENDER-DIFFERENCES; PATTERNS	Background Statin therapy is among the most effective treatments to improve short-and long-term mortality after acute myocardial infarction. The use of statin, and the intensity of their use, has not been described in acute myocardial infarction patients in China, a country with a rapidly growing burden of cardiovascular disease. Methods and Results Using a nationally representative sample of patients with acute myocardial infarction admitted to 162 Chinese hospitals in 2001, 2006 and 2011, we identified 14,958 patients eligible for statin therapy to determine rates of statin use and the intensity of statin therapy, defined as those statin regimens with expected low-density lipoprotein cholesterol lowering of at least 40%, to identify factors associated with the use of statin therapy. Statin use among hospitalized patients with acute myocardial infarction increased from 27.9% in 2001 to 72.5% in 2006, and 88.8% in 2011 (P<0.001 for trend). Regional variation in statin use correspondingly decreased over time. Among treated patients, those receiving intensive statin therapy increased from 1.0% in 2001 to 24.2% in 2006 to 57.2% in 2011(P<0.001 for trend). Patients without low-density lipoprotein cholesterol measured were less likely to be treated with statin or to receive intensive therapy. Conclusions The use of statin therapy has dramatically increased over the past decade in Chinese patients with acute myocardial infarction. However, half of patients still did not receive intensive statin therapy in 2011. Given that guidelines strongly endorse intensive statin therapy for acute myocardial infarction patients, initiatives promoting the use of statin therapy, with attention to treatment intensity, would support further improvements in practice.	[Zhang, Lihua; Li, Jing; Li, Xi; Zhang, Haibo; Wu, Yongjian; Hu, Shuang; Wang, Qing; Jiang, Lixin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China; [Zhang, Lihua; Li, Jing; Li, Xi; Zhang, Haibo; Wu, Yongjian; Hu, Shuang; Wang, Qing; Jiang, Lixin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Nasir, Khurram] Baptist Hlth South Florida, Ctr Healthcare Adv & Outcomes, Miami, FL USA; [Nasir, Khurram; Krumholz, Harlan M.] Baptist Hlth South Florida, Miami Cardiac & Vasc Inst, Miami, FL USA; [Downing, Nicholas S.; Desai, Nihar R.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Masoudi, Frederick A.] Univ Colorado, Div Cardiol, Anschutz Med Campus, Aurora, CO USA; [Spertus, John A.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Baptist Cardiac & Vascular Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Yale University; Yale University; Yale University	Jiang, LX (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China.; Jiang, LX (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	jiangl@fwoxford.org	Spertus, John/ABD-3075-2021; Masoudi, Frederick/Q-7467-2019; , Harlan/AAI-2875-2020	Li, Xi/0000-0003-2249-688X; Wu, Yongjian/0000-0002-5590-8396	Research Special Fund for Public Welfare Industry of Health from National Health and Family Planning Commission of China [201202025]; National Heart, Lung, and Blood Institute [U01 HL105270-03]; Chinese government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	Research Special Fund for Public Welfare Industry of Health from National Health and Family Planning Commission of China; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Chinese government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was partly supported by the Research Special Fund for Public Welfare Industry of Health (201202025) from National Health and Family Planning Commission of China. Dr. Krumholz are supported by grant U01 HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the multiple contributions made by study teams at the China Oxford Centre for International Health Research and the Yale-New Haven Hospital Center for Outcomes Research and Evaluation in the realms of study design and operations, particularly the data collection by the China PEACE Collaborative Group of Yi Pi, Jiamin Liu, Wuhanbilige Hundei, Xue Du, Wenchi Guan, Xin Zheng, and Yuanlin Guo. We are grateful for the support provided by the Chinese government.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P295; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Arnold SV, 2014, CIRCULATION, V129, P1303, DOI 10.1161/CIRCULATIONAHA.113.003589; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Buettner C, 2008, J GEN INTERN MED, V23, P1182, DOI 10.1007/s11606-008-0636-7; Cannon CP, 2013, J AM COLL CARDIOL, V61, P992, DOI 10.1016/j.jacc.2012.10.005; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cao Q, 2012, INT J HEALTH SERV, V42, P177, DOI 10.2190/HS.42.2.b; China Society of Cardiology of Chinese Medical Association, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P675; Chong PH, 2002, ANN PHARMACOTHER, V36, P1907, DOI 10.1345/aph.1C116; Dallongevillle J, 2010, HEART, V96, P1744, DOI 10.1136/hrt.2010.196170; Dharmarajan K, 2013, CIRC-CARDIOVASC QUAL, V6, P732, DOI 10.1161/CIRCOUTCOMES.113.000441; Elbarouni B, 2012, AM J CARDIOL, V109, P1418, DOI 10.1016/j.amjcard.2012.01.352; Ferrieres J, 2009, ATHEROSCLEROSIS, V204, P491, DOI 10.1016/j.atherosclerosis.2008.09.031; Guan F, 2010, CHINESE MED J-PEKING, V123, P884, DOI 10.3760/cma.j.issn.0366-6999.2010.07.022; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Hulten E, 2006, ARCH INTERN MED, V166, P1814, DOI 10.1001/archinte.166.17.1814; Jacobs AK, 2007, CIRCULATION, V116, P217, DOI 10.1161/CIRCULATIONAHA.107.184043; Ko DT, 2005, AM HEART J, V150, P419, DOI 10.1016/j.ahj.2004.09.057; Krumholz HM, 2008, J AM COLL CARDIOL, V52, P2046, DOI 10.1016/j.jacc.2008.10.012; Larsen AI, 2014, AM J CARDIOL, V113, P1273, DOI 10.1016/j.amjcard.2014.01.401; Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057; Lenderink T, 2006, EUR HEART J, V27, P1799, DOI 10.1093/eurheartj/ehl125; Li J, 2015, LANCET, V385, P441, DOI 10.1016/S0140-6736(14)60921-1; Li X, 2012, CHINESE MED J-PEKING, V125, P1703, DOI 10.3760/cma.j.issn.0366-6999.2012.10.005; Liao JK, 2007, AM J CARDIOL, V99, P410, DOI 10.1016/j.amjcard.2006.08.051; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Ministry of Labour and Social Security, 2004, ESS DRUG CAT NAT BAS; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Shiu JR, 2012, AM J CARDIOL, V109, P1, DOI 10.1016/j.amjcard.2011.07.064; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; The World Bank, HLTH HARM LIF CHIN S; Vale N, 2011, COCHRANE DB SYST REV, V6; Victor BM, 2014, AM J CARDIOL, V113, P1611, DOI 10.1016/j.amjcard.2014.02.018; Wang C, 2013, CHEST, V143, P524, DOI 10.1378/chest.12-1839	37	49	53	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0150806	10.1371/journal.pone.0150806	http://dx.doi.org/10.1371/journal.pone.0150806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058862	Green Submitted, Green Published, gold			2022-12-26	WOS:000373604800001
J	Fridrich, S; Hahn, SA; Linzmaier, M; Felten, M; Zwarg, J; Lennerz, V; Tuettenberg, A; Stocker, W				Fridrich, Sven; Hahn, Susanne A.; Linzmaier, Marion; Felten, Matthias; Zwarg, Jenny; Lennerz, Volker; Tuettenberg, Andrea; Stoecker, Walter			How Soluble GARP Enhances TGF beta Activation	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; LATENT COMPLEX; EXPRESSION; PROTEINS; SURFACE; TGF-BETA-1; GENES; TREG	GARP (glycoprotein A repetitions predominant) is a cell surface receptor on regulatory Tlymphocytes, platelets, hepatic stellate cells and certain cancer cells. Its described function is the binding and accommodation of latent TGF beta (transforming growth factor), before the activation and release of the mature cytokine. For regulatory T cells it was shown that a knockdown of GARP or a treatment with blocking antibodies dramatically decreases their immune suppressive capacity. This confirms a fundamental role of GARP in the basic function of regulatory T cells. Prerequisites postulated for physiological GARP function include membrane anchorage of GARP, disulfide bridges between the propeptide of TGF beta and GARP and connection of this propeptide to alpha(v)beta(6) or alpha(v)beta(8) integrins of target cells during mechanical TGF beta release. Other studies indicate the existence of soluble GARP complexes and a functionality of soluble GARP alone. In order to clarify the underlying molecular mechanism, we expressed and purified recombinant TGF beta and a soluble variant of GARP. Surprisingly, soluble GARP and TGF beta formed stable non-covalent complexes in addition to disulfide-coupled complexes, depending on the redox conditions of the microenvironment. We also show that soluble GARP alone and the two variants of complexes mediate different levels of TGF beta activity. TGF beta activation is enhanced by the non-covalent GARP-TGF beta complex already at low (nanomolar) concentrations, at which GARP alone does not show any effect. This supports the idea of soluble GARP acting as immune modulator in vivo.	[Fridrich, Sven; Linzmaier, Marion; Felten, Matthias; Stoecker, Walter] JGU Mainz, Inst Zool, Cell & Matrix Biol, Mainz, Germany; [Hahn, Susanne A.; Tuettenberg, Andrea] Univ Hosp Mainz, Dermatol, Mainz, Germany; [Zwarg, Jenny; Lennerz, Volker] Univ Hosp Mainz, Med Ctr 3, Mainz, Germany	Johannes Gutenberg University of Mainz; University Hospital Mainz; University Hospital Mainz	Stocker, W (corresponding author), JGU Mainz, Inst Zool, Cell & Matrix Biol, Mainz, Germany.	stoecker@uni-mainz.de	Stöcker, Walter/AAB-9704-2019	Stöcker, Walter/0000-0002-1515-6994	Deutsche Forschungsgemeinschaft (DFG) [GRK1043]; Research Center for Immunotherapy at the University Hospital Mainz; Wilhelm-Sander-Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Research Center for Immunotherapy at the University Hospital Mainz; Wilhelm-Sander-Stiftung	The authors acknowledge support by the Deutsche Forschungsgemeinschaft (DFG, GRK1043), by the Research Center for Immunotherapy at the University Hospital Mainz to WS and by the Wilhelm-Sander-Stiftung to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABSHER M, 1991, J IMMUNOL METHODS, V138, P301, DOI 10.1016/0022-1759(91)90179-J; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Buscemi L, 2011, CURR BIOL, V21, P2046, DOI 10.1016/j.cub.2011.11.037; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; D'Alise AM, 2011, P NATL ACAD SCI USA, V108, P8737, DOI 10.1073/pnas.1105364108; Gauthy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076186; Hahn SA, 2013, BLOOD, V122, P1182, DOI 10.1182/blood-2012-12-474478; Kalathil S, 2013, CANCER RES, V73, P2435, DOI 10.1158/0008-5472.CAN-12-3381; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; Kehrl BYJH, 1986, J EXP MED, V163, P1037; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Li YH, 2015, 3RD INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND INFORMATION ENGINEERING (CSIE 2015), P1; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; McMahon GA, 1996, BIOCHEM J, V313, P343, DOI 10.1042/bj3130343; Miller MM, 2013, AIDS RES HUM RETROV, V29, P641, DOI 10.1089/aid.2012.0322; Oida T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018365; OLLENDORFF V, 1994, CELL GROWTH DIFFER, V5, P213; Probst-Kepper M, 2009, J CELL MOL MED, V13, P3343, DOI 10.1111/j.1582-4934.2009.00782.x; Probst-Kepper M, 2009, TRANSFUS MED HEMOTH, V36, P302, DOI 10.1159/000235929; Robertson IB, 2013, CYTOKINE GROWTH F R, V24, P355, DOI 10.1016/j.cytogfr.2013.06.003; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Suarez-Pinzon WL, 2002, CELL TRANSPLANT, V11, P519; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu F, 1996, AM J PHYSIOL, pL879	31	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153290	10.1371/journal.pone.0153290	http://dx.doi.org/10.1371/journal.pone.0153290			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054568	Green Published, Green Submitted, gold			2022-12-26	WOS:000373608000116
J	Hoffmann, H; Zhao, G; Asseng, S; Bindi, M; Biernath, C; Constantin, J; Coucheney, E; Dechow, R; Doro, L; Eckersten, H; Gaiser, T; Grosz, B; Heinlein, F; Kassie, BT; Kersebaum, KC; Klein, C; Kuhnert, M; Lewan, E; Moriondo, M; Nendel, C; Priesack, E; Raynal, H; Roggero, PP; Rotter, RP; Siebert, S; Specka, X; Tao, FL; Teixeira, E; Trombi, G; Wallach, D; Weihermuller, L; Yeluripati, J; Ewert, F				Hoffmann, Holger; Zhao, Gang; Asseng, Senthold; Bindi, Marco; Biernath, Christian; Constantin, Julie; Coucheney, Elsa; Dechow, Rene; Doro, Luca; Eckersten, Henrik; Gaiser, Thomas; Grosz, Balazs; Heinlein, Florian; Kassie, Belay T.; Kersebaum, Kurt-Christian; Klein, Christian; Kuhnert, Matthias; Lewan, Elisabet; Moriondo, Marco; Nendel, Claas; Priesack, Eckart; Raynal, Helene; Roggero, Pier P.; Rotter, Reimund P.; Siebert, Stefan; Specka, Xenia; Tao, Fulu; Teixeira, Edmar; Trombi, Giacomo; Wallach, Daniel; Weihermueller, Lutz; Yeluripati, Jagadeesh; Ewert, Frank			Impact of Spatial Soil and Climate Input Data Aggregation on Regional Yield Simulations	PLOS ONE			English	Article							SYSTEMS SIMULATION; NITROGEN DYNAMICS; WINTER-WHEAT; CROP MODELS; DATA RESOLUTION; SCALE; WATER; VARIABILITY; CALIBRATION; WEATHER	We show the error in water-limited yields simulated by crop models which is associated with spatially aggregated soil and climate input data. Crop simulations at large scales (regional, national, continental) frequently use input data of low resolution. Therefore, climate and soil data are often generated via averaging and sampling by area majority. This may bias simulated yields at large scales, varying largely across models. Thus, we evaluated the error associated with spatially aggregated soil and climate data for 14 crop models. Yields of winter wheat and silage maize were simulated under water-limited production conditions. We calculated this error from crop yields simulated at spatial resolutions from 1 to 100 km for the state of North Rhine-Westphalia, Germany. Most models showed yields biased by <15% when aggregating only soil data. The relative mean absolute error (rMAE) of most models using aggregated soil data was in the range or larger than the inter-annual or inter-model variability in yields. This error increased further when both climate and soil data were aggregated. Distinct error patterns indicate that the rMAE may be estimated from few soil variables. Illustrating the range of these aggregation effects across models, this study is a first step towards an ex-ante assessment of aggregation errors in large-scale simulations.	[Hoffmann, Holger; Zhao, Gang; Gaiser, Thomas; Siebert, Stefan; Ewert, Frank] Univ Bonn, INRES, Crop Sci Grp, Bonn, Germany; [Asseng, Senthold; Kassie, Belay T.] Univ Florida, Agr & Biol Engn Dept, Gainesville, FL USA; [Bindi, Marco; Trombi, Giacomo] Univ Florence, Dept Agrifood Prod & Environm Sci, Florence, Italy; [Biernath, Christian; Heinlein, Florian; Klein, Christian; Priesack, Eckart] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biochem Plant Pathol, Neuherberg, Germany; [Constantin, Julie; Raynal, Helene; Wallach, Daniel] INRA, Auzeville, France; [Coucheney, Elsa; Lewan, Elisabet] Swedish Univ Agr Sci, Dept Soil & Environm, Uppsala, Sweden; [Dechow, Rene; Grosz, Balazs] Thunen Inst Climate Smart Agr, Braunschweig, Germany; [Doro, Luca; Roggero, Pier P.] Univ Sassari, Desertificat Res Grp, I-07100 Sassari, Italy; [Eckersten, Henrik] Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden; [Kersebaum, Kurt-Christian; Nendel, Claas; Specka, Xenia] Leibniz Ctr Agr Landscape Res, Inst Landscape Syst Anal, Muncheberg, Germany; [Kuhnert, Matthias] Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen, Scotland; [Moriondo, Marco] CNR, Ibimet, Florence, Italy; [Rotter, Reimund P.; Tao, Fulu] Nat Resources Inst Finland Luke, Environm Impacts Grp, Vantaa, Finland; [Teixeira, Edmar] New Zealand Inst Plant & Food Res Ltd, Canterbury Agr & Sci Ctr, Syst Modelling Team, Sustainable Prod Grp, Lincoln, New Zealand; [Weihermueller, Lutz] Forschungszentrum Julich, Agrosphere Inst IBG 3, D-52425 Julich, Germany; [Yeluripati, Jagadeesh] Craigiebuckler, James Hutton Inst, Aberdeen, Scotland	University of Bonn; State University System of Florida; University of Florida; University of Florence; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; INRAE; Swedish University of Agricultural Sciences; Johann Heinrich von Thunen Institute; University of Sassari; Swedish University of Agricultural Sciences; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); University of Aberdeen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); Natural Resources Institute Finland (Luke); New Zealand Institute for Plant & Food Research Ltd; Helmholtz Association; Research Center Julich; James Hutton Institute	Hoffmann, H (corresponding author), Univ Bonn, INRES, Crop Sci Grp, Bonn, Germany.	hhoffmann@uni-bonn.de	Specka, Xenia/U-8770-2019; Kersebaum, Kurt Christian/A-7558-2010; bindi, marco/M-6415-2014; Teixeira, Edmar/K-1238-2016; Priesack, Eckart/M-7341-2014; Wallach, Daniel/A-1194-2012; Grosz, Balazs/AFT-1500-2022; Gaiser, Thomas/AAD-6326-2021; Nendel, Claas/C-8844-2013; Doro, Luca/AAA-5596-2021; Asseng, Senthold/Y-6014-2019; Moriondo, Marco/H-5279-2019; Rötter, Reimund/Y-9579-2019; Roggero, Pier Paolo/D-2580-2012; Yeluripati, Jagadeesh/AAF-3283-2020; Siebert, Stefan/B-8621-2009; Hoffmann, Holger/A-8169-2013	Specka, Xenia/0000-0002-1890-0192; Kersebaum, Kurt Christian/0000-0002-3679-8427; bindi, marco/0000-0002-8968-954X; Teixeira, Edmar/0000-0002-4835-0590; Wallach, Daniel/0000-0003-3500-8179; Gaiser, Thomas/0000-0002-5820-2364; Nendel, Claas/0000-0001-7608-9097; Asseng, Senthold/0000-0002-7583-3811; Moriondo, Marco/0000-0002-8356-7517; Rötter, Reimund/0000-0002-3804-9964; Roggero, Pier Paolo/0000-0002-7269-4334; Yeluripati, Jagadeesh/0000-0003-3107-2595; Siebert, Stefan/0000-0002-9998-0672; Hoffmann, Holger/0000-0001-9811-5065; Trombi, Giacomo/0000-0002-3775-272X; Tao, F/0000-0001-8574-0080; coucheney, elsa/0000-0001-5988-2085; Kuhnert, Matthias/0000-0003-3284-2133; DORO, Luca/0000-0003-1404-2255; Ewert, Frank/0000-0002-4392-8154; Weihermuller, Lutz/0000-0003-1991-7735; Priesack, Eckart/0000-0002-5088-9528; Constantin, Julie/0000-0001-9647-5374	German Federal Ministry of Food and Agriculture (BMEL) through Federal Office for Agriculture and Food (BLE) [2851ERA01J]; FACCE MACSUR through Finnish Ministry of Agriculture and Forestry (MMM) [3200009600]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [220-2007-1218]; faculty of Natural Resources and Agricultural Sciences (Swedish University of Agricultural Sciences); INRA ACCAF metaprogram; UR MIAT INRA; Helmholtz project "REKLIM - Regional Climate Change"; HGF Alliance "Remote Sensing and Earth System Dynamics" (EDA); German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [FOR1695]; German Science Foundation [EW 119/5-1]; BBSRC [BB/K009265/1, BB/N004922/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K009265/1, BB/N004922/1] Funding Source: researchfish	German Federal Ministry of Food and Agriculture (BMEL) through Federal Office for Agriculture and Food (BLE); FACCE MACSUR through Finnish Ministry of Agriculture and Forestry (MMM); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); faculty of Natural Resources and Agricultural Sciences (Swedish University of Agricultural Sciences); INRA ACCAF metaprogram; UR MIAT INRA; Helmholtz project "REKLIM - Regional Climate Change"; HGF Alliance "Remote Sensing and Earth System Dynamics" (EDA); German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); German Science Foundation(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was financially supported by the German Federal Ministry of Food and Agriculture (BMEL) through the Federal Office for Agriculture and Food (BLE), (2851ERA01J). FT and RPR were supported by FACCE MACSUR (3200009600) through the Finnish Ministry of Agriculture and Forestry (MMM). EC, HE, and EL were supported by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (220-2007-1218) and by the strategic funding 'Soil-Water-Landscape' from the faculty of Natural Resources and Agricultural Sciences (Swedish University of Agricultural Sciences) and thank professor P-E Jansson (Royal Institute of Technology, Stockholm) for support. JC, HR, and DW thank the INRA ACCAF metaprogram for funding and Eric Casellas from UR MIAT INRA for support. CB was funded by the Helmholtz project "REKLIM - Regional Climate Change". CK was funded by the HGF Alliance "Remote Sensing and Earth System Dynamics" (EDA). FH was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) under the Grant FOR1695. FE and SS acknowledge support by the German Science Foundation (project EW 119/5-1). HH, GZ, SS, TG, and FE thank Andreas Enders and Gunther Krauss (INRES, University of Bonn) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AG-Boden, 2005, AD HOC ARB BOD BOD K; Angulo C, 2014, EUR J AGRON, V61, P35, DOI 10.1016/j.eja.2014.07.005; Angulo C, 2013, EUR J AGRON, V49, P104, DOI 10.1016/j.eja.2013.04.003; Asseng S, 2004, FIELD CROP RES, V85, P85, DOI 10.1016/S0378-4290(03)00154-0; Asseng S, 1998, FIELD CROP RES, V57, P163, DOI 10.1016/S0378-4290(97)00117-2; Baranowski P, 2015, CLIM RES, V65, P39, DOI 10.3354/cr01321; Baron C, 2005, PHILOS T R SOC B, V360, P2095, DOI 10.1098/rstb.2005.1741; Bergez JE, 2013, ENVIRON MODELL SOFTW, V39, P39, DOI 10.1016/j.envsoft.2012.03.011; Brisson N, 1998, AGRONOMIE, V18, P311, DOI 10.1051/agro:19980501; Brisson N., 2009, FORMALISATIONS PARAM; CALE WG, 1983, J THEOR BIOL, V100, P539, DOI 10.1016/0022-5193(83)90446-0; Cologne District Council (Bezirksregierung Koln), 2013, NORDRH WESTF ZAHL GE; Conrad Y, 2009, PHYS CHEM EARTH, V34, P530, DOI 10.1016/j.pce.2008.08.003; de Wit AJW, 2005, AGR FOREST METEOROL, V135, P156, DOI 10.1016/j.agrformet.2005.11.012; Del Grosso SJ, 2006, J ENVIRON QUAL, V35, P1451, DOI 10.2134/jeq2005.0160; Del Grosso SJ, 2001, MODELING CARBON AND NITROGEN DYNAMICS FOR SOIL MANAGEMENT, P303; Easterling WE, 1998, AGR FOREST METEOROL, V90, P51, DOI 10.1016/S0168-1923(97)00091-9; Ershadi A, 2013, REMOTE SENS ENVIRON, V131, P51, DOI 10.1016/j.rse.2012.12.007; Evans LT, 1999, CROP SCI, V39, P1544, DOI 10.2135/cropsci1999.3961544x; Ewert F, 2015, HDB CLIMATE CHANGE A, P262; Ewert F, 2011, AGR ECOSYST ENVIRON, V142, P6, DOI 10.1016/j.agee.2011.05.016; FAO, 2015, FAO WORLD SOIL RES R; Folberth C, 2012, ECOL MODEL, V235, P8, DOI 10.1016/j.ecolmodel.2012.03.035; Hansen JW, 2006, CLIM RES, V33, P27, DOI 10.3354/cr033027; Hansen JW, 2000, AGR SYST, V65, P43, DOI 10.1016/S0308-521X(00)00025-1; Herbst M, 2008, ECOL MODEL, V214, P271, DOI 10.1016/j.ecolmodel.2008.02.007; Hoffmann H, 2015, CLIM RES, V65, P53, DOI 10.3354/cr01326; Hoffmann H, 2016, CLIMATE SOIL INPUT D; Hoffmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075033; Holzworth DP, 2014, ENVIRON MODELL SOFTW, V62, P327, DOI 10.1016/j.envsoft.2014.07.009; Janssen S, 2009, ENVIRON SCI POLICY, V12, P573, DOI 10.1016/j.envsci.2009.01.007; Jansson PE, 2012, T ASABE, V55, P1335; Jansson P.E., 2004, COUPLED HEAT MASS TR; Keating BA, 2003, EUR J AGRON, V18, P267, DOI 10.1016/S1161-0301(02)00108-9; Kersebaum KC, 2011, ADV AGR SYST MODEL, V2, P65, DOI 10.2134/advagricsystmodel2.c2; Kersebaum KC, 1998, NUTR CYCL AGROECOSYS, V50, P313, DOI 10.1023/A:1009721218584; Kersebaum KC, 2007, NUTR CYCL AGROECOSYS, V77, P39, DOI 10.1007/s10705-006-9044-8; Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813; Lugato E, 2006, GEODERMA, V135, P315, DOI 10.1016/j.geoderma.2006.01.012; Meentemeyer V, 1989, LANDSCAPE ECOL, V3, P163, DOI 10.1007/BF00131535; Nendel C, 2013, FIELD CROP RES, V145, P67, DOI 10.1016/j.fcr.2013.02.014; Nendel C, 2011, ECOL MODEL, V222, P1614, DOI 10.1016/j.ecolmodel.2011.02.018; Olesen JE, 2000, AGR ECOSYST ENVIRON, V82, P213, DOI 10.1016/S0167-8809(00)00227-9; Parton WJ, 2001, J GEOPHYS RES-ATMOS, V106, P17403, DOI 10.1029/2001JD900101; Parton WJ, 1992, CENTURY USERS MANUAL; PIERCE LL, 1995, LANDSCAPE ECOL, V10, P239, DOI 10.1007/BF00129258; POESEN J, 1994, CATENA, V23, P1, DOI 10.1016/0341-8162(94)90050-7; Priesack E, 2006, NUTR CYCL AGROECOSYS, V75, P1, DOI 10.1007/s10705-006-9006-1; RASTETTER EB, 1992, ECOL APPL, V2, P55, DOI 10.2307/1941889; Rezaei EE, 2015, EUR J AGRON, V65, P69, DOI 10.1016/j.eja.2015.02.003; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Shibu ME, 2010, EUR J AGRON, V32, P255, DOI 10.1016/j.eja.2010.01.003; Specka X, 2015, EUR J AGRON, V71, P73, DOI 10.1016/j.eja.2015.08.004; Stockle CO, 2003, EUR J AGRON, V18, P289, DOI 10.1016/S1161-0301(02)00109-0; Tao F, 2009, AGR FOREST METEOROL, V149, P831, DOI 10.1016/j.agrformet.2008.11.004; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Therond O, 2011, AGR ECOSYST ENVIRON, V142, P85, DOI 10.1016/j.agee.2010.05.007; TORRI D, 1994, CATENA, V23, P65, DOI 10.1016/0341-8162(94)90053-1; van Bussel LGJ, 2011, AGR ECOSYST ENVIRON, V142, P75, DOI 10.1016/j.agee.2010.03.019; van Ittersum MK, 2003, EUR J AGRON, V18, P201, DOI 10.1016/S1161-0301(02)00106-5; vanIttersum MK, 1997, FIELD CROP RES, V52, P197, DOI 10.1016/S0378-4290(97)00037-3; Wang EL, 2000, ENVIRON MODELL SOFTW, V15, P179, DOI 10.1016/S1364-8152(99)00033-X; Wassenaar T, 1999, CLIMATE RES, V11, P209, DOI 10.3354/cr011209; Webber H, 2015, EUR J AGRON, V71, P123, DOI 10.1016/j.eja.2015.09.002; WENDLING U, 1995, WASSERWIRTSCHAFT, V85, P602; Williams J. R., 1995, Computer models of watershed hydrology., P909; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Yeluripati JB, 2009, SOIL BIOL BIOCHEM, V41, P2579, DOI 10.1016/j.soilbio.2009.08.021; Zhao G, 2015, CLIM RES, V65, P141, DOI 10.3354/cr01301; Zhao G, 2015, AGR FOREST METEOROL, V200, P156, DOI 10.1016/j.agrformet.2014.09.026; Zhao G, 2013, GLOBAL CHANGE BIOL, V19, P1585, DOI 10.1111/gcb.12145; [No title captured], DOI DOI 10.1016/J.AGRFORMET.2011.10.003	72	65	72	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0151782	10.1371/journal.pone.0151782	http://dx.doi.org/10.1371/journal.pone.0151782			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055028	Green Published, Green Accepted, gold			2022-12-26	WOS:000373608000007
J	Lizandra, J; Devis-Devis, J; Perez-Gimeno, E; Valencia-Peris, A; Peiro-Velert, C				Lizandra, Jorge; Devis-Devis, Jose; Perez-Gimeno, Esther; Valencia-Peris, Alexandra; Peiro-Velert, Carmen			Does Sedentary Behavior Predict Academic Performance in Adolescents or the Other Way Round? A Longitudinal Path Analysis	PLOS ONE			English	Article							ELECTRONIC MEDIA USE; PHYSICAL-ACTIVITY; PROSOCIAL BEHAVIOR; PROSPECTIVE COHORT; ACHIEVEMENT; HEALTH; SCHOOL; TELEVISION; CHILDREN; YOUTH	This study examined whether adolescents' time spent on sedentary behaviors (academic, technological-based and social-based activities) was a better predictor of academic performance than the reverse. A cohort of 755 adolescents participated in a three-year period study. Structural Equation Modeling techniques were used to test plausible causal hypotheses. Four competing models were analyzed to determine which model best fitted the data. The Best Model was separately tested by gender. The Best Model showed that academic performance was a better predictor of sedentary behaviors than the other way round. It also indicated that students who obtained excellent academic results were more likely to succeed academically three years later. Moreover, adolescents who spent more time in the three different types of sedentary behaviors were more likely to engage longer in those sedentary behaviors after the three-year period. The better the adolescents performed academically, the less time they devoted to social-based activities and more to academic activities. An inverse relationship emerged between time dedicated to technological-based activities and academic sedentary activities. A moderating auto-regressive effect by gender indicated that boys were more likely to spend more time on technological-based activities three years later than girls. To conclude, previous academic performance predicts better sedentary behaviors three years later than the reverse. The positive longitudinal auto-regressive effects on the four variables under study reinforce the 'success breeds success' hypothesis, with academic performance and social-based activities emerging as the strongest ones. Technological-based activities showed a moderating effect by gender and a negative longitudinal association with academic activities that supports a displacement hypothesis. Other longitudinal and covariate effects reflect the complex relationships among sedentary behaviors and academic performance and the need to explore these relationships in depth. Theoretical and practical implications for school health are outlined.	[Lizandra, Jorge; Devis-Devis, Jose] Univ Valencia, Dept Educ Fis & Esport, Valencia, Spain; [Perez-Gimeno, Esther; Valencia-Peris, Alexandra; Peiro-Velert, Carmen] Univ Valencia, Dept Didact Expressio Mus Plast & Corporal, Valencia, Spain	University of Valencia; University of Valencia	Devis-Devis, J (corresponding author), Univ Valencia, Dept Educ Fis & Esport, Valencia, Spain.	jose.devis@uv.es	Valencia-Peris, Alexandra/ABE-5860-2020; Devis-Devis, Jose/G-8758-2015; Lizandra, Jorge/O-6916-2015; Valencia-Peris, Alexandra/L-2260-2014; Peiró-Velert, Carmen/N-6056-2015	Valencia-Peris, Alexandra/0000-0002-2031-9743; Devis-Devis, Jose/0000-0003-4599-3782; Lizandra, Jorge/0000-0001-5599-133X; Peiró-Velert, Carmen/0000-0003-4794-6541	Ministry of Science and Innovation [EDU2009-13664]; Generalitat Valenciana (Spain) [ACIF/2013/214]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF))	The Ministry of Science and Innovation partially funded this paper (research project EDU2009-13664 to CPV). The Generalitat Valenciana (Spain) supported the VALi+d predoctoral contract to Jorge Lizandra (ACIF/2013/214). There was no additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Biddle SJH, 2009, INT J BEHAV MED, V16, P278, DOI 10.1007/s12529-008-9028-y; Bryant AL, 2003, J RES ADOLESCENCE, V13, P361, DOI 10.1111/1532-7795.1303005; CDC (Centers for Disease Control and Prevention), 2010, ASS SCH BAS PHYS ACT; Costigan SA, 2013, J ADOLESCENT HEALTH, V52, P382, DOI 10.1016/j.jadohealth.2012.07.018; Crespo CJ, 2001, ARCH PEDIAT ADOL MED, V155, P360, DOI 10.1001/archpedi.155.3.360; Flaig G., 1994, EMPIR ECON, V19, P55, DOI [DOI 10.1007/BF01205728, 10.1007/BF01205728]; Garcia-Continente X, 2014, EUR J PUBLIC HEALTH, V24, P5, DOI 10.1093/eurpub/ckt013; Gonzalez LM, 2011, HAEMOPHILIA, V17, P676, DOI 10.1111/j.1365-2516.2010.02469.x; Greenberg MT, 2010, J CONSULT CLIN PSYCH, V78, P156, DOI 10.1037/a0018607; Hardy LL, 2007, PREV MED, V45, P71, DOI 10.1016/j.ypmed.2007.03.014; Hardy LL, 2006, AUST NZ J PUBL HEAL, V30, P534, DOI 10.1111/j.1467-842X.2006.tb00782.x; Hardy LL, 2007, J ADOLESCENT HEALTH, V40, P158, DOI 10.1016/j.jadohealth.2006.09.009; Hardy LL, 2010, ARCH PEDIAT ADOL MED, V164, P643, DOI 10.1001/archpediatrics.2010.88; Hardy LL, 2009, AM J PREV MED, V36, P120, DOI 10.1016/j.amepre.2008.09.034; Henry KL, 2007, HEALTH EDUC RES, V22, P372, DOI 10.1093/her/cyl083; Hinkley T, 2014, JAMA PEDIATR, V168, P485, DOI 10.1001/jamapediatrics.2014.94; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iannotti RJ, 2009, INT J PUBLIC HEALTH, V54, P191, DOI 10.1007/s00038-009-5410-z; Ingles CJ, 2009, AN PSICOL-SPAIN, V25, P93; Jackson LA, 2011, COMPUT HUM BEHAV, V27, P228, DOI 10.1016/j.chb.2010.08.001; Johnson JG, 2007, ARCH PEDIAT ADOL MED, V161, P480, DOI 10.1001/archpedi.161.5.480; Kam Chi-Ming, 2003, Prev Sci, V4, P55, DOI 10.1023/A:1021786811186; Lassen SR, 2006, PSYCHOL SCHOOLS, V43, P701, DOI 10.1002/pits.20177; Le-Scherban F, 2014, ANN EPIDEMIOL, V24, P344, DOI 10.1016/j.annepidem.2014.02.008; Levine LE, 2007, CYBERPSYCHOL BEHAV, V10, P560, DOI 10.1089/cpb.2007.9990; Little TD, 1997, MULTIVAR BEHAV RES, V32, P53, DOI 10.1207/s15327906mbr3201_3; Lubans DR, 2011, OBES REV, V12, P781, DOI 10.1111/j.1467-789X.2011.00896.x; Majem LS, 2003, MED CLIN-BARCELONA, V121, P725, DOI 10.1016/S0025-7753(03)74077-9; Mathers M, 2009, ACAD PEDIATR, V9, P307, DOI 10.1016/j.acap.2009.04.003; Morley BC, 2012, MED J AUSTRALIA, V196, P189, DOI 10.5694/mja11.11184; Nelson MC, 2006, PEDIATRICS, V117, P1281, DOI 10.1542/peds.2005-1692; Norris T.L., 2010, THESIS; Peiro-Velert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099478; Prot S, 2014, PSYCHOL SCI, V25, P358, DOI 10.1177/0956797613503854; Rideout V. J., 2010, MEDIA LIVES 8 18 YEA; Romer D, 2013, J ADOLESCENT HEALTH, V52, P613, DOI 10.1016/j.jadohealth.2012.11.012; Ross CE, 2000, SOCIOL EDUC, V73, P270, DOI 10.2307/2673234; Ruiz JR, 2010, J PEDIATR-US, V157, P917, DOI 10.1016/j.jpeds.2010.06.026; Salanova M, 2010, ANXIETY STRESS COPIN, V23, P53, DOI 10.1080/10615800802609965; Santoro M. D., 2000, J HIGH TECHNOLOGY MA, V11, P255, DOI DOI 10.1016/S1047-8310(00)00032-8; Serrano-Sanchez JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024453; Sharif I, 2010, J ADOLESCENT HEALTH, V46, P52, DOI 10.1016/j.jadohealth.2009.05.012; Shin N, 2004, J GENET PSYCHOL, V165, P367, DOI 10.3200/GNTP.165.4.367-382; Solana AA, 2015, RES Q EXERCISE SPORT, V86, P233, DOI 10.1080/02701367.2015.1039891; Subrahmanyam K, 2001, J APPL DEV PSYCHOL, V22, P7, DOI 10.1016/S0193-3973(00)00063-0; Swing EL, 2010, PEDIATRICS, V126, P214, DOI 10.1542/peds.2009-1508; Valencia-Peris A, CULT ED IN PRESS; Walsh JL, 2013, EMERG ADULTHOOD, V1, P219, DOI 10.1177/2167696813479780; Westerlund H, 2013, J EPIDEMIOL COMMUN H, V67, P508, DOI 10.1136/jech-2012-202052	51	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153272	10.1371/journal.pone.0153272	http://dx.doi.org/10.1371/journal.pone.0153272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27055121	Green Published, gold			2022-12-26	WOS:000373608000112
J	Lopes, MW; Sapio, MR; Leal, RB; Fricker, LD				Lopes, Mark William; Sapio, Matthew R.; Leal, Rodrigo B.; Fricker, Lloyd D.			Knockdown of Carboxypeptidase A6 in Zebrafish Larvae Reduces Response to Seizure-Inducing Drugs and Causes Changes in the Level of mRNAs Encoding Signaling Molecules	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; AMPA RECEPTOR PHOSPHORYLATION; TIME-DEPENDENT MODULATION; PILOCARPINE MODEL; STATUS EPILEPTICUS; RAT HIPPOCAMPUS; CORTEX; ANTICONVULSANT; IDENTIFICATION; ENDOTHELIN-1	Carboxypeptidase A6 (CPA6) is an extracellular matrix metallocarboxypeptidase that modulates peptide and protein function by removal of hydrophobic C-terminal amino acids. Mutations in the human CPA6 gene that reduce enzymatic activity in the extracellular matrix are associated with febrile seizures, temporal lobe epilepsy, and juvenile myoclonic epilepsy. The characterization of these human mutations suggests a dominant mode of inheritance by haploinsufficiency through loss of function mutations, however the total number of humans with pathologic mutations in CPA6 identified to date remains small. To better understand the relationship between CPA6 and seizures we investigated the effects of morpholino knockdown of cpa6 mRNA in zebrafish (Danio rerio) larvae. Knockdown of cpa6 mRNA resulted in resistance to the effect of seizure-inducing drugs pentylenetetrazole and pilocarpine on swimming behaviors. Knockdown of cpa6 mRNA also reduced the levels of mRNAs encoding neuropeptide precursors (bdnf, npy, chga, pcsk1nl, tac1, nts, edn1), a neuropeptide processing enzyme (cpe), transcription factor (c-fos), and molecules implicated in glutamatergic signaling (grin1a and slc1a2b). Treatment of zebrafish embryos with 60 mM pilocarpine for 1 hour led to reductions in levels of many of the same mRNAs when measured 1 day after pilocarpine exposure, except for c-fos which was elevated 1 day after pilocarpine treatment. Pilocarpine treatment, like cpa6 knockdown, led to a reduced sensitivity to pentylenetetrazole when tested 1 day after pilocarpine treatment. Taken together, these results add to mounting evidence that peptidergic systems participate in the biological effects of seizure-inducing drugs, and are the first in vivo demonstration of the molecular and behavioral consequences of cpa6 insufficiency.	[Lopes, Mark William; Leal, Rodrigo B.] Univ Fed Santa Catarina, Programa Posgrad Bioquim, Dept Bioquim, Ctr Ciencias Biol, Florianopolis, SC, Brazil; [Sapio, Matthew R.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Universidade Federal de Santa Catarina (UFSC); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA.; Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	lloyd.fricker@einstein.yu.edu	Sapio, Matthew R/J-5096-2016; Leal, Rodrigo Bainy/AAL-1938-2020; Lopes, Mark William/F-3109-2015	Sapio, Matthew R/0000-0002-8855-5419; Leal, Rodrigo/0000-0003-2536-6888; Lopes, Mark William/0000-0002-5292-8455	U. S. National Institutes of Health [R01-DA004494]; National Council for Scientific and Technological Development (CNPq) Brazil [308459/2013-0]; National Coordination for the Training and Improvement of Higher Education Personnel (CAPES) [249/14]; Santa Catarina State Research Foundation (FAPESC/PRONEX Program - NENASC project) [1262/2012-9]; INCT-National Institute of Science and Technology; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Council for Scientific and Technological Development (CNPq) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Coordination for the Training and Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Santa Catarina State Research Foundation (FAPESC/PRONEX Program - NENASC project); INCT-National Institute of Science and Technology; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by U. S. National Institutes of Health grant R01-DA004494 and by the National Council for Scientific and Technological Development (CNPq) Brazil (#308459/2013-0); National Coordination for the Training and Improvement of Higher Education Personnel (CAPES; #249/14); Santa Catarina State Research Foundation (FAPESC/PRONEX Program - NENASC project; and #1262/2012-9), INCT-National Institute of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054166; Allen NM, 2016, EPILEPSIA, V57, pE12, DOI 10.1111/epi.13250; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2007, EPILEPSIA, V48, P1151, DOI 10.1111/j.1528-1167.2007.01075.x; Baraban SC, 2009, NEUROMETHODS, V40, P59, DOI 10.1007/978-1-60327-263-6_4; BARKAI E, 1994, J NEUROPHYSIOL, V72, P72, DOI 10.1152/jn.1994.72.1.72; Bartolomei F, 2005, EPILEPSIA, V46, P677, DOI 10.1111/j.1528-1167.2005.43804.x; BIAGINI G, 1995, NEUROSCI LETT, V190, P212, DOI 10.1016/0304-3940(95)11529-6; Brunson KL, 2002, INT REV NEUROBIOL, V49, P185; Campbell PD, 2014, J NEUROSCI, V34, P14717, DOI 10.1523/JNEUROSCI.2770-14.2014; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; Clynen E, 2014, MOL NEUROBIOL, V50, P626, DOI 10.1007/s12035-014-8669-x; Eddins D, 2010, NEUROTOXICOL TERATOL, V32, P99, DOI 10.1016/j.ntt.2009.02.005; FERRENDELLI JA, 1989, EPILEPSIA, V30, P617, DOI 10.1111/j.1528-1157.1989.tb05482.x; Fontenele-Neto JD, 2005, MOL BRAIN RES, V137, P132, DOI 10.1016/j.molbrainres.2005.02.026; Goto EM, 2010, NEUROPEPTIDES, V44, P169, DOI 10.1016/j.npep.2009.12.007; Guipponi M, 2015, HUM MOL GENET, V24, P3082, DOI 10.1093/hmg/ddv060; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hortopan GA, 2010, DIS MODEL MECH, V3, P144, DOI 10.1242/dmm.002139; Jo SM, 2011, NEUROSCI LETT, V501, P25, DOI 10.1016/j.neulet.2011.06.032; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kovac S, 2013, NEUROPEPTIDES, V47, P467, DOI 10.1016/j.npep.2013.10.015; Kudo H, 2009, ENDOCRINOLOGY, V150, P1393, DOI 10.1210/en.2008-1301; Lawrence C, 2011, METHOD CELL BIOL, V104, P431, DOI 10.1016/B978-0-12-374814-0.00023-9; Lee HK, 2009, CHEMMEDCHEM, V4, P400, DOI 10.1002/cmdc.200800421; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lopes MW, 2015, NEUROCHEM INT, V87, P22, DOI 10.1016/j.neuint.2015.05.003; Lopes MW, 2013, EXP BRAIN RES, V226, P153, DOI 10.1007/s00221-013-3421-8; Lopes MW, 2012, NEUROCHEM RES, V37, P1868, DOI 10.1007/s11064-012-0797-y; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Lyons PJ, 2010, J BIOL CHEM, V285, P38234, DOI 10.1074/jbc.M110.158626; Lyons PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012967; McNamara J.O., 2012, JASPERS BASIC MECH E; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; MIRSKI MA, 1986, BRAIN RES, V399, P212, DOI 10.1016/0006-8993(86)91511-8; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Okumura A, 2006, SEIZURE-EUR J EPILEP, V15, P469, DOI 10.1016/j.seizure.2006.05.010; Patrylo PR, 1999, J NEUROPHYSIOL, V82, P478, DOI 10.1152/jn.1999.82.1.478; PIREDDA S, 1985, NATURE, V317, P623, DOI 10.1038/317623a0; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; PSARROPOULOU C, 1994, EPILEPSIA, V35, P12, DOI 10.1111/j.1528-1157.1994.tb02906.x; Salzmann Annick, 2012, Epilepsy Res Treat, V2012, P863702, DOI 10.1155/2012/863702; Salzmann A, 2012, HUM MUTAT, V33, P124, DOI 10.1002/humu.21613; Sapio MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123180; Sapio MR, 2014, PROTEOM CLIN APPL, V8, P327, DOI 10.1002/prca.201300090; Sapio MR, 2012, J BIOL CHEM, V287, P42900, DOI 10.1074/jbc.M112.414094; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; SHANK RP, 1994, EPILEPSIA, V35, P450, DOI 10.1111/j.1528-1157.1994.tb02459.x; SHIMEKAKE Y, 1992, FEBS LETT, V309, P185, DOI 10.1016/0014-5793(92)81091-Y; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; Tsenov G, 2007, EPILEPSIA, V48, P7, DOI 10.1111/j.1528-1167.2007.01282.x; Vermoesen K, 2011, EPILEPSY BEHAV, V22, P450, DOI 10.1016/j.yebeh.2011.08.016; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	55	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152905	10.1371/journal.pone.0152905	http://dx.doi.org/10.1371/journal.pone.0152905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050163	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500065
J	Sharma, S; Toledo, O; Hedden, M; Lyon, KF; Brooks, SB; David, RP; Limtong, J; Newsome, JM; Novakovic, N; Rajasekaran, S; Thapar, V; Williams, SR; Schiller, MR				Sharma, Surbhi; Toledo, Oniel; Hedden, Michael; Lyon, Kenneth F.; Brooks, Steven B.; David, Roxanne P.; Limtong, Justin; Newsome, Jacklyn M.; Novakovic, Nemanja; Rajasekaran, Sanguthevar; Thapar, Vishal; Williams, Sean R.; Schiller, Martin R.			The Functional Human C-Terminome	PLOS ONE			English	Article							MINIMOTIF MINER; PROTEIN-INTERACTION; DATABASE; RESOURCE; DOMAIN; PREDICTION; SIGNATURES; DIVERSITY; LIGANDS; BINDING	All translated proteins end with a carboxylic acid commonly called the C-terminus. Many short functional sequences (minimotifs) are located on or immediately proximal to the C-terminus. However, information about the function of protein C-termini has not been consolidated into a single source. Here, we built a new "C-terminome" database and web system focused on human proteins. Approximately 3,600 C-termini in the human proteome have a minimotif with an established molecular function. To help evaluate the function of the remaining C-termini in the human proteome, we inferred minimotifs identified by experimentation in rodent cells, predicted minimotifs based upon consensus sequence matches, and predicted novel highly repetitive sequences in C-termini. Predictions can be ranked by enrichment scores or Gene Evolutionary Rate Profiling (GERP) scores, a measurement of evolutionary constraint. By searching for new anchored sequences on the last 10 amino acids of proteins in the human proteome with lengths between 3-10 residues and up to 5 degenerate positions in the consensus sequences, we have identified new consensus sequences that predict instances in the majority of human genes. All of this information is consolidated into a database that can be accessed through a C-terminome web system with search and browse functions for minimotifs and human proteins. A known consensus sequence-based predicted function is assigned to nearly half the proteins in the human proteome. Weblink: http://cterminome.bio-toolkit.com.	[Sharma, Surbhi; Toledo, Oniel; Hedden, Michael; Lyon, Kenneth F.; Brooks, Steven B.; David, Roxanne P.; Limtong, Justin; Newsome, Jacklyn M.; Novakovic, Nemanja; Williams, Sean R.; Schiller, Martin R.] Univ Nevada, Nevada Inst Personalized Med, Las Vegas, NV 89154 USA; [Sharma, Surbhi; Toledo, Oniel; Hedden, Michael; Lyon, Kenneth F.; Brooks, Steven B.; David, Roxanne P.; Limtong, Justin; Newsome, Jacklyn M.; Novakovic, Nemanja; Williams, Sean R.; Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Rajasekaran, Sanguthevar] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Thapar, Vishal] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Connecticut; Harvard University; Massachusetts General Hospital	Schiller, MR (corresponding author), Univ Nevada, Nevada Inst Personalized Med, Las Vegas, NV 89154 USA.; Schiller, MR (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	martin.schiller@unlv.edu		Schiller, Martin R/0000-0003-1671-6823; Sharma, Surbhi/0000-0001-9288-2685; Novakovic, Nemanja/0000-0002-1681-7715	National Institutes of Health [R15 GM107983, R01 GM079689, R01 LM010101]; Graduate and Professional Students Association, University of Nevada, Las Vegas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079689, R15GM107983] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate and Professional Students Association, University of Nevada, Las Vegas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institutes of Health (http://www.nih.gov) grants R15 GM107983, R01 GM079689 to MRS, and R01 LM010101 to SR. The Graduate and Professional Students Association, University of Nevada, Las Vegas also funded SS.	Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Agarwala R, 2015, NUCLEIC ACIDS RES, V43, pD6, DOI 10.1093/nar/gku1130; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Attwood TK, 1997, J CHEM INF COMP SCI, V37, P417, DOI 10.1021/ci960468e; Austin RS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-191; Bahir I, 2005, NUCLEIC ACIDS RES, V33, pW277, DOI 10.1093/nar/gki371; Bahir I, 2006, PROTEINS, V63, P996, DOI 10.1002/prot.20903; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Chung JJ, 2003, MOL CELL PROTEOMICS, V2, P173, DOI 10.1074/mcp.M300008-MCP200; Chung JJ, 2002, TRENDS CELL BIOL, V12, P146, DOI 10.1016/S0962-8924(01)02241-3; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Davey NE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-14; Dinkel H, 2011, NUCL ACIDS RES; Ezkurdia I, 2014, HUM MOL GENET; Fernandez-Suarez XM, 2014, NUCLEIC ACIDS RES, V42, pD1, DOI 10.1093/nar/gkt1282; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; FUJIKI Y, 1992, No To Hattatsu, V24, P181; Gatto GJ, 2003, GENOME RES, V13, P617, DOI 10.1101/gr.667603; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hui S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-507; Jacob E, 2007, BIOINFORMATICS, V23, pE225, DOI 10.1093/bioinformatics/btl318; Jones JM, 1999, J BIOL CHEM, V274, P9216, DOI 10.1074/jbc.274.14.9216; Kadaveru K, 2008, FRONT BIOSCI, V13, P6455, DOI 10.2741/3166; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; Lam HYK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-243; Lange PF, 2012, NUCLEIC ACIDS RES, V40, pD351, DOI 10.1093/nar/gkr1025; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lyon KF, 2015, NUCL ACIDS RES; McEntyre J, 2001, CAN MED ASSOC J, V164, P1317; Mi T, 2012, NUCLEIC ACIDS RES, V40, pD252, DOI 10.1093/nar/gkr1189; Mullen RT, 1997, PLANT J, V12, P313, DOI 10.1046/j.1365-313X.1997.12020313.x; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Nikolaus Fortelny SY, 2014, NUCL ACIDS RES; Parthasarathi L, 2008, J CHEM INF MODEL, V48, P1943, DOI 10.1021/ci800174c; Prakash T, 2004, BIOINFORMATICS, V20, P2886, DOI 10.1093/bioinformatics/bth325; Rajasekaran S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012276; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Sargeant DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049957; Schilling O, 2010, NAT METHODS, V7, P508, DOI [10.1038/NMETH.1467, 10.1038/nmeth.1467]; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Takeda J, 2010, NUCLEIC ACIDS RES, V38, pD86, DOI 10.1093/nar/gkp984; Uyar B, 2014, MOL BIOSYST, V10, P2626, DOI 10.1039/c4mb00290c; Vyas J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-360; Weatheritt RJ, 2012, NUCL ACIDS RES	54	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152731	10.1371/journal.pone.0152731	http://dx.doi.org/10.1371/journal.pone.0152731			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050421	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500051
J	Brendtke, R; Wiehl, M; Groeber, F; Schwarz, T; Walles, H; Hansmann, J				Brendtke, Rico; Wiehl, Michael; Groeber, Florian; Schwarz, Thomas; Walles, Heike; Hansmann, Jan			Feasibility Study on a Microwave-Based Sensor for Measuring Hydration Level Using Human Skin Models	PLOS ONE			English	Article							HYPERNATREMIA; PERFORMANCE; POWER	Tissue dehydration results in three major types of exsiccosis-hyper-, hypo-, or isonatraemia. All three types entail alterations of salt concentrations leading to impaired biochemical processes, and can finally cause severe morbidity. The aim of our study was to demonstrate the feasibility of a microwave-based sensor technology for the non-invasive measurement of the hydration status. Electromagnetic waves at high frequencies interact with molecules, especially water. Hence, if a sample contains free water molecules, this can be detected in a reflected microwave signal. To develop the sensor system, human three-dimensional skin equivalents were instituted as a standardized test platform mimicking reproducible exsiccosis scenarios. Therefore, skin equivalents with a specific hydration and density of matrix components were generated and microwave measurements were performed. Hydration-specific spectra allowed deriving the hydration state of the skin models. A further advantage of the skin equivalents was the characterization of the impact of distinct skin components on the measured signals to investigate mechanisms of signal generation. The results demonstrate the feasibility of a non-invasive microwave-based hydration sensor technology. The sensor bears potential to be integrated in a wearable medical device for personal health monitoring.	[Brendtke, Rico; Walles, Heike; Hansmann, Jan] Univ Hosp Wuerzburg, Chair Tissue Engn & Regenerat Med TERM, Roentgenring 11, D-97070 Wurzburg, Germany; [Brendtke, Rico; Wiehl, Michael] Senet Healthcare Grp GmbH & Co KG, Henkestr 91, D-91052 Erlangen, Germany; [Groeber, Florian; Schwarz, Thomas; Walles, Heike; Hansmann, Jan] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Translat Ctr Oncol Wuerzburg Regenerat Therapies, Roentgenring 11, D-97070 Wurzburg, Germany	University of Wurzburg; Fraunhofer Gesellschaft	Hansmann, J (corresponding author), Univ Hosp Wuerzburg, Chair Tissue Engn & Regenerat Med TERM, Roentgenring 11, D-97070 Wurzburg, Germany.; Hansmann, J (corresponding author), Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Translat Ctr Oncol Wuerzburg Regenerat Therapies, Roentgenring 11, D-97070 Wurzburg, Germany.	Jan.Hansmann@uni-wuerzburg.de		Walles, Heike/0000-0002-1512-7448	German Federal Ministry of Education and Research (BMBF) [16SV6259]; GmbH Co.	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); GmbH Co.	This project was supported by the German Federal Ministry of Education and Research (BMBF, funding number: 16SV6259). senetics healthcare group GmbH & Co. KG provided support in the form of salaries for authors [RB, MW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 60601 1 VDE 0750 1 2; Attas-Fox L, 2014, ORBIT, V33, P331, DOI 10.3109/01676830.2014.882362; Brendtke R, 2015, BR J HEAL INFORM MON, V2, P11; DAGGETT P, 1979, BRIT MED J, V1, P1177, DOI 10.1136/bmj.1.6172.1177; De Wever B., 2015, APPL IN VITRO TOXICO, V1, P5, DOI [10.1089/aivt.2014.0011, DOI 10.1089/AIVT.2014.0011, 10.1089/AIVT.2014.0011]; FAYAD IM, 1992, LANCET, V339, P389, DOI 10.1016/0140-6736(92)90079-I; Groeber F, 2014, PHARM RES, P1; Guiraud B, 2014, INT J COSMETIC SCI, V36, P485, DOI 10.1111/ics.12150; Hofmann M, 2013, IEEE TOPIC CONF BIOM, P46, DOI 10.1109/BioWireleSS.2013.6613670; Hofmann M., 2012, IEEE MTT S INT MICR, P1, DOI DOI 10.1109/MWSYM.2012.6259771; Hofmann M, 2013, MICROWAVE BASED NONI; Huang CY, 2014, SENSORS-BASEL, V14, P17586, DOI 10.3390/s140917586; Hung K., 2015, MOBILE HLTH, P319, DOI [DOI 10.1007/978-3-319-12817-7_15, 10.1007/978-3-319-12817-7_15]; ICRP, 2012, ICRP PUBL, V118, P40; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Jequier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111; JOINES WT, 1980, INT J RADIAT ONCOL, V6, P681, DOI 10.1016/0360-3016(80)90223-0; Judelson DA, 2007, MED SCI SPORT EXER, V39, P1817, DOI 10.1249/mss.0b013e3180de5f22; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; Kozier B., 2008, FUNDAMENTALS NURSING; LOVELL CR, 1987, BRIT J DERMATOL, V117, P419, DOI 10.1111/j.1365-2133.1987.tb04921.x; Marino FE, 2004, J THERM BIOL, V29, P21, DOI 10.1016/j.jtherbio.2003.08.008; Mathes SH, 2014, ADV DRUG DELIVER REV, V69, P81, DOI 10.1016/j.addr.2013.12.006; MONTAIN SJ, 1992, J APPL PHYSIOL, V73, P1340, DOI 10.1152/jappl.1992.73.4.1340; Moritz ML, 2010, METAB BRAIN DIS, V25, P91, DOI 10.1007/s11011-010-9173-2; Oncescu V, 2013, LAB CHIP, V13, P3232, DOI 10.1039/c3lc50431j; Oppliger RA, 2002, SPORTS MED, V32, P959, DOI 10.2165/00007256-200232150-00001; Rami L, 2014, J BIOMED MATER RES A, V102, P3666, DOI 10.1002/jbm.a.35035; Rimann M, 2015, J LAB AUTOM; Sandulescu V, 2015, LECT NOTES COMPUT SC, V9107, P526, DOI 10.1007/978-3-319-18914-7_55; Sawka MN, 2001, COMP BIOCHEM PHYS A, V128, P679, DOI 10.1016/S1095-6433(01)00274-4; Schwerthoeffer U., 2014, P GERM MICR C GEMIC, P1; Semenov S, 2009, PHILOS T R SOC A, V367, P3021, DOI 10.1098/rsta.2009.0092; Solovei D, 2015, SENSORS-BASEL, V15, P1479, DOI 10.3390/s150101479; Sterns R. H., 2013, HYPONATREMIA SE 12, P221, DOI [DOI 10.1007/978-1-4614-6645-1_12, 10.1007/978-1-4614-6645-1_12]; Tucker R, 2004, PFLUG ARCH EUR J PHY, V448, P422, DOI 10.1007/s00424-004-1267-4; Verdier-Sevrain Sylvie, 2007, J Cosmet Dermatol, V6, P75, DOI 10.1111/j.1473-2165.2007.00300.x; Walsh NP, 2004, MED SCI SPORT EXERC, V36; Wheeler H.A., 1942, P IRE, V30, P412, DOI DOI 10.1109/JRPROC.1942.232015; WHO, 2014, WORLD WAT DEV REP WW, V1, P1	40	11	11	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153145	10.1371/journal.pone.0153145	http://dx.doi.org/10.1371/journal.pone.0153145			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046226	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600071
J	Miller, CL; Muthupalani, S; Shen, Z; Drees, F; Ge, ZM; Feng, Y; Chen, XW; Gong, GY; Nagar, KK; Wang, TC; Gertler, FB; Fox, JG				Miller, Cassandra L.; Muthupalani, Sureshkumar; Shen, Zeli; Drees, Frauke; Ge, Zhongming; Feng, Yan; Chen, Xiaowei; Gong, Guanyu; Nagar, Karan K.; Wang, Timothy C.; Gertler, Frank B.; Fox, James G.			Lamellipodin-Deficient Mice: A Model of Rectal Carcinoma	PLOS ONE			English	Article							HELICOBACTER-HEPATICUS INFECTION; INFLAMMATORY-BOWEL-DISEASE; PYLORI INFECTION; COLON-CANCER; GASTRIC INFLAMMATION; BACTERIAL-INFECTION; MOUSE MODELS; A/JCR MICE; COLITIS; TISSUE	During a survey of clinical rectal prolapse (RP) cases in the mouse population at MIT animal research facilities, a high incidence of RP in the lamellipodin knock-out strain, C57BL/6-Raph1tm1Fbg (Lpd(-/-)) was documented. Upon further investigation, the Lpd(-/-) colony was found to be infected with multiple endemic enterohepatic Helicobacter species (EHS). Lpd(-/-) mice, a transgenic mouse strain produced at MIT, have not previously shown a distinct immune phenotype and are not highly susceptible to other opportunistic infections. Predominantly male Lpd(-/-) mice with RP exhibited lesions consistent with invasive rectal carcinoma concomitant to clinically evident RP. Multiple inflammatory cytokines, CD11b+Gr1+myeloid-derived suppressor cell (MDSC) populations, and epithelial cells positive for a DNA damage biomarker, H2AX, were elevated in affected tissue, supporting their role in the neoplastic process. An evaluation of Lpd(-/-) mice with RP compared to EHS-infected, but clinically normal (CN) Lpd(-/-) animals indicated that all of these mice exhibit some degree of lower bowel inflammation; however, mice with prolapses had significantly higher degree of focal lesions at the colo-rectal junction. When Helicobacter spp. infections were eliminated in Lpd(-/-) mice by embryo transfer rederivation, the disease phenotype was abrogated, implicating EHS as a contributing factor in the development of rectal carcinoma. Here we describe lesions in Lpd(-/-) male mice consistent with a focal inflammation-induced neoplastic transformation and propose this strain as a mouse model of rectal carcinoma.	[Miller, Cassandra L.; Muthupalani, Sureshkumar; Shen, Zeli; Ge, Zhongming; Feng, Yan; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Drees, Frauke; Gertler, Frank B.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chen, Xiaowei; Nagar, Karan K.; Wang, Timothy C.] Columbia Univ, Div Digest & Liver Dis, New York, NY USA; [Gong, Guanyu; Fox, James G.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Miller, Cassandra L.] SNBL USA Ltd, Everett, WA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Columbia University; Massachusetts Institute of Technology (MIT)	Fox, JG (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.; Fox, JG (corresponding author), MIT, Dept Biol Engn, Cambridge, MA 02139 USA.	jgfox@mit.edu	Muthupalani, Sureshkumar/C-7244-2015; Gong, Guanyu/ABA-1935-2021	Gong, Guanyu/0000-0002-5791-0916; Ge, Zhongming/0000-0003-0924-7563; Wang, Timothy/0000-0001-5730-3019	NIH [T32-OD010978, R01-OD011141, P30-ES002109]; Ludwig Center at MIT [U54-CA114462]; NCI Core grant [P30-CA14051]; NATIONAL CANCER INSTITUTE [R01CA114462, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010978, R01OD011141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center at MIT; NCI Core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants T32-OD010978, R01-OD011141, and P30-ES002109 (to JGF); funds from the Ludwig Center at MIT, U54-CA114462 (FBG); and NCI Core grant P30-CA14051 (Koch Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asfaha S, 2013, GASTROENTEROLOGY, V144, P155, DOI 10.1053/j.gastro.2012.09.057; Bae YH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004838; BARTHOLD SW, 1978, VET PATHOL, V15, P223, DOI 10.1177/030098587801500209; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Bouma G, 2009, IMMUNOBIOLOGY, V214, P778, DOI 10.1016/j.imbio.2009.06.009; Cahill RJ, 1997, INFECT IMMUN, V65, P3126, DOI 10.1128/IAI.65.8.3126-3131.1997; Carmona G, ONCOGENE IN PRESS; Chan V, 2005, HELICOBACTER, V10, P114, DOI 10.1111/j.1523-5378.2005.00298.x; Chandanos E, 2008, EUR J CANCER, V44, P2397, DOI 10.1016/j.ejca.2008.07.031; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Chichlowski M, 2008, COMPARATIVE MED, V58, P534; Chin EY, 2000, COMPARATIVE MED, V50, P586; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Coppolino MG, 2001, J CELL SCI, V114, P4307; Corley DA, 2009, GUT, V58, P182, DOI 10.1136/gut.2008.163360; Drazenovich NL, 2002, COMPARATIVE MED, V52, P347; EDIGER RD, 1974, LAB ANIM SCI, V24, P488; Endris V, 2011, J CELL SCI, V124, P3941, DOI 10.1242/jcs.077081; Engle SJ, 2002, CANCER RES, V62, P6362; Erdman SE, 1997, AM J PATHOL, V151, P273; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Erdman SE, 2001, J IMMUNOL, V166, P1443, DOI 10.4049/jimmunol.166.3.1443; Feng SL, 2005, CLIN DIAGN LAB IMMUN, V12, P531, DOI 10.1128/CDLI.12.4.531-536.2005; Foltz CJ, 1998, HELICOBACTER, V3, P69, DOI 10.1046/j.1523-5378.1998.08006.x; FORMAN D, 1993, LANCET, V341, P1359; Fox JG, 2011, MUCOSAL IMMUNOL, V4, P22, DOI 10.1038/mi.2010.61; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; FOX JG, 1991, INFECT IMMUN, V59, P1875, DOI 10.1128/IAI.59.6.1875-1880.1991; Fox JG, 1997, VET PATHOL, V34, P225, DOI 10.1177/030098589703400308; FOX JG, 1990, GASTROENTEROLOGY, V99, P352, DOI 10.1016/0016-5085(90)91016-Y; Fox JG, 1996, INFECT IMMUN, V64, P1548, DOI 10.1128/IAI.64.5.1548-1558.1996; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; Fox JG, 1999, INFECT IMMUN, V67, P1757; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Ge ZM, 2005, INFECT IMMUN, V73, P3559, DOI 10.1128/IAI.73.6.3559-3567.2005; Ge ZM, 2001, J CLIN MICROBIOL, V39, P2598, DOI 10.1128/JCM.39.7.2598-2602.2001; Ham H, 2011, NAT REV MICROBIOL, V9, P635, DOI 10.1038/nrmicro2602; Hanada K, 2014, INFECT IMMUN, V82, P4182, DOI 10.1128/IAI.02368-14; Huang FY, 2013, EUR J CANCER, V49, P2760, DOI 10.1016/j.ejca.2013.03.031; Jergens AE, 2007, GUT, V56, P934, DOI 10.1136/gut.2006.099242; KARNES WE, 1991, GASTROENTEROLOGY, V101, P167, DOI 10.1016/0016-5085(91)90474-Y; Knauer O, 2008, CELL MICROBIOL, V10, P2285, DOI 10.1111/j.1462-5822.2008.01207.x; Knutson CG, 2013, P NATL ACAD SCI USA, V110, pE2332, DOI 10.1073/pnas.1222669110; Koeppel M, 2015, CELL REP, V11, P1703, DOI 10.1016/j.celrep.2015.05.030; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Law AL, 2013, J CELL BIOL, V203, P673, DOI 10.1083/jcb.201304051; Lee UJ, 2008, AM J PHYSIOL-RENAL, V295, pF545, DOI 10.1152/ajprenal.00063.2008; Li Y, 2011, ONCOGENE, V30, P2633, DOI 10.1038/onc.2010.632; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Maggio-Price L, 2005, AM J PATHOL, V166, P1793, DOI 10.1016/S0002-9440(10)62489-3; Maggio-Price L, 2009, AM J PATHOL, V174, P317, DOI 10.2353/ajpath.2009.080485; Mangerich A, 2012, P NATL ACAD SCI USA, V109, pE1820, DOI 10.1073/pnas.1207829109; Michael M, 2010, CURR BIOL, V20, P783, DOI 10.1016/j.cub.2010.03.048; Miller CL, 2014, COMPARATIVE MED, V64, P171; Mutsaers AJ, 2003, J VET INTERN MED, V17, P136, DOI 10.1892/0891-6640(2003)017&lt;0136:CTCC&gt;2.3.CO;2; Nagamine CM, 2008, INFECT IMMUN, V76, P2758, DOI 10.1128/IAI.01604-07; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Nguyen DD, 2013, INFLAMM BOWEL DIS, V19, P2041, DOI 10.1097/MIB.0b013e318295fd8f; Ohtani M, 2011, CARCINOGENESIS, V32, P1244, DOI 10.1093/carcin/bgr072; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Percy DH, 2007, PATHOLOGY LAB RODENT; Petignat P, 2007, BMJ-BRIT MED J, V335, P765, DOI 10.1136/bmj.39337.615197.80; Pinheiro EM, 2011, NAT CELL BIOL, V13, P989, DOI 10.1038/ncb2292; Rogers AB, 2004, AM J PHYSIOL-GASTR L, V286, pG361, DOI 10.1152/ajpgi.00499.2003; Rogers Arlin B., 2009, V511, P267, DOI 10.1007/978-1-59745-447-6_11; Runck LA, 2010, CELL CYCLE, V9, P3039, DOI 10.4161/cc.9.15.12437; SHAMES B, 1995, J CLIN MICROBIOL, V33, P2968, DOI 10.1128/JCM.33.11.2968-2972.1995; Sheh A, 2011, CANCER PREV RES, V4, P1426, DOI 10.1158/1940-6207.CAPR-11-0219; Shen ZL, 2000, HELICOBACTER, V5, P121, DOI 10.1046/j.1523-5378.2000.00019.x; Shomer NH, 1998, LAB ANIM SCI, V48, P455; Slattery ML, 2011, CANCER CAUSE CONTROL, V22, P955, DOI 10.1007/s10552-011-9768-x; Smith K, 2010, CELL HOST MICROBE, V7, P13, DOI 10.1016/j.chom.2009.12.004; Takayama H, 2001, LAB INVEST, V81, P297, DOI 10.1038/labinvest.3780238; Tasaka G, 2012, J NEUROSCI, V32, P8293, DOI 10.1523/JNEUROSCI.0799-12.2012; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; U.S. Cancer Statistics Working Group United States Cancer Statistics, 2013, 1999 2009 INC MORT W; VANZANTEN SJOV, 1994, CAN MED ASSOC J, V150, P177; Ward JM, 1996, LAB ANIM SCI, V46, P15; WARD JM, 1994, JNCI-J NATL CANCER I, V86, P1222, DOI 10.1093/jnci/86.16.1222; Whary MT, 2001, COMPARATIVE MED, V51, P413; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070783; Zhang H, 2002, AM J GASTROENTEROL, V97, P1037; Zhang P, 2013, ONCOGENE, V32, P2087, DOI 10.1038/onc.2012.220; Zhu YT, 2012, EXP CELL RES, V318, P2520, DOI 10.1016/j.yexcr.2012.07.021	91	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152940	10.1371/journal.pone.0152940	http://dx.doi.org/10.1371/journal.pone.0152940			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045955	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600050
J	Zhang, YX; Lee, KM; Kinch, LN; Clark, L; Grishin, NV; Rosenbaum, DM; Brown, MS; Goldstein, JL; Radhakrishnan, A				Zhang, Yinxin; Lee, Kwang Min; Kinch, Lisa N.; Clark, Lindsay; Grishin, Nick V.; Rosenbaum, Daniel M.; Brown, Michael S.; Goldstein, Joseph L.; Radhakrishnan, Arun			Direct Demonstration That Loop1 of Scap Binds to Loop7 A CRUCIAL EVENT IN CHOLESTEROL HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE-ACTIVATING PROTEIN; STEROL-REGULATED TRANSPORT; ENDOPLASMIC-RETICULUM; SENSING DOMAIN; COPII PROTEINS; SREBPS; GOLGI; INSIG; IDENTIFICATION; METABOLISM	Cholesterol homeostasis is mediated by Scap, a polytopic endoplasmic reticulum (ER) protein that transports sterol regulatory element-binding proteins from the ER to Golgi, where they are processed to forms that activate cholesterol synthesis. Scap has eight transmembrane helices and two large luminal loops, designated Loop1 and Loop7. We earlier provided indirect evidence that Loop1 binds to Loop7, allowing Scap to bind COPII proteins for transport in coated vesicles. When ER cholesterol rises, it binds to Loop1. We hypothesized that this causes dissociation from Loop7, abrogating COPII binding. Here we demonstrate direct binding of the two loops when expressed as isolated fragments or as a fusion protein. Expressed alone, Loop1 remained intracellular and membrane-bound. When Loop7 was co-expressed, it bound to Loop1, and the soluble complex was secreted. A Loop1-Loop7 fusion protein was also secreted, and the two loops remained bound when the linker between them was cleaved by a protease. Point mutations that disrupt the Loop1-Loop7 interaction prevented secretion of the Loop1-Loop7 fusion protein. These data provide direct documentation of intramolecular Loop1-Loop7 binding, a central event in cholesterol homeostasis.	[Zhang, Yinxin; Lee, Kwang Min; Brown, Michael S.; Goldstein, Joseph L.; Radhakrishnan, Arun] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Clark, Lindsay; Grishin, Nick V.; Rosenbaum, Daniel M.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Grishin, Nick V.; Rosenbaum, Daniel M.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Grishin, Nick V.; Radhakrishnan, Arun] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Zhang, Yinxin] Rockefeller Univ, Mol Genet Lab, New York, NY 10065 USA; [Zhang, Yinxin] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Lee, Kwang Min] Korea Food Res Inst, Songnam 13539, Gyeonggi Do, South Korea	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Korea Food Research Institute (KFRI)	Brown, MS; Goldstein, JL; Radhakrishnan, A (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu; arun.radhakrishnan@utsouthwestern.edu	Radhakrishnan, Arun/Q-7437-2019; Zhang, Yinxin/I-9996-2019	Radhakrishnan, Arun/0000-0002-7266-7336; Zhang, Yinxin/0000-0001-5909-3676; Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [GM HL20948, GM094575, R01GM113050]; Robert A. Welch Foundation [I-1793, I-1505, I-1770]; American Heart Association [12SDG12040267, 16PRE27200004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575, R01GM113050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM HL20948 (to J. L. G. and M. S. B.), GM094575 (to N. V. G.), and R01GM113050 (to D. M. R.); Robert A. Welch Foundation Grants I-1793 (to A. R.), I-1505 (to N. V. G.), and I-1770 (to D. M. R.); and American Heart Association Grants 12SDG12040267 (to A. R.) and 16PRE27200004 (to L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1396, DOI 10.1073/pnas.78.3.1396; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Zhang YX, 2013, J BIOL CHEM, V288, P14059, DOI 10.1074/jbc.M113.469528	16	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12888	12896		10.1074/jbc.M116.729798	http://dx.doi.org/10.1074/jbc.M116.729798			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27068746	hybrid, Green Published			2022-12-26	WOS:000378119900039
J	Chowdhury, NP; Klomann, K; Seubert, A; Buckel, W				Chowdhury, Nilanjan Pal; Klomann, Katharina; Seubert, Andreas; Buckel, Wolfgang			Reduction of Flavodoxin by Electron Bifurcation and Sodium Ion-dependent Reoxidation by NAD(+) Catalyzed by Ferredoxin-NAD(+) Reductase (Rnf)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTACONYL-COA DECARBOXYLASE; TRANSFERRING FLAVOPROTEIN; 2-HYDROXYGLUTARYL-COA DEHYDRATASE; ACETOBACTERIUM-WOODII; NADH; DEHYDROGENASE; COMPLEX; NA+; PURIFICATION; HYDROGENASE	Electron-transferring flavoprotein (Etf) and butyryl-CoA dehydrogenase (Bcd) from Acidaminococcus fermentans catalyze the endergonic reduction of ferredoxin by NADH, which is also driven by the concomitant reduction of crotonyl-CoA by NADH, a process called electron bifurcation. Here we show that recombinant flavodoxin from A. fermentans produced in Escherichia coli can replace ferredoxin with almost equal efficiency. After complete reduction of the yellow quinone to the blue semiquinone, a second 1.4 times faster electron transfer affords the colorless hydroquinone. Mediated by a hydrogenase, protons reoxidize the fully reduced flavodoxin or ferredoxin to the semi-reduced species. In this hydrogen-generating system, both electron carriers act catalytically with apparent K-m = 0.26 mu M ferredoxin or 0.42 mu M flavodoxin. Membrane preparations of A. fermentans contain a highly active ferredoxin/flavodoxin-NAD(+) reductase (Rnf) that catalyzes the irreversible reduction of flavodoxin by NADH to the blue semiquinone. Using flavodoxin hydroquinone or reduced ferredoxin obtained by electron bifurcation, Rnf can be measured in the forward direction, whereby one NADH is recycled, resulting in the simple equation: crotonyl-CoA + NADH + H+ = butyryl-CoA + NAD(+) with K-m = 1.4 mu M ferredoxin or 2.0 mu M flavodoxin. This reaction requires Na+ (K-m = 0.12 mM) or Li+ (K-m = 0.25 mM) for activity, indicating that Rnf acts as a Na+ pump. The redox potential of the quinone/semiquinone couple of flavodoxin (Fld) is much higher than that of the semiquinone/hydroquinone couple. With free riboflavin, the opposite is the case. Based on this behavior, we refine our previous mechanism of electron bifurcation.	[Chowdhury, Nilanjan Pal; Klomann, Katharina; Buckel, Wolfgang] Univ Marburg, Fachbereich Biol, Lab Mikrobiol, Karl von Frisch Str 8, D-35032 Marburg, Germany; [Chowdhury, Nilanjan Pal; Klomann, Katharina; Buckel, Wolfgang] Univ Marburg, Synmikro, D-35032 Marburg, Germany; [Seubert, Andreas] Univ Marburg, Fachbereich Chem, Hans Meerwein Str, D-35032 Marburg, Germany; [Chowdhury, Nilanjan Pal; Buckel, Wolfgang] Max Planck Inst Terr Mikrobiol, Karl Von Frisch Str, D-35043 Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Max Planck Society	Buckel, W (corresponding author), Univ Marburg, Fachbereich Biol, Lab Mikrobiol, Karl von Frisch Str 8, D-35032 Marburg, Germany.	buckel@staff.uni-marburg.de	Chowdhury, Nilanjan Pal/AAE-5125-2021	Pal Chowdhury, Nilanjan/0000-0002-7645-3706	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported in part by a grant from the German Research Foundation (DFG). The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSON RF, 1983, BIOCHIM BIOPHYS ACTA, V722, P158, DOI 10.1016/0005-2728(83)90169-X; Bertsch J, 2013, J BIOL CHEM, V288, P11304, DOI 10.1074/jbc.M112.444919; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Bienenstock J, 2015, NUTR REV, V73, P28, DOI 10.1093/nutrit/nuv019; Boiangiu CD, 2005, J MOL MICROB BIOTECH, V10, P105, DOI 10.1159/000091558; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brock M, 2004, EUR J BIOCHEM, V271, P3227, DOI 10.1111/j.1432-1033.2004.04255.x; BUCKEL W, 1986, METHOD ENZYMOL, V125, P547; BUCKEL W, 1982, FEBS LETT, V148, P35, DOI 10.1016/0014-5793(82)81237-4; Buckel W, 2001, BBA-BIOENERGETICS, V1505, P15, DOI 10.1016/S0005-2728(00)00273-5; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Buckel W, 2012, BBA-PROTEINS PROTEOM, V1824, P1278, DOI 10.1016/j.bbapap.2011.11.009; Campbell C, 2015, INT J SYST EVOL MICR, V65, P3203, DOI 10.1099/ijs.0.000347; Chang YJ, 2010, STAND GENOMIC SCI, V3, P1, DOI 10.4056/sigs.1002553; Chowdhury N.R., 2014, THESIS; Chowdhury NP, 2015, FEBS J, V282, P3149, DOI 10.1111/febs.13308; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Chung WSF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-015-0224-3; CORNFORTH JW, 1959, J LIPID RES, V1, P3; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; DIMROTH P, 1986, EUR J BIOCHEM, V156, P157, DOI 10.1111/j.1432-1033.1986.tb09561.x; FILLAT MF, 1991, BIOCHEM J, V280, P187, DOI 10.1042/bj2800187; Hans M, 2002, BIOCHEMISTRY-US, V41, P5873, DOI 10.1021/bi020033m; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hess V, 2013, J BIOL CHEM, V288, P31496, DOI 10.1074/jbc.M113.510255; Hess V, 2013, APPL ENVIRON MICROB, V79, P1942, DOI 10.1128/AEM.03604-12; Imkamp F, 2007, J BACTERIOL, V189, P8145, DOI 10.1128/JB.01017-07; Jayamani E., 2011, THESIS; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Kim J, 2008, NATURE, V452, P239, DOI 10.1038/nature06637; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Mayhew S. G., 1992, CHEM BIOCH FLAVOENZY, V3, P389; NAKOS G, 1971, BIOCHIM BIOPHYS ACTA, V227, P576, DOI 10.1016/0005-2744(71)90008-8; Nitschke W, 2012, BIOESSAYS, V34, P106, DOI 10.1002/bies.201100134; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Parthasarathy A, 2011, BIOCHEMISTRY-US, V50, P3540, DOI 10.1021/bi1020056; Sato K, 2013, J BIOCHEM, V153, P565, DOI 10.1093/jb/mvt026; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Talfournier F, 2001, J BIOL CHEM, V276, P20190, DOI 10.1074/jbc.M010853200; Thamer W, 2003, ARCH MICROBIOL, V179, P197, DOI 10.1007/s00203-003-0517-8; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Vital M, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-8; Wang SN, 2013, APPL ENVIRON MICROB, V79, P6176, DOI 10.1128/AEM.02015-13; Wang SN, 2013, J BACTERIOL, V195, P1267, DOI 10.1128/JB.02158-12; Wang SN, 2010, J BACTERIOL, V192, P5115, DOI 10.1128/JB.00612-10; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008; ZIEGENHORN J, 1976, CLIN CHEM, V22, P151	53	37	38	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					11993	12002		10.1074/jbc.M116.726299	http://dx.doi.org/10.1074/jbc.M116.726299			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27048649	Green Published, hybrid			2022-12-26	WOS:000378092800004
J	Al-Khanbashi, M; Caramuta, S; Alajmi, AM; Al-Haddabi, I; Al-Riyami, M; Lui, WO; Al-Moundhri, MS				Al-Khanbashi, Manal; Caramuta, Stefano; Alajmi, Adil M.; Al-Haddabi, Ibrahim; Al-Riyami, Marwa; Lui, Weng-Onn; Al-Moundhri, Mansour S.			Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; GENE-EXPRESSION; DOWN-REGULATION; POTENTIAL ROLE; TUMOR RELAPSE; MICRORNA; SURVIVAL; MIR-21; IDENTIFICATION; BIOMARKERS	Introduction MicroRNAs (miRNAs) are small non-coding RNA that plays a vital role in cancer progression. Neo-adjuvant chemotherapy (NAC) has become the standard of care for locally advanced breast cancer. The aim of this study was to evaluate miRNA alterations during NAC using multiple samples of tissue and serum to correlate miRNA expression with clinico-pathological features and patient outcomes. Methods Tissue and serum samples were collected from patients with locally advanced breast cancer undergoing NAC at four time points: time of diagnosis, after the first and fourth cycle of doxorubicin/cyclophosphamide treatment, and after the fourth cycle of docetaxel administration. First, we evaluated the miRNA expression profiles in tissue and correlated expression with clinico-pathological features. Then, a panel of four miRNAs (miR-451, miR-3200, miR-21, and miR-205) in serum samples was further validated using quantitative reverse-transcription polymerase chain reaction (RT-qPCR). The alterations in serum levels of miRNA, associations with clinical and pathological responses, correlation with clinico-pathological features, and survival outcomes were studied using Friedman, Mann-Whitney U, and Spearman, Wilcoxon signed-ranks tests. P <= 0.05 was considered statistically significant. Results We analyzed 72 tissue samples and 108 serum samples from 9 patients and 27 patients, respectively. MicroRNA expression profiling of tumor versus normal tissue revealed more than 100 differentially expressed miRNAs. Serum miR-451 levels were significantly decreased during treatment, and higher serum levels were associated with improved clinical and pathological responses and disease-free survival. This is one of the early reports on miR-3200 in response to treatment in breast cancer, as serum levels of miR-3200 found to decline during NAC, and higher serum levels were associated with lower residual breast cancer burden and relapse rates at time of diagnosis. Conclusion Variations in serum miRNA levels during NAC treatment may be therapeutically significant for predicting response and survival outcomes.	[Al-Khanbashi, Manal; Al-Moundhri, Mansour S.] Sultan Qaboos Univ, Dept Med, Coll Med & Hlth Sci, Med Oncol Unit, Muscat, Oman; [Caramuta, Stefano; Lui, Weng-Onn] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Alajmi, Adil M.] Sultan Qaboos Univ, Dept Surg, Coll Med & Hlth Sci, Muscat, Oman; [Al-Haddabi, Ibrahim; Al-Riyami, Marwa] Sultan Qaboos Univ, Dept Pathol, Coll Med, Muscat, Oman	Sultan Qaboos University; Karolinska Institutet; Karolinska University Hospital; Sultan Qaboos University; Sultan Qaboos University	Al-Moundhri, MS (corresponding author), Sultan Qaboos Univ, Dept Med, Coll Med & Hlth Sci, Med Oncol Unit, Muscat, Oman.	mansours@squ.edu.om	Lui, Weng-Onn/X-5957-2019; Lui, Weng-Onn/G-6703-2013	Lui, Weng-Onn/0000-0003-4717-4473; Lui, Weng-Onn/0000-0003-4717-4473; Al-Moundhri, Mansour/0000-0003-3963-1232	Oman research council; Research Council, Sultanate of Oman [RC/MED/MEDI/11/01]	Oman research council(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman); Research Council, Sultanate of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	The study is funded by Oman research council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Dr. Amal Gadalla for her guidance in some of the statistical analyses and Dr. Andreas Montelius and Mr. Jonathan Mustonen for their assistance in depositing microarray data. We also would like to thank the core facility at Novum, BEA, Bioinformatics and Expression Analysis, which is supported by the board of research at the Karolinska Institute and the research committee at the Karolinska hospital. We also thank our colleagues in Medical Oncology Unit at Sultan Qaboos University Hospital for their support. This work was funded and supported by the Research Council, Sultanate of Oman (RC/MED/MEDI/11/01).	Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Ashish B A, 2005, J CANCER RES THER, V1, P21; Bisso A, 2013, CELL CYCLE, V12, P1679, DOI 10.4161/cc.24757; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cance WG, 2002, ANN SURG, V236, P295, DOI 10.1097/00000658-200209000-00006; D'Ippolito E, 2013, INT J MOL SCI, V14, P22202, DOI 10.3390/ijms141122202; de Planell-Saguer M, 2013, CLIN BIOCHEM, V46, P869, DOI 10.1016/j.clinbiochem.2013.02.017; Edge SB, 2010, AJCC CANC STAGING MA; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Freres R, 2014, EUR J CANCER, V50, P53; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Hutchinson L, 2010, NAT REV CLIN ONCOL, V7, P669, DOI 10.1038/nrclinonc.2010.192; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kalniete D, 2013, ACTA CHIRURG LATVIE, V13, P7; Kang WK, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0227-0; Khokher S, 2012, ASIAN PAC J CANCER P, V13, P3213, DOI 10.7314/APJCP.2012.13.7.3213; Kjersem JB, 2014, MOL ONCOL, V8, P59, DOI 10.1016/j.molonc.2013.09.001; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee MC, 2007, SURG CLIN N AM, V87, P379, DOI 10.1016/j.suc.2007.01.012; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Molnar V, 2008, SEMIN CANCER BIOL, V18, P111, DOI 10.1016/j.semcancer.2008.01.001; Nahleh Z, 2008, CURR ONCOL, V15, P271; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; Pan X, 2013, MOL CANCER THER, V12, P1153, DOI 10.1158/1535-7163.MCT-12-0802; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Sahlberg KK, 2015, CLIN CANCER RES, V21, P1207, DOI 10.1158/1078-0432.CCR-14-2011; Scarpati GDV, 2014, BIOMED RES INT, V2014, P8; To KKW, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-99; Vageli D., 2013, EUR RESPIR J, V42, P4639; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; Wang B, 2014, IUBMB LIFE, V66, P371, DOI 10.1002/iub.1273; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang GN, 2015, ANN LAB MED, V35, P226, DOI 10.3343/alm.2015.35.2.226; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Xiong YZ, 2013, CLIN VACCINE IMMUNOL, V20, P1089, DOI 10.1128/CVI.00044-13; Xu HD, 2014, CELL BIOCHEM BIOPHYS, V69, P163, DOI 10.1007/s12013-013-9783-5; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang XW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-909; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	46	38	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152032	10.1371/journal.pone.0152032	http://dx.doi.org/10.1371/journal.pone.0152032			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064979	Green Published, gold			2022-12-26	WOS:000373891000008
J	Bizzarri, M; Giudici, P; Cassanelli, S; Solieri, L				Bizzarri, Melissa; Giudici, Paolo; Cassanelli, Stefano; Solieri, Lisa			Chimeric Sex-Determining Chromosomal Regions and Dysregulation of Cell-Type Identity in a Sterile Zygosaccharomyces Allodiploid Yeast	PLOS ONE			English	Article							HETEROTHALLIC HAPLOID YEAST; MATING-TYPE GENES; COMPARATIVE GENOMICS; POPULATION GENOMICS; HYBRID STERILITY; LIFE-CYCLE; HO GENE; EVOLUTION; PROTEIN; ROUXII	Allodiploidization is a fundamental yet evolutionarily poorly characterized event, which impacts genome evolution and heredity, controlling organismal development and polyploid cell-types. In this study, we investigated the sex determination system in the allodiploid and sterile ATCC 42981 yeast, a member of the Zygosaccharomyces rouxii species complex, and used it to study how a chimeric mating-type gene repertoire contributes to hybrid reproductive isolation. We found that ATCC 42981 has 7 MAT-like (MTL) loci, 3 of which encode alpha-idiomorph and 4 encode a-idiomorph. Two phylogenetically divergent MAT expression loci were identified on different chromosomes, accounting for a hybrid a/alpha genotype. Furthermore, extra a-idimorph-encoding loci (termed MTLa copies 1 to 3) were recognized, which shared the same MATa1 ORFs but diverged for MATa2 genes. Each MAT expression locus was linked to a HML silent cassette, while the corresponding HMR loci were located on another chromosome. Two putative parental sex chromosome pairs contributed to this unusual genomic architecture: one came from an as-yet-undescribed taxon, which has the NCYC 3042 strain as a unique representative, while the other did not match any MAT-HML and HMR organizations previously described in Z. rouxii species. This chimeric rearrangement produces two copies of the HO gene, which encode for putatively functional endonucleases essential for mating-type switching. Although both a and a coding sequences, which are required to obtain a functional cell-type a1-alpha 2 regulator, were present in the allodiploid ATCC 42981 genome, the transcriptional circuit, which regulates entry into meiosis in response to meiosis-inducing salt stress, appeared to be turned off. Furthermore, haploid and a-specific genes, such as MAT alpha 1 and HO, were observed to be actively transcribed and up-regulated under hypersaline stress. Overall, these evidences demonstrate that ATCC 42981 is unable to repress haploid a-specific genes and to activate meiosis in response to stress. We argue that sequence divergence within the chimeric a1-alpha 2 heterodimer could be involved in the generation of negative epistasis, contributing to the allodiploid sterility and the dysregulation of cell identity.	[Bizzarri, Melissa; Giudici, Paolo; Cassanelli, Stefano; Solieri, Lisa] Univ Modena & Reggio Emilia, Dept Life Sci, Via Amendola 2, I-42122 Reggio Emilia, Italy	Universita di Modena e Reggio Emilia	Solieri, L (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Via Amendola 2, I-42122 Reggio Emilia, Italy.	lisa.solieri@unimore.it	Solieri, Lisa/I-4352-2012	Solieri, Lisa/0000-0003-3546-6903				Alipaz JA, 2005, AM NAT, V165, P429, DOI 10.1086/428407; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JS, 2000, BIOCHEMISTRY-US, V39, P10045, DOI 10.1021/bi000677z; Baker CR, 2012, CELL, V151, P80, DOI 10.1016/j.cell.2012.08.018; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayes JJ, 2009, SCIENCE, V326, P1538, DOI 10.1126/science.1181756; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COVITZ PA, 1991, GENE DEV, V5, P1982, DOI 10.1101/gad.5.11.1982; Coyne J.A., 2004, SPECIATION; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; Dunn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003366; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Friedrich A, 2015, MOL BIOL EVOL, V32, P184, DOI 10.1093/molbev/msu295; Gelfand B, 2011, MOL CELL BIOL, V31, P1701, DOI 10.1128/MCB.01071-10; Goossens KVY, 2015, MBIO, V6, DOI 10.1128/mBio.00427-15; Gordon JL, 2008, YEAST, V25, P449, DOI 10.1002/yea.1598; Gordon JL, 2011, P NATL ACAD SCI USA, V108, P20024, DOI 10.1073/pnas.1112808108; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; Granek JA, 2011, CURR OPIN MICROBIOL, V14, P676, DOI 10.1016/j.mib.2011.09.004; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Hafez M, 2012, GENOME, V55, P553, DOI [10.1139/G2012-049, 10.1139/g2012-049]; HARASHIMA S, 1989, MOL CELL BIOL, V9, P4523, DOI 10.1128/MCB.9.10.4523; Heitman J, 2009, NATURE, V460, P807, DOI 10.1038/460807a; HERSKOWITZ I, 1988, MICROBIOL REV, V52, P536, DOI 10.1128/MMBR.52.4.536-553.1988; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; James SA, 2005, FEMS YEAST RES, V5, P747, DOI 10.1016/j.femsyr.2005.02.004; Johnson NA, 2010, TRENDS GENET, V26, P317, DOI 10.1016/j.tig.2010.04.005; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kinclova O, 2001, J BIOTECHNOL, V88, P151, DOI 10.1016/S0168-1656(01)00274-7; Knop M, 2006, BIOESSAYS, V28, P696, DOI 10.1002/bies.20435; KUES U, 1992, MYCOL RES, V96, P993; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leandro MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068165; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallona I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-404; Marcet-Houben M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002220; Martin T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015199; Mathias JR, 2004, NUCLEIC ACIDS RES, V32, P6469, DOI 10.1093/nar/gkh985; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; MORI H, 1967, APPL MICROBIOL, V15, P928, DOI 10.1128/AEM.15.4.928-934.1967; MORI H, 1973, J FERMENT TECHNOL, V51, P379; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Orr HA, 2001, EVOLUTION, V55, P1085; Otto SP, 2008, CURR BIOL, V18, pR1121, DOI 10.1016/j.cub.2008.09.039; Piatkowska EM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003836; Pribylova L, 2007, YEAST, V24, P171, DOI 10.1002/yea.1470; Rajaei N, 2014, P NATL ACAD SCI USA, V111, P15491, DOI 10.1073/pnas.1406027111; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; SILICIANO PG, 1984, CELL, V37, P969, DOI 10.1016/0092-8674(84)90431-8; Solieri L, 2014, G3-GENES GENOM GENET, V4, P1011, DOI 10.1534/g3.114.010405; Solieri L, 2014, FEMS YEAST RES, V14, P586, DOI 10.1111/1567-1364.12146; Solieri L, 2013, FEMS YEAST RES, V13, P245, DOI 10.1111/1567-1364.12027; Solieri L, 2013, INT J SYST EVOL MICR, V63, P364, DOI 10.1099/ijs.0.043323-0; Solieri L, 2008, FUNGAL GENET BIOL, V45, P1582, DOI 10.1016/j.fgb.2008.10.001; Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109; Steensels J, 2014, FEMS MICROBIOL REV, V38, P947, DOI 10.1111/1574-6976.12073; STERNBERG PW, 1987, CELL, V48, P567, DOI 10.1016/0092-8674(87)90235-2; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; STRATHERN J, 1988, GENETICS, V120, P75; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; van Dyk D, 2003, GENETICS, V165, P1045; Watanabe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062121; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Wolfe KH, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002221; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zorgo E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003388	81	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152558	10.1371/journal.pone.0152558	http://dx.doi.org/10.1371/journal.pone.0152558			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065237	Green Published, Green Submitted, gold			2022-12-26	WOS:000373891000012
J	Zhang, HQ; Liu, ZK; Chen, H; Tang, M				Zhang, Haoqiang; Liu, Zhenkun; Chen, Hui; Tang, Ming			Symbiosis of Arbuscular Mycorrhizal Fungi and Robinia pseudoacacia L. Improves Root Tensile Strength and Soil Aggregate Stability	PLOS ONE			English	Article							BLACK LOCUST; LOESS PLATEAU; FUNCTIONAL DIVERSITY; SLOPE STABILITY; PLANT-GROWTH; GLOMALIN; NITROGEN; PROTEIN; PHOSPHORUS; DROUGHT	Robinia pseudoacacia L. (black locust) is a widely planted tree species on Loess Plateau for revegetation. Due to its symbiosis forming capability with arbuscular mycorrhizal (AM) fungi, we explored the influence of arbuscular mycorrhizal fungi on plant biomass, root morphology, root tensile strength and soil aggregate stability in a pot experiment. We inoculated R. pseudoacacia with/without AM fungus (Rhizophagus irregularis or Glomus versiforme), and measured root colonization, plant growth, root morphological characters, root tensile force and tensile strength, and parameters for soil aggregate stability at twelve weeks after inoculation. AM fungi colonized more than 70% plant root, significantly improved plant growth. Meanwhile, AM fungi elevated root morphological parameters, root tensile force, root tensile strength, Glomalin-related soil protein (GRSP) content in soil, and parameters for soil aggregate stability such as water stable aggregate (WSA), mean weight diameter (MWD) and geometric mean diameter (GMD). Root length was highly correlated with WSA, MWD and GMD, while hyphae length was highly correlated with GRSP content. The improved R. pseudoacacia growth, root tensile strength and soil aggregate stability indicated that AM fungi could accelerate soil fixation and stabilization with R. pseudoacacia, and its function in revegetation on Loess Plateau deserves more attention.	[Zhang, Haoqiang; Liu, Zhenkun; Chen, Hui; Tang, Ming] Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Tang, M (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China.	tangm@nwsuaf.edu.cn		Tang, Ming/0000-0002-8158-6300	Special Fund for Forest Scientific Research in the Public Welfare [201404217]; National Natural Science Foundation of China [31270639, 31170567]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT1035]; Northwest A & F University doctoral research start-up fund [Z109021503]	Special Fund for Forest Scientific Research in the Public Welfare; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Northwest A & F University doctoral research start-up fund	This research was supported by Special Fund for Forest Scientific Research in the Public Welfare (201404217), the National Natural Science Foundation of China (31270639 and 31170567), the Program for Changjiang Scholars and Innovative Research Team in University of China (IRT1035), and Northwest A & F University doctoral research start-up fund (Z109021503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT LK, 1984, NEW PHYTOL, V97, P437, DOI 10.1111/j.1469-8137.1984.tb03609.x; An SS, 2010, CATENA, V81, P226, DOI 10.1016/j.catena.2010.04.002; Auge RM, 2004, CAN J SOIL SCI, V84, P373, DOI 10.4141/S04-002; Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Auge RM, 2001, PLANT SOIL, V230, P87, DOI 10.1023/A:1004891210871; Avio L, 2006, NEW PHYTOL, V172, P347, DOI 10.1111/j.1469-8137.2006.01839.x; Balat M, 2010, ENERG EXPLOR EXPLOIT, V28, P173, DOI 10.1260/0144-5987.28.3.173; Bedini S, 2009, SOIL BIOL BIOCHEM, V41, P1491, DOI 10.1016/j.soilbio.2009.04.005; BONFANTEFASOLO P, 1990, PLANTA, V180, P537, DOI 10.1007/BF02411452; Brown LK, 2013, PLANT SOIL, V372, P195, DOI 10.1007/s11104-013-1718-9; Bucking H, 2005, NEW PHYTOL, V165, P899, DOI 10.1111/j.1469-8137.2004.01274.x; Cierjacks A, 2013, J ECOL, V101, P1623, DOI 10.1111/1365-2745.12162; Dalby R, 2004, AM BEE J, V144, P382; De Baets S, 2008, PLANT SOIL, V305, P207, DOI 10.1007/s11104-008-9553-0; Driver JD, 2005, SOIL BIOL BIOCHEM, V37, P101, DOI 10.1016/j.soilbio.2004.06.011; Duiker SW, 2001, CATENA, V45, P103, DOI 10.1016/S0341-8162(01)00145-X; Fokom R, 2012, SOIL TILL RES, V120, P69, DOI 10.1016/j.still.2011.11.004; Gao J., 2006, EXPT GUIDANCE PLANT; Genet M, 2005, PLANT SOIL, V278, P1, DOI 10.1007/s11104-005-8768-6; GEORGE E, 1995, CRIT REV BIOTECHNOL, V15, P257, DOI 10.3109/07388559509147412; GILLESPIE AR, 1990, SOIL SCI SOC AM J, V54, P538, DOI 10.2136/sssaj1990.03615995005400020042x; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gong MG, 2012, ANN MICROBIOL, V62, P1579, DOI 10.1007/s13213-011-0413-4; Gonzalez-Garcia S, 2011, INT J LIFE CYCLE ASS, V16, P465, DOI 10.1007/s11367-011-0272-z; Gray DH, 1996, BIOTECHNICAL SOIL BI; Grunewald H, 2009, BIOENERG RES, V2, P123, DOI 10.1007/s12155-009-9038-x; Guo XiaoPing, 2005, Forestry Studies in China, V7, P57, DOI 10.1007/s11632-005-0023-y; Hallett PD, 2009, PLANT SOIL, V314, P183, DOI 10.1007/s11104-008-9717-y; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1; Li T, 2014, MYCORRHIZA, V24, P595, DOI 10.1007/s00572-014-0578-3; MARSCHNER H, 1994, PLANT SOIL, V159, P89, DOI 10.1007/BF00000098; MILLER RM, 1990, SOIL BIOL BIOCHEM, V22, P579, DOI 10.1016/0038-0717(90)90001-G; Olesniewicz KS, 1999, NEW PHYTOL, V142, P133, DOI 10.1046/j.1469-8137.1999.00372.x; Operstein V., 2000, PROC INST CIV ENG-GR, V4, P81, DOI DOI 10.1680/GRIM.2000.4.2.81; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Purin S, 2007, PEDOBIOLOGIA, V51, P123, DOI 10.1016/j.pedobi.2007.03.002; Qiu LP, 2010, PLANT SOIL, V332, P207, DOI 10.1007/s11104-010-0286-5; Reubens B, 2007, TREES-STRUCT FUNCT, V21, P385, DOI 10.1007/s00468-007-0132-4; Rice SK, 2004, PLANT ECOL, V174, P97, DOI 10.1023/B:VEGE.0000046049.21900.5a; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2002, PLANT SOIL, V238, P325, DOI 10.1023/A:1014483303813; Schroeder MS, 2005, MYCORRHIZA, V15, P203, DOI 10.1007/s00572-004-0324-3; Schussler A., 2010, GLOMEROMYCOTA SPECIE; SCHWEIGER PF, 1995, NEW PHYTOL, V131, P247, DOI 10.1111/j.1469-8137.1995.tb05726.x; Sheng M, 2009, CAN J MICROBIOL, V55, P879, DOI [10.1139/W09-031, 10.1139/w09-031]; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2004, NEW PHYTOL, V162, P511, DOI 10.1111/j.1469-8137.2004.01039.x; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; Tateno R, 2007, FOREST ECOL MANAG, V241, P84, DOI 10.1016/j.foreco.2006.12.026; Tosi M, 2007, GEOMORPHOLOGY, V87, P268, DOI 10.1016/j.geomorph.2006.09.019; Ussiri DAN, 2006, SOIL SCI SOC AM J, V70, P1797, DOI 10.2136/sssaj2005.0352; Wang B, 2012, ENVIRON EARTH SCI, V65, P597, DOI 10.1007/s12665-011-1107-8; Wang S, 2014, SCI HORTIC-AMSTERDAM, V170, P137, DOI 10.1016/j.scienta.2014.03.003; Wright SF, 1998, SOIL BIOL BIOCHEM, V30, P1853, DOI 10.1016/S0038-0717(98)00047-9; Wright SF, 1996, SOIL SCI, V161, P575, DOI 10.1097/00010694-199609000-00003; Wu QS, 2012, SOIL BIOL BIOCHEM, V45, P181, DOI 10.1016/j.soilbio.2011.10.002; Wu QS, 2008, EUR J SOIL BIOL, V44, P122, DOI 10.1016/j.ejsobi.2007.10.001; Yang YR, 2014, J PLANT GROWTH REGUL, V33, P612, DOI 10.1007/s00344-013-9410-0; Zhang HQ, 2014, MYCORRHIZA, V24, P419, DOI 10.1007/s00572-013-0553-4	63	26	30	13	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153378	10.1371/journal.pone.0153378	http://dx.doi.org/10.1371/journal.pone.0153378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064570	gold, Green Published, Green Submitted			2022-12-26	WOS:000373891000052
J	Betik, AC; Aguila, J; McConell, GK; McAinch, AJ; Mathai, ML				Betik, Andrew C.; Aguila, Jay; McConell, Glenn K.; McAinch, Andrew J.; Mathai, Michael L.			Tocotrienols and Whey Protein Isolates Substantially Increase Exercise Endurance Capacity in Diet -Induced Obese Male Sprague-Dawley Rats	PLOS ONE			English	Article							RICH FRACTION SUPPLEMENTATION; SKELETAL-MUSCLE; INSULIN SENSITIVITY; MITOCHONDRIAL BIOGENESIS; ENZYME-ACTIVITY; FAT; RESISTANCE; METABOLISM; MORTALITY; OXIDATION	Background and Aims Obesity and impairments in metabolic health are associated with reductions in exercise capacity. Both whey protein isolates (WPIs) and vitamin E tocotrienols (TCTs) exert favorable effects on obesity-related metabolic parameters. This research sought to determine whether these supplements improved exercise capacity and increased glucose tolerance in diet-induced obese rats. Methods Six week old male rats (n = 35) weighing 187 +/- 32g were allocated to either: Control (n = 9), TCT (n = 9), WPI (n = 8) or TCT + WPI (n = 9) and placed on a high-fat diet (40% of energy from fat) for 10 weeks. Animals received 50mg/kg body weight and 8% of total energy intake per day of TCTs and/or WPIs respectively. Food intake, body composition, glucose tolerance, insulin sensitivity, exercise capacity, skeletal muscle glycogen content and oxidative enzyme activity were determined. Results Both TCT and WPI groups ran >50% longer (2271 +/- 185m and 2195 +/- 265m respectively) than the Control group (1428 +/- 139m) during the run to exhaustion test (P<0.05), TCT + WPI did not further improve exercise endurance (2068 +/- 104m). WPIs increased the maximum in vitro activity of beta-hydroxyacyl-CoA in the soleus muscle (P<0.05 vs. Control) but not in the plantaris. Citrate synthase activity was not different between groups. Neither supplement had any effect on weight gain, adiposity, glucose tolerance or insulin sensitivity. Conclusion Ten weeks of both TCTs and WPIs increased exercise endurance by 50% in sedentary, diet-induced obese rats. These positive effects of TCTs and WPIs were independent of body weight, adiposity or glucose tolerance.	[Betik, Andrew C.; Aguila, Jay; McConell, Glenn K.; McAinch, Andrew J.; Mathai, Michael L.] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis, Melbourne, Vic 8001, Australia; [Betik, Andrew C.; McConell, Glenn K.; McAinch, Andrew J.] Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia	Victoria University; Victoria University	Betik, AC (corresponding author), Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis, Melbourne, Vic 8001, Australia.; Betik, AC (corresponding author), Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia.	Andrew.Betik@vu.edu.au		McConell, Glenn/0000-0002-8572-9065; Betik, Andrew/0000-0001-8294-9719; McAinch, Andrew/0000-0002-8762-4865	Australian Government's Collaborative Research Networks (CRN) program	Australian Government's Collaborative Research Networks (CRN) program(Australian Government)	This research was supported through the Australian Government's Collaborative Research Networks (CRN) program (AJM).	ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Baliarsingh S, 2005, ATHEROSCLEROSIS, V182, P367, DOI 10.1016/j.atherosclerosis.2005.02.020; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Betik AC, 2008, EXP PHYSIOL, V93, P863, DOI 10.1113/expphysiol.2008.042069; Betik AC, 2009, AM J PHYSIOL-REG I, V297, pR744, DOI 10.1152/ajpregu.90959.2008; Bishop DJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE225, DOI 10.1152/ajpendo.00738.2009; Britton SL, 2005, IUBMB LIFE, V57, P631, DOI 10.1080/15216540500251684; Bruckbauer A, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-91; Budin SB, 2009, CLINICS, V64, P235, DOI 10.1590/S1807-59322009000300015; Chen WC, 2014, MED SCI SPORT EXER, V46, P1517, DOI 10.1249/MSS.0000000000000272; Chin SF, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-42; Coen PM, 2013, OBESITY, V21, P2362, DOI 10.1002/oby.20381; Cornall LM, 2013, MOL CELL ENDOCRINOL, V365, P108, DOI 10.1016/j.mce.2012.10.003; Fang F, 2010, MOL NUTR FOOD RES, V54, P345, DOI 10.1002/mnfr.200900119; Fock KM, 2013, J GASTROEN HEPATOL, V28, P59, DOI 10.1111/jgh.12407; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Furnes MW, 2009, OBES SURG, V19, P1430, DOI 10.1007/s11695-009-9863-1; Hall LML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014197; Haram PM, 2009, CARDIOVASC RES, V81, P723, DOI 10.1093/cvr/cvn332; Hayes A, 2008, CURR OPIN CLIN NUTR, V11, P40, DOI 10.1097/MCO.0b013e3282f2a57d; Henderson KK, 2002, J APPL PHYSIOL, V93, P1265, DOI 10.1152/japplphysiol.00809.2001; Hill KM, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-8; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Jenkin KA, 2016, BRIT J PHARMACOL, V173, P1128, DOI 10.1111/bph.13056; Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Contarteze RVL, 2008, COMP BIOCHEM PHYS A, V151, P415, DOI 10.1016/j.cbpa.2007.03.005; Lee JS, 2001, EXP PHYSIOL, V86, P499, DOI 10.1113/eph8602158; Lee SP, 2009, EUR J APPL PHYSIOL, V107, P587, DOI 10.1007/s00421-009-1159-6; Lessard SJ, 2011, AM J PHYSIOL-REG I, V300, pR175, DOI 10.1152/ajpregu.00338.2010; Morifuji M, 2005, BRIT J NUTR, V93, P439, DOI 10.1079/BJN20051373; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; NAHORSKI SR, 1972, ANAL BIOCHEM, V49, P492, DOI 10.1016/0003-2697(72)90453-8; Nowak G, 2012, J PHARMACOL EXP THER, V340, P330, DOI 10.1124/jpet.111.186882; Oberbach A, 2006, DIABETES CARE, V29, P895, DOI 10.2337/diacare.29.04.06.dc05-1854; Pal S, 2013, OBES REV, V14, P324, DOI 10.1111/obr.12005; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Premilovac D, 2013, CARDIOVASC RES, V98, P28, DOI 10.1093/cvr/cvt015; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rivas DA, 2011, AM J PHYSIOL-REG I, V300, pR835, DOI 10.1152/ajpregu.00659.2010; Robinson MJ, 2013, APPL PHYSIOL NUTR ME, V38, P120, DOI 10.1139/apnm-2012-0092; Schloesser A, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/789710; Shen YQ, 2015, OBESITY, V23, P1000, DOI 10.1002/oby.21056; Sousa GTD, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-67; Srere PA., 1969, METHODS ENZYMOLOGY, P3, DOI DOI 10.1016/0076-6879(69)13005-0; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; St-Pierre P, 2012, DIABETES OBES METAB, V14, P753, DOI 10.1111/j.1463-1326.2012.01598.x; St-Pierre P, 2010, DIABETES OBES METAB, V12, P798, DOI 10.1111/j.1463-1326.2010.01235.x; Sun XC, 2007, LIPIDS, V42, P297, DOI 10.1007/s11745-007-3029-5; Sun XC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-26; Tanaka S, 2007, METABOLISM, V56, P1719, DOI 10.1016/j.metabol.2007.07.017; Theriault A, 1999, CLIN BIOCHEM, V32, P309, DOI 10.1016/S0009-9120(99)00027-2; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Wong WY, 2012, NUTRIENTS, V4, P1527, DOI 10.3390/nu4101527; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhou J, 2011, OBESITY, V19, P1568, DOI 10.1038/oby.2011.14	58	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152562	10.1371/journal.pone.0152562	http://dx.doi.org/10.1371/journal.pone.0152562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058737	gold, Green Accepted, Green Published			2022-12-26	WOS:000373604800008
J	Beutler, E; Beltrami, FG; Boutellier, U; Spengler, CM				Beutler, Eveline; Beltrami, Fernando G.; Boutellier, Urs; Spengler, Christina M.			Effect of Regular Yoga Practice on Respiratory Regulation and Exercise Performance	PLOS ONE			English	Article							VENTILATORY RESPONSE; CHEMOREFLEX RESPONSE; TRAINED MALES; BAROREFLEX; PRESSURES; CAPACITY; HYPOXIA; VALUES; SLOPE; CYCLE	Yoga alters spontaneous respiratory regulation and reduces hypoxic and hypercapnic ventilatory responses. Since a lower ventilatory response is associated with an improved endurance capacity during whole-body exercise, we tested whether yogic subjects (YOGA) show an increased endurance capacity compared to matched non-yogic individuals (CON) with similar physical activity levels. Resting ventilation, the ventilatory response to hypercapnia, passive leg movement and exercise, as well as endurance performance were assessed. YOGA (n = 9), compared to CONTROL (n = 6), had a higher tidal volume at rest (0.7 +/- 0.2 vs. 0.5 +/- 0.1 l, p = 0.034) and a reduced ventilatory response to hypercapnia (33 +/- 15 vs. 47 +/- 15 l.min(-1), p = 0.048). A YOGA subgroup (n = 6) with maximal performance similar to CONTROL showed a blunted ventilatory response to passive cycling (11 +/- 2 vs. 14 +/- 2 l.min(-1), p = 0.039) and a tendency towards lower exercise ventilation (33 +/- 2 vs. 36 +/- 3 l.min(-1), p = 0.094) while cycling endurance (YOGA: 17.3 +/- 3.3; CON: 19.6 +/- 8.5 min, p = 0.276) did not differ. Thus, yoga practice was not associated with improved exercise capacity nor with significant changes in exercise ventilation despite a significantly different respiratory regulation at rest and in response to hypercapnia and passive leg movement.	[Beutler, Eveline; Beltrami, Fernando G.; Boutellier, Urs; Spengler, Christina M.] ETH, Inst Human Movement Sci, Exercise Physiol Lab, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Boutellier, Urs; Spengler, Christina M.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Winterthurerstr 190, CH-8057 Zurich, Switzerland	ETH Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Spengler, CM (corresponding author), ETH, Inst Human Movement Sci, Exercise Physiol Lab, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Spengler, CM (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	christina.spengler@hest.ethz.ch	Spengler, Christina M./E-9776-2012	Spengler, Christina M./0000-0002-4598-3595				Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; BALASUBRAMANIAN B, 1991, Indian Journal of Physiology and Pharmacology, V35, P281; Bernardi L, 1998, LANCET, V351, P1308, DOI 10.1016/S0140-6736(97)10341-5; Bernardi L, 2001, J HYPERTENS, V19, P2221, DOI 10.1097/00004872-200112000-00016; Bernardi L, 2007, EUR J APPL PHYSIOL, V99, P511, DOI 10.1007/s00421-006-0373-8; Birkel DA, 2000, ALTERN THER HEALTH M, V6, P55; Bowman AJ, 1997, EUR J CLIN INVEST, V27, P443, DOI 10.1046/j.1365-2362.1997.1340681.x; BYRNEQUINN E, 1971, J APPL PHYSIOL, V30, P91, DOI 10.1152/jappl.1971.30.1.91; Calbet JAL, 2006, RESP PHYSIOL NEUROBI, V151, P132, DOI 10.1016/j.resp.2006.01.014; Clark AL, 1997, HEART, V77, P138, DOI 10.1136/hrt.77.2.138; Evans JA, 2009, RESP CARE, V54, P1348; FLUME PA, 1994, RESP PHYSIOL, V95, P53, DOI 10.1016/0034-5687(94)90047-7; Flume PA, 1996, RESP PHYSIOL, V103, P221, DOI 10.1016/0034-5687(95)00094-1; FOWLER WS, 1954, J APPL PHYSIOL, V6, P539, DOI 10.1152/jappl.1954.6.9.539; GOPAL K S, 1973, Indian Journal of Physiology and Pharmacology, V17, P273; Guenette JA, 2006, APPL PHYSIOL NUTR ME, V31, P159, DOI 10.1139/H05-016; Hagins Marshall, 2007, BMC Complement Altern Med, V7, P40, DOI 10.1186/1472-6882-7-40; Harms CA, 2008, MED SCI SPORT EXER, V40, P664, DOI 10.1249/MSS.0b013e3181621325; Harver A, 2000, CHEST, V118, P679, DOI 10.1378/chest.118.3.679; Ingle L, 2007, INT J CARDIOL, V118, P350, DOI 10.1016/j.ijcard.2006.07.105; JOSHI L N, 1992, Indian Journal of Physiology and Pharmacology, V36, P105; Joshi M, 2009, J ALTERN COMPLEM MED, V15, P281, DOI 10.1089/acm.2008.0250; Lansing RW, 2000, AM J RESP CRIT CARE, V162, P1690, DOI 10.1164/ajrccm.162.5.9907096; LEVINE BD, 1992, MED SCI SPORT EXER, V24, P769; LORINC Z, 1991, AM J PHYSIOL, V261, pR747, DOI 10.1152/ajpregu.1991.261.3.R747; MAKWANA K, 1988, Indian Journal of Physiology and Pharmacology, V32, P202; MCCONNELL AK, 1992, J GERONTOL, V47, pB137, DOI 10.1093/geronj/47.4.B137; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miyamura M, 2002, JPN J PHYSIOL, V52, P313, DOI 10.2464/jilm.52.313; Ohtake PJ, 1998, MED SCI SPORT EXER, V30, P17, DOI 10.1097/00005768-199801000-00004; Oosthuyse T, 2010, SPORTS MED, V40, P207, DOI 10.2165/11317090-000000000-00000; Ozkaplan A, 2005, EUR J APPL PHYSIOL, V95, P52, DOI 10.1007/s00421-005-1399-z; Pomidori L, 2009, J CARDIOPULM REHABIL, V29, P133, DOI 10.1097/HCR.0b013e31819a0227; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Raju P S, 1986, Indian J Physiol Pharmacol, V30, P121; Raju P S, 1997, J Altern Complement Med, V3, P291, DOI 10.1089/acm.1997.3.291; RAJU PS, 1994, INDIAN J MED RES, V100, P81; Ray U. S., 2001, Indian Journal of Physiology and Pharmacology, V45, P37; Ray US, 2001, INDIAN J MED RES, V114, P215; READ DJC, 1967, AUSTRALAS ANN MED, V16, P20; Sarang PS, 2006, APPL PSYCHOPHYS BIOF, V31, P143, DOI 10.1007/s10484-006-9012-8; Spengler CM, 2000, J PHYSIOL-LONDON, V526, P683, DOI 10.1111/j.1469-7793.2000.00683.x; Spicuzza L, 2000, LANCET, V356, P1495, DOI 10.1016/S0140-6736(00)02881-6; STANESCU DC, 1981, J APPL PHYSIOL, V51, P1625, DOI 10.1152/jappl.1981.51.6.1625; Tatsumi K, 1997, J APPL PHYSIOL, V83, P1706, DOI 10.1152/jappl.1997.83.5.1706; Telles S, 1993, Indian J Med Sci, V47, P235; Tran M D, 2001, Prev Cardiol, V4, P165, DOI 10.1111/j.1520-037X.2001.00542.x; ULDRY C, 1995, THORAX, V50, P371, DOI 10.1136/thx.50.4.371; Verges S, 2008, RESP PHYSIOL NEUROBI, V161, P16, DOI 10.1016/j.resp.2007.11.004; Villien F, 2005, RESP PHYSIOL NEUROBI, V146, P85, DOI 10.1016/j.resp.2004.11.010; WHITE DP, 1983, J APPL PHYSIOL, V54, P874, DOI 10.1152/jappl.1983.54.4.874; WHITE DP, 1985, J APPL PHYSIOL, V59, P1452, DOI 10.1152/jappl.1985.59.5.1452; Wilkie SS, 2015, J APPL PHYSIOL, V118, P255, DOI 10.1152/japplphysiol.00400.2014; WILSON SH, 1984, THORAX, V39, P535, DOI 10.1136/thx.39.7.535; Yadav Raj Kumar, 2001, Indian Journal of Physiology and Pharmacology, V45, P493	55	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153159	10.1371/journal.pone.0153159	http://dx.doi.org/10.1371/journal.pone.0153159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055287	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000373608000090
J	Kahlert, S; Junnikkala, S; Renner, L; Hynonen, U; Hartig, R; Nossol, C; Barta-Boszormenyi, A; Danicke, S; Souffrant, WB; Palva, A; Rothkotter, HJ; Kluess, J				Kahlert, Stefan; Junnikkala, Sami; Renner, Lydia; Hynonen, Ulla; Hartig, Roland; Nossol, Constanze; Barta-Boszormenyi, Aniko; Daenicke, Sven; Souffrant, Wolfgang-Bernhard; Palva, Airi; Rothkoetter, Hermann-Josef; Kluess, Jeannette			Physiological Concentration of Exogenous Lactate Reduces Antimycin A Triggered Oxidative Stress in Intestinal Epithelial Cell Line IPEC-1 and IPEC-J2 In Vitro	PLOS ONE			English	Article							MONOCARBOXYLATE TRANSPORTERS MCT1; MITOCHONDRIAL-FUNCTION; HYDROGEN-PEROXIDE; SUPEROXIDE ANION; WEANED PIGLETS; PIG; PATHOGENESIS; MODULATION; EXPRESSION; AR-C155858	Weaning triggers an adaptation of the gut function including luminal lactate generation by lactobacilli, depending on gastrointestinal site. We hypothesized that both lactobacilli and lactate influence porcine intestinal epithelial cells. In vivo experiments showed that concentration of lactate was significantly higher in gastric, duodenal and jejunal chyme of suckling piglets compared to their weaned counterparts. In an in vitro study we investigated the impact of physiological lactate concentration as derived from the in vivo study on the porcine intestinal epithelial cells IPEC-1 and IPEC-J2. We detected direct adherence of lactobacilli on the apical epithelial surface and a modulated F-actin structure. Application of lactobacilli culture supernatant alone or lactate (25 mM) at low pH (pH 4) changed the F-actin structure in a similar manner. Treatment of IPEC cultures with lactate at near neutral pH resulted in a significantly reduced superoxide-generation in Antimycin A-challenged cells. This protective effect was nearly completely reversed by inhibition of cellular lactate uptake via monocarboxylate transporter. Lactate treatment enhanced NADH autofluorescence ratio (F-cytosol/F-nucleus) in non-challenged cells, indicating an increased availability of reduced nucleotides, but did not change the overall ATP content of the cells. Lactobacilli-derived physiological lactate concentration in intestine is relevant for alleviation of redox stress in intestinal epithelial cells.	[Kahlert, Stefan; Renner, Lydia; Nossol, Constanze; Barta-Boszormenyi, Aniko; Rothkoetter, Hermann-Josef] Univ Magdeburg, Inst Anat, D-39106 Magdeburg, Germany; [Daenicke, Sven; Kluess, Jeannette] Fed Res Inst Anim Hlth, Inst Anim Nutr, Friedrich Loeffler Inst, Braunschweig, Germany; [Hartig, Roland] Univ Magdeburg, Inst Mol & Clin Immunol, D-39106 Magdeburg, Germany; [Junnikkala, Sami; Hynonen, Ulla; Palva, Airi] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Souffrant, Wolfgang-Bernhard] Leibniz Inst Farm Anim Biol, Res Unit Nutr Physiol Oskar Kellner, Dummerstorf, Germany	Otto von Guericke University; Friedrich Loeffler Institute; Otto von Guericke University; University of Helsinki; Forschungsinstitut fur Nutztierbiologie (FBN)	Kahlert, S (corresponding author), Univ Magdeburg, Inst Anat, D-39106 Magdeburg, Germany.	stefan.kahlert@med.ovgu.de		Hartig, Roland/0000-0002-3706-7458; Hynonen, Ulla/0000-0002-2002-7804	EU 5th frame-work program "HealthyPigut" [QLK5-CT-2000-00522]; EU 7th frame-work program INTERPLAY [227549]	EU 5th frame-work program "HealthyPigut"; EU 7th frame-work program INTERPLAY	Funded by EU 5th frame-work program "HealthyPigut" (contract-no.: QLK5-CT-2000-00522) and EU 7th frame-work program INTERPLAY (grant agreement no.: 227549).	Arpaia N, 2014, IMMUNOL CELL BIOL, V92, P561, DOI 10.1038/icb.2014.40; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Castilho RF, 1999, J NEUROCHEM, V72, P1394, DOI 10.1046/j.1471-4159.1999.721394.x; CRANWELL PD, 1976, BRIT J NUTR, V36, P71, DOI 10.1079/BJN19760059; Degroote J, 2012, J ANIM SCI, V90, P359, DOI 10.2527/jas.53809; Diesing AK, 2011, TOXICOL LETT, V200, P8, DOI 10.1016/j.toxlet.2010.10.006; HAACKER K, 1983, ARCH TIERERNAHR, V33, P505, DOI 10.1080/17450398309425704; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; Hinoi E, 2006, MOL PHARMACOL, V70, P925, DOI 10.1124/mol.106.024398; Hou YQ, 2011, BRIT J NUTR, V106, P357, DOI 10.1017/S0007114511000249; Hynonen U, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-199; Ishiguro K, 2014, IMMUNOL CELL BIOL, V92, P624, DOI 10.1038/icb.2014.31; Kahlert S, 2008, J NEUROSCI METH, V171, P87, DOI 10.1016/j.jneumeth.2008.02.015; Kaur T, 2003, MOL CELL BIOCHEM, V253, P15, DOI 10.1023/A:1026088915240; Kluess J, 2003, ARCH ANIMAL BREEDING, V36, P101; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Latham T, 2012, NUCLEIC ACIDS RES, V40, P4794, DOI 10.1093/nar/gks066; Marti R, 2010, APPL ENVIRON MICROB, V76, P1456, DOI 10.1128/AEM.01895-09; Mayevsky A, 2013, J CLIN MONIT COMPUT, V27, P1, DOI 10.1007/s10877-012-9414-5; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Ovens MJ, 2010, BIOCHEM J, V431, P217, DOI 10.1042/BJ20100890; Ovens MJ, 2010, BIOCHEM J, V425, P523, DOI 10.1042/BJ20091515; Piechota-Polanczyk A, 2014, N-S ARCH PHARMACOL, V387, P605, DOI 10.1007/s00210-014-0985-1; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Robert F., 2009, Journees de la Recherche Porcine en France, V41, P173; Schnackenberg CG, 2002, CURR OPIN PHARMACOL, V2, P121, DOI 10.1016/S1471-4892(02)00133-9; Sepponen K, 2007, VET J, V174, P122, DOI 10.1016/j.tvjl.2006.05.015; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Shieh JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030240; Stanley A, 2014, ANTIOXID REDOX SIGN, V20, P2026, DOI 10.1089/ars.2013.5713; Steube KG, 2012, CYTOTECHNOLOGY, V64, P373, DOI 10.1007/s10616-011-9420-3; Tang YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012417; Tuohy KM, 2003, DRUG DISCOV TODAY, V8, P692, DOI 10.1016/S1359-6446(03)02746-6; Turroni F, 2014, CELL MOL LIFE SCI, V71, P183, DOI 10.1007/s00018-013-1318-0; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Wentworth CC, 2011, J BIOL CHEM, V286, P38448, DOI 10.1074/jbc.M111.268938; Wu MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100591; Xu JX, 2014, NUTRITION, V30, P584, DOI 10.1016/j.nut.2013.10.018; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	42	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153135	10.1371/journal.pone.0153135	http://dx.doi.org/10.1371/journal.pone.0153135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054581	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000084
J	Liu, WL; Shih, HC; Weng, IS; Ko, YZ; Tsai, CC; Chou, CH; Chiang, YC				Liu, Wen-Lin; Shih, Huei-Chuan; Weng, I-Szu; Ko, Ya-Zhu; Tsai, Chi-Chu; Chou, Chang-Hung; Chiang, Yu-Chung			Characterization of Genomic Inheritance of Intergeneric Hybrids between Ascocenda and Phalaenopsis Cultivars by GISH, PCR-RFLP and RFLP	PLOS ONE			English	Article							INTERSPECIFIC HYBRIDS; RIBOSOMAL DNA; CHLOROPLAST DNA; PATERNAL INHERITANCE; MATERNAL INHERITANCE; CONCERTED EVOLUTION; LINKAGE MAP; RDNA; SEQUENCES; DISCRIMINATION	Background The intergeneric hybrids between Ascocenda John De Biase ` Blue' and Phalaenopsis Chih Shang's Stripes have been generated to introduce the blue color into the Phalaenopsis germplasm in prior study. In order to confirm the inheritance in hybrid progenies, genomic in situ hybridization (GISH) and restriction fragment length polymorphism (RFLP) analysis were conducted to confirm the intergeneric hybridization status. Methods/Results GISH analysis showed the presence of both maternal and paternal chromosomes in the cells of the putative hybrids indicating that the putative hybrid seedlings were intergeneric hybrids of the two parents. Furthermore, twenty-seven putative hybrids were randomly selected for DNA analysis, and the external transcribed spacer (ETS) regions of nrDNA were analyzed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and RFLP analyses to identify the putative hybrids. RFLP analysis showed that the examined seedlings were intergeneric hybrids of the two parents. However, PCRRFLP analysis showed bias to maternal genotype. Conclusions Both GISH and RFLP analyses are effective detection technology to identify the intergeneric hybridization status of putative hybrids. Furthermore, the use of PCR-RFLP analysis to identify the inheritance of putative hybrids should be carefully evaluated.	[Liu, Wen-Lin; Weng, I-Szu; Tsai, Chi-Chu] Kaohsiung Dist Agr Res & Extens Stn, Pingtung 900, Taiwan; [Shih, Huei-Chuan] Meiho Univ, Dept Nursing, Pingtung 912, Taiwan; [Ko, Ya-Zhu; Chiang, Yu-Chung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan; [Tsai, Chi-Chu] Natl Pingtung Univ Sci & Technol, Pingtung 912, Taiwan; [Chou, Chang-Hung] China Med Univ, Res Ctr Biodivers, Taichung 404, Taiwan; [Chiang, Yu-Chung] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan	National Sun Yat Sen University; National Pingtung University Science & Technology; China Medical University Taiwan; Kaohsiung Medical University	Tsai, CC (corresponding author), Kaohsiung Dist Agr Res & Extens Stn, Pingtung 900, Taiwan.; Chiang, YC (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan.; Tsai, CC (corresponding author), Natl Pingtung Univ Sci & Technol, Pingtung 912, Taiwan.; Chou, CH (corresponding author), China Med Univ, Res Ctr Biodivers, Taichung 404, Taiwan.; Chiang, YC (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan.	tsaicc@mail.kdais.gov.tw; choumasa@mail.cmu.edu.tw; yuchung@mail.nsysu.edu.tw	Chiang, Yu-Chung/E-9143-2011	Ko, Ya-Zhu/0000-0002-5810-6487	Ministry of Science and Technology, Taiwan [MOST 103-2321-B-067E-001]; China Medical University, Taichung, Taiwan;  [MOST 103-2621-B-110 -001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taichung, Taiwan(China Medical University); 	This research was supported by funding from the Ministry of Science and Technology, Taiwan, MOST 103-2321-B-067E-001 to CCT, partial from MOST 103-2621-B-110 -001 to YCC, and from the China Medical University, Taichung, Taiwan to CHC.	ANAMTHAWATJONSSON K, 1990, THEOR APPL GENET, V79, P721, DOI 10.1007/BF00224236; Asker S. E., 1992, APOMIXIS PLANTS; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; BELLAMY A, 1995, THEOR APPL GENET, V91, P505, DOI 10.1007/BF00222980; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRANDHAM PE, 1982, GENETICA, V59, P29, DOI 10.1007/BF00130812; CHANG C, 1988, P NATL ACAD SCI USA, V85, P6856, DOI 10.1073/pnas.85.18.6856; Chang SB, 2000, BOT BULL ACAD SINICA, V41, P219; Christenson E.A., 2001, PHALAENOPSIS MONOGRA; CIPRIANI G, 1995, MOL GEN GENET, V247, P693, DOI 10.1007/BF00290400; DEJONG JH, 1993, GENOME, V36, P1032, DOI 10.1139/g93-138; Devos N, 2006, MOL PHYLOGENET EVOL, V38, P767, DOI 10.1016/j.ympev.2005.11.013; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Diaz RS, 1998, BRAZ J MED BIOL RES, V31, P1239, DOI 10.1590/S0100-879X1998001000001; Doyle J. J., 1987, PHYTOCHEM B, P11; Dressler RL, 1993, PHYLOGENY CLASSIFICA; ELLERSTROM S, 1977, HEREDITAS, V87, P107; Fagerlind F, 1940, SV BOT TIDSK, V34, P335; Franzke A, 1999, THEOR APPL GENET, V98, P831, DOI 10.1007/s001220051140; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HILLIS DM, 1991, SCIENCE, V251, P308, DOI 10.1126/science.1987647; Holderegger R, 2005, TREES-STRUCT FUNCT, V19, P742, DOI 10.1007/s00468-005-0006-6; Holttum RE, 1952, ORCHID J, V1, P58; Housley DJE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-253; Hu ZanMin, 1996, Acta Botanica Sinica, V38, P253; Huang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133722; Jian Li, 2013, Journal of Plant Breeding and Crop Science, V5, P158; JONES D L, 1989, Lindleyana, V4, P139; KAMEMOTO H., 1964, BOT GAZ, V125, P132, DOI 10.1086/336259; Kao YY, 2001, ANN BOT-LONDON, V87, P387, DOI 10.1006/anbo.2000.1348; Kelch DG, 2003, MOL ECOL, V12, P141, DOI 10.1046/j.1365-294X.2003.01710.x; Khrustaleva LI, 2005, GENETICS, V169, P1673, DOI 10.1534/genetics.104.038687; KIM KJ, 1994, PLANT SYST EVOL, V190, P157, DOI 10.1007/BF00986191; Kovarik A, 1996, THEOR APPL GENET, V92, P1108, DOI 10.1007/BF00224057; KUROIWA T, 1991, INT REV CYTOL, V128, P1; Li DW, 2013, MOL GENET GENOMICS, V288, P101, DOI 10.1007/s00438-012-0732-6; Liao PC, 2010, BOT STUD, V51, P413; Lim KB, 2003, THEOR APPL GENET, V106, P568, DOI 10.1007/s00122-002-1070-6; Lin CC, 2005, BOT BULL ACAD SINICA, V46, P339; Logacheva MD, 2010, MOL PHYLOGENET EVOL, V57, P471, DOI 10.1016/j.ympev.2010.06.001; MANHART JR, 1992, J PHYCOL, V28, P730, DOI 10.1111/j.0022-3646.1992.00730.x; McKinnon GE, 2001, GENOME, V44, P831, DOI 10.1139/gen-44-5-831; Moir WWG, 1995, AN ORCHID DATABASE; Nwakanma DC, 2003, THEOR APPL GENET, V108, P154, DOI 10.1007/s00122-003-1402-1; OCHMAN H, 1988, GENETICS, V120, P621; Piperidis N, 2014, METHODS MOL BIOL, V1115, P325, DOI 10.1007/978-1-62703-767-9_16; Poczai P, 2010, MOL BIOL REP, V37, P1897, DOI 10.1007/s11033-009-9630-3; Raina S. N., 2001, Methods in Cell Science, V23, P83, DOI 10.1023/A:1013197705523; Ruano G, 1992, PCR Methods Appl, V2, P112; Sang T, 1995, THESIS OHIO STATE U; SCHLOTTERER C, 1994, CURR BIOL, V4, P777, DOI 10.1016/S0960-9822(00)00175-5; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; SHINDO K, 1963, CYTOLOGIA, V28, P390, DOI 10.1508/cytologia.28.390; Shore JS, 1998, AM J BOT, V85, P328, DOI 10.2307/2446324; Skalick a K, 2003, AM J BOT, V90, P988, DOI [10.3732/ajb.90.7.988, DOI 10.3732/AJB.90.7.988]; SOLIMAN KM, 1993, THEOR APPL GENET, V85, P913, DOI 10.1007/BF00225038; STINE M, 1989, THEOR APPL GENET, V78, P768, DOI 10.1007/BF00266656; Tsai CC, 2006, J HORTIC SCI BIOTECH, V81, P691, DOI 10.1080/14620316.2006.11512125; Tsai CC, 2009, ACTA HORTIC, V829, P413; Tsai CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141761; Tsai CC, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0560-z; Tsai CC, 2012, SCI HORTIC-AMSTERDAM, V142, P84, DOI 10.1016/j.scienta.2012.05.004; Volkov RA, 1999, MOL BIOL EVOL, V16, P311, DOI 10.1093/oxfordjournals.molbev.a026112; Wan DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089769; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Yang TW, 2000, AM J BOT, V87, P1452, DOI 10.2307/2656871	68	3	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153512	10.1371/journal.pone.0153512	http://dx.doi.org/10.1371/journal.pone.0153512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055268	gold, Green Published, Green Submitted			2022-12-26	WOS:000373608000130
J	Rosier, BT; Lazova, MD				Rosier, Bob T.; Lazova, Milena D.			Dose-Response Analysis of Chemotactic Signaling Response in Salmonella typhimurium LT2 upon Exposure to Cysteine/Cystine Redox Pair	PLOS ONE			English	Article							INTESTINAL MUCUS BARRIER; ESCHERICHIA-COLI; REPELLENT TAXIS; BACTERIAL; CHEMORECEPTORS; CYSTINE; RECEPTOR; COOPERATIVITY; SENSITIVITY; PATHWAY	The chemotaxis system enables motile bacteria to search for an optimum level of environmental factors. Salmonella typhimurium senses the amino acid cysteine as an attractant and its oxidized dimeric form, cystine, as a repellent. We investigated the dose-response dependence of changes in chemotactic signaling activity upon exposure to cysteine and cystine of S. typhimurium LT2 using in vivo fluorescence resonance energy transfer (FRET) measurements. The dose-response curve of the attractant response to cysteine had a sigmoidal shape, typical for receptor-ligand interactions. However, in a knockout strain of the chemoreceptor genes tsr and tar, we detected a repellent response to cysteine solutions, scaling linearly with the logarithm of the cysteine concentration. Interestingly, the magnitude of the repellent response to cystine also showed linear dependence to the logarithm of the cystine concentration. This linear dependence was observed over more than four orders of magnitude, where detection started at nanomolar concentrations. Notably, low concentrations of another oxidized compound, benzoquinone, triggered similar responses. In contrast to S. typhimurium 14028, where no response to cystine was observed in a knockout strain of chemoreceptor genes mcpB and mcpC, here we showed that McpB/McpC-independent responses to cystine existed in the strain S. typhimurium LT2 even at nanomolar concentrations. Additionally, knocking out mcpB and mcpC did not affect the linear dose-response dependence, whereas enhanced responses were only observed to solutions that where not pH neutral (>100 mu M cystine) in the case of McpC overexpression. We discuss that the linear dependence of the response on the logarithm of cystine concentrations could be a result of a McpB/C-independent redox-sensing pathway that exists in S. typhimurium LT2. We supported this hypothesis with experiments with defined cysteine/cystine mixed solutions, where a transition from repellent to attractant response occurred depending on the estimated redox potential.	[Rosier, Bob T.; Lazova, Milena D.] FOM Inst Atom & Mol Phys AMOLF, Amsterdam, Netherlands; [Rosier, Bob T.] Max Planck Inst MPI Terr Microbiol Marburg, Hessen, Germany; [Lazova, Milena D.] MIT, Dept Biol, Cambridge, MA USA	AMOLF; Massachusetts Institute of Technology (MIT)	Lazova, MD (corresponding author), FOM Inst Atom & Mol Phys AMOLF, Amsterdam, Netherlands.; Lazova, MD (corresponding author), MIT, Dept Biol, Cambridge, MA USA.	lazova@mit.edu		Rosier, Bob T./0000-0002-3267-6561	Netherlands Organization for Scientific Research / Foundation for Fundamental Research on Matter	Netherlands Organization for Scientific Research / Foundation for Fundamental Research on Matter(FOM (The Netherlands)Netherlands Organization for Scientific Research (NWO))	This work was supported by The Netherlands Organization for Scientific Research / Foundation for Fundamental Research on Matter.	ADLER J, 1973, J BACTERIOL, V115, P824, DOI 10.1128/JB.115.3.824-847.1973; ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; ADLER J, 1969, SCIENCE, V166, P1588, DOI 10.1126/science.166.3913.1588; BERG HC, 1984, J GEN MICROBIOL, V130, P2915; Berg HC, 2000, PHYS TODAY, V53, P24, DOI 10.1063/1.882934; Bespalov VA, 1996, P NATL ACAD SCI USA, V93, P10084, DOI 10.1073/pnas.93.19.10084; Bibikov SI, 1997, J BACTERIOL, V179, P4075, DOI 10.1128/jb.179.12.4075-4079.1997; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; BRIGHAM MP, 1960, J CLIN INVEST, V39, P1633, DOI 10.1172/JCI104186; Burne R A, 2012, Adv Dent Res, V24, P77, DOI 10.1177/0022034512449462; Corazziari ES, 2009, J PEDIATR GASTR NUTR, V48, pS54, DOI 10.1097/MPG.0b013e3181a117ea; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; CRAWHALL JC, 1967, BIOCHEM J, V105, P891, DOI 10.1042/bj1050891; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEWEY DL, 1965, NATURE, V206, P1369, DOI 10.1038/2061369a0; Edwards JC, 2006, MOL MICROBIOL, V62, P823, DOI 10.1111/j.1365-2958.2006.05411.x; Englert DL, 2010, J BACTERIOL, V192, P2633, DOI 10.1128/JB.00854-09; Falke JJ, 2002, P NATL ACAD SCI USA, V99, P6530, DOI 10.1073/pnas.112214199; Garcia-Quintanilla M, 2011, PLASMID, V65, P169, DOI 10.1016/j.plasmid.2010.12.001; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hazelbauer GL, 1971, NAT NEW BIO, V230; HEDBLOM ML, 1983, J BACTERIOL, V155, P1463, DOI 10.1128/JB.155.3.1463-1466.1983; Ishii T, 1999, FREE RADICAL RES, V31, P351, DOI 10.1080/10715769900300921; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; KELLN RA, 1990, MOL GEN GENET, V222, P438, DOI 10.1007/BF00633852; KIHARA M, 1981, J BACTERIOL, V145, P1209, DOI 10.1128/JB.145.3.1209-1221.1981; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; KONDOH H, 1979, P NATL ACAD SCI USA, V76, P260, DOI 10.1073/pnas.76.1.260; Lane MC, 2006, J BACTERIOL, V188, P5618, DOI 10.1128/JB.00449-06; Lazova MD, 2012, MOL MICROBIOL, V84, P697, DOI 10.1111/j.1365-2958.2012.08051.x; Lazova MD, 2011, P NATL ACAD SCI USA, V108, P13870, DOI 10.1073/pnas.1108608108; Lengeler JW, 1996, HDB BIOL PHYS, V2; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Lux R, 1999, MOL BIOL CELL, V10, P1133, DOI 10.1091/mbc.10.4.1133; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; MOWBRAY SL, 1987, CELL, V50, P171, DOI 10.1016/0092-8674(87)90213-3; Neidhardt FCeic, 1996, ESCHERICHIA COLI SAL; Neumann S, 2014, PLOS ONE, V9; Prinz Heino, 2010, J Chem Biol, V3, P37, DOI 10.1007/s12154-009-0029-3; Rebbapragada A, 1997, P NATL ACAD SCI USA, V94, P10541, DOI 10.1073/pnas.94.20.10541; Rosner JL, 1997, CURR TOP CELL REGUL, V35, P163, DOI 10.1016/S0070-2137(97)80007-6; Salman H, 2007, NAT CELL BIOL, V9, P1098, DOI 10.1038/ncb1632; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Sourjik V, 2012, CURR OPIN CELL BIOL, V24, P262, DOI 10.1016/j.ceb.2011.11.008; Stock J, 1999, TRENDS MICROBIOL, V7, P1, DOI 10.1016/S0966-842X(98)01429-2; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; TREVORS JT, 1980, B ENVIRON CONTAM TOX, V25, P672, DOI 10.1007/BF01985590; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Yang Y, 2012, MOL MICROBIOL, V62, P823; Yang YL, 2015, MOL MICROBIOL, V96, P1272, DOI 10.1111/mmi.13006; Yuan JH, 2008, P NATL ACAD SCI USA, V105, P1182, DOI 10.1073/pnas.0711539105	56	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152815	10.1371/journal.pone.0152815	http://dx.doi.org/10.1371/journal.pone.0152815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054963	Green Submitted, Green Published, gold			2022-12-26	WOS:000373608000047
J	Braczkowski, AR; Balme, GA; Dickman, A; Fattebert, J; Johnson, P; Dickerson, T; Macdonald, DW; Hunter, L				Braczkowski, Alexander Richard; Balme, Guy Andrew; Dickman, Amy; Fattebert, Julien; Johnson, Paul; Dickerson, Tristan; Macdonald, David Whyte; Hunter, Luke			Scent Lure Effect on Camera-Trap Based Leopard Density Estimates	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; PANTHERA-PARDUS; SOUTH-AFRICA; MARK-RECAPTURE; POPULATIONS; INFERENCE; CARNIVORES; JAGUAR; CONSERVATION; INFORMATION	Density estimates for large carnivores derived from camera surveys often have wide confidence intervals due to low detection rates. Such estimates are of limited value to authorities, which require precise population estimates to inform conservation strategies. Using lures can potentially increase detection, improving the precision of estimates. However, by altering the spatio-temporal patterning of individuals across the camera array, lures may violate closure, a fundamental assumption of capture-recapture. Here, we test the effect of scent lures on the precision and veracity of density estimates derived from camera-trap surveys of a protected African leopard population. We undertook two surveys (a 'control' and 'treatment' survey) on Phinda Game Reserve, South Africa. Survey design remained consistent except a scent lure was applied at camera-trap stations during the treatment survey. Lures did not affect the maximum movement distances (p = 0.96) or temporal activity of female (p = 0.12) or male leopards (p = 0.79), and the assumption of geographic closure was met for both surveys (p >0.05). The numbers of photographic captures were also similar for control and treatment surveys (p = 0.90). Accordingly, density estimates were comparable between surveys (although estimates derived using non-spatial methods (7.28-9.28 leopards/100km(2)) were considerably higher than estimates from spatially-explicit methods (3.40-3.65 leopards/100km(2)). The precision of estimates from the control and treatment surveys, were also comparable and this applied to both non-spatial and spatial methods of estimation. Our findings suggest that at least in the context of leopard research in productive habitats, the use of lures is not warranted.	[Braczkowski, Alexander Richard; Dickman, Amy; Johnson, Paul; Macdonald, David Whyte] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney House, Tubney, Oxon, England; [Balme, Guy Andrew; Fattebert, Julien; Dickerson, Tristan; Hunter, Luke] Panthera, 8 West 40th St,18th Floor, New York, NY USA; [Balme, Guy Andrew] Univ Cape Town, Dept Biol Sci, ZA-7700 Rondebosch, South Africa; [Dickman, Amy] Ruaha Carnivore Project, Iringa, Tanzania; [Fattebert, Julien] Univ Kwazulu Natal, Sch Life Sci, Westville Campus, Durban, South Africa	University of Oxford; University of Cape Town; University of Kwazulu Natal	Braczkowski, AR (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney House, Tubney, Oxon, England.	alexander.braczkowski@gmail.com	Hunter, Luke T.B./H-3324-2019; Fattebert, Julien/I-8126-2019	Hunter, Luke T.B./0000-0001-9653-6544; Fattebert, Julien/0000-0001-5510-6804; Braczkowski, Alexander/0000-0002-0099-7803	Panthera New York; Timbo-Stichting Foundation; Albert and Didy Hartog; Robertson Foundation; Recanati-Kaplan Foundation	Panthera New York; Timbo-Stichting Foundation; Albert and Didy Hartog; Robertson Foundation; Recanati-Kaplan Foundation	Panthera New York provided vehicles, camera-traps and funding for fieldwork. Albert and Didy Hartog and the Timbo-Stichting Foundation also provided funding for fieldwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Albert and Didy Hartog, the Timbo-Stichting Foundation and Panthera for funding the study and the provision of materials to perform this research. & Beyond is thanked for access to research sites. DWM thanks the Robertson Foundation and the Recanati-Kaplan Foundation for support. The authors have no conflicts of interest to declare.	Ariefiandy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058800; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Bailey, 1993, AFRICAN LEOPARD ECOL; Balme G, 2014, BIOL CONSERV, V179, P144, DOI 10.1016/j.biocon.2014.09.021; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Balme GA, 2014, CONSERV LETT, V7, P3, DOI 10.1111/conl.12028; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; Borchers D, 2014, METHODS ECOL EVOL, V5, P656, DOI 10.1111/2041-210X.12196; Bothma J.d.P., 1999, LARGER CARNIVORES AF, P22, DOI [10.1007/978-3-662-03766-9_2/COVER, DOI 10.1007/978-3-662-03766-9_2/COVER]; Braczkowski AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123100; Braczkowski Alexander, 2013, Cat News, V58, P13; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Di Minin E, 2013, ANIM CONSERV, V16, P249, DOI 10.1111/j.1469-1795.2012.00595.x; du Preez BD, 2014, BIOL CONSERV, V176, P153, DOI 10.1016/j.biocon.2014.05.021; Gray TNE, 2012, J WILDLIFE MANAGE, V76, P163, DOI 10.1002/jwmg.230; Efford M., 2015, PACKAGE SECR VERSION; Efford M. G., 2004, Animal Biodiversity and Conservation, V27, P217; Fattebert J, 2013, THESIS U KWAZULU NAT; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Gopalaswamy AM, 2012, ECOLOGY, V93, P1741, DOI 10.1890/11-2110.1; Grant TL, 2012, THESIS RHODES U GRAH; Grey JNC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082832; Hijmans RJ., 2013, RASTER PACKAGE R VER; Janecka JE, 2011, J MAMMAL, V92, P771, DOI 10.1644/10-MAMM-A-036.1; Karanth KU, 1998, ECOLOGY, V79, P2852; Keitt T., 2013, RGDAL PACKAGE R VERS; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Maputla NW, 2013, AFR J ECOL, V51, P422, DOI 10.1111/aje.12047; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; Martins Q, 2013, AFR J ECOL, V51, P571, DOI 10.1111/aje.12068; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; MITHTHAPALA S, 1989, J ZOOL, V218, P527, DOI 10.1111/j.1469-7998.1989.tb04996.x; Noss AJ, 2012, ANIM CONSERV, V15, P527, DOI 10.1111/j.1469-1795.2012.00545.x; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; Obbard ME, 2010, J APPL ECOL, V47, P76, DOI 10.1111/j.1365-2664.2009.01758.x; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pesenti E, 2013, J MAMMAL, V94, P73, DOI 10.1644/11-MAMM-A-322.1; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; R Core Team, 2018, R LANG ENV STAT COMP; Ray J.C., 2005, 24 WILDL CONS SOC; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Sollmann R, 2013, BIOL CONSERV, V167, P242, DOI 10.1016/j.biocon.2013.08.003; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Sunquist ME, 2002, WILD CATS WORLD; Thomas P., 2005, ANIM KEEPERSFORUM, V32, P342; Thorn M, 2009, S AFR J WILDL RES, V39, P1, DOI 10.3957/056.039.0101; Tobler MW, 2013, BIOL CONSERV, V159, P375, DOI 10.1016/j.biocon.2012.12.012; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Zar JH, 1999, BIOSTATISTICAL ANAL	56	56	56	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151033	10.1371/journal.pone.0151033	http://dx.doi.org/10.1371/journal.pone.0151033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050816	gold, Green Published			2022-12-26	WOS:000373603500005
J	Chen, PL; Mancini, M; Sonis, ST; Fernandez-Martinez, J; Liu, J; Cohen, EEW; Toback, FG				Chen, Peili; Mancini, Maria; Sonis, Stephen T.; Fernandez-Martinez, Juan; Liu, Jing; Cohen, Ezra E. W.; Toback, F. Gary			A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; 1 INDUCES SENESCENCE; NUDE-MOUSE MODEL; TIGHT JUNCTIONS; EPITHELIAL-CELLS; GASTRIC-CANCER; ECONOMIC OUTCOMES; APOPTOSIS; BARRIER; PROTEIN	We have characterized a novel 21 amino acid-peptide derived from Antrum Mucosal Protein (AMP)-18 that mediates growth promotion of cultured normal epithelial cells and mitigates radiation-induced oral mucositis in animal models, while suppressing in vitro function of cancer cells. The objective of this study was to evaluate these dual potential therapeutic effects of AMP peptide in a clinically relevant animal model of head and neck cancer (HNC) by simultaneously assessing its effect on tumor growth and radiation-induced oral mucositis in an orthotopic model of HNC. Bioluminescent SCC-25 HNC cells were injected into the anterior tongue and tumors that formed were then subjected to focal radiation treatment. Tumor size was assessed using an in vivo imaging system, and the extent of oral mucositis was compared between animals treated with AMP peptide or vehicle (controls). Synergism between AMP peptide and radiation therapy was suggested by the finding that tumors in the AMP peptide/radiation therapy cohort demonstrated inhibited growth vs. radiation therapy-only treated tumors, while AMP peptide-treatment delayed the onset and reduced the severity of radiation therapy-induced oral mucositis. A differential effect on apoptosis appears to be one mechanism by which AMP-18 can stimulate growth and repair of injured mucosal epithelial cells while inhibiting proliferation of HNC cells. RNA microarray analysis identified pathways that are differentially targeted by AMP-18 in HNC vs. nontransformed cells. These observations confirm the notion that normal cells and tumor cells may respond differently to common biological stimuli, and that leveraging this finding in the case of AMP-18 may provide a clinically relevant opportunity.	[Chen, Peili; Liu, Jing; Cohen, Ezra E. W.; Toback, F. Gary] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Mancini, Maria; Sonis, Stephen T.; Fernandez-Martinez, Juan] Biomodels LLC, Watertown, MA 02472 USA; [Sonis, Stephen T.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Fernandez-Martinez, Juan] Univ Oviedo, Dept Math, Asturias, Spain; [Liu, Jing] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Cohen, Ezra E. W.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of Chicago; Harvard University; Brigham & Women's Hospital; University of Oviedo; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Chen, PL; Toback, FG (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	pchen@medicine.bsd.uchicago.edu; gtoback@medicine.bsd.uchicago.edu	Fernandez-Martinez, Juan Luis/M-1446-2017	Fernandez-Martinez, Juan Luis/0000-0002-4758-2832	National Cancer Institute [CA 176032]; NATIONAL CANCER INSTITUTE [R21CA176032] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute (www.cancer.gov): CA 176032 to FGT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biomodels, LLC. provided support in the form of salaries for authors MM, STS and JFM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Bell S, 2012, MOL ORAL MICROBIOL, V27, P160, DOI 10.1111/j.2041-1014.2012.640.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chen PL, 2015, INFLAMM BOWEL DIS, V21, P2393, DOI 10.1097/MIB.0000000000000499; Chen PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125490; Chen PL, 2012, INFLAMM BOWEL DIS, V18, P1749, DOI 10.1002/ibd.22886; Chen PL, 2011, ORAL ONCOL, V47, P831, DOI 10.1016/j.oraloncology.2011.06.012; Cohen EEW, 2013, ORAL ONCOL, V49, P1025, DOI 10.1016/j.oraloncology.2013.07.009; Elting LS, 2003, CANCER, V98, P1531, DOI 10.1002/cncr.11671; Fang LY, 2010, J ORAL PATHOL MED, V39, P342, DOI 10.1111/j.1600-0714.2009.00836.x; Hawkes WC, 2012, J CELL BIOCHEM, V113, P61, DOI 10.1002/jcb.23328; Knox JJ, 2000, DRUG AGING, V17, P257, DOI 10.2165/00002512-200017040-00002; Lee TK, 2007, CANCER RES, V67, P8800, DOI 10.1158/0008-5472.CAN-07-0801; Li SH, 2015, SURGERY, V157, P570, DOI 10.1016/j.surg.2014.10.014; Li Z, 2013, EUR REV MED PHARMACO, V17, P2166; Liu ZY, 2012, HEAD NECK-J SCI SPEC, V34, P1789, DOI 10.1002/hed.22013; Logan RM, 2007, CANCER TREAT REV, V33, P448, DOI 10.1016/j.ctrv.2007.03.001; Lyng G, 2013, PATHOBIOLOGY CANC RE, P75; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Maggioni D, 2013, INT J ONCOL, V43, P1675, DOI 10.3892/ijo.2013.2072; Martin TE, 2003, AM J PHYSIOL-GASTR L, V285, pG332, DOI 10.1152/ajpgi.00453.2002; McCarthy KM, 1996, J CELL SCI, V109, P2287; Mitic LL, 2000, AM J PHYSIOL-GASTR L, V279, pG250, DOI 10.1152/ajpgi.2000.279.2.G250; Moss SF, 2008, CLIN CANCER RES, V14, P4161, DOI 10.1158/1078-0432.CCR-07-4381; Myers JN, 2002, CLIN CANCER RES, V8, P293; Oien KA, 2004, J PATHOL, V203, P789, DOI 10.1002/path.1583; Resnick MB, 2006, GUT, V55, P1717, DOI 10.1136/gut.2006.095646; RHEINWALD JG, 1980, CELL, V22, P629, DOI 10.1016/0092-8674(80)90373-6; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rippa E, 2011, J CELL PHYSIOL, V226, P2571, DOI 10.1002/jcp.22601; Saligan LN, 2014, CANCER INFORM, V13, P141, DOI 10.4137/CIN.S19745; Schlienger S, 2014, MOL BIOL CELL, V25, P17, DOI 10.1091/mbc.E13-06-0335; Seto K, 2013, ONCOL REP, V29, P2147, DOI 10.3892/or.2013.2387; Shrivastava R., 2013, J CANC RES TREATMENT, V1, P4, DOI [10.12691/jcrt-1-1-2, DOI 10.12691/JCRT-1-1-2]; Sonis S, 2007, ORAL ONCOL, V43, P289, DOI 10.1016/j.oraloncology.2006.03.014; Sonis ST, 2013, ORAL DIS, V19, P721, DOI 10.1111/odi.12146; Sonis ST, 2001, J CLIN ONCOL, V19, P2201, DOI 10.1200/JCO.2001.19.8.2201; Sonis ST, 2002, ONCOLOGY-NY, V16, P680; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Sonis ST, 1999, CANCER-AM CANCER SOC, V85, P2103, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0; Sonis ST, 2009, CORE EVID, V4, P199; Toback FG, 2003, AM J PHYSIOL-GASTR L, V285, pG344, DOI 10.1152/ajpgi.00455.2002; Uchida K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-353; Walsh-Reitz MM, 2005, AM J PHYSIOL-GASTR L, V289, pG163, DOI 10.1152/ajpgi.00013.2005; WEICHSELBAUM R, 1984, BRIT J CANCER, V49, P595, DOI 10.1038/bjc.1984.94; WEICHSELBAUM RR, 1985, P NATL ACAD SCI USA, V82, P4732, DOI 10.1073/pnas.82.14.4732; Winck FV, 2014, J PROTEOMICS, V96, P67, DOI 10.1016/j.jprot.2013.10.039; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Wu XY, 2012, INT J RADIAT ONCOL, V83, pE409, DOI 10.1016/j.ijrobp.2012.01.006; Xing R, 2011, GUT; Xing R, 2012, GUT, V61, P43, DOI 10.1136/gut.2010.230623; Yoon JH, 2011, J CANC RES CLIN ONCO; Yoon JH, 2014, J GASTRIC CANCER, V14, P147, DOI 10.5230/jgc.2014.14.3.147; Yoon JH, 2014, ONCOTARGET, V5, P11695, DOI 10.18632/oncotarget.2586; Zuo T, 2015, NUTR CANCER, V67, P364, DOI 10.1080/01635581.2015.989369	54	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152995	10.1371/journal.pone.0152995	http://dx.doi.org/10.1371/journal.pone.0152995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049860	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500079
J	Johnson, C; Giles, JT; Bathon, J; Lederer, D; Hoffman, EA; Barr, RG; Danoff, SK				Johnson, Cheilonda; Giles, Jon T.; Bathon, Joan; Lederer, David; Hoffman, Eric A.; Barr, R. Graham; Danoff, Sonye K.			Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; RHEUMATOID-ARTHRITIS; CIGARETTE-SMOKING; CARDIAC CT; HLA-DRB1; MESA; GENE	A population-based cohort showed an association between cigarette smoking and subclinical parenchymal lung disease defined as regions of increased computed tomography (CT) lung densitometry. This technique has not been applied to the rheumatoid arthritis (RA) population where associated ILD is highly prevalent. The association between cumulative cigarette smoking and volume of areas of high attenuation (HAA: >-600 and <-250 Hounsfield Units) on full inspiratory CT was compared in 172 RA participants and 3,969 controls in a general population sample. Multivariable regression models were used to adjust for demography, anthropometrics, percent emphysema, and CT parameters. The mean cumulative cigarette smoking exposure was 25 (IQR 10-42) and 15(IQR 5-31) pack-years for the RA and non-RA cohorts, respectively. Mean HAA was 153(+/- 57) cm(3) and 129(+/- 50) cm(3) in the RA and non-RA cohorts, respectively. Each 10 cigarette pack-year increment was associated with a higher HAA by 0.03% (95% CI, 0.007-0.05%) in RA patients and by 0.008% (95% CI, 0.003-0.01%) in those without RA (interaction p = 0.001). Cigarette smoking was associated with higher lung attenuation; with a magnitude of association more pronounced in those with RA than in the general population. These data suggest that cigarette smoking may be a more potent ILD risk factor for RA patients than in the general population.	[Johnson, Cheilonda; Danoff, Sonye K.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Giles, Jon T.; Bathon, Joan] Columbia Univ, Dept Med, Coll Phys & Surg, Div Rheumatol, New York, NY USA; [Lederer, David; Barr, R. Graham] Columbia Univ, Dept Med, Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, New York, NY USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Carver Coll Med, Iowa City, IA 52242 USA; [Barr, R. Graham] Columbia Univ, Dept Med, Coll Phys & Surg, Div Gen Med, New York, NY USA; [Barr, R. Graham] Columbia Univ, Dept Epidemiol, Coll Phys & Surg, New York, NY USA	Johns Hopkins University; Columbia University; Columbia University; University of Iowa; Columbia University; Columbia University	Danoff, SK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA.	sdanoff@jhmi.edu	Lederer, David/W-7957-2018; Johnson, Cheilonda/AAB-4555-2020	Lederer, David/0000-0001-5258-0228; Johnson, Cheilonda/0000-0003-3040-4981; Hoffman, Eric/0000-0001-8456-9437; Danoff, Sonye K./0000-0001-9172-8977	Arthritis Foundation [6127]; American College of Rheumatology Within Our Reach; National Institutes of Health [R01-H077162, RC1-100543, R01-093081, R01-HL103676]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077612, R01HL112986, R01HL103676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	Arthritis Foundation; American College of Rheumatology Within Our Reach; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded by the Arthritis Foundation 6127, American College of Rheumatology Within Our Reach, and National Institutes of Health R01-H077162, RC1-100543, R01-093081, and R01-HL103676.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baka Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2751; Best AC, 2003, RADIOLOGY, V228, P407, DOI 10.1148/radiol.2282020274; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bongartz T, 2007, RHEUMATOLOGY, V46, P70, DOI 10.1093/rheumatology/kel202; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cavagna L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/759760; Demoruelle MK, 2012, ARTHRITIS RHEUM-US, V64, P1756, DOI 10.1002/art.34344; ELLMAN P, 1948, BMJ-BRIT MED J, V2, P816, DOI 10.1136/bmj.2.4583.816; Furukawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033133; Giles JT, 2014, ANN RHEUM DIS, V73, P1487, DOI 10.1136/annrheumdis-2012-203160; Giles JT, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2641; Gochuico BR, 2008, ARCH INTERN MED, V168, P159, DOI 10.1001/archinternmed.2007.59; Habib HM, 2011, CLIN RHEUMATOL, V30, P217, DOI 10.1007/s10067-010-1492-5; Harlow L, 2013, ARTHRITIS RHEUM-US, V65, P869, DOI 10.1002/art.37881; Hoffman Eric A, 2014, Ann Am Thorac Soc, V11, P898, DOI 10.1513/AnnalsATS.201310-364OC; Hoffman EA, 2009, ACAD RADIOL, V16, P689, DOI 10.1016/j.acra.2008.12.024; Hutchinson D, 2001, ANN RHEUM DIS, V60, P223, DOI 10.1136/ard.60.3.223; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2011, SEMIN IMMUNOL, V23, P92, DOI 10.1016/j.smim.2011.01.014; Lederer DJ, 2009, AM J RESP CRIT CARE, V180, P407, DOI 10.1164/rccm.200812-1966OC; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; LUUKKAINEN R, 1995, SCAND J RHEUMATOL, V24, P119, DOI 10.3109/03009749509099296; Mikuls TR, 2010, ARTHRITIS RHEUM-US, V62, P3560, DOI 10.1002/art.27716; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mori S, 2012, RESP MED, V106, P1591, DOI 10.1016/j.rmed.2012.07.006; Olson AL, 2011, AM J RESP CRIT CARE, V183, P372, DOI 10.1164/rccm.201004-0622OC; Pappas DA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3037; Pedersen M, 2007, ARTHRITIS RHEUM-US, V56, P1446, DOI 10.1002/art.22597; Reynisdottir G, 2016, ANN RHEUM DIS, V75, P1722, DOI 10.1136/annrheumdis-2015-208216; Reynisdottir G, 2014, ARTHRITIS RHEUMATOL, V66, P31, DOI 10.1002/art.38201; Saag KG, 1996, ARTHRITIS RHEUM-US, V39, P1711, DOI 10.1002/art.1780391014; Thorley Andrew J, 2007, Int J Chron Obstruct Pulmon Dis, V2, P409; Tsuchiya Y, 2011, EUR RESPIR J, V37, P1411, DOI 10.1183/09031936.00019210; Vassallo R, 2012, CLIN CHEST MED, V33, P165, DOI 10.1016/j.ccm.2011.11.004; Westedt ML, 1998, RHEUMATOL INT, V18, P1, DOI 10.1007/s002960050045; Willis VC, 2013, ARTHRITIS RHEUM-US, V65, P2545, DOI 10.1002/art.38066; Wolfe F, 2000, J RHEUMATOL, V27, P630; Yahya A, 2012, MOD RHEUMATOL, V22, P524, DOI 10.1007/s10165-011-0544-2	41	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153024	10.1371/journal.pone.0153024	http://dx.doi.org/10.1371/journal.pone.0153024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050433	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500086
J	Ren, C; Tong, TJ; Hong, Y; Yang, QE				Ren, Chen; Tong, Tian-Jing; Hong, Yu; Yang, Qin-Er			Senecio changii (Asteraceae: Senecioneae), a New Species from Sichuan, China	PLOS ONE			English	Article							EXTERNAL TRANSCRIBED SPACER; DELIMITATION; CONFIDENCE; POSITION; RDNA; ETS	Senecio changii (Asteraceae: Senecioneae), a new species from Muli, Sichuan, southwestern China, is described. It is distinguished in Chinese Senecio s.s. by having lyrate-pinnatisect to pinnatisect leaves and a single terminal large discoid capitulum which is somewhat nodding. Evidence from floral micromorphology, karyology and molecular phylogenetic analyses based on the nuclear ITS/ETS sequence data all support its membership within Senecio s.s.	[Ren, Chen; Tong, Tian-Jing; Hong, Yu; Yang, Qin-Er] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China; [Yang, Qin-Er] Jishou Univ, Key Lab Plant Resources Conservat & Utilizat Huna, Jishou 416000, Peoples R China; [Tong, Tian-Jing; Hong, Yu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Jishou University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ren, C (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China.	chenren@scbg.ac.cn			National Natural Science Foundation of China [31300169, 31370232]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (www.nsfc.gov.cn/; grant nos. 31300169 to Chen Ren and 31370232 to Qin-Er Yang). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Chen Y. L., 2011, FLORA CHINA, V20-21, P371; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Markos S, 2001, SYST BOT, V26, P168; Mittermeier R.A., 2004, HOTSPOTS REVISITED; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nordenstam B, 1977, BIOL CHEM COMPOSITAE, P799; Nordenstam B, 2006, COMPOSITAE NEWSLETT, V44, P12; Nordenstam B, 1978, OPERA BOT, V44, P1; Nordenstam B., 2009, SYSTEMATICS EVOLUTIO, P503; Pelser P.B., 2006, COMPOSITAE NEWSLETTE, V44, P1; Pelser PB, 2002, AM J BOT, V89, P929, DOI 10.3732/ajb.89.6.929; Pelser PB, 2007, TAXON, V56, P1077, DOI 10.2307/25065905; Pelser PB, 2010, AM J BOT, V97, P856, DOI 10.3732/ajb.0900287; Rambaut A., 2014, TRACER V1 6; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tang Ming, 2013, Journal of Tropical and Subtropical Botany, V21, P220; WETTER MA, 1983, BRITTONIA, V35, P1, DOI 10.2307/2806039; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	31	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151423	10.1371/journal.pone.0151423	http://dx.doi.org/10.1371/journal.pone.0151423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050905	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500006
J	Zhang, YC; Xu, ZF; Wu, Q; Peng, M; Liu, YC; Liu, X; Shi, L; Shen, GM; Pan, Y; He, L				Zhang, Yichao; Xu, Zhifeng; Wu, Qiong; Peng, Miao; Liu, Yanchao; Liu, Xing; Shi, Li; Shen, Guangmao; Pan, Yu; He, Lin			Identification of Differentially Expressed microRNAs between the Fenpropathrin Resistant and Susceptible Strains in Tetranychus cinnabarinus	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; 2-SPOTTED SPIDER-MITE; PYRETHROID RESISTANCE; DEVELOPMENTAL-STAGES; ACARI TETRANYCHIDAE; SODIUM-CHANNEL; DNA-SEQUENCES; CULEX-PIPIENS; GENES; URTICAE	The carmine spider mite (Tetranychus cinnabarinus) is one of the most serious pests on crops and its control mainly depends on chemical acaricides. The excessive and improper acaricides use has resulted in mite resistance to many acaricides, including fenpropathrin. Previous studies have indicated fenpropathrin resistance is a complex development process involving many genes, but information on resistance mechanism of post-transcription regulation is rare. Using Illumina sequencing, several categories of sRNAs were identified from susceptible (TS) and fenpropathrin-resistant strains (TR) of T. cinnabarinus, including 75 known microRNAs (miRNAs) and 64 novel miRNAs, whose target genes containing 78592 miRNA-target pairs were predicted by 6 algorithms. Also, 12 significantly differently expressed miRNAs were identified between the TS and TR libraries and RT-qPCR validation also performed a well consistency with sequencing. The targets of significantly differentially expressed miRNAs included 7 glutathione S-transferase, 7 cytochrome P450 and 16 carboxyl/choline esterase genes, their function in fenpropathrin resistance were further analyzed. The present study provides the firstly large-scale characterization of miRNAs in T. cinnabarinus and the comparison between TS and TR strains gives a clue on how miRNA involves in fenpropathrin resistance.	[Zhang, Yichao; Xu, Zhifeng; Wu, Qiong; Peng, Miao; Liu, Yanchao; Liu, Xing; Shi, Li; Shen, Guangmao; He, Lin] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China; [Pan, Yu] Southwest Univ, Coll Hort & Landscape Agr, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	He, L (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.; Pan, Y (corresponding author), Southwest Univ, Coll Hort & Landscape Agr, Chongqing, Peoples R China.	ipying@163.com; helinok@vip.tom.com			National Nature Sciences Foundation [31272059, 31470115]; Special Fund for Agro-scientific Research in the Public Interest [201203038]; Fundamental Research Funds for the Central Universities [XDJK2016A005]	National Nature Sciences Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was funded in part by the National Nature Sciences Foundation (31272059, 31470115), the Special Fund for Agro-scientific Research in the Public Interest (201203038), and the Fundamental Research Funds for the Central Universities (XDJK2016A005).	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Auger P, 2013, ACAROLOGIA, V53, P383; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRIDGES CC, 1966, PSYCHOL REP, V18, P851, DOI 10.2466/pr0.1966.18.3.851; Capinera JL., 2001, HDB VEGETABLE PESTS; Chawla G, 2012, DEVELOPMENT, V139, P1788, DOI 10.1242/dev.077743; de Mendonca RS, 2011, EXP APPL ACAROL, V55, P1, DOI 10.1007/s10493-011-9453-5; Devaney E, 2010, TRENDS PARASITOL, V26, P428, DOI 10.1016/j.pt.2010.05.003; Enright AJ, 2004, GENOME BIOL, V5; Estabrook RW, 2003, DRUG METAB DISPOS, V31, P1461, DOI 10.1124/dmd.31.12.1461; Feng YN, 2011, PEST MANAG SCI, V67, P904, DOI 10.1002/ps.2129; Feng YN, 2011, PESTIC BIOCHEM PHYS, V100, P70, DOI 10.1016/j.pestbp.2011.02.007; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Guo Fengying, 1998, Systematic and Applied Acarology, V3, P3; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2009, PESTIC BIOCHEM PHYS, V93, P47, DOI 10.1016/j.pestbp.2008.11.001; Hong S, 2014, INSECT BIOCHEM MOLEC, V55, P39, DOI 10.1016/j.ibmb.2014.10.007; Jia F, 2011, CHINESE AGR SCI B, V24; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; KUANG H-Y, 1990, Acta Entomologica Sinica, V33, P109; Kwon DH, 2010, PESTIC BIOCHEM PHYS, V97, P93, DOI 10.1016/j.pestbp.2009.07.009; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lei ZT, 2015, PARASITOL RES, V114, P699, DOI 10.1007/s00436-014-4236-7; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li T, 2009, ANN ENTOMOL SOC AM, V102, P674, DOI 10.1603/008.102.0412; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu B, 2014, INSECT MOL BIOL, V23, P216, DOI 10.1111/imb.12075; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rong X, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1122; Rougemont J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-431; Shen GM, 2014, INT J MOL SCI, V15, P22626, DOI 10.3390/ijms151222626; Shi L, 2015, PESTIC BIOCHEM PHYS, V119, P33, DOI 10.1016/j.pestbp.2015.02.009; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Sogorb MA, 2002, TOXICOL LETT, V128, P215, DOI 10.1016/S0378-4274(01)00543-4; Solomon KR, 2001, ENVIRON TOXICOL CHEM, V20, P652, DOI [10.1897/1551-5028(2001)020&lt;0652:PRAOCP&gt;2.0.CO;2, 10.1002/etc.5620200326]; Sun W, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20801; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Thadani R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S20; Tsagkarakou A, 2009, INSECT MOL BIOL, V18, P583, DOI 10.1111/j.1365-2583.2009.00900.x; Vickers KC, 2015, TRENDS BIOCHEM SCI, V40, P4, DOI 10.1016/j.tibs.2014.10.009; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wostenberg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051829; Xu ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094779; Yang Shun-Yi, 2013, Acta Entomologica Sinica, V56, P1152; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Young M. D., 2012, GOSEQ GENE ONTOLOGY; Yu AM, 2009, EXPERT OPIN DRUG MET, V5, P1513, DOI 10.1517/17425250903307448; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang XF, 2014, INSECT BIOCHEM MOLEC, V47, P12, DOI 10.1016/j.ibmb.2014.01.008; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zhao Lian-Feng, 2015, Acta Entomologica Sinica, V58, P90, DOI 10.16380/j.kcxb.2015.01.012; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zhu Z, 2010, DOMEST ANIM ENDOCRIN, V38, P200, DOI 10.1016/j.domaniend.2009.10.004	68	8	9	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152924	10.1371/journal.pone.0152924	http://dx.doi.org/10.1371/journal.pone.0152924			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050424	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500068
J	Li, JL; Sunde, RA				Li, Jin-Long; Sunde, Roger A.			Selenoprotein Transcript Level and Enzyme Activity as Biomarkers for Selenium Status and Selenium Requirements of Chickens (Gallus gallus)	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; THIOREDOXIN REDUCTASE-ACTIVITY; GENE-EXPRESSION PROFILES; DIETARY SELENIUM; DEPENDENT PARAMETERS; DEFICIENCY; LIVER; SUPPLEMENTATION; METHIONINE	The NRC selenium (Se) requirement for broiler chicks is 0.15 mu g Se/g diet, based primarily on weight gain and feed intake studies reported in 1986. To determine Se requirements in today's rapidly growing broiler chick, day-old male chicks were fed Se-deficient basal diets supplemented with graded levels of Se (0, 0.025, 0.05, 0.075, 0.1, 0.2, 0.3, 0.5, 0.75, and 1.0 mu g Se/g) as Na2SeO3 (5/treatment). Diets contained 15X the vitamin E requirement, and there were no gross signs of Se-deficiency. At 29 d, Se-deficient chicks weighed 62% of Se-supplemented chicks; 0.025 mu g Se/g reversed this effect, indicating a minimum Se requirement of 0.025 mu g Se/g diet for growth for male broiler chicks. Enzyme activities in Se-deficient chicks for plasma GPX3, liver and gizzard GPX1, and liver and gizzard GPX4 decreased dramatically to 3, 2, 5, 10 and 5%, respectively, of Se-adequate levels, with minimum Se requirements of 0.10-0.13 mu g Se/g, and with defined plateaus above these levels. Pancreas GPX1 and GPX4 activities, however, lacked defined plateaus, with breakpoints at 0.3 mu g Se/g. qPCR measurement of all 24 chicken selenoprotein transcripts, plus SEPHS1, found that SEPP1 in liver, GPX3 in gizzard, and SEPP1, GPX3 and SELK in pancreas were expressed at levels comparable to housekeeping transcripts. Only 33%, 25% and 50% of selenoprotein transcripts were down-regulated significantly by Se deficiency in liver, gizzard and pancreas, respectively. No transcripts could be used as biomarkers for supernutritional Se status. For export selenoproteins SEPP1 and GPX3, tissue distribution, high expression and Se-regulation clearly indicate unique Se metabolism, which may underlie tissues targeted by Se deficiency. Based on enzyme activities in liver, gizzard, and plasma, the minimum Se requirement in today's broiler chick is 0.15 mu g Se/g diet; pancreas data indicate that the Se requirement should be raised to 0.2 mu g Se/g diet to provide a margin of safety.	[Li, Jin-Long] Northeast Agr Univ, Coll Vet Med, Harbin 150030, Peoples R China; [Sunde, Roger A.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA	Northeast Agricultural University - China; University of Wisconsin System; University of Wisconsin Madison	Sunde, RA (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	sunde@nutrisci.wisc.edu	Li, Jin-Long/S-4288-2016	Li, Jin-Long/0000-0002-5133-9165	National Institute of Food and Agriculture, United States Department of Agriculture, Hatch projects [233618, 1004389]; Northeast Agricultural University Program for New Century Excellent Talents in University [NECT-1207-02]; New Century Excellent Talents in Heilongjiang Provincial University [1252-NCET-009]; Wisconsin Alumni Foundation Selenium Nutrition Research Fund [12046295]	National Institute of Food and Agriculture, United States Department of Agriculture, Hatch projects; Northeast Agricultural University Program for New Century Excellent Talents in University; New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET)); Wisconsin Alumni Foundation Selenium Nutrition Research Fund	This Research was supported by the National Institute of Food and Agriculture, United States Department of Agriculture (www.csrees.usda.gov), Hatch projects 233618 and 1004389, by Northeast Agricultural University (www.neau.edu.cn) Program for New Century Excellent Talents in University (No. NECT-1207-02) and New Century Excellent Talents in Heilongjiang Provincial University (No. 1252-NCET-009), and by the Wisconsin Alumni Foundation (http://www.uwalumni.com) Selenium Nutrition Research Fund (No. 12046295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applegate TJ, 2014, J APPL POULTRY RES, V23, P567, DOI 10.3382/japr.2014-00980; ATTAIX D, 1989, J NUTR, V119, P463, DOI 10.1093/jn/119.3.463; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Brennan KM, 2011, ANIM REPROD SCI, V125, P180, DOI 10.1016/j.anireprosci.2011.02.027; Brennan KM, 2012, BIOL TRACE ELEM RES, V145, P330, DOI 10.1007/s12011-011-9205-8; BUNK MJ, 1981, P SOC EXP BIOL MED, V167, P87, DOI 10.3181/00379727-167-41130; Burk RF, 2011, AM J PHYSIOL-GASTR L, V301, pG32, DOI 10.1152/ajpgi.00064.2011; GRIES CL, 1972, J NUTR, V102, P1287, DOI 10.1093/jn/102.10.1287; Hadley KB, 2001, J NUTR BIOCHEM, V12, P693, DOI 10.1016/S0955-2863(01)00189-9; HAFEMAN DG, 1974, J NUTR, V104, P580, DOI 10.1093/jn/104.5.580; Hill KE, 1997, ANAL BIOCHEM, V253, P123, DOI 10.1006/abio.1997.2373; Hill KE, 2012, J BIOL CHEM, V287, P40414, DOI 10.1074/jbc.M112.421404; Huang JQ, 2015, FREE RADICAL BIO MED, V83, P129, DOI 10.1016/j.freeradbiomed.2015.01.033; Huang JQ, 2011, J NUTR, V141, P1605, DOI 10.3945/jn.111.145722; Institute of Medicine (US) Panel on Micronutrients, 2000, DIET REF INT VIT C V, P284, DOI [10.17226/9810, DOI 10.17226/9810]; JENSEN LS, 1986, BIOL TRACE ELEM RES, V10, P11, DOI 10.1007/BF02795314; Khoso PA, 2015, CELL STRESS CHAPERON; Khoso PA, 2015, BIOL TRACE ELEM RES, V167, P48, DOI 10.1007/s12011-015-0282-y; KNIGHT SAB, 1988, J NUTR, V118, P853, DOI 10.1093/jn/118.7.853; LAWRENCE RA, 1974, EXP EYE RES, V18, P563, DOI 10.1016/0014-4835(74)90062-1; LEI XG, 1995, J NUTR, V125, P1438; Liang Y, 2014, BIOL TRACE ELEM RES, V160, P41, DOI 10.1007/s12011-014-0024-6; Liu CP, 2014, BIOL TRACE ELEM RES, V159, P192, DOI 10.1007/s12011-014-0005-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mariotti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033066; National Research Council, 1994, NUTR REQ POULTR; OMAYE ST, 1974, J NUTR, V104, P747, DOI 10.1093/jn/104.6.747; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raines AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-26; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; SUNDE RA, 1981, J NUTR, V111, P76, DOI 10.1093/jn/111.1.76; Sunde RA, 2005, J NUTR, V135, P2144, DOI 10.1093/jn/135.9.2144; Sunde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129801; Sunde RA, 2011, ADV NUTR, V2, P138, DOI 10.3945/an.110.000240; Sunde RA, 2010, EXP BIOL MED, V235, P1046, DOI 10.1258/ebm.2010.010111; Sunde RA, 2010, J NUTR BIOCHEM, V21, P665, DOI 10.1016/j.jnutbio.2009.11.012; Sunde RA, 2010, EXP BIOL MED, V235, P23, DOI 10.1258/ebm.2009.009262; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Taylor RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151665; THOMPSON JN, 1969, J NUTR, V97, P335, DOI 10.1093/jn/97.3.335; THOMPSON JN, 1970, J NUTR, V100, P797, DOI 10.1093/jn/100.7.797; Thompson KM, 1998, J NUTR, V128, P1289, DOI 10.1093/jn/128.8.1289; THOMPSON KM, 1995, J NUTR, V125, P864; WASCHULEWSKI IH, 1988, BRIT J NUTR, V60, P57, DOI 10.1079/BJN19880076; Weiss SL, 1996, J NUTR, V126, P2260, DOI 10.1093/jn/126.9.2260; Weiss SL, 1997, J NUTR BIOCHEM, V8, P85, DOI 10.1016/S0955-2863(96)00178-7; Xia YM, 2010, AM J CLIN NUTR, V92, P525, DOI 10.3945/ajcn.2010.29642; Xu JX, 2016, BIOL TRACE ELEM RES, V170, P438, DOI 10.1007/s12011-015-0470-9; YANG JG, 1989, J NUTR, V119, P1010, DOI 10.1093/jn/119.7.1010; Yao HD, 2013, J NUTR, V143, P613, DOI 10.3945/jn.112.172395; Yao HD, 2014, BIOL TRACE ELEM RES, V161, P318, DOI 10.1007/s12011-014-0125-2; Zhao X, 2014, BIOL TRACE ELEM RES, V161, P341, DOI 10.1007/s12011-014-0139-9; Zoidis E, 2010, COMP BIOCHEM PHYS B, V155, P294, DOI 10.1016/j.cbpb.2009.11.017	55	37	39	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152392	10.1371/journal.pone.0152392	http://dx.doi.org/10.1371/journal.pone.0152392			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045754	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600018
J	Zhang, LM; Cen, L; Qu, SG; Wei, L; Mo, MS; Feng, JM; Sun, CC; Xiao, YS; Luo, Q; Li, SM; Yang, XL; Xu, PY				Zhang, Limin; Cen, Luan; Qu, Shaogang; Wei, Lei; Mo, Mingshu; Feng, Junmin; Sun, Congcong; Xiao, Yousheng; Luo, Qin; Li, Shaomin; Yang, Xinling; Xu, Pingyi			Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction	PLOS ONE			English	Article							DOPAMINERGIC-NEURONS; SIGNALING PATHWAY; DICKKOPF-1 CONTRIBUTES; INDUCED CYTOTOXICITY; PARKINSONS-DISEASE; DOWN-REGULATION; MOUSE MODEL; ACTIVATION; EXPRESSION; APOPTOSIS	Parkinson's disease (PD) is characterized by progressive degeneration of dopaminergic (DA) neurons in the substantial nigra pars compacta. Increasing evidence showed that Wnt/beta-catenin pathway and the orphan nuclear receptor Nurr1 play crucial roles in the survival and functional maintenance of DA neurons in the midbrain and GSK-3 beta antagonists LiCl and SB216763 were used to activate Wnt/beta-catenin pathway experimentally. However, the detail mechanism underlying the neuroprotection against apoptosis on DA neuron is still unclear and the interaction between Wnt/beta-catenin and Nurr1 remains undisclosed. In this study, using cell biological assay we investigated the function of Wnt/beta-catenin and its crosstalk with Nurr1 on the course of PC12 cell degeneration in vitro. Our data showed that PC12 cell viability was inhibited by rotenone, but attenuated by GSK-3 beta antagonists LiCl or SB216763. The activity of Wnt/beta-catenin pathway was deregulated on exposure of rotenone in a concentration-dependent manner. After the interference of beta-catenin with siRNA, LiCl or SB216763 failed to protect PC12 cells from apoptosis by the rotenone toxicity. Our data confirmed that Wnt/beta-catenin signaling activated by LiCl or SB216763 enhanced Nurr1 expression to 2.75 +/- 0.55 and 4.06 +/- 0.41 folds respectively compared with control detected by real-time PCR and the interaction of beta-catenin with Nurr1 was identified by co-immunoprecipitate analysis. In conclusion, the data suggested that Wnt/beta-catenin and Nurr1 are crucial factors in the survival of DA neurons, and the activation of Wnt/beta-catenin pathway exerts protective effects on DA neurons partly by mean of a co-active pattern with Nurr1. This finding may shed a light on the potential treatment of Parkinson disease.	[Zhang, Limin; Cen, Luan; Wei, Lei; Mo, Mingshu; Xiao, Yousheng; Xu, Pingyi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Limin] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan Province, Peoples R China; [Qu, Shaogang; Feng, Junmin] Southern Med Univ, Affiliated Hosp 5, Dept Blood Transfus, Guangzhou 510900, Guangdong, Peoples R China; [Wei, Lei] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China; [Sun, Congcong] Shandong Univ, Qilu Affiliated Hosp, Dept Neurol, Jinan 250001, Shandong, Peoples R China; [Luo, Qin; Yang, Xinling] Xinjiang Med Univ, Affiliated Hosp 3, Dept Neurol, Urumqi 830011, Peoples R China; [Li, Shaomin] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Xu, Pingyi] Guangzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Zhengzhou University; Southern Medical University - China; Sun Yat Sen University; Shandong University; Xinjiang Medical University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Guangzhou Medical University	Xu, PY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China.; Yang, XL (corresponding author), Xinjiang Med Univ, Affiliated Hosp 3, Dept Neurol, Urumqi 830011, Peoples R China.; Li, SM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.; Xu, PY (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China.	shaomin_li@hms.harvard.edu; pingyixu@sina.com	Yang, xinling/HHC-1621-2022; Mo, Mingshu/S-1388-2019		State Key Development Program for Basic Research of China [2011CB510000]; National Natural Science Foundation of China [81271428, 81471292, U1503222, 81430021]; Science Foundation of Guangdong of China [2015A030311021]; technology project of Guangzhou [20151260]; assisting research project of science and technology for Xinjiang [201591160]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Guangdong of China; technology project of Guangzhou; assisting research project of science and technology for Xinjiang	This work was supported by research grants from the State Key Development Program for Basic Research of China (2011CB510000), the National Natural Science Foundation of China (81271428, 81471292, U1503222 and 81430021) the Science Foundation of Guangdong of China (2015A030311021), a grant supported by technology project of Guangzhou (20151260) and a grant supported by assisting research project of science and technology for Xinjiang (201591160).	Ahmadi FA, 2003, J NEUROCHEM, V87, P914, DOI 10.1046/j.1471-4159.2003.02068.x; Arenas E, 2005, ANN NY ACAD SCI, V1049, P51, DOI 10.1196/annals.1334.007; Backman C, 1999, BRAIN RES, V851, P125, DOI 10.1016/S0006-8993(99)02149-6; Berthon A, 2014, HUM MOL GENET, V23, P889, DOI 10.1093/hmg/ddt484; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Chong ZZ, 2007, CELL SIGNAL, V19, P1150, DOI 10.1016/j.cellsig.2006.12.009; Condello S, 2011, J NEUROCHEM, V116, P67, DOI 10.1111/j.1471-4159.2010.07085.x; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Dun YY, 2013, NEUROPHARMACOLOGY, V67, P168, DOI 10.1016/j.neuropharm.2012.10.031; Dun YY, 2012, NEUROSCI LETT, V525, P83, DOI 10.1016/j.neulet.2012.07.030; Freese JL, 2010, NEUROBIOL DIS, V38, P148, DOI 10.1016/j.nbd.2009.09.003; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Gelinas S, 2002, J NEUROSCI RES, V70, P90, DOI 10.1002/jnr.10315; Gollamudi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036191; Hongo H, 2012, BIOCHEM BIOPH RES CO, V426, P94, DOI 10.1016/j.bbrc.2012.08.042; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Jiang JK, 2014, J NEUROSCI RES, V92, P783, DOI 10.1002/jnr.23352; Joksimovic M, 2014, J MOL CELL BIOL, V6, P27, DOI 10.1093/jmcb/mjt043; Kadota T, 1996, J HISTOCHEM CYTOCHEM, V44, P989, DOI 10.1177/44.9.8773564; L'Episcopo F, 2011, NEUROBIOL DIS, V41, P508, DOI 10.1016/j.nbd.2010.10.023; L'Episcopo F, 2014, STEM CELLS, V32, P2147, DOI 10.1002/stem.1708; L'Episcopo F, 2014, J MOL CELL BIOL, V6, P13, DOI 10.1093/jmcb/mjt053; L'Episcopo F, 2012, J NEUROSCI, V32, P2062, DOI 10.1523/JNEUROSCI.5259-11.2012; L'Episcopo F, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-49; Le W, 1999, J NEUROCHEM, V73, P2218; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Le WD, 1999, EXP NEUROL, V159, P451, DOI 10.1006/exnr.1999.7191; Li DW, 2014, INT J MOL MED, V34, P1358, DOI 10.3892/ijmm.2014.1904; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Maiese K, 2008, PHARMACOL THERAPEUT, V118, P58, DOI 10.1016/j.pharmthera.2008.01.004; Mazemondet O, 2011, CELL MOL BIOL LETT, V16, P515, DOI 10.2478/s11658-011-0021-0; Morale MC, 2004, FASEB J, V18, P164, DOI 10.1096/fj.03-0501fje; Nilsen J, 1998, MENOPAUSE, V5, P211; Priyadarsini RV, 2012, ORAL ONCOL, V48, P33, DOI 10.1016/j.oraloncology.2011.08.008; Radad K, 2006, NEUROCHEM INT, V49, P379, DOI 10.1016/j.neuint.2006.02.003; Rajalin AM, 2011, ARCH BIOCHEM BIOPHYS, V509, P44, DOI 10.1016/j.abb.2011.02.018; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Warner TT, 2003, ANN NEUROL, V53, pS16, DOI 10.1002/ana.10487; Watabe M, 2004, J PHARMACOL EXP THER, V311, P948, DOI 10.1124/jpet.104.071381; Wei L, 2013, J MOL NEUROSCI, V49, P105, DOI 10.1007/s12031-012-9900-8; Wisniewska MB, 2013, NEUROCHEM RES, V38, P1144, DOI 10.1007/s11064-013-0980-9; Wurst W, 2014, J MOL CELL BIOL, V6, P34, DOI 10.1093/jmcb/mjt046; Xu GF, 2013, NEUROTOXICOLOGY, V37, P63, DOI 10.1016/j.neuro.2013.04.005; Yang YX, 2008, NEUROREPORT, V19, P867, DOI 10.1097/WNR.0b013e3282ffda48; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	52	29	29	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152931	10.1371/journal.pone.0152931	http://dx.doi.org/10.1371/journal.pone.0152931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045591	gold, Green Published			2022-12-26	WOS:000373599600046
J	Englund, E; Bartoschek, M; Reitsma, B; Jacobsson, L; Escudero-Esparza, A; Orimo, A; Leandersson, K; Hagerling, C; Aspberg, A; Storm, P; Okroj, M; Mulder, H; Jirstrom, K; Pretras, K; Blom, AM				Englund, E.; Bartoschek, M.; Reitsma, B.; Jacobsson, L.; Escudero-Esparza, A.; Orimo, A.; Leandersson, K.; Hagerling, C.; Aspberg, A.; Storm, P.; Okroj, M.; Mulder, H.; Jirstrom, K.; Pretras, K.; Blom, A. M.			Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM STRESS; EXPRESSION; COMPLEMENT; COMP; ACTIVATION; DOMAIN; BETA; ER	Cartilage oligomeric matrix protein (COMP) is a soluble pentameric protein expressed in cartilage and involved in collagen organization. Tissue microarrays derived from two cohorts of patients with breast cancer (n= 122 and n = 498) were immunostained, revealing varying expression of COMP, both in the tumor cells and surrounding stroma. High levels of COMP in tumor cells correlated, independently of other variables, with poor survival and decreased recurrence-free survival. Breast cancer cells, MDA-MB-231, stably expressing COMP were injected into the mammary fat pad of SCID (CB-17/Icr-Prkdc(scid)/Rj) mice. Tumors expressing COMP were significantly larger and were more prone to metastasize as compared with control, mock-transfected, tumors. In vitro experiments confirmed that COMP-expressing cells had a more invasive phenotype, which could in part be attributed to an upregulation of matrix metalloprotease-9. Furthermore, microarray analyses of gene expression in tumors formed in vivo showed that COMP expression induced higher expression of genes protecting against endoplasmic reticulum stress. This observation was confirmed in vitro as COMP-expressing cells showed better survival as well as a higher rate of protein synthesis when treated with brefeldin A, compared with control cells. Further, COMP-expressing cells appeared to undergo a metabolic switch, that is, a Warburg effect. Thus, in vitro measurement of cell respiration indicated decreased mitochondrial metabolism. In conclusion, COMP is a novel biomarker in breast cancer, which contributes to the severity of the disease by metabolic switching and increasing invasiveness and tumor cell viability, leading to reduced survival in animal models and human patients.	[Englund, E.; Reitsma, B.; Escudero-Esparza, A.; Okroj, M.; Blom, A. M.] Lund Univ, Dept Translat Med, Div Med Prot Chem, Malmo, Sweden; [Bartoschek, M.; Pretras, K.] Lund Univ, Dept Lab Med, Div Translat Canc Res, Lund, Sweden; [Jacobsson, L.; Mulder, H.] Lund Univ, Unit Mol Metab, Dept Clin Sci Malmo, Lund, Sweden; [Orimo, A.] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo, Japan; [Leandersson, K.; Hagerling, C.] Lund Univ, Ctr Mol Pathol, Dept Lab Med, Malmo, Sweden; [Aspberg, A.] Lund Univ, Dept Clin Sci Lund, Div Rheumatol & Mol Skeletal Biol, Lund, Sweden; [Storm, P.] Lund Univ, Dept Clin Sci Malmo, Div Diabet & Endocrinol, Malmo, Sweden; [Okroj, M.] Med Univ Gdansk, UG MUG, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, Gdansk, Poland; [Jirstrom, K.] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, Lund, Sweden	Lund University; Lund University; Lund University; Juntendo University; Lund University; Lund University; Lund University; Fahrenheit Universities; Medical University Gdansk; Lund University	Blom, AM (corresponding author), Lund Univ, Skane Univ Hosp, Wallenberg Lab, Div Med Prot Chem,Dept Translat Med, Inga Maria Nilssons St 53, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734; Pietras, Kristian/0000-0001-6738-4705; Storm, Petter/0000-0002-7655-3731; Mulder, Hindrik/0000-0002-6593-8417; Aspberg, Anders/0000-0002-6588-6944; Orimo, Akira/0000-0001-5330-7282	Cancerfonden; Swedish Research Council [K2012-66X-14928-09-5]; Swedish Government Funds for Clinical research; Foundation of Osterlund; Foundation of Crafoord; Foundation of Greta and Johan Kock; King Gustav V's 80th anniversary; Knut and Alice Wallenberg; Inga-Britt and Arne Lundberg; Royal Physiographic Society; Skane University Hospital; National Science Centre, Poland [2014/14/E/NZ6/00182]; Grants-in-Aid for Scientific Research [15K14385] Funding Source: KAKEN	Cancerfonden(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Government Funds for Clinical research; Foundation of Osterlund; Foundation of Crafoord; Foundation of Greta and Johan Kock; King Gustav V's 80th anniversary; Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Inga-Britt and Arne Lundberg; Royal Physiographic Society; Skane University Hospital; National Science Centre, Poland(National Science Centre, Poland); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Cancerfonden, the Swedish Research Council (K2012-66X-14928-09-5), the Swedish Government Funds for Clinical research (ALF) and the Foundations of Osterlund, Crafoord, Greta and Johan Kock, King Gustav V's 80th anniversary, Knut and Alice Wallenberg and Inga-Britt and Arne Lundberg, Royal Physiographic Society, as well as a grant from the Skane University Hospital. MO was supported by National Science Centre, Poland (2014/14/E/NZ6/00182).	Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Agarwal P, 2013, MATRIX BIOL, V32, P325, DOI 10.1016/j.matbio.2013.02.010; Anderson BO, 2008, CANCER-AM CANCER SOC, V113, P2221, DOI 10.1002/cncr.23844; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Borgquist S, 2008, J CLIN PATHOL, V61, P197, DOI 10.1136/jcp.2006.040378; Borgquist S, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2146; Briggs MD, 2014, EUR J HUM GENET, V22, P1278, DOI 10.1038/ejhg.2014.30; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Englund E, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1734-7; Escudero-Esparza A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-43; Farina G, 2006, MATRIX BIOL, V25, P213, DOI 10.1016/j.matbio.2006.01.007; Furge K, 2012, PGSEA PARAMETRIC GEN; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Happonen KE, 2010, ARTHRITIS RHEUM-US, V62, P3574, DOI 10.1002/art.27720; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Hesselstrand R, 2008, ANN RHEUM DIS, V67, P1242, DOI 10.1136/ard.2007.082099; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kung LHW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117016; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Otteby KE, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4410; Ryden L, 2005, J CLIN ONCOL, V23, P4695, DOI 10.1200/JCO.2005.08.126; Sodersten F, 2006, CONNECT TISSUE RES, V47, P85, DOI 10.1080/03008200600584124; Svensson KJ, 2011, INT J ONCOL, V39, P1421, DOI 10.3892/ijo.2011.1164; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	31	49	50	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 27	2016	35	43					5585	5596		10.1038/onc.2016.98	http://dx.doi.org/10.1038/onc.2016.98			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XP	27065333				2022-12-26	WOS:000386998300002
J	Black, SA; Nelson, AC; Gurule, NJ; Futscher, BW; Lyons, TR				Black, S. A.; Nelson, A. C.; Gurule, N. J.; Futscher, B. W.; Lyons, T. R.			Semaphorin 7a exerts pleiotropic effects to promote breast tumor progression	ONCOGENE			English	Article							CARCINOMA IN-SITU; MAMMARY-TUMOR; CANCER; EXPRESSION; MODEL; ARCHITECTURE; METASTASIS; SIGNATURE; RESPONSES; GUIDANCE	Understanding what drives breast tumor progression is of utmost importance for blocking tumor metastasis; we have identified that semaphorin 7a is a potent driver of ductal carcinoma in situ (DCIS) progression. Semaphorin 7a is a glycophosphatidylinositol membrane-anchored protein that promotes attachment and spreading in multiple cell types. Here, we show that increased expression of SEMA7A occurs in a large percentage of breast cancers and is associated with decreased overall and distant metastasis-free survival. In both in vitro and in vivo models, short hairpin-mediated silencing of SEMA7A reveals roles for semaphorin 7a in the promotion of DCIS growth, motility and invasion as well as lymphangiogenesis in the tumor microenvironment. Our studies also uncover a relationship between COX-2 and semaphorin 7a expression and suggest that semaphorin 7a promotes tumor cell invasion on collagen and lymphangiogenesis via activation of beta(1)-integrin receptor. Our results suggest that semaphorin 7a may be novel target for blocking breast tumor progression.	[Black, S. A.; Gurule, N. J.; Lyons, T. R.] Univ Colorado Anschutz Med Campus, Sch Med, Dept Med, Div Med Oncol, Aurora, CO USA; [Nelson, A. C.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Gurule, N. J.; Lyons, T. R.] Univ Colorado Anschutz Med Campus, Univ Colorado Canc Biol Grad Program, Aurora, CO USA; [Futscher, B. W.] Univ Arizona, Univ Arizona Canc Ctr, Tucson, AZ USA; [Futscher, B. W.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Lyons, T. R.] Univ Colorado Anschutz Med Campus, Univ Colorado Canc Ctr, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Arizona; University of Arizona; University of Colorado System; University of Colorado Anschutz Medical Campus	Lyons, TR (corresponding author), Univ Colorado Anschutz Med Campus, Div Med Oncol, MS8117,L18-8103,12801 East 17th Ave, Aurora, CO 80045 USA.	Traci.Lyons@ucdenver.edu			Cancer League of Colorado CCTSI Mentored Career Development Award [1KL2TR001080-01]; CCTSI CO PILOT NIH/NCI [M-13-161, 1R21CA185226-01]; University of Colorado Cancer Center Summer Fellowship; Cancer League of Colorado;  [U01CA153086]; NATIONAL CANCER INSTITUTE [R21CA185226] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001080] Funding Source: NIH RePORTER	Cancer League of Colorado CCTSI Mentored Career Development Award; CCTSI CO PILOT NIH/NCI; University of Colorado Cancer Center Summer Fellowship; Cancer League of Colorado; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We gratefully acknowledge K Polyak and A Marusyk (Harvard Medical School) for providing MCF10DCIS parental cells and shCOX-2 derivatives; AC Tan, K Hunter (NCI), J Richer, T Rogers and M Gordon for advice on dataset analysis; L Crump, A Elder, M Kobritz, J Pruitt, A Pham, S Tarullo and V Wessells for technical support; V Borges and P Schedin for critical review of the manuscript and crucial advice. This work was supported by Cancer League of Colorado, 1KL2TR001080-01 CCTSI Mentored Career Development Award, CCTSI CO PILOT M-13-161 and 1R21CA185226-01 NIH/NCI to TL. University of Colorado Cancer Center Summer Fellowship and Cancer League of Colorado to SB and U01CA153086 to BF.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Allegra M, 2012, MOL BIOL CELL, V23, P3873, DOI 10.1091/mbc.E12-04-0276; ASLAKSON CJ, 1991, INT J CANCER, V47, P466, DOI 10.1002/ijc.2910470327; Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Czopik AK, 2006, IMMUNITY, V24, P591, DOI 10.1016/j.immuni.2006.03.013; Delorme G, 2005, BIOL CELL, V97, P589; Esserman L, 2015, JAMA ONCOL, V1, P881, DOI 10.1001/jamaoncol.2015.2607; Formolo CA, 2011, J PROTEOME RES, V10, P3149, DOI 10.1021/pr200210w; Garcia-Areas R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00017; Gelfand MV, 2009, TRENDS CELL BIOL, V19, P99, DOI 10.1016/j.tcb.2009.01.001; Ghanem RC, 2011, CURR EYE RES, V36, P989, DOI 10.3109/02713683.2011.593730; Gu CH, 2013, EXP CELL RES, V319, P1306, DOI 10.1016/j.yexcr.2013.02.003; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Hua M, 2009, P NATL ACAD SCI USA, V106, P3372, DOI 10.1073/pnas.0813306106; Koh JM, 2006, J HUM GENET, V51, P112, DOI 10.1007/s10038-005-0331-z; Lyons TR, 2014, J CLIN INVEST, V124, P3901, DOI 10.1172/JCI73777; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Maller O, 2013, J CELL SCI, V126, P4108, DOI 10.1242/jcs.121590; Maurin JC, 2005, MATRIX BIOL, V24, P232, DOI 10.1016/j.matbio.2005.03.005; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Moserle L, 2012, EMBO MOL MED, V4, P168, DOI 10.1002/emmm.201200206; Narod SA, 2015, JAMA ONCOL, V1, P888, DOI 10.1001/jamaoncol.2015.2510; Pasterkamp RJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-98; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Scott GA, 2008, J INVEST DERMATOL, V128, P151, DOI 10.1038/sj.jid.5700974; Stefanou D, 2004, HISTOL HISTOPATHOL, V19, P465, DOI 10.14670/HH-19.465; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Tait LR, 2007, INT J CANCER, V120, P2127, DOI 10.1002/ijc.22572; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang Xiaojuan, 2002, Breast Cancer, V9, P216, DOI 10.1007/BF02967592; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764	35	35	35	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 29	2016	35	39					5170	5178		10.1038/onc.2016.49	http://dx.doi.org/10.1038/onc.2016.49			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX5PI	27065336	Green Accepted			2022-12-26	WOS:000384433000008
J	Tesikova, M; Dezitter, X; Nenseth, HZ; Klokk, TI; Mueller, F; Hager, GL; Saatcioglu, F				Tesikova, Martina; Dezitter, Xavier; Nenseth, Hatice Z.; Klokk, Tove I.; Mueller, Florian; Hager, Gordon L.; Saatcioglu, Fahri			Divergent Binding and Transactivation by Two Related Steroid Receptors at the Same Response Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-SPECIFIC DYNAMICS; TUMOR VIRUS PROMOTER; RNA-POLYMERASE-II; ANDROGEN RECEPTOR; GLUCOCORTICOID-RECEPTOR; LIVING CELLS; HISTONE DEACETYLASES; GENE-EXPRESSION; PROSTATE-CANCER; TRANSCRIPTION	Transcription factor (TF) recruitment to chromatin is central to activation of transcription. TF-chromatin interactions are highly dynamic, which are evaluated by recovery half time (t(1/2)) in seconds, determined by fluorescence recovery experiments in living cells, and chromatin immunoprecipitation (ChIP) analysis, measured in minutes. These two states are related: the larger the t(1/2), the longer the ChIP occupancy resulting in increased transcription. Here we present data showing that this relationship does not always hold. We found that histone deacetylase inhibitors (HDACis) significantly increased t(1/2) of green fluorescent protein (GFP) fused androgen receptor (AR) on a tandem array of positive hormone response elements (HREs) in chromatin. This resulted in increased ChIP signal of GFP-AR. Unexpectedly, however, transcription was inhibited. In contrast, the GFP-fused glucocorticoid receptor (GR), acting through the same HREs, displayed a profile consistent with current models. We provide evidence that these differences are mediated, at least in part, by HDACs. Our results provide insight into TF action in living cells and show that very closely related TFs may trigger significantly divergent outcomes at the same REs.	[Tesikova, Martina; Dezitter, Xavier; Nenseth, Hatice Z.; Klokk, Tove I.; Saatcioglu, Fahri] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Mueller, Florian] Inst Pasteur, Computat Imaging & Modeling Unit, F-75015 Paris, France; [Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Saatcioglu, Fahri] Oslo Univ Hosp, Inst Canc Genet & Informat, Div Canc & Surg, N-0310 Oslo, Norway; [Dezitter, Xavier] Univ Lille Nord France, UDSL, ICPAL, Plateforme Binding, F-59000 Lille, France; [Klokk, Tove I.] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, Ctr Canc Biomed, N-0310 Oslo, Norway	University of Oslo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo; Universite de Lille - ISITE; Universite de Lille; University of Oslo	Saatcioglu, F (corresponding author), Univ Oslo, Dept Biosci, N-0316 Oslo, Norway.; Saatcioglu, F (corresponding author), Oslo Univ Hosp, Inst Canc Genet & Informat, Div Canc & Surg, N-0310 Oslo, Norway.	fahris@ibv.uio.no	Dezitter, Xavier/H-6923-2018; Mueller, Florian/C-9075-2012	Dezitter, Xavier/0000-0001-6932-6947; Mueller, Florian/0000-0002-9622-4396; Saatcioglu, Fahri/0000-0002-5366-4391; Nenseth, Hatice Zeynep/0000-0002-8385-3476	Norwegian Research Council [191733]; Norwegian Cancer Society [PR-2006-0335]; NATIONAL CANCER INSTITUTE [ZIABC005450] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Norwegian Research Council (191733, to F. S.) and Norwegian Cancer Society (PR-2006-0335, to F. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; BRESNICK EH, 1990, P NATL ACAD SCI USA, V87, P3977, DOI 10.1073/pnas.87.10.3977; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Coffey K, 2013, NUCLEIC ACIDS RES, V41, P4433, DOI 10.1093/nar/gkt106; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Faus H, 2008, J CELL BIOCHEM, V104, P511, DOI 10.1002/jcb.21640; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gaughan L, 2011, NUCLEIC ACIDS RES, V39, P1266, DOI 10.1093/nar/gkq861; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Korkmaz CG, 2004, J ENDOCRINOL, V182, P377, DOI 10.1677/joe.0.1820377; Lavery DN, 2011, J BIOL CHEM, V286, P17796, DOI 10.1074/jbc.M110.198655; LEFEBVRE P, 1991, MOL CELL BIOL, V11, P2529, DOI 10.1128/MCB.11.5.2529; List HJ, 1999, EXP CELL RES, V252, P471, DOI 10.1006/excr.1999.4638; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nenseth HZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105204; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Qiu Y, 2011, J BIOL CHEM, V286, P7641, DOI 10.1074/jbc.M110.185488; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Seo WY, 2013, NUCLEIC ACIDS RES, V41, P8526, DOI 10.1093/nar/gkt644; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600	36	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11899	11910		10.1074/jbc.M115.684480	http://dx.doi.org/10.1074/jbc.M115.684480			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27056330	Green Published, hybrid			2022-12-26	WOS:000377264800038
J	Rabelo, LA; Todiras, M; Nunes-Souza, V; Qadri, F; Szijarto, IA; Gollasch, M; Penninger, JM; Bader, M; Santos, RA; Alenina, N				Rabelo, Luiza A.; Todiras, Mihail; Nunes-Souza, Valeria; Qadri, Fatimunnisa; Szijarto, Istvan Andras; Gollasch, Maik; Penninger, Josef M.; Bader, Michael; Santos, Robson A.; Alenina, Natalia			Genetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative Stress	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; IMPROVES ENDOTHELIAL FUNCTION; BLOOD-PRESSURE; SUPEROXIDE GENERATION; DEFICIENT MICE; KNOCKOUT MICE; NADPH OXIDASE; FREE-RADICALS; RECEPTOR MAS; SYNTHASE	Accumulating evidence indicates that angiotensin-converting enzyme 2 (ACE2) plays a critical role in cardiovascular homeostasis, and its altered expression is associated with major cardiac and vascular disorders. The aim of this study was to evaluate the regulation of vascular function and assess the vascular redox balance in ACE2-deficient (ACE2(-/y)) animals. Experiments were performed in 20-22 week-old C57BL/6 and ACE2(-/y) male mice. Evaluation of endothelium-dependent and -independent relaxation revealed an impairment of in vitro and in vivo vascular function in ACE2(-/y) mice. Drastic reduction in eNOS expression at both protein and mRNA levels, and a decrease in (NO)-N-center dot concentrations were observed in aortas of ACE2(-/y) mice in comparison to controls. Consistently, these mice presented a lower plasma and urine nitrite concentration, confirming reduced (NO)-N-center dot availability in ACE2-deficient animals. Lipid peroxidation was significantly increased and superoxide dismutase activity was decreased in aorta homogenates of ACE2(-/y) mice, indicating impaired antioxidant capacity. Taken together, our data indicate, that ACE2 regulates vascular function by modulating nitric oxide release and oxidative stress. In conclusion, we elucidate mechanisms by which ACE2 is involved in the maintenance of vascular homeostasis. Furthermore, these findings provide insights into the role of the renin-angiotensin system in both vascular and systemic redox balance.	[Rabelo, Luiza A.; Todiras, Mihail; Nunes-Souza, Valeria; Qadri, Fatimunnisa; Bader, Michael; Alenina, Natalia] Max Delbruck Ctr Mol Med, Berlin, Germany; [Rabelo, Luiza A.; Nunes-Souza, Valeria] Univ Fed Alagoas, Lab Reatividade Cardiovasc, Maceio, Alagoas, Brazil; [Rabelo, Luiza A.; Todiras, Mihail; Nunes-Souza, Valeria; Bader, Michael; Santos, Robson A.; Alenina, Natalia] Inst Nacl Ciencia & Tecnol NanoBiofarmaceut NanoB, Sao Paulo, Brazil; [Qadri, Fatimunnisa; Bader, Michael] Charite, D-13353 Berlin, Germany; [Szijarto, Istvan Andras; Gollasch, Maik] Charite Campus Virchow Klinikum, ECRC, Nephrol Intens Care, Berlin, Germany; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Bader, Michael; Santos, Robson A.; Alenina, Natalia] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Universidade Federal de Alagoas; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Universidade Federal de Minas Gerais	Alenina, N (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.; Alenina, N (corresponding author), Inst Nacl Ciencia & Tecnol NanoBiofarmaceut NanoB, Sao Paulo, Brazil.; Alenina, N (corresponding author), Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.	alenina@mdc-berlin.de	Bader, Michael/K-2124-2013; Santos, Robson A S/C-9336-2011; Penninger, Josef M/I-6860-2013; Rabêlo, Luiza A./S-4050-2019; Todiras, Mihail/AAT-4426-2020	Santos, Robson A S/0000-0001-8738-5852; Penninger, Josef M/0000-0002-8194-3777; Todiras, Mihail/0000-0002-9373-4753; Bader, Michael/0000-0003-4780-4164; Szijarto, Istvan/0000-0002-0796-9450	Deutsche Forschungsgemeinschaft (DFG); Deutsche Akademische Austauschdienst (DAAD); Brazilian fellowship [BJT 407352/2013-9]; CNPq-Brazil [202139/2010-7]; Fellowship DAAD/CNPq/CAPES - Brazil [246794/2012-7]; DAAD/CNPq program PROBRAL	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Akademische Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Brazilian fellowship; CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fellowship DAAD/CNPq/CAPES - Brazil; DAAD/CNPq program PROBRAL	The Deutsche Forschungsgemeinschaft (DFG) and Deutsche Akademische Austauschdienst (DAAD) to MG, the Brazilian fellowship BJT 407352/2013-9 to NA, the Postdoctoral Fellowship from CNPq-Brazil (Grant 202139/2010-7) to LAR, the Fellowship DAAD/CNPq/CAPES - Brazil (Grant 246794/2012-7) to VNS, and the DAAD/CNPq program PROBRAL to NA and RAS supportred this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghamri MS, 2013, J CARDIOVASC PHARM T, V18, P138, DOI 10.1177/1074248412460124; Bandeira SD, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/819310; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Berka V, 2004, J BIOL CHEM, V279, P32243, DOI 10.1074/jbc.M404044200; Bodiga S, 2011, CARDIOVASC RES, V91, P151, DOI 10.1093/cvr/cvr036; Botelho-Santos Giancarla Aparecida, 2012, Ther Adv Cardiovasc Dis, V6, P201, DOI 10.1177/1753944712461164; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandes RP, 2000, HYPERTENSION, V35, P231, DOI 10.1161/01.HYP.35.1.231; Briones AM, 2009, HYPERTENSION, V54, P142, DOI 10.1161/HYPERTENSIONAHA.109.133710; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Cosentino F, 2001, ARTERIOSCL THROM VAS, V21, P496, DOI 10.1161/01.ATV.21.4.496; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; DEISSEROTH A, 1970, PHYSIOL REV, V50, P319, DOI 10.1152/physrev.1970.50.3.319; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fesus G, 2007, CARDIOVASC RES, V75, P719, DOI 10.1016/j.cardiores.2007.05.025; Fraga-Silva RA, 2013, HYPERTENSION, V61, P1233, DOI 10.1161/HYPERTENSIONAHA.111.00627; Gurley SB, 2008, EXP PHYSIOL, V93, P538, DOI 10.1113/expphysiol.2007.040014; Gurley SB, 2006, J CLIN INVEST, V116, P2218, DOI 10.1172/JCI16980; Higashi Y, 2002, NEW ENGL J MED, V346, P1954, DOI 10.1056/NEJMoa013591; Jin HY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042432, 10.1371/journal.pone.0038502]; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025; Lei XG, 2007, ANNU REV NUTR, V27, P41, DOI 10.1146/annurev.nutr.27.061406.093716; Lovren F, 2008, AM J PHYSIOL-HEART C, V295, pH1377, DOI 10.1152/ajpheart.00331.2008; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; MUGGE A, 1991, CIRC RES, V69, P1293, DOI 10.1161/01.RES.69.5.1293; Nakaoka H, 2013, J AM SOC HYPERTENS, V7, P259, DOI 10.1016/j.jash.2013.03.002; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Patel SK, 2012, AM J HYPERTENS, V25, P216, DOI 10.1038/ajh.2011.188; Patel VB, 2014, HYPERTENSION, V64, P157, DOI 10.1161/HYPERTENSIONAHA.114.03388; Pena-Silva RA, 2012, STROKE, V43, P3358, DOI 10.1161/STROKEAHA.112.667063; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; Rabelo LA, 2011, HYPERTENS RES, V34, P154, DOI 10.1038/hr.2010.235; Rabelo LA, 2008, J AM SOC HYPERTENS, V2, P418, DOI 10.1016/j.jash.2008.05.003; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Rentzsch B, 2008, HYPERTENSION, V52, P967, DOI 10.1161/HYPERTENSIONAHA.108.114322; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Saraswathi R, 2011, CLIN EXP HYPERTENS, V33, P437, DOI 10.3109/10641963.2010.549259; Shi Y, 2007, BRIT J PHARMACOL, V152, P1033, DOI 10.1038/sj.bjp.0707439; Shi Y, 2009, J DIABETES, V1, P151, DOI 10.1111/j.1753-0407.2009.00030.x; Shiota A, 2010, HYPERTENS RES, V33, P298, DOI 10.1038/hr.2009.231; Thatcher SE, 2011, ARTERIOSCL THROM VAS, V31, P758, DOI 10.1161/ATVBAHA.110.221614; Thomas MC, 2010, CIRC RES, V107, P888, DOI 10.1161/CIRCRESAHA.110.219279; Tian XY, 2012, CIRC RES, V110, P1211, DOI [10.1161/CIRCRESAHA.111.262170, 10.1161/circresaha.111.262170]; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vinh A, 2008, CARDIOVASC RES, V77, P178, DOI 10.1093/cvr/cvm021; White AR, 2006, HYPERTENSION, V47, P245, DOI 10.1161/01.HYP.0000198543.34502.d7; Wilkinson IB, 2002, BRIT J CLIN PHARMACO, V53, P189, DOI 10.1046/j.1365-2125.2002.1528adoc.x; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Xu P, 2008, HYPERTENSION, V51, P574, DOI 10.1161/HYPERTENSIONAHA.107.102764; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b; Zhang Y, 2015, ANTIOXID REDOX SIGN, V23, P880, DOI 10.1089/ars.2014.6070	55	46	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0150255	10.1371/journal.pone.0150255	http://dx.doi.org/10.1371/journal.pone.0150255			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070147	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000373900700003
J	Deryugina, T; Shurchkov, O				Deryugina, Tatyana; Shurchkov, Olga			The Effect of Information Provision on Public Consensus about Climate Change	PLOS ONE			English	Article							SUPPORT; SCIENCE; PERCEPTIONS	Despite over 20 years of research and scientific consensus on the topic, climate change continues to be a politically polarizing issue. We conducted a survey experiment to test whether providing the public with information on the exact extent of scientific agreement about the occurrence and causes of climate change affects respondents' own beliefs and bridges the divide between conservatives and liberals. First, we show that the public significantly underestimated the extent of the scientific consensus. We then find that those given concrete information about scientists' views were more likely to report believing that climate change was already underway and that it was caused by humans. However, their beliefs about the necessity of making policy decisions and their willingness to donate money to combat climate change were not affected. Information provision affected liberals, moderates, and conservatives similarly, implying that the gap in beliefs between liberals and conservatives is not likely to be bridged by information treatments similar to the one we study. Finally, we conducted a 6-month follow-up with respondents to see if the treatment effect persisted; the results were statistically inconclusive.	[Deryugina, Tatyana] Univ Illinois, Dept Finance, Urbana, IL 61801 USA; [Shurchkov, Olga] Wellesley Coll, Dept Econ, Wellesley, MA 02181 USA	University of Illinois System; University of Illinois Urbana-Champaign; Wellesley College	Deryugina, T (corresponding author), Univ Illinois, Dept Finance, Urbana, IL 61801 USA.	deryugin@illinois.edu		Shurchkov, Olga/0000-0003-1962-7551	University of Illinois, Urbana-Champaign (UIUC) Campus Research Board [13013]	University of Illinois, Urbana-Champaign (UIUC) Campus Research Board	Research support was received from the University of Illinois, Urbana-Champaign (UIUC) Campus Research Board ID# 13013 https://crb.research.illinois.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklin M, 2014, ENVIRON SCI POLICY, V38, P173, DOI 10.1016/j.envsci.2013.10.006; Andreoni J, 2014, 20649 NBER; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Bauer MW, 2007, PUBLIC UNDERST SCI, V16, P79, DOI 10.1177/0963662506071287; Bollinger B, 2011, AM ECON J-ECON POLIC, V3, P91, DOI 10.1257/pol.3.1.91; Bolsen T, 2014, AM POLIT RES, V42, P65, DOI 10.1177/1532673X13484173; Cameron TA, 2005, J RISK UNCERTAINTY, V30, P63, DOI 10.1007/s11166-005-5833-8; Census Bureau of the United States, 2016, QUICK FACTS; Corbett JB, 2004, SCI COMMUN, V26, P129, DOI 10.1177/1075547004270234; Dunlap RE, 2008, ENVIRONMENT; Edenhofer O., 2014, CONTRIBUTION WORKING; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Gentzkow M, 2011, Q J ECON, V126, P1799, DOI 10.1093/qje/qjr044; Kellstedt PM, 2008, RISK ANAL, V28, P113, DOI 10.1111/j.1539-6924.2008.01010.x; Kiesel K, 2013, INT J IND ORGAN, V31, P153, DOI 10.1016/j.ijindorg.2010.11.002; Kuziemko I, 2015, AM ECON REV, V105, P1478, DOI 10.1257/aer.20130360; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; McCright AM, 2013, CLIMATIC CHANGE, V119, P511, DOI 10.1007/s10584-013-0704-9; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Pew Research Center, 2015, PUBL SCIENT VIEWS SC; Ramirez MD, 2014, POLIT PSYCHOL, V35, P401, DOI 10.1111/pops.12064; Rosenberg S, 2010, CLIM CHANG, V101, P3; Schwartzstein J, 2014, J EUR ECON ASSOC, V12, P1423, DOI 10.1111/jeea.12104; Sturgis P, 2004, PUBLIC UNDERST SCI, V13, P55, DOI 10.1177/0963662504042690; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; van der Linden SL, 2014, CLIMATIC CHANGE, V126, P255, DOI 10.1007/s10584-014-1190-4	27	54	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0151469	10.1371/journal.pone.0151469	http://dx.doi.org/10.1371/journal.pone.0151469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0KH	27064486	Green Published, Green Submitted, gold			2022-12-26	WOS:000373891000003
J	Rambli, A; Abuzaid, AHM; Bin Mohamed, I; Hussin, AG				Rambli, Adzhar; Abuzaid, Ali H. M.; Bin Mohamed, Ibrahim; Hussin, Abdul Ghapor			Procedure for Detecting Outliers in a Circular Regression Model	PLOS ONE			English	Article								A number of circular regression models have been proposed in the literature. In recent years, there is a strong interest shown on the subject of outlier detection in circular regression. An outlier detection procedure can be developed by defining a new statistic in terms of the circular residuals. In this paper, we propose a new measure which transforms the circular residuals into linear measures using a trigonometric function. We then employ the row deletion approach to identify observations that affect the measure the most, a candidate of outlier. The corresponding cut-off points and the performance of the detection procedure when applied on Down and Mardia's model are studied via simulations. For illustration, we apply the procedure on circadian data.	[Rambli, Adzhar; Bin Mohamed, Ibrahim] Univ Malaya, Inst Math Sci, Kuala Lumpur, Malaysia; [Abuzaid, Ali H. M.] Al Azhar Univ Gaza, Fac Sci, Dept Math, Gaza, Israel; [Hussin, Abdul Ghapor] Natl Def Univ Malaysia, Ctr Def Fdn Studies, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Pertahanan Nasional Malaysia	Rambli, A (corresponding author), Univ Malaya, Inst Math Sci, Kuala Lumpur, Malaysia.	adzfranc@gmail.com	BIN MOHAMED, IBRAHIM/B-8643-2010; RAMBLI, ADZHAR/ABD-1232-2020	BIN MOHAMED, IBRAHIM/0000-0001-5518-4132; Abuzaid, Ali/0000-0002-6680-7371; Rambli, Adzhar/0000-0001-9947-1176	University of Malaya Research Grant Scheme [RP009C-13AFR, RP014C-15SUS]	University of Malaya Research Grant Scheme	University of Malaya Research Grant Scheme (no. RP009C-13AFR) - website: http://umresearch.um.edu.my. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are most grateful to the Associate Editor and referees for their through reading and valuable suggestions, which led to a substantial improvement of the article. This research is financially supported by the University of Malaya Research Grant Scheme (no. RP014C-15SUS).	Abuzaid AH, 2013, J STAT COMPUT SIM, V83, P269, DOI 10.1080/00949655.2011.602679; Abuzaid A, 2011, CHIANG MAI J SCI, V38, P321; Barnett V., 1984, OUTLIERS STAT DATA; Downs TD, 2002, BIOMETRIKA, V89, P683, DOI 10.1093/biomet/89.3.683; FISHER NI, 1992, BIOMETRICS, V48, P665, DOI 10.2307/2532334; GOULD AL, 1969, BIOMETRICS, V25, P683, DOI 10.2307/2528567; Hayakawa T, 1993, STAT SCI DATA ANAL, P109; Hussin A.G., 2004, J APPL SCI TECHNOL, V9, P1; Ibrahim S, 2013, COMMUN STAT-SIMUL C, V42, P2272, DOI 10.1080/03610918.2012.697239; JOHNSON RA, 1978, J AM STAT ASSOC, V73, P602, DOI 10.2307/2286608; LAYCOCK PJ, 1975, BIOMETRIKA, V62, P305, DOI 10.1093/biomet/62.2.305; Rao JS., 2001, TOPICS CIRCULAR STAT; Rivest LP, 1997, BIOMETRIKA, V84, P717, DOI 10.1093/biomet/84.3.717; Welsch R, 1980, REGRESSION DIAGNOSTI	14	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153074	10.1371/journal.pone.0153074	http://dx.doi.org/10.1371/journal.pone.0153074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064566	Green Published, gold, Green Submitted			2022-12-26	WOS:000373891000028
J	Rosenlund, S; Holsgaard-Larsen, A; Overgaard, S; Jensen, C				Rosenlund, Signe; Holsgaard-Larsen, Anders; Overgaard, Soren; Jensen, Carsten			The Gait Deviation Index Is Associated with Hip Muscle Strength and Patient-Reported Outcome in Patients with Severe Hip Osteoarthritis-A Cross-Sectional Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; LATERAL APPROACH; CEREBRAL-PALSY; WALKING SPEED; ARTHROPLASTY; KNEE; CHILDREN; PAIN; VALIDITY; INDIVIDUALS	Background The Gait Deviation Index summarizes overall gait 'quality', based on kinematic data from a 3-dimensional gait analysis. However, it is unknown which clinical outcomes may affect the Gait Deviation Index in patients with primary hip osteoarthritis. The aim of this study was to investigate associations between Gait Deviation Index as a measure of gait 'quality' and hip muscle strength and between Gait Deviation Index and patient-reported outcomes in patients with primary hip osteoarthritis. Method Forty-seven patients (34 males), aged 61.1 +/- 6.7 years, with BMI 27.3 +/- 3.4 (kg/m(2)) and with severe primary hip osteoarthritis underwent 3-dimensional gait analysis. Mean Gait Deviation Index, pain after walking and maximal isometric hip muscle strength (flexor, extensor, and abductor) were recorded. All patients completed the 'Physical Function Short-form of the Hip disability and Osteoarthritis Outcome Score (HOOS-Physical Function) and the Hip disability and Osteoarthritis Outcome Score subscales for pain (HOOS-Pain) and quality-of-life (HOOS-QOL). Results Mean Gait Deviation Index was positively associated with hip abduction strength (p<0.01, r = 0.40), hip flexion strength (p = 0.01, r = 0.37), HOOS-Physical Function (p<0.01, r = 0.41) HOOS-QOL (p<0.01, r = 0.41), and negatively associated with HOOS-Pain after walking (p<0.01, r = -0.45). Adjusting the analysis for walking speed did not affect the association. Conclusion Patients with the strongest hip abductor and hip flexor muscles had the best gait 'quality'. Furthermore, patients with higher physical function, quality of life scores and lower pain levels demonstrated better gait 'quality'. These findings indicate that interventions aimed at improving hip muscle strength and pain management may to a moderate degree improve the overall gait 'quality' in patients with primary hip OA.	[Rosenlund, Signe; Holsgaard-Larsen, Anders; Overgaard, Soren; Jensen, Carsten] Univ Southern Denmark, Dept Orthopaed Surg & Traumatol, Odense Univ Hosp, Inst Clin Res, Odense C, Denmark; [Rosenlund, Signe] Koge Hosp, Dept Orthopaed Surg & Traumatol, Koge, Denmark	University of Southern Denmark; Odense University Hospital	Rosenlund, S (corresponding author), Univ Southern Denmark, Dept Orthopaed Surg & Traumatol, Odense Univ Hosp, Inst Clin Res, Odense C, Denmark.; Rosenlund, S (corresponding author), Koge Hosp, Dept Orthopaed Surg & Traumatol, Koge, Denmark.	signe.rosenlund@gmail.com	Holsgaard-Larsen, Anders/F-1033-2013; Jensen, C./H-9034-2019; Overgaard, Søren/AAX-9407-2020	Holsgaard-Larsen, Anders/0000-0003-4106-6930; Jensen, C./0000-0002-8074-1583; Overgaard, Soren/0000-0001-6829-4787	Danish Rheumatism Association [R102-A2116, R108-A2436]; Region of Zealand [1641013, 12-000095/64]; Region of Southern Denmark [11/28589]; Bevica Foundation; Bjarne Jensen Foundation; Odense University Hospital	Danish Rheumatism Association; Region of Zealand; Region of Southern Denmark; Bevica Foundation; Bjarne Jensen Foundation; Odense University Hospital	This work was supported by the Danish Rheumatism Association (R102-A2116 and R108-A2436), (https://www.gigtforeningen.dk) (SR), the Region of Zealand (Brevid: 1641013 and Sagsnummer: 12-000095/64), (http://www.regionsjaelland.dk/Sundhed/forskning/forskningsfinansiering/Sider/oekonomi.aspx) (SR), the Region of Southern Denmark (j.nr. 11/28589), (http://www.regionsyddanmark.dk/wm325002) (SR), the Bevica Foundation (no grant number), (http://www.bevica.dk/bevica-fonden/formalansogning) (SR), the Bjarne Jensen Foundation (no grant number), (http://www.bjarnejensensfond.dk) (SR), and Odense University Hospital (no grant number), (http://www.ouh.dk/default.asp?id=402241) (SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amlie E, 2014, ACTA ORTHOP, V85, P463, DOI 10.3109/17453674.2014.934183; Arokoski MH, 2002, J RHEUMATOL, V29, P2185; Behery OA, 2014, CLIN ORTHOP RELAT R, V472, P3452, DOI 10.1007/s11999-014-3886-1; Bejek Z, 2006, KNEE SURG SPORT TR A, V14, P612, DOI 10.1007/s00167-005-0005-6; Bellamy N, 1997, J RHEUMATOL, V24, P799; Bennell KL, 2010, OSTEOARTHR CARTILAGE, V18, P621, DOI 10.1016/j.joca.2010.01.010; Bergh I, 2000, AGING CLIN EXP RES, V12, P380, DOI 10.1007/BF03339864; Beyer NT, 2008, TRANSLATION CROSS CU; Bhave A, 2005, J BONE JOINT SURG AM, V87A, P9, DOI 10.2106/JBJS.E.00628; Brostrom EW, 2013, SCAND J RHEUMATOL, V42, P356, DOI 10.3109/03009742.2013.776102; Cimolin V, 2014, GAIT POSTURE, V39, P1005, DOI 10.1016/j.gaitpost.2014.02.001; Cimolin V, 2011, RES DEV DISABIL, V32, P377, DOI 10.1016/j.ridd.2010.10.017; Constantinou M, 2014, J ORTHOP SPORT PHYS, V44, P291, DOI 10.2519/jospt.2014.4634; Davis AM, 2009, OSTEOARTHR CARTILAGE, V17, P843, DOI 10.1016/j.joca.2009.01.005; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Esbjornsson AC, 2014, SCAND J RHEUMATOL, V43, P124, DOI 10.3109/03009742.2013.822095; Foucher KC, 2007, J BIOMECH, V40, P3432, DOI 10.1016/j.jbiomech.2007.05.020; Galli M, 2012, J MOTOR BEHAV, V44, P161, DOI 10.1080/00222895.2012.664180; Hassan BS, 2002, ANN RHEUM DIS, V61, P422, DOI 10.1136/ard.61.5.422; Holnapy G, 2013, J ELECTROMYOGR KINES, V23, P966, DOI 10.1016/j.jelekin.2013.04.005; Horstmann T, 2013, AM J PHYS MED REHAB, V92, P1060, DOI 10.1097/PHM.0b013e3182970fc4; Hurwitz DE, 1997, J ORTHOP RES, V15, P629, DOI 10.1002/jor.1100150421; Jensen C, 2011, OSTEOARTHR CARTILAGE, V19, P1108, DOI 10.1016/j.joca.2011.06.011; Jensen C, 2015, J ARTHROPLASTY, V30, P2343, DOI 10.1016/j.arth.2015.06.049; Jensen C, 2015, GAIT POSTURE, V42, P36, DOI 10.1016/j.gaitpost.2015.02.009; Jones CA, 2012, CLIN GERIATR MED, V28, P395, DOI 10.1016/j.cger.2012.06.001; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kean CO, 2015, CLIN BIOMECH, V30, P226, DOI 10.1016/j.clinbiomech.2015.01.008; Kiss RM, 2012, HUM MOVEMENT SCI, V31, P1302, DOI 10.1016/j.humov.2012.02.004; Landry SC, 2007, J BIOMECH, V40, P1754, DOI 10.1016/j.jbiomech.2006.08.010; Laroche D, 2011, OSTEOARTHR CARTILAGE, V19, P194, DOI 10.1016/j.joca.2010.10.024; Lindemann U, 2006, CLIN REHABIL, V20, P413, DOI 10.1191/0269215506cr958oa; LONG WT, 1993, CLIN ORTHOP RELAT R, P73; Maanum G, 2012, J REHABIL MED, V44, P272, DOI 10.2340/16501977-0930; Massaad A, 2014, GAIT POSTURE, V39, P354, DOI 10.1016/j.gaitpost.2013.08.001; Molloy M, 2010, GAIT POSTURE, V31, P479, DOI 10.1016/j.gaitpost.2010.01.025; Rasmussen HM, 2015, GAIT POSTURE, V42, P133, DOI 10.1016/j.gaitpost.2015.04.019; Reidy J, 2011, STAT MATHS PSYCHOL; Rosenlund S, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-354; Rozumalski A, 2012, GAIT POSTURE, V36, pS51, DOI DOI 10.1016/J.GAITPOST.2011.10.267; Samuel D, 2012, AGE AGEING, V41, P224, DOI 10.1093/ageing/afr156; Schwartz MH, 2008, GAIT POSTURE, V28, P351, DOI 10.1016/j.gaitpost.2008.05.001; SHIH CH, 1994, CLIN ORTHOP RELAT R, P115; Sicard-Rosenbaum L, 2002, J GERONTOL A-BIOL, V57, pM47, DOI 10.1093/gerona/57.1.M47; Steinhilber B, 2013, J GERIATR PHYS THER, V37, P99, DOI [10.1097/JPT.0000000000000008, DOI 10.1097/JPT.0000000000000008]; Thorborg K, 2010, BRIT J SPORT MED, V44, P1186, DOI 10.1136/bjsm.2009.060889; van der Krogt MM, 2012, GAIT POSTURE, V36, P113, DOI 10.1016/j.gaitpost.2012.01.017; Vicon&REG, 2010, PLUG IN GAIT PROD GU; WHO, 2014, GLOB HLTH EST 2014; WHO, 2002, WHOEIPGPECAS013; Widler KS, 2009, J BONE JOINT SURG AM, V91A, P2666, DOI 10.2106/JBJS.H.01119; Wilson JLA, 2012, CLIN BIOMECH, V27, P210, DOI 10.1016/j.clinbiomech.2011.09.009; Wren TAL, 2013, GAIT POSTURE, V38, P236, DOI 10.1016/j.gaitpost.2012.11.018; Zeni J, 2015, J ORTHOP RES, V33, P382, DOI 10.1002/jor.22772; Zeni J, 2014, ARTHRIT CARE RES, V66, P1506, DOI 10.1002/acr.22329	55	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153177	10.1371/journal.pone.0153177	http://dx.doi.org/10.1371/journal.pone.0153177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0KH	27065007	Green Published, Green Submitted, gold			2022-12-26	WOS:000373891000034
J	Shen, YQ; Ng, LF; Low, NPW; Hagen, T; Gruber, J; Inoue, T				Shen, Yanqing; Ng, Li Fang; Low, Natarie Pei Wen; Hagen, Thilo; Gruber, Jan; Inoue, Takao			C. elegans miro-1 Mutation Reduces the Amount of Mitochondria and Extends Life Span	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; UNFOLDED PROTEIN RESPONSE; SYSTEMATIC RNAI SCREEN; ELECTRON-TRANSPORT; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; GENE-EXPRESSION; LONGEVITY; GTPASE; MIRO	Mitochondria play a critical role in aging, however, the underlying mechanism is not well understood. We found that a mutation disrupting the C. elegans homolog of Miro GTPase (miro-1) extends life span. This phenotype requires simultaneous loss of miro-1 from multiple tissues including muscles and neurons, and is dependent on daf-16/FOXO. Notably, the amount of mitochondria in the miro-1 mutant is reduced to approximately 50% of the wildtype. Despite this reduction, oxygen consumption is only weakly reduced, suggesting that mitochondria of miro-1 mutants are more active than wild-type mitochondria. The ROS damage is slightly reduced and the mitochondrial unfolded protein response pathway is weakly activated in miro-1 mutants. Unlike previously described long-lived mitochondrial electron transport chain mutants, miro-1 mutants have normal growth rate. These results suggest that the reduction in the amount of mitochondria can affect the life span of an organism through activation of stress pathways.	[Shen, Yanqing; Low, Natarie Pei Wen; Hagen, Thilo; Gruber, Jan; Inoue, Takao] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Ng, Li Fang; Gruber, Jan] Yale NUS Coll, Div Sci, Singapore, Singapore	National University of Singapore; Yale NUS College	Inoue, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchti@nus.edu.sg			Singapore Ministry of Education Academic Research Fund [T1-2012-Bridging-04, MOE2015-T2-1-106, MOE2014-T2-2-120]; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Singapore Ministry of Education Academic Research Fund(Ministry of Education, Singapore); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Singapore Ministry of Education Academic Research Fund: T1-2012-Bridging-04; Singapore Ministry of Education Academic Research Fund: MOE2015-T2-1-106; and Singapore Ministry of Education Academic Research Fund: MOE2014-T2-2-120. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Goh Kah Yee for help with the manuscript. We thank the Mitani Laboratory at the Tokyo Women's Medical University School of Medicine for providing the miro-1(tm1966) mutant. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Bennett CF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4483; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BRENNER S, 1974, GENETICS, V77, P71; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Dancy BM, 2014, EXP GERONTOL, V56, P245, DOI 10.1016/j.exger.2014.03.028; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; FRIEDMAN DB, 1988, J GERONTOL, V43, pB102, DOI 10.1093/geronj/43.4.B102; Golden TR, 2007, AGING CELL, V6, P179, DOI 10.1111/j.1474-9726.2007.00273.x; Gruber J, 2015, ANTIOXIDANTS REDOX S; Gruber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019444; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; JENSEN PK, 1966, BIOCHIM BIOPHYS ACTA, V122, P157, DOI 10.1016/0926-6593(66)90057-9; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Koshiba T, 2011, J BIOL CHEM, V286, P354, DOI 10.1074/jbc.M110.180034; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; MADURO M, 1995, GENETICS, V141, P977; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nguyen TT, 2014, P NATL ACAD SCI USA, V111, pE3631, DOI 10.1073/pnas.1402449111; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Ranjan M, 2013, FREE RADICAL BIO MED, V63, P381, DOI 10.1016/j.freeradbiomed.2013.05.025; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Rube DA, 2004, MOL CELL BIOCHEM, V256, P331, DOI 10.1023/B:MCBI.0000009879.01256.f6; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Schaffer S, 2011, BIOGERONTOLOGY, V12, P195, DOI 10.1007/s10522-010-9310-7; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730; Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yamaoka S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00350; Yang CC, 2011, AGING CELL, V10, P724, DOI 10.1111/j.1474-9726.2011.00711.x; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788	53	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153233	10.1371/journal.pone.0153233	http://dx.doi.org/10.1371/journal.pone.0153233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064409	gold, Green Submitted, Green Published			2022-12-26	WOS:000373891000038
J	Silva, LMG; da Silva, CAA; da Silva, A; Vieira, RP; Mesquita-Ferrari, RA; Cogo, JC; Zamuner, SR				Goncalves Silva, Luciana Miato; Alves da Silva, Camila Aparecida; da Silva, Aline; Vieira, Rodolfo Paula; Mesquita-Ferrari, Raquel Agnelli; Cogo, Jose Carlos; Zamuner, Stella Regina			Photobiomodulation Protects and Promotes Differentiation of C2C12 Myoblast Cells Exposed to Snake Venom	PLOS ONE			English	Article							LEVEL LASER THERAPY; MUSCLE HEALING-PROCESS; SKELETAL-MUSCLE; PHOSPHOLIPASES A(2); SAO-PAULO; IRRADIATION; INFLAMMATION; ANTIVENOMS; MECHANISM; PROTEINS	Background Snakebites is a neglected disease and in Brazil is considered a serious health problem, with the majority of the snakebites caused by the genus Bothrops. Antivenom therapy and other first-aid treatments do not reverse local myonecrose which is the main sequel caused by the envenomation. Several studies have shown the effectiveness of low level laser (LLL) therapy in reducing local myonecrosis induced by Bothropic venoms, however the mechanism involved in this effect is unknown. In this in vitro study, we aimed to analyze the effect of LLL irradiation against cytotoxicity induced by Bothrops jararacussu venom on myoblast C2C12 cells. Methodology C2C12 were utilized as a model target and were incubated with B. jararacussu venom (12.5 mu g/mL) and immediately irradiated with LLL at wavelength of red 685 nm or infrared 830 nm with energy density of 2.0, 4.6 and 7.0 J/cm(2). Effects of LLL on cellular responses of venom-induced cytotoxicity were examined, including cell viability, measurement of cell damage and intra and extracellular ATP levels, expression of myogenic regulatory factors, as well as cellular differentiation. Results In non-irradiated cells, the venom caused a decrease in cell viability and a massive release of LDH and CK levels indicating myonecrosis. Infrared and red laser at all energy densities were able to considerably decrease venom-induced cytotoxicity. Laser irradiation induced myoblasts to differentiate into myotubes and this effect was accompanied by up regulation of MyoD and specially myogenin. Moreover, LLL was able to reduce the extracellular while increased the intracellular ATP content after venom exposure. In addition, no difference in the intensity of cytotoxicity was shown by non-irradiated and irradiated venom. Conclusion LLL irradiation caused a protective effect on C2C12 cells against the cytotoxicity caused by B. jararacussu venom and promotes differentiation of these cells by up regulation of myogenic factors. A modulatory effect of ATP synthesis may be suggested as a possible mechanism mediating cytoprotection observed under laser irradiation.	[Goncalves Silva, Luciana Miato; Alves da Silva, Camila Aparecida; da Silva, Aline; Vieira, Rodolfo Paula; Zamuner, Stella Regina] Univ Nove de Julho UNINOVE, Posgrad Program Med, Sao Paulo, SP, Brazil; [Mesquita-Ferrari, Raquel Agnelli] Univ Nove de Julho UNINOVE, Posgrad Program Biophoton, Sao Paulo, SP, Brazil; [Cogo, Jose Carlos] Univ Vale Paraiba, UNIVAP, Inst Res & Dev, Sao Jose Dos Campos, SP, Brazil	Universidade Nove de Julho; Universidade Nove de Julho; Universidade do Vale do Paraiba	Zamuner, SR (corresponding author), Univ Nove de Julho UNINOVE, Posgrad Program Med, Sao Paulo, SP, Brazil.	stella.rz@uninove.br	Fernandes, Kristianne Porta Santos/I-4417-2016; Ferrari, Raquel/I-4419-2016; de Paula Vieira, Rodolfo/E-9315-2011; Zamuner, Stella R/C-3132-2012; Zamuner, Stella Regina/AAA-8106-2019	Fernandes, Kristianne Porta Santos/0000-0001-7156-9286; Ferrari, Raquel/0000-0001-5142-9526; de Paula Vieira, Rodolfo/0000-0001-6379-1143; Zamuner, Stella R/0000-0002-4694-7617; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/04660-0, 2011/14376-6]; FAPESP [2011/04660-0, 2011/14376-6, 2012/15165-2]; CNPq-PQ [449948/2014-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-PQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge the financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), 2011/04660-0 and 2011/14376-6. CMS is recipient of FAPESP M.Sc. fellowship (Grant no 2011/04660-0), RPV is recipient of FAPESP grant process: 2012/15165-2 and SRZ is recipient of CNPq-PQ grant Process: 449948/2014-0 and FAPESP 2011/14376-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avci P, 2013, SEMIN CUTAN MED SURG, V32, P41; Barbosa AM, 2010, J VENOM ANIM TOXINS, V16, P470, DOI 10.1590/S1678-91992010000300014; Barbosa AM, 2008, TOXICON, V51, P1236, DOI 10.1016/j.toxicon.2008.02.007; Barbosa AM, 2009, PHOTOMED LASER SURG, V27, P591, DOI 10.1089/pho.2008.2296; Barretto SR, 2013, J PHOTOCH PHOTOBIO B, V129, P135, DOI 10.1016/j.jphotobiol.2013.10.002; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Brunelli RM, 2014, LASER MED SCI, V29, P91, DOI 10.1007/s10103-013-1277-6; Burattini S, 2004, EUR J HISTOCHEM, V48, P223; Bustillo S, 2012, TOXICON, V59, P338, DOI 10.1016/j.toxicon.2011.11.007; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; CARDOSO JLC, 1993, Q J MED, V86, P315; Cintra-Francischinelli M, 2010, P NATL ACAD SCI USA, V107, P14140, DOI 10.1073/pnas.1009128107; da Silva CJ, 2003, TOXICON, V41, P251, DOI 10.1016/S0041-0101(02)00287-8; de Araujo CEN, 2007, J PHOTOCH PHOTOBIO B, V86, P87, DOI 10.1016/j.jphotobiol.2006.08.006; de Sousa EA, 2013, PHOTOCH PHOTOBIO SCI, V12, P1895, DOI 10.1039/c3pp50036e; Doin-Silva R, 2009, PHOTOCHEM PHOTOBIOL, V85, P63, DOI 10.1111/j.1751-1097.2008.00397.x; dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858; Dourado DM, 2003, LASER SURG MED, V33, P352, DOI 10.1002/lsm.10237; Dourado DM, 2011, PHOTOCHEM PHOTOBIOL, V87, P418, DOI 10.1111/j.1751-1097.2010.00878.x; Fernandes CAH, 2014, BBA-PROTEINS PROTEOM, V1844, P2265, DOI 10.1016/j.bbapap.2014.09.015; Ferraz MC, 2014, MOLECULES, V19, P5790, DOI 10.3390/molecules19055790; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; Hawkins D, 2005, ANN NY ACAD SCI, V1056, P486, DOI 10.1196/annals.1352.040; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Idzko M, 2013, ALLERGY, V68, P472, DOI 10.1111/all.12119; KARU T, 1995, J PHOTOCH PHOTOBIO B, V27, P219, DOI 10.1016/1011-1344(94)07078-3; Lomonte B, 1999, TOXICON, V37, P145, DOI 10.1016/S0041-0101(98)00171-8; Milani R, 1997, QJM-MON J ASSOC PHYS, V90, P323, DOI 10.1093/qjmed/90.5.323; Mora-Obando D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109846; Nadur-Andrade N, 2014, PHOTOCH PHOTOBIO SCI, V13, P1561, DOI 10.1039/c4pp00111g; Nadur-Andrade N, 2014, PHOTOCHEM PHOTOBIOL, V90, P207, DOI 10.1111/php.12189; Nadur-Andrade N, 2012, LASER MED SCI, V27, P65, DOI 10.1007/s10103-011-0914-1; Nakano J, 2009, EXP PHYSIOL, V94, P1005, DOI 10.1113/expphysiol.2009.047738; Neto HS, 2004, TOXICON, V44, P847, DOI 10.1016/j.toxicon.2004.08.007; Peplow PV, 2010, PHOTOMED LASER SURG, V28, pS3, DOI 10.1089/pho.2010.2771; Rangel J, 2011, CELL BIOCHEM FUNCT, V29, P365, DOI 10.1002/cbf.1758; Rodrigues NC, 2013, J REHABIL RES DEV, V50, P985, DOI 10.1682/JRRD.2012.08.0147; Segura A, 2010, TOXICON, V56, P980, DOI 10.1016/j.toxicon.2010.07.001; Shefer G, 2003, BBA-MOL CELL RES, V1593, P131, DOI 10.1016/S0167-4889(02)00350-6; Silva CAA, 2012, CLIN EXP MED LETT, V53, P7; Souza L.G., 2011, CLIN EXP MED LETT, V52, P97; Vomero VU, 2009, TOXICON, V54, P361, DOI 10.1016/j.toxicon.2009.04.006; Yen YP, 2010, ENVIRON HEALTH PERSP, V118, P949, DOI 10.1289/ehp.0901525; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zamuner SR, 2004, TOXICON, V44, P259, DOI 10.1016/j.toxicon.2004.05.029	45	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152890	10.1371/journal.pone.0152890	http://dx.doi.org/10.1371/journal.pone.0152890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058357	Green Published, Green Submitted, gold			2022-12-26	WOS:000373604800014
J	Changsom, D; Lerdsamran, H; Wiriyarat, W; Chakritbudsabong, W; Siridechadilok, B; Prasertsopon, J; Noisumdaeng, P; Masamae, W; Puthavathana, P				Changsom, Don; Lerdsamran, Hatairat; Wiriyarat, Witthawat; Chakritbudsabong, Warunya; Siridechadilok, Bunpote; Prasertsopon, Jarunee; Noisumdaeng, Pirom; Masamae, Wanibtisam; Puthavathana, Pilaipan			Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response	PLOS ONE			English	Article							A VIRUS; LETHAL INFLUENZA; ANTINEURAMINIDASE ANTIBODY; CROSS-PROTECTION; PANDEMIC H1N1; RECOMBINANT; HEMAGGLUTININ; INFECTION; IMMUNITY; IMMUNIZATION	Influenza neuraminidase (NA) proteins expressed in TK- cells infected with recombinant vaccinia virus carrying NA gene of highly pathogenic avian influenza H5N1 virus or 2009 pandemic H1N1 (H1N1pdm) virus were characterized for their biological properties, i.e., cell localization, molecular weight (MW), glycosylation and sialidase activity. Immune sera collected from BALB/c mice immunized with these recombinant viruses were assayed for binding and functional activities of anti-NA antibodies. Recombinant NA proteins were found localized in cytoplasm and cytoplasmic membrane of the infected cells. H1N1pdm NA protein had MW at about 75 kDa while it was 55 kDa for H5N1 NA protein. Hyperglycosylation was more pronounced in H1N1pdm NA compared to H5N1 NA according to N-glycosidase F treatment. Three dimensional structures also predicted that H1N1 NA globular head contained 4 and that of H5N1 contained 2 potential glycosylation sites. H5N1 NA protein had higher sialidase activity than H1N1pdm NA protein as measured by both MUNANA-based assay and fetuin-based enzyme-linked lectin assay (ELLA). Plaque reduction assay demonstrated that anti-NA antibody could reduce number of plaques and plaque size through inhibiting virus release, not virus entry. Assay for neuraminidase-inhibition (NI) antibody by ELLA showed specific and cross reactivity between H5N1 NA and H1N1pdm NA protein derived from reverse genetic viruses or wild type viruses. In contrast, replication-inhibition assay in MDCK cells showed that anti-H1N1 NA antibody moderately inhibited viruses with homologous NA gene only, while anti-H5N1 NA antibody modestly inhibited the replication of viruses containing homologous NA gene and NA gene derived from H1N1pdm virus. Anti-H1N1 NA antibody showed higher titers of inhibiting virus replication than anti-H5N1 NA antibody, which are consistent with the results on reduction in plaque numbers and sizes as well as in inhibiting NA enzymatic activity. No assay showed cross reactivity with reassorted PR8 (H1N1) virus and H3N2 wild type viruses.	[Changsom, Don; Masamae, Wanibtisam; Puthavathana, Pilaipan] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; [Lerdsamran, Hatairat; Prasertsopon, Jarunee; Puthavathana, Pilaipan] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Nakhon Pathom, Thailand; [Wiriyarat, Witthawat; Chakritbudsabong, Warunya] Mahidol Univ, Dept Preclin & Appl Anim Sci, Fac Vet Sci, Nakhon Pathom, Thailand; [Siridechadilok, Bunpote] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Noisumdaeng, Pirom] Thammasat Univ, Fac Publ Hlth, Pathum Thani, Thailand; [Puthavathana, Pilaipan] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Nakhon Pathom, Thailand	Mahidol University; Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Thammasat University; Mahidol University	Puthavathana, P (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand.; Puthavathana, P (corresponding author), Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Nakhon Pathom, Thailand.; Puthavathana, P (corresponding author), Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Nakhon Pathom, Thailand.	pilaipan.put@mahidol.ac.th			Office of the Higher Education Commission; Faculty of Medicine Siriraj Hospital (Mahidol University); Mahidol University under the National Research Universities Initiative	Office of the Higher Education Commission; Faculty of Medicine Siriraj Hospital (Mahidol University); Mahidol University under the National Research Universities Initiative	The Office of the Higher Education Commission, Siriraj Thesis Scholarship from the Faculty of Medicine Siriraj Hospital (Mahidol University), and Mahidol University under the National Research Universities Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Bright RA, 2009, VACCINE, V27, P6366, DOI 10.1016/j.vaccine.2009.02.084; Cate TR, 2010, VACCINE, V28, P2076, DOI 10.1016/j.vaccine.2009.12.041; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; Chen Z, 1999, VACCINE, V17, P653, DOI 10.1016/S0264-410X(98)00247-3; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Chen ZY, 2012, VACCINE, V30, P2516, DOI 10.1016/j.vaccine.2012.01.090; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; Couch RB, 2012, VACCINE, V31, P190, DOI 10.1016/j.vaccine.2012.10.065; Couzens L, 2014, J VIROL METHODS, V210, P7, DOI 10.1016/j.jviromet.2014.09.003; Deroo T, 1996, VACCINE, V14, P561, DOI 10.1016/0264-410X(95)00157-V; Easterbrook JD, 2012, VIROLOGY, V432, P39, DOI 10.1016/j.virol.2012.06.003; Eichelberger M, 2008, VACCINE, V26, P4299, DOI 10.1016/j.vaccine.2008.06.012; EPSTEIN SL, 1993, J IMMUNOL, V150, P5484; Halbherr SJ, 2015, J VIROL, V89, P1550, DOI 10.1128/JVI.02949-14; Hessel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012217; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; JAHIEL RI, 1966, J BACTERIOL, V92, P1521, DOI 10.1128/JB.92.5.1521-1534.1966; JAKEMAN KJ, 1989, J GEN VIROL, V70, P1523, DOI 10.1099/0022-1317-70-6-1523; JOHANSSON BE, 1987, P NATL ACAD SCI USA, V84, P6869, DOI 10.1073/pnas.84.19.6869; JOHANSSON BE, 1995, VACCINE, V13, P841, DOI 10.1016/0264-410X(94)00071-T; JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989; Johansson BE, 1999, VACCINE, V17, P2073, DOI 10.1016/S0264-410X(98)00413-7; Kilbourne ED, 2004, J INFECT DIS, V189, P459, DOI 10.1086/381123; KILBOURNE ED, 1968, J VIROL, V2, P281, DOI 10.1128/JVI.2.4.281-288.1968; Knossow M, 2002, VIROLOGY, V302, P294, DOI 10.1006/viro.2002.1625; Lerdsamran H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016164; Li YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095539; Marcelin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026335; Martinet W, 1997, EUR J BIOCHEM, V247, P332, DOI 10.1111/j.1432-1033.1997.00332.x; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; MONTO AS, 1973, LANCET, V1, P623, DOI 10.1016/S0140-6736(73)92196-X; Noisumdaeng P, 2014, VIROLOGY, V454, P254, DOI 10.1016/j.virol.2014.02.024; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Panaampon J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036318; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quan FS, 2012, VIROLOGY, V430, P127, DOI 10.1016/j.virol.2012.05.006; Rockman S, 2013, J VIROL, V87, P3053, DOI 10.1128/JVI.02434-12; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Sandbulte MR, 2009, INFLUENZA OTHER RESP, V3, P233, DOI 10.1111/j.1750-2659.2009.00094.x; SCHULMAN JL, 1969, B WORLD HEALTH ORGAN, V41, P647; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SMITH GL, 1987, VIROLOGY, V160, P336, DOI 10.1016/0042-6822(87)90004-3; Sylte MJ, 2007, VACCINE, V25, P3763, DOI 10.1016/j.vaccine.2007.02.011; Tanimoto T, 2005, VACCINE, V23, P4598, DOI 10.1016/j.vaccine.2005.04.042; Wan HQ, 2013, J VIROL, V87, P9290, DOI 10.1128/JVI.01203-13; WEBSTER RG, 1988, VIROLOGY, V164, P230, DOI 10.1016/0042-6822(88)90640-X; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wohlbold TJ, 2015, MBIO, V6, DOI 10.1128/mBio.02556-14; Wu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042363; Yang YL, 2012, MOL BIOL REP, V39, P857, DOI 10.1007/s11033-011-0809-z; Yongkiettrakul S, 2009, J VIROL METHODS, V156, P44, DOI 10.1016/j.jviromet.2008.10.025	55	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153183	10.1371/journal.pone.0153183	http://dx.doi.org/10.1371/journal.pone.0153183			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054879	gold, Green Published, Green Submitted			2022-12-26	WOS:000373608000094
J	Estrela, HFG; Damasio, ES; Fonseca, EKUN; Bergamaschi, CT; Campos, RR				Estrela, Heder F. G.; Damasio, Elaine S.; Fonseca, Eduardo K. U. N.; Bergamaschi, Cassia T.; Campos, Ruy R.			Differential Sympathetic Vasomotor Activation Induced by Liver Cirrhosis in Rats	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NERVOUS-SYSTEM REGULATION; ARTERIAL-BLOOD-PRESSURE; DUCT-LIGATED RATS; PORTAL-HYPERTENSION; BAROREFLEX SENSITIVITY; VENTROLATERAL MEDULLA; ALCOHOLIC CIRRHOSIS; SPLANCHNIC VASODILATION; AUTONOMIC DYSFUNCTION	We tested the hypothesis that there is a topographical sympathetic activation in rats submitted to experimental cirrhosis. Baseline renal (rSNA) and splanchnic (sSNA) sympathetic nerve activities were evaluated in anesthetized rats. In addition, we evaluated main arterial pressure (MAP), heart rate (HR), and baroreceptor reflex sensitivity (BRS). Cirrhotic Wistar rats were obtained by bile duct ligation (BDL). MAP and HR were measured in conscious rats, and cardiac BRS was assessed by changes in blood pressure induced by increasing doses of phenylephrine or sodium nitroprusside. The BRS and baseline for the control of sSNA and rSNA were also evaluated in urethane-anesthetized rats. Cirrhotic rats had increased baseline sSNA (BDL, 102 vs control, 58 spikes/s; p<0.05), but no baseline changes in the rSNA compared to controls. These data were accompanied by increased splanchnic BRS (p<0.05) and decreased cardiac (p<0.05) and renal BRS (p<0.05). Furthermore, BDL rats had reduced basal MAP (BDL, 93 vs control, 101 mmHg; p<0.05) accompanied by increased HR (BDL, 378 vs control, 356; p<0.05). Our data have shown topographical sympathetic activation in rats submitted to experimental cirrhosis. The BDL group had increased baseline sSNA, independent of dysfunction in the BRS and no changes in baseline rSNA. However, an impairment of rSNA and HR control by arterial baroreceptor was noted. We suggest that arterial baroreceptor impairment of rSNA and HR is an early marker of cardiovascular dysfunction related to liver cirrhosis and probably a major mechanism leading to sympathoexcitation in decompensated phase.	[Estrela, Heder F. G.; Damasio, Elaine S.; Fonseca, Eduardo K. U. N.; Bergamaschi, Cassia T.; Campos, Ruy R.] Univ Fed Sao Paulo, Dept Physiol, Escola Paulista Med, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Campos, RR (corresponding author), Univ Fed Sao Paulo, Dept Physiol, Escola Paulista Med, Sao Paulo, Brazil.	ruy.camposjr@unifesp.br	Fonseca, Eduardo Kaiser U./M-7298-2019; Campos, Ruy R/H-8339-2017; Campos, Ruy R R/I-3691-2015; Bergamaschi, Cassia/AAZ-9441-2020	Campos, Ruy R/0000-0002-9404-0817; Campos, Ruy R R/0000-0002-9404-0817; Kaiser Ururahy Nunes Fonseca, Eduardo/0000-0002-0233-0041; Bergamaschi, Cassia/0000-0002-5741-6993	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/22522-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472613/2013-8, 301840/2013-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) 2013/22522-9 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) 472613/2013-8 and 301840/2013-0. Heder F. G. Estrela was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller MA, 2010, EUR J GASTROEN HEPAT, V22, P651, DOI 10.1097/MEG.0b013e32832e0a2f; ANDRESEN MC, 1994, ANNU REV PHYSIOL, V56, P93, DOI 10.1146/annurev.physiol.56.1.93; ARRANZ CT, 1995, ARCH PHYSIOL BIOCHEM, V103, P422, DOI 10.3109/13813459509047132; BIOULACSAGE P, 1990, J HEPATOL, V10, P105, DOI 10.1016/0168-8278(90)90080-B; Bomzon A, 1998, J PHARMACOL TOXICOL, V39, P75, DOI 10.1016/S1056-8719(98)00005-7; CARRIVE P, 1989, BRAIN RES, V493, P385, DOI 10.1016/0006-8993(89)91176-1; Coll M, 2008, J HEPATOL, V49, P43, DOI 10.1016/j.jhep.2008.03.015; Coll M, 2010, LIVER INT, V30, P593, DOI 10.1111/j.1478-3231.2009.02176.x; Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041; Coote JH, 1998, CLIN EXP PHARMACOL P, V25, P461, DOI 10.1111/j.1440-1681.1998.tb02235.x; DEAN C, 1986, BRAIN RES, V377, P271, DOI 10.1016/0006-8993(86)90868-1; DEAN C, 1992, J AUTONOM NERV SYST, V37, P1, DOI 10.1016/0165-1838(92)90139-8; DIBONA GF, 1991, AM J PHYSIOL, V260, pR298, DOI 10.1152/ajpregu.1991.260.2.R298; DiBona GF, 1996, AM J PHYSIOL-REG I, V271, pR295, DOI 10.1152/ajpregu.1996.271.1.R295; Dietrich P, 2013, J HEPATOL, V58, P254, DOI 10.1016/j.jhep.2012.09.027; Dillon JF, 1997, J HEPATOL, V26, P331, DOI 10.1016/S0168-8278(97)80049-9; Ezkurdia N, 2012, LIVER INT, V32, P1295, DOI 10.1111/j.1478-3231.2012.02762.x; Farah VMA, 1999, BRAZ J MED BIOL RES, V32, P361, DOI 10.1590/S0100-879X1999000300018; Fink GD, 2009, HYPERTENSION, V53, P307, DOI 10.1161/HYPERTENSIONAHA.108.119990; GAUDIN C, 1989, LIFE SCI, V45, P1333, DOI 10.1016/0024-3205(89)90019-2; GAUDIN C, 1992, GASTROEN CLIN BIOL, V16, P498; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; HAYES K, 1990, J PHYSIOL-LONDON, V428, P371, DOI 10.1113/jphysiol.1990.sp018217; HENDRICKSE MT, 1992, LANCET, V339, P1462, DOI 10.1016/0140-6736(92)92042-E; HENRIKSEN JH, 1987, GUT, V28, P1637, DOI 10.1136/gut.28.12.1637; HENRIKSEN JH, 1991, CLIN PHYSIOL, V11, P293, DOI 10.1111/j.1475-097X.1991.tb00658.x; HENRIKSEN JH, 1989, CIRC RES, V65, P388, DOI 10.1161/01.RES.65.2.388; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; Jensen KJ, 2013, COMPR PHYSIOL, V3, P655, DOI 10.1002/cphy.c120018; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; La Villa G, 2002, HEPATOLOGY, V35, P1441, DOI 10.1053/jhep.2002.33334; Laffi G, 1996, HEPATOLOGY, V24, P1063; Lanfranchi A, 1998, Blood Press Suppl, V3, P40; Larsen PD, 2001, AM J PHYSIOL-REG I, V280, pR1704, DOI 10.1152/ajpregu.2001.280.6.R1704; LEE SS, 1986, AM J PHYSIOL, V251, pG176, DOI 10.1152/ajpgi.1986.251.2.G176; LLACH J, 1988, GASTROENTEROLOGY, V94, P482, DOI 10.1016/0016-5085(88)90441-6; LOVICK TA, 1987, J PHYSIOL-LONDON, V389, P23, DOI 10.1113/jphysiol.1987.sp016644; LOVICK TA, 1985, BRAIN RES, V331, P353, DOI 10.1016/0006-8993(85)91562-8; MACGILCHRIST AJ, 1991, HEPATOLOGY, V13, P689, DOI 10.1016/0270-9139(91)92565-P; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; MCALLEN RM, 1995, CLIN EXP HYPERTENS, V17, P209, DOI 10.3109/10641969509087066; McAllen RM, 1997, CLIN EXP HYPERTENS, V19, P607, DOI 10.3109/10641969709083173; Milovanovic B, 2009, GEN PHYSIOL BIOPHYS, V28, P251; Moller S, 2008, GUT, V57, P268, DOI 10.1136/gut.2006.112177; MOLLER S, 1995, HEPATOLOGY, V22, P88, DOI 10.1016/0270-9139(95)90357-7; Moller S, 2007, AM J PHYSIOL-HEART C, V292, pH2966, DOI 10.1152/ajpheart.01227.2006; Morrison SF, 2001, AM J PHYSIOL-REG I, V281, pR683, DOI 10.1152/ajpregu.2001.281.3.R683; Mueller PJ, 2011, AM J PHYSIOL-REG I, V300, pR1230, DOI 10.1152/ajpregu.00713.2010; MURRAY BM, 1985, CIRC RES, V57, P424, DOI 10.1161/01.RES.57.3.424; NICHOLLS KM, 1985, CIRC RES, V56, P457, DOI 10.1161/01.RES.56.3.457; Oben JA, 2004, ANAT REC PART A, V280A, P874, DOI 10.1002/ar.a.20081; Osborn JW, 2011, CURR HYPERTENS REP, V13, P221, DOI 10.1007/s11906-011-0188-9; Peinado MA, 2002, AUTON NEUROSCI-BASIC, V99, P67, DOI 10.1016/S1566-0702(02)00135-2; Pereira RM, 2008, WORLD J GASTROENTERO, V14, P4505, DOI 10.3748/wjg.14.4505; Pozzi M, 2001, HEPATOLOGY, V34, P1113, DOI 10.1053/jhep.2001.29198; RODRIGUEZMARTINEZ M, 1995, AM J PHYSIOL-REG I, V268, pR117, DOI 10.1152/ajpregu.1995.268.1.R117; Scislo TJ, 2005, NEUROL RES, V27, P182, DOI 10.1179/016164105X21959; SHALDON C, 1961, LANCET, V1, P957; Stocker SD, 2004, AM J PHYSIOL-REG I, V286, pR719, DOI 10.1152/ajpregu.00494.2003; Struthers AD, 2004, HEART, V90, P1229, DOI 10.1136/hrt.2003.025312; Tank J, 2003, HYPERTENSION, V41, P1234, DOI 10.1161/01.HYP.0000070957.08219.C9; Thiesson HC, 2007, AM J PHYSIOL-REG I, V292, pR625, DOI 10.1152/ajpregu.00418.2005; Van de Casteele M, 2001, PHARMACOL THERAPEUT, V90, P35, DOI 10.1016/S0163-7258(01)00123-1; Veelken R, 2005, AM J PHYSIOL-RENAL, V288, pF1267, DOI 10.1152/ajprenal.00069.2003; Veglio F, 1998, LIVER, V18, P420; Wong F, 1998, GASTROENTEROLOGY, V115, P397, DOI 10.1016/S0016-5085(98)70206-9; Yang YY, 2002, J HEPATOL, V36, P600, DOI 10.1016/S0168-8278(02)00037-5; Yang Z, 2006, EXP PHYSIOL, V91, P791, DOI 10.1113/expphysiol.2006.034082; Zollner G, 2009, BRIT J PHARMACOL, V156, P7, DOI 10.1111/j.1476-5381.2008.00030.x	69	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152512	10.1371/journal.pone.0152512	http://dx.doi.org/10.1371/journal.pone.0152512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055088	Green Submitted, gold, Green Published			2022-12-26	WOS:000373608000023
J	Hegner, B; Schaub, T; Catar, R; Kusch, A; Wagner, P; Essin, K; Lange, C; Riemekasten, G; Dragun, D				Hegner, Bjoern; Schaub, Theres; Catar, Rusan; Kusch, Angelika; Wagner, Philine; Essin, Kirill; Lange, Claudia; Riemekasten, Gabriela; Dragun, Duska			Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis	PLOS ONE			English	Article							STEM-CELLS; ANGIOGENESIS; MECHANISMS; EXPRESSION; PERICYTES; COLLAGEN; MARKERS; TISSUE; PDGF	Introduction Obliterative vasculopathy and fibrosis are hallmarks of systemic sclerosis (SSc), a severe systemic autoimmune disease. Bone marrow-derived mesenchymal stromal cells (MSCs) from SSc patients may harbor disease-specific abnormalities. We hypothesized disturbed vascular smooth muscle cell (VSMC) differentiation with increased propensity towards myofibroblast differentiation in response to SSc-microenvironment defining growth factors and determined responsible mechanisms. Methods We studied responses of multipotent MSCs from SSc-patients (SSc-MSCs) and healthy controls (H-MSCs) to long-term exposure to CTGF, b-FGF, PDGF-BB or TGF-beta 1. Differentiation towards VSMC and myofibroblast lineages was analyzed on phenotypic, biochemical, and functional levels. Intracellular signaling studies included analysis of TGF-beta receptor regulation, SMAD, AKT, ERK1/2 and autocrine loops. Results VSMC differentiation towards both, contractile and synthetic VSMC phenotypes in response to CTGF and b-FGF was disturbed in SSc-MSCs. H-MSCs and SSc-MSCs responded equally to PDGF-BB with prototypic fibroblastic differentiation. TGF-beta 1 initiated myofibroblast differentiation in both cell types, yet with striking phenotypic and functional differences: In relation to H-MSC-derived myofibroblasts induced by TGF-beta 1, those obtained from SSc-MSCs expressed more contractile proteins, migrated towards TGF-beta 1, had low proliferative capacity, and secreted higher amounts of collagen paralleled by reduced MMP expression. Higher levels of TGF-beta receptor 1 and enhanced canonical and noncanonical TGF-beta signaling in SSc-MSCs accompanied aberrant differentiation response of SSc-MSCs in comparison to H-MSCs. Conclusions Deregulated VSMC differentiation with a shift towards myofibroblast differentiation expands the concept of disturbed endogenous regenerative capacity of MSCs from SSc patients. Disease related intrinsic hyperresponsiveness to TGF-beta 1 with increased collagen production may represent one responsible mechanism. Better understanding of repair barriers and harnessing beneficial differentiation processes in MSCs could widen options of autologous MSC application in SSc patients.	[Hegner, Bjoern; Schaub, Theres; Catar, Rusan; Kusch, Angelika; Wagner, Philine; Dragun, Duska] Charite, Clin Nephrol & Intens Care Med, Berlin, Germany; [Hegner, Bjoern; Schaub, Theres; Dragun, Duska] Berlin Brandenburg Sch Regenerat Therapies BSRT, Berlin, Germany; [Hegner, Bjoern; Schaub, Theres; Catar, Rusan; Kusch, Angelika; Dragun, Duska] Charite, CCR, Berlin, Germany; [Schaub, Theres] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Essin, Kirill] Fac Med Charite, Expt & Clin Res Ctr, Berlin, Germany; [Essin, Kirill] Max Delbruck Ctr Mol Med, Berlin, Germany; [Lange, Claudia] Univ Med Ctr Hamburg Eppendorf, Dept Cell & Gene Therapy, Clin Stem Cell Transplantat, Hamburg, Germany; [Riemekasten, Gabriela] Charite, Clin Rheumatol & Clin Immunol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hegner, B (corresponding author), Charite, Clin Nephrol & Intens Care Med, Berlin, Germany.; Hegner, B (corresponding author), Berlin Brandenburg Sch Regenerat Therapies BSRT, Berlin, Germany.; Hegner, B (corresponding author), Charite, CCR, Berlin, Germany.	bjoern.hegner@charite.de	Catar, Rusan Ali/I-3948-2019; Riemekasten, Gabriela/B-5019-2017	Catar, Rusan Ali/0000-0002-7000-7860; Hegner, Bjorn/0000-0003-3524-1165; Dragun, Duska/0000-0002-0310-9269	European Union; Berlin [HEALTH-F2-2009-241544]; German Scleroderma Foundation (Berlin)	European Union; Berlin; German Scleroderma Foundation (Berlin)	The European Union Framework Programme 7 as part of the SysKid project (HEALTH-F2-2009-241544; Berlin; B.H., T.S. and D.D.) and the German Scleroderma Foundation (Berlin; B.H., G.R. and D.D.) supported the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Caplan AI, 2011, J ORTHOP RES, V29, P1795, DOI 10.1002/jor.21462; Cipriani P, 2007, ARTHRITIS RHEUM-US, V56, P1994, DOI 10.1002/art.22698; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crisan M, 2011, ORGANOGENESIS, V7, P101, DOI 10.4161/org.7.2.16150; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; Del Papa N, 2006, ARTHRITIS RHEUM-US, V54, P2605, DOI 10.1002/art.22035; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eyden B, 2008, J CELL MOL MED, V12, P22, DOI 10.1111/j.1582-4934.2007.00213.x; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Guiducci S, 2007, AUTOIMMUN REV, V6, P520, DOI 10.1016/j.autrev.2006.12.006; Guiducci S, 2011, ANN RHEUM DIS, V70, P2011, DOI 10.1136/ard.2011.150607; Hegner B, 2005, J HYPERTENS, V23, P1191, DOI 10.1097/01.hjh.0000170382.31085.5d; Hegner B, 2009, ARTERIOSCL THROM VAS, V29, P232, DOI 10.1161/ATVBAHA.108.179457; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Jimenez SA, 2001, J CLIN INVEST, V108, P1395, DOI 10.1172/JCI200112347; Jinnin M, 2010, J DERMATOL, V37, P11, DOI 10.1111/j.1346-8138.2009.00738.x; KIRK TZ, 1995, J BIOL CHEM, V270, P3423, DOI 10.1074/jbc.270.7.3423; Lange C, 2007, J CELL PHYSIOL, V213, P18, DOI 10.1002/jcp.21081; Larghero J, 2008, ANN RHEUM DIS, V67, P443, DOI 10.1136/ard.2007.071233; Mendoza FA, 2016, ARTHRITIS RHEUMATOL, V68, P210, DOI 10.1002/art.39421; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pattanaik D, 2011, J INFLAMM RES, V4, P105, DOI 10.2147/JIR.S18145; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Rajkumar VS, 2005, ARTHRITIS RES THER, V7, pR1113, DOI 10.1186/ar1790; Trojanowska M, 2010, NAT REV RHEUMATOL, V6, P453, DOI 10.1038/nrrheum.2010.102; Vanneaux V, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001890; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Zeisberg EM, 2010, CIRC RES, V107, P1304, DOI 10.1161/CIRCRESAHA.110.231910	32	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153101	10.1371/journal.pone.0153101	http://dx.doi.org/10.1371/journal.pone.0153101			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054717	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000373608000077
J	Larson, LR; Jennings, V; Cloutier, SA				Larson, Lincoln R.; Jennings, Viniece; Cloutier, Scott A.			Public Parks and Wellbeing in Urban Areas of the United States	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; GREEN SPACE; ECOSYSTEM SERVICES; ENVIRONMENTAL-HEALTH; NATURE EXPERIENCE; LOCAL PARKS; LOS-ANGELES; NEIGHBORHOOD; COMMUNITY; HAPPINESS	Sustainable development efforts in urban areas often focus on understanding and managing factors that influence all aspects of health and wellbeing. Research has shown that public parks and green space provide a variety of physical, psychological, and social benefits to urban residents, but few studies have examined the influence of parks on comprehensive measures of subjective wellbeing at the city level. Using 2014 data from 44 U.S. cities, we evaluated the relationship between urban park quantity, quality, and accessibility and aggregate self-reported scores on the Gallup-Healthways Wellbeing Index (WBI), which considers five different domains of wellbeing (e.g., physical, community, social, financial, and purpose). In addition to park-related variables, our best-fitting OLS regression models selected using an information theory approach controlled for a variety of other typical geographic and socio-demographic correlates of wellbeing. Park quantity (measured as the percentage of city area covered by public parks) was among the strongest predictors of overall wellbeing, and the strength of this relationship appeared to be driven by parks' contributions to physical and community wellbeing. Park quality (measured as per capita spending on parks) and accessibility (measured as the overall percentage of a city's population within 1/2 mile of parks) were also positively associated with wellbeing, though these relationships were not significant. Results suggest that expansive park networks are linked to multiple aspects of health and wellbeing in cities and positively impact urban quality of life.	[Larson, Lincoln R.] Clemson Univ, Dept Pk Recreat & Tourism Management, Clemson, SC USA; [Jennings, Viniece] US Forest Serv, USDA, Southern Res Stn, Integrating Human & Nat Syst, Athens, GA USA; [Cloutier, Scott A.] Arizona State Univ, Julie Ann Wrigley Global Inst Sustainabil, Tempe, AZ USA	Clemson University; United States Department of Agriculture (USDA); United States Forest Service; Arizona State University; Arizona State University-Tempe	Larson, LR (corresponding author), Clemson Univ, Dept Pk Recreat & Tourism Management, Clemson, SC USA.	LRL@clemson.edu		Larson, Lincoln/0000-0001-9591-1269	U.S.D.A. joint venture Forest Service [14-JV-11330144-060]	U.S.D.A. joint venture Forest Service	U.S.D.A. joint venture Forest Service agreement #14-JV-11330144-060; U.S. Forest Service employee VJ was involved with the study design, data collection and analysis, and preparation of the manuscript. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the Forest Service or USDA.	Alcock I, 2014, ENVIRON SCI TECHNOL, V48, P1247, DOI 10.1021/es403688w; Anderson DR, 2001, J WILDLIFE MANAGE, V65, P373, DOI 10.2307/3803088; Arnberger A, 2012, URBAN FOR URBAN GREE, V11, P41, DOI 10.1016/j.ufug.2011.11.003; Asah ST, 2012, ENVIRON BEHAV, V44, P545, DOI 10.1177/0013916510397757; Bancroft C, 2015, SOC SCI MED, V138, P22, DOI 10.1016/j.socscimed.2015.05.034; Bartolini S, 2013, SOC INDIC RES, V110, P1033, DOI 10.1007/s11205-011-9971-x; Baur JWR, 2014, J PARK RECREAT ADM, V32, P19; Bedimo-Rung AL, 2005, AM J PREV MED, V28, P159, DOI 10.1016/j.amepre.2004.10.024; Bell SL, 2014, HEALTH PLACE, V30, P287, DOI 10.1016/j.healthplace.2014.10.005; Blanchflower DG, 2004, SCAND J ECON, V106, P393, DOI 10.1111/j.0347-0520.2004.00369.x; Boillot A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052708, 10.1371/journal.pone.0064417]; Bratman GN, 2015, P NATL ACAD SCI USA, V112, P8567, DOI 10.1073/pnas.1510459112; Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; Brereton F, 2008, ECOL ECON, V65, P386, DOI 10.1016/j.ecolecon.2007.07.008; Brown G, 2014, LANDSCAPE URBAN PLAN, V121, P34, DOI 10.1016/j.landurbplan.2013.09.006; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cattell V, 2008, HEALTH PLACE, V14, P544, DOI 10.1016/j.healthplace.2007.10.007; Centers for Disease Control and Prevention (CDC), 2012, NAT ENV PUBL HLTH TR; Chiesura A, 2004, LANDSCAPE URBAN PLAN, V68, P129, DOI 10.1016/j.landurbplan.2003.08.003; Cho SH, 2008, ECOL ECON, V66, P403, DOI 10.1016/j.ecolecon.2007.10.012; Cloutier Scott, 2014, Environment Development and Sustainability, V16, P633, DOI 10.1007/s10668-013-9499-0; Cloutier S, 2014, ECOL INDIC, V40, P147, DOI 10.1016/j.ecolind.2014.01.012; Cohen DA, 2007, AM J PUBLIC HEALTH, V97, P509, DOI 10.2105/AJPH.2005.072447; Comstock N, 2010, J ENVIRON PSYCHOL, V30, P435, DOI 10.1016/j.jenvp.2010.05.001; Dadvand P, 2015, P NATL ACAD SCI USA, V112, P7937, DOI 10.1073/pnas.1503402112; Dai D, 2011, LANDSCAPE URBAN PLAN, V102, P234, DOI 10.1016/j.landurbplan.2011.05.002; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Diener E., 2008, HAPPINESS UNLOCKING; Diener E., 2005, J HAPPINESS STUD, V7, P397, DOI DOI 10.1007/S10902-006-9000-Y; Diener E, 2008, APPL PSYCHOL-INT REV, V57, P37, DOI 10.1111/j.1464-0597.2008.00353.x; Duncan G, 2010, J HAPPINESS STUD, V11, P163, DOI 10.1007/s10902-008-9129-y; Easterlin RA, 2003, P NATL ACAD SCI USA, V100, P11176, DOI 10.1073/pnas.1633144100; Elmqvist T, 2015, CURR OPIN ENV SUST, V14, P101, DOI 10.1016/j.cosust.2015.05.001; Fan YL, 2011, HEALTH PLACE, V17, P1202, DOI 10.1016/j.healthplace.2011.08.008; Florida R, 2014, SINGLES NOW MAKE MOR; Florida R, 2013, REG STUD, V47, P613, DOI 10.1080/00343404.2011.589830; Galea S, 2005, ANNU REV PUBL HEALTH, V26, P341, DOI 10.1146/annurev.publhealth.26.021304.144708; Gallup Inc, 2009, GALL HEALTH WELL BEI; Godbey G, 2010, BENEFITS PHYS ACTIVI; Gomez-Baggethun E, 2013, ECOL ECON, V86, P235, DOI 10.1016/j.ecolecon.2012.08.019; Graham Carol, 2009, HAPPINESS WORLD PARA; Han B, 2014, PREV MED, V69, pS106, DOI 10.1016/j.ypmed.2014.08.033; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Hur M, 2010, J ENVIRON PSYCHOL, V30, P52, DOI 10.1016/j.jenvp.2009.05.005; Jennings V, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020196; Jennings V, 2015, INT J ENV RES PUB HE, V12, P1952, DOI 10.3390/ijerph120201952; Jennings VL, 2016, AM J PREV MED, V50, P642, DOI 10.1016/j.amepre.2015.11.001; Jesdale BM, 2013, ENVIRON HEALTH PERSP, V121, P811, DOI 10.1289/ehp.1205919; Joassart-Marcelli P, 2010, ENVIRON PLANN A, V42, P1174, DOI 10.1068/a42198; Kabisch N, 2015, ENVIRON IMPACT ASSES, V50, P25, DOI 10.1016/j.eiar.2014.08.007; Kabisch N, 2014, LANDSCAPE URBAN PLAN, V122, P129, DOI 10.1016/j.landurbplan.2013.11.016; Kaczynski AT, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0146-4; Kaczynski AT, 2009, LEISURE SCI, V31, P174, DOI 10.1080/01490400802686045; Kahneman D, 2004, AM ECON REV, V94, P429, DOI 10.1257/0002828041301713; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kazmierczak A, 2013, LANDSCAPE URBAN PLAN, V109, P31, DOI 10.1016/j.landurbplan.2012.05.007; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Kuo FE, 1998, AM J COMMUN PSYCHOL, V26, P823, DOI 10.1023/A:1022294028903; Kuo M, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fpsyg.2015.01093, 10.3389/fpg.2015.01093]; Lachowycz K, 2013, LANDSCAPE URBAN PLAN, V118, P62, DOI 10.1016/j.landurbplan.2012.10.012; Lawless NM, 2011, SOC INDIC RES, V101, P341, DOI 10.1007/s11205-010-9667-7; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P212, DOI 10.1093/pubmed/fdq068; Leung A., 2013, SEARCHING HAPPINESS, P247; Leyden KM, 2011, URBAN AFF REV, V47, P861, DOI 10.1177/1078087411403120; Litt JS, 2011, AM J PUBLIC HEALTH, V101, P1466, DOI 10.2105/AJPH.2010.300111; Low S, 2013, ASHGATE RESEARCH COMPANION TO PLANNING AND CULTURE, P295; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; McGranahan D, 2012, NATURAL AMENITIES SC; Miles R, 2012, J URBAN HEALTH, V89, P1, DOI 10.1007/s11524-011-9621-2; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; Nahlik A.M, 2013, EPA600R13ORD004914; Newman P., 2008, CITIES SUSTAINABLE E; O'Brien C, 2008, CAN PSYCHOL, V49, P289, DOI 10.1037/a0013235; Pennock M, 2011, ENVIRON IMPACT ASSES, V31, P61, DOI 10.1016/j.eiar.2010.04.003; Pfeiffer D, J AM PLANNI IN PRESS; Rath T., 2010, WELLBEING 5 ESSENTIA; Rehdanz K, 2005, ECOL ECON, V52, P111, DOI 10.1016/j.ecolecon.2004.06.015; Rentfrow PJ, 2009, J RES PERS, V43, P1073, DOI 10.1016/j.jrp.2009.08.005; Richardson EA, 2012, J EPIDEMIOL COMMUN H, V66, P160, DOI 10.1136/jech.2011.137240; Royall R., 1997, STAT EVIDENCE LIKELI; Russell R, 2013, ANNU REV ENV RESOUR, V38, P473, DOI 10.1146/annurev-environ-012312-110838; Sears LE, 2014, POPUL HEALTH MANAG, V17, P357, DOI 10.1089/pop.2013.0119; Seltenrich N, 2015, ENVIRON HEALTH PERSP, V123, pA254, DOI 10.1289/ehp.123-A254; Shafer CS, 2000, LANDSCAPE URBAN PLAN, V49, P163, DOI 10.1016/S0169-2046(00)00057-8; Shanahan DF, 2015, BIOSCIENCE, V65, P476, DOI 10.1093/biosci/biv032; Shanahan Danielle F, 2015, Am J Public Health, V105, P470, DOI 10.2105/AJPH.2014.302324; Smith LM, 2013, ECOL INDIC, V28, P79, DOI 10.1016/j.ecolind.2012.02.032; Stiglitz E., 2009, REPORT COMMISSION ME; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Talen E, 1999, URBAN STUD, V36, P1361, DOI 10.1080/0042098993033; Thin N, 2012, SOCIAL HAPPINESS RES; Thompson CW, 2012, LANDSCAPE URBAN PLAN, V105, P221, DOI 10.1016/j.landurbplan.2011.12.015; Trust for Public Land, 2014, 2014 CIT PARK FACTS; Tzoulas K, 2007, LANDSCAPE URBAN PLAN, V81, P167, DOI 10.1016/j.landurbplan.2007.02.001; U. S. Census Bureau, 2014, STAT COUNT QUICKFACT; van den Berg AE, 2010, SOC SCI MED, V70, P1203, DOI 10.1016/j.socscimed.2010.01.002; Voicu I, 2008, REAL ESTATE ECON, V36, P241, DOI 10.1111/j.1540-6229.2008.00213.x; Wakefield S, 2007, HEALTH PROMOT INT, V22, P92, DOI 10.1093/heapro/dam001; Wakefield SEL, 2001, HEALTH PLACE, V7, P163, DOI 10.1016/S1353-8292(01)00006-5; Weiss CC, 2011, J URBAN HEALTH, V88, P297, DOI 10.1007/s11524-011-9551-z; West ST, 2012, J PUBLIC HEALTH MAN, V18, P423, DOI 10.1097/PHH.0b013e318238ea27; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Wolch J, 2011, HEALTH PLACE, V17, P207, DOI 10.1016/j.healthplace.2010.10.001; Wolf KL, 2015, ENVIRON HEALTH PERSP, V123, P390, DOI 10.1289/ehp.1408216; World Health Organization, 2014, URB POP GROWTH; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548; Zelenski JM, 2015, J ENVIRON PSYCHOL, V42, P24, DOI 10.1016/j.jenvp.2015.01.005; Zidansek EH, 2009, ENERGY, V32, P891	109	149	154	19	234	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153211	10.1371/journal.pone.0153211	http://dx.doi.org/10.1371/journal.pone.0153211			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054887	Green Published, gold			2022-12-26	WOS:000373608000102
J	Sung, SY; Chang, JL; Chen, KC; Yeh, SD; Liu, YR; Su, YH; Hsueh, CY; Chung, LWK; Hsieh, CL				Sung, Shian-Ying; Chang, Junn-Liang; Chen, Kuan-Chou; Yeh, Shauh-Der; Liu, Yun-Ru; Su, Yen-Hao; Hsueh, Chia-Yen; Chung, Leland W. K.; Hsieh, Chia-Ling			Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; COTARGETING TUMOR; METASTASIS; EXPRESSION; SEQUENCE; REPLICATION; FIBROBLASTS; MODALITY; PROTEIN; MODEL	Stromal-epithelial interaction has been shown to promote local tumor growth and distant metastasis. We sought to create a promising gene therapy approach that co-targets cancer and its supporting stromal cells for combating castration-resistant prostate tumors. Herein, we demonstrated that human osteonectin is overexpressed in the prostate cancer epithelium and tumor stroma in comparison with their normal counterpart. We designed a novel human osteonectin promoter (hON-522E) containing positive transcriptional regulatory elements identified in both the promoter and exon 1 region of the human osteonectin gene. In vitro reporter assays revealed that the hON-522E promoter is highly active in androgen receptor negative and metastatic prostate cancer and bone stromal cells compared to androgen receptor-positive prostate cancer cells. Moreover, in vivo prostate-tumor-promoting activity of the hON-522E promoter was confirmed by intravenous administration of an adenoviral vector containing the hON-522E promoter-driven luciferase gene (Ad-522E-Luc) into mice bearing orthotopic human prostate tumor xenografts. In addition, an adenoviral vector with the hON-522E-promoter-driven herpes simplex virus thymidine kinase gene (Ad-522E-TK) was highly effective against the growth of androgen-independent human prostate cancer PC3M and bone stromal cell line in vitro and in pre-established PC3M tumors in vivo upon addition of the prodrug ganciclovir. Because of the heterogeneity of human prostate tumors, hON-522E promoter-mediated gene therapy has the potential for the treatment of hormone refractory and bone metastatic prostate cancers.	[Sung, Shian-Ying; Hsueh, Chia-Yen; Hsieh, Chia-Ling] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Chang, Junn-Liang] Taoyuan Armed Forces Gen Hosp, Dept Pathol & Lab Med, Taoyuan, Taiwan; [Chang, Junn-Liang] Ming Chuan Univ, Dept Biomed Engn, Taoyuan, Taiwan; [Chen, Kuan-Chou] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Chen, Kuan-Chou] Minist Hlth & Welf, TMU Shuang Ho Hosp, Div Urol, New Taipei, Taiwan; [Yeh, Shauh-Der] Taipei Med Univ Hosp, Div Urol, Taipei, Taiwan; [Liu, Yun-Ru] Taipei Med Univ, Off Human Res, Joint Biobank, Taipei, Taiwan; [Su, Yen-Hao] Minist Hlth & Welf, TMU Shuang Ho Hosp, Dept Surg, Div Gen Surg, New Taipei, Taiwan; [Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	Taipei Medical University; Ming Chuan University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Cedars Sinai Medical Center	Hsieh, CL (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan.	chsieh2@tmu.edu.tw			Ministry of Science and Technology [MOST 103-2320-B-038-040-MY3, 103-2320-B-038-039-MY3]; Ministry of Health and Welfare [MOHW105-TDU-B-212-134001]; Taipei Medical University, Taiwan [TMUTOP103003-6, TMUTOP103003-3, 104TMU-SHH-01-3]; NATIONAL CANCER INSTITUTE [P01CA098912] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Taipei Medical University, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grant MOST 103-2320-B-038-040-MY3 (CLH) and 103-2320-B-038-039-MY3 (SYS) from the Ministry of Science and Technology, MOHW105-TDU-B-212-134001 (SYS) from the Ministry of Health and Welfare, and TMUTOP103003-6 (CLH), TMUTOP103003-3 (SYS) and 104TMU-SHH-01-3 (YHS) from Taipei Medical University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Bisanz K, 2005, MOL THER, V12, P634, DOI 10.1016/j.ymthe.2005.05.012; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brower V, 2008, J NATL CANCER I, V100, P1276, DOI 10.1093/jnci/djn335; Chen NY, 2007, CANCER RES, V67, P6544, DOI 10.1158/0008-5472.CAN-07-1330; Cheville JC, 2002, CANCER-AM CANCER SOC, V95, P1028, DOI 10.1002/cncr.10788; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; Choudhury KR, 2010, J HISTOCHEM CYTOCHEM, V58, P95, DOI 10.1369/jhc.2009.953554; CHUNG LWK, 1991, CANCER METAST REV, V10, P263, DOI 10.1007/BF00050797; De S, 2003, J BIOL CHEM, V278, P39044, DOI 10.1074/jbc.M304494200; DeRosa CA, 2012, PROSTATE CANCER P D, V15, P150, DOI 10.1038/pcan.2011.61; GLEAVE ME, 1992, J UROLOGY, V147, P1151, DOI 10.1016/S0022-5347(17)37506-7; GRAHAM FL, 1995, MOL BIOTECHNOL, V3, P207, DOI 10.1007/BF02789331; Hafner M, 1995, MATRIX BIOL, V14, P733, DOI 10.1016/S0945-053X(05)80016-2; Hsiao WC, 2012, MOL PHARMACEUT, V9, P1396, DOI 10.1021/mp200649g; Hsieh CL, 2004, CANCER GENE THER, V11, P148, DOI 10.1038/sj.cgt.7700665; Hsieh CL, 2002, CANCER RES, V62, P3084; Hsieh CL, 2003, CANC GENE THER; Jacob K, 1999, CANCER RES, V59, P4453; Jin FS, 2005, CANCER GENE THER, V12, P257, DOI 10.1038/sj.cgt.7700790; Johnson NA, 2010, J GENE MED, V12, P892, DOI 10.1002/jgm.1516; Josson S, 2010, SEMIN CELL DEV BIOL, V21, P26, DOI 10.1016/j.semcdb.2009.11.016; Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134; Ko SC, 1996, CANCER RES, V56, P4614; Koeneman KS, 1999, PROSTATE, V39, P246; Lecrone V, 2000, CELL CALCIUM, V27, P35, DOI 10.1054/ceca.1999.0083; Matsubara S, 2001, CANCER RES, V61, P6012; NOMURA S, 1990, ANN NY ACAD SCI, V580, P252, DOI 10.1111/j.1749-6632.1990.tb17934.x; NOMURA S, 1989, J BIOL CHEM, V264, P12201; Omlin A, 2014, THER ADV UROL, V6, P3, DOI 10.1177/1756287213509677; Ribeiro N, 2014, J CELL BIOCHEM, V115, P17, DOI 10.1002/jcb.24649; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Seruga B, 2011, NAT REV CLIN ONCOL, V8, P12, DOI 10.1038/nrclinonc.2010.136; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Wong YC, 2000, INT REV CYTOL, V199, P65, DOI 10.1016/S0074-7696(00)99002-8; YOUNG MF, 1989, J BIOL CHEM, V264, P450	40	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153350	10.1371/journal.pone.0153350	http://dx.doi.org/10.1371/journal.pone.0153350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054343	Green Submitted, Green Published, gold			2022-12-26	WOS:000373608000123
J	Choo, HY; Li, Y; Cao, F; Sato, H				Choo, Hao Yu; Li, Yao; Cao, Feng; Sato, Hirotaka			Electrical Stimulation of Coleopteran Muscle for Initiating Flight	PLOS ONE			English	Article							INSECT; AERODYNAMICS	Some researchers have long been interested in reconstructing natural insects into steerable robots or vehicles. However, until recently, these so-called cyborg insects, biobots, or living machines existed only in science fiction. Owing to recent advances in nano/micro manufacturing, data processing, and anatomical and physiological biology, we can now stimulate living insects to induce user-desired motor actions and behaviors. To improve the practicality and applicability of airborne cyborg insects, a reliable and controllable flight initiation protocol is required. This study demonstrates an electrical stimulation protocol that initiates flight in a beetle (Mecynorrhina torquata, Coleoptera). A reliable stimulation protocol was determined by analyzing a pair of dorsal longitudinal muscles (DLMs), flight muscles that oscillate the wings. DLM stimulation has achieved with a high success rate (> 90%), rapid response time (< 1.0 s), and small variation (< 0.33 s; indicating little habituation). Notably, the stimulation of DLMs caused no crucial damage to the free flight ability. In contrast, stimulation of optic lobes, which was earlier demonstrated as a successful flight initiation protocol, destabilized the beetle in flight. Thus, DLM stimulation is a promising secure protocol for inducing flight in cyborg insects or biobots.	[Choo, Hao Yu; Li, Yao; Cao, Feng; Sato, Hirotaka] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Sato, H (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.	hirosato@ntu.edu.sg	Sato, Hirotaka/D-5203-2014	Sato, Hirotaka/0000-0003-4634-1639	Nanyang Assistant Professorship (NAP); Agency for Science, Technology and Research (A*STAR) Public Sector Research Funding (PSF); A*STAR-JST (The Japan Science and Technology Agency) joint grant	Nanyang Assistant Professorship (NAP); Agency for Science, Technology and Research (A*STAR) Public Sector Research Funding (PSF); A*STAR-JST (The Japan Science and Technology Agency) joint grant	This work has been supported by Nanyang Assistant Professorship (NAP), Agency for Science, Technology and Research (A*STAR) Public Sector Research Funding (PSF), and A*STAR-JST (The Japan Science and Technology Agency) joint grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozkurt A, 2014, BIOBOTIC INSECT SWAR; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P2304, DOI 10.1109/TBME.2009.2022551; Cao F, 2015, IEEE INT CONF ROBOT, P4576, DOI 10.1109/ICRA.2015.7139833; Cao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105389; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; Dickinson M, 2006, CURR BIOL, V16, pR309, DOI 10.1016/j.cub.2006.03.087; DOWDY AK, 1994, J ECON ENTOMOL, V87, P1714, DOI 10.1093/jee/87.6.1714; Dyhr JP, 2013, J EXP BIOL, V216, P1523, DOI 10.1242/jeb.077644; Ellington CP, 1999, J EXP BIOL, V202, P3439; Fedorenko D N, 2009, EVOLUTION BEETLE HIN; Ferdinandus, 2015, 2015 TRANSDUCERS - 2015 18TH INTERNATIONAL CONFERENCE ON SOLID-STATE SENSORS, ACTUATORS AND MICROSYSTEMS (TRANSDUCERS), P2228, DOI 10.1109/TRANSDUCERS.2015.7181404; Ferdinandus, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116655; Haas F, 2001, ZOOL-ANAL COMPLEX SY, V104, P123, DOI 10.1078/0944-2006-00017; Haas F, 2000, SOLID MECH APPL, V80, P137; Heide G, 1996, J EXP BIOL, V199, P1711; Hinterwirth AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052725; Latif T, 2012, ENG MED BIOL SOC EMB; Maharbiz MM, 2010, SCI AM, V303, P94, DOI 10.1038/scientificamerican1210-94; Roeder K.D., 1998, NERVE CELLS INSECT B; Sanchez CJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1363; Sato H, 2015, CURR BIOL, V25, P798, DOI 10.1016/j.cub.2015.01.051; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; Shoji K, 2012, BIOMED MICRODEVICES, V14, P1063, DOI 10.1007/s10544-012-9706-z; Truong TV, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036021; Truong TV, 2012, J BIONIC ENG, V9, P304, DOI 10.1016/S1672-6529(11)60127-3; Verderber A, 2014, JOVE-J VIS EXP, DOI 10.3791/50901; Visvanathan K, SOL STAT SENS ACT MI, P126; Vo Doan TT, 2015, MICR EL MECH SYST ME; WeiselEichler A, 1996, J COMP PHYSIOL A, V179, P103, DOI 10.1007/BF00193438; Wood RJ, 2008, IEEE T ROBOT, V24, P341, DOI 10.1109/TRO.2008.916997; Wootton R, 2000, NATURE, V403, P144, DOI 10.1038/35003074	31	16	16	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151808	10.1371/journal.pone.0151808	http://dx.doi.org/10.1371/journal.pone.0151808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050093	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500013
J	Jones, AG; Lonergan, M; Henley, WE; Pearson, ER; Hattersley, AT; Shields, BM				Jones, Angus G.; Lonergan, Mike; Henley, William E.; Pearson, Ewan R.; Hattersley, Andrew T.; Shields, Beverley M.			Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?	PLOS ONE			English	Article							REGRESSION; INSULIN; SULFONYLUREAS; METAANALYSIS; ASSOCIATION; ADJUSTMENT; EFFICACY; TARGET	Aims Baseline HbA1c is a major predictor of response to glucose lowering therapy and therefore a potential confounder in studies aiming to identify other predictors. However, baseline adjustment may introduce error if the association between baseline HbA1c and response is substantially due to measurement error and regression to the mean. We aimed to determine whether studies of predictors of response should adjust for baseline HbA1c. Methods We assessed the relationship between baseline HbA1c and glycaemic response in 257 participants treated with GLP-1R agonists and assessed whether it reflected measurement error and regression to the mean using duplicate 'pre-baseline' HbA1c measurements not included in the response variable. In this cohort and an additional 2659 participants treated with sulfonylureas we assessed the relationship between covariates associated with baseline HbA1c and treatment response with and without baseline adjustment, and with a bias correction using pre-baseline HbA1c to adjust for the effects of error in baseline HbA1c. Results Baseline HbA1c was a major predictor of response (R-2 = 0.19, beta = -0.44, p<0.001). The association between pre-baseline and response was similar suggesting the greater response at higher baseline HbA1cs is not mainly due to measurement error and subsequent regression to the mean. In unadjusted analysis in both cohorts, factors associated with baseline HbA1c were associated with response, however these associations were weak or absent after adjustment for baseline HbA1c. Bias correction did not substantially alter associations. Conclusions Adjustment for the baseline HbA1c measurement is a simple and effective way to reduce bias in studies of predictors of response to glucose lowering therapy.	[Jones, Angus G.; Hattersley, Andrew T.; Shields, Beverley M.] Univ Exeter, Sch Med, NIHR Exeter Clin Res Facil, Exeter, Devon, England; [Lonergan, Mike; Pearson, Ewan R.] Univ Dundee, Med Res Inst, Dundee, Scotland; [Henley, William E.] Univ Exeter, Sch Med, Inst Hlth Serv Res, Exeter, Devon, England	University of Exeter; University of Dundee; University of Exeter	Jones, AG (corresponding author), Univ Exeter, Sch Med, NIHR Exeter Clin Res Facil, Exeter, Devon, England.	angus.jones@exeter.ac.uk		Hattersley, Andrew/0000-0001-5620-473X; Jones, Angus/0000-0002-0883-7599; Pearson, Ewan/0000-0001-9237-8585	National Institute of Health Research (NIHR) (UK); NIHR Clinical Research Network; Wellcome trust; Diabetes UK; MRC/ABPI MASTERMIND project; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula; MRC [MR/N00633X/1, MR/K005707/1] Funding Source: UKRI; Medical Research Council [MR/N00633X/1, MR/K005707/1] Funding Source: researchfish; National Institute for Health Research [DRF-2010-03-72, NF-SI-0611-10219, CL-2014-23-001, CS-2015-15-018] Funding Source: researchfish	National Institute of Health Research (NIHR) (UK)(National Institute for Health Research (NIHR)); NIHR Clinical Research Network; Wellcome trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); MRC/ABPI MASTERMIND project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The Predicting Response to Incretin Based Agents (PRIBA) study was funded by the National Institute of Health Research (NIHR) (UK) and supported by the NIHR Clinical Research Network. The GoDARTS study was funded by the Wellcome trust and is supported by Diabetes UK. ATH, ERP, BMS, WEH and ML are funded for this analysis as part of the MRC/ABPI MASTERMIND project. AGJ is an NIHR Clinician Scientist. ATH is an NIHR Senior Investigator and a Wellcome Trust Senior Investigator. ERP is a Wellcome Trust New Investigator. ATH and BMS are core staff members of the NIHR Exeter Clinical Research Facility. WEH is partially supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula. The views given in this paper do not necessarily represent those of NIHR, the NHS or the Department of Health.	[Anonymous], 2013, DIABETOLOGIA S1, V56; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Bloomgarden ZT, 2006, DIABETES CARE, V29, P2137, DOI 10.2337/dc06-1120; Deenen MJ, 2011, ONCOLOGIST, V16, P811, DOI 10.1634/theoncologist.2010-0258; DeFronzo RA, 2010, DIABETIC MED, V27, P309, DOI 10.1111/j.1464-5491.2010.02941.x; Diamant M, 2010, LANCET, V375, P2234, DOI 10.1016/S0140-6736(10)60406-0; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Donnelly LA, 2006, DIABETIC MED, V23, P128, DOI 10.1111/j.1464-5491.2005.01755.x; Gale Edwin A M, 2007, Diabetes Care, V30, P2989, DOI 10.2337/dc07-0155; Giugliano D, 2011, INT J CLIN PRACT, V65, P602, DOI 10.1111/j.1742-1241.2010.02619.x; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; Harrison L, 2009, STAT MED, V28, P3260, DOI 10.1002/sim.3725; Hopewell JC, 2013, EUR HEART J, V34, P982, DOI 10.1093/eurheartj/ehs344; Jones AG, 2016, DIABETES CARE, V39, P250, DOI 10.2337/dc15-0258; Kraha A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00044; McArdle PF, 2009, HUM HERED, V67, P176, DOI 10.1159/000181156; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Senn S., 2007, STAT ISSUES DRUG DEV; Senn S, 2006, STAT MED, V25, P4334, DOI 10.1002/sim.2682; 't Hart LM, 2013, DIABETES, V62, P3275, DOI 10.2337/db13-0227; Thong KY, 2014, DIABETIC MED, V31, P403, DOI 10.1111/dme.12367; Trusheim MR, 2007, NAT REV DRUG DISCOV, V6, P287, DOI 10.1038/nrd2251; Yanez ND, 2002, ANN EPIDEMIOL, V12, P34, DOI 10.1016/S1047-2797(01)00280-0; Yanez ND, 1998, STAT MED, V17, P2597, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2597::AID-SIM940>3.0.CO;2-G	25	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152428	10.1371/journal.pone.0152428	http://dx.doi.org/10.1371/journal.pone.0152428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050911	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500040
J	Puthiyedth, N; Riveros, C; Berretta, R; Moscato, P				Puthiyedth, Nisha; Riveros, Carlos; Berretta, Regina; Moscato, Pablo			Identification of Differentially Expressed Genes through Integrated Study of Alzheimer's Disease Affected Brain Regions	PLOS ONE			English	Article							LONG NONCODING RNAS; UBIQUITIN-PROTEASOME SYSTEM; PENTOSE-PHOSPHATE PATHWAY; FIBROBLAST-GROWTH-FACTOR; ENTORHINAL CORTEX; TRANSMEMBRANE SEMAPHORIN; REDUCED EXPRESSION; LIPID-METABOLISM; GABRG2 MUTATION; NERVOUS-SYSTEM	Background Alzheimer's disease (AD) is the most common form of dementia in older adults that damages the brain and results in impaired memory, thinking and behaviour. The identification of differentially expressed genes and related pathways among affected brain regions can provide more information on the mechanisms of AD. In the past decade, several studies have reported many genes that are associated with AD. This wealth of information has become difficult to follow and interpret as most of the results are conflicting. In that case, it is worth doing an integrated study of multiple datasets that helps to increase the total number of samples and the statistical power in detecting biomarkers. In this study, we present an integrated analysis of five different brain region datasets and introduce new genes that warrant further investigation. Methods The aim of our study is to apply a novel combinatorial optimisation based meta-analysis approach to identify differentially expressed genes that are associated to AD across brain regions. In this study, microarray gene expression data from 161 samples (74 non-demented controls, 87 AD) from the Entorhinal Cortex (EC), Hippocampus (HIP), Middle temporal gyrus (MTG), Posterior cingulate cortex (PC), Superior frontal gyrus (SFG) and visual cortex (VCX) brain regions were integrated and analysed using our method. The results are then compared to two popular meta-analysis methods, RankProd and GeneMeta, and to what can be obtained by analysing the individual datasets. Results We find genes related with AD that are consistent with existing studies, and new candidate genes not previously related with AD. Our study confirms the up-regualtion of INFAR2 and PTMA along with the down regulation of GPHN, RAB2A, PSMD14 and FGF. Novel genes PSMB2, WNK1, RPL15, SEMA4C, RWDD2A and LARGE are found to be differentially expressed across all brain regions. Further investigation on these genes may provide new insights into the development of AD. In addition, we identified the presence of 23 non-coding features, including four miRNA precursors (miR-7, miR570, miR-1229 and miR-6821), dysregulated across the brain regions. Furthermore, we compared our results with two popular meta-analysis methods RankProd and GeneMeta to validate our findings and performed a sensitivity analysis by removing one dataset at a time to assess the robustness of our results. These new findings may provide new insights into the disease mechanisms and thus make a significant contribution in the near future towards understanding, prevention and cure of AD.	[Puthiyedth, Nisha; Berretta, Regina; Moscato, Pablo] Hunter Med Res Inst, Informat Based Med Program, New Lambton Hts, NSW, Australia; [Puthiyedth, Nisha; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Sch Elect Engn & Comp Sci, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Riveros, Carlos] Hunter Med Res Inst, Clin Res Design, Informat Technol & Stat Suport Unit, New Lambton Hts, NSW, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Moscato, P (corresponding author), Hunter Med Res Inst, Informat Based Med Program, New Lambton Hts, NSW, Australia.; Moscato, P (corresponding author), Univ Newcastle, Sch Elect Engn & Comp Sci, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	pablo.moscato@newcastle.edu.au		Berretta, Regina/0000-0002-4420-3446; Moscato, Pablo/0000-0003-2570-5966	Australian Research Council (ARC) Future Fellowship [FT120100060]; Australian Research Council Discovery Project [DP120102576]; Hunter Medical Research Institute Research Grant [HMRI 13-27]	Australian Research Council (ARC) Future Fellowship(Australian Research Council); Australian Research Council Discovery Project(Australian Research Council); Hunter Medical Research Institute Research Grant	PM is supported by Australian Research Council (ARC) Future Fellowship FT120100060 (http://arc.gov.au/). This project partially funded by Australian Research Council Discovery Project DP120102576 (http://arc.gov.au/) and Hunter Medical Research Institute Research Grant HMRI 13-27 (http://hmri.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, J ALZHEIMERS DIS, V14, P313; Antoniou D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00155; Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045535; Aubry S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120352; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beecham GW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004606; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Boisgueheneuc F., 2006, BRAIN, V129, p[12, 3315], DOI DOI 10.1093/BRAIN/AWL244; Bradbury R, 2007, TOPICS MED CHEM; Brekke EMF, 2012, J CEREBR BLOOD F MET, V32, P1788, DOI 10.1038/jcbfm.2012.85; Brewer AA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00074; Bridge H, 2008, BRAIN, V131, P1433, DOI 10.1093/brain/awn063; Brooks WM, 2007, BRAIN RES, V1127, P127, DOI 10.1016/j.brainres.2006.09.106; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Convit A, 2000, NEUROBIOL AGING, V21, P19, DOI 10.1016/S0197-4580(99)00107-4; Cotta C, 2004, LECT NOTES COMPUT SC, V3005, P21; de Paula MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017481; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Ding BQ, 2014, AM J ALZHEIMERS DIS, V29, P526, DOI 10.1177/1533317514523487; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; El Fiky A, 2005, J CELL PHYSIOL, V204, P567, DOI 10.1002/jcp.20305; Fatemi SH, 2009, CEREBELLUM, V8, P64, DOI 10.1007/s12311-008-0075-3; Faust M, 2015, HDB NEUROPSYCHOLOGY, V2; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Fernandez-Enright F, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.121; Fernandez-Medarde A, 2007, NEUROSCIENCE, V146, P272, DOI 10.1016/j.neuroscience.2007.01.022; Fiandaca MS, 2014, ALZHEIMERS DEMENT, V10, pS196, DOI 10.1016/j.jalz.2014.04.015; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Fragkouli A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00182; Fransen E, 2005, NEURAL NETWORKS, V18, P1141, DOI 10.1016/j.neunet.2005.08.004; Friston K.J., 2004, HUMAN BRAIN FUNCTION; Fu W, 2014, BIOGERONTOLOGY, V15, P579, DOI 10.1007/s10522-014-9525-0; Fujita R, 2009, CELL DEATH DIFFER, V16, P349, DOI 10.1038/cdd.2008.159; GOLDBERG AL, 1995, CHEM BIOL, V2, P503, DOI 10.1016/1074-5521(95)90182-5; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Greco D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001880; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; Gueli MC, 2013, NEUROL SCI, V34, P1575, DOI 10.1007/s10072-013-1289-9; Guerreiro RJ, 2012, NEUROBIOL AGING, V33, P437, DOI 10.1016/j.neurobiolaging.2010.03.025; Hales CM, 2013, J NEUROPATH EXP NEUR, V72, P1009, DOI 10.1097/01.jnen.0000435847.59828.db; Henderson ST, 2004, MED HYPOTHESES, V62, P689, DOI 10.1016/j.mehy.2003.11.028; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hossini AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1262-5; Hu J, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.60; Humpel C, 2011, TRENDS BIOTECHNOL, V29, P26, DOI 10.1016/j.tibtech.2010.09.007; INAGAKI S, 1995, FEBS LETT, V370, P269, DOI 10.1016/0014-5793(95)00850-9; Inagaki S, 2001, J BIOL CHEM, V276, P9174, DOI 10.1074/jbc.M009051200; Iwakiri M, 2005, ACTA NEUROPATHOL, V109, P467, DOI 10.1007/s00401-005-0985-9; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kang JH, 2012, ENDOCR REV, V33, P715, DOI 10.1210/er.2011-1049; Kang JQ, 2009, J NEUROSCI, V29, P2845, DOI 10.1523/JNEUROSCI.4772-08.2009; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kelley JM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-1; Khan UA, 2014, NAT NEUROSCI, V17, P304, DOI 10.1038/nn.3606; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim JM, 2006, DNA RES, V13, P275, DOI 10.1093/dnares/dsl016; Kleiber ML, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-6; Ko JA, 2005, FEBS LETT, V579, P2236, DOI 10.1016/j.febslet.2005.03.022; Kong W, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-5; Kowalski JR, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/892749; Krueger KR, 2009, EXP AGING RES, V35, P45, DOI 10.1080/03610730802545028; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee M, 2011, J BIOL CHEM, V286, P41230, DOI 10.1074/jbc.M111.270470; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Li MD, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0093-y; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Liang DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040498; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu F, 2002, FEBS LETT, V512, P101, DOI 10.1016/S0014-5793(02)02228-7; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Liu ZP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S11; Luo C, 2012, J CLIN NEUROSCI, V19, P920, DOI 10.1016/j.jocn.2011.11.001; Lusa L, GENEMETA METAANALYSI; Lyall DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080513; Maass A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6547; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Manning EN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097608; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Minces VH, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00016; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Mulligan R, 2003, CLIN MANAGEMENT EARL; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Newington Jordan T, 2013, J Neurodegener Dis, V2013, P234572, DOI 10.1155/2013/234572; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Orre M, 2013, BRAIN, V136, P1415, DOI 10.1093/brain/awt083; Palmer AM, 1999, J NEURAL TRANSM, V106, P317, DOI 10.1007/s007020050161; Paolinelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070233; Parra-Damas A, 2014, J NEUROSCI, V34, P5776, DOI 10.1523/JNEUROSCI.5288-13.2014; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Pecorelli Alessandra, 2013, Mediators Inflamm, V2013, P137629, DOI 10.1155/2013/137629; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Persengiev S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00032; Pich EM, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt276; Puthiyedth N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127702; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rafalski VA, 2013, NAT CELL BIOL, V15, P614, DOI 10.1038/ncb2735; Rai K, 2011, MOL CANCER THER, V10, P1720, DOI 10.1158/1535-7163.MCT-11-0220; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Ray M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-136; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Riederer BM, 2011, EXP BIOL MED, V236, P268, DOI 10.1258/ebm.2010.010327; Ristic G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00072; Saleh AZM, 2004, ONCOGENE, V23, P7076, DOI 10.1038/sj.onc.1207955; Sanchez D, 2015, EXP GERONTOL, V67, P19, DOI 10.1016/j.exger.2015.04.003; Saxena U, 2009, EXPERT OPIN THER TAR, V13, P331, DOI [10.1517/14728220902738720 , 10.1517/14728220902738720]; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Scheubert L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-266; Sekar S, 2015, NEUROBIOL AGING, V36, P583, DOI 10.1016/j.neurobiolaging.2014.09.027; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Seneff S, 2011, EUR J INTERN MED, V22, P134, DOI 10.1016/j.ejim.2010.12.017; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Spulber G, 2013, J INTERN MED, V273, P396, DOI 10.1111/joim.12028; Stallings JD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1058; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; STOPA EG, 1990, BIOCHEM BIOPH RES CO, V171, P690, DOI 10.1016/0006-291X(90)91201-3; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Szafranskil K, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00087; Tan MG, 2010, J NEUROSCI RES, V88, P1157, DOI 10.1002/jnr.22290; Taniguchi M, 2012, J ALZHEIMERS ASS, V8, P119, DOI [10.1016/j.jalz.2012.05.311, DOI 10.1016/J.JALZ.2012.05.311]; Tian MN, 2012, J NEUROSCI, V32, P5937, DOI 10.1523/JNEUROSCI.5332-11.2012; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Upadhya SC, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S12; Vasconcelos LD, 2014, CLINICS, V69, P28, DOI 10.6061/clinics/2014(01)05; Vlassenko AG, 2012, BBA-MOL BASIS DIS, V1822, P370, DOI 10.1016/j.bbadis.2011.11.005; Wang J, 2008, GENES BRAIN BEHAV, V7, P78, DOI 10.1111/j.1601-183X.2007.00328.x; Wang LJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S2-S15; Wilcock Donna M, 2012, Curr Gerontol Geriatr Res, V2012, P170276, DOI 10.1155/2012/170276; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu HT, 2009, J MOL NEUROSCI, V39, P27, DOI 10.1007/s12031-009-9177-8; Xiao F, 2011, NEUROSCI BULL, V27, P143, DOI 10.1007/s12264-011-1028-2; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Yamagata H, 2004, BIOCHEM BIOPH RES CO, V321, P320, DOI 10.1016/j.bbrc.2004.06.142; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Young KWH, 2005, J GERONTOL A-BIOL, V60, P1039, DOI 10.1093/gerona/60.8.1039; Zai CC, 2014, NEUROPSYCHOBIOLOGY, V69, P154, DOI 10.1159/000358839; Zai G, 2005, AM J MED GENET B, V134B, P25, DOI 10.1002/ajmg.30452; Zaits MN, 2014, MOL PSYCHIATR, V19, P848, DOI 10.1038/mp.2013.93; Zeitschel U, 2002, J NEUROCHEM, V83, P371, DOI 10.1046/j.1471-4159.2002.01127.x; Zhang P, 2012, GLYCOBIOLOGY, V22, P235, DOI 10.1093/glycob/cwr131; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	162	47	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152342	10.1371/journal.pone.0152342	http://dx.doi.org/10.1371/journal.pone.0152342			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050411	gold, Green Submitted, Green Published			2022-12-26	WOS:000373603500033
J	Sohani, ZN; Anand, SS; Robiou-du-Pont, S; Morrison, KM; McDonald, SD; Atkinson, SA; Teo, KK; Meyre, D				Sohani, Zahra N.; Anand, Sonia S.; Robiou-du-Pont, Sebastien; Morrison, Katherine M.; McDonald, Sarah D.; Atkinson, Stephanie A.; Teo, Koon K.; Meyre, David			Risk Alleles in/near ADCY5, ADRA2A, CDKAL1, CDKN2A/B, GRB10, and TCF7L2 Elevate Plasma Glucose Levels at Birth and in Early Childhood: Results from the FAMILY Study	PLOS ONE			English	Article							FASTING GLUCOSE; ASSOCIATION ANALYSIS; INSULIN-RESISTANCE; GLYCEMIC TRAITS; GENETIC-LOCI; PREVALENCE; CHILDREN; OBESITY; ADOLESCENTS; TOLERANCE	Background Metabolic abnormalities that lead to type 2 diabetes mellitus begin in early childhood. Objectives We investigate whether common genetic variants identified in adults have an effect on glucose in early life. Methods 610 newborns, 463 mothers, and 366 fathers were included in the present study. Plasma glucose and anthropometric characteristics were collected at birth, 3, and 5 years. After quality assessment, 37 SNPs, which have demonstrated an association with fasting plasma glucose at the genome-wide threshold in adults, were studied. Quantitative trait disequilibrium tests and mixed-effects regressions were conducted to estimate an effect of the SNPs on glucose. Results Risk alleles for 6 loci increased glucose levels from birth to 5 years of age (ADCY5, ADRA2A, CDKAL1, CDKN2A/B, GRB10, and TCF7L2, 4.85x10(-3) <= P <= 4.60x10(-2)). Together, these 6 SNPs increase glucose by 0.05 mmol/L for each risk allele in a genotype score (P = 6.33x10(-5)). None of the associations described in the present study have been reported previously in early childhood. Conclusion Our data support the notion that a subset of loci contributing to plasma glucose variation in adults has an effect at birth and in early life.	[Sohani, Zahra N.; Anand, Sonia S.; Robiou-du-Pont, Sebastien; McDonald, Sarah D.; Teo, Koon K.; Meyre, David] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Anand, Sonia S.; Morrison, Katherine M.; Teo, Koon K.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Morrison, Katherine M.; Atkinson, Stephanie A.] Hamilton Hlth Sci, Dept Pediat, Hamilton, ON, Canada; [Morrison, Katherine M.] McMaster Univ, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [Meyre, David] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Meyre, D (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.; Meyre, D (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	meyred@mcmaster.ca	Atkinson, Stephanie/AAS-4146-2021; Meyre, David/D-7315-2011; Morrison, Katherine/AAO-8046-2021	Atkinson, Stephanie/0000-0002-5680-7546; Meyre, David/0000-0003-4850-7444; Morrison, Katherine/0000-0002-1737-256X; Teo, Koon/0000-0002-3731-0956	Heart and Stroke Foundation of Canada [NA 7293]; Canadian Diabetes Association Doctoral Research Award; Ontario Graduate Scholarship; Canadian Institutes of Health Research New Investigator Salary Award; Population Health Research Institute	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Diabetes Association Doctoral Research Award; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research New Investigator Salary Award(Canadian Institutes of Health Research (CIHR)); Population Health Research Institute	This study was funded by the Heart and Stroke Foundation of Canada (grant #NA 7293 "Early genetic origins of cardiovascular risk factors"). ZNS was funded by the Canadian Diabetes Association Doctoral Research Award and the Ontario Graduate Scholarship. SSA holds the Heart and Stroke Foundation of Ontario, Michael G. DeGroote endowed Chair in Population Health and a Canada Research Chair in Ethnicity and Cardiovascular Disease. SRP was supported by the Heart and Stroke Foundation of Canada (grant #NA 7293 "Early genetic origins of cardiovascular risk factors"), DM holds a Canada Research Chair in Genetics of Obesity, and SDM was supported by a Canadian Institutes of Health Research New Investigator Salary Award. The authors also acknowledge the internal support from the Population Health Research Institute for making continuation of the study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1997, AM J HUM GENET, V60, P676; Barker A, 2011, DIABETES, V60, P1805, DOI 10.2337/db10-1575; Cauchi S, 2006, DIABETES, V55, P2903, DOI 10.2337/db06-0474; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; Drong AW, 2012, CLIN PHARMACOL THER, V92, P707, DOI 10.1038/clpt.2012.149; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Esmaillzadeh A, 2006, OBESITY, V14, P377, DOI 10.1038/oby.2006.50; Freathy RM, 2007, AM J HUM GENET, V80, P1150, DOI 10.1086/518517; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Hodson DJ, 2014, DIABETES, V63, P3009, DOI 10.2337/db13-1607; Horikoshi M, 2013, NAT GENET, V45, P76, DOI 10.1038/ng.2477; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Katoh S, 2005, J CLIN ENDOCR METAB, V90, P2642, DOI 10.1210/jc.2004-2471; Kelliny C, 2009, DIABETES, V58, P2939, DOI 10.2337/db09-0374; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marom R, 2010, ACTA PAEDIATR, V99, P1474, DOI 10.1111/j.1651-2227.2010.01865.x; Morrison KM, 2009, AM HEART J, V158, P533, DOI 10.1016/j.ahj.2009.07.005; Schousboe K, 2003, DIABETOLOGIA, V46, P1276, DOI 10.1007/s00125-003-1165-x; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; Whincup PH, 2005, DIABETIC MED, V22, P1275, DOI 10.1111/j.1464-5491.2005.01587.x; Wiegand S, 2004, EUR J ENDOCRINOL, V151, P199, DOI 10.1530/eje.0.1510199; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152107	10.1371/journal.pone.0152107	http://dx.doi.org/10.1371/journal.pone.0152107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049325	gold, Green Submitted, Green Published			2022-12-26	WOS:000373603500024
J	Zhang, XH; Zhong, SL; Xu, Y; Yu, DD; Ma, TF; Chen, L; Zhao, Y; Chen, X; Yang, SJ; Wu, YQ; Tang, JH; Zhao, JH				Zhang, Xiaohui; Zhong, Shanliang; Xu, Yong; Yu, Dandan; Ma, Tengfei; Chen, Lin; Zhao, Yang; Chen, Xiu; Yang, Sujin; Wu, Yueqin; Tang, Jinhai; Zhao, Jianhua			MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3 beta/beta-Catenin Signaling Pathway	PLOS ONE			English	Article							DRUG-RESISTANCE; DIFFERENTIATION; INHIBITION	Acquisition of resistance to docetaxel (Doc) is one of the most important problems in treatment of breast cancer patients, but the underlying mechanisms are still not fully understood. In present study, Doc-resistant MDA-MB-231 and MCF-7 breast cancer cell lines (MDA-MB-231/Doc and MCF-7/Doc) were successfully established in vitro by gradually increasing Doc concentration on the basis of parental MDA-MB-231 and MCF-7 cell lines (MDA-MB-231/S and MCF-7/S). The potential miRNAs relevant to the Doc resistance were screened by miRNA microarray. We selected 5 upregulated miRNAs (has-miR-3646, has-miR-3658, has-miR-4438, has-miR-1246, and has-miR-574-3p) from the results of microarray for RT-qPCR validation. The results showed that expression level of miR-3646 in MDA-MB-231/Doc cells was significantly higher than in MDA-MB-231/S cells. Compared to MCF-7/S cells, miR-3646 expression was up-regulated in MCF-7/Doc cells. Further studies revealed that transfection of miR-3646 mimics into MDA-MB-231/S or MCF-7/S cells remarkably increased their drug resistance, in contrast, transfection of miR-3646 inhibitors into MDA-MB-231/Doc or MCF-7/Doc cells resulted in significant reduction of the drug resistance. By the pathway enrichment analyses for miR-3646, we found that GSK-3 beta/beta-catenin signaling pathway was a significant pathway, in which GSK-3 beta was an essential member. RT-qPCR and Western blot results demonstrated that miR-3646 could regulate GSK-3 beta mRNA and protein expressions. Furthermore, a marked increase of both nuclear and cytoplasmic beta-catenin expressions (with phosphorylated-beta-catenin decrease) was observed in MDA-MB-231/Doc cells compared with MDA-MB-231/S cells, and their expression were positively related to miR-3646 and negatively correlated with GSK-3 beta. Taken together, our results suggest that miR-3646-mediated Doc resistance of breast cancer cells maybe, at least in part, through suppressing expression of GSK-3 beta and resultantly activating GSK-3 beta/beta-catenin signaling pathway.	[Zhang, Xiaohui; Zhong, Shanliang; Zhao, Yang; Wu, Yueqin; Zhao, Jianhua] Nanjing Med Univ, Jiangsu Canc Hosp, Ctr Clin Lab Sci, Nanjing 210009, Jiangsu, Peoples R China; [Xu, Yong] Nanjing First Hosp, Dept Oncol, Nanjing 210006, Jiangsu, Peoples R China; [Yu, Dandan; Chen, Lin; Chen, Xiu; Yang, Sujin; Tang, Jinhai] Jiangsu Canc Hosp, Dept Gen Surg, Nanjing 210009, Jiangsu, Peoples R China; [Ma, Tengfei] Wuxi Second Hosp, Dept Clin Lab, Wuxi 214002, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhao, JH (corresponding author), Nanjing Med Univ, Jiangsu Canc Hosp, Ctr Clin Lab Sci, Nanjing 210009, Jiangsu, Peoples R China.	jhzhao2838@sina.com	zhao, yang/GXF-4424-2022		National Natural Science Foundation of China [81272470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81272470), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Aamir, 2013, ISRN Oncol, V2013, P290568, DOI 10.1155/2013/290568; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Hassan S, 2015, ANN SURG ONCOL, V22, DOI 10.1245/s10434-014-4303-4; Hsieh CH, 2013, BIOSCI BIOTECH BIOCH, V77, P2397, DOI 10.1271/bbb.130503; Hu Q, 2014, TUMOR BIOL, V35, P6327, DOI 10.1007/s13277-014-1834-z; Kastl L, 2012, BREAST CANCER RES TR, V131, P445, DOI 10.1007/s10549-011-1424-3; Kesharwani RK, 2015, APPL BIOCHEM BIOTECH, V176, P1996, DOI 10.1007/s12010-015-1696-x; Kim JS, 2014, BIOCHEM BIOPH RES CO, V446, P894, DOI 10.1016/j.bbrc.2014.03.027; Korner C, 2013, J BIOL CHEM, V288, P8750, DOI 10.1074/jbc.M112.414128; Kutanzi KR, 2011, CLIN EPIGENETICS, V2, P171, DOI 10.1007/s13148-011-0040-8; Maia ARR, 2015, ANN ONCOL, V26, P2180, DOI 10.1093/annonc/mdv293; Maia AR, 2015, ANN ONCOLOGY OFFICIA; Nagano H, 2013, INT J ONCOL, V43, P1066, DOI 10.3892/ijo.2013.2037; Rogler A, 2013, INT J CLIN EXP PATHO, V6, P1984; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sokolosky M, 2014, CELL CYCLE, V13, P820, DOI 10.4161/cc.27728; Takahashi Ru, 2015, CANCERS, V7, P598, DOI 10.3390/cancers7020598; Takahashi R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02474; Tian W, 2013, CLIN TRANSL ONCOL, V15, P335, DOI 10.1007/s12094-012-0929-5; Tzeng HE, 2015, ONCOTARGET, V6, P11061, DOI 10.18632/oncotarget.3568; Wang PS, 2009, J SURG RES, V153, P210, DOI 10.1016/j.jss.2008.05.032; Wang SH, 2014, MOL MED REP, V9, P973, DOI 10.3892/mmr.2014.1889; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Ward J, 2014, P NATL ACAD SCI USA, V111, P12169, DOI 10.1073/pnas.1412608111; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Yi TF, 2014, P NATL ACAD SCI USA, V111, pE2182, DOI 10.1073/pnas.1404943111; Zhong SL, 2013, GENE, V531, P8, DOI 10.1016/j.gene.2013.08.062	27	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153194	10.1371/journal.pone.0153194	http://dx.doi.org/10.1371/journal.pone.0153194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045586	Green Submitted, Green Published, gold			2022-12-26	WOS:000373599600076
J	Guillevic, O; Ferratge, S; Pascaud, J; Driancourt, C; Boyer-Di-Ponio, J; Uzan, G				Guillevic, Oriane; Ferratge, Segolene; Pascaud, Juliette; Driancourt, Catherine; Boyer-Di-Ponio, Julie; Uzan, Georges			A Novel Molecular and Functional Stemness Signature Assessing Human Cord Blood-Derived Endothelial Progenitor Cell Immaturity	PLOS ONE			English	Article							PODOCALYXIN-LIKE PROTEIN; IN-VITRO; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; LINES; ANGIOGENESIS; MOBILIZATION; DNMT3A; OCT-4	Endothelial Colony Forming Cells (ECFCs), a distinct population of Endothelial Progenitor Cells (EPCs) progeny, display phenotypic and functional characteristics of endothelial cells while retaining features of stem/progenitor cells. Cord blood-derived ECFCs (CB-ECFCs) have a high clonogenic and proliferative potentials and they can acquire different endothelial phenotypes, this requiring some plasticity. These properties provide angiogenic and vascular repair capabilities to CB-ECFCs for ischemic cell therapies. However, the degree of immaturity retained by EPCs is still confused and poorly defined. Consequently, to better characterize CB-ECFC stemness, we quantified their clonogenic potential and demonstrated that they were reprogrammed into induced pluripotent stem cells (iPSCs) more efficiently and rapidly than adult endothelial cells. Moreover, we analyzed the transcriptional profile of a broad gene panel known to be related to stem cells. We showed that, unlike mature endothelial cells, CB-ECFCs expressed genes involved in the maintenance of embryonic stem cell properties such as DNMT3B, GDF3 or SOX2. Thus, these results provide further evidence and tools to appreciate EPC-derived cell stemness. Moreover this novel stem cell transcriptional signature of ECFCs could help better characterizing and ranging EPCs according to their immaturity profile.	[Guillevic, Oriane; Ferratge, Segolene; Pascaud, Juliette; Driancourt, Catherine; Boyer-Di-Ponio, Julie; Uzan, Georges] Hop Paul Brousse, INSERM, U972, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Uzan, G (corresponding author), Hop Paul Brousse, INSERM, U972, Villejuif, France.	georges.uzan@inserm.fr	Uzan, Georges/M-8199-2018	Uzan, Georges/0000-0002-0178-5386	French National Research Agency (ANR) grant MATRIXCELL [ANR-2010-TECS-010-02]	French National Research Agency (ANR) grant MATRIXCELL(French National Research Agency (ANR))	Support from the French National Research Agency (ANR) grant MATRIXCELL (ANR-2010-TECS-010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the financial support from the French National Research Agency (ANR) grant MATRIXCELL (ANR-2010-TECS-010-02). The authors wish to thank The Cord Blood Bank of St Louis Hospital directed by Pr. Jerome Larghero for providing cord blood samples and the human cell culture platform of the Myology Institute (Universite Pierre et Marie Curie, Paris 6) for providing adult fibroblasts. We acknowledge Denis Clay for cell sorting experiments, Julie Tosca for karyotype analysis, Janine Wechsler for teratomas histological analysis, Christophe Desterke for his help with primers design. Ibrahim Casal for mice experiments. We thank also Richard Proust for helpful readings of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318; Baal N, 2004, THROMB HAEMOSTASIS, V92, P767, DOI 10.1160/TH04-02-0079; Barclay GR, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt114; Barzelay A, 2010, THROMB HAEMOSTASIS, V103, P188, DOI 10.1160/TH09-07-0433; Bayat H, 2013, CELL J, V14, P298; BERENSON RJ, 1988, J CLIN INVEST, V81, P951, DOI 10.1172/JCI113409; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer-Di Ponio J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084179; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Challen GA, 2014, CELL STEM CELL, V15, P350, DOI 10.1016/j.stem.2014.06.018; CIVIN CI, 1984, J IMMUNOL, V133, P157; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Gehling UM, 2000, BLOOD, V95, P3106; Giorgetti A, 2010, NAT PROTOC, V5, P811, DOI 10.1038/nprot.2010.16; Goldman O, 2009, STEM CELLS, V27, P1750, DOI 10.1002/stem.100; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; Hara T, 1999, IMMUNITY, V11, P567, DOI 10.1016/S1074-7613(00)80132-6; Howe M, 2009, CELL PROLIFERAT, V42, P265, DOI 10.1111/j.1365-2184.2009.00593.x; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Kershaw DB, 1997, J BIOL CHEM, V272, P15708, DOI 10.1074/jbc.272.25.15708; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Masuda H, 2003, CARDIOVASC RES, V58, P390, DOI 10.1016/S0008-6363(02)00785-X; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; MCPHERRON AC, 1993, J BIOL CHEM, V268, P3444; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Thommes K, 1999, BIOCHEM J, V341, P211, DOI 10.1042/0264-6021:3410211; Thomson JA, 2000, TRENDS BIOTECHNOL, V18, P53, DOI 10.1016/S0167-7799(99)01410-9; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Vanneaux V, 2010, CELL TRANSPLANT, V19, P1143, DOI 10.3727/096368910X504487; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Yamanaka Shinya, 2006, Tanpakushitsu Kakusan Koso, V51, P2346; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zangrossi S, 2007, STEM CELLS, V25, P1675, DOI 10.1634/stemcells.2006-0611	52	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152993	10.1371/journal.pone.0152993	http://dx.doi.org/10.1371/journal.pone.0152993			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043207	Green Published, gold			2022-12-26	WOS:000373592100060
J	Zhu, YY; Lin, XS; Li, H; Li, YQ; Shi, XB; Zhao, F; Xu, XL; Li, CB; Zhou, GH				Zhu, Yingying; Lin, Xisha; Li, He; Li, Yingqiu; Shi, Xuebin; Zhao, Fan; Xu, Xinglian; Li, Chunbao; Zhou, Guanghong			Intake of Meat Proteins Substantially Increased the Relative Abundance of Genus Lactobacillus in Rat Feces	PLOS ONE			English	Article							COLORECTAL-CANCER RISK; GUT MICROBIOTA; DIETARY-PROTEIN; RED MEAT; HUMAN-NUTRITION; CONSUMPTION; HEALTH; IMPACT; INFLAMMATION; OBESITY	Diet has been shown to have a critical influence on gut bacteria and host health, and high levels of red meat in diet have been shown to increase colonic DNA damage and thus be harmful to gut health. However, previous studies focused more on the effects of meat than of meat proteins. In order to investigate whether intake of meat proteins affects the composition and metabolic activities of gut microbiota, feces were collected from growing rats that were fed with either meat proteins (from beef, pork or fish) or non-meat proteins (casein or soy) for 14 days. The resulting composition of gut microbiota was profiled by sequencing the V4-V5 region of the 16S ribosomal RNA genes and the short chain fatty acids (SCFAs) were analyzed using gas chromatography. The composition of gut microbiota and SCFA levels were significantly different between the five diet groups. At a recommended dose of 20% protein in the diet, meat protein-fed rats had a higher relative abundance of the beneficial genus Lactobacillus, but lower levels of SCFAs and SCFA-producing bacteria including Fusobacterium, Bacteroides and Prevotella, compared with the soy protein-fed group. Further work is needed on the regulatory pathways linking dietary protein intake to gut microbiota.	[Li, Chunbao; Zhou, Guanghong] MOE, Key Lab Meat Proc & Qual Control, Nanjing 210095, Jiangsu, Peoples R China; MOA, Key Lab Anim Prod Proc, Nanjing 210095, Jiangsu, Peoples R China; Jiang Synerget Innovat Ctr Meat Proc & Qual Contr, Nanjing 210095, Jiangsu, Peoples R China; Nanjing Agr Univ, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, CB; Zhou, GH (corresponding author), MOE, Key Lab Meat Proc & Qual Control, Nanjing 210095, Jiangsu, Peoples R China.	chunbao.li@njau.edu.cn; guanghong.zhou@hotmail.com			National Natural Science Foundation of China [31471600, 31530054]; Ministry of Education of China [20110097110024, NCET-11-0668]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	The work was supported by grant of 31471600 and 31530054 (National Natural Science Foundation of China; http://www.nsfc.gov.cn/), 20110097110024 and NCET-11-0668 (Ministry of Education of China; http://www.moe.edu.cn/). Authors GZ and CL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora T, 2012, BRIT J NUTR, V108, P1382, DOI 10.1017/S0007114511006957; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bastide NM, 2015, CANCER RES, V75, P870, DOI 10.1158/0008-5472.CAN-14-2554; Birt DF, 2013, ADV NUTR, V4, P587, DOI 10.3945/an.113.004325; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Corpet DE, 2011, MEAT SCI, V89, P310, DOI 10.1016/j.meatsci.2011.04.009; CORRING T, 1987, REPROD NUTR DEV, V27, P967, DOI 10.1051/rnd:19870801; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; Day L, 2013, TRENDS FOOD SCI TECH, V32, P25, DOI 10.1016/j.tifs.2013.05.005; Pereira PMDC, 2013, MEAT SCI, V93, P586, DOI 10.1016/j.meatsci.2012.09.018; Geypens B, 1997, GUT, V41, P70, DOI 10.1136/gut.41.1.70; Gilbert JA, 2011, NUTR METAB CARDIOVAS, V21, pB16, DOI 10.1016/j.numecd.2010.12.008; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; IJssennagger N, 2012, GUT, V61, P1041, DOI 10.1136/gutjnl-2011-300239; Marco ML, 2010, ISME J, V4, P1481, DOI 10.1038/ismej.2010.61; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mostafa S.E., 2009, APPL ENVIRON MICROB, V75, P5277; Pham NM, 2014, JPN J CLIN ONCOL, V44, P641, DOI 10.1093/jjco/hyu061; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Ollberding NJ, 2012, INT J CANCER, V131, pE1125, DOI 10.1002/ijc.27546; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Qi HW, 2011, AFR J BIOTECHNOL, V10, P3704; Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Rist VTS, 2013, ANIMAL, V7, P1067, DOI 10.1017/S1751731113000062; Rist VTS, 2014, ANAEROBE, V25, P72, DOI 10.1016/j.anaerobe.2013.10.003; Shen Q, 2010, ANAEROBE, V16, P572, DOI 10.1016/j.anaerobe.2010.09.007; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Toden S, 2014, CANCER BIOL THER, V5, P267; Toden S, 2007, CARCINOGENESIS, V28, P2355, DOI 10.1093/carcin/bgm216; Vlieg JETV, 2011, CURR OPIN BIOTECH, V22, P211, DOI 10.1016/j.copbio.2010.12.004; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zhu QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090849; Zhu YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep15220	42	28	30	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152678	10.1371/journal.pone.0152678	http://dx.doi.org/10.1371/journal.pone.0152678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27042829	Green Published, gold, Green Submitted			2022-12-26	WOS:000373592100024
J	Nakamura, Y; Morrow, DH; Modgil, A; Huyghe, D; Deeb, TZ; Lumb, MJ; Davies, PA; Moss, SJ				Nakamura, Yasuko; Morrow, Danielle H.; Modgil, Amit; Huyghe, Deborah; Deeb, Tarek Z.; Lumb, Michael J.; Davies, Paul A.; Moss, Stephen J.			Proteomic Characterization of Inhibitory Synapses Using a Novel pHluorin-tagged gamma-Aminobutyric Acid Receptor, Type A (GABA(A)), alpha 2 Subunit Knock-in Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DIRECT BINDING; BETA 2; SUBTYPES; GEPHYRIN; PHOSPHORYLATION; TRAFFICKING; DYNAMICS; BENZODIAZEPINES; SCHIZOPHRENIA	Theaccumulation of gamma-aminobutyric acid receptors(GABA(A)Rs) at the appropriate postsynaptic sites is critical for determining the efficacy of fast inhibitory neurotransmission. Although we know that the majority of synaptic GABA(A)R subtypes are assembled from alpha 1-3, beta, and gamma 2 subunits, our understanding of how neurons facilitate their targeting to and stabilization at inhibitory synapses is rudimentary. To address these issues, we have created knock-in mice in which the pH-sensitive green fluorescent protein (GFP) and the Myc epitope were introduced to the extracellular domain of the mature receptor alpha 2 subunit (pH alpha 2). Using immunoaffinity purification and mass spectroscopy, we identified a stable complex of 174 proteins that were associated with pH alpha 2, including other GABA(A)R subunits, and previously identified receptor-associated proteins such as gephyrin and collybistin. 149 of these proteins were novel GABA(A)R binding partners and included G-protein-coupled receptors and ion channel subunits, proteins that regulate trafficking and degradation, regulators of protein phosphorylation, GTPases, and a number of proteins that regulate their activity. Notably, members of the postsynaptic density family of proteins that are critical components of excitatory synapses were not associated with GABA(A)Rs. Crucially, we demonstrated for a subset of these novel proteins (including cullin1, ephexin, potassium channel tetramerization domain containing protein 12, mitofusin2, metabotropic glutamate receptor 5, p21-activated kinase 7, and Ras-related protein 5A) bind directly to the intracellular domains of GABA(A)Rs, validating our proteomic analysis. Thus, our experiments illustrate the complexity of the GABA(A)R proteome and enhance our understanding of the mechanisms neurons use to construct inhibitory synapses.	[Nakamura, Yasuko; Morrow, Danielle H.; Modgil, Amit; Huyghe, Deborah; Deeb, Tarek Z.; Davies, Paul A.; Moss, Stephen J.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Lumb, Michael J.; Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, Mortimer St, London WC1E 6BT, England	Tufts University; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.; Moss, SJ (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Mortimer St, London WC1E 6BT, England.	Stephen.Moss@Tufts.edu	Nakamura, Yasuko/O-5551-2016; Davies, Paul A/P-4595-2017	Nakamura, Yasuko/0000-0002-0660-4126; Davies, Paul A/0000-0002-3973-3143	National Institutes of Health from NINDS [NS051195, NS056359, NS081735, R21NS080064, NS087662]; National Institute of Mental Health [MH097446]; Department of Defense Grant [AR140209]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH106954, R01MH097446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056359, R01NS081986, R21NS080064, R01NS051195, R01NS087662] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Defense Grant(United States Department of Defense); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS051195, NS056359, NS081735, R21NS080064, and NS087662 from NINDS ( to S. J. M.), National Institute of Mental Health Grant MH097446 ( to P. A. D. and S. J. M.), and Department of Defense Grant AR140209 ( to P. A. D. and S. J. M.). S. J. M. serves as a consultant for AstraZeneca and SAGE Therapeutics relationships that are regulated by Tufts University and do not impact this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramian AM, 2010, J BIOL CHEM, V285, P41795, DOI 10.1074/jbc.M110.149229; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Benke D, 2004, J BIOL CHEM, V279, P43654, DOI 10.1074/jbc.M407154200; Besheer J, 2005, NEUROPSYCHOPHARMACOL, V30, P747, DOI 10.1038/sj.npp.1300616; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Charych EI, 2009, NEUROPHARMACOLOGY, V57, P481, DOI 10.1016/j.neuropharm.2009.07.027; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; del Rio JC, 2001, J NEUROCHEM, V79, P183; DUGGAN MJ, 1991, J BIOL CHEM, V266, P24778; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Heller EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039572; Hortnagl H, 2013, NEUROSCIENCE, V236, P345, DOI 10.1016/j.neuroscience.2013.01.008; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jacob TC, 2012, P NATL ACAD SCI USA, V109, P18595, DOI 10.1073/pnas.1204994109; Ju YH, 2009, J NEUROSCI RES, V87, P1737, DOI 10.1002/jnr.21991; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; McDonald BJ, 1997, NEUROPHARMACOLOGY, V36, P1377, DOI 10.1016/S0028-3908(97)00111-1; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Patel B, 2014, BRIT J PHARMACOL, V171, P985, DOI 10.1111/bph.12514; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; POLLARD S, 1995, J BIOL CHEM, V270, P21285, DOI 10.1074/jbc.270.36.21285; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Rudolph U, 2014, ANNU REV PHARMACOL, V54, P483, DOI 10.1146/annurev-pharmtox-011613-135947; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Shi Lei, 2010, Commun Integr Biol, V3, P622, DOI 10.4161/cib.3.6.13481; Shi L, 2010, NEURON, V65, P204, DOI 10.1016/j.neuron.2010.01.012; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Smith KR, 2014, CELL REP, V9, P298, DOI 10.1016/j.celrep.2014.08.061; Smith KR, 2012, J NEUROSCI, V32, P2485, DOI 10.1523/JNEUROSCI.1622-11.2011; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stuppia G, 2015, J NEUROL SCI, V356, P7, DOI 10.1016/j.jns.2015.05.033; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173	53	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12394	12407		10.1074/jbc.M116.724443	http://dx.doi.org/10.1074/jbc.M116.724443			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27044742	hybrid, Green Published			2022-12-26	WOS:000378092800037
J	Huang, K; Zhang, JJ; O'Neill, KL; Gurumurthy, CB; Quadros, RM; Tu, YP; Luo, X				Huang, Kai; Zhang, Jingjing; O'Neill, Katelyn L.; Gurumurthy, Channabasavaiah B.; Quadros, Rolen M.; Tu, Yaping; Luo, Xu			Cleavage by Caspase 8 and Mitochondrial Membrane Association Activate the BH3-only Protein Bid during TRAIL-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; BCL-2 FAMILY; PROMOTES APOPTOSIS; BAX; RECEPTORS; PATHWAYS; PERMEABILIZATION; MODULATION; AGONISTS	The BH3-only protein Bid is known as a critical mediator of the mitochondrial pathway of apoptosis following death receptor activation. However, since full-length Bid possesses potent apoptotic activity, the role of a caspase-mediated Bid cleavage is not established in vivo. In addition, due to the fact that multiple caspases cleave Bid at the same site in vitro, the identity of the Bid-cleaving caspase during death receptor signaling remains uncertain. Moreover, as Bid maintains its overall structure following its cleavage by caspase 8, it remains unclear how Bid is activated upon cleavage. Here, Bid-deficient (Bid KO) colon cancer cells were generated by gene editing, and were reconstituted with wild-type or mutants of Bid. While the loss of Bid blocked apoptosis following treatment by TNF-related apoptosis inducing ligand (TRAIL), this blockade was relieved by re-introduction of the wild-type Bid. In contrast, the caspase-resistant mutant Bid(D60E) and a BH3 defective mutant Bid(G94E) failed to restore TRAIL-induced apoptosis. By generating Bid/Bax/Bak-deficient (TKO) cells, we demonstrated that Bid is primarily cleaved by caspase 8, not by effector caspases, to give rise to truncated Bid (tBid) upon TRAIL treatment. Importantly, despite the presence of an intact BH3 domain, a tBid mutant lacking the mitochondrial targeting helices (alpha 6 and alpha 7) showed diminished apoptotic activity. Together, these results for the first time establish that cleavage by caspase 8 and the subsequent association with the outer mitochondrial membrane are two critical events that activate Bid during death receptor-mediated apoptosis.	[Huang, Kai; Zhang, Jingjing; O'Neill, Katelyn L.; Luo, Xu] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Gurumurthy, Channabasavaiah B.; Quadros, Rolen M.] Univ Nebraska Med Ctr, Munroe Meyer Inst Genet & Rehabil, Dept Dev Neurosci, Omaha, NE 68198 USA; [Gurumurthy, Channabasavaiah B.] Univ Nebraska Med Ctr, Mouse Genome Engn Core Facil, Vice Chancellor Res Off, Omaha, NE 68198 USA; [Tu, Yaping] Creighton Univ, Sch Med, Dept Pharmacol, Omaha, NE 68178 USA; [Zhang, Jingjing] Cent S Univ, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Creighton University; Central South University	Luo, X (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	xuluo@unmc.edu	Gurumurthy, Channabasavaiah B/H-8268-2016; Gurumurthy, Channabasavaiah B/E-7205-2011	Gurumurthy, Channabasavaiah B/0000-0002-8022-4033; 	Nebraska Center for Cellular Signaling; NIGMS, National Institutes of Health [P30 GM106397]; National Institutes of Health [1R21CA193271]; NATIONAL CANCER INSTITUTE [R21CA193271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	Nebraska Center for Cellular Signaling; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Nebraska Center for Cellular Signaling, which is funded by an Institutional Development Award (IDeA) from NIGMS, National Institutes of Health under Grant P30 GM106397, and by National Institutes of Health Grant 1R21CA193271 (to Y. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Gao ZH, 2005, J BIOL CHEM, V280, P38271, DOI 10.1074/jbc.M506488200; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; Luo X, 1996, MOL CELL BIOL, V16, P1367; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Stegh AH, 2002, J BIOL CHEM, V277, P4351, DOI 10.1074/jbc.M108947200; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang L, 2011, CELL DEATH DIFFER, V18, P864, DOI 10.1038/cdd.2010.152	47	71	74	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11843	11851		10.1074/jbc.M115.711051	http://dx.doi.org/10.1074/jbc.M115.711051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27053107	Green Published, hybrid			2022-12-26	WOS:000377264800033
J	Sparks, AE; Chen, C; Breslin, MB; Lan, MS				Sparks, Avis E.; Chen, Chiachen; Breslin, Mary B.; Lan, Michael S.			Functional Domains of Autoimmune Regulator (AIRE) Modulate INS-VNTR Transcription in Human Thymic Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; insulin; protein domain; transcription; type 1 diabetes; AIRE; VNTR; insulin autoimmunity; thymus	CANDIDIASIS-ECTODERMAL DYSTROPHY; CENTRAL TOLERANCE; INSULIN-TREATMENT; GENE-EXPRESSION; BINDING PROTEIN; HISTONE H3K4; PHD FINGER; MUTATIONS; AUTOANTIBODIES; INHERITANCE	INS-VNTR (insulin-variable number of tandem repeats) and AIRE (autoimmune regulator) have been associated with the modulation of insulin gene expression in thymus, which is essential to induce either insulin tolerance or the development of insulin autoimmunity and type 1 diabetes. We sought to analyze whether each functional domain of AIRE is critical for the activation of INS-VNTR in human thymic epithelial cells. Twelve missense or nonsense mutations in AIRE and two chimeric AIRE constructs were generated. A luciferase reporter assay and a pulldown assay using biotinylated INS-class I VNTR probe were performed to examine the transactivation and binding activities of WT, mutant, and chimeric AIREs on the INS-VNTR promoter. Confocal microscopy analysis was performed for WT or mutant AIRE cellular localization. We found that all of the AIRE mutations resulted in loss of transcriptional activation of INS-VNTR except mutant P252L. Using WT/mutant AIRE heterozygous forms to modulate the INS-VNTR target revealed five mutations (R257X, G228W, C311fsX376, L397fsX478, and R433fsX502) that functioned in a dominant negative fashion. The LXXLL-3 motif is identified for the first time to be essential for DNA binding to INS-VNTR, whereas the intact PHD1, PHD2, LXXLL-3, and LXXLL-4 motifs were important for successful transcriptional activation. AIRE nuclear localization in the human thymic epithelial cell line was disrupted by mutations in the homogenously staining region domain and the R257X mutation in the PHD1 domain. This study supports the notion that AIRE mutation could specifically affect human insulin gene expression in thymic epithelial cells through INS-VNTR and subsequently induce either insulin tolerance or autoimmunity.	[Sparks, Avis E.; Chen, Chiachen; Breslin, Mary B.; Lan, Michael S.] Childrens Hosp, Res Inst Children, 200 Henry Clay Ave, New Orleans, LA 70118 USA; [Lan, Michael S.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA; [Lan, Michael S.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA	Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Lan, MS (corresponding author), Childrens Hosp, Res Inst Children, 200 Henry Clay Ave, New Orleans, LA 70118 USA.	mlan@chnola-research.org	Lan, Michael/CAF-1839-2022		American Diabetes Association [ADA-1-13-BS-101]; Research Institute for Children, Children's Hospital, New Orleans, LA	American Diabetes Association(American Diabetes Association); Research Institute for Children, Children's Hospital, New Orleans, LA	This work was supported by American Diabetes Association Research Grant ADA-1-13-BS-101 (to M. S. L.) and in part by the Research Institute for Children, Children's Hospital, New Orleans, LA. Part of the data was presented as a poster in the 74th Scientific Sessions of the American Diabetes Association annual meeting, June 13-17, 2014 in San Francisco. The authors declare that they have no conflicts of interest with the contents of this article.	AHONEN P, 1985, CLIN GENET, V27, P535, DOI 10.1111/j.1399-0004.1985.tb02037.x; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Awata T, 2007, J CLIN ENDOCR METAB, V92, P1791, DOI 10.1210/jc.2006-2242; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; Cai CQ, 2011, DIABETES, V60, P336, DOI 10.2337/db10-0255; Cetani F, 2001, J CLIN ENDOCR METAB, V86, P4747, DOI 10.1210/jc.86.10.4747; Cihakova D, 2001, HUM MUTAT, V18, P225, DOI 10.1002/humu.1178; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Fan Y, 2009, EMBO J, V28, P2812, DOI 10.1038/emboj.2009.212; Ferguson BJ, 2008, J BIOL CHEM, V283, P1723, DOI 10.1074/jbc.M707211200; FERNANDEZ E, 1994, BLOOD, V83, P3245; Finnish-German A.C., 1997, NAT GENET, V17, P399, DOI DOI 10.1038/NG1297-399; Giraud M, 2007, NATURE, V448, P934, DOI 10.1038/nature06066; Halonen M, 2004, HUM MUTAT, V23, P245, DOI 10.1002/humu.20003; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heino M, 1999, HUM MUTAT, V13, P69, DOI 10.1002/(SICI)1098-1004(1999)13:1<69::AID-HUMU8>3.0.CO;2-6; Heino M, 2001, HUM MUTAT, V18, P205, DOI 10.1002/humu.1176; Ilmarinen T, 2005, HUM MUTAT, V26, P322, DOI 10.1002/humu.20224; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; KUGLIN B, 1988, DIABETES, V37, P130, DOI 10.2337/diabetes.37.1.130; Kumar PG, 2001, J BIOL CHEM, V276, P41357, DOI 10.1074/jbc.M104898200; Kyewski B, 2010, CELL, V140, P24, DOI 10.1016/j.cell.2009.12.036; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Meloni A, 2005, Hum Mutat, V25, P319, DOI 10.1002/humu.9309; Meloni A, 2008, MOL IMMUNOL, V45, P805, DOI 10.1016/j.molimm.2007.06.156; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Oftedal BE, 2015, IMMUNITY, V42, P1185, DOI 10.1016/j.immuni.2015.04.021; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Pitkanen J, 2001, J BIOL CHEM, V276, P19597, DOI 10.1074/jbc.M008322200; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Wang CY, 1998, HUM GENET, V103, P681, DOI 10.1007/s004390050891; Ward L, 1999, J CLIN ENDOCR METAB, V84, P844, DOI 10.1210/jc.84.3.844; Zumer K, 2012, MOL CELL BIOL, V32, P1354, DOI 10.1128/MCB.06359-11	40	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11313	11322		10.1074/jbc.M116.722488	http://dx.doi.org/10.1074/jbc.M116.722488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27048654	hybrid, Green Published			2022-12-26	WOS:000377042100030
J	Sun, J; Zhang, J; Lu, JL; Gao, J; Ren, XY; Teng, LH; Duan, HL; Lin, YS; Li, XY; Zhang, B; Liang, ZY				Sun, Jian; Zhang, Jing; Lu, Junliang; Gao, Jie; Ren, Xinyu; Teng, Lianghong; Duan, Huanli; Lin, Yansong; Li, Xiaoyi; Zhang, Bo; Liang, Zhiyong			BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients	PLOS ONE			English	Article							ASSOCIATION; CANCER; AGE	Background The BRAF V600E and telomerase reverse transcriptase (TERT) promoter mutations have been reported in papillary thyroid carcinoma (PTC). The aim of this retrospective cross-sectional study was to add further information regarding the prevalence of the BRAF V600E and TERT promoter mutations in Chinese PTC and their clinicopathological associations. Methods We detected the BRAF V600E mutation and TERT promoter mutations in 455 Chinese PTC patients and analyzed the association of these mutations with several clinicopathological features. Results The BRAF V600E mutation was detected in 343 (75.4%) of 455 cases and was significantly associated with older age (p<0.001) and conventional subtype (p = 0.003). TERT promoter mutations were detected in 19 (4.4%) of 434 PTCs and were associated with older age (p<0.001), larger tumor size (p = 0.024), and advanced TNM stage(p<0.001). Of the 19 patients that were positive for TERT promoter mutations, 18 (94.7%) also harbored the BRAF V600E mutation. Conclusion We determined the prevalence and clinicopathological associations of BRAF V600E and TERT promoter mutations in Chinese PTC patients. TERT promoter mutations but not the BRAF V600E mutation were associated with more advanced TNM stage upon diagnosis.	[Sun, Jian; Zhang, Jing; Lu, Junliang; Gao, Jie; Ren, Xinyu; Duan, Huanli; Liang, Zhiyong] Chinese Acad Med Sci, Dept Pathol, Beijing 100730, Peoples R China; [Sun, Jian; Zhang, Jing; Lu, Junliang; Gao, Jie; Ren, Xinyu; Duan, Huanli; Lin, Yansong; Li, Xiaoyi; Zhang, Bo; Liang, Zhiyong] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Teng, Lianghong] Capital Med Univ, Xuanwu Hosp, Dept Pathol, Beijing, Peoples R China; [Lin, Yansong] Chinese Acad Med Sci, Dept Nucl Med, Beijing 100730, Peoples R China; [Li, Xiaoyi] Chinese Acad Med Sci, Dept Surg, Beijing 100730, Peoples R China; [Zhang, Bo] Chinese Acad Med Sci, Dept Ultrasound, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Liang, ZY (corresponding author), Chinese Acad Med Sci, Dept Pathol, Beijing 100730, Peoples R China.; Liang, ZY (corresponding author), Peking Union Med Coll Hosp, Beijing, Peoples R China.	liangzhiyong1220@yahoo.com		Sun, Jian/0000-0003-4997-2604; LU, JUNLIANG/0000-0002-3118-2025	Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology	Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology	The present study was funded by Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology. The funder does not have a website. The funder had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Caronia LM, 2011, CLIN CANCER RES, V17, P7511, DOI 10.1158/1078-0432.CCR-11-1155; Dean D S, 2000, Cancer Control, V7, P229; Edge Stephen DRB, 2010, AJCC CANC STAGING MA, VXV; Ellison G, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-132; Fugazzola L, 2004, CLIN ENDOCRINOL, V61, P239, DOI 10.1111/j.1365-2265.2004.02089.x; Gandolfi G, 2015, EUR J ENDOCRINOL, V172, P403, DOI 10.1530/EJE-14-0837; George JR, 2015, J CLIN ENDOCRINOLOGY; Howell GM, 2011, ANN SURG ONCOL, V18, P3566, DOI 10.1245/s10434-011-1781-5; Huang TG, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-3; Hughes DT, 2011, THYROID, V21, P231, DOI 10.1089/thy.2010.0137; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Lakshmanan A, 2015, ONCOTARGET, V6, P31792, DOI 10.18632/oncotarget.5172; Lee JH, 2007, CANCER-AM CANCER SOC, V110, P38, DOI 10.1002/cncr.22754; Li C, 2012, J CLIN ENDOCR METAB, V97, P4559, DOI 10.1210/jc.2012-2104; Liu XL, 2014, J CLIN ENDOCR METAB, V99, pE1130, DOI 10.1210/jc.2013-4048; Liu XL, 2013, ENDOCR-RELAT CANCER, V20, P603, DOI 10.1530/ERC-13-0210; Liu XL, 2013, CELL CYCLE, V12, P1637, DOI 10.4161/cc.24662; Melo M, 2014, J CLIN ENDOCR METAB, V99, pE754, DOI 10.1210/jc.2013-3734; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Shi XG, 2015, J CLIN ENDOCR METAB, V100, pE632, DOI 10.1210/jc.2014-3606; Trovisco V, 2005, VIRCHOWS ARCH, V446, P589, DOI 10.1007/s00428-005-1236-0; Xing MZ, 2014, J CLIN ONCOL, V32, P2718, DOI 10.1200/JCO.2014.55.5094; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190	24	36	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153319	10.1371/journal.pone.0153319	http://dx.doi.org/10.1371/journal.pone.0153319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064992	gold, Green Submitted, Green Published			2022-12-26	WOS:000373891000045
J	Zhang, WJ; Le, TD; Liu, L; Zhou, ZH; Li, JY				Zhang, Weijia; Thuc Duy Le; Liu, Lin; Zhou, Zhi-Hua; Li, Jiuyong			Predicting miRNA Targets by Integrating Gene Regulatory Knowledge with Expression Profiles	PLOS ONE			English	Article							BAYESIAN NETWORKS; MICRORNA REGULATION; ALGORITHM	Motivation microRNAs (miRNAs) play crucial roles in post-transcriptional gene regulation of both plants and mammals, and dysfunctions of miRNAs are often associated with tumorigenesis and development through the effects on their target messenger RNAs (mRNAs). Identifying miRNA functions is critical for understanding cancer mechanisms and determining the efficacy of drugs. Computational methods analyzing high-throughput data offer great assistance in understanding the diverse and complex relationships between miRNAs and mRNAs. However, most of the existing methods do not fully utilise the available knowledge in biology to reduce the uncertainty in the modeling process. Therefore it is desirable to develop a method that can seamlessly integrate existing biological knowledge and high-throughput data into the process of discovering miRNA regulation mechanisms. Results In this article we present an integrative framework, CIDER (Causal miRNA target Discovery with Expression profile and Regulatory knowledge), to predict miRNA targets. CIDER is able to utilise a variety of gene regulation knowledge, including transcriptional and post-transcriptional knowledge, and to exploit gene expression data for the discovery of miRNA-mRNA regulatory relationships. The benefits of our framework is demonstrated by both simulation study and the analysis of the epithelial-to-mesenchymal transition (EMT) and the breast cancer (BRCA) datasets. Our results reveal that even a limited amount of either Transcription Factor (TF)-miRNA or miRNA-mRNA regulatory knowledge improves the performance of miRNA target prediction, and the combination of the two types of knowledge enhances the improvement further. Another useful property of the framework is that its performance increases monotonically with the increase of regulatory knowledge.	[Zhang, Weijia; Thuc Duy Le; Liu, Lin; Li, Jiuyong] Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia; [Zhou, Zhi-Hua] Nanjing Univ, Natl Key Labotorary, Nanjing 210008, Jiangsu, Peoples R China	University of South Australia; Nanjing University	Li, JY (corresponding author), Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia.	jiuyong.li@unisa.edu.au	Liu, Lin/ABD-1224-2020; Li, Jiuyong/AAY-2706-2020; Le, Thuc Duy D/G-8444-2019; Li, Jiuyong/A-8134-2008	Liu, Lin/0000-0003-2843-5738; Li, Jiuyong/0000-0002-9023-1878; Le, Thuc Duy D/0000-0002-9732-4313; Li, Jiuyong/0000-0002-9023-1878; Zhang, Weijia/0000-0001-8103-5325	Australian Research Council [DP130104090]	Australian Research Council(Australian Research Council)	This work is supported by Australian Research Council Discovery Project DP130104090 (in part). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An O, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau015; Chen CY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S41; Chickering DM, 2004, J MACH LEARN RES, V5, P1287; Chu TJ, 2015, BIOINFORMATICS, V31, P1780, DOI 10.1093/bioinformatics/btv038; Colombo D, 2014, J MACH LEARN RES, V15, P3741; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; De Bie T, 2007, BIOINFORMATICS, V23, pI125, DOI 10.1093/bioinformatics/btm187; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fisher R., 1971, DESIGN EXPT; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang GT, 2011, NUCLEIC ACIDS RES, V39, pW416, DOI 10.1093/nar/gkr276; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kalisch M, 2007, J MACH LEARN RES, V8, P613; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Le TD, 2014, BRIEF BIOINFORM, P1; Le TD, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-92; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku182; Liu B, 2014, BRIEF BIOINFORM, V15, P1, DOI 10.1093/bib/bbs075; Liu B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-408; Liu H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S12; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lu YM, 2011, BIOINFORMATICS, V27, P2406, DOI 10.1093/bioinformatics/btr410; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Moqadam FA, 2013, LEUKEMIA, V27, P16, DOI 10.1038/leu.2012.179; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Service RF, 2013, SCIENCE, V342, P186, DOI 10.1126/science.342.6155.186; Smyth G, 2005, LIMMA LINEAR MODELS; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Spirtes P., 2000, CAUSATION PREDICTION; Tai F, 2007, BIOINFORMATICS, V23, P1775, DOI 10.1093/bioinformatics/btm234; Le TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131627; Le TD, 2013, BIOINFORMATICS, V29, P765, DOI 10.1093/bioinformatics/btt048; Tian Z, 2009, BIOINFORMATICS, V25, P2831, DOI 10.1093/bioinformatics/btp467; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang ZX, 2014, CANCER INFORM, V13, P19, DOI 10.4137/CIN.S16348; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Zhao Z., 2008, P 14 ACM SIGKDD INT, P839	51	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152860	10.1371/journal.pone.0152860	http://dx.doi.org/10.1371/journal.pone.0152860			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064982	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000373891000020
J	Arellano, B; Hussain, R; Miller-Little, WA; Herndon, E; Lambracht-Washington, D; Eagar, TN; Lewis, R; Healey, D; Vernino, S; Greenberg, BM; Stuve, O				Arellano, Benjamine; Hussain, Rehana; Miller-Little, William A.; Herndon, Emily; Lambracht-Washington, Doris; Eagar, Todd N.; Lewis, Robert; Healey, Don; Vernino, Steven; Greenberg, Benjamin M.; Stueve, Olaf			A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; 4-SPECIFIC T-CELLS; HUMAN B-CELLS; NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; PROTEOLIPID PROTEIN; TRANSGENIC MICE; RITUXIMAB; ANTIGEN	Background Aquaporin 4 (AQP4) is considered a putative autoantigen in patients with Neuromyelitis optica (NMO), an autoinflammatory disorder of the central nervous system (CNS). HLA haplotype analyses of patients with NMO suggest a positive association with HLA-DRB1*03:01. We previously showed that the human (h) AQP4 peptide 281-300 is the dominant immunogenic determinant of hAQP4 in the context of HLA-DRB1*03:01. This immunogenic peptide stimulates a strong Th-1 and Th-17 immune response. AQP4(281-300)-specific encephalitogenic CD4(+) T cells should initiate CNS inflammation that results in a clinical phenotype in HLA-DRB1*03:01 transgenic mice. Methods Controlled study with humanized experimental animals. HLA-DRB1*03:01 transgenic mice were immunized with hAQP4281-300, or whole-length hAQP4 protein emulsified in complete Freund's adjuvant. Humoral immune responses to both antigens were assessed longitudinally. In vivo T cell frequencies were assessed by tetramer staining. Mice were followed clinically, and the anterior visual pathway was tested by pupillometry. CNS tissue was examined histologically post-mortem. Flow cytometry was utilized for MHC binding assays and to immunophenotype T cells, and T cell frequencies were determined by ELISpot assay. Results Immunization with hAQP4281-300 resulted in an in vivo expansion of antigen-specific CD4(+) T cells, and an immunoglobulin isotype switch. HLA-DRB1*03:01 TG mice actively immunized with hAQP4(281-300), or with whole-length hAQP4 protein were resistant to developing a neurological disease that resembles NMO. Experimental mice show no histological evidence of CNS inflammation, nor change in pupillary responses. Subsequent analysis reveals that a single amino acid substitution from aspartic acid in hAQP4 to glutamic acid in murine (m)AQP4 at position 290 prevents the recognition of hAQP4(281-300) by the murine T cell receptor (TCR). Conclusion Induction of a CNS inflammatory autoimmune disorder by active immunization of HLA-DRB1*03:01 TG mice with human hAQP4281-300 will be complex due to a single amino acid substitution. The pathogenic role of T cells in this disorder remains critical despite these observations.	[Arellano, Benjamine; Hussain, Rehana; Miller-Little, William A.; Lambracht-Washington, Doris; Lewis, Robert; Vernino, Steven; Greenberg, Benjamin M.; Stueve, Olaf] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Herndon, Emily] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Eagar, Todd N.] Methodist Hosp Phys Org, Dept Pathol & Genom Med, Histocompatibil & Transplant Immunol, Houston, TX USA; [Healey, Don] Opexa Therapeut, The Woodlands, TX USA; [Stueve, Olaf] VA North Texas Hlth Care Syst, Med Serv, Neurol Sect, Dallas, TX USA; [Stueve, Olaf] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Technical University of Munich	Stuve, O (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.; Stuve, O (corresponding author), VA North Texas Hlth Care Syst, Med Serv, Neurol Sect, Dallas, TX USA.; Stuve, O (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany.	olaf.stuve@utsouthwestern.edu	Vernino, Steven/AAD-5181-2020; Greenberg, Benjamin/AAT-1027-2020	Vernino, Steven/0000-0001-7799-8495; Greenberg, Benjamin/0000-0002-2091-8201; Lambracht-Washington, Doris/0000-0002-3161-9207	Opexa Therapeutics	Opexa Therapeutics	Opexa Therapeutics played no role in funding this project, in the study design, data collection and analysis, decision to publish, preparation of the manuscript, and neither did the company provide any financial support in the form of authors' salaries or research materials.	Arellano B, 2012, ARCH NEUROL-CHICAGO, V69, P1125, DOI 10.1001/archneurol.2012.1300; Brum DG, 2010, MULT SCLER J, V16, P21, DOI 10.1177/1352458509350741; BUSCH R, 1990, J IMMUNOL METHODS, V134, P1, DOI 10.1016/0022-1759(90)90107-7; COCKS BG, 1993, INT IMMUNOL, V5, P657, DOI 10.1093/intimm/5.6.657; Cravens PD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-73; Filippi M, 2002, J MAGN RESON IMAGING, V15, P499, DOI 10.1002/jmri.10097; GELUK A, 1994, EUR J IMMUNOL, V24, P3241, DOI 10.1002/eji.1830241251; Griffin1 Robert S., 2007, J NEUROSCI, V27, P8699; Hohler T, 1997, J HEPATOL, V27, P259, DOI 10.1016/S0168-8278(97)80169-9; Hussain RZ, 2009, AUTON NEUROSCI-BASIC, V151, P164, DOI 10.1016/j.autneu.2009.07.021; Jacob A, 2008, ARCH NEUROL-CHICAGO, V65, P1443, DOI 10.1001/archneur.65.11.noc80069; Jones MV, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0207-1; Kalluri SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016083; Kim SH, 2011, ARCH NEUROL-CHICAGO, V68, P1412, DOI 10.1001/archneurol.2011.154; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Mangalam AK, 2004, EUR J IMMUNOL, V34, P280, DOI 10.1002/eji.200324597; Matsuya N, 2011, INT IMMUNOL, V23, P565, DOI 10.1093/intimm/dxr056; Morrow MJ, 2012, J NEURO-OPHTHALMOL, V32, P154, DOI 10.1097/WNO.0b013e31825662f1; Nelson PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015050; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Pellkofer HL, 2011, NEUROLOGY, V76, P1310, DOI 10.1212/WNL.0b013e3182152881; Recommendation of the Immunization Practices Advisory Committee (ACIP), 1981, MMWR MORB MORTAL WKL, V30, P535; SHAPIRA SK, 1991, P NATL ACAD SCI USA, V88, P7528, DOI 10.1073/pnas.88.17.7528; SHENOY M, 1994, CLIN IMMUNOL IMMUNOP, V73, P338, DOI 10.1006/clin.1994.1207; Slavin AJ, 2001, J CLIN INVEST, V108, P1133, DOI 10.1172/JCI200113360; STRAUSS G, 1994, IMMUNOGENETICS, V40, P104; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Varrin-Doyer M, 2012, ANN NEUROL, V72, P53, DOI 10.1002/ana.23651; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; Zeka B, 2015, ACTA NEUROPATHOL, V130, P783, DOI 10.1007/s00401-015-1501-5; Zephir H, 2009, MULT SCLER J, V15, P571, DOI 10.1177/1352458508102085	34	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152720	10.1371/journal.pone.0152720	http://dx.doi.org/10.1371/journal.pone.0152720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054574	Green Published, Green Submitted, gold			2022-12-26	WOS:000373608000036
J	Romero, Y; Guzman, J; Moreno, S; Cocotl-Yanez, M; Vences-Guzman, MA; Castaneda, M; Espin, G; Segura, D				Romero, Yanet; Guzman, Josefina; Moreno, Soledad; Cocotl-Yanez, Miguel; Angel Vences-Guzman, Miguel; Castaneda, Miguel; Espin, Guadalupe; Segura, Daniel			The GacS/A-RsmA Signal Transduction Pathway Controls the Synthesis of Alkylresorcinol Lipids that Replace Membrane Phospholipids during Encystment of Azotobacter vinelandii SW136	PLOS ONE			English	Article							III POLYKETIDE SYNTHASES; CYST FORMATION; RNA; EXPRESSION; CSRA; BIOSYNTHESIS; PROTEIN; GENES; ROLES; GACA	Azotobacter vinelandii is a soil bacterium that undergoes a differentiation process that forms cysts resistant to desiccation. During encystment, a family of alkylresorcinols lipids (ARs) are synthesized and become part of the membrane and are also components of the outer layer covering the cyst, where they play a structural role. The synthesis of ARs in A. vinelandii has been shown to occur by the activity of enzymes encoded in the arsABCD operon. The expression of this operon is activated by ArpR, a LysR-type transcriptional regulator whose transcription occurs during encystment and is dependent on the alternative sigma factor RpoS. In this study, we show that the two component response regulator GacA, the small RNA RsmZ1 and the translational repressor protein RsmA, implicated in the control of the synthesis of other cysts components (i.e., alginate and poly-beta-hydroxybutyrate), are also controlling alkylresorcinol synthesis. This control affects the expression of arsABCD and is exerted through the regulation of arpR expression. We show that RsmA negatively regulates arpR expression by binding its mRNA, repressing its translation. GacA in turn, positively regulates arpR expression through the activation of transcription of RsmZ1, that binds RsmA, counteracting its repressor activity. This regulatory cascade is independent of RpoS. We also show evidence suggesting that GacA exerts an additional regulation on arsABCD expression through an ArpR independent route.	[Romero, Yanet; Guzman, Josefina; Moreno, Soledad; Cocotl-Yanez, Miguel; Angel Vences-Guzman, Miguel; Espin, Guadalupe; Segura, Daniel] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Microbiol Mol, Cuernavaca 62191, Morelos, Mexico; [Castaneda, Miguel] Benemerita Univ Autonoma Puebla, Inst Ciencias, Ctr Invest Ciencias Microbiol, Puebla, Mexico; [Romero, Yanet] Univ Autonoma Guerrero, Unidad Acad Ciencias Quim Biol, Lab Microbiol Mol & Biotecnol Ambiental, Chilpancingo, Guerrero, Mexico	Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla	Segura, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Microbiol Mol, Cuernavaca 62191, Morelos, Mexico.	daniel@ibt.unam.mx		Cocotl-Yanez, Miguel/0000-0002-4932-2284; ROMERO, YANET/0000-0002-8383-4128	Consejo Nacional de Ciencia y Tecnologia [127979]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [IT200415]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico	This work was supported by the Consejo Nacional de Ciencia y Tecnologia, Grant 127979 to DS and the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, Grant IT200415 to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; BARRY T, 1992, NUCLEIC ACIDS RES, V20, P4940, DOI 10.1093/nar/20.18.4940; BUSH JA, 1959, NATURE, V184, P381, DOI 10.1038/184381a0; Castaneda M, 2001, J BACTERIOL, V183, P6787, DOI 10.1128/JB.183.23.6787-6793.2001; Cocotl-Yanez M, 2011, MICROBIOL-SGM, V157, P1685, DOI 10.1099/mic.0.046268-0; Dubey AK, 2005, RNA, V11, P1579, DOI 10.1261/rna.2990205; Muriel-Millan LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117184; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Hernandez-Eligio A, 2012, MICROBIOL-SGM, V158, P1953, DOI 10.1099/mic.0.059329-0; KENNEDY C, 1986, MOL GEN GENET, V205, P318, DOI 10.1007/BF00430445; Liu MY, 1997, J BACTERIOL, V179, P4639, DOI 10.1128/jb.179.14.4639-4642.1997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manzo J, 2011, J MOL MICROB BIOTECH, V21, P147, DOI 10.1159/000334244; MartinezSalazar JM, 1996, J BACTERIOL, V178, P1800, DOI 10.1128/jb.178.7.1800-1808.1996; Miyanaga A, 2008, P NATL ACAD SCI USA, V105, P871, DOI 10.1073/pnas.0709819105; Peralta-Gil M, 2002, J BACTERIOL, V184, P5672, DOI 10.1128/JB.184.20.5672-5677.2002; REUSCH RN, 1983, NATURE, V302, P268, DOI 10.1038/302268a0; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Romero Y, 2013, J BACTERIOL, V195, P1834, DOI 10.1128/JB.01946-12; SADOFF HL, 1975, BACTERIOL REV, V39, P516, DOI 10.1128/MMBR.39.4.516-539.1975; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Segura D, 2009, J BACTERIOL, V191, P3142, DOI 10.1128/JB.01575-08; TLUSCIK F, 1981, ACTA SOC BOT POL, V50, P645, DOI 10.5586/asbp.1981.086; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x	26	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153266	10.1371/journal.pone.0153266	http://dx.doi.org/10.1371/journal.pone.0153266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055016	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000111
J	Boulos, PK; Dalwani, MS; Tanabe, J; Mikulich-Gilbertson, SK; Banich, MT; Crowley, TJ; Sakai, JT				Boulos, Peter K.; Dalwani, Manish S.; Tanabe, Jody; Mikulich-Gilbertson, Susan K.; Banich, Marie T.; Crowley, Thomas J.; Sakai, Joseph T.			Brain Cortical Thickness Differences in Adolescent Females with Substance Use Disorders	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; ANTERIOR CINGULATE CORTEX; ENVIRONMENTAL RISK-FACTORS; HUMAN ORBITOFRONTAL CORTEX; HUMAN CEREBRAL-CORTEX; GRAY-MATTER VOLUME; CONDUCT DISORDER; ALCOHOL DEPENDENCE; SEX-DIFFERENCES; SURFACE-AREA	Some youths develop multiple substance use disorders early in adolescence and have severe, persistent courses. Such youths often exhibit impulsivity, risk-taking, and problems of inhibition. However, relatively little is known about the possible brain bases of these behavioral traits, especially among females. Methods We recruited right-handed female patients, 14-19 years of age, from a university-based treatment program for youths with substance use disorders and community controls similar for age, race and zip code of residence. We obtained 43 T1-weighted structural brain images (22 patients and 21 controls) to examine group differences in cortical thickness across the entire brain as well as six a priori regions-of-interest: 1) medial orbitofrontal cortex; 2) rostral anterior cingulate cortex; and 3) middle frontal cortex, in each hemisphere. Age and IQ were entered as nuisance factors for all analyses. Results A priori region-of-interest analyses yielded no significant differences. However, whole-brain group comparisons revealed that the left pregenual rostral anterior cingulate cortex extending into the left medial orbitofrontal region (355.84 mm(2) in size), a subset of two of our a priori regions-of-interest, was significantly thinner in patients compared to controls (vertex-level threshold p = 0.005 and cluster-level family wise error corrected threshold p = 0.05). The whole-brain group differences did not survive after adjusting for depression or externalizing scores. Whole-brain within-patient analyses demonstrated a positive association between cortical thickness in the left precuneus and behavioral disinhibition scores (458.23 mm(2) in size). Conclusions Adolescent females with substance use disorders have significant differences in brain cortical thickness in regions engaged by the default mode network and that have been associated with problems of emotional dysregulation, inhibition, and behavioral control in past studies.	[Boulos, Peter K.] Univ Colorado Denver, Sch Med, Aurora, CO USA; [Dalwani, Manish S.; Mikulich-Gilbertson, Susan K.; Crowley, Thomas J.; Sakai, Joseph T.] Univ Colorado Denver, Div Subst Dependence, Dept Psychiat, Sch Med, Aurora, CO USA; [Tanabe, Jody] Univ Colorado Denver, Dept Radiol, Sch Med, Aurora, CO USA; [Banich, Marie T.] Univ Colorado, Inst Cognit Sci, Dept Psychol & Neurosci, Boulder, CO 80309 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Sakai, JT (corresponding author), Univ Colorado Denver, Div Subst Dependence, Dept Psychiat, Sch Med, Aurora, CO USA.	joseph.sakai@ucdenver.edu	Sakai, Joseph/AAH-5984-2020	BANICH, MARIE/0000-0001-9373-9194; Sakai, Joseph/0000-0003-1600-6100	NIDA [DA009842, DA011015, DA034604, DA031761]; Kane Family Foundation; Hewit Family Foundation;  [R25DA033219]; NATIONAL INSTITUTE ON DRUG ABUSE [P60DA011015, R37DA009842, R01DA031761, R01DA034604, R25DA033219, R01DA009842] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Kane Family Foundation; Hewit Family Foundation; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIDA grants DA009842, DA011015, DA034604 and the Kane Family Foundation. Drs. Sakai, Crowley, Tanabe, and Mikulich-Gilbertson and Mr. Dalwani are also supported by NIDA grant DA031761. Dr. Sakai's lab is also supported by the Hewit Family Foundation. Peter Boulos' effort on this project was supported under R25DA033219.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; [Anonymous], 1991, MANUAL CHILD BEHAV C; Becker JB, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-14; Benegal V, 2007, ADDICT BIOL, V12, P122, DOI 10.1111/j.1369-1600.2006.00043.x; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Blakemore SJ, 2006, DEVELOPMENTAL SCI, V9, P11, DOI 10.1111/j.1467-7687.2005.00456.x; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CARROLL BJ, 1981, BRIT J PSYCHIAT, V138, P194, DOI 10.1192/bjp.138.3.194; Chen CY, 2009, ADDICT BEHAV, V34, P319, DOI 10.1016/j.addbeh.2008.10.021; Chumachenko SY, 2015, AM J DRUG ALCOHOL AB, P1; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Crowley T. J., 1995, RES MONOGRAPH SERIES, V156, P49; Crowley TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132322; Crowley TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012835; Crowley TJ, 2006, J AM ACAD CHILD PSY, V45, P175, DOI 10.1097/01.chi.0000188893.60551.31; Crowley TJ, 2001, J AM ACAD CHILD PSY, V40, P265, DOI 10.1097/00004583-200103000-00005; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Dalwani M, 2011, DRUG ALCOHOL DEPEN, V118, P295, DOI 10.1016/j.drugalcdep.2011.04.006; Dalwani MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126368; De Brito SA, 2009, BRAIN, V132, P843, DOI 10.1093/brain/awp011; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dore V, 2013, JAMA NEUROL, V70, P903, DOI 10.1001/jamaneurol.2013.1062; Ducharme S, 2011, BIOL PSYCHIAT, V70, P283, DOI 10.1016/j.biopsych.2011.03.015; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; EYSENCK SBG, 1978, PSYCHOL REP, V43, P1247, DOI 10.2466/pr0.1978.43.3f.1247; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P86, DOI 10.1111/j.1469-7610.2012.02617.x; Fein G, 2013, PSYCHIAT RES-NEUROIM, V214, P1, DOI 10.1016/j.pscychresns.2013.06.001; Field M, 2007, ADDICTION, V102, P579, DOI 10.1111/j.1360-0443.2007.01743.x; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Forman SD, 2004, BIOL PSYCHIAT, V55, P531, DOI 10.1016/j.biopsych.2003.09.011; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friedman NP, 2011, DEV PSYCHOL, V47, P1410, DOI 10.1037/a0023750; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Greenfield SF, 2010, PSYCHIAT CLIN N AM, V33, P339, DOI 10.1016/j.psc.2010.01.004; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hardan AY, 2009, BIOL PSYCHIAT, V66, P320, DOI 10.1016/j.biopsych.2009.04.024; Hardee J, 2015, COLL PROBL DRUG DEP; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hicks BM, 2007, J ABNORM PSYCHOL, V116, P433, DOI 10.1037/0021-843X.116.3.433; Hicks BM, 2012, DRUG ALCOHOL DEPEN, V123, pS18, DOI 10.1016/j.drugalcdep.2011.12.017; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Hong SB, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-11; Hopfer C, 2013, J AM ACAD CHILD PSY, V52, P511, DOI 10.1016/j.jaac.2013.02.014; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Iacono WG, 1999, DEV PSYCHOPATHOL, V11, P869, DOI 10.1017/S0954579499002369; Johnston L. D., 2012, MONITORING FUTURE NA, VI; Jung P, 2003, NEUROIMAGE, V19, P913, DOI 10.1016/S1053-8119(03)00164-2; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Koester P, 2012, NEUROSCIENCE, V221, P182, DOI 10.1016/j.neuroscience.2012.06.049; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Krueger RF, 1999, J PERS, V67, P39, DOI 10.1111/1467-6494.00047; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921; Krueger RF, 2007, J ABNORM PSYCHOL, V116, P645, DOI 10.1037/0021-843X.116.4.645; Kuhn S, 2010, BIOL PSYCHIAT, V68, P1061, DOI 10.1016/j.biopsych.2010.08.004; London ED, 2000, CEREB CORTEX, V10, P334, DOI 10.1093/cercor/10.3.334; Lopez-Larson MP, 2011, BEHAV BRAIN RES, V220, P164, DOI 10.1016/j.bbr.2011.02.001; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Matochik JA, 2003, NEUROIMAGE, V19, P1095, DOI 10.1016/S1053-8119(03)00244-1; McGue M, 2005, AM J PSYCHIAT, V162, P1118, DOI 10.1176/appi.ajp.162.6.1118; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Mutlu AK, 2013, NEUROIMAGE, V82, P200, DOI 10.1016/j.neuroimage.2013.05.076; Pajer Kathleen, 2008, Child Adolesc Psychiatry Ment Health, V2, P28, DOI 10.1186/1753-2000-2-28; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Pardoe HR, 2013, HUM BRAIN MAPP, V34, P3000, DOI 10.1002/hbm.22120; Parsons CE, 2013, SOC NEUROSCI-UK, V8, P525, DOI 10.1080/17470919.2013.842610; Pope AW, 1999, DEV PSYCHOL, V35, P335, DOI 10.1037/0012-1649.35.2.335; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rakic P, 2007, BRAIN RES REV, V55, P204, DOI 10.1016/j.brainresrev.2007.02.010; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roberts GMP, 2010, NEUROIMAGE, V52, P429, DOI 10.1016/j.neuroimage.2010.04.192; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194; Schilling C, 2012, NEUROIMAGE, V59, P824, DOI 10.1016/j.neuroimage.2011.07.058; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Silberg J, 2003, J CHILD PSYCHOL PSYC, V44, P664, DOI 10.1111/1469-7610.00153; Soros P, 1999, NEUROSCI LETT, V271, P89, DOI 10.1016/S0304-3940(99)00528-5; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Squeglia LM, 2009, CLIN EEG NEUROSCI, V40, P31, DOI 10.1177/155005940904000110; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Substance Abuse and Mental Health Services Administration, 2013, RES 2012 NAT SURV DR; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2013, DAWN REP HIGHL 2011; Tanabe J, 2013, AM J NEURORADIOL, V34, P1150, DOI 10.3174/ajnr.A3347; Tapert SF, 2002, J INT NEUROPSYCH SOC, V8, P873, DOI 10.1017/S1355617702870011; Thompson LL, 2012, DRUG ALCOHOL DEPEN, V123, P84, DOI 10.1016/j.drugalcdep.2011.10.017; Thompson LL, 2006, ASSESSMENT, V13, P3, DOI 10.1177/1073191105282247; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; Thurstone C, 2013, AM J ADDICTION, V22, P558, DOI 10.1111/j.1521-0391.2013.12064.x; Tyrfingsson T, 2010, ANN NY ACAD SCI, V1187, P208, DOI 10.1111/j.1749-6632.2009.05151.x; US Department of Justice, 2011, EC IMP ILL DRUG US A; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; Verstraete E, 2012, J NEUROL NEUROSUR PS, V83, P383, DOI 10.1136/jnnp-2011-300909; Volkow ND, 2014, NEUROPHARMACOLOGY, V76, P235, DOI 10.1016/j.neuropharm.2013.05.007; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Wierenga LM, 2014, NEUROIMAGE, V87, P120, DOI 10.1016/j.neuroimage.2013.11.010; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; YOUNG SE, 1995, DRUG ALCOHOL DEPEN, V37, P149, DOI 10.1016/0376-8716(94)01069-W; Young SE, 2000, AM J MED GENET, V96, P684, DOI 10.1002/1096-8628(20001009)96:5<684::AID-AJMG16>3.3.CO;2-7; Yuan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053055; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	118	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152983	10.1371/journal.pone.0152983	http://dx.doi.org/10.1371/journal.pone.0152983			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049765	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500078
J	Houben, AJ; D'Onofrio, R; Kokelj, SV; Blais, JM				Houben, Adam James; D'Onofrio, Rebecca; Kokelj, Steven V.; Blais, Jules M.			Factors Affecting Elevated Arsenic and Methyl Mercury Concentrations in Small Shield Lakes Surrounding Gold Mines near the Yellowknife, NT, (Canada) Region	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; NORTHWEST-TERRITORIES; GIANT MINE; WATER; ENVIRONMENT; SEDIMENTS; NWT; BIOACCUMULATION; EXTRACTION; SPECIATION	Gold mines in the Yellowknife, NT, region-in particular, the Giant Mine-operated from 1949-99, releasing 237,000 tonnes of waste arsenic trioxide (As2O3) dust, among other compounds, from gold ore extraction and roasting processes. For the first time, we show the geospatial distribution of roaster-derived emissions of several chemical species beyond the mine property on otherwise undisturbed taiga shield lakes within a 25 km radius of the mine, 11 years after its closing. Additionally, we demonstrate that underlying bedrock is not a significant source for the elevated concentrations in overlying surface waters. Aquatic arsenic (As) concentrations are well above guidelines for drinking water (10 mu g/L) and protection for aquatic life (5 mu g/L), ranging up to 136 mu g/L in lakes within 4 km from the mine, to 2.0 mu g/L in lakes 24 km away. High conversion ratios of methyl mercury were shown in lakes near the roaster stack as well, with MeHg concentrations reaching 44% of total mercury. The risk of elevated exposures by these metals is significant, as many lakes used for recreation and fishing near the City of Yellowknife are within this radius of elevated As and methyl Hg concentrations.	[Houben, Adam James; D'Onofrio, Rebecca; Blais, Jules M.] Univ Ottawa, Dept Biol, Program Chem & Environm Toxicol, Ottawa, ON K1N 6N5, Canada; [Kokelj, Steven V.] Govt Northwest Terr, NWT Geosci Off, Yellowknife, NT X1A 2R3, Canada	University of Ottawa	Houben, AJ (corresponding author), Univ Ottawa, Dept Biol, Program Chem & Environm Toxicol, Ottawa, ON K1N 6N5, Canada.	ahouben@uottawa.ca	Blais, Jules/AAV-2321-2020	Blais, Jules/0000-0002-7188-3598; Houben, Adam/0000-0002-0336-7583	Natural Sciences and Engineering Research Council, Canada, Northern Research Internship [396140-2010]; Natural Sciences and Engineering Research Council, Canada, Strategic Grant [90421529]; Cumulative Impact Monitoring Program through Environment and Natural Resources, Government of Northwest Territories, Canada	Natural Sciences and Engineering Research Council, Canada, Northern Research Internship; Natural Sciences and Engineering Research Council, Canada, Strategic Grant; Cumulative Impact Monitoring Program through Environment and Natural Resources, Government of Northwest Territories, Canada	This work was supported by the Natural Sciences and Engineering Research Council, Canada, Northern Research Internship, Application Number: 396140-2010 received by AH; Natural Sciences and Engineering Research Council, Canada, Strategic Grant, Reference Number: 90421529 received by JB; Cumulative Impact Monitoring Program through Environment and Natural Resources, Government of Northwest Territories, Canada received by SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade CF, 2010, APPL GEOCHEM, V25, P199, DOI 10.1016/j.apgeochem.2009.11.005; Avramescu ML, 2011, SCI TOTAL ENVIRON, V409, P968, DOI 10.1016/j.scitotenv.2010.11.016; Barkay T, 1997, APPL ENVIRON MICROB, V63, P4267, DOI 10.1128/AEM.63.11.4267-4271.1997; Bromstad M, 2011, METABOLISM ARSENITE, V5, P25; Cai Y, 1996, ANAL CHIM ACTA, V334, P251, DOI 10.1016/S0003-2670(96)00309-1; Canario J, 2008, WATER AIR SOIL POLL, V187, P219, DOI 10.1007/s11270-007-9510-1; Chetelat J, 2015, SCI TOTAL ENVIRON, V509, P41, DOI 10.1016/j.scitotenv.2014.05.151; Clark ID, 2004, ISOT ENVIRON HEALT S, V40, P115, DOI 10.1080/10256010410001671014; Coleman L. C., 1957, ECON GEOL, V52, P400, DOI DOI 10.2113/GSECONGEO.52.4.400; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; Daguene V, 2012, ENVIRON SCI TECHNOL, V46, P6645, DOI 10.1021/es300760e; Ecosystem Classification Group, 2008, EC REG NW TERR TAIG; Engstrom DR, 2014, ENVIRON SCI TECHNOL, V48, P6533, DOI 10.1021/es405558e; French TD, 2014, ENVIRON SCI TECHNOL, V48, P3162, DOI 10.1021/es403849d; Galloway JM, 2015, GEOCHEMISTRY LAKES 1, DOI [10.4095/296954, DOI 10.4095/296954]; GILMOUR CC, 1992, ENVIRON SCI TECHNOL, V26, P2281, DOI 10.1021/es00035a029; Hellweger FL, 2004, ENVIRON SCI TECHNOL, V38, P6716, DOI 10.1021/es049660k; Hellweger FL, 2003, LIMNOL OCEANOGR, V48, P2275; HOCKING D, 1978, JAPCA J AIR WASTE MA, V28, P133, DOI 10.1080/00022470.1978.10470580; HUTCHINSON TC, 1982, J RADIOANAL CHEM, V71, P59, DOI 10.1007/BF02516141; Indian and Northern Affairs Canada, 2010, BRUL MIN PROJ ASS RE; Isachsen CE, 1997, CAN J EARTH SCI, V34, P169, DOI 10.1139/e17-014; Jeremiason JD, 2006, ENVIRON SCI TECHNOL, V40, P3800, DOI 10.1021/es0524144; KELLER W, 2004, RECOVERY ACID METAL; Kerr DE, 2000, GEOL SURV CANADA C, VC3; Koch I, 2000, ENVIRON SCI TECHNOL, V34, P22, DOI 10.1021/es9906756; Koch I, 2000, APPL ORGANOMET CHEM, V14, P245, DOI 10.1002/(SICI)1099-0739(200005)14:5<245::AID-AOC986>3.0.CO;2-K; Koch L, 2005, ENVIRON TOXICOL CHEM, V24, P1468, DOI 10.1897/04-155R.1; Lloyd JR, 2006, ELEMENTS, V2, P85, DOI 10.2113/gselements.2.2.85; Ng JC, 2005, ENVIRON CHEM, V2, P146, DOI 10.1071/EN05062; O'Driscoll NJ, 2005, MET IONS BIOL SYST, V43, P221; Raab A, 2007, ANGEW CHEM INT EDIT, V46, P2594, DOI 10.1002/anie.200604805; Rahman MA, 2012, ENVIRON RES, V116, P118, DOI 10.1016/j.envres.2012.03.014; Semkin RG, 2005, SCI TOTAL ENVIRON, V342, P199, DOI 10.1016/j.scitotenv.2004.12.047; Sharma VK, 2009, ENVIRON INT, V35, P743, DOI 10.1016/j.envint.2009.01.005; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; St-Onge SM, 2007, THESIS CARLETON U; Ullrich SM, 2001, CRIT REV ENV SCI TEC, V31, P241, DOI 10.1080/20016491089226; WAGEMANN R, 1978, ARCH ENVIRON CON TOX, V7, P169, DOI 10.1007/BF02332047; Walker SR, 2005, CAN MINERAL, V43, P1205, DOI 10.2113/gscanmin.43.4.1205	40	31	31	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0150960	10.1371/journal.pone.0150960	http://dx.doi.org/10.1371/journal.pone.0150960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050658	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500003
J	Nilsson, L; Larsson, A; Begum, A; Iakovleva, I; Carlsson, M; Brannstrom, K; Sauer-Eriksson, AE; Olofsson, A				Nilsson, Lina; Larsson, Andreas; Begum, Afshan; Iakovleva, Irina; Carlsson, Marcus; Brannstrom, Kristoffer; Sauer-Eriksson, A. Elisabeth; Olofsson, Anders			Modifications of the 7-Hydroxyl Group of the Transthyretin Ligand Luteolin Provide Mechanistic Insights into Its Binding Properties and High Plasma Specificity	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; AMYLOIDOGENESIS; POLYNEUROPATHY; METABOLISM; GLUCURONIDATION; DENATURATION; TAFAMIDIS; DISEASE; COMPLEX; DRUGS	Amyloid formation of the plasma protein transthyretin (TTR) has been linked to familial amyloid polyneuropathy and senile systemic amyloidosis. Binding of ligands within its natural hormone binding site can stabilize the tetrameric structure and impair amyloid formation. We have recently shown that the flavonoid luteolin stabilizes TTR in human plasma with a very high selectivity. Luteolin, however, is inactivated in vivo via glucuronidation for which the preferred site is the hydroxy group at position 7 on its aromatic A-ring. We have evaluated the properties of two luteolin variants in which the 7-hydroxy group has been exchanged for a chlorine (7-Cl-Lut) or a methoxy group (7-MeO-Lut). Using an in vitro model, based on human liver microsomes, we verified that these modifications increase the persistence of the drug. Crystal structure determinations show that 7-Cl-Lut binds similarly to luteolin. The larger MeO substituent cannot be accommodated within the same space as the chlorine or hydroxy group and as a result 7-MeO-Lut binds in the opposite direction with the methoxy group in position 7 facing the solvent. Both 7-Cl-Lut and 7-MeO-Lut qualify as high-affinity binders, but in contrast to luteolin, they display a highly non-specific binding to other plasma components. The binding of the two conformations and the key-interactions to TTR are discussed in detail. Taken together, these results show a proof-of-concept that the persistence of luteolin towards enzymatic modification can be increased. We reveal two alternative high-affinity binding modes of luteolin to TTR and that modification in position 7 is restricted only to small substituents if the original orientation of luteolin should be preserved. In addition, the present work provides a general and convenient method to evaluate the efficacy of TTR-stabilizing drugs under conditions similar to an in vivo environment.	[Nilsson, Lina; Iakovleva, Irina; Brannstrom, Kristoffer; Olofsson, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Nilsson, Lina; Larsson, Andreas; Begum, Afshan; Carlsson, Marcus; Sauer-Eriksson, A. Elisabeth] Umea Univ, Dept Chem, SE-90187 Umea, Sweden; [Larsson, Andreas] Swedish Def Res Agcy, CBRN Def & Secur, SE-90621 Umea, Sweden	Umea University; Umea University; Saab Group	Olofsson, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	anders.olofsson@umu.se	Brännström, Kristoffer/AAC-1204-2020	Sauer-Eriksson, Elisabeth/0000-0003-0124-0199; BEGUM, AFSHAN/0000-0001-5047-5168	Swedish Research Council; Parkinsonfonden; Insamlingsstiftelsen vid Umea Universitet; Alzheimerfonden; Ahlenstiftelsen; J.C. Kempes stiftelse; Hjarnfonden; Magn. Bergvalls stiftelse; O.E. och Edlas stiftelse; Torsten Soderbergs stiftelse; Vasterbottens Lans lasting (ALF-medel); Patientforeningen FAMY/AMYL; Medical Faculty of Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinsonfonden; Insamlingsstiftelsen vid Umea Universitet; Alzheimerfonden; Ahlenstiftelsen; J.C. Kempes stiftelse; Hjarnfonden; Magn. Bergvalls stiftelse; O.E. och Edlas stiftelse; Torsten Soderbergs stiftelse; Vasterbottens Lans lasting (ALF-medel); Patientforeningen FAMY/AMYL; Medical Faculty of Umea University	This work was funded by The Swedish Research Council to AESE, AO; Parkinsonfonden to AO; Insamlingsstiftelsen vid Umea Universitet to AO; Alzheimerfonden to AO; Ahlenstiftelsen to AO; J.C. Kempes stiftelse to AO, KB; Hjarnfonden to AO, KB; Magn. Bergvalls stiftelse to KB; O.E. och Edlas stiftelse to AO; Torsten Soderbergs stiftelse to AO; Vasterbottens Lans lasting (ALF-medel) to AO; Patientforeningen FAMY/AMYL to AO; and The Medical Faculty of Umea University to AO.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Berk JL, 2012, AMYLOID, V19, P37, DOI 10.3109/13506129.2012.678509; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Boersma MG, 2002, CHEM RES TOXICOL, V15, P662, DOI 10.1021/tx0101705; Buchheit D, 2011, BIOL CHEM, V392, P1089, DOI [10.1515/BC-2011-194, 10.1515/BC.2011.194]; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; Cotrina EY, 2013, J MED CHEM, V56, P9110, DOI 10.1021/jm401061w; Donato MT, 2003, CLIN PHARMACOKINET, V42, P153, DOI 10.2165/00003088-200342020-00004; Dubrey S, 2015, POSTGRAD MED J, V91, P439, DOI 10.1136/postgradmedj-2014-133224; Dunitz JD, 1997, CHEM-EUR J, V3, P89, DOI 10.1002/chem.19970030115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein M, 2002, J HYPERTENS, V20, pS17; Florio P, 2015, J BIOL CHEM; Florio P, 2015, J BIOL CHEM, V290, P29769, DOI 10.1074/jbc.M115.690172; Gales L, 2005, BIOCHEM J, V388, P615, DOI 10.1042/BJ20042035; Grimster NP, 2013, J AM CHEM SOC, V135, P5656, DOI 10.1021/ja311729d; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; HARRELL SA, 1964, J AM CHEM SOC, V86, P4497, DOI 10.1021/ja01074a061; HOLMGREN G, 1991, CLIN GENET, V40, P242; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Iakovleva I, 2015, J MED CHEM, V58, P6507, DOI 10.1021/acs.jmedchem.5b00544; Iakovleva I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128222; Ihse E, 2011, J MOL MED, V89, P171, DOI 10.1007/s00109-010-0695-1; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaivosaari S, 2011, XENOBIOTICA, V41, P652, DOI 10.3109/00498254.2011.563327; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Li LP, 2013, PHARMAZIE, V68, P195, DOI 10.1691/ph.2013.2744; Lindhagen-Persson M, 2008, AMYLOID, V15, P240, DOI 10.1080/13506120802524916; Lozeron P, 2013, EUR J NEUROL, V20, P1539, DOI 10.1111/ene.12225; Maetzler W, 2012, PLOS ONE, V7, P25; Mairal T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004124; Mangione PP, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Morais-de-Sa E, 2004, J BIOL CHEM, V279, P53483, DOI 10.1074/jbc.M408053200; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; Palaninathan SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006290; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Plante-Bordeneuve V, 2014, J NEUROL, V261, P1227, DOI 10.1007/s00415-014-7373-0; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Raghu P, 2004, BBA-PROTEINS PROTEOM, V1703, P1, DOI 10.1016/j.bbapap.2004.09.023; Shimoi K, 1998, FEBS LETT, V438, P220, DOI 10.1016/S0014-5793(98)01304-0; Taliou A, 2013, CLIN THER, V35, P592, DOI 10.1016/j.clinthera.2013.04.006; Trelle S, 2011, BMJ, V11; Trivella DBB, 2012, J STRUCT BIOL, V180, P143, DOI 10.1016/j.jsb.2012.07.008; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Van Vranken DL, 2004, CHEM BIOL, V11, P1604, DOI 10.1016/j.chembiol.2004.11.016; Wallace JL, 2001, BEST PRACT RES CL GA, V15, P691, DOI 10.1053/bega.2001.0229; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	56	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153112	10.1371/journal.pone.0153112	http://dx.doi.org/10.1371/journal.pone.0153112			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050398	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500101
J	Park, SA; Lee, JW; Herbst, RS; Koo, JS				Park, Sin-Aye; Lee, Jong Woo; Herbst, Roy S.; Koo, Ja Seok			GSK-3 alpha Is a Novel Target of CREB and CREB-GSK-3 alpha Signaling Participates in Cell Viability in Lung Cancer	PLOS ONE			English	Article							ELEMENT-BINDING-PROTEIN; GLYCOGEN-SYNTHASE KINASE-3; ACUTE MYELOID-LEUKEMIA; GENOME-WIDE ANALYSIS; PANCREATIC-CANCER; PROSTATE-CANCER; GENE-EXPRESSION; BETA-CATENIN; GSK-3-BETA; TRANSCRIPTION	Overexpression or activation of cyclic AMP-response element-binding protein (CREB) has been known to be involved in several human malignancies, including lung cancer. Genes regulated by CREB have been reported to suppress apoptosis, induce cell proliferation, inflammation, and tumor metastasis. However, the critical target genes of CREB in lung cancer have not been well understood. Here, we identified GSK-3 alpha as one of the CREB target genes which is critical for the viability of lung cancer cells. The CREB knockdown significantly reduced the expression of GSK-3 alpha and the direct binding of CREB on the promoter of GSK3A was identified. Kaplan-Meier analysis with a public database showed a prognostic significance of aberrant GSK-3 alpha expression in lung cancer. Inhibition of GSK-3 alpha suppressed cell viability, colony formation, and tumor growth. For the first time, we demonstrated that GSK-3 alpha is regulated by CREB in lung cancer and is required for the cell viability. These findings implicate CREB-GSK-3 alpha axis as a novel therapeutic target for lung cancer treatment.	[Park, Sin-Aye; Lee, Jong Woo; Herbst, Roy S.; Koo, Ja Seok] Yale Univ, Sch Med, Dept Internal Med, Sect Med Oncol,Yale Comprehens Canc Ctr, 333 Cedar St, New Haven, CT 06520 USA; [Koo, Ja Seok] Yale Comprehens Canc Ctr, Translat Res Program, Dev Therapeut, New Haven, CT 06520 USA	Yale University; Yale University	Koo, JS (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Med Oncol,Yale Comprehens Canc Ctr, 333 Cedar St, New Haven, CT 06520 USA.; Koo, JS (corresponding author), Yale Comprehens Canc Ctr, Translat Res Program, Dev Therapeut, New Haven, CT 06520 USA.	jpeter.koo@yale.edu	Koo, J Peter/AAE-6700-2019; Park, Sin-Aye/E-2303-2019	Park, Sin-Aye/0000-0003-2456-3572	National Cancer Institute [R01-CA126801]; Cancer Center Support Grant [CA-16359]; NATIONAL CANCER INSTITUTE [R01CA126801, P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Cancer Institute grant R01-CA126801 (to Ja Seok Koo) and Cancer Center Support Grant CA-16359 (to Yale Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Alao JP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-40; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Banerji V, 2012, J CLIN INVEST, V122, P935, DOI 10.1172/JCI46465; Bang D, 2013, CANCER DISCOV, V3, P690, DOI 10.1158/2159-8290.CD-12-0541; Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; Bender RA, 2001, EUR J NEUROSCI, V13, P679, DOI 10.1046/j.1460-9568.2001.01432.x; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Crans-Vargas HN, 2002, BLOOD, V99, P2617, DOI 10.1182/blood.V99.7.2617; Darrington RS, 2012, INT J CANCER, V131, pE872, DOI 10.1002/ijc.27620; Deng XH, 2008, CANCER RES, V68, P9663, DOI 10.1158/0008-5472.CAN-08-2229; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Esfandiari F, 2012, STEM CELLS DEV, V21, P3233, DOI 10.1089/scd.2011.0678; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hansen TV, 2004, NEUROREPORT, V15, P841, DOI 10.1097/00001756-200404090-00021; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Li DS, 2006, CELL RES, V16, P609, DOI 10.1038/sj.cr.7310082; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu H, 2009, DIABETES, V58, P663, DOI 10.2337/db07-1208; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Park MH, 2013, ONCOGENE, V32, P2475, DOI 10.1038/onc.2012.255; Pellegrini Matteo, 2008, BMC Cancer, V8, P264, DOI 10.1186/1471-2407-8-264; Pigazzi M, 2009, CANCER RES, V69, P2471, DOI 10.1158/0008-5472.CAN-08-3404; Rix LLR, 2014, ACS CHEM BIOL, V9, P353, DOI 10.1021/cb400660a; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seo HS, 2008, CANCER RES, V68, P6065, DOI 10.1158/0008-5472.CAN-07-5376; Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wang L, 2004, J BIOL CHEM, V279, P32444, DOI 10.1074/jbc.M313963200; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Zeng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091231; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhang YQ, 2013, EMBO MOL MED, V5, P1322, DOI 10.1002/emmm.201302507	50	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153075	10.1371/journal.pone.0153075	http://dx.doi.org/10.1371/journal.pone.0153075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049759	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500095
J	Kamio, T; Gu, BW; Olson, TS; Zhang, YP; Mason, PJ; Bessler, M				Kamio, Takuya; Gu, Bai-wei; Olson, Timothy S.; Zhang, Yanping; Mason, Philip J.; Bessler, Monica			Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; HEMATOPOIETIC-CELLS; S19 DEFICIENCY; P53 ACTIVATION; IN-VITRO; EXPANSION; PATHWAY; GROWTH; L11; PHENOTYPE	MDM2, an E3 ubiquitin ligase, is an important negative regulator of tumor suppressor p53. In turn the Mdm2 gene is a transcriptional target of p53, forming a negative feedback loop that is important in cell cycle control. It has recently become apparent that the ubiquitination of p53 by MDM2 can be inhibited when certain ribosomal proteins, including RPL5 and RPL11, bind to MDM2. This inhibition, and the resulting increase in p53 levels has been proposed to be responsible for the red cell aplasia seen in Diamond-Blackfan anemia (DBA) and in 5q-myelodysplastic syndrome (MDS). DBA and 5q-MDS are associated with inherited (DBA) or acquired (5q-MDS) haploinsufficiency of ribosomal proteins. A mutation in Mdm2 causing a C305F amino acid substitution blocks the binding of ribosomal proteins. Mice harboring this mutation (Mdm2(C305F)), retain a normal p53 response to DNA damage, but lack the p53 response to perturbations in ribosome biogenesis. While studying the interaction between RP haploinsufficiency and the Mdm2(C305F) mutation we noticed that Mdm2(C305F) homozygous mice had altered hematopoiesis. These mice developed a mild macrocytic anemia with reticulocytosis. In the bone marrow (BM), these mice showed a significant decrease in Ter119(hi) cells compared to wild type (WT) littermates, while no decrease in the number of mature erythroid cells (Ter119(hi)CD71(low)) was found in the spleen, which showed compensated bone marrow hematopoiesis. In methylcellulose cultures, BFU-E colonies from the mutant mice were slightly reduced in number and there was a significant reduction in CFU-E colony numbers in mutant mice compared with WT controls (p < 0.01). This erythropoietic defect was abrogated by concomitant p53 deficiency (Trp53(ko/ko)). Further investigation revealed that in Mdm2C305F animals, there was a decrease in Lin(-)Sca-1(+)c-Kit(+) (LSK) cells, accompanied by significant decreases in multipotent progenitor (MPP) cells (p < 0.01). Competitive BM repopulation experiments showed that donor BM harboring the Mdm2(C305F) mutation possessed decreased repopulation capacity compared to WT BM, suggesting a functional stem cell deficit. These results suggest that there is a fine tuned balance in the interaction of ribosomal proteins with the MDM2/p53 axis which is important in normal hematopoiesis.	[Kamio, Takuya; Gu, Bai-wei; Olson, Timothy S.; Mason, Philip J.; Bessler, Monica] Childrens Hosp Philadelphia, Dept Hematol, Philadelphia, PA 19104 USA; [Olson, Timothy S.; Bessler, Monica] Childrens Hosp Philadelphia, Comprehens Bone Marrow Failure Ctr, Philadelphia, PA 19104 USA; [Zhang, Yanping] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC USA; [Zhang, Yanping] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kamio, T (corresponding author), Childrens Hosp Philadelphia, Dept Hematol, Philadelphia, PA 19104 USA.	kamiotak@gmail.com			Research Grant of Pediatric Oncology Research Fellowship from Children's Cancer Association of Japan [NIH/NHLBI K08 HL 122306]; NIH [R01-CA105312]; NATIONAL CANCER INSTITUTE [R01CA105312] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL122306] Funding Source: NIH RePORTER	Research Grant of Pediatric Oncology Research Fellowship from Children's Cancer Association of Japan; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Research Grant of Pediatric Oncology Research Fellowship from Children's Cancer Association of Japan to TK, NIH/NHLBI K08 HL 122306 to TSO, and NIH R01-CA105312 to MB.	Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; CHINYEE I, 1991, CLIN LAB HAEMATOL, V13, P177; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Dey A, 2010, SEMIN CANCER BIOL, V20, P3, DOI 10.1016/j.semcancer.2010.02.004; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Farrar JE, 2011, BLOOD, V118, P6943, DOI 10.1182/blood-2011-08-375170; GLADER BE, 1983, NEW ENGL J MED, V309, P1486, DOI 10.1056/NEJM198312153092404; Ikeda K, 2011, BLOOD, V117, P5860, DOI 10.1182/blood-2011-02-334425; Jaako P, 2015, LEUKEMIA, V29, P2221, DOI 10.1038/leu.2015.128; Jaako P, 2011, BLOOD, V118, P6087, DOI 10.1182/blood-2011-08-371963; Jin SK, 2001, J CELL SCI, V114, P4139; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lipton JM, 2009, HEMATOL ONCOL CLIN N, V23, P261, DOI 10.1016/j.hoc.2009.01.004; Liu G, 2007, J PATHOL, V213, P360, DOI 10.1002/path.2238; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; McGowan KA, 2011, BLOOD, V118, P3622, DOI 10.1182/blood-2010-11-318584; Moniz H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.88; OKADA S, 1992, BLOOD, V80, P3044; Olney HJ, 2001, BEST PRACT RES CL HA, V14, P479, DOI 10.1053/beha.2001.0151; Olson TS, 2013, BLOOD, V121, P5238, DOI 10.1182/blood-2012-10-463414; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	31	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152263	10.1371/journal.pone.0152263	http://dx.doi.org/10.1371/journal.pone.0152263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27042854	Green Submitted, gold, Green Published			2022-12-26	WOS:000373592100013
J	Niu, L; Qiu, YY; Luo, D; Chen, X; Wang, M; Pakenham, KI; Zhang, XX; Huang, ZL; Xiao, SY				Niu, Lu; Qiu, Yangyang; Luo, Dan; Chen, Xi; Wang, Min; Pakenham, Kenneth I.; Zhang, Xixing; Huang, Zhulin; Xiao, Shuiyuan			Cross-Culture Validation of the HIV/AIDS Stress Scale: The Development of a Revised Chinese Version	PLOS ONE			English	Article							PERCEIVED STRESS; SOCIAL SUPPORT; LIFE EVENTS; HIV; INDIVIDUALS; DISTRESS; TRAUMA; WOMEN	Background Being HIV-infected is a stressful experience for many individuals. To assess HIV-related stress in the Chinese context, ameasure with satisfied psychometric properties is yet underdeveloped. This study aimed to examine the psychometric characteristics of a simplified Chinese version of the HIV/AIDS Stress Scale (SS-HIV) among people living with HIV/AIDS in central China. Method A total of 667 people living with HIV (92% were male) were recruited from March 1st 2014 to August 31th 2015 by consecutive sampling. A standard questionnaire package containing the Chinese HIV/AIDS Stress Scale (CSS-HIV), the Chinese Patient Health Questionnaire 9 (PHQ-9), and the Chinese Generalized Anxiety Disorder Scale (GAD-7) were administered to all participants, and 38 of the participants were selected randomly to be re-tested in four weeks after the initial testing. Results Our data supported that a revised 17-item CSS-HIV had adequate psychometric properties. It consisted of 3 factors: emotional stress (6 items), social stress (6 items) and instrumental stress (5 items). The overall Cronbach's a was 0.906, and the test-retest reliability coefficient was 0.832. The revised CSS-HIV was significantly correlated with the number of HIV-related symptoms, as well as scores on the PHQ-9 and GAD-7, indicating acceptable concurrent validity. Conclusion The 17-item Chinese version of the SS-HIV has potential research and clinical utility in identifying important stressors among the Chinese HIV-infected population and in understanding the effects of stress on adjustment to HIV.	[Niu, Lu; Qiu, Yangyang; Luo, Dan; Xiao, Shuiyuan] Cent S Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China; [Chen, Xi] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Wang, Min] First Hosp Changsha, Changsha, Hunan, Peoples R China; [Pakenham, Kenneth I.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Zhang, Xixing; Huang, Zhulin] Changsha Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China	Central South University; University of Queensland	Luo, D (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China.	luodan_csu_2011@126.com	Pakenham, Kenneth/A-9973-2008	Pakenham, Kenneth/0000-0002-8653-4593	National Natural Science Foundation of China [81202290]; Hunan Academy of Social Science [13WTB22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Academy of Social Science	This study was funded by the National Natural Science Foundation of China (81202290), and the Hunan Academy of Social Science (13WTB22), which are both received by DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CHINA NEWS      1201; Bian C., 2009, J TONGJI U, V132, P136; Byrnes DM, 1998, PSYCHOSOM MED, V60, P714, DOI 10.1097/00006842-199811000-00009; Chinese Center for Disease Control and Prevention, 2015, 2014 NAT REP NOT INF; Chinese Center for Disease Control and Prevention, 2013, 2012 NAT REP NOT INF; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Crystal S, 1998, SOC WORK HEALTH CARE, V28, P41, DOI 10.1300/J010v28n01_03; Eller LS, 2003, J NURS SCHOLARSHIP, V35, P53, DOI 10.1111/j.1547-5069.2003.00053.x; Gao LL, 2008, THESIS SUN YS U; He XY., 2010, SHANGHAI ARCH PSYCHI, V22, P200, DOI DOI 10.3969/J.ISSN.1002-0829.2010.04.002; Ho AHY, 2015, COMPR PSYCHIAT, V56, P198, DOI 10.1016/j.comppsych.2014.09.016; Hou J., 2004, STRUCTURAL EQUATION; Joiner TE, 2009, J ABNORM PSYCHOL, V118, P634, DOI 10.1037/a0016500; Kelly BC, 2009, AIDS BEHAV, V13, P792, DOI 10.1007/s10461-009-9586-2; KESSLER RC, 1991, AM J PSYCHIAT, V148, P733; Koopman C, 2000, AIDS CARE, V12, P663, DOI 10.1080/095401200750003833; Lazarus R.S., 1984, EMOTION ADAPTATION; Lee EH, 2015, SCAND J CARING SCI, V29, P183, DOI 10.1111/scs.12131; Leserman J, 2005, PSYCHOSOM MED, V67, P500, DOI 10.1097/01.psy.0000160459.78182.d9; LIN XY, 2004, CHINESE J APPL PSYCH, V10, P49; Liu Yan, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P658, DOI 10.11817/j.issn.1672-7347.2014.07.002; Marshall MM, 2011, ADDICT BEHAV, V36, P61, DOI 10.1016/j.addbeh.2010.08.022; McNaught A, 2000, SOC SCI MED, V51, P65, DOI 10.1016/S0277-9536(99)00433-5; Meade CS, 2010, AIDS BEHAV, V14, P328, DOI 10.1007/s10461-008-9494-x; Myers HF, 2009, J BEHAV HEALTH SER R, V36, P233, DOI 10.1007/s11414-008-9134-2; National Health and Family Planning Commission of China, 2014, 2014 CHIN AIDS RESP; Ndlovu U, 2010, ARCH WOMEN MENT HLTH, V13, P215, DOI 10.1007/s00737-010-0148-4; NOTT KH, 1995, AIDS CARE, V7, P55, DOI 10.1080/09540129550126966; Pakenham KI, 2002, PSYCHOL HEALTH, V17, P203, DOI 10.1080/08870440290013680; Pakenham KI, 1996, SOC SCI MED, V42, P245, DOI 10.1016/0277-9536(95)00099-2; Pakenham KI, 2011, OXFORD HDB STRESS HL, P242; Pakenharn KI, 2007, REHABIL PSYCHOL, V52, P380, DOI 10.1037/0090-5550.52.4.380; Qiu Yangyang, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P835, DOI 10.3969/j.issn.1672-7347.2014.08.014; Qiu YY, 2015, THESIS CENTRAL S U; Qu W., 2005, CHINA J AIDS STD, V2, P91; Reif S, 2011, AIDS CARE, V23, P152, DOI 10.1080/09540121.2010.498872; Roberts JE, 2001, PERS INDIV DIFFER, V30, P241, DOI 10.1016/S0191-8869(00)00042-8; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Su XY, 2013, AIDS CARE, V25, P239, DOI 10.1080/09540121.2012.701713; Su XY, 2008, AIDS PATIENT CARE ST, V22, P989, DOI 10.1089/apc.2008.0095; The former Ministry of Health of the Republic of China, 2012, 2012 CHIN AIDS RESP; Thompson SC, 1996, AIDS CARE, V8, P5, DOI 10.1080/09540129650125957; Tseng W-S, 2003, CLIN GUIDE CULTURAL; Wu Y., 2007, CHINESE J DIS CONTRO, V4, P342; Wu YL, 2015, INT J STD AIDS, V26, P496, DOI 10.1177/0956462414544722; Yi ZY, 2014, RED NET         1201; Zhang YB, 2010, MED STAT	48	23	27	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152990	10.1371/journal.pone.0152990	http://dx.doi.org/10.1371/journal.pone.0152990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27043134	Green Submitted, gold, Green Published			2022-12-26	WOS:000373592100059
J	Tabak, NM; Laba, M; Spector, S				Tabak, Nava M.; Laba, Magdeline; Spector, Sacha			Simulating the Effects of Sea Level Rise on the Resilience and Migration of Tidal Wetlands along the Hudson River	PLOS ONE			English	Article							FRESH-WATER MARSH; NEW-YORK; COASTAL WETLANDS; ESTUARY; VEGETATION; SEDIMENT; IMPACTS; BAY; OPPORTUNITIES; ACCRETION	Sea Level Rise (SLR) caused by climate change is impacting coastal wetlands around the globe. Due to their distinctive biophysical characteristics and unique plant communities, freshwater tidal wetlands are expected to exhibit a different response to SLR as compared with the better studied salt marshes. In this study we employed the Sea Level Affecting Marshes Model (SLAMM), which simulates regional- or local-scale changes in tidal wetland habitats in response to SLR, and adapted it for application in a freshwater-dominated tidal river system, the Hudson River Estuary. Using regionally-specific estimated ranges of SLR and accretion rates, we produced simulations for a spectrum of possible future wetland distributions and quantified the projected wetland resilience, migration or loss in the HRE through the end of the 21(st) century. Projections of total wetland extent and migration were more strongly determined by the rate of SLR than the rate of accretion. Surprisingly, an increase in net tidal wetland area was projected under all scenarios, with newly-formed tidal wetlands expected to comprise at least 33% of the HRE's wetland area by year 2100. Model simulations with high rates of SLR and/or low rates of accretion resulted in broad shifts in wetland composition with widespread conversion of high marsh habitat to low marsh, tidal flat or permanent inundation. Wetland expansion and resilience were not equally distributed through the estuary, with just three of 48 primary wetland areas encompassing >50% of projected new wetland by the year 2100. Our results open an avenue for improving predictive models of the response of freshwater tidal wetlands to sea level rise, and broadly inform the planning of conservation measures of this critical resource in the Hudson River Estuary.	[Tabak, Nava M.; Spector, Sacha] Scenic Hudson Inc, Dept Conservat Sci, Poughkeepsie, NY USA; [Laba, Magdeline] Cornell Univ, Sch Integrat Plant Sci, Sect Soil & Crop Sci, Ithaca, NY USA	Cornell University	Tabak, NM (corresponding author), Scenic Hudson Inc, Dept Conservat Sci, Poughkeepsie, NY USA.	ntabak@scenichudson.org			Wildlife Conservation Society Climate Adaptation Fund	Wildlife Conservation Society Climate Adaptation Fund	An early iteration of this research was supported by a grant from the Wildlife Conservation Society Climate Adaptation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank our partners in the study, conservation and restoration of the Hudson's tidal wetlands, which include staff at the NYS Department of Environmental Conservation's Hudson River Estuary Program, the Hudson River National Estuarine Research Reserve (HRNERR), the Cary Institute of Ecosystem Studies (CIES), The Nature Conservancy, and Hudsonia Ltd.; in particular Stuart Findlay (CIES) and Sarah Fernald (HRNERR) who assisted us in parameterizing the accretion models. Jonathan Clough, Marco Propato, and Amy Polaczyk of Warren Pinnacle Consulting, Inc. generously shared their expertise and time to assist us in adapting SLAMMto our study area and using accretion models. Jason Winner and James Mudd provided technical GIS support for model inputs and uncertainty analyses, respectively. We are also grateful to the academic editor and three anonymous peer reviewers who provided extremely valuable comments to improve this manuscript. An early iteration of this research was supported by a grant from the Wildlife Conservation Society Climate Adaptation Fund.	Arrigoni A, 2008, ECOSYSTEMS, V11, P790, DOI 10.1007/s10021-008-9161-0; Baldwin, 2009, TIDAL FRESHWATER WET, P71; Baldwin A. H., 2009, TIDAL FRESHWATER WET, P1; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Benoit G, 1999, ESTUARIES, V22, P167, DOI 10.2307/1352974; Biging G., 2012, IMPACTS PREDICTED SE; BOKUNIEWICZ H, 2006, HUDSON RIVER ESTUARY, P39; Cadol D, 2014, LIMNOL OCEANOGR, V59, P1065, DOI 10.4319/lo.2014.59.3.1065; Chu ML, 2014, ENVIRON MODELL SOFTW, V52, P111, DOI 10.1016/j.envsoft.2013.10.020; Chu-Agor ML, 2011, ENVIRON MODELL SOFTW, V26, P593, DOI 10.1016/j.envsoft.2010.12.003; Clough J., 2015, APPL SLAMM COASTAL C; Clough J, 2014, APPL SEA LEVEL AFFEC; Clough J.S., 2012, SLAMM 6 2 TECHNICAL; Cornell Institute for Resource Information Sciences, 2011, HUDS RIV EST TID WET; Craft C, 2009, FRONT ECOL ENVIRON, V7, P127, DOI 10.1890/09.WB.006; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Craft CB, 2012, GLOBAL CHANGE BIOL, V18, P3615, DOI 10.1111/gcb.12009; de Vries M.P., 2001, SALT FRONT MOVEMENT; Edinger G.J., 2002, ECOLOGICAL IN PRESS; ESRI Inc, 2013, ARCGIS DESKT; Fry J, 2011, PHOTOGRAMM ENG REMOT, V77, P858; Georgas N, 2013, HUDSON RIVER ESTUARY; Geselbracht L, 2011, CLIMATIC CHANGE, V107, P35, DOI [10.1007/s10584-011-0084-y, 10.1007/s10584-011-0084-v]; Geyer W.R., 2006, HUDSON RIVER ESTUARY, P24, DOI DOI 10.1017/CBO9780511550539.005; Glick P, 2013, J COASTAL RES, P211, DOI [10.2112/S163-017.1, 10.2112/SI63-0017.1]; Gornitz V, 2001, GLOBAL PLANET CHANGE, V32, P61, DOI 10.1016/S0921-8181(01)00150-3; Hartig EK, 2002, WETLANDS, V22, P71, DOI 10.1672/0277-5212(2002)022[0071:AACCIO]2.0.CO;2; Hassan R, 2005, ECOSYSTEMS HUMAN WEL, V1; Horton R, 2015, KNOWLEDGE BASE CLIMA, V1336, P36, DOI DOI 10.1111/NYAS.12593; Horton R, 2014, CLIMATE CHANGE NEW Y; Houghton J. T., 2001, CLIMATE CHANGE 2001; KEARNEY MS, 1988, GEOGR REV, V78, P205, DOI 10.2307/214178; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Kiviat Erik, 2006, P279, DOI 10.1017/CBO9780511550539.022; Laba M, 2008, REMOTE SENS ENV; Leck M.A., 2009, TIDAL FRESHWATER WET, P145; Levinton J. S., 2005, HUDSON RIVER ESTUARY, P1; Li SS, 2015, OCEAN COAST MANAGE, V109, P1, DOI 10.1016/j.ocecoaman.2015.02.006; McIvor, 1984, ECOLOGY TIDAL FRESHW; Mcleod E, 2010, OCEAN COAST MANAGE, V53, P507, DOI 10.1016/j.ocecoaman.2010.06.009; Miller D, 2006, AM FISH S S, V51, P29; Mitchell SB, 2015, ESTUAR COAST SHELF S, V156, P1, DOI 10.1016/j.ecss.2014.12.027; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; National Oceanic and Atmospheric Administration, TID CURR WAT LEV; Neubauer S.C., 2007, TIDAL FRESHWATER WET, P253; Neubauer SC, 2008, ESTUAR COAST SHELF S, V78, P78, DOI 10.1016/j.ecss.2007.11.011; Neubauer SC, 2013, ESTUAR COAST, V36, P491, DOI 10.1007/s12237-011-9455-x; New York Sea Level Rise Task Force, 2010, NEW YORK STAT SEA LE; New York State Department of State, 2012, SIGN COAST FISH WILD; Nicholls RJ, 2014, WIRES CLIM CHANGE, V5, P129, DOI 10.1002/wcc.253; Nyman JA, 2006, ESTUAR COAST SHELF S, V69, P370, DOI 10.1016/j.ecss.2006.05.041; ODUM WE, 1995, ESTUARIES, V18, P547, DOI 10.2307/1352375; ODUM WE, 1988, ANNU REV ECOL SYST, V19, P147, DOI 10.1146/annurev.es.19.110188.001051; Park R.A., 1993, GEOCARTO INT, V8, P99, DOI DOI 10.1080/10106049309354433; Pederson DC, 2005, QUATERNARY RES, V63, P238, DOI 10.1016/j.yqres.2005.01.001; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Penhollow M.E., 2006, HUDSON RIVER ESTUARY; Perry JE, 1999, WETLANDS, V19, P90, DOI 10.1007/BF03161737; Photo Science Inc, 2012, COAST NEW YORK LIDAR; Robideau RM, 1997, SEDIMENTATION RATES; Rogers K, 2014, ESTUAR COAST, V37, P67, DOI 10.1007/s12237-013-9664-6; Rosenzweig C, 2011, ANN NY ACAD SCI, V1244; Scenic Hudson Inc, 2014, HRE SLAMM SLOP; Scenic Hudson Inc, 2014, HRE SLAMM 2007 DEM; Schile LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088760; Sritrairat S, 2012, ESTUAR COAST SHELF S, V102, P24, DOI 10.1016/j.ecss.2012.03.003; Stevenson KA, 1985, POLGAR FELLOWSHIP RE; Strayer DL, 2012, HUDSON PRIMER: THE ECOLOGY OF AN ICONIC RIVER, P1; Tiner R.W., 2013, TIDAL WETLANDS PRIME; Tol R.S.J., 2009, ENCY OCEAN SCI, P197; Traill LW, 2011, DIVERS DISTRIB, V17, P1225, DOI 10.1111/j.1472-4642.2011.00807.x; Wall GR, 2008, ESTUAR COAST, V31, P542, DOI 10.1007/s12237-008-9050-y; WARREN RS, 1993, ECOLOGY, V74, P96, DOI 10.2307/1939504	74	13	13	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152437	10.1371/journal.pone.0152437	http://dx.doi.org/10.1371/journal.pone.0152437			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043136	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100015
J	Kumar, AS; Jagadeeshan, S; Subramanian, A; Chidambaram, SB; Surabhi, RP; Singhal, M; Bhoopalan, H; Sekar, S; Pitani, RS; Duvuru, P; Venkatraman, G; Rayala, SK				Kumar, Arathy S.; Jagadeeshan, Sankar; Subramanian, Anirudh; Chidambaram, Saravana Babu; Surabhi, Rohan Prasad; Singhal, Mahak; Bhoopalan, Hemadev; Sekar, Sathiya; Pitani, Ravi Shankar; Duvuru, Prathiba; Venkatraman, Ganesh; Rayala, Suresh K.			Molecular Mechanism of Regulation of MTA1 Expression by Granulocyte Colony-stimulating Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-HYDROXYLASE GENE; PARKINSONS-DISEASE; C-FOS; G-CSF; FACTOR PROTECTS; TRANSCRIPTION; RECEPTOR; MODEL; MICE; INDUCTION	Parkinson disease (PD) is a neurodegenerative disorder with loss of dopaminergic neurons of the brain, which results in insufficient synthesis and action of dopamine. Metastasis-associated protein 1 (MTA1) is an upstream modulator of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis, and hence MTA1 plays a significant role in PD pathogenesis. To impart functional and clinical significance to MTA1, we analyzed MTA1 and TH levels in the substantia nigra region of a large cohort of human brain tissue samples by Western blotting, quantitative PCR, and immunohistochemistry. Our results showed that MTA1 and TH levels were significantly down-regulated in PD samples as compared with normal brain tissue. Correspondingly, immunohistochemistry analysis for MTA1 in substantia nigra sections revealed that 74.1% of the samples had a staining intensity of <6 in the PD samples as compared with controls, 25.9%, with an odds ratio of 8.54. Because of the clinical importance of MTA1 established in PD, we looked at agents to modulate MTA1 expression in neuronal cells, and granulocyte colony-stimulating factor (G-CSF) was chosen, due to its clinically proven neurogenic effects. Treatment of the human neuronal cell line KELLY and acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model with G-CSF showed significant induction of MTA1 and TH with rescue of phenotype in the mouse model. Interestingly, the observed induction of TH was compromised on silencing of MTA1. The underlying molecular mechanism of MTA1 induction by G-CSF was proved to be through induction of c-Fos and its recruitment to the MTA1 promoter.	[Kumar, Arathy S.; Jagadeeshan, Sankar; Subramanian, Anirudh; Singhal, Mahak; Rayala, Suresh K.] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Chidambaram, Saravana Babu; Sekar, Sathiya] Sri Ramachandra Univ, Ctr Toxicol & Dev Res CEFT, Madras 600116, Tamil Nadu, India; [Surabhi, Rohan Prasad; Bhoopalan, Hemadev; Venkatraman, Ganesh] Sri Ramachandra Univ, Dept Human Genet, Madras 600116, Tamil Nadu, India; [Pitani, Ravi Shankar] Sri Ramachandra Univ, Dept Community Med, Madras 600116, Tamil Nadu, India; [Duvuru, Prathiba] Sri Ramachandra Univ, Dept Pathol, Madras 600116, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research	Rayala, SK (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.; Venkatraman, G (corresponding author), Sri Ramachandra Univ, Madras 600116, Tamil Nadu, India.	ganeshv@sriramachandra.edu.in; rayala@iitm.ac.in	JAGADEESHAN, SANKAR/S-8384-2019; Chidambaram, Saravana babu/V-2319-2019; Sekar, Sathiya/AAN-7175-2020; Venkatraman, Ganesh/AAB-1467-2020; Singhal, Mahak/V-4017-2019	JAGADEESHAN, SANKAR/0000-0002-3778-8757; Venkatraman, Ganesh/0000-0003-0179-9785; Singhal, Mahak/0000-0002-7303-9585; Rayala, Suresh/0000-0003-4394-4450; Muralikrishnan, Anirudh Subramanian/0000-0001-7102-9968	Department of Biotechnology from the Government of India [BT/PR14372/Med/30/529/2010]; IIT MADRAS, India	Department of Biotechnology from the Government of India; IIT MADRAS, India	This work was supported by Department of Biotechnology Grant BT/PR14372/Med/30/529/2010 from the Government of India and IIT MADRAS, India. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1996, GUID CAR US LAB AN, P45; Bademci G, 2012, CNS NEUROL DISORD-DR, V11, P469, DOI 10.2174/187152712800792866; Cao XQ, 2006, J NEUROCHEM, V99, P861, DOI 10.1111/j.1471-4159.2006.04125.x; Charafe-Jaufrret E, 2004, J PATHOL, V202, P265, DOI 10.1002/path.1515; COLOTTA F, 1987, J EXP MED, V165, P1224, DOI 10.1084/jem.165.4.1224; Deshpande RV, 1998, MOL CELL BIOCHEM, V178, P47, DOI 10.1023/A:1006894329316; Duarte RF, 2000, BLOOD, V96, P3422; Fernagut PO, 2002, J NEUROSCI METH, V113, P123, DOI 10.1016/S0165-0270(01)00485-X; Feve AP, 2012, CNS NEUROL DISORD-DR, V11, P450; Frank T, 2012, BRAIN, V135, P1914, DOI 10.1093/brain/aws054; Hu N, 2015, J BIOL CHEM, V290, P24561, DOI 10.1074/jbc.M115.668871; Huang HY, 2007, NEUROBIOL AGING, V28, P1258, DOI 10.1016/j.neurobiolaging.2006.05.037; Ishikawa S, 2010, J BIOL CHEM, V285, P39718, DOI 10.1074/jbc.M110.137034; Jeong H, 2006, NEUROSCI LETT, V396, P57, DOI 10.1016/j.neulet.2005.11.011; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Khan MS, 2012, CNS NEUROL DISORD-DR, V11, P369; Kingwell Katie, 2011, Nat Rev Neurol, V7, P241, DOI 10.1038/nrneurol.2011.48; Lu LL, 2012, INT J BIOCHEM CELL B, V44, P65, DOI 10.1016/j.biocel.2011.09.007; Ma H., 2008, NAT SCI, V6, P66; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McCollum M, 2010, MOL NEUROBIOL, V41, P410, DOI 10.1007/s12035-010-8118-4; Messmer K, 2007, INT J DEV NEUROSCI, V25, P29, DOI 10.1016/j.ijdevneu.2006.11.003; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; Michael J. Z., 1996, 5 GENERATION PROGR, P1781; Mullin S, 2015, BRIT MED BULL, V114, P39, DOI 10.1093/bmb/ldv022; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pezzoli G, 2010, CLIN NEUROL NEUROSUR, V112, P65, DOI 10.1016/j.clineuro.2009.08.023; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; Reddy SDN, 2011, P NATL ACAD SCI USA, V108, P4200, DOI 10.1073/pnas.1101193108; Romano G, 2007, J CELL PHYSIOL, V211, P431, DOI 10.1002/jcp.20949; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Schumm S, 2012, J NEUROCHEM, V122, P1032, DOI 10.1111/j.1471-4159.2012.07837.x; Sen N, 2014, CANCER METAST REV, V33, P869, DOI 10.1007/s10555-014-9514-4; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Solaroglu I, 2007, FRONT BIOSCI-LANDMRK, V12, P712, DOI 10.2741/2095; Solaroglu I, 2009, NEUROL RES, V31, P167, DOI 10.1179/174313209X393582; Sun BY, 2003, J NEUROCHEM, V85, P1421, DOI 10.1046/j.1471-4159.2003.01789.x; Sun BY, 2002, J NEUROCHEM, V80, P295, DOI 10.1046/j.0022-3042.2001.00692.x; Tabrez S, 2012, CNS NEUROL DISORD-DR, V11, P395, DOI 10.2174/187152712800792785; Trinh J, 2013, NAT REV NEUROL, V9, P445, DOI 10.1038/nrneurol.2013.132; Huynh T, 2011, NAT REV DRUG DISCOV, V10, P571, DOI 10.1038/nrd3515; Wang WJ, 2012, NEUROSCI LETT, V524, P10, DOI 10.1016/j.neulet.2012.06.063; Zhu YZ, 2012, CNS NEUROL DISORD-DR, V11, P350, DOI 10.2174/187152712800792901	44	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12310	12321		10.1074/jbc.M115.707224	http://dx.doi.org/10.1074/jbc.M115.707224			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27044752	hybrid, Green Published			2022-12-26	WOS:000378092800030
J	Smith, N; Wei, WZ; Zhao, MY; Qin, XJ; Seravalli, J; Kim, H; Lee, J				Smith, Nathan; Wei, Wenzhong; Zhao, Miaoyun; Qin, Xiaojuan; Seravalli, Javier; Kim, Heejeong; Lee, Jaekwon			Cadmium and Secondary Structure-dependent Function of a Degron in the Pca1p Cadmium Exporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; PROTEIN-QUALITY CONTROL; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRANSPORTING P-1B-TYPE ATPASE; UBIQUITIN-PROTEASOME PATHWAY; ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONES; CHEMICAL CHAPERONES; ALZHEIMERS-DISEASE	Protein turnover is a critical cellular process regulating biochemical pathways and destroying terminally misfolded or damaged proteins. Pca1p, a cadmium exporter in the yeast Saccharomyces cerevisiae, is rapidly degraded by the endoplasmic reticulum-associated degradation (ERAD) system via a cis-acting degron that exists at the 250-350 amino acid region of Pca1p and is transferable to other proteins to serve as a degradation signal. Cadmium stabilizes Pca1p in a manner dependent on the degron. This suggested that cadmium-mediated masking of the degron impedes its interaction with the molecular factors involved in the ERAD. The characteristics and mechanisms of action of the degron in Pca1p and most of those in other proteins however remain to be determined. The results presented here indicate that specific cysteine residues in a degron of Pca1p sense cadmium. An unbiased approach selecting non-functional degrons indicated a critical role of hydrophobic amino acids in the degron for its function. A secondary structure modeling predicted the formation of an amphipathic helix. Site-directed mutagenesis confirmed the functional significance of the hydrophobic patch. Last, hydrophobic amino acids in the degron- and cadmium-binding region affected the interaction of Pca1p with the Ssa1p molecular chaperone, which is involved in ERAD. These results reveal the mechanism of action of the degron, which might be useful for the identification and characterization of other degrons.	[Smith, Nathan; Wei, Wenzhong; Zhao, Miaoyun; Qin, Xiaojuan; Seravalli, Javier; Kim, Heejeong; Lee, Jaekwon] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Smith, Nathan; Wei, Wenzhong; Zhao, Miaoyun; Qin, Xiaojuan; Seravalli, Javier; Kim, Heejeong; Lee, Jaekwon] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Qin, Xiaojuan] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Shanghai Normal University	Lee, J (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.; Lee, J (corresponding author), Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA.	jlee7@unl.edu			National Institutes of Health [ES16337, P30GM103335]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants ES16337 ( to J. L.) and P30GM103335 ( to the Nebraska Redox Biology Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adle DJ, 2008, J BIOL CHEM, V283, P31460, DOI 10.1074/jbc.M806054200; Adle DJ, 2007, J BIOL CHEM, V282, P947, DOI 10.1074/jbc.M609535200; Adle DJ, 2009, P NATL ACAD SCI USA, V106, P10189, DOI 10.1073/pnas.0812114106; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansari N, 2013, CURR DRUG TARGETS, V14, P114, DOI 10.2174/138945013804806532; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Ausubel FM, 1987, CURR PROTOC MOL BIOL; Babst M, 2014, J CELL BIOL, V205, P11, DOI 10.1083/jcb.201310113; Becker J, 1996, MOL CELL BIOL, V16, P4378; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Epping EA, 2002, J BIOL CHEM, V277, P34860, DOI 10.1074/jbc.M202987200; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fukutomi T, 2014, MOL CELL BIOL, V34, P832, DOI 10.1128/MCB.01191-13; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Gilon T, 2000, MOL CELL BIOL, V20, P7214, DOI 10.1128/MCB.20.19.7214-7219.2000; Guerriero CJ, 2013, J BIOL CHEM, V288, P18506, DOI 10.1074/jbc.M113.475905; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; He L, 2009, TOXICOL APPL PHARM, V238, P250, DOI 10.1016/j.taap.2009.02.017; Heo DH, 2012, BIOTECHNOL LETT, V34, P303, DOI 10.1007/s10529-011-0763-9; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kanarek N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000166; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Marques C, 2004, FASEB J, V18, P1424, DOI 10.1096/fj.04-1743fje; McCullum EO, 2010, METHODS MOL BIOL, V634, P103, DOI 10.1007/978-1-60761-652-8_7; Meplan C, 1999, J BIOL CHEM, V274, P31663, DOI 10.1074/jbc.274.44.31663; Mercado G, 2013, TRENDS MOL MED, V19, P165, DOI 10.1016/j.molmed.2012.12.005; Mollereau B, 2014, J CELL COMMUN SIGNAL, V8, P311, DOI 10.1007/s12079-014-0251-9; MORIUCHI H, 1995, P NATL ACAD SCI USA, V92, P9333, DOI 10.1073/pnas.92.20.9333; Moulis JM, 2010, BIOMETALS, V23, P877, DOI 10.1007/s10534-010-9336-y; Moxley MA, 2014, J BIOL CHEM, V289, P3639, DOI 10.1074/jbc.M113.523704; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Pariyarath R, 2001, J BIOL CHEM, V276, P541, DOI 10.1074/jbc.M007944200; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Singh MV, 2002, ANAL BIOCHEM, V307, P13, DOI 10.1016/S0003-2697(02)00018-0; Smith AT, 2014, J BIOL INORG CHEM, V19, P947, DOI 10.1007/s00775-014-1129-2; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Smith N., 2013, ENCY INORGANIC BIOIN, P1; Summers DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052099; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Viana RJS, 2012, MOL NEUROBIOL, V46, P522, DOI 10.1007/s12035-012-8301-x; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wei WZ, 2014, ANTIOXID REDOX SIGN, V21, P1475, DOI 10.1089/ars.2013.5436; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	72	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12420	12431		10.1074/jbc.M116.724930	http://dx.doi.org/10.1074/jbc.M116.724930			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27059957	Green Published, hybrid			2022-12-26	WOS:000378092800039
J	Anderson, KW; Mast, N; Hudgens, JW; Lin, JB; Turko, IV; Pikuleva, IA				Anderson, Kyle W.; Mast, Natalia; Hudgens, Jeffrey W.; Lin, Joseph B.; Turko, Illarion V.; Pikuleva, Irina A.			Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450 OXIDOREDUCTASE; MASS-SPECTROMETRY; DIRECTED EVOLUTION; HYDROGEN-EXCHANGE; STRUCTURAL BASIS; HUMAN BRAIN; 46A1; TURNOVER; BINDING; MICE	Cytochrome P450 46A1 (CYP46A1) is a microsomal enzyme and cholesterol 24-hydroxylase that controls cholesterol elimination from the brain. This P450 is also a potential target for Alzheimer disease because it can be activated pharmacologically by some marketed drugs, as exemplified by efavirenz, the anti-HIV medication. Previously, we suggested that pharmaceuticals activate CYP46A1 allosterically through binding to a site on the cytosolic protein surface, which is different from the enzyme active site facing the membrane. Here we identified this allosteric site for efavirenz on CYP46A1 by using a combination of hydrogen-deuterium exchange coupled to MS, computational modeling, site-directed mutagenesis, and analysis of the CYP46A1 crystal structure. We also mapped the binding region for the CYP46A1 redox partner oxidoreductase and found that the allosteric and redox partner binding sites share a common border. On the basis of the data obtained, we propose the mechanism of CYP46A1 allostery and the pathway for the signal transmission from the P450 allosteric site to the active site.	[Anderson, Kyle W.; Hudgens, Jeffrey W.; Turko, Illarion V.] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Anderson, Kyle W.; Hudgens, Jeffrey W.; Turko, Illarion V.] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Mast, Natalia; Lin, Joseph B.; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd, Cleveland, OH 44106 USA	National Institute of Standards & Technology (NIST) - USA; Case Western Reserve University	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	iap8@case.edu		Pikuleva, Irina/0000-0001-9742-6232; Hudgens, Jeffrey/0000-0003-2805-1048; Lin, Joseph/0000-0001-6667-9018; Anderson, Kyle/0000-0002-2808-3026	Public Health Service Grant [GM062882]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER	Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Public Health Service Grant GM062882 (to I. A. P). The authors declare that they have no conflicts of interest with the contents of this article. Certain commercial materials, instruments, and equipment are identified in this manuscript in order to specify the experimental procedure as completely as possible. In no case does such identification imply a recommendation or endorsement by the National Institute of Standards and Technology nor does it imply that the materials, instruments, or equipment identified are necessarily the best available for the purpose.	Bjorkhem I, 1998, J LIPID RES, V39, P1594; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Chali F, 2015, EUR J NEUROSCI, V41, P1345, DOI 10.1111/ejn.12911; Chalmers MJ, 2011, INT J MASS SPECTROM, V302, P59, DOI 10.1016/j.ijms.2010.08.002; Decloedt EH, 2015, CLIN PHARMACOKINET, V54, P581, DOI 10.1007/s40262-015-0257-3; Djelti F, 2015, BRAIN, V138, P2383, DOI 10.1093/brain/awv166; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Konermann L, 2014, ANALYST, V139, P6078, DOI 10.1039/c4an01307g; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Kumar S, 2005, J BIOL CHEM, V280, P19569, DOI 10.1074/jbc.M500158200; Kumar S, 2005, BIOCHEM BIOPH RES CO, V338, P456, DOI 10.1016/j.bbrc.2005.08.080; LAMBETH JD, 1980, J BIOL CHEM, V255, P138; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Maioli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068534; Mast N, 2004, ARCH BIOCHEM BIOPHYS, V428, P99, DOI 10.1016/j.abb.2004.05.012; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Mast N, 2014, J BIOL CHEM, V289, P3529, DOI 10.1074/jbc.M113.532846; Mast N, 2013, MOL PHARMACOL, V84, P86, DOI 10.1124/mol.113.085902; Mast N, 2013, J BIOL CHEM, V288, P4613, DOI 10.1074/jbc.M112.438754; Mast N, 2012, MOL PHARMACOL, V82, P824, DOI 10.1124/mol.112.080424; Mast N, 2010, J BIOL CHEM, V285, P31783, DOI 10.1074/jbc.M110.143313; Mast N, 2009, ARCH BIOCHEM BIOPHYS, V483, P81, DOI 10.1016/j.abb.2009.01.002; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Poulos T. L., 2005, CYTOCHROME P450 STRU, P87; Shafaati M, 2010, J LIPID RES, V51, P318, DOI 10.1194/jlr.M900174-JLR200; Shinkyo R, 2011, J BIOL CHEM, V286, P4632, DOI 10.1074/jbc.M110.193409; Sun MY, 2016, NEUROSCIENTIST, V22, P132, DOI 10.1177/1073858414568122; White MA, 2008, ACTA CRYSTALLOGR D, V64, P487, DOI 10.1107/S0907444908004046; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	35	32	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11876	11886		10.1074/jbc.M116.723577	http://dx.doi.org/10.1074/jbc.M116.723577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27056331	Green Published, hybrid			2022-12-26	WOS:000377264800036
J	Yuan, Q; Dohrmann, PR; Sutton, MD; McHenry, CS				Yuan, Quan; Dohrmann, Paul R.; Sutton, Mark D.; McHenry, Charles S.			DNA Polymerase III, but Not Polymerase IV, Must Be Bound to a tau-Containing DnaX Complex to Enable Exchange into Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SLIDING-CLAMP; TRANSLESION SYNTHESIS; PROCESSIVITY CLAMP; ALPHA-SUBUNIT; HOLOENZYME; PURIFICATION; BINDING; PROTEINS; DOMAIN	Examples of dynamic polymerase exchange have been previously characterized in model systems provided by coliphages T4 and T7. Using a dominant negative D403E polymerase (Pol) III alpha that can form initiation complexes and sequester primer termini but not elongate, we investigated the possibility of exchange at the Escherichia coli replication fork on a rolling circle template. Unlike other systems, addition of polymerase alone did not lead to exchange. Only when D403E Pol III was bound to a tau-containing DnaX complex did exchange occur. In contrast, addition of Pol IV led to rapid exchange in the absence of bound DnaX complex. Examination of Pol III* with varying composition of tau or the alternative shorter dnaX translation product gamma showed that tau-, tau(2)-, or tau(3)-DnaX complexes supported equivalent levels of synthesis, identical Okazaki fragment size, and gaps between fragments, possessed the ability to challenge pre-established replication forks, and displayed equivalent susceptibility to challenge by exogenous D403E Pol III*. These findings reveal that redundant interactions at the replication fork must stabilize complexes containing only one tau. Previously, it was thought that at least two tau s in the trimeric DnaX complex were required to couple the leading and lagging strand polymerases at the replication fork. Possible mechanisms of exchange are discussed.	[Yuan, Quan; Dohrmann, Paul R.; McHenry, Charles S.] Univ Colorado, Dept Chem & Biochem, 3415 Colorado Ave, Boulder, CO 80303 USA; [Sutton, Mark D.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept of Biochem, Buffalo, NY 14214 USA	University of Colorado System; University of Colorado Boulder; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	McHenry, CS (corresponding author), Univ Colorado, Dept Chem & Biochem, 3415 Colorado Ave, Boulder, CO 80303 USA.	charles.mchenry@colorado.edu	yuan, quan/GZM-5597-2022		National Science Foundation [MCB-1329285]; Public Health Service Award from the NIGMS/National Institutes of Health [R01 GM066094]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066094] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1329285] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Public Health Service Award from the NIGMS/National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Award MCB-1329285 (to C. S. M.) and a Public Health Service Award R01 GM066094 from the NIGMS/National Institutes of Health (to M. D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This is the last original research paper based on work initiated in the McHenry laboratory during our 40 years of investigating mechanisms of DNA replication. It is particularly fitting that the first paper from our laboratory (1) was also published in this Journal.	Burnouf DY, 2004, J MOL BIOL, V335, P1187, DOI 10.1016/j.jmb.2003.11.049; CARTER JR, 1993, NUCLEIC ACIDS RES, V21, P3281, DOI 10.1093/nar/21.14.3281; Clover BP, 2001, CELL, V105, P925, DOI 10.1016/S0092-8674(01)00400-7; Dohrmann PR, 2016, NUCLEIC ACIDS RES, V44, P1285, DOI 10.1093/nar/gkv1510; Dohrmann PR, 2011, J MOL BIOL, V414, P15, DOI 10.1016/j.jmb.2011.09.039; Downey CD, 2011, J MOL BIOL, V412, P340, DOI 10.1016/j.jmb.2011.07.051; Downey CD, 2010, MOL CELL, V37, P481, DOI 10.1016/j.molcel.2010.01.013; Eckstein F., 1995, NUCLEIC ACIDS MOL BI, P115; Fernandez-Leiro R, 2015, ELIFE, V4, DOI 10.7554/eLife.11134; Furukohri A, 2008, J BIOL CHEM, V283, P11260, DOI 10.1074/jbc.M709689200; Gabbai CB, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.613257; Gao DX, 2001, J BIOL CHEM, V276, P4441, DOI 10.1074/jbc.M009830200; Georgescu RE, 2012, NAT STRUCT MOL BIOL, V19, P113, DOI 10.1038/nsmb.2179; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; Heltzel JMH, 2012, J BACTERIOL, V194, P3589, DOI 10.1128/JB.00520-12; Heltzel JMH, 2009, P NATL ACAD SCI USA, V106, P12664, DOI 10.1073/pnas.0903460106; Ikeda M, 2014, NUCLEIC ACIDS RES, V42, P8461, DOI 10.1093/nar/gku547; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Jergic S, 2013, EMBO J, V32, P1322, DOI 10.1038/emboj.2012.347; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Johnson DE, 2007, P NATL ACAD SCI USA, V104, P5312, DOI 10.1073/pnas.0701062104; KABOORD BF, 1995, CURR BIOL, V5, P149, DOI 10.1016/S0960-9822(95)00036-4; Kath JE, 2016, NUCLEIC ACIDS RES, V44, P1681, DOI 10.1093/nar/gkv1375; Kath JE, 2014, P NATL ACAD SCI USA, V111, P7647, DOI 10.1073/pnas.1321076111; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; Kim DR, 1996, J BIOL CHEM, V271, P20690, DOI 10.1074/jbc.271.34.20690; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Lia G, 2012, SCIENCE, V335, P328, DOI 10.1126/science.1210400; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; Maul RW, 2007, MOL MICROBIOL, V65, P811, DOI 10.1111/j.1365-2958.2007.05828.x; McHenry C. S., 1988, DNA REPLICATION MUTA, P14; McHenry C. S., 2015, MOL LIFE SCI ENCY RE; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; Postow L, 1999, BIOESSAYS, V21, P805, DOI 10.1002/(SICI)1521-1878(199910)21:10<805::AID-BIES1>3.0.CO;2-7; Pritchard AE, 1999, J MOL BIOL, V285, P1067, DOI 10.1006/jmbi.1998.2352; Scotland MK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005507; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Tanner NA, 2011, EMBO J, V30, P1830, DOI 10.1038/emboj.2011.84; Wieczorek A, 2006, J BIOL CHEM, V281, P12561, DOI 10.1074/jbc.M513844200; Wieczorek A, 2010, J BIOL CHEM, V285, P29049, DOI 10.1074/jbc.C110.165076; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Yuan Q, 2014, NUCLEIC ACIDS RES, V42, P1747, DOI 10.1093/nar/gkt1098; Yuan Q, 2009, J BIOL CHEM, V284, P31672, DOI 10.1074/jbc.M109.050740	47	13	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11727	11735		10.1074/jbc.M116.725358	http://dx.doi.org/10.1074/jbc.M116.725358			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27056333	Green Published, hybrid			2022-12-26	WOS:000377264800023
J	Guerrera, D; Shah, J; Vasileva, E; Sluysmans, S; Mean, I; Jond, L; Poser, I; Mann, M; Hyman, AA; Citi, S				Guerrera, Diego; Shah, Jimit; Vasileva, Ekaterina; Sluysmans, Sophie; Mean, Isabelle; Jond, Lionel; Poser, Ina; Mann, Matthias; Hyman, Anthony A.; Citi, Sandra			PLEKHA7 Recruits PDZD11 to Adherens Junctions to Stabilize Nectins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adherens junction; cadherin; epithelium; kidney; PDZ domain; PLEKHA7; nectin	GENOME-WIDE ASSOCIATION; ANGLE-CLOSURE GLAUCOMA; CELL-CELL ADHESION; EPITHELIAL-CELLS; TIGHT-JUNCTION; BLOOD-PRESSURE; CONTAINING PROTEIN; DOMAIN PROTEIN; CINGULIN; CADHERIN	PLEKHA7 is a junctional protein implicated in stabilization of the cadherin protein complex, hypertension, cardiac contractility, glaucoma, microRNA processing, and susceptibility to bacterial toxins. To gain insight into the molecular basis for the functions of PLEKHA7, we looked for new PLEKHA7 interactors. Here, we report the identification of PDZ domain-containing protein 11 (PDZD11) as a new interactor of PLEKHA7 by yeast two-hybrid screening and by mass spectrometry analysis of PLEKHA7 immunoprecipitates. We show that PDZD11 (17 kDa) is expressed in epithelial and endothelial cells, where it forms a complex with PLEKHA7, as determined by co-immunoprecipitation analysis. The N-terminal Trp-Trp (WW) domain of PLEKHA7 interacts directly with the N-terminal 44 amino acids of PDZD11, as shown by GST-pulldown assays. Immunofluorescence analysis shows that PDZD11 is localized at adherens junctions in a PLEKHA7-dependent manner, because its junctional localization is abolished by knock-out of PLEKHA7, and is rescued by re-expression of exogenous PLEKHA7. The junctional recruitment of nectin-1 and nectin-3 and their protein levels are decreased via proteasome-mediated degradation in epithelial cells where either PDZD11 or PLEKHA7 have been knocked-out. PDZD11 forms a complex with nectin-1 and nectin-3, and its PDZ domain interacts directly with the PDZ-binding motif of nectin-1. PDZD11 is required for the efficient assembly of apical junctions of epithelial cells at early time points in the calcium-switch model. These results show that the PLEKHA7-PDZD11 complex stabilizes nectins to promote efficient early junction assembly and uncover a new molecular mechanism through which PLEKHA7 recruits PDZ-binding membrane proteins to epithelial adherens junctions.	[Guerrera, Diego; Shah, Jimit; Vasileva, Ekaterina; Sluysmans, Sophie; Mean, Isabelle; Jond, Lionel; Citi, Sandra] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Guerrera, Diego; Shah, Jimit; Vasileva, Ekaterina; Sluysmans, Sophie; Mean, Isabelle; Jond, Lionel; Citi, Sandra] Univ Geneva, Inst Genet & Genom Geneva iGE3, CH-1211 Geneva 4, Switzerland; [Poser, Ina; Hyman, Anthony A.] Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; [Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Geneva; University of Geneva; Max Planck Society; Max Planck Society	Citi, S (corresponding author), Dept Cell Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	sandra.citi@unige.ch	Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017	Hyman, Anthony A/0000-0003-3664-154X; Citi, Sandra/0000-0002-6537-4818; Guerrera, Diego/0000-0002-5323-4447	Swiss National Fund [31003A103637, 31003A116763]; Swiss Cancer League [KFS-2813-08-2011]	Swiss National Fund(Swiss National Science Foundation (SNSF)); Swiss Cancer League	This work was supported in part by Swiss National Fund Grants 31003A103637 and 31003A116763 and the Swiss Cancer League Grant KFS-2813-08-2011 (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi M, 2009, MOL CELL BIOL, V29, P2372, DOI 10.1128/MCB.01505-08; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Asakura T, 1999, GENES CELLS, V4, P573, DOI 10.1046/j.1365-2443.1999.00283.x; Cardellini P, 1996, DEV DYNAM, V207, P104, DOI 10.1002/(SICI)1097-0177(199609)207:1<104::AID-AJA10>3.0.CO;2-0; Chen YH, 2014, INVEST OPHTH VIS SCI, V55, P3797, DOI 10.1167/iovs.14-14370; Citi S, 2001, CELL CELL INTERACTIO, P153; Citi S, 2012, ANN NY ACAD SCI, V1257, P125, DOI 10.1111/j.1749-6632.2012.06506.x; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; Dudak A, 2011, EUR J CELL BIOL, V90, P365, DOI 10.1016/j.ejcb.2011.01.004; Endres BT, 2014, P NATL ACAD SCI USA, V111, P12817, DOI 10.1073/pnas.1410745111; Fukuhara A, 2002, GENES CELLS, V7, P1059, DOI 10.1046/j.1365-2443.2002.00578.x; Goellner GM, 2003, ANN NY ACAD SCI, V986, P461, DOI 10.1111/j.1749-6632.2003.tb07230.x; Guillemot L, 2014, MOL BIOL CELL, V25, P1995, DOI 10.1091/mbc.E13-11-0680; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hong KW, 2010, J HUM GENET, V55, P336, DOI 10.1038/jhg.2010.31; Hoshino T, 2004, MOL BIOL CELL, V15, P1077, DOI 10.1091/mbc.E03-05-0321; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Ishiuchi T, 2012, GENES CELLS, V17, P387, DOI 10.1111/j.1365-2443.2012.01593.x; Kourtidis A, 2015, NAT CELL BIOL, V17, P1145, DOI 10.1038/ncb3227; Kurita S, 2013, J BIOL CHEM, V288, P29356, DOI 10.1074/jbc.M113.453464; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lin YH, 2011, ATHEROSCLEROSIS, V219, P709, DOI 10.1016/j.atherosclerosis.2011.09.006; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Mandai K, 2015, CURR TOP DEV BIOL, V112, P197, DOI 10.1016/bs.ctdb.2014.11.019; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; Nabokina SM, 2011, AM J PHYSIOL-GASTR L, V300, pG561, DOI 10.1152/ajpgi.00530.2010; Paschoud S, 2008, MOL MEMBR BIOL, V25, P1, DOI 10.1080/09687680701474009; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Paschoud S, 2011, MOL MEMBR BIOL, V28, P123, DOI 10.3109/09687688.2010.538937; Popov LM, 2015, P NATL ACAD SCI USA, V112, P14337, DOI 10.1073/pnas.1510265112; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Reymond N, 2005, FEBS LETT, V579, P2243, DOI 10.1016/j.febslet.2005.03.010; Rikitake Y, 2012, J CELL SCI, V125, P3713, DOI 10.1242/jcs.099572; Shah J, 2016, INT J BIOCHEM CELL B, V75, P112, DOI 10.1016/j.biocel.2016.04.001; Spadaro D, 2014, J BIOL CHEM, V289, P22500, DOI 10.1074/jbc.M114.556449; Stephenson SEM, 2005, J BIOL CHEM, V280, P33270, DOI 10.1074/jbc.M505889200; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wythe JD, 2011, DIS MODEL MECH, V4, P607, DOI 10.1242/dmm.002204; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783; Zhang JX, 2012, J BIOL CHEM, V287, P11132, DOI 10.1074/jbc.M111.321216	50	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11016	11029		10.1074/jbc.M115.712935	http://dx.doi.org/10.1074/jbc.M115.712935			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27044745	hybrid, Green Published			2022-12-26	WOS:000377042100006
J	Hsieh, LS; Su, WM; Han, GS; Carman, GM				Hsieh, Lu-Sheng; Su, Wen-Min; Han, Gil-Soo; Carman, George M.			Phosphorylation of Yeast Pah1 Phosphatidate Phosphatase by Casein Kinase II Regulates Its Function in Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL-ELECTROPHORESIS; NUCLEAR-MEMBRANE GROWTH; PATCH PROTEIN APP1P; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; GLOBAL ANALYSIS; BETA-SUBUNIT; SIGNAL-TRANSDUCTION; MEDIATED REGULATION; ORTHOLOGUE PAH1P	Pah1 phosphatidate phosphatase in Saccharomyces cerevisiae catalyzes the penultimate step in the synthesis of triacylglycerol (i.e. the production of diacylglycerol by dephosphorylation of phosphatidate). The enzyme playing a major role in lipid metabolism is subject to phosphorylation (e.g. by Pho85-Pho80, Cdc28-cyclin B, and protein kinases A and C) and dephosphorylation (e.g. by Nem1-Spo7) that regulate its cellular location, catalytic activity, and stability/degradation. In this work, we show that Pah1 is a substrate for casein kinase II (CKII); its phosphorylation was time-and dose-dependent and was dependent on the concentrations of Pah1 (K-m = 0.23 mu M) and ATP (K-m = 5.5 mu M). By mass spectrometry, truncation analysis, site-directed mutagenesis, phosphopeptide mapping, and phosphoamino acid analysis, we identified that >90% of its phosphorylation occurs on Thr-170, Ser-250, Ser-313, Ser-705, Ser-814, and Ser-818. The CKII-phosphorylated Pah1 was a substrate for the Nem1-Spo7 protein phosphatase and was degraded by the 20S proteasome. The prephosphorylation of Pah1 by protein kinase A or protein kinase C reduced its subsequent phosphorylation by CKII. The prephosphorylation of Pah1 by CKII reduced its subsequent phosphorylation by protein kinase A but not by protein kinase C. The expression of Pah1 with combined mutations of S705D and 7A, which mimic its phosphorylation by CKII and lack of phosphorylation by Pho85-Pho80, caused an increase in triacylglycerol content and lipid droplet number in cells expressing the Nem1-Spo7 phosphatase complex.	Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Lu-Sheng, Hsieh/AAZ-9188-2020	Lu-Sheng, Hsieh/0000-0001-7555-759X; Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health [NS046593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge Symeon Siniossoglou for supplying the pah1 Delta and pah1 Delta nem1 Delta mutants used in this study. The mass spectrometry data were obtained from an instrument purchased in part by National Institutes of Health Grant NS046593 for the support of the Rutgers Mass Spectrometry Center for Integrative Neuroscience Research.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; BIDWAI AP, 1995, J BIOL CHEM, V270, P10395, DOI 10.1074/jbc.270.18.10395; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 1996, CHEM PHYS LIPIDS, V80, P45, DOI 10.1016/0009-3084(96)02545-5; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Chae M, 2013, J BIOL CHEM, V288, P6427, DOI 10.1074/jbc.M112.449629; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Chang YF, 2006, J BIOL CHEM, V281, P4754, DOI 10.1074/jbc.M513064200; CHENWU JLP, 1988, MOL CELL BIOL, V8, P4981, DOI 10.1128/MCB.8.11.4981; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P1698, DOI 10.1021/bi00536a035; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leggett David S., 2005, V301, P57; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIN YP, 1989, J BIOL CHEM, V264, P8641; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lussier M, 1997, GENETICS, V147, P435; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; PADMANABHA R, 1987, J BIOL CHEM, V262, P1829; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; REED JC, 1994, J BIOL CHEM, V269, P18192; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Rose MD., 1990, METHODS YEAST GENETI; Ruiz C, 1999, YEAST, V15, P1001; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Siniossoglou S, 2009, TRAFFIC, V10, P1181, DOI 10.1111/j.1600-0854.2009.00923.x; SMITH SW, 1957, J BIOL CHEM, V228, P915; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; WHITE MJ, 1991, J BIOL CHEM, V266, P863; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983	108	27	29	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9974	9990		10.1074/jbc.M116.726588	http://dx.doi.org/10.1074/jbc.M116.726588			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27044741	hybrid, Green Published			2022-12-26	WOS:000375602800012
J	Miyazaki, R; Anayama, T; Hirohashi, K; Okada, H; Kume, M; Orihashi, K				Miyazaki, Ryohei; Anayama, Takashi; Hirohashi, Kentaro; Okada, Hironobu; Kume, Motohiko; Orihashi, Kazumasa			In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; DROPLET-EMBEDDED CULTURE; CHEMOSENSITIVITY TEST; CELL; GEFITINIB; IMMUNOHISTOCHEMISTRY; CHEMOTHERAPY; SPECIMENS; SARCOMA; PATIENT	Background Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and anaplastic lymphoma kinase (ALK) inhibitors have dramatically changed the strategy of medical treatment of lung cancer. Patients should be screened for the presence of the EGFR mutation or echinoderm microtubule-associated protein-like 4 (EML4)-ALK fusion gene prior to chemotherapy to predict their clinical response. The succinate dehydrogenase inhibition (SDI) test and collagen gel droplet embedded culture drug sensitivity test (CD-DST) are established in vitro drug sensitivity tests, which may predict the sensitivity of patients to cytotoxic anticancer drugs. We applied in vitro drug sensitivity tests for cyclopedic prediction of clinical responses to different molecular targeting drugs. Methods The growth inhibitory effects of erlotinib and crizotinib were confirmed for lung cancer cell lines using SDI and CD-DST. The sensitivity of 35 cases of surgically resected lung cancer to erlotinib was examined using SDI or CD-DST, and compared with EGFR mutation status. Results HCC827 (Exon19: E746-A750 del) and H3122 (EML4-ALK) cells were inhibited by lower concentrations of erlotinib and crizotinib, respectively than A549, H460, and H1975 (L858R+T790M) cells were. The viability of the surgically resected lung cancer was 60.0 +/- 9.8 and 86.8 +/- 13.9% in EGFR-mutants vs. wild types in the SDI (p = 0.0003). The cell viability was 33.5 +/- 21.2 and 79.0 +/- 18.6% in EGFR mutants vs. wild-type cases (p = 0.026) in CD-DST. Conclusions In vitro drug sensitivity evaluated by either SDI or CD-DST correlated with EGFR gene status. Therefore, SDI and CD-DST may be useful predictors of potential clinical responses to the molecular anticancer drugs, cyclopedically.	[Miyazaki, Ryohei; Anayama, Takashi; Hirohashi, Kentaro; Okada, Hironobu; Kume, Motohiko; Orihashi, Kazumasa] Kochi Univ, Kochi Med Sch, Div Thorac Surg, Dept Surg 2, Nankoku, Kochi, Japan	Kochi University	Anayama, T (corresponding author), Kochi Univ, Kochi Med Sch, Div Thorac Surg, Dept Surg 2, Nankoku, Kochi, Japan.	anayamat@kochi-u.ac.jp			Kochi Medical School, Kochi University, Japan	Kochi Medical School, Kochi University, Japan	The study was fully funded by the unlimited official fund provided by Kochi Medical School, Kochi University, Japan, http://www.kochi-ms.ac.jp/.	Akobeng AK., 2007, ACTA PAEDIATR, V96; Anayama T, 2001, INT J ONCOL, V18, P151; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Higashiyama M, 2010, LUNG CANCER, V68; Hoekstra R, 2005, CLIN CANCER RES, V11, P6908, DOI 10.1158/1078-0432.CCR-05-0720; Kawamura M, 2007, CANCER CHEMOTH PHARM, V59, P507, DOI 10.1007/s00280-006-0292-8; KIMURA H, 1992, SURG TODAY, V22, P508, DOI 10.1007/BF00308895; Kobayashi H, 2005, METH MOLEC MED, V110, P59; Kobayashi H, 1997, INT J ONCOL, V11, P449; Kobayashi H, 2003, RECENT RESULTS CANC, V161, P48; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Le Quesne J, 2014, J THORAC ONCOL, V9, P769, DOI 10.1097/JTO.0000000000000157; Mitsudomi T, 2010, JPN J CLIN ONCOL, V40, P101, DOI 10.1093/jjco/hyp174; Nagai Y, 2005, CANCER RES, V65; Nakatani K, 2007, EUR J CANCER CARE, V16; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schwitter M, 2013, CASE REP ONCOL, V6, P263, DOI 10.1159/000351607; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Sholl LM, 2013, J THORAC ONCOL, V8, P322, DOI 10.1097/JTO.0b013e31827db604; Sudo M, 2013, CANCER CHEMOTH PHARM, V71, P1325, DOI 10.1007/s00280-013-2132-y; TAKEUCHI H, 1994, ANTICANCER RES, V14, P169; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Tanahashi M, 2010, J THORAC ONCOL, V5, P1376, DOI 10.1097/JTO.0b013e3181e7d035; Tanaka T, 2007, CANCER SCI, V98; Tsai TH, 2013, LUNG CANCER, V82, P420, DOI 10.1016/j.lungcan.2013.10.005; Uramoto H, 2007, BRIT J CANCER, V96, P857, DOI 10.1038/sj.bjc.6603665; Yamamoto Y, 2012, INTERNAL MED, V51, P2893, DOI 10.2169/internalmedicine.51.8325; Yoshimasu T, 2009, GEN THORAC CARDIOVAS, V57, P138, DOI 10.1007/s11748-008-0332-x	30	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152665	10.1371/journal.pone.0152665	http://dx.doi.org/10.1371/journal.pone.0152665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070423	Green Published, gold			2022-12-26	WOS:000373900700013
J	Collins, FL; Irwin, R; Bierhalter, H; Schepper, J; Britton, RA; Parameswaran, N; McCabe, LR				Collins, Fraser L.; Irwin, Regina; Bierhalter, Hayley; Schepper, Jonathan; Britton, Robert A.; Parameswaran, Narayanan; McCabe, Laura R.			Lactobacillus reuteri 6475 Increases Bone Density in Intact Females Only under an Inflammatory Setting	PLOS ONE			English	Article							INTESTINAL MICROBIOME; GENDER-DIFFERENCES; T-CELLS; EXPRESSION; CYTOKINES; OBESITY; TYPE-1; OSTEOCLASTOGENESIS; OSTEOPROTEGERIN; INTERLEUKIN-10	Background & Aims We previously demonstrated that short-term oral administration of the probiotic Lactobacillus reuteri 6475 enhanced bone density in male but not female mice. We also established that L. reuteri 6475 enhanced bone health and prevented bone loss in estrogen-deficient female mice. In this study, we tested whether a mild inflammatory state and/or a long-term treatment with the probiotic was required to promote a positive bone effect in estrogen-sufficient female mice. Methods A mild inflammatory state was induced in female mice by dorsal surgical incision (DSI). Following DSI animals were orally supplemented with L. reuteri or vehicle control for a period of 8 weeks. Gene expression was measured in the intestine and bone marrow by qPCR. Distal femoral bone density and architecture was analyzed by micro-CT. Results We report that 8 weeks after DSI there is a significant increase in the weight of spleen, thymus and visceral (retroperitoneal) fat pads. Expression of intestinal cytokines and tight junction proteins are also altered 8 weeks post-DSI. Interestingly, L. reuteri treatment was found to display both intestinal region-and inflammation-dependent effects. Unexpectedly we identified that 1) L. reuteri treatment increased bone density in females but only in those that underwent DSI and 2) DSI benefited cortical bone parameters. In the bone marrow, dorsal surgery induced CD4(+) T cell numbers, a response that was unaffected by L. reuteri treatment, whereas expression of RANKL, OPG and IL-10 were significantly affected by L. reuteri treatment. Conclusion Our data reveals a previously unappreciated effect of a mild surgical procedure causing a long-lasting effect on inflammatory gene expression in the gut and the bone. Additionally, we demonstrate that in intact female mice, the beneficial effect of L. reuteri on bone requires an elevated inflammatory status.	[Collins, Fraser L.; Irwin, Regina; Bierhalter, Hayley; Schepper, Jonathan; Parameswaran, Narayanan; McCabe, Laura R.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Britton, Robert A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [McCabe, Laura R.] Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA; [McCabe, Laura R.] Michigan State Univ, Biomed Imaging Res Ctr, E Lansing, MI 48824 USA	Michigan State University; Baylor College of Medicine; Michigan State University; Michigan State University	Parameswaran, N; McCabe, LR (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.; McCabe, LR (corresponding author), Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA.; McCabe, LR (corresponding author), Michigan State Univ, Biomed Imaging Res Ctr, E Lansing, MI 48824 USA.	narap@msu.edu; mccabel@msu.edu	Collins, Fraser/AAT-7889-2020; Parameswaran, Narayanan/V-1969-2019	Collins, Fraser/0000-0002-1156-6873; Parameswaran, Narayanan/0000-0002-8894-5564	National Center for Complementary and Integrative Health, U.S National Institutes of Health [1R01AT007695-01]; National Institute of Diabetes and Digestive and Kidney Diseases, U.S National Institutes of Health [R01DK101050]; National Institute of Health [RO1 DK101050, RO1 AT007695]; National Center for Complementary & Integrative Health [R01AT007695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101050, P30DK020572] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health, U.S National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases, U.S National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Study funded by National Center for Complementary and Integrative Health (https://nccih.nih.gov/), U.S National Institutes of Health (Grant Code: 1R01AT007695-01) awarded to LRM, NP and RAB and by National Institute of Diabetes and Digestive and Kidney Diseases (www.niddk.nih.gov/), U.S National Institutes of Health (Grant code: R01DK101050) awarded to LRM and NP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Investigative Histology Laboratory in the Department of Physiology, Division of Human Pathology and the Biomedical Imaging Center at Michigan State University for their assistance with histology and imaging, respectively. The authors are also grateful to the staff of Campus Animal Resources for the excellent care of our animals. These studies were supported by funding from the National Institute of Health, grants RO1 DK101050 and RO1 AT007695.	Amarasekara DS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/832127; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Blair HC, 2004, HISTOL HISTOPATHOL, V19, P189, DOI 10.14670/HH-19.189; Britton RA, 2014, J CELL PHYSIOL, V229, P1822, DOI 10.1002/jcp.24636; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cao JJ, 2010, ANN NY ACAD SCI, V1192, P292, DOI 10.1111/j.1749-6632.2009.05252.x; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Diodato MD, 2001, CYTOKINE, V14, P162, DOI 10.1006/cyto.2001.0861; Ducy P, 2010, J CELL BIOL, V191, P7, DOI 10.1083/jcb.201006123; Dunne JL, 2014, CLIN EXP IMMUNOL, V177, P30, DOI 10.1111/cei.12321; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Halade GV, 2011, EXP GERONTOL, V46, P43, DOI 10.1016/j.exger.2010.09.014; Harris L, 2009, AM J PHYSIOL-GASTR L, V296, pG1020, DOI 10.1152/ajpgi.90696.2008; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Irwin R, 2015, AM J PHYSL GAS UNPUB; Irwin R, 2013, INFLAMM BOWEL DIS, V19, P1586, DOI 10.1097/MIB.0b013e318289e17b; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Kyung TW, 2009, J NUTR, V139, P502, DOI 10.3945/jn.108.100032; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Liu DW, 2006, EUR J ORAL SCI, V114, P42, DOI 10.1111/j.1600-0722.2006.00283.x; Mccabe LR, 2013, J CELL PHYSIOL, V228, P1793, DOI 10.1002/jcp.24340; McCabe LR, 2011, CRIT REV EUKAR GENE, V21, P187, DOI 10.1615/CritRevEukarGeneExpr.v21.i2.70; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nakchbandi IA, 2009, NAT REV GASTRO HEPAT, V6, P660, DOI 10.1038/nrgastro.2009.166; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; O'Brien CA, 2013, BONE, V54, P258, DOI 10.1016/j.bone.2012.08.121; Ohlsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092368; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020; Shirkey TW, 2006, EXP BIOL MED, V231, P1333, DOI 10.1177/153537020623100807; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Udagawa N, 2000, ENDOCRINOLOGY, V141, P3478, DOI 10.1210/en.141.9.3478; Verdam FJ, 2013, OBESITY, V21, pE607, DOI 10.1002/oby.20466; Wei S, 2005, TNF INDUCED OSTEOCLA, V115, DOI [10.1172/JCI200523394.282, DOI 10.1172/JCI200523394.282]; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Xu SQ, 2012, RHEUMATOL INT, V32, P3397, DOI 10.1007/s00296-011-2175-5; Zhang J, 2015, ENDOCRINOLOGY, V156, P3169, DOI 10.1210/EN.2015-1308	52	61	67	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153180	10.1371/journal.pone.0153180	http://dx.doi.org/10.1371/journal.pone.0153180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058036	Green Published, gold, Green Submitted			2022-12-26	WOS:000373604800020
J	Chen, G; Le, Y; Zhou, L; Gong, L; Li, XX; Li, YL; Liao, Q; Duan, KM; Tong, JB; Ouyang, W				Chen, Gong; Le, Yuan; Zhou, Lei; Gong, Li; Li, Xiaoxiao; Li, Yunli; Liao, Qin; Duan, Kaiming; Tong, Jianbin; Ouyang, Wen			Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23	PLOS ONE			English	Article							CANCER RECURRENCE; ANESTHETIC TECHNIQUE; BREAST-CANCER; IN-VITRO; T-CELLS; ACTIVATION; SURGERY; METASTASIS; ISOFLURANE; PROPOFOL	Aims To investigate the effects and underlying mechanism of dexmedetomidine on the cultured human dendritic cells (DCs). Methods Human DCs and cytotoxic T lymphocytes (CTLs) were obtained from human cord blood mononuclear cells by density gradient centrifugation. Cultured DCs were divided into three groups: dexmedetomidine group, dexmedetomidine plus yohimbine (dexmedetomidine inhibitor) group and control group. DCs in the three groups were treated with dexmedetomidine, dexmedetomidine plus yohimbine and culture medium, respectively. After washing, the DCs were co-incubated with cultured CTLs. The maturation degree of DCs was evaluated by detecting (1) the ratios of HLA-DR-, CD86-, and CD80-positive cells (flow cytometry), and (2) expression of IL-12 and IL-23 (PCR and Elisa). The function of DCs was evaluated by detecting the proliferation (MTS assay) and cytotoxicity activity (the Elisa of IFN-gamma) of CTLs. In addition, in order to explore the mechanisms of dexmedetomidine modulating DCs, alpha 2-adrenergic receptor and its downstream signals in DCs were also detected. Results The ratios of HLA-DR-, CD86-, and CD80-positive cells to total cells were similar among the three groups (P>0.05). Compared to the control group, the protein levels of IL-12 and IL-23 in the culture medium and the mRNA levels of IL-12 p35, IL-12 p40 and IL-23 p19 in the DCs all decreased in dexmedetomidine group (P<0.05). In addition, the proliferation of CTLs and the secretion of IFN-gamma also decreased in the dexmedetomidine group, compared with the control group (P<0.05). Moreover, these changes induced by dexmedetomidine in the dexmedetomidine group were reversed by alpha 2-adrenergic receptor inhibitor yohimbine in the dexmedetomidine plus yohimbine group. It was also found the decrease of mRNA levels of IL-12 p35, IL-12 p40 and IL-23 p19 in the dexmedetomidine group could be reversed by ERK1/2 or AKT inhibitors. Conclusion Dexmedetomidine could negatively modulate human immunity by inhibiting the maturation of DCs and then decreasing the proliferation and cytotoxicity activity of CTLs. The alpha 2-adrenergic receptors and its downstream molecules ERK1/2 and AKT are closely involved in the modulation of dexmedetomidine on DCs.	[Chen, Gong; Le, Yuan; Zhou, Lei; Gong, Li; Li, Xiaoxiao; Li, Yunli; Liao, Qin; Duan, Kaiming; Tong, Jianbin; Ouyang, Wen] Cent S Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China; [Tong, Jianbin] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China	Central South University; Central South University	Tong, JB; Ouyang, W (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China.; Tong, JB (corresponding author), Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China.	jianbintong@aliyun.com; ouyangwen133@vip.sina.com			National Natural Science Foundation of China [81172200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from National Natural Science Foundation of China (No. 81172200), www.nsfc.gov.cn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CANCER PREV RES, V6, P1262, DOI [10.1158/1940-6207.CAPR-13-0079, DOI 10.1158/1940-6207.CAPR-13-0079]; [Anonymous], 2008, ANESTHESIOLOGY, V109, P180, DOI [10.1097/ALN.0b013e31817f5b73, DOI 10.1097/ALN.0B013E31817F5B73]; [Anonymous], 2010, ANESTHESIOLOGY, V113, P570, DOI [10.1097/ALN.0b013e3181e4f6ec, DOI 10.1097/ALN.0B013E3181E4F6EC]; [Anonymous], 2011, ANESTHESIOLOGY, V114, P355, DOI [10.1097/ALN.0b013e3182070c1f, DOI 10.1097/ALN.0B013E3182070C1F]; Benzonana LL, 2013, ANESTHESIOLOGY, V119, P593, DOI 10.1097/ALN.0b013e31829e47fd; Dudek AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00438; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Gong L, 2013, MED HYPOTHESES, V80, P308, DOI 10.1016/j.mehy.2012.12.013; Gottschalk A, 2010, ANESTH ANALG, V110, P1636, DOI 10.1213/ANE.0b013e3181de0ab6; Gu JT, 2011, CRIT CARE, V15, DOI 10.1186/cc10283; Guery L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/314620; Hennon Mark W, 2013, Zhongguo Fei Ai Za Zhi, V16, pC5, DOI 10.3779/j.issn.1009-3419.2013.03.11; Hiller J, 2013, BEST PRAC RES-CL ANA, V27, P427, DOI 10.1016/j.bpa.2013.10.003; Huang H, 2014, BRIT J CANCER, V111, P1338, DOI 10.1038/bjc.2014.426; Iwasaki Masae, 2015, Acta Anaesthesiol Taiwan, V53, P99, DOI 10.1016/j.aat.2015.07.002; Kang BY, 2003, EUR J PHARMACOL, V467, P223, DOI 10.1016/S0014-2999(03)01628-5; Koda K, 2003, J AM COLL SURGEONS, V197, P254, DOI 10.1016/S1072-7515(03)00115-7; Koda K, 1997, INT SURG, V82, P190; Liu QL, 2009, HEPATOB PANCREAT DIS, V8, P529; Luo X, 2015, BRIT J ANAESTH, V114, P831, DOI 10.1093/bja/aeu408; Ma DQ, 2004, EUR J PHARMACOL, V502, P87, DOI 10.1016/j.ejphar.2004.08.044; Mansfield AS, 2011, VIRCHOWS ARCH, V459, P391, DOI 10.1007/s00428-011-1145-3; Matsen CB, 2013, JAMA SURG, V148, P971, DOI 10.1001/jamasurg.2013.3393; Meng JJ, 2013, INT IMMUNOPHARMACOL, V17, P1084, DOI 10.1016/j.intimp.2013.10.012; Messmer D, 2006, MOL MED, V12, P284, DOI 10.2119/2006-00043.Messmer; Ngiow SF, 2013, TRENDS IMMUNOL, V34, P548, DOI 10.1016/j.it.2013.07.004; Ohta N, 2009, ANESTH ANALG, V109, P793, DOI 10.1213/ane.0b013e3181adc384; Qiao H, 2009, CRIT CARE, V13, DOI 10.1186/cc8012; Snyder GL, 2010, BRIT J ANAESTH, V105, P106, DOI 10.1093/bja/aeq164; Sud R, 2008, EUR J PHARMACOL, V588, P217, DOI 10.1016/j.ejphar.2008.04.043; Tavare AN, 2012, INT J CANCER, V130, P1237, DOI 10.1002/ijc.26448; Ueshima H, 2013, IMMUNOPHARM IMMUNOT, V35, P558, DOI 10.3109/08923973.2013.822509; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang JH, 2011, J BIOL CHEM, V286, P10225, DOI 10.1074/jbc.M110.188680; Xia ZQ, 2013, J SURG RES, V185, P833, DOI 10.1016/j.jss.2013.06.062; Yanagawa Y, 2010, J IMMUNOL, V185, P5762, DOI 10.4049/jimmunol.1001899; Yaniv SP, 2010, EUR J CELL BIOL, V89, P712, DOI 10.1016/j.ejcb.2010.05.002; YJ L., 2001, CELL, V106, P259	38	11	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153288	10.1371/journal.pone.0153288	http://dx.doi.org/10.1371/journal.pone.0153288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054340	gold, Green Published, Green Submitted			2022-12-26	WOS:000373608000115
J	Herdman, MT; Maude, RJ; Chowdhury, MS; Kingston, HWF; Jeeyapant, A; Samad, R; Karim, R; Dondorp, AM; Hossain, MA				Herdman, M. Trent; Maude, Richard James; Chowdhury, Md. Safiqul; Kingston, Hugh W. F.; Jeeyapant, Atthanee; Samad, Rasheda; Karim, Rezaul; Dondorp, Arjen M.; Hossain, Md. Amir			The Relationship between Poverty and Healthcare Seeking among Patients Hospitalized with Acute Febrile Illnesses in Chittagong, Bangladesh	PLOS ONE			English	Article							SOCIOECONOMIC-DEVELOPMENT; OBSTETRIC CARE; CHILD HEALTH; MANAGEMENT; BEHAVIOR; INTERVENTIONS; MALARIA; DISEASE; GENDER; EQUITY	Delays in seeking appropriate healthcare can increase the case fatality of acute febrile illnesses, and circuitous routes of care-seeking can have a catastrophic financial impact upon patients in low-income settings. To investigate the relationship between poverty and pre-hospital delays for patients with acute febrile illnesses, we recruited a cross-sectional, convenience sample of 527 acutely ill adults and children aged over 6 months, with a documented fever >= 38.0 degrees C and symptoms of up to 14 days' duration, presenting to a tertiary referral hospital in Chittagong, Bangladesh, over the course of one year from September 2011 to September 2012. Participants were classified according to the socioeconomic status of their households, defined by the Oxford Poverty and Human Development Initiative's multidimensional poverty index (MPI). 51% of participants were classified as multidimensionally poor (MPI>0.33). Median time from onset of any symptoms to arrival at hospital was 22 hours longer for MPI poor adults compared to non-poor adults (123 vs. 101 hours) rising to a difference of 26 hours with adjustment in a multivariate regression model (95% confidence interval 7 to 46 hours; P = 0.009). There was no difference in delays for children from poor and non-poor households (97 vs. 119 hours; P = 0.394). Case fatality was 5.9% vs. 0.8% in poor and non-poor individuals respectively (P = 0.001)-5.1% vs. 0.0% for poor and non-poor adults (P = 0.010) and 6.4% vs. 1.8% for poor and non-poor children (P = 0.083). Deaths were attributed to central nervous system infection (11), malaria (3), urinary tract infection (2), gastrointestinal infection (1) and undifferentiated sepsis (1). Both poor and non-poor households relied predominantly upon the (often informal) private sector for medical advice before reaching the referral hospital, but MPI poor participants were less likely to have consulted a qualified doctor. Poor participants were more likely to attribute delays in decision-making and travel to a lack of money (P<0.001), and more likely to face catastrophic expenditure of more than 25% of monthly household income (P<0.001). We conclude that multidimensional poverty is associated with greater pre-hospital delays and expenditure in this setting. Closer links between health and development agendas could address these consequences of poverty and streamline access to adequate healthcare.	[Herdman, M. Trent; Maude, Richard James; Kingston, Hugh W. F.; Jeeyapant, Atthanee; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Herdman, M. Trent] Univ Oxford, Univ Coll, Oxford, England; [Maude, Richard James; Dondorp, Arjen M.] Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Chowdhury, Md. Safiqul; Samad, Rasheda; Karim, Rezaul; Hossain, Md. Amir] Chittagong Med Coll Hosp, Chittagong, Bangladesh; [Kingston, Hugh W. F.] Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT, Australia; [Kingston, Hugh W. F.] Charles Darwin Univ, Darwin, NT 0909, Australia	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of Oxford; Chittagong Medical College; Charles Darwin University; Menzies School of Health Research; Charles Darwin University	Herdman, MT (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.; Herdman, MT (corresponding author), Univ Oxford, Univ Coll, Oxford, England.	mtherdman@gmail.com	Maude, Richard James/AAV-3567-2020	Maude, Richard James/0000-0002-5355-0562	Radcliffe Travelling Fellowship, University College, University of Oxford; National Institute for Health Research [ACF-2014-18-007] Funding Source: researchfish	Radcliffe Travelling Fellowship, University College, University of Oxford; National Institute for Health Research(National Institute for Health Research (NIHR))	MTH was funded by the Radcliffe Travelling Fellowship, University College, University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269; Afsana K, 2004, REPROD HEALTH MATTER, V12, P171, DOI 10.1016/S0968-8080(04)24142-8; Ahmed S M, 2001, Asia Pac J Public Health, V13, P100, DOI 10.1177/101053950101300208; Ahmed S, 2011, HEALTH POLICY PLANN, V26, P25, DOI 10.1093/heapol/czq015; Ahmed SM, 2005, B WORLD HEALTH ORGAN, V83, P109; Ahmed SM, 2003, HEALTH POLICY PLANN, V18, P306, DOI 10.1093/heapol/czg037; Ahmed SM, 2000, SOC SCI MED, V51, P361, DOI 10.1016/S0277-9536(99)00461-X; Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Ahmed SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-173; ALKIRE S., 2010, 38 OPHI; ASHRAF A, 1982, SOC SCI MED, V16, P2041, DOI 10.1016/0277-9536(82)90160-5; Bangladesh Bureau of Statistics, 2012, POP HOUS CENS 2011 S; Bangladesh Bureau of Statistics, 2011, REP SAMPL VIT REG SY; Bhuiya A, 2007, J HEALTH POPUL NUTR, V25, P134; Chaudhury N, 2006, J ECON PERSPECT, V20, P91, DOI 10.1257/089533006776526058; Chaudhury N, 2003, 3065 WORLD BANK DEV; Chowdhury, 2018, CREATING CULTURE INN; Cockroft A, 2004, BANGLADESH HLTH POPU; Dhillon PK, 2012, INT J EPIDEMIOL, V41, P847, DOI 10.1093/ije/dys046; Dror DM, 2008, INDIAN J MED RES, V127, P347; El Arifeen S, 2008, J HEALTH POPUL NUTR, V26, P22; Elsinga J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004237; FerroLuzzi A, 1996, BRIT J NUTR, V75, P3, DOI 10.1079/BJN19960105; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Health WCoSDo, 2008, CLOS GAP GEN HLTH EQ; Killewo J, 2006, J HEALTH POPUL NUTR, V24, P403; Killingsworth JR, 1999, HEALTH POLICY PLANN, V14, P152, DOI 10.1093/heapol/14.2.152; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lin AL, 2010, NEUROLOGIST, V16, P143, DOI 10.1097/NRL.0b013e3181d14185; Najnin N, 2011, J HEALTH POPUL NUTR, V29, P523, DOI 10.3329/jhpn.v29i5.8907; National Institute of Population Research and Training Mitra and Associates & Macro International, 2009, BANGL DEM HLTH SURV; Organization for Economic Co-operation & Development, 1982, OECD LIST SOC IND; Pitchforth E, 2007, HEALTH POLICY PLANN, V22, P311, DOI 10.1093/heapol/czm022; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Ryan GW, 1998, SOC SCI MED, V46, P209, DOI 10.1016/S0277-9536(97)00151-2; Sayem ASM, 2011, THESIS; Sen B, 1997, HLTH POVERTY CONTEXT; Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X; United Nations Development Program, 2010, HUM DEV REP 2010 REA; Vialle-Valentin Catherine E, 2015, J Pharm Policy Pract, V8, P1, DOI 10.1186/s40545-014-0024-0; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; Webb P, 2005, MANUAL MEASURING INT; Werner WJ, 2009, J HEALTH POPUL NUTR, V27, P563; WHO, 2007, WHO BANGL COUNTR COO; World Bank Development Research Group, 2013, POV HEADC RAT 1 25 D	49	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152965	10.1371/journal.pone.0152965	http://dx.doi.org/10.1371/journal.pone.0152965			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054362	Green Published, gold			2022-12-26	WOS:000373608000059
J	Mezaal, YS; Eyyuboglu, HT				Mezaal, Yaqeen S.; Eyyuboglu, Halil T.			Investigation of New Microstrip Bandpass Filter Based on Patch Resonator with Geometrical Fractal Slot	PLOS ONE			English	Article							DEGENERATE MODES	A compact dual-mode microstrip bandpass filter using geometrical slot is presented in this paper. The adopted geometrical slot is based on first iteration of Cantor square fractal curve. This filter has the benefits of possessing narrower and sharper frequency responses as compared to microstrip filters that use single mode resonators and traditional dual-mode square patch resonators. The filter has been modeled and demonstrated by Microwave Office EM simulator designed at a resonant frequency of 2 GHz using a substrate of epsilon(r) = 10.8 and thickness of h = 1.27 mm. The output simulated results of the proposed filter exhibit 22 dB return loss, 0.1678 dB insertion loss and 12 MHz bandwidth in the passband region. In addition to the narrow band gained, miniaturization properties as well as weakened spurious frequency responses and blocked second harmonic frequency in out of band regions have been acquired. Filter parameters including insertion loss, return loss, bandwidth, coupling coefficient and external quality factor have been compared with different values of perturbation dimension (d). Also, a full comparative study of this filter as compared with traditional square patch filter has been considered.	[Mezaal, Yaqeen S.; Eyyuboglu, Halil T.] Cankaya Univ, Elect & Commun Engn Dept, Ankara, Turkey	Cankaya University	Mezaal, YS (corresponding author), Cankaya Univ, Elect & Commun Engn Dept, Ankara, Turkey.	yakeen_sbah@yahoo.com	Mezaal, Yaqeen Sabah/O-5095-2019	Mezaal, Yaqeen Sabah/0000-0002-9953-9975	Scientific and Technological Research Council of Turkey (TUBITAK) [21514107-115.02-188888]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work is supported by the Scientific and Technological Research Council of Turkey (TUBITAK) for Post-Doc Research Fellowship for Foreign Citizens Program under Fund Reference (21514107-115.02-188888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ES, 2012, RADIOENGINEERING, V21, P617; Barra M., 2004, THESIS U NAPOLI; Chang K., 2004, MICROWAVE RING CIRCU; Choi WW, 2005, ASIA PACIF MICROWAVE, P508; Hasan A, 2008, PROG ELECTROMAGN RES, V78, P393, DOI 10.2528/PIER07091401; Hong J.-S., 2001, WILEY MICRO; HONG JS, 1995, IEEE MICROW GUIDED W, V5, P371, DOI 10.1109/75.473539; Hong JS, 2004, IEEE T MICROW THEORY, V52, P1237, DOI 10.1109/TMTT.2004.825653; Hong JS, 1997, IEEE T MICROW THEORY, V45, P2358, DOI 10.1109/22.643844; HONG JS, 1995, ELECTRON LETT, V31, P891, DOI 10.1049/el:19950591; Kundu AC, 2001, IEEE T MICROW THEORY, V49, P1113, DOI 10.1109/22.925499; Sheta AF, 2008, PROCEEDINGS OF THE 25TH NATIONAL RADIO SCIENCE CONFERENCE: NRSC 2008; Sheta AF, 2006, IEE P-MICROW ANTEN P, V153, P89, DOI 10.1049/ip-map:20050103; Singhal P. K., 2010, Journal of Electromagnetic Analysis and Applications, V2, P98, DOI 10.4236/jemaa.2010.22014; WHEELER HA, 1965, IEEE T MICROW THEORY, VMT13, P172, DOI 10.1109/TMTT.1965.1125962; WOLFF I, 1972, ELECTRON LETT, V8, P302, DOI 10.1049/el:19720223	16	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152615	10.1371/journal.pone.0152615	http://dx.doi.org/10.1371/journal.pone.0152615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054755	Green Published, Green Submitted, gold			2022-12-26	WOS:000373608000029
J	Rahiman, SSF; Morgan, M; Gray, P; Shaw, PN; Cabot, PJ				Rahiman, Siti Sarah Fazalul; Morgan, Michael; Gray, Paul; Shaw, Paul Nicholas; Cabot, Peter John			Dynorphin 1-17 and Its N-Terminal Biotransformation Fragments Modulate Lipopolysaccharide-Stimulated Nuclear Factor-kappa B Nuclear Translocation, Interleukin-1beta and Tumor Necrosis Factor-alpha in Differentiated THP-1 Cells	PLOS ONE			English	Article							OPIOID AGONIST U50,488H; PERITONEAL-MACROPHAGES; CYTOKINE PRODUCTION; ENDOGENOUS LIGAND; INFLAMED TISSUE; IMMUNE-RESPONSE; NITRIC-OXIDE; IN-VITRO; T-CELLS; RECEPTOR	Dynorphin 1-17, (DYN 1-17) opioid peptide produces antinociception following binding to the kappa-opioid peptide (KOP) receptor. Upon synthesis and release in inflamed tissues by immune cells, DYN 1-17 undergoes rapid biotransformation and yields a unique set of opioid and non-opioid fragments. Some of these major fragments possess a role in immunomodulation, suggesting that opioid-targeted therapeutics may be effective in diminishing the severity of inflammatory disorders. This study aimed to examine the immunomodulatory effects of DYN 1-17 and major N-terminal fragments found in the inflammatory environment on nuclear factor-kappaB/p65 (NF-kappa B/p65) nuclear translocation and the release of interleukin-1beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) from lipopolysaccharide (LPS)-stimulated, differentiated THP-1 cells. The results demonstrate that NF-kappa B/p65 nuclear translocation was significantly attenuated following treatment with DYN 1-17 and a specific range of fragments, with the greatest reduction observed with DYN 1-7 at a low concentration (10 nM). Antagonism with a selective KOP receptor antagonist, ML-190, significantly reversed the inhibitory effects of DYN 1-17, DYN 1-6, DYN 1-7 and DYN 1-9, but not other DYN 1-17 N-terminal fragments (DYN 1-10 and 1-11) on NF-kappa B/p65 nuclear translocation. DYN 1-17 and selected fragments demonstrated differential modulation on the release of IL-1 beta and TNF-alpha with significant inhibition observed with DYN 1-7 at low concentrations (1 nM and 10 pM). These effects were blocked by ML-190, suggesting a KOP receptor-mediated pathway. The results demonstrate that DYN 1-17 and certain N-terminal fragments, produced in an inflamed environment, play an anti-inflammatory role by inhibiting NF-kappa B/p65 translocation and the subsequent cytokine release through KOP receptor-dependent and independent pathways.	[Rahiman, Siti Sarah Fazalul; Shaw, Paul Nicholas; Cabot, Peter John] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Rahiman, Siti Sarah Fazalul] Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Penang, Malaysia; [Morgan, Michael] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Gray, Paul] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Gray, Paul] Princess Alexandra Hosp, Dept Anaesthesia, Brisbane, Qld 4102, Australia	University of Queensland; Universiti Sains Malaysia; University of Queensland; University of Queensland	Cabot, PJ (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.	p.cabot@uq.edu.au	Gray, Paul/F-5507-2010; Morgan, Michael/C-1323-2015; Shaw, Paul/Q-8454-2019; Cabot, Peter John/B-2424-2013; Gray, Paul/S-6355-2019; Rahiman, Siti Sarah Fazalul/S-9187-2018; Shaw, Paul N/G-4418-2010; Morgan, Michael/AAC-2044-2021	Gray, Paul/0000-0002-1369-1483; Morgan, Michael/0000-0002-3641-2774; Shaw, Paul/0000-0001-7154-592X; Cabot, Peter John/0000-0003-1778-3753; Rahiman, Siti Sarah Fazalul/0000-0002-7970-5323; Shaw, Paul N/0000-0001-7154-592X; Morgan, Michael/0000-0002-3641-2774	Ministry of Higher Education Malaysia; Universiti Sains Malaysia (USM)	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); Universiti Sains Malaysia (USM)(Universiti Sains Malaysia)	Siti Sarah Fazalul Rahiman was supported by a student scholarship from Ministry of Higher Education Malaysia and Universiti Sains Malaysia (USM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alicea C, 1996, J NEUROIMMUNOL, V64, P83, DOI 10.1016/0165-5728(95)00159-X; Alt A, 1998, J PHARMACOL EXP THER, V286, P282; Auwerx J., 1991, J EXP, V47, P22, DOI DOI 10.1007/BF02041244; Banerjee P, 1996, LIFE SCI, V58, P1277, DOI 10.1016/0024-3205(96)00089-6; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; BELKOWSKI SM, 1995, J PHARMACOL EXP THER, V273, P1491; Borner C, 2013, J IMMUNOL, V191, P4640, DOI 10.4049/jimmunol.1300320; Borner C, 2009, J IMMUNOL, V183, P882, DOI 10.4049/jimmunol.0802763; Buchner RR, 1997, J IMMUNOL, V158, P1670; BUDD K, 2004, ACUTE PAIN, V6, P123; Cabot PJ, 2001, CLIN EXP PHARMACOL P, V28, P230, DOI 10.1046/j.1440-1681.2001.03425.x; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Dietis N, 2011, BRIT J ANAESTH, V107, P8, DOI 10.1093/bja/aer115; FADEN AI, 1990, EUR J PHARMACOL, V175, P165, DOI 10.1016/0014-2999(90)90227-W; FOSTER JS, 1987, J LEUKOCYTE BIOL, V42, P171, DOI 10.1002/jlb.42.2.171; Frankowski KJ, 2012, ACS CHEM NEUROSCI, V3, P221, DOI 10.1021/cn200128x; Gabrilovac J, 2012, J NEUROIMMUNOL, V245, P56, DOI 10.1016/j.jneuroim.2012.02.006; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guan LM, 1997, J NEUROIMMUNOL, V75, P163, DOI 10.1016/S0165-5728(97)00018-0; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HASSAN AHS, 1992, NEUROSCI LETT, V140, P85, DOI 10.1016/0304-3940(92)90688-4; Hedrick M. P., 2010, PROBE REPORTS NIH MO; ICHINOSE M, 1995, J NEUROIMMUNOL, V60, P37, DOI 10.1016/0165-5728(95)00050-C; Ishihara S, 2001, JPN J PHARMACOL, V87, P14, DOI 10.1254/jjp.87.14; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kanduri M, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.9; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Kong LY, 1997, J PHARMACOL EXP THER, V280, P61; Kumar S, 2011, J EXP BIOL, V214, P4217, DOI 10.1242/jeb.062935; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li JG, 2003, J PHARMACOL EXP THER, V305, P531, DOI 10.1124/jpet.102.045559; MEYER ME, 1993, PHARMACOL BIOCHEM BE, V44, P329, DOI 10.1016/0091-3057(93)90469-A; Morgan EL, 1996, J NEUROIMMUNOL, V65, P21, DOI 10.1016/0165-5728(95)00171-9; Morgan M, 2012, ANAL BIOANAL CHEM, V404, P3111, DOI 10.1007/s00216-012-6406-8; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; OLSON KG, 1991, LIFE SCI, V48, P575, DOI 10.1016/0024-3205(91)90473-O; PAUL D, 1991, J PHARMACOL EXP THER, V257, P1; PRETE P, 1986, EXP NEUROL, V92, P349, DOI 10.1016/0014-4886(86)90086-5; RADULOVIC J, 1995, J NEUROIMMUNOL, V57, P55, DOI 10.1016/0165-5728(94)00161-G; Roy S, 1998, BIOCHEM BIOPH RES CO, V245, P392, DOI 10.1006/bbrc.1998.8415; SAFAVI A, 1995, J NEUROCHEM, V65, P389; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Singh R, 2010, PEPTIDES, V31, P973, DOI 10.1016/j.peptides.2010.01.009; Smith MA, 2002, PSYCHOPHARMACOLOGY, V162, P255, DOI 10.1007/s00213-002-1102-6; SZABO I, 1993, J PHARMACOL EXP THER, V267, P703; TOSK JM, 1993, INT J IMMUNOPHARMACO, V15, P615, DOI 10.1016/0192-0561(93)90079-E; Trask OJ Jr, 2012, NUCL FACTOR KAPPA B; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Walker JS, 2003, ADV EXP MED BIOL, V521, P148; Welters ID, 2000, ANESTHESIOLOGY, V92, P1677, DOI 10.1097/00000542-200006000-00027; Zhang Q, 1998, NEUROSCIENCE, V85, P281, DOI 10.1016/S0306-4522(97)00647-7	55	9	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153005	10.1371/journal.pone.0153005	http://dx.doi.org/10.1371/journal.pone.0153005			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055013	Green Published, gold			2022-12-26	WOS:000373608000063
J	Taghizadeh, N; Vonk, JM; Boezen, HM				Taghizadeh, Niloofar; Vonk, Judith M.; Boezen, H. Marike			Lifetime Smoking History and Cause-Specific Mortality in a Cohort Study with 43 Years of Follow-Up	PLOS ONE			English	Article							NEGATIVE EXPONENTIAL MODEL; ALL-CAUSE MORTALITY; BREAST-CANCER RISK; CIGARETTE-SMOKING; LUNG-CANCER; EPIDEMIOLOGIC EVIDENCE; QUITTING SMOKING; PIPE SMOKING; WOMEN; DISEASE	Background In general, smoking increases the risk of mortality. However, it is less clear how the relative risk varies by cause of death. The exact impact of changes in smoking habits throughout life on different mortality risks is less studied. Methods We studied the impact of baseline and lifetime smoking habits, and duration of smoking on the risk of all-cause mortality, mortality of cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), any cancer and of the four most common types of cancer (lung, colorectal, prostate, and breast cancer) in a cohort study (Vlagtwedde-Vlaardingen 1965-1990, with a follow-up on mortality status until 2009, n = 8,645). We used Cox regression models adjusted for age, BMI, sex, and place of residence. Since previous studies suggested a potential effect modification of sex, we additionally stratified by sex and tested for interactions. In addition, to determine which cause of death carried the highest risk we performed competing-risk analyses on mortality due to CVD, cancer, COPD and other causes. Results Current smoking (light, moderate, and heavy cigarette smoking) and lifetime persistent smoking were associated with an increased risk of all-cause, CVD, COPD, any cancer, and lung cancer mortality. Higher numbers of pack years at baseline were associated with an increased risk of all-cause, CVD, COPD, any cancer, lung, colorectal, and prostate cancer mortality. Males who were lifetime persistent pipe/cigar smokers had a higher risk of lung cancer [HR (95% CI) = 7.72 (1.72-34.75)] as well as all-cause and any cancer mortality. A longer duration of smoking was associated with a higher risk of COPD, any and lung cancer [HR (95% CI) = 1.06 (1.00-1.12), 1.03 (1.00-1.06) and 1.10 (1.03-1.17) respectively], but not with other mortality causes. The competing risk analyses showed that ex-and current smokers had a higher risk of cancer, CVD, and COPD mortality compared to all other mortality causes. In addition, heavy smokers had a higher risk for COPD mortality compared to cancer, and CVD mortality. Conclusion Our study indicates that lifetime numbers of cigarettes smoked and the duration of smoking have different impacts for different causes of mortality. Moreover, our findings emphasize the importance of smoking-related competing risks when studying the smoking-related cancer mortality in a general population and that smoking cessation immediately effectively reduces the risk of all-cause and any cancer mortality.	[Taghizadeh, Niloofar; Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Taghizadeh, Niloofar] Univ Calgary, Cumming Sch Med, Div Resp Med, Calgary, AB, Canada; [Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands	University of Groningen; University of Calgary; University of Groningen	Boezen, HM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.; Boezen, HM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands.	H.M.Boezen@umcg.nl	Vonk, Judith M/ABA-3009-2020; Taghizadeh, Niloofar/AAF-2008-2020; Vonk, Judith/K-8477-2019	Vonk, Judith M/0000-0001-7531-4547; Vonk, Judith/0000-0001-7531-4547	Netherlands Asthma Foundation [187, 32.96.69]; Stichting Astma Bestrijding [2005/020]; GUIDE/University Medical Center Groningen, The Netherlands	Netherlands Asthma Foundation; Stichting Astma Bestrijding; GUIDE/University Medical Center Groningen, The Netherlands	This study was supported by the Netherlands Asthma Foundation (grant numbers 187 and 32.96.69), and Stichting Astma Bestrijding (grant number 2005/020), and GUIDE/University Medical Center Groningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo A, 2012, J CLIN ONCOL, V30, P4550, DOI 10.1200/JCO.2011.41.0183; Athyros VG, 2013, CURR MED RES OPIN, V29, P1263, DOI 10.1185/03007995.2013.827566; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Bosse Y, 2012, CANCER RES, V72, P3753, DOI 10.1158/0008-5472.CAN-12-1160; Braithwaite D, 2012, BREAST CANCER RES TR, V136, P521, DOI 10.1007/s10549-012-2276-1; Carter BD, 2015, NEW ENGL J MED, V372, P631, DOI 10.1056/NEJMsa1407211; Chang CM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1617-5; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Cotterchio M, 2014, BREAST J, V20, P468, DOI 10.1111/tbj.12304; Dossus L, 2014, INT J CANCER, V134, P1871, DOI 10.1002/ijc.28508; Fry JS, 2015, REGUL TOXICOL PHARM, V72, P49, DOI 10.1016/j.yrtph.2015.02.010; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Hospers JJ, 2000, EPIDEMIOLOGY, V11, P261, DOI 10.1097/00001648-200005000-00006; Hurley MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-95; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents, 2012, IARC MON EV CARC RIS, V100; International Agency for Research on Cancer, 1986, IARC MON EV CARC RIS, V38, P37; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83, P1017; Jurgens V, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13771; Kenfield SA, 2010, TOB CONTROL, V19, P248, DOI 10.1136/tc.2009.032839; Lee PN, 2014, REGUL TOXICOL PHARM, V68, P85, DOI 10.1016/j.yrtph.2013.11.013; Lee PN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-189; Lee PN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-385; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McCormack VA, 2010, INT J CANCER, V127, P2402, DOI 10.1002/ijc.25252; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Reynolds P, 2013, J MAMMARY GLAND BIOL, V18, P15, DOI 10.1007/s10911-012-9269-x; Shaper AG, 2003, INT J EPIDEMIOL, V32, P802, DOI 10.1093/ije/dyg206; Sorheim IC, 2010, THORAX, V65, P480, DOI 10.1136/thx.2009.122002; Streppel MT, 2007, TOB CONTROL, V16, P107, DOI 10.1136/tc.2006.017715; Taghizadeh N, 2015, CANCER CAUSE CONTROL, V26, P99, DOI 10.1007/s10552-014-0489-9; Tashkin DP, 2009, RESP MED, V103, P963, DOI 10.1016/j.rmed.2009.02.013; Terry PD, 2002, CANCER EPIDEM BIOMAR, V11, P953; Tverdal A, 2011, TOB CONTROL, V20, P123, DOI 10.1136/tc.2010.036780; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; World Health Organization, 2012, WHO GLOB REP MORT AT; Xu XP, 1997, LANCET, V350, P1431, DOI 10.1016/S0140-6736(97)10041-1; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179	39	53	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153310	10.1371/journal.pone.0153310	http://dx.doi.org/10.1371/journal.pone.0153310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055053	Green Submitted, Green Published, gold			2022-12-26	WOS:000373608000119
J	Golebski, K; van Tongeren, J; van Egmond, D; de Groot, EJ; Fokkens, WJ; van Drunen, CM				Golebski, Korneliusz; van Tongeren, Joost; van Egmond, Danielle; de Groot, Esther J.; Fokkens, Wytske J.; van Drunen, Cornelis M.			Specific Induction of TSLP by the Viral RNA Analogue Poly(I:C) in Primary Epithelial Cells Derived from Nasal Polyps	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; INNATE LYMPHOID-CELLS; EXPRESSION; IL-33; IL-25; VIRUSES; MITE	Introduction Chronic rhinosinusitis with nasal polyposis is an inflammatory disease that, although not directly linked to allergy, often displays a Th2-skewed inflammation characterized by elevated local IgE and IL-5 levels. The nasal cavity is constantly exposed to bacteria and viruses that may trigger epithelial inflammatory responses. To gain more insight into mechanisms by which such a biased inflammation might arise, we have investigated the epithelial expression of the Th2 skewing mediators (TSLP, IL-25, and IL-33) in relationship to disease and microbial triggers. Methods Epithelial cells were obtained from polyp tissues of nasal polyposis patients and from inferior turbinates of non-diseased controls. Cells were exposed to various TLR-specific triggers to study the effect on mRNA and protein expression level of TSLP, IL-25, and IL-33 and the potential regulatory mechanisms through the expression profile the transcription factors ATF-3, DUSP-1, EGR-1, and NFKB-1. Results The TLR3 agonist and viral analogue poly(I: C) induced TSLP mRNA 13.0 +/- 3.1 fold (p < 0.05) and protein expression by 12.1 +/- 2.3-fold (p < 0.05) higher in epithelium isolated from nasal polyposis patients than in epithelium form healthy controls. This enhanced induction of TSLP may be a consequence of a down-regulated expression of DUSP-1 in polyp epithelium. Conclusion The TLR3 induced expression of TSLP introduces a mechanism by which the Th2-skewed tissue environment might arise in nasal polyps and invites a further evaluation of the potential contribution of current or past viral infections to polyposis pathogenesis.	[Golebski, Korneliusz; van Tongeren, Joost; van Egmond, Danielle; de Groot, Esther J.; Fokkens, Wytske J.; van Drunen, Cornelis M.] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam	Golebski, K (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	K.Golebski@amc.uva.nl	Fokkens, Wytske WJ/ABF-2185-2020	van Drunen, Cornelis M/0000-0001-5503-066X	Academic Medical Center, University of Amsterdam	Academic Medical Center, University of Amsterdam	Internal sources of the Academic Medical Center, University of Amsterdam.	Ashrin MN, 2014, J IMMUNOL, V192, P4025, DOI 10.4049/jimmunol.1300276; Bae CH, 2014, BIOCHEM BIOPH RES CO, V448, P231, DOI 10.1016/j.bbrc.2014.04.100; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Copenhaver CC, 2004, AM J RESP CRIT CARE, V170, P175, DOI 10.1164/rccm.200312-1647OC; Fokkens Wytske J, 2012, Rhinol Suppl, V23, P1; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Golebski K, 2015, MOL IMMUNOL, V65, P43, DOI 10.1016/j.molimm.2014.12.011; Golebski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087768; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Jang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056433; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Lee KH, 2011, EXP DERMATOL, V20, P149, DOI 10.1111/j.1600-0625.2010.01203.x; Lin CF, 2007, ACTA OTO-LARYNGOL, V127, P395, DOI 10.1080/00016480601089416; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; McDermott AJ, 2014, IMMUNOLOGY, V142, P24, DOI 10.1111/imm.12231; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Muto T, 2014, INT IMMUNOL, V26, P539, DOI 10.1093/intimm/dxu058; Nagarkar DR, 2013, J ALLERGY CLIN IMMUN, V132, P593, DOI 10.1016/j.jaci.2013.04.005; Nagarkar DR, 2012, J ALLERGY CLIN IMMUN, V130, P225, DOI 10.1016/j.jaci.2012.04.019; Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x; Ryu WI, 2015, EXP DERMATOL, V24, P857, DOI 10.1111/exd.12788; Ueta M, 2010, BRIT J OPHTHALMOL, V94, P1528, DOI 10.1136/bjo.2010.180554; Vroling AB, 2008, ALLERGY, V63, P1110, DOI 10.1111/j.1398-9995.2008.01785.x; Vroling AB, 2008, AM J RESP CELL MOL, V38, P293, DOI 10.1165/rcmb.2007-0278OC; Vu AT, 2011, J INVEST DERMATOL, V131, P2205, DOI 10.1038/jid.2011.185; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Xie Y, 2012, J DERMATOL SCI, V66, P233, DOI 10.1016/j.jdermsci.2012.03.007	31	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152808	10.1371/journal.pone.0152808	http://dx.doi.org/10.1371/journal.pone.0152808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050744	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500056
J	Jain, S; Park, G; Sproule, TJ; Christianson, GJ; Leeth, CM; Wang, HS; Roopenian, DC; Morse, HC				Jain, Shweta; Park, Giljun; Sproule, Thomas J.; Christianson, Gregory J.; Leeth, Caroline M.; Wang, Hongsheng; Roopenian, Derry C.; Morse, Herbert C., III			Interleukin 6 Accelerates Mortality by Promoting the Progression of the Systemic Lupus Erythematosus-Like Disease of BXSB. Yaa Mice	PLOS ONE			English	Article							CD4(+) T-CELLS; TOLL-LIKE RECEPTORS; ACTIVATE B-CELLS; MURINE LUPUS; ANTI-DNA; IN-VIVO; IL-6; TLR7; DIFFERENTIATION; EXPRESSION	IL6 is a multifunctional cytokine that drives terminal B cell differentiation and secretion of immunoglobulins. IL6 also cooperates with IL21 to promote differentiation of CD4(+) T follicular helper cells (TFH). Elevated serum levels of IL6 correlate with disease flares in patients with systemic lupus erythematosus (SLE). We previously reported that IL21 produced by T-FH plays a critical role in the development of the SLE-like disease of BXSB. Yaa mice. To examine the possible contributions of IL6 to disease, we compared disease parameters in IL6-deficient and IL6-competent BXSB. Yaa mice. We report that survival of IL6-deficient BXSB. Yaa mice was significantly prolonged in association with significant reductions in a variety of autoimmune manifestations. Moreover, B cells stimulated by co-engagement of TLR7 and B cell receptor (BCR) produced high levels of IL6 that was further augmented by stimulation with Type I interferon (IFN1). Importantly, the frequencies of T-FH and serum levels of IL21 were significantly reduced in IL6-deficient mice. These findings suggest that high-level production of IL6 by B cells induced by integrated signaling from the IFN1 receptor, TLR7 and BCR promotes the differentiation of IL21-secreting T-FH in a signaling sequence that drives the lethal autoimmune disease of BXSB. Yaa mice.	[Jain, Shweta; Wang, Hongsheng; Morse, Herbert C., III] NIAID, Virol & Cellular Immunol Sect, Immunogenet Lab, NIH, Rockville, MD USA; [Park, Giljun; Sproule, Thomas J.; Christianson, Gregory J.; Roopenian, Derry C.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Park, Giljun] Univ Helsinki, Cent Hosp, Ctr Canc, Hematol Res Unit,Biomedicum Helsinki 1, Helsinki, Finland; [Leeth, Caroline M.] Virginia Tech, Coll Agr & Life Sci, Dept Anim & Poultry Sci, Blacksburg, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Jackson Laboratory; University of Helsinki; Helsinki University Central Hospital; Virginia Polytechnic Institute & State University	Morse, HC (corresponding author), NIAID, Virol & Cellular Immunol Sect, Immunogenet Lab, NIH, Rockville, MD USA.; Roopenian, DC (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	dcr@jax.org; hmorse@niaid.nih.gov	Jain, Shweta/I-4139-2019	Jain, Shweta/0000-0001-6297-0078; Christianson, Gregory/0000-0001-5532-342X	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (NIAID); Alliance for Lupus Research; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (NIAID); Alliance for Lupus Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (NIAID), and by the Alliance for Lupus Research.	ALARCONRIQUELME ME, 1993, CLIN EXP IMMUNOL, V91, P220; Amano H, 2003, J IMMUNOL, V170, P2293, DOI 10.4049/jimmunol.170.5.2293; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Bishop GA, 2001, CELL IMMUNOL, V208, P9, DOI 10.1006/cimm.2001.1769; Braun D, 2002, INT IMMUNOL, V14, P411, DOI 10.1093/intimm/14.4.411; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Bush TJV, 2008, EUR J IMMUNOL, V38, P400, DOI 10.1002/eji.200737602; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crow MK, 2003, AUTOIMMUNITY, V36, P481, DOI 10.1080/08916930310001625952; Cui Y, 2013, J AUTOIMMUN, V41, P25, DOI 10.1016/j.jaut.2013.01.008; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Diehl SA, 2012, IMMUNOL CELL BIOL, V90, P802, DOI 10.1038/icb.2012.17; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; FINCK BK, 1994, J CLIN INVEST, V94, P585, DOI 10.1172/JCI117373; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Glaum MC, 2009, J ALLERGY CLIN IMMUN, V123, P224, DOI 10.1016/j.jaci.2008.09.018; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Illei GG, 2010, ARTHRITIS RHEUM-US, V62, P542, DOI 10.1002/art.27221; KITANI A, 1989, CLIN EXP IMMUNOL, V77, P31; KLASHMAN DJ, 1991, ARTHRITIS RHEUM, V34, P276, DOI 10.1002/art.1780340305; KOBAYASHI I, 1992, INT IMMUNOL, V4, P1407, DOI 10.1093/intimm/4.12.1407; KOFLER R, 1991, J IMMUNOL, V146, P1375; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; LINKERISRAELI M, 1991, J IMMUNOL, V147, P117; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; McPhee CG, 2013, J IMMUNOL, V191, P4581, DOI 10.4049/jimmunol.1300439; McPhee CG, 2011, J IMMUNOL, V187, P4695, DOI 10.4049/jimmunol.1101776; MIHARA M, 1990, INT ARCH ALLER A IMM, V93, P89, DOI 10.1159/000235285; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murphy E. D., 1978, Genetic control of autoimmune disease. Proceedings of the workshop on the genetic control of autoimmune disease held in Bloomfield Hills, Michigan, USA, on July 10-12, 1978., P207; MURPHY ED, 1979, ARTHRITIS RHEUM, V22, P1188, DOI 10.1002/art.1780221105; NAGAFUCHI H, 1993, J IMMUNOL, V151, P6525; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Rau FC, 2009, J IMMUNOL, V183, P7661, DOI 10.4049/jimmunol.0803783; Richards HB, 1998, J EXP MED, V188, P985, DOI 10.1084/jem.188.5.985; Rogers NJ, 2007, GENES IMMUN, V8, P619, DOI 10.1038/sj.gene.6364424; Ronnblom L, 2011, SEMIN IMMUNOL, V23, P113, DOI 10.1016/j.smim.2011.01.009; Santiago-Raber ML, 2008, J IMMUNOL, V181, P1556, DOI 10.4049/jimmunol.181.2.1556; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; SUZUKI H, 1993, EUR J IMMUNOL, V23, P1078, DOI 10.1002/eji.1830230515; Szepietowski JC, 2013, ARTHRITIS RHEUM-US, V65, P2661, DOI 10.1002/art.38091; TANG B, 1991, INT IMMUNOL, V3, P273, DOI 10.1093/intimm/3.3.273; von Landenberg P, 2007, CURR OPIN IMMUNOL, V19, P606, DOI 10.1016/j.coi.2007.10.004; WOFSY D, 1984, J EXP MED, V159, P629, DOI 10.1084/jem.159.2.629; Yang ZX, 2014, RHEUMATOL INT, V34, P199, DOI 10.1007/s00296-013-2855-4	60	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153059	10.1371/journal.pone.0153059	http://dx.doi.org/10.1371/journal.pone.0153059			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050763	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500090
J	Salamekh, S; Rong, Y; Ayan, AS; Mo, XK; Williams, TM; Mayr, NA; Grecula, JC; Chakravarti, A; Xu-Welliver, M				Salamekh, Samer; Rong, Yi; Ayan, Ahmet S.; Mo, Xiaokui; Williams, Terence M.; Mayr, Nina A.; Grecula, John C.; Chakravarti, Arnab; Xu-Welliver, Meng			Inter-Fraction Tumor Volume Response during Lung Stereotactic Body Radiation Therapy Correlated to Patient Variables	PLOS ONE			English	Article							CONE-BEAM CT; TARGET VOLUMES; RADIOTHERAPY SBRT; CANCER; REGRESSION; POSITION	Purpose Analyze inter-fraction volumetric changes of lung tumors treated with stereotactic body radiation therapy (SBRT) and determine if the volume changes during treatment can be predicted and thus considered in treatment planning. Methods and Materials Kilo-voltage cone-beam CT (kV-CBCT) images obtained immediately prior to each fraction were used to monitor inter-fraction volumetric changes of 15 consecutive patients (18 lung nodules) treated with lung SBRT at our institution (45-54 Gy in 3-5 fractions) in the year of 2011-2012. Spearman's (rho) correlation and Spearman's partial correlation analysis was performed with respect to patient/tumor and treatment characteristics. Multiple hypothesis correction was performed using False Discovery Rate (FDR) and q-values were reported. Results All tumors studied experienced volume change during treatment. Tumor increased in volume by an average of 15% and regressed by an average of 11%. The overall volume increase during treatment is contained within the planning target volume (PTV) for all tumors. Larger tumors increased in volume more than smaller tumors during treatment (q = 0.0029). The volume increase on CBCT was correlated to the treatment planning gross target volume (GTV) as well as internal target volumes (ITV) (q = 0.0085 and q = 0.0039 respectively) and could be predicted for tumors with a GTV less than 22 mL. The volume increase was correlated to the integral dose (ID) in the ITV at every fraction (q = 0.0049). The peak inter-fraction volume occurred at an earlier fraction in younger patients (q = 0.0122). Conclusions We introduced a new analysis method to follow inter-fraction tumor volume changes and determined that the observed changes during lung SBRT treatment are correlated to the initial tumor volume, integral dose (ID), and patient age. Furthermore, the volume increase during treatment of tumors less than 22mL can be predicted during treatment planning. The volume increase remained significantly less than the overall PTV expansion, and radiation re-planning was therefore not required for the purpose of tumor control. The presence of the studied correlations suggests that the observed volumetric changes may reflect some underlying biologic process rather than random fluctuations.	[Salamekh, Samer; Ayan, Ahmet S.; Williams, Terence M.; Grecula, John C.; Chakravarti, Arnab; Xu-Welliver, Meng] Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Columbus, OH 43210 USA; [Rong, Yi] Univ Calif Davis, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Mo, Xiaokui] Ohio State Univ, Wexner Med Ctr, Ctr Biostat, Columbus, OH 43210 USA; [Mayr, Nina A.] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA	University System of Ohio; Ohio State University; University of California System; University of California Davis; University System of Ohio; Ohio State University; University of Washington; University of Washington Seattle	Xu-Welliver, M (corresponding author), Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Columbus, OH 43210 USA.	meng.welliver@osumc.edu		Salamekh, Samer/0000-0002-2315-0277	Ohio State University Comprehensive Cancer Center; NIH/NCI [1U10CA180850-01, 1R01CA188500-01]; Ohio State University College of Medicine Fellowship; NATIONAL CANCER INSTITUTE [P30CA016058, U10CA180850, R01CA188500] Funding Source: NIH RePORTER	Ohio State University Comprehensive Cancer Center; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ohio State University College of Medicine Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the following: The Ohio State University Comprehensive Cancer Center (to AC); NIH/NCI 1U10CA180850-01 and 1R01CA188500-01 (to AC); and The Ohio State University College of Medicine Fellowship (to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatt AD, 2015, AM J CLIN ONCOL-CANC, V38, P41, DOI 10.1097/COC.0b013e318287bd7f; Brinkman KL, 2012, J RADIOL ONCOL, V1, P311, DOI 10.1007/s13566-012-0023-1; Britton KR, 2007, INT J RADIAT ONCOL, V68, P1036, DOI 10.1016/j.ijrobp.2007.01.021; Gomez DR, 2011, J ONCOL, V2011, DOI 10.1155/2011/898391; Gunter T, 2014, J MED IMAG RADIAT ON, V58, P384, DOI 10.1111/1754-9485.12168; Haasbeek CJA, 2007, INT J RADIAT ONCOL, V67, P1370, DOI 10.1016/j.ijrobp.2006.11.018; Kupelian PA, 2005, INT J RADIAT ONCOL, V63, P1024, DOI 10.1016/j.ijrobp.2005.04.046; Lo SS, 2010, NAT REV CLIN ONCOL, V7, P44, DOI 10.1038/nrclinonc.2009.188; Matsugi K, 2009, INT J RADIAT ONCOL, V75, P543, DOI 10.1016/j.ijrobp.2008.12.091; Morin O, 2006, MED DOSIM, V31, P51, DOI 10.1016/j.meddos.2005.12.009; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34; Onozato Y, 2014, INT J RADIAT ONCOL, V89, P416, DOI 10.1016/j.ijrobp.2014.02.007; Rong Y, 2007, MED PHYS, V34, P2334, DOI 10.1118/1.2760362; Rong Y, 2010, MED DOSIM, V35, P195, DOI 10.1016/j.meddos.2009.06.001; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Tatekawa K, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-8; Underberg RWM, 2006, INT J RADIAT ONCOL, V64, P1221, DOI 10.1016/j.ijrobp.2005.09.045; Yi BSK, 2011, TECHNOL CANCER RES T, V10, P495, DOI 10.7785/tcrt.2012.500226	20	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153245	10.1371/journal.pone.0153245	http://dx.doi.org/10.1371/journal.pone.0153245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049962	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500114
J	Shi, CY; He, J; Yu, J; Yu, B; Mao, XB; Zheng, P; Huang, ZQ; Chen, DW				Shi, Changyou; He, Jun; Yu, Jie; Yu, Bing; Mao, Xiangbing; Zheng, Ping; Huang, Zhiqing; Chen, Daiwen			Physicochemical Properties Analysis and Secretome of Aspergillus niger in Fermented Rapeseed Meal	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; NUTRITIONAL QUALITY; PHYTIC ACID; DIGESTIBILITY; HYDROLYSIS; PURIFICATION; PERFORMANCE; REDUCTION; CELLULOSE; PROTEINS	The nutrient digestibility and feeding value of rapeseed meal (RSM) for non-ruminant animals is poor due to the presence of anti-nutritional substances such as glucosinolate, phytic acid, crude fiber etc. In the present study, a solid state fermentation (SSF) using Aspergillus niger was carried out with the purpose of improving the nutritional quality of RSM. The chemical composition and physicochemical properties of RSM before and after fermentation were compared. To further understand possible mechanism of solid state fermentation, the composition of extracellular enzymes secreted by Aspergillus niger during fermentation was analysed using two-dimentional difference gel electrophoresis (2D-DIGE) combined with matrix assisted laser desorption ionization-time of flight-mass spectrometer (MALDI-TOF-MS). Results of the present study indicated that SSF had significant effects on chemical composition of RSM. The fermented rapeseed meal (FRSM) contained more crude protein (CP) and amino acid (AA) (except His) than unfermented RSM. Notably, the small peptide in FRSM was 2.26 time larger than that in unfermented RSM. Concentrations of anti-nutritional substrates in FRSM including neutral detergent fiber (NDF), glucosinolates, isothiocyanate, oxazolidithione, and phytic acid declined (P < 0.05) by 13.47, 43.07, 55.64, 44.68 and 86.09%, respectively, compared with unfermented RSM. A. niger fermentation disrupted the surface structure, changed macromolecular organic compounds, and reduced the protein molecular weights of RSM substrate. Total proteins of raw RSM and FRSM were separated and 51 protein spots were selected for mass spectrometry according to 2D-DIGE map. In identified proteins, there were 15 extracellular hydrolases secreted by A. niger including glucoamylase, acid protease, beta-glucanase, arabinofuranosidase, xylanase, and phytase. Some antioxidant related enzymes also were identified. These findings suggested that A. niger is able to secrete many extracellular degradation enzymes (especially lignocellulosic hydrolyzing enzymes, acid proteases and phytase) during fermentation of RSM, thus altering chemical composition and physicochemical properties of RSM.	[Chen, Daiwen] Sichuan Agr Univ, Inst Anim Nutr, Yaan 625014, Peoples R China; Sichuan Agr Univ, Anim Dis Resistance Nutr Key Lab Sichuan Prov, Yaan 625014, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Chen, DW (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yaan 625014, Peoples R China.	dwchen@sicau.edu.cn			Modern Agro-industry Technology Research System of China [CARS-36]; Science and Technology Support Program of Sichuan Province of China [2010GZ0193, 2012NZ0001, 2013NC0056]	Modern Agro-industry Technology Research System of China; Science and Technology Support Program of Sichuan Province of China	Modern Agro-industry Technology Research System of China (CARS-36), the role of this funder is the study design, data collection and analysis. Science and Technology Support Program of Sichuan Province of China (Grant no. 2010GZ0193, 2012NZ0001 and 2013NC0056), the role of this funder is decision to publish and preparation of the manuscript.	Adav SS, 2010, J PROTEOME RES, V9, P3932, DOI 10.1021/pr100148j; Association of Official Analytical Chemists, 2007, OFFICIAL METHODS ANA; BAU HM, 1994, J SCI FOOD AGR, V65, P315, DOI 10.1002/jsfa.2740650309; Berot S, 2005, J CHROMATOGR B, V818, P35, DOI 10.1016/j.jchromb.2004.08.001; Chen CC, 2010, ASIAN AUSTRAL J ANIM, V23, P598, DOI 10.5713/ajas.2010.90341; Chiang G, 2010, ASIAN AUSTRAL J ANIM, V23, P263; Choi MMF, 2004, ANAL CHIM ACTA, V516, P155, DOI 10.1016/j.aca.2004.04.010; El-Batal AI, 2001, FOOD RES INT, V34, P715, DOI 10.1016/S0963-9969(01)00093-X; ELLIS R, 1977, ANAL BIOCHEM, V77, P536, DOI 10.1016/0003-2697(77)90269-X; Faurobert M, 1997, ELECTROPHORESIS, V18, P170, DOI 10.1002/elps.1150180130; Guggenbuhl P, 2007, LIVEST SCI, V109, P261, DOI 10.1016/j.livsci.2007.01.110; Hishikawa Y, 2005, BIOMACROMOLECULES, V6, P2468, DOI 10.1021/bm050032k; HOLST DO, 1973, J ASSOC OFF ANA CHEM, V56, P1352; Hong KJ, 2004, J MED FOOD, V7, P430, DOI 10.1089/jmf.2004.7.430; Hsiao NW, 2014, ELECTRON J BIOTECHN, V17, DOI 10.1016/j.ejbt.2014.02.002; Khajali F, 2012, POULTRY SCI, V91, P2564, DOI 10.3382/ps.2012-02332; Khalaf M. A., 2008, International Journal of Agriculture and Biology, V10, P185; Kiran EU, 2012, ENZYME MICROB TECH, V50, P337, DOI 10.1016/j.enzmictec.2012.03.004; LI XM, 1989, CARLSBERG RES COMMUN, V54, P241; Lomascolo A, 2012, APPL MICROBIOL BIOT, V95, P1105, DOI 10.1007/s00253-012-4250-6; Lu X, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-23; Mahajan A, 1998, INT J FOOD SCI NUTR, V49, P435, DOI 10.3109/09637489809086422; Mouyna I, 1998, MICROBIOL-SGM, V144, P3171, DOI 10.1099/00221287-144-11-3171; Noda I., 2004, 2 DIMENSIONAL CORREL; Oh SY, 2005, CARBOHYD RES, V340, P417, DOI 10.1016/j.carres.2004.11.027; Oso AO, 2015, ANIM FEED SCI TECH, V210, P281, DOI 10.1016/j.anifeedsci.2015.09.015; Ovissipour M, 2009, FOOD CHEM, V115, P238, DOI 10.1016/j.foodchem.2008.12.013; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Rakariyatham N, 2002, BIODEGRADATION, V13, P395, DOI 10.1023/A:1022851129684; Rozan P, 1996, INT J FOOD SCI TECH, V31, P85, DOI 10.1111/j.1365-2621.1996.17-315.x; Rutherfurd SM, 2010, J AOAC INT, V93, P1515; SEGUEILHA L, 1992, J FERMENT BIOENG, V74, P7, DOI 10.1016/0922-338X(92)90259-W; Shi C, 2015, J ANIM SCI, V93, P2916, DOI 10.2527/jas.2014-8326; Shi CY, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0015-2; SMITS JP, 1994, J FERMENT BIOENG, V77, P579, DOI 10.1016/0922-338X(94)90135-X; Tripathi MK, 2007, ANIM FEED SCI TECH, V132, P1, DOI 10.1016/j.anifeedsci.2006.03.003; Vig AP, 2001, BIORESOURCE TECHNOL, V78, P309, DOI 10.1016/S0960-8524(01)00030-X; Wang LP, 2012, BIORESOURCE TECHNOL, V105, P88, DOI 10.1016/j.biortech.2011.11.064; Wang XS, 2012, ANN MICROBIOL, V62, P1013, DOI 10.1007/s13213-011-0341-3; WATHELET JP, 1988, FRESEN Z ANAL CHEM, V332, P689, DOI 10.1007/BF00472670; Xu FZ, 2011, ASIAN AUSTRAL J ANIM, V24, P678, DOI 10.5713/ajas.2011.10458; Zhang B, 2012, INT J FOOD MICROBIOL, V155, P113, DOI 10.1016/j.ijfoodmicro.2012.01.014	42	70	75	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153230	10.1371/journal.pone.0153230	http://dx.doi.org/10.1371/journal.pone.0153230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049858	gold, Green Submitted, Green Published			2022-12-26	WOS:000373603500113
J	Sloan, CE; Luskin, MR; Boccuti, AM; Sehgal, AR; Zhao, JH; Daber, RD; Morrissette, JJD; Luger, SM; Bagg, A; Gimotty, PA; Carroll, M				Sloan, Caroline E.; Luskin, Marlise R.; Boccuti, Anne M.; Sehgal, Alison R.; Zhao, Jianhua; Daber, Robert D.; Morrissette, Jennifer J. D.; Luger, Selina M.; Bagg, Adam; Gimotty, Phyllis A.; Carroll, Martin			A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia	PLOS ONE			English	Article							STUDY-GROUP ULM; AML STUDY-GROUP; PROGNOSTIC-SIGNIFICANCE; NORMAL CYTOGENETICS; EUROPEAN LEUKEMIANET; MUTATIONS; ADULTS; ASXL1; TRIAL; MLL	Background Although cytogenetics-based prognostication systems are well described in acute myeloid leukemia (AML), overall survival (OS) remains highly variable within risk groups. An integrated genetic prognostic (IGP) model using cytogenetics plus mutations in nine genes was recently proposed for patients <= 60 years to improve classification. This model has not been validated in clinical practice. Methods and Findings We retrospectively studied 197 patients with newly diagnosed de novo AML. We compared OS curves among the mutational profiles defined by the IGP model. The IGP model assigned patients with intermediate cytogenetics as having favorable, intermediate or unfavorable mutational profiles. The IGP model reassigned 50 of 137 patients with intermediate cytogenetics to favorable or unfavorable mutational profiles. Median OS was 2.8 years among 14 patients with intermediate cytogenetics and favorable mutational profiles (mutant NPM1 and mutant IDH1 or IDH2) and 1.3 years among patients with intermediate mutational profiles. Among patients with intermediate cytogenetics labeled as having unfavorable mutational profiles, median OS was 0.8 years among 24 patients with FLT3-ITD positive AML and high-risk genetic changes (trisomy 8, TET2 and/or DNMT3A) and 1.7 years among 12 patients with FLT3-ITD negative AML and high-risk mutations (TET2, ASXL1 and/or PHF6). OS for patients with intermediate cytogenetics and favorable mutational profiles was similar to OS for patients with favorable cytogenetics (p = 0.697) and different from patients with intermediate cytogenetics and intermediate mutational profiles (p = 0.028). OS among patients with FLT3-ITD positive AML and high-risk genetic changes was similar to patients with unfavorable cytogenetics (p = 0.793) and different from patients with intermediate IGP profile (p = 0.022). Patients with FLT3-ITD negative AML and high-risk mutations, defined as 'unfavorable' in the IGP model, had OS similar to patients with intermediate IGP profile (p = 0.919). Conclusions The IGP model was not completely validated in our cohort. However, mutations in six out of the nine genes can be used to characterize survival (NPMI, IDH1, IDH2, FLT3-ITD, TET2, DNMT3A) and allow for more robust prognostication in the patients who are re-categorized by the IGP model. These mutations should be incorporated into clinical testing for younger patients outside of clinical trials, in order to guide therapy.	[Sloan, Caroline E.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sloan, Caroline E.; Zhao, Jianhua; Daber, Robert D.; Morrissette, Jennifer J. D.; Bagg, Adam] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Luskin, Marlise R.; Luger, Selina M.; Carroll, Martin] Univ Penn, Div Hematol & Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Boccuti, Anne M.; Gimotty, Phyllis A.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sehgal, Alison R.] Univ Pittsburgh, Sch Med, Div Hematol & Oncol, Pittsburgh, PA USA; [Carroll, Martin] Philadelphia Vet Adm Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carroll, M (corresponding author), Univ Penn, Div Hematol & Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Carroll, M (corresponding author), Philadelphia Vet Adm Med Ctr, Philadelphia, PA USA.	carroll2@mail.med.upenn.edu	Bagg, Adam/R-8450-2019; Gimotty, Phyllis/GWZ-4136-2022	Gimotty, Phyllis/0000-0002-3850-9799; Sloan, Caroline/0000-0003-1611-3846; Luskin, Marlise/0000-0002-5781-4529	NCI [R21CA185365]; Hematologic Malignancies Translational Center of Excellence of the Abramson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016520, R21CA185365] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hematologic Malignancies Translational Center of Excellence of the Abramson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI grant R21CA185365 and by the Hematologic Malignancies Translational Center of Excellence of the Abramson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab, 2012, HEMATOLOGY, DOI [10.1179/102453312X13336169155411, DOI 10.1179/102453312X13336169155411]; Caligiuri MA, 1998, CANCER RES, V58, P55; Chou WC, 2011, BLOOD, V118, P3803, DOI 10.1182/blood-2011-02-339747; Damm F, 2011, J CLIN ONCOL, V29, P682, DOI 10.1200/JCO.2010.31.1118; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dohner K, 2002, J CLIN ONCOL, V20, P3254, DOI 10.1200/JCO.2002.09.088; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Gaidzik VI, 2012, J CLIN ONCOL, V30, P1350, DOI 10.1200/JCO.2011.39.2886; Green CL, 2010, J CLIN ONCOL, V28, P2739, DOI 10.1200/JCO.2009.26.2501; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Luskin MR, 2014, COMMUNICATION; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Metzeler KH, 2011, BLOOD, V118, P6920, DOI 10.1182/blood-2011-08-368225; Metzeler KH, 2011, J CLIN ONCOL, V29, P1373, DOI 10.1200/JCO.2010.32.7742; Mrozek K, 2012, J CLIN ONCOL, V30, P4515, DOI 10.1200/JCO.2012.43.4738; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pratcorona M, 2012, HAEMATOL-HEMATOL J, V97, P388, DOI 10.3324/haematol.2011.051532; Rollig C, 2015, J CLIN ONCOL, V33, P403, DOI 10.1200/JCO.2013.54.4973; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schnittger S, 2013, LEUKEMIA, V27, P82, DOI 10.1038/leu.2012.262; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Steven H, 2008, WHO CLASSIFICATION T; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Taskesen E, 2011, BLOOD, V117, P2469, DOI 10.1182/blood-2010-09-307280; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247	29	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153016	10.1371/journal.pone.0153016	http://dx.doi.org/10.1371/journal.pone.0153016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050425	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000373603500085
J	Wang, NL; Li, LT; Wu, BB; Gong, JY; Abuduxikuer, K; Li, G; Wang, JS				Wang, Neng-Li; Li, Li-Ting; Wu, Bing-Bing; Gong, Jing-Yu; Abuduxikuer, Kuerbanjiang; Li, Gang; Wang, Jian-She			The Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency	PLOS ONE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; GAMMA-GLUTAMYL-TRANSFERASE; CHINESE CHILDREN; CYTOMEGALOVIRUS-INFECTION; NEONATAL HEPATITIS; GENE-MUTATIONS; DISORDERS; FIC1; INFANTS; DISEASE	Background and Aims Genetic defects in ATP8B1 or ABCB11 account for the majority of cholestasis with low GGT. But the ranges for GGT in patients with ATP8B1 or ABCB11 deficiency are unclear. This study tried to unravel the features of GGT in these patients that improve diagnostic efficiency. Methods This study enrolled 207 patients with chronic cholestasis who were ordered to test for ATP8B1 and/or ABCB11 from January 2012 to December 2015. Additional 17 patients with ATPB81 or ABCB11 deficiency diagnosed between January 2004 and December 2011 were also enrolled in this study. 600 population-matched children served as controls. Clinical data were obtained by retrospectively reviewing medical records. Results A total of 26 patients were diagnosed with ATP8B1 deficiency and 30 patients were diagnosed with ABCB11 deficiency. GGT levels were similar between the two disorders at any observed month of age, but varied with age. The peak GGT value was <70U/L in the 2nd similar to 6th month of life, <60U/L in the 7th similar to 12th month and <50U/L beyond one year. GGT levels in patients with a genetic diagnosis were different from that in patients without a genetic diagnosis and controls. Larger ranges for GGT were found in patients without a genetic diagnosis. Some controls had GGT >= 70U/L in the 2nd similar to 6th month. Of the 207 patients, 39 (18.8%) obtained a genetic diagnosis. 111 patients met the ranges described above, including all the 39 patients with ATP8B1 or ABCB11 deficiency. The sensitivity was 100.0%. The rate of a positive molecular diagnosis increased to 35.1% (39/111 vs. 39/207, chi(2) = 10.363, P = 0.001). The remaining 96 patients exceeded the ranges described above and failed to receive a genetic diagnosis. These patients accounted for 43.8% of sequencing cost. Conclusions GGT levels in patients with ATP8B1 or ABCB11 deficiency varied with age. The peak GGT value was <70U/L in the 2nd similar to 6th month of life, <60U/L in the 7th similar to 12th month and <50U/L beyond one year.	[Wang, Neng-Li; Gong, Jing-Yu; Wang, Jian-She] Fudan Univ, Jinshan Hosp, Dept Pediat, Shanghai 200433, Peoples R China; [Li, Li-Ting; Abuduxikuer, Kuerbanjiang; Wang, Jian-She] Fudan Univ, Childrens Hosp, Ctr Pediat Liver Dis, Shanghai 200433, Peoples R China; [Wu, Bing-Bing; Li, Gang] Fudan Univ, Childrens Hosp, Pediat Res Inst, Mol Genet Diag Ctr,Shanghai Key Lab Birth Defects, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, JS (corresponding author), Fudan Univ, Jinshan Hosp, Dept Pediat, Shanghai 200433, Peoples R China.; Wang, JS (corresponding author), Fudan Univ, Childrens Hosp, Ctr Pediat Liver Dis, Shanghai 200433, Peoples R China.	jshwang@shmu.edu.cn	Abuduxikuer, Kuerbanjiang/T-6521-2019; wang, Jian-She/F-1154-2011	Abuduxikuer, Kuerbanjiang/0000-0003-0298-3269; wang, jianshe/0000-0003-0823-586X; Wang, Neng-Li/0000-0001-6967-9873	National Natural Science Foundation of China [81070281, 81361128006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was supported by the National Natural Science Foundation of China (No. 81070281 and No. 81361128006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo LS, 2015, CLINICS, V70, P515, DOI 10.6061/clinics/2015(07)09; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Cabrera-Abreu JC, 2002, ANN CLIN BIOCHEM, V39, P22, DOI 10.1258/0004563021901685; CHANG MH, 1987, J PEDIATR GASTR NUTR, V6, P203, DOI 10.1097/00005176-198703000-00006; Chen HL, 2002, J PEDIATR-US, V140, P119, DOI 10.1067/mpd.2002.119993; Davit-Spraul A, 2010, HEPATOLOGY, V51, P1645, DOI 10.1002/hep.23539; Fang LJ, 2012, J PEDIATR GASTR NUTR, V55, P150, DOI 10.1097/MPG.0b013e31824ef36f; Herbst SM, 2015, MOL CELL PROBE, V29, P291, DOI 10.1016/j.mcp.2015.03.001; Hirschfield GM, 2013, GASTROENTEROLOGY, V144, P1357, DOI 10.1053/j.gastro.2013.03.053; Jim WT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001835; Li LT, 2015, J PEDIATR-US, V167, P1334, DOI 10.1016/j.jpeds.2015.08.037; Liu LU, 2010, SEMIN LIVER DIS, V30, P205, DOI 10.1055/s-0030-1253523; Liu LY, 2010, LIVER INT, V30, P809, DOI 10.1111/j.1478-3231.2009.02112.x; Liu LY, 2010, J PEDIATR GASTR NUTR, V50, P179, DOI 10.1097/MPG.0b013e3181c1b368; Morotti RA, 2011, SEMIN LIVER DIS, V31, P3, DOI 10.1055/s-0031-1272831; Pawlikowska L, 2010, J HEPATOL, V53, P170, DOI 10.1016/j.jhep.2010.01.034; Sambrotta M, 2014, NAT GENET, V46, P326, DOI 10.1038/ng.2918; Stormon MO, 2001, J PAEDIATR CHILD H, V37, P47, DOI 10.1046/j.1440-1754.2001.00613.x; Strautnieks SS, 2008, GASTROENTEROLOGY, V134, P1203, DOI 10.1053/j.gastro.2008.01.038; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; van der Woerd WL, 2010, BEST PRACT RES CL GA, V24, P541, DOI 10.1016/j.bpg.2010.07.010; van Mil SWC, 2005, J MED GENET, V42, P449, DOI 10.1136/jmg.2004.026187; Van Mil SWC, 2004, GASTROENTEROLOGY, V127, P379, DOI 10.1053/j.gastro.2004.04.065; van Mil SWC, 2001, SEMIN LIVER DIS, V21, P535, DOI 10.1055/s-2001-19034; van Ooteghem NAM, 2002, J HEPATOL, V36, P439, DOI 10.1016/S0168-8278(01)00299-9; Wang JS, 2006, EUR J PEDIATR, V165, P795, DOI 10.1007/s00431-006-0175-3; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zollner G, 2008, CLIN LIVER DIS, V12, P1, DOI 10.1016/j.cld.2007.11.010	28	9	30	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153114	10.1371/journal.pone.0153114	http://dx.doi.org/10.1371/journal.pone.0153114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050426	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500102
J	Weihrauch, D; Krolikowski, JG; Jones, DW; Zaman, T; Bamkole, O; Struve, J; Pillai, S; Pagel, PS; Lohr, NL; Pritchard, KA				Weihrauch, Dorothee; Krolikowski, John G.; Jones, Deron W.; Zaman, Tahniyath; Bamkole, Omoshalewa; Struve, Janine; Pillai, Savin; Pagel, Paul S.; Lohr, Nicole L.; Pritchard, Kirkwood A., Jr.			An IRF5 Decoy Peptide Reduces Myocardial Inflammation and Fibrosis and Improves Endothelial Cell Function in Tight-Skin Mice	PLOS ONE			English	Article							HEART; DISEASE; VASODILATION; POLYMORPHISM; CONTRIBUTES; EXPRESSION; MARKERS; RISK	Interferon regulatory factor 5 (IRF5) has been called a "master switch" for its ability to determine whether cells mount proinflammatory or anti-inflammatory responses. Accordingly, IRF5 should be an attractive target for therapeutic drug development. Here we report on the development of a novel decoy peptide inhibitor of IRF5 that decreases myocardial inflammation and improves vascular endothelial cell (EC) function in tight-skin (Tsk/+) mice. Biolayer interferometry studies showed the Kd of IRF5D for recombinant IRF5 to be 3.72 +/- 0.74x10(-6)M. Increasing concentrations of IRF5D (0-100 mu g/mL, 24h) had no significant effect on EC proliferation or apoptosis. Treatment of Tsk/+ mice with IRF5D (1mg/kg/d subcutaneously, 21d) reduced IRF5 and ICAM-1 expression and monocyte/macrophage and neutrophil counts in Tsk/+ hearts compared to expression in hearts from PBS-treated Tsk/+ mice (p<0.05). EC-dependent vasodilatation of facialis arteries isolated from PBS-treated Tsk/+ mice was reduced (similar to 15%). IRF5D treatments (1mg/kg/d, 21d) improved vasodilatation in arteries isolated from Tsk/+ mice nearly 3-fold (similar to 45%, p<0.05), representing nearly 83% of the vasodilatation in arteries isolated from C57Bl/6J mice (similar to 55%). IRF5D (50 mu g/mL, 24h) reduced nuclear translocation of IRF5 in myocytes cultured on both Tsk/+ cardiac matrix and C57Bl/6J cardiac matrix (p<0.05). These data suggest that IRF5 plays a causal role in inflammation, fibrosis and impaired vascular EC function in Tsk/+ mice and that treatment with IRF5D effectively counters IRF5-dependent mechanisms of inflammation and fibrosis in the myocardium in these mice.	[Weihrauch, Dorothee; Krolikowski, John G.; Bamkole, Omoshalewa; Pillai, Savin; Pagel, Paul S.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Jones, Deron W.; Zaman, Tahniyath; Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Dept Surg, Div Pediat Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Jones, Deron W.; Zaman, Tahniyath; Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Struve, Janine] Med Coll Wisconsin, Orthoped Surg, Milwaukee, WI 53226 USA; [Pagel, Paul S.] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA; [Lohr, Nicole L.] Med Coll Wisconsin, Dept Med, Div Cardiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Weihrauch, D (corresponding author), Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA.	dorothee@mcw.edu			National Institutes of Health from the United States Public Health Service (Bethesda, MD) [HL089779, HL102836, HL112270]; Cimphoni Life Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112270, R01HL128371, R01HL089779, R01HL102836] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service (Bethesda, MD); Cimphoni Life Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health grants HL089779, HL102836 and HL112270 from the United States Public Health Service (Bethesda, MD), Cimphoni Life Sciences (part of DW salary) and by departmental funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOSTA D, 1977, IN VITRO CELL DEV B, V13, P818; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Baxter RM, 2005, LAB INVEST, V85, P1199, DOI 10.1038/labinvest.3700331; Bi XH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3053; BOTSTEIN GR, 1981, AM HEART J, V102, P913, DOI 10.1016/0002-8703(81)90043-0; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Dieude P, 2010, J RHEUMATOL, V37, P987, DOI 10.3899/jrheum.091163; Dimitroulas T, 2014, CURR PHARM DESIGN, V20, P536, DOI 10.2174/13816128113199990555; Foreman HCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033098; Frenzel D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106882; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Krolikowski J, 2012, THROMB VASC BIOL, V32, pA314; Mayes MD, 2014, AM J HUM GENET, V94, P47, DOI 10.1016/j.ajhg.2013.12.002; Murai C, 1998, AUTOIMMUNITY, V28, P151, DOI 10.3109/08916939808996283; ORAM S, 1961, BRIT HEART J, V23, P243; Ou JS, 2003, CIRCULATION, V107, P2337, DOI 10.1161/01.CIR.0000070589.61860.A9; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Rabinovich A, 2015, THROMB RES, V136, P289, DOI 10.1016/j.thromres.2015.06.024; Roy S, 2011, AUTOIMMUNE DISORDERS, P35; Sharif R, 2012, ANN RHEUM DIS, V71, P1197, DOI 10.1136/annrheumdis-2011-200901; Steen Virginia, 2004, Curr Rheumatol Rep, V6, P137, DOI 10.1007/s11926-004-0058-4; Weihrauch D, 2007, AM J PHYSIOL-HEART C, V293, pH1432, DOI 10.1152/ajpheart.00038.2007; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052046; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	27	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151999	10.1371/journal.pone.0151999	http://dx.doi.org/10.1371/journal.pone.0151999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050551	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500020
J	Koo, BK; Lee, JH; Kim, J; Jang, EJ; Lee, CH				Koo, Bo Kyung; Lee, Joon Ho; Kim, Jimin; Jang, Eun Jin; Lee, Chang-Hoon			Prevalence of Gestational Diabetes Mellitus in Korea: A National Health Insurance Database Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; INCREASING PREVALENCE; METABOLIC SYNDROME; UNITED-STATES; WOMEN; INSULIN; GLYBURIDE; TRENDS; TUBERCULOSIS; METAANALYSIS	Aims/Introduction This study aimed to estimate the prevalence of gestational diabetes mellitus (GDM) and use of anti-diabetic medications for patients with GDM in Korea, using data of the period 2007-2011 from the Health Insurance Review and Assessment (HIRA) database, which includes the claims data of 97% of the Korean population. Materials and Methods We used the Healthcare Common Procedure Coding System codes provided by the HIRA to identify women with delivery in the HIRA database between 2009 and 2011. GDM was defined according to ICD-10 codes, and patients with pre-existing diabetes between January 1, 2007 and pregnancy were excluded. A Poisson regression was performed to evaluate the trends in annual prevalence rates. Results The annual numbers of deliveries in 2009-2011 were 479,160 in 2009, 449,747 in 2010, and 377,374 in 2011. The prevalence of GDM during that period was 7.5% in 2009-2011: 5.7% in 2009, 7.8% in 2010, and 9.5% in 2011. The age-stratified analysis showed that the prevalence of GDM was highest in women aged 40-44 years, at 10.6% in 2009-2011, and that the annual prevalence significantly increased even in young women aged 20-29 years during that period (P < 0.05). More than 95% of the patients with GDM did not take any antidiabetic medication. Among the anti-diabetic medications prescribed for patients with GDM, insulin was most commonly prescribed (for >98% of the patients with GDM on medication). Conclusions The prevalence of GDM in Korean women recently reached 5.7-9.5% in recent years. This represents a public health concern that warrants proper screening and medical care for GDM in women during the childbearing years.	[Koo, Bo Kyung; Lee, Chang-Hoon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 151, South Korea; [Koo, Bo Kyung] Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Lee, Joon Ho] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul Natl Univ Hosp, Seoul 151, South Korea; [Kim, Jimin; Jang, Eun Jin; Lee, Chang-Hoon] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; National Evidence-based Healthcare Collaborating Agency (NECA)	Lee, CH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 151, South Korea.; Lee, CH (corresponding author), Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea.	kauri670@empal.com	Lee, Chang-Hoon/AAC-7650-2021; Koo, Bo Kyung/ABB-7170-2020	Koo, Bo Kyung/0000-0002-6489-2656	National Evidence-Based Healthcare Collaborating Agency, Seoul, Republic of Korea [NA13-004]	National Evidence-Based Healthcare Collaborating Agency, Seoul, Republic of Korea	This study was funded by the National Evidence-Based Healthcare Collaborating Agency, Seoul, Republic of Korea. - Grant number: NA13-004 - Receiver: Chang-Hoon Lee - Website: http://www.neca.re.kr/nHTA/eng/ The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, DIABETES CARE, V38, pS5, DOI 10.2337/dc15-S004; [Anonymous], 2013, Obstet Gynecol, V122, P406, DOI 10.1097/01.AOG.0000433006.09219.f1; [Anonymous], 2014, INCR PREV GEST DIAB; Balsells M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h102; Campbell SK, 2012, MATERN CHILD HLTH J, V16, P1284, DOI 10.1007/s10995-011-0889-3; Castillo WC, 2015, JAMA PEDIATR, V169, P452, DOI 10.1001/jamapediatrics.2015.74; Castillo WC, 2014, OBSTET GYNECOL, V123, P1177, DOI 10.1097/AOG.0000000000000285; Charvat H, 2015, J DIABETES INVEST, V6, P533, DOI 10.1111/jdi.12333; Choi NK, 2010, PHARMACOEPIDEM DR S, V19, P238, DOI 10.1002/pds.1902; Choi SK, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-6; DeSisto CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130415; Ferrara A, 2004, OBSTET GYNECOL, V103, P526, DOI 10.1097/01.AOG.0000113623.18286.20; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Jang HC, 2011, DIABETES METAB J, V35, P1, DOI 10.4093/dmj.2011.35.1.1; Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866; Jesmin S, 2014, DIABETES RES CLIN PR, V103, P57, DOI 10.1016/j.diabres.2013.11.024; JEWELL SE, 1995, OBSTET GYNECOL, V85, P229, DOI 10.1016/0029-7844(94)00354-G; Kang YA, 2014, INT J TUBERC LUNG D, V18, P717, DOI 10.5588/ijtld.13.0854; Kang YK, 2011, 2010 HLTH INSURANCE; Kim CH, 2015, J DIABETES INVEST, V6, P51, DOI 10.1111/jdi.12245; Kim YS, 2014, LIVE BIRTHS AGE GROU; Koo BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110650; Koo BK, 2013, DIABETES CARE, V36, pE95, DOI 10.2337/dc13-0247; Korean Diabetes Association, 2011, TREATM GUID DIAB; Korean Diabetes Association, 2007, TREATM GUID DIAB; Kwak SH, 2012, DIABETES, V61, P531, DOI 10.2337/db11-1034; Lamberg S, 2012, EUR J PUBLIC HEALTH, V22, P278, DOI 10.1093/eurpub/ckq193; Langer O, 2000, NEW ENGL J MED, V343, P1134, DOI 10.1056/NEJM200010193431601; Lauenborg J, 2005, J CLIN ENDOCR METAB, V90, P4004, DOI 10.1210/jc.2004-1713; Lee CH, 2013, THORAX, V68, P1105, DOI 10.1136/thoraxjnl-2012-203175; Lee CH, 2013, RESP MED, V107, P1222, DOI 10.1016/j.rmed.2012.12.002; Leng JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121029; Mayo K, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.027; Nicholson W, 2009, OBSTET GYNECOL, V113, P193, DOI 10.1097/AOG.0b013e318190a459; Noctor E, 2015, ACTA DIABETOL, V52, P153, DOI 10.1007/s00592-014-0621-z; 변은경, 2005, Endocrinology and Metabolism, V20, P120; Sloan FA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1548, DOI 10.1001/archopht.126.11.1548; SPELLACY WN, 1978, OBSTET GYNECOL, V52, P210; Vanky E, 2012, ACTA OBSTET GYN SCAN, V91, P1460, DOI 10.1111/aogs.12015; Freire CMV, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-59; Wong VW, 2012, DIABETIC MED, V29, P366, DOI 10.1111/j.1464-5491.2011.03439.x; Zeng YC, 2014, ADV MED SCI-POLAND, V59, P95, DOI 10.1016/j.advms.2014.03.001; Zhang F, 2011, DIABETIC MED, V28, P652, DOI 10.1111/j.1464-5491.2010.03205.x	43	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153107	10.1371/journal.pone.0153107	http://dx.doi.org/10.1371/journal.pone.0153107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046149	Green Published, gold, Green Submitted			2022-12-26	WOS:000373599600068
J	Thomas, EW; Stepanek, JG; Kociolek, JP				Thomas, Evan W.; Stepanek, Joshua G.; Kociolek, J. Patrick			Historical and Current Perspectives on the Systematics of the 'Enigmatic' Diatom Genus Rhoicosphenia (Bacillariophyta), with Single and Multi-Molecular Marker and Morphological Analyses and Discussion on the Monophyly of 'Monoraphid' Diatoms	PLOS ONE			English	Article							LIFE-HISTORY; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENY; MULTIGENE PHYLOGENY; SEQUENCE ALIGNMENT; SIZE-REDUCTION; EVOLUTION; CLASSIFICATION; GENERA; ALGAE	This study seeks to determine the phylogenetic position of the diatom genus Rhoicosphenia. Currently, four hypotheses based on the morphology of the siliceous valve and its various ultrastructural components, sexual reproduction, and chloroplasts have been proposed. Two previous morphological studies have tentatively placed Rhoicosphenia near members of the Achnanthidiaceae and Gomphonemataceae, and no molecular studies have been completed. The position of Rhoicosphenia as sister to 'monoraphid' diatoms is problematic due to the apparent non-monophyly of that group, so hypotheses of 'monoraphid' monophyly are also tested. Using an analysis of morphological and cytological features, as well as sequences from three genes, SSU, LSU, and rbcL, recovered from several freshwater Rhoicosphenia populations that have similar morphology to Rhoicosphenia abbreviata (Agardh) Lange-Bertalot, we have analyzed the phylogenetic position of Rhoicosphenia in the context of raphid diatoms. Further, we have used topology testing to determine the statistical likelihoods of these relationships. The hypothesis that Rhoicosphenia is a member of the Achnanthidiaceae cannot be rejected, while the hypothesis that it is a member of the Gomphonemataceae can be rejected. In our analyses, members of the Achnanthidiaceae are basal to Rhoicosphenia, and Rhoicosphenia is basal to the Cymbellales, or a basal member of the Cymbellales, which includes the Gomphonemataceae. Hypothesis testing rejects the monophyly of 'monoraphid' diatoms.	[Thomas, Evan W.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Thomas, EW (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	ewt@colorado.edu			University of Colorado Boulder Museum of Natural History Student Research Award; University of Colorado Boulder Department of Ecology & Evolutionary Biology Graduate Student Research Grant; University of Colorado Boulder (UCB) Museum of Natural History	University of Colorado Boulder Museum of Natural History Student Research Award; University of Colorado Boulder Department of Ecology & Evolutionary Biology Graduate Student Research Grant; University of Colorado Boulder (UCB) Museum of Natural History	Funded by University of Colorado Boulder Museum of Natural History Student Research Award and University of Colorado Boulder Department of Ecology & Evolutionary Biology Graduate Student Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; EWT would like to thank the University of Colorado Boulder (UCB) Museum of Natural History for a Student Research Award which assisted in field collections of Rhoicosphenia in California and Oregon. EWT also thanks the UCB Department of Ecology & Evolutionary Biology for a Graduate Student Research Grant to sequence Rhoicosphenia populations. The authors thank Dr. Sarah Hamsher for assistance with hypothesis testing software and valuable phylogenetic discussions.	Agardh C.A., 1830, CONSPECTUS CRITICU 1, P1; Alverson AJ, 2008, PROTIST, V159, P339, DOI 10.1016/j.protis.2008.04.001; Alverson AJ, 2007, MOL PHYLOGENET EVOL, V45, P193, DOI 10.1016/j.ympev.2007.03.024; Bory de Saint-Vincent J. B. G. M., 1824, DICT CLASSIQUE HIST, V6, DOI [10.5962/bhl.title.33901, DOI 10.5962/BHL.TITLE.33901]; Bruder K, 2008, DIATOM RES, V23, P331; Bruder K, 2008, DIATOM RES, V23, P283; Bukhtiyarova Ludmila, 1996, Diatom Research, V11, P1; Chen J-Y., 1983, ACTA PHYTOTAXONOMICA, V21, P449; Cleve P.T., 1894, KONGLIGA SVENSKA VET, V4, P1, DOI DOI 10.5962/BHL.TITLE.54740; CLEVE PT, 1895, KONGLIGA SVENSKA VET, V27, P1, DOI DOI 10.5962/BHL.TITLE.68663; CLEVE-EULER ASTRID, 1953, K SVENSKA VETENSKAPSAKAD HANDL, V4, P1; Cox EJ, 2006, SYST BIODIVERS, V4, P385, DOI 10.1017/S1477200006001940; Cox EJ, 2006, EUR J PHYCOL, V41, P67, DOI 10.1080/09670260500491543; Daugbjerg N, 1997, J PHYCOL, V33, P1031, DOI 10.1111/j.0022-3646.1997.01031.x; de Queiroz Kevin, 2012, Bibliotheca Herpetologica, V9, P135; De Toni GB, 1891, BACILLARIAE PATAVIA, VII, P1891, DOI [10.5962/bhl.title.10544, DOI 10.5962/BHL.TITLE.10544]; Drummond A. J., 2012, GENEIOUS V5 6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar SM, 2004, J PHYCOL, V40, P772, DOI 10.1111/j.1529-8817.2004.03126.x; Ehrenberg C.G., 1831, ABH PREUSS AKAD WISS, V1831, P1; Ehrenberg CG, 1835, ABH PREUSS AKAD WISS, P150; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grunow A., 1877, MONTHLY MICROSCOPICA, V18, P165, DOI [10.1111/j.1365-2818.1877.tb00123.x, DOI 10.1111/J.1365-2818.1877.TB00123.X]; Grunow A., 1860, VERHANDLUNGEN KAISER, V10, P503; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; Hustedt F, 1959, L RABENHORSTS KRYPTO, V7, P1; Hustedt F., 1934, ABHANDLUNGEN VORTRAG, V8, P362; Jones HM, 2005, EUR J PHYCOL, V40, P61, DOI 10.1080/09670260400024675; Kermarrec L, 2011, DIATOM RES, V26, P305, DOI 10.1080/0269249X.2011.633255; Kociolek JP, 2013, EUR J PHYCOL, V48, P474, DOI 10.1080/09670262.2013.860239; KOCIOLEK JP, 1986, PHYCOLOGIA, V25, P297, DOI 10.2216/i0031-8884-25-3-297.1; KOCIOLEK JP, 1988, J PHYCOL, V24, P377, DOI 10.1111/j.1529-8817.1988.tb00187.x; KOCIOLEK JP, 1987, SYST BOT, V12, P451, DOI 10.2307/2418882; Kooistra WHCF, 2003, PROG MOLEC, V33, P59; Krammer K., 2004, SUSSWASSERFLORA MITT; Krammer K., 1997, BIBLIOTHECA DIATOMOL, V36, P382; Kulikovskiy M, 2014, PHYTOTAXA, V177, P249, DOI 10.11646/phytotaxa.177.5.1; Kutzing F.T., 1833, LINNAEA, V8, P529, DOI DOI 10.5962/BHL.TITLE.65634; Kutzing F.T., 1844, KIESELSCHALIGEN BACI, pi, DOI DOI 10.1080/037454809495289; Lange-Bertalot H, 1996, ANNOTATED DIATOM MIC, V2, DOI [10.2216/i0031-8884-36-3-255.1, DOI 10.2216/I0031-8884-36-3-255.1]; Lange-Bertalot H., 1999, ANNOTATED DIATOM MIC, V6; MANN DG, 1982, J PHYCOL, V18, P162, DOI 10.1111/j.1529-8817.1982.tb03170.x; MANN DG, 1982, J PHYCOL, V18, P264; MANN DG, 1984, J PHYCOL, V20, P544, DOI 10.1111/j.0022-3646.1984.00544.x; MANN DG, 1995, PHYCOLOGIA, V34, P74, DOI 10.2216/i0031-8884-34-1-74.1; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Medlin L.K., 1984, P 7 INT DIAT S, P255; MEDLIN LK, 1984, J PHYCOL, V20, P101, DOI 10.1111/j.0022-3646.1984.00101.x; Medlin LK, 2004, PHYCOLOGIA, V43, P245, DOI 10.2216/i0031-8884-43-3-245.1; Mereschkowsky C., 1902, SCRIPTA BOT HORTI U, V21, P1; Mereschkowsky C, 1903, BOT CENTRALBLATT S, V15, P1; Moser G., 1998, BIBLIOTHECA DIATOMOL, V38, P1; Nakov T, 2014, PHYCOLOGIA, V53, P359, DOI 10.2216/14-002.1; Patrick R., 1966, DIATOMS US EXCLUSIVE, DOI [10.2307/1351135, DOI 10.2307/1351135]; Peragallo H., 1897, MICROGRAPHIE PREPARA, V5, P9, DOI [10.5962/bhl.title.13501, DOI 10.5962/BHL.TITLE.13501]; Pfitzer E, 1871, BOT ABHANDLUNGEN GEB, V2; Richlen ML, 2005, MOL ECOL NOTES, V5, P688, DOI 10.1111/j.1471-8286.2005.01032.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Round F. E., 1998, Diatom Research, V13, P181; Round F. E., 1996, Diatom Research, V11, P345; Round F. E., 1997, Diatom Research, V12, P71; Round F. E., 1990, DIATOMS BIOL MORPHOL; Ruck EC, 2011, PROTIST, V162, P723, DOI 10.1016/j.protis.2011.02.003; Schmidt M, 1899, ATLAS DIATOMACEENKUN, DOI [10.5962/bhl.title.64254, DOI 10.5962/BHL.TITLE.64254]; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Schutt F., 1896, NATURLICHEN PFLANZEN, VI, P31, DOI DOI 10.5962/BHL.TITLE.4635; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silva P.C., 1962, PHYSL BIOCH ALGAE, P827; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; SIMONSEN R, 1979, Bacillaria, V2, P9; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Smith W., 1853, SYNOPSIS BRIT DIATOM, P89, DOI DOI 10.5962/BHL.TITLE.10706; Sorhannus U, 2004, CLADISTICS, V20, P487, DOI 10.1111/j.1096-0031.2004.00034.x; Souffreau C, 2011, MOL PHYLOGENET EVOL, V61, P866, DOI 10.1016/j.ympev.2011.08.031; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stepanek JG, 2014, PROTIST, V165, P177, DOI 10.1016/j.protis.2014.02.002; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Van Heurck H, 1896, TREATISE DIATOMACEAE, DOI [10.5962/bhl.title.2002, DOI 10.5962/BHL.TITLE.2002]	82	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152797	10.1371/journal.pone.0152797	http://dx.doi.org/10.1371/journal.pone.0152797			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045763	gold, Green Published, Green Submitted			2022-12-26	WOS:000373599600033
J	Al-Janabi, B; Kruse, I; Graiff, A; Winde, V; Lenz, M; Wahl, M				Al-Janabi, Balsam; Kruse, Inken; Graiff, Angelika; Winde, Vera; Lenz, Mark; Wahl, Martin			Buffering and Amplifying Interactions among OAW (Ocean Acidification & Warming) and Nutrient Enrichment on Early Life-Stage Fucus vesiculosus L. (Phaeophyceae) and Their Carry Over Effects to Hypoxia Impact	PLOS ONE			English	Article							LONG-TERM CHANGES; BALTIC SEA; DEPTH DISTRIBUTION; GENETIC DIVERSITY; MARINE ECOSYSTEM; CLIMATE-CHANGE; GROWTH; TEMPERATURE; PHOTOSYNTHESIS; SEAWEED	Ocean acidification and warming (OAW) are occurring globally. Additionally, at a more local scale the spreading of hypoxic conditions is promoted by eutrophication and warming. In the semi-enclosed brackish Baltic Sea, occasional upwelling in late summer and autumn may expose even shallow-water communities including the macroalga Fucus vesiculosus to particularly acidified, nutrient-rich and oxygen-poor water bodies. During summer 2014 (July-September) sibling groups of early life-stage F. vesiculosus were exposed to OAW in the presence and absence of enhanced nutrient levels and, subsequently to a single upwelling event in a near-natural scenario which included all environmental fluctuations in the Kiel Fjord, southwestern Baltic Sea, Germany (54 degrees 27 'N, 10 degrees 11 'W). We strove to elucidate the single and combined impacts of these potential stressors, and how stress sensitivity varies among genetically different sibling groups. Enhanced by a circumstantial natural heat wave, warming and acidification increased mortalities and reduced growth in F. vesiculosus germlings. This impact, however, was mitigated by enhanced nutrient conditions. Survival under OAW conditions strongly varied among sibling groups hinting at a substantial adaptive potential of the natural Fucus populations in the Western Baltic. A three-day experimental upwelling caused severe mortality of Fucus germlings, which was substantially more severe in those sibling groups which previously had been exposed to OAW. Our results show that global (OAW), regional (nutrient enrichment) and local pressures (upwelling), both alone and co-occurring may have synergistic and antagonistic effects on survival and/or growth of Fucus germlings. This result emphasizes the need to consider combined stress effects.	[Al-Janabi, Balsam; Kruse, Inken; Lenz, Mark; Wahl, Martin] GEOMAR, Helmholtz Ctr Ocean Res Kiel, Benth Ecol Grp, Kiel, Germany; [Graiff, Angelika] Univ Rostock, Inst Biol Sci Appl Ecol & Phycol, D-18055 Rostock, Germany; [Winde, Vera] Leibniz Inst Balt Sea Res, Geochem & Isotope Biogeochem Grp, Dept Marine Geol, Warnemunde, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Rostock; Leibniz Institut fur Ostseeforschung Warnemunde	Al-Janabi, B (corresponding author), GEOMAR, Helmholtz Ctr Ocean Res Kiel, Benth Ecol Grp, Kiel, Germany.	baljanabi@geomar.de	Wahl, Martin/D-2038-2016	Wahl, Martin/0000-0001-8703-3857	Project BIOACID II of the German Federal Ministry of Education and Research (BMBF) [FKZ 03F0655]	Project BIOACID II of the German Federal Ministry of Education and Research (BMBF)	The research was funded by the Project BIOACID II of the German Federal Ministry of Education and Research (BMBF; FKZ 03F0655, A). They support this project, the experimental setup and all accompanied costs.	AErtebjerg G., 2003, NUTR EUTROPHICATION; Al-Janabi B, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2804-8; Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Andersen GS, 2013, J PHYCOL, V49, P689, DOI 10.1111/jpy.12077; [Anonymous], 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Assis J, 2014, MOL ECOL, V23, P2797, DOI 10.1111/mec.12772; BACC II Author Team, 2015, 2 ASS CLIM CHANG BAL, DOI [10.1007/978-3-319-16006-1, DOI 10.1007/978-3-319-16006-1]; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Berger R, 2004, HYDROBIOLOGIA, V514, P243, DOI 10.1023/B:hydr.0000018222.44511.b7; Bergstrom L, 2003, EUR J PHYCOL, V38, P41, DOI 10.1080/0967026031000096236; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Brewer PG, 2009, SCIENCE, V324, P347, DOI 10.1126/science.1170756; Burnett LE, 1997, AM ZOOL, V37, P633; Pineda MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046672; Carstensen J, 2014, AMBIO, V43, P26, DOI 10.1007/s13280-013-0474-7; Coelho Susana M., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P317, DOI 10.1023/A:1009916129009; Diaz RJ, 1996, OCEANOGRAPH LIT REV, V43, P1250; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Elken J, 2015, REG CLIM STUD, P131, DOI 10.1007/978-3-319-16006-1_7; Eriksson BK, 2003, EUR J PHYCOL, V38, P217, DOI 10.1080/0967026031000121688; Eriksson BK, 1998, EUR J PHYCOL, V33, P241, DOI 10.1080/09670269810001736743; Fernandez PA, 2015, PHOTOSYNTH RES, V124, P293, DOI 10.1007/s11120-015-0138-5; Frankham R, 2003, CR BIOL, V326, pS22, DOI 10.1016/S1631-0691(03)00023-4; Gordillo FJL, 2001, PLANTA, V213, P64, DOI 10.1007/s004250000468; Graiff A, 2015, J EXP MAR BIOL ECOL, V471, P8, DOI 10.1016/j.jembe.2015.05.009; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; HADER DP, 1994, ENVIRON MONIT ASSESS, V32, P259, DOI 10.1007/BF00546280; HELCOM, BALT SEA ENV P 2007; Hemmi A, 2002, ECOLOGY, V83, P1052, DOI 10.2307/3071913; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Johannesson K, 2011, AMBIO, V40, P179, DOI 10.1007/s13280-010-0129-x; Jueterbock A, 2013, ECOL EVOL, V3, P1356, DOI 10.1002/ece3.541; Jutterstrom S, 2014, MAR POLLUT BULL, V86, P468, DOI 10.1016/j.marpolbul.2014.06.027; KAUTSKY N, 1986, MAR ECOL PROG SER, V28, P1, DOI 10.3354/meps028001; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Lehvo A, 2001, BOT MAR, V44, P345, DOI 10.1515/BOT.2001.044; Lloret J, 2011, MAR POLLUT BULL, V62, P2732, DOI 10.1016/j.marpolbul.2011.09.014; Lloret J, 2009, MAR POLLUT BULL, V58, P1827, DOI 10.1016/j.marpolbul.2009.08.001; Lotze HK, 2001, LIMNOL OCEANOGR, V46, P749, DOI 10.4319/lo.2001.46.4.0749; Maczassek K., 2014, THESIS; Meier HEM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049929; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Neumann T, 2010, J MARINE SYST, V81, P213, DOI 10.1016/j.jmarsys.2009.12.001; Nicastro KR, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-6; Nielsen SL, 2014, MAR BIOL, V161, P1895, DOI 10.1007/s00227-014-2471-1; Nygard CA, 2008, EUR J PHYCOL, V43, P253, DOI 10.1080/09670260802172627; Olischlager M, 2013, PHYCOL RES, V61, P180, DOI 10.1111/pre.12006; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; PECKOL P, 1995, J EXP MAR BIOL ECOL, V190, P1, DOI 10.1016/0022-0981(95)00026-N; Plaxton WC, 2006, CRIT REV PLANT SCI, V25, P159, DOI 10.1080/07352680600563876; Queiros AM, 2015, GLOBAL CHANGE BIOL, V21, P130, DOI 10.1111/gcb.12675; Reusch TBH, 2006, ESTUARIES COASTS, V29, P159, DOI 10.1007/BF02784707; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Reusch TBH, 2007, MOL ECOL, V16, P3973, DOI 10.1111/j.1365-294X.2007.03454.x; Rinne H, 2011, ESTUAR COAST SHELF S, V94, P182, DOI 10.1016/j.ecss.2011.06.010; Rohde S, 2008, EUR J PHYCOL, V43, P143, DOI 10.1080/09670260801901018; Saderne V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062689; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schmidt AL, 2011, MAR ECOL PROG SER, V437, P51, DOI 10.3354/meps09276; Serrao EA, 1996, OECOLOGIA, V107, P1, DOI 10.1007/BF00582229; Steen H, 2004, MAR BIOL, V144, P61, DOI 10.1007/s00227-003-1175-8; Stocker T.F., 2013, CONTRIBUTION WORKING, P1, DOI [DOI 10.1017/CBO9781107415324, 10.1017/CBO9781107415324]; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Torn K, 2006, AQUAT BOT, V84, P53, DOI 10.1016/j.aquabot.2005.07.011; VERARDO DJ, 1990, DEEP-SEA RES, V37, P157, DOI 10.1016/0198-0149(90)90034-S; VOGT H, 1991, MAR ECOL PROG SER, V69, P189, DOI 10.3354/meps069189; Wahl M, 2016, MAR FRESHWATER RES, V67, P25, DOI 10.1071/MF14154; Wahl M, 2015, LIMNOL OCEANOGR METH; Wahl M., 2015, PERSPECTIVES PHYCOLO, V2, P11, DOI [10.1127/pip/2015/0019, DOI 10.1127/PIP/2015/0019]; Wahl M, 2011, ADV MAR BIOL, V59, P37, DOI 10.1016/B978-0-12-385536-7.00002-9; WALLENTINUS I, 1984, MAR BIOL, V80, P215, DOI 10.1007/BF02180189; WEIGELT M, 1991, MEERESFORSCHUNG, V33, P197; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wikstrom SA, 2007, ESTUAR COAST SHELF S, V72, P168, DOI 10.1016/j.ecss.2006.10.009; Winde V, 2014, J MARINE SYST, V129, P396, DOI 10.1016/j.jmarsys.2013.08.005; Worm B, 2000, MAR ECOL PROG SER, V202, P283, DOI 10.3354/meps202283; YORDANOV I, 1986, PHOTOBIOCH PHOTOBIOP, V12, P147; Zou DH, 2005, AQUACULTURE, V250, P726, DOI 10.1016/j.aquaculture.2005.05.014; Zou DH, 2011, J PHYCOL, V47, P87, DOI 10.1111/j.1529-8817.2010.00929.x	81	13	13	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152948	10.1371/journal.pone.0152948	http://dx.doi.org/10.1371/journal.pone.0152948			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043710	Green Published, gold, Green Accepted			2022-12-26	WOS:000373592100052
J	van Zelst, M; Hesta, M; Gray, K; Beech, K; Cools, A; Alexander, LG; Du Laing, G; Janssens, GPJ				van Zelst, Marielle; Hesta, Myriam; Gray, Kerry; Beech, Karen; Cools, An; Alexander, Lucille G.; Du Laing, Gijs; Janssens, Geert P. J.			Selenium Digestibility and Bioactivity in Dogs: What the Can Can, the Kibble Can't	PLOS ONE			English	Article							CANCER PREVENTION; GLUTATHIONE-PEROXIDASE; TISSUE SELENIUM; PROSTATE-CANCER; T-CELL; DIETARY; TRIIODOTHYRONINE; SUPPLEMENTATION; THIOREDOXIN; ANTIOXIDANT	There is a growing concern for the long-term health effects of selenium (Se) over-or underfeeding. The efficiency of utilization of dietary Se is subject to many factors. Our study in dogs evaluated the effect of diet type (canned versus kibble) and dietary protein concentration on Se digestibility and bioactivity. Canned and kibble diets are commonly used formats of dog food, widely ranging in protein concentration. Twenty-four Labrador retrievers were used and four canned and four kibble diets were selected with crude protein concentrations ranging from 10.1 to 27.5 g/MJ. Crude protein concentration had no influence on the digestibility of Se in either canned or kibble diets, but a lower Se digestibility was observed in canned compared to kibble diets. However, the biological activity of Se, as measured by whole blood glutathione peroxidase, was higher in dogs fed the canned diets than in dogs fed the kibble diets and decreased with increasing crude protein intake. These results indicate that selenium recommendations in dog foods need to take diet type into account.	[van Zelst, Marielle; Hesta, Myriam; Cools, An; Janssens, Geert P. J.] Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Merelbeke, Belgium; [Gray, Kerry; Beech, Karen; Alexander, Lucille G.] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England; [Du Laing, Gijs] Univ Ghent, Fac Biosci Engn, Dept Appl Analyt & Phys Chem, B-9000 Ghent, Belgium	Ghent University; Mars; WALTHAM Petcare Science Institute; Ghent University	Janssens, GPJ (corresponding author), Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Merelbeke, Belgium.	Nutrition@UGent.be	Janssens, Geert/C-2264-2008	Hesta, Myriam/0000-0001-9423-9765; Du Laing, Gijs/0000-0001-6661-1312	WALTHAM(R) Centre for Pet Nutrition	WALTHAM(R) Centre for Pet Nutrition	This study is part of a PhD project of MvZ funded by the WALTHAM (R) Centre for Pet Nutrition (grant number not applicable) (www.waltham.com). The funders, other than the named authors, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich G, 2006, ESSENT RENDER, P159; [Anonymous], 2013, RSTUDIO INT DEV ENV; Basu S., 2007, Scandinavian Journal of Food & Nutrition, V51, P48, DOI 10.1080/17482970701411642; Bierla K, 2008, ANAL BIOANAL CHEM, V390, P1789, DOI 10.1007/s00216-008-1883-5; Carlson BA, 2010, P NUTR SOC, V69, P300, DOI 10.1017/S002966511000176X; Clark LC, 1998, BRIT J UROL, V81, P730; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; DARRAS VM, 1992, COMP BIOCHEM PHYS A, V103, P131, DOI 10.1016/0300-9629(92)90252-L; de Lorgeril M, 2001, EUR J HEART FAIL, V3, P661, DOI 10.1016/S1388-9842(01)00179-9; Dumont E, 2006, ANAL BIOANAL CHEM, V385, P1304, DOI 10.1007/s00216-006-0529-8; FEDIAF, 2013, NUTR GUID COMPL COMP; German AJ, 2006, J NUTR, V136, p2031S, DOI 10.1093/jn/136.7.2031S; Gregus Z, 1998, BIOCHEM PHARMACOL, V56, P1391, DOI 10.1016/S0006-2952(98)00190-7; Hughes DJ, 2015, INT J CANCER, V136, P1149, DOI 10.1002/ijc.29071; ISO, 2005, 59831 ISO; Kantrowitz LB, 2001, J AM VET MED ASSOC, V219, P765, DOI 10.2460/javma.2001.219.765; Koller G, 1984, ABBILD EMOTION OSTER; Lavu RVS, 2012, J AGR FOOD CHEM, V60, P10930, DOI 10.1021/jf302931z; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; MCCONNELL KP, 1952, J BIOL CHEM, V194, P183; Myers WD, 2004, J ANIM SCI, V82, P179; National Research Council, 2006, NUTR REQ DOGS CATS; OLIVIERI O, 1995, CLIN SCI, V89, P637, DOI 10.1042/cs0890637; Payne RL, 2005, POULTRY SCI, V84, P1268, DOI 10.1093/ps/84.8.1268; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; REASBECK PG, 1985, DIGEST DIS SCI, V30, P489, DOI 10.1007/BF01318184; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Schneider H A, 1936, Science, V83, P32, DOI 10.1126/science.83.2141.32-a; Selenius M, 2010, ANTIOXID REDOX SIGN, V12, P867, DOI 10.1089/ars.2009.2884; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; Souci S. W., 2008, FOOD COMPOSITION NUT; Tinggi Ujang, 2008, Environmental Health and Preventive Medicine, V13, P102, DOI 10.1007/s12199-007-0019-4; Todd SE, 2012, J ANIM SCI, V90, P2549, DOI 10.2527/jas.2011-3911; Todd SE, 2012, J ANIM PHYSIOL AN N, V96, P148, DOI 10.1111/j.1439-0396.2011.01132.x; Todd SE, 2006, THESIS MASSEY U PALM; Toufektsian MC, 2000, TOXICOLOGY, V148, P125, DOI 10.1016/S0300-483X(00)00203-1; van Zelst M, 2015, BRIT J NUTR, V113, P1888, DOI 10.1017/S0007114515001324; WASCHULEWSKI IH, 1988, BRIT J NUTR, V60, P57, DOI 10.1079/BJN19880076; Wedekind K, 2001, FASEB J, V15, pA953; Wedekind K. J., 1997, FASEB Journal, V11, pA360; Wedekind KJ, 2004, J ANIM PHYSIOL AN N, V88, P340, DOI 10.1111/j.1439-0396.2004.00489.x; Wedekind KJ, 1998, FASEB J, V12, pA823; Wedekind KJ, 2000, COMPEND CONTIN ED VE, V22, P17; World CJ, 2006, J MOL MED-JMM, V84, P997, DOI 10.1007/s00109-006-0109-6; YOUNG VR, 1982, AM J CLIN NUTR, V35, P1076, DOI 10.1093/ajcn/35.5.1076; Yu S, 2002, J ANIM PHYSIOL AN N, V86, P36, DOI 10.1046/j.1439-0396.2002.00338.x; Zentek J., CHANGING LANDSCAPE P	47	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152709	10.1371/journal.pone.0152709	http://dx.doi.org/10.1371/journal.pone.0152709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043433	Green Submitted, Green Published, gold			2022-12-26	WOS:000373592100029
J	Douetts-Peres, JC; Cruz, MAL; Reis, RS; Heringer, AS; de Oliveira, EAG; Elbl, PM; Floh, EIS; Silveira, V; Santa-Catarina, C				Douetts-Peres, Jackellinne C.; Cruz, Marco Antonio L.; Reis, Ricardo S.; Heringer, Angelo S.; de Oliveira, Eduardo A. G.; Elbl, Paula M.; Floh, Eny I. S.; Silveira, Vanildo; Santa-Catarina, Claudete			Mps1 (Monopolar Spindle 1) Protein Inhibition Affects Cellular Growth and Pro-Embryogenic Masses Morphology in Embryogenic Cultures of Araucaria angustifolia (Araucariaceae)	PLOS ONE			English	Article							NITRIC-OXIDE; SOMATIC EMBRYOGENESIS; KINASE; CHECKPOINT; PHOSPHORYLATION; GLUTATHIONE; ACTIVATION; POLYAMINE; KUNTZE; IAA	Somatic embryogenesis has been shown to be an efficient tool for studying processes based on cell growth and development. The fine regulation of the cell cycle is essential for proper embryo formation during the process of somatic embryogenesis. The aims of the present work were to identify and perform a structural and functional characterization of Mps1 and to analyze the effects of the inhibition of this protein on cellular growth and pro-embryogenic mass (PEM) morphology in embryogenic cultures of A. angustifolia. A singlecopy Mps1 gene named AaMps1 was retrieved from the A. angustifolia transcriptome database, and through a mass spectrometry approach, AaMps1 was identified and quantified in embryogenic cultures. The Mps1 inhibitor SP600125 (10 mu M) inhibited cellular growth and changed PEMs, and these effects were accompanied by a reduction in AaMps1 protein levels in embryogenic cultures. Our work has identified the Mps1 protein in a gymnosperm species for the first time, and we have shown that inhibiting Mps1 affects cellular growth and PEM differentiation during A. angustifolia somatic embryogenesis. These data will be useful for better understanding cell cycle control during somatic embryogenesis in plants.	[Douetts-Peres, Jackellinne C.; Santa-Catarina, Claudete] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, CBB, Lab Biol Celular & Tecidual, Rio De Janeiro, Brazil; [Cruz, Marco Antonio L.; de Oliveira, Eduardo A. G.] Univ Fed Rio de Janeiro, Nucleo Ecol & Desenvolvimento Socioambiental Maca, Lab Biotecnol Vegetal, Rio De Janeiro, Brazil; [Reis, Ricardo S.; Heringer, Angelo S.; Silveira, Vanildo] UENF, CBB, Lab Biotecnol, Rio De Janeiro, Brazil; [Reis, Ricardo S.; Heringer, Angelo S.; Silveira, Vanildo] UENF, Setor Prote, Unidade Biol Integrat, Rio De Janeiro, Brazil; [Elbl, Paula M.; Floh, Eny I. S.] Univ Sao Paulo, Inst Biociencias, Dept Bot, Lab Biol Celular Plantas, Sao Paulo, Brazil	Universidade Estadual do Norte Fluminense; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Santa-Catarina, C (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro UENF, CBB, Lab Biol Celular & Tecidual, Rio De Janeiro, Brazil.	claudete@uenf.br	Heringer, Angelo/S-3033-2019; Silveira, Vanildo/E-8887-2011; Heringer, Angelo S/M-8275-2014; Santa-Catarina, Claudete/L-5531-2014; Iochevet Segal Floh, Eny/D-9526-2012	Heringer, Angelo/0000-0002-2723-7353; Silveira, Vanildo/0000-0001-5697-6932; Heringer, Angelo S/0000-0002-2723-7353; Santa-Catarina, Claudete/0000-0002-1669-660X; Iochevet Segal Floh, Eny/0000-0001-6529-2065; Reis, Ricardo/0000-0002-9683-8195; Cruz, Marco Antonio Lopes/0000-0002-3013-657X	National Council for Scientific and Technological Development (CNPq) [476465/2011-7, 305645/2013-7]; Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ) [E26/112.055/2011, E26/110.390/2012, E26/111.389-2012, E26/102.989/2012, E26/010.001507/2014]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the National Council for Scientific and Technological Development (CNPq) (476465/2011-7 and 305645/2013-7) and the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ) (E26/112.055/2011, E26/110.390/2012, E26/111.389-2012, E26/102.989/2012, and E26/010.001507/2014).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, SCIENCE, V342, P1241089, DOI [10.1126/science.1241089, DOI 10.1126/SCIENCE.1241089]; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ATTREE SM, 1993, PLANT CELL TISS ORG, V35, P1, DOI 10.1007/BF00043936; Balbuena TS, 2009, J PROTEOMICS, V72, P337, DOI 10.1016/j.jprot.2009.01.011; BECWAR MR, 1989, IN VITRO CELL DEV B, V25, P575, DOI 10.1007/BF02623571; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Carrier DJ, 1999, J EXP BOT, V50, P1359, DOI 10.1093/jexbot/50.337.1359; Chu MLH, 2008, J BIOL CHEM, V283, P21495, DOI 10.1074/jbc.M803026200; Chu MLH, 2010, BIOCHEMISTRY-US, V49, P1689, DOI 10.1021/bi901970c; de Osti RZ, 2010, PLANT SCI, V178, P448, DOI 10.1016/j.plantsci.2010.02.006; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; Dinkel H, 2013, NUCLEIC ACIDS RES, V42; Elbl P, 2015, PLANT CELL TISS ORG, V120, P917, DOI 10.1007/s11240-015-0730-6; Elbl P, 2015, PLANT CELL TISS ORG, V120, P903, DOI 10.1007/s11240-014-0523-3; Farias-Soares FL, 2014, ACTA PHYSIOL PLANT, V36, P1853, DOI 10.1007/s11738-014-1560-6; Feher A, 2015, BBA-GENE REGUL MECH, V1849, P385, DOI 10.1016/j.bbagrm.2014.07.005; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; de Oliveira EAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045707; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Lee TY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-261; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Otvos K, 2005, PLANT J, V43, P849, DOI 10.1111/j.1365-313X.2005.02494.x; Pasternak T, 2014, PLANT PHYSIOL BIOCH, V74, P16, DOI 10.1016/j.plaphy.2013.10.028; Planchais S, 2000, FEBS LETT, V476, P78, DOI 10.1016/S0014-5793(00)01675-6; Reis RS, 2016, J PROTEOMICS, V130, P170, DOI 10.1016/j.jprot.2015.09.029; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santa-Catarina C, 2007, PLANT CELL TISS ORG, V90, P93, DOI 10.1007/s11240-007-9259-7; Santa-Catarina C, 2006, PLANT GROWTH REGUL, V49, P237, DOI 10.1007/s10725-006-9129-z; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Silveira V, 2006, PLANT SCI, V171, P91, DOI 10.1016/j.plantsci.2006.02.015; Steiner N, 2005, BRAZ ARCH BIOL TECHN, V48, P895, DOI 10.1590/S1516-89132005000800005; Steiner N, 2015, KUNTZE PROTOPLASMA, P1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tipton AR, 2013, J BIOL CHEM, V288, P35149, DOI 10.1074/jbc.M113.522375; Vieira LD, 2012, PLANT SCI, V195, P80, DOI 10.1016/j.plantsci.2012.06.011; Wang W, 2009, J CELL MOL MED, V13, P1679, DOI 10.1111/j.1582-4934.2008.00605.x; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	45	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153528	10.1371/journal.pone.0153528	http://dx.doi.org/10.1371/journal.pone.0153528			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064899	Green Submitted, gold, Green Published			2022-12-26	WOS:000373891000055
J	Drygala, F; Korablev, N; Ansorge, H; Fickel, J; Isomursu, M; Elmeros, M; Kowalczyk, R; Baltrunaite, L; Balciauskas, L; Saarma, U; Schulze, C; Borkenhagen, P; Frantz, AC				Drygala, Frank; Korablev, Nikolay; Ansorge, Hermann; Fickel, Joerns; Isomursu, Marja; Elmeros, Morten; Kowalczyk, Rafal; Baltrunaite, Laima; Balciauskas, Linas; Saarma, Urmas; Schulze, Christoph; Borkenhagen, Peter; Frantz, Alain C.			Homogenous Population Genetic Structure of the Non-Native Raccoon Dog (Nyctereutes procyonoides) in Europe as a Result of Rapid Population Expansion	PLOS ONE			English	Article							DISTANCE SEED DISPERSAL; MEDIUM-SIZED CARNIVORES; BIOLOGICAL INVASION; N-E; DIVERSITY; HISTORY; SOFTWARE; RABIES; COLONIZATION; NUMBER	The extent of gene flow during the range expansion of non-native species influences the amount of genetic diversity retained in expanding populations. Here, we analyse the population genetic structure of the raccoon dog (Nyctereutes procyonoides) in north-eastern and central Europe. This invasive species is of management concern because it is highly susceptible to fox rabies and an important secondary host of the virus. We hypothesized that the large number of introduced animals and the species' dispersal capabilities led to high population connectivity and maintenance of genetic diversity throughout the invaded range. We genotyped 332 tissue samples from seven European countries using 16 microsatellite loci. Different algorithms identified three genetic clusters corresponding to Finland, Denmark and a large 'central' population that reached from introduction areas in western Russia to northern Germany. Cluster assignments provided evidence of long-distance dispersal. The results of an Approximate Bayesian Computation analysis supported a scenario of equal effective population sizes among different pre-defined populations in the large central cluster. Our results are in line with strong gene flow and secondary admixture between neighbouring demes leading to reduced genetic structuring, probably a result of its fairly rapid population expansion after introduction. The results presented here are remarkable in the sense that we identified a homogenous genetic cluster inhabiting an area stretching over more than 1500km. They are also relevant for disease management, as in the event of a significant rabies outbreak, there is a great risk of a rapid virus spread among raccoon dog populations.	[Drygala, Frank; Frantz, Alain C.] Musee Natl Hist Nat, Luxembourg, Luxembourg; [Korablev, Nikolay] Velikie Luki State Agr Acad, Velikie Luki, Russia; [Ansorge, Hermann] Senckenberg Museum Nat Kunde Gorlitz, Gorlitz, Germany; [Fickel, Joerns] Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany; [Fickel, Joerns] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Isomursu, Marja] Finnish Food Safety Author, Prod Anim & Wildlife Res Unit, Oulu, Finland; [Elmeros, Morten] Aarhus Univ, Dept Biosci, Ronde, Denmark; [Kowalczyk, Rafal] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Baltrunaite, Laima; Balciauskas, Linas] Inst Ecol, Nat Res Ctr, Vilnius, Lithuania; [Saarma, Urmas] Univ Tartu, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia; [Schulze, Christoph] Landeslab Berlin Brandenburg, Frankfurt, Oder, Germany; [Borkenhagen, Peter] Univ Kiel, Faunistisch Okol Arbeitsgemeinschaft SH, Kiel, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Leibniz Institut fur Zoo und Wildtierforschung; University of Potsdam; Finnish Food Authority; Aarhus University; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Nature Research Center - Lithuania; University of Tartu; University of Kiel	Frantz, AC (corresponding author), Musee Natl Hist Nat, Luxembourg, Luxembourg.	alainfrantz@yahoo.co.uk	Baltrunaite, Laima/AAW-4167-2021; Saarma, Urmas/AAC-9813-2019; Balčiauskas, Linas/ABE-2454-2021; Balciauskas, Linas/GRS-8910-2022; Elmeros, Morten/K-3094-2013	Saarma, Urmas/0000-0002-3222-571X; Balčiauskas, Linas/0000-0001-9672-5265; Elmeros, Morten/0000-0001-5811-9205; Baltrunaite, Laima/0000-0002-2059-4884; Kowalczyk, Rafal/0000-0001-7264-2158				Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Ahlroth P, 2003, OECOLOGIA, V137, P617, DOI 10.1007/s00442-003-1344-y; Ansorge H, 2009, ANN ZOOL FENN, V46, P51, DOI 10.5735/086.046.0106; Asferg T., 1991, DANMARKS PATTEDYR, V2, P7; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Baagoe HJ, 2007, DANSK PATTEDYR ATLAS, P182; BARBUJANI G, 1995, P NATL ACAD SCI USA, V92, P9171, DOI 10.1073/pnas.92.20.9171; Belkhir K., 2004, GENETIX 4 05 POPULAT; Bialozyt R, 2006, J EVOLUTION BIOL, V19, P12, DOI 10.1111/j.1420-9101.2005.00995.x; Brockerhoff EG, 2014, ECOLOGY, V95, P594, DOI 10.1890/13-0465.1; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Drygala F, 2013, HYSTRIX, V24, P190, DOI 10.4404/hystrix-24.2-8867; Drygala F, 2013, EUR J WILDLIFE RES, V59, P683, DOI 10.1007/s10344-013-0722-y; Drygala F, 2010, WILDLIFE BIOL, V16, P150, DOI 10.2981/08-076; Etherington TR, 2011, METHODS ECOL EVOL, V2, P52, DOI 10.1111/j.2041-210X.2010.00048.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Forsyth DM, 2004, CONSERV BIOL, V18, P557, DOI 10.1111/j.1523-1739.2004.00423.x; Francisco LV, 1996, MAMM GENOME, V7, P359, DOI 10.1007/s003359900104; Frantz AC, 2010, HEREDITY, V104, P493, DOI 10.1038/hdy.2009.136; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HELLE E, 1993, J MAMMAL, V74, P936, DOI 10.2307/1382432; HELLE E, 1991, HOLARCTIC ECOL, V14, P278; Holmala K, 2009, ANN ZOOL FENN, V46, P233, DOI 10.5735/086.046.0401; Hong Y, 2013, GENES GENET SYST, V88, P69, DOI 10.1266/ggs.88.69; KAUHALA K, 1993, J ZOOL, V231, P95, DOI 10.1111/j.1469-7998.1993.tb05355.x; Kauhala K, 2006, ANN ZOOL FENN, V43, P348; Kauhala K, 2011, CURR ZOOL, V57, P584, DOI 10.1093/czoolo/57.5.584; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Korablev NP, 2011, RUSS J GENET+, V47, P1227, DOI 10.1134/S1022795411100103; Kowalczyk R, 2009, ANN ZOOL FENN, V46, P291, DOI 10.5735/086.046.0406; Laurimaa L, 2016, VET PARASIT IN PRESS; Lavrov N.P., 1971, T KAFEDRY BIOLOGII M, V29, P101; LeCorre V, 1997, GENET RES, V69, P117, DOI 10.1017/S0016672397002668; Lively C. M., 1995, P421, DOI 10.1017/CBO9780511629396.017; Lucek K, 2010, MOL ECOL, V19, P3995, DOI 10.1111/j.1365-294X.2010.04781.x; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; Nasimovich AA, 1985, PESETS LISITSA ENOTO, P116; NEI M, 1978, GENETICS, V89, P583; Norgaard Louise Solveig, 2014, Flora og Fauna, V120, P8; Nowak E., 1973, Beitrage Jagd-Wildforsch, V8, P351; Nowak E., 1964, Acta Theriologica, V9, P81; NYBERG M, 1992, ACTA VET SCAND, V33, P43; Paulauskas A, 2016, TURK J ZOOL, V40, P933, DOI 10.3906/zoo-1502-34; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pitra C, 2010, EUR J WILDLIFE RES, V56, P117, DOI 10.1007/s10344-009-0283-2; Pope LC, 2006, MOL ECOL, V15, P371, DOI 10.1111/j.1365-294X.2005.02815.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Sacks BN, 2008, MOL BIOL EVOL, V25, P1384, DOI 10.1093/molbev/msn082; Singer A, 2009, J WILDLIFE DIS, V45, P1121, DOI 10.7589/0090-3558-45.4.1121; Spencer PBS, 2012, J WILDLIFE MANAGE, V76, P1254, DOI 10.1002/jwmg.381; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Sutor A, 2008, EUR J WILDLIFE RES, V54, P321, DOI 10.1007/s10344-007-0153-8; Sutor A, 2014, ACTA THERIOL, V59, P49, DOI 10.1007/s13364-013-0138-9; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Thulin CG, 2006, MOL ECOL, V15, P3947, DOI 10.1111/j.1365-294X.2006.03084.x; Tinghitella RM, 2011, J EVOLUTION BIOL, V24, P1199, DOI 10.1111/j.1420-9101.2011.02255.x; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Whiteside HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022145; Zenger KR, 2003, MOL ECOL, V12, P789, DOI 10.1046/j.1365-294X.2003.01759.x	78	18	18	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153098	10.1371/journal.pone.0153098	http://dx.doi.org/10.1371/journal.pone.0153098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064784	Green Published, gold, Green Submitted			2022-12-26	WOS:000373891000030
J	Diaz, J; Terrazas, S; Bierrenbach, AL; Toscano, CM; Alencar, GP; Alvarez, A; Valenzuela, MT; Andrus, J; del Aguila, R; Hormazabal, JC; Araya, P; Pidal, P; Matus, CR; de Oliveira, LH				Diaz, Janepsy; Terrazas, Solana; Bierrenbach, Ana L.; Toscano, Cristiana M.; Alencar, Gizelton P.; Alvarez, Andres; Valenzuela, Maria T.; Andrus, Jon; del Aguila, Roberto; Hormazabal, Juan C.; Araya, Pamela; Pidal, Paola; Matus, Cuauhtemoc R.; de Oliveira, Lucia H.			Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data	PLOS ONE			English	Article							IMMORTAL TIME BIAS; IMMUNIZATION; PREVENTION; DISEASE; COHORTS; IMPACT	Background The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Chilean National Immunization Program (NIP) in January 2011 with a 3+1 schedule (2, 4, 6 and 12 months) without catch-up vaccination. We evaluated the effectiveness of PCV10 on pneumonia morbidity and mortality among infants during the first two years after vaccine introduction. Methods This is a population-based nested case-control study using four merged nationwide case-based electronic health data registries: live birth, vaccination, hospitalization and mortality. Children born in 2010 and 2011 were followed from two moths of age for a period of two years. Using four different case definitions of pneumonia hospitalization and/or mortality (all-cause and pneumonia related deaths), all cases and four randomly selected matched controls per case were selected. Controls were matched to cases on analysis time. Vaccination status was then assessed. Vaccine effectiveness (VE) was estimated using conditional logistic regression. Results There were a total of 497,996 children in the 2010 and 2011 Chilean live-birth cohorts. PCV10 VE was 11.2% (95% CI 8.5-13.6) when all pneumonia hospitalizations and deaths were used to define cases. VE increased to 20.7 (95% CI 17.3-23.8) when ICD10 codes used to denote viral pneumonia were excluded from the case definition. VE estimates on pneumonia deaths and all-cause deaths were 71.5 (95% CI 9.0-91.8) and 34.8 (95% CI 23.7-44.4), respectively. Conclusion PCV10 vaccination substantially reduced the number of hospitalizations due to pneumonia and deaths due to pneumonia and to all-causes over this study period. Our findings also reinforce the importance of having quality health information systems for measuring VE.	[Diaz, Janepsy; Terrazas, Solana; Hormazabal, Juan C.; Araya, Pamela; Pidal, Paola] Natl Inst Hlth, Santiago, Chile; [Bierrenbach, Ana L.] Sanas Epidemiol & Pesquisa, Sao Paulo, Brazil; [Toscano, Cristiana M.] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Community Hlth, Goiania, Go, Brazil; [Alencar, Gizelton P.] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil; [Alvarez, Andres] Minist Hlth Santiago, Dept Stat & Hlth Informat, Santiago, Chile; [Valenzuela, Maria T.] Univ Los Andes, Sch Med, Santiago, Chile; [Andrus, Jon] Sabin Vaccine Inst, Washington, DC USA; [del Aguila, Roberto] PWR Chile, Pan Amer Hlth Org, Santiago, Chile; [Matus, Cuauhtemoc R.; de Oliveira, Lucia H.] Pan Amer Hlth Org, Comprehens Family Immunizat Project, Washington, DC USA	Universidade Federal de Goias; Universidade de Sao Paulo; Universidad de los Andes - Chile; Pan American Health Organization; Pan American Health Organization	de Oliveira, LH (corresponding author), Pan Amer Hlth Org, Comprehens Family Immunizat Project, Washington, DC USA.	oliveirl@paho.org	Alencar, Gizelton P/H-1248-2014; Bierrenbach, Ana L/F-3185-2014	Alencar, Gizelton P/0000-0002-2354-9050; Bierrenbach, Ana L/0000-0002-6837-0636; TOSCANO, CRISTIANA/0000-0002-9453-2643; Valenzuela, M Teresa/0000-0002-9433-6423	Sabin Vaccine Institute	Sabin Vaccine Institute	This project was supported by Sabin Vaccine Institute, which is a non-profit organization that promotes advances in vaccine development, delivery and distribution. The funders had no role in study design, data collection, analysis and decision to publish. The funders helped in the written review of the paper.	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; Andrade AL, 2012, VACCINE, V30, P1901, DOI 10.1016/j.vaccine.2011.12.012; De Wals P, 2008, PEDIATR INFECT DIS J, V27, P963, DOI 10.1097/INF.0b013e31817cf76f; Grijalva CG, 2008, EXPERT REV VACCINES, V7, P83, DOI 10.1586/14760584.7.1.83; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Groom H, 2015, J PUBLIC HEALTH MAN, V21, P227, DOI 10.1097/PHH.0000000000000069; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Jardine A, 2010, PEDIATR INFECT DIS J, V29, P607, DOI 10.1097/INF.0b013e3181d7d09c; Jokinen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120290; King C, 2015, VACCINE, V33, P4748, DOI 10.1016/j.vaccine.2015.07.062; Klugman KP, 2009, VACCINE, V27, pC9, DOI 10.1016/j.vaccine.2009.06.007; Lanata CF, 2004, INT J EPIDEMIOL, V33, P1362, DOI 10.1093/ije/dyh229; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS140, DOI 10.1097/INF.0000000000000082; Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828; Pacheco AG, 2008, AM J EPIDEMIOL, V168, P1326, DOI 10.1093/aje/kwn249; Palmu AA, 2015, PEDIATRICS, V136, pE22, DOI 10.1542/peds.2015-0458; Rodrigues LC, 1999, EPIDEMIOL REV, V21, P56, DOI 10.1093/oxfordjournals.epirev.a017988; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Taylor S, 2012, CLIN INFECT DIS, V54, P1765, DOI 10.1093/cid/cis292; Valenzuela MT, 2014, REV CHIL INFECTOL, V31, P651, DOI 10.4067/S0716-10182014000600002; World Health Organization (2012), MEAS IMP STREPT PNEU, P4	23	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153141	10.1371/journal.pone.0153141	http://dx.doi.org/10.1371/journal.pone.0153141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058873	Green Published, gold			2022-12-26	WOS:000373604800017
J	Liu, X; Li, SQ; Peng, WZ; Feng, SS; Feng, JX; Mahboob, S; Al-Ghanim, KA; Xu, P				Liu, Xiang; Li, Shangqi; Peng, Wenzhu; Feng, Shuaisheng; Feng, Jianxin; Mahboob, Shahid; Al-Ghanim, Khalid A.; Xu, Peng			Genome-Wide Identification, Characterization and Phylogenetic Analysis of ATP-Binding Cassette (ABC) Transporter Genes in Common Carp (Cyprinus carpio)	PLOS ONE			English	Article							MUTATION; FAMILY; DUPLICATION; EVOLUTION; INSIGHT; SUPERFAMILY; MECHANISM; PLANT; MAP	The ATP-binding cassette (ABC) gene family is considered to be one of the largest gene families in all forms of prokaryotic and eukaryotic life. Although the ABC transporter genes have been annotated in some species, detailed information about the ABC superfamily and the evolutionary characterization of ABC genes in common carp (Cyprinus carpio) are still unclear. In this research, we identified 61 ABC transporter genes in the common carp genome. Phylogenetic analysis revealed that they could be classified into seven subfamilies, namely 11 ABCAs, six ABCBs, 19 ABCCs, eight ABCDs, two ABCEs, four ABCFs, and 11 ABCGs. Comparative analysis of the ABC genes in seven vertebrate species including common carp, showed that at least 10 common carp genes were retained from the third round of whole genome duplication, while 12 duplicated ABC genes may have come from the fourth round of whole genome duplication. Gene losses were also observed for 14 ABC genes. Expression profiles of the 61 ABC genes in six common carp tissues (brain, heart, spleen, kidney, intestine, and gill) revealed extensive functional divergence among the ABC genes. Different copies of some genes had tissue-specific expression patterns, which may indicate some gene function specialization. This study provides essential genomic resources for future studies in common carp.	[Liu, Xiang; Li, Shangqi; Peng, Wenzhu; Feng, Shuaisheng; Xu, Peng] Chinese Acad Fishery Sci, CAFS Key Lab Aquat Genom, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Liu, Xiang; Li, Shangqi; Peng, Wenzhu; Feng, Shuaisheng; Xu, Peng] Chinese Acad Fishery Sci, Beijing Key Lab Fishery Biotechnol, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Liu, Xiang] Shanxi Agr Univ, Dept Aquaculture, Coll Anim Sci, Taigu, Shanxi, Peoples R China; [Feng, Jianxin] Henan Acad Fishery Sci, Zhengzhou, Peoples R China; [Mahboob, Shahid; Al-Ghanim, Khalid A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Mahboob, Shahid] GC Univ, Dept Zool, Faisalabad, Pakistan; [Xu, Peng] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Shanxi Agricultural University; King Saud University; Government College University Faisalabad; Xiamen University	Xu, P (corresponding author), Chinese Acad Fishery Sci, CAFS Key Lab Aquat Genom, Ctr Appl Aquat Genom, Beijing, Peoples R China.; Xu, P (corresponding author), Chinese Acad Fishery Sci, Beijing Key Lab Fishery Biotechnol, Ctr Appl Aquat Genom, Beijing, Peoples R China.; Xu, P (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China.	xupeng@cafs.ac.cn	Rana, Shahid Mahboob/P-1131-2014; Xu, Peng/J-4018-2012	Rana, Shahid Mahboob/0000-0003-4969-5387; Xu, Peng/0000-0002-1531-5078	National Natural Science Foundation of China [31422057]; National High-Technology Research and Development Program of China (863 program) [2011AA100401]; Special Scientific Research Funds for Central Non-profit Institutes of Chinese Academy of Fishery Sciences [2014A03YQ01, 2014C008]; Foundation of Beijing Key Laboratory of Fishery Biotechnology [201602]; Deanship of Scientific Research at King Saud University [RG 1435-012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Special Scientific Research Funds for Central Non-profit Institutes of Chinese Academy of Fishery Sciences; Foundation of Beijing Key Laboratory of Fishery Biotechnology; Deanship of Scientific Research at King Saud University(King Saud University)	The authors acknowledge grant support from the National Natural Science Foundation of China (No.31422057), National High-Technology Research and Development Program of China (863 program; 2011AA100401), Special Scientific Research Funds for Central Non-profit Institutes of Chinese Academy of Fishery Sciences (2014A03YQ01; 2014C008) and Foundation of Beijing Key Laboratory of Fishery Biotechnology (201602). The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this research (No. RG 1435-012).	Annilo T, 2003, MAMM GENOME, V14, P7, DOI 10.1007/s00335-002-2229-9; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Aryal B, 2015, BIOCHEM SOC T, V43, P966, DOI 10.1042/BST20150128; Baker A, 2015, BIOCHEM SOC T, V43, P959, DOI 10.1042/BST20150127; Beis K, 2015, BIOCHEM SOC T, V43, P889, DOI 10.1042/BST20150047; Carmona-Antonanzas G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137394; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Fu YH, 2015, J ALZHEIMERS DIS, V43, P857, DOI 10.3233/JAD-141320; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guan GF, 2015, ONCOL LETT, V10, P631, DOI 10.3892/ol.2015.3359; Gurkan H, 2015, CLIN DYSMORPHOL, V24, P115, DOI 10.1097/MCD.0000000000000071; Hedditch EL, 2015, ASIA-PAC J CLIN ONCO, V11, P114; Hlavac V, 2015, BIOCHEM SOC T, V43, P937, DOI 10.1042/BST20150114; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Jeong CB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15409; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jiang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108200; Kaminski WE, 2006, BBA-MOL BASIS DIS, V1762, P510, DOI 10.1016/j.bbadis.2006.01.011; Keitel V, 2003, AM J PHYSIOL-GASTR L, V284, pG165, DOI 10.1152/ajpgi.00362.2002; Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Liu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063895; Moitra K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016318; Nagel G, 1999, BBA-BIOMEMBRANES, V1461, P263, DOI 10.1016/S0005-2736(99)00162-5; Nakayama A, 2011, NUCLEOS NUCLEOT NUCL, V30, P1091, DOI 10.1080/15257770.2011.633953; Peca D, 2015, BIOCHEM SOC T, V43, P913, DOI 10.1042/BST20150100; Phan J, 2015, AM J GASTROENTEROL, V110, pS344, DOI 10.14309/00000434-201510001-00786; Popovic M, 2010, MAR ENVIRON RES, V69, pS11, DOI 10.1016/j.marenvres.2009.10.016; Proks P, 2007, HUM MOL GENET, V16, P2011, DOI 10.1093/hmg/ddm149; Ren JF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1677-z; Schatton T, 2015, CELL REP, V12, P1564, DOI 10.1016/j.celrep.2015.08.010; Slomka M, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0271-3; Theodoulou FL, 2015, BIOCHEM SOC T, V43, P1033, DOI 10.1042/BST20150139; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Woodward OM, 2011, FEBS J, V278, P3215, DOI 10.1111/j.1742-4658.2011.08171.x; Xu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-307; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yabuuchi H, 2002, BIOCHEM BIOPH RES CO, V299, P410, DOI 10.1016/S0006-291X(02)02658-X; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9; Zhao L, 2013, ABSTR APPL ANAL, V2013, P8, DOI [DOI 10.1371/J0URNAL.P0NE.0063928, DOI 10.1155/2013/812143]	50	5	6	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153246	10.1371/journal.pone.0153246	http://dx.doi.org/10.1371/journal.pone.0153246			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058731	Green Published, gold, Green Submitted			2022-12-26	WOS:000373604800024
J	Smart, JJ; Chin, A; Baje, L; Green, ME; Appleyard, SA; Tobin, AJ; Simpfendorfer, CA; White, WT				Smart, Jonathan J.; Chin, Andrew; Baje, Leontine; Green, Madeline E.; Appleyard, Sharon A.; Tobin, Andrew J.; Simpfendorfer, Colin A.; White, William T.			Effects of Including Misidentified Sharks in Life History Analyses: A Case Study on the Grey Reef Shark Carcharhinus amblyrhynchos from Papua New Guinea	PLOS ONE			English	Article							MODELING FISH GROWTH; BLACKTIP SHARK; REPRODUCTIVE-BIOLOGY; AGE-DETERMINATION; MULTIMODEL INFERENCE; FISHERIES; TILSTONI; LIMBATUS; VALIDATION; SELECTION	Fisheries observer programs are used around the world to collect crucial information and samples that inform fisheries management. However, observer error may misidentify similar -looking shark species. This raises questions about the level of error that species misidentifications could introduce to estimates of species' life history parameters. This study addressed these questions using the Grey Reef Shark Carcharhinus amblyrhynchos as a case study. Observer misidentification rates were quantified by validating species identifications using diagnostic photographs taken on board supplemented with DNA barcoding. Length-at-age and maturity ogive analyses were then estimated and compared with and without the misidentified individuals. Vertebrae were retained from a total of 155 sharks identified by observers as C. amblyrhynchos. However, 22 (14%) of these were sharks were misidentified by the observers and were subsequently re -identified based on photographs and/or DNA barcoding. Of the 22 individuals misidentified as C. amblyrhynchos, 16 (73%) were detected using photographs and a further 6 via genetic validation. If misidentified individuals had been included, substantial error would have been introduced to both the length -at -age and the maturity estimates. Thus validating the species identification, increased the accuracy of estimated life history parameters for C. amblyrhynchos. From the corrected sample a multi -model inference approach was used to estimate growth for C. amblyrhynchos using three candidate models. The model averaged length-at-age parameters for C. amblyrhynchos with the sexes combined were (L) over bar infinity= 159 cm TL and L,= 72 cm TL. Females mature at a greater length (150 = 136 cm TL) and older age (A(50) = 9.1 years) than males (150 = 123 cm TL; A(50) = 5.9 years). The inclusion of techniques to reduce misidentification in observer programs will improve the results of life history studies and ultimately improve management through the use of more accurate data for assessments.	[Smart, Jonathan J.; Chin, Andrew; Baje, Leontine; Tobin, Andrew J.; Simpfendorfer, Colin A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Smart, Jonathan J.; Chin, Andrew; Baje, Leontine; Tobin, Andrew J.; Simpfendorfer, Colin A.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Baje, Leontine] Natl Fisheries Author, Port Moresby, Papua N Guinea; [Green, Madeline E.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Green, Madeline E.; Appleyard, Sharon A.; White, William T.] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Green, Madeline E.; Appleyard, Sharon A.; White, William T.] CSIRO Natl Res Collect Australia, Australian Natl Fish Collect, Hobart, Tas, Australia	James Cook University; James Cook University; University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Smart, JJ (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.; Smart, JJ (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia.	jonathan.smart@my.jcu.edu.au	Appleyard, Sharon/AAJ-9942-2020; White, William T/B-9748-2009; Smart, jonathan/W-2971-2019; appleyard, sharon/D-6076-2012; Chin, Andrew/C-2254-2008; Simpfendorfer, Colin A/G-9681-2011	Appleyard, Sharon/0000-0002-3105-1690; White, William T/0000-0001-9705-2453; Smart, jonathan/0000-0003-2070-3208; appleyard, sharon/0000-0002-3105-1690; Chin, Andrew/0000-0003-1813-4042; Simpfendorfer, Colin A/0000-0002-0295-2238	Australian Centre for International Agricultural Research (ACIAR) [FIS/2012/102]; National Fisheries Authority (NFA); Commonwealth Scientific and Industrial Research Organisation (CSIRO); James Cook University (JCU); Australian post-graduate award; Oceania Chondrichthyan Society (OCS) Passions of Paradise award; CSIRO Wealth from Oceans scholarship	Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); National Fisheries Authority (NFA); Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); James Cook University (JCU); Australian post-graduate award(Australian Government); Oceania Chondrichthyan Society (OCS) Passions of Paradise award; CSIRO Wealth from Oceans scholarship	This project was funded by the Australian Centre for International Agricultural Research (ACIAR; project FIS/2012/102), National Fisheries Authority (NFA), the Commonwealth Scientific and Industrial Research Organisation (CSIRO), and James Cook University (JCU). Special thanks to Drs Chris Barlow and Jes Sammut for their support of this project. The lead author was supported by an Australian post-graduate award, an Oceania Chondrichthyan Society (OCS) Passions of Paradise award, and a CSIRO Wealth from Oceans scholarship. The authors would like to thank Brian Kumasi, Luanah Yaman, Leban Gisawa and Ludwig Kumoru from the NFA for their continued support and collaboration on this project. For laboratory assistance we thank Brooke D'Alberto, Samantha Sherman, Satoshi Shiratsuchi and Andrea Cabrera Garcia. We would like to thank the fishers of the longline vessels and a special thanks to the NFA on-board fisheries observers who collected the data and vertebrae: Jackson Maravee, Noah Lurang Jr, Daniel Sau, Murphy John, Paliau Parkop, Towai Peli and Udill Jotham.	Baldwin CC, 2008, ZOOTAXA, V2008, P1; Beamish RJ, 1995, BEL BAR LIB, P545; Bishop SDH, 2006, MAR FRESHWATER RES, V57, P143, DOI 10.1071/MF05077; BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; CHANG WYB, 1982, CAN J FISH AQUAT SCI, V39, P1208, DOI 10.1139/f82-158; Chin A, 2013, MAR FRESHWATER RES, V64, P965, DOI 10.1071/MF13017; Compagno L. J. V., 1984, FAO Fisheries Synopsis, P251; Cortes E, 2012, CRC MAR BIOL SER, P453; DAVENPORT S, 1988, AUST J MAR FRESH RES, V39, P417; DECROSTA MA, 1981, PAC SCI, V35, P266; Dulvy NK, 2014, PEERJ, V2, DOI 10.7717/peerj.400; Evans GT, 1998, BIOMETRICS, V54, P620, DOI 10.2307/3109768; Fernandez-Carvalho J, 2011, AQUAT LIVING RESOUR, V24, P359, DOI 10.1051/alr/2011046; Francis MP, 2006, ENVIRON BIOL FISH, V77, P407, DOI 10.1007/s10641-006-9109-1; Haddon M., 2012, MODELLING QUANTITATI, V2nd; Hall NG, 2012, J FISH BIOL, V80, P1320, DOI 10.1111/j.1095-8649.2012.03240.x; Harry AV, 2013, MAR FRESHWATER RES, V64, P277, DOI 10.1071/MF12142; Katsanevakis S, 2008, FISH FISH, V9, P178, DOI 10.1111/j.1467-2979.2008.00279.x; Katsanevakis S, 2006, FISH RES, V81, P229, DOI 10.1016/j.fishres.2006.07.002; KILLAM KA, 1989, FISH B-NOAA, V87, P845; KIMURA DK, 1980, FISH B-NOAA, V77, P765; Kumar KVA, 2015, J APPL ICHTHYOL, V31, P301, DOI 10.1111/jai.12682; Kumoru L., 2003, 176 M STAND COMM TUN; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Liu KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143008; Morgan JAT, 2012, CONSERV GENET, V13, P455, DOI 10.1007/s10592-011-0298-6; O'Shea OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077194; Ogle D., 2016, FSA FISHERIES STOCK; Ovenden JR, 2015, FISH FISH, V16, P125, DOI 10.1111/faf.12052; Pilling GM, 2002, CAN J FISH AQUAT SCI, V59, P424, DOI 10.1139/F02-022; R Core Team, 2013, LANG ENV STAT COMP; RICKER W E, 1975, P382; Ricker W.E., 1979, BIOENERGETICS GROWTH, VVIII, P677, DOI DOI 10.1016/S1546-5098(08)60034-5; Robbins WD., 2006, THESIS J COOK U AUST; Smart JJ, 2015, AFR J MAR SCI, V37, P177, DOI 10.2989/1814232X.2015.1025428; Smart JJ, 2016, FISH FISHERIES; Spaet JLY, 2015, FISH RES, V161, P356, DOI 10.1016/j.fishres.2014.08.022; STEVENS JD, 1991, AUST J MAR FRESH RES, V42, P151; Taylor IG, 2013, FISH RES, V142, P75, DOI 10.1016/j.fishres.2012.08.021; Tillett BJ, 2012, FISH RES, V127, P109, DOI 10.1016/j.fishres.2012.04.007; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Walker Terence I., 2005, P81; Wetherbee BM, 1997, MAR ECOL PROG SER, V151, P181, DOI 10.3354/meps151181; White WT, 2007, J FISH BIOL, V71, P1512, DOI 10.1111/j.1095-8649.2007.01623.x; Zhu LX, 2009, CHIN J OCEANOL LIMN, V27, P457, DOI 10.1007/s00343-009-9236-6	49	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153116	10.1371/journal.pone.0153116	http://dx.doi.org/10.1371/journal.pone.0153116			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058734	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000373604800016
J	Biber-Freudenberger, L; Ziemacki, J; Tonnang, HEZ; Borgemeister, C				Biber-Freudenberger, Lisa; Ziemacki, Jasmin; Tonnang, Henri E. Z.; Borgemeister, Christian			Future Risks of Pest Species under Changing Climatic Conditions	PLOS ONE			English	Article							BACTROCERA-INVADENS DIPTERA; ECOLOGICAL NICHE; POTENTIAL DISTRIBUTION; CHANGE IMPACTS; FOOD SECURITY; PRECIPITATION; CLIMATOLOGY; TEMPERATURE; VARIABILITY; PREDICTION	Most agricultural pests are poikilothermic species expected to respond to climate change. Currently, they are a tremendous burden because of the high losses they inflict on crops and livestock. Smallholder farmers in developing countries of Africa are likely to suffer more under these changes than farmers in the developed world because more severe climatic changes are projected in these areas. African countries further have a lower ability to cope with impacts of climate change through the lack of suitable adapted management strategies and financial constraints. In this study we are predicting current and future habitat suitability under changing climatic conditions for Tuta absoluta, Ceratitis cosyra, and Bactrocera invadens, three important insect pests that are common across some parts of Africa and responsible for immense agricultural losses. We use presence records from different sources and bioclimatic variables to predict their habitat suitability using the maximum entropy modelling approach. We find that habitat suitability for B. invadens, C. cosyra and T. absoluta is partially increasing across the continent, especially in those areas already overlapping with or close to most suitable sites under current climate conditions. Assuming a habitat suitability at three different threshold levels we assessed where each species is likely to be present under future climatic conditions and if this is likely to have an impact on productive agricultural areas. Our results can be used by African policy makers, extensionists and farmers for agricultural adaptation measures to cope with the impacts of climate change.	[Biber-Freudenberger, Lisa; Ziemacki, Jasmin; Borgemeister, Christian] Univ Bonn, Ctr Dev Res ZEF, Dept Ecol & Nat Resources Management, Walter Flex Str 3, D-53113 Bonn, Germany; [Tonnang, Henri E. Z.] Int Maize & Wheat Improvement Ctr CIMMYT, ICRAF House,United Nations Ave,POB 1041, Nairobi 00621, Kenya	University of Bonn; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); World Agroforestry (ICRAF)	Biber-Freudenberger, L (corresponding author), Univ Bonn, Ctr Dev Res ZEF, Dept Ecol & Nat Resources Management, Walter Flex Str 3, D-53113 Bonn, Germany.	lfreuden@uni-bonn.de	TONNANG, Henri/AAQ-2206-2021; Biber-Freudenberger, Lisa/H-9867-2019	TONNANG, Henri/0000-0002-9424-9186; Biber-Freudenberger, Lisa/0000-0001-8106-5372	Volkswagen Foundation [VW-89362]; Center for Development Research (ZEF), Department of Ecology and Natural Resources Management, at the University of Bonn	Volkswagen Foundation(Volkswagen); Center for Development Research (ZEF), Department of Ecology and Natural Resources Management, at the University of Bonn	This study was funded by the Volkswagen Foundation (project VW-89362) who provided financial support for the collaboration of the research team and the Center for Development Research (ZEF), Department of Ecology and Natural Resources Management, at the University of Bonn that supported the study through salaries and research infrastructure.	[Anonymous], 2015, AFSUN FOOD SECURITY; Balde A, 1917, DETECTION TUTA ABSOL; Barredo J. I., 2015, Bulletin OEPP, V45, P273, DOI 10.1111/epp.12208; Bettaibi A, 2012, CHIL J AGR RES, V72, P212, DOI 10.4067/S0718-58392012000200008; Coakley SM, 1999, ANNU REV PHYTOPATHOL, V37, P399, DOI 10.1146/annurev.phyto.37.1.399; De Meyer M, 2010, B ENTOMOL RES, V100, P35, DOI 10.1017/S0007485309006713; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; DFID research strategy 2008-2013, 2008, WORK PAP SER SUST AG, P27; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; EMBL, 2014, GEOGR TAGG INSDC SEQ; Fadlelmula A. A., 2014, Persian Gulf Crop Protection, V3, P17; Gacemi, 2012, ACAD J ENTOMOLOGY, V5, P37; Gbobaniyi E, 2014, INT J CLIMATOL, V34, P2241, DOI 10.1002/joc.3834; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Goergen G, 2011, ENVIRON ENTOMOL, V40, P844, DOI 10.1603/EN11017; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harrington R, 2001, AGR FOREST ENTOMOL, V3, P233, DOI 10.1046/j.1461-9555.2001.00120.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans R., WORLDCLIM SET GLOBAL; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Knox J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034032; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Kumar S, 2015, J ECON ENTOMOL, V108, P1708, DOI 10.1093/jee/tov166; Kumar S, 2014, J ECON ENTOMOL, V107, P1032, DOI 10.1603/EC14052; Kumar S, 2014, COMPUT ELECTRON AGR, V103, P55, DOI 10.1016/j.compag.2014.02.007; Li Bai-Ni, 2009, Acta Entomologica Sinica, V52, P1122; Li BN, 2009, J ECON ENTOMOL, V102, P1781, DOI 10.1603/029.102.0508; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Muller C, 2013, ANNU REV NUTR, V33, P395, DOI 10.1146/annurev-nutr-071812-161121; Muller C, 2011, P NATL ACAD SCI USA, V108, P4313, DOI 10.1073/pnas.1015078108; Nboyine JA, 2012, SPECIES RANGE FRUIT; Netherer S, 2010, FOREST ECOL MANAG, V259, P831, DOI 10.1016/j.foreco.2009.07.034; Nikulin G, 2012, J CLIMATE, V25, P6057, DOI 10.1175/JCLI-D-11-00375.1; Oerke EC., 1994, CROP PRODUCTION CROP; Olwoch JM, 2007, ONDERSTEPOORT J VET, V74, P45, DOI 10.4102/ojvr.v74i1.139; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pretty J, 2011, INT J AGR SUSTAIN, V9, P5, DOI 10.3763/ijas.2010.0583; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Royal Museum of Central Africa, 2014, TUR FRUIT FLIES DIPT; Russell IPM L, 2015, TUT ABS INF NETW; Sobek-Swant S, 2012, FOREST ECOL MANAG, V281, P23, DOI 10.1016/j.foreco.2012.06.017; Solhjouy-Fard S, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.11601; Steck GJ, 2000, ENTOMOL CIRULAR, P403; Sylla M.B., 2013, CLIMATE VARIABILITY; Thornton PK, 2009, GLOBAL ENVIRON CHANG, V19, P54, DOI 10.1016/j.gloenvcha.2008.08.005; Thornton PhilipK., 2006, MAPPING CLIMATE VULN; Tonnang HEZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135283; Vermeulen SJ, 2012, ENVIRON SCI POLICY, V15, P136, DOI 10.1016/j.envsci.2011.09.003; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wand MP, 1994, J COMPUT GRAPH STAT, V3, P433, DOI [DOI 10.1080/10618600.1994.10474656, DOI 10.2307/1390904]; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]	62	46	48	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153237	10.1371/journal.pone.0153237	http://dx.doi.org/10.1371/journal.pone.0153237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054718	gold, Green Published, Green Submitted			2022-12-26	WOS:000373608000109
J	Tadesse, S				Tadesse, Sebsibe			Stigma against Tuberculosis Patients in Addis Ababa, Ethiopia	PLOS ONE			English	Article							SOUTHERN THAILAND; RURAL DISTRICT; SOCIAL SUPPORT; GENDER; INDIA; RISK; HIV; CONSEQUENCES; VIETNAM; DEFAULT	Background Stigma attached to tuberculosis contributes to the limited effectiveness of current TB control approaches. However, there is a dearth of studies that explore the causes of stigma attached to tuberculosis and its effects on patients and tuberculosiscontrol programs in Ethiopia. Methods An institution-based qualitative study was conducted at St. Peter Tuberculosis Specialized Hospital in Addis Ababa, Ethiopia from July to August, 2015. Ten in-depth interviews and 6 key-informant interviews were carried out among tuberculosis patients and healthcare workers, respectively. The Open Code computer software package was used to analyze the data thematically. Results The study revealed that fear of infection and inappropriate health education messages by media were the main causes of tuberculosis stigma. The patients experienced isolation within their family and community, separation, and financial crisis. The stigma attached to tuberculosis may contribute to delayed healthcare seeking, poor treatment adherence, and poor prognosis. Conclusion Interventions thatreduce the stigma attached to tuberculosis should target on areas, such as creating community awareness, patient counseling on problem-solving and emotional skills, preparing culturally sensitive and scientifically sound media messages, providing financial support for the patients, and enhancing the qualities of the healthcare workers, such as empathy, concern, respect for the patient and cultural sensitivity.	[Tadesse, Sebsibe] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia	University of Gondar	Tadesse, S (corresponding author), Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia.	sbsbtadesse90@gmail.com	Tadesse, Sebsibe/AGG-7272-2022	Tadesse, Sebsibe/0000-0002-9153-5400				Armijos RX, 2008, REV PANAM SALUD PUBL, V23, P188, DOI 10.1590/S1020-49892008000300006; Atre SR, 2004, TROP MED INT HEALTH, V9, P1228, DOI 10.1111/j.1365-3156.2004.01321.x; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Berger P., 1967, SOCIAL CONSTRUCTION; Cambanis A, 2005, TROP MED INT HEALTH, V10, P330, DOI 10.1111/j.1365-3156.2005.01393.x; Collins PY, 2008, SOC SCI MED, V67, P389, DOI 10.1016/j.socscimed.2008.03.013; Creswell J.W, 2003, RES DESIGN QUALITATI; Dodor EA, 2005, T ROY SOC TROP MED H, V99, P827, DOI 10.1016/j.trstmh.2005.06.011; Eastwood SV, 2004, INT J TUBERC LUNG D, V8, P70; Edginton ME, 2002, INT J TUBERC LUNG D, V6, P1075; Federal Ministry of Health, 2008, TUB LEPR TB HIV PREV, V4th; Getahun H, 2000, INT J TUBERC LUNG D, V4, P174; Godfrey-Faussett R, 2002, INT J TUBERC LUNG D, V6, P796; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Heijnders Miriam, 2006, Psychol Health Med, V11, P353, DOI 10.1080/13548500600595327; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P46; Jittimanee SX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006360; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Macq J, 2005, HEALTH POLICY, V74, P205, DOI 10.1016/j.healthpol.2005.01.003; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Meulemans H, 2002, INT J HEALTH PLAN M, V17, P249, DOI 10.1002/hpm.675; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; Seale C., 2004, QUALITATIVE RES PRAC; Sengupta S, 2006, INT J TUBERC LUNG D, V10, P1008; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Somma D, 2008, INT J TUBERC LUNG D, V12, P856; Tadesse T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-424; Van Rie A, 2008, TROP MED INT HEALTH, V13, P21, DOI 10.1111/j.1365-3156.2007.01971.x; Weiss Mitchell G, 2006, Psychol Health Med, V11, P277; World Health Organization, 2015, GLOB TUB REP 2015; Yang LH, 2007, SOC SCI MED, V64, P1524, DOI 10.1016/j.socscimed.2006.11.013	34	32	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152900	10.1371/journal.pone.0152900	http://dx.doi.org/10.1371/journal.pone.0152900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054714	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000053
J	Watanabe, T; Takahashi, N; Hirabara, S; Ishiguro, N; Kojima, T				Watanabe, Tatsuo; Takahashi, Nobunori; Hirabara, Shinya; Ishiguro, Naoki; Kojima, Toshihisa			Hyaluronan Inhibits Tlr-4-Dependent RANKL Expression in Human Rheumatoid Arthritis Synovial Fibroblasts	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION FACTOR; TOLL-LIKE RECEPTORS; NF-KAPPA-B; MOLECULAR-WEIGHT; ACTIVATOR; FLUID; JOINT; PATHOGENESIS; LIGAND; TISSUE	The Toll-like receptor (TLR) signaling pathway is activated in synovial fibroblast cells in patients with rheumatoid arthritis (RA). The receptor activator of nuclear factor-kappa B (RANK) and its ligand, RANKL, are key molecules involved in the differentiation of osteoclasts and joint destruction in RA. Hyaluronan (HA) is a major extracellular component and an important immune regulator. In this study, we show that lipopolysaccharide (LPS) stimulation significantly increases RANKL expression via a TLR-4 signaling pathway. We also demonstrate that HA suppresses LPS-induced RANKL expression, which is dependent on CD44, but not intercellular adhesion molecule-1 (ICAM-1). Our study provides evidence for HA-mediated suppression of TLR-4-dependent RANKL expression. This could present an alternative target for the treatment of destructed joint bones and cartilages in RA.	[Watanabe, Tatsuo; Takahashi, Nobunori; Hirabara, Shinya; Ishiguro, Naoki; Kojima, Toshihisa] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4648601, Japan	Nagoya University	Takahashi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4648601, Japan.	nobunori@med.nagoya-u.ac.jp			JSPS [26462290]; Grants-in-Aid for Scientific Research [25462366] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 26462290. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, ARTHRITIS RHEUM, V58, P3753, DOI 10.1002/art.24127; Ariyoshi W, 2014, OSTEOARTHR CARTILAGE, V22, P111, DOI 10.1016/j.joca.2013.10.013; Arnett FC, 1988, ARTHRITIS RHEUMATISM, V32, P315; Brentano F, 2005, CELL IMMUNOL, V233, P90, DOI 10.1016/j.cellimm.2005.04.018; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; BROMLEY M, 1984, ARTHRITIS RHEUM, V27, P968, DOI 10.1002/art.1780270902; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; DAHL LB, 1985, ANN RHEUM DIS, V44, P817, DOI 10.1136/ard.44.12.817; Drexler Stefan K, 2006, Expert Rev Clin Immunol, V2, P585, DOI 10.1586/1744666X.2.4.585; Goto M, 2001, CLIN EXP RHEUMATOL, V19, P377; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Haynes DR, 2001, RHEUMATOLOGY, V40, P623, DOI 10.1093/rheumatology/40.6.623; Hirabara S, 2013, BIOCHEM BIOPH RES CO, V430, P519, DOI 10.1016/j.bbrc.2012.12.003; Hiramitsu T, 2006, RHEUMATOLOGY, V45, P824, DOI 10.1093/rheumatology/kel026; Jiang D, 2011, 91, V91, P221, DOI [10.1152/physrev.00052.2009, DOI 10.1152/PHYSREV.00052.2009]; Jin ZX, 2015, MOL ENDOCRINOL, V29, P172, DOI 10.1210/me.2014-1316; Julovi SM, 2004, ARTHRITIS RHEUM-US, V50, P516, DOI 10.1002/art.20004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim KW, 2007, IMMUNOL LETT, V110, P54, DOI 10.1016/j.imlet.2007.03.004; Kyburz D, 2003, ARTHRITIS RHEUM-US, V48, P642, DOI 10.1002/art.10848; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Ohno S, 2005, ARTHRITIS RHEUM-US, V52, P800, DOI 10.1002/art.20937; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Saito S, 2009, MOD RHEUMATOL, V19, P643, DOI 10.1007/s10165-009-0207-8; Shimizu M, 2003, J RHEUMATOL, V30, P1164; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P1063, DOI 10.1002/art.21655; Vastesaeger N, 2009, RHEUMATOLOGY, V48, P1114, DOI 10.1093/rheumatology/kep155; Weinblatt ME, 2013, ARTHRITIS RHEUM-US, V65, P28, DOI 10.1002/art.37711	30	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153142	10.1371/journal.pone.0153142	http://dx.doi.org/10.1371/journal.pone.0153142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054952	gold, Green Submitted, Green Published			2022-12-26	WOS:000373608000086
J	Park, HJ; Lee, SW; Park, SH; Hong, S				Park, Hyun Jung; Lee, Sung Won; Park, Se-Ho; Hong, Seokmann			iNKT Cells Are Responsible for the Apoptotic Reduction of Basophils That Mediate Th2 Immune Responses Elicited by Papain in Mice Following gamma PGA Stimulation	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; KILLER T-CELLS; ALLERGIC AIRWAY INFLAMMATION; GLUTAMIC ACID; IFN-GAMMA; DENDRITIC CELLS; MAST-CELLS; CYTOKINE PRODUCTION; ATOPIC-DERMATITIS; BACILLUS-SUBTILIS	Recent studies have demonstrated that Bacillus subtilis-derived poly-gamma glutamic acid (gamma PGA) treatment suppresses the development of allergic diseases such as atopic dermatitis (AD). Although basophils, an innate immune cell, are known to play critical roles in allergic immune responses and repeated long-term administration of gamma PGA results in decreased splenic basophils in an AD murine model, the underlying mechanisms by which gamma PGA regulates basophil frequency remain unclear. To investigate how gamma PGA modulates basophils, we employed basophil-mediated Th2 induction in vivo model elicited by the allergen papain protease. Repeated injection of gamma PGA reduced the abundance of basophils and their production of IL4 in mice, consistent with our previous study using NC/Nga AD model mice. The depletion of basophils by a single injection of gamma PGA was dependent on the TLR4/DC/IL12 axis. CD1d-dependent V alpha 14 TCR invariant natural killer T (iNKT) cells are known to regulate a variety of immune responses, such as allergy. Because iNKT cell activation is highly sensitive to IL12 produced by DCs, we evaluated whether the effect of gamma PGA on basophils is mediated by iNKT cell activation. We found that in vivo gamma PGA treatment did not induce the reduction of basophils in iNKT cell-deficient CD1d KO mice, suggesting the critical role of iNKT cells in gamma PGA-mediated basophil depletion at the early time points. Furthermore, increased apoptotic basophil reduction triggered by iNKT cells upon gamma PGA stimulation was mainly attributed to Th1 cytokines such as IFN gamma and TNF alpha, consequently resulting in inhibition of papain-induced Th2 differentiation via diminishing basophil-derived IL4. Taken together, our results clearly demonstrate that gamma PGA-induced iNKT cell polarization toward the Th1 phenotype induces apoptotic basophil depletion, leading to the suppression of Th2 immune responses. Thus, elucidation of the crosstalk between innate immune cells will contribute to the design and development of new therapeutics for Th2-mediated immune diseases such as AD.	[Park, Hyun Jung; Lee, Sung Won; Hong, Seokmann] Sejong Univ, Inst Anticanc Med Dev, Dept Biosci & Biotechnol, Seoul 143747, South Korea; [Lee, Sung Won; Park, Se-Ho] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Sejong University; Korea University	Hong, S (corresponding author), Sejong Univ, Inst Anticanc Med Dev, Dept Biosci & Biotechnol, Seoul 143747, South Korea.	shong@sejong.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2010772]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2010772). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; de Bruin AM, 2010, BLOOD, V116, P2559, DOI 10.1182/blood-2009-12-261339; Didichenko SA, 2008, BLOOD, V112, P3949, DOI 10.1182/blood-2008-04-149419; Ding SQ, 2010, HEPATOB PANCREAT DIS, V9, P645; Duthie MS, 2005, INFECT IMMUN, V73, P1890, DOI 10.1128/IAI.73.3.1890-1894.2005; Gomez MR, 2014, MUCOSAL IMMUNOL, V7, P188, DOI 10.1038/mi.2013.38; Hachem P, 2005, EUR J IMMUNOL, V35, P2793, DOI 10.1002/eji.200535268; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hida S, 2005, BLOOD, V106, P2011, DOI 10.1182/blood-2005-04-1344; Hubner MP, 2011, CLIN IMMUNOL, V141, P205, DOI 10.1016/j.clim.2011.08.004; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Kim S, 2009, INT IMMUNOL, V21, P977, DOI 10.1093/intimm/dxp065; Kim TW, 2007, J IMMUNOL, V179, P775, DOI 10.4049/jimmunol.179.2.775; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kuroda E, 2011, J IMMUNOL, V186, P323, DOI 10.4049/jimmunol.1002778; Lee K, 2011, CLIN EXP ALLERGY, V41, P1143, DOI 10.1111/j.1365-2222.2011.03792.x; Lee SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132329; Lee SW, 2015, BIOCHEM BIOPH RES CO, V461, P86, DOI 10.1016/j.bbrc.2015.03.174; Lee SW, 2014, BIOCHEM BIOPH RES CO, V443, P413, DOI 10.1016/j.bbrc.2013.11.097; Lee SW, 2013, EXP DERMATOL, V22, P561, DOI 10.1111/exd.12198; Lee TY, 2014, J INVEST DERMATOL, V134, P704, DOI 10.1038/jid.2013.389; Lee TY, 2009, CANCER IMMUNOL IMMUN, V58, P1783, DOI 10.1007/s00262-009-0689-4; Lu X, 2006, CHEMBIOCHEM, V7, P1750, DOI 10.1002/cbic.200600197; Luttmann W, 2000, SCAND J IMMUNOL, V51, P54; Mann-Chandler MN, 2005, J IMMUNOL, V175, P3000, DOI 10.4049/jimmunol.175.5.3000; Matsumoto K, 2008, INT ARCH ALLERGY IMM, V146, P40, DOI 10.1159/000126060; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Moore ML, 2009, J IMMUNOL, V183, P2016, DOI 10.4049/jimmunol.0803167; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Noti M, 2014, J ALLERGY CLIN IMMUN, V133, P1390, DOI 10.1016/j.jaci.2014.01.021; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Oki S, 2005, INT IMMUNOL, V17, P1619, DOI 10.1093/intimm/dxh342; Otsuka A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2740; Poo H, 2010, CHEM BIODIVERS, V7, P1555, DOI 10.1002/cbdv.200900283; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Sakurai T, 2014, CLIN EXP IMMUNOL, V178, P65, DOI 10.1111/cei.12399; Scanlon ST, 2012, CURR OPIN IMMUNOL, V24, P707, DOI 10.1016/j.coi.2012.08.009; Schneider E, 2004, J IMMUNOL, V172, P5262, DOI 10.4049/jimmunol.172.9.5262; Schroeder JT, 2009, J IMMUNOL, V182, P2432, DOI 10.4049/jimmunol.0801782; Schweitzer AN, 1998, J IMMUNOL, V161, P2762; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Waring P, 1999, IMMUNOL CELL BIOL, V77, P312, DOI 10.1046/j.1440-1711.1999.00837.x; Yang YF, 2000, INT IMMUNOL, V12, P1669, DOI 10.1093/intimm/12.12.1669; Yasumi T, 2005, J IMMUNOL, V174, P1325, DOI 10.4049/jimmunol.174.3.1325; Zhang YL, 2012, EUR J IMMUNOL, V42, P1735, DOI 10.1002/eji.201142123; Zheng XY, 2002, IMMUNOLOGY, V107, P306, DOI 10.1046/j.1365-2567.2002.01517.x	53	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152189	10.1371/journal.pone.0152189	http://dx.doi.org/10.1371/journal.pone.0152189			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049954	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500029
J	Vandenplas, S; Willems, M; Witten, PE; Hansen, T; Fjelldal, PG; Huysseune, A				Vandenplas, Sam; Willems, Maxime; Witten, P. Eckhard; Hansen, Tom; Fjelldal, Per Gunnar; Huysseune, Ann			Epithelial Label-Retaining Cells Are Absent during Tooth Cycling in Salmo salar and Polypterus senegalus	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; LOWER JAW DENTITION; STEM-CELLS; ATLANTIC SALMON; DENTAL LAMINA; DERMAL SKELETON; ADULT STEM; REPLACEMENT; TEETH; SOX2	The Atlantic salmon (Salmo salar) and African bichir (Polypterus senegalus) are both actinopterygian fish species that continuously replace their teeth without the involvement of a successional dental lamina. Instead, they share the presence of a middle dental epithelium: an epithelial tier enclosed by inner and outer dental epithelium. It has been hypothesized that this tier could functionally substitute for a successional dental lamina and might be a potential niche to house epithelial stem cells involved in tooth cycling. Therefore, in this study we performed a BrdU pulse chase experiment on both species to (1) determine the localization and extent of proliferating cells in the dental epithelial layers, (2) describe cell dynamics and (3) investigate if label-retaining cells are present, suggestive for the putative presence of stem cells. Cells proliferate in the middle dental epithelium, outer dental epithelium and cervical loop at the lingual side of the dental organ to form a new tooth germ. Using long chase times, both in S. salar (eight weeks) and P. senegalus (eight weeks and twelve weeks), we could not reveal the presence of label-retaining cells in the dental organ. Immunostaining of P. senegalus dental organs for the transcription factor Sox2, often used as a stem cell marker, labelled cells in the zone of outer dental epithelium which grades into the oral epithelium (ODE transition zone) and the inner dental epithelium of a successor only. The location of Sox2 distribution does not provide evidence for epithelial stem cells in the dental organ and, more specifically, in the middle dental epithelium. Comparison of S. salar and P. senegalus reveals shared traits in tooth cycling and thus advances our understanding of the developmental mechanism that ensures lifelong replacement.	[Vandenplas, Sam; Witten, P. Eckhard; Huysseune, Ann] Univ Ghent, Evolutionary Dev Biol, B-9000 Ghent, Belgium; [Willems, Maxime] Univ Ghent, Pharmaceut Technol, B-9000 Ghent, Belgium; [Hansen, Tom; Fjelldal, Per Gunnar] Inst Marine Res, Matre Res Stn, Matredal, Norway	Ghent University; Ghent University; Institute of Marine Research - Norway	Huysseune, A (corresponding author), Univ Ghent, Evolutionary Dev Biol, B-9000 Ghent, Belgium.	Ann.Huysseune@UGent.be	Witten, Paul Eckhard/AAY-3113-2020	Witten, Paul Eckhard/0000-0002-2928-5762				Abduweli D, 2014, MICROSCOPY-JPN, V63, P141, DOI 10.1093/jmicro/dft085; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Berkovitz B.K., 2000, P186, DOI 10.1017/CBO9780511542626.013; BERKOVITZ BKB, 1977, J EXP ZOOL, V200, P65, DOI 10.1002/jez.1402000109; BERKOVITZ BKB, 1975, J EXP ZOOL, V193, P221, DOI 10.1002/jez.1401930211; BERKOVITZ BKB, 1974, ARCH ORAL BIOL, V19, P1111, DOI 10.1016/0003-9969(74)90239-8; BERKOVITZ BKB, 1978, J BIOL BUCCALE, V6, P205; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bluteau G, 2008, EUR CELLS MATER, V16, P1; Davit-Beal T, 2007, BIOL REV, V82, P49, DOI 10.1111/j.1469-185X.2006.00003.x; Fraser GJ, 2006, EVOL DEV, V8, P446, DOI 10.1111/j.1525-142X.2006.00118.x; Fraser GJ, 2013, DEV BIOL, V377, P399, DOI 10.1016/j.ydbio.2013.02.007; Fraser GJ, 2011, J EXP ZOOL PART B, V316B, P99, DOI 10.1002/jez.b.21387; Fraser GJ, 2004, P ROY SOC B-BIOL SCI, V271, P2311, DOI 10.1098/rspb.2004.2878; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gaete M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074484; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Guzman A, 2013, BIOL OPEN, V2, P1179, DOI 10.1242/bio.20136023; Handrigan GR, 2010, DEVELOPMENT, V137, P3545, DOI 10.1242/dev.052415; Handrigan GR, 2010, DEV BIOL, V337, P171, DOI 10.1016/j.ydbio.2009.10.020; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada Hidemitsu, 2002, Odontology, V90, P1, DOI 10.1007/s102660200000; Huysseune A, 2008, EVOL DEV, V10, P6, DOI 10.1111/j.1525-142X.2007.00209.x; Huysseune A, 2004, BIOESSAYS, V26, P665, DOI 10.1002/bies.20039; Huysseune A, 2012, J APPL ICHTHYOL, V28, P330, DOI 10.1111/j.1439-0426.2012.02002.x; Huysseune A., 1989, Progress in Zoology, V35, P456; Huysseune A, 2008, DEV GENES EVOL, V218, P427, DOI 10.1007/s00427-008-0237-9; Huysseune A, 2007, J ANAT, V211, P471, DOI 10.1111/j.1469-7580.2007.00788.x; Huysseune A, 2006, INT J DEV BIOL, V50, P637, DOI 10.1387/ijdb.052098ah; Huysseune A, 2006, J EXP ZOOL PART B, V306B, P204, DOI 10.1002/jez.b.21091; Juuri E, 2013, DEVELOPMENT, V140, P1424, DOI 10.1242/dev.089599; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Lau AN, 2012, MOL THER, V20, P1116, DOI 10.1038/mt.2012.37; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Matalova E, 2004, J DENT RES, V83, P11, DOI 10.1177/154405910408300103; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027; Moriyama K, 2010, CELL TISSUE RES, V340, P189, DOI 10.1007/s00441-010-0935-2; Reif W.E., 1984, PATTERN FORMATION PR, P603; REIF WE, 1980, J MORPHOL, V166, P275, DOI 10.1002/jmor.1051660303; REIF WE, 1982, EVOL BIOL, V15, P287; Sasagawa I, 2004, CONNECT TISSUE RES, V46, P33; Shannon JM, 2004, ANNU REV PHYSIOL, V66, P625, DOI 10.1146/annurev.physiol.66.032102.135749; Shimada A, 2008, J IMMUNOL METHODS, V339, P11, DOI 10.1016/j.jim.2008.07.013; Smith MM, 2009, J EXP ZOOL PART B, V312B, P260, DOI 10.1002/jez.b.21272; Sotiropoulou PA, 2012, COLD SPRING HARB PER, V4, P1; Trapani J, 2001, COPEIA, P35, DOI 10.1643/0045-8511(2001)001[0035:PODRTI]2.0.CO;2; Tucker AS, 2014, SEMIN CELL DEV BIOL, V25, P71, DOI 10.1016/j.semcdb.2013.12.013; Tummers M., 2004, HDB STEM CELLS, V1, P265; Van der heyden C, 2001, ARCH ORAL BIOL, V46, P1051, DOI 10.1016/S0003-9969(01)00064-4; Van der Heyden C, 2000, DEV DYNAM, V219, P486; Vandenplas S, 2012, J APPL ICHTHYOL, V28, P336, DOI 10.1111/j.1439-0426.2012.02003.x; Vandenplas S, 2016, DEV BIOL, V413, P39, DOI 10.1016/j.ydbio.2016.03.004; Vandenplas S, 2014, J EXP ZOOL PART B, V322, P281, DOI 10.1002/jez.b.22577; Vieira FA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-490; Whitear M., 1986, BIOL INTEGUMENT, P8, DOI DOI 10.1007/978-3-662-00989-5; Witten PE, 2005, ARCH ORAL BIOL, V50, P213, DOI 10.1016/j.archoralbio.2004.10.018; Zaminy A, 2012, FLOW CYTOMETRY RECEN, P261	63	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152870	10.1371/journal.pone.0152870	http://dx.doi.org/10.1371/journal.pone.0152870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049953	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000373603500063
J	Zheng, YF; Cai, JL; Hutchins, AP; Jia, L; Liu, PF; Yang, DD; Chen, SB; Ge, LH; Pei, DQ; Wei, SC				Zheng, Yunfei; Cai, Jinglei; Hutchins, Andrew Paul; Jia, Lingfei; Liu, Pengfei; Yang, Dandan; Chen, Shubin; Ge, Lihong; Pei, Duanqing; Wei, Shicheng			Remission for Loss of Odontogenic Potential in a New Micromilieu In Vitro	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; NEURAL CREST; MESENCHYMAL CELLS; TISSUE INTERACTIONS; DENTAL MESENCHYME; TOOTH; DIFFERENTIATION; TEETH; BMP4; EXPRESSION	During embryonic organogenesis, the odontogenic potential resides in dental mesenchyme from the bud stage until birth. Mouse dental mesenchymal cells (mDMCs) isolated from the inductive dental mesenchyme of developing molars are frequently used in the context of tooth development and regeneration. We wondered if and how the odontogenic potential could be retained when mDMCs were cultured in vitro. In the present study, we undertook to test the odontogenic potential of cultured mDMCs and attempted to maintain the potential during culturing. We found that cultured mDMCs could retain the odontogenic potential for 24 h with a ratio of 60% for tooth formation, but mDMCs were incapable of supporting tooth formation after more than 24 h in culture. This loss of odontogenic potential was accompanied by widespread transcriptomic alteration and, specifically, the downregulation of some dental mesenchyme-specific genes, such as Pax9, Msx1, and Pdgfra. To prolong the odontogenic potential of mDMCs in vitro, we then cultured mDMCs in a serum-free medium with Knockout Serum Replacement (KSR) and growth factors (fibroblastic growth factor 2 and epidermal growth factor). In this new micromilieu, mDMCs could maintain the odontogenic potential for 48 h with tooth formation ratio of 50%. Moreover, mDMCs cultured in KSR-supplemented medium gave rise to tooth-like structures when recombined with non-dental second-arch epithelium. Among the supplements, KSR is essential for the survival and adhesion of mDMCs, and both Egf and Fgf2 induced the expression of certain dental mesenchyme-related genes. Taken together, our results demonstrated that the transcriptomic changes responded to the alteration of odontogenic potential in cultured mDMCs and a new micromilieu partly retained this potential in vitro, providing insight into the long-term maintenance of odontogenic potential in mDMCs.	[Zheng, Yunfei; Jia, Lingfei; Wei, Shicheng] Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100081, Peoples R China; [Zheng, Yunfei; Cai, Jinglei; Hutchins, Andrew Paul; Liu, Pengfei; Yang, Dandan; Chen, Shubin; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Jia, Lingfei; Wei, Shicheng] Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100081, Peoples R China; [Ge, Lihong] Peking Univ, Dept Pediat Dent, Sch & Hosp Stomatol, Beijing 100081, Peoples R China	Peking University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Peking University; Peking University	Wei, SC (corresponding author), Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100081, Peoples R China.; Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China.; Wei, SC (corresponding author), Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100081, Peoples R China.	pei_duanqing@gibh.ac.cn; sc-wei@pku.edu.cn	Ge, Li/T-3955-2018; Wei, Shicheng/F-9552-2017; zheng, yunfei/M-4172-2018; YANG, Dan/HHD-2733-2022; Hutchins, Andrew/O-5708-2018	Ge, Li/0000-0002-1824-8034; Wei, Shicheng/0000-0001-6024-9615; Hutchins, Andrew/0000-0001-7784-2255	Peking University's 985 Grants, Open Project of Key Laboratory of Regenerative Biology, Chinese Academy of Sciences [KLRB201401]; National Natural Science Foundation of China [81371697, 81570944]	Peking University's 985 Grants, Open Project of Key Laboratory of Regenerative Biology, Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Peking University's 985 Grants, Open Project of Key Laboratory of Regenerative Biology, Chinese Academy of Sciences (KLRB201401), and National Natural Science Foundation of China (No. 81371697; 81570944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bei M, 1998, DEVELOPMENT, V125, P4325; Benveniste P, 2014, BLOOD, V123, P1167, DOI 10.1182/blood-2013-07-505099; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Brunskill EW, 2014, DEV BIOL, V391, P133, DOI 10.1016/j.ydbio.2014.04.016; Cai Jinglei, 2013, Cell Regen, V2, P6, DOI 10.1186/2045-9769-2-6; Chai Y, 2000, DEVELOPMENT, V127, P1671; Duailibi MT, 2004, J DENT RES, V83, P523, DOI 10.1177/154405910408300703; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Honda MJ, 2007, BIOMATERIALS, V28, P680, DOI 10.1016/j.biomaterials.2006.09.039; Hu X, 2014, J DENT RES, V93, P490, DOI 10.1177/0022034514523988; Huang YD, 2015, J DENT, V43, P576, DOI 10.1016/j.jdent.2015.02.008; Hutchins Andrew Paul, 2014, Cell Regen, V3, P1, DOI 10.1186/2045-9769-3-1; Imai H, 1996, DEV BIOL, V176, P151, DOI 10.1006/dbio.1996.9985; Jia SH, 2013, DEVELOPMENT, V140, P423, DOI 10.1242/dev.081927; Keller L, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00007; Keller LV, 2012, INT J DEV BIOL, V56, P737, DOI 10.1387/ijdb.120076hl; KOLLAR EJ, 1970, J EMBRYOL EXP MORPH, V24, P173; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Liu C, 2013, DEVELOPMENT, V140, P4375, DOI 10.1242/dev.097733; LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155; MacDougall M, 1995, Connect Tissue Res, V33, P97, DOI 10.3109/03008209509016988; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0; Minamino Y, 2015, STEM CELLS DEV, V24, P172, DOI 10.1089/scd.2014.0152; Morito A, 2009, ARCH HISTOL CYTOL, V72, P51, DOI 10.1679/aohc.72.51; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Otsu K, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00036; Otsu K, 2012, STEM CELLS DEV, V21, P1156, DOI 10.1089/scd.2011.0210; PARTANEN A-M, 1989, International Journal of Developmental Biology, V33, P165; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Priam F, 2005, ARCH ORAL BIOL, V50, P271, DOI 10.1016/j.archoralbio.2004.10.007; Saito K, 2013, J ENDODONT, V39, P1250, DOI 10.1016/j.joen.2013.06.017; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; SAXEN L, 1992, CIBA F SYMP, V165, P183; Seki D, 2015, STEM CELL TRANSL MED, V4, P993, DOI 10.5966/sctm.2014-0292; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shetty S, 1999, BIOCHEM J, V339, P751, DOI 10.1042/0264-6021:3390751; THESLEFF I, 1995, INT J DEV BIOL, V39, P35; Thomas BL, 1997, DEVELOPMENT, V124, P4811; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Volponi AA, 2013, J DENT RES, V92, P329, DOI 10.1177/0022034513481041; Wang BM, 2010, DEV BIOL, V344, P795, DOI 10.1016/j.ydbio.2010.05.511; Wang F, 2013, IN VITRO CELL DEV-AN, V49, P626, DOI 10.1007/s11626-013-9641-1; Wu L, 2015, J CELL PHYSIOL, V230, P2588, DOI 10.1002/jcp.25061; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299	48	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152893	10.1371/journal.pone.0152893	http://dx.doi.org/10.1371/journal.pone.0152893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050091	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500064
J	Bane, CE; Ivanov, I; Matafonov, A; Boyd, KL; Cheng, QF; Sherwood, ER; Tucker, EI; Smiley, ST; McCarty, OJT; Gruber, A; Gailani, D				Bane, Charles E., Jr.; Ivanov, Ivan; Matafonov, Anton; Boyd, Kelli L.; Cheng, Qiufang; Sherwood, Edward R.; Tucker, Erik I.; Smiley, Stephen T.; McCarty, Owen J. T.; Gruber, Andras; Gailani, David			Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in Mice	PLOS ONE			English	Article							MOLECULAR-WEIGHT KININOGEN; COAGULATION-FACTOR-XI; CECAL LIGATION; HAGEMAN-FACTOR; PLASMA PREKALLIKREIN; BLOOD-COAGULATION; SYSTEM; KALLIKREIN; RISK; COAGULOPATHY	Sepsis, a systemic inflammatory response to infection, is often accompanied by abnormalities of blood coagulation. Prior work with a mouse model of sepsis induced by cecal ligation and puncture (CLP) suggested that the protease factor XIa contributed to disseminated intravascular coagulation (DIC) and to the cytokine response during sepsis. We investigated the importance of factor XI to cytokine and coagulation responses during the first 24 hours after CLP. Compared to wild type littermates, factor XI-deficient (FXI-/-) mice had a survival advantage after CLP, with smaller increases in plasma levels of TNF-alpha and IL-10 and delayed IL-1 beta and IL-6 responses. Plasma levels of serum amyloid P, an acute phase protein, were increased in wild type mice 24 hours post-CLP, but not in FXI(-/-)mice, supporting the impression of a reduced inflammatory response in the absence of factor XI. Surprisingly, there was little evidence of DIC in mice of either genotype. Plasma levels of the contact factors factor XII and prekallikrein were reduced in WT mice after CLP, consistent with induction of contact activation. However, factor XII and PK levels were not reduced in FXI(-/-)animals, indicating factor XI deficiency blunted contact activation. Intravenous infusion of polyphosphate into WT mice also induced changes in factor XII, but had much less effect in FXI deficient mice. In vitro analysis revealed that factor XIa activates factor XII, and that this reaction is enhanced by polyanions such polyphosphate and nucleic acids. These data suggest that factor XI deficiency confers a survival advantage in the CLP sepsis model by altering the cytokine response to infection and blunting activation of the contact (kallikrein-kinin) system. The findings support the hypothesis that factor XI functions as a bidirectional interface between contact activation and thrombin generation, allowing the two processes to influence each other.	[Bane, Charles E., Jr.; Ivanov, Ivan; Matafonov, Anton; Boyd, Kelli L.; Cheng, Qiufang; Gailani, David] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Matafonov, Anton] Tomsk Polytech Univ, Dept Bioengn & Organ Chem, Tomsk, Russia; [Sherwood, Edward R.] Vanderbilt Univ, Dept Anesthesiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Tucker, Erik I.; Gruber, Andras] Aronora Inc, Portland, OR USA; [Smiley, Stephen T.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA; [McCarty, Owen J. T.; Gruber, Andras] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA	Vanderbilt University; Tomsk Polytechnic University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Oregon Health & Science University	Gailani, D (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.	dave.gailani@vanderbilt.edu		Gruber, Andras/0000-0001-6212-2247	National Institutes of Health [HL81326, HL58837, GM116184]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101972, R01HL058837, R01HL081326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to acknowledge the support of National Institutes of Health grants HL81326 and HL58837 (DG) and GM116184 (OJM). DG is a consultant, and receives consultant's fees from several pharmaceutical companies. These fees were not used to support the work described in this manuscript. EIT and AG are employees of the company Aronora. Aronora provided support in the form of salaries for these individuals, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen Karen S, 2015, World J Crit Care Med, V4, P105, DOI 10.5492/wjccm.v4.i2.105; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Ayala A, 1996, SHOCK, V6, pS27, DOI 10.1097/00024382-199610001-00007; Bane CE, 2014, DRUG DISCOV TODAY, V19, P1454, DOI 10.1016/j.drudis.2014.05.018; Berthelsen LO, 2011, THROMB RES, V128, P103, DOI 10.1016/j.thromres.2010.12.002; Bjorkqvist J, 2014, THROMB HAEMOSTASIS, V112, P868, DOI 10.1160/TH14-04-0311; Chen D, 2009, J THROMB HAEMOST, V7, P122, DOI 10.1111/j.1538-7836.2009.03413.x; Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; Corral J, 2005, AM J PATHOL, V166, P1089, DOI 10.1016/S0002-9440(10)62329-2; Couture R, 2014, CURR VASC PHARMACOL, V12, P223, DOI 10.2174/1570161112666140226121627; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; DELACADENA RA, 1993, BLOOD, V81, P3313; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Doggen CJM, 2006, BLOOD, V108, P4045, DOI 10.1182/blood-2005-12-023697; Emsley J, 2010, BLOOD, V115, P2569, DOI 10.1182/blood-2009-09-199182; Esmon CT, 2013, THROMB HAEMOSTASIS, V109, P416, DOI 10.1160/TH12-08-0634; EWALD GA, 1995, CIRCULATION, V91, P28, DOI 10.1161/01.CIR.91.1.28; Frick IM, 2007, THROMB HAEMOSTASIS, V98, P497, DOI 10.1160/TH07-01-0051; Gailani D, 2015, J THROMB HAEMOST, V13, P1383, DOI 10.1111/jth.13005; Gailani D, 1997, BLOOD COAGUL FIBRIN, V8, P134, DOI 10.1097/00001721-199703000-00008; GALLIMORE MJ, 1978, THROMB RES, V12, P307, DOI 10.1016/0049-3848(78)90301-8; Ganopolsky JG, 2004, AM J PATHOL, V165, P1433, DOI 10.1016/S0002-9440(10)63401-3; Geng Y, 2013, J THROMB HAEMOST, V11, P1374, DOI 10.1111/jth.12275; Gould TJ, 2015, J THROMB HAEMOST, V13, pS82, DOI 10.1111/jth.12977; GRIFFIN JH, 1978, P NATL ACAD SCI USA, V75, P1998, DOI 10.1073/pnas.75.4.1998; Hawiger J, 2015, J THROMB HAEMOST, V13, P1743, DOI 10.1111/jth.13061; Herwald H, 2003, SCAND J INFECT DIS, V35, P604, DOI 10.1080/00365540310016268; Hoffmeister HM, 1998, J CARDIOVASC PHARM, V31, P764, DOI 10.1097/00005344-199805000-00016; Iwaki T, 2008, J THROMB HAEMOST, V6, P1993, DOI 10.1111/j.1538-7836.2008.03142.x; Kenniston JA, 2014, J BIOL CHEM, V289, P23596, DOI 10.1074/jbc.M114.569061; Key NS, 2014, HEMATOL-AM SOC HEMAT, P66, DOI 10.1182/asheducation-2014.1.66; Khan MM, 2006, ARTERIOSCL THROM VAS, V26, P2260, DOI 10.1161/01.ATV.0000240290.70852.c0; Lang JD, 2009, CRIT CARE, V13, DOI 10.1186/cc7144; Levi M, 2015, SEMIN THROMB HEMOST, V41, P9, DOI 10.1055/s-0034-1398376; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Liu J, 2011, NAT MED, V17, P206, DOI 10.1038/nm.2295; MANDLE RJ, 1976, P NATL ACAD SCI USA, V73, P4179, DOI 10.1073/pnas.73.11.4179; Matafonov A, 2011, BLOOD, V118, P437, DOI 10.1182/blood-2010-10-312983; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2056, DOI 10.1021/bi00222a008; MEIER HL, 1977, J CLIN INVEST, V60, P18, DOI 10.1172/JCI108754; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; Patel KN, 2010, J THROMB HAEMOST, V8, P1403, DOI 10.1111/j.1538-7836.2010.03853.x; Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250; Pawlinski R, 2004, CRIT CARE MED, V32, pS293, DOI 10.1097/01.CCM.0000128445.95144.B8; Pawlinski R, 2010, THROMB RES, V125, pS70, DOI 10.1016/j.thromres.2010.01.042; PIXLEY RA, 1993, J CLIN INVEST, V91, P61, DOI 10.1172/JCI116201; Ponczek MB, 2008, J THROMB HAEMOST, V6, P1876, DOI 10.1111/j.1538-7836.2008.03143.x; Revenko AS, 2011, BLOOD, V118, P5302, DOI 10.1182/blood-2011-05-355248; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Schmaier AH, 2014, THROMB RES, V133, pS41, DOI 10.1016/j.thromres.2014.03.018; Schmidt GA, INVESTIGATIONAL INEF; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; SCOTT CF, 1985, J BIOL CHEM, V260, P856; Semeraro N, 2015, SEMIN THROMB HEMOST, V41, P650, DOI 10.1055/s-0035-1556730; Sharma Jagdish N, 2014, Prog Drug Res, V69, P1; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Suri MFK, 2010, CEREBROVASC DIS, V29, P497, DOI 10.1159/000297966; Tao WK, 2004, SHOCK, V21, P31, DOI 10.1097/01.shk.0000101673.49265.5d; THOMPSON RE, 1979, P NATL ACAD SCI USA, V76, P4862, DOI 10.1073/pnas.76.10.4862; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898; THOMPSON RE, 1978, J EXP MED, V147, P488, DOI 10.1084/jem.147.2.488; TOOSSI Z, 1992, P NATL ACAD SCI USA, V89, P11969, DOI 10.1073/pnas.89.24.11969; Tucker EI, 2008, J INFECT DIS, V198, P271, DOI 10.1086/589514; Tucker EI, 2012, BLOOD, V119, P4762, DOI 10.1182/blood-2011-10-386185; van der Poll T, 2012, CURR VASC PHARMACOL, V10, P632, DOI 10.2174/157016112801784549; van Montfoort ML, 2014, HEMATOL-AM SOC HEMAT, P60, DOI 10.1182/asheducation-2014.1.60; Vilahur G, 2015, VASC PHARMACOL, V73, P38, DOI 10.1016/j.vph.2015.05.001; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; WIGGINS RC, 1977, P NATL ACAD SCI USA, V74, P4636, DOI 10.1073/pnas.74.10.4636; Wu Y, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0048-y; Yun TH, 2009, J CELL MOL MED, V13, P4146, DOI 10.1111/j.1582-4934.2009.00884.x	74	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152968	10.1371/journal.pone.0152968	http://dx.doi.org/10.1371/journal.pone.0152968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046148	gold, Green Published, Green Submitted			2022-12-26	WOS:000373599600053
J	Nagy, E; Rodriguiz, RM; Wetsel, WC; MacIver, NJ; Hale, LP				Nagy, Eniko; Rodriguiz, Ramona M.; Wetsel, William C.; MacIver, Nancie J.; Hale, Laura P.			Reproduction and Growth in a Murine Model of Early Life-Onset Inflammatory Bowel Disease	PLOS ONE			English	Article							RESTING ENERGY-EXPENDITURE; GUT MICROBIOTA; TNF-ALPHA; CROHNS; POPULATION; VARIANTS; COLITIS; OBESITY; LEPTIN; FAT	Studies in transgenic murine models have provided insight into the complexity underlying inflammatory bowel disease (IBD), a disease hypothesized to result from an injurious immune response against intestinal microbiota. We recently developed a mouse model of IBD that phenotypically and histologically resembles human childhood-onset ulcerative colitis (UC), using mice that are genetically modified to be deficient in the cytokines TNF and IL-10 ("T/I" mice). Here we report the effects of early life onset of colon inflammation on growth and reproductive performance of T/I mice. T/I dams with colitis often failed to get pregnant or had small litters with pups that failed to thrive. Production was optimized by breeding double homozygous mutant T/I males to females homozygous mutant for TNF deficiency and heterozygous for deficiency of IL-10 ("T/I-het" dams) that were not susceptible to spontaneous colon inflammation. When born to healthy (T/I-het) dams, T/I pups initially gained weight similarly to wild type (WT) pups and to their non-colitis-susceptible T/I-het littermates. However, their growth curves diverged between 8 and 13 weeks, when most T/I mice had developed moderate to severe colitis. The observed growth failure in T/I mice occurred despite a significant increase in their food consumption and in the absence of protein loss in the stool. This was not due to TNF-induced anorexia or altered food consumption due to elevated leptin levels. Metabolic studies demonstrated increased consumption of oxygen and water and increased production of heat and CO2 in T/I mice compared to their T/I-het littermates, without differences in motor activity. Based on the clinical similarities of this early life onset model of IBD in T/I mice to human IBD, these results suggest that mechanisms previously hypothesized to explain growth failure in children with IBD require re-evaluation. The T/I mouse model may be useful for further investigation of such mechanisms and for development of therapies to prevent reproductive complications and/or growth failure in humans with IBD.	[Nagy, Eniko; Hale, Laura P.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [MacIver, Nancie J.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Hale, Laura P.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Hale, LP (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.; Hale, LP (corresponding author), Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC USA.	laura.hale@duke.edu		MacIver, Nancie/0000-0003-3676-9391	United States National Institutes of Health [5R21CA170069]; National Multiple Sclerosis Society Grant [RG-5333]; NATIONAL CANCER INSTITUTE [R21CA170069] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society Grant(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grant number 5R21CA170069 (to LPH) from the United States National Institutes of Health and the National Multiple Sclerosis Society Grant RG-5333 (to NJM). Some of the equipment and software was purchased through a grant (to WCW) from the North Carolina Biotechnology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu DB, 2011, WORLD J GASTROENTERO, V17, P2696, DOI 10.3748/wjg.v17.i22.2696; Billiet T, 2014, EXPERT OPIN BIOL TH, V14, P75, DOI 10.1517/14712598.2014.858695; Blandizzi C, 2014, INT J IMMUNOPATH PH, V27, P1, DOI 10.1177/03946320140270S101; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Cioffi Michele, 2015, World J Gastrointest Pathophysiol, V6, P13, DOI 10.4291/wjgp.v6.i1.13; Clarke G, 2014, MOL ENDOCRINOL, V28, P1221, DOI 10.1210/me.2014-1108; Cormier K, 2005, JPEN-PARENTER ENTER, V29, P102, DOI 10.1177/0148607105029002102; Dalal SR, 2014, J CLIN INVEST, V124, P4190, DOI 10.1172/JCI72330; Day AS, 2012, WORLD J GASTROENTERO, V18, P5862, DOI 10.3748/wjg.v18.i41.5862; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Griffiths AM, 2004, BEST PRACT RES CL GA, V18, P509, DOI 10.1016/j.bpg.2004.01.002; Hale LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041797; Hale LP, 2005, CLIN IMMUNOL, V116, P135, DOI 10.1016/j.clim.2005.04.011; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P346, DOI 10.1002/ibd.21283; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Manosa M, 2013, SCAND J GASTROENTERO, V48, P427, DOI 10.3109/00365521.2013.772229; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Meyer SU, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0083-0; Neuman MG, 2007, TRANSL RES, V149, P173, DOI 10.1016/j.trsl.2006.11.009; Pawlowska Katarzyna, 2014, Dev Period Med, V18, P323; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Saini A, 2006, CYTOKINE GROWTH F R, V17, P475, DOI 10.1016/j.cytogfr.2006.09.006; Sammarco R, 2017, CLIN NUTR, V36, P467, DOI 10.1016/j.clnu.2016.01.005; Sartor RB, 2012, AM J GASTROENTEROL S, V1, P15, DOI DOI 10.1038/AJGSUP.2012.4; Sasaki M, 2010, J CLIN BIOCHEM NUTR, V47, P32, DOI 10.3164/jcbn.10-07; Saucillo DC, 2014, J IMMUNOL, V192, P136, DOI 10.4049/jimmunol.1301158; Selinger CP, 2012, WORLD J GASTROENTERO, V18, P2600, DOI 10.3748/wjg.v18.i21.2600; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Subramaniam K, 2015, ALIMENT PHARM THER, V41, P419, DOI 10.1111/apt.13058; Terpstra AHM, 2002, J NUTR, V132, P940, DOI 10.1093/jn/132.5.940; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Heel DA, 2002, HUM MOL GENET, V11, P1281, DOI 10.1093/hmg/11.11.1281; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081; Vanderford DA, 2010, EXP DERMATOL, V19, P518, DOI 10.1111/j.1600-0625.2009.01032.x; Varille V, 1996, J PEDIATR GASTR NUTR, V23, P13, DOI 10.1097/00005176-199607000-00003; Vernier-Massouille G, 2008, GASTROENTEROLOGY, V135, P1106, DOI 10.1053/j.gastro.2008.06.079; Wang H, 2015, REV ENDOCR METAB DIS, V16, P47, DOI 10.1007/s11154-014-9306-8; Yang Y, 2014, DIS MODEL MECH, V7, P1131, DOI 10.1242/dmm.016428	45	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152764	10.1371/journal.pone.0152764	http://dx.doi.org/10.1371/journal.pone.0152764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045690	Green Published, Green Submitted, gold			2022-12-26	WOS:000373599600032
J	Ranjbar, B; Krogh, LB; Laursen, MB; Primo, MN; Marques, SC; Dybkaer, K; Mikkelsen, JG				Ranjbar, Benyamin; Krogh, Louise Bechmann; Laursen, Maria Bach; Primo, Maria Nascimento; Marques, Sara Correia; Dybkaer, Karen; Mikkelsen, Jacob Giehm			Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells	PLOS ONE			English	Article							MICRORNA EXPRESSION; CD43 EXPRESSION; DOWN-REGULATION; GENE; CHEMOTHERAPY; CD20; RESISTANCE; CHOP; SURVIVAL; THERAPY	Diffuse large B-cell lymphoma (DLBCL) is characterized by great genetic and clinical heterogeneity which complicates prognostic prediction and influences treatment efficacy. The most common regimen, R-CHOP, consists of a combination of anthracycline- and immuno-based drugs including Rituximab. It remains elusive how and to which extent genetic variability impacts the response and potential tolerance to R-CHOP. Hence, an improved understanding of mechanisms leading to drug tolerance in B-cells is crucial, and modelling by genetic intervention directly in B-cells is fundamental in such investigations. Lentivirus-based gene vectors are widely used gene vehicles, which in B-cells are an attractive alternative to potentially toxic transfection-based methodologies. Here, we investigate the use of VSV-G-pseudotyped lentiviral vectors in B-cells for exploring the impact of microRNAs on tolerance to Rituximab. Notably, we find that robust lentiviral transduction of cancerous B-cell lines markedly and specifically enhances the resistance of transduced germinal center B-cells (GCBs) to Rituximab. Although Rituximab works partially through complement-mediated cell lysis, increased tolerance is not achieved through effects of lentiviral transduction on cell death mediated by complement. Rather, reduced levels of PARP1 and persistent high levels of CD43 in Rituximab-treated GCBs demonstrate anti-apoptotic effects of lentiviral transduction that may interfere with the outcome and interpretation of Rituximab tolerance studies. Our findings stress that caution should be exercised exploiting lentiviral vectors in studies of tolerance to therapeutics in DLBCL. Importantly, however, we demonstrate the feasibility of using the lentiviral gene delivery platform in studies addressing the impact of specific microRNAs on Rituximab responsiveness.	[Ranjbar, Benyamin; Krogh, Louise Bechmann; Primo, Maria Nascimento; Mikkelsen, Jacob Giehm] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Laursen, Maria Bach; Marques, Sara Correia; Dybkaer, Karen] Aalborg Univ Hosp, Dept Hematol, Aalborg, Denmark; [Marques, Sara Correia] Aarhus Univ, Dept Clin Med, Aarhus, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Mikkelsen, JG (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	giehm@biomed.au.dk	Primo, Maria/P-1780-2017	Primo, Maria/0000-0003-2808-0607; Mikkelsen, Jacob Giehm/0000-0002-1322-3209; Dybkaer, Karen/0000-0003-2488-435X	Agnes og Poul Friis Fond; Aase og Ejnar Danielsens Fond; Frits, Georg og Marie Cecilie Gluds Legat; Else og Mogens Wedell-Wedellsborgs Fond; Civilingenior Frode V. Nyegaard og hustrus Fond; Arvid Nilssons Fond; Fabrikant Ejnar Willumsens Legat; Aarhus University; The Danish Cancer Society [R124-A7623] Funding Source: researchfish	Agnes og Poul Friis Fond; Aase og Ejnar Danielsens Fond; Frits, Georg og Marie Cecilie Gluds Legat; Else og Mogens Wedell-Wedellsborgs Fond; Civilingenior Frode V. Nyegaard og hustrus Fond; Arvid Nilssons Fond; Fabrikant Ejnar Willumsens Legat; Aarhus University; The Danish Cancer Society(Danish Cancer Society)	This work was supported by Agnes og Poul Friis Fond; Aase og Ejnar Danielsens Fond; Frits, Georg og Marie Cecilie Gluds Legat; Else og Mogens Wedell-Wedellsborgs Fond; Civilingenior Frode V. Nyegaard og hustrus Fond; Arvid Nilssons Fond; Fabrikant Ejnar Willumsens Legat. All received by J.G. Mikkelsen. PhD mobility fellowship from Aarhus University received by B. Ranjbar.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bai HT, 2013, INT J HEMATOL, V97, P223, DOI 10.1007/s12185-012-1256-x; Bak RO, 2013, RNA, V19, P280, DOI 10.1261/rna.034850.112; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Baruch M, 1996, LEUKEMIA LYMPHOMA, V21, P485, DOI 10.3109/10428199609093448; Bodogai M, 2013, CANCER RES, V73, P2127, DOI 10.1158/0008-5472.CAN-12-4184; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Czuczman MS, 2008, CLIN CANCER RES, V14, P1561, DOI 10.1158/1078-0432.CCR-07-1254; DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7; Di Lisio L, 2012, BLOOD, V120, P1782, DOI 10.1182/blood-2012-05-402784; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; Falgreen S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1237-6; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Girard-Gagnepain A, 2014, BLOOD, V124, P1221, DOI 10.1182/blood-2014-02-558163; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Henry C, 2010, BLOOD, V115, P2420, DOI 10.1182/blood-2009-06-229112; Hernandez JD, 2006, J IMMUNOL, V177, P5328, DOI 10.4049/jimmunol.177.8.5328; Hollensen AK, 2013, RNA BIOL, V10, P406, DOI 10.4161/rna.23543; Iqbal J, 2015, BLOOD, V125, P1137, DOI 10.1182/blood-2014-04-566778; Jakobsen M, 2009, MOL THER, V17, P1743, DOI 10.1038/mt.2009.141; Jorgensen LK, 2015, DAN MED J, V62; Kadaja-Saarepuu L, 2008, ONCOGENE, V27, P1705, DOI 10.1038/sj.onc.1210802; Karaayvaz M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.193; Kneissl S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079047; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Maloney DG, 2012, NEW ENGL J MED, V366, P2008, DOI 10.1056/NEJMct1114348; Marques SC, 2015, ONCOTARGET, V6, P7, DOI 10.18632/oncotarget.3057; Mehra S, 2002, GENE CHROMOSOME CANC, V33, P225, DOI 10.1002/gcc.10025; Mitrovic Z, 2013, BRIT J HAEMATOL, V162, P87, DOI 10.1111/bjh.12356; Mitrovic Z, 2009, CLIN LYMPHOMA MYELOM, V9, P133, DOI 10.3816/CLM.2009.n.033; Musilova K, 2015, LEUKEMIA, V29, P1004, DOI 10.1038/leu.2014.351; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Nusbaum P, 2004, BIOCHEM SOC T, V32, P477, DOI 10.1042/BST0320477; Olejniczak SH, 2008, CLIN CANCER RES, V14, P1550, DOI 10.1158/1078-0432.CCR-07-1255; Ostberg JR, 1998, IMMUNOL TODAY, V19, P546, DOI 10.1016/S0167-5699(98)01343-7; Perez-Callejo D, 2015, CANCER TREAT REV, V41, P680, DOI 10.1016/j.ctrv.2015.05.007; Rasmussen TK, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0660-z; Roschewski M, 2014, NAT REV CLIN ONCOL, V11, P12, DOI 10.1038/nrclinonc.2013.197; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Song GQ, 2014, CURR CANCER DRUG TAR, V14, P659, DOI 10.2174/1568009614666140818211103; Song GQ, 2014, ANN HEMATOL, V93, P1735, DOI 10.1007/s00277-014-2111-3; Takwi AA, 2014, ONCOGENE, V33, P3717, DOI 10.1038/onc.2013.330; THNG KH, 1987, INT J CANCER, V39, P89, DOI 10.1002/ijc.2910390116; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Tsai PC, 2012, CLIN CANCER RES, V18, P1039, DOI 10.1158/1078-0432.CCR-11-1429; TSCHOPP J, 1993, J IMMUNOL, V151, P2159; Vega MI, 2004, ONCOGENE, V23, P3530, DOI 10.1038/sj.onc.1207336; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	52	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153069	10.1371/journal.pone.0153069	http://dx.doi.org/10.1371/journal.pone.0153069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045839	Green Published, gold			2022-12-26	WOS:000373599600064
J	Rumberg, F; Bakir, MS; Taylor, WR; Haberl, H; Sarpong, A; Sharankou, I; Lebek, S; Funk, JF				Rumberg, Franziska; Bakir, Mustafa Sinan; Taylor, William R.; Haberl, Hannes; Sarpong, Akosua; Sharankou, Ilya; Lebek, Susanne; Funk, Julia F.			The Effects of Selective Dorsal Rhizotomy on Balance and Symmetry of Gait in Children with Cerebral Palsy	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; ORTHOPEDIC-SURGERY; POSTURAL BALANCE; SPASTIC DIPLEGIA; FOLLOW-UP; WALKING; PATTERNS	Aim Cerebral palsy (CP) is associated with dysfunction of the upper motor neuron and results in balance problems and asymmetry during locomotion. Selective dorsal rhizotomy (SDR) is a surgical procedure that results in reduced afferent neuromotor signals from the lower extremities with the aim of improving gait. Its influence on balance and symmetry has not been assessed. The aim of this prospective cohort study was to evaluate the impact of SDR on balance and symmetry during walking. Methods 18 children (10 girls, 8 boys; age 6 years (y) 3 months (m), SD 1y 8m) with bilateral spastic CP and Gross Motor Function Classification System levels I to II underwent gait analysis before and 6 to 12 months after SDR. Results were compared to 11 typically developing children (TDC; 6 girls, 5 boys; age 6y 6m, SD 1y 11m). To analyse balance, sway velocity, radial displacement and frequency were calculated. Symmetry ratios were calculated for balance measures and spatio-temporal parameters during walking. Results Most spatio-temporal parameters of gait, as well as all parameters of balance, improved significantly after SDR. Preoperative values of symmetry did not vary considerably between CP and TDC group and significant postoperative improvement did not occur. Interpretation The reduction of afferent signalling through SDR improves gait by reducing balance problems rather than enhancing movement symmetry.	[Rumberg, Franziska; Bakir, Mustafa Sinan; Lebek, Susanne; Funk, Julia F.] Charite, Ctr Musculoskeletal Surg CMSC, Dept Orthopaed, Paediat Orthopaed Surg & Neuroorthopaed, D-13353 Berlin, Germany; [Taylor, William R.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Haberl, Hannes] Univ Ulm, Dept Neurosurg, Sect Paediat Neurosurg, D-89069 Ulm, Germany; [Sarpong, Akosua] Charite, Social Paediat Ctr, D-13353 Berlin, Germany; [Sharankou, Ilya] Charite, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Funk, JF (corresponding author), Charite, Ctr Musculoskeletal Surg CMSC, Dept Orthopaed, Paediat Orthopaed Surg & Neuroorthopaed, D-13353 Berlin, Germany.	julia.funk@charite.de	Taylor, William R./F-8692-2010	Taylor, William R./0000-0003-4060-4098; Bakir, Sinan/0000-0002-2448-2150				Bakir MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069500; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; BERGER W, 1984, HUM NEUROBIOL, V3, P163; BLECK EE, 1994, DEV MED CHILD NEUROL, V36, P377; Bolster EAM, 2013, DEV MED CHILD NEUROL, V55, P610, DOI 10.1111/dmcn.12148; Buckon CE, 2004, ARCH PHYS MED REHAB, V85, P457, DOI 10.1016/j.apmr.2003.05.009; Burtner PA, 1998, GAIT POSTURE, V8, P163, DOI 10.1016/S0966-6362(98)00032-0; Chan SHS, 2008, PEDIATR NEUROL, V39, P22, DOI 10.1016/j.pediatrneurol.2008.03.017; Chen J, 2007, J MOTOR BEHAV, V39, P306, DOI 10.3200/JMBR.39.4.306-316; Cole GF, 2007, ARCH DIS CHILD, V92, P781, DOI 10.1136/adc.2006.111559; Crenna P, 1998, NEUROSCI BIOBEHAV R, V22, P571, DOI 10.1016/S0149-7634(97)00046-8; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Dudley RWR, 2013, J NEUROSURG-PEDIATR, V12, P142, DOI 10.3171/2013.4.PEDS12539; Engsberg J R, 1998, Neurosurg Focus, V4, pe4; Engsberg JR, 2006, J NEUROSURG S, V105, P8; Eyre JA, 2007, NEUROSCI BIOBEHAV R, V31, P1136, DOI 10.1016/j.neubiorev.2007.05.011; Funk JF, 2015, RES DEV DISABIL, V37, P127, DOI 10.1016/j.ridd.2014.11.012; Funk JF, 2016, CHILD NERV SYST, V32, P819, DOI 10.1007/s00381-016-3016-3; Goble DJ, 2003, HUM MOVEMENT SCI, V22, P271, DOI 10.1016/S0167-9457(03)00047-2; Grunt S, 2010, NEUROPEDIATRICS, V41, P209, DOI 10.1055/s-0030-1267983; HANNAH RE, 1984, ARCH PHYS MED REHAB, V65, P155; HOF AL, 1996, GAIT POSTURE, V4, P222; Hsue BJ, 2009, GAIT POSTURE, V29, P471, DOI 10.1016/j.gaitpost.2008.11.008; Hsue BJ, 2009, GAIT POSTURE, V29, P465, DOI 10.1016/j.gaitpost.2008.11.007; Josenby AL, 2012, DEV MED CHILD NEUROL, V54, P429, DOI 10.1111/j.1469-8749.2012.04258.x; Kim CM, 2003, GAIT POSTURE, V18, P23, DOI 10.1016/S0966-6362(02)00122-4; Krageloh-Mann I, 2007, DEV MED CHILD NEUROL, V49, P144; Langerak NG, 2012, GAIT POSTURE, V35, P244, DOI 10.1016/j.gaitpost.2011.09.014; Liao HF, 1997, DEV MED CHILD NEUROL, V39, P106, DOI 10.1111/j.1469-8749.1997.tb07392.x; Lundkvist A, 2006, J PEDIATR ORTHOP B, V15, P244, DOI 10.1097/01202412-200607000-00002; Lythgo N, 2011, GAIT POSTURE, V33, P29, DOI 10.1016/j.gaitpost.2010.09.017; Lythgo N, 2009, GAIT POSTURE, V30, P502, DOI 10.1016/j.gaitpost.2009.07.119; Macwilliams BA, 2011, DEV MED CHILD NEUROL, V53, P717, DOI 10.1111/j.1469-8749.2011.04010.x; McLaughlin J, 2002, DEV MED CHILD NEUROL, V44, P17, DOI 10.1017/S0012162201001608; Mittal S, 2002, J NEUROSURG, V97, P315, DOI 10.3171/jns.2002.97.2.0315; MURRAY MP, 1964, J BONE JOINT SURG AM, V46, P335, DOI 10.2106/00004623-196446020-00009; NASHNER LM, 1983, EXP BRAIN RES, V49, P393; Nordmark E, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-54; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Park TS, 2006, TECHNICAL NOTE NEURO, V21, pe7, DOI DOI 10.3171/F0C.2006.21.2.8; Patterson KK, 2010, GAIT POSTURE, V31, P241, DOI 10.1016/j.gaitpost.2009.10.014; Pavao SL, 2013, RES DEV DISABIL, V34, P1367, DOI 10.1016/j.ridd.2013.01.034; PEACOCK WJ, 1991, J NEUROSURG, V74, P380, DOI 10.3171/jns.1991.74.3.0380; Phillips LH, 1989, NEUROSURGERY STATE A, P459; Prosser LA, 2010, GAIT POSTURE, V31, P522, DOI 10.1016/j.gaitpost.2010.03.001; Roberts A, 2015, GAIT POSTURE, V42, P16, DOI 10.1016/j.gaitpost.2015.04.004; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Rose J, 2002, DEV MED CHILD NEUROL, V44, P58, DOI 10.1017/S0012162201001669; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V109, P8, DOI DOI 10.1111/J.1469-8749.2007.TB12610.X; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; Sharenkov A, 2014, GAIT POSTURE, V40, P730, DOI 10.1016/j.gaitpost.2014.07.025; Sheean G, 2002, EUR J NEUROL, V9, P3, DOI 10.1046/j.1468-1331.2002.0090s1003.x; Shumway-Cook A, 2003, DEV MED CHILD NEUROL, V45, P591, DOI 10.1017/S0012162203001099; Stolze H, 1998, GAIT POSTURE, V7, P125, DOI 10.1016/S0966-6362(97)00043-X; Taylor WR, 2010, GAIT POSTURE, V32, P231, DOI 10.1016/j.gaitpost.2010.05.005; Tedroff K, 2011, DEV MED CHILD NEUROL, V53, P724, DOI 10.1111/j.1469-8749.2011.03969.x; THILMANN AF, 1991, BRAIN, V114, P233; Thomas SS, 1996, J PEDIATR ORTHOPED, V16, P747, DOI 10.1097/01241398-199611000-00009; Trost JP, 2008, DEV MED CHILD NEUROL, V50, P765, DOI 10.1111/j.1469-8749.2008.03031.x; van Schie PEM, 2011, J NEUROSURG-PEDIATR, V7, P557, DOI 10.3171/2011.2.PEDS10452; Wallard L, 2014, GAIT POSTURE, V40, P43, DOI 10.1016/j.gaitpost.2014.02.009; Wolff DR, 1998, J ORTHOPAED RES, V16, P271, DOI 10.1002/jor.1100160215; Woollacott Marjorie Hines, 2005, Neural Plasticity, V12, P211, DOI 10.1155/NP.2005.211	64	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152930	10.1371/journal.pone.0152930	http://dx.doi.org/10.1371/journal.pone.0152930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043310	Green Published, Green Submitted, gold			2022-12-26	WOS:000373592100050
J	Xu, K; Wang, L; Feng, W; Feng, Y; Shu, HKG				Xu, K.; Wang, L.; Feng, W.; Feng, Y.; Shu, H-K G.			Phosphatidylinositol-3 kinase-dependent translational regulation of Id1 involves the PPM1G phosphatase	ONCOGENE			English	Article							LOOP-HELIX PROTEINS; HIGH-GRADE GLIOMA; DNA-DAMAGE; GENOMIC ANALYSIS; ID-1 PROTEIN; CELL-GROWTH; CANCER; GLIOBLASTOMA; EXPRESSION; DEPHOSPHORYLATION	Id1 is a helix-loop-helix transcriptional modulator that increases the aggressiveness of malignant glial neoplasms. Since most glioblastomas (GBMs) show increased phosphatidylinositol-3 kinase (PI-3K) signaling, we sought to determine whether this pathway regulates Id1 expression. Higher basal Id1 expression correlates with dysregulated PI-3K signaling in multiple established GBM cell lines. Further characterization of PI-3K-dependent Id1 regulation reveals that chemical or genetic inhibition of PI-3K signaling reduces Id1 protein but not mRNA expression. Overall, PI-3K signaling appears to enhance Id1 translation with no significant effect on its stability. PI-3K signaling is known to regulate protein translation through mTORC1-dependent phosphorylation of 4E-BP1, which reduces its association with and inhibition of the translation initiation factor eIF4E. Interestingly, while inhibition of PI-3K and AKT lowers 4E-BP1 phosphorylation and expression of Id1 in all cases, inhibition of TORC1 with rapamycin does not consistently have a similar effect, suggesting an alternative mechanism for PI-3K-dependent regulation of Id1 translation. We now identify a potential role for the serine-threonine phosphatase PPM1G in translational regulation of Id1 protein expression. PPM1G knockdown by siRNA increase both 4E-BP1 phosphorylation and Id1 expression and PPM1G and 4E-BP1 co-associates in GBM cells. Furthermore, PPM1G is a phosphoprotein and this phosphorylation appears to be regulated by PI-3K activity. Finally, PI-3K inhibition increases PPM1G activity when assessed by an in vitro phosphatase assay. Our findings provide the first evidence that the PI-3K/AKT signaling pathway modulates PPM1G activity resulting in a shift in the balance between hyperand hypo-phosphorylated 4E-BP1 and translational regulation of Id1 expression.	[Xu, K.; Wang, L.; Shu, H-K G.] Emory Univ, Dept Radiat Oncol, 1365 Clifton Rd,NE,Suite CT-104, Atlanta, GA 30322 USA; [Xu, K.; Wang, L.; Shu, H-K G.] Emory Univ, Winship Canc Inst, 1365 Clifton Rd,NE,Suite CT-104, Atlanta, GA 30322 USA; [Feng, W.; Feng, Y.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Shu, HKG (corresponding author), Emory Univ, Dept Radiat Oncol, 1365 Clifton Rd,NE,Suite CT-104, Atlanta, GA 30322 USA.; Shu, HKG (corresponding author), Emory Univ, Winship Canc Inst, 1365 Clifton Rd,NE,Suite CT-104, Atlanta, GA 30322 USA.	hgshu@emory.edu	FENG, WEI/B-8713-2018	FENG, WEI/0000-0002-9106-4258	Southeast Brain Tumor Foundation; Cancer Center grant from the National Cancer Institute [P30-CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER	Southeast Brain Tumor Foundation; Cancer Center grant from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Walter Curran for providing departmental funding support and Dr Chi-Ming Chang for helpful discussion in regard to this project. This work was supported in part by a grant (to H-KGS) from the Southeast Brain Tumor Foundation and a Cancer Center grant from the National Cancer Institute (P30-CA138292).	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Allemand E, 2007, NAT STRUCT MOL BIOL, V14, P630, DOI 10.1038/nsmb1257; Anand G, 1997, J BIOL CHEM, V272, P19140, DOI 10.1074/jbc.272.31.19140; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Foster WH, 2013, DEV DYNAM, V242, P1101, DOI 10.1002/dvdy.23990; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Helmy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046965; Khoronenkova SV, 2012, MOL CELL, V45, P801, DOI 10.1016/j.molcel.2012.01.021; Kimura H, 2006, J CELL BIOL, V175, P389, DOI 10.1083/jcb.200608001; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Liu JY, 2013, J BIOL CHEM, V288, P23225, DOI 10.1074/jbc.M113.492371; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Murray MV, 1999, GENE DEV, V13, P87, DOI 10.1101/gad.13.1.87; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; Perry DM, 2012, J LIPID RES, V53, P1513, DOI 10.1194/jlr.M025395; Petri S, 2007, J CELL BIOL, V179, P451, DOI 10.1083/jcb.200704163; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Roux PP, 2012, COLD SPRING HARB PER, V4; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Schindl M, 2003, CLIN CANCER RES, V9, P779; Schindl M, 2001, CANCER RES, V61, P5703; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Travis SM, 1997, FEBS LETT, V412, P415, DOI 10.1016/S0014-5793(97)00837-5; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Vandeputte DAA, 2002, GLIA, V38, P329, DOI 10.1002/glia.10076; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Xu KM, 2014, ONCOTARGET, V5, P1241, DOI 10.18632/oncotarget.1370	50	12	13	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 3	2016	35	44					5807	5816		10.1038/onc.2016.115	http://dx.doi.org/10.1038/onc.2016.115			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XQ	27065332	Green Accepted			2022-12-26	WOS:000386998400011
J	Stalin, J; Nollet, M; Garigue, P; Fernandez, S; Vivancos, L; Essaadi, A; Muller, A; Bachelier, R; Foucault-Bertaud, A; Fugazza, L; Leroyer, AS; Bardin, N; Guillet, B; Dignat-George, F; Blot-Chabaud, M				Stalin, J.; Nollet, M.; Garigue, P.; Fernandez, S.; Vivancos, L.; Essaadi, A.; Muller, A.; Bachelier, R.; Foucault-Bertaud, A.; Fugazza, L.; Leroyer, A. S.; Bardin, N.; Guillet, B.; Dignat-George, F.; Blot-Chabaud, M.			Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors	ONCOGENE			English	Article							ENDOTHELIAL PROGENITOR CELLS; HUMAN BREAST-CANCER; HUMAN-MELANOMA; ADHESION MOLECULE; PROSTATE-CANCER; C-MYC; EXPRESSION; THERAPY; ANGIOGENESIS; ANGIOMOTIN	CD146 (MUC-18, MCAM) expression on cancer cells correlates with cancer progression and a bad prognosis in several tumors, including melanoma and pancreatic tumors. Deciphering the mechanism mediating the CD146 role in cancer is essential for generating new therapeutic strategies. We found that CD146 expression in cancer cells is associated with a secretion of soluble CD146 (sCD146) that constitutes an active player in tumor development. Indeed, sCD146 induces the overexpression of its binding protein, angiomotin, on both endothelial and cancer cells and promotes both paracrine effects on angiogenesis and autocrine effects on cancer cells proliferation and survival. These last effects are mediated in part through the induction and phosphorylation of c-myc in cancer cells. In mice models xenografted with human CD146-positive melanoma or pancreatic cancer cells, administration of a novel monoclonal antibody specifically targeting sCD146, but not its membrane form, successfully suppresses tumor vascularization and growth. Our findings demonstrate that sCD146 secreted by CD146-positive tumors mediates important pro-angiogenic and pro-tumoral effects. Targeting sCD146 with a novel neutralizing antibody could thus constitute an innovative therapeutic strategy for the treatment of CD146-positive tumors.	[Stalin, J.; Nollet, M.; Garigue, P.; Vivancos, L.; Essaadi, A.; Muller, A.; Bachelier, R.; Foucault-Bertaud, A.; Leroyer, A. S.; Bardin, N.; Guillet, B.; Dignat-George, F.; Blot-Chabaud, M.] Aix Marseille Univ, UFR Pharm, INSERM, UMR S 1076, 27 Bd J Moulin, F-13005 Marseille, France; [Garigue, P.; Fernandez, S.; Guillet, B.] Aix Marseille Univ, CERIMED European Ctr Res Med Imaging, Marseille, France; [Fugazza, L.] Adv Accelerator Applicat SRL, Colleretto Giacosa, TO, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Blot-Chabaud, M (corresponding author), Aix Marseille Univ, UFR Pharm, INSERM, UMR S 1076, 27 Bd J Moulin, F-13005 Marseille, France.	marcel.blot-chabaud@laposte.net	Blot-Chabaud, Marcel/D-4064-2017; Bardin, Nathalie/AAL-3663-2020; DIGNAT-GEORGE, Françoise/R-1129-2016; NOLLET, MARIE/M-2752-2017; Leroyer, Aurelie S./M-4400-2016	Bardin, Nathalie/0000-0003-3680-082X; DIGNAT-GEORGE, Françoise/0000-0001-7006-4462; NOLLET, MARIE/0000-0002-9667-8216; Leroyer, Aurelie S./0000-0002-8079-7122; Stalin, Jimmy/0000-0001-8092-7057	Inserm, Aix-Marseille University; Region Provence-Alpes-Cote d'Azur; Martine Midy Fundation; FRM; ANR	Inserm, Aix-Marseille University; Region Provence-Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); Martine Midy Fundation; FRM(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR))	We thank Biocytex company (Marseille, France) for rsCD146, CD146 Elisa and S-Endo-1 antibody. We thank E Mas, G Pommier, N Alfaidy and D Lombardo for providing us with several cell lines. This study was financed by grants from Inserm, Aix-Marseille University and ANR. Jimmy Stalin was financed by grants from Region Provence-Alpes-Cote d'Azur, FRM and Martine Midy Fundation.	Anfosso F, 1998, J BIOL CHEM, V273, P26852, DOI 10.1074/jbc.273.41.26852; Anfosso F, 2001, J BIOL CHEM, V276, P1564, DOI 10.1074/jbc.M007065200; Aulakh GK, 2014, CELL TISSUE RES, V355, P375, DOI 10.1007/s00441-013-1753-0; Bardin N, 2003, THROMB HAEMOSTASIS, V90, P915, DOI 10.1160/TH02-11-0285; Bardin N, 1998, FEBS LETT, V421, P12, DOI 10.1016/S0014-5793(97)01455-5; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Bardin N, 2009, ARTERIOSCL THROM VAS, V29, P746, DOI 10.1161/ATVBAHA.108.183251; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Chen HX, 2009, NAT REV CLIN ONCOL, V6, P465, DOI 10.1038/nrclinonc.2009.94; Dagur PK, 2014, CLIN IMMUNOL, V152, P36, DOI 10.1016/j.clim.2014.01.009; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Feng G, 2012, INT UROL NEPHROL, V44, P1663, DOI 10.1007/s11255-012-0255-4; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gerber HP, 2005, CANCER RES, V65, P671; Gomes FG, 2013, LIFE SCI, V92, P101, DOI 10.1016/j.lfs.2012.10.008; Harhouri K, 2010, BLOOD, V115, P3843, DOI 10.1182/blood-2009-06-229591; Ilie M, 2014, BRIT J CANCER, V110, P1236, DOI 10.1038/bjc.2014.11; Imbert AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043752; Jiang WG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-16; Kebir A, 2010, CIRC RES, V107, P66, DOI 10.1161/CIRCRESAHA.109.213827; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Liu JW, 2008, PROSTATE, V68, P418, DOI 10.1002/pros.20709; Liu WF, 2012, INT J MOL SCI, V13, P6399, DOI 10.3390/ijms13056399; LUCA M, 1993, MELANOMA RES, V3, P35, DOI 10.1097/00008390-199304000-00006; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Maitra A, 2003, CLIN CANCER RES, V9, P5988; Mao BB, 2011, INT J BIOCHEM CELL B, V43, P1573, DOI 10.1016/j.biocel.2011.07.006; Mills L, 2002, CANCER RES, V62, P5106; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; Oka S, 2012, ANTICANCER RES, V32, P861; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Roudier E, 2009, J PHYSIOL-LONDON, V587, P4105, DOI 10.1113/jphysiol.2009.175554; Salgaller ML, 2003, CURR OPIN MOL THER, V5, P657; Satchi-Fainaro R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044395; SENGER DR, 1986, CANCER RES, V46, P5629; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; Shojaei F, 2007, CANCER J, V13, P345, DOI 10.1097/PPO.0b013e31815a7b69; Shojaei F, 2007, LAB INVEST, V87, P227, DOI 10.1038/labinvest.3700526; Stalin J, 2013, J BIOL CHEM, V288, P8991, DOI 10.1074/jbc.M112.446518; Ueno S, 2008, J CELL PHYSIOL, V217, P13, DOI 10.1002/jcp.21445; Wu GJ, 2005, J UROLOGY, V173, P1778, DOI 10.1097/01.ju.0000154643.30048.2c; Wu GJ, 2001, PROSTATE, V48, P305, DOI 10.1002/pros.1111; Yan XY, 2003, BLOOD, V102, P184, DOI 10.1182/blood-2002-04-1004; Zabouo G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2215; Zeng GF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-113; Zeng QQ, 2012, P NATL ACAD SCI USA, V109, P1127, DOI 10.1073/pnas.1111053108; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	50	30	36	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 20	2016	35	42					5489	5500		10.1038/onc.2016.83	http://dx.doi.org/10.1038/onc.2016.83			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XO	27065325				2022-12-26	WOS:000386998200004
J	Wakita, M; Edamatsu, H; Li, MZ; Emi, A; Kitazawa, S; Kataoka, T				Wakita, Masahiro; Edamatsu, Hironori; Li, Mingzhen; Emi, Aki; Kitazawa, Sohei; Kataoka, Tohru			Phospholipase C epsilon Activates Nuclear Factor-kappa B Signaling by Causing Cytoplasmic Localization of Ribosomal S6 Kinase and Facilitating Its Phosphorylation of Inhibitor kappa B in Colon Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; INDUCED INTERLEUKIN-8 PRODUCTION; PROTEIN-KINASE; CRUCIAL ROLE; NEUTROPHIL INFILTRATION; LYSOPHOSPHATIDIC ACID; MAINTENANCE THERAPY; CHEMOKINE RECEPTORS; SKIN INFLAMMATION; PLC-EPSILON	Phospholipase C epsilon (PLC epsilon), an effector of Ras and Rap small GTPases, plays a crucial role in inflammation by augmenting proinflammatory cytokine expression. This proinflammatory function of PLC epsilon is implicated in its facilitative role in tumor promotion and progression during skin and colorectal carcinogenesis, although their direct link remains to be established. Moreover, the molecular mechanism underlying these functions of PLC epsilon remains unknown except that PKD works downstream of PLC epsilon. Here we show by employing the colitis-induced colorectal carcinogenesis model, where Apc(Min/+) mice are administered with dextran sulfate sodium, that PLC epsilon knock-out alleviates the colitis and suppresses the following tumorigenesis concomitant with marked attenuation of proinflammatory cytokine expression. In human colon epithelial Caco2 cells, TNF-alpha induces sustained expression of proinflammatory molecules and sustained activation of nuclear factor-kappa B (NF-kappa B) and PKD, the late phases of which are suppressed by not only siRNA-mediated PLC epsilon knockdown but also treatment with a lysophosphatidic acid (LPA) receptor antagonist. Also, LPA stimulation induces these events in an early time course, suggesting that LPA mediates TNF-alpha signaling in an autocrine manner. Moreover, PLC epsilon knockdown results in inhibition of phosphorylation of I kappa B by ribosomal S6 kinase (RSK) but not by I kappa B kinases. Subcellular fractionation suggests that enhanced phosphorylation of a scaffolding protein, PEA15 (phosphoprotein enriched in astrocytes 15), downstream of the PLC epsilon-PKD axis causes sustained cytoplasmic localization of phosphorylated RSK, thereby facilitating I kappa B phosphorylation in the cytoplasm. These results suggest the crucial role of the TNF-alpha-LPA-LPA receptor-PLC epsilon-PKD-PEA15-RSK-I kappa B-NF-kappa B pathway in facilitating inflammation and inflammation-associated carcinogenesis in the colon.	[Wakita, Masahiro; Edamatsu, Hironori; Li, Mingzhen; Emi, Aki; Kataoka, Tohru] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan; [Kitazawa, Sohei] Ehime Univ, Grad Sch Med, Dept Mol Pathol, Toon, Ehime 7910295, Japan; [Li, Mingzhen] Beijing Ctr Phys & Chem Anal, Beijing 100089, Peoples R China	Kobe University; Ehime University	Kataoka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kataoka@people.kobe-u.ac.jp	Kitazawa, Sohei/E-5602-2010	Kitazawa, Sohei/0000-0002-7466-7356; Edamatsu, Hironori/0000-0002-1335-4217	JSPS KAKENHI [23390071, 24590379]; Global COE Program [A08]; Project for Development of Innovative Research on Cancer Therapeutics from MEXT; Grants-in-Aid for Scientific Research [26670176] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Development of Innovative Research on Cancer Therapeutics from MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants 23390071 and 24590379 and in part by Global COE Program A08 and the Project for Development of Innovative Research on Cancer Therapeutics from MEXT. The authors declare that they have no conflicts of interest with the contents of this article.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Ajuebor MN, 2002, IMMUNOLOGY, V105, P137, DOI 10.1046/j.1365-2567.2002.01309.x; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Cicalese L, 1996, TRANSPLANTATION, V62, P161, DOI 10.1097/00007890-199607270-00003; Cooper HS, 2001, GASTROENTEROLOGY, V121, P1407, DOI 10.1053/gast.2001.29609; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dudhgaonkar S. P., 2007, Inflammopharmacology, V15, P188, DOI 10.1007/s10787-007-1603-3; Dusaban SS, 2015, J BIOL CHEM, V290, P26776, DOI 10.1074/jbc.M115.676098; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Farooq SM, 2009, J PHARMACOL EXP THER, V329, P123, DOI 10.1124/jpet.108.145862; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Harada Y, 2011, BIOCHEM BIOPH RES CO, V414, P106, DOI 10.1016/j.bbrc.2011.09.032; Hu LZ, 2010, J IMMUNOL, V184, P993, DOI 10.4049/jimmunol.0901816; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; Ishikawa TO, 2011, CARCINOGENESIS, V32, P417, DOI 10.1093/carcin/bgq268; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; Kucharzik T, 2005, GUT, V54, P1565, DOI 10.1136/gut.2004.061168; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nagano T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108373; Noguchi M, 1998, GUT, V43, P203, DOI 10.1136/gut.43.2.203; Oka M, 2011, LAB INVEST, V91, P711, DOI 10.1038/labinvest.2011.10; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Pasparakis M, 2012, IMMUNOL REV, V246, P346, DOI 10.1111/j.1600-065X.2012.01109.x; Peng C, 2010, FASEB J, V24, P3490, DOI 10.1096/fj.09-151290; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tadano M, 2005, MOL CELL BIOL, V25, P2191, DOI 10.1128/MCB.25.6.2191-2199.2005; Takenaka N, 2011, EUR J IMMUNOL, V41, P202, DOI 10.1002/eji.201040675; Taylor JA, 1999, J MOL BIOL, V290, P839, DOI 10.1006/jmbi.1999.2912; Vaidyanathan H, 2003, J BIOL CHEM, V278, P32367, DOI 10.1074/jbc.M303988200; Vaidyanathan H, 2007, P NATL ACAD SCI USA, V104, P19837, DOI 10.1073/pnas.0704514104; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu DM, 2003, EUR J NEUROSCI, V17, P1571, DOI 10.1046/j.1460-9568.2003.02591.x; Wu JM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-71; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yamaguchi T, 2011, INT J ONCOL, V39, P23, DOI 10.3892/ijo.2011.1015; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhang LY, 2005, J NUTR, V135, P1752, DOI 10.1093/jn/135.7.1752	62	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12586	12600		10.1074/jbc.M116.717561	http://dx.doi.org/10.1074/jbc.M116.717561			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27053111	Green Published, hybrid			2022-12-26	WOS:000378119900016
J	Brozzi, F; Gerlo, S; Grieco, FA; Juusola, M; Balhuizen, A; Lievens, S; Gysemans, C; Bugliani, M; Mathieu, C; Marchetti, P; Tavernier, J; Eizirik, DL				Brozzi, Flora; Gerlo, Sarah; Grieco, Fabio Arturo; Juusola, Matilda; Balhuizen, Alexander; Lievens, Sam; Gysemans, Conny; Bugliani, Marco; Mathieu, Chantal; Marchetti, Piero; Tavernier, Jan; Eizirik, Decio L.			Ubiquitin D Regulates IRE1 alpha/c-Jun N-terminal Kinase (JNK) Protein-dependent Apoptosis in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; MAJOR HISTOCOMPATIBILITY COMPLEX; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; INTERFERON-GAMMA; SIGNAL-TRANSDUCTION; DIABETES-MELLITUS; GENE-EXPRESSION; CANDIDATE GENE; CYTOKINES	Pro-inflammatory cytokines contribute to pancreatic beta cell apoptosis in type 1 diabetes at least in part by inducing endoplasmic reticulum (ER) stress and the consequent unfolded protein response (UPR). It remains to be determined what causes the transition from "physiological" to "apoptotic" UPR, but accumulating evidence indicates that signaling by the ER transmembrane protein IRE1 alpha is critical for this transition. IRE1 alpha activation is regulated by both intra-ER and cytosolic cues. We evaluated the role for the presently discovered cytokine-induced and IRE1 alpha-interacting protein ubiquitin D (UBD) on the regulation of IRE1 alpha and its downstream targets. UBD was identified by use of a MAPPIT (mammalian protein-protein interaction trap)-based IRE1 alpha interactome screen followed by comparison against functional genomic analysis of human and rodent beta cells exposed to pro-inflammatory cytokines. Knockdown ofUBDin human and rodent beta cells and detailed signal transduction studies indicated that UBD modulates cytokine-induced UPR/IRE1 alpha activation and apoptosis. UBD expression is induced by the pro-inflammatory cytokines interleukin (IL)-1 beta and interferon (IFN)-gamma in rat and human pancreatic beta cells, and it is also up-regulated in beta cells of inflamed islets from non-obese diabetic mice. UBD interacts with IRE1 alpha in human and rodent beta cells, modulating IRE1 alpha-dependent activation of JNK and cytokine-induced apoptosis. Our data suggest that UBD provides a negative feedback on cytokine-induced activation of the IRE1 alpha/JNK pro-apoptotic pathway in cytokine-exposed beta cells.	[Brozzi, Flora; Grieco, Fabio Arturo; Juusola, Matilda; Balhuizen, Alexander; Eizirik, Decio L.] Univ Libre Bruxelles, Fac Med, Ctr Diabet Res, B-1070 Brussels, Belgium; [Gerlo, Sarah; Lievens, Sam; Tavernier, Jan; Eizirik, Decio L.] Flanders Interuniv Inst Biotechnol VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Gerlo, Sarah; Lievens, Sam; Tavernier, Jan] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Gysemans, Conny; Mathieu, Chantal] KULeuven, Lab Clin & Expt Endocrinol, B-3000 Leuven, Belgium; [Bugliani, Marco; Marchetti, Piero] Univ Pisa, Islet Cell Lab, Dept Clin & Expt Med, I-56126 Pisa, Italy	Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); Ghent University; KU Leuven; University of Pisa	Eizirik, DL (corresponding author), Univ Libre Bruxelles, Ctr Diabet Res, Route Lennik 808 CP618, B-1070 Brussels, Belgium.	deizirik@ulb.ac.be	mathieu, chantal/ABD-5505-2021; Tavernier, Jan/AAG-3636-2019; Bugliani, Marco/I-3168-2019; Juusola, Matilda/W-4754-2018	mathieu, chantal/0000-0002-4055-5233; Bugliani, Marco/0000-0002-1744-1561; Juusola, Matilda/0000-0002-2834-3211; gysemans, conny/0000-0003-3559-6089; Balhuizen, Alexander/0000-0001-7581-121X	Juvenile Diabetes Research Foundation International Grant [17-2013-515]; NIDDK, Human Islet Research, National Institutes of Health Network Consortium [1UC4DK104166-01]; Fund for Scientific Research Flanders (FWO) [1522313N]; European Union; Actions de Recherche Concertee de la Communaute Francaise; Fonds National de la Recherche Scientifique, Belgium; Ghent University GROUP-ID Multidisciplinary Research Platform; Katholieke Universiteit Leuven; Seventh Framework Program of the European Union NAIMIT; Innovative Medicines Initiative 2 Joint Undertaking [115797]; Union's Horizon research and innovation program; EFPIA; JDRF; The Leona M. and Harry B. Helmsley Charitable Trust; ERC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104166] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation International Grant(Juvenile Diabetes Research Foundation); NIDDK, Human Islet Research, National Institutes of Health Network Consortium; Fund for Scientific Research Flanders (FWO)(FWO); European Union(European Commission); Actions de Recherche Concertee de la Communaute Francaise; Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); Ghent University GROUP-ID Multidisciplinary Research Platform; Katholieke Universiteit Leuven(KU Leuven); Seventh Framework Program of the European Union NAIMIT; Innovative Medicines Initiative 2 Joint Undertaking; Union's Horizon research and innovation program; EFPIA; JDRF(Juvenile Diabetes Research Foundation); The Leona M. and Harry B. Helmsley Charitable Trust; ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the Juvenile Diabetes Research Foundation International Grant 17-2013-515 and NIDDK, Human Islet Research, National Institutes of Health Network Consortium Grant 1UC4DK104166-01 (to D. L. E.), the Fund for Scientific Research Flanders (FWO Grant 1522313N), European Union (Seventh Framework Projects of the European Union. NAIMIT and BetaBat), Actions de Recherche Concertee de la Communaute Francaise, and the Fonds National de la Recherche Scientifique, Belgium (to D. L. E.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Ghent University GROUP-ID Multidisciplinary Research Platform.r Supported by the Katholieke Universiteit Leuven and the Seventh Framework Program of the European Union NAIMIT.r Supported by the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement 115797 (INNODIA). This Joint Undertaking receives support from the Union's Horizon 2020 research and innovation program and "EFPIA," "JDRF," and "The Leona M. and Harry B. Helmsley Charitable Trust."r Recipient of an ERC advanced grant.	Aichem A, 2012, J CELL SCI, V125, P4576, DOI 10.1242/jcs.107789; Aly TA, 2008, DIABETES, V57, P770, DOI 10.2337/db07-0900; Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Baschal EE, 2011, J DIABETES, V3, P238, DOI 10.1111/j.1753-0407.2011.00131.x; Blankenhorn EP, 2009, DIABETES, V58, P2930, DOI 10.2337/db09-0387; Bonny C, 2000, J BIOL CHEM, V275, P16466, DOI 10.1074/jbc.M908297199; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Brozzi F, 2014, J BIOL CHEM, V289, P20677, DOI 10.1074/jbc.M114.568808; Buerger S, 2015, J IMMUNOL, V195, P4106, DOI 10.4049/jimmunol.1500592; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cardozo AK, 2001, DIABETES, V50, P909, DOI 10.2337/diabetes.50.5.909; Chen MC, 2001, DIABETOLOGIA, V44, P325, DOI 10.1007/s001250051622; Cort L, 2014, GENES IMMUN, V15, P168, DOI 10.1038/gene.2013.72; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Ebstein F, 2009, INT J BIOCHEM CELL B, V41, P1205, DOI 10.1016/j.biocel.2008.10.023; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3110pe7; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Gong PF, 2010, J AM SOC NEPHROL, V21, P316, DOI 10.1681/ASN.2009050479; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lievens S, 2012, METHODS MOL BIOL, V812, P283, DOI 10.1007/978-1-61779-455-1_17; Lievens S, 2009, J PROTEOME RES, V8, P877, DOI 10.1021/pr8005167; Lisak RP, 2011, J NEUROIMMUNOL, V238, P19, DOI 10.1016/j.jneuroim.2011.06.010; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Marroqui L, 2015, EBIOMEDICINE, V2, P378, DOI 10.1016/j.ebiom.2015.03.012; Marroqui L, 2014, DIABETES, V63, P2516, DOI 10.2337/db13-1443; Miani M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.236; Miani M, 2012, ENDOCRINOLOGY, V153, P3017, DOI 10.1210/en.2011-2090; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Ortis F, 2010, DIABETES, V59, P358, DOI 10.2337/db09-1159; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Raasi S, 1999, EUR J IMMUNOL, V29, P4030, DOI 10.1002/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schmidtke G, 2014, BBA-MOL CELL RES, V1843, P97, DOI 10.1016/j.bbamcr.2013.01.009; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Yu X, 2012, DIGEST DIS SCI, V57, P2347, DOI 10.1007/s10620-012-2189-1	61	36	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12040	12056		10.1074/jbc.M115.704619	http://dx.doi.org/10.1074/jbc.M115.704619			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27044747	Green Published, hybrid			2022-12-26	WOS:000378092800009
J	Ahmed, UK; Maller, NC; Iqbal, AJ; Al-Riyami, L; Harnett, W; Raynes, JG				Ahmed, Umul Kulthum; Maller, N. Claire; Iqbal, Asif J.; Al-Riyami, Lamyaa; Harnett, William; Raynes, John G.			The Carbohydrate-linked Phosphorylcholine of the Parasitic Nematode Product ES-62 Modulates Complement Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; N-GLYCANS; IN-VIVO; LYMPHATIC FILARIASIS; SECRETED PRODUCT; LECTIN PATHWAY; GLOBULAR HEAD; BRUGIA-MALAYI; PHOSPHOCHOLINE; GLYCOPROTEIN	Parasitic nematodes manufacture various carbohydrate-linked phosphorylcholine (PCh)-containing molecules, including ES-62, a protein with an N-linked glycan terminally substituted with PCh. The PCh component is biologically important because it is required for immunomodulatory effects. We showed that most ES-62 was bound to a single protein, C-reactive protein (CRP), in normal human serum, displaying a calcium-dependent, high-avidity interaction and ability to form large complexes. Unexpectedly, CRP binding to ES-62 failed to efficiently activate complement as far as the C3 convertase stage in comparison with PCh-BSA and PCh-containing Streptococcus pneumoniae cell wall polysaccharide. C1q capture assays demonstrated an ES-62-CRP-C1q interaction in serum. The three ligands all activated C1 and generated C4b to similar extents. However, a C2a active site was not generated following ES-62 binding to CRP, demonstrating that C2 cleavage was far less efficient for ES-62-containing complexes. Weproposed that failure of C2 cleavage was due to the flexible nature of carbohydrate-bound PCh and that reduced proximity of the C1 complex was the reason that C2 was poorly cleaved. This was confirmed using synthetic analogues that were similar to ES-62 only in respect of having a flexible PCh. Furthermore, ES-62 was shown to deplete early complement components, such as the rate-limiting C4, following CRP interaction and thereby inhibit classical pathway activation. Thus, flexible PCh-glycan represents a novel mechanism for subversion of complement activation. These data illustrate the importance of the rate-limiting C4/C2 stage of complement activation and reveal a new addition to the repertoire of ES-62 immunomodulatory mechanisms with possible therapeutic applications.	[Ahmed, Umul Kulthum; Maller, N. Claire; Iqbal, Asif J.; Raynes, John G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, Keppel St, London WC1E 7HT, England; [Al-Riyami, Lamyaa; Harnett, William] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of Strathclyde	Raynes, JG (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, Keppel St, London WC1E 7HT, England.	john.raynes@lshtm.ac.uk	Raynes, John G/G-7932-2011	Raynes, John G/0000-0002-8536-1328; Harnett, William/0000-0001-9545-9401; Iqbal, Asif/0000-0002-3224-3651	Medical Research Council (MRC); Wellcome Trust	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by a Medical Research Council (MRC) studentship.; Supported by the Wellcome Trust.	Azzimonti F, 2003, J CHROMATOGR B, V784, P33, DOI 10.1016/S1570-0232(02)00749-3; Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Bodman-Smith KB, 2002, IMMUNOLOGY, V107, P252, DOI 10.1046/j.1365-2567.2002.01481.x; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Clarke EV, 2014, J LEUKOCYTE BIOL, V96, P745, DOI 10.1189/jlb.3MR0214-109R; Culley FJ, 1996, J IMMUNOL, V156, P4691; Culley FJ, 2000, GLYCOBIOLOGY, V10, P59, DOI 10.1093/glycob/10.1.59; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Goodridge HS, 2001, J IMMUNOL, V167, P940, DOI 10.4049/jimmunol.167.2.940; Haapasalo K, 2009, INFECT IMMUN, V77, P3886, DOI 10.1128/IAI.01583-08; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Harnett MM, 2008, ANN RHEUM DIS, V67, P518, DOI 10.1136/ard.2007.073502; Harnett MM, 2010, CLIN EXP IMMUNOL, V159, P256, DOI 10.1111/j.1365-2249.2009.04064.x; Harnett W, 1999, MOL BIOCHEM PARASIT, V104, P11, DOI 10.1016/S0166-6851(99)00113-9; HARNETT W, 1993, J IMMUNOL, V151, P4829; Harnett W, 1999, IMMUNOL TODAY, V20, P125, DOI 10.1016/S0167-5699(98)01419-4; Haslam SM, 1999, J BIOL CHEM, V274, P20953, DOI 10.1074/jbc.274.30.20953; Hebecker M, 2010, MOL IMMUNOL, V47, P1347, DOI 10.1016/j.molimm.2009.12.005; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Holm L, 2012, IMMUNOBIOLOGY, V217, P256, DOI 10.1016/j.imbio.2011.07.021; Kojouharova M, 2010, MOL IMMUNOL, V47, P2154, DOI 10.1016/j.molimm.2010.05.011; Kouser L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00317; LAL RB, 1989, T ROY SOC TROP MED H, V83, P652, DOI 10.1016/0035-9203(89)90387-8; LAL RB, 1991, J CLIN IMMUNOL, V11, P46, DOI 10.1007/BF00918794; LAL RB, 1987, J IMMUNOL, V138, P3454; LOVELESS RW, 1992, EMBO J, V11, P813, DOI 10.1002/j.1460-2075.1992.tb05118.x; MAIZELS RM, 1987, PARASITE IMMUNOL, V9, P49, DOI 10.1111/j.1365-3024.1987.tb00488.x; McGrath FDG, 2006, J IMMUNOL, V176, P2950, DOI 10.4049/jimmunol.176.5.2950; McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; NIELSEN HE, 1992, APMIS, V100, P1053, DOI 10.1111/j.1699-0463.1992.tb04040.x; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Paschinger K, 2012, INT J PARASITOL, V42, P279, DOI 10.1016/j.ijpara.2012.01.002; Paschinger K, 2012, GLYCOBIOLOGY, V22, P300, DOI 10.1093/glycob/cwr149; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Poltl G, 2007, FEBS J, V274, P714, DOI 10.1111/j.1742-4658.2006.05615.x; RAO UR, 1987, IMMUNOL CELL BIOL, V65, P365, DOI 10.1038/icb.1987.41; Rawal N, 2008, J BIOL CHEM, V283, P7853, DOI 10.1074/jbc.M707591200; Simons JP, 2014, IMMUNOLOGY, V142, P414, DOI 10.1111/imm.12266; Singh SK, 2012, J BIOL CHEM, V287, P3550, DOI 10.1074/jbc.M111.310011; SUGANE K, 1983, PARASITE IMMUNOL, V5, P385, DOI 10.1111/j.1365-3024.1983.tb00754.x; SUGANE K, 1983, IMMUNOLOGY, V50, P113; Taylor K, 1997, PARASITOLOGY, V115, P297, DOI 10.1017/S0031182097001418; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Vassal-Stermann E, 2014, J IMMUNOL, V193, P5699, DOI 10.4049/jimmunol.1400127; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; Wallis R, 2007, J BIOL CHEM, V282, P7844, DOI 10.1074/jbc.M606326200; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Weinhold B, 1997, BIOCHEM J, V325, P617, DOI 10.1042/bj3250617; Wilson EH, 2003, IMMUNOLOGY, V109, P238, DOI 10.1046/j.1365-2567.2003.01661.x; Wuhrer M, 2000, BIOCHEM J, V348, P417, DOI 10.1042/0264-6021:3480417; YOUNG NM, 1978, J IMMUNOL, V121, P1893	53	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11939	11953		10.1074/jbc.M115.702746	http://dx.doi.org/10.1074/jbc.M115.702746			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27044740	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000377264800041
J	Bruijnzeel, AW; Qi, XL; Guzhva, LV; Wall, S; Deng, JV; Gold, MS; Febo, M; Setlow, B				Bruijnzeel, Adriaan W.; Qi, Xiaoli; Guzhva, Lidia V.; Wall, Shannon; Deng, Jie V.; Gold, Mark S.; Febo, Marcelo; Setlow, Barry			Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats	PLOS ONE			English	Article							CEREBELLAR CB1 RECEPTOR; PHARMACOLOGICAL-ACTIVITY; PRECIPITATED WITHDRAWAL; ENDOCANNABINOID SYSTEM; SELECTIVE ANTAGONIST; MOTOR INCOORDINATION; TOBACCO-SMOKE; OPEN-FIELD; MARIJUANA; BRAIN	Cannabis is the most widely used illicit drug in the world. Delta-9-tetrahydrocannabinol (Delta 9-THC) is the main psychoactive component of cannabis and its effects have been well-studied. However, cannabis contains many other cannabinoids that affect brain function. Therefore, these studies investigated the effect of cannabis smoke exposure on locomotor activity, rearing, anxiety-like behavior, and the development of dependence in rats. It was also investigated if cannabis smoke exposure leads to tolerance to the locomotor-suppressant effects of the endogenous cannabinoid anandamide. Cannabis smoke was generated by burning 5.7% Delta 9-THC cannabis cigarettes in a smoking machine. The effect of cannabis smoke on the behavior of rats in a small and large open field and an elevated plus maze was evaluated. Cannabis smoke exposure induced a brief increase in locomotor activity followed by a prolonged decrease in locomotor activity and rearing in the 30-min small open field test. The cannabinoid receptor type 1 (CB1) receptor antagonist rimonabant increased locomotor activity and prevented the smoke-induced decrease in rearing. Smoke exposure also increased locomotor activity in the 5-min large open field test and the elevated plus maze test. The smoke exposed rats spent more time in the center zone of the large open field, which is indicative of a decrease in anxiety-like behavior. A high dose of anandamide decreased locomotor activity and rearing in the small open field and this was not prevented by rimonabant or pre-exposure to cannabis smoke. Serum Delta 9-THC levels were 225 ng/ml after smoke exposure, which is similar to levels in humans after smoking cannabis. Exposure to cannabis smoke led to dependence as indicated by more rimonabant-precipitated somatic withdrawal signs in the cannabis smoke exposed rats than in the air-control rats. In conclusion, chronic cannabis smoke exposure in rats leads to clinically relevant Delta 9-THC levels, dependence, and has a biphasic effect on locomotor activity.	[Bruijnzeel, Adriaan W.; Qi, Xiaoli; Guzhva, Lidia V.; Wall, Shannon; Deng, Jie V.; Gold, Mark S.; Febo, Marcelo; Setlow, Barry] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Bruijnzeel, Adriaan W.; Febo, Marcelo; Setlow, Barry] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Bruijnzeel, Adriaan W.; Deng, Jie V.; Febo, Marcelo; Setlow, Barry] Univ Florida, Ctr Addict Res & Educ, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bruijnzeel, AW (corresponding author), Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA.; Bruijnzeel, AW (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.; Bruijnzeel, AW (corresponding author), Univ Florida, Ctr Addict Res & Educ, Gainesville, FL USA.	awbruijn@ufl.edu	Febo, Marcelo/G-5718-2011; Febo, Marcelo/X-6769-2019	Febo, Marcelo/0000-0001-8981-4163; Setlow, Barry/0000-0001-9133-9445; Bruijnzeel, Adriaan/0000-0001-8466-1970	University of Florida McKnight Brain Institute seed funds; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA039349] Funding Source: NIH RePORTER	University of Florida McKnight Brain Institute seed funds; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by University of Florida McKnight Brain Institute seed funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACETO MD, 1995, EUR J PHARMACOL, V282, pR1, DOI 10.1016/0014-2999(95)00447-S; Adams IB, 1998, J PHARMACOL EXP THER, V284, P1209; Agrawal A, 2009, DRUG ALCOHOL DEPEN, V99, P240, DOI 10.1016/j.drugalcdep.2008.08.007; Aguiar DC, 2009, PSYCHOPHARMACOLOGY, V205, P217, DOI 10.1007/s00213-009-1532-5; ALBONETTI ME, 1992, BEHAV PROCESS, V28, P97, DOI 10.1016/0376-6357(92)90052-F; Ashton CH, 2001, BRIT J PSYCHIAT, V178, P101, DOI 10.1192/bjp.178.2.101; Aung MM, 2000, DRUG ALCOHOL DEPEN, V60, P133, DOI 10.1016/S0376-8716(99)00152-0; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Bruijnzeel AW, 2011, PHARMACOL BIOCHEM BE, V100, P109, DOI 10.1016/j.pbb.2011.08.005; Bruijnzeel AW, 2011, BRAIN RES, V1413, P32, DOI 10.1016/j.brainres.2011.07.041; Bruijnzeel AW, 2006, BIOL PSYCHIAT, V59, P477, DOI 10.1016/j.biopsych.2005.07.020; Budney AJ, 2001, ARCH GEN PSYCHIAT, V58, P917, DOI 10.1001/archpsyc.58.10.917; Campos AC, 2009, PROG NEURO-PSYCHOPH, V33, P1517, DOI 10.1016/j.pnpbp.2009.08.017; Cohen J.E., 1988, STAT POWER ANAL BEHA; Compton DR, 1996, J PHARMACOL EXP THER, V277, P586; Costain WF, 2008, INT J MENT HEALTH NU, V17, P227, DOI 10.1111/j.1447-0349.2008.00538.x; Cota D, 2008, J NEUROENDOCRINOL, V20, P35, DOI 10.1111/j.1365-2826.2008.01673.x; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Crean RD, 2011, J ADDICT MED, V5, P1, DOI 10.1097/ADM.0b013e31820c23fa; Dar MS, 2000, BRAIN RES, V864, P186, DOI 10.1016/S0006-8993(00)02103-X; DeSanty KP, 2001, PHARMACOL BIOCHEM BE, V69, P251, DOI 10.1016/S0091-3057(01)00539-1; EDEN S, 1979, ENDOCRINOLOGY, V105, P555, DOI 10.1210/endo-105-2-555; El-Alfy AT, 2010, PHARMACOL BIOCHEM BE, V95, P434, DOI 10.1016/j.pbb.2010.03.004; Febo M, 2003, J NEUROCHEM, V86, P405, DOI 10.1046/j.1471-4159.2003.01858.x; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Freeman D, 2015, SCHIZOPHRENIA BULL, V41, P391, DOI 10.1093/schbul/sbu098; FRIDE E, 1993, EUR J PHARMACOL, V231, P313, DOI 10.1016/0014-2999(93)90468-W; GEORGE FR, 1991, PSYCHOPHARMACOLOGY, V104, P457, DOI 10.1007/BF02245649; Grant BF, 1998, J SUBST ABUSE, V10, P255, DOI 10.1016/S0899-3289(99)00006-1; Green B, 2003, DRUG ALCOHOL REV, V22, P453, DOI 10.1080/09595230310001613976; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Haney M, 1999, PSYCHOPHARMACOLOGY, V141, P395, DOI 10.1007/s002130050849; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Huestis MA, 2007, CHEM BIODIVERS, V4, P1770, DOI 10.1002/cbdv.200790152; Jarbe TUC, 2002, PHARMACOL BIOCHEM BE, V73, P911, DOI 10.1016/S0091-3057(02)00938-3; JOLLES J, 1979, BEHAV NEURAL BIOL, V25, P563, DOI 10.1016/S0163-1047(79)90362-5; Karch SB, 2006, MARIJUANA CANNABINOI; Katsidoni V, 2013, INT J NEUROPSYCHOPH, V16, P2273, DOI 10.1017/S1461145713000709; Khanolkar AD, 1996, J MED CHEM, V39, P4515, DOI 10.1021/jm960152y; KLAUSNER HA, 1971, LIFE SCI, V10, P49, DOI 10.1016/0024-3205(71)90245-1; Klenerova V, 2009, J PHYSIOL PHARMACOL, V60, P57; Lam PMW, 2005, BRIT J ANAESTH, V94, P649, DOI 10.1093/bja/aei098; Lev-Ran S, 2014, PSYCHOL MED, V44, P797, DOI 10.1017/S0033291713001438; Lichtman AH, 2002, J CLIN PHARMACOL, V42, p20S, DOI 10.1002/j.1552-4604.2002.tb05999.x; Lichtman AH, 2001, DRUG ALCOHOL DEPEN, V63, P107, DOI 10.1016/S0376-8716(00)00205-2; Liebsch G, 1998, BEHAV BRAIN RES, V94, P301, DOI 10.1016/S0166-4328(97)00198-8; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; MARTIN BR, 1991, PHARMACOL BIOCHEM BE, V40, P471, DOI 10.1016/0091-3057(91)90349-7; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; MILLER NS, 1989, J SUBST ABUSE TREAT, V6, P183, DOI 10.1016/0740-5472(89)90005-6; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Pearce DD, 2014, J ALTERN COMPLEM MED, V20, P787, DOI 10.1089/acm.2013.0190; Pickel VM, 2004, NEUROSCIENCE, V127, P101, DOI 10.1016/j.neuroscience.2004.05.015; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; PRYOR GT, 1978, PHARMACOL BIOCHEM BE, V8, P295, DOI 10.1016/0091-3057(78)90320-9; Ramesh D, 2011, ILAR J, V52, P295, DOI 10.1093/ilar.52.3.295; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; ROSENKRANTZ H, 1974, TOXICOL APPL PHARM, V28, P18, DOI 10.1016/0041-008X(74)90126-4; Rylkova D, 2009, PSYCHOPHARMACOLOGY, V203, P629, DOI 10.1007/s00213-008-1409-z; Schlosburg JE, 2009, AAPS J, V11, P342, DOI 10.1208/s12248-009-9110-7; SJODEN P-O, 1973, Pharmacology Biochemistry and Behavior, V1, P243, DOI 10.1016/0091-3057(73)90111-1; Small E, 2010, PSYCHOPHARMACOLOGY, V208, P143, DOI 10.1007/s00213-009-1716-z; SMITH PB, 1994, J PHARMACOL EXP THER, V270, P219; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; Sulcova E, 1998, PHARMACOL BIOCHEM BE, V59, P347, DOI 10.1016/S0091-3057(97)00422-X; Tallett AJ, 2007, PSYCHOPHARMACOLOGY, V195, P27, DOI 10.1007/s00213-007-0880-2; Tanda G, 2003, PSYCHOPHARMACOLOGY, V169, P115, DOI 10.1007/s00213-003-1485-z; TEAGUE SV, 1994, INHAL TOXICOL, V6, P79, DOI 10.3109/08958379409029697; TERRANOVA JP, 1995, N-S ARCH PHARMACOL, V352, P576, DOI 10.1007/BF00169393; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; TSOU K, 1995, EUR J PHARMACOL, V280, pR13, DOI 10.1016/0014-2999(95)00360-W; UNODC, UN OFF DRUGS CRIM WO; VARGA K, 1995, EUR J PHARMACOL, V278, P279, DOI 10.1016/0014-2999(95)00181-J; Varvel SA, 2005, J PHARMACOL EXP THER, V314, P329, DOI 10.1124/jpet.104.080739; Vickers SP, 2003, PSYCHOPHARMACOLOGY, V167, P103, DOI 10.1007/s00213-002-1384-8; WEINBERG AD, 1977, TOXICOL APPL PHARM, V42, P301, DOI 10.1016/0041-008X(77)90006-0; Wiley JL, 2003, EUR J PHARMACOL, V471, P185, DOI 10.1016/S0014-2999(03)01856-9; Wilson DM, 2006, PHARMACOL BIOCHEM BE, V85, P105, DOI 10.1016/j.pbb.2006.07.018; World Health Organization United Nations Office on Drugs and Crime, 2020, EXECUTIVE SUMMARY; Yamada H, 2010, PHARMACOL BIOCHEM BE, V95, P401, DOI 10.1016/j.pbb.2010.02.018	84	45	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153327	10.1371/journal.pone.0153327	http://dx.doi.org/10.1371/journal.pone.0153327			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065006	Green Submitted, Green Published, gold			2022-12-26	WOS:000373891000046
J	Hudson, LE; McDermott, CD; Stewart, TP; Hudson, WH; Rios, D; Fasken, MB; Corbett, AH; Lamb, TJ				Hudson, Lauren E.; McDermott, Courtney D.; Stewart, Taryn P.; Hudson, William H.; Rios, Daniel; Fasken, Milo B.; Corbett, Anita H.; Lamb, Tracey J.			Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; SMALL-INTESTINE; WALL; RESPONSES; ANTIGEN; STIMULATION; PREVENTION; DELIVERY	The probiotic yeast Saccharomyces boulardii has been shown to ameliorate disease severity in the context of many infectious and inflammatory conditions. However, use of S. boulardii as a prophylactic agent or therapeutic delivery vector would require delivery of S. boulardii to a healthy, uninflamed intestine. In contrast to inflamed mucosal tissue, the diverse microbiota, intact epithelial barrier, and fewer inflammatory immune cells within the healthy intestine may all limit the degree to which S. boulardii contacts and influences the host mucosal immune system. Understanding the nature of these interactions is crucial for application of S. boulardii as a prophylactic agent or therapeutic delivery vehicle. In this study, we explore both intrinsic and immunomodulatory properties of S. boulardii in the healthy mucosal immune system. Genomic sequencing and morphological analysis of S. boulardii reveals changes in cell wall components compared to non-probiotic S. cerevisiae that may partially account for probiotic functions of S. boulardii. Flow cytometry and immunohistochemistry demonstrate limited S. boulardii association with murine Peyer's patches. We also show that although S. boulardii induces a systemic humoral immune response, this response is small in magnitude and not directed against S. boulardii itself. RNA-seq of the draining mesenteric lymph nodes indicates that even repeated administration of S. boulardii induces few transcriptional changes in the healthy intestine. Together these data strongly suggest that interaction between S. boulardii and the mucosal immune system in the healthy intestine is limited, with important implications for future work examining S. boulardii as a prophylactic agent and therapeutic delivery vehicle.	[Hudson, Lauren E.; McDermott, Courtney D.; Stewart, Taryn P.; Lamb, Tracey J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Hudson, William H.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Rios, Daniel] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Fasken, Milo B.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Lamb, TJ (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA.	tracey.j.lamb@emory.edu	Corbett, Anita/AAH-6106-2021; Hudson, William/E-6622-2012; Fasken, Milo/K-2177-2019	Corbett, Anita/0000-0002-0461-6895; Hudson, William/0000-0002-2513-1213; Fasken, Milo/0000-0003-4317-7909	NIAID [DP2AI112242]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI112242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIAID (DP2AI112242), https://www.niaid.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Hong Yi and Dr. Liz Wright of the Emory University Robert P. Apkarian Integrated Electron Microscopy Core for their assistance and expertise in imaging. We would also like to thank Aaron Rae of the Emory University Pediatric Research Flow Cytometry Core for technical assistance and advice. We also thank the Emory University Integrated Genomics Core for assistance in sequencing the S. boulardii genome, and the Huntsman Cancer Institute Genomics Core for expertise in RNA sequencing. We thank Dr. Ifor Williams for helpful discussion and assistance in analyzing histology samples, Dr. Caline Matar for kind assistance in flow cytometry analysis, and Moon Young Lee for technical assistance. This work was funded by NIAID (DP2AI112242).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bonaccorsi I, 2016, IMMUNOL LETT, V170, P95, DOI 10.1016/j.imlet.2015.11.008; BUTS JP, 1986, PEDIATR RES, V20, P192, DOI 10.1203/00006450-198602000-00020; BUTS JP, 1990, DIGEST DIS SCI, V35, P251, DOI 10.1007/BF01536771; CASTEX F, 1990, J GEN MICROBIOL, V136, P1085, DOI 10.1099/00221287-136-6-1085; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; De Jesus M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091002; De Smet R, 2013, J CONTROL RELEASE, V172, P671, DOI 10.1016/j.jconrel.2013.09.007; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Everard A, 2014, MBIO, V5, DOI 10.1128/mBio.01011-14; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Goldenberg JZ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004827.pub4; Hamedi Hassan, 2013, Avicenna Journal of Medical Biotechnology, V5, P29; Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507; Huang HB, 2010, MBIO, V1, DOI 10.1128/mBio.00164-10; Hudson LE, 2016, JOVE-J VIS EXP, DOI 10.3791/53453; Hudson LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112660; Jahn HU, 1996, DIGESTION, V57, P95, DOI 10.1159/000201320; Jawhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040648; Khatri I, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-30; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SH, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.165; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Letscher-Bru V, 2003, J ANTIMICROB CHEMOTH, V51, P513, DOI 10.1093/jac/dkg117; Levitz SM, 2009, CURR FUNGAL INFECT R, V3, P179, DOI 10.1007/s12281-009-0023-9; Lin CPC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003700; Lo DD, 2013, EXPERT OPIN DRUG DEL, V10, P157, DOI 10.1517/17425247.2013.740008; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manzi A, 2001, Curr Protoc Mol Biol, VChapter 17, DOI 10.1002/0471142727.mb1709s32; Martins FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008925; Matar CG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004858; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; McFarland LV, 1996, CLIN INFECT DIS, V22, P200, DOI 10.1093/clinids/22.1.200; Michael S, 2013, INFLAMM BOWEL DIS, V19, P185, DOI 10.1002/ibd.23006; MUTHUKUMAR G, 1993, J BACTERIOL, V175, P386, DOI 10.1128/JB.175.2.386-394.1993; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Perez-Garcia LA, 2012, GLYCOBIOLOGY, V1, P1, DOI [10.4172/jgb.1000102, DOI 10.4172/JGB.1000102]; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pothoulakis C, 2009, ALIMENT PHARM THER, V30, P826, DOI 10.1111/j.1365-2036.2009.04102.x; Qamar A, 2001, INFECT IMMUN, P69, DOI [10.1128/IAI.69.4.2762, DOI 10.1128/IAI.69.4.2762]; Rodrigues ACP, 2000, J APPL MICROBIOL, V89, P404, DOI 10.1046/j.1365-2672.2000.01128.x; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Santos B, 2000, MOL BIOL CELL, V11, P435, DOI 10.1091/mbc.11.2.435; Schulz O, 2013, TRENDS IMMUNOL, V34, P155, DOI 10.1016/j.it.2012.09.006; Shakweh Monjed, 2004, Expert Opin Drug Deliv, V1, P141, DOI 10.1517/17425247.1.1.141; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; Stack HM, 2010, APPL ENVIRON MICROB, V76, P500, DOI 10.1128/AEM.01524-09; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Walter J, 2003, APPL ENVIRON MICROB, V69, P2044, DOI 10.1128/AEM.69.4.2044-2051.2003	57	41	43	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153351	10.1371/journal.pone.0153351	http://dx.doi.org/10.1371/journal.pone.0153351			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064405	Green Submitted, Green Published, gold			2022-12-26	WOS:000373891000050
J	Balakrishnan, A; Stykel, MG; Touahri, Y; Stratton, JA; Biernaskie, J; Schuurmans, C				Balakrishnan, Anjali; Stykel, Morgan G.; Touahri, Yacine; Stratton, Jo Anne; Biernaskie, Jeff; Schuurmans, Carol			Temporal Analysis of Gene Expression in the Murine Schwann Cell Lineage and the Acutely Injured Postnatal Nerve	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX10; NEURAL CREST DEVELOPMENT; STEM-CELLS; GLIAL-CELLS; PERIPHERAL-NERVE; C-JUN; EMBRYONIC-DEVELOPMENT; MYELIN MAINTENANCE; REGULATORY NETWORK; FACTOR ERM	Schwann cells (SCs) arise from neural crest cells (NCCs) that first give rise to SC precursors (SCPs), followed by immature SCs, pro-myelinating SCs, and finally, non-myelinating or myelinating SCs. After nerve injury, mature SCs 'de-differentiate', downregulating their myelination program while transiently re-activating early glial lineage genes. To better understand molecular parallels between developing and de-differentiated SCs, we characterized the expression profiles of a panel of 12 transcription factors from the onset of NCC migration through postnatal stages, as well as after acute nerve injury. Using Sox10 as a pan-glial marker in co-expression studies, the earliest transcription factors expressed in E9.0 Sox10(+) NCCs were Sox9, Pax3, AP2a and Nfatc4. E10.5 Sox10(+) NCCs coalescing in the dorsal root ganglia differed slightly, expressing Sox9, Pax3, AP2a and Etv5. E12.5 SCPs continued to express Sox10, Sox9, AP2 alpha and Pax3, as well as initiating Sox2 and Egr1 expression. E14.5 immature SCs were similar to SCPs, except that they lost Pax3 expression. By E18.5, AP2 alpha, Sox2 and Egr1 expression was turned off in the nerve, while Jun, Oct6 and Yy1 expression was initiated in pro-myelinating Sox9(+)/Sox10(+) SCs. Early postnatal and adult SCs continued to express Sox9, Jun, Oct6 and Yy1 and initiated Nfatc4 and Egr2 expression. Notably, at all stages, expression of each marker was observed only in a subset of Sox10(+) SCs, highlighting the heterogeneity of the SC pool. Following acute nerve injury, Egr1, Jun, Oct6, and Sox2 expression was upregulated, Egr2 expression was downregulated, while Sox9, Yy1, and Nfatc4 expression was maintained at similar frequencies. Notably, de-differentiated SCs in the injured nerve did not display a transcription factor profile corresponding to a specific stage in the SC lineage. Taken together, we demonstrate that uninjured and injured SCs are heterogeneous and distinct from one another, and de-differentiation recapitulates transcriptional aspects of several different embryonic stages.	[Balakrishnan, Anjali; Touahri, Yacine; Schuurmans, Carol] Univ Calgary, Alberta Childrens Hosp, Dept Biochem & Mol Biol, Cumming Sch Med,Res Inst, Calgary, AB T2N 4N1, Canada; [Balakrishnan, Anjali; Stykel, Morgan G.; Touahri, Yacine; Stratton, Jo Anne; Biernaskie, Jeff; Schuurmans, Carol] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Stykel, Morgan G.; Touahri, Yacine; Stratton, Jo Anne; Biernaskie, Jeff] Univ Calgary, Alberta Childrens Hosp, Dept Comparat Biol & Expt Med, Fac Vet Med,Res Inst, Calgary, AB T2N 4N1, Canada; [Stratton, Jo Anne] Univ Calgary, Alberta Childrens Hosp, Dept Clin Neurosci, Cumming Sch Med,Res Inst, Calgary, AB T2N 4N1, Canada	Alberta Childrens Hospital; University of Calgary; University of Calgary; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary	Schuurmans, C (corresponding author), Univ Calgary, Alberta Childrens Hosp, Dept Biochem & Mol Biol, Cumming Sch Med,Res Inst, Calgary, AB T2N 4N1, Canada.; Biernaskie, J; Schuurmans, C (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada.; Biernaskie, J (corresponding author), Univ Calgary, Alberta Childrens Hosp, Dept Comparat Biol & Expt Med, Fac Vet Med,Res Inst, Calgary, AB T2N 4N1, Canada.	jabierna@ucalgary.ca; cschuurm@ucalgary.ca		Stykel, Morgan/0000-0002-4799-4220; Schuurmans, Carol/0000-0003-3567-0058; Stratton, Jo/0000-0002-1205-1353	Alberta Innovates Health Solutions [201200859]; Alberta Innovates [201200859] Funding Source: researchfish	Alberta Innovates Health Solutions; Alberta Innovates	This work was supported by Alberta Innovates Health Solutions Grant #: 201200859 (http://www.aihealthsolutions.ca/) to JB and CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Adameyko I, 2010, CELL MOL LIFE SCI, V67, P3037, DOI 10.1007/s00018-010-0390-y; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Arroyo EJ, 1998, J NEUROSCI, V18, P7891; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Blake JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059184; Blanchard AD, 1996, J NEUROSCI RES, V46, P630, DOI 10.1002/(SICI)1097-4547(19961201)46:5<630::AID-JNR11>3.0.CO;2-0; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Bremer M, 2011, GLIA, V59, P1022, DOI 10.1002/glia.21173; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Buchstaller J, 2004, J NEUROSCI, V24, P2357, DOI 10.1523/JNEUROSCI.4083-03.2004; Chen Y, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-9; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; D'Antonio M, 2006, GLIA, V53, P501, DOI 10.1002/glia.20309; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Feltri ML, 2016, NEUROSCIENTIST, V22, P252, DOI 10.1177/1073858415572361; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; FU SY, 1995, J NEUROSCI, V15, P3886; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Gao XG, 2007, MOL CELL NEUROSCI, V36, P501, DOI 10.1016/j.mcn.2007.08.013; Ghazvini M, 2002, EMBO J, V21, P4612, DOI 10.1093/emboj/cdf475; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Goethals S, 2010, GLIA, V58, P1701, DOI 10.1002/glia.21041; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Hagedorn L, 2000, DEV BIOL, V219, P44, DOI 10.1006/dbio.1999.9595; He Y, 2010, NAT NEUROSCI, V13, P1472, DOI 10.1038/nn.2686; Jagalur NB, 2011, J NEUROSCI, V31, P8585, DOI 10.1523/JNEUROSCI.0659-11.2011; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Jessen KR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020487; Jones EA, 2007, NEURON GLIA BIOL, V3, P377, DOI 10.1017/S1740925X08000173; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Kawasaki T, 2003, ACTA NEUROPATHOL, V105, P203, DOI 10.1007/s00401-002-0630-9; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kioke T, 2014, HISTOCHEM CELL BIOL, V141, P301, DOI 10.1007/s00418-013-1158-x; KIOUSSI C, 1995, NEURON, V15, P553, DOI 10.1016/0896-6273(95)90144-2; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Le Douarin M.L., 1999, NEURAL CREST; Le Douarin NM, 2003, CURR OPIN GENET DEV, V13, P529, DOI 10.1016/j.gde.2003.08.002; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Meier C, 1999, J NEUROSCI, V19, P3847; Miller SJ, 2009, EMBO MOL MED, V1, P236, DOI 10.1002/emmm.200900027; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Monk KR, 2015, GLIA, V63, P1376, DOI 10.1002/glia.22852; Nakazaki H, 2009, INT J DEV BIOL, V53, P69, DOI 10.1387/ijdb.082682hn; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Pannese E, 2010, NEURON GLIA BIOL, V6, P3, DOI 10.1017/S1740925X10000037; Paratore C, 2002, DEV BIOL, V250, P168, DOI 10.1006/dbio.2002.0795; Paratore C, 2001, DEVELOPMENT, V128, P3949; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Pham K, 2009, NEUROSCI LETT, V465, P194, DOI 10.1016/j.neulet.2009.09.014; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Ryu EJ, 2007, J NEUROSCI, V27, P11552, DOI 10.1523/JNEUROSCI.5497-06.2007; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Spokony RF, 2002, DEVELOPMENT, V129, P421; Stewart HJS, 2001, EUR J NEUROSCI, V14, P363, DOI 10.1046/j.0953-816x.2001.01650.x; Stoll G, 1999, BRAIN PATHOL, V9, P313; Stratton JA, 2016, EUR J NEUROSCI, V43, P365, DOI 10.1111/ejn.13006; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; Touahri Yacine, 2015, Curr Protoc Neurosci, V70, DOI 10.1002/0471142301.ns0122s70; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wakamatsu Y, 2004, DEV DYNAM, V229, P74, DOI 10.1002/dvdy.10498; Wang JJ, 2014, DIAM RELAT MATER, V43, P43, DOI 10.1016/j.diamond.2014.01.007; WHITE FV, 1989, J NEUROCHEM, V52, P1085, DOI 10.1111/j.1471-4159.1989.tb01851.x; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323	76	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153256	10.1371/journal.pone.0153256	http://dx.doi.org/10.1371/journal.pone.0153256			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058953	Green Published, gold			2022-12-26	WOS:000373604800026
J	Huang, YN; Amin, A; Qin, Y; Wang, ZY; Jiang, HD; Liang, L; Shi, LJ; Liang, C				Huang, Yining; Amin, Aftab; Qin, Yan; Wang, Ziyi; Jiang, Huadong; Liang, Lu; Shi, Linjing; Liang, Chun			A Role of hIPI3 in DNA Replication Licensing in Human Cells	PLOS ONE			English	Article							ORIGIN RECOGNITION COMPLEX; LAMIN B2 ORIGIN; SACCHAROMYCES-CEREVISIAE; RIBOSOME BIOGENESIS; INITIATION PROTEINS; MCM COMPLEX; CHROMATIN; SUBUNITS; BINDING; YEAST	The yeast Ipi3p is required for DNA replication and cell viability in Sacharomyces cerevisiae. It is an essential component of the Rix1 complex (Rix1p/Ipi2p-Ipi1p-Ipi3p) that is required for the processing of 35S pre-rRNA in pre-60S ribosomal particles and for the initiation of DNA replication. The human IPI3 homolog is WDR18 (WD repeat domain 18), which shares significant homology with yIpi3p. Here we report that knockdown of hIPI3 resulted in substantial defects in the chromatin association of the MCM complex, DNA replication, cell cycle progression and cell proliferation. Importantly, hIPI3 silencing did not result in a reduction of the protein level of hCDC6, hMCM7, or the ectopically expressed GFP protein, indicating that protein synthesis was not defective in the same time frame of the DNA replication and cell cycle defects. Furthermore, the mRNA and protein levels of hIPI3 fluctuate in the cell cycle, with the highest levels from M phase to early G1 phase, similar to other pre-replicative (preRC) proteins. Moreover, hIPI3 interacts with other replication-initiation proteins, co-localizes with hMCM7 in the nucleus, and is important for the nuclear localization of hMCM7. We also found that hIPI3 preferentially binds to the origins of DNA replication including those at the cMyc, Lamin-B2 and beta-Globin loci. These results indicate that hIPI3 is involved in human DNA replication licensing independent of its role in ribosome biogenesis.	[Huang, Yining; Wang, Ziyi; Liang, Chun] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Peoples R China; [Huang, Yining; Amin, Aftab; Qin, Yan; Wang, Ziyi; Jiang, Huadong; Liang, Lu; Shi, Linjing; Liang, Chun] Hong Kong Univ Sci & Technol, Div Life Sci, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Huang, Yining; Amin, Aftab; Qin, Yan; Wang, Ziyi; Jiang, Huadong; Liang, Lu; Shi, Linjing; Liang, Chun] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China; [Huang, Yining; Wang, Ziyi; Liang, Chun] HKUST Fok Ying Tung Res Inst, Guangzhou, Guangdong, Peoples R China; [Liang, Chun] Intelgen Ltd, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Liang, C (corresponding author), Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Peoples R China.; Liang, C (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China.; Liang, C (corresponding author), Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China.; Liang, C (corresponding author), Intelgen Ltd, Hong Kong, Hong Kong, Peoples R China.	bccliang@ust.hk		Amin, Aftab/0000-0003-3285-3422; HUANG, Yining/0000-0001-6370-5559; Shi, Linjing/0000-0002-3851-968X	Shenzhen Dept. of Science and Information [JCYJ20130329110752138]; Hong Kong Research Grants Council [GRF661508]; National Natural Science Foundation of China [31171282]; Center for Nasopharyngeal Carcinoma Research, Hong Kong [AoE/M-06/08]; Intelgen (HK) Limited	Shenzhen Dept. of Science and Information; Hong Kong Research Grants Council(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Nasopharyngeal Carcinoma Research, Hong Kong; Intelgen (HK) Limited	This work was supported by the Shenzhen Dept. of Science and Information (JCYJ20130329110752138 to CL), Hong Kong Research Grants Council (GRF661508 to CL), National Natural Science Foundation of China (31171282 to CL), Center for Nasopharyngeal Carcinoma Research, Hong Kong (AoE/M-06/08), and Intelgen (HK) Limited.	Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Aladjem MI, 2004, FRONT BIOSCI-LANDMRK, V9, P2540, DOI 10.2741/1415; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Bryant JA, 2011, ANN BOT-LONDON, V107, P1119, DOI 10.1093/aob/mcr075; Castle CD, 2012, MOL BIOL CELL, V23, P716, DOI 10.1091/mbc.E11-06-0530; Chen XM, 2013, NUCLEIC ACIDS RES, V41, P6460, DOI 10.1093/nar/gkt368; Chen ZQ, 2008, P NATL ACAD SCI USA, V105, P10326, DOI 10.1073/pnas.0803829105; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Eward KL, 2004, J CELL SCI, V117, P5875, DOI 10.1242/jcs.01503; Fanis P, 2012, MOL CELL PROTEOMICS, V11, P1263, DOI 10.1074/mcp.M112.017194; Feng DR, 2003, CANCER RES, V63, P7356; Fragkos M, 2015, NAT REV MOL CELL BIO, V16, P360, DOI 10.1038/nrm4002; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Galani K, 2004, J BIOL CHEM, V279, P55411, DOI 10.1074/jbc.M406876200; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Harlow Ed, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4531; Huo L, 2012, CELL CYCLE, V11, P1325, DOI 10.4161/cc.19709; Kan JS, 2008, J BIOL CHEM, V283, P33803, DOI 10.1074/jbc.C800182200; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Leonard AC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010116; Matsuda K, 2007, FEMS YEAST RES, V7, P1263, DOI 10.1111/j.1567-1364.2007.00298.x; Mechali M, 2001, NAT REV GENET, V2, P640, DOI 10.1038/35084598; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Nissan TA, 2004, MOL CELL, V15, P295, DOI 10.1016/j.molcel.2004.06.033; Rajewska M, 2012, FEMS MICROBIOL REV, V36, P408, DOI 10.1111/j.1574-6976.2011.00300.x; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Shen Z, 2010, MOL CELL, V40, P99, DOI 10.1016/j.molcel.2010.09.021; Swarnalatha M, 2012, NUCLEIC ACIDS RES, V40, P9021, DOI 10.1093/nar/gks617; van Betteraey-Nikoleit M, 2003, EUR J BIOCHEM, V270, P3880, DOI 10.1046/j.1432-1033.2003.03769.x; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Wu RT, 2012, J CELL SCI, V125, P209, DOI 10.1242/jcs.094169; Yoshida K, 2004, ONCOGENE, V23, P3802, DOI 10.1038/sj.onc.1207488; Yu ZL, 2004, J MOL BIOL, V340, P1197, DOI 10.1016/j.jmb.2004.05.024; Zhai Y., 2011, FUNDAMENTAL ASPECTS; Zhai YL, 2010, J CELL SCI, V123, P3933, DOI 10.1242/jcs.075366; Zhang JJ, 2010, CELL CYCLE, V9, P4848, DOI 10.4161/cc.9.24.14136; Zhang X, 2014, MOL CANCER RES, V12, P1535, DOI 10.1158/1541-7786.MCR-13-0641	37	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0151803	10.1371/journal.pone.0151803	http://dx.doi.org/10.1371/journal.pone.0151803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27057756	Green Published, Green Submitted, gold			2022-12-26	WOS:000373604800003
J	Alari-Pahissa, E; Grandclement, C; Jeevan-Raj, B; Leclercq, G; Veillette, A; Held, W				Alari-Pahissa, Elisenda; Grandclement, Camille; Jeevan-Raj, Beena; Leclercq, Georges; Veillette, Andre; Held, Werner			Activation by SLAM Family Receptors Contributes to NK Cell Mediated "Missing-Self" Recognition	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; H-2-DEFICIENT LYMPHOMA VARIANTS; HEMATOPOIETIC-CELLS; GRAFT-REJECTION; BONE-MARROW; TOLERANCE; EXPRESSION; SURVEILLANCE; ENGAGEMENT; TRANSGENE	Natural Killer (NK) cells attack normal hematopoietic cells that do not express inhibitory MHC class I (MHC-I) molecules, but the ligands that activate NK cells remain incompletely defined. Here we show that the expression of the Signaling Lymphocyte Activation Molecule (SLAM) family members CD48 and Ly9 (CD229) by MHC-I-deficient tumor cells significantly contributes to NK cell activation. When NK cells develop in the presence of T cells or B cells that lack inhibitory MHC-I but express activating CD48 and Ly9 ligands, the NK cells' ability to respond to MHC-I-deficient tumor cells is severely compromised. In this situation, NK cells express normal levels of the corresponding activation receptors 2B4 (CD244) and Ly9 but these receptors are non-functional. This provides a partial explanation for the tolerance of NK cells to MHC-I-deficient cells in vivo. Activating signaling via 2B4 is restored when MHC-I-deficient T cells are removed, indicating that interactions with MHC-I-deficient T cells dominantly, but not permanently, impair the function of the 2B4 NK cell activation receptor. These data identify an important role of SLAM family receptors for NK cell mediated "missing-self" reactivity and suggest that NK cell tolerance in MHC-I mosaic mice is in part explained by an acquired dysfunction of SLAM family receptors.	[Alari-Pahissa, Elisenda; Grandclement, Camille; Jeevan-Raj, Beena; Held, Werner] Univ Lausanne, Dept Oncol, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland; [Leclercq, Georges] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ, Canada	University of Lausanne; Ghent University; McGill University	Held, W (corresponding author), Univ Lausanne, Dept Oncol, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland.	Werner.Held@unil.ch	Leclercq, Georges/H-9659-2017	Leclercq, Georges/0000-0002-1691-5294	Scheizerischer Nationalfonds [310030_159598]; Krensliga Schweiz [KFS-02736-02-2011]	Scheizerischer Nationalfonds; Krensliga Schweiz	This work was supported by 1. Scheizerischer Nationalfonds (www.snf.ch/) to WH, 310030_159598; and 2. Krensliga Schweiz (http://www.krebsliga.ch/de/fachpersonen/forschung/) to WH, KFS-02736-02-2011.	Bessoles S, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00349; Bessoles S, 2013, J IMMUNOL, V191, P5044, DOI 10.4049/jimmunol.1301971; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Coudert JD, 2008, BLOOD, V111, P3571, DOI 10.1182/blood-2007-07-100057; Cruz-Munoz ME, 2009, NAT IMMUNOL, V10, P297, DOI 10.1038/ni.1693; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Guia S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001608; HOGLUND P, 1991, P NATL ACAD SCI USA, V88, P10332, DOI 10.1073/pnas.88.22.10332; Ioannidis V, 2001, J IMMUNOL, V167, P6256, DOI 10.4049/jimmunol.167.11.6256; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim TJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07157; Lee KM, 2006, BLOOD, V107, P3181, DOI 10.1182/blood-2005-01-0185; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sun JC, 2008, J EXP MED, V205, P1819, DOI 10.1084/jem.20072448; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Van Beneden K, 2001, J IMMUNOL, V166, P4302, DOI 10.4049/jimmunol.166.7.4302; Veillette A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002469; ZIJLSTRA M, 1992, J EXP MED, V175, P885, DOI 10.1084/jem.175.4.885	30	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153236	10.1371/journal.pone.0153236	http://dx.doi.org/10.1371/journal.pone.0153236			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054584	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000108
J	Hu, WL; Zhang, X; Wang, B; Liu, JQ; Duan, HL; Dai, N; Si, JM				Hu, Weiling; Zhang, Xu; Wang, Bin; Liu, Jiquan; Duan, Huilong; Dai, Ning; Si, Jianmin			Homographic Patch Feature Transform: A Robustness Registration for Gastroscopic Surgery	PLOS ONE			English	Article							ENDOSCOPIC IMAGES; SEQUENCES; SYSTEM; SCALE; SITE	Image registration is a key component of computer assistance in image guided surgery, and it is a challenging topic in endoscopic environments. In this study, we present a method for image registration named Homographic Patch Feature Transform (HPFT) to match gastroscopic images. HPFT can be used for tracking lesions and augmenting reality applications during gastroscopy. Furthermore, an overall evaluation scheme is proposed to validate the precision, robustness and uniformity of the registration results, which provides a standard for rejection of false matching pairs from corresponding results. Finally, HPFT is applied for processing in vivo gastroscopic data. The experimental results show that HPFT has stable performance in gastroscopic applications.	[Hu, Weiling; Dai, Ning; Si, Jianmin] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Weiling; Dai, Ning; Si, Jianmin] Zhejiang Univ, Inst Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xu; Wang, Bin; Liu, Jiquan; Duan, Huilong] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xu; Wang, Bin; Liu, Jiquan; Duan, Huilong] Zhejiang Univ, Minist Educ, Key Lab Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Si, JM (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.; Si, JM (corresponding author), Zhejiang Univ, Inst Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.; Liu, JQ (corresponding author), Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310003, Zhejiang, Peoples R China.; Liu, JQ (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China.	liujq@zju.edu.cn; jianmin_si@zju.edu.cn		hu, weiling/0000-0002-8602-4665	Zhejiang province key science and technology innovation team [2013TD13]; Natural Science Foundation of Zhejiang Province [LY14H160029]; National Natural Science Foundation of China [31470955]	Zhejiang province key science and technology innovation team; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	1. Zhejiang province key science and technology innovation team (2013TD13) (http://www.zjkjt.gov.cn/). 2. Natural Science Foundation of Zhejiang Province (LY14H160029) (http://www.zjnsf.gov.cn/). 3. the National Natural Science Foundation of China (No. 31470955) (http://www.nsfc.gov.cn/).	Allain B, 2012, MED IMAGE ANAL, V16, P482, DOI 10.1016/j.media.2011.11.005; [Anonymous], 2011, HAMLYN CTR LAPAROSCO; [Anonymous], 2009, FEATURE DETECTORS DE; Atasoy S, 2009, LECT NOTES COMPUT SC, V5761, P499, DOI 10.1007/978-3-642-04268-3_62; Bai WJ, 2011, IEEE T MED IMAGING, V30, P351, DOI 10.1109/TMI.2010.2078514; BROWN DC, 1971, PHOTOGRAMM ENG, V37, P855; Burschka D, 2005, MED IMAGE ANAL, V9, P413, DOI 10.1016/j.media.2005.05.005; Chum O, 2005, COMPUT VIS IMAGE UND, V97, P86, DOI 10.1016/j.cviu.2004.03.004; Crum W., 2014, BRIT J RADIOLOGY; Feuerstein M, 2008, IEEE T MED IMAGING, V27, P355, DOI 10.1109/TMI.2007.907327; Hu MX, 2008, LECT NOTES COMPUT SC, V5241, P720; Kalal Zdenek, 2010, PATT REC ICPR 2010 2; Leitner R, 2013, PATTERN RECOGN LETT, V34, P85, DOI 10.1016/j.patrec.2012.07.020; Liu JQ, 2014, BIO-MED MATER ENG, V24, P2673, DOI 10.3233/BME-141084; LIU JQ, 2015, BIOMEDICAL ENG IEEE, V62, P2296; Luong QT, 1996, INT J COMPUT VISION, V17, P43, DOI 10.1007/BF00127818; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Mikolajczyk K, 2004, INT J COMPUT VISION, V60, P63, DOI 10.1023/B:VISI.0000027790.02288.f2; Miranda-Luna R, 2008, IEEE T BIO-MED ENG, V55, P541, DOI 10.1109/TBME.2007.903520; Oliveira FPM, 2014, COMPUT METHOD BIOMEC, V17, P73, DOI 10.1080/10255842.2012.670855; Oliveira FPM, 2013, MED BIOL ENG COMPUT, V51, P267, DOI 10.1007/s11517-012-0988-3; Puerto-Souza GA, 2013, IEEE T MED IMAGING, V32, P1201, DOI 10.1109/TMI.2013.2239306; Selka F, 2012, MED IMAGE UNDERSTAND, P249; Sotiras A, 2013, IEEE T MED IMAGING, V32, P1153, DOI 10.1109/TMI.2013.2265603; Sun DY, 2013, LECT NOTES COMPUT SC, V8090, P127, DOI 10.1007/978-3-642-40843-4_14; Sun DY, 2012, J MED SYST, V36, P2909, DOI 10.1007/s10916-011-9769-z; Tavares JMRS, 2014, LECT NOTES COMPUT SC, V8887, P21, DOI 10.1007/978-3-319-14249-4_3; Wang B, 2014, COMP MATH MATH PHYS, V2014, P1; Wang B, 2014, J MED IMAG HEALTH IN, V4, P797, DOI 10.1166/jmihi.2014.1323; Wang XW, 2010, IEEE T MED IMAGING, V29, P1213, DOI 10.1109/TMI.2009.2028341; Ye ML, 2013, LECT NOTES COMPUT SC, V8150, P67, DOI 10.1007/978-3-642-40763-5_9; Zhang LB, 2013, PROC SPIE, V8878, DOI 10.1117/12.2030818; Zhang Z, 1999, COMP VIS 1999 P 7 IE; Zhang ZY, 1998, INT J COMPUT VISION, V27, P161, DOI 10.1023/A:1007941100561; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	35	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153202	10.1371/journal.pone.0153202	http://dx.doi.org/10.1371/journal.pone.0153202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054567	Green Published, gold, Green Submitted			2022-12-26	WOS:000373608000100
J	Meng, YF; Zhang, C; Yi, J; Zhou, ZJ; Fa, ZZ; Zhao, JY; Yang, YL; Fang, W; Wang, Y; Liao, WQ				Meng, Yunfang; Zhang, Chao; Yi, Jiu; Zhou, Zhaojing; Fa, Zhenzong; Zhao, Jingyu; Yang, Yali; Fang, Wei; Wang, Yan; Liao, Wan-qing			Deubiquitinase Ubp5 Is Required for the Growth and Pathogenicity of Cryptococcus gattii	PLOS ONE			English	Article							FUNGAL PATHOGEN; SACCHAROMYCES-CEREVISIAE; UBIQUITIN HOMEOSTASIS; SIGNALING PATHWAYS; CANDIDA-ALBICANS; VANCOUVER-ISLAND; NEOFORMANS; VIRULENCE; YEAST; GENE	Cryptococcus gattii is a resurgent fungal pathogen that primarily infects immunocompetent hosts. Thus, it poses an increasingly significant impact on global public health; however, the mechanisms underlying its pathogenesis remain largely unknown. We conducted a detailed characterization of the deubiquitinase Ubp5 in the biology and virulence of C. gattii using the hypervirulent strain R265, and defined its properties as either distinctive or shared with C. neoformans. Deletion of the C. gattii Ubp5 protein by site-directed disruption resulted in a severe growth defect under both normal and stressful conditions (such as high temperature, high salt, cell wall damaging agents, and antifungal agents), similar to the effects observed in C. neoformans. However, unlike C. neoformans, the C. gattii ubp5 Delta mutant displayed a slight enhancement of capsule and melanin production, indicating the evolutionary convergence and divergence of Ubp5 between these two sibling species. Attenuated virulence of the Cg-ubp5. mutant was not solely due to its reduced thermotolerance at 37 degrees C, as shown in both worm and mouse survival assays. In addition, the assessment of fungal burden in mammalian organs further indicated that Ubp5 was required for C. gattii pulmonary survival and, consequently, extrapulmonary dissemination. Taken together, our work highlights the importance of deubiquitinase Ubp5 in the virulence composite of both pathogenic cryptococcal species, and it facilitates a better understanding of C. gattii virulence mechanisms.	[Meng, Yunfang; Liao, Wan-qing] Second Mil Med Univ, Shanghai Inst Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China; [Zhang, Chao; Yi, Jiu; Zhou, Zhaojing; Fa, Zhenzong; Yang, Yali; Fang, Wei] Changzheng Hosp, Dept Dermatol & Venereol, PLA Key Lab Mycosis, Shanghai, Peoples R China; [Zhao, Jingyu] Shanghai Dermatol Hosp, Shanghai, Peoples R China; [Wang, Yan] Second Mil Med Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Meng, Yunfang] Shandong Univ, Shandong Prov Hosp, Dept Dermatol, Jinan 250100, Shandong, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Liao, WQ (corresponding author), Second Mil Med Univ, Shanghai Inst Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China.; Fang, W (corresponding author), Changzheng Hosp, Dept Dermatol & Venereol, PLA Key Lab Mycosis, Shanghai, Peoples R China.	weifang081782@163.com; liaowanqing@sohu.com	Lang, Ming/HIK-0758-2022; Yang, Ya-Li/GYU-4320-2022; yang, yang/HGT-7999-2022		National Key Basic Research Programs of China [2013CB531601]; Shanghai Municipal Natural Science Foundation [12JC1411000, 12ZR1454400, 14495800500]; National Natural Science Foundation of China [81401651, 81471926, 31170139]; Shanghai Key Laboratory of Molecular Medical Mycology [14DZ2272900]	National Key Basic Research Programs of China(National Basic Research Program of China); Shanghai Municipal Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Molecular Medical Mycology	This study was supported by the National Key Basic Research Programs of China (2013CB531601, WL), the Shanghai Municipal Natural Science Foundation (12JC1411000, 12ZR1454400 and 14495800500, WF), the National Natural Science Foundation of China (81401651, 81471926 and 31170139, WL), and Shanghai Key Laboratory of Molecular Medical Mycology (14DZ2272900, WL).	Alby K, 2011, P NATL ACAD SCI USA, V108, P2510, DOI 10.1073/pnas.1017234108; Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Bahn YS, 2013, EUKARYOT CELL, V12, P1564, DOI 10.1128/EC.00218-13; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; Bozza WP, 2011, BIOCHEMISTRY-US, V50, P6423, DOI 10.1021/bi200529z; Brouwer Annemarie E, 2007, J Infect, V54, pe165, DOI 10.1016/j.jinf.2006.10.002; Byrnes EJ, 2011, MICROBES INFECT, V13, P895, DOI 10.1016/j.micinf.2011.05.009; Chaturvedi V, 2011, TRENDS MICROBIOL, V19, P564, DOI 10.1016/j.tim.2011.07.010; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Cheon KW, 2006, INT J ONCOL, V28, P1209; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Coelho C, 2014, ANNU REV PATHOL-MECH, V9, P219, DOI 10.1146/annurev-pathol-012513-104653; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; DONG ZM, 1995, INFECT IMMUN, V63, P2632, DOI 10.1128/IAI.63.7.2632-2644.1995; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; Enyenihi AH, 2003, GENETICS, V163, P47; Fang W, 2015, FUNGAL GENET BIOL, V78, P7, DOI 10.1016/j.fgb.2014.10.017; Fang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038326; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Fonseca FL, 2009, EUKARYOT CELL, V8, P1543, DOI 10.1128/EC.00142-09; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Gutteridge A, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-68; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Hu GG, 2006, CURR GENET, V49, P341, DOI 10.1007/s00294-005-0054-x; Kahana A, 2001, BIOCHEM BIOPH RES CO, V282, P916, DOI 10.1006/bbrc.2001.4669; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Ko YJ, 2009, EUKARYOT CELL, V8, P1197, DOI 10.1128/EC.00120-09; Komada Masayuki, 2008, Curr Drug Discov Technol, V5, P78, DOI 10.2174/157016308783769469; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; Kronstad J, 2012, EUKARYOT CELL, V11, P109, DOI 10.1128/EC.05273-11; Leach MD, 2011, MOL MICROBIOL, V79, P1574, DOI 10.1111/j.1365-2958.2011.07542.x; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; Ma HS, 2009, ADV APPL MICROBIOL, V67, P131, DOI 10.1016/S0065-2164(08)01005-8; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Narasipura SD, 2003, MOL MICROBIOL, V47, P1681, DOI 10.1046/j.1365-2958.2003.03393.x; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; Nicholson Benjamin, 2007, Future Oncol, V3, P191, DOI 10.2217/14796694.3.2.191; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; Park YD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004037; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Petzold EW, 2006, INFECT IMMUN, V74, P5877, DOI 10.1128/IAI.00624-06; Ramanathan Arvind, 2007, J Biol, V6, P3, DOI 10.1186/jbiol56; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Sato N, 2003, MOL CELL BIOL, V23, P6662, DOI 10.1128/MCB.23.18.6662-6671.2003; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Springer DJ, 2010, EMERG INFECT DIS, V16, P14, DOI 10.3201/eid1601.090369; Upadhya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055110; Vidotto Valerio, 2004, Revista Iberoamericana de Micologia, V21, P87; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005	56	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153219	10.1371/journal.pone.0153219	http://dx.doi.org/10.1371/journal.pone.0153219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049762	gold, Green Published, Green Submitted			2022-12-26	WOS:000373603500112
J	Oga, EA; Schumaker, LM; Alabi, BS; Obaseki, D; Umana, A; Bassey, IA; Ebughe, G; Oluwole, O; Akeredolu, T; Adebamowo, SN; Dakum, P; Cullen, K; Adebamowo, CA				Oga, Emmanuel A.; Schumaker, Lisa M.; Alabi, Biodun Sulyman; Obaseki, Darlington; Umana, Aniefon; Bassey, Ima-Abasi; Ebughe, Godwin; Oluwole, Olabode; Akeredolu, Teniola; Adebamowo, Sally N.; Dakum, Patrick; Cullen, Kevin; Adebamowo, Clement A.			Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; PAPILLOMAVIRUS-ASSOCIATED HEAD; INCIDENCE TRENDS; ORAL SEX; PREVALENCE; INFECTION; ADOLESCENTS; SMOKING; IMPACT; TUMORS	Introduction The burden of HPV-related Head and Neck Cancers (HNC) has been rising in the U.S. and other developed countries but this trend has not been reported in Africa. Objective of study was to evaluate the prevalence of HPV infection in HNC cancer cases seen between 1990 and 2011 at the tertiary health care institutions in Nigeria. Methods We retrieved 149 head and neck cancer formalin fixed, paraffin embedded tumor specimens diagnosed between 1990 and 2011 from four teaching hospitals in Nigeria. One hundred and twenty-three blocks (83%) contained appropriate HNC for analysis while DNA extraction was successful in 60% (90/149). PCR amplification was successful in 33% (49/149) and Linear Array genotyping for HPV was successful in 11% (17/149) of these cases. These were in tumors from the larynx (6), cervical lymph nodes (3), nasal cavity (2), parotid (1), palate (1), maxillary sinus (1) and mandible (1). Two cases were non-specific and none were from the oropharynx. Histologically, 41% (7/17) of the successfully genotyped blocks were squamous cell carcinomas (larynx 6, maxillary sinus 1). Results and Conclusion We were unable to detect HPV in any of the HNC samples in our study. Our result may suggest that there is a low prevalence of HPV-related HNC among the adult population in Nigeria. Our results provide a benchmark to compare future incidence of HPV-related HNC in this community in future. We had significant analytical challenges from possible poor tissue processing and urge that future studies should prospectively collect samples and ensure high quality sample processing.	[Oga, Emmanuel A.; Adebamowo, Clement A.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Oga, Emmanuel A.; Akeredolu, Teniola; Adebamowo, Sally N.; Dakum, Patrick; Adebamowo, Clement A.] Inst Human Virol Nigeria, Off Res Training & Strateg Informat, Abuja, Fct, Nigeria; [Schumaker, Lisa M.; Cullen, Kevin; Adebamowo, Clement A.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Alabi, Biodun Sulyman] Univ Ilorin Teaching Hosp, Dept Ear Nose & Throat Head & Neck Surg, Ilorin, Kwara State, Nigeria; [Obaseki, Darlington] Univ Benin Teaching Hosp, Benin, Edo State, Nigeria; [Umana, Aniefon; Bassey, Ima-Abasi; Ebughe, Godwin] Univ Calabar Teaching Hosp, Calabar, Cross River Sta, Nigeria; [Oluwole, Olabode] Univ Abuja Teaching Hosp, Abuja, Fct, Nigeria; [Adebamowo, Sally N.; Adebamowo, Clement A.] Harvard Univ, Dept Nutr, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Adebamowo, Sally N.] NHGRI, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Ilorin; University of Benin; University of Calabar; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Oga, EA (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.; Oga, EA (corresponding author), Inst Human Virol Nigeria, Off Res Training & Strateg Informat, Abuja, Fct, Nigeria.	eoga@umaryland.edu	Adebamowo, Clement/C-8778-2011; Oga, Emmanuel/P-5899-2018	Adebamowo, Clement/0000-0002-6571-2880; Oga, Emmanuel/0000-0002-0744-5681; Ebughe, Godwin/0000-0002-3744-5690; Adebamowo, Sally/0000-0003-4713-2433	NCI/NIH [D43CA153792-01]; NATIONAL CANCER INSTITUTE [D43CA153792] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006947] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The project described was supported by Grant Number D43CA153792-01 (PI - Adebamowo) from the NCI/NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.	Adeyi A, 2011, PAN AFR MED J, V10; Bamidele James Olusegun, 2009, Int J Adolesc Med Health, V21, P387, DOI 10.1515/IJAMH.2009.21.3.387; Beachler DC, 2015, AM J EPIDEMIOL, V181, P40, DOI 10.1093/aje/kwu247; Betiol J, 2013, BRAZ J MED BIOL RES, V46, P217, DOI 10.1590/1414-431X20132703; Boscolo-Rizzo P, 2013, ACTA OTORHINOLARYNGO, V33, P77; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Boy S, 2006, J ORAL PATHOL MED, V35, P86, DOI 10.1111/j.1600-0714.2006.00385.x; Braakhuis BJM, 2009, EUR J CANCER, V45, P2935, DOI 10.1016/j.ejca.2009.08.018; Chai RC, 2015, CANCER MED-US, V4, P596, DOI 10.1002/cam4.424; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Cherie A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-5; Chernock RD, 2011, ARCH OTOLARYNGOL, V137, P163, DOI 10.1001/archoto.2010.246; Colevas AD, 2014, HEAD NECK-J SCI SPEC, V36, P34, DOI 10.1002/hed.23253; D'Souza G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086023; da Lilly-Tariah OB, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-14; Dareng EO, 2016, EPIDEMIOL INFECT, V144, P123, DOI 10.1017/S0950268815000965; Diaz EM, 2003, HOLLAND FREI CANC ME; Ferlay J., 2013, IARC CANCERBASE; Friedman JM, 2014, WORLD J CLIN ONCOL, V5, P781, DOI 10.5306/wjco.v5.i4.781; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Haraf DJ, 1996, CLIN CANCER RES, V2, P755; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer, 2007, HUM PAP, Vviii; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji XM, 2009, CANCER-AM CANCER SOC, V115, P1660, DOI 10.1002/cncr.24184; Joseph AW, 2012, OTOLARYNG CLIN N AM, V45, P739, DOI 10.1016/j.otc.2012.04.003; Kazaura MR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-373; Kerwin JT, 2014, INT J SEX HEALTH, V26, P66, DOI 10.1080/19317611.2013.830671; Kreimer AR, 2013, LANCET, V382, P877, DOI 10.1016/S0140-6736(13)60809-0; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lajer CB, 2010, APMIS, V118, P510, DOI 10.1111/j.1600-0463.2010.02624.x; Leichliter JS, 2007, J INFECT DIS, V196, P1852, DOI 10.1086/522867; Licitra L, 2008, HEMATOL ONCOL CLIN N, V22, P1143, DOI 10.1016/j.hoc.2008.10.002; Marron M, 2010, INT J EPIDEMIOL, V39, P182, DOI 10.1093/ije/dyp291; MASHBERG A, 1993, CANCER-AM CANCER SOC, V72, P1369, DOI 10.1002/1097-0142(19930815)72:4<1369::AID-CNCR2820720436>3.0.CO;2-L; Monk BJ, 2007, GYNECOL ONCOL, V107, pS6, DOI 10.1016/j.ygyno.2007.07.076; Ndiaye C, 2014, LANCET ONCOL, V15, P1319, DOI 10.1016/S1470-2045(14)70471-1; Ndiaye C, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-14; Nwawolo C C, 2001, West Afr J Med, V20, P111; Ologe FE, 2005, TROP DOCT, V35, P2, DOI 10.1258/0049475053001949; Otoh E C, 2004, West Afr J Med, V23, P305; Paquette C, 2013, HEAD NECK PATHOL, V7, P361, DOI 10.1007/s12105-013-0453-0; Psyrri A, 2009, CURR OPIN ONCOL, V21, P201, DOI 10.1097/CCO.0b013e328329ab64; Rettig E, 2015, EXPERT REV ANTICANC, V15, P35, DOI 10.1586/14737140.2015.957189; Sanders AE, 2012, ORAL DIS, V18, P430, DOI 10.1111/j.1601-0825.2011.01892.x; Schlecht NF, 2011, MODERN PATHOL, V24, P1295, DOI 10.1038/modpathol.2011.91; Settle K, 2009, CANCER PREV RES, V2, P776, DOI 10.1158/1940-6207.CAPR-09-0149; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Stenson KM, 2014, EPIDEMIOLOGY RISK FA; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Tribius S, 2013, DTSCH ARZTEBL INT, V110, P184, DOI 10.3238/arztebl.2013.0184; Van Rensburg EJ, 1995, DETECTION HUMAN PAPI; vanRensburg EJ, 1996, ANTICANCER RES, V16, P969; Wang XHI, 2012, ANN DIAGN PATHOL, V16, P7, DOI 10.1016/j.anndiagpath.2011.07.003; Weinberger PM, 2010, LARYNGOSCOPE, V120, P1531, DOI 10.1002/lary.20984	54	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152828	10.1371/journal.pone.0152828	http://dx.doi.org/10.1371/journal.pone.0152828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050815	Green Published, Green Submitted, gold			2022-12-26	WOS:000373603500057
J	van der Graaf-van Bloois, L; Miller, WG; Yee, E; Gorkiewicz, G; Forbes, KJ; Zomer, AL; Wagenaar, JA; Duim, B				van der Graaf-van Bloois, Linda; Miller, William G.; Yee, Emma; Gorkiewicz, Gregor; Forbes, Ken J.; Zomer, Aldert L.; Wagenaar, Jaap A.; Duim, Birgitta			Campylobacter fetus Subspecies Contain Conserved Type IV Secretion Systems on Multiple Genomic Islands and Plasmids	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; PATHOGENICITY ISLAND; HELICOBACTER-PYLORI; SERUM-RESISTANCE; INFECTIONS; VIRULENCE; PATHOGENESIS; PROTEINS; HUMANS; CAG	The features contributing to differences in pathogenicity of the Campylobacter fetus subspecies are unknown. Putative factors involved in pathogenesis are located in genomic islands that encode a type IV secretion system (T4SS) and fic domain (filamentation induced by cyclic AMP) proteins, which may disrupt host cell processes. In the genomes of 27 C. fetus strains, three phylogenetically-different T4SS-encoding regions (T4SSs) were identified: one was located in both the chromosome and in extra-chromosomal plasmids; one was located exclusively in the chromosome; and one exclusively in extra-chromosomal plasmids. We observed that C. fetus strains can contain multiple T4SSs and that homologous T4SSs can be present both in chromosomal genomic islands (GI) and on plasmids in the C. fetus strains. The GIs of the chromosomally located T4SS differed mainly by the presence of fic genes, insertion sequence elements and phage-related or hypothetical proteins. Comparative analysis showed that T4SS sequences, inserted in the same locations, were conserved in the studied C. fetus genomes. Using phylogenetic analysis of the T4SSs, it was shown that C. fetus may have acquired the T4SS regions from other Campylobacter species by horizontal gene transfer. The identified T4SSs and fic genes were found in Cff and Cfv strains, although the presence of T4SSs and fic genes were significantly associated with Cfv strains. The T4SSs and fic genes could not be associated with S-layer serotypes or geographical origin of the strains.	[van der Graaf-van Bloois, Linda; Zomer, Aldert L.; Wagenaar, Jaap A.; Duim, Birgitta] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [van der Graaf-van Bloois, Linda; Zomer, Aldert L.; Wagenaar, Jaap A.; Duim, Birgitta] WHO Collaborating Ctr Campylobacter OIE Reference, Utrecht, Netherlands; [Miller, William G.; Yee, Emma] ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA; [Gorkiewicz, Gregor] Med Univ Graz, Inst Pathol, Graz, Austria; [Forbes, Ken J.] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Wagenaar, Jaap A.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands	Utrecht University; United States Department of Agriculture (USDA); Medical University of Graz; University of Aberdeen; Wageningen University & Research	Duim, B (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.; Duim, B (corresponding author), WHO Collaborating Ctr Campylobacter OIE Reference, Utrecht, Netherlands.	B.Duim@uu.nl	Gorkiewicz, Gregor/ABF-1602-2021	Gorkiewicz, Gregor/0000-0003-1149-4782; van der Graaf-van Bloois, Linda/0000-0001-8181-3393; Zomer, Aldert/0000-0002-0758-5190				Abril C, 2010, ANTIMICROB AGENTS CH, V54, P3052, DOI 10.1128/AAC.00304-10; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; AltMorbe J, 1996, J BACTERIOL, V178, P4248, DOI 10.1128/jb.178.14.4248-4257.1996; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; BLASER MJ, 1987, J INFECT DIS, V155, P696, DOI 10.1093/infdis/155.4.696; BLASER MJ, 1993, AM J MED SCI, V306, P325, DOI 10.1097/00000441-199311000-00011; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Dekeyser J, 1984, CAMPYLOBACTER INFECT, P181; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fitzgerald C, 2014, INT J SYST EVOL MICR, V64, P2944, DOI 10.1099/ijs.0.057778-0; Gilbert MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101599; Gorkiewicz G, 2010, J BACTERIOL, V192, P502, DOI 10.1128/JB.00803-09; Hofreuter D, 2002, J BACTERIOL, V184, P2755, DOI 10.1128/JB.184.10.2755-2766.2002; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kienesberger S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085491; Kienesberger S, 2011, J BACTERIOL, V193, P744, DOI 10.1128/JB.00798-10; Moolhuijzen PM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-86; On SLW, 2001, J APPL MICROBIOL, V90, P285, DOI 10.1046/j.1365-2672.2001.01247.x; Pearson BM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01056-13; PEI ZH, 1990, J CLIN INVEST, V85, P1036, DOI 10.1172/JCI114533; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Thompson SA, 2000, CAMPYLOBACTER, P321; Tu ZC, 2005, J CLIN MICROBIOL, V43, P3334, DOI 10.1128/JCM.43.7.3334-3340.2005; van Bergen MAP, 2005, J CLIN MICROBIOL, V43, P5888, DOI 10.1128/JCM.43.12.5888-5898.2005; van der Graaf-van Bloois L, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01246-13; van der Graaf-van Bloois L, 2014, J CLIN MICROBIOL, V52, P4183, DOI 10.1128/JCM.01837-14; VERON M, 1973, INT J SYST BACTERIOL, V23, P122, DOI 10.1099/00207713-23-2-122; Wagenaar JA, 2014, CLIN INFECT DIS, V58, P1579, DOI 10.1093/cid/ciu085; Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16; WESLEY IV, 1989, AM J VET RES, V50, P807; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008	33	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152832	10.1371/journal.pone.0152832	http://dx.doi.org/10.1371/journal.pone.0152832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049518	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500059
J	Yum, HR; Park, SH; Park, HYL; Shin, SY				Yum, Hae Ri; Park, Shin Hae; Park, Hae-Young Lopilly; Shin, Sun Young			Macular Ganglion Cell Analysis Determined by Cirrus HD Optical Coherence Tomography for Early Detecting Chiasmal Compression	PLOS ONE			English	Article							NERVE-FIBER LAYER; VISUAL-FIELD SENSITIVITY; NORMAL-PRESSURE GLAUCOMA; BAND ATROPHY; PREPERIMETRIC GLAUCOMA; THICKNESS; DISK; ABILITY; SCANS; OCT	Purpose To evaluate the performance of macular ganglion cell-inner plexiform layer (mGCIPL) measurement with Cirrus high-definition (HD) optical coherence tomography (OCT) for early detection of optic chiasmal compression. Methods Forty-six eyes of 46 patients with optic chiasmal compression caused by a pituitary adenoma (PA group), 31 eyes of 31 patients with normal tension glaucoma (NTG group), and 32 eyes of 32 normal participants (control group) were enrolled. The PA group was subdivided into two subgroups, which comprised patients with temporal visual field (VF) defects (perimetric PA group, 34 eyes) and without VF defect (preperimetric PA group, 12 eyes). The mGCIPL thickness and circumpapillary retinal nerve fiber layer (cpRNFL) thickness were measured using Cirrus HD-OCT. We calculated the number of patients who had an abnormal GCA sector map, defined as at least one yellow or red sector. Results Eyes in the perimetric PA group had significantly decreased mGCIPL thickness in all sectors. Eyes in the preperimetric PA group had significantly thinner mGCIPL in the superior, superonasal, inferonasal, and inferior sectors than eyes in control group, but no changes in cpRNFL parameters were observed. The mGCIPL thickness in inferonasal area showed the greatest AUC value (0.965), followed by the superonasal area (0.958) for discriminating preperimetric PA group from the control group. A higher reduction rate of mGCIPL thickness was noted in the nasal sector compared to other sectors, which was irrespective of temporal visual field defects. The mGCIPL thickness maps showed superonasal (P = 0.003) and inferonasal thinning in the PA group (P = 0.003), while inferotemporal thinning was revealed in the NTG group (P = 0.001). Conclusions Macular GCIPL thickness parameters obtained with the Cirrus HD-OCT were useful in early detection of chiasmal compression and differentiating from NTG by characteristic nasal mGCIPL thinning.	[Yum, Hae Ri] Konyang Univ, Konyang Univ Hosp, Dept Ophthalmol, Coll Med, Daejeon, South Korea; [Park, Shin Hae; Park, Hae-Young Lopilly; Shin, Sun Young] Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea	Konyang University; Konyang University Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Shin, SY (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea.	eyeshin@catholic.ac.kr						Ahmed IIK, 2002, J GLAUCOMA, V11, P279, DOI 10.1097/00061198-200208000-00002; Ajtony C, 2007, INVEST OPHTH VIS SCI, V48, P258, DOI 10.1167/iovs.06-0410; Asrani S, 2003, J GLAUCOMA, V12, P119, DOI 10.1097/00061198-200304000-00006; Begum VU, 2014, INVEST OPHTH VIS SCI, V55, P4768, DOI 10.1167/iovs.14-14598; Choi YJ, 2013, INVEST OPHTH VIS SCI, V54, P2296, DOI 10.1167/iovs.12-10530; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Danesh-Meyer HV, 2008, INVEST OPHTH VIS SCI, V49, P1879, DOI 10.1167/iovs.07-1127; Danesh-Meyer HV, 2006, INVEST OPHTH VIS SCI, V47, P4827, DOI 10.1167/iovs.06-0327; Drummond Suzannah R., 2010, International Ophthalmology, V30, P215, DOI 10.1007/s10792-009-9308-9; Greenfield D S, 1999, Semin Ophthalmol, V14, P95, DOI 10.3109/08820539909056069; Greenfield DS, 1998, OPHTHALMOLOGY, V105, P1866, DOI 10.1016/S0161-6420(98)91031-4; HITCHINGS RA, 1977, BRIT J OPHTHALMOL, V61, P107, DOI 10.1136/bjo.61.2.107; HITCHINGS RA, 1976, BRIT J OPHTHALMOL, V60, P778, DOI 10.1136/bjo.60.11.778; HOYT W. F., 1962, BULL JOHNS HOPKINS HOSP, V111, P57; HOYT WF, 1963, ARCH OPHTHALMOL-CHIC, V70, P69, DOI 10.1001/archopht.1963.00960050071013; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jacob M, 2009, AM J OPHTHALMOL, V147, P64, DOI 10.1016/j.ajo.2008.07.016; KALENAK JW, 1992, J CLIN NEURO-OPHTHAL, V12, P230; Kanamori A, 2004, OPHTHALMOLOGY, V111, P2278, DOI 10.1016/j.ophtha.2004.05.035; Kanamori A, 2013, GRAEF ARCH CLIN EXP, V251, P591, DOI 10.1007/s00417-012-2096-3; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim MJ, 2014, INVEST OPHTH VIS SCI, V55, P2079, DOI 10.1167/iovs.13-13506; Kotowski J, 2012, BRIT J OPHTHALMOL, V96, P1420, DOI 10.1136/bjophthalmol-2011-301021; Monteiro MLR, 2007, AM J OPHTHALMOL, V143, P896, DOI 10.1016/j.ajo.2006.11.054; Monteiro MLR, 2014, INVEST OPHTH VIS SCI, V55, P3328, DOI 10.1167/iovs.14-14118; Monteiro MLR, 2004, BRIT J OPHTHALMOL, V88, P896, DOI 10.1136/bjo.2003.038489; Moura FC, 2007, OPHTHALMOLOGY, V114, P175, DOI 10.1016/j.ophtha.2006.06.045; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; Na JH, 2012, INVEST OPHTH VIS SCI, V53, P3817, DOI 10.1167/iovs.11-9369; Nouri-Mahdavi K, 2013, AM J OPHTHALMOL, V156, P1297, DOI 10.1016/j.ajo.2013.08.001; OH JY, 2008, ASIAN J OPHTHALMOL, V10, P364; Qu YZ, 2011, ACTA OPHTHALMOL, V89, pE428, DOI 10.1111/j.1755-3768.2011.02118.x; Shin HY, 2014, GRAEF ARCH CLIN EXP, V252, P1501, DOI 10.1007/s00417-014-2706-3; Stewart W, 1992, J GLAUCOMA, V1, P27, DOI DOI 10.1097/00061198-199204000-00007; Sung MS, 2014, J GLAUCOMA, V23, pE144, DOI 10.1097/IJG.0000000000000028; SWARTZ NG, 1993, SEMIN ULTRASOUND CT, V14, P206, DOI 10.1016/S0887-2171(05)80081-2; Takayama K, 2012, INVEST OPHTH VIS SCI, V53, P6904, DOI 10.1167/iovs.12-10210; TROBE JD, 1980, ARCH OPHTHALMOL-CHIC, V98, P1046; UNSOLD R, 1980, ARCH OPHTHALMOL-CHIC, V98, P1637, DOI 10.1001/archopht.1980.01020040489020; WYBAR K, 1977, P ROY SOC MED, V70, P307, DOI 10.1177/003591577707000505; Yamashita T, 2012, JPN J OPHTHALMOL, V56, P502, DOI 10.1007/s10384-012-0146-3	42	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153064	10.1371/journal.pone.0153064	http://dx.doi.org/10.1371/journal.pone.0153064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049647	Green Submitted, Green Published, gold			2022-12-26	WOS:000373603500094
J	Toren, P; Kim, S; Johnson, F; Zoubeidi, A				Toren, Paul; Kim, Soojin; Johnson, Fraser; Zoubeidi, Amina			Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer	PLOS ONE			English	Article							PROTEIN-KINASE KINASE; GROWTH IN-VITRO; ANDROGEN RECEPTOR; CASTRATION-RESISTANT; MOUSE MODEL; PHASE-II; PROGRESSION; PI3K/AKT/MTOR; ACTIVATION; INHIBITION	Despite recent improvements in patient outcomes using newer androgen receptor (AR) pathway inhibitors, treatment resistance in castrate resistant prostate cancer (CRPC) continues to remain a clinical problem. Co-targeting alternate resistance pathways are of significant interest to treat CRPC and delay the onset of resistance. Both the AKT and MEK signaling pathways become activated as prostate cancer develops resistance to AR-targeted therapies. This pre-clinical study explores co-targeting these pathways in AR-positive prostate cancer models. Using various in vitro models of prostate cancer disease states including androgen dependent (LNCaP), CRPC (V16D and 22RV1) and ENZ-resistant prostate cancer (MR49C and MR49F), we evaluate the relevance of targeting both AKT and MEK pathways. Our data reveal that AKT inhibition induces apoptosis and inhibits cell growth in PTEN null cell lines independently of their sensitivity to hormone therapy; however, AKT inhibition had no effect on the PTEN positive 22RV1 cell line. Interestingly, we found that MEK inhibition had greater effect on 22RV1 cells compared to LNCaP, V16D or ENZ-resistant cells MR49C and MR49F cells. In vitro, combination AKT and MEK blockade had evidence of synergy observed in some cell lines and assays, but this was not consistent across all results. In vivo, the combination of AKT and MEK inhibition resulted in more consistent tumor growth inhibition of MR49F xenografts and longer disease specific survival compared to AKT inhibitor monotherapy. As in our in vitro study, 22RV1 xenografts were more resistant to AKT inhibition while they were more sensitive to MEK inhibition. Our results suggest that targeting AKT and MEK in combination may be a valuable strategy in prostate cancer when both pathways are activated and further support the importance of characterizing the dominant oncogenic pathway in each patient's tumor in order to select optimal therapy.	[Toren, Paul; Kim, Soojin; Johnson, Fraser; Zoubeidi, Amina] Univ British Columbia, Fac Med, Dept Urol Sci, Vancouver Prostate Ctr, Vancouver, BC, Canada	University of British Columbia	Zoubeidi, A (corresponding author), Univ British Columbia, Fac Med, Dept Urol Sci, Vancouver Prostate Ctr, Vancouver, BC, Canada.	azoubeidi@prostatecentre.com		Toren, Paul/0000-0002-5762-5787	Prostate Cancer Canada; AstraZeneca; Canadian Urological Association Scholarship Foundation; Discovery Grant	Prostate Cancer Canada; AstraZeneca(AstraZeneca); Canadian Urological Association Scholarship Foundation; Discovery Grant	Funding was provided by Discovery Grant, Prostate Cancer Canada and AstraZeneca to A. Zoubeidi. PT was supported by the Canadian Urological Association Scholarship Foundation. AstraZeneca was involved in discussions regarding the study design and review of the manuscript, but the data collection and analysis and decision to publish was made by the authors. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Discovery Grant, Prostate Cancer Canada. We would like to thank Dr Barry Davies (AstraZeneca) for providing AZD5363 and selumetinib, and for helpful discussions. AZD5363 was discovered by AstraZeneca subsequent to a collaboration with Astex Therapeutics (and its collaboration with the Institute of Cancer Research and Cancer Research Technology Limited). We also thank Virginia Yago, Darrell Trendall, and Mary Bowden for their technical assistance.	Abreu-Martin MT, 1999, MOL CELL BIOL, V19, P5143; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chee KG, 2007, CLIN GENITOURIN CANC, V5, P433, DOI 10.3816/CGC.2007.n.031; Cirone P, 2014, CANCER CHEMOTH PHARM, V73, P525, DOI 10.1007/s00280-014-2376-1; Clark DE, 2005, CANCER RES, V65, P3108; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Drake JM, 2013, P NATL ACAD SCI USA, V110, pE4762, DOI 10.1073/pnas.1319948110; Ewald F, 2014, INVEST NEW DRUG, V32, P1144, DOI 10.1007/s10637-014-0149-7; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Georgi B, 2014, INT J ONCOL, V45, P1337, DOI 10.3892/ijo.2014.2567; Gioeli D, 2005, CLIN SCI, V108, P293, DOI 10.1042/CS20040329; Gioeli D, 1999, CANCER RES, V59, P279; HSIEH JT, 1993, CANCER RES, V53, P2852; Huggins C, 1941, CANCER RES, V1, P293; Kandil E, 2013, J SURG RES, V184, P898, DOI 10.1016/j.jss.2013.03.052; Karantanos T, 2015, EUR UROL, V67, P470, DOI 10.1016/j.eururo.2014.09.049; Kharaziha P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.1; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Kuruma H, 2013, MOL CANCER THER, V12, P567, DOI 10.1158/1535-7163.MCT-12-0798; Lamoureux F, 2013, CLIN CANCER RES, V19, P833, DOI 10.1158/1078-0432.CCR-12-3114; Lee JT, 2008, CELL CYCLE, V7, P631, DOI 10.4161/cc.7.5.5416; Liu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108780; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Loriot Y, 2012, UROL CLIN N AM, V39, P517, DOI 10.1016/j.ucl.2012.07.008; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Matsumoto H, 2013, CANCER RES, V73, P5206, DOI 10.1158/0008-5472.CAN-13-0359; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Park H, 2015, PROSTATE, V75, P1747, DOI 10.1002/pros.23057; Pitts TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113037; Posadas EM, 2005, CANCER BIOL THER, V4, P1133, DOI 10.4161/cbt.4.10.2064; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Toren P, 2015, EUR UROL, V67, P986, DOI 10.1016/j.eururo.2014.08.006; Toren PJ, 2015, MOL CANCER THER, V14, P59, DOI 10.1158/1535-7163.MCT-14-0521; Toulany M, 2013, CANC BIOL THER, V15; Watson AL, 2014, ONCOTARGET, V5, P1502, DOI 10.18632/oncotarget.1609; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Zardan A, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.30; Zoubeidi A, 2010, CANCER RES, V70, P2307, DOI 10.1158/0008-5472.CAN-09-3252; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	45	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152861	10.1371/journal.pone.0152861	http://dx.doi.org/10.1371/journal.pone.0152861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046225	gold, Green Submitted, Green Published			2022-12-26	WOS:000373599600041
J	Solleti, SK; Srisuma, S; Bhattacharya, S; Rangel-Moreno, J; Bijli, KM; Randall, TD; Rahman, A; Mariani, TJ				Solleti, Siva Kumar; Srisuma, Sorachai; Bhattacharya, Soumyaroop; Rangel-Moreno, Javier; Bijli, Kaiser M.; Randall, Troy D.; Rahman, Arshad; Mariani, Thomas J.			Serpine2 deficiency results in lung lymphocyte accumulation and bronchus-associated lymphoid tissue formation	FASEB JOURNAL			English	Article						serine protease inhibitor; protease nexin-1; thrombin; chemokines; tertiary lymphoid structures	OBSTRUCTIVE PULMONARY-DISEASE; NF-KAPPA-B; PROTEASE NEXIN 1; ENDOTHELIAL-CELLS; THROMBIN ACTIVITY; EPITHELIAL-CELLS; MICE LACKING; ACTIVATION; EXPRESSION; GENE	Serine proteinase inhibitor, clade E, member 2 (SERPINE2), is a cell- and extracellular matrix-associated inhibitor of thrombin. Although SERPINE2 is a candidate susceptibility gene for chronic obstructive pulmonary disease, the physiologic role of this protease inhibitor in lung development and homeostasis is unknown. We observed spontaneous monocytic-cell infiltration in the lungs of Serpine2-deficient (SE2(-/-)) mice, beginning at or before the time of lung maturity, which resulted in lesions that resembled bronchus-associated lymphoid tissue (BALT). The initiation of lymphocyte accumulation in the lungs of SE2(-/-) mice involved the excessive expression of chemokines, cytokines, and adhesion molecules that are essential for BALT induction, organization, and maintenance. BALT-like lesion formation in the lungs of SE2(-/-) mice was also associated with a significant increase in the activation of thrombin, a recognized target of SE2, and excess stimulation of NF-kappa B, a major regulator of chemokine expression and inflammation. Finally, systemic delivery of thrombin rapidly stimulated lung chemokine expression in vivo. These data uncover a novelmechanism where by loss of serine protease inhibition leads to lung lymphocyte accumulation.-Solleti, S. K., Srisuma, S., Bhattacharya, S., Rangel-Moreno, J., Bijli, K. M., Randall, T. D., Rahman, A., Mariani, T. J. Serpine2 deficiency results in lung lymphocyte accumulation and bronchus-associated lymphoid tissue formation.	[Solleti, Siva Kumar; Bhattacharya, Soumyaroop; Bijli, Kaiser M.; Rahman, Arshad; Mariani, Thomas J.] Univ Rochester, Med Ctr, Dept Pediat, Div Neonatol, Rochester, NY 14642 USA; [Rangel-Moreno, Javier] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Srisuma, Sorachai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Physiol, Bangkok 10700, Thailand; [Bijli, Kaiser M.] Emory Univ, Atlanta Vet Affairs Med Ctr, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Randall, Troy D.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA	University of Rochester; University of Rochester; Mahidol University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Alabama System; University of Alabama Birmingham	Mariani, TJ (corresponding author), Univ Rochester, Med Ctr, Div Neonatol & Pediat Mol, 601 Elmwood Ave,Box 850, Rochester, NY 14642 USA.; Mariani, TJ (corresponding author), Univ Rochester, Med Ctr, Personalized Med Program, 601 Elmwood Ave,Box 850, Rochester, NY 14642 USA.	tom_mariani@urmc.rochester.edu		Solleti, Siva Kumar/0000-0002-7885-3164; Rangel-Moreno, Javier/0000-0002-9738-1182	Flight Attendant Medical Research Institute; U.S. National Institutes of Health (NIH); National Institute of Environmental Health Sciences [ES014372]; NIH National Heart, Lung, and Blood Institutes [HL094431, HL116632]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094431, R01HL116632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014372] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH National Heart, Lung, and Blood Institutes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Flight Attendant Medical Research Institute, U.S. National Institutes of Health (NIH), National Institute of Environmental Health Sciences (Grant ES014372), and NIH National Heart, Lung, and Blood Institutes (Grants HL094431 and HL116632). The authors thank Dr. Mohammad Minhajuddin, Dr. Fabeha Fazal, Dr. Maria da la Luz Garcia-Hernandez, Valerie Lunger, Ashley Lopez, Swati Shimpi, Jared Mereness, and Muranda Maurer (University of Rochester Medical Center, Rochester, NY, USA) and Temana Andalcio, Jungha Hong, and Roberto Landazury (Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA) for assistance.	An L, 2012, MOL BIOL REP, V39, P1427, DOI 10.1007/s11033-011-0877-0; Ashitani J, 2002, INTERNAL MED, V41, P181, DOI 10.2169/internalmedicine.41.181; BAKER JB, 1980, CELL, V21, P37, DOI 10.1016/0092-8674(80)90112-9; Baraldo S, 2015, AM J RESP CRIT CARE, V191, P402, DOI 10.1164/rccm.201403-0529OC; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bedard J, 2003, MOL REPROD DEV, V64, P152, DOI 10.1002/mrd.10239; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Boulaftali Y, 2013, ARTERIOSCL THROM VAS, V33, P1647, DOI 10.1161/ATVBAHA.113.301494; Bouton MC, 2012, BLOOD, V119, P2452, DOI 10.1182/blood-2011-10-387464; Bouton MC, 2003, ARTERIOSCL THROM VAS, V23, P142, DOI 10.1161/01.ATV.0000047867.98019.2D; Bracke KR, 2013, AM J RESP CRIT CARE, V188, P343, DOI 10.1164/rccm.201211-2055OC; Brusselle GG, 2009, EUR RESPIR J, V34, P219, DOI 10.1183/09031936.00150208; Castaldi PJ, 2009, CHEST, V135, P737, DOI 10.1378/chest.08-1993; Cha SI, 2009, J KOREAN MED SCI, V24, P1119, DOI 10.3346/jkms.2009.24.6.1119; Chen D, 2009, J THROMB HAEMOST, V7, P122, DOI 10.1111/j.1538-7836.2009.03413.x; Davalos-Misslitz ACM, 2007, EUR J IMMUNOL, V37, P613, DOI 10.1002/eji.200636656; DeMeo DL, 2006, AM J HUM GENET, V78, P253, DOI 10.1086/499828; Demoor T, 2009, EUR RESPIR J, V34, P405, DOI 10.1183/09031936.00101408; Drapkin Paola T, 2002, BMC Developmental Biology, V2, P1; Fazal F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059965; Feutz AC, 2008, J CELL SCI, V121, P1435, DOI 10.1242/jcs.018689; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Francois D, 2014, LAB INVEST, V94, P1237, DOI 10.1038/labinvest.2014.111; Gabazza EC, 1999, LUNG, V177, P253, DOI 10.1007/PL00007645; Gomez D, 2013, ARTERIOSCL THROM VAS, V33, P2222, DOI 10.1161/ATVBAHA.113.301327; GUTTRIDGE DC, 1993, J BIOL CHEM, V268, P18966; HERNANDEZRODRIGUEZ NA, 1995, LANCET, V346, P1071, DOI 10.1016/S0140-6736(95)91744-6; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Jankowski M, 2011, THROMB RES, V127, P242, DOI 10.1016/j.thromres.2010.11.005; Kelly FM, 2009, AM J PHYSIOL-RENAL, V296, pF512, DOI 10.1152/ajprenal.90629.2008; Kleeberger SR, 2005, ANNU REV MED, V56, P383, DOI 10.1146/annurev.med.56.062904.144908; Kukkonen MK, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-157; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Lin CH, 2014, J IMMUNOL, V192, P338, DOI 10.4049/jimmunol.1203323; Lin CH, 2013, CELL SIGNAL, V25, P1166, DOI 10.1016/j.cellsig.2013.01.018; Lin CH, 2011, J BIOL CHEM, V286, P10483, DOI 10.1074/jbc.M110.112433; Lino MM, 2007, J NEUROSCI, V27, P3677, DOI 10.1523/JNEUROSCI.0277-07.2007; Livraghi A, 2009, J IMMUNOL, V182, P4357, DOI 10.4049/jimmunol.0802557; Lomas DA, 2001, RESP RES, V2, P20, DOI 10.1186/rr34; Luthi A, 1997, J NEUROSCI, V17, P4688; MANSUY IM, 1993, DEVELOPMENT, V119, P1119; Marin V, 2001, BLOOD, V98, P667, DOI 10.1182/blood.V98.3.667; Mckee CM, 2015, ONCOTARGET, V6, P3784, DOI 10.18632/oncotarget.2921; McKee CM, 2013, ONCOTARGET, V4, P1; Minhajuddin M, 2009, J BIOL CHEM, V284, P4052, DOI 10.1074/jbc.M805032200; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Polverino F, 2015, AM J RESP CRIT CARE, V192, P695, DOI 10.1164/rccm.201501-0107OC; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rahman Arshad, 2011, Proc Am Thorac Soc, V8, P497, DOI 10.1513/pats.201101-009MW; Solleti SK, 2015, AM J PHYSIOL-LUNG C, V309, pL293, DOI 10.1152/ajplung.00287.2014; Sorheim IC, 2010, COPD, V7, P262, DOI 10.3109/15412555.2010.496821; Srisuma S, 2010, AM J RESP CRIT CARE, V181, P838, DOI 10.1164/rccm.200904-0544OC; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Terada M, 2004, AM J RESP CRIT CARE, V169, P373, DOI 10.1164/rccm.200308-1156OC; VAUGHAN PJ, 1993, J BIOL CHEM, V268, P3720; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787; Zhu G, 2007, AM J RESP CRIT CARE, V176, P167, DOI 10.1164/rccm.200611-1723OC	59	17	18	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2615	2626		10.1096/fj.201500159R	http://dx.doi.org/10.1096/fj.201500159R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27059719	Green Published			2022-12-26	WOS:000379249500016
J	Rorsman, C; Tsioumpekou, M; Heldin, CH; Lennartsson, J				Rorsman, Charlotte; Tsioumpekou, Maria; Heldin, Carl-Henrik; Lennartsson, Johan			The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor beta (PDGFR beta) Internalization and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; EGF RECEPTOR; DOWN-REGULATION; BINDING DOMAIN; IN-VIVO; PROTEIN; DEGRADATION; ENDOCYTOSIS; PHOSPHORYLATION; FAMILY	Protein ubiquitination controls protein stability and subcellular localization of tyrosine kinase receptors, hence affecting signaling both quantitatively and qualitatively. In this report, we demonstrate that, after ligand stimulation, the PDGF beta receptor (PDGFR beta) becomes ubiquitinated in a manner requiring both the c-Cbl and Cbl-b ubiquitin ligases. Simultaneous depletion of c-Cbl and Cbl-b resulted in reduced ligand-induced PDGFR beta clearance from the cell surface because of reduced endocytosis of the receptor. Cbl-b formed a complex with c-Cbl, as well as with the PDGFR beta, in response to PDGF-BB stimulation. We were unable to find a direct interaction between the receptor and c-Cbl, raising the possibility that Cbl-b is necessary for c-Cbl to interact with PDGFR beta. Phosphorylated Tyr-1021 in PDGFR beta was the primary interaction site for Cbl-b, with some contribution from Tyr-1009. Depletion of c-Cbl and Cbl-b led to an increased ligand-induced tyrosine phosphorylation of the receptor. Several tyrosine residues with elevated phosphorylation (i.e. Tyr-579, Tyr-581, Tyr-1009, and Tyr-1021) have previously been shown to interact with Src kinases and PLC gamma. Indeed, in cells depleted of c-Cbl and Cbl-b, both Src and PLC gamma phosphorylation were enhanced, whereas activation of other pathways, such as Erk1/2 MAP kinase and Akt, were not affected. In addition, Stat3 phosphorylation, which has been connected to Src activity, was also elevated in cells lacking c-Cbl and Cbl-b. Functionally, we found that cells depleted of c-Cbl and Cbl-b were more prone to migrate toward PDGF-BB, whereas no reproducible effect on cell proliferation could be observed. In conclusion, internalization as well as signaling via PDGFR beta are controlled by ubiquitination.	[Rorsman, Charlotte; Tsioumpekou, Maria; Heldin, Carl-Henrik; Lennartsson, Johan] Uppsala Univ, Sci Life Lab, Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Lennartsson, J (corresponding author), Biomed Ctr, Ludwig Inst Canc Res, Box 595, S-75124 Uppsala, Sweden.	Johan.Lennartsson@LICR.uu.se			Swedish Cancer Society [140332]; Ludwig Institute for Cancer Research	Swedish Cancer Society(Swedish Cancer Society); Ludwig Institute for Cancer Research	This work was supported by Swedish Cancer Society Grant 140332 and the Ludwig Institute for Cancer Research. The authors declare that they have no conflicts of interest with the contents of this article.	Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; Bornfeldt KE, 1995, ANN NY ACAD SCI, V766, P416, DOI 10.1111/j.1749-6632.1995.tb26691.x; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; HELDIN CH, 1982, J BIOL CHEM, V257, P4216; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Lennartsson J, 2013, J BIOL CHEM, V288, P15736, DOI 10.1074/jbc.M113.476424; Mao YF, 2011, J BIOL CHEM, V286, P41852, DOI 10.1074/jbc.M111.288514; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; MORI S, 1993, EMBO J, V12, P2257, DOI 10.1002/j.1460-2075.1993.tb05879.x; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; Wang YZ, 2000, ONCOGENE, V19, P2075, DOI 10.1038/sj.onc.1203548	26	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11608	11618		10.1074/jbc.M115.705814	http://dx.doi.org/10.1074/jbc.M115.705814			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27048651	Green Published, hybrid			2022-12-26	WOS:000377264800013
J	Duhrsen, L; Emami, P; Matschke, J; Abboud, T; Westphal, M; Regelsberger, J				Duehrsen, Lasse; Emami, Pedram; Matschke, Jakob; Abboud, Tammam; Westphal, Manfred; Regelsberger, Jan			Meninigiomas of the Craniocervical Junction - A Distinctive Subgroup of Meningiomas	PLOS ONE			English	Article							FORAMEN MAGNUM MENINGIOMAS; OF-THE-LITERATURE; MICROSURGICAL RESECTION; LABELING INDEX; CLASSIFICATION; PREDICTION; MANAGEMENT; RECURRENCE; ANTIGEN; SYSTEM	Objective Meningioma of the cranio-cervical junction is a rare diagnosis and demand a thorough surgical planning as radical excision of these tumors is difficult. In this context recurrence is most likely due to regrowth of residual tumor. The aim of this study was to evaluate the clinical course of patients operated for craniocervical meningioma (CCM) and to investigate the histological features of these tumors and their impact on recurrence rate. Methods All patients who were operated for CCM at our institution between 2003 and 2012 were identified. Presenting symptoms, MRI findings, surgical approaches and recurrence rate were reviewed retrospectively using medical charts. Histological features of the included tumors were studied focusing on subtypes and MIB-1 immunoreactivity and compared with MIB-1 immunoreactivity in an age and gender-matched control group of patients with supratentorial meningioma. Results 18 patients with CCM with a mean age of 56.2 years and median follow-up of 60 months were included in the study. Sensory or motor deficit was the most frequent presenting symptom followed by neck pain and lower cranial nerve palsy. Simpson grade II resection was achieved in 16 patients and Simpson grade III resection in two patients. Mortality, morbidity and recurrence rates were 16.7%, 5.5% and 5.5%, respectively. According to the WHO-grading all were found to be grade I meningiomas. Histological subtypes included meningotheliomatous (10), transitional (2), fibrillar (2), angiomatous (3) and secretory (1) meningioma. The mean MIB-1 labeling index in the study group was significantly higher than in the control group, (7.2% and 3.6%, respectively), p < 0.05. There was no correlation between MIB-1 levels and tumor recurrence. Conclusions CCM seems to have a benign character. Despite a significantly higher MIB-1 index, a high rate of recurrence was not observed. Therefore, approaches with high morbidity are not justified. Nevertheless, in view of the challenging approaches with limited access to the lesion, CCM should be considered a distinctive clinical subgroup.	[Duehrsen, Lasse; Emami, Pedram; Abboud, Tammam; Westphal, Manfred; Regelsberger, Jan] Univ Klinikum Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Matschke, Jakob] Univ Klinikum Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Duhrsen, L (corresponding author), Univ Klinikum Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany.	l.duehrsen@uke.de	Matschke, Jakob/F-6641-2013	Matschke, Jakob/0000-0001-6080-0198				Abry E, 2010, PATHOL RES PRACT, V206, P810, DOI 10.1016/j.prp.2010.09.002; Arnautovic KI, 2000, J NEUROSURG, V92, P71, DOI 10.3171/spi.2000.92.1.0071; Bassiouni H, 2006, NEUROSURGERY, V59, P1177, DOI 10.1227/01.NEU.0000245629.77968.37; Bruneau M, 2008, NEUROSURG REV, V31, P19, DOI 10.1007/s10143-007-0097-1; CATTORETTI G, 1992, J PATHOL, V168, P357, DOI 10.1002/path.1711680404; Eicker SO, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.2.FOCUS14799; Flores BC, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.10.FOCUS13332; Hwang WL, 2016, NEURO-ONCOLOGY, V18, P863, DOI 10.1093/neuonc/nov285; LEVY WJ, 1982, J NEUROSURG, V57, P804, DOI 10.3171/jns.1982.57.6.0804; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Marciscano AE, 2016, J NEUROSURG, V124, P106, DOI 10.3171/2015.1.JNS142228; McGovern SL, 2010, J NEUROSURG, V112, P925, DOI 10.3171/2009.9.JNS09617; MEYER FB, 1984, J NEUROSURG, V61, P136, DOI 10.3171/jns.1984.61.1.0136; Moller ML, 1997, J NEURO-ONCOL, V34, P241, DOI 10.1023/A:1005794700267; OHTA M, 1994, CANCER, V74, P3176, DOI 10.1002/1097-0142(19941215)74:12<3176::AID-CNCR2820741217>3.0.CO;2-N; Oya S, 2012, J NEUROSURG, V117, P121, DOI 10.3171/2012.3.JNS111945; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Roser F, 2004, ACTA NEUROCHIR, V146, P37, DOI 10.1007/s00701-003-0173-4; Sade B, 2007, NEUROSURGERY, V61, P1194, DOI 10.1227/01.neu.0000306097.38141.65; Samii M, 1996, NEUROSURGERY, V39, P1086, DOI 10.1097/00006123-199612000-00003; Scheitzach J, 2014, J NEURO-ONCOL, V116, P381, DOI 10.1007/s11060-013-1309-x; Talacchi A, 2012, NEUROSURG REV, V35, P359, DOI 10.1007/s10143-012-0381-6; YASUOKA S, 1978, J NEUROSURG, V49, P828, DOI 10.3171/jns.1978.49.6.0828	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153405	10.1371/journal.pone.0153405	http://dx.doi.org/10.1371/journal.pone.0153405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070421	Green Submitted, gold, Green Published			2022-12-26	WOS:000373900700061
J	Mallory, HS; Howard, AF; Weiss, MR				Mallory, Heather S.; Howard, Aaron F.; Weiss, Martha R.			Timing of Environmental Enrichment Affects Memory in the House Cricket, Acheta domesticus	PLOS ONE			English	Article							CELL-PROLIFERATION; NEUROGENESIS; BRAIN; REWARD	Learning appears to be ubiquitous among animals, as it plays a key role in many behaviors including foraging and reproduction. Although there is some genetic basis for differences in learning ability and memory retention, environment also plays an important role, as it does for any other trait. For example, adult animals maintained in enriched housing conditions learn faster and remember tasks for longer than animals maintained in impoverished conditions. Such plasticity in adult learning ability has often been linked to plasticity in the brain, and studies aimed at understanding the mechanisms, stimuli, and consequences of adult behavioral and brain plasticity are numerous. However, the role of experiences during postembryonic development in shaping plasticity in adult learning ability and memory retention remain relatively unexplored. Using the house cricket (Acheta domesticus) as a model organism, we developed a protocol to allow the odor preference of a large number of crickets to be tested in a short period of time. We then used this new protocol to examine how enrichment or impoverishment at two developmental stages (either the last nymphal instar or young adult) affected adult memory. Our results show that regardless of nymphal rearing conditions, crickets that experienced an enriched rearing condition as young adults performed better on a memory task than individuals that experienced an impoverished condition. Older adult crickets (more than 1 week post adult molt) did not demonstrate differences in memory of the odor task, regardless of rearing condition as a young adult. Our results suggest that environmentally-induced plasticity in memory may be restricted to the young adult stage.	[Mallory, Heather S.; Weiss, Martha R.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Howard, Aaron F.] NE Illinois Univ, Dept Biol, Chicago, IL 60625 USA; [Mallory, Heather S.] Ravenscroft Sch, Dept Sci, Raleigh, NC USA; [Howard, Aaron F.] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA	Georgetown University; Franklin & Marshall College	Mallory, HS (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.; Mallory, HS (corresponding author), Ravenscroft Sch, Dept Sci, Raleigh, NC USA.	heather.mallory@ravenscroft.org			Georgetown University's Graduate School of Arts and Sciences; Georgetown University's Department of Biology; Georgetown University's Center for the Brain Basis of Cognition	Georgetown University's Graduate School of Arts and Sciences; Georgetown University's Department of Biology; Georgetown University's Center for the Brain Basis of Cognition	Funding was provided by Georgetown University's Graduate School of Arts and Sciences, by Georgetown University's Department of Biology, and by a seed grant from Georgetown University's Center for the Brain Basis of Cognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral OB, 2008, PHYSIOL BEHAV, V93, P388, DOI 10.1016/j.physbeh.2007.09.009; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; BENNETT EL, 1974, PHYSIOL BEHAV, V12, P621, DOI 10.1016/0031-9384(74)90212-1; Burns JG, 2011, P ROY SOC B-BIOL SCI, V278, P923, DOI 10.1098/rspb.2010.2488; Cayre M, 2002, COMP BIOCHEM PHYS B, V132, P1, DOI 10.1016/S1096-4959(01)00525-5; Chapman RF, 2002, J MORPHOL, V254, P186, DOI 10.1002/jmor.10026; Coolen I, 2005, CURR BIOL, V15, P1931, DOI 10.1016/j.cub.2005.09.015; Dickel L, 2000, DEV PSYCHOBIOL, V36, P101, DOI 10.1002/(SICI)1098-2302(200003)36:2<101::AID-DEV2>3.0.CO;2-L; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Dukas R, 2003, ANIM BEHAV, V66, P741, DOI 10.1006/anbe.2002.2261; Dukas R, 1998, COGNITIVE ECOLOGY EV; Iso H, 2007, BEHAV BRAIN RES, V179, P90, DOI 10.1016/j.bbr.2007.01.025; Kobayashi S, 2002, J NEUROSCI RES, V70, P340, DOI 10.1002/jnr.10442; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; Lomassese SS, 2000, J NEUROBIOL, V45, P162; Malaterre J, 2002, J COMP NEUROL, V452, P215, DOI 10.1002/cne.10319; Matsumoto Y, 2000, J EXP BIOL, V203, P2581; Matsumoto Y, 2004, LEARN MEMORY, V11, P288, DOI 10.1101/lm.72504; Matsumoto Y, 2002, J COMP PHYSIOL A, V188, P295, DOI 10.1007/s00359-002-0303-0; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Opstad R, 2004, J INSECT PHYSIOL, V50, P725, DOI 10.1016/j.jinsphys.2004.05.010; RENNER MJ, 1986, DEV PSYCHOBIOL, V19, P303, DOI 10.1002/dev.420190403; Scotto-Lomassese S, 2002, CURR BIOL, V12, P1001, DOI 10.1016/S0960-9822(02)00889-8; Shettleworth, 2010, COGNITION EVOLUTION; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Williams BM, 2001, PHYSIOL BEHAV, V73, P649, DOI 10.1016/S0031-9384(01)00543-1	30	9	9	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152245	10.1371/journal.pone.0152245	http://dx.doi.org/10.1371/journal.pone.0152245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058038	Green Submitted, Green Published, gold			2022-12-26	WOS:000373604800004
J	Cai, ZB; Zhao, L; Zhang, X; Yue, W; Zhu, MH				Cai, Zhen-bing; Zhao, Lei; Zhang, Xu; Yue, Wen; Zhu, Min-hao			Combined Effect of Textured Patterns and Graphene Flake Additives on Tribological Behavior under Boundary Lubrication	PLOS ONE			English	Article							NANOFLUIDS; NANOSHEETS; GRAPHITE; ROUTE	A ball-on-plate wear test was employed to investigate the effectiveness of graphene (GP) nanoparticles dispersed in a synthetic-oil-based lubricant in reducing wear. The effect by area ratio of elliptically shaped dimple textures and elevated temperatures were also explored. Pure PAO4 based oil and a mixture of this oil with 0.01 wt% GP were compared as lubricants. At pit area ratio of 5%, GP-base oil effectively reduced friction and wear, especially at 60 and 100 degrees C. Under pure PAO4 oil lubrication, the untextured surfaces gained low friction coefficients (COFs) and wear rates under 60 and 100 degrees C. With increasing laser-texture area ratio, the COF and wear rate decreased at 25 and 150 degrees C but increased at 60 and 100 degrees C. Under the GP-based oil lubrication, the textured surface with 5% area ratio achieved the lowest COF among those of the area ratios tested at all test temperatures. Meanwhile, the textured surface with 20% area ratio obtained the highest COF among those of the area ratios. With the joint action of GP and texture, the textured surface with 10% area ratio exhibited the best anti-wear performance among all of the textured surfaces at all test temperatures.	[Cai, Zhen-bing; Zhao, Lei; Zhang, Xu; Zhu, Min-hao] Southwest Jiaotong Univ, Tribol Res Inst, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China; [Yue, Wen] China Univ Geosci, Sch Engn & Technol, Dept Mech Engn, Beijing 100083, Peoples R China	Southwest Jiaotong University; China University of Geosciences	Cai, ZB (corresponding author), Southwest Jiaotong Univ, Tribol Res Inst, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.	czb-jiaoda@126.com	Yue, Wen/G-8980-2013	Yue, Wen/0000-0003-1622-9953				Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; Cai ZB, 2015, WEAR, V332, P1158, DOI 10.1016/j.wear.2015.01.064; Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Costa HL, 2007, TRIBOL INT, V40, P1227, DOI 10.1016/j.triboint.2007.01.014; Eswaraiah V, 2011, ACS APPL MATER INTER, V3, P4221, DOI 10.1021/am200851z; Etsion I, 2005, J TRIBOL-T ASME, V127, P248, DOI 10.1115/1.1828070; Etsion I, 2009, TRIBOL INT, V42, P542, DOI 10.1016/j.triboint.2008.02.015; Feng XF, 2013, ACS NANO, V7, P1718, DOI 10.1021/nn305722d; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Hirata M, 2004, CARBON, V42, P2929, DOI 10.1016/j.carbon.2004.07.003; Kovalchenko A, 2004, TRIBOL T, V47, P299, DOI 10.1080/05698190490440902; Lee K, 2009, TRIBOL LETT, V35, P127, DOI 10.1007/s11249-009-9441-7; Leven I, 2013, J PHYS CHEM LETT, V4, P115, DOI 10.1021/jz301758c; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Lin JS, 2011, TRIBOL LETT, V41, P209, DOI 10.1007/s11249-010-9702-5; Meyer JC, 2007, SOLID STATE COMMUN, V143, P101, DOI 10.1016/j.ssc.2007.02.047; N'guessan HE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2247; Pettersson U, 2003, TRIBOL INT, V36, P857, DOI 10.1016/S0301-679X(03)00104-X; Senatore A, 2013, ISRN TRIBOLOGY, V2013; Song HJ, 2011, APPL PHYS A-MATER, V105, P827, DOI 10.1007/s00339-011-6636-1; Tadmor R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266101; Taha-Tijerina J, 2013, WEAR, V302, P1241, DOI 10.1016/j.wear.2012.12.010; [汤勇 Tang Yong], 2010, [机械工程学报, Chinese Journal of Mechanical Engineering], V46, P93; Varrla E, 2011, ACS APPL MATER INTER, V3, P4221; Wei JX, 2014, TRIBOL LETT, V53, P521, DOI 10.1007/s11249-013-0290-z; Zhang WQ, 2011, LUBR ENG, V9	26	17	18	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152143	10.1371/journal.pone.0152143	http://dx.doi.org/10.1371/journal.pone.0152143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054762	gold, Green Published			2022-12-26	WOS:000373608000013
J	Li, HB; Xu, ZQ; Zhang, WC; Wang, SQ; Zhang, GT; Xiao, T				Li, Haibo; Xu, Zhiqiang; Zhang, Wuchang; Wang, Shaoqing; Zhang, Guangtao; Xiao, Tian			Boreal Tintinnid Assemblage in the Northwest Pacific and Its Connection with the Japan Sea in Summer 2014	PLOS ONE			English	Article							SOUTHWESTERN ATLANTIC; MEDITERRANEAN SEA; MICROZOOPLANKTON; BIOGEOGRAPHY; DIVERSITY; ABUNDANCE; ECOLOGY; PATTERNS; TRENDS; LORICA	Tintinnids are planktonic ciliates that play an important role in marine ecosystem. According to their distribution in the world oceans, tintinnid genera were divided into several biogeographical types such as boreal, warm water, austral and neritic. Therefore, the oceanic tintinnid assemblage could be correspondingly divided into boreal assemblage, warm water assemblage and austral assemblage. The purpose of this study was to investigate the characteristics of boreal tintinnid assemblage in the Northwest Pacific and the Arctic, and to identify the connection between boreal tintinnid assemblage and neighboring assemblages. Surface water samples were collected along a transect from the East China Sea to the Chukchi Sea in summer 2014. According to the presence of boreal genera and warm water genera, three tintinnid assemblages (the East China Sea neritic assemblage, the Japan Sea warm water assemblage, and the boreal assemblage) were identified along the transect. The boreal assemblage extended from the Chukchi Sea to the waters north of the Soya Strait. Densities peaks occurred at stations in the two branches of the Alaska Current and decreased both northward and southward. The densities were <10 ind./dm(3) at most stations in Arctic region. The dominant genera (Acanthostomella, Codonellopsis, Parafavella, and Ptychocylis) accounted for 79.07 +/- 29.67% (n = 49) of the abundance in the boreal assemblage. The densities of the dominant genera covaried with strongly significant positive correlations. Tintinnids with lorica oral diameter of 22-26 mu m and 38-42 mu m were dominant and contributed 67.35% and 15.13%, respectively, to the total abundance in the boreal assemblage. The distribution and densities of tintinnids in the study area suggest that the Soya Strait might be a geographical barrier for tintinnids expansion.	[Li, Haibo; Xu, Zhiqiang; Zhang, Wuchang; Zhang, Guangtao; Xiao, Tian] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Li, Haibo; Xu, Zhiqiang; Zhang, Wuchang; Zhang, Guangtao; Xiao, Tian] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Wang, Shaoqing] Chinese Acad Sci, Inst Oceanol, Marine Biol Museum, Qingdao, Peoples R China; [Li, Haibo; Xu, Zhiqiang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, WC (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.; Zhang, WC (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	wuchangzhang@163.com			Chinese Polar Environment Comprehensive investigation & Assessment Programs; Strategic Priority Research Program-Western Pacific Ocean System: Structure, Dynamics and Consequences [XDA11030202]; China Arctic Strategic Fund [20140304]	Chinese Polar Environment Comprehensive investigation & Assessment Programs; Strategic Priority Research Program-Western Pacific Ocean System: Structure, Dynamics and Consequences; China Arctic Strategic Fund	Chinese Polar Environment Comprehensive investigation & Assessment Programs (CHINARE2011-2015)", Strategic Priority Research Program-Western Pacific Ocean System: Structure, Dynamics and Consequences (Grant No. XDA11030202.2) and "China Arctic Strategic Fund (20140304).	DAVIS CC, 1978, CAN J ZOOL, V56, P1822, DOI 10.1139/z78-248; Dolan JR, 2007, BIOGEOSCIENCES, V4, P297, DOI 10.5194/bg-4-297-2007; Dolan JR, 2014, ACTA PROTOZOOL, V53, P101, DOI 10.4467/16890027AP.14.010.1447; Dolan JR, 2010, ACTA PROTOZOOL, V49, P235; Dolan JR, 2002, DEEP-SEA RES PT I, V49, P1217, DOI 10.1016/S0967-0637(02)00021-3; Dolan JR, 1999, DEEP-SEA RES PT I, V46, P2025, DOI 10.1016/S0967-0637(99)00043-6; Dolan JR, 2000, AQUAT MICROB ECOL, V22, P69, DOI 10.3354/ame022069; Dolan JR, 2013, BIOL ECOLOGY TINTINN; FAGER EW, 1963, SCIENCE, V140, P453, DOI 10.1126/science.140.3566.453; Haury L.R., 1978, NATO Conference Series IV Marine Sciences, V3, P277; Kofoid C.A., 1939, B MUSEUM COMP ZOOLOG; Kofoid CA, 1929, CONSPECTUS MARINE FR; Li H, 2016, DEEP-SEA RES PT II, V124, P84, DOI 10.1016/j.dsr2.2015.06.008; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Lynn D.H, 2008, CIL PROT CHAR CLASS, V3rd ed.; Modigh M, 2003, HYDROBIOLOGIA, V503, P251, DOI 10.1023/B:HYDR.0000008477.38383.d6; PICES, 2004, PICES SPEC PUBL, V1; PIERCE RW, 1992, REV AQUAT SCI, V6, P139; PIERCE RW, 1993, MAR ECOL PROG SER, V94, P11, DOI 10.3354/meps094011; Priede IG, 2014, PURE APPL GEOPHYS, V171, P1013, DOI 10.1007/s00024-013-0708-4; Santoferrara L, 2009, J PLANKTON RES, V31, P837, DOI 10.1093/plankt/fbp033; Senjyu T., 1999, J OCEANOGR, V55, P111, DOI [10.1023/A:1007825609622, DOI 10.1023/A:1007825609622]; Springer AM, 1996, FISH OCEANOGR, V5, P205, DOI 10.1111/j.1365-2419.1996.tb00118.x; Steele M, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002009; Taniguchi A., 1984, Memoirs of National Institute of Polar Research Special Issue, P63; Thompson GA, 2005, AQUAT MICROB ECOL, V40, P85, DOI 10.3354/ame040085; Thompson GA, 2004, AQUAT MICROB ECOL, V35, P93, DOI 10.3354/ame035093; Thompson GA, 1999, J PLANKTON RES, V21, P1265, DOI 10.1093/plankt/21.7.1265; WILLIAMS R, 1994, MAR ECOL PROG SER, V107, P263, DOI 10.3354/meps107263; Zhang W.C., 2012, ILLUSTRATED GUIDE CO	30	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153379	10.1371/journal.pone.0153379	http://dx.doi.org/10.1371/journal.pone.0153379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054884	Green Submitted, Green Published, gold			2022-12-26	WOS:000373608000126
J	Nie, SJ; Xu, HL				Nie, Shengjun; Xu, Huilian			Riboflavin-Induced Disease Resistance Requires the Mitogen-Activated Protein Kinases 3 and 6 in Arabidopsis thaliana	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; BETA-AMINOBUTYRIC ACID; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; BOTRYTIS-CINEREA; INNATE IMMUNITY; PHYTOALEXIN BIOSYNTHESIS; TRANSCRIPTION FACTOR; PATHOGEN DEFENSE	As a resistance elicitor, riboflavin (vitamin B-2) protects plants against a wide range of pathogens. At molecular biological levels, it is important to elucidate the signaling pathways underlying the disease resistance induced by riboflavin. Here, riboflavin was tested to induce resistance against virulent Pseudomonas syringae pv. Tomato DC3000 (Pst DC3000) in Arabidopsis. Results showed that riboflavin induced disease resistance based on MAPK-dependent priming for the expression of PR1 gene. Riboflavin induced transient expression of PR1 gene. However, following Pst DC3000 inoculation, riboflavin potentiated stronger PR1 gene transcription. Further was suggested that the transcript levels of mitogen-activated protein kinases, MPK3 and MPK6, were primed under riboflavin. Upon infection by Pst DC3000, these two enzymes were more strongly activated. The elevated activation of both MPK3 and MPK6 was responsible for enhanced defense gene expression and resistance after riboflavin treatment. Moreover, riboflavin significantly reduced the transcript levels of MPK3 and MPK6 by application of AsA and BAPTA, an H2O2 scavenger and a calcium (Ca2+) scavenger, respectively. In conclusion, MPK3 and MPK6 were responsible for riboflavin-induced resistance, and played an important role in H2O2- and Ca2+-related signaling pathways, and this study could provide a new insight into the mechanistic study of riboflavin-induced defense responses.	[Nie, Shengjun; Xu, Huilian] Int Nat Farming Res Ctr, Hata 5632, Matsumoto, Nagano 3901401, Japan		Xu, HL (corresponding author), Int Nat Farming Res Ctr, Hata 5632, Matsumoto, Nagano 3901401, Japan.	yf120nsj@163.com						Ahn IP, 2007, PLANT PHYSIOL, V143, P838, DOI 10.1104/pp.106.092627; Ahn IP, 2005, PLANT PHYSIOL, V138, P1505, DOI 10.1104/pp.104.058693; Alzwiy IA, 2007, PLANT SCI, V173, P302, DOI 10.1016/j.plantsci.2007.06.007; Anderson JC, 2011, PLANT J, V67, P258, DOI 10.1111/j.1365-313X.2011.04588.x; Asai S, 2010, PLANT J, V62, P911, DOI [10.1111/j.1365-313X.2010.04206.x, 10.1111/j.0960-7412.2010.04206.x]; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Besteiro MAG, 2011, PLANT J, V68, P727, DOI 10.1111/j.1365-313X.2011.04725.x; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Bowler C, 2000, TRENDS PLANT SCI, V5, P241, DOI 10.1016/S1360-1385(00)01628-9; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chung E, 2004, PLANTA, V220, P286, DOI 10.1007/s00425-004-1372-9; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Combs G.F., 2008, VITAMINS FUNDAMENTAL; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; Dong H, 2000, PHYTOPATHOLOGY, V90, P801, DOI 10.1094/PHYTO.2000.90.8.801; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fischer M, 2005, NAT PROD REP, V22, P324, DOI 10.1039/b210142b; Galletti R, 2011, PLANT PHYSIOL, V157, P804, DOI 10.1104/pp.111.174003; Gastaldi G, 1999, J NUTR, V129, P406, DOI 10.1093/jn/129.2.406; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Gregory JF, 1998, ANNU REV NUTR, V18, P277, DOI 10.1146/annurev.nutr.18.1.277; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Han L, 2010, PLANT J, V64, P114, DOI 10.1111/j.1365-313X.2010.04318.x; HAYES MP, 1993, INFECT IMMUN, V61, P3222, DOI 10.1128/IAI.61.8.3222-3227.1993; HAYES MP, 1991, J LEUKOCYTE BIOL, V50, P176, DOI 10.1002/jlb.50.2.176; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Hirt H, 2000, P NATL ACAD SCI USA, V97, P2405, DOI 10.1073/pnas.97.6.2405; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jakab G, 2001, EUR J PLANT PATHOL, V107, P29, DOI 10.1023/A:1008730721037; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kachroo A, 2003, TRANSGENIC RES, V12, P577, DOI 10.1023/A:1025896513472; Kim S, 2001, MOL CELLS, V11, P115; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Rentel MC, 2004, PLANT PHYSIOL, V135, P1471, DOI 10.1104/pp.104.042663; Roje S, 2007, PHYTOCHEMISTRY, V68, P1904, DOI 10.1016/j.phytochem.2007.03.038; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Sessa G, 2000, MICROBES INFECT, V2, P1591, DOI 10.1016/S1286-4579(00)01315-0; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; Vorwieger A, 2007, PLANTA, V226, P147, DOI 10.1007/s00425-006-0476-9; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang PC, 2010, PLANT CELL, V22, P2981, DOI 10.1105/tpc.109.072959; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Zhang SJ, 2009, J INTEGR PLANT BIOL, V51, P167, DOI 10.1111/j.1744-7909.2008.00763.x; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439; Zimmerli L, 2000, P NATL ACAD SCI USA, V97, P12920, DOI 10.1073/pnas.230416897; Zimmerli L, 2001, PLANT PHYSIOL, V126, P517, DOI 10.1104/pp.126.2.517; Zubay G, 1998, BIOCHEMISTRY	67	13	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153175	10.1371/journal.pone.0153175	http://dx.doi.org/10.1371/journal.pone.0153175			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054585	Green Published, Green Submitted, gold			2022-12-26	WOS:000373608000092
J	Norlin, J; Fink, LN; Kvist, PH; Galsgaard, ED; Coppieters, K				Norlin, Jenny; Fink, Lisbeth Nielsen; Kvist, Peter Helding; Galsgaard, Elisabeth Douglas; Coppieters, Ken			Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy	PLOS ONE			English	Article							RECRUITMENT; ACTIVATION; PODOCYTES; INJURY	Diabetic nephropathy (DN) is one of the most severe complications of diabetes and remains the largest cause of end-stage renal disease in the Western world. Treatment options are limited and novel therapies that effectively slow disease progression are warranted. Previous work suggested that treatment with CTLA4-Ig (abatacept), a molecule that binds and blocks B7-1 and is licensed for the treatment of rheumatoid arthritis, could ameliorate DN. This study was designed to assess whether B7-1 signalling constitutes a promising therapeutic pathway for DN. Mice injected with streptozotocin (STZ) were treated with abatacept and glycemia and renal function were assessed. No differences were found in diabetes progression, albumin excretion rates or albumin/creatine ratios, while mesangial expansion was unaltered at endpoint. Except for increased renal CCL5, treatment did not affect a panel of gene expression endpoints reflecting early fibrotic changes, inflammation and kidney injury. Finally, abatacept treatment effectively reduced the accumulation of activated CD4(+) T cells in the kidney, suggesting that renal T cell inflammation is not a driving factor in the pathology of the STZ model. In conjunction with the recent data discounting the expression of B7-1 on podocytes, our present data do not support a role for abatacept in DN treatment.	[Norlin, Jenny; Fink, Lisbeth Nielsen; Kvist, Peter Helding; Galsgaard, Elisabeth Douglas; Coppieters, Ken] Novo Nordisk AS, Malov, Denmark	Novo Nordisk	Coppieters, K (corresponding author), Novo Nordisk AS, Malov, Denmark.	kncp@novonordisk.com	Fink, Lisbeth/AAN-7830-2020		Novo Nordisk	Novo Nordisk(Novo Nordisk)	All work and editorial assistance was funded by Novo Nordisk. The funder provided support in the form of salaries for authors JN, LNF, PHK, EDG, and KC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Editorial assistance was funded by Novo Nordisk. The authors thank Dr. Jorn Drostrup for providing extensive stability data on the frozen abatacept stock formulation used in this study.	Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chow FY, 2006, KIDNEY INT, V69, P73, DOI 10.1038/sj.ki.5000014; Doria A, 2012, SEMIN NEPHROL, V32, P437, DOI 10.1016/j.semnephrol.2012.07.006; Fiorina P, 2014, J AM SOC NEPHROL, V25, P1415, DOI 10.1681/ASN.2013050518; Gagliardini E, 2016, J AM SOC NEPHROL, V27, P999, DOI 10.1681/ASN.2015030266; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Goldwich A, 2013, J AM SOC NEPHROL, V24, P906, DOI 10.1681/ASN.2012020133; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Moon JY, 2012, AM J NEPHROL, V35, P164, DOI 10.1159/000334928; Omote K, 2014, AM J PHYSIOL-RENAL, V306, pF1335, DOI 10.1152/ajprenal.00509.2013; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078	14	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152315	10.1371/journal.pone.0152315	http://dx.doi.org/10.1371/journal.pone.0152315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055155	Green Published, gold			2022-12-26	WOS:000373608000016
J	Uranga, S; Marinova, D; Martin, C; Pardo, J; Aguilo, N				Uranga, Santiago; Marinova, Dessislava; Martin, Carlos; Pardo, Julian; Aguilo, Nacho			Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In Vivo	PLOS ONE			English	Article							CELL-DEATH; PERFORIN; INDUCE	Granzyme A, a serine protease expressed in the granules of cytotoxic T and Natural Killer cells, is involved in the generation of pro-inflammatory cytokines by macrophages. Granzyme A has been described to induce in macrophages in vitro the activation of pro-inflammatory pathways that impair intracellular mycobacterial replication. In the present study, we explored the physiological relevance of Granzyme A in the control of pulmonary Mycobacterium tuberculosis infection in vivo. Our results show that, even though Granzyme A is expressed by cytotoxic cells from mouse lungs during pulmonary infection, its deficiency in knockout mice does not have an effect in the control of M. tuberculosis infection. In addition our findings indicate that absence of Granzyme A does not affect the protection conferred by the live-attenuated M. tuberculosis vaccine MTBVAC. Altogether, our findings are in apparent contradiction with previously published in vitro results and suggest that Granzyme A does not have a crucial role in vivo in the protective response to tuberculosis.	[Uranga, Santiago; Marinova, Dessislava; Martin, Carlos; Aguilo, Nacho] Univ Zaragoza, Dpto Microbiol Med Prevent & Salud Publ, Grp Genet Micobacterias, C Domingo Miral S-N, E-50009 Zaragoza, Spain; [Uranga, Santiago; Marinova, Dessislava; Martin, Carlos; Aguilo, Nacho] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Martin, Carlos] Hosp Univ Miguel Servet, ISS Aragon, Serv Microbiol, Paseo Isabel Catolica 1-3, Zaragoza 50009, Spain; [Pardo, Julian] 3 Aragon Hlth Res Inst IIS Aragon, Immune Effector Cells Grp ICE, Biomed Res Ctr Aragon CIBA, Edificio CIBA, Zaragoza, Spain; [Pardo, Julian] Univ Zaragoza, Nanosci Inst Aragon INA, E-50009 Zaragoza, Spain; [Pardo, Julian] Fdn Aragon I D ARAID, Gobierno Aragon, Zaragoza, Spain	University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Miguel Servet University Hospital; University of Zaragoza	Aguilo, N (corresponding author), Univ Zaragoza, Dpto Microbiol Med Prevent & Salud Publ, Grp Genet Micobacterias, C Domingo Miral S-N, E-50009 Zaragoza, Spain.; Aguilo, N (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	naguilo@unizar.es	Martin, Carlos/A-7283-2008; Pardo, Julián/K-6764-2014; AGUILO, NACHO/GPK-7678-2022; AGUILO, NACHO/K-2750-2014	Martin, Carlos/0000-0003-2993-5478; Pardo, Julián/0000-0003-0154-0730; AGUILO, NACHO/0000-0001-7897-9173; AGUILO, NACHO/0000-0001-7897-9173	Spanish Ministry of Economy and Competitiveness [SAF2014-54763-C2-1-R, BIO2014-5258P]; European Commission [TBVAC2020 643381]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Spanish Ministry of Economy and Competitiveness (grant numbers SAF2014-54763-C2-1-R, BIO2014-5258P) and the European Commission (grant number TBVAC2020 643381). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anthony DA, 2010, J IMMUNOL, V185, P1794, DOI 10.4049/jimmunol.1000430; Arbues A, 2013, VACCINE, V31, P4867, DOI 10.1016/j.vaccine.2013.07.051; Arias MA, 2014, CELL REP, V8, P419, DOI 10.1016/j.celrep.2014.06.012; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; Cooper AM, 1997, INFECT IMMUN, V65, P1317, DOI 10.1128/IAI.65.4.1317-1320.1997; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; Garcia-Laorden MI, 2015, TUBERCULOSIS, V95, P575, DOI 10.1016/j.tube.2015.05.016; Hazlewood GS, 2013, ARTHRIT CARE RES, V65, P1722, DOI 10.1002/acr.22063; Hochegger K, 2004, BLOOD, V103, P1176, DOI 10.1182/blood-2003-10-3708; Joeckel LT, 2014, BIOL CHEM, V395, P181, DOI 10.1515/hsz-2013-0238; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Martin P, 2005, BLOOD, V106, P2871, DOI 10.1182/blood-2005-04-1522; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pardo J, 2009, MICROBES INFECT, V11, P452, DOI 10.1016/j.micinf.2009.02.004; Spencer CT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003119; Spertini F, 2015, LANCET RESP IN PRESS; Vidyarani M, 2009, EXP MOL PATHOL, V86, P69, DOI 10.1016/j.yexmp.2008.10.002; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	19	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153028	10.1371/journal.pone.0153028	http://dx.doi.org/10.1371/journal.pone.0153028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055232	gold, Green Published, Green Submitted			2022-12-26	WOS:000373608000065
J	Bekkevold, D; Gross, R; Arula, T; Helyar, SJ; Ojaveer, H				Bekkevold, Dorte; Gross, Riho; Arula, Timo; Helyar, Sarah J.; Ojaveer, Henn			Outlier Loci Detect Intraspecific Biodiversity amongst Spring and Autumn Spawning Herring across Local Scales	PLOS ONE			English	Article							GENE-ASSOCIATED MARKERS; CLUPEA-HARENGUS L.; MARINE FISH; POPULATION DIFFERENTIATION; ATLANTIC COD; SEA; CONNECTIVITY; ADAPTATION; STRATEGIES; COMPONENTS	Herring, Clupea harengus, is one of the ecologically and commercially most important species in European northern seas, where two distinct ecotypes have been described based on spawning time; spring and autumn. To date, it is unknown if these spring and autumn spawning herring constitute genetically distinct units. We assessed levels of genetic divergence between spring and autumn spawning herring in the Baltic Sea using two types of DNA markers, microsatellites and Single Nucleotide Polymorphisms, and compared the results with data for autumn spawning North Sea herring. Temporally replicated analyses reveal clear genetic differences between ecotypes and hence support reproductive isolation. Loci showing non-neutral behaviour, so-called outlier loci, show convergence between autumn spawning herring from demographically disjoint populations, potentially reflecting selective processes associated with autumn spawning ecotypes. The abundance and exploitation of the two ecotypes have varied strongly over space and time in the Baltic Sea, where autumn spawners have faced strong depression for decades. The results therefore have practical implications by highlighting the need for specific management of these co-occurring ecotypes to meet requirements for sustainable exploitation and ensure optimal livelihood for coastal communities.	[Bekkevold, Dorte] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Gross, Riho] Estonian Univ Life Sci, Inst Vet Med & Anim Sci, Dept Aquaculture, Tartu, Estonia; [Arula, Timo; Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Parnu, Estonia; [Helyar, Sarah J.] Queens Univ Belfast, Inst Global Food Secur, Belfast, Antrim, North Ireland	Technical University of Denmark; Estonian University of Life Sciences; University of Tartu; Estonian Marine Institute; Queens University Belfast	Bekkevold, D (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark.	db@aqua.dtu.dk	Bekkevold, Dorte/AAT-1098-2021; Ojaveer, Henn/K-2160-2016; Gross, Riho/A-1735-2009; Helyar, Sarah/C-4988-2013; arula, timo/G-8710-2017	Ojaveer, Henn/0000-0003-2742-6063; Gross, Riho/0000-0003-0311-3003; Helyar, Sarah/0000-0002-1600-997X; arula, timo/0000-0001-9621-1168; Bekkevold, Dorte/0000-0002-5297-032X	joint Baltic Sea research and development programme BONUS [185]; EU; Estonian Research Council; Technological Development and Demonstration, and Innovation Fund Denmark; Estonian Ministry of Education and Research [SF0180005s10, IUT8-2]	joint Baltic Sea research and development programme BONUS; EU(European Commission); Estonian Research Council(Estonian Research Council); Technological Development and Demonstration, and Innovation Fund Denmark; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work resulted from the BONUS INSPIRE and BIO-C3 projects, which were supported by the joint Baltic Sea research and development programme BONUS (Art 185) funded jointly by the EU, Estonian Research Council, Technological Development and Demonstration, and Innovation Fund Denmark provided general funding for man hours. HO and TA were partially financed by the Estonian Ministry of Education and Research (grant SF0180005s10), which provided general funding for man hours and consumables. RG was supported by the institutional research funding project IUT8-2 (Estonian Ministry of Education and Research), which provided general funding for man hours and consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2014, MOL ECOL, V23, P502, DOI 10.1111/mec.12609; Andre C., 2010, HEREDITY, V106, P1; Arula T, 2012, J SEA RES, V68, P33, DOI 10.1016/j.seares.2011.12.003; Bekkevold D, 2005, EVOLUTION, V59, P2656; Bekkevold D, 2007, MAR ECOL PROG SER, V337, P187, DOI 10.3354/meps337187; Bekkevold D, 2015, ICES J MAR SCI, V72, P1790, DOI 10.1093/icesjms/fsu247; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradbury IR, 2010, P ROY SOC B-BIOL SCI, V277, P3725, DOI 10.1098/rspb.2010.0985; Brophy D, 2006, CAN J FISH AQUAT SCI, V63, P607, DOI 10.1139/f05-235; Corander J, 2013, MOL ECOL, V22, P2931, DOI 10.1111/mec.12174; Cushing DH, 1975, MARINE ECOLOGY FISHE; DFO, 2015, DFO CAN SCI ADVIS SE; Dickey-Collas M, 2010, ICES J MAR SCI, V67, P1875, DOI 10.1093/icesjms/fsq033; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Gagnaire PA, 2015, EVOL APPL, V8, P769, DOI 10.1111/eva.12288; GOMULKIEWICZ R, 1992, EVOLUTION, V46, P390, DOI [10.2307/2409860, 10.1111/j.1558-5646.1992.tb02047.x]; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Harma C, 2012, FISH RES, V121, P31, DOI 10.1016/j.fishres.2012.01.005; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Helyar SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042089; Hemmer-Hansen J, 2013, MOL ECOL, V22, P2653, DOI 10.1111/mec.12284; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; ICES, 2011, 2011ACOM46 ICES CM; ICES, 2021, REP BALT FISH ASS WO; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Lamichhaney S, 2012, P NATL ACAD SCI USA, V109, P19345, DOI 10.1073/pnas.1216128109; Larsson LC, 2010, HEREDITY, V104, P40, DOI 10.1038/hdy.2009.98; Larsson LC, 2007, MOL ECOL, V16, P1135, DOI 10.1111/j.1365-294X.2006.03217.x; LEWONTIN RC, 1973, GENETICS, V74, P175; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Mariani S, 2005, MAR ECOL PROG SER, V303, P245, DOI 10.3354/meps303245; McPherson AA, 2004, T AM FISH SOC, V133, P434, DOI 10.1577/02-106; Melvin GD, 2009, ICES J MAR SCI, V66, P1784, DOI 10.1093/icesjms/fsp173; Nielsen EE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1845; Ojaveer E, 2005, ICES J MAR SCI, V62, P1492, DOI 10.1016/j.icesjms.2005.08.002; OJAVEER E, 1989, RAP PROCES, V190, P17; Ojaveer E., 1970, T BALT NAUTCHNO ISSL, V4, P205; Ojaveer E, 1988, BALTIC HERRINGS BIOL; Ojaveer H, 2015, ICES J MAR SCI, V72, P2332, DOI 10.1093/icesjms/fsv103; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Raid T, 2010, ICES J MAR SCI, V67, P1914, DOI 10.1093/icesjms/fsq128; Rannak L, 1971, ICES CM 1971 SPEC M; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rideout RM, 2011, MAR COAST FISH, V3, P176, DOI 10.1080/19425120.2011.556943; RYMAN N, 1984, HEREDITY, V53, P687, DOI 10.1038/hdy.1984.127; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Teacher AGF, 2012, CONSERV GENET RESOUR, V4, P71, DOI 10.1007/s12686-011-9477-5; Teacher AGF, 2013, EVOL APPL, V6, P549, DOI 10.1111/eva.12042; Therkildsen NO, 2013, EVOL APPL, V6, P690, DOI 10.1111/eva.12055; van Damme CJG, 2009, CAN J FISH AQUAT SCI, V66, P2130, DOI 10.1139/F09-153; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Winters GH, 1996, ICES J MAR SCI, V53, P73, DOI 10.1006/jmsc.1996.0007	57	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0148499	10.1371/journal.pone.0148499	http://dx.doi.org/10.1371/journal.pone.0148499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050440	Green Published, Green Accepted, gold			2022-12-26	WOS:000373603500001
J	Laubitz, D; Harrison, CA; Midura-Kiela, MT; Ramalingam, R; Larmonier, CB; Chase, JH; Caporaso, JG; Besselsen, DG; Ghishan, FK; Kiela, PR				Laubitz, Daniel; Harrison, Christy A.; Midura-Kiela, Monica T.; Ramalingam, Rajalakshmy; Larmonier, Claire B.; Chase, John H.; Caporaso, J. Gregory; Besselsen, David G.; Ghishan, Fayez K.; Kiela, Pawel R.			Reduced Epithelial Na+/H+ Exchange Drives Gut Microbial Dysbiosis and Promotes Inflammatory Response in T Cell-Mediated Murine Colitis	PLOS ONE			English	Article							CD4(+)CD25(-)FOXP3(+) CELLS; ULCERATIVE-COLITIS; BOWEL-DISEASE; NHE3; EXPRESSION; DIVERSITY; MODEL; MICE; TRANSPORTERS; DEFICIENCY	Inflammatory bowel diseases (IBD) are associated with functional inhibition of epithelial Na+/H+ exchange. In mice, a selective disruption of NHE3 (Slc9a3), a major apical Na+/H+ exchanger, also promotes IBD-like symptoms and gut microbial dysbiosis. We hypothesized that disruption of Na+/H+ exchange is necessary for the development of dysbiosis, which promotes an exacerbated mucosal inflammatory response. Therefore, we performed a temporal analysis of gut microbiota composition, and mucosal immune response to adoptive T cell transfer was evaluated in Rag2(-/-) and NHE3(-/-)/Rag2(-/-) (DKO) mice with and without broad-spectrum antibiotics. Microbiome (16S profiling), colonic histology, T cell and neutrophil infiltration, mucosal inflammatory tone, and epithelial permeability were analyzed. In adoptive T cell transfer colitis model, Slc9a3 status was the most significant determinant of gut microbial community. In DKO mice, NHE3-deficiency and dysbiosis were associated with dramatically accelerated and exacerbated disease, with rapid body weight loss, increased mucosal T cell and neutrophil influx, increased mucosal cytokine expression, increased permeability, and expansion of CD25-FoxP3(+) Tregs; this enhanced susceptibility was alleviated by oral broad-spectrum antibiotics. Based on these results and our previous work, we postulate that epithelial electrolyte homeostasis is an important modulator in the progression of colitis, acting through remodeling of the gut microbial community.	[Laubitz, Daniel; Harrison, Christy A.; Midura-Kiela, Monica T.; Ramalingam, Rajalakshmy; Larmonier, Claire B.; Ghishan, Fayez K.; Kiela, Pawel R.] Univ Arizona, Dept Pediat, Steele Childrens Res Ctr, Tucson, AZ 85721 USA; [Chase, John H.; Caporaso, J. Gregory] No Arizona Univ, Dept Biol Sci, Ctr Microbial Genet & Genom, Box 5640, Flagstaff, AZ 86011 USA; [Besselsen, David G.] Univ Arizona, Univ Anim Care, Tucson, AZ USA; [Kiela, Pawel R.] Univ Arizona, Dept Immunobiol, Tucson, AZ USA; [Ramalingam, Rajalakshmy] Ventana Med Syst Inc, Roche Grp, Tucson, AZ USA; [Larmonier, Claire B.] Ctr Hosp Univ Pellegrin, GRIC, Pole Biol & Pathol, Labs Immunol & Immunogenet, F-33000 Bordeaux, France	University of Arizona; Northern Arizona University; University of Arizona; University of Arizona; Roche Holding; Ventana Medical Systems, Inc.; CHU Bordeaux	Kiela, PR (corresponding author), Univ Arizona, Dept Pediat, Steele Childrens Res Ctr, Tucson, AZ 85721 USA.	pkiela@peds.arizona.edu	Kiela, Pawel/AAF-5320-2020	Clutter, Christy/0000-0001-6236-5636; Caporaso, Greg/0000-0002-8865-1670; Laubitz, Daniel/0000-0002-7482-8500; Kiela, Pawel/0000-0002-0014-3517	National Institute of Diabetes and Digestive and Kidney Diseases [2R01 DK-041274]; Cancer Center Support Grant [CA 023074]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041274] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases Grant 2R01 DK-041274 (to F. Ghishan and P. Kiela). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the UACC/ARL Cytometry Core Facility supported by Cancer Center Support Grant (CA 023074) and Paula Campbell for the assistance with flow cytometry and flow sorting.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Barmeyer C, 2004, AM J PHYSIOL-GASTR L, V286, pG244, DOI 10.1152/ajpgi.00141.2003; Bonelli M, 2009, J IMMUNOL, V182, P1689, DOI 10.4049/jimmunol.182.3.1689; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Dalal SR, 2014, J CLIN INVEST, V124, P4190, DOI 10.1172/JCI72330; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Du ZY, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0080-2; Engevik MA, 2015, AM J PHYSIOL-GASTR L, V308, pG497, DOI 10.1152/ajpgi.00090.2014; Engevik MA, 2013, AM J PHYSIOL-GASTR L, V305, pG697, DOI 10.1152/ajpgi.00184.2013; Farkas K, 2011, INFLAMM BOWEL DIS, V17, P884, DOI 10.1002/ibd.21432; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fransson M, 2010, AUTOIMMUNITY, V43, P590, DOI 10.3109/08916930903541190; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Ghishan FK, 2014, INFLAMM BOWEL DIS, V20, P1099, DOI 10.1097/MIB.0000000000000029; Hecht G, 2004, AM J PHYSIOL-GASTR L, V287, pG370, DOI 10.1152/ajpgi.00432.2003; Horwitz DA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2894; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Ishikawa D, 2013, MUCOSAL IMMUNOL, V6, P267, DOI 10.1038/mi.2012.67; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Kaakoush NO, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2014.21; Kiela PR, 2009, GASTROENTEROLOGY, V137, P965, DOI 10.1053/j.gastro.2009.05.043; Kim TW, 2006, WORLD J GASTROENTERO, V12, P302, DOI 10.3748/wjg.v12.i2.302; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Larmonier CB, 2013, AM J PHYSIOL-GASTR L, V305, pG667, DOI 10.1152/ajpgi.00189.2013; Laubitz D, 2008, AM J PHYSIOL-GASTR L, V295, pG63, DOI 10.1152/ajpgi.90207.2008; Lenzen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040657; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Martinez-Augustin O, 2009, INFLAMM BOWEL DIS, V15, P114, DOI 10.1002/ibd.20579; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Rocha F, 2001, AM J PHYSIOL-CELL PH, V280, pC1224, DOI 10.1152/ajpcell.2001.280.5.C1224; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 2010, GASTROENTEROLOGY, V139, P1816, DOI 10.1053/j.gastro.2010.10.036; Sartor RB, 2012, AM J GASTROENTEROL S, V1, P15, DOI DOI 10.1038/AJGSUP.2012.4; Sartor RB, 2015, ANTIBIOTICS TREATMEN; Siddique I, 2009, SCAND J GASTROENTERO, V44, P56, DOI 10.1080/00365520802321253; Singh V, 2012, AM J PHYSIOL-GASTR L, V303, pG1393, DOI 10.1152/ajpgi.00345.2012; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Sullivan S, 2009, INFLAMM BOWEL DIS, V15, P261, DOI 10.1002/ibd.20743; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Teke HU, 2013, PLATELETS, V24, P625, DOI 10.3109/09537104.2012.748188; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van Lierop PPE, 2010, INFLAMM BOWEL DIS, V16, P442, DOI 10.1002/ibd.21073; Wlodarska M, 2015, CELL HOST MICROBE, V17, P577, DOI 10.1016/j.chom.2015.04.008; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang HX, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2829; Yeruva S, 2010, INFLAMM BOWEL DIS, V16, P1149, DOI 10.1002/ibd.21183; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016	57	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152044	10.1371/journal.pone.0152044	http://dx.doi.org/10.1371/journal.pone.0152044			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050757	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500022
J	Poonsuk, K; Gimenez-Lirola, LG; Zhang, JQ; Arruda, P; Chen, Q; Carrion, LCD; Magtoto, R; Pineyro, P; Sarmento, L; Wang, C; Sun, YX; Madson, D; Johnson, J; Yoon, KJ; Zimmerman, J; Main, R				Poonsuk, Korakrit; Gimenez-Lirola, Luis Gabriel; Zhang, Jianqiang; Arruda, Paolo; Chen, Qi; Carrion, Lucas Correa da Silva; Magtoto, Ronaldo; Pineyro, Pablo; Sarmento, Luciana; Wang, Chong; Sun, Yaxuan; Madson, Darin; Johnson, John; Yoon, Kyoung-Jin; Zimmerman, Jeffrey; Main, Rodger			Does Circulating Antibody Play a Role in the Protection of Piglets against Porcine Epidemic Diarrhea Virus?	PLOS ONE			English	Article							TRANSMISSIBLE GASTROENTERITIS VIRUS; B-CELL RESPONSES; MATERNAL ANTIBODIES; PASSIVE TRANSFER; HUMAN ROTAVIRUS; MONOCLONAL-ANTIBODIES; GNOTOBIOTIC PIGS; PRRSV INFECTION; CORONAVIRUS; COLOSTRUM	The contribution of circulating antibody to the protection of naive piglets against porcine epidemic diarrhea virus (PEDV) was evaluated using a passive antibody transfer model. Piglets (n = 62) derived from 6 sows were assigned to one of 6 different treatments using a randomized block design which provided for allocation of all treatments to all sows' litters. Each treatment was designed to achieve a different level of circulating anti-PEDV antibody via intraperitoneally administration of concentrated serum antibody. Piglets were orally inoculated with PEDV (USA/IN/2013/19338E, 1 x 10(3) TCID50 per piglet) 24 hours later and then monitored for 14 days. Piglets remained with their dam throughout the experiment. Sow milk samples, piglet fecal samples, and data on piglet clinical signs, body weight, and body temperature were collected daily. Fecal samples were tested by PEDV real-time reverse transcriptase PCR. Serum, colostrum, and milk were tested for PEDV IgG, IgA, and virus-neutralizing antibody. The data were evaluated for the effects of systemic PEDV antibody levels on growth, body temperature, fecal shedding, survival, and antibody response. The analysis showed that circulating antibody partially ameliorated the effect of PEDV infection. Specifically, antibody-positive groups returned to normal body temperature faster and demonstrated a higher rate of survivability than piglets without PEDV antibody. When combined with previous literature on PEDV, it can be concluded that both systemic antibodies and maternal secretory IgA in milk contribute to the protection of the neonatal pig against PEDV infections. Overall, the results of this experiment suggested that passively administered circulating antibodies contributed to the protection of neonatal piglets against PEDV infection.	[Poonsuk, Korakrit; Gimenez-Lirola, Luis Gabriel; Zhang, Jianqiang; Arruda, Paolo; Chen, Qi; Carrion, Lucas Correa da Silva; Magtoto, Ronaldo; Pineyro, Pablo; Sarmento, Luciana; Wang, Chong; Sun, Yaxuan; Madson, Darin; Johnson, John; Yoon, Kyoung-Jin; Zimmerman, Jeffrey; Main, Rodger] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA; [Wang, Chong; Sun, Yaxuan] Iowa State Univ, Dept Stat, Coll Liberal Arts & Sci, Ames, IA 50011 USA	Iowa State University; Iowa State University	Gimenez-Lirola, LG (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.	luisggl@iastate.edu	Zimmerman, Jeff/ABC-6361-2020	Zimmerman, Jeff/0000-0002-8107-2422; Wang, Chong/0000-0003-4489-4344	Checkoff Dollars	Checkoff Dollars	This study was fully funded by Checkoff Dollars administered through the National Pork Board, Des Moines, Iowa (USA). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai T, 2015, VET IMMUNOL IMMUNOP, V168, P193, DOI 10.1016/j.vetimm.2015.09.006; Bjustrom-Kraft J, 2016, BMC VET RES UNPUB; BOHL EH, 1972, INFECT IMMUN, V6, P289, DOI 10.1128/IAI.6.3.289-301.1972; BOHL EH, 1975, INFECT IMMUN, V11, P23, DOI 10.1128/IAI.11.1.23-32.1975; BOHL EH, 1972, J AM VET MED ASSOC, V160, P543; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Casadevall A, 2003, TRENDS IMMUNOL, V24, P474, DOI 10.1016/S1471-4906(03)00228-X; CHASEY D, 1978, RES VET SCI, V25, P255, DOI 10.1016/S0034-5288(18)32994-1; Chattha KS, 2015, ANNU REV ANIM BIOSCI, V3, P375, DOI 10.1146/annurev-animal-022114-111038; Chen Q, 2015, VIROLOGY, V482, P51, DOI 10.1016/j.virol.2015.03.024; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; COUSSEMENT W, 1982, VET PATHOL, V19, P46, DOI 10.1177/030098588201900108; DOYLE LP, 1946, J AM VET MED ASSOC, V108, P257; Doyle LP, 1958, DISEASES SWINE, P107; GREIG AS, 1962, CAN J COMP MED VET S, V26, P49; Grodzki AC, 2010, METHODS MOL BIOL, V588, P33, DOI 10.1007/978-1-59745-324-0_5; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Harlow E, 1988, ANTIBODIES LAB MANUA, P112; HEBERT GA, 1973, APPL MICROBIOL, V25, P26, DOI 10.1128/AEM.25.1.26-36.1973; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; Hoare CM, 1997, VACCINE, V15, P273, DOI 10.1016/S0264-410X(96)00184-3; Hodgins DC, 1999, J VIROL, V73, P186, DOI 10.1128/JVI.73.1.186-197.1999; HOFMANN M, 1988, J CLIN MICROBIOL, V26, P2235, DOI 10.1128/JCM.26.11.2235-2239.1988; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Jung K, 2014, EMERG INFECT DIS, V20, P662, DOI 10.3201/eid2004.131685; Kim O, 2002, CAN J VET RES, V66, P112; Kim SH, 2007, J VIROL METHODS, V146, P172, DOI 10.1016/j.jviromet.2007.06.021; Lopez OJ, 2007, CLIN VACCINE IMMUNOL, V14, P269, DOI 10.1128/CVI.00304-06; Madson DM, 2016, VET PATHOL, V53, P44, DOI 10.1177/0300985815591080; Madson DM, 2014, VET MICROBIOL, V174, P60, DOI 10.1016/j.vetmic.2014.09.002; MOON HW, 1971, P SOC EXP BIOL MED, V137, P151, DOI 10.3181/00379727-137-35533; Muradrasoli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013640; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nguyen TV, 2006, CLIN VACCINE IMMUNOL, V13, P475, DOI 10.1128/CVI.13.4.475-485.2006; Nguyen TV, 2006, VACCINE, V24, P2302, DOI 10.1016/j.vaccine.2005.11.043; Olanratmanee EO, 2010, ANIM REPROD SCI, V122, P42, DOI 10.1016/j.anireprosci.2010.07.004; Opriessnig T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104766; Paarlberg P.L., 2014, 144 PURD U DEP AGR E; Parreno V, 1999, J GEN VIROL, V80, P1417, DOI 10.1099/0022-1317-80-6-1417; PENSAERT M, 1986, VET QUART, V8, P257, DOI 10.1080/01652176.1986.9694050; Pensaert MB., 1999, DIS SWINE, V8, P179; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saif L. J., 2012, DIS SWINE, P501; Shibata I, 2000, VET MICROBIOL, V72, P173, DOI 10.1016/S0378-1135(99)00199-6; Shibata I, 2001, J VET MED SCI, V63, P655, DOI 10.1292/jvms.63.655; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; STEPANEK J, 1982, ACTA VET BRNO, V51, P99, DOI 10.2754/avb198251010099; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Thomas JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139266; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; WALSH EE, 1984, INFECT IMMUN, V43, P756, DOI 10.1128/IAI.43.2.756-758.1984; Wang LY, 2014, EMERG INFECT DIS, V20, P1594, DOI 10.3201/eid2009.140756; WERDIN RE, 1976, J AM VET MED ASSOC, V168, P240; Wesley R D, 1990, J Vet Diagn Invest, V2, P312; Yoon KJ, 1996, VIRAL IMMUNOL, V9, P51, DOI 10.1089/vim.1996.9.51; Yoshida M, 2006, SPRINGER SEMIN IMMUN, V28, P397, DOI 10.1007/s00281-006-0054-z; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	61	19	25	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153041	10.1371/journal.pone.0153041	http://dx.doi.org/10.1371/journal.pone.0153041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050556	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500088
J	Mirkovic, J; Gaskell, MG				Mirkovic, Jelena; Gaskell, M. Gareth			Does Sleep Improve Your Grammar? Preferential Consolidation of Arbitrary Components of New Linguistic Knowledge	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; COMPLEMENTARY LEARNING-SYSTEMS; MEMORY CONSOLIDATION; EPISODIC MEMORIES; TIME-COURSE; REPRESENTATION; HIPPOCAMPUS; ORGANIZATION; ACQUISITION; VOCABULARY	We examined the role of sleep-related memory consolidation processes in learning new form-meaning mappings. Specifically, we examined a Complementary Learning Systems account, which implies that sleep-related consolidation should be more beneficial for new hippocampally dependent arbitrary mappings (e.g. new vocabulary items) relative to new systematic mappings (e.g. grammatical regularities), which can be better encoded neocortically. The hypothesis was tested using a novel language with an artificial grammatical gender system. Stem-referent mappings implemented arbitrary aspects of the new language, and determiner/suffix+natural gender mappings implemented systematic aspects (e.g. tib scoiffesh + ballerina, tib mofeem + bride; ked jorool + cowboy, ked heefaff + priest). Importantly, the determiner-gender and the suffix-gender mappings varied in complexity and salience, thus providing a range of opportunities to detect beneficial effects of sleep for this type of mapping. Participants were trained on the new language using a word-picture matching task, and were tested after a 2-hour delay which included sleep or wakefulness. Participants in the sleep group outperformed participants in the wake group on tests assessing memory for the arbitrary aspects of the new mappings (individual vocabulary items), whereas we saw no evidence of a sleep benefit in any of the tests assessing memory for the systematic aspects of the new mappings: Participants in both groups extracted the salient determiner-natural gender mapping, but not the more complex suffix-natural gender mapping. The data support the predictions of the complementary systems account and highlight the importance of the arbitrariness/systematicity dimension in the consolidation process for declarative memories.	[Mirkovic, Jelena] York St John Univ, Fac Hlth & Life Sci, York YO31 7EX, N Yorkshire, England; [Mirkovic, Jelena; Gaskell, M. Gareth] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	York Saint John University; University of York - UK	Mirkovic, J (corresponding author), York St John Univ, Fac Hlth & Life Sci, York YO31 7EX, N Yorkshire, England.; Mirkovic, J; Gaskell, MG (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	jelena.mirkovic@york.ac.uk; gareth.gaskell@york.ac.uk	Gaskell, M. Gareth/B-4870-2008	Gaskell, M. Gareth/0000-0001-8325-1427	Economic and Social Research Council [ES/I032452/1]; ESRC [ES/I032452/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The research presented here was supported by the Economic and Social Research Council grant ES/I032452/1 awarded to MGG and JM. The funder had no involvement in any aspect of the research.	[Anonymous], 1987, MECH LANGUAGE ACQUIS, DOI DOI 10.4324/9781315798721; Batterink LJ, 2014, NEUROPSYCHOLOGIA, V65, P169, DOI 10.1016/j.neuropsychologia.2014.10.024; Bayley PJ, 2008, HIPPOCAMPUS, V18, P575, DOI 10.1002/hipo.20417; BERKO J, 1958, WORD, V14, P150, DOI 10.1080/00437956.1958.11659661; Breitenstein C, 2005, NEUROIMAGE, V25, P958, DOI 10.1016/j.neuroimage.2004.12.019; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; Cassidy KW, 2001, PSYCHON B REV, V8, P519; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Corbett G., 1991, GENDER; Coutanche MN, 2013, HIPPOCAMPUS, V23, P1189, DOI 10.1002/hipo.22157; Cumming G., 2012, UNDERSTANDING THE NE; Davis MH, 2009, PHILOS T R SOC B, V364, P3773, DOI 10.1098/rstb.2009.0111; DeKeyser RM, 2005, LANG LEARN, V55, P1, DOI 10.1111/j.0023-8333.2005.00294.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dikker S, 2010, PSYCHOL SCI, V21, P629, DOI 10.1177/0956797610367751; Dingemanse M, 2015, TRENDS COGN SCI, V19, P603, DOI 10.1016/j.tics.2015.07.013; Dobel C, 2010, J COGNITIVE NEUROSCI, V22, P1251, DOI 10.1162/jocn.2009.21297; Dumay N, 2007, PSYCHOL SCI, V18, P35, DOI 10.1111/j.1467-9280.2007.01845.x; Durrant SJ, 2013, CEREB CORTEX, V23, P2467, DOI 10.1093/cercor/bhs244; Durrant SJ, 2011, NEUROPSYCHOLOGIA, V49, P1322, DOI 10.1016/j.neuropsychologia.2011.02.015; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Ellis NC, 2006, APPL LINGUIST, V27, P164, DOI 10.1093/applin/aml015; Estes KG, 2007, PSYCHOL SCI, V18, P254, DOI 10.1111/j.1467-9280.2007.01885.x; Farmer TA, 2006, P NATL ACAD SCI USA, V103, P12203, DOI 10.1073/pnas.0602173103; Feldman LB, 2000, J EXP PSYCHOL LEARN, V26, P1431, DOI 10.1037/0278-7393.26.6.1431; Fernald A, 2006, HDB PSYCHOLINGUISTIC; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fitneva SA, 2009, J CHILD LANG, V36, P967, DOI 10.1017/S0305000908009252; Foerde K, 2013, J NEUROSCI, V33, P5698, DOI 10.1523/JNEUROSCI.5217-12.2013; Franck J, 2016, J MEM LANG, V87, P84, DOI 10.1016/j.jml.2015.11.003; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Friedrich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7004; Gomez RL, 2006, PSYCHOL SCI, V17, P670, DOI 10.1111/j.1467-9280.2006.01764.x; Gomez RL, 2015, CHILD DEV PERSPECT, V9, P183, DOI 10.1111/cdep.12130; Gomez RL, 2000, TRENDS COGN SCI, V4, P178, DOI 10.1016/S1364-6613(00)01467-4; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Gonnerman LM, 2007, J EXP PSYCHOL GEN, V136, P323, DOI 10.1037/0096-3445.136.2.323; Henderson LM, 2012, DEVELOPMENTAL SCI, V15, P674, DOI 10.1111/j.1467-7687.2012.01172.x; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Hupbach A, 2009, DEVELOPMENTAL SCI, V12, P1007, DOI 10.1111/j.1467-7687.2009.00837.x; Iber C, 2007, AASM MANUAL SCROING; KELLY MH, 1992, PSYCHOL REV, V99, P349, DOI 10.1037/0033-295X.99.2.349; Kielar A, 2010, J COGNITIVE NEUROSCI, V22, P1373, DOI 10.1162/jocn.2009.21353; Kielar A, 2008, J MEM LANG, V58, P327, DOI 10.1016/j.jml.2007.10.002; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Kumaran D, 2012, PSYCHOL REV, V119, P573, DOI 10.1037/a0028681; Lahl O, 2008, J SLEEP RES, V17, P3, DOI 10.1111/j.1365-2869.2008.00622.x; Lau H, 2010, NEUROBIOL LEARN MEM, V93, P554, DOI 10.1016/j.nlm.2010.02.003; Lau HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027139; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MARR D, 1970, PROC R SOC SER B-BIO, V176, P161, DOI 10.1098/rspb.1970.0040; MARSLENWILSON WD, 1987, COGNITION, V25, P71, DOI 10.1016/0010-0277(87)90005-9; McClelland JL, 2013, J EXP PSYCHOL GEN, V142, P1190, DOI 10.1037/a0033812; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Melinger A, 2003, LANG COGNITIVE PROC, V18, P335, DOI 10.1080/01690960244000072; Mirkovic J, 2005, LANG COGNITIVE PROC, V20, P139, DOI 10.1080/01690960444000205; Monaghan P, 2005, COGNITION, V96, P143, DOI 10.1016/j.cognition.2004.09.001; Monaghan P, 2007, COGNITIVE PSYCHOL, V55, P259, DOI 10.1016/j.cogpsych.2006.12.001; Monaghan P, 2011, J EXP PSYCHOL GEN, V140, P325, DOI 10.1037/a0022924; Nieuwenhuis ILC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065046; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Pallier C., 2002, COMPUTING DISCRIMINA; Pillon A, 1998, LANG COGNITIVE PROC, V13, P465, DOI 10.1080/016909698386465; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Pinker S., 1995, LANGUAGE INSTINCT NE; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Rastle K, 2008, LANG COGNITIVE PROC, V23, P942, DOI 10.1080/01690960802069730; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Schreiner T, 2015, CEREB CORTEX, V25, P4169, DOI 10.1093/cercor/bhu139; Seidenberg MS, 1997, SCIENCE, V275, P1599, DOI 10.1126/science.275.5306.1599; Seidenberg MS, 2000, TRENDS COGN SCI, V4, P353, DOI 10.1016/S1364-6613(00)01515-1; Smith L, 2008, COGNITION, V106, P1558, DOI 10.1016/j.cognition.2007.06.010; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Sweegers CCG, 2014, CORTEX, V59, P49, DOI 10.1016/j.cortex.2014.07.006; Tamminen J, 2015, COGNITIVE PSYCHOL, V79, P1, DOI 10.1016/j.cogpsych.2015.03.003; Tamminen J, 2012, COGNITION, V125, P107, DOI 10.1016/j.cognition.2012.06.014; Tamminen J, 2010, J NEUROSCI, V30, P14356, DOI 10.1523/JNEUROSCI.3028-10.2010; van den Bos E, 2012, J MEM LANG, V67, P507, DOI 10.1016/j.jml.2012.07.008; Vouloumanos A, 2009, DEV PSYCHOL, V45, P1611, DOI 10.1037/a0016134; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Werchan DM, 2014, CHILD DEV, V85, P429, DOI 10.1111/cdev.12149; Werchan DM, 2013, NEUROBIOL LEARN MEM, V100, P70, DOI 10.1016/j.nlm.2012.12.006; Williams SE, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00184; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yu C, 2007, PSYCHOL SCI, V18, P414, DOI 10.1111/j.1467-9280.2007.01915.x; Yu C, 2011, DEVELOPMENTAL SCI, V14, P165, DOI 10.1111/j.1467-7687.2010.00958.x; Zubin DA, 1981, 17 REG M CHIC LING S	99	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152489	10.1371/journal.pone.0152489	http://dx.doi.org/10.1371/journal.pone.0152489			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27046022	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000373599600021
J	Pereira, RC; Andersen, TL; Friedman, PA; Tumber, N; Salusky, IB; Wesseling-Perry, K				Pereira, Renata C.; Andersen, Thomas L.; Friedman, Peter A.; Tumber, Navdeep; Salusky, Isidro B.; Wesseling-Perry, Katherine			Bone Canopies in Pediatric Renal Osteodystrophy	PLOS ONE			English	Article							REMODELING COMPARTMENT CANOPIES; ADULT HUMAN BONE; PARATHYROID-HORMONE; REVERSAL-CELLS; HISTOMORPHOMETRY; RESORPTION; HYPERPARATHYROIDISM; OSTEOPOROSIS; OUTCOMES; DISEASE	Pediatric renal osteodystrophy (ROD) is characterized by changes in bone turnover, mineralization, and volume that are brought about by alterations in bone resorption and formation. The resorptive and formative surfaces on the cancellous bone are separated from the marrow cavity by canopies consisting of a layer of flat osteoblastic cells. These canopies have been suggested to play a key role in the recruitment of osteoprogenitors during the process of bone remodeling. This study was performed to address the characteristics of the canopies above bone formation and resorption sites and their association with biochemical and bone histomorphometric parameters in 106 pediatric chronic kidney disease (CKD) patients (stage 2-5) across the spectrum of ROD. Canopies in CKD patients often appeared as thickened multilayered canopies, similar to previous reports in patients with primary hyperparathyroidism. This finding contrasts with the thin appearance reported in healthy individuals with normal kidney function. Furthermore, canopies in pediatric CKD patients showed immunoreactivity to the PTH receptor (PTHR1) as well as to the receptor activator of nuclear factor kappa-B ligand (RANKL). The number of surfaces with visible canopy coverage was associated with plasma parathyroid hormone (PTH) levels, bone formation rate, and the extent of remodeling surfaces. Collectively, these data support the conclusion that canopies respond to the elevated PTH levels in CKD and that they possess the molecular machinery necessary to respond to PTH signaling.	[Pereira, Renata C.; Tumber, Navdeep; Salusky, Isidro B.; Wesseling-Perry, Katherine] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Andersen, Thomas L.] Univ Southern Denmark, Inst Reg Hlth Sci, Lillebaelt Hosp, Dept Clin Cell Biol KCB,Vejle Hosp, Vejle, Denmark; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern Denmark; Lillebaelt Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wesseling-Perry, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.	kwesseling@mednet.ucla.edu	Levin Andersen, Thomas/AAY-6777-2021	Levin Andersen, Thomas/0000-0002-6981-7276	US Public Health Service [DK-67563, DK-35423, DK-54171, DK-080984]; University of California's Clinical Translational Science Institute [UL1 TR-000124]; Children's Discovery and Innovation Institute; American Society of Nephrology Foundation's Norman Siegel Research Scholar Award; Casey Lee Ball Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054171, R01DK067563, K23DK080984, R01DK035423] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of California's Clinical Translational Science Institute; Children's Discovery and Innovation Institute; American Society of Nephrology Foundation's Norman Siegel Research Scholar Award; Casey Lee Ball Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by US Public Health Service grants DK-67563, DK-35423, DK-54171 (PAF), DK-080984 and University of California's Clinical Translational Science Institute grant UL1 TR-000124, funds from the Children's Discovery and Innovation Institute, from the American Society of Nephrology Foundation's Norman Siegel Research Scholar Award, and from the Casey Lee Ball Foundation.	Abdelgawad ME, 2016, HISTOCHEM CELL BIOL; Andersen TL, 2014, AM J PATHOL, V184, P1142, DOI 10.1016/j.ajpath.2013.12.005; Andersen TL, 2013, AM J PATHOL, V183, P235, DOI 10.1016/j.ajpath.2013.03.006; Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Aubin JE, 2000, OSTEOPOROSIS INT, V11, P905, DOI 10.1007/s001980070028; Bartosh SM, 2003, TRANSPLANTATION, V76, P1195, DOI 10.1097/01.TP.0000092524.75807.84; Bi L. X., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P43; Delaisse Jean-Marie, 2014, Bonekey Rep, V3, P561, DOI 10.1038/bonekey.2014.56; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dobnig H, 1997, ENDOCRINOLOGY, V138, P4607, DOI 10.1210/en.138.11.4607; Gomes SA, 2008, J BONE MINER METAB, V26, P110, DOI 10.1007/s00774-007-0788-2; Groothoff JW, 2003, KIDNEY INT, V63, P266, DOI 10.1046/j.1523-1755.2003.00727.x; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Hernandez JD, 2008, CLIN J AM SOC NEPHRO, V3, pS164, DOI 10.2215/CJN.00460107; Jensen PR, 2015, BONE, V73, P16, DOI 10.1016/j.bone.2014.12.004; Jensen PR, 2012, J BONE MINER RES, V27, P770, DOI 10.1002/jbmr.1490; Kidney Disease: Improving Global Outcomes, 2009, KIDNEY INT S, pS1, DOI DOI 10.1038/KI.2009.188; Kristensen HB, 2014, AM J PATHOL, V184, P778, DOI 10.1016/j.ajpath.2013.11.022; Lupp A, 2010, EUR J ENDOCRINOL, V162, P979, DOI 10.1530/EJE-09-0821; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; Uchiyama T, 1999, J BONE MINER METAB, V17, P283, DOI 10.1007/s007740050096; Wesseling-Perry K, 2011, KIDNEY INT, V79, P112, DOI 10.1038/ki.2010.352	24	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152871	10.1371/journal.pone.0152871	http://dx.doi.org/10.1371/journal.pone.0152871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045269	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000373599600042
J	Polyakov, P; Breban, R				Polyakov, Pavel; Breban, Romulus			Bayesian Monitoring of Emerging Infectious Diseases	PLOS ONE			English	Article							VACCINATION; MEASLES; VIRUS	We define data analyses to monitor a change in R, the average number of secondary cases caused by a typical infected individual. The input dataset consists of incident cases partitioned into outbreaks, each initiated from a single index case. We split the input dataset into two successive subsets, to evaluate two successive R values, according to the Bayesian paradigm. We used the Bayes factor between the model with two different R values and that with a single R value to justify that the change in R is statistically significant. We validated our approach using simulated data, generated using known R. In particular, we found that claiming two distinct R values may depend significantly on the number of outbreaks. We then reanalyzed data previously studied by Jansen et al. [Jansen et al. Science 301 (5634), 804], concerning the effective reproduction number for measles in the UK, during 1995-2002. Our analyses showed that the 1995-2002 dataset should be divided into two separate subsets for the periods 1995-1998 and 1999-2002. In contrast, Jansen et al. take this splitting point as input of their analysis. Our estimated effective reproduction numbers R are in good agreement with those found by Jansen et al. In conclusion, our methodology for detecting temporal changes in R using outbreak-size data worked satisfactorily with both simulated and real-world data. The methodology may be used for updating R in real time, as surveillance outbreak data become available.	[Polyakov, Pavel; Breban, Romulus] Inst Pasteur, Emerging Dis Epidemiol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Polyakov, P (corresponding author), Inst Pasteur, Emerging Dis Epidemiol, Paris, France.	pavel.polyakov@pasteur.fr		Breban, Romulus/0000-0002-5821-8139	Agence Nationale de la Recherche (Labex Integrative Biology of Emerging Infectious Diseases)	Agence Nationale de la Recherche (Labex Integrative Biology of Emerging Infectious Diseases)(French National Research Agency (ANR))	This work was funded by Agence Nationale de la Recherche (Labex Integrative Biology of Emerging Infectious Diseases) (https://research.pasteur.fr/en/program_project/integrative-biology-ofemerging-infectious-diseases/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof V.A.A. Jansen (Royal Holloway University of London) for the epidemiological data. We thank the reviewers for their helpful comments. P.P. is grateful for financing in the form of a postdoctoral scholarship from Agence Nationale de la Recherche (Labex Integrative Biology of Emerging Infectious Diseases).	Angelov AG, 2012, COMPUT MATH APPL, V64, P229, DOI 10.1016/j.camwa.2012.01.049; [Anonymous], 2005, BRANCHING PROCESSES; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Blumberg S, 2014, AM J EPIDEMIOL, V179, P1375, DOI 10.1093/aje/kwu068; Blumberg S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002993; Cotten M, 2014, MBIO, V5, DOI 10.1128/mBio.01062-13; Diekmann O., 2013, PRINCETON SERIES THE; Farrington CP, 2003, BIOSTATISTICS, V4, P621, DOI 10.1093/biostatistics/4.4.621; Farrington CP, 2003, BIOSTATISTICS, V4, P279, DOI 10.1093/biostatistics/4.2.279; FINE PEM, 1988, INT J EPIDEMIOL, V17, P643, DOI 10.1093/ije/17.3.643; HAIGHT FA, 1960, BIOMETRIKA, V47, P143, DOI 10.2307/2332966; Hamborsky J., 2015, EPIDEMIOLOGY PREVENT, P209; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Kaas RE, 1995, J AM STAT ASSOC, V90, P773; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; MacKay D. J. C., 2003, INFORM THEORY INFERE; Pitman J, 1998, DIMACS SER DISCRET M, V41, P163; Press W. H., 2007, NUMERICAL RECIPES AR, P487; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Robert H., 2004, INFECT DIS HUMANS, P27; World Health Organization (WHO), DIS INC PREV DIS; [No title captured]	23	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152629	10.1371/journal.pone.0152629	http://dx.doi.org/10.1371/journal.pone.0152629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045370	gold, Green Submitted, Green Published			2022-12-26	WOS:000373599600029
J	Chang, TP; Lin, YW; Sung, PY; Chuang, HY; Chung, HY; Liao, WL				Chang, Tzu-Pu; Lin, Yueh-Wen; Sung, Pi-Yu; Chuang, Hsun-Yang; Chung, Hsien-Yang; Liao, Wen-Ling			Benign Paroxysmal Positional Vertigo after Dental Procedures: A Population-Based Case-Control Study	PLOS ONE			English	Article							COMPLICATION; OSTEOTOME; MALLET	Background Benign paroxysmal positional vertigo (BPPV), the most common type of vertigo in the general population, is thought to be caused by dislodgement of otoliths from otolithic organs into the semicircular canals. In most cases, however, the cause behind the otolith dislodgement is unknown. Dental procedures, one of the most common medical treatments, are considered to be a possible cause of BPPV, although this has yet to be proven. This study is the first nationwide population-based case-control study conducted to investigate the correlation between BPPV and dental manipulation. Methods Patients diagnosed with BPPV between January 1, 2007 and December 31, 2012 were recruited from the National Health Insurance Research Database in Taiwan. We further identified those who had undergone dental procedures within 1 month and within 3 months before the first diagnosis date of BPPV. We also identified the comorbidities of the patients with BPPV, including head trauma, osteoporosis, migraine, hypertension, diabetes, hyperlipidemia and stroke. These variables were then compared to those in age-and gender-matched controls. Results In total, 768 patients with BPPV and 1536 age-and gender-matched controls were recruited. In the BPPV group, 9.2% of the patients had undergone dental procedures within 1 month before the diagnosis of BPPV. In contrast, only 5.5% of the controls had undergone dental treatment within 1 month before the date at which they were identified (P = 0.001). After adjustments for demographic factors and comorbidities, recent exposure to dental procedures was positively associated with BPPV (adjusted odds ratio 1.77; 95% confidence interval 1.27-2.47). This association was still significant if we expanded the time period from 1 month to 3 months (adjusted odds ratio 1.77; 95% confidence interval 1.39-2.26). Conclusions Our results demonstrated a correlation between dental procedures and BPPV. The specialists who treat patients with BPPV should consider dental procedures to be a risk factor, and dentists should recognize BPPV as a possible complication of dental treatment.	[Chang, Tzu-Pu] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Neurol, Neuromed Sci Ctr, Taichung, Taiwan; [Chang, Tzu-Pu] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lin, Yueh-Wen] Taipei Med Univ Hosp, Dept Dent, Taipei, Taiwan; [Sung, Pi-Yu; Liao, Wen-Ling] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Chuang, Hsun-Yang] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Res, Taichung, Taiwan; [Chung, Hsien-Yang] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Dent, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Taipei Medical University; Taipei Medical University Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital	Liao, WL (corresponding author), Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan.	wling00921@gmail.com		liao, wen-ling/0000-0001-7429-4126				Amir I, 2010, J LARYNGOL OTOL, V124, P796, DOI 10.1017/S0022215109992441; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chiarella G, 2007, Acta Otorhinolaryngol Ital, V27, P126; Chiarella G, 2008, EUR ARCH OTO-RHINO-L, V265, P119, DOI 10.1007/s00405-007-0397-7; Cohen HS, 2004, ORL J OTO-RHINO-LARY, V66, P11, DOI 10.1159/000077227; GORDON N, 1954, LANCET, V1, P1216; GYO K, 1988, LARYNGOSCOPE, V98, P332; Ishiyama A, 2000, ANN OTO RHINOL LARYN, V109, P377, DOI 10.1177/000348940010900407; Kansu L, 2015, J MAXILLOFAC ORAL SU, V14, pS113, DOI 10.1007/s12663-012-0356-8; NIGAM A, 1989, J LARYNGOL OTOL, V103, P203, DOI 10.1017/S0022215100108448; Penarrocha M, 2001, J ORAL MAXIL SURG, V59, P106, DOI 10.1053/joms.2001.19307; Penarrocha M, 2006, J ORAL MAXIL SURG, V64, P1324, DOI 10.1016/j.joms.2006.02.024; Saker M, 2005, J ORAL MAXIL SURG, V63, P1385, DOI 10.1016/j.joms.2005.05.296; Sammartino G, 2011, CLIN ORAL IMPLAN RES, V22, P669, DOI 10.1111/j.1600-0501.2010.01998.x; Vibert D, 2003, ANN OTO RHINOL LARYN, V112, P885, DOI 10.1177/000348940311201010; Vibert D, 2007, ANN OTO RHINOL LARYN, V116, P887, DOI 10.1177/000348940711601203; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420	18	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153092	10.1371/journal.pone.0153092	http://dx.doi.org/10.1371/journal.pone.0153092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044009	Green Submitted, Green Published, gold			2022-12-26	WOS:000373592100066
J	Engin, HB; Kreisberg, JF; Carter, H				Engin, H. Billur; Kreisberg, Jason F.; Carter, Hannah			Structure-Based Analysis Reveals Cancer Missense Mutations Target Protein Interaction Interfaces	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SOMATIC MUTATIONS; GENOME; STABILITY; COMPLEXES; DRIVER; REPAIR; GENES; SITES; HEAD	Recently it has been shown that cancer mutations selectively target protein-protein interactions. We hypothesized that mutations affecting distinct protein interactions involving established cancer genes could contribute to tumor heterogeneity, and that novel mechanistic insights might be gained into tumorigenesis by investigating protein interactions under positive selection in cancer. To identify protein interactions under positive selection in cancer, we mapped over 1.2 million nonsynonymous somatic cancer mutations onto 4,896 experimentally determined protein structures and analyzed their spatial distribution. In total, 20% of mutations on the surface of known cancer genes perturbed protein-protein interactions (PPIs), and this enrichment for PPI interfaces was observed for both tumor suppressors (Odds Ratio 1.28, P-value < 10(-4)) and oncogenes (Odds Ratio 1.17, P-value < 10(-3)). To study this further, we constructed a bipartite network representing structurally resolved PPIs from all available human complexes in the Protein Data Bank (2,864 proteins, 3,072 PPIs). Analysis of frequently mutated cancer genes within this network revealed that tumor-suppressors, but not oncogenes, are significantly enriched with functional mutations in homo-oligomerization regions (Odds Ratio 3.68, P-Value < 10(-8)). We present two important examples, TP53 and beta-2-microglobulin, for which the patterns of somatic mutations at interfaces provide insights into specifically perturbed biological circuits. In patients with TP53 mutations, patient survival correlated with the specific interactions that were perturbed. Moreover, we investigated mutations at the interface of protein-nucleotide interactions and observed an unexpected number of missense mutations but not silent mutations occurring within DNA and RNA binding sites. Finally, we provide a resource of 3,072 PPI interfaces ranked according to their mutation rates. Analysis of this list highlights 282 novel candidate cancer genes that encode proteins participating in interactions that are perturbed recurrently across tumors. In summary, mutation of specific protein interactions is an important contributor to tumor heterogeneity and may have important implications for clinical outcomes.	[Engin, H. Billur; Kreisberg, Jason F.; Carter, Hannah] Univ Calif San Diego, Dept Med, Div Med Genet, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Carter, H (corresponding author), Univ Calif San Diego, Dept Med, Div Med Genet, 9500 Gilman Dr, La Jolla, CA 92093 USA.	hkcarter@ucsd.edu	Carter, Hannah/R-8425-2017	Carter, Hannah/0000-0002-1729-2463; Kreisberg, Jason/0000-0002-3616-079X	National Institutes of Health [DP5 OD017937-01, P50 GM085764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health DP5 OD017937-01 to HC and P50 GM085764 to JFK.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Carter H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S3; Chen D, 2005, CELL DEATH DIFFER, V12, P358, DOI 10.1038/sj.cdd.4401536; Chen KX, 2007, CLIN CANCER RES, V13, P4300, DOI 10.1158/1078-0432.CCR-07-0469; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cox DR O, 1987, ANAL SURVIVAL DATA; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; del Campo AB, 2014, INT J CANCER, V134, P102, DOI 10.1002/ijc.28338; Engin HB, 2015, BIOCOMPUT-PAC SYM, P84; Engin HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081035; Espinosa O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084598; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hubbard S. J., 1993, NACCESS; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7161; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li SY, 2010, BIOCOMPUT-PAC SYM, P337; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; Meyer MJ, 2013, BIOINFORMATICS, V29, P1577, DOI 10.1093/bioinformatics/btt181; Miller ML, 2015, CELL SYST, V1, P197, DOI 10.1016/j.cels.2015.08.014; Mosca R, 2015, NAT METHODS, V12, P167, DOI 10.1038/nmeth.3289; Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]; Nishi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066273; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Porta-Pardo E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004518; Porta-Pardo E, 2014, BIOINFORMATICS, V30, P3109, DOI 10.1093/bioinformatics/btu499; RCore Team, 2020, R LANG ENV STAT COMP; Reimand J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.68; Robson S, 2006, RECENT PAT ANTI-CANC, V1, P305, DOI 10.2174/157489206778776934; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Seagle BL, 2015, GYNECOLOGIC ONCOLOGY; Shi Z, 2011, J MOL BIOL, V413, P495, DOI 10.1016/j.jmb.2011.06.046; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Vazquez M, 2015, BIOINFORMATICS; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Yang F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004147; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	57	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152929	10.1371/journal.pone.0152929	http://dx.doi.org/10.1371/journal.pone.0152929			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043210	Green Submitted, gold, Green Published			2022-12-26	WOS:000373592100049
J	Lee, EJ; Jan, AT; Baig, MH; Ashraf, JM; Nahm, SS; Kim, YW; Park, SY; Choi, I				Lee, Eun Ju; Jan, Arif Tasleem; Baig, Mohammad Hassan; Ashraf, Jalaluddin Mohammad; Nahm, Sang-Soep; Kim, Yong-Woon; Park, So-Young; Choi, Inho			Fibromodulin: a master regulator of myostatin controlling progression of satellite cells through a myogenic program	FASEB JOURNAL			English	Article						extracellular matrix; myostatin; myogenesis; ACRVIIB	GENE-EXPRESSION PROFILES; SKELETAL-MUSCLE ATROPHY; SELF-RENEWAL; STEM-CELL; TRANSCRIPTION FACTORS; DIFFERENTIATION; PROTEIN; TRANSDIFFERENTIATION; IDENTIFICATION; REGENERATION	Differentiation of muscle satellite cells (MSCs) involves interaction of the proteins present in the extracellular matrix (ECM) with MSCs to regulate their activity, and therefore phenotype. Herein, we report fibromodulin(FMOD), a member of the proteoglycan family participating in the assembly of ECM, as a novel regulator of myostatin (MSTN) during myoblast differentiation. In addition to having a pronounced effect on the expression of myogenic marker genes [myogenin (MYOG) and myosin light chain 2 (MYL2)], FMOD was found to maintain the transcriptional activity of MSTN. Moreover, coimmunoprecipitation and in silico studies performed to investigate the interaction of FMOD helped confirm that it antagonizes MSTN function by distorting its folding and preventing its binding to activin receptor type IIB. Furthermore, in vivo studies revealed that FMOD plays an active role in healing by increasing satellite cell recruitment to sites of injury. Together, these findings disclose a hitherto unrecognized regulatory role for FMOD in MSCs and highlight new mechanisms whereby FMOD circumvents the inhibitory effects of MSTN and triggers myoblast differentiation. These findings offer a basis for the design of novel MSTN inhibitors that promote muscle regeneration after injury or for the development of pharmaceutical agents for the treatment of different muscle atrophies.	[Lee, Eun Ju; Jan, Arif Tasleem; Baig, Mohammad Hassan; Ashraf, Jalaluddin Mohammad; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, South Korea; [Kim, Yong-Woon; Park, So-Young] Yeungnam Univ, Dept Physiol, Coll Med, Gyongsan, South Korea; [Nahm, Sang-Soep] Konkuk Univ, Coll Vet Med, Seoul, South Korea	Yeungnam University; Yeungnam University; Konkuk University	Choi, I (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, South Korea.	inhochoi@ynu.ac.kr	Ashraf, Jalauddin M/P-5391-2014; Jan, Arif Tasleem/AAX-6531-2020; Park, So-Young/AAC-5528-2022	Ashraf, Jalauddin M/0000-0001-7885-2551; Jan, Arif Tasleem/0000-0002-3607-543X; Park, So-Young/0000-0002-6018-0440; Baig, Mohd Hassan/0000-0001-8227-4838	National Research Foundation (NRF) of Korea - Ministry of Education [NRF-2013R1A1A2059308]; NRF - Republic of Korea (MSIP) [2014R1A2A2A01006324]	National Research Foundation (NRF) of Korea - Ministry of Education; NRF - Republic of Korea (MSIP)	This work was supported by the Basic Science Research Program, National Research Foundation (NRF) of Korea, which is funded by Ministry of Education Grant NRF-2013R1A1A2059308, along with the NRF funded by the Republic of Korea (MSIP; 2014R1A2A2A01006324). The authors declare no conflicts of interest.	Allen DL, 2008, COMP BIOCHEM PHYS B, V150, P432, DOI 10.1016/j.cbpb.2008.05.002; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Valdes JA, 2008, AM J PHYSIOL-CELL PH, V294, pC715, DOI 10.1152/ajpcell.00195.2007; Artaza JN, 2002, J CELL PHYSIOL, V190, P170, DOI 10.1002/JCP.10044; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Dominique JE, 2006, EXP CELL RES, V312, P2401, DOI 10.1016/j.yexcr.2006.04.012; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Grobet L, 2003, GENESIS, V35, P227, DOI 10.1002/gene.10188; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Kim DS, 2015, BIOCHEM BIOPH RES CO, V459, P534, DOI 10.1016/j.bbrc.2015.02.144; Kook SH, 2006, MOL CELLS, V22, P239; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092447; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079780; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063627; Lee EJ, 2012, GENOMICS, V100, P195, DOI 10.1016/j.ygeno.2012.06.005; Lee EJ, 2012, GENES GENOM, V34, P133, DOI 10.1007/s13258-011-0096-z; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; Mikaelsson E, 2005, BLOOD, V105, P4828, DOI 10.1182/blood-2004-10-3941; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Picard B, 1998, BASIC APPL MYOL, V8, P197; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Taylor WE, 2001, AM J PHYSIOL-ENDOC M, V280, pE221, DOI 10.1152/ajpendo.2001.280.2.E221; Valdes JA, 2013, J CELL PHYSIOL, V228, P1452, DOI 10.1002/jcp.24298; Velica P, 2011, MUSCLE NERVE, V44, P366, DOI 10.1002/mus.22056; Wagner KR, 2005, P NATL ACAD SCI USA, V102, P2519, DOI 10.1073/pnas.0408729102; Wang Q, 2012, J PHYSIOL-LONDON, V590, P2151, DOI 10.1113/jphysiol.2011.226001; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x; Zhu XY, 2004, CYTOKINE, V26, P262, DOI 10.1016/j.cyto.2004.03.007	44	48	50	5	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2708	2719		10.1096/fj.201500133R	http://dx.doi.org/10.1096/fj.201500133R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27069062				2022-12-26	WOS:000380994000008
J	Katuwal, GJ; Baum, SA; Cahill, ND; Michael, AM				Katuwal, Gajendra J.; Baum, Stefi A.; Cahill, Nathan D.; Michael, Andrew M.			Divide and Conquer: Sub-Grouping of ASD Improves ASD Detection Based on Brain Morphometry	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; SURFACE-BASED ANALYSIS; CLASSIFICATION; ABNORMALITIES; SEGMENTATION; DIAGNOSIS; CHILDREN; HETEROGENEITY; MRI	Low success (<60%) in autism spectrum disorder (ASD) classification using brain morphometry from the large multi-site ABIDE dataset and inconsistent findings on brain morphometric abnormalities in ASD can be attributed to the ASD heterogeneity. In this study, we show that ASD brain morphometry is highly heterogeneous, and demonstrate that the heterogeneity can be mitigated and classification improved if autism severity (AS), verbal IQ (VIQ) and age are used with morphometric features. Morphometric features from structural MRIs (sMRIs) of 734 males (ASD: 361, controls: 373) of ABIDE were derived using FreeSurfer. Applying the Random Forest classifier, an AUC of 0.61 was achieved. Adding VIQ and age to morphometric features, AUC improved to 0.68. Sub-grouping the subjects by AS, VIQ and age improved the classification with the highest AUC of 0.8 in the moderate-AS sub-group (AS = 7-8). Matching subjects on age and/or VIQ in each sub-group further improved the classification with the highest AUC of 0.92 in the low AS sub-group (AS = 4-5). AUC decreased with AS and VIQ, and was the lowest in the mid-age sub-group (1318 years). The important features were mainly from the frontal, temporal, ventricular, right hippocampal and left amygdala regions. However, they highly varied with AS, VIQ and age. The curvature and folding index features from frontal, temporal, lingual and insular regions were dominant in younger subjects suggesting their importance for early detection. When the experiments were repeated using the Gradient Boosting classifier similar results were obtained. Our findings suggest that identifying brain biomarkers in sub-groups of ASD can yield more robust and insightful results than searching across the whole spectrum. Further, it may allow identification of sub-group specific brain biomarkers that are optimized for early detection and monitoring, increasing the utility of sMRI as an important tool for early detection of ASD.	[Katuwal, Gajendra J.; Michael, Andrew M.] Geisinger Hlth Syst, Autism & Dev Med Inst, Danville, PA USA; [Katuwal, Gajendra J.; Baum, Stefi A.; Cahill, Nathan D.; Michael, Andrew M.] Rochester Inst Technol, Chester F Carlson Ctr Imaging Sci, Rochester, NY 14623 USA; [Cahill, Nathan D.] Rochester Inst Technol, Sch Math Sci, Rochester, NY 14623 USA; [Baum, Stefi A.] Univ Manitoba, Fac Sci, Winnipeg, MB, Canada	Geisinger Health System; Rochester Institute of Technology; Rochester Institute of Technology; University of Manitoba	Katuwal, GJ (corresponding author), Geisinger Hlth Syst, Autism & Dev Med Inst, Danville, PA USA.; Katuwal, GJ (corresponding author), Rochester Inst Technol, Chester F Carlson Ctr Imaging Sci, Rochester, NY 14623 USA.	gjk3423@rit.edu			Geisinger Health System Foundation; Autism and Developmental Medicine Institute at Geisinger Health System	Geisinger Health System Foundation; Autism and Developmental Medicine Institute at Geisinger Health System	This work was supported by Geisinger Health System Foundation.r The authors would like to thank the individual sites of the ABIDE consortium that collected brain scans and all research participants who participated in their studies. The authors would also like to thank the ABIDE consortium for their efforts in putting together this large valuable dataset and making it freely available. The preprocessing and analyses involved in this study was supported by Autism and Developmental Medicine Institute at Geisinger Health System. The authors have no conflict of interest to declare.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Auzias G, 2014, NEUROIMAGE-CLIN, V4, P593, DOI 10.1016/j.nicl.2014.03.008; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1996, MACH LEARN, V24, P41, DOI 10.1023/A:1018094028462; Calderoni S, 2012, NEUROIMAGE, V59, P1013, DOI 10.1016/j.neuroimage.2011.08.070; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chawla NV, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P853, DOI 10.1007/0-387-25465-X_40; Chen R, 2011, PEDIATR RES, V69, p63R, DOI 10.1203/PDR.0b013e318212c2b3; Close HA, 2012, PEDIATRICS, V129, pE305, DOI 10.1542/peds.2011-1717; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig MC, 2007, BRIT J PSYCHIAT, V191, P224, DOI 10.1192/bjp.bp.106.034603; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Martino A, 2014, Mol Psychiatry, V19, P659, DOI 10.1038/mp.2013.78; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Floris DL, 2013, J AUTISM DEV DISORD, V43, P1758, DOI 10.1007/s10803-012-1720-8; Fombonne E, 2005, J APPL RES INTELLECT, V18, P281, DOI 10.1111/j.1468-3148.2005.00266.x; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; GIEDD JN, 1995, PSYCHIAT RES-NEUROIM, V61, P113, DOI 10.1016/0925-4927(95)02593-M; Glenn OA, 2010, PEDIATR RADIOL, V40, P68, DOI 10.1007/s00247-009-1459-3; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Haar S, 2016, CEREB CORTEX, V26, P1440, DOI 10.1093/cercor/bhu242; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; Jiao Y, 2010, NEUROIMAGE, V50, P589, DOI 10.1016/j.neuroimage.2009.12.047; Katuwal GJ, 2015, IEEE ENG MED BIO, P4270, DOI 10.1109/EMBC.2015.7319338; Katuwal GJ, 2015, ORGANIZATION FOR HUM, DOI 10.13140/RG.2.1.3449.2249; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lenroot RK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00733; Lin HY, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0022-3; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; Nordahl CW, 2007, J NEUROSCI, V27, P11725, DOI 10.1523/JNEUROSCI.0777-07.2007; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Radua J, 2011, PSYCHOL MED, V41, P1539, DOI 10.1017/S0033291710002187; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Sabuncu MR, 2015, NEUROINFORMATICS, V13, P31, DOI 10.1007/s12021-014-9238-1; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sordo M, 2005, LECT NOTES COMPUT SC, V3745, P193, DOI 10.1007/11573067_20; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Takao H, 2011, J MAGN RESON IMAGING, V34, P438, DOI 10.1002/jmri.22636; Uddin LQ, 2011, BIOL PSYCHIAT, V70, P833, DOI 10.1016/j.biopsych.2011.07.014; Via E, 2011, ARCH GEN PSYCHIAT, V68, P409, DOI 10.1001/archgenpsychiatry.2011.27; Volkmar FR, 2009, J CHILD PSYCHOL PSYC, V50, P108, DOI 10.1111/j.1469-7610.2008.02010.x; Wee CY, 2014, HUM BRAIN MAPP, V35, P3414, DOI 10.1002/hbm.22411	57	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153331	10.1371/journal.pone.0153331	http://dx.doi.org/10.1371/journal.pone.0153331			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065101	Green Submitted, Green Published, gold			2022-12-26	WOS:000373891000047
J	Leckie, BM; D'Ambrosio, DA; Chappell, TM; Halitschke, R; De Jong, DM; Kessler, A; Kennedy, GG; Mutschler, MA				Leckie, Brian M.; D'Ambrosio, Damon A.; Chappell, Thomas M.; Halitschke, Rayko; De Jong, Darlene M.; Kessler, Andre; Kennedy, George G.; Mutschler, Martha A.			Differential and Synergistic Functionality of Acylsugars in Suppressing Oviposition by Insect Herbivores	PLOS ONE			English	Article							HEMIPTERA ALEYRODIDAE BIOTYPES; TOMATO LYCOPERSICON-PENNELLII; ESSENTIAL OIL COMPOUNDS; GREEN PEACH APHID; LEAF CURL VIRUS; GLANDULAR TRICHOMES; BEMISIA-TABACI; WILD TOMATO; SOLANUM-BERTHAULTII; SECONDARY METABOLITES	Acylsugars are secondary metabolites exuded from type IV glandular trichomes that provide broad-spectrum insect suppression for Solanum pennellii Correll, a wild relative of cultivated tomato. Acylsugars produced by different S. pennellii accessions vary by sugar moieties (glucose or sucrose) and fatty acid side chains (lengths and branching patterns). Our objective was to determine which acylsugar compositions more effectively suppressed oviposition of the whitefly Bemisia tabaci (Gennadius) (Middle East-Asia Minor 1 Group), tobacco thrips, Frankliniella fusca (Hinds), and western flower thrips, Frankliniella occidentalis (Pergande). We extracted and characterized acylsugars from four S. pennellii accessions with different compositions, as well as from an acylsugar-producing tomato breeding line. We also fractionated the acylsugars of one S. pennellii accession to examine the effects of its components. Effects of acylsugars on oviposition were evaluated by administering a range of doses to oviposition sites of adult whiteflies and thrips in non-choice and choice bioassays, respectively. The acylsugars from S. pennellii accessions and the tomato breeding line demonstrated differential functionality in their ability to alter the distribution of whitefly oviposition and suppress oviposition on acylsugar treated substrates. Tobacco thrips were sensitive to all compositions while western flower thrips and whiteflies were more sensitive to acylsugars from a subset of S. pennellii accessions. It follows that acylsugars could thus mediate plant-enemy interactions in such a way as to affect evolution of host specialization, resistance specificity, and potentially host differentiation or local adaptation. The acylsugars from S. pennellii LA1376 were separated by polarity into two fractions that differed sharply for their sugar moieties and fatty acid side chains. These fractions had different efficacies, with neither having activity approaching that of the original exudate. When these two fractions were recombined, the effect on both whiteflies and thrips exceeded the sum of the two fractions' effects, and was similar to that of the original exudate. These results suggest that increasing diversity of components within a mixture may increase suppression through synergistic interactions. This study demonstrates the potential for composition-specific deployment of acylsugars for herbivore oviposition suppression, either through in planta production by tomato lines, or as biocides applied by a foliar spray.	[Leckie, Brian M.; De Jong, Darlene M.; Mutschler, Martha A.] Cornell Univ, Sch Integrat Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY USA; [D'Ambrosio, Damon A.; Chappell, Thomas M.; Kennedy, George G.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Halitschke, Rayko; Kessler, Andre] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Leckie, Brian M.] Tennessee Technol Univ, Sch Agr, Cookeville, TN 38505 USA	Cornell University; University of North Carolina; North Carolina State University; Cornell University; Tennessee Technological University	Mutschler, MA (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY USA.	mam13@cornell.edu	Halitschke, Rayko/AAY-2365-2020	Halitschke, Rayko/0000-0002-1109-8782; Kessler, Andre/0000-0002-1797-7518; , Thomas/0000-0003-1399-5468	USDA National Institute of Food and Agriculture Special Research Grants Program - Pest Management Alternatives Research [2011-34381-30764]; Coordinated Agricultural Project [2012-68004-20166]; USDA National Institute of Food and Agriculture hatch funds [0223495, 1000793]	USDA National Institute of Food and Agriculture Special Research Grants Program - Pest Management Alternatives Research; Coordinated Agricultural Project; USDA National Institute of Food and Agriculture hatch funds	This work was supported by the USDA National Institute of Food and Agriculture Special Research Grants Program - Pest Management Alternatives Research grant 2011-34381-30764 received by GK, MAM and AK and Coordinated Agricultural Project grant 2012-68004-20166 received by GK and MAM. Additional support provided by USDA National Institute of Food and Agriculture hatch funds 0223495 and 1000793 were received by MAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the USDA National Institute of Food and Agriculture Special Research Grants Program-Pest Management Alternatives Research grant 2011-34381-30764 received by GK MAM and AK and Coordinated Agricultural Project grant 2012-68004-20166 received by GK and MAM. Additional support provided by USDA National Institute of Food and agriculture hatch funds 0223495 and 1000793 received by MAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENBAUM M, 1985, J CHEM ECOL, V11, P1349, DOI 10.1007/BF01012136; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Blanca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048198; Blauth SL, 1998, THEOR APPL GENET, V96, P458, DOI 10.1007/s001220050762; Blauth SL, 1999, THEOR APPL GENET, V99, P373, DOI 10.1007/s001220051247; BURKE BA, 1987, PHYTOCHEMISTRY, V26, P2567; Buta GJ, 1993, PHYTOCHEMISTRY, V32, P859; Chortyk OT, 1997, J AGR FOOD CHEM, V45, P270, DOI 10.1021/jf960322f; Cutler HG, 1986, NATURAL RESISTANCE P, P178; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dyer LA, 2003, J CHEM ECOL, V29, P2499, DOI 10.1023/A:1026310001958; Elle E, 1999, EVOLUTION, V53, P22, DOI 10.1111/j.1558-5646.1999.tb05330.x; Firdaus S, 2012, EUPHYTICA, V187, P31, DOI 10.1007/s10681-012-0704-2; Gardner RG, 2012, HORTSCIENCE, V47, P531, DOI 10.21273/HORTSCI.47.4.531; Garrido E, 2012, NEW PHYTOL, V193, P445, DOI 10.1111/j.1469-8137.2011.03923.x; GIBSON R W, 1976, Potato Research, V19, P179, DOI 10.1007/BF02360422; GIBSON RW, 1978, POTATO RES, V21, P217, DOI 10.1007/BF02356376; GOFFREDA JC, 1988, ENTOMOL EXP APPL, V48, P101, DOI 10.1007/BF00185621; GOFFREDA JC, 1989, THEOR APPL GENET, V78, P210, DOI 10.1007/BF00288801; Gould F., 1984, Bulletin of the Entomological Society of America, V30, P34; GOULD F, 1991, ANNU REV ENTOMOL, V36, P305, DOI 10.1146/annurev.en.36.010191.001513; Hare JD, 2003, EVOLUTION, V57, P793, DOI 10.1111/j.0014-3820.2003.tb00291.x; HAWTHORNE DJ, 1992, ENTOMOL EXP APPL, V65, P65, DOI 10.1007/BF00189718; HOLLEY JD, 1987, CAN J PLANT PATHOL, V9, P291, DOI 10.1080/07060668709501859; Huang Z, 2008, PAK J BOT, V40, P1983; Hummelbrunner LA, 2001, J AGR FOOD CHEM, V49, P715, DOI 10.1021/jf000749t; JUVIK JA, 1982, HORTSCIENCE, V17, P764; JUVIK JA, 1994, J ECON ENTOMOL, V87, P482, DOI 10.1093/jee/87.2.482; KENNEDY BS, 1992, J CHEM ECOL, V18, P1467, DOI 10.1007/BF00993221; Koul O, 2013, IND CROP PROD, V49, P428, DOI 10.1016/j.indcrop.2013.05.032; LANGE WH, 1981, ANNU REV ENTOMOL, V26, P345, DOI 10.1146/annurev.en.26.010181.002021; Leckie BM, 2014, MOL BREEDING, V34, P1201, DOI 10.1007/s11032-014-0110-7; Leckie BM, 2013, MOL BREEDING, V31, P957, DOI 10.1007/s11032-013-9849-5; Leckie BM, 2012, MOL BREEDING, V30, P1621, DOI 10.1007/s11032-012-9746-3; LIEDL BE, 1995, J ECON ENTOMOL, V88, P742, DOI 10.1093/jee/88.3.742; McKenzie CL, 2009, J ECON ENTOMOL, V102, P670, DOI 10.1603/029.102.0227; McKenzie CL, 2012, J ECON ENTOMOL, V105, P753, DOI 10.1603/EC11337; McKey D, 1979, HERBIVORES THEIR INT, P55; Mutschler MA, 2006, NATURAL RESISTANCE MECHANISMS OF PLANTS TO VIRUSES, P241, DOI 10.1007/1-4020-3780-5_11; Navas-Castillo J, 1999, PLANT DIS, V83, P29, DOI 10.1094/PDIS.1999.83.1.29; NEAL JJ, 1989, ENTOMOL EXP APPL, V51, P133, DOI 10.1007/BF00186730; NEAL JJ, 1990, J CHEM ECOL, V16, P487, DOI 10.1007/BF01021780; Pedersen DS, 2001, SYNTHESIS-STUTTGART, P2431, DOI 10.1055/s-2001-18722; Polston JE, 1999, PLANT DIS, V83, P984, DOI 10.1094/PDIS.1999.83.4.397A; Polston JE, 1997, PLANT DIS, V81, P1358, DOI 10.1094/PDIS.1997.81.12.1358; Puterka GJ, 2003, J ECON ENTOMOL, V96, P636, DOI 10.1603/0022-0493-96.3.636; RODRIGUEZ AE, 1993, J ECON ENTOMOL, V86, P34, DOI 10.1093/jee/86.1.34; Rosenthal JP, 1997, EVOL ECOL, V11, P337, DOI 10.1023/A:1018420504439; Schilmiller A, 2010, PLANT J, V62, P391, DOI 10.1111/j.1365-313X.2010.04154.x; Schuster David J., 1996, P153; Severson RF., 1985, RECENT ADV TOBACCO S, V11, P105; SHAPIRO JA, 1994, BIOCHEM SYST ECOL, V22, P545, DOI 10.1016/0305-1978(94)90067-1; Shatters RG, 2009, J ECON ENTOMOL, V102, P750, DOI 10.1603/029.102.0236; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; TRUMBLE JT, 1990, J ECON ENTOMOL, V83, P519, DOI 10.1093/jee/83.2.519; Whittaker M. S., 2004, Acta Phytopathologica et Entomologica Hungarica, V39, P115, DOI 10.1556/APhyt.39.2004.1-3.11; WINK M, 1988, THEOR APPL GENET, V75, P225, DOI 10.1007/BF00303957; Wink M., 2010, FUNCTIONS BIOTECHNOL; Zhao N, 2013, CRIT REV PLANT SCI, V32, P369, DOI 10.1080/07352689.2013.789648	60	47	48	6	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153345	10.1371/journal.pone.0153345	http://dx.doi.org/10.1371/journal.pone.0153345			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065236	Green Submitted, Green Published, gold			2022-12-26	WOS:000373891000048
J	Chen, GQ; Yang, FF; Wu, TF; Jiang, JF; Zhou, WD				Chen, Guiqian; Yang, Feifei; Wu, Taofen; Jiang, Junfang; Zhou, Weidong			The Stimulatory Effect of Cerebral Intraventricular Injection of cNPY on Precocial Feeding Behavior in Neonatal Chicks (Gallus domesticus)	PLOS ONE			English	Article							NEUROPEPTIDE-Y CONTENT; AMINO-ACID-SEQUENCE; FOOD-INTAKE; PARAVENTRICULAR NUCLEUS; ENERGY-BALANCE; NPY; RECEPTOR; LOCOMOTION; BRAIN; RATS	Neuropeptide Y (NPY) is one of the most potent stimulants of food intake in many animals. Most of the supporting evidence for the effects of NPY has been gathered in mammalian species using porcine NPY. To investigate the effects of NPY on precocial feeding initiation in chicks, we firstly used chicken NPY (cNPY) to study its role in food intake and spontaneous activities in 3-day-old male chicks. Food intake was monitored at different times after intracerebroventricular (ICV) injection of cNPY (2.5, 5.0 or 10.0 mu g/10 mu L) and anti-cNPY antibody (anti-cNPY) (1:9000, 1:3000 or 1:1000 in dilution). cNPY given at different doses significantly increased food intake at 30 min, 60 min, 90 min and 120 min after injection. Chicks treated with 5.0 mu g/10 mu L of cNPY showed a maximal 4.48 fold increase in food intake comparing to the control at 30 min. There is still more than 2 fold increase in food intake at 120 min after injection of cNPY. Food intake was significantly inhibited by a single ICV injection of anti-cNPY diluted to 1:9000 (60% inhibition), 1:3000 (92% inhibition), and 1:1000 (95% inhibition) at 30 min with 1:1000 being the maximally effective concentration. The inhibitory effects of anti-cNPY (diluted to 1:9000, 1:3000, 1:1000) at 120 min post ICV injection were 22%, 42% and 46%, respectively. But ICV of anti-cNPY (1: 3000 in dilution) did not block the orexigenic effect of 2.5 mu g/10 mu L of cNPY. ICV injection of different concentrations of cNPY increases locomotor activity in a dose-dependent manner while ICV antic-NPY greatly decreased the distance moved by each chick compared to control groups. Taken together, our results demonstrated that cNPY has a promoting effect on chick food intake and locomotor activity, and that endogenous cNPY might play a positive role in regulating precocial feeding behavior in newly hatched chicks.	[Chen, Guiqian; Yang, Feifei; Jiang, Junfang; Zhou, Weidong] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou 310021, Zhejiang, Peoples R China; [Chen, Guiqian] Jiaxing Univ, Sch Med, Jiaxing 314000, Zhejiang, Peoples R China; [Yang, Feifei] Lianyungang Biol Engn Specialty Secondary Sch, Lianyungang 222248, Jiangsu, Peoples R China; [Wu, Taofen] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Wu, Taofen] Zhejiang EBVAC Biotech Co Ltd, R&D Ctr, Hangzhou 310018, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences; Jiaxing University; Zhejiang University	Zhou, WD (corresponding author), Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou 310021, Zhejiang, Peoples R China.	zhouwd@mail.zaas.ac.cn			Natural Science Foundation [Y306220]; Jiaxing University [N70513009]	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiaxing University	This study was supported by the Grants of Natural Science Foundation (Y306220) and Jiaxing University (N70513009).	Bartness TJ, 2011, CELL METAB, V13, P493, DOI 10.1016/j.cmet.2011.04.006; BECK B, 1990, NEUROPEPTIDES, V17, P197, DOI 10.1016/0143-4179(90)90036-X; BLOMQVIST AG, 1992, P NATL ACAD SCI USA, V89, P2350, DOI 10.1073/pnas.89.6.2350; BRIEF DJ, 1992, PHYSIOL BEHAV, V51, P1105, DOI 10.1016/0031-9384(92)90294-C; DUBE MG, 1994, BRAIN RES, V646, P341, DOI 10.1016/0006-8993(94)90103-1; Erlanson-Albertsson C, 2005, ACTA PAEDIATR, V94, P40, DOI 10.1080/08035320510035249; FLOOD JF, 1991, PEPTIDES, V12, P1329, DOI 10.1016/0196-9781(91)90215-B; FRALEY GS, 1993, LIFE SCI, V52, P1649, DOI 10.1016/0024-3205(93)90047-7; Furuse M, 1997, BRAIN RES, V764, P289, DOI 10.1016/S0006-8993(97)00623-9; Ishii T, 2007, BRAIN RES, V1144, P91, DOI 10.1016/j.brainres.2007.01.086; Kanatani A, 2001, MOL PHARMACOL, V59, P501, DOI 10.1124/mol.59.3.501; King PJ, 1998, DRUG NEWS PERSPECT, V11, P402, DOI 10.1358/dnp.1998.11.7.659946; KUENZEL WJ, 1987, PEPTIDES, V8, P823, DOI 10.1016/0196-9781(87)90066-0; KUENZEL WJ, 1988, PHYSIOL BEHAV, V44, P669, DOI 10.1016/0031-9384(88)90334-4; Kuenzel WJ, 1999, J EXP ZOOL, V283, P348, DOI 10.1002/(SICI)1097-010X(19990301/01)283:4/5&lt;348::AID-JEZ5&gt;3.0.CO;2-5; Larhammar D, 1998, ANN NY ACAD SCI, V839, P35, DOI 10.1111/j.1749-6632.1998.tb10729.x; Larhammar D, 2004, NEUROPEPTIDES, V38, P141, DOI 10.1016/j.npep.2004.06.002; Larhammar D, 2001, PEPTIDES, V22, P295, DOI 10.1016/S0196-9781(01)00331-X; MCLAUGHLIN CL, 1991, PHYSIOL BEHAV, V49, P521, DOI 10.1016/0031-9384(91)90274-R; MINER JL, 1989, AM J PHYSIOL, V257, pR383, DOI 10.1152/ajpregu.1989.257.2.R383; MOGENSEN J, 1994, PHARMACOL BIOCHEM BE, V47, P427, DOI 10.1016/0091-3057(94)90139-2; MORLEY JE, 1987, AM J PHYSIOL, V253, pR516, DOI 10.1152/ajpregu.1987.253.3.R516; Morton GJ, 2001, INT J OBESITY, V25, pS56, DOI 10.1038/sj.ijo.0801915; Narnaware YK, 2000, AM J PHYSIOL-REG I, V279, pR1025, DOI 10.1152/ajpregu.2000.279.3.R1025; Parker SL, 2001, EUR J BIOCHEM, V268, P877, DOI 10.1046/j.1432-1327.2001.01966.x; PAU MYC, 1988, PHYSIOL BEHAV, V44, P797, DOI 10.1016/0031-9384(88)90065-0; Pratt WE, 2009, BEHAV NEUROSCI, V123, P1046, DOI 10.1037/a0016882; Russell AP, 2001, COMP BIOCHEM PHYS A, V131, P1; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; Sipols AJ, 1996, PHYSIOL BEHAV, V60, P717, DOI 10.1016/S0031-9384(96)00105-9; STANLEY BG, 1984, LIFE SCI, V35, P2635, DOI 10.1016/0024-3205(84)90032-8; STEINMAN JL, 1994, PHARMACOL BIOCHEM BE, V47, P207, DOI 10.1016/0091-3057(94)90001-9; STEINMAN JL, 1987, PEPTIDES, V8, P585, DOI 10.1016/0196-9781(87)90029-5; Strader AD, 2001, J NEUROENDOCRINOL, V13, P386, DOI 10.1046/j.1365-2826.2001.00642.x; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; Yokobori E, 2012, J NEUROENDOCRINOL, V24, P766, DOI 10.1111/j.1365-2826.2012.02281.x; YOUNGREN OM, 1978, J COMP NEUROL, V181, P567, DOI 10.1002/cne.901810307; Zhou WD, 2006, BRAIN RES, V1072, P26, DOI 10.1016/j.brainres.2005.11.029; Zhou WD, 2005, COMP BIOCHEM PHYS A, V141, P146, DOI 10.1016/j.cbpb.2005.04.015	39	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153342	10.1371/journal.pone.0153342	http://dx.doi.org/10.1371/journal.pone.0153342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055273	Green Submitted, gold, Green Published			2022-12-26	WOS:000373608000122
J	Giardini, ME; Zippo, AG; Valente, M; Krstajic, N; Biella, GEM				Giardini, Mario E.; Zippo, Antonio G.; Valente, Maurizio; Krstajic, Nikola; Biella, Gabriele E. M.			Electrophysiological and Anatomical Correlates of Spinal Cord Optical Coherence Tomography	PLOS ONE			English	Article							IMAGE-GUIDED NAVIGATION; DORSAL-HORN NEURONS; CT ANGIOGRAPHY; SURGERY; LOCALIZATION; RESPONSES; CELLS	Despite the continuous improvement in medical imaging technology, visualizing the spinal cord poses severe problems due to structural or incidental causes, such as small access space and motion artifacts. In addition, positional guidance on the spinal cord is not commonly available during surgery, with the exception of neuronavigation techniques based on static pre-surgical data and of radiation-based methods, such as fluoroscopy. A fast, bedside, intraoperative real-time imaging, particularly necessary during the positioning of endoscopic probes or tools, is an unsolved issue. The objective of our work, performed on experimental rats, is to demonstrate potential intraoperative spinal cord imaging and probe guidance by optical coherence tomography (OCT). Concurrently, we aimed to demonstrate that the electromagnetic OCT irradiation exerted no particular effect at the neuronal and synaptic levels. OCT is a user-friendly, low-cost and endoscopy-compatible photonics-based imaging technique. In particular, by using a Fourier-domain OCT imager, operating at 850 nm wavelength and scanning transversally with respect to the spinal cord, we have been able to: 1) accurately image tissue structures in an animal model (muscle, spine bone, cerebro-spinal fluid, dura mater and spinal cord), and 2) identify the position of a recording microelectrode approaching and inserting into the cord tissue 3) check that the infrared radiation has no actual effect on the electrophysiological activity of spinal neurons. The technique, potentially extendable to full three-dimensional image reconstruction, shows prospective further application not only in endoscopic intraoperative analyses and for probe insertion guidance, but also in emergency and adverse situations (e.g. after trauma) for damage recognition, diagnosis and fast image-guided intervention.	[Giardini, Mario E.] Univ Strathclyde, Dept Biomed Engn, Wolfson Ctr, 106 Rottenrow, Glasgow G4 0NW, Lanark, Scotland; [Zippo, Antonio G.; Valente, Maurizio; Biella, Gabriele E. M.] CNR, Inst Mol Bioimaging & Physiol, Via Fratelli Cervi 93, I-20090 Milan, Italy; [Krstajic, Nikola] Univ Edinburgh, Sch Engn, CMOS Sensors Grp, Integrated Micro & Nano Syst, Kings Bldg, Edinburgh EH9 3JL, Midlothian, Scotland	University of Strathclyde; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); University of Edinburgh	Biella, GEM (corresponding author), CNR, Inst Mol Bioimaging & Physiol, Via Fratelli Cervi 93, I-20090 Milan, Italy.	gabriele.biella@ibfm.cnr.it	Giardini, Mario/C-3552-2008; Zippo, Antonio G./O-7313-2017; Zippo, Antonio Giuliano/AAF-8781-2020	Giardini, Mario/0000-0003-4849-9683; Zippo, Antonio G./0000-0001-8421-7554; Zippo, Antonio Giuliano/0000-0001-8421-7554; Krstajic, Nikola/0000-0002-4165-8111	European Union [225464, 224014]	European Union(European Commission)	The authors acknowledge funding from the European Union Framework Programme 7 under grant agreements no. 225464 (ARAKNES-Array of Robots Augmenting the Kinematics of Endoluminal Surgery) and 224014 sub 2.16 (Photonics4Life-Fibre Optic Sensors as Guidance and Diagnostic Tools for Epiduroscopy). Part of the study was performed when MEG was employed at the University of St Andrews, UK, and significant sections of OCT software were written while NK was employed by the University of Sheffield. PON01_01297 and from the Ministero dell'Istruzione Universita'e Ricerca (MIUR).	Barker R, 2009, CHILD NERV SYST, V25, P955, DOI 10.1007/s00381-009-0904-9; Biella G, 1997, EUR J NEUROSCI, V9, P1017, DOI 10.1111/j.1460-9568.1997.tb01452.x; Boppart SA, 1998, RADIOLOGY, V208, P81, DOI 10.1148/radiology.208.1.9646796; Cadotte DW, 2012, BIOMED OPT EXPRESS, V3, P911, DOI 10.1364/BOE.3.000911; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen Y, 2009, J NEUROSCI METH, V178, P162, DOI 10.1016/j.jneumeth.2008.11.026; Habara M, 2012, CIRC-CARDIOVASC INTE, V5, P193, DOI 10.1161/CIRCINTERVENTIONS.111.965111; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Jaffe GJ, 2004, AM J OPHTHALMOL, V137, P156, DOI 10.1016/S0002-9394(03)00792-X; Jones MR, 2012, AM J NEURORADIOL, V33, P1494, DOI 10.3174/ajnr.A3016; Kim KH, 2007, OPT EXPRESS, V15, P18130, DOI 10.1364/OE.15.018130; Krstajic N, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.071305; Krstajic N, 2011, OPT COMMUN, V284, P3168, DOI 10.1016/j.optcom.2011.02.073; Kuo WC, 2015, ANESTHESIOLOGY, V122, P585, DOI 10.1097/ALN.0000000000000531; Leitch JK, 2010, MAGN RESON IMAGING, V28, P1225, DOI 10.1016/j.mri.2010.03.032; Liang CP, 2011, OPT EXPRESS, V19, P26283, DOI 10.1364/OE.19.026283; Gutierrez-Chico JL, 2012, EUR HEART J-CARD IMG, V13, P370, DOI 10.1093/ehjci/jes025; MENDELL LM, 1966, EXP NEUROL, V16, P316, DOI 10.1016/0014-4886(66)90068-9; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Nellensteijn J, 2010, EUR SPINE J, V19, P879, DOI 10.1007/s00586-009-1272-6; Ou P, 2007, AM J NEURORADIOL, V28, P216; PALECEK J, 1992, J NEUROPHYSIOL, V67, P1562, DOI 10.1152/jn.1992.67.6.1562; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Sammon PM, 2011, BRIT J NEUROSURG, V25, P778, DOI 10.3109/02688697.2011.584987; Sotgiu ML, 2004, SOMATOSENS MOT RES, V21, P211, DOI 10.1080/08990220400012539; Squire LR, 2012, FUNDAMENTAL NEUROSCI, P93; Stelter K, 2012, COMPUT AIDED SURG, V17, P153, DOI 10.3109/10929088.2012.668937; Stroman PW, 2008, MAGN RESON IMAGING, V26, P809, DOI 10.1016/j.mri.2008.01.038; Tjardes T, 2010, EUR SPINE J, V19, P25, DOI 10.1007/s00586-009-1091-9; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang XD, 2011, J CRANIOFAC SURG, V22, P1552, DOI 10.1097/SCS.0b013e31822e5d3d; Watanabe H, 2011, BIOMED OPT EXPRESS, V2, P3129, DOI 10.1364/BOE.2.003129; Weng HR, 2006, NEUROSCIENCE, V138, P1351, DOI 10.1016/j.neuroscience.2005.11.061; Wojtkowski M, 2010, APPL OPTICS, V49, pD30, DOI 10.1364/AO.49.000D30; Yaqoob Z, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2360525	35	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152539	10.1371/journal.pone.0152539	http://dx.doi.org/10.1371/journal.pone.0152539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050096	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000373603500047
J	Naha, D; Jhala, YV; Qureshi, Q; Roy, M; Sankar, K; Gopal, R				Naha, Dipanjan; Jhala, Yadvendradev V.; Qureshi, Qamar; Roy, Manjari; Sankar, Kalyansundaram; Gopal, Rajesh			Ranging, Activity and Habitat Use by Tigers in the Mangrove Forests of the Sundarban	PLOS ONE			English	Article							PANTHERA-TIGRIS-ALTAICA; RADIO-TRACKING DATA; HOME-RANGE; BANGLADESH SUNDARBANS; PREY ABUNDANCE; CONSERVATION; INDIA; MANAGEMENT; LANDSCAPE; DENSITIES	The Sundarban of India and Bangladesh (about 6000 km(2)) are the only mangrove forests inhabited by a sizeable population of tigers. The adjoining area also supports one of the highest human densities and experiences severe human-tiger conflicts. We used GPS-Satellite and VHF radio-collars on 6 (3 males and 3 female) tigers to study their ranging patterns and habitat preference. The average home range (95% Fixed Kernel) for resident females was 56.4 (SE 5.69) and for males it was 110 (SE 49) km(2). Tigers crossed an average of 5 water channels > 30 meters per day with a mean width of 54 meters, whereas channels larger than 400 meters were rarely crossed. Tigers spent over 58% of their time within Phoenix habitat but compositional analysis showed a habitat preference of the order Avicennia-Sonneratia > Phoenix > Ceriops > Barren > Water. Average daily distance moved was 4.6 km (range 0.1-23). Activity of tigers peaked between 05: 00 hours and 10: 00 hours showing some overlap with human activity. Territory boundaries were demarcated by large channels which tigers intensively patrolled. Extra caution should be taken while fishing or honey collection during early morning in Avicennia-Sonneratia and Phoenix habitat types along wide channels to reduce human-tiger conflict. Considering home-range core areas as exclusive, tiger density was estimated at 4.6 (SE range 3.6 to 6.7) tigers/100 km(2) giving a total population of 76 (SE range 59-110) tigers in the Indian Sundarban. Reluctance of tigers to cross wide water channels combined with increasing commercial boat traffic and sea level rise due to climate change pose a real threat of fragmenting the Sundarban tiger population.	[Naha, Dipanjan; Jhala, Yadvendradev V.; Roy, Manjari] Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, Uttarakhand, India; [Qureshi, Qamar] Wildlife Inst India, Dept Landscape Level Planning & Management, Dehra Dun, Uttarakhand, India; [Sankar, Kalyansundaram] Wildlife Inst India, Dept Habitat Ecol, Dehra Dun, Uttarakhand, India; [Gopal, Rajesh] Global Tiger Forum, New Delhi, India	Wildlife Institute of India; Wildlife Institute of India; Wildlife Institute of India	Jhala, YV (corresponding author), Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, Uttarakhand, India.	yvjhala@gmail.com	Jhala, Yadvendradev/AAL-9711-2020		National Tiger Conservation Authority	National Tiger Conservation Authority	This work was supported by projecttiger.nic.in/National Tiger Conservation Authority to YVJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; [Anonymous], 2011, DISTRICT POPULATION; Athreya V, 2014, TROP CONSERV SCI, V7, P75, DOI 10.1177/194008291400700111; Barlow A. C. D., 2009, THESIS U MINNESOTA S; Barlow ACD, 2008, BIOL CONSERV, V141, P2032, DOI 10.1016/j.biocon.2008.05.018; Barlow ACD, 2011, ORYX, V45, P125, DOI 10.1017/S0030605310001456; Barlow ACD, 2010, CONSERV BIOL, V24, P1338, DOI 10.1111/j.1523-1739.2010.01496.x; Bates D., PACKAGE LME4; Bera G. K., 2010, LAGOONS GANGETIC DEL; Blanford WT., 1891, FAUNA BIRT INDIA; Calenge C, 2009, ECOL INFORM, V4, P34, DOI 10.1016/j.ecoinf.2008.10.002; Chaknabarti K., 1984, Tigerpaper (Bangkok), V11, P29; Chakrabarti K., 1992, MAN EATING TIGERS; Champion S.H.G., 1968, REVISED SURVEY FORES; Chowdhury MK, 1985, ENV ECOL, V2, P243; Chundawat Raghunandan S., 1999, P123; Dey T, 2015, TIGER ABUNDANCE BANG; Dey TK, 2004, THESIS U DHAKA; Dinerstein E, 1997, FRAMEWORK WORK IDENT; Garga DP, 1947, J BOMBAY NATURAL HIS, V47, P545; Garton Edward O., 2001, P15, DOI 10.1016/B978-012497781-5/50003-7; Global Tiger Initiative Secretariat, 2012, GLOB TIG REV PROGR I; Goodrich JM, 2008, J ZOOL, V276, P323, DOI 10.1111/j.1469-7998.2008.00458.x; Goodrich JM, 2005, ORYX, V39, P454, DOI 10.1017/S0030605305001146; Goodrich JM, 2010, J MAMMAL, V91, P737, DOI 10.1644/09-MAMM-A-293.1; Gopal B, 2006, AQUAT SCI, V68, P338, DOI 10.1007/s00027-006-0868-8; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hazra S., 2002, SCI CULT-INDIA, V68, P309; HENDRICHS H, 1975, Saeugetierkundliche Mitteilungen, V23, P161; Hooge P. M., 2000, ANIMAL MOVEMENT EXTE, P2; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jhala Y. V., 2011, STATUS TIGERS COPRED; Jhala YV, 2014, NATL TIGER CONSERVAT; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 1998, ECOLOGY, V79, P2852; Karanth KU, 2000, J ZOOL, V250, P255; Kawanishi K, 2004, BIOL CONSERV, V120, P329, DOI 10.1016/j.biocon.2004.03.005; Kerley LL, 2003, J MAMMAL, V84, P288, DOI 10.1644/1545-1542(2003)084<0288:RPOWFA>2.0.CO;2; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Khan M.M.H., 2004, THESIS U CAMBRIDGE THESIS U CAMBRIDGE; Khan MMH, 2008, BNHS, V3, P105; Kotwal P.C., 1995, Tigerpaper (Bangkok), V22, P6; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Kreeger T.J., 1996, HDB WILDLIFE CHEM IM; Loucks C, 2010, CLIMATIC CHANGE, V98, P291, DOI 10.1007/s10584-009-9761-5; Meade J, 2005, P ROY SOC B-BIOL SCI, V272, P17, DOI 10.1098/rspb.2004.2873; Miller CS, 2014, BIOL CONSERV, V170, P120, DOI 10.1016/j.biocon.2013.12.012; Miquelle Dale G., 1999, P71; Miquelle Dale G., 2010, P325; Mohr CO, 1996, WILDL MANAG, V30, P293; Montgomery S., 2008, SPELL TIGER MAN EATE; Powell RA, 2000, METH C CONS, P65; Reza AHMA., 2000, THESIS JAHANGIRNAGAR; Reza AHMA, 2002, BANGLADESH J LIFE SC, V14, P75; Rhinos Simson BF., 1999, OXFORD ANTHOLOGY IND, P58; Rodgers A.R., 2011, HRT HOME RANGE TOOLS; Rodgers Arthur R., 2001, P79, DOI 10.1016/B978-012497781-5/50005-0; Roy M, 2015, POPUL ECOL IN PRESS; Schaller GB., 1967, DEER TIGER; SEIDENSTICKER J, 1976, BIOTROPICA, V8, P225, DOI 10.2307/2989714; Sen N., 2003, ALGAL FLORA SUNDARBA; Sharma R.N., 2010, J CURR PHARM RES, V1, P1; Sharma Rishi Kumar, 2011, Cat News, V54, P13; Simcharoen A, 2014, ORYX, V48, P370, DOI 10.1017/S0030605312001408; Smith J.L.D., 1987, P97; Smith JLD, 1998, CONSERV BIOL, V12, P1338, DOI 10.1046/j.1523-1739.1998.97068.x; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Smith JLD, 1998, ANIM BEHAV, V37, P1; Sunquist M. E., 1981, SOCIAL ORG TIGERS PA; Tak PC, RECORDS ZOOLOGICAL S; White G. C., 1990, ANAL WILDLIFE RADIO, P383, DOI 10.1016/B978-0-08-092657-5.50008-2; Withey J. C., 2001, RADIO TRACKING ANIMA, P45; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zar H.H., 2009, BIOSTATISTICAL ANAL	75	19	19	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152119	10.1371/journal.pone.0152119	http://dx.doi.org/10.1371/journal.pone.0152119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049644	gold, Green Published			2022-12-26	WOS:000373603500026
J	Ortea, I; Roschitzki, B; Lopez-Rodriguez, R; Tomero, EG; Ovalles, JG; Lopez-Longo, J; de la Torre, I; Gonzalez-Alvaro, I; Gomez-Reino, JJ; Gonzalez, A				Ortea, Ignacio; Roschitzki, Bernd; Lopez-Rodriguez, Rosario; Tomero, Eva G.; Ovalles, Juan G.; Lopez-Longo, Javier; de la Torre, Inmaculada; Gonzalez-Alvaro, Isidoro; Gomez-Reino, Juan J.; Gonzalez, Antonio			Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study	PLOS ONE			English	Article							FORGET PERSONALIZED MEDICINE; ANTI-TNF AGENTS; RITUXIMAB; TOCILIZUMAB; METAANALYSIS; ANTAGONISTS; PREDICTION; MONOTHERAPY; ASSOCIATION; ETANERCEPT	Response to treatment of rheumatoid arthritis shows large inter-individual variability. This heterogeneity is observed with all the anti-rheumatic drugs, including the commonly used TNF inhibitors. It seems that drug-specific and target-specific factors lead individual patients to respond or not to a given drug, although this point has been challenged. The search of biomarkers distinguishing responders from non-responders has included shotgun proteomics of serum, as a previous study of response to infliximab, an anti-TNF antibody. Here, we have used the same study design and technology to search biomarkers of response to a different anti-TNF antibody, adalimumab, and we have compared the results obtained for the two anti-TNF drugs. Search of biomarkers of response to adalimumab included depletion of the most abundant serum proteins, 8-plex isobaric tag for relative and absolute quantitation (iTRAQ) labeling, two-dimensional liquid chromatography fractionation and relative quantification with a hybrid Orbitrap mass spectrometer. With this approach, 264 proteins were identified in all the samples with at least 2 peptides and 95% confidence. Nine proteins showed differences between non-responders and responders (P < 0.05), representing putative biomarkers of response to adalimumab. These results were compared with the previous study of infliximab. Surprisingly, the non-responder/responder differences in the two studies were not correlated (rs = 0.07; P = 0.40). This overall independence with all the proteins showed two identifiable components. On one side, the putative biomarkers of response to either adalimumab or infliximab, which were not shared and showed an inverse correlation (rs = -0.69; P = 0.0023). On the other, eight proteins showing significant non-responder/ responder differences in the analysis combining data of response to the two drugs. These results identify new putative biomarkers of response to treatment of rheumatoid arthritis and indicate that they are notably drug-specific.	[Ortea, Ignacio; Lopez-Rodriguez, Rosario; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ de Santiago, Inst Invest Sanitaria, Lab Invest 10, Santiago De Compostela, Spain; [Ortea, Ignacio; Lopez-Rodriguez, Rosario; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ de Santiago, Inst Invest Sanitaria, Rheumatol Unit, Santiago De Compostela, Spain; [Roschitzki, Bernd] Univ Zurich, Funct Genom Ctr Zurich, CH-8006 Zurich, Switzerland; [Roschitzki, Bernd] Swiss Fed Inst Technol, Zurich, Switzerland; [Tomero, Eva G.; Gonzalez-Alvaro, Isidoro] Hosp Univ La Princesa, Inst Invest Sanitaria Princesa, Rheumatol Unit, Madrid, Spain; [Ovalles, Juan G.; Lopez-Longo, Javier; de la Torre, Inmaculada] Hosp Gen Univ Gregorio Maranon, Rheumatol Unit, Madrid, Spain; [Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain; [Ortea, Ignacio] Maimonides Hlth Res Inst IMIBIC, Cordoba, Spain	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; General University Gregorio Maranon Hospital; Universidade de Santiago de Compostela	Gonzalez, A (corresponding author), Hosp Clin Univ de Santiago, Inst Invest Sanitaria, Lab Invest 10, Santiago De Compostela, Spain.; Gonzalez, A (corresponding author), Hosp Clin Univ de Santiago, Inst Invest Sanitaria, Rheumatol Unit, Santiago De Compostela, Spain.	agmartinezp@ser.es	Lopez-Rodriguez, Rosario/M-3381-2014; López-Rodríguez, Rosario/AAB-2290-2022; Gonzalez, Antonio/C-4444-2008; Gomez-Reino, Juan/ABI-2853-2020	Lopez-Rodriguez, Rosario/0000-0002-4713-0633; López-Rodríguez, Rosario/0000-0002-4713-0633; Gonzalez, Antonio/0000-0002-2624-0606; Gomez-Reino, Juan/0000-0001-5229-6294; Ortea, Ignacio/0000-0001-8917-5525	Instituto de Salud Carlos III (Spain) [PI14/01651, PI11/01048, PI12/01909]; Instituto de Salud Carlos III (Spain) [RETICS Program (RIER)] [RD08/0075/0019, RD12/0009/0008]; European Regional Development Fund of the European Union; 7th Framework Program of the European Union [PRIME-XS project grant] [262067]	Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); Instituto de Salud Carlos III (Spain) [RETICS Program (RIER)]; European Regional Development Fund of the European Union; 7th Framework Program of the European Union [PRIME-XS project grant]	This work was supported by the Instituto de Salud Carlos III (Spain) [grants PI14/01651, PI11/01048, PI12/01909; and RETICS Program (RIER) grants RD08/0075/0019, RD12/0009/0008; which are partially financed by the European Regional Development Fund of the European Union]; and the 7th Framework Program of the European Union [PRIME-XS project grant agreement number 262067]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora T, 2009, CYTOKINE, V45, P124, DOI 10.1016/j.cyto.2008.11.008; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Berleth ES, 1999, CANCER RES, V59, P5497; Chatzidionysiou K, 2011, ANN RHEUM DIS, V70, P1575, DOI 10.1136/ard.2010.148759; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; Dennis G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4555; Du Pan SM, 2012, ANN RHEUM DIS, V71, P997, DOI 10.1136/annrheumdis-2011-200882; Elewaut D, 2009, RHEUMATOLOGY, V48, P1029, DOI 10.1093/rheumatology/kep146; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Evans C, 2012, ANAL BIOANAL CHEM, V404, P1011, DOI 10.1007/s00216-012-5918-6; Finckh A, 2010, ANN RHEUM DIS, V69, P387, DOI 10.1136/ard.2008.105064; Frazier-Mironer A, 2014, JOINT BONE SPINE, V81, P352, DOI 10.1016/j.jbspin.2014.02.014; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Gomez-Reino JJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1881; Gomez-Reino JJ, 2012, ANN RHEUM DIS, V71, P1861, DOI 10.1136/annrheumdis-2012-201324; Greenberg JD, 2012, ANN RHEUM DIS, V71, P1134, DOI 10.1136/annrheumdis-2011-150573; Hyrich KL, 2007, ARTHRITIS RHEUM-US, V56, P13, DOI 10.1002/art.22331; Isaacs JD, 2013, ANN RHEUM DIS, V72, P329, DOI 10.1136/annrheumdis-2011-201117; Isaacs JD, 2011, ANN RHEUM DIS, V70, P4, DOI 10.1136/ard.2010.135376; Karsdal MA, 2014, ARTHRIT CARE RES, V66, P1273, DOI 10.1002/acr.22289; Krintel SB, 2013, RHEUMATOLOGY, V52, P1245, DOI 10.1093/rheumatology/ket017; Maneiro RJ, 2013, SEMIN ARTHRITIS RHEU, V43, P9, DOI 10.1016/j.semarthrit.2012.11.007; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Montes A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0571-z; Montes A, 2014, PHARMACOGENET GENOM, V24, P238, DOI 10.1097/FPC.0000000000000042; Orme ME, 2012, BIOL-TARGETS THER, V6, P429, DOI 10.2147/BTT.S36707; Ortea I, 2012, J PROTEOMICS, V77, P372, DOI 10.1016/j.jprot.2012.09.011; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Maneiro JR, 2013, JAMA INTERN MED, V173, P1416, DOI 10.1001/jamainternmed.2013.7430; Raterman HG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3819; Rauniyar N, 2014, J PROTEOME RES, V13, P5293, DOI 10.1021/pr500880b; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Salgado E, 2014, JOINT BONE SPINE, V81, P41, DOI 10.1016/j.jbspin.2013.04.004; Sanayama Y, 2014, ARTHRITIS RHEUMATOL, V66, P1421, DOI 10.1002/art.38400; Schmitt J, 2014, BRIT J DERMATOL, V170, P274, DOI 10.1111/bjd.12663; Schmitz S, 2012, ANN RHEUM DIS, V71, P225, DOI 10.1136/annrheumdis-2011-200228; Sellam J, 2014, ARTHRITIS RHEUMATOL, V66, P2015, DOI 10.1002/art.38671; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Smolen JS, 2013, ANN RHEUM DIS, V72, P3, DOI 10.1136/annrheumdis-2012-202361; Soliman MM, 2012, ARTHRIT CARE RES, V64, P1108, DOI 10.1002/acr.21663; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Trocme C, 2009, ANN RHEUM DIS, V68, P1328, DOI 10.1136/ard.2008.093153; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; Wilke WS, 2013, ANN RHEUM DIS, V72, pE8, DOI 10.1136/annrheumdis-2013-203297	47	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153140	10.1371/journal.pone.0153140	http://dx.doi.org/10.1371/journal.pone.0153140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050469	Green Published, gold, Green Submitted			2022-12-26	WOS:000373603500104
J	Shi, XJ; Yu, Y; Luo, M; Zhang, ZR; Shi, SS; Feng, XL; Chen, ZL; He, J				Shi, Xuejiao; Yu, Yue; Luo, Mei; Zhang, Zhirong; Shi, Susheng; Feng, Xiaoli; Chen, Zhaoli; He, Jie			Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TET FAMILY PROTEINS; MAMMALIAN DNA; MUTATIONS; 5-METHYLCYTOSINE; CONVERSION; CANCERS; EXPRESSION	Ten-eleven translocation (TET) enzymes catalyze the oxidation of 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC), 5-formylcytosine and 5-carboxylcytosine, which result in genomic DNA demethylation. It was reported that 5-hmC levels were decreased in a variety of cancers and could be regarded as an epigenetic hallmark of cancer. In the present study, 5-hmC levels were detected by immunohistochemistry (IHC) in 173 esophageal squamous cell carcinoma (ESCC) tissues and 91 corresponding adjacent non-tumor tissues; DNA dot blot assays were used to detect the 5-hmC level in another 50 pairs of ESCC tissues and adjacent non-tumor tissues. In addition, the mRNA level of TET1, TET2 and TET3 in these 50 pairs of ESCC tissues was detected by real-time PCR. The IHC and DNA dot blot results showed that 5-hmC levels were significantly lower in ESCC tissues compared with corresponding adjacent non-tumor tissues (P = 0.029). TET2 and TET3 expression was also significantly decreased in tumor tissues compared with paired non-tumor tissues (TET2, P < 0.0001; TET3, P = 0.009), and the decrease in 5-hmC was significantly associated with the downregulation of TET2 expression (r = 0.405, P = 0.004). Moreover, the loss of 5-hmC in ESCC tissues was significantly associated with poor overall survival among patients with ESCC (P = 0.043); multivariate Cox regression analysis showed that the loss of 5-hmC in ESCC tissues was an independent unfavorable prognostic indicator for patients with ESCC (HR = 1.569, P = 0.029). In conclusion, 5-hmC levels were decreased in ESCC tissues, and the loss of 5-hmC in tumor tissues was an independent unfavorable prognostic factor for patients with ESCC.	[Shi, Xuejiao; Yu, Yue; Luo, Mei; Zhang, Zhirong; Chen, Zhaoli; He, Jie] Chinese Acad Med Sci, Canc Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China; [Shi, Susheng; Feng, Xiaoli] Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Chen, ZL; He, J (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China.	chenzhaoli@126.com; prof.hejie@263.net			National Natural Science Foundation of China [81172336, 81372219, 81301851, U1302223]; National Key Basic Research Development Plan973 Plan [2014CB542006]; Beijing Natural Science Foundation [7141011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Development Plan973 Plan(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National Natural Science Foundation of China (81172336, 81372219) and the National Key Basic Research Development Plan973 Plan (2014CB542006) (JH); National Natural Science Foundation of China (81301851 and U1302223) and Beijing Natural Science Foundation (7141011) (ZLC).	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cazzola M, 2010, HAEMATOL-HEMATOL J, V95, P1623, DOI 10.3324/haematol.2010.030015; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Frycz BA, 2014, BIOMED PHARMACOTHER, V68, P209, DOI 10.1016/j.biopha.2013.12.011; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Haffner MC, 2011, ONCOTARGET, V2, P627; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Konstandin N, 2011, LEUKEMIA, V25, P1649, DOI 10.1038/leu.2011.134; Kriukiene E, 2012, CHEM SOC REV, V41, P6916, DOI 10.1039/c2cs35104h; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Murata A, 2015, ONCOTARGET, V6, P23372, DOI 10.18632/oncotarget.4281; Neri F, 2015, ONCOGENE, V34, P4168, DOI 10.1038/onc.2014.356; Pronier E, 2011, BLOOD, V118, P2551, DOI 10.1182/blood-2010-12-324707; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67	24	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153100	10.1371/journal.pone.0153100	http://dx.doi.org/10.1371/journal.pone.0153100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050164	Green Submitted, gold, Green Published			2022-12-26	WOS:000373603500099
J	Zhou, Y; Shah, SZA; Yang, LF; Zhang, ZQ; Zhou, XM; Zhao, DM				Zhou, Yang; Shah, Syed Zahid Ali; Yang, Lifeng; Zhang, Zhongqiu; Zhou, Xiangmei; Zhao, Deming			Virulent Mycobacterium bovis Beijing Strain Activates the NLRP7 Inflammasome in THP-1 Macrophages	PLOS ONE			English	Article							AIM2 INFLAMMASOME; TUBERCULOSIS INFECTION; LISTERIA-MONOCYTOGENES; IL-1-BETA PRODUCTION; PROTEIN; SECRETION; HUMANS; RECOGNITION; LIPOPROTEIN; PYROPTOSIS	Mycobacterium bovis is the causative agent of tuberculosis in a wide range of mammals, including humans. Macrophages are the first line of host defense. They secrete proinflammatory cytokines, such as interleukin-1 beta (IL-1 beta), in response to mycobacterial infection, but the underlying mechanisms by which human macrophages are activated and release IL-1 beta following M. bovis infection are poorly understood. Here we show that the 'nucleotide binding and oligomerization of domain-like receptor (NLR) family pyrin domain containing 7 protein' (NLRP7) inflammasome is involved in IL-1 beta secretion and caspase-1 activation induced by M. bovis infection in THP-1 macrophages. NLRP7 inflammasome activation promotes the induction of pyroptosis as well as the expression of tumor necrosis factor alpha (TNF-alpha), Chemokine (C-C motif) ligand 3 (CCL3) and IL-1 beta mRNAs. Thus, the NLRP7 inflammasome contributes to IL-1 beta secretion and induction of pyroptosis in response to M. bovis infection in THP-1 macrophages.	[Zhou, Yang; Shah, Syed Zahid Ali; Yang, Lifeng; Zhou, Xiangmei; Zhao, Deming] China Agr Univ, Coll Vet Med, Natl Anim Transmissible Spongiform Encephalopathy, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing 100193, Peoples R China; [Zhou, Yang; Shah, Syed Zahid Ali; Yang, Lifeng; Zhou, Xiangmei; Zhao, Deming] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Zhang, Zhongqiu] Minist Agr Peoples Republ China, Vet Bur, Beijing 100125, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhou, XM; Zhao, DM (corresponding author), China Agr Univ, Coll Vet Med, Natl Anim Transmissible Spongiform Encephalopathy, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing 100193, Peoples R China.; Zhou, XM; Zhao, DM (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	zhouxm@cau.edu.cn; zhaodm@cau.edu.cn	Shah, Syed Zahid Ali/GQQ-7452-2022; Buchowski, Maciej S./A-2683-2008	Buchowski, Maciej S./0000-0002-0566-1743; Shah, Syed Zahid Ali/0000-0003-4705-229X; Shah, Syed Zahid Ali/0000-0002-9638-5800	MoSTRCUK international cooperation project [2013DFG32500]; National Natural Science Foundation of China [31572487]; Funding of State Key Lab of Agrobiotechnology [2012SKLAB06-14]; CAU Foreign Experts Major Projects [2012z018]; Foreign Experts Recruitment Program [GDW20151100036]; NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER	MoSTRCUK international cooperation project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding of State Key Lab of Agrobiotechnology; CAU Foreign Experts Major Projects; Foreign Experts Recruitment Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by MoSTRCUK international cooperation project (Project No. 2013DFG32500) http://www.istcp.org.cn, National Natural Science Foundation of China (Project No. 31572487) https://isisn.nsfc.gov.cn, Funding of State Key Lab of Agrobiotechnology (Project No. 2012SKLAB06-14) http://cbs.cau.edu.cn, 2015 CAU Foreign Experts Major Projects (Project No: 2012z018) http://cau.edu.cn, and High-end Foreign Experts Recruitment Program (Project No: GDW20151100036) http://cepms.safea.gov.cn.	Alfonso-Loeches S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00216; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Baker MG, 2006, EPIDEMIOL INFECT, V134, P1068, DOI 10.1017/S0950268806005930; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bigi F, 1997, MICROBIOL-SGM, V143, P3599, DOI 10.1099/00221287-143-11-3599; Bigi F, 2000, MICROBIOL-UK, V146, P1011, DOI 10.1099/00221287-146-4-1011; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036292; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Fend R, 2005, J CLIN MICROBIOL, V43, P1745, DOI 10.1128/JCM.43.4.1745-1751.2005; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Lee HM, 2013, GLIA, V61, P441, DOI 10.1002/glia.22448; Loria JRD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066818; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saiga H, 2012, INT IMMUNOL, V24, P637, DOI 10.1093/intimm/dxs062; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Segueni N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126058; Shah S, 2013, J IMMUNOL, V191, P3514, DOI 10.4049/jimmunol.1301331; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Wiker HG, 1998, INFECT IMMUN, V66, P1445, DOI 10.1128/IAI.66.4.1445-1452.1998; Yang Y, 2013, J INFECT DIS, V208, P1849, DOI 10.1093/infdis/jit347; Zhou Y, 2015, ANTON LEEUW INT J G, V108, P163, DOI 10.1007/s10482-015-0475-6	41	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152853	10.1371/journal.pone.0152853	http://dx.doi.org/10.1371/journal.pone.0152853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27583358	gold, Green Published, Green Submitted			2022-12-26	WOS:000373592100039
J	Zhou, YE; Buchowski, MS; Liu, JG; Schlundt, DG; Ukoli, FAM; Blot, WJ; Hargreaves, MK				Zhou, Yuan E.; Buchowski, Maciej S.; Liu, Jianguo; Schlundt, David G.; Ukoli, Flora A. M.; Blot, William J.; Hargreaves, Margaret K.			Plasma Lycopene Is Associated with Pizza and Pasta Consumption in Middle-Aged and Older African American and White Adults in the Southeastern USA in a Cross-Sectional Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; 3RD NATIONAL-HEALTH; ALPHA-TOCOPHEROL; DIETARY PATTERNS; UNITED-STATES; RACIAL-DIFFERENCES; NUTRIENT INTAKE; ENERGY-INTAKE; CANCER-RISK; NHANES-III	Background The role of dietary lycopene in chronic disease prevention is not well known. Methods This study examined intake of lycopene and other antioxidants from lycopene-rich foods (e.g., pizza and pasta) simultaneously with plasma levels of lycopene and other antioxidants in a representative cross-sectional sample (187 Blacks, 182 Whites, 40-79 years old) from the Southern Community Cohort Study (SCCS). The SCCS is an ongoing study conducted in populations at high risk for chronic diseases living in Southeastern United States. Dietary intake was assessed using a validated food frequency questionnaire (FFQ), and plasma levels of lycopene and other antioxidants were measured at baseline (2002-2005). The participants were classified into tertiles according to consumption of pizza and pasta food groups. Results Lycopene dietary intake and plasma lycopene concentrations were significantly higher in the highest (tertile 3) compared to tertiles 1 and 2 (both P < 0.01). Total energy intake ranged from 1964.3 +/- 117.1 kcal/day (tertile 1) to 3277.7 +/- 115.8 kcal/day (tertile 3) (P<0.0001). After adjusting for age and energy intake, total dietary fat, saturated fatty acids, trans-fatty acids, and sodium intakes were significantly higher in tertile 3 than tertiles 2 and 1 (all P < 0.01). Vitamin C intake was significantly lower in tertile 3 than tertiles 1 and 2 (P = 0.003). Except for gamma-tocopherol being higher in tertile 3 than tertiles 1 and 2 (P = 0.015), the plasma concentrations of antioxidants were lower in tertile 3 than tertiles 1 and 2 ( beta-carotene, alpha-carotene, lutein and zeaxanthin, all P<0.05). Conclusions In the SCCS population, pizza and pasta were the main sources of dietary lycopene and their intake was associated with plasma lycopene concentration. Diets with frequent pizza and pasta consumption were high in energy, saturated fatty acids, trans-fatty acids, sodium and low in other antioxidants. Future studies of lycopene as a protective dietary factor against chronic disease should consider the overall nutritional quality of lycopene-containing foods.	[Zhou, Yuan E.; Liu, Jianguo; Hargreaves, Margaret K.] Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA; [Buchowski, Maciej S.; Blot, William J.] Vanderbilt Univ, Dept Med, Nashville, TN 37212 USA; [Schlundt, David G.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Ukoli, Flora A. M.] Meharry Med Coll, Dept Surg, Nashville, TN 37208 USA	Meharry Medical College; Vanderbilt University; Vanderbilt University; Meharry Medical College	Zhou, YE (corresponding author), Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA.	yzhou@mmc.edu	Shah, Syed Zahid Ali/GQQ-7452-2022; Buchowski, Maciej S./A-2683-2008	Buchowski, Maciej S./0000-0002-0566-1743; Shah, Syed Zahid Ali/0000-0003-4705-229X; Shah, Syed Zahid Ali/0000-0002-9638-5800	NCI grant from the National Cancer Institute [R01 CA092447]; CTSA grant from the National Center for Advancing Translational Sciences [202815-502001-20]; CNPC grant from the National Cancer Institute [3 U54 CA1 S3708-03]; NIDDK grant from the National Institute of Diabetes and Digestive and Kidney Diseases [1 P30 DK092986]; Vanderbilt-Ingram Cancer Center (US) [P30CA068485]; NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER	NCI grant from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CTSA grant from the National Center for Advancing Translational Sciences; CNPC grant from the National Cancer Institute; NIDDK grant from the National Institute of Diabetes and Digestive and Kidney Diseases; Vanderbilt-Ingram Cancer Center (US); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NCI grant R01 CA092447 from the National Cancer Institute, CTSA grant 202815-502001-20 from the National Center for Advancing Translational Sciences, CNPC grant 3 U54 CA1 S3708-03 from the National Cancer Institute, NIDDK grant 1 P30 DK092986 from the National Institute of Diabetes and Digestive and Kidney Diseases, and Vanderbilt-Ingram Cancer Center (US) P30CA068485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron KJ, 2011, AM J CLIN NUTR, V94, P1071, DOI 10.3945/ajcn.111.013094; Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007; Bovell-Benjamin A, 2010, J HEALTH CARE POOR U, V21, P57, DOI 10.1353/hpu.0.0361; Buchowski MS, 2003, CELL MOL BIOL, V49, P1295; Clinton SK, 1996, CANCER EPIDEM BIOMAR, V5, P823; COATES RJ, 1991, AM J EPIDEMIOL, V134, P658, DOI 10.1093/oxfordjournals.aje.a116138; Cook A, 2000, J EPIDEMIOL COMMUN H, V54, P611, DOI 10.1136/jech.54.8.611; CRAFT NE, 1988, CLIN CHEM, V34, P44; Cullen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032930; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Dulloo AG, 2012, OBES REV, V13, P1, DOI 10.1111/j.1467-789X.2012.01032.x; Epplein M, 2009, CANCER EPIDEM BIOMAR, V18, P1962, DOI 10.1158/1055-9965.EPI-09-0003; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; FRANKE AA, 1993, J CHROMATOGR-BIOMED, V614, P43, DOI 10.1016/0378-4347(93)80222-P; Garcia AL, 2008, BRIT J NUTR, V99, P1293, DOI 10.1017/S0007114507868486; Gerster H, 1997, J AM COLL NUTR, V16, P109; Grainger EM, 2015, BRIT J NUTR, V114, P596, DOI 10.1017/S0007114515002202; Gross M, 2003, AM J CLIN NUTR, V77, P458, DOI 10.1093/ajcn/77.2.458; GROSS MD, 1995, CLIN CHEM, V41, P943; Gutierrez OM, 2014, AM J KIDNEY DIS, V64, P204, DOI 10.1053/j.ajkd.2014.02.013; Hajjar I, 2003, J NUTR, V133, P211, DOI 10.1093/jn/133.1.211; Hall WD, 1997, AM J MED SCI, V313, P195, DOI 10.1097/00000441-199704000-00002; Hargreaves MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084972; HORNE DW, 1988, CLIN CHEM, V34, P2357; Institute of Medicine, 2004, DIET REF INT WAT POT; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Judd SE, 2013, STROKE, V44, P3305, DOI 10.1161/STROKEAHA.113.002636; Kachan D, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140023; Kiage JN, 2014, AM J CLIN NUTR, V99, P1071, DOI 10.3945/ajcn.113.075713; Locher JL, 2004, ALABAMA HERITAGE, V74, P6; Mackinnon ES, 2011, J NUTR HEALTH AGING, V15, P133, DOI 10.1007/s12603-011-0026-4; Mayne ST, 2003, J NUTR, V133, p933S, DOI 10.1093/jn/133.3.933S; Mayne ST, 1999, J NUTR, V129, P849, DOI 10.1093/jn/129.4.849; MENEELY GR, 1976, AM J CARDIOL, V38, P768, DOI 10.1016/0002-9149(76)90356-8; Obisesan TO, 2000, STROKE, V31, P19, DOI 10.1161/01.STR.31.1.19; Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Rao AV, 2006, ADV FOOD NUTR RES, V51, P99, DOI 10.1016/S1043-4526(06)51002-2; Re R, 2003, EUR J CLIN NUTR, V57, P1545, DOI 10.1038/sj.ejcn.1601723; Riccioni G, 2008, EUR REV MED PHARMACO, V12, P183; Schwab U, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.25145; Shah M, 2010, J NUTR EDUC BEHAV, V42, P99, DOI 10.1016/j.jneb.2009.02.001; Shi J, 2000, CRIT REV FOOD SCI, V40, P1, DOI 10.1080/10408690091189275; Siega-Riz A M, 2001, J Am Med Womens Assoc (1972), V56, P44; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Signorello LB, 2010, AM J EPIDEMIOL, V171, P488, DOI 10.1093/aje/kwp402; Signorello LB, 2009, AM J EPIDEMIOL, V170, P104, DOI 10.1093/aje/kwp098; Soory Mena, 2012, Infectious Disorders - Drug Targets, V12, P388; Stimpson JP, 2007, J AM DIET ASSOC, V107, P1895, DOI 10.1016/j.jada.2007.08.016; Stimpson JP, 2007, J AM DIET ASSOC, V107, P1218, DOI 10.1016/j.jada.2007.04.008; Talegawkar SA, 2007, J NUTR, V137, P2297, DOI 10.1093/jn/137.10.2297; Testa R, 2014, CURR OPIN CLIN NUTR, V17, P338, DOI 10.1097/MCO.0000000000000066; TONUCCI LH, 1995, J AGR FOOD CHEM, V43, P579, DOI 10.1021/jf00051a005; United States Department of Agriculture (USDA) National Agricultural Library, 2016, USDA NUTR DAT LISTS; Voeks JH, 2008, STROKE, V39, P1675, DOI 10.1161/STROKEAHA.107.507053; Wei MY, 2012, J ONCOL, V2012, DOI 10.1155/2012/271063; Whelton PK, 2014, CURR OPIN LIPIDOL, V25, P75, DOI 10.1097/MOL.0000000000000033; Williams CD, 2009, CANCER EPIDEM BIOMAR, V18, P1552, DOI 10.1158/1055-9965.EPI-08-1146	59	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161918	10.1371/journal.pone.0161918	http://dx.doi.org/10.1371/journal.pone.0161918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583358	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600074
